| CodeList |
| CodeListItem |
| NCI attributes |
| OID | Name (CDISC Submission Value) | DataType Extensible | NCI Code | CDISC Synonym | CDISC Definition | Preferred Term |
|---|---|---|---|---|---|---|
| CDISC Submission Value [ODM:CodedValue] | ||||||
| CL.C66767.ACN | Action Taken with Study Treatment (ACN) | text Extensible: No | C66767 | Action Taken with Study Treatment | Terminology specifying changes to the study treatment as a result of an adverse event. | CDISC SDTM Action Taken with Study Treatment Terminology |
| DOSE INCREASED | C49503 | An indication that a medication schedule was modified by addition; either by changing the frequency, strength or amount. (NCI) | Dose Increased | |||
| DOSE NOT CHANGED | C49504 | An indication that a medication schedule was maintained. (NCI) | Dose Not Changed | |||
| DOSE REDUCED | C49505 | An indication that a medication schedule was modified by subtraction, either by changing the frequency, strength or amount. (NCI) | Dose Reduced | |||
| DRUG INTERRUPTED | C49501 | An indication that a medication schedule was modified by temporarily terminating a prescribed regimen of medication. (NCI) | Drug Interrupted | |||
| DRUG WITHDRAWN | C49502 | An indication that a medication schedule was modified through termination of a prescribed regimen of medication. (NCI) | Drug Withdrawn | |||
| NOT APPLICABLE | C48660 | NA;Not Applicable | Determination of a value is not relevant in the current context. (NCI) | Not Applicable | ||
| UNKNOWN | C17998 | U;Unknown | Not known, not observed, not recorded, or refused. (NCI) | Unknown | ||
| Back to top | ||||||
| CL.C101865.ACSPCAT | Acute Coronary Syndrome Presentation Category (ACSPCAT) | text Extensible: No | C101865 | Acute Coronary Syndrome Presentation Category | A classification of the presentation of acute coronary syndrome. | CDISC SDTM Acute Coronary Syndrome Presentation Category Terminology |
| NON-ST ELEVATION MYOCARDIAL INFARCTION | C80383 | NON-STEMI;NSTEMI | A myocardial infarction that does not produce elevation in the ST segments of the ECG. | Non-ST Elevation Myocardial Infarction by ECG Finding | ||
| OTHER | C17649 | Other | Different than the one(s) previously specified or mentioned. (NCI) | Other | ||
| ST ELEVATION MYOCARDIAL INFARCTION | C101888 | STEMI | A myocardial infarction that produces elevation in the ST segments of the ECG. | ST Elevation Myocardial Infarction by ECG Finding | ||
| STABLE ANGINA | C66914 | Angina pectoris which has not recently changed in frequency, duration or intensity. Stable angina pectoris is relieved by rest or administration of oral, sublingual or transdermal antianginal medications. | Stable Angina | |||
| UNSTABLE ANGINA | C66911 | Angina pectoris (or equivalent type of ischemic discomfort) which has recently changed in frequency, duration, intensity, or occurs at rest. | Unstable Angina | |||
| Back to top | ||||||
| CL.C66781.AGEU | Age Unit (AGEU) | text Extensible: No | C66781 | Age Unit | Those units of time that are routinely used to express the age of a subject. | CDISC SDTM Age Unit Terminology |
| DAYS | C25301 | Day | The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours. This also refers to a specific day. (NCI) | Day | ||
| HOURS | C25529 | Hour;hr | A unit measure of time equal to 3,600 seconds or 60 minutes. It is approximately 1/24 of a median day. (NCI) | Hour | ||
| MONTHS | C29846 | Month | One of the 12 divisions of a year as determined by a calendar. It corresponds to the unit of time of approximately to one cycle of the moon's phases, about 30 days or 4 weeks. (NCI) | Month | ||
| WEEKS | C29844 | Week | Any period of seven consecutive days. (NCI) | Week | ||
| YEARS | C29848 | Year | The period of time that it takes for Earth to make a complete revolution around the sun, approximately 365 days; a specific one year period. (NCI) | Year | ||
| Back to top | ||||||
| CL.C74456.LOC | Anatomical Location (LOC) | text Extensible: Yes | C74456 | Anatomical Location | Terminology codelist used for anatomical location within CDISC. | CDISC SDTM Anatomical Location Terminology |
| 5TH LUMBAR SPINOUS PROCESS | C116163 | The spinous process of the 5th lumbar vertebra. | Fifth Lumbar Spinous Process | |||
| ABDOMINAL AORTA | C32038 | The portion of the descending aorta that lies within the abdomen, beginning below the diaphragm and ending at its division into the right and left common iliac arteries. (NCI) | Abdominal Aorta | |||
| ABDOMINAL CAVITY | C12664 | Abdomen;Abdominal Cavity | The portion of the body that lies between the thorax and the pelvis. (NCI) | Abdomen | ||
| ABDOMINAL LYMPH NODE | C12360 | Any lymph node within the abdomen. | Intra-Abdominal Lymph Node | |||
| ABDOMINAL SKIN | C52758 | Abdominal Skin | The skin or integument surrounding the abdomen. (NCI) | Abdominal Skin | ||
| ABDOMINAL WALL | C77608 | The tissues that surround the organs that are present within the abdominal cavity. The abdominal wall tissue is composed of layers of fat, parietal peritoneum, fascia, and muscles. (NCI) | Abdominal Wall | |||
| ABDUCENS NERVE | C12665 | The sixth cranial nerve. | Abducens Nerve | |||
| ACCESSORY RENAL ARTERY | C116183 | An additional renal vessel originating from the aorta and entering the kidney at the proximal or distal end of the organ. Accessory renal arteries are found in 26-30% of humans. | Accessory Renal Artery | |||
| ACETABULUM | C32042 | Acetabulum | Two cup shaped areas, one each on the lateral side of the lower pelvis that house the head of the femur to form the ball and socket joint of the hip. (NCI) | Acetabulum | ||
| ACHILLES TENDON | C32043 | Calcaneal Tendon | The tendon that connects the heel bone to the calf muscles at the back of the lower leg. (NCI) | Achilles Tendon | ||
| ACROMIOCLAVICULAR JOINT | C32047 | Acromioclavicular Joint | The junction of the upper distal end of the scapula to the distal edge of the collarbone, also known as the acromion and the clavicle. (NCI) | Acromioclavicular Joint | ||
| ACROMION | C32048 | Acromion | The upper distal process of the scapula. (NCI) | Acromion | ||
| ACUTE MARGINAL ARTERY | C102285 | ACUTE MARGINAL ARTERY SEGMENT(S);AMARG | The arteries that arise at the junction of the proximal and mid-right coronary artery conduit segments. | Acute Marginal Artery | ||
| ADRENAL GLAND | C12666 | Adrenal Gland | Suprarenal gland. A flattened, roughly triangular body resting upon the upper end of each kidney; it is one of the ductless glands furnishing internal secretions (epinephrine and norepinephrine from the medulla and steroid hormones from the cortex). (NCI) | Adrenal Gland | ||
| AMYGDALA | C12440 | Amygdaloid Nucleus | An almond-shaped group of basal nuclei anterior to the inferior horn of the lateral ventricle of the brain, within the temporal lobe. The amygdala is part of the limbic system. (MESH) | Amygdala | ||
| ANASTOMOSIS | C15609 | Anastomosis | A natural or surgically-induced connection between tubular structures in the body. (NCI) | Anastomosis | ||
| ANKLE JOINT | C32078 | Ankle;Ankle Joint | A gliding joint between the distal ends of the tibia and fibula and the proximal end of the talus. (NCI) | Ankle Joint | ||
| ANKLE MORTISE | C117868 | Talar Mortise | A rectangular socket or bony arch that connects the ends of the tibia and fibula to the talus. | Ankle Mortise | ||
| ANTERIOR TIBIAL ARTERY | C12825 | An artery of the lower extremity that supplies blood to the anterior part of the leg and the foot. | Anterior Tibial Artery | |||
| ANTRUM PYLORI | C12259 | Antrum Pylori | The initial part of the pyloric canal of the stomach. This site contains endocrine cells that produce gastrin and somatostatin. (NCI) | Antrum Pylori | ||
| ANUS | C43362 | Anus | The lower opening of the digestive tract, lying in the cleft between the buttocks, through which fecal matter is extruded. (NCI) | Anus | ||
| AORTA | C12669 | Aorta | The major arterial trunk that carries oxygenated blood from the left ventricle into the ascending aorta behind the heart, the aortic arch, through the thorax as the descending aorta and through the abdomen as the abdominal aorta; it bifurcates into the left and right common iliac arteries. (NCI) | Aorta | ||
| AORTIC ARCH | C32123 | Aortic Arch | The curved segment of the aorta between the ascending and the descending segments. | Aortic Arch | ||
| AORTIC VALVE | C12670 | A valve that is located between and controls the flow of blood from the left ventricle of the heart and the aorta. (NCI) | Aortic Valve | |||
| AORTO-ILIAC PERIPHERAL ARTERY | C116166 | The segment of the blood vessels that includes the iliac artery and its origin from the aorta. | Aortoiliac Artery Segment | |||
| AORTOPULMONARY WINDOW LYMPH NODE | C116165 | A lymph node located in the aortopulmonary window. | Aortopulmonary Window Lymph Node | |||
| APPENDICEAL TIP | C83470 | The distal end of the appendix. (NCI) | Appendiceal Tip | |||
| APPENDICULAR SKELETON | C49477 | The part of the skeleton that includes the bones of the upper and lower limbs, including the shoulder and pelvic girdles | Appendicular Skeleton | |||
| APPENDIX | C12380 | Appendix | Small tissue projection existing as a cecal diverticulum with a questionable history of vestigial versus specialized organ. (NCI) | Appendix | ||
| ARM | C32141 | Arm | The portion of the upper extremity between the shoulder and the elbow. For clinical purposes this term is also used to refer to the whole superior limb. (NCI) | Arm | ||
| ARM SKIN | C52754 | Arm Skin | The skin or integument covering the arm. (NCI) | Arm Skin | ||
| ARTERY | C12372 | Artery | A blood vessel that carries blood away from the heart. (NCI) | Artery | ||
| AXIAL SKELETON | C32172 | The part of the skeleton that includes the skull and spinal column and sternum and ribs. (NCI) | Axial Skeleton | |||
| AXILLA | C12674 | Axilla | The underside concavity where the arm and the shoulder are joined. (NCI) | Axilla | ||
| AXILLARY ARTERY | C32169 | An artery that originates from the subclavian artery at the lateral margin of the first rib. It supplies the brachial artery. | Axillary Artery | |||
| AXILLARY LYMPH NODE | C12904 | Axillary Lymph Node | One of approximately 20-30 lymph nodes in chain formation that traverse the concavity of the underarm to the clavicle. (NCI) | Axillary Lymph Node | ||
| AXILLARY VEIN | C32171 | A large blood vessel which returns blood to the heart from the lateral thorax, axilla and upper limb. Each side of the body contains one axillary vein. | Axillary Vein | |||
| BACK | C13062 | Back | The dorsal area between the base of the neck and the sacrum. (NCI) | Back | ||
| BASAL GANGLIA | C12447 | Basal Ganglia | Clusters of neurons comprising the globus pallidus, putamen, caudate, nucleus accumbens, substantia nigra and subthalamic nucleus. They are involved with high level aspects of inhibitory motor activity in coordination with the excitation commands issued from the cerebellum. (NCI) | Basal Ganglia | ||
| BASILIC VEIN | C32197 | Basilic Vein | One of the moderately large superficial veins of the forearm that transports blood from the hand and the medial aspect of the forearm to the axillary vein. (NCI) | Basilic Vein | ||
| BICEPS FEMORIS MUSCLE | C53147 | A muscle in the back of the thigh. Its action involves the knee flexion and hip extension. (NCI) | Biceps Femoris | |||
| BILE DUCT | C12376 | Any of the ducts conveying bile between the liver and the intestine, including hepatic, cystic, and common bile duct. | Bile Duct | |||
| BILIARY TRACT | C12678 | Biliary Tract | The duct system that transports bile from its origination by hepatocytes in the liver to the small intestine. It is comprised of the common bile duct that connects the liver and gall bladder to the small intestine and the cystic duct that connects the gall bladder to the common bile duct. (NCI) | Biliary Tract | ||
| BLADDER | C12414 | Bladder | The distensible sac-like organ that functions as a reservoir of urine, collecting from the kidneys and eliminating via the urethra. (NCI) | Bladder | ||
| BLADDER, DOME | C12332 | Dome of the Bladder | The upper, convex surface of the bladder. (NCI) | Dome of the Bladder | ||
| BLADDER, FUNDUS | C48939 | Fundus of the Bladder | The portion of the bladder that is formed by the posterior wall and is located opposite to the bladder opening. (NCI) | Bladder Fundus | ||
| BLADDER, NECK | C12336 | Neck of the Bladder | The inferior portion of the urinary bladder which is formed as the walls of the bladder converge and become contiguous with the proximal urethra. (NCI) | Bladder Neck | ||
| BLADDER, TRIGONE | C12331 | Trigone of the Bladder | The triangular area in the bladder mucosa that is formed by the two ureteral orifices and the urethral orifice. (NCI) | Bladder Trigone | ||
| BLOOD | C12434 | Blood;Peripheral Blood | A liquid tissue with the primary function of transporting oxygen and carbon dioxide. It supplies the tissues with nutrients, removes waste products, and contains various components of the immune system defending the body against infection. | Blood | ||
| BLOOD VESSEL | C12679 | Blood Vessel | A tubular structure through which the blood circulates in the body. Blood vessels constitute a network composed of arteries, arterioles, capillaries, venules, and veins. (NCI) | Blood Vessel | ||
| BODY | C13041 | Body | The entire physical structure of an organism. It is composed of anatomic systems, regions, cavities, and spaces. (NCI) | Body | ||
| BODY OF STOMACH | C12258 | Body of Stomach | The main section of the digestive tube that connects the esophagus to the small intestine. The body proper excludes the upper and lower sections of the fundus and pyloric portion respectively. (NCI) | Body of Stomach | ||
| BONE | C12366 | Bone | Calcified connective tissue that forms the skeletal components of the body. (NCI) | Bone | ||
| BONE MARROW | C12431 | Bone Marrow | The tissue occupying the spaces of bone. It consists of blood vessel sinuses and a network of hematopoietic cells which give rise to the red cells, white cells, and megakaryocytes. (NCI) | Bone Marrow | ||
| BRACHIAL ARTERY | C12681 | Brachial Artery | An artery originating at the axillary artery and branching into the radial and ulnar arteries. (NCI) | Brachial Artery | ||
| BRACHIAL LYMPH NODE | C92221 | An axillary lymph node along the brachial vein. (NCI) | Brachial Lymph Node | |||
| BRACHIAL PLEXUS | C12682 | Brachial Plexus | A nerve network originating from C5 to T1 that supplies cutaneous and muscular innervation to the arm and hand. (NCI) | Brachial Plexus | ||
| BRAIN | C12439 | Brain;Nervous System, Brain | An organ composed of grey and white matter containing billions of neurons that is the center for intelligence and reasoning. It is protected by the bony cranium. (NCI) | Brain | ||
| BRAIN STEM | C12441 | Brain Stem | The part of the brain that connects the cerebral hemispheres with the spinal cord. It consists of the mesencephalon, pons, and medulla oblongata. (NCI) | Brain Stem | ||
| BRAIN VENTRICLE | C12356 | Brain Ventricle | The four connected cavities (hollow spaces) centrally located within the brain that connect posteriorly with the central canal of the spinal cord. (NCI) | Brain Ventricle | ||
| BREAST | C12971 | Breast | One of two hemispheric projections of variable size situated in the subcutaneous layer over the pectoralis major muscle on either side of the chest. (NCI) | Breast | ||
| BRONCHUS | C12683 | Bronchi;Bronchus | Tubular structure in continuation with the trachea, serving as air passage. It terminates in the lung (terminal bronchiole). (NCI) | Bronchus | ||
| BUTTOCK | C89806 | Buttock | Either of the fleshy mounds in the rear pelvic area of the human body formed by the gluteal muscles. | Buttock | ||
| C1 VERTEBRA | C32239 | C1 Vertebra | The first of the seven cervical vertebrae. (NCI) | C1 Vertebra | ||
| C2 VERTEBRA | C32240 | C2 Vertebra | The second of the seven cervical vertebrae. (NCI) | C2 Vertebra | ||
| C3 VERTEBRA | C32241 | C3 Vertebra | The third of the seven cervical vertebrae. (NCI) | C3 Vertebra | ||
| C4 VERTEBRA | C32242 | C4 Vertebra | The fourth of the seven cervical vertebrae. (NCI) | C4 Vertebra | ||
| C5 VERTEBRA | C32243 | C5 Vertebra | The fifth of the seven cervical vertebrae. (NCI) | C5 Vertebra | ||
| C6 VERTEBRA | C32244 | C6 Vertebra | The sixth of the seven cervical vertebrae. (NCI) | C6 Vertebra | ||
| C7 VERTEBRA | C32245 | C7 Vertebra | The seventh of the seven cervical vertebrae. (NCI) | C7 Vertebra | ||
| CALCARINE SULCUS | C32252 | A cerebral fissure that originates near the occipital lobe and terminates below the corpus callosum. (NCI) | Calcarine Sulcus | |||
| CALF | C93027 | The posterior aspect of the lower extremity that extends from the knee to the foot. (NCI) | Calf | |||
| CANINE TOOTH | C32258 | Canine Tooth | A single-cusped (pointed) and usually single-rooted tooth located between the incisors and premolars. (NCI) | Canine Tooth | ||
| CAPITATE BONE | C12856 | Capitate Bone | The largest of eight carpal bones, located in the center of the hand. (NCI) | Capitate Bone | ||
| CAROTID ARTERY | C12687 | Carotid Artery | One of two arteries that supply oxygenated blood to the head and neck; the left common carotid branches from the aorta and the right common carotid from the innominate (brachiocephalic artery). (NCI) | Carotid Artery | ||
| CARPAL BONE | C12688 | Any of the small bones of the wrist joint, located between the radius and the ulna and the metacarpus. (NCI) | Carpal Bone | |||
| CARPOMETACARPAL JOINT 1 | C103912 | CMC1 | A saddle-shaped synovial joint between the metacarpal of the thumb and the trapezium. (NCI) | Carpometacarpal Joint 1 | ||
| CARPOMETACARPAL JOINT 2 | C103913 | CMC2 | A plane joint primarily between the second metacarpal and the trapezoid, which also connects with the trapezium and capitate. (NCI) | Carpometacarpal Joint 2 | ||
| CARPOMETACARPAL JOINT 3 | C103914 | CMC3 | A plane joint between the third metacarpal and the capitate. (NCI) | Carpometacarpal Joint 3 | ||
| CARPOMETACARPAL JOINT 4 | C103915 | CMC4 | A plane joint between the fourth metacarpal and the hamate. (NCI) | Carpometacarpal Joint 4 | ||
| CARPOMETACARPAL JOINT 5 | C103916 | CMC5 | A plane joint between the fifth metacarpal and the pisiform. (NCI) | Carpometacarpal Joint 5 | ||
| CAUDATE NUCLEUS | C12451 | An elongated gray mass of the neostriatum located adjacent to the lateral ventricle of the brain. (MeSH) | Caudate Nucleus | |||
| CECUM | C12381 | Cecal;Cecum | A blind pouch-like commencement of the colon in the right lower quadrant of the abdomen at the end of the small intestine and the start of the large intestine. (OMD) | Cecum | ||
| CELIAC LYMPH NODE | C65166 | Celiac Axis Lymph Node;Celiac Lymph Node | A lymph node at the base of the celiac artery. (NCI) | Celiac Lymph Node | ||
| CENTRAL NERVOUS SYSTEM | C12438 | The part of the nervous system that consists of the brain, spinal cord, and meninges. (NCI) | Central Nervous System | |||
| CEPHALIC VEIN | C32286 | Cephalic Vein;Vena Cephalica | One of five superficial veins of the upper extremity, beginning at the radial aspect of the wrist area, wrapping around the forearm and emptying into the axillary vein. (NCI) | Cephalic Vein | ||
| CEREBELLUM | C12445 | The portion of the brain located at the base of the skull that is responsible for balance, equilibrium and movement. (NCI) | Cerebellum | |||
| CEREBRAL CORTEX | C12443 | Cerebral Cortex | The outer layer of the cerebrum composed of neurons and unmyelinated nerve fibers. It is responsible for memory, attention, consciousness and other higher levels of mental function. | Cerebral Cortex | ||
| CEREBRAL HEMISPHERE, LEFT | C32955 | The left half of the cerebrum. | Left Cerebral Hemisphere | |||
| CEREBRAL HEMISPHERE, RIGHT | C33472 | The right half of the cerebrum. | Right Cerebral Hemisphere | |||
| CEREBRAL SUBCORTEX | C98712 | Cerebral Subcortex | The layer located below the cerebral cortex that includes the forebrain, midbrain and hindbrain. (NCI) | Cerebral Subcortex | ||
| CEREBRUM | C12351 | Cerebral Hemisphere | One half of the cerebrum, the part of the brain that controls muscle functions and also controls speech, thought, emotions, reading, writing, and learning. The right hemisphere controls the muscles on the left side of the body, and the left hemisphere controls the muscles on the right side of the body. (NCI) | Cerebral Hemisphere | ||
| CERVICAL LYMPH NODE | C32298 | Cervical Lymph Node | Any of the lymph nodes located in the neck. (NCI) | Cervical Lymph Node | ||
| CERVICAL VERTEBRA | C12693 | Cervical Vertebra | Any one of the seven vertebrae that start with C1, connecting the skull to the spine, and ends with C7, which joins the cervical with the thoracic spine. (NCI) | Cervical Vertebra | ||
| CERVIX UTERI | C12311 | Cervix Uteri;Uterine Cervix | The lower part of the uterus occupying the region between the isthmus of the uterus and the vagina. It is divided into supravaginal and vaginal portions. (NCI) | Cervix Uteri | ||
| CHEEK | C13070 | The fleshy part of the face bounded by the eyes, nose, ear, and jaw line. (NCI) | Cheek | |||
| CHEST | C25389 | Chest | The anterior side of the thorax from the neck to the abdomen. The shape of the chest is often regarded as potential insight into a disease process, as in the case of barrel chest and respiratory dysfunction. (NCI) | Chest | ||
| CHEST WALL | C62484 | Chest Wall | The total system of structures outside the lungs that move as a part of breathing; it includes all structures from the skin to the parietal pleura. (NCI) | Chest Wall | ||
| CHOROID PLEXUS | C12694 | Choroid Plexus | Blood vessels forming villous structures in the third, fourth, and lateral ventricles of the brain. (NCI) | Choroid Plexus | ||
| CINGULATE CORTEX | C52713 | Part of the medial aspect of the cerebral cortex. (NCI) | Cingulate Cortex | |||
| CIRCUMFLEX ARTERY AV GROOVE CONTINUATION ARTERY | C102287 | CIRC AV;CIRCUMFLEX ARTERY AV GROOVE CONTINUATION ARTERY SEGMENT | The segment of the left circumflex artery that is distal to the third marginal branch, located in the atrioventricular groove. | Circumflex Artery AV Groove Continuation Artery | ||
| CIRCUMFLEX, OBTUSE MARGINALS, LEFT POSTEROLETERAL AND LEFT POSTERIOR DESCENDING ARTERY BRANCHES | C102286 | The left circumflex coronary artery and all of its branches. | Circumflex Artery and its Branches | |||
| CLAVICLE | C12695 | Clavicle | A bone linking the scapula and the sternum. The clavicle is part of the pectoral girdle. | Clavicle | ||
| CLITORIS | C12308 | The erectile tissue in the vulva. It is composed of the corpora cavernosa and the glans clitoris. | Clitoris | |||
| COCCYGEAL VERTEBRA | C32334 | Coccygeal Vertebra | Four vertebral segments positioned at the base of the spine that are fused. (NCI) | Coccygeal Vertebra | ||
| COCCYX | C12696 | Coccyx | A small bone located at the bottom of the spine. The coccyx is a result of 3-5 fused rudimentary vertebrae. (NCI) | Coccyx | ||
| COLON | C12382 | Colon | The part of the large intestine measured from the cecum to the rectum consisting of ascending, transverse, descending and sigmoid portions. The purpose of the colon is to remove water from digested food prior to excretion. (NCI) | Colon | ||
| COLON, ASCENDING | C12265 | Ascending Colon | The first part of the colon (large intestine) that starts in the right lower quadrant of the abdomen and ends at the transverse colon in the right upper quadrant of the abdomen. (NCI) | Ascending Colon | ||
| COLON, DESCENDING | C12268 | Descending Colon | The fourth portion of the large intestine (colon) that communicates with the transverse colon in the left-upper quadrant of the abdomen and the rectum below. (NCI) | Descending Colon | ||
| COLON, LEFT | C33929 | Left Colon | The portion of the large intestine that includes the descending and sigmoid colon. (NCI) | Left Colon | ||
| COLON, RECTOSIGMOID | C103438 | A portion of the large intestine that includes the descending colon, sigmoid colon and rectum. | Rectosigmoid Colon | |||
| COLON, RIGHT | C12383 | Right Colon | The proximal segment of the large intestine that is located in the right side of the abdominal cavity. It includes the cecum (with the attached appendix) and the ascending colon. (NCI) | Right Colon | ||
| COLON, SIGMOID | C12384 | Sigmoid Colon | The portion of the colon that connects to the descending colon above and the rectum below. (NCI) | Sigmoid Colon | ||
| COLON, TRANSVERSE | C12385 | Transverse Colon | The third division of the colon (large intestine). It communicates with the ascending colon in the upper right-hand quadrant of the abdomen and the descending colon in the upper left-hand quadrant. (NCI) | Transverse Colon | ||
| COMMON FEMORAL ARTERY | C32354 | An artery arising from the external iliac artery at the inguinal ligament which bifurcates forming the deep and superficial femoral arteries. | Common Femoral Artery | |||
| COMMON ILIAC ARTERY | C32357 | An artery arising from the bifurcation of the abdominal aorta which then bifurcates forming the internal and external iliac arteries. | Common Iliac Artery | |||
| COMMON ILIAC LYMPH NODE | C103384 | A lymph node located adjacent to the common iliac artery. (NCI) | Common Iliac Lymph Node | |||
| CONJUNCTIVA | C12341 | Conjunctiva | A thin, transparent tissue divided into the palpebral conjunctiva (covering the inner side of the eye lid) and the bulbar conjunctiva (covering the eyeball). (NCI) | Conjunctiva | ||
| CORNEA | C12342 | Cornea | A dome-shaped, transparent, avascular tissue covering the front of the eye. It is composed of five layers: squamous epithelium, Bowman's membrane, stroma, Descemet's membrane, and endothelium. Refraction of light contributing to eye's focusing ability is its characteristic function. It contains unmyelinated nerve endings which are responsible for the high sensitivity of the tissue. (NCI) | Cornea | ||
| CORONARY ARTERY | C12843 | Coronary Artery | A principal artery that originates in the aorta. It supplies blood to the muscular tissue of the heart. (NCI) | Coronary Artery | ||
| CORONARY ARTERY, ANTERIOR DESCENDING | C32089 | Anterior Descending Coronary Artery;Left Anterior Descending Coronary Artery | A left coronary artery branch that descends on the anterior portion of the heart through the anterior interventricular groove. (NCI) | Anterior Descending Coronary Artery | ||
| CORONARY ARTERY, LEFT | C12872 | LM;Left Coronary Artery;Left Main Coronary Artery;Left Main Coronary Artery Segment | A coronary artery that arises from the aorta and bifurcates into the left anterior descending artery and the left circumflex artery. (NCI) | Left Coronary Artery | ||
| CORONARY ARTERY, RIGHT | C12875 | Right Coronary Artery | A coronary artery that originates above the right coronary cusp and supplies blood predominantly to the right side of the heart. (NCI) | Right Coronary Artery | ||
| CORONARY SINUS | C32378 | The coronary vein that terminates in the right atrium and transports deoxygenated blood from the coronary circulation. | Coronary Sinus | |||
| CORONARY VEIN | C12882 | A blood vessel in the heart which returns coronary blood to the right atrium. | Coronary Vein | |||
| CORPUS CALLOSUM | C12446 | A white matter structure within the cleft that separates the left and right cerebral hemispheres in the mammalian brain. It is composed of a wide, flat bundle of 200-250 million axonal projections. (NCI) | Corpus Callosum | |||
| CORPUS LUTEUM | C26465 | Corpus Luteum | A group of cells that remain of the Graafian follicle following ovulation. This structure is composed of endocrine tissue and produces progesterone. This is needed to prepare the uterine lining for implantation by the fertilized egg. (NCI) | Corpus Luteum | ||
| CORPUS STRIATUM | C12448 | The portion of the brain consisting of the neostriatum and globus pallidus. | Corpus Striatum | |||
| COSTAL CARTILAGE | C32391 | Costal Cartilage | The cartilage positioned between the anterior end of the rib and the sternum. Its elasticity allows the ribcage to expand while breathing. (NCI) | Costal Cartilage | ||
| COSTOCHONDRAL JOINT 1 | C102288 | The first hyaline cartilaginous joint between the ribs and costal cartilage. | Costochondral Joint 1 | |||
| COSTOCHONDRAL JOINT 7 | C102289 | The seventh hyaline cartilaginous joint between the ribs and costal cartilage. | Costochondral Joint 7 | |||
| CRANIAL NERVE | C12700 | Any of the 12 paired nerves that originate in the brain stem. (NCI) | Cranial Nerve | |||
| CUBOID BONE | C32414 | Cuboid Bone | A bone on the lateral side of the tarsus between the calcaneus and the fourth and fifth metatarsal bones. (NCI) | Cuboid Bone | ||
| DIAPHRAGM | C12702 | Fibromuscular tissue that separates the thoracic from the abdominal cavity. It increases the volume of the thoracic cavity through contractions, thus facilitating respiration. | Diaphragm | |||
| DISTAL CIRCUMFLEX ARTERY | C102290 | DCIRC;DISTAL CIRCUMFLEX ARTERY SEGMENT | The segment of the left circumflex artery that is between the second and third obtuse marginal branches. | Distal Circumflex Artery | ||
| DISTAL INTERPHALANGEAL JOINT 2 | C102291 | DIP2 | A condyloid synovial joint within the second digit of the hand or foot connecting the middle and distal phalanges. (NCI) | Distal Interphalangeal Joint 2 | ||
| DISTAL INTERPHALANGEAL JOINT 2 OF THE FOOT | C114198 | DIP2 of the Foot | A ginglymoid (hinge) synovial joint within the second digit of the foot connecting the middle and distal phalanges. (NCI) | Distal Interphalangeal Joint 2 of the Foot | ||
| DISTAL INTERPHALANGEAL JOINT 2 OF THE HAND | C114188 | DIP2 of the Hand | A ginglymoid (hinge) synovial joint within the second digit of the hand connecting the middle and distal phalanges. (NCI) | Distal Interphalangeal Joint 2 of the Hand | ||
| DISTAL INTERPHALANGEAL JOINT 3 | C102292 | DIP3 | A condyloid synovial joint within the third digit of the hand or foot connecting the middle and distal phalanges. (NCI) | Distal Interphalangeal Joint 3 | ||
| DISTAL INTERPHALANGEAL JOINT 3 OF THE FOOT | C114199 | DIP3 of the Foot | A ginglymoid (hinge) synovial joint within the third digit of the foot connecting the middle and distal phalanges. (NCI) | Distal Interphalangeal Joint 3 of the Foot | ||
| DISTAL INTERPHALANGEAL JOINT 3 OF THE HAND | C114189 | DIP3 of the Hand | A ginglymoid (hinge) synovial joint within the third digit of the hand connecting the middle and distal phalanges. (NCI) | Distal Interphalangeal Joint 3 of the Hand | ||
| DISTAL INTERPHALANGEAL JOINT 4 | C102293 | DIP4 | A condyloid synovial joint within the fourth digit of the hand or foot connecting the middle and distal phalanges. (NCI) | Distal Interphalangeal Joint 4 | ||
| DISTAL INTERPHALANGEAL JOINT 4 OF THE FOOT | C114275 | DIP4 of the Foot | A ginglymoid (hinge) synovial joint within the fourth digit of the foot connecting the middle and distal phalanges. (NCI) | Distal Interphalangeal Joint 4 of the Foot | ||
| DISTAL INTERPHALANGEAL JOINT 4 OF THE HAND | C114273 | DIP4 of the Hand | A ginglymoid (hinge) synovial joint within the fourth digit of the hand connecting the middle and distal phalanges. (NCI) | Distal Interphalangeal Joint 4 of the Hand | ||
| DISTAL INTERPHALANGEAL JOINT 5 | C102294 | DIP5 | A condyloid synovial joint within the fifth digit of the hand or foot connecting the middle and distal phalanges. (NCI) | Distal Interphalangeal Joint 5 | ||
| DISTAL INTERPHALANGEAL JOINT 5 OF THE FOOT | C114276 | DIP5 of the Foot | A ginglymoid (hinge) synovial joint within the fifth digit of the foot connecting the middle and distal phalanges. (NCI) | Distal Interphalangeal Joint 5 of the Foot | ||
| DISTAL INTERPHALANGEAL JOINT 5 OF THE HAND | C114274 | DIP5 of the Hand | A ginglymoid (hinge) synovial joint within the fifth digit of the hand connecting the middle and distal phalanges. (NCI) | Distal Interphalangeal Joint 5 of the Hand | ||
| DISTAL LAD ARTERY | C102295 | DISTAL LAD ARTERY SEGMENT;DLAD | The segment of the left anterior descending (LAD) artery that is distal to the third diagonal branch. | Distal Left Anterior Descending Artery | ||
| DISTAL RIGHT CORONARY ARTERY CONDUIT | C102296 | DISTAL RIGHT CORONARY ARTERY CONDUIT SEGMENT;DRCA | The section of the right coronary artery distal to the origin of the acute marginal artery. | Distal Right Coronary Artery Conduit | ||
| DORSAL MOTOR NUCLEUS | C12934 | A brain nucleus located in the medulla oblongata. (NCI) | Dorsal Motor Nucleus | |||
| DORSALIS PEDIS ARTERY | C32478 | Dorsalis Pedis Artery | An artery of the dorsal surface of the foot, originating from the anterior tibial artery of the lower leg. The following arterial branches originate from the dorsalis pedis artery: the arcuate artery of the foot and deep plantar artery. (NCI) | Dorsalis Pedis Artery | ||
| DUODENUM | C12263 | A jointed tube 25-30 cm long that connects the stomach to the jejunum. (NCI) | Duodenum | |||
| DURAL VENOUS SINUS | C102627 | Venous channels within the dura mater of the brain which receives both blood from blood vessels within the brain as well as cerebrospinal fluid then drains into the internal jugular vein. Unlike other blood vessels, dural venous sinuses lack valves and other vessel associated layers. | Dural Venous Sinus | |||
| EAR | C12394 | Ear | A sense organ needed for the detection of sound and for establishing balance. The outer ear consists of the auricle, the ear canal as well as the tympanic membrane. The middle ear is made up of an air-filled cavity behind the tympanic membrane that contains the ossicles (malleus, incus and stapes). The inner ear is made up of the cochlea needed for hearing and the vestibular apparatus required for balance. (NCI) | Ear | ||
| EAR, INNER | C12499 | Cochlea;Internal Ear;Labyrinth | The portion of the ear located within the temporal bone that is involved in both hearing and balance and includes the semicircular canals, vestibule, and cochlea. (from American Heritage Dictionary online) | Inner Ear | ||
| EAR, OUTER | C12292 | Auricle;External Ear | The external part of the ear. (NCI) | External Ear | ||
| ELBOW JOINT | C32497 | Elbow Joint | A joint involving the humerus, radius and ulna bones. | Elbow Joint | ||
| ENDOCARDIUM | C13004 | The layer of endothelial cells and connective tissue lining the chambers of the heart. (NCI) | Endocardium | |||
| ENDOCERVIX | C12309 | The portion of the cervix which is lined by single columnar epithelium (mucosa). (NCI) | Endocervix | |||
| ENDOMETRIAL CAVITY | C32514 | Endometrial Cavity | A space inside the uterus lined by a layer of mucus membranes called the endometrium. (NCI) | Endometrial Cavity | ||
| ENTORHINAL CORTEX | C97338 | A brain region in the medial temporal lobe near the hippocampus. (NCI) | Entorhinal Cortex | |||
| EPICARDIUM | C13164 | The outer membranous connective tissue layer of the heart tissue. (NCI) | Epicardium | |||
| EPICONDYLE | C69300 | Epicondyle | A bone prominence to which ligaments and tendons of the joints are attached. (NCI) | Epicondyle | ||
| EPIDIDYMIS | C12328 | A crescent-like structure located in the upper and posterior surfaces of the testis. It consists of the efferent ductules and the duct of the epididymis. It facilitates the maturation of sperm that is produced in the testis. (NCI) | Epididymis | |||
| EPIGLOTTIS | C12709 | Epiglottis | A small cartilagenous flap-like valve that closes over the larynx during swallowing to prevent food entering the lungs. (NCI) | Epiglottis | ||
| EPITROCHLEAR LYMPH NODE | C98182 | A lymph node located above and adjacent to the elbow. (NCI) | Epitrochlear Lymph Node | |||
| ESOPHAGUS | C12389 | Esophagus | The portion of the digestive canal between the pharynx and stomach. It consists of three parts: the cervical part, from the cricoid cartilage to the thoracic inlet; thoracic part, from thoracic inlet to the diaphragm; and abdominal part, below the diaphragm to the cardiac opening of the stomach. | Esophagus | ||
| ESOPHAGUS, ABDOMINAL | C12252 | Abdominal Esophagus | Clinical esophageal segment composed of smooth muscle. It corresponds to the inferior part of the lower third topographic segment of the esophagus. (NCI) | Abdominal Esophagus | ||
| ESOPHAGUS, CERVICAL | C12250 | Cervical Esophagus | Clinical esophageal segment composed of skeletal muscle. It corresponds to the superior part of the upper third topographic segment of the esophagus. (NCI) | Cervical Esophagus | ||
| ESOPHAGUS, LOWER THIRD | C12255 | Lower Third of the Esophagus | The lower one third of the esophagus in which the muscle layer is composed of muscle cells predominantly of the smooth type. (NCI) | Lower Third of the Esophagus | ||
| ESOPHAGUS, MIDDLE THIRD | C12254 | Middle Third of the Esophagus | The middle one third of the esophagus in which the muscle layer is composed of muscle cells of the striated and smooth types. | Middle Third of the Esophagus | ||
| ESOPHAGUS, THORACIC | C12251 | Thoracic Esophagus | Clinical esophageal segment composed of smooth muscle. It includes the middle third topographic segment, as well as parts of the upper and lower thirds. (NCI) | Thoracic Esophagus | ||
| ESOPHAGUS, UPPER THIRD | C12253 | Upper Third of the Esophagus | The upper one third of esophagus in which the muscle layer is composed of muscle cells of the striated type. (NCI) | Upper Third of the Esophagus | ||
| ETHMOID BONE | C12711 | Ethmoid Bone | A light and spongy bone that is cubical in shape. This bone is positioned at the anterior part of the cranium, sitting between the two orbits, at the roof of the nose. It consists of four parts: a horizontal or cribriform plate; a perpendicular plate; and two lateral masses or labyrinths. (NCI) | Ethmoid Bone | ||
| ETHMOID SINUS | C12276 | Ethmoid Sinus | A sinus of the meatuses of the nasal cavity. (NCI) | Ethmoid Sinus | ||
| EXTERNAL ILIAC ARTERY | C32558 | An artery arising from the bifurcation of the common iliac artery in the lower torso. The external iliac artery becomes the femoral artery and is the main blood supply for the leg. | External Iliac Artery | |||
| EXTERNAL ILIAC LYMPH NODE | C88143 | A lymph node located along the external iliac artery. (NCI) | External Iliac Lymph Node | |||
| EXTRAHEPATIC BILE DUCT | C32573 | The portion of the biliary tract outside the liver; the common hepatic duct joins the cystic duct to form the common bile duct. (NCI) | Extrahepatic Bile Duct | |||
| EYE | C12401 | Eye;Eyeball | The organ of sight or vision. (NCI) | Eye | ||
| EYE, ANTERIOR CHAMBER | C12667 | The space in the eye, filled with aqueous humor, bounded anteriorly by the cornea and a small portion of the sclera and posteriorly by a small portion of the ciliary body, the iris, and that part of the crystalline lens which presents through the pupil. (Cline et al., Dictionary of Visual Science, 4th ed, p109) (NCI) | Anterior Chamber of the Eye | |||
| EYE, VITREOUS CHAMBER | C33885 | Postremal Chamber | The largest space within the eye which is bounded by the lens and the retina and filled with the gelatinous vitreous humor. (NCI) | Vitreous Chamber | ||
| EYELASH | C32576 | Anyone of the short hairs that grow on the edge of the eyelid. (NCI) | Eyelash | |||
| EYELID | C12713 | Eyelid;Palpebra | A thin membrane of skin with the purpose of covering and protecting an eye. (NCI) | Eyelid | ||
| FACE | C13071 | Face;Facial | The anterior portion of the head extending from the forehead to the chin and ear to ear. The facial structures contain the eyes, nose and mouth, cheeks and jaws. (NCI) | Face | ||
| FACET JOINT | C32577 | Facet Joint | A synovial joint between two adjacent vertebrae. The facet joint links the articular process of one vertebra and the inferior articular process of the adjacent vertebra. (NCI) | Facet Joint | ||
| FACIAL BONE | C63706 | Facial Bone | Any bone that contributes to the facial structures, except those bones that are part of the braincase. (NCI) | Facial Bone | ||
| FACIAL NERVE | C12714 | Seventh Cranial Nerve | The 7th cranial nerve. The facial nerve has two parts, the larger motor root which may be called the facial nerve proper, and the smaller intermediate or sensory root. Together they provide efferent innervation to the muscles of facial expression and to the lacrimal and salivary glands, and convey afferent information for taste from the anterior two-thirds of the tongue and for touch from the external ear. (MeSH) | Facial Nerve | ||
| FALLOPIAN TUBE | C12403 | Fallopian Tube | One of a pair of tubes that extend from the uterus to each of the ovaries. Following ovulation the egg travels down the fallopian tube to the uterus where fertilization may or may not occur. (NCI) | Fallopian Tube | ||
| FASCIA | C13108 | A sheet or band of fibrous connective tissue enveloping, separating, or binding together muscles, organs and other soft structures of the body. | Fascia | |||
| FEMALE GENITALIA | C61600 | Female Genitalia | Female internal and external organs of reproduction. | Female Genitalia | ||
| FEMALE REPRODUCTIVE SYSTEM | C12402 | The sex organs of the female. | Female Reproductive System | |||
| FEMORAL ARTERY | C12715 | Femoral Artery | An artery that starts within the inguinal region and extends to the lower extremities. (NCI) | Femoral Artery | ||
| FEMORAL CONDYLE | C114186 | The rounded bony projection at the distal end of the femur. | Femoral Condyle | |||
| FEMORAL HEAD | C32718 | Femur Head | The highest portion of the femoral bone that articulates with the acetabulum. (NCI) | Head of the Femur | ||
| FEMORAL LYMPH NODE | C98183 | A lymph node located in the upper inner portion of the thigh. (NCI) | Femoral Lymph Node | |||
| FEMORAL NECK | C61563 | Femoral Neck | The short, constricted portion of the thigh bone between the femur head and the trochanter. (NCI) | Femoral Neck | ||
| FEMORAL VEIN | C12716 | Femoral Vein | A vein that starts within the inguinal region and extends to the lower extremities. (NCI) | Femoral Vein | ||
| FEMORO-POPLITEAL PERIPHERAL ARTERY | C116167 | The segment of the blood vessels that includes the popliteal artery and its origin from the femoral artery. | Femoropopliteal Artery Segment | |||
| FEMUR | C12717 | Bone, Femoral;Femur | The upper leg bone positioned between the pelvis and the knee. (NCI) | Femur | ||
| FEMUR SHAFT | C96209 | The cylindrical body of the femur. (NCI) | Femoral Shaft | |||
| FIBULA | C12718 | Fibula | The small, lateral calf bone extending from the knee to the ankle. (NCI) | Fibula | ||
| FINGER | C32608 | Finger | Any of the digits of the hand. (NCI) | Finger | ||
| FINGERNAIL | C32609 | Fingernail | The nail at the end of a finger. (NCI) | Fingernail | ||
| FIRST DIAGONAL BRANCH ARTERY | C102297 | 1ST DIAG;FIRST DIAGONAL BRANCH ARTERY SEGMENT | The first artery arising from the left anterior descending (LAD) artery that supplies the anterolateral wall, when counted from proximal to distal. | First Diagonal Branch Artery | ||
| FIRST LEFT POSTEROLATERAL BRANCH ARTERY | C102298 | 1ST LPL;FIRST LEFT POSTEROLATERAL BRANCH ARTERY SEGMENT | In an individual with a left-dominant heart, this is the first branch that arises from the circumflex artery atrioventricular groove continuation when counted from proximal to distal. It supplies the posterolateral wall. | First Left Posterolateral Branch Artery | ||
| FIRST OBTUSE MARGINAL BRANCH ARTERY | C102299 | 1ST OM;FIRST OBTUSE MARGINAL BRANCH ARTERY SEGMENT | The first artery arising from the left circumflex artery that supplies the lateral wall, when counted from proximal to distal. | First Obtuse Marginal Branch Artery | ||
| FIRST RIGHT POSTEROLATERAL ARTERY | C102300 | 1ST RPL;FIRST RIGHT POSTEROLATERAL ARTERY SEGMENT | In an individual with a right-dominant heart, this is the first branch that arises from the right coronary artery distal to the right posterior descending artery, when counted from proximal to distal. | First Right Posterolateral Artery | ||
| FLOOR OF MOUTH | C54187 | The area of the mouth under the ventral surface of the tongue. | Floor of Mouth | |||
| FOOT | C32622 | Feet;Foot | The structure found below the ankle joint required for locomotion. (NCI) | Foot | ||
| FOOT DIGIT 1 | C52839 | Big Toe | The largest and most medial toe of the foot. (NCI) | Foot Digit 1 | ||
| FOOT DIGIT 2 | C52840 | Index Toe | The second toe from the medial side of the foot. (NCI) | Foot Digit 2 | ||
| FOOT DIGIT 3 | C52841 | Middle Toe | The middle or third toe from the medial side of the foot. (NCI) | Foot Digit 3 | ||
| FOOT DIGIT 4 | C52842 | Fourth Toe | The fourth toe from the medial side of the foot. (NCI) | Foot Digit 4 | ||
| FOOT DIGIT 5 | C52843 | Little Toe | The smallest and most lateral toe of the foot. (NCI) | Foot Digit 5 | ||
| FOOT PHALANX | C52772 | Foot Phalanx | A bone of the foot. (NCI) | Foot Phalanx | ||
| FOREARM | C32628 | Forearm | The structure on the upper limb, between the elbow and the wrist. (NCI) | Forearm | ||
| FOREBRAIN | C40185 | The largest part of the brain composed of the cerebral hemispheres, thalamus, hypothalamus, and the limbic system. (NCI) | Forebrain | |||
| FOREHEAD | C89803 | Forehead | The part of the face between the eyebrows and the normal hairline. | Forehead | ||
| FRONTAL LOBE | C12352 | Frontal Lobe | The part of the brain located anterior to the parietal lobes at the front of each cerebral hemisphere. (NCI) | Frontal Lobe | ||
| FRONTAL SINUS | C12277 | Frontal Sinus | The paired, mucosal lined air spaces located above the orbit and communicating with the nasal passages. (NCI) | Frontal Sinus | ||
| FUNDUS OF THE STOMACH | C12257 | Fundus of the Stomach | The portion of the stomach that lies above the cardiac notch. It allows for the accumulation of gases produced by chemical digestion. (NCI) | Fundus of the Stomach | ||
| GALLBLADDER | C12377 | Gallbladder | A pear-shaped organ located under the liver that stores and concentrates bile secreted by the liver. From the gallbladder the bile is delivered through the bile ducts into the intestine thereby aiding the digestion of fat-containing foods. (NCI) | Gallbladder | ||
| GANGLION | C12719 | Ganglia;Ganglion;Neural Ganglion | A cluster of nervous tissue principally composed of neuronal cell bodies external to the central nervous system (CNS). (NCI) | Ganglion | ||
| GASTRIC CARDIA | C12256 | Gastric Cardia | The area around the esophagogastric mucosal junction where the esophageal mucosa transitions into the gastric mucosa. (NCI) | Gastric Cardia | ||
| GASTROESOPHAGEAL JUNCTION | C32668 | Gastroesophageal Junction | The anatomical location where the esophagus joins to the stomach. (NCI) | Gastroesophageal Junction | ||
| GASTROINTESTINAL SYSTEM | C12378 | Gastrointestinal System | The system that includes the esophagus, stomach, small and large intestine, anus, liver, biliary tract, and pancreas. (NCI) | Gastrointestinal System | ||
| GASTROINTESTINAL TRACT | C34082 | Gastrointestinal Tract | The upper gastrointestinal (GI) tract is comprised of mouth, pharynx, esophagus and stomach while the lower GI tract consists of intestines and anus. The primary function of the GI tract is to ingest, digest, absorb and ultimately excrete food stuff. (NCI) | Gastrointestinal Tract | ||
| GASTROINTESTINAL TRACT, LOWER | C33010 | Lower Gastrointestinal Tract | The lower part of the gastrointestinal tract that includes the jejunum and ileum of the small intestine and the large intestine. (NCI) | Lower Gastrointestinal Tract | ||
| GASTROINTESTINAL TRACT, UPPER | C33837 | Upper Gastrointestinal Tract | The upper part of the gastrointestinal tract that includes the esophagus, stomach, and duodenum. (NCI) | Upper Gastrointestinal Tract | ||
| GENITALIA | C25177 | The external sex organs. (NCI) | Genitalia | |||
| GINGIVA | C32677 | Gingiva;Gum | The soft tissue surrounding the neck of individual teeth as well as covering the alveolar bone. The tissue is fibrous and continuous with the periodontal ligament and mucosal covering. (NCI) | Gingiva | ||
| GLENOID FOSSA | C32682 | Glenoid Fossa | The trough in the head of the scapula that receives the head of the humerus to form the shoulder joint. (NCI) | Glenoid Fossa | ||
| GLOSSOPHARYNGEAL NERVE | C12723 | The ninth cranial nerve. | Glossopharyngeal Nerve | |||
| GLOTTIS | C12724 | Glottis | The space in which the vocal cords are located. (NCI) | Glottis | ||
| GLUTEUS MAXIMUS | C52560 | The outermost and largest muscle of the buttocks. (NCI) | Gluteus Maximus | |||
| GREAT TROCHANTER | C32698 | Great Trochanter | A large, irregular, quadrilateral area of bone found at the neck of the femur. (NCI) | Great Trochanter | ||
| GREATER CURVATURE OF THE STOMACH | C12262 | Greater Curvature of the Stomach | The lateral and inferior border of the stomach. Attached to it is the greater omentum. (NCI) | Greater Curvature of the Stomach | ||
| HAIR | C32705 | Hair | The filamentous outgrowth of the epidermis. (NCI) | Hair | ||
| HAIR BULB | C32706 | The lower segment of the hair that circles the dermal papilla and the hair matrix. (NCI) | Hair Bulb | |||
| HAIR FOLLICLE | C13317 | A tube-like invagination of the epidermis from which the hair shaft develops and into which the sebaceous glands open; the follicle is lined by a cellular inner and outer root sheath of epidermal origin and is invested with a fibrous sheath derived from the dermis. (NCI) | Hair Follicle | |||
| HAIR ROOT | C32711 | The portion of the hair that is enclosed within the hair follicle. (NCI) | Hair Root | |||
| HAIR SHAFT | C33543 | Shaft of the Hair | The segment of the hair that projects above the skin surface. (NCI) | Shaft of the Hair | ||
| HAMATE BONE | C12860 | Hamate Bone | The medial bone in the distal row of carpal bones. (NCI) | Hamate Bone | ||
| HAND | C32712 | Hand | The distal portion of the upper extremity. It consists of the carpus, metacarpus, and digits. (NCI) | Hand | ||
| HAND DIGIT 1 | C52834 | Thumb | The thick and short hand digit which is next to the index finger in humans. (NCI) | Hand Digit 1 | ||
| HAND DIGIT 2 | C52835 | Index Finger | The second finger from the radial side of the hand, next to the thumb. (NCI) | Hand Digit 2 | ||
| HAND DIGIT 3 | C52836 | Middle Finger | The middle or third finger from the radial side of the hand. (NCI) | Hand Digit 3 | ||
| HAND DIGIT 4 | C52837 | Ring Finger | The fourth finger from the radial side of the hand. (NCI) | Hand Digit 4 | ||
| HAND DIGIT 5 | C52838 | Little Finger | The fifth and smallest finger from the radial side of the hand. (NCI) | Hand Digit 5 | ||
| HAND PHALANX | C52771 | Hand Phalanx | A bone of the hand. (NCI) | Hand Phalanx | ||
| HARD PALATE | C12230 | Hard Palate | The bony anterior part of the roof of the mouth separating the nose from the mouth. (NCI) | Hard Palate | ||
| HEAD | C12419 | Head | The anterior and superior part of a human or animal bearing the mouth, the brain and sensory organs. | Head | ||
| HEAD AND NECK | C12418 | The area of the body comprising the skull, facial bones and the cervical vertebrae, sinuses, orbits, salivary glands, oral cavity, oropharynx, larynx, thyroid, facial and neck musculature, soft tissue and lymph nodes draining these areas. | Head and Neck | |||
| HEAD OF THE HUMERUS | C32720 | Head of the Humerus | The upper rounded part of the humerus that fits into the glenoid cavity of the scapula. (NCI) | Head of the Humerus | ||
| HEART | C12727 | Cardiac;Heart | A hollow muscular organ which receives the blood from the veins and propels it into the arteries. It is divided by a musculomembranous septum into two halves -- right or venous and left or arterial -- each of which consists of a receiving chamber (atrium) and an ejecting chamber (ventricle). (NCI) | Heart | ||
| HEART, APEX | C32126 | Apex of the Heart | The most outer superficial part of the heart which is situated on the left 5th intercostal space. (NCI) | Apex of the Heart | ||
| HEART, ATRIUM | C12728 | Cardiac Atrium | The paired upper chambers of the heart. The left atrium receives oxygenated blood from the pulmonary vein and pumps blood into the left ventricle. The right atrium receives venous deoxygenated blood from the entire body via the superior and inferior vena cavae and pumps blood into the right ventricle. (NCI) | Cardiac Atrium | ||
| HEART, BASE | C48589 | Base of the Heart | The superior portion of the heart located opposite to the apical portion. It is formed mainly by the left atrium. (NCI) | Base of the Heart | ||
| HEART, LEFT VENTRICLE | C12871 | Left Ventricle | The left lower chamber of the heart that receives blood from the left atrium and pumps it through the aorta to the body. (NCI) | Left Ventricle | ||
| HEART, RIGHT VENTRICLE | C12870 | Right Ventricle | The lower chamber of the heart located in the right side. It receives blood from the right atrium that is no longer oxygenated and it pumps it to the pulmonary artery. (NCI) | Right Ventricle | ||
| HEART, SEPTUM | C49485 | Cardiac Septum | The tissue in the heart that separates the two atria (atrial septum) and the two ventricles (ventricular septum). (NCI) | Heart Septum | ||
| HEART, VENTRICLE | C12730 | Cardiac Ventricle | The lower right and left chambers of the heart. The right pumps venous blood into the lungs and the left pumps oxygenated blood into the systemic arterial circulation. (MeSH) | Cardiac Ventricle | ||
| HEART, VENTRICULAR WALL | C119295 | The tissue layers that form the cardiac ventricle. They include myocardium, endocardium, and pericardium. (NCI) | Ventricular Wall of the Heart | |||
| HEPATIC LYMPH NODE | C77640 | Any of the lymph nodes adjacent to the stomach and duodenum. (NCI) | Hepatic Lymph Node | |||
| HILAR | C25724 | Hilar | Refers to the area associated with the hilum. (NCI) | Hilar | ||
| HILAR LYMPH NODE | C98187 | A lymph node located in the hilum of the lung within the mediastinum. | Pulmonary Hilar Lymph Node | |||
| HIP | C64193 | Hip | The lateral prominence of the pelvis from the waist to the thigh. (NCI) | Hip | ||
| HIP JOINT | C32742 | Coxofemoral Joint;Hip Joint | A ball-and-socket joint between the head of the femur and the acetabulum. (NCI) | Hip Joint | ||
| HIPPOCAMPUS | C12444 | Hippocampus | A curved gray matter structure of the temporal lobe lying on the floor of the lateral ventricle of the brain. (NCI) | Hippocampus | ||
| HUMERAL EPICONDYLE | C114187 | The bone prominence at the distal end of the humerus to which ligaments and tendons of the joints are attached. | Humeral Epicondyle | |||
| HUMERUS | C12731 | Bone, Humeral;Humerus | The upper arm bone between the shoulder and elbow. (NCI) | Humerus | ||
| HYOID BONE | C32752 | Hyoid Bone | A U-shaped bone supporting the tongue. This bone is located at the base of the tongue and is suspended from the tips of the styloid processes of the temporal bones by the stylohyoid ligaments. (NCI) | Hyoid Bone | ||
| HYPOGLOSSAL NERVE | C12732 | The twelfth cranial nerve. | Hypoglossal Nerve | |||
| HYPOPHARYNX | C12246 | Hypopharynx | The lower part of the pharynx that connects to the esophagus. (NCI) | Hypopharynx | ||
| HYPOTHALAMUS | C12458 | Hypothalamus | The supervisory center in the brain, rich in ganglia, nerve fibers, and synaptic connections. It is composed of several sections called nuclei, each of which controls a specific function. | Hypothalamus | ||
| ILEUM | C12387 | Ileum | The final section of the small intestine. (NCI) | Ileum | ||
| ILEUM, TERMINAL | C33757 | Terminal Ileum | The most distal section of the ileum that is continuous with the cecum. (NCI) | Terminal Ileum | ||
| ILIAC CREST | C103818 | A predominate bone structure which borders the ilium wing stretching from the anterior superior iliac spine to the posterior superior iliac spine. | Iliac Crest | |||
| ILIAC FOSSA | C103454 | The large smooth and concave surface of the ilium. (NCI) | Iliac Fossa | |||
| ILIAC LYMPH NODE | C32761 | Iliac Lymph Node | One of the three lymph nodes of the pelvis: the superior gluteal, interior gluteal or sacral. (NCI) | Iliac Lymph Node | ||
| ILIUM | C32765 | Ilium | The broad, dorsal, upper, and widest of the three principal bones composing either half of the pelvis. (NCI) | Ilium | ||
| INCISOR | C32769 | Incisor | One of the teeth in front of the canines in either jaw designed for cutting or gnawing. (NCI) | Incisor | ||
| INCUS | C32770 | Incus | One of the three bones comprising the middle ear. This anvil-shaped bone is positioned between the malleus and the stapes. (NCI) | Incus | ||
| INFRACLAVICULAR LYMPH NODE | C63705 | Infraclavicular Lymph Node | A lymph node located in the area below the clavicle. (NCI) | Infraclavicular Lymph Node | ||
| INFRARENAL AORTA | C116179 | The portion of the abdominal aorta that lies below the kidneys. | Infrarenal Aortic Segment | |||
| INFRATENTORIAL BRAIN | C12509 | The part of the brain below the tentorium cerebellum. (NCI) | Infratentorial Brain | |||
| INGUINAL LYMPH NODE | C32801 | Inguinal Lymph Node | A superficial or deep lymph node located in the inguinal area. (NCI) | Inguinal Lymph Node | ||
| INGUINAL REGION | C12726 | Groin | The lower region of the anterior abdominal wall located laterally to the pubic region. (NCI) | Inguinal Region | ||
| INTERNAL ILIAC ARTERY | C32845 | A short thick blood vessel arising from the bifurcation of the common iliac artery with numerous branches that supply the organs, walls and viscera of the pelvis as well as the inner thigh. | Internal Iliac Artery | |||
| INTERNAL ILIAC LYMPH NODE | C88142 | A lymph node located along the internal iliac artery. (NCI) | Internal Iliac Lymph Node | |||
| INTERNAL MAMMARY ARTERY | C52941 | The blood vessel that supplies the breast and the anterior chest wall with arterial blood. It is located in the chest wall. (NCI) | Internal Mammary Artery | |||
| INTERNAL MAMMARY LYMPH NODE | C32853 | Any of the lymph nodes of the breast located under the ribcage, near the sternum. (NCI) | Internal Mammary Lymph Node | |||
| INTERPHALANGEAL JOINT 1 | C102301 | IP1 | A ginglymoid (hinge) synovial joint within the first digit of the hand or foot connecting the proximal and distal phalanges. (NCI) | Interphalangeal Joint 1 | ||
| INTERPHALANGEAL JOINT 1 OF THE FOOT | C114200 | IP1 of the Foot | A ginglymoid (hinge) synovial joint within the first digit of the foot connecting the proximal and distal phalanges. (NCI) | Interphalangeal Joint 1 of the Foot | ||
| INTERPHALANGEAL JOINT 2 | C102302 | IP2 | A ginglymoid (hinge) synovial joint between the phalanges of the second digit of the hand or foot. (NCI) | Interphalangeal Joint 2 | ||
| INTERPHALANGEAL JOINT 2 OF THE FOOT | C114201 | IP2 of the Foot | A ginglymoid (hinge) synovial joint between the phalanges of the second digit of the foot. (NCI) | Interphalangeal Joint 2 of the Foot | ||
| INTERPHALANGEAL JOINT 2 OF THE HAND | C114190 | IP2 of the Hand | A ginglymoid (hinge) synovial joint between the phalanges of the second digit of the hand. (NCI) | Interphalangeal Joint 2 of the Hand | ||
| INTERPHALANGEAL JOINT 3 | C102303 | IP3 | A ginglymoid (hinge) synovial joint between the phalanges of the third digit of the hand or foot. (NCI) | Interphalangeal Joint 3 | ||
| INTERPHALANGEAL JOINT 3 OF THE FOOT | C114202 | IP3 of the Foot | A ginglymoid (hinge) synovial joint between the phalanges of the third digit of the foot. (NCI) | Interphalangeal Joint 3 of the Foot | ||
| INTERPHALANGEAL JOINT 3 OF THE HAND | C114191 | IP3 of the Hand | A ginglymoid (hinge) synovial joint between the phalanges of the third digit of the hand. (NCI) | Interphalangeal Joint 3 of the Hand | ||
| INTERPHALANGEAL JOINT 4 | C102304 | IP4 | A ginglymoid (hinge) synovial joint between the phalanges of the fourth digit of the hand or foot. (NCI) | Interphalangeal Joint 4 | ||
| INTERPHALANGEAL JOINT 4 OF THE FOOT | C114203 | IP4 of the Foot | A ginglymoid (hinge) synovial joint between the phalanges of the fourth digit of the foot. (NCI) | Interphalangeal Joint 4 of the Foot | ||
| INTERPHALANGEAL JOINT 4 OF THE HAND | C114192 | IP4 of the Hand | A ginglymoid (hinge) synovial joint between the phalanges of the fourth digit of the hand. (NCI) | Interphalangeal Joint 4 of the Hand | ||
| INTERPHALANGEAL JOINT 5 | C102305 | IP5 | A ginglymoid (hinge) synovial joint between the phalanges of the fifth digit of the hand or foot. (NCI) | Interphalangeal Joint 5 | ||
| INTERPHALANGEAL JOINT 5 OF THE FOOT | C114204 | IP5 of the Foot | A ginglymoid (hinge) synovial joint between the phalanges of the fifth digit of the foot. (NCI) | Interphalangeal Joint 5 of the Foot | ||
| INTERPHALANGEAL JOINT 5 OF THE HAND | C114193 | IP5 of the Hand | A ginglymoid (hinge) synovial joint between the phalanges of the fifth digit of the hand. (NCI) | Interphalangeal Joint 5 of the Hand | ||
| INTERPHALANGEAL JOINT OF THE HAND | C32868 | Interphalangeal Joint of the Hand | The hinge synovial joints between the phalanges of the fingers. (NCI) | Interphalangeal Joint of the Hand | ||
| INTERPHALANGEAL OF THE FOOT | C32867 | IP of the Foot | The hinge synovial joints between the bones of the toes. (NCI) | Interphalangeal Joint of the Foot | ||
| INTERPHALANGEAL THUMB JOINT | C102306 | IP THUMB;IP1 of the Hand;Interphalangeal Joint 1 of the Hand | A condyloid synovial joint within the thumb connecting the proximal and distal phalanges. | Interphalangeal Thumb Joint | ||
| INTERVENTRICULAR SEPTUM | C32874 | The wall that separates the left and right ventricles of the heart. (NCI) | Interventricular Septum | |||
| INTESTINE | C12736 | Intestine | The portion of the gastrointestinal tract between the stomach and the anus. It includes the small intestine and large intestine. (NCI) | Intestine | ||
| INTRAHEPATIC BILE DUCT | C12677 | The bile ducts that pass through and drain bile from the liver. (NCI) | Intrahepatic Bile Duct | |||
| INTRATHORACIC LYMPH NODE | C12359 | Any lymph node within the thoracic cavity. | Intrathoracic Lymph Node | |||
| ISCHIAL TUBEROSITY | C105446 | The bony prominence of the lower part of the ischium. (NCI) | Ischial Tuberosity | |||
| ISCHIORECTAL FOSSA | C103455 | A tetrahedral region of adipose tissue located in the ischiorectal region with its base between the tuberosity of the ischium and the lower end of the rectum and its apex at the point where the obturator fascia and the Levator ani membrane divide. | Ischiorectal Fossa | |||
| ISCHIUM | C32884 | Ischium | The most posterior and ventral bone making up the pelvis. (NCI) | Ischium | ||
| JEJUNUM | C12388 | Jejunum | The portion of the small intestine that extends from the duodenum to the ileum. (NCI) | Jejunum | ||
| JOINT | C13044 | Articulation;Joint | The connection point between two bones or skeletal elements. The joint may be fixed or movable. (NCI) | Joint | ||
| JUGULAR VEIN | C12738 | Vena Jugularis | Veins in the neck which drain the brain, face, and neck into the brachiocephalic or subclavian veins. (NCI) | Jugular Vein | ||
| KIDNEY | C12415 | Kidney | One of the two bean-shaped organs located on each side of the spine in the retroperitoneum. The right kidney is located below the liver and the left kidney below the diaphragm. The kidneys filter and secret the metabolic products and minerals from the blood, thus maintaining the homeostasis. On the superior pole of each kidney there is an adrenal gland. Each kidney and adrenal gland is surrounded by fat. (NCI) | Kidney | ||
| KIDNEY, CORTEX | C12739 | Renal Cortex | The outer zone of the KIDNEY, beneath the capsule, consisting of KIDNEY GLOMERULUS; KIDNEY TUBULES, DISTAL; and KIDNEY TUBULES, PROXIMAL. (MSH2001) | Renal Cortex | ||
| KIDNEY, HILUM | C32740 | Hilar Area of the Kidney | The concave area of the kidney through which the renal artery enters and the renal vein and ureter exit the organ. (NCI) | Hilar Area of the Kidney | ||
| KIDNEY, LOWER LOBE | C93180 | Lower Lobe of the Kidney | The lobe of the kidney located in the lowest portion of the kidney. (NCI) | Lower Lobe of Kidney | ||
| KIDNEY, MEDULLA | C12740 | Renal Medulla | The internal portion of the kidney, consisting of striated conical masses, the renal pyramids, whose bases are adjacent to the cortex and whose apices form prominent papillae projecting into the lumen of the minor calyces. (MSH2001) | Renal Medulla | ||
| KIDNEY, UPPER LOBE | C93179 | Upper Lobe of the Kidney | The lobe of the kidney located in the uppermost region of the kidney. (NCI) | Upper Lobe of Kidney | ||
| KNEE JOINT | C32898 | Knee Joint;Tibiofemoral Joint | A joint connecting the lower part of the femur with the upper part of the tibia. The lower part of the femur and the upper part of the tibia are attached to each other by ligaments. Other structures of the knee joint include the upper part of the fibula, located below and parallel to the tibia, and the patella which moves as the knee bends. (NCI) | Knee Joint | ||
| L1 VERTEBRA | C32899 | L1 Vertebra | The first lumbar vertebra counting from the top down. (NCI) | L1 Vertebra | ||
| L2 VERTEBRA | C32900 | L2 Vertebra | The second lumbar vertebra counting from the top down. (NCI) | L2 Vertebra | ||
| L2-L3 INTERVERTEBRAL SPACE | C112327 | The space between the L2 and L3 vertebrae. | L2-L3 Intervertebral Space | |||
| L3 VERTEBRA | C32901 | L3 Vertebra | The third lumbar vertebra counting from the top down. (NCI) | L3 Vertebra | ||
| L3-L4 INTERVERTEBRAL SPACE | C112328 | The space between the L3 and L4 vertebrae. | L3-L4 Intervertebral Space | |||
| L4 VERTEBRA | C32902 | L4 Vertebra | The fourth lumbar vertebra counting from the top down. (NCI) | L4 Vertebra | ||
| L5 VERTEBRA | C32903 | L5 Vertebra | The fifth lumbar vertebra counting from the top down. (NCI) | L5 Vertebra | ||
| LACRIMAL BONE | C32906 | Lacrimal Bone | A small rectangular thin plate forming part of the medial orbit wall. It is located posterior to the frontal process of the maxilla and articulates with the inferior nasal concha, ethmoid, frontal, and maxillary bones. (NCI) | Lacrimal Bone | ||
| LACRIMAL GLAND | C12346 | Paired, almond-shaped exocrine glands situated superior and posterior to each orbit of the eye that produce and secrete the watery serous component of tears. (NCI) | Lacrimal Gland | |||
| LAD SEPTAL PERFORATOR ARTERY | C102313 | LAD SEPTAL PERFORATOR ARTERY SEGMENTS;LAD SP | The arteries that arise from the left anterior descending (LAD) artery that supply the interventricular septum. | Left Anterior Descending Septal Perforator Artery | ||
| LARGE INTESTINE | C12379 | Large Intestine | A muscular tube that extends from the end of the small intestine to the anus. (NCI) | Large Intestine | ||
| LARYNX | C12420 | Larynx | The cartilaginous structure of the respiratory tract between the pharynx and the trachea. It contains elastic vocal cords required for sound production. (NCI) | Larynx | ||
| LATERAL FIRST DIAGONAL BRANCH ARTERY | C102307 | LAT 1ST DIAG;LATERAL FIRST DIAGONAL BRANCH ARTERY SEGMENT | The lateral branch distal to a bifurcation of the first diagonal artery. | Lateral First Diagonal Branch Artery | ||
| LATERAL FIRST OBTUSE MARGINAL BRANCH ARTERY | C102308 | First Obtuse Marginal Lateral Branch;LAT 1ST OM;LATERAL FIRST OBTUSE MARGINAL BRANCH ARTERY SEGMENT | The lateral branch distal to a bifurcation of the first obtuse marginal artery. | Lateral First Obtuse Marginal Branch Artery | ||
| LATERAL RAMUS INTERMEDIUS ARTERY | C102309 | LAT RAMUS;LATERAL RAMUS INTERMEDIUS ARTERY SEGMENT | The lateral branch distal to a bifurcation of the ramus intermedius artery. | Lateral Ramus Intermedius Artery | ||
| LATERAL SECOND DIAGONAL BRANCH ARTERY | C102310 | LAT 2ND DIAG;LATERAL SECOND DIAGONAL BRANCH ARTERY SEGMENT | The lateral branch distal to a bifurcation of the second diagonal artery. | Lateral Second Diagonal Branch Artery | ||
| LATERAL SECOND OBTUSE MARGINAL BRANCH ARTERY | C102311 | LAT 2ND OM;LATERAL SECOND OBTUSE MARGINAL BRANCH ARTERY SEGMENT;Second Obtuse Marginal Lateral Branch | The lateral branch distal to a bifurcation of the second obtuse marginal artery. | Lateral Second Obtuse Marginal Branch Artery | ||
| LATERAL THIRD DIAGONAL BRANCH ARTERY | C102312 | LAT 3RD DIAG;LATERAL THIRD DIAGONAL BRANCH ARTERY SEGMENT | The lateral branch distal to a bifurcation of the third diagonal artery. | Lateral Third Diagonal Branch Artery | ||
| LATERAL THIRD OBTUSE MARGINAL BRANCH ARTERY | C102425 | LAT 3RD OM;LATERAL THIRD OBTUSE MARGINAL BRANCH ARTERY SEGMENT;Third Obtuse Marginal Lateral Branch | The lateral branch distal to a bifurcation of the third obtuse marginal artery. | Lateral Third Obtuse Marginal Branch Artery | ||
| LEFT ANTERIOR DESCENDING ARTERY OSTIUM | C116175 | The opening of the left anterior descending coronary artery at its origin. | Left Anterior Descending Artery Ostium | |||
| LEFT ATRIOVENTRICULAR ARTERY | C116177 | The first posterolateral branch originating from the posterior atrioventricular left circumflex artery in left dominant and mixed circulations. | Left Atrioventricular Artery | |||
| LEFT CIRCUMFLEX ARTERY OSTIUM | C116176 | The opening of the left circumflex artery at its origin. | Left Circumflex Artery Ostium | |||
| LEFT CIRCUMFLEX CORONARY ARTERY | C12874 | An artery arising from the bifurcation of the left coronary artery that runs along the coronary groove. | Circumflex Branch of the Left Coronary Artery | |||
| LEFT MAIN CORONARY ARTERY BIFURCATION | C116174 | The portion of the distal end of the left main coronary artery that branches into the left anterior descending artery and the left circumflex artery. | Left Main Coronary Artery Bifurcation | |||
| LEFT MAIN CORONARY ARTERY BODY | C116173 | The segment of the left main coronary artery that is bounded by its ostium and bifurcation. | Left Main Coronary Artery Body | |||
| LEFT MAIN CORONARY ARTERY OSTIUM | C116172 | The opening of the left coronary artery at its origin. | Left Main Coronary Artery Ostium | |||
| LEFT POSTERIOR DESCENDING ARTERY | C116178 | The second posterolateral branch originating from the posterior atrioventricular left circumflex artery in left dominant and mixed circulations. | Left Posterior Descending Artery | |||
| LEFT POSTEROLATERAL DESCENDING ARTERY | C102314 | LEFT POSTEROLATERAL DESCENDING ARTERY SEGMENT;LPDA | In an individual with a left-dominant heart, this branch arises from the circumflex artery atrioventricular groove continuation and supplies the inferior apex of the heart. | Left Posterolateral Descending Artery | ||
| LEFT VENTRICULAR EPICARDIUM | C102315 | The outermost layer of cardiac tissue lining of the left ventricle. | Left Ventricular Epicardium | |||
| LEG | C32974 | Leg | One of the two lower extremities in humans used for locomotion and support. (NCI) | Leg | ||
| LEG SKIN | C52749 | Leg Skin | The skin or integument surrounding the leg. (NCI) | Leg Skin | ||
| LENS | C12743 | Crystalline Lens;Lens;Lens Of Eye;Ocular Lens | A biconvex transparent structure of the eye through which light is focused on the retina. The lens sits behind the iris and is supported by the zonule, which connects it to the ciliary body. The lens is an avascular structure. (NCI) | Lens | ||
| LESSER TROCHANTER | C32982 | A cone-shaped projection in the shaft of the femur in which the iliopsoas muscle is attached. (NCI) | Lesser Trochanter | |||
| LIGAMENT | C13046 | Ligament | Band of fibrous tissue connecting bone to bone or cartilage to bone thereby supporting or strengthening a joint. (NCI) | Ligament | ||
| LIMB | C12429 | Extremities;Limb | A body region referring to an upper or lower extremity. (NCI) | Limb | ||
| LIMB, LOWER | C12742 | Lower Extremity | The limb that is composed of the hip, thigh, leg and foot. (NCI) | Lower Extremity | ||
| LIMB, UPPER | C12671 | Upper Extremity | The region of the body that includes the arm, the forearm, and hand. (NCI) | Upper Extremity | ||
| LINGULA OF THE LUNG | C40373 | A small tongue-like projection from the lower portion of the upper lobe of the left lung. | Lingula of the Lung | |||
| LIP | C12220 | Lip | Fleshy fold which surrounds the opening of the mouth. (NCI) | Lip | ||
| LIP, LOWER | C12222 | External Lower Lip | The external surface of the lower lip. (NCI) | External Lower Lip | ||
| LIP, UPPER | C12221 | External Upper Lip | The external surface of the upper lip. (NCI) | External Upper Lip | ||
| LIVER | C12392 | Liver | A triangular-shaped organ located under the diaphragm in the right hypochondrium. It is the largest internal organ of the body, weighting up to 2 kg. Metabolism and bile secretion are its main functions. It is composed of cells which have the ability to regenerate. (NCI) | Liver | ||
| LIVER FISSURE | C32996 | Liver Fissure | A groove on the surface of the liver. | Liver Fissure | ||
| LIVER, CAUDATE LOBE | C33000 | The lobe of the liver situated posteriorly located between the left lobe and the inferior vena cava. | Caudate Lobe | |||
| LIVER, LEFT LOBE | C32965 | The smaller lobe of the liver extending into the left side of the body. | Left Lobe of the Liver | |||
| LIVER, QUADRATE LOBE | C112404 | An oblong shaped area of the liver that is situated inferior to the right lobe, bounded by the anterior margin of the liver and the porta hepatis. | Quadrate Lobe of Liver | |||
| LIVER, RIGHT LOBE | C33481 | The larger lobe of the liver extending into the right side of the body. | Right Lobe of the Liver | |||
| LOCUS CERULEUS | C97333 | A brainstem nucleus. It is the major brain site for the synthesis and secretion of norepinephrine. (NCI) | Locus Coeruleus | |||
| LUMBAR REGION | C34004 | The area of the body below the ribs and above the hipbones. (NCI) | Lumbar Region | |||
| LUMBAR SPINE | C69314 | The vertebrae located below the thoracic and above the sacral vertebrae. | Lumbar Spine | |||
| LUMBAR VERTEBRA | C12744 | Lumbar Vertebra | Any of the vertebrae situated between the thoracic vertebrae and the sacrum in the lower part of the spine. | Lumbar Vertebra | ||
| LUNATE BONE | C12786 | Lunate Bone | The bone in the proximal row of carpal bones that lies between the scaphoid and triquetral bones. (NCI) | Lunate Bone | ||
| LUNG | C12468 | Lung | One of a pair of viscera occupying the pulmonary cavities of the thorax, the organs of respiration in which aeration of the blood takes place. As a rule, the right lung is slightly larger than the left and is divided into three lobes (an upper, a middle, and a lower or basal), while the left has two lobes (an upper and a lower or basal). Each lung is irregularly conical in shape, presenting a blunt upper extremity (the apex), a concave base following the curve of the diaphragm, an outer convex surface (costal surface), an inner or mediastinal surface (mediastinal surface), a thin and sharp anterior border, and a thick and rounded posterior border. (NCI) | Lung | ||
| LUNG, HILUM | C49282 | Hilar Area of the Lung | The wedge-shaped area at the central portion of the lung through which the bronchi, vessels and nerves enter or exit the organ. (NCI) | Hilar Area of the Lung | ||
| LUNG, LEFT | C32967 | Left Lung | The 2-lobed lung located on the left side of the body. (NCI) | Left Lung | ||
| LUNG, LEFT LOWER LOBE | C33020 | Lower Lobe of the Left Lung | The larger lobe of the left lung, situated below and behind the oblique fissure. (NCI) | Lower Lobe of the Left Lung | ||
| LUNG, LEFT UPPER LOBE | C33021 | Upper Lobe of the Left Lung | The smaller lobe of the left lung, situated above and in front the oblique fissure, which includes the apex. (NCI) | Upper Lobe of the Left Lung | ||
| LUNG, RIGHT | C33483 | Right Lung | The 3-lobed lung located on the right side of the body. (NCI) | Right Lung | ||
| LUNG, RIGHT LOWER LOBE | C33022 | Lower Lobe of the Right Lung | The lobe of the right lung situated below the oblique fissure. (NCI) | Lower Lobe of the Right Lung | ||
| LUNG, RIGHT MIDDLE LOBE | C12286 | Middle Lobe of the Right Lung | The smallest lobe of the right lung, situated above the oblique fissure and below the horizontal fissure. (NCI) | Middle Lobe of the Right Lung | ||
| LUNG, RIGHT UPPER LOBE | C33023 | Upper Lobe of the Right Lung | The lobe of the right lung, situated above the horizontal fissure, which includes the apex. (NCI) | Upper Lobe of the Right Lung | ||
| LYMPH NODE | C12745 | Lymph Node;Lymphatic Gland | A bean-shaped organ surrounded by a connective tissue capsule. It is part of the lymphatic system and is found through out the body. It is composed predominantly of lymphocytes and its main function is immune protection. (NCI) | Lymph Node | ||
| LYMPH NODE HILUM | C33031 | Lymph Node Hilum | The concave side of the lymph node. (NCI) | Lymph Node Hilum | ||
| MAIN BRONCHUS, LEFT | C32968 | Left Main Bronchus | One of the two main bronchi. It is narrower but longer than the right main bronchus and connects to the left lung. (NCI) | Left Main Bronchus | ||
| MAIN BRONCHUS, RIGHT | C33486 | Right Main Bronchus | One of the two main bronchi. It is wider but shorter than the left main bronchus and connects to the right lung. (NCI) | Right Main Bronchus | ||
| MALE GENITALIA | C61599 | Male Genitalia | Male internal and external organs of reproduction. | Male Genitalia | ||
| MALE REPRODUCTIVE SYSTEM | C12722 | The sex organs of the male. | Male Reproductive System | |||
| MALLEUS | C33051 | Malleus | A hammer-shaped bone, part of three interconnected small bones located in the middle ear. It is attached to the inner surface of the tympanic membrane and its function is to transmit sound vibrations. (NCI) | Malleus | ||
| MAMMARY GLAND | C12367 | Lactiferous glands consisting of fibrous tissue connecting the lobes and fatty tissue in between the lobes. | Mammary Gland | |||
| MANDIBLE | C12290 | Bone, Mandibular;Inferior Maxillary Bone;Lower Jaw;Mandible | The lower jaw bone holding the lower teeth. (NCI) | Mandible | ||
| MASTOID PROCESS | C12503 | Mastoid Process | A honeycombed section of bone located near the base of the skull, protruding behind the outer ear. It is connected to the middle ear. (NCI) | Mastoid Process | ||
| MAXILLA | C26470 | Maxilla | The upper jawbone in vertebrates: it is fused to the cranium. (NCI) | Maxilla | ||
| MAXILLARY SINUS | C12275 | Maxillary Sinus | A pyramidal-shaped, thin-walled, air-filled cavity located in the maxilla. It is lined by mucus membrane and periosteum (mucoperiosteum) which contains cilia. It is adjacent to the nasal cavity and communicates with the middle meatus of the nose. It is the largest paranasal sinus and is composed of three recesses: alveolar, zygomatic, and infraorbital. (NCI) | Maxillary Sinus | ||
| MEDIAN OR LOWER CERVICAL LYMPH NODE | C103417 | A lymph node located in the median or lower region of the neck. (NCI) | Median Or Lower Cervical Lymph Node | |||
| MEDIASTINAL LYMPH NODE | C33073 | Mediastinal Lymph Node | A lymph node located in the mediastinum. Mediastinal lymph nodes are arranged in three groups, one on the lateral, another on the medial, and a third on the anterior aspect of the vessels; the third group is, however, sometimes absent. (NCI) | Mediastinal Lymph Node | ||
| MEDIASTINUM | C12748 | Mediastinum | A group of organs surrounded by loose connective tissue, separating the two pleural sacs, between the sternum anteriorly and the vertebral column posteriorly as well as from the thoracic inlet superiorly to the diaphragm inferiorly. The mediastinum contains the heart and pericardium, the bases of the great vessels, the trachea and bronchi, esophagus, thymus, lymph nodes, thoracic duct, phrenic and vagus nerves, and other structures and tissues. (NCI) | Mediastinum | ||
| MEDIASTINUM, ANTERIOR | C32098 | Anterior Mediastinum | The area between the lungs; it contains the thymus, some lymph nodes, and vessels and branches of the internal thoracic artery. (NCI) | Anterior Mediastinum | ||
| MEDIASTINUM, MIDDLE | C33123 | Middle Mediastinum | The broadest part of the lower portion of the mediastinum. It contains the heart and the great vessels. (NCI) | Middle Mediastinum | ||
| MEDIASTINUM, POSTERIOR | C33368 | Posterior Mediastinum | The part of the lower portion of the mediastinum that is located behind the pericardium. (NCI) | Posterior Mediastinum | ||
| MEDIASTINUM, SUPERIOR | C33684 | Superior Mediastinum | The part of the mediastinum that is located between the upper part of the sternum in the front and the upper thoracic vertebrae in the back. (NCI) | Superior Mediastinum | ||
| MEDULLA OBLONGATA | C12442 | Medulla Oblongata | The lower portion of the brainstem located between the pons and brainstem. This structure contains several descending and ascending tracts, lower cranial nerve nuclei, a significant proportion of the reticular system of the brainstem and other structures. (NCI) | Medulla Oblongata | ||
| MESENTERIC LYMPH NODE | C77641 | A lymph node located in the mesentery. (NCI) | Mesenteric Lymph Node | |||
| MESENTERY | C33103 | A double layer of peritoneum that attaches to the back wall of the abdominal cavity and supports the small intestines. (NCI) | Mesentery | |||
| METACARPAL BONE | C12751 | Any of the five bones between the wrist and the fingers that form the skeleton of the palm. (NCI) | Metacarpal Bone | |||
| METACARPOPHALANGEAL JOINT 1 | C102316 | MCP1 | A condyloid synovial joint within the first digit of the hand connecting the metacarpal to the proximal phalanx. | Metacarpophalangeal Joint 1 | ||
| METACARPOPHALANGEAL JOINT 2 | C102317 | MCP2 | A condyloid synovial joint within the second digit of the hand connecting the metacarpal to the proximal phalanx. | Metacarpophalangeal Joint 2 | ||
| METACARPOPHALANGEAL JOINT 3 | C102318 | MCP3 | A condyloid synovial joint within the third digit of the hand connecting the metacarpal to the proximal phalanx. | Metacarpophalangeal Joint 3 | ||
| METACARPOPHALANGEAL JOINT 4 | C102319 | MCP4 | A condyloid synovial joint within the fourth digit of the hand connecting the metacarpal to the proximal phalanx. | Metacarpophalangeal Joint 4 | ||
| METACARPOPHALANGEAL JOINT 5 | C102320 | MCP5 | A condyloid synovial joint within the fifth digit of the hand connecting the metacarpal to the proximal phalanx. | Metacarpophalangeal Joint 5 | ||
| METATARSAL BONE | C12752 | Metatarsal Bone | A bone belonging to the middle part of the foot located between toes and ankle. There are 5 metatarsal bones and they are numbered from the medial side. (NCI) | Metatarsal Bone | ||
| METATARSOPHALANGEAL JOINT | C33108 | Metatarsophalangeal Joint | A spheroid joint located between the heads of the metatarsal bone and the base of the proximal phalanx of the toe. (NCI) | Metatarsophalangeal Joint | ||
| METATARSOPHALANGEAL JOINT 1 | C102321 | MTP1 | A condyloid synovial joint within the first digit of the foot connecting metatarsal with the proximal phalanx. | Metatarsophalangeal Joint 1 | ||
| METATARSOPHALANGEAL JOINT 2 | C102322 | MTP2 | A condyloid synovial joint within the second digit of the foot connecting metatarsal with the proximal phalanx. | Metatarsophalangeal Joint 2 | ||
| METATARSOPHALANGEAL JOINT 3 | C102323 | MTP3 | A condyloid synovial joint within the third digit of the foot connecting metatarsal with the proximal phalanx. | Metatarsophalangeal Joint 3 | ||
| METATARSOPHALANGEAL JOINT 4 | C102324 | MTP4 | A condyloid synovial joint within the fourth digit of the foot connecting metatarsal with the proximal phalanx. | Metatarsophalangeal Joint 4 | ||
| METATARSOPHALANGEAL JOINT 5 | C102325 | MTP5 | A condyloid synovial joint within the fifth digit of the foot connecting metatarsal with the proximal phalanx. | Metatarsophalangeal Joint 5 | ||
| MID-CIRCUMFLEX ARTERY | C102326 | MCIRC;MID-CIRCUMFLEX ARTERY SEGMENT | The segment of the left circumflex artery between the first and second marginal branches. | Mid-Circumflex Artery | ||
| MID-LAD ARTERY | C102328 | MID-LAD ARTERY SEGMENT;MLAD | The segment of the left anterior descending (LAD) artery between the first and third diagonal branches. | Mid-Left Anterior Descending Artery | ||
| MID-RIGHT CORONARY ARTERY CONDUIT | C102329 | MID-RIGHT CORONARY ARTERY CONDUIT SEGMENT;MRCA;Mid-right Coronary Artery | The section of the right coronary artery between the right ventricular artery and the acute marginal artery. | Mid-Right Coronary Artery Conduit | ||
| MID/DISTAL LEFT ANTERIOR DESCENDING CORONARY ARTERY AND ALL DIAGONAL CORONARY BRANCHES | C102327 | All of the arterial branches distal to the proximal left anterior descending coronary artery. | Mid-Distal Left Anterior Descending Coronary Artery and All Diagonal Coronary Branches | |||
| MIDBRAIN | C12510 | Mesencephalon;Midbrain | The uppermost portion of the brainstem located between the pons and the diencephalon. The midbrain contains the cerebral peduncles, oculomotor, trochlear and red nuclei, substantia nigra and various other nuclei and tracts. (NCI) | Mesencephalon | ||
| MIDDLE EAR | C12274 | Middle Ear | The part of the ear including the eardrum and ossicles. The middle ear leads to the inner ear. (NCI) | Middle Ear | ||
| MITRAL VALVE | C12753 | A dual-flap valve of the heart that regulates the flow of blood between the left atrium and the left ventricle of the heart. (NCI) | Mitral Valve | |||
| MOTOR CORTEX | C97339 | A brain region that is located in the dorsal part of the precentral gyrus. (NCI) | Primary Motor Cortex | |||
| MUCOSA | C13166 | Mucosa;Mucous Membrane | The moist, inner lining of some organs and body cavities (such as the nose, mouth, lungs, and stomach). Glands in the mucosa make mucus (a thick, slippery fluid). | Mucosa | ||
| MUCOSA OF THE LIP | C12226 | The lining of the fleshy folds surrounding the mouth. It is comprised of the epithelium, basement membrane, lamina propria mucosae, and lamina muscularis mucosae. (NCI) | Mucosa of the Lip | |||
| MUSCLE | C13056 | A fibrous soft tissue with the ability to contract to produce force and motion. | Muscle | |||
| MYOMETRIUM | C12314 | Myometrium | The smooth muscle lining the uterus. (NCI) | Myometrium | ||
| NAIL | C33156 | Nail | The cutaneous plate on the dorsal surface of the distal end of a finger or toe. (NCI) | Nail | ||
| NASAL BONE | C33157 | Nasal Bone | One of two small oblong bones placed side by side at the middle and upper part of the face. (NCI) | Nasal Bone | ||
| NASAL CAVITY | C12424 | Nasal Cavity | The proximal portion of the respiratory passages on either side of the nasal septum lying between the floor of the cranium and the roof of the mouth and extending from the face to the pharynx. The nasal cavity is lined with ciliated mucosa, extending from the nares to the pharynx. (NCI) | Nasal Cavity | ||
| NASAL SEPTUM | C33160 | Nasal Septum | The thin wall between the two nasal cavities. (NCI) | Nasal Septum | ||
| NASOPHARYNX | C12423 | Nasopharynx | The part of the pharynx in the back of the throat, at and above the soft palate. The nasopharynx is continuous with the nasal passages. (NCI) | Nasopharynx | ||
| NAVICULAR BONE | C33162 | Navicular Bone | An oval-shaped bone of the tarsus found on the medial side of the foot. (NCI) | Navicular Bone | ||
| NECK | C13063 | Neck | The region that connects the head to the rest of the body. (NCI) | Neck | ||
| NERVE | C12466 | A bundle of fibers that transmits electrochemical impulses encoding sensory and motor information from one body part to another. | Nerve | |||
| NIPPLE | C12299 | Nipple | The pigmented protuberance on the surface of the breast through which milk is drawn from the breast. (NCI) | Nipple | ||
| NOSE | C12756 | Nose | A structure of special sense serving as an organ of the sense of smell and as an entrance to the respiratory tract. (NCI) | Nose | ||
| NOSTRIL | C33178 | Nostril | One of the two channels of the nose, from the point where they divide to the external opening. (NCI) | Nostril | ||
| NUCLEUS OF DIAGONAL BAND | C97342 | BASAL NUCLEUS/DIAGONAL BAND | A brain structure that is part of the septal nuclear complex. It is connected with the hippocampus, hypothalamus and amygdala. | Nucleus of Diagonal Band | ||
| OCCIPITAL LOBE | C12355 | The posterior part of the cerebral hemisphere. (MeSH) | Occipital Lobe | |||
| OCCIPITAL LYMPH NODE | C98188 | A lymph node located in the back of the head adjacent to the trapezius muscle. | Occipital Lymph Node | |||
| OCCIPITAL SCALP | C103456 | The occipital region of the skin that covers the top of the head. (NCI) | Occipital Scalp | |||
| OCULOMOTOR NERVE | C12758 | The third cranial nerve. | Oculomotor Nerve | |||
| ODONTOGENIC TISSUE | C33794 | Teeth | The tissue that forms the tooth. It consists of the dental pulp, dentin, enamel, cementum, odontogenic epithelium, and periodontium. (NCI) | Odontogenic Tissue | ||
| OLECRANON | C33200 | Olecranon | A prominence at the proximal end of the ulna. It forms the tip of the elbow. (NCI) | Olecranon | ||
| OLFACTORY BULB | C28401 | Olfactory Bulb | Anatomical structure located in the vertebral forebrain that receives neural input regarding odors that have been detected by cells within the nasal cavity. The axons of olfactory receptor cells extend into the olfactory bulb. (NCI) | Olfactory Bulb | ||
| OLFACTORY MUCOSA | C33205 | Olfactory Mucosa | The part of the nasal mucosa composed of neuroepithelial tissue and mucus-producing Bowman's glands. The mucus moistens the epithelium and helps dissolve odor-containing gases. (NCI) | Olfactory Mucosa | ||
| OLFACTORY NERVE | C12759 | The first cranial nerve. | Olfactory Nerve | |||
| OMENTUM | C33209 | Omental Fat | A fold of peritoneum originating at the stomach and supporting the viscera. (NCI) | Omentum | ||
| OPTIC DISC | C12760 | Optic Nerve Head;Optic Papilla;Second Cranial Nerve | A portion of the retina at which the axons of the ganglion cells exit the eyeball to form the optic nerve. No light-sensitive photoreceptors are contained within this portion of the retina. (NCI) | Optic Disc | ||
| OPTIC NERVE | C12761 | Optic Nerve | The second cranial nerve. (NCI) | Optic Nerve | ||
| ORAL CAVITY | C12421 | Mouth;Oral Cavity | The cavity located at the upper end of the alimentary canal, behind the teeth and gums that is bounded on the outside by the lips, above by the hard and soft palates and below by the tongue. (NCI) | Oral Cavity | ||
| ORAL MUCOSA | C77637 | Moist tissue lining the oral cavity, containing mucus secreting glands. | Oral Mucosa | |||
| ORBIT | C12347 | Eye Socket;Ocular Orbit;Orbit;Orbital Cavity | The bony cavity of the skull which contains the eye, anterior portion of the optic nerve, ocular muscles and ocular adnexa. Seven bones contribute to the structure of the orbit: the frontal, maxillary, zygomatic, sphenoid, lacrimal, ethmoid, and palatine bones. (NCI) | Orbit | ||
| OROPHARYNX | C12762 | The part of the pharynx between the soft palate and the upper portion of the epiglottis. (NCI) | Oropharynx | |||
| OVARY | C12404 | Ovary | One of the paired female reproductive glands containing the ova or germ cells; the ovary's stroma is a vascular connective tissue containing numbers of ovarian follicles enclosing the ova. (NCI) | Ovary | ||
| PALATINE BONE | C52745 | Palatine Bone | An irregularly shaped bone positioned at the back part of the nasal cavity between the maxilla and the pterygoid process of the sphenoid. It forms the posterior part of the hard palate and the lateral wall of the nasal fossa and helps to form the floor of the orbit as well as several adjoining parts. (NCI) | Palatine Bone | ||
| PALM | C33252 | The undersurface of the hand. (NCI) | Palmar Region | |||
| PANCREAS | C12393 | Pancreas | An organ behind the lower part of the stomach that is the shape of a fish and about the size of a hand. It is a compound gland composed of both exocrine and endocrine tissues. The endocrine pancreas makes insulin so that the body can use glucose (sugar) for energy. The exocrine pancreas makes enzymes that help the body digest food. Spread all over the pancreas are areas called the Islets of Langerhans. The cells in these areas each have a special purpose. The alpha cells make glucagon, which raises the level of glucose in the blood; the beta cells make insulin; the delta cells make somatostatin. There are also PP cells and D1 cells, about which little is known. (NCI) | Pancreas | ||
| PANCREAS, BODY | C12270 | Body of the Pancreas | The part of the pancreas from the point where it crosses the portal vein to the point where it enters the lienorenal ligament. (NCI) | Body of the Pancreas | ||
| PANCREAS, ENDOCRINE | C12608 | Endocrine Pancreas | The pancreatic tissue that contains the islets of Langerhans. It is responsible for the production and secretions of the pancreatic hormones. (NCI) | Islet of Langerhans | ||
| PANCREAS, EXOCRINE | C32546 | Exocrine Pancreas | An enzyme producing region of the pancreatic tissue containing the pancreatic acini and exocrine intralobular ducts which collectively secrete the digestive enzymes into the main pancreatic duct to drain into the duodenal part of the small intestine. (NCI) | Exocrine Pancreas | ||
| PANCREAS, HEAD | C12269 | Head of the Pancreas | That portion of the pancreas lying in the concavity of the duodenum. (NCI) | Head of the Pancreas | ||
| PANCREAS, TAIL | C12271 | Tail of the Pancreas | The left extremity of the pancreas within the lienorenal ligament. (NCI) | Tail of the Pancreas | ||
| PARA-AORTIC LYMPH NODE | C77643 | Lymph Node, Para-Aortic | A lymph node located adjacent to the lumbar region of the spine. (NCI) | Paraaortic Lymph Node | ||
| PARACAVAL LYMPH NODE | C117869 | A lymph node located adjacent to the lumbar region of the spine, along the right lateral aspect of the inferior vena cava. (NCI) | Paracaval Lymph Node | |||
| PARAMETRIUM | C12320 | Parametrium | The subserous connective tissue of the pelvic floor of the supracervical portion of the uterus. The parametrium extends laterally between the layers of the broad ligament. (NCI) | Parametrium | ||
| PARANASAL SINUS | C12763 | Accessory Sinuses;Nasal Cavity;Nasal Sinuses;Paranasal Sinus | An air-filled cavity adjacent to the nasal cavity lined by a mucous membrane and located in the bones of the skull. There are four paranasal sinuses on each side of the face: ethmoid, frontal, maxillary, and sphenoid sinus. (NCI) | Paranasal Sinus | ||
| PARASYMPATHETIC GANGLIA | C52557 | A usually small autonomic ganglion of the parasympathetic nervous system. The majority are located near or in the organs that they innervate. (NCI) | Parasympathetic Ganglion | |||
| PARATHYROID GLAND | C12765 | One of two small paired endocrine glands, superior and inferior, usually found embedded in the connective tissue capsule on the posterior surface of the thyroid gland; these glands secrete parathyroid hormone that regulates the metabolism of calcium and phosphorus. The parenchyma is composed of chief and oxyphilic cells arranged in anastomosing cords. (NCI) | Parathyroid Gland | |||
| PARATRACHEAL LYMPH NODE | C103426 | A lymph node located adjacent to the trachea within the mediastinum. (NCI) | Paratracheal Lymph Node | |||
| PARAVERTEBRAL GANGLIA | C97925 | A cluster of neuronal cell bodies and their dendrites located just ventral and lateral to the spinal cord that give rise to the sympathetic nervous system. | Para-Spinal Ganglion | |||
| PARIETAL LOBE | C12354 | Parietal Lobe | One of the lobes of the cerebral hemisphere located superiorly to the occipital lobe and posteriorly to the frontal lobe. Cognition and visuospatial processing are its main function. (NCI) | Parietal Lobe | ||
| PAROTID GLAND | C12427 | Parotid Gland | The largest of the three paired salivary glands, located in front of the ear. (NCI) | Parotid Gland | ||
| PAROTID GLAND LYMPH NODE | C33278 | Parotid Gland Lymph Node | A lymph node located close to, on, or within the parotid gland. (NCI) | Parotid Gland Lymph Node | ||
| PARS COMPACTA | C97341 | A part of the substantia nigra. The pars compacta nerve cells contain melanin and are involved in motor control. (NCI) | Pars Compacta | |||
| PATELLA | C33282 | Patella | A small flat triangular bone in front of the knee that articulates with the femur and protects the knee joint. (NCI) | Patella | ||
| PELVIC BONE | C33287 | Pelvic Bone;Pelvis Bone | The caudal portion of the trunk, bounded anteriorly and laterally by the two hip bones incorporating the socket portion of the hip joint for each leg. Posteriorly it is bounded by the sacrum and coccyx. (NCI) | Pelvic Bone | ||
| PELVIC LYMPH NODE | C12363 | Pelvic Lymph Node | Any lymph node within the pelvic region. (NCI) | Pelvic Lymph Node | ||
| PELVIS | C12767 | Pelvic Cavity;Pelvic Region;Pelvis | The bony, basin-shaped structure formed by the hipbones and the base of the backbone supporting the lower limbs in humans. (NCI) | Pelvis | ||
| PENIS | C12409 | Penis | The male organ of urination and copulation. (NCI) | Penis | ||
| PERIANAL REGION | C99148 | The skin area around the anus. (NCI) | Perianal Region | |||
| PERICARDIAL CAVITY | C38662 | Pericardial Cavity | The potential body space formed between the parietal and visceral layers of the pericardial sac. (NCI) | Pericardial Cavity | ||
| PERICARDIAL LYMPH NODE | C117870 | A lymph node located anterior to the pericardium, posterior to the xiphoid process, and in the right and left cardiophrenic fat. (NCI) | Pericardial Lymph Node | |||
| PERICARDIUM | C13005 | Pericardium | A conical membranous sac filled with serous fluid in which the heart as well as the roots of the aorta and other large blood vessels are contained. (NCI) | Pericardium | ||
| PERIHILAR LYMPH NODE | C102330 | A lymph node located in the area around the hilum. | Perihilar Lymph Node | |||
| PERINEUM | C33301 | Perineum | The area located between the anus and vulva in females, and anus and scrotum in males. (NCI) | Perineum | ||
| PERIPANCREATIC LYMPH NODE | C77642 | A lymph node of the pancreas. (NCI) | Pancreatic Lymph Node | |||
| PERIPHERAL NERVE | C12768 | Peripheral Nerve | Any nerve outside the brain or spinal cord that connects with peripheral receptors or effectors. (NCI) | Peripheral Nerve | ||
| PERITONEAL CAVITY | C12769 | Peritoneal Cavity | The lower part of the abdomen that contains the intestines (the last part of the digestive tract), the stomach, and the liver. It is bound by thin membranes. (NCI) | Peritoneal Cavity | ||
| PERITONEUM | C12770 | Peritoneum | The tissue that lines the wall of the abdominal cavity, intestine, and mesentery. It consists of the parietal peritoneum that covers the inside of the abdominal wall and the visceral peritoneum that covers the surface of the intestine and mesentery. (NCI) | Peritoneum | ||
| PERIURETHRAL REGION | C111287 | The tissue surrounding the urethra. | Periurethral Region | |||
| PERONEAL ARTERY | C33314 | An artery arising from the posterior tibial artery that supplies the muscles on the lateral side of the lower leg. | Peroneal Artery | |||
| PHARYNGEAL TONSIL | C33318 | Adenoid;Pharyngeal Tonsil | A fold of lymphatic tissue covered by ciliated epithelium at the very back of the nose, in the roof of the nasopharynx. (NCI) | Pharyngeal Tonsil | ||
| PHARYNX | C12425 | Pharynx | A hollow tube that starts posterior to the mouth and nasal cavity and ends superior to the trachea and esophagus. (NCI) | Pharynx | ||
| PINEAL GLAND | C12398 | A small endocrine gland within the diencephalon of the brain, situated beneath the back part of the corpus callosum, that secretes melatonin. | Pineal Gland | |||
| PISIFORM BONE | C12855 | Pisiform Bone | The medial bone of the proximal row of carpal bones. (NCI) | Pisiform Bone | ||
| PITUITARY GLAND | C12399 | Hypophysis;Hypophysis Cerebri | Pea-sized endocrine gland located at the base of the brain in the pituitary fossa. It produces and secretes hormones such as oxytocin and vasopressin, to regulate the activities of the hypothalamus. (NCI) | Pituitary Gland | ||
| PLEURA | C12469 | Pleural Tissue | The tissue that lines the wall of the thoracic cavity and the surface of the lungs. (NCI) | Pleura | ||
| PLEURAL CAVITY | C12840 | Pleural Cavity | The cavity lined by the pleura, located in the thorax and contains heart and lungs. (NCI) | Pleural Cavity | ||
| PONS VAROLII | C12511 | Pons Varolii | The middle portion of the brainstem located between the midbrain and the medulla oblongata. | Pons Varolii | ||
| POPLITEAL ARTERY ABOVE KNEE | C116180 | The segment of the popliteal artery that is located above the knee. | Popliteal Artery Above the Knee | |||
| POPLITEAL ARTERY BELOW KNEE | C116181 | The segment of the popliteal artery that is located below the knee. | Popliteal Artery Below the Knee | |||
| POPLITEAL LYMPH NODE | C53146 | Lymph node located within the fat layer of the knee joint. (NCI) | Popliteal Lymph Node | |||
| PORTA HEPATIS LYMPH NODE | C117871 | A lymph node located in the transverse fissure of the liver. (NCI) | Porta Hepatis Lymph Node | |||
| PORTACAVAL LYMPH NODE | C117872 | Portocaval Lymph Node | A lymph node located in the space between the portal vein and inferior vena cava, along the hepatoduodenal ligament. (NCI) | Portacaval Lymph Node | ||
| PORTAL LYMPH NODE | C77645 | Periportal Lymph Node | Lymph nodes surrounding the portal vein. (NCI) | Portal Lymph Node | ||
| PORTAL VEIN | C33343 | Hepatic Portal Vein;Portal Vein | A short thick trunk vein that transports blood containing the absorbed products of digestion from the intestine directly to the liver. (NCI) | Portal Vein | ||
| POSTERIOR CERVICAL LYMPH NODE | C103428 | A lymph node located in the posterior region of the neck. (NCI) | Posterior Cervical Lymph Node | |||
| POSTERIOR DESCENDING SEPTAL PERFORATORS ARTERY | C102348 | PDSP;POSTERIOR DESCENDING SEPTAL PERFORATORS ARTERY SEGMENT | The arteries arising from the right posterior descending artery that supply the interventricular septum. | Septal Perforator Artery | ||
| POSTERIOR TIBIAL ARTERY | C12826 | A terminal branch of the popliteal artery that runs along the tibia from the lower portion of the popliteus muscle to the lower ankle with numerous branches supplying the lower leg and foot. | Posterior Tibial Artery | |||
| POSTEROLATERAL SEGMENTAL ARTERY | C116170 | In an individual with a right-dominant heart, the arterial branch that arises from the distal right coronary artery in the posterior atrioventricular groove after the origin of the right posterior descending artery. | Posterolateral Coronary Artery | |||
| PREAURICULAR LYMPH NODE | C103429 | A lymph node located anterior to the auricle of the ear. (NCI) | Preauricular Lymph Node | |||
| PRECUNEUS | C112399 | The posteromedial region of the parietal lobe bounded by the marginal branch of the cingulate sulcus anteriorly, by the medial portion of the parieto-occipital fissure posteriorly and by the subparietal sulcus inferiorly. | Precuneus | |||
| PREPUTIAL GLAND | C79432 | Exocrine glands located at the anterior aspect of the genitals of some mammals, such as mice and rats, that produce and secrete pheromones. (NCI) | Preputial Gland | |||
| PRIMARY VISUAL CORTEX | C97340 | A brain region in the occipital cortex that receives visual stimuli from the retina. (NCI) | Primary Visual Cortex | |||
| PROFUNDA FEMORIS ARTERY | C32436 | An artery arising from the common femoral artery just below the inguinal ligament running close to the femur and ending in the lower third of the thigh with branches supplying the thigh muscles. | Deep Femoral Artery | |||
| PROSTATE GLAND | C12410 | Prostate Gland | The walnut shaped accessory sex gland of the male reproductive system. It is located in the pelvis just below the bladder, surrounding the prostatic part of the urethra. The prostate gland secretes a fluid which is part of the semen. (NCI) | Prostate Gland | ||
| PROSTATE GLAND, LATERAL LOBE | C13092 | Lateral Lobe of the Prostate | The prostate gland lobe that is located on the lateral side of the organ. (NCI) | Lateral Lobe of the Prostate | ||
| PROSTATE GLAND, MIDDLE LOBE | C13094 | Middle Lobe of the Prostate | The upper, smaller part of the prostate between the ejaculatory ducts and the urethra. (NCI) | Middle Lobe of the Prostate | ||
| PROSTATE GLAND, POSTERIOR LOBE | C13093 | Posterior Lobe of the Prostate | The prostate gland lobe that is located on the posterior side of the organ. (NCI) | Posterior Lobe of the Prostate | ||
| PROXIMAL CIRCUMFLEX ARTERY | C102331 | PCIRC;PROXIMAL CIRCUMFLEX ARTERY SEGMENT | The section of the left circumflex coronary artery that arises from the left main coronary artery and extends to the first marginal branch. | Proximal Circumflex Artery | ||
| PROXIMAL INTERPHALANGEAL JOINT 2 | C102332 | PIP2 | A condyloid synovial joint within the second digit of the hand or foot connecting the proximal and middle phalanges. (NCI) | Proximal Interphalangeal Joint 2 | ||
| PROXIMAL INTERPHALANGEAL JOINT 2 OF THE FOOT | C114205 | PIP2 of the Foot | A ginglymoid (hinge) synovial joint within the second digit of the foot connecting the proximal and middle phalanges. (NCI) | Proximal Interphalangeal Joint 2 of the Foot | ||
| PROXIMAL INTERPHALANGEAL JOINT 2 OF THE HAND | C114194 | PIP2 of the Hand | A ginglymoid (hinge) synovial joint within the second digit of the hand connecting the proximal and middle phalanges. (NCI) | Proximal Interphalangeal Joint 2 of the Hand | ||
| PROXIMAL INTERPHALANGEAL JOINT 3 | C102333 | PIP3 | A condyloid synovial joint within the third digit of the hand or foot connecting the proximal and middle phalanges. (NCI) | Proximal Interphalangeal Joint 3 | ||
| PROXIMAL INTERPHALANGEAL JOINT 3 OF THE FOOT | C114206 | PIP3 of the Foot | A ginglymoid (hinge) synovial joint within the third digit of the foot connecting the proximal and middle phalanges. (NCI) | Proximal Interphalangeal Joint 3 of the Foot | ||
| PROXIMAL INTERPHALANGEAL JOINT 3 OF THE HAND | C114195 | PIP3 of the Hand | A ginglymoid (hinge) synovial joint within the third digit of the hand connecting the proximal and middle phalanges. (NCI) | Proximal Interphalangeal Joint 3 of the Hand | ||
| PROXIMAL INTERPHALANGEAL JOINT 4 | C102334 | PIP4 | A condyloid synovial joint within the fourth digit of the hand or foot connecting the proximal and middle phalanges. (NCI) | Proximal Interphalangeal Joint 4 | ||
| PROXIMAL INTERPHALANGEAL JOINT 4 OF THE FOOT | C114207 | PIP4 of the Foot | A ginglymoid (hinge) synovial joint within the fourth digit of the foot connecting the proximal and middle phalanges. (NCI) | Proximal Interphalangeal Joint 4 of the Foot | ||
| PROXIMAL INTERPHALANGEAL JOINT 4 OF THE HAND | C114196 | PIP4 of the Hand | A ginglymoid (hinge) synovial joint within the fourth digit of the hand connecting the proximal and middle phalanges. (NCI) | Proximal Interphalangeal Joint 4 of the Hand | ||
| PROXIMAL INTERPHALANGEAL JOINT 5 | C102335 | PIP5 | A condyloid synovial joint within the fifth digit of the hand or foot connecting the proximal and middle phalanges. (NCI) | Proximal Interphalangeal Joint 5 | ||
| PROXIMAL INTERPHALANGEAL JOINT 5 OF THE FOOT | C114208 | PIP5 of the Foot | A ginglymoid (hinge) synovial joint within the fifth digit of the foot connecting the proximal and middle phalanges. (NCI) | Proximal Interphalangeal Joint 5 of the Foot | ||
| PROXIMAL INTERPHALANGEAL JOINT 5 OF THE HAND | C114197 | PIP5 of the Hand | A ginglymoid (hinge) synovial joint within the fifth digit of the hand connecting the proximal and middle phalanges. (NCI) | Proximal Interphalangeal Joint 5 of the Hand | ||
| PROXIMAL LAD ARTERY | C102336 | PLAD;PROXIMAL LAD ARTERY SEGMENT | The section of the left anterior descending coronary artery that arises from the left main coronary artery and extends to the first diagonal branch. | Proximal Left Anterior Descending Artery | ||
| PROXIMAL RIGHT CORONARY ARTERY CONDUIT | C102337 | PRCA;PROXIMAL RIGHT CORONARY ARTERY CONDUIT SEGMENT | The section of the right coronary artery proximal to the origin of the right ventricular artery. | Proximal Right Coronary Artery Conduit | ||
| PUBIC BONE | C33423 | Either of the two bones (left and right) that form the front of the pelvis. (NCI) | Pubic Bone | |||
| PUTAMEN | C12452 | Putamen | The largest and most lateral of the basal ganglia lying between the lateral medullary lamina of the globus pallidus and the external capsule. It is part of the neostriatum and forms part of the lentiform nucleus along with the globus pallidus. (MeSH) | Putamen | ||
| PYLORIC SPHINCTER | C33433 | Pyloric Sphincter | The muscular structure at the distal portion of the stomach, opening into the duodenum. (NCI) | Pyloric Sphincter | ||
| QUADRICEPS MUSCLE | C33441 | Muscle, Quadriceps;Muscle, Thigh | A group of four powerful muscles in the front of the thigh. Their actions involve the extension of the knee joint. (NCI) | Quadriceps Muscle of the Thigh | ||
| RADIAL ARTERY | C12838 | Radial Artery | The branch of the brachial artery that passes down the forearm. (NCI) | Radial Artery | ||
| RADIUS | C12777 | Radius;Radius Bone | The long bone that extends from the lateral aspect of the elbow to the medial side of the carpus. | Radius Bone | ||
| RAMUS INTERMEDIUS ARTERY | C102338 | RAMUS;RAMUS ARTERY;RAMUS INTERMEDIUS ARTERY SEGMENT | An artery that arises from the left main coronary artery and is positioned between the left anterior descending coronary artery and the circumflex artery. | Ramus Intermedius Artery | ||
| RAPHE | C97335 | A group of nuclei that are located in the midline of the brainstem and release serotonin. (NCI) | Raphe Nuclei | |||
| RECTOSIGMOID JUNCTION | C54188 | The area where the sigmoid colon joins the rectum. | Rectosigmoid Region | |||
| RECTUM | C12390 | The terminal portion of the gastrointestinal tract, extending from the rectosigmoid junction to the anal canal. (NCI) | Rectum | |||
| RECTUS FEMORIS MUSCLE | C53175 | One of the four quadriceps muscles, located in the middle of the front of the thigh. Its actions involve the extension of the knee joint and flexion of the hip. (NCI) | Rectus Femoris | |||
| REGIONAL LYMPH NODE | C49018 | Regional Lymph Node | A lymph node that drains lymph from a region of interest. (NCI) | Regional Lymph Node | ||
| RENAL ARTERY | C12778 | Either of two arteries (right or left) that arise from the aorta to supply the kidneys. | Renal Artery | |||
| RENAL PELVIS | C12887 | The funnel-shaped proximal portion of the ureter located within the kidney into which urine is secreted, from the collecting duct system of the kidney. (NCI) | Renal Pelvis | |||
| RETINA | C12343 | Retina | A light-sensitive membrane that lines the back wall of the eyeball. The retina is continuous with the optic nerve and this way transmits optical images to the brain. (NCI) | Retina | ||
| RETINAL NERVE FIBER LAYER | C32953 | A retina layer that contains the axons of ganglion cells. It collects the visual impulses. (NCI) | Layer of the Ophthalmic Nerve Fibers | |||
| RETROCRURAL LYMPH NODE | C103439 | A lymph node located within the most inferior portion of the posterior mediastinum. (NCI) | Retrocrural Lymph Node | |||
| RETROPERITONEAL LYMPH NODE | C98189 | A lymph node located in the retroperitoneal space. (NCI) | Retroperitoneal Lymph Node | |||
| RETROPERITONEUM | C12298 | RETROPERITONEAL CAVITY | The back of the abdomen where the kidneys lie and the great blood vessels run. (NCI) | Retroperitoneum | ||
| RIB | C12782 | Rib | Any one of the paired bones, 12 on either side, extending from the thoracic vertebrae toward the median line on the ventral aspect of the trunk. The long curved bones which form the rib cage. Generally, ribs 1 to 7 are connected to the sternum by their costal cartilages and are called true ribs, whereas ribs 8 to 12 are termed false ribs. (NCI) | Rib | ||
| RIB 1 | C52770 | Rib 1 | The first rib counting from the top of the rib cage down. (NCI) | Rib 1 | ||
| RIB 10 | C52769 | Rib 10 | The tenth rib counting from the top of the rib cage down. (NCI) | Rib 10 | ||
| RIB 11 | C52768 | Rib 11 | The eleventh rib counting from the top of the rib cage down. (NCI) | Rib 11 | ||
| RIB 12 | C52767 | Rib 12 | The twelfth rib counting from the top of the rib cage down. (NCI) | Rib 12 | ||
| RIB 2 | C52766 | Rib 2 | The second rib counting from the top of the rib cage down. (NCI) | Rib 2 | ||
| RIB 3 | C52765 | Rib 3 | The third rib counting from the top of the rib cage down. (NCI) | Rib 3 | ||
| RIB 4 | C52764 | Rib 4 | The fourth rib counting from the top of the rib cage down. (NCI) | Rib 4 | ||
| RIB 5 | C52763 | Rib 5 | The fifth rib counting from the top of the rib cage down. (NCI) | Rib 5 | ||
| RIB 6 | C52762 | Rib 6 | The sixth rib counting from the top of the rib cage down. (NCI) | Rib 6 | ||
| RIB 7 | C52761 | Rib 7 | The seventh rib counting from the top of the rib cage down. (NCI) | Rib 7 | ||
| RIB 8 | C52760 | Rib 8 | The eighth rib counting from the top of the rib cage down. (NCI) | Rib 8 | ||
| RIB 9 | C52759 | Rib 9 | The ninth rib counting from the top of the rib cage down. (NCI) | Rib 9 | ||
| RIGHT ATRIAL ENDOCARDIUM | C102339 | The innermost layer of endothelial cells and connective tissue that lines the right atrium. | Right Atrial Endocardium | |||
| RIGHT CORONARY ARTERY OSTIUM | C116169 | The opening of the right coronary artery at its origin. | Right Coronary Artery Ostium | |||
| RIGHT CORONARY ARTERY, RIGHT POSTERIOR DESCENDING, RIGHT POSTERIOLATERAL AND ACUTE MARGINAL BRANCHES | C102340 | The right coronary artery and all of its branches. | Right Coronary Artery and its Branches | |||
| RIGHT POSTERIOR ATRIOVENTRICULAR ARTERY | C102341 | RIGHT POSTERIOR ATRIOVENTRICULAR ARTERY SEGMENT;RPAV | The arterial branch between the right posterior descending artery segment and the first right posterolateral segment. | Right Posterior Atrioventricular Artery | ||
| RIGHT POSTERIOR DESCENDING ARTERY | C102342 | RIGHT POSTERIOR DESCENDING ARTERY SEGMENT;RPDA | In an individual with a right-dominant heart, the arterial branch that arises from the distal right coronary artery between the acute marginal artery and the first right posterolateral segment. It supplies the inferior apex of the heart. | Right Posterior Descending Artery | ||
| RIGHT VENTRICULAR BRANCH | C116171 | The branch of the right coronary artery that supplies blood to the right ventricular wall. | Right Ventricular Branch of Right Coronary Artery | |||
| RIGHT VENTRICULAR ENDOCARDIUM | C102343 | The innermost layer of endothelial cells and connective tissue that lines the right ventricle. | Right Ventricular Endocardium | |||
| SACRAL TUBEROSITY | C105447 | The prominence on the lateral surface of the sacrum, posterior to the auricular surface of the sacrum. (NCI) | Sacral Tuberosity | |||
| SACRAL VERTEBRA | C12853 | Sacral Vertebra | Any of the vertebrae forming the triangular bone just below the lumbar vertebrae. | Sacral Vertebra | ||
| SACROILIAC JOINT | C33507 | Sacroiliac Joint | The joint located between the sacrum and the ilium. (NCI) | Sacroiliac Joint | ||
| SACRUM | C33508 | Sacrum | The triangular bone, made up of 5 fused bones of the spine, located in the lower area of the spine between the fifth lumbar vertebra and the coccyx. (NCI) | Sacrum | ||
| SALIVARY GLAND | C12426 | An exocrine gland that secretes saliva. Salivary glands are mostly located in and around the oral cavity. | Salivary Gland | |||
| SAPHENOUS VEIN | C33511 | Saphenous Vein | One of two (Greater, Small) superficial veins of the leg and thigh. (NCI) | Saphenous Vein | ||
| SCALP | C89807 | The skin which covers the top of the head and which is usually covered by hair. (NCI) | Scalp | |||
| SCAPHOID BONE | C12854 | Scaphoid Bone | A nut-shaped bone of the wrist located in the radial site of the hand. It is one of the eight carpal bones. (NCI) | Scaphoid Bone | ||
| SCAPULA | C12783 | Scapula;Shoulder Blade | The flat triangle-shaped bone that connects the humerus with the clavicle in the back of the shoulder. (NCI) | Scapula | ||
| SCIATIC NERVE | C52810 | Sciatic Nerve | The longest single nerve that is formed by the merging of the ventral rami of the L4, L5, and S1 in the pelvis and passes down the lower limb where it divides into the common peroneal and tibial nerves. (NCI) | Sciatic Nerve | ||
| SCLERA | C12784 | The white, opaque, fibrous, outer tunic of the eyeball, covering it entirely excepting the segment covered anteriorly by the cornea. It is essentially avascular but contains apertures for vessels, lymphatics, and nerves. It receives the tendons of insertion of the extraocular muscles and at the corneoscleral junction contains the canal of Schlemm. (From Cline et al., Dictionary of Visual Science, 4th ed) | Sclera | |||
| SCROTUM | C12785 | Scrotum | The musculocutaneous pouch that encloses the testicles. (NCI) | Scrotum | ||
| SEBACEOUS GLAND | C33519 | Small glands located within the epidermis, and associated with the hair follicle, that produce and secrete an oily substance that lubricates the skin and hair. (NCI) | Sebaceous Gland | |||
| SECOND DIAGONAL BRANCH ARTERY | C102344 | 2ND DIAG;SECOND DIAGONAL BRANCH ARTERY SEGMENT | The second artery arising from the left anterior descending (LAD) artery that supplies the anterolateral wall, when counted from proximal to distal. | Second Diagonal Branch Artery | ||
| SECOND LEFT POSTEROLATERAL BRANCH ARTERY | C102345 | 2ND LPL;SECOND LEFT POSTEROLATERAL BRANCH ARTERY SEGMENT | In an individual with a left-dominant heart, this is the second branch that arises from the circumflex artery atrioventricular groove continuation when counted from proximal to distal. It supplies the posterolateral wall. | Second Left Posterolateral Branch Artery | ||
| SECOND OBTUSE MARGINAL BRANCH ARTERY | C102346 | 2ND OM;SECOND OBTUSE MARGINAL BRANCH ARTERY SEGMENT | The second artery arising from the left circumflex artery that supplies the lateral wall, when counted from proximal to distal. | Second Obtuse Marginal Branch Artery | ||
| SECOND RIGHT POSTEROLATERAL ARTERY | C102347 | 2ND RPL;SECOND RIGHT POSTEROLATERAL ARTERY SEGMENT | In an individual with a right-dominant heart, this is the second branch that arises from the right coronary artery distal to the right posterior descending artery, when counted from proximal to distal. | Second Right Posterolateral Artery | ||
| SEMINAL VESICLE | C12787 | Seminal Sacs | One of the two paired glands in the male genitourinary system, posterior to the bladder and superior to the prostate gland, that produces fructose-rich seminal fluid which is a component of semen. These glands join the ipsilateral ductus deferens to form the ejaculatory duct. (NCI) | Seminal Vesicle | ||
| SEMITENDINOSUS MUSCLE | C53176 | A muscle located at the posterior and medial aspect of the thigh that extends the hip joint, flexes the knee joint and assists in medially rotating the knee. | Semitendinosus | |||
| SHOULDER | C25203 | Shoulder | The region of the body between the neck and the upper arm. (NCI) | Shoulder | ||
| SHOULDER JOINT | C33548 | Shoulder Joint | A ball-and-socket joint at the upper end of the humerus, located at the junction of humerus and scapula. (NCI) | Shoulder Joint | ||
| SINUS | C33556 | Sinus | A recess, cavity, or channel. (NCI) | Sinus | ||
| SKIN | C12470 | Integument;Skin | An organ that constitutes the external surface of the body. It consists of the epidermis, dermis, and skin appendages. (NCI) | Skin | ||
| SKIN OF THE AXILLA | C116164 | The skin or integument surrounding the axilla, or underarm. | Skin Of The Axilla | |||
| SKIN OF THE HEAD | C52757 | The skin or integument surrounding the head. | Head Skin | |||
| SKIN OF THE LIP | C12291 | The skin portion of the lip that contains hair. | Skin of the Lip | |||
| SKIN OF THE NECK | C52756 | The skin or integument surrounding the neck. | Neck Skin | |||
| SKIN OF THE TRUNK | C12295 | Skin of the Trunk | The skin or integument surrounding the trunk of the body. (NCI) | Skin of the Trunk | ||
| SKULL | C12789 | Bone, Cranial;Cranium;Skull | The bones that form the head, made up of the bones of the braincase and face. (NCI) | Skull | ||
| SMALL INTESTINE | C12386 | Small Intestine | The section of the intestines between the pylorus and cecum. The small intestine is approximately 20 feet long and consists of the duodenum, the jejunum, and the ileum. Its main function is to absorb nutrients from food as the food is transported to the large intestine. (NCI) | Small Intestine | ||
| SOFT PALATE | C12231 | A movable fold suspended from the posterior border of the hard palate. (MeSH) | Soft Palate | |||
| SOLE | C33326 | The undersurface of the foot. (NCI) | Plantar Region | |||
| SPINAL ACCESSORY NERVE | C32041 | ACCESSORY NERVE;CRANIAL ACCESSORY NERVE | The eleventh cranial nerve. | Accessory Nerve | ||
| SPINAL CORD | C12464 | Medulla Spinalis | The elongated, approximately cylindrical part of the central nervous system of vertebrates that lies in the vertebral canal and from which the spinal nerves emerge. (NCI) | Spinal Cord | ||
| SPINOUS PROCESS | C116112 | A bony projection arising from the posterior vertebral arch that serves for the attachment of muscles and ligaments. | Spinous Process | |||
| SPLEEN | C12432 | Spleen | An organ that is part of the hematopoietic and immune systems. It is composed of the white pulp and the red pulp and is surrounded by a capsule. It is located in the left hypochondriac region. Its functions include lymphocyte production, blood cell storage, and blood cell destruction. (NCI) | Spleen | ||
| SPLEEN, HILUM | C33601 | Splenic Hilum | The area of the spleen through which the vessels and nerves enter or exit the organ. (NCI) | Splenic Hilum | ||
| SPLENIC HILAR LYMPH NODE | C33600 | A lymph node located in the hilar region of the spleen. (NCI) | Splenic Hilar Lymph Node | |||
| STERNAL MANUBRIUM | C52730 | Sternal Manubrium | The upper segment of the sternum, quadrangular in shape, as well as wider superiorly and narrower inferiorly. The sternal manubrium articulates with the clavicle and first two ribs. (NCI) | Sternal Manubrium | ||
| STERNOCLAVICULAR JOINT | C33615 | Sternoclavicular Joint | The synovial juncture between the medial end of the clavicle and the anterior segment of the sternum. (NCI) | Sternoclavicular Joint | ||
| STERNUM | C12793 | Sterna;Sternum | The long, flat bone connecting with the cartilages of the first seven ribs and the clavicle. (NCI) | Sternum | ||
| STOMACH | C12391 | Stomach | An organ located under the diaphragm, between the liver and the spleen as well as between the esophagus and the small intestine. The stomach is the primary organ of food digestion. (NCI) | Stomach | ||
| SUBCARINAL LYMPH NODE | C117873 | A lymph node located in the thoracic cavity between the lungs. It is bordered by the carina of the trachea, lower lobe bronchus on the left and the bronchus intermedius on the right. (NCI) | Subcarinal Lymph Node | |||
| SUBCLAVIAN VEIN | C12794 | The vein that drains the axillary vein and joins the internal jugular vein to form the brachiocephalic vein. It runs parallel to the subclavian artery. | Subclavian Vein | |||
| SUBCUTIS | C33645 | Subcutaneous Adipose Tissue;Subcutaneous Tissue | Adipose tissue located under the dermis. It binds underlying structures with the skin. The subcutis is important in the regulation of temperature of the skin itself and the body. The size of this layer varies throughout the body and from subject to subject. | Subcutis | ||
| SUBGLOTTIS | C12280 | Subglottis | The area of the larynx below the vocal cords down to the trachea. (NCI) | Subglottis | ||
| SUBLINGUAL REGION | C102349 | A body region relating to the area under or adjacent to the tongue. | Sublingual Region | |||
| SUBMANDIBULAR LYMPH NODE | C77650 | Lymph Node, Submandibular | A lymph node located beneath the floor of the oral cavity. (NCI) | Submandibular Lymph Node | ||
| SUBSTANTIA NIGRA | C12453 | Substantia Nigra | A large cell mass extending forward, over the dorsal surface of the crus cerebri, from the rostral border of the pons into the subthalamic region. It is composed of a dorsal stratum of closely spaced pigmented cells, the pars compacta, and a larger ventral region of widely scattered cells, the pars reticulata. The pars compacta includes numerous cells that project forward to the striatum (caudate nucleus and putamen) and contain dopamine, which acts as the primary neurotransmitter at the synaptic endings. Other, apparently non-dopaminergic cells project to portions of the ventral nucleus of thalamus, the superior colliculus and reticular formation. The nigrostriatal projection is reciprocated by a striatonigral fiber system with multiple neurotransmitters, chief among which is gamma-aminobutyric acid (GABA). The substantia nigra is involved in the metabolic disturbances associated with Parkinson's disease and Huntington's disease. (NCI) | Substantia Nigra | ||
| SUBTALAR JOINT | C33653 | Talocalcaneal Joint | The plane synovial joint between the talus and calcaneus bones of the foot. | Subtalar Joint | ||
| SUDORIFEROUS GLAND | C33712 | Sweat Gland | The small coiled tubular glands in the skin that produce and secrete sweat. | Sweat Gland | ||
| SUPERFICIAL FEMORAL ARTERY | C33661 | The portion of the femoral artery distal to the branching of the deep femoral artery that runs close to the skin. | Superficial Femoral Artery | |||
| SUPERFICIAL LYMPH NODE | C102716 | A lymph node located in a superficial part of the body. | Superficial Lymph Node | |||
| SUPERIOR VENA CAVA | C12816 | The large vein that terminates in the right atrium and transports deoxygenated blood from the head, neck, arms, and chest to the heart. | Superior Vena Cava | |||
| SUPRACLAVICULAR LYMPH NODE | C12903 | Supraclavicular Lymph Node | A lymph node which is located above the clavicle. (NCI) | Supraclavicular Lymph Node | ||
| SUPRATENTORIAL BRAIN | C12512 | The part of the brain above the tentorium cerebellum. (NCI) | Supratentorial Brain | |||
| SYMPATHETIC GANGLIA | C12467 | A mass containing the cell bodies of sympathetic nerves. Sympathetic ganglia exist as paravertebral ganglia (located bilaterally adjacent to the spinal cord) or prevertebral ganglia (located close to the target organ). | Sympathetic Ganglion | |||
| SYNOVIAL FLUID | C33718 | Synovia;Synovial Fluid | A viscid fluid secreted by the synovial membrane, serving as a lubricant. (NCI) | Synovial Fluid | ||
| T1 VERTEBRA | C33720 | T1 Vertebra | The first thoracic vertebra counting from the top down. (NCI) | T1 Vertebra | ||
| T10 VERTEBRA | C33721 | T10 Vertebra | The tenth thoracic vertebra counting from the top down. (NCI) | T10 Vertebra | ||
| T11 VERTEBRA | C33722 | T11 Vertebra | The eleventh thoracic vertebra counting from the top down. (NCI) | T11 Vertebra | ||
| T12 VERTEBRA | C33723 | T12 Vertebra | The twelfth thoracic vertebra counting from the top down. (NCI) | T12 Vertebra | ||
| T2 VERTEBRA | C33724 | T2 Vertebra | The second thoracic vertebra counting from the top down. (NCI) | T2 Vertebra | ||
| T3 VERTEBRA | C33725 | T3 Vertebra | The third thoracic vertebra counting from the top down. (NCI) | T3 Vertebra | ||
| T4 VERTEBRA | C33726 | T4 Vertebra | The fourth thoracic vertebra counting from the top down. (NCI) | T4 Vertebra | ||
| T5 VERTEBRA | C33727 | T5 Vertebra | The fifth thoracic vertebra counting from the top down. (NCI) | T5 Vertebra | ||
| T6 VERTEBRA | C33728 | T6 Vertebra | The sixth thoracic vertebra counting from the top down. (NCI) | T6 Vertebra | ||
| T7 VERTEBRA | C33729 | T7 Vertebra | The seventh thoracic vertebra counting from the top down. (NCI) | T7 Vertebra | ||
| T8 VERTEBRA | C33730 | T8 Vertebra | The eighth thoracic vertebra counting from the top down. (NCI) | T8 Vertebra | ||
| T9 VERTEBRA | C33731 | T9 Vertebra | The ninth thoracic vertebra counting from the top down. (NCI) | T9 Vertebra | ||
| TALUS | C52799 | Talus | The bone of the foot that connects with the tibia and fibula to form the ankle joint. (NCI) | Talus | ||
| TARSUS BONE | C12796 | Bone, Tarsal;Tarsus;Tarsus Bone | Any one of the seven bones forming the instep of the foot. (NCI) | Tarsal Bone | ||
| TEMPORAL BONE | C12797 | Temporal Bone | A large irregular bone situated at the base and side of the skull, connected with the mandible via the temporomandibular joint. The temporal bone consists of the squamous, tympanic and petrous parts. The petrous portion of the temporal bone contains the vestibulocochlear organ of the inner ear. (NCI) | Temporal Bone | ||
| TEMPORAL LOBE | C12353 | Lower lateral part of the cerebral hemisphere. (MSH2001) | Temporal Lobe | |||
| TEMPOROMANDIBULAR JOINT | C32888 | Jaw Joint;TMJ | The joint between the head of the lower mandible and the temporal bone. (NCI) | Jaw Joint | ||
| TENTORIUM CEREBELLI | C33749 | A laminar extension of the dura mater that lies between, and separates, the cerebrum and the cerebellum. (NCI) | Tentorium Cerebelli | |||
| TESTIS | C12412 | Testicle;Testis | Either of the paired male reproductive glands that produce the male germ cells and the male hormones. (NCI) | Testis | ||
| THALAMUS | C12459 | Thalamus | An ovoid mass composed predominantly of gray substance and associated laminae of white substance. The thalamus is divided into anterior, medial, and lateral parts. The function of the thalamus is to relay sensory impulses and cerebellar and basal ganglia projections to the cerebral cortex. The thalamus is positioned within the posterior part of the diencephalon forming most of each lateral wall of the third ventricle. (NCI) | Thalamus | ||
| THIGH | C33763 | Thigh | A part of the lower limb, located between hip and knee. (NCI) | Thigh | ||
| THIRD DIAGONAL BRANCH ARTERY | C102350 | 3RD DIAG;THIRD DIAGONAL BRANCH ARTERY SEGMENT | The third artery arising from the left anterior descending (LAD) artery that supplies the anterolateral wall, when counted from proximal to distal. | Third Diagonal Branch Artery | ||
| THIRD OBTUSE MARGINAL BRANCH ARTERY | C102351 | 3RD OM;THIRD OBTUSE MARGINAL BRANCH ARTERY SEGMENT | The third artery arising from the left circumflex artery that supplies the lateral wall, when counted from proximal to distal. | Third Obtuse Marginal Branch Artery | ||
| THIRD POSTEROLATERAL DESCENDING ARTERY | C102352 | 3RD LPL;THIRD POSTEROLATERAL DESCENDING ARTERY SEGMENT | In an individual with a left-dominant heart, this is the third branch that arises from the circumflex artery atrioventricular groove continuation when counted from proximal to distal. It supplies the posterolateral wall. | Third Posterolateral Descending Artery | ||
| THIRD RIGHT POSTEROLATERAL ARTERY | C102353 | 3RD RPL;THIRD RIGHT POSTEROLATERAL ARTERY SEGMENT | In an individual with a right-dominant heart, this is the third branch that arises from the right coronary artery distal to the right posterior descending artery, when counted from proximal to distal. | Third Right Posterolateral Artery | ||
| THORACIC AORTA | C33766 | The section of the aorta between the lower border of the fourth dorsal vertebrae and the aortic opening in the diaphragm. (NCI) | Thoracic Aorta | |||
| THORACIC CAVITY | C12905 | Thoracic Cavity | The cavity in the vertebrate body enclosed by the ribs between the diaphragm and the neck and containing the lungs and heart. (NCI) | Thoracic Cavity | ||
| THORACIC LYMPH NODE | C33769 | Lymph node located in the thoracic cavity. (NCI) | Thoracic Lymph Node | |||
| THORACIC VERTEBRA | C12798 | Thoracic Vertebra | Any of the vertebrae situated between the cervical and lumbar vertebrae. | Thoracic Vertebra | ||
| THORAX | C12799 | Thorax | The division of the body lying between the neck and the abdomen. (NCI) | Thorax | ||
| THROAT | C54272 | Throat | The narrow passage from the mouth to the cavity at the back of the mouth. (NCI) | Throat | ||
| THYMUS GLAND | C12433 | Thymus Gland | A bi-lobed organ surrounded by a connective tissue capsule. It is located in the upper anterior portion of the chest, behind the sternum. It is composed predominantly of lymphocytes and fewer epithelial cells. Connective tissue septa separate the lobes into lobules. The lobules contain an outer portion (cortical zone) which is rich in lymphocytes and an inner portion (medullary zone) which is rich in epithelial cells. It is an organ essential for the development of the immune system. Its function is the maturation of the progenitor lymphoid cells to thymocytes and subsequently to mature T-cells. It reaches its greatest weight at puberty and subsequently begins to involute. (NCI) | Thymus Gland | ||
| THYROID GLAND | C12400 | Thyroid Gland | An endocrine gland located at the base of the neck that produces and secretes thyroxine and other hormones. Thyroxine is important for metabolic control. (NCI) | Thyroid Gland | ||
| THYROID GLAND ISTHMUS | C32887 | The narrow, central portion of the thyroid gland that crosses the trachea anteriorly and connects the two lobes of the gland. (NCI) | Thyroid Gland Isthmus | |||
| THYROID GLAND, LEFT LOBE | C32973 | Left Thyroid Gland Lobe | The cone-like lobe of the thyroid gland that is located in the left side of the trachea. (NCI) | Left Thyroid Gland Lobe | ||
| THYROID GLAND, RIGHT LOBE | C33491 | Right Thyroid Gland Lobe | The cone-like lobe of the thyroid gland that is located in the right side of the trachea. (NCI) | Right Thyroid Gland Lobe | ||
| TIBIA | C12800 | Tibia | A bone located between the femur and the tarsus, being part of the lower leg. (NCI) | Tibia | ||
| TIBIAL-CRURAL PERIPHERAL ARTERY | C116168 | The blood vessels segment that includes the crural artery and the tibial artery. | Tibialcrural Artery | |||
| TIBIALIS ANTERIOR MUSCLE | C117874 | A muscle that originates from the lateral condyle of tibia, spans the upper two-thirds of the lateral surface of the tibia, and is attached to the first cuneiform and metatarsal bones of the foot. It is a dorsiflexor of the ankle and invertor of the foot. | Tibialis Anterior Muscle | |||
| TIBIO-PERONEAL TRUNK | C116182 | An arterial trunk that contains parts of the posterior tibial artery and fibular artery. | Tibioperoneal Arterial Trunk | |||
| TOE | C33788 | Toe | One of the terminal digits of the foot. (NCI) | Toe | ||
| TOENAIL | C33790 | Toenail | A thin, horny translucent plate covering the end of each toe. (NCI) | Toenail | ||
| TONGUE | C12422 | Tongue | The muscular organ located in the floor of the mouth and serving as the principal organ of taste and modification of the voice in speech. (NCI) | Tongue | ||
| TONSIL | C12802 | Tonsil | The two organs situated in the throat on either side of the narrow passage from the mouth to the pharynx. They are composed of lymphoid tissues. (NCI) | Tonsil | ||
| TOOTH CANAL | C66864 | Tooth Canal | The anatomic space in the root of a tooth that contains nerves, blood vessels, and connective tissue. (NCI) | Tooth Canal | ||
| TRACHEA | C12428 | Trachea;Windpipe | The fibrocartilaginous, mucous-lined tube passing from the larynx to the bronchi. (NCI) | Trachea | ||
| TRACHEOBRONCHIAL TREE | C117875 | An anatomical structure comprised of trachea, bronchi, and bronchioles that terminate with the alveolar ducts, sacs, and alveoli. (NCI) | Tracheobronchial Tree | |||
| TRANSVERSE TARSAL JOINT | C102354 | A combination of syndesmosis and synovial joints formed by the articulation of the talus with the navicular and the calcaneus with the cuboid. | Transverse Tarsal Joint | |||
| TRAPEZIAL BONE | C12857 | Trapezial Bone | A carpal bone on the thumb side of the hand that articulates with the 1st and 2nd metacarpals. (NCI) | Trapezial Bone | ||
| TRAPEZIUS MUSCLE | C33809 | Trapezius Muscle | One of a pair of flat, large, triangular muscles that extend from the external occipital protuberance and the medial third of the superior nuchal line of the occipital bone to the middle of the back. The trapezius muscle is involved in moving the shoulder and arm. (NCI) | Trapezius Muscle | ||
| TRAPEZOID BONE | C12859 | Trapezoid Bone | A carpal bone located between the trapezium and capitate bones. (NCI) | Trapezoid Bone | ||
| TRIANGULAR BONE | C12858 | Triangular Bone | A carpal bone located between the lunate and pisiform bones. (NCI) | Triangular Bone | ||
| TRICUSPID VALVE | C12805 | A three-cusp valve of the heart that regulates the flow of blood between the right atrium and the right ventricle of the heart. (NCI) | Tricuspid Valve | |||
| TRIGEMINAL NERVE | C12806 | Fifth Cranial Nerve;Nervus Trigeminus;Trigeminal Nerve | The fifth set of paired nerves of the face that emerge from the brain steam. These nerves have sensory and motor functions in the face, oral cavity, and nasal cavity. (NCI) | Trigeminal Nerve | ||
| TROCHANTER | C33814 | Trochanter | A bony protrusion on the femoral bone to which muscles are attached. (NCI) | Trochanter | ||
| TROCHLEAR NERVE | C12808 | Trochlear Nerve | The cranial nerve that controls the superior oblique muscle of the eye. (NCI) | Trochlear Nerve | ||
| TRUNK | C33816 | Trunk | The body excluding the head and neck and limbs. (NCI) | Trunk | ||
| TUNICA INTIMA | C33820 | Tunica Intima | The inner most layer of the blood vessel wall. The consistency of the intima will vary depending on the type of blood vessel, but will always have an endothelial layer with a basal lamina. It may contain collagen and elastic fibers. (NCI) | Tunica Intima | ||
| TYMPANIC MEMBRANE | C12502 | Tympanic Membrane | A thin membrane that separates the external auditory canal from the middle ear. The movement of the tympanic membrane in response to air pressure changes in the external ear facilitates the transmission of sound energy by causing vibration of the ossicular chain. (NCI) | Tympanic Membrane | ||
| ULNA | C12809 | Ulna Bone | The long bone that extends from the elbow to the lateral side of the carpus. | Ulna | ||
| UMBILICUS | C77533 | Navel | The depression or scar on the abdomen that marks the former site of attachment of the umbilical cord. (NCI) | Umbilicus | ||
| UNCINATE PROCESS OF PANCREAS | C62432 | Uncinate Process of Pancreas | A portion of the pancreas that extends behind the superior mesenteric artery and superior mesenteric vein. (NCI) | Uncinate Process of Pancreas | ||
| UPPER CERVICAL LYMPH NODE | C103447 | A lymph node located in the upper region of the neck. (NCI) | Upper Cervical Lymph Node | |||
| UPPER RESPIRATORY SYSTEM | C33839 | The sinuses and those parts of the respiratory system above the trachea. It includes the nares, nasopharynx, oropharynx, larynx, vocal cords, glottis and upper trachea. | Upper Respiratory System | |||
| URETER | C12416 | Ureter | The thick-walled tube that carries urine from each kidney to the bladder. (NCI) | Ureter | ||
| URETHRA | C12417 | Urethra | The tube carrying urine from the bladder to outside of the body. (NCI) | Urethra | ||
| URETHRA, ANTERIOR | C61125 | Anterior Portion of the Urethra | The portion of the urethra that extends from the meatus to the membranous urethra. (NCI) | Anterior Portion of the Urethra | ||
| URETHRA, PENILE | C61123 | Penile Portion of the Urethra | The portion of the urethra that spans the corpus spongiosum. (NCI) | Penile Portion of the Urethra | ||
| URETHRA, POSTERIOR | C61126 | Posterior Portion of the Urethra | The portion of the urethra that is located on the posterior aspect of the urogenital diaphragm. (NCI) | Posterior Portion of the Urethra | ||
| URETHRA, PROSTATIC | C13101 | Prostatic Urethra | That part of the male urethra that passes through the prostate gland. (NCI) | Prostatic Urethra | ||
| URINARY SYSTEM | C12413 | Urinary System | The organs involved in the creation and excretion of urine. (NCI) | Urinary System | ||
| UTERUS | C12405 | Uterus;Womb | A hollow, thick-walled, muscular organ located within the pelvic cavity of a woman. Within the uterus the fertilized egg implants and the fetus develops during pregnancy. (NCI) | Uterus | ||
| UVEA | C12811 | Uvea | The pigmented layer of the eyeball between the tough, white outer coat of the eye and the retina. (NCI) | Uvea | ||
| VAGINA | C12407 | Vagina | The female genital canal, extending from the uterus to the vulva. (NCI) | Vagina | ||
| VAGUS NERVE | C12812 | The 10th cranial nerve. The vagus is a mixed nerve which contains somatic afferents (from skin in back of the ear and the external auditory meatus), visceral afferents (from the pharynx, larynx, thorax, and abdomen), parasympathetic efferents (to the thorax and abdomen), and efferents to striated muscle (of the larynx and pharynx). (MSH2001) | Vagus Nerve | |||
| VAS DEFERENS | C12813 | Duct carrying spermatozoa. (NCI) | Vas Deferens | |||
| VASTUS INTERMEDIUS MUSCLE | C117876 | The portion of the quadriceps femoris muscle group that is underneath the Rectus Femoris muscle, spans and covers the upper two-thirds of the anterior and lateral surfaces of the femur, and inserts into the lateral border of the patella. | Vastus Intermedius Muscle | |||
| VASTUS LATERALIS MUSCLE | C53073 | The largest muscle of the quadriceps femoris muscle group that extends laterally from the intertrochanteric line of the femur to the lateral aspects of the quadriceps femoris tendon and patella. | Vastus Lateralis | |||
| VASTUS MEDIALIS MUSCLE | C117736 | The portion of the quadriceps femoris muscle group that extends medially from the intertrochanteric line of the femur to the medial aspects of the quadriceps femoris tendon and patella. (NCI) | Vastus Medialis Muscle | |||
| VEIN | C12814 | Vein | A blood vessel that carries blood towards the heart. | Vein | ||
| VENA CAVA | C12817 | Vena Cava | A large vein which returns blood from the head, neck and extremities to the heart. (NCI) | Vena Cava | ||
| VERTEBRAL COLUMN | C12998 | Vertebral Column | A series of bones, muscles, tendons, and other tissues reaching from the base of the skull to the tailbone. The vertebral column forms the axis of the skeleton and encloses as well as protects the spinal cord and the fluid surrounding the spinal cord. (NCI) | Vertebral Column | ||
| VESTIBULOCOCHLEAR NERVE | C12996 | The eighth cranial nerve. | Vestibulocochlear Nerve | |||
| VOCAL CORD | C12822 | Vocal Cord | A pair of small bands of muscle that stretch from the thyroid cartilage in front to the arytenoid cartilage in back of the larynx. The vocal cords help prevent food entering the lungs and produce sound through vibration. (NCI) | Vocal Cord | ||
| VOMER | C33888 | Vomer | A thin, paired or unpaired, trapezoidal bone of the skull located in the floor of the nasal cavity. The vomer forms the posterior and inferior parts of the nasal septum. (NCI) | Vomer | ||
| VULVA | C12408 | External Genitalia;Vulva | The external, visible part of the female genitalia surrounding the urethral and vaginal opening. The vulva includes the clitoris and inner as well as outer labia. (NCI) | Vulva | ||
| WAIST | C64192 | Waist | The abdominal circumference at the navel. (NCI) | Waist | ||
| WALDEYER'S TONSILLAR RING | C73468 | The ring of lymphoid tissue located in the pharynx, consisting of the pharyngeal, tubal, palatine, and lingual tonsils. (NCI) | Waldeyer's Tonsillar Ring | |||
| WRIST JOINT | C33894 | Wrist Joint | A joint between the distal end of the radius and the proximal row of carpal bones. (NCI) | Wrist Joint | ||
| XIPHOID PROCESS | C33895 | Xiphoid Process | The cartilage just below the sternal body. (NCI) | Xiphoid Process | ||
| Back to top | ||||||
| CL.C101842.CACRDSC | Canadian Cardiovascular Society Classification (CACRDSC) | text Extensible: No | C101842 | Canadian Cardiovascular Society Classification | The anginal classifications as measured by the Canadian Cardiovascular Society grading scale. | CDISC SDTM Canadian Cardiovascular Society Classification Terminology |
| CCS CLASS 1 | C77265 | Canadian Cardiovascular Society Classification 1 | Ordinary physical activity, such as walking or climbing stairs, does not cause angina. Angina occurs with strenuous, rapid, or prolonged exertion at work or recreation. | Canadian Cardiovascular Society Grading Scale Class I | ||
| CCS CLASS 2 | C77266 | Canadian Cardiovascular Society Classification 2 | Slight limitation of ordinary activity. Angina occurs on walking or climbing stairs rapidly, walking uphill, walking or climbing stairs after meals, or in cold, in wind, or under emotional stress, or only during the few hours after awakening. Angina occurs on walking more than 2 blocks on the level and climbing more than 1 flight of ordinary stairs at a normal pace and in normal conditions. | Canadian Cardiovascular Society Grading Scale Class II | ||
| CCS CLASS 3 | C77267 | Canadian Cardiovascular Society Classification 3 | Marked limitations of ordinary physical activity. Angina occurs on walking 1 to 2 blocks on the level and climbing 1 flight of stairs in normal conditions and at a normal pace. | Canadian Cardiovascular Society Grading Scale Class III | ||
| CCS CLASS 4 | C77268 | Canadian Cardiovascular Society Classification 4 | Inability to perform any physical activity without discomfort - anginal symptoms may be present at rest. | Canadian Cardiovascular Society Grading Scale Class IV | ||
| Back to top | ||||||
| CL.C101859.CVPRCIND | Cardiac Procedure Indication (CVPRCIND) | text Extensible: Yes | C101859 | Cardiac Procedure Indication | The reason that a subject had a cardiac procedure. | CDISC SDTM Cardiac Procedure Indication Terminology |
| CANDIDATE TO RECEIVE CARDIAC TRANSPLANT | C99919 | The intended recipient of a heart transplant. | Candidate to Receive Cardiac Transplant | |||
| CARDIAC ARREST/ARRHYTHMIA ETIOLOGY UNKNOWN | C100033 | An episode of cardiac arrest or arrhythmia where the etiology was unknown. | Cardiac Arrest/Arrhythmia Etiology Unknown | |||
| CARDIOMYOPATHY | C34830 | A disease of the heart muscle or myocardium proper. Cardiomyopathies may be classified as either primary or secondary, on the basis of etiology, or on the pathophysiology of the lesion: hypertrophic, dilated, or restrictive. | Cardiomyopathy | |||
| CHRONIC TOTAL OCCLUSION | C99938 | A longstanding, complete blockage of a vessel. | Chronic Total Occlusion Vessel | |||
| DONOR FOR CARDIAC TRANSPLANT | C99947 | The subject contributing a heart for a cardiac transplant. | Donor for Cardiac Transplant | |||
| END OF EXPECTED BATTERY LIFE | C99949 | The battery that supplies the device has reached the end of its life. | End of Expected Battery Life | |||
| FAULTY CONNECTOR/HEADER | C100035 | There is a faulty connector/header in the device. | Faulty Device Connector/Header | |||
| GENERATOR IS BEING REPLACED AT THE TIME OF LEAD REVISION | C99925 | A cardiac lead requires revision, at which time the generator to the device will be replaced. | Cardiac Device Generator is Being Replaced at Time of Lead Revision | |||
| GENERATOR MALFUNCTION | C99943 | The device has a generator malfunction. | Device Generator Malfunction | |||
| IMMEDIATE PERCUTANEOUS CORONARY INTERVENTION (PCI) FOR ST ELEVATION MYOCARDIAL INFARCTION (STEMI) | C99961 | An immediate percutaneous coronary intervention is necessary for a myocardial infarction that presents with ST segment elevation. | Immediate Percutaneous Coronary Intervention for ST Elevation Myocardial Infarction | |||
| INFECTION | C26726 | A disorder resulting from the presence and activity of a microbial, viral, or parasitic agent. It can be transmitted by direct or indirect contact. (NCI) | Infectious Disorder | |||
| LEAD EROSION | C99931 | A cardiac lead has damaged local tissue enough to require treatment. | Cardiac Lead Erosion | |||
| LEFT VENTRICULAR SYSTOLIC DYSFUNCTION | C64251 | The degree of impairment of the left cardiac ventricle to contract efficiently. | Left Ventricular Systolic Dysfunction | |||
| MANUFACTURER RECALL | C100045 | An imperative issued by the manufacturer of a device that the device needs to be returned to a designated source for repair or replacement. | Manufacturer Recall | |||
| MANUFACTURER RECOGNIZED A RECURRING PERFORMANCE FAILURE | C99980 | The device manufacturer had recognized a recurrent performance failure in the device. | Manufacturer Recognized a Recurring Performance Failure | |||
| MEDICAL CONDITION OR PROCEDURE AFFECTS IMPLANTATION SITE | C99982 | The medical condition or the procedure affects the device implantation site. | Medical Condition or Procedure Affects Implantation Site | |||
| MEDICAL OR SURGICAL PROCEDURE REQUIRING RELOCATION OF LEAD | C99983 | An intended medical or surgical procedure necessitates the relocation of a cardiac lead. | Medical or Surgical Procedure Requiring Relocation of Lead | |||
| PERCUTANEOUS CORONARY INTERVENTION (PCI) FOR HIGH RISK NON-ST ELEVATION MYOCARDIAL INFARCTION OR UNSTABLE ANGINA | C99999 | Includes patients with unstable angina or Non-STEMI who have high risk features for short-term risk of death or nonfatal MI. High risk features includes at least one of the following: history of accelerating tempo of ischemic symptoms in preceding 48 hours; character of pain - prolonged ongoing (greater than 20 minutes) rest pain; clinical findings - pulmonary edema, most likely due to ischemia or new or worsening mitral regurgitation murmur; or S3 or new worsening rales or Hypotension, bradycardia, tachycardia or age greater than 75 years; ECG - angina at rest with transient ST-segment changes greater than 0.5 mm or bundle-branch block, new or presumed new or sustained ventricular tachycardia; cardiac markers - NSTEMI patients with elevated cardiac TnT, Tnl, or CK-MB. | Percutaneous Coronary Intervention for High Risk Non-ST Elevation Myocardial Infarction or Unstable Angina | |||
| PERCUTANEOUS CORONARY INTERVENTION (PCI) FOR ST ELEVATION MYOCARDIAL INFARCTION (STEMI) (STABLE AFTER SUCCESSFUL FULL-DOSE THROMBOLYTICS) | C100001 | A percutaneous coronary intervention is necessary for a myocardial infarction that presents with ST segment elevation and the subject does not have recurrent or persistent symptoms, symptoms of heart failure or ventricular arrhythmia after a successful dose of thrombolytic therapy. | Percutaneous Coronary Intervention for ST Elevation Myocardial Infarction-Stable After Successful Full-Dose Thrombolytic Therapy | |||
| PERCUTANEOUS CORONARY INTERVENTION (PCI) FOR ST ELEVATION MYOCARDIAL INFARCTION (STEMI) (STABLE, >12 HRS FROM SYMPTOM ONSET) | C100000 | A percutaneous coronary intervention is necessary for a myocardial infarction that presents with ST segment elevation and the subject does not have recurrent or persistent symptoms, symptoms of heart failure or ventricular arrhythmia. The presentation is past twelve hours since onset of symptoms. | Percutaneous Coronary Intervention for ST Elevation Myocardial Infarction-Stable-Over 12 Hours From Symptom Onset | |||
| PERCUTANEOUS CORONARY INTERVENTION (PCI) FOR ST ELEVATION MYOCARDIAL INFARCTION (STEMI) (UNSTABLE, >12 HRS FROM SYMPTOM ONSET) | C100002 | A percutaneous coronary intervention is necessary for a myocardial infarction that presents with ST segment elevation and the subject has recurrent or persistent symptoms, symptoms of heart failure or ventricular arrhythmia. The presentation is past twelve hours since onset of symptoms. | Percutaneous Coronary Intervention for ST Elevation Myocardial Infarction-Unstable-Over 12 Hours From Symptom Onset | |||
| POST-CARDIAC TRANSPLANT | C100005 | A procedure to evaluate the health of the an individual after receiving a heart transplant. | Post-Cardiac Transplant Evaluation | |||
| PRE-OPERATIVE EVALUATION FOR NON-CARDIOVASCULAR SURGERY | C100006 | A procedure to evaluate the health of the cardiac system to determine feasibility of a non-cardiac related surgical procedure. | Pre-Operative Evaluation for Non-Cardiovascular Surgery | |||
| PRIMARY PREVENTION | C15306 | A procedure performed to avoid the first occurrence of a disease condition. | Primary Prevention | |||
| RESCUE PERCUTANEOUS CORONARY INTERVENTION (PCI) FOR ST ELEVATION MYOCARDIAL INFARCTION (STEMI) (AFTER FAILED FULL-DOSE THROMBOLYTICS) | C100008 | A percutaneous coronary intervention is imperative for a myocardial infarction that presents with ST segment elevation after an unsatisfactory response to a full dose of thrombolytic therapy. | Rescue Percutaneous Coronary Intervention for ST Elevation Myocardial Infarction After Failed Full-Dose Thrombolytic Therapy | |||
| SECONDARY PREVENTION | C15712 | A procedure performed to avoid a subsequent occurrence of a disease condition. | Secondary Prevention | |||
| SPONTANEOUS SUSTAINED VENTRICULAR TACHYCARDIA | C100014 | Ventricular tachycardia that occurs without provocation and does not resolve spontaneously. | Spontaneous Sustained Ventricular Tachycardia by ECG Finding | |||
| STAGED PERCUTANEOUS CORONARY INTERVENTION (PCI) | C100015 | A subsequent Percutaneous Coronary Intervention in a planned series of procedures, where the first PCI could have been during a prior admission, or during this admission. | Staged Percutaneous Coronary Intervention | |||
| SYNCOPE WITH HIGH RISK CHARACTERISTICS | C100018 | A sudden loss of consciousness with loss of postural tone not related to anesthesia with high risk characteristics. High risk characteristics include non-ischemic dilated cardiomyopathy, or ischemic heart disease with significant ventricular dysfunction, hypertrophic cardiomyopathy, Brugada Syndrome, or Long QT Syndrome. | Syncope with High Risk Cardiac Characteristics | |||
| SYNCOPE WITH INDUCIBLE VENTRICULAR TACHYCARDIA | C100019 | Sudden loss of consciousness with loss of postural tone not related to anesthesia with ventricular tachycardia (VT) that can be induced during an electrophysiological study. | Syncope with Inducible Ventricular Tachycardia by ECG Finding | |||
| UNKNOWN | C17998 | U;Unknown | Not known, not observed, not recorded, or refused. (NCI) | Unknown | ||
| UPGRADE TO A DEVICE WITH ADDITIONAL PACING CAPABILITIES | C100030 | A device with additional pacing capabilities is replacing the current device. | Upgrade to Cardiac Device with Additional Pacing Capabilities | |||
| VENTRICULAR FIBRILLATION | C50799 | Ventricular Fibrillation is characterized by rapid, usually more than 300 bpm (cycle length: 180 ms or less), grossly irregular ventricular rhythm with marked variability in QRS cycle length, morphology, and amplitude. | Ventricular Fibrillation | |||
| Back to top | ||||||
| CL.C101866.CRYDFMAN | Cardiac Rhythm Device Failure Manifestation (CRYDFMAN) | text Extensible: Yes | C101866 | Cardiac Rhythm Device Failure Manifestation | The effect that a cardiac rhythm device malfunction had on the ability to stimulate the heart. | CDISC SDTM Cardiac Rhythm Device Failure Manifestation Terminology |
| ATRIAL PACING MALFUNCTION | C99921 | The cardiac rhythm device malfunction affected atrial pacing. | Cardiac Atrial Pacing Malfunction | |||
| DEFIBRILLATION MALFUNCTION | C99923 | The cardiac rhythm device malfunction affected the defibrillator. | Cardiac Defibrillator Malfunction | |||
| LEFT VENTRICULAR PACING MALFUNCTION | C99973 | The cardiac rhythm device malfunction affected the left ventricular (LV) pacing. | Left Cardiac Ventricular Pacing Malfunction | |||
| RIGHT VENTRICULAR PACING MALFUNCTION | C100011 | The cardiac rhythm device malfunction affected the right ventricular (RV) pacing. | Right Cardiac Ventricle Pacing Malfunction | |||
| Back to top | ||||||
| CL.C101853.CVLVRSEV | Cardiac Valvular Regurgitation Severity (CVLVRSEV) | text Extensible: No | C101853 | Cardiac Valvular Regurgitation Severity | A terminology codelist to describe the severity of cardiac valvular regurgitation. | CDISC SDTM Cardiac Valvular Regurgitation Severity Terminology |
| MILD CARDIAC VALVE REGURGITATION | C99985 | Evidence of mild retrograde blood flow through the valve(s) of the heart. | Mild Cardiac Valve Regurgitation | |||
| MODERATE CARDIAC VALVE REGURGITATION | C99989 | Evidence of moderate retrograde blood flow through the valve(s) of the heart. | Moderate Cardiac Valve Regurgitation | |||
| NO CARDIAC VALVE REGURGITATION | C99991 | No evidence of any retrograde blood flow through the valve(s) in the heart. | No Cardiac Valve Regurgitation | |||
| SEVERE CARDIAC VALVE REGURGITATION | C100012 | Evidence of severe retrograde blood flow through the valve(s) of the heart. | Severe Cardiac Valve Regurgitation | |||
| Back to top | ||||||
| CL.C101854.CVLSTSEV | Cardiac Valvular Stenosis Severity (CVLSTSEV) | text Extensible: No | C101854 | Cardiac Valvular Stenosis Severity | A terminology codelist to describe the severity of cardiac valvular stenosis. | CDISC SDTM Cardiac Valvular Stenosis Severity Terminology |
| MILD CARDIAC VALVE STENOSIS | C99986 | The cardiac valve orifice is abnormally narrow, to a mild degree. | Mild Cardiac Valve Stenosis | |||
| MODERATE CARDIAC VALVE STENOSIS | C99990 | The cardiac valve orifice is abnormally narrow, to a moderate degree. | Moderate Cardiac Valve Stenosis | |||
| NO CARDIAC VALVE STENOSIS | C99992 | The cardiac valve orifice is not abnormally narrow. | No Cardiac Valve Stenosis | |||
| SEVERE CARDIAC VALVE STENOSIS | C100013 | The cardiac valve orifice is abnormally narrow, to a severe degree. | Severe Cardiac Valve Stenosis | |||
| Back to top | ||||||
| CL.C119016.CVFARS | Cardiovascular Findings About Results (CVFARS) | text Extensible: No | C119016 | Cardiovascular Findings About Results | Terminology responses used for the cardiovascular findings about test codes and names codelist within CDISC. | CDISC SDTM Cardiovascular Findings About Results Terminology |
| ANGIOGRAPHY | C20080 | A method used to create an image of blood vessels. | Angiography | |||
| AUGMENTATION OF ORAL DIURETIC THERAPY | C119199 | Initiation or intensification of orally administered medication(s) that promote diuresis to treat heart failure. | Oral Diuretic Therapy Augmentation for Heart Failure | |||
| AUTOPSY | C25153 | A postmortem examination of the body. | Autopsy | |||
| CLINICALLY SIGNIFICANT OR RAPID WEIGHT GAIN | C119200 | Weight gain thought to be related to fluid retention. | Weight Gain Due to Fluid Retention | |||
| CORONARY LESION ON ANGIOGRAPHY | C119201 | Angiographic evidence of new or worse greater than or equal to 70 percent lesion and/or thrombus in an epicardial coronary artery believed to be responsible for the myocardial ischemic symptoms/signs. (Hicks KA, Tcheng JE, Bozkurt B, Chaitman BR, Cutlip DE, Farb A, Fonarow GC, Jacobs JP, Jaff MR, Lichtman JH, Limacher MC, Mahaffey KW, Mehran, R, Nissen SE, Smith EE, Targum SL. 2014 ACC/AHA Key Data Elements and Definitions For Cardiovascular Endpoint Events In Clinical Trials: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Cardiovascular End Points Data Standards) J Am Coll Cardiol 2014; In Press) | Coronary Lesion by Angiographic Finding | |||
| CORONARY REVASCULARIZATION | C119202 | Need for coronary revascularization procedure (PCI or CABG) for the presumed culprit lesion(s). This criterion would be fulfilled if revascularization was undertaken during the unscheduled hospitalization, or subsequent to transfer to another institution without interceding home discharge. (Hicks KA, Tcheng JE, Bozkurt B, Chaitman BR, Cutlip DE, Farb A, Fonarow GC, Jacobs JP, Jaff MR, Lichtman JH, Limacher MC, Mahaffey KW, Mehran, R, Nissen SE, Smith EE, Targum SL. 2014 ACC/AHA Key Data Elements and Definitions For Cardiovascular Endpoint Events In Clinical Trials: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Cardiovascular End Points Data Standards) J Am Coll Cardiol 2014; In Press) | Coronary Revascularization Procedure | |||
| DECREASED EXERCISE TOLERANCE | C119203 | Reduced ability to withstand or participate in activities that induce physical or mental exertion. | Decreased Exercise Tolerance | |||
| DYSPNEA | C2998 | Includes dyspnea on exertion, dyspnea at rest, orthopnea, and paroxysmal nocturnal dyspnea. | Dyspnea | |||
| FATIGUE | C3036 | Unusual tiredness and inability to perform usual activities. | Fatigue | |||
| HEART FAILURE HOSPITALIZATION | C119204 | An event where the patient is admitted to the hospital with a primary diagnosis of heart failure (HF), where the length of stay is at least 24 hours (or extends over a calendar date), where the patient exhibits new or worsening symptoms of HF on presentation, has objective evidence of new or worsening HF, and receives initiation or intensification of treatment specifically for HF. (Hicks KA, Tcheng JE, Bozkurt B, Chaitman BR, Cutlip DE, Farb A, Fonarow GC, Jacobs JP, Jaff MR, Lichtman JH, Limacher MC, Mahaffey KW, Mehran, R, Nissen SE, Smith EE, Targum SL. 2014 ACC/AHA Key Data Elements and Definitions For Cardiovascular Endpoint Events In Clinical Trials: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Cardiovascular End Points Data Standards) J Am Coll Cardiol 2014; In Press) | Hospitalization Due to Heart Failure | |||
| HEMORRHAGIC STROKE | C95803 | An acute episode of focal or global cerebral or spinal dysfunction caused by intraparenchymal, intraventricular, or subarachnoid hemorrhage. | Hemorrhagic Cerebrovascular Accident | |||
| INCREASE IN HEART FAILURE BIOMARKER | C119205 | Biomarker increase (B-type natriuretic peptide (BNP)/ N-terminal pro-BNP (NT-proBNP)) consistent with decompensation of heart failure (such as BNP greater than 500 pg/mL or NT-proBNP greater than 2,000 pg/mL). In patients with chronically elevated natriuretic peptides, a significant increase above baseline is required. (Hicks KA, Tcheng JE, Bozkurt B, Chaitman BR, Cutlip DE, Farb A, Fonarow GC, Jacobs JP, Jaff MR, Lichtman JH, Limacher MC, Mahaffey KW, Mehran, R, Nissen SE, Smith EE, Targum SL. 2014 ACC/AHA Key Data Elements and Definitions For Cardiovascular Endpoint Events In Clinical Trials: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Cardiovascular End Points Data Standards) J Am Coll Cardiol 2014; In Press) | Increase in B-type Natriuretic Peptide or N-terminal pro-B-type Natriuretic Peptide | |||
| INCREASED JUGULAR VENOUS PRESSURE OR HEPATOJUGULAR REFLUX | C119206 | Increase in the estimated height of the mean jugular venous waveform above the right atrium in cm. | Increase in Jugular Venous Pressure | |||
| INCREASING ABDOMINAL DISTENTION OR ASCITES | C2885 | Intra-abdominal fluid accumulation as determined by physical examination (in the absence of primary hepatic disease). | Ascites | |||
| INDUCIBLE MYOCARDIAL ISCHEMIA | C119207 | Definite evidence of inducible myocardial ischemia believed to be responsible for the myocardial ischemic symptoms/signs, demonstrated by any of the following: a) an early positive exercise stress test, defined as ST elevation of greater than or equal to 2 mm ST depression prior to 5 mets, b) stress echocardiography (reversible wall motion abnormality), c) myocardial scintigraphy (reversible perfusion defect), d) MRI (myocardial perfusion deficit under pharmacologic stress). (Hicks KA, Tcheng JE, Bozkurt B, Chaitman BR, Cutlip DE, Farb A, Fonarow GC, Jacobs JP, Jaff MR, Lichtman JH, Limacher MC, Mahaffey KW, Mehran, R, Nissen SE, Smith EE, Targum SL. 2014 ACC/AHA Key Data Elements and Definitions For Cardiovascular Endpoint Events In Clinical Trials: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Cardiovascular End Points Data Standards) J Am Coll Cardiol 2014; In Press) | Inducible Myocardial Ischemia | |||
| INTRAVENOUS DIURETIC, INOTROPE, OR VASODILATOR THERAPY | C119208 | Initiation or intensification of medication(s) administered by vein to treat heart failure, to increase the production of urine, increase cardiac performance, and/or reduce cardiac preload or afterload. | Intravenous Diuretic, Inotropic or Vasodilator Augmentation for Heart Failure | |||
| INVASIVE DIAGNOSTIC EVIDENCE OF HEART FAILURE | C119209 | Invasive diagnostic evidence with right heart catheterization showing a pulmonary capillary wedge pressure (pulmonary artery occlusion pressure) greater than or equal to 18 mmHg, central venous pressure greater than or equal to 12 mmHg, or a cardiac index less than 2.2 L/min/m2. (Hicks KA, Tcheng JE, Bozkurt B, Chaitman BR, Cutlip DE, Farb A, Fonarow GC, Jacobs JP, Jaff MR, Lichtman JH, Limacher MC, Mahaffey KW, Mehran, R, Nissen SE, Smith EE, Targum SL. 2014 ACC/AHA Key Data Elements and Definitions For Cardiovascular Endpoint Events In Clinical Trials: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Cardiovascular End Points Data Standards) J Am Coll Cardiol 2014; In Press) | Heart Failure by Invasive Diagnostic Technique | |||
| ISCHEMIC STROKE | C95802 | Ischemic stroke is defined as an acute episode of focal cerebral, spinal, or retinal dysfunction caused by infarction of central nervous system tissue. | Ischemic Cerebrovascular Accident | |||
| LOSS OF A SIDE BRANCH | C119210 | Angiographic loss of patency of a side branch. | Loss of Patency of Side Branch | |||
| LOSS OF MAJOR CORONARY | C119211 | Angiographic loss of patency of a major epicardial vessel. | Loss of Patency of Major Vessel | |||
| MECHANICAL OR SURGICAL INTERVENTION | C119212 | Mechanical circulatory support (e.g., intra-aortic balloon pump, ventricular assist device, extracorporeal membrane oxygenation, total artificial heart) or mechanical fluid removal (e.g., ultrafiltration, hemofiltration, dialysis). (Hicks KA, Tcheng JE, Bozkurt B, Chaitman BR, Cutlip DE, Farb A, Fonarow GC, Jacobs JP, Jaff MR, Lichtman JH, Limacher MC, Mahaffey KW, Mehran, R, Nissen SE, Smith EE, Targum SL. 2014 ACC/AHA Key Data Elements and Definitions For Cardiovascular Endpoint Events In Clinical Trials: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Cardiovascular End Points Data Standards) J Am Coll Cardiol 2014; In Press) | Vasculature Mechanical or Surgical Intervention | |||
| NEW LOSS OF VIABLE MYOCARDIUM | C119213 | Non-invasive imaging evidence of a loss of viable myocardium when compared with the most recent previous non-invasive imaging study. | New Loss of Viable Myocardium by Non-invasive Imaging Technique | |||
| NEW REGIONAL WALL MOTION ABNORMALITY | C119214 | Non-invasive imaging evidence of a decrease in regional wall motion contractility compared with the most recent previous non-invasive imaging study. | New Regional Wall Motion Abnormality by Non-invasive Imaging Technique | |||
| NON-INVASIVE DIAGNOSTIC EVIDENCE OF HEART FAILURE | C119215 | Non-invasive diagnostic evidence of clinically significant elevated left- or right-sided ventricular filling pressure or low cardiac output. For example, echocardiographic criteria could include: E/e' greater than 15 or D-dominant pulmonary venous inflow pattern, plethoric inferior vena cava with minimal collapse on inspiration, or decreased left ventricular outflow tract (LVOT) minute stroke distance (time velocity integral (TVI)). (Hicks KA, Tcheng JE, Bozkurt B, Chaitman BR, Cutlip DE, Farb A, Fonarow GC, Jacobs JP, Jaff MR, Lichtman JH, Limacher MC, Mahaffey KW, Mehran, R, Nissen SE, Smith EE, Targum SL. 2014 ACC/AHA Key Data Elements and Definitions For Cardiovascular Endpoint Events In Clinical Trials: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Cardiovascular End Points Data Standards) J Am Coll Cardiol 2014; In Press) | Heart Failure by Non-invasive Diagnostic Technique | |||
| PERIPHERAL EDEMA | C78262 | Increased tissue fluid indicated by perceptible pitting indentation on lower leg, foot or sacrum after palpation. | Edema Limbs | |||
| PULMONARY RALES/CRACKLES/CREPITATIONS | C119216 | Abnormal breath sounds caused by the accumulation of fluid in the lungs. | Rales | |||
| RADIOLOGICAL EVIDENCE OF PULMONARY CONGESTION | C119217 | Imaging findings consistent with increased intravascular blood volume in the lungs. | Pulmonary Congestion by Radiological Technique | |||
| RESTING ECG CHANGES | C119218 | New or worsening ST or T wave changes on resting ECG (in the absence of confounders, such as LBBB or LVH), defined as either: a) Transient ST elevation (duration less than 20 minutes): new ST elevation at the J point in any two contiguous leads (other than leads V2-V3) of greater than or equal to 0.1 mV. In leads V2-V3, the following cut-points apply: greater than or equal to 0.2 mV in men greater than or equal to 40 years, greater than or equal to 0.25 mV in men less than 40 years, and greater than or equal to 0.15 mV in women, or b) ST depression and T-wave changes: new horizontal or down-sloping ST depression greater than or equal to 0.05 mV in two contiguous leads and/or new T inversion greater than or equal to 0.3 mV in two contiguous leads with prominent R wave or R/S ratio greater than 1. | Resting ECG Changes | |||
| S3 GALLOP | C61455 | Presence of mid-diastolic heart sound. | S3 Gallop | |||
| SLOW-FLOW/NO-FLOW/EMBOLIZATION | C119219 | Angiographic reduction of flow into the coronary microcirculation. | Flow Reduced in Coronary Microcirculation | |||
| TYPE 1 MYOCARDIAL INFARCTION | C119220 | Spontaneous clinical syndrome related to atherosclerotic plaque rupture, ulceration, fissuring, erosion, or dissection, with resulting intraluminal thrombus, and leading to decreased myocardial blood flow or distal platelet emboli with ensuing myocyte necrosis. This classification requires a) detection of a rise and/or fall of cardiac biomarker values [preferably cardiac troponin (cTn)] with at least one value greater than 99th percentile of the upper reference limit (URL) and b) at least one of the following: symptoms of myocardial ischemia; new or presumed new significant ST-segment-T wave (ST-T) changes or new left bundle branch block (LBBB) on the ECG; development of pathological Q waves on the ECG; imaging evidence of new loss of viable myocardium or new regional wall motion abnormality; identification of an intracoronary thrombus by angiography or autopsy. (Universal definition of myocardial infarction, Kristian Thygesen, Joseph S. Alpert and Harvey D. White on behalf of the Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction, Eur Heart J (2007) 28 (20): 2525-2538.) | Joint Task Force Type 1 Myocardial Infarction | |||
| TYPE 2 MYOCARDIAL INFARCTION | C119221 | Ischemic imbalance: Spontaneous clinical syndrome where a condition other than coronary artery disease contributes to an imbalance between myocardial oxygen supply and/or demand, e.g. coronary endothelial dysfunction, coronary artery spasm, coronary embolism, tachy-/brady-arrhythmias, anemia, respiratory failure, hypotension, and hypertension with or without left ventricular hypertrophy. This classification requires detection of a rise and/or fall of cardiac biomarker values [preferably cardiac troponin (cTn)] with at least one value greater than 99th percentile of the upper reference limit (URL) and b) at least one of the following: symptoms of myocardial ischemia; new or presumed new significant ST-segment-T wave (ST-T) changes or new left bundle branch block (LBBB) on the ECG; development of pathological Q waves on the ECG; imaging evidence of new loss of viable myocardium or new regional wall motion abnormality. (Universal definition of myocardial infarction, Kristian Thygesen, Joseph S. Alpert and Harvey D. White on behalf of the Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction, Eur Heart J (2007) 28 (20): 2525-2538.) | Joint Task Force Type 2 Myocardial Infarction | |||
| TYPE 3 MYOCARDIAL INFARCTION | C119222 | Death, No Biomarkers: Death where symptoms suggestive of myocardial ischemia are present, and with (presumed) new ischemic changes or new LBBB on ECG, but where death occurs before cardiac biomarkers can be obtained, or before cardiac biomarker values could rise. (Universal definition of myocardial infarction, Kristian Thygesen, Joseph S. Alpert and Harvey D. White on behalf of the Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction, Eur Heart J (2007) 28 (20): 2525-2538.) | Joint Task Force Type 3 Myocardial Infarction | |||
| TYPE 4A MYOCARDIAL INFARCTION | C119223 | PCI Related: PCI Related Myocardial infarction associated with and occurring within 48h of percutaneous coronary intervention, with elevation of cardiac biomarker values to greater than 5x 99th percentile of the upper reference limit (URL) in patients with normal baseline values (less than or equal to 99th percentile URL), or a rise of cardiac biomarker values greater than or equal to 20% if the baseline values are elevated and are stable or falling. This classification also requires at least one of the following: symptoms of myocardial ischemia; new ischemic ECG changes or new LBBB; angiographic loss of patency of a major coronary artery or a side branch or persistent slow- or no-flow or embolization; imaging evidence of new loss of viable myocardium or new regional wall motion abnormality. (Universal definition of myocardial infarction, Kristian Thygesen, Joseph S. Alpert and Harvey D. White on behalf of the Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction, Eur Heart J (2007) 28 (20): 2525-2538.) | Joint Task Force Type 4A Myocardial Infarction | |||
| TYPE 4B MYOCARDIAL INFARCTION | C119224 | Stent Thrombosis: Myocardial infarction associated with stent thrombosis as detected by coronary angiography or at autopsy, where symptoms suggestive of myocardial ischemia are present, and with a rise and/or fall of cardiac biomarkers values, with at least one value greater than 99th percentile of the upper reference limit. (Universal definition of myocardial infarction, Kristian Thygesen, Joseph S. Alpert and Harvey D. White on behalf of the Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction, Eur Heart J (2007) 28 (20): 2525-2538.) | Joint Task Force Type 4B Myocardial Infarction | |||
| TYPE 4C MYOCARDIAL INFARCTION | C119225 | Stent Restenosis: Myocardial infarction associated with stent restenosis as detected by coronary angiography or at autopsy, occurring more than 48h after percutaneous coronary intervention, without evidence of stent thrombosis but with symptoms suggestive of myocardial ischemia, and with elevation of cardiac biomarker values to greater than 99th percentile of the upper reference limit (URL). This classification also requires the following: does not meet criteria for any other classification of myocardial infarction; presence of a greater than or equal to 50 percent stenosis at the site of previous successful stent PCI. (Universal definition of myocardial infarction, Kristian Thygesen, Joseph S. Alpert and Harvey D. White on behalf of the Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction, Eur Heart J (2007) 28 (20): 2525-2538.) | Joint Task Force Type 4C Myocardial Infarction | |||
| TYPE 5 MYOCARDIAL INFARCTION | C119226 | CABG Related: Myocardial infarction associated with and occurring within 48h of coronary artery bypass graft surgery, with elevation of cardiac biomarker values to greater than 10x 99th percentile of the upper reference limit (URL) in patients with normal baseline cardiac biomarker values (less than or equal to 99th percentile URL). This classification also requires at least one of the following: new pathologic Q waves or new LBBB on ECG; angiographic new graft or new native coronary artery occlusion; imaging evidence of new loss of viable myocardium or new regional wall motion abnormality. (Universal definition of myocardial infarction, Kristian Thygesen, Joseph S. Alpert and Harvey D. White on behalf of the Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction, Eur Heart J (2007) 28 (20): 2525-2538.) | Joint Task Force Type 5 Myocardial Infarction | |||
| UNDETERMINED STROKE | C3390 | An acute episode of focal or global neurological dysfunction caused by presumed brain, spinal cord, or retinal vascular injury as a result of hemorrhage or infarction but with insufficient information to allow categorization as ischemic or hemorrhagic. | Cerebrovascular Accident | |||
| URGENT HEART FAILURE VISIT | C119227 | An event where the patient has an urgent, unscheduled office/practice or emergency department visit for a primary diagnosis of heart failure (HF) but is not admitted to the hospital, where the patient exhibits new or worsening symptoms of HF on presentation, has objective evidence of new or worsening HF, and receives initiation or intensification of treatment specifically for HF, with the exception that changes to oral diuretic therapy do no qualify as initiation or intensification of treatment. (Hicks KA, Tcheng JE, Bozkurt B, Chaitman BR, Cutlip DE, Farb A, Fonarow GC, Jacobs JP, Jaff MR, Lichtman JH, Limacher MC, Mahaffey KW, Mehran, R, Nissen SE, Smith EE, Targum SL. 2014 ACC/AHA Key Data Elements and Definitions For Cardiovascular Endpoint Events In Clinical Trials: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Cardiovascular End Points Data Standards) J Am Coll Cardiol 2014; In Press) | ER or Office Visit Due to Heart Failure | |||
| VOLUME OVERLOAD | C50591 | Excessive accumulation of intravascular fluid resulting from compromised regulatory mechanisms. | Hypervolemia | |||
| WORSENED END-ORGAN PERFUSION | C119228 | Decreased blood supply to the vital organs (kidney, liver, lungs, heart, brain). | Worsened End-Organ Perfusion | |||
| Back to top | ||||||
| CL.C119015.CVFATSCD | Cardiovascular Findings About Test Code (CVFATSCD) | text Extensible: No | C119015 | Cardiovascular Findings About Test Code | Terminology relevant to the test codes that describe findings about a cardiovascular event or intervention. | CDISC SDTM Cardiovascular Findings About Test Code Terminology |
| ACMITYPE | C118936 | Acute Myocardial Infarction Type | Categorization of the type of acute myocardial infarction. | Acute Myocardial Infarction Type | ||
| CATMTHID | C119229 | Coronary Artery Thrombosis Method Ident | The method by which the coronary artery thrombosis event is determined or diagnosed. | Coronary Artery Thrombosis Method of Identification | ||
| ENDPTIND | C119230 | Endpoint Event Indicator | An indication as to whether the event meets the criteria for being a clinical endpoint. | Endpoint Event Indicator | ||
| HETYPE | C119231 | Healthcare Encounter Type | Categorization of the type of healthcare encounter. | Healthcare Encounter Type | ||
| HFLBFNW | C119232 | Heart Failure New/Worsening Lab Findings | Categorization of the type(s) of new and/or worsening laboratory findings of heart failure present at the time of patient presentation. | Lab Findings of New or Worsening Heart Failure | ||
| HFPEFNW | C119233 | Heart Failure New/Worsening PE Findings | Categorization of the type(s) of new and/or worsening physical exam findings of heart failure present at the time of patient presentation. | Physical Examination Findings of New or Worsening Heart Failure | ||
| HFTHERIN | C119234 | Heart Failure Therapy, Intensification | Categorization of the type(s) of new and/or intensified treatment administered for heart failure management. | Heart Failure Therapy Intensification Type | ||
| ISCDIND | C119235 | Ischemic Discomfort Indicator | An indicator as to whether the subject has symptoms of ischemic discomfort. | Ischemic Discomfort Indicator | ||
| ISCETYP | C119236 | Ischemic Evidence Type | Categorization of the type of objective evidence of new or worsening ischemia. | Ischemic Evidence Type | ||
| MI12EXC | C119237 | Exclusion of Type 1 and Type 2 MI | An indication of whether a Type 1 and Type 2 myocardial infarction is excluded as a diagnosis. | Exclusion of Type 1 and Type 2 Myocardial Infarction Diagnosis Indicator | ||
| NWSYMP | C119238 | New or Worsening Symptoms | A description of the new or worsening symptoms related to a clinical event. | New or Worsening Symptom | ||
| PCIAAC | C119239 | PCI Acute Angiographic Complication | Categorization of the type of acute PCI angiographic complication resulting in acute myocardial ischemia. | Acute Myocardial Infarction From PCI Complication Type | ||
| PRSUCIND | C119240 | Procedure Success Indicator | An indication as to whether the procedure is considered successful. | Procedure Success Indicator | ||
| PRUSTAT | C101230 | Procedure Urgency Status Type | The degree of urgency in which a medical procedure must be performed. | Triage Status | ||
| STROKTYP | C119579 | Stroke Type | Categorization of the type of stroke. | Stroke Type | ||
| SYMPINDC | C119241 | Symptom Indicator | An indication as to whether the subject had symptoms related to the clinical event. | Symptom Indicator | ||
| SYMSTDTC | C119242 | Symptom Onset Date | The date time of the onset of symptoms of the clinical event. | Symptom Onset Date | ||
| VOC48IND | C119243 | Vessel Occlusion After CABG 48 Ind | An indication as to whether vessel occlusion, in the native or bypass graft, occurred within 48 hours after the coronary artery bypass graft procedure. | Vessel Occlusion 48 Hours after CABG Indicator | ||
| Back to top | ||||||
| CL.C119014.CVFATS | Cardiovascular Findings About Test Name (CVFATS) | text Extensible: No | C119014 | Cardiovascular Findings About Test Name | Terminology relevant to the test names that describe findings about a cardiovascular event or intervention. | CDISC SDTM Cardiovascular Findings About Test Name Terminology |
| Acute Myocardial Infarction Type | C118936 | Acute Myocardial Infarction Type | Categorization of the type of acute myocardial infarction. | Acute Myocardial Infarction Type | ||
| Coronary Artery Thrombosis Method Ident | C119229 | Coronary Artery Thrombosis Method Ident | The method by which the coronary artery thrombosis event is determined or diagnosed. | Coronary Artery Thrombosis Method of Identification | ||
| Endpoint Event Indicator | C119230 | Endpoint Event Indicator | An indication as to whether the event meets the criteria for being a clinical endpoint. | Endpoint Event Indicator | ||
| Exclusion of Type 1 and Type 2 MI | C119237 | Exclusion of Type 1 and Type 2 MI | An indication of whether a Type 1 and Type 2 myocardial infarction is excluded as a diagnosis. | Exclusion of Type 1 and Type 2 Myocardial Infarction Diagnosis Indicator | ||
| Healthcare Encounter Type | C119231 | Healthcare Encounter Type | Categorization of the type of healthcare encounter. | Healthcare Encounter Type | ||
| Heart Failure New/Worsening Lab Findings | C119232 | Heart Failure New/Worsening Lab Findings | Categorization of the type(s) of new and/or worsening laboratory findings of heart failure present at the time of patient presentation. | Lab Findings of New or Worsening Heart Failure | ||
| Heart Failure New/Worsening PE Findings | C119233 | Heart Failure New/Worsening PE Findings | Categorization of the type(s) of new and/or worsening physical exam findings of heart failure present at the time of patient presentation. | Physical Examination Findings of New or Worsening Heart Failure | ||
| Heart Failure Therapy, Intensification | C119234 | Heart Failure Therapy, Intensification | Categorization of the type(s) of new and/or intensified treatment administered for heart failure management. | Heart Failure Therapy Intensification Type | ||
| Ischemic Discomfort Indicator | C119235 | Ischemic Discomfort Indicator | An indicator as to whether the subject has symptoms of ischemic discomfort. | Ischemic Discomfort Indicator | ||
| Ischemic Evidence Type | C119236 | Ischemic Evidence Type | Categorization of the type of objective evidence of new or worsening ischemia. | Ischemic Evidence Type | ||
| New or Worsening Symptoms | C119238 | New or Worsening Symptoms | A description of the new or worsening symptoms related to a clinical event. | New or Worsening Symptom | ||
| PCI Acute Angiographic Complication | C119239 | PCI Acute Angiographic Complication | Categorization of the type of acute PCI angiographic complication resulting in acute myocardial ischemia. | Acute Myocardial Infarction From PCI Complication Type | ||
| Procedure Success Indicator | C119240 | Procedure Success Indicator | An indication as to whether the procedure is considered successful. | Procedure Success Indicator | ||
| Procedure Urgency Status Type | C101230 | Procedure Urgency Status Type | The degree of urgency in which a medical procedure must be performed. | Triage Status | ||
| Stroke Type | C119579 | Stroke Type | Categorization of the type of stroke. | Stroke Type | ||
| Symptom Indicator | C119241 | Symptom Indicator | An indication as to whether the subject had symptoms related to the clinical event. | Symptom Indicator | ||
| Symptom Onset Date | C119242 | Symptom Onset Date | The date time of the onset of symptoms of the clinical event. | Symptom Onset Date | ||
| Vessel Occlusion After CABG 48 Ind | C119243 | Vessel Occlusion After CABG 48 Ind | An indication as to whether vessel occlusion, in the native or bypass graft, occurred within 48 hours after the coronary artery bypass graft procedure. | Vessel Occlusion 48 Hours after CABG Indicator | ||
| Back to top | ||||||
| CL.C101847.CVTESTCD | Cardiovascular Test Code (CVTESTCD) | text Extensible: Yes | C101847 | Cardiovascular Test Code | A terminology codelist to describe the test code for a physiological examination of the cardiovascular system. | CDISC SDTM Cardiovascular Test Code Terminology |
| CARDIDX | C119245 | Cardiac Index | The measure of an individual's cardiac output divided by the individual's body surface area (CI= CO/BSA). | Cardiac Index | ||
| CARDOUT | C119246 | Cardiac Output | The total volume of blood pumped by the heart over a set period of time, conventionally one minute; it is calculated as heart rate times stroke volume (CO= HR x SV). | Cardiac Output | ||
| COARTDOM | C100086 | Coronary Artery Dominance | The pattern of the epicardial vessels supplying the posterolateral and posterior descending coronary arteries. | Coronary Artery Dominance | ||
| CVLREGTS | C102244 | Cardiac Valvular Regurgitation Severity | The qualitative measurement of the severity of cardiac valvular regurgitation. | Cardiac Valvular Regurgitation Severity | ||
| CVLSTNS | C102245 | Cardiac Valvular Stenosis Severity | The qualitative measurement of the severity of cardiac valvular stenosis. | Cardiac Valvular Stenosis Severity | ||
| ISHMYOP | C80494 | Ischemic Myocardium Percentage | The percentage of myocardial tissue which exhibits characteristics of inadequate blood flow (ischemia). | Ischemic Myocardium Percentage | ||
| LADMN | C99970 | Left Atrium Dimension | The diameter across the left atrium measured at the end of systole. | Left Atrium Dimension | ||
| LVDMNED | C99976 | Left Ventricle Dimension, End-Diastole | The diameter across the ventricle at the end of diastole, excluding the thickness of the walls. | Left Ventricle Dimension at End-Diastole | ||
| LVDMNES | C99977 | Left Ventricular Dimension, End-Systole | The diameter across the ventricle at the end of systole, excluding the thickness of the walls. | Left Ventricular Dimension at End-Systole | ||
| LVEF | C99524 | Left Ventricular Ejection Fraction | The percent or fraction of the left ventricular end diastolic volume ejected in systole. The left ventricular ejection fraction is equal to the left ventricular stroke volume divided by the left ventricular end diastolic volume. | Left Ventricular Ejection Fraction | ||
| NUMDCAV | C99996 | Number of Diseased Coronary Vessels | Number of major epicardial vessels with greater than or equal to 70% reduction in diameter or greater than or equal to 50% reduction in cross-sectional area. | Number of Diseased Coronary Artery Vessels | ||
| PVR | C119247 | Pulmonary Vascular Resistance | The resistance to blood flow through the pulmonary vasculature. | Pulmonary Vascular Resistance | ||
| SVR | C119248 | Systemic Vascular Resistance | The resistance to blood flow through the systemic vasculature. | Systemic Vascular Resistance | ||
| Back to top | ||||||
| CL.C101846.CVTEST | Cardiovascular Test Name (CVTEST) | text Extensible: Yes | C101846 | Cardiovascular Test Name | A terminology codelist to describe the test name for a physiological examination of the cardiovascular system. | CDISC SDTM Cardiovascular Test Name Terminology |
| Cardiac Index | C119245 | Cardiac Index | The measure of an individual's cardiac output divided by the individual's body surface area (CI= CO/BSA). | Cardiac Index | ||
| Cardiac Output | C119246 | Cardiac Output | The total volume of blood pumped by the heart over a set period of time, conventionally one minute; it is calculated as heart rate times stroke volume (CO= HR x SV). | Cardiac Output | ||
| Cardiac Valvular Regurgitation Severity | C102244 | Cardiac Valvular Regurgitation Severity | The qualitative measurement of the severity of cardiac valvular regurgitation. | Cardiac Valvular Regurgitation Severity | ||
| Cardiac Valvular Stenosis Severity | C102245 | Cardiac Valvular Stenosis Severity | The qualitative measurement of the severity of cardiac valvular stenosis. | Cardiac Valvular Stenosis Severity | ||
| Coronary Artery Dominance | C100086 | Coronary Artery Dominance | The pattern of the epicardial vessels supplying the posterolateral and posterior descending coronary arteries. | Coronary Artery Dominance | ||
| Ischemic Myocardium Percentage | C80494 | Ischemic Myocardium Percentage | The percentage of myocardial tissue which exhibits characteristics of inadequate blood flow (ischemia). | Ischemic Myocardium Percentage | ||
| Left Atrium Dimension | C99970 | Left Atrium Dimension | The diameter across the left atrium measured at the end of systole. | Left Atrium Dimension | ||
| Left Ventricle Dimension, End-Diastole | C99976 | Left Ventricle Dimension, End-Diastole | The diameter across the ventricle at the end of diastole, excluding the thickness of the walls. | Left Ventricle Dimension at End-Diastole | ||
| Left Ventricular Dimension, End-Systole | C99977 | Left Ventricular Dimension, End-Systole | The diameter across the ventricle at the end of systole, excluding the thickness of the walls. | Left Ventricular Dimension at End-Systole | ||
| Left Ventricular Ejection Fraction | C99524 | Left Ventricular Ejection Fraction | The percent or fraction of the left ventricular end diastolic volume ejected in systole. The left ventricular ejection fraction is equal to the left ventricular stroke volume divided by the left ventricular end diastolic volume. | Left Ventricular Ejection Fraction | ||
| Number of Diseased Coronary Vessels | C99996 | Number of Diseased Coronary Vessels | Number of major epicardial vessels with greater than or equal to 70% reduction in diameter or greater than or equal to 50% reduction in cross-sectional area. | Number of Diseased Coronary Artery Vessels | ||
| Pulmonary Vascular Resistance | C119247 | Pulmonary Vascular Resistance | The resistance to blood flow through the pulmonary vasculature. | Pulmonary Vascular Resistance | ||
| Systemic Vascular Resistance | C119248 | Systemic Vascular Resistance | The resistance to blood flow through the systemic vasculature. | Systemic Vascular Resistance | ||
| Back to top | ||||||
| CL.C74558.DSCAT | Category for Disposition Event (DSCAT) | text Extensible: No | C74558 | Category for Disposition Event | Classifications that describe and group pertinent events that occur throughout the conduct of a clinical trial. | CDISC SDTM Category For Disposition Event Terminology |
| DISPOSITION EVENT | C74590 | Disposition Event | The group of incidents that occur during a clinical trial and describe whether a subject completed the study epoch or the reason this event did not occur. The subject's disposition is often described for each phase of the study. | Protocol Disposition Event | ||
| OTHER EVENT | C74589 | Other Event | Other important events that occur during a trial but are not driven by protocol requirements. | Protocol Event | ||
| PROTOCOL MILESTONE | C74588 | Protocol Milestone | Occurrences within some epochs that are initiated by a protocol-specified event. The most common protocol milestone is "Informed Consent Obtained" which usually documents the start of the study. | Protocol Milestone | ||
| Back to top | ||||||
| CL.C66797.IECAT | Category for Inclusion/Exclusion (IECAT) | text Extensible: No | C66797 | Category for Inclusion/Exclusion | A collection of criteria on which subjects are evaluated and that must be met by all study subjects. (NCI) | CDISC SDTM Category for Inclusion And Or Exclusion Terminology |
| EXCLUSION | C25370 | List of characteristics in a protocol, any one of which may exclude a potential subject from participation in a study. (CDISC glossary) | Exclusion Criteria | |||
| INCLUSION | C25532 | The criteria in a protocol that prospective subjects must meet to be eligible for participation in a study. NOTE: Exclusion and inclusion criteria define the study population. See also exclusion criteria. (CDISC glossary) | Inclusion Criteria | |||
| Back to top | ||||||
| CL.C66784.TOXGRV3 | Common Terminology Criteria for Adverse Events V3.0 (TOXGRV3) | text Extensible: No | C66784 | Common Terminology Criteria for Adverse Events V3.0 | A standard terminology developed to report adverse events occurring in cancer clinical trials. Common terminology criteria for adverse events (CTCAE) are used in study adverse event summaries and Investigational New Drug reports to the Food and Drug Administration. The CTCAE contain a grading scale for each adverse event term representing the severity of the event. (NCI) | CDISC SDTM Common Terminology Criteria for Adverse Event Grade Terminology V3.0 |
| 1 | C41338 | 1;Grade 1 | A type of adverse event that is usually transient and may require only minimal treatment or therapeutic intervention. The event does not generally interfere with usual activities of daily living. | Mild Adverse Event | ||
| 2 | C41339 | 2;Grade 2 | A type of adverse event that is usually alleviated with additional specific therapeutic intervention. The event interferes with usual activities of daily living, causing discomfort but poses no significant or permanent risk of harm to the research participant. | Moderate Adverse Event | ||
| 3 | C41340 | 3;Grade 3 | A type of adverse event that interrupts usual activities of daily living, or significantly affects clinical status, or may require intensive therapeutic intervention. | Severe Adverse Event | ||
| 4 | C41337 | 4;Grade 4;LIFE THREATENING | An adverse event, and/or its immediate sequelae, which is associated with an imminent risk of death or which is associated with physical or mental disabilities that affect or limit the ability of a person to perform activities of daily living (eating, ambulation, toileting, etc.) See NCI Common Terminology Criteria for Adverse Events. | Life Threatening or Disabling Adverse Event | ||
| 5 | C48275 | 5;FATAL;Grade 5 | The termination of life as a result of an adverse event. (NCI) | Death Related to Adverse Event | ||
| Back to top | ||||||
| CL.C87162.TOXGRV4 | Common Terminology Criteria for Adverse Events V4.0 (TOXGRV4) | text Extensible: No | C87162 | Common Terminology Criteria for Adverse Events V4.0 | The version 4.0 standard terminology developed to report adverse events occurring in cancer clinical trials. Common terminology criteria for adverse events (CTCAE) are used to study adverse event summaries and Investigational New Drug reports to the Food and Drug Administration. The CTCAE contain a grading scale for each adverse event term representing the severity of the event. (NCI) | CDISC SDTM Common Terminology Criteria for Adverse Event Grade Terminology Version 4.0 |
| 0 | C75533 | 0;ABSENT;Grade 0 | Grade 0 is universally defined as absence of Adverse Events or within normal limits or values. | Absent Adverse Event | ||
| 1 | C84263 | 1;Grade 1;MILD | An adverse event that is asymptomatic; or involves mild or minor symptoms; or is of marginal clinical relevance; or consists of clinical or diagnostic observations alone; or for which intervention is not indicated; or for which only non-prescription intervention is indicated. | Mild Adverse Event | ||
| 2 | C84264 | 2;Grade 2;MODERATE | An adverse event for which only minimal, local, or noninvasive intervention (e.g. packing, cautery) is indicated; or that limits instrumental activities of daily living (ADLs, e.g., shopping, laundry, transportation, or ability to conduct finances). | Moderate Adverse Event | ||
| 3 | C84265 | 3;Grade 3;SEVERE | An adverse event that is medically significant but not life-threatening; or for which inpatient care or prolongation of hospitalization are indicated; or that is an important medical event that does not result in hospitalization, but may jeopardize the patient or may require intervention either to prevent hospitalization, to prevent the AE from becoming life-threatening or causing death; or that is disabling; or that results in persistent or significant disability, incapacity, or limitation of self care activities of daily living (ADLs, e.g., getting in and out of bed, dressing, eating, getting around inside, bathing, or using the toilet). | Severe Adverse Event | ||
| 4 | C84266 | 4;Grade 4;LIFE THREATENING | An adverse event that has life-threatening consequences; for which urgent intervention is indicated; that puts the patient at risk of death at the time of the event if immediate intervention is not undertaken; or that causes blindness or deafness. | Life Threatening Adverse Event | ||
| 5 | C48275 | 5;FATAL;Grade 5 | The termination of life as a result of an adverse event. (NCI) | Death Related to Adverse Event | ||
| Back to top | ||||||
| CL.C66727.NCOMPLT | Completion/Reason for Non-Completion (NCOMPLT) | text Extensible: Yes | C66727 | Completion/Reason for Non-Completion | The status of the subject's completion of the study or a segment of the study, or the reason the subject discontinued the study or segment of the study. | CDISC SDTM Reason for Non-Completion Terminology |
| ADVERSE EVENT | C41331 | Any untoward medical occurrence in a patient or clinical investigation subject administered a pharmaceutical product and which does not necessarily have a causal relationship with this treatment. An adverse event (AE) can therefore be any unintended sign (including an abnormal laboratory finding), symptom, or disease temporally associated with the use of a medicinal (investigational) product, whether or not related to the medicinal (investigational) product. NOTE: For further information, see the ICH Guideline for Clinical Safety Data Management: Definitions and Standards for Expedited Reporting. [Modified from ICH E2A] Synonyms: side effect, adverse experience. See also serious adverse event, serious adverse experience. (CDISC glossary) | Adverse Event | |||
| COMPLETED | C25250 | To possess every necessary or normal part or component or step; having come or been brought to a conclusion. (NCI) | Complete | |||
| DEATH | C28554 | Died | The absence of life or state of being dead. (NCI) | Death | ||
| DISEASE RELAPSE | C38155 | Recurrent Disease | The return of a disease after a period of remission. | Recurrent Disease | ||
| FAILURE TO MEET RANDOMIZATION CRITERIA | C105448 | An indication that the subject has been unable to fulfill/satisfy the criteria required for assignment into a randomized group. | Failure to Meet Randomization Criteria | |||
| LACK OF EFFICACY | C48226 | The lack of expected or desired effect related to a therapy. (NCI) | Lack of Efficacy | |||
| LOST TO FOLLOW-UP | C48227 | The loss or lack of continuation of a subject to follow-up. | Lost To Follow-up | |||
| NON-COMPLIANCE WITH STUDY DRUG | C49631 | An indication that a subject has not agreed with or followed the instructions related to the study medication. (NCI) | Non-Compliance With Study Drug | |||
| OTHER | C17649 | Other | Different than the one(s) previously specified or mentioned. (NCI) | Other | ||
| PHYSICIAN DECISION | C48250 | A position, opinion or judgment reached after consideration by a physician with reference to subject. (NCI) | Physician Decision | |||
| PREGNANCY | C25742 | Pregnancy is the state or condition of having a developing embryo or fetus in the body (uterus), after union of an ovum and spermatozoon, during the period from conception to birth. (NCI) | Pregnancy | |||
| PROGRESSIVE DISEASE | C35571 | Progressive Disease | A disease process that is increasing in scope or severity. (NCI) | Progressive Disease | ||
| PROTOCOL DEVIATION | C48251 | An event or decision that stands in contrast to the guidelines set out by the protocol. (NCI) | Protocol Violation | |||
| RECOVERY | C25746 | A healing process and/or an outcome implying relative health. The term is typically used in the context of direct and indirect effects of sickness or injury. (NCI) | Recovery | |||
| SCREEN FAILURE | C49628 | The potential subject who does not meet one or more criteria required for participation in a trial. | Trial Screen Failure | |||
| SITE TERMINATED BY SPONSOR | C106576 | An indication that a clinical study was stopped at a particular site by its sponsor. (NCI) | Trial Site Terminated by Sponsor | |||
| STUDY TERMINATED BY SPONSOR | C49632 | An indication that a clinical study was stopped by its sponsor. (NCI) | Study Terminated By Sponsor | |||
| TECHNICAL PROBLEMS | C49633 | A problem with some technical aspect of a clinical study, usually related to an instrument. (NCI) | Technical Problem | |||
| WITHDRAWAL BY PARENT/GUARDIAN | C102355 | An indication that a study participant has been removed from the study by the parent or legal guardian. | Study Subject Withdrawal by Parent or Guardian | |||
| WITHDRAWAL BY SUBJECT | C49634 | An indication that a study participant has removed itself from the study. (NCI) | Withdrawal by Subject | |||
| Back to top | ||||||
| CL.C101838.CCRCLSCD | Consensus Cardiac Classification System Test Code (CCRCLSCD) | text Extensible: Yes | C101838 | Consensus Cardiac Classification System Test Code | Classification system test code for cardiac parameters that are authored or endorsed by organizations. | CDISC SDTM Consensus Cardiac Classification Systems Test Code Terminology |
| CCSGRDS | C66910 | Canadian CV Society Grading Scale | A finding associated with a patient based on the functional classification developed by the Canadian Cardiovascular Society (CCS), for categorizing patients with angina. The classification system comprises four classes, which are defined in terms of the level of physical activity associated with the subject's anginal symptoms. | Canadian Cardiovascular Society Grading Scale Class | ||
| KILLIPCL | C66916 | Killip Class | A finding associated with a patient based on the classification developed by Killip and Kimball, which classifies patients with myocardial infarction based on routine physical examination parameters, such as the presence or absence of rales, or a decreased systolic blood pressure. | Killip Class | ||
| LSNCPCLS | C100032 | ACC/AHA Lesion Complexity Class | A classification system for coronary stenosis based upon characteristics that influence the difficulty of percutaneous coronary revascularization. | American College of Cardiology/American Heart Association Lesion Complexity Class | ||
| NYHACLS | C66909 | New York Heart Association Class | A finding associated with a patient based on the functional classification developed by the New York Heart Association (NYHA), for categorizing patients with defined or presumed cardiac disease. The classification system is based on the ability to engage in physical activity. The classification system comprises four classes, though NYHA Class III and Class IV are often aggregated for the purpose of outcomes analysis. | New York Heart Association Class | ||
| TIMIFLOW | C100021 | TIMI Flow | A grading system for coronary blood flow based on the classification developed by the Thrombolysis in Myocardial Infarction Group. It classifies coronary blood flow into four classes based upon the angiographic appearance of the blood vessels. | Thrombolysis in Myocardial Infarction Flow | ||
| Back to top | ||||||
| CL.C101837.CCRCLS | Consensus Cardiac Classification System Test Name (CCRCLS) | text Extensible: Yes | C101837 | Consensus Cardiac Classification System Test Name | Classification system test name for cardiac parameters that are authored or endorsed by organizations. | CDISC SDTM Consensus Cardiac Classification Systems Test Name Terminology |
| ACC/AHA Lesion Complexity Class | C100032 | ACC/AHA Lesion Complexity Class | A classification system for coronary stenosis based upon characteristics that influence the difficulty of percutaneous coronary revascularization. | American College of Cardiology/American Heart Association Lesion Complexity Class | ||
| Canadian CV Society Grading Scale | C66910 | Canadian CV Society Grading Scale | A finding associated with a patient based on the functional classification developed by the Canadian Cardiovascular Society (CCS), for categorizing patients with angina. The classification system comprises four classes, which are defined in terms of the level of physical activity associated with the subject's anginal symptoms. | Canadian Cardiovascular Society Grading Scale Class | ||
| Killip Class | C66916 | Killip Class | A finding associated with a patient based on the classification developed by Killip and Kimball, which classifies patients with myocardial infarction based on routine physical examination parameters, such as the presence or absence of rales, or a decreased systolic blood pressure. | Killip Class | ||
| New York Heart Association Class | C66909 | New York Heart Association Class | A finding associated with a patient based on the functional classification developed by the New York Heart Association (NYHA), for categorizing patients with defined or presumed cardiac disease. The classification system is based on the ability to engage in physical activity. The classification system comprises four classes, though NYHA Class III and Class IV are often aggregated for the purpose of outcomes analysis. | New York Heart Association Class | ||
| TIMI Flow | C100021 | TIMI Flow | A grading system for coronary blood flow based on the classification developed by the Thrombolysis in Myocardial Infarction Group. It classifies coronary blood flow into four classes based upon the angiographic appearance of the blood vessels. | Thrombolysis in Myocardial Infarction Flow | ||
| Back to top | ||||||
| CL.C102575.CCINVTYP | Contact Case Investigation Contact Type (CCINVTYP) | text Extensible: Yes | C102575 | Contact Case Investigation Contact Type | Terminology relevant to the identification and clinical investigation of disease contacts. | CDISC SDTM Contact Case Investigation Contact Type Terminology |
| CASUAL CONTACT | C102606 | A way of contracting a disease through everyday interactions (nonsexual) with an infected person. | Casual Contact | |||
| CONTACT WITH EXPOSURE DURING MEDICAL PROCEDURE | C102609 | A way of contracting a disease by interacting with an individual that has been exposed to the disease while undergoing a medical procedure. | Contact With Exposure During Medical Procedure | |||
| CONTACT WITH EXPOSURE IN CROWD SETTING | C102610 | A way of contracting a disease by physically associating with an infected group of individuals. | Contact With Exposure In Crowd Setting | |||
| CONTACT WITH MEDICAL RISK FACTOR | C102611 | A way of contracting a disease by interacting with an individual that is considered at high risk for having the disease. | Contact With Medical Risk Factor | |||
| HOUSEHOLD CONTACT | C102646 | A way of contracting a disease through interactions with an infected person in the same residence. | Household Contact | |||
| Back to top | ||||||
| CL.C102588.SETCON | Contact Setting (SETCON) | text Extensible: Yes | C102588 | Contact Setting | Terminology relevant to the environment within which the subject may have come into contact with a disease carrier, or played the role of a disease carrier. | CDISC SDTM Contact Setting Terminology |
| FARM | C48953 | A tract of land cultivated for the purpose of agricultural production or devoted to the raising and breeding of domestic animals. | Farm | |||
| HOUSEHOLD ENVIRONMENT | C102647 | The area in which an individual lives. | Household Environment | |||
| NON-HOUSEHOLD ENVIRONMENT | C102679 | An area outside of that in which an individual lives. | Non-household Environment | |||
| PRISON | C85862 | An institution where persons are confined for punishment and to protect the public. | Correctional Institution | |||
| SCHOOL | C17118 | An educational institution. | School | |||
| SOCIAL SETTING | C102712 | The surroundings or environment in which social activities occur. | Social Setting | |||
| WORKSITE | C17556 | Place or physical location of work or employment. | Worksite | |||
| Back to top | ||||||
| CL.C66785.TCNTRL | Control Type (TCNTRL) | text Extensible: Yes | C66785 | Control Type | Comparator against which the study treatment is evaluated (e.g., concurrent (placebo, no treatment, dose-response, active), external (historical, published literature). | CDISC SDTM Control Type Terminology |
| ACTIVE | C49649 | A type of control, which has a demonstrated effect, administered as a comparator, to subjects in a clinical trial. [From ICH E10]. | Active Control | |||
| NONE | C41132 | No person or thing, nobody, not any. (NCI) | None | |||
| PLACEBO | C49648 | Use of an inactive compound identical in appearance to drug or treatment being tested in experimental research, which may or may not be known to the physician and/or subject, administered to distinguish between drug action and suggestive effect of the drug or treatment under study. The effects of the active drug or treatment are compared to the effects of the placebo. (NCI) | Placebo Control | |||
| Back to top | ||||||
| CL.C101843.CADPRSN | Coronary Artery Disease Presentation (CADPRSN) | text Extensible: No | C101843 | Coronary Artery Disease Presentation | A terminology codelist associated with coronary artery disease presentation. | CDISC SDTM Coronary Artery Disease Presentation Terminology |
| NON-ST ELEVATION MYOCARDIAL INFARCTION | C80383 | NON-STEMI;NSTEMI | A myocardial infarction that does not produce elevation in the ST segments of the ECG. | Non-ST Elevation Myocardial Infarction by ECG Finding | ||
| ST ELEVATION MYOCARDIAL INFARCTION | C101888 | STEMI | A myocardial infarction that produces elevation in the ST segments of the ECG. | ST Elevation Myocardial Infarction by ECG Finding | ||
| STABLE ANGINA | C66914 | Angina pectoris which has not recently changed in frequency, duration or intensity. Stable angina pectoris is relieved by rest or administration of oral, sublingual or transdermal antianginal medications. | Stable Angina | |||
| UNSTABLE ANGINA | C66911 | Angina pectoris (or equivalent type of ischemic discomfort) which has recently changed in frequency, duration, intensity, or occurs at rest. | Unstable Angina | |||
| VARIANT ANGINA | C66915 | A variant form of angina pectoris caused by coronary artery vasospasm, usually occurring spontaneously and frequently associated with ST segment elevation. | Variant Angina | |||
| Back to top | ||||||
| CL.C101849.CADRISK | Coronary Artery Disease Risk (CADRISK) | text Extensible: No | C101849 | Coronary Artery Disease Risk | A terminology codelist to describe the relative risk of coronary artery disease. | CDISC SDTM Coronary Artery Disease Risk Terminology |
| HIGH CAD RISK | C99955 | High Coronary Artery Disease Risk | The likelihood an individual will develop coronary artery disease is almost certain or greater than 90%. (Gibbons RJ, Balady GJ, Bricker JT, Chaitman BR, Fletcher GF, Froelicher VF, Mark DB, McCallister BD, Mooss AN, O'Reilly MG, Winters WL Jr. ACC/AHA 2002 guideline update for exercise testing: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Exercise Testing). 2002. American College of Cardiology Web site. Available at: www.acc.org/clinical/guidelines/exercise/dirIndex.htm.) | High Coronary Artery Disease Risk | ||
| INTERMEDIATE CAD RISK | C99966 | Intermediate Coronary Artery Disease Risk | The likelihood an individual will develop coronary artery disease (CAD) is moderate or between 10% and 90%. (Gibbons RJ, Balady GJ, Bricker JT, Chaitman BR, Fletcher GF, Froelicher VF, Mark DB, McCallister BD, Mooss AN, O'Reilly MG, Winters WL Jr. ACC/AHA 2002 guideline update for exercise testing: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Exercise Testing). 2002. American College of Cardiology Web site. Available at: www.acc.org/clinical/guidelines/exercise/dirIndex.htm.) | Intermediate Coronary Artery Disease Risk | ||
| KNOWN CAD | C99968 | Known Coronary Artery Disease | The individual has coronary artery disease (CAD). (Gibbons RJ, Balady GJ, Bricker JT, Chaitman BR, Fletcher GF, Froelicher VF, Mark DB, McCallister BD, Mooss AN, O'Reilly MG, Winters WL Jr. ACC/AHA 2002 guideline update for exercise testing: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Exercise Testing). 2002. American College of Cardiology Web site. Available at: www.acc.org/clinical/guidelines/exercise/dirIndex.htm.) | Known Coronary Artery Disease | ||
| LOW CAD RISK | C99978 | Low Coronary Artery Disease Risk | The likelihood an individual will develop coronary artery disease (CAD) is minimal or less than10%.(Gibbons RJ, Balady GJ, Bricker JT, Chaitman BR, Fletcher GF, Froelicher VF, Mark DB, McCallister BD, Mooss AN, O'Reilly MG, Winters WL Jr. ACC/AHA 2002 guideline update for exercise testing: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Exercise Testing). 2002. American College of Cardiology Web site. Available at: www.acc.org/clinical/guidelines/exercise/dirIndex.htm.) | Low Coronary Artery Disease Risk | ||
| Back to top | ||||||
| CL.C101844.CADSYMP | Coronary Artery Disease Symptoms (CADSYMP) | text Extensible: No | C101844 | Coronary Artery Disease Symptoms | A terminology codelist that contains symptoms associated with coronary artery disease. | CDISC SDTM Coronary Artery Disease Symptoms Terminology |
| ATYPICAL CORONARY ARTERY DISEASE SYMPTOMS | C99917 | Sharp stabbing chest pain or reproduction of pain on palpation. Less common isolated presentations, primarily in older adults, include nausea and vomiting, diaphoresis, and unexplained fatigue. J Am Coll Cardiol, 2007; 50:1-157, doi:10.1016/j.jacc.2007.02.013 (Published online 6 August 2007). | Atypical Coronary Artery Disease Symptom | |||
| NO SYMPTOMS | C3833 | The finding of no indications of a particular disease or injury. | Asymptomatic | |||
| NON-CARDIAC CHEST PAIN | C78504 | A discomfort in the chest area that is not related to the heart. | Non-Cardiac Chest Pain | |||
| TYPICAL CORONARY ARTERY DISEASE SYMPTOMS | C100024 | Deep, poorly localized chest or arm discomfort that is reproducibly associated with physical exertion or emotional stress and is relieved promptly (ie, in less than 5 minutes) with rest and/or the use of sublingual nitroglycerin. Some patients may have no chest discomfort but present solely with jaw, neck, ear, arm, shoulder, back, or epigastric discomfort or with unexplained dyspnea without discomfort. If these symptoms have a clear relationship to exertion or stress or are relieved promptly with nitrates, they should be considered equivalent to angina. J Am Coll Cardiol, 2007; 50:1-157, doi:10.1016/j.jacc.2007.02.013 (Published online 6 August 2007). | Typical Coronary Artery Disease Symptom | |||
| Back to top | ||||||
| CL.C119018.CADGRS | Coronary Artery Dissection NHLBI Grade Responses (CADGRS) | text Extensible: No | C119018 | Coronary Artery Dissection NHLBI Grade Responses | A terminology codelist relevant to the National Heart, Lung, and Blood Institute grade for coronary artery dissection and perforation. | CDISC SDTM NHLBI Coronary Artery Dissection Grade Responses Terminology |
| CORONARY DISSECTION NHLBI GRADE A | C119588 | Minor radiolucencies within the lumen during contrast injection with no persistence after dye clearance. (Adapted from: Coronary artery angiographic changes after PTCA: Manual of Operations NHLBI PTCA Registry 1985-6:9) | NHLBI Coronary Artery Dissection Type A | |||
| CORONARY DISSECTION NHLBI GRADE B | C119589 | Parallel tracts or double lumen separated by a radiolucent area during contrast injection with no persistence after dye clearance. (Adapted from: Coronary artery angiographic changes after PTCA: Manual of Operations NHLBI PTCA Registry 1985-6:9) | NHLBI Coronary Artery Dissection Type B | |||
| CORONARY DISSECTION NHLBI GRADE C | C119590 | Extraluminal cap with persistence of contrast after dye clearance from the lumen. (Adapted from: Coronary artery angiographic changes after PTCA: Manual of Operations NHLBI PTCA Registry 1985-6:9) | NHLBI Coronary Artery Dissection Type C | |||
| CORONARY DISSECTION NHLBI GRADE D | C119591 | Spiral luminal filling defect with delayed but complete distal flow. (Adapted from: Coronary artery angiographic changes after PTCA: Manual of Operations NHLBI PTCA Registry 1985-6:9) | NHLBI Coronary Artery Dissection Type D | |||
| CORONARY DISSECTION NHLBI GRADE E | C119592 | New persistent filling defect with delayed antegrade flow. May represent thrombus. (Adapted from: Coronary artery angiographic changes after PTCA: Manual of Operations NHLBI PTCA Registry 1985-6:9) | NHLBI Coronary Artery Dissection Type E | |||
| CORONARY DISSECTION NHLBI GRADE F | C119593 | Non-A-E types with total coronary occlusion and no distal antegrade flow. May represent thrombus. (Adapted from: Coronary artery angiographic changes after PTCA: Manual of Operations NHLBI PTCA Registry 1985-6:9) | NHLBI Coronary Artery Dissection Type F | |||
| Back to top | ||||||
| CL.C101860.CARTDOM | Coronary Artery Dominance (CARTDOM) | text Extensible: No | C101860 | Coronary Artery Dominance | A codelist to describe the pattern of the epicardial vessels supplying the posterior descending artery and the posterolateral branches. | CDISC SDTM Coronary Artery Dominance Terminology |
| CO-DOMINANT | C99941 | The right coronary artery supplies the posterior descending artery and the circumflex supplies the posterolateral branches. | Co-Dominant Artery | |||
| LEFT DOMINANT | C99971 | The left circumflex artery supplies the posterior descending artery and the posterolateral branches. | Left Cardiac Artery Dominance | |||
| RIGHT DOMINANT | C99942 | The right coronary artery supplies the posterior descending artery and the posterolateral branches. | Coronary Artery Right Dominance | |||
| Back to top | ||||||
| CL.C119017.CTTIMIRS | Coronary Thrombus TIMI Grade Responses (CTTIMIRS) | text Extensible: No | C119017 | Coronary Thrombus TIMI Grade Responses | A terminology codelist relevant to the Thrombolysis in Myocardial Infarction group grade for the description of coronary thrombus as visualized during angiography. | CDISC SDTM Coronary Thrombus TIMI Grade Responses Terminology |
| CORONARY THROMBUS TIMI GRADE 1 | C119583 | Possible thrombus present - angiography demonstrates characteristics such as reduced contrast density, haziness, irregular lesion contour or a smooth convex 'meniscus' at the site of total occlusion suggestive but not diagnostic of thrombus. (Gibson, C. M., de Lemos, J. A., Murphy, S. A., Marble, S. J., McCabe, C. H., Cannon, C. P., Antman, E. M., Braunwald, E. Combination therapy with abciximab reduces angiographically evident thrombus in acute myocardial infarction: a TIMI 14 substudy Circulation. 2001;103(21):2550-4.) | TIMI Coronary Thrombus Grade 1 | |||
| CORONARY THROMBUS TIMI GRADE 2 | C119584 | Small size definite thrombus, with greatest dimensions less than or equal to 1/2 vessel diameter. (Gibson, C. M., de Lemos, J. A., Murphy, S. A., Marble, S. J., McCabe, C. H., Cannon, C. P., Antman, E. M., Braunwald, E. Combination therapy with abciximab reduces angiographically evident thrombus in acute myocardial infarction: a TIMI 14 substudy Circulation. 2001;103(21):2550-4.) | TIMI Coronary Thrombus Grade 2 | |||
| CORONARY THROMBUS TIMI GRADE 3 | C119585 | Moderate size definite thrombus, with greatest linear dimension greater than 1/2 but less than 2 vessel diameters. (Gibson, C. M., de Lemos, J. A., Murphy, S. A., Marble, S. J., McCabe, C. H., Cannon, C. P., Antman, E. M., Braunwald, E. Combination therapy with abciximab reduces angiographically evident thrombus in acute myocardial infarction: a TIMI 14 substudy Circulation. 2001;103(21):2550-4.) | TIMI Coronary Thrombus Grade 3 | |||
| CORONARY THROMBUS TIMI GRADE 4 | C119586 | Large size definite thrombus, with the largest dimension greater than or equal to 2 vessel diameters. (Gibson, C. M., de Lemos, J. A., Murphy, S. A., Marble, S. J., McCabe, C. H., Cannon, C. P., Antman, E. M., Braunwald, E. Combination therapy with abciximab reduces angiographically evident thrombus in acute myocardial infarction: a TIMI 14 substudy Circulation. 2001;103(21):2550-4.) | TIMI Coronary Thrombus Grade 4 | |||
| CORONARY THROMBUS TIMI GRADE 5 | C119587 | Total vessel occlusion. (Gibson, C. M., de Lemos, J. A., Murphy, S. A., Marble, S. J., McCabe, C. H., Cannon, C. P., Antman, E. M., Braunwald, E. Combination therapy with abciximab reduces angiographically evident thrombus in acute myocardial infarction: a TIMI 14 substudy Circulation. 2001;103(21):2550-4.) | TIMI Coronary Thrombus Grade 5 | |||
| Back to top | ||||||
| CL.C101850.CVSLDEXT | Coronary Vessel Disease Extent (CVSLDEXT) | text Extensible: No | C101850 | Coronary Vessel Disease Extent | A terminology codelist to describe the extent of coronary artery disease. | CDISC SDTM Coronary Vessel Disease Extent Terminology |
| INDETERMINATE | C48658 | Inconclusive | Cannot distinguish between two or more possible values in the current context. (NCI) | Indeterminate | ||
| INSIGNIFICANT DISEASE | C119244 | A finding of stenosis of less than 70 percent reduction in diameter (or 50 percent reduction in cross-sectional area) in a major epicardial vessel, without stenosis of greater than or equal to 70 percent reduction in diameter (or 50 percent reduction in cross-sectional area) in any major epicardial vessel. (NCI) | Insignificant Disease by ECG Finding | |||
| NO DISEASE | C99993 | There was no stenosis in any coronary artery or branch vessel. | No Evidence of Coronary Artery Disease | |||
| ONE VESSEL DISEASE | C99997 | There was stenosis of greater than or equal to 70 percent reduction in diameter (or 50 percent reduction in cross-sectional area) in one major epicardial vessel or its major branches. | One Vessel Coronary Disease | |||
| THREE VESSEL DISEASE | C100020 | There was one of the following: Stenosis of greater than or equal to 70 percent reduction in diameter (or 50 percent reduction in cross-sectional area) in all three major epicardial vessels (anterior descending, posterior descending, circumflex) or their major branches; Stenosis of greater than or equal to 50 percent reduction in diameter of the left main and greater than or equal to 70 percent reduction in diameter, or 50 percent reduction in cross-sectional area of the right coronary artery with a right dominant or co-dominant circulation; Stenosis of greater than or equal to 50 percent reduction in diameter of the left main with a left dominant circulation. | Three Vessel Coronary Disease | |||
| TWO VESSEL DISEASE | C100023 | There was one of the following: Stenosis of greater than or equal to 70 percent reduction in diameter (or 50 percent reduction in cross-sectional area) in two major epicardial vessels or their major branches; Stenosis of greater than or equal to 50 percent reduction in diameter of the left main with a right dominant or co-dominant circulation, and no stenosis of greater than or equal to 70 percent reduction in diameter, or 50 percent reduction in cross-sectional area in the right coronary artery. | Two Vessel Coronary Disease | |||
| UNKNOWN | C17998 | U;Unknown | Not known, not observed, not recorded, or refused. (NCI) | Unknown | ||
| Back to top | ||||||
| CL.C66786.COUNTRY | Country (COUNTRY) | text Extensible: No | C66786 | Country | A collective generic term that refers here to a wide variety of dependencies, areas of special sovereignty, uninhabited islands, and other entities in addition to the traditional countries or independent states. (NCI) | CDISC SDTM Country Terminology |
| ABW | C17884 | ARUBA | Island in the Caribbean Sea, north of Venezuela. (NCI) | Aruba | ||
| AFG | C16267 | AFGHANISTAN | A country in Southern Asia, north and west of Pakistan, east of Iran. (NCI) | Afghanistan | ||
| AGO | C16292 | ANGOLA | A country in Southern Africa, bordering the South Atlantic Ocean, between Namibia and Democratic Republic of the Congo. (NCI) | Angola | ||
| AIA | C20133 | ANGUILLA | An island in the Caribbean Sea, east of Puerto Rico. (NCI) | Anguilla | ||
| ALA | C44481 | ALAND ISLANDS | An archipelago in the Baltic Sea at the entrance to the Gulf of Bothnia between Sweden and Finland. (NCI) | Aland Islands | ||
| ALB | C16271 | ALBANIA | A country in Southeastern Europe, bordering the Adriatic Sea and Ionian Sea, between Greece and Serbia and Montenegro. (NCI) | Albania | ||
| AND | C16289 | ANDORRA | A country in Southwestern Europe, between France and Spain. (NCI) | Andorra | ||
| ARE | C17232 | UNITED ARAB EMIRATES | A country in the Middle East, bordering the Gulf of Oman and the Persian Gulf, between Oman and Saudi Arabia. (NCI) | United Arab Emirates | ||
| ARG | C16305 | ARGENTINA | A country in Southern South America, bordering the South Atlantic Ocean, between Chile and Uruguay. (NCI) | Argentina | ||
| ARM | C16306 | ARMENIA | A country in Southwestern Asia, east of Turkey. (NCI) | Armenia | ||
| ASM | C17739 | AMERICAN SAMOA | A group of islands in the South Pacific Ocean, about half way between Hawaii and New Zealand. (NCI) | American Samoa | ||
| ATA | C18007 | ANTARCTICA | The continent lying mostly south of the Antarctic Circle. (NCI) | Antarctica | ||
| ATF | C20105 | FRENCH SOUTHERN TERRITORIES | Islands in the southern Indian Ocean, south of Africa, about equidistant between Africa, Antarctica, and Australia. (NCI) | French Southern and Antarctic Lands | ||
| ATG | C16303 | ANTIGUA AND BARBUDA | Islands between the Caribbean Sea and the North Atlantic Ocean, east-southeast of Puerto Rico. (NCI) | Antigua and Barbuda | ||
| AUS | C16311 | AUSTRALIA | The continent between the Indian Ocean and the South Pacific Ocean. (NCI) | Australia | ||
| AUT | C16312 | AUSTRIA | A country in Central Europe, north of Italy and Slovenia. (NCI) | Austria | ||
| AZE | C16316 | AZERBAIJAN | A country in Southwestern Asia, bordering the Caspian Sea, between Iran and Russia. (NCI) | Azerbaijan | ||
| BDI | C16371 | BURUNDI | A country in Central Africa, east of Democratic Republic of the Congo. (NCI) | Burundi | ||
| BEL | C16329 | BELGIUM | A country in Western Europe, bordering the North Sea, between France and the Netherlands. (NCI) | Belgium | ||
| BEN | C16333 | BENIN;BENIN REPUBLIC | A country in Western Africa, bordering the North Atlantic Ocean, between Nigeria and Togo. (NCI) | Benin | ||
| BES | C101224 | BONAIRE, SINT EUSTATIUS AND SABA | Three Caribbean islands that are part of the Lesser Antilles; Bonaire is east of Aruba and Curacao off the coast of Venezuela, Sint Eustatius and Saba are located south of Sint Maarten and northeast of Saint Kitts and Nevis. (NCI) | Bonaire, Sint Eustatius and Saba | ||
| BFA | C16369 | BURKINA FASO | A country in Western Africa, north of Ghana. (NCI) | Burkina Faso | ||
| BGD | C16323 | BANGLADESH | A country in Southern Asia, bordering the Bay of Bengal, between Burma and India. (NCI) | Bangladesh | ||
| BGR | C16368 | BULGARIA | A country in Southeastern Europe, bordering the Black Sea, between Romania and Turkey. (NCI) | Bulgaria | ||
| BHR | C16322 | BAHRAIN | An archipelago in the Persian Gulf, east of Saudi Arabia. (NCI) | Bahrain | ||
| BHS | C16321 | BAHAMAS | A chain of islands in the North Atlantic Ocean, southeast of Florida. (NCI) | Bahamas | ||
| BIH | C16361 | BOSNIA AND HERZEGOVINA;BOSNIA-HERZEGOVINA | A country in Southeastern Europe, bordering the Adriatic Sea and Croatia. (NCI) | Bosnia and Herzegovina | ||
| BLM | C83609 | SAINT BARTHELEMY | An island in the Caribbean sea, between Saint Martin and Saint Kitts and Nevis. (NCI) | Saint Barthelemy | ||
| BLR | C16372 | BELARUS | A country in Eastern Europe, east of Poland. (NCI) | Belarus | ||
| BLZ | C16331 | BELIZE | A country in Central America, bordering the Caribbean Sea, between Guatemala and Mexico. (NCI) | Belize | ||
| BMU | C16334 | BERMUDA | A group of islands in the North Atlantic Ocean, east of South Carolina. (NCI) | Bermuda | ||
| BOL | C16359 | BOLIVIA;BOLIVIA, PLURINATIONAL STATE OF | A country in Central South America, southwest of Brazil. (NCI) | Bolivia, Plurinational State of | ||
| BRA | C16364 | BRAZIL | A country in Eastern South America, bordering the Atlantic Ocean. (NCI) | Brazil | ||
| BRB | C16324 | BARBADOS | An island between the Caribbean Sea and the North Atlantic Ocean, northeast of Venezuela. (NCI) | Barbados | ||
| BRN | C16367 | BRUNEI;BRUNEI DARUSSALAM | A country in Southeastern Asia, bordering the South China Sea and Malaysia. (NCI) | Brunei Darussalam | ||
| BTN | C16336 | BHUTAN | A country in Southern Asia, between China and India. (NCI) | Bhutan | ||
| BVT | C20104 | BOUVET ISLAND | An island in the South Atlantic Ocean, south-southwest of the Cape of Good Hope (South Africa). (NCI) | Bouvet Island | ||
| BWA | C16363 | BOTSWANA | A country in Southern Africa, north of South Africa. (NCI) | Botswana | ||
| CAF | C16409 | CENTRAL AFRICAN REPUBLIC | A country in Central Africa, north of Democratic Republic of the Congo. (NCI) | Central African Republic | ||
| CAN | C16380 | CANADA | A country in Northern North America, bordering the North Atlantic Ocean on the east, North Pacific Ocean on the west, and the Arctic Ocean on the north, north of the conterminous US. (NCI) | Canada | ||
| CCK | C16445 | COCOS (KEELING) ISLANDS | A group of islands in the Indian Ocean, south of Indonesia, about halfway from Australia to Sri Lanka. (NCI) | Cocos (Keeling) Islands | ||
| CHE | C17181 | SWITZERLAND | A country in Central Europe, east of France, north of Italy. (NCI) | Switzerland | ||
| CHL | C16427 | CHILE | A country in Southern South America, bordering the South Atlantic Ocean and South Pacific Ocean, between Argentina and Peru. (NCI) | Chile | ||
| CHN | C16428 | CHINA | A country in Eastern Asia, bordering the East China Sea, Korea Bay, Yellow Sea, and South China Sea, between North Korea and Vietnam. (NCI) | China | ||
| CIV | C16762 | COTE D'IVOIRE | A country in Western Africa, bordering the North Atlantic Ocean, between Ghana and Liberia. (NCI) | Cote d'Ivoire | ||
| CMR | C16379 | CAMEROON | A country in Western Africa, bordering the Bight of Biafra, between Equatorial Guinea and Nigeria. (NCI) | Cameroon | ||
| COD | C17266 | CONGO, THE DEMOCRATIC REPUBLIC OF;DEMOCRATIC REPUBLIC OF THE CONGO | A country in Central Africa, northeast of Angola. (NCI) | Congo, the Democratic Republic of the | ||
| COG | C16467 | CONGO | A country in Western Africa, bordering the South Atlantic Ocean, between Angola and Gabon. (NCI) | Congo | ||
| COK | C16469 | COOK ISLANDS | A group of islands in the South Pacific Ocean, about one-half of the way from Hawaii to New Zealand. (NCI) | Cook Islands | ||
| COL | C16449 | COLOMBIA | A country in Northern South America, bordering the Caribbean Sea, between Panama and Venezuela, and bordering the North Pacific Ocean, between Ecuador and Panama. (NCI) | Colombia | ||
| COM | C16458 | COMOROS | A group of islands in the Mozambique Channel, about two-thirds of the way between northern Madagascar and northern Mozambique. (NCI) | Comoros | ||
| CPV | C16382 | CAPE VERDE | A group of islands in the North Atlantic Ocean, west of Senegal. (NCI) | Cape Verde | ||
| CRI | C16470 | COSTA RICA | A country in Central America, bordering both the Caribbean Sea and the North Pacific Ocean, between Nicaragua and Panama. (NCI) | Costa Rica | ||
| CUB | C16477 | CUBA | An island between the Caribbean Sea and the North Atlantic Ocean, 150 km south of Key West, Florida. (NCI) | Cuba | ||
| CUW | C101225 | CURACAO | An island nation located in the Caribbean Sea off the coast of Venezuela. (NCI) | Curacao | ||
| CXR | C44482 | CHRISTMAS ISLAND | An Australian-administered island in the eastern Indian Ocean south of Java, Indonesia. (NCI) | Christmas Island | ||
| CYM | C16391 | CAYMAN ISLANDS | An island group in the Caribbean Sea, nearly one-half of the way from Cuba to Honduras. (NCI) | Cayman Islands | ||
| CYP | C16480 | CYPRUS | An island in the Mediterranean Sea, south of Turkey. (NCI) | Cyprus | ||
| CZE | C17668 | CZECH REPUBLIC | A country in Central Europe, southeast of Germany. (NCI) | Czech Republic | ||
| DEU | C16636 | GERMANY | A country in Central Europe, bordering the Baltic Sea and the North Sea, between the Netherlands and Poland, south of Denmark. (NCI) | Germany | ||
| DJI | C16506 | DJIBOUTI | A country in Eastern Africa, bordering the Gulf of Aden and the Red Sea, between Eritrea and Somalia. (NCI) | Djibouti | ||
| DMA | C16519 | DOMINICA | An island between the Caribbean Sea and the North Atlantic Ocean, about one-half of the way from Puerto Rico to Trinidad and Tobago. (NCI) | Dominica | ||
| DNK | C16496 | DENMARK | A country in Northern Europe, bordering the Baltic Sea and the North Sea, on a peninsula north of Germany (Jutland); also includes two major islands (Sjaelland and Fyn). (NCI) | Denmark | ||
| DOM | C16520 | DOMINICAN REPUBLIC | A country comprising the eastern two-thirds of the island of Hispaniola, between the Caribbean Sea and the North Atlantic Ocean, east of Haiti. (NCI) | Dominican Republic | ||
| DZA | C16274 | ALGERIA | A country in Northern Africa, bordering the Mediterranean Sea, between Morocco and Tunisia. (NCI) | Algeria | ||
| ECU | C16528 | ECUADOR | A country in Western South America, bordering the Pacific Ocean at the Equator, between Colombia and Peru. (NCI) | Ecuador | ||
| EGY | C16530 | EGYPT | A country in Northern Africa, bordering the Mediterranean Sea, between Libya and the Gaza Strip. (NCI) | Egypt | ||
| ERI | C16558 | ERITREA | A country in Eastern Africa, bordering the Red Sea, between Djibouti and Sudan. (NCI) | Eritrea | ||
| ESH | C20113 | WESTERN SAHARA | A country in Northern Africa, bordering the North Atlantic Ocean, between Mauritania and Morocco. (NCI) | Western Sahara | ||
| ESP | C17152 | SPAIN | A country in Southwestern Europe, bordering the Bay of Biscay, Mediterranean Sea, North Atlantic Ocean, and Pyrenees Mountains, southwest of France. (NCI) | Spain | ||
| EST | C16562 | ESTONIA | A country in Eastern Europe, bordering the Baltic Sea and Gulf of Finland, between Latvia and Russia. (NCI) | Estonia | ||
| ETH | C16563 | ETHIOPIA | A country in Eastern Africa, west of Somalia. (NCI) | Ethiopia | ||
| FIN | C16584 | FINLAND | A country in Northern Europe, bordering the Baltic Sea, Gulf of Bothnia, and Gulf of Finland, between Sweden and Russia. (NCI) | Finland | ||
| FJI | C16582 | FIJI | An island group in the South Pacific Ocean, about two-thirds of the way from Hawaii to New Zealand. (NCI) | Fiji | ||
| FLK | C17954 | FALKLAND ISLANDS;FALKLAND ISLANDS (MALVINAS) | Islands in the South Atlantic Ocean, east of southern Argentina. (NCI) | Falkland Islands (Malvinas) | ||
| FRA | C16592 | FRANCE | A country in Western Europe, bordering the Bay of Biscay and English Channel, between Belgium and Spain, southeast of the UK; bordering the Mediterranean Sea, between Italy and Spain. (NCI) | France | ||
| FRO | C16573 | FAROE ISLANDS | An island group between the Norwegian Sea and the North Atlantic Ocean, about one-half of the way from Iceland to Norway. (NCI) | Faroe Islands | ||
| FSM | C17881 | MICRONESIA, FEDERATED STATES OF | An island group in the North Pacific Ocean, about three-quarters of the way from Hawaii to Indonesia. (NCI) | Micronesia, Federated States of | ||
| GAB | C16596 | GABON | A country in Western Africa, bordering the Atlantic Ocean at the Equator, between Republic of the Congo and Equatorial Guinea. (NCI) | Gabon | ||
| GBR | C17233 | UNITED KINGDOM | A country in Western Europe, comprising islands, including the northern one-sixth of the island of Ireland, between the North Atlantic Ocean and the North Sea, northwest of France. (NCI) | United Kingdom | ||
| GEO | C16634 | GEORGIA | A country in Southwestern Asia, bordering the Black Sea, between Turkey and Russia. (NCI) | Georgia (Republic) | ||
| GGY | C64375 | GUERNSEY | The island of Guernsey and the other Channel Islands represent the last remnants of the medieval Dukedom of Normandy, which held sway in both France and England. Guernsey is a British crown dependency, but is not part of the UK. (NCI) | Guernsey | ||
| GHA | C26330 | GHANA | A country in Western Africa, bordering the Gulf of Guinea, between Cote d'Ivoire and Togo. (NCI) | Ghana | ||
| GIB | C16638 | GIBRALTAR | A dependency in Southwestern Europe, bordering the Strait of Gibraltar, on the southern coast of Spain. (NCI) | Gibraltar | ||
| GIN | C16655 | GUINEA | A country in Western Africa, bordering the North Atlantic Ocean, between Guinea-Bissau and Sierra Leone. (NCI) | Guinea | ||
| GLP | C16651 | GUADELOUPE | Islands in the eastern Caribbean Sea, southeast of Puerto Rico. (NCI) | Guadeloupe | ||
| GMB | C16598 | GAMBIA | A country in Western Africa, bordering the North Atlantic Ocean and Senegal. (NCI) | The Gambia | ||
| GNB | C16656 | GUINEA-BISSAU | A country in Western Africa, bordering the North Atlantic Ocean, between Guinea and Senegal. (NCI) | Guinea-Bissau | ||
| GNQ | C16557 | EQUATORIAL GUINEA | A country in Western Africa, bordering the Bight of Biafra, between Cameroon and Gabon; composed of a mainland portion and five inhabited islands. (NCI) | Equatorial Guinea | ||
| GRC | C16645 | GREECE | A country in Southern Europe, bordering the Aegean Sea, Ionian Sea, and the Mediterranean Sea, between Albania and Turkey. (NCI) | Greece | ||
| GRD | C16647 | GRENADA | An island between the Caribbean Sea and Atlantic Ocean, north of Trinidad and Tobago. (NCI) | Grenada | ||
| GRL | C16646 | GREENLAND | An island between the Arctic Ocean and the North Atlantic Ocean, northeast of Canada. (NCI) | Greenland | ||
| GTM | C16654 | GUATEMALA | A country in Central America, bordering the Caribbean Sea, between Honduras and Belize and bordering the North Pacific Ocean, between El Salvador and Mexico. (NCI) | Guatemala | ||
| GUF | C16593 | FRENCH GUIANA | A country in Northern South America, bordering the North Atlantic Ocean, between Brazil and Suriname. (NCI) | French Guiana | ||
| GUM | C16652 | GUAM | Island in the North Pacific Ocean, about three-quarters of the way from Hawaii to the Philippines. (NCI) | Guam | ||
| GUY | C16657 | GUYANA | A country in Northern South America, bordering the North Atlantic Ocean, between Suriname and Venezuela. (NCI) | Guyana | ||
| HKG | C16695 | HONG KONG | A special administrative region of China, bordering the South China Sea and China. (NCI) | Hong Kong | ||
| HMD | C20106 | HEARD ISLAND AND MCDONALD ISLANDS | Islands in the Indian Ocean, about two-thirds of the way from Madagascar to Antarctica. (NCI) | Heard Island and McDonald Islands | ||
| HND | C16694 | HONDURAS | A country in Central America, bordering the Caribbean Sea, between Guatemala and Nicaragua and bordering the North Pacific Ocean, between El Salvador and Nicaragua. (NCI) | Honduras | ||
| HRV | C16474 | CROATIA | A country in Southeastern Europe, bordering the Adriatic Sea, between Bosnia and Herzegovina and Slovenia. (NCI) | Croatia | ||
| HTI | C16660 | HAITI | A country comprising the western one-third of the island of Hispaniola, between the Caribbean Sea and the North Atlantic Ocean, west of the Dominican Republic. (NCI) | Haiti | ||
| HUN | C16699 | HUNGARY | A country in Central Europe, northwest of Romania. (NCI) | Hungary | ||
| IDN | C16728 | INDONESIA | A country in Southeastern Asia, comprising the archipelago between the Indian Ocean and the Pacific Ocean. (NCI) | Indonesia | ||
| IMN | C44480 | ISLE OF MAN | An island in the Irish Sea, between Great Britain and Ireland. (NCI) | Isle of Man | ||
| IND | C16727 | INDIA | A country in Southern Asia, bordering the Arabian Sea and the Bay of Bengal, between Burma and Pakistan. (NCI) | India | ||
| IOT | C16365 | BRITISH INDIAN OCEAN TERRITORY | An archipelago in the Indian Ocean, about one-half the way from Africa to Indonesia. (NCI) | British Indian Ocean Territory | ||
| IRL | C16757 | IRELAND | A country in Western Europe, occupying five-sixths of the island of Ireland in the North Atlantic Ocean, west of Great Britain. (NCI) | Ireland | ||
| IRN | C16755 | IRAN | A country in the Middle East, bordering the Gulf of Oman, the Persian Gulf, and the Caspian Sea, between Iraq and Pakistan. (NCI) | Iran, Islamic Republic of | ||
| IRQ | C16756 | IRAQ | A country in the Middle East, bordering the Persian Gulf, between Iran and Kuwait. (NCI) | Iraq | ||
| ISL | C16704 | ICELAND | A country in Northern Europe, island between the Greenland Sea and the North Atlantic Ocean, northwest of the UK. (NCI) | Iceland | ||
| ISR | C16760 | ISRAEL | A country in the Middle East, bordering the Mediterranean Sea, between Egypt and Lebanon. (NCI) | Israel | ||
| ITA | C16761 | ITALY | A country in Southern Europe, occupying a peninsula extending into the central Mediterranean Sea, northeast of Tunisia. (NCI) | Italy | ||
| JAM | C16763 | JAMAICA | An island in the Caribbean Sea, south of Cuba. (NCI) | Jamaica | ||
| JEY | C64374 | JERSEY | Jersey and the other Channel Islands represent the last remnants of the medieval Dukedom of Normandy that held sway in both France and England. Jersey is a British crown dependency, but is not part of the UK. (NCI) | Jersey | ||
| JOR | C16765 | JORDAN | A country in the Middle East, northwest of Saudi Arabia. (NCI) | Jordan | ||
| JPN | C16764 | JAPAN | A country in Eastern Asia, occupying an island chain between the North Pacific Ocean and the Sea of Japan, east of the Korean Peninsula. (NCI) | Japan | ||
| KAZ | C20107 | KAZAKHSTAN | A country in Central Asia, northwest of China. (NCI) | Kazakhstan | ||
| KEN | C16769 | KENYA | A country in Eastern Africa, bordering the Indian Ocean, between Somalia and Tanzania. (NCI) | Kenya | ||
| KGZ | C16771 | KYRGYZSTAN | A country in Central Asia, west of China. (NCI) | Kyrgyzstan | ||
| KHM | C16378 | CAMBODIA | A country in Southeastern Asia, bordering the Gulf of Thailand, between Thailand, Vietnam, and Laos. (NCI) | Cambodia | ||
| KIR | C16639 | KIRIBATI | A group of 33 coral atolls in the Pacific Ocean, straddling the equator; the capital Tarawa is about one-half of the way from Hawaii to Australia. (NCI) | Kiribati | ||
| KNA | C17885 | SAINT KITTS AND NEVIS | Islands in the Caribbean Sea, about one-third of the way from Puerto Rico to Trinidad and Tobago. (NCI) | Saint Kitts and Nevis | ||
| KOR | C16774 | KOREA, REPUBLIC OF;SOUTH KOREA | A country in Eastern Asia, occupying the southern half of the Korean Peninsula, bordering the Sea of Japan and the Yellow Sea. (NCI) | Korea, Republic of | ||
| KWT | C16775 | KUWAIT | A country in the Middle East, bordering the Persian Gulf, between Iraq and Saudi Arabia. (NCI) | Kuwait | ||
| LAO | C16780 | LAO PEOPLE'S DEMOCRATIC REPUBLIC | A country in Southeastern Asia, northeast of Thailand, west of Vietnam. (NCI) | Lao People's Democratic Republic | ||
| LBN | C16784 | LEBANON | A country in the Middle East, bordering the Mediterranean Sea, between Israel and Syria. (NCI) | Lebanon | ||
| LBR | C16791 | LIBERIA | A country in Western Africa, bordering the North Atlantic Ocean, between Cote d'Ivoire and Sierra Leone. (NCI) | Liberia | ||
| LBY | C16793 | LIBYA | A country in Northern Africa, bordering the Mediterranean Sea, between Egypt and Tunisia. (NCI) | Libya | ||
| LCA | C17113 | SAINT LUCIA | A country in the Caribbean, occupying an island between the Caribbean Sea and North Atlantic Ocean, north of Trinidad and Tobago. (NCI) | Saint Lucia | ||
| LIE | C16794 | LIECHTENSTEIN | A country in Central Europe, between Austria and Switzerland. (NCI) | Liechtenstein | ||
| LKA | C17163 | SRI LANKA | A country in Southern Asia, occupying an island in the Indian Ocean, south of India. (NCI) | Sri Lanka | ||
| LSO | C16787 | LESOTHO | A country in Southern Africa, an enclave of South Africa. (NCI) | Lesotho | ||
| LTU | C16799 | LITHUANIA | A country in Eastern Europe, bordering the Baltic Sea, between Latvia and Russia. (NCI) | Lithuania | ||
| LUX | C16803 | LUXEMBOURG | A country in Western Europe, between France, Belgium, and Germany. (NCI) | Luxembourg | ||
| LVA | C16783 | LATVIA | A country in Eastern Europe, bordering the Baltic Sea, between Estonia and Lithuania. (NCI) | Latvia | ||
| MAC | C16807 | MACAO | A country in Eastern Asia, bordering the South China Sea and China. (NCI) | Macau | ||
| MAF | C83610 | SAINT MARTIN (FRENCH PART);SAINT MARTIN, FRENCH | An island in the Caribbean sea, between Anguilla and Saint Barthelemy. (NCI) | Saint Martin (French Part) | ||
| MAR | C16878 | MOROCCO | A country in Northern Africa, bordering the North Atlantic Ocean and the Mediterranean Sea, between Algeria and Western Sahara. (NCI) | Morocco | ||
| MCO | C16874 | MONACO | A country in Western Europe, bordering the Mediterranean Sea on the southern coast of France, near the border with Italy. (NCI) | Monaco | ||
| MDA | C16871 | MOLDOVA, REPUBLIC OF | A country in Eastern Europe, northeast of Romania. (NCI) | Moldova, Republic of | ||
| MDG | C16808 | MADAGASCAR | A country in Southern Africa, occupying an island in the Indian Ocean, east of Mozambique. (NCI) | Madagascar | ||
| MDV | C16815 | MALDIVES | A country in Southern Asia, occupying a group of atolls in the Indian Ocean, south-southwest of India. (NCI) | Maldives | ||
| MEX | C16850 | MEXICO | A country in Central America, bordering the Caribbean Sea and the Gulf of Mexico, between Belize and the US and bordering the North Pacific Ocean, between Guatemala and the US. (NCI) | Mexico | ||
| MHL | C16822 | MARSHALL ISLANDS | A group of atolls and reefs in the North Pacific Ocean, about one-half of the way from Hawaii to Australia. (NCI) | Marshall Islands | ||
| MKD | C17654 | MACEDONIA, THE FORMER YUGOSLAV REPUBLIC OF;REPUBLIC OF MACEDONIA | A country in Southeastern Europe, north of Greece. (NCI) | Macedonia, the Former Yugoslav Republic of | ||
| MLI | C16816 | MALI | A country in Western Africa, southwest of Algeria. (NCI) | Mali | ||
| MLT | C16817 | MALTA | A country in Southern Europe, occupying islands in the Mediterranean Sea, south of Sicily (Italy). (NCI) | Malta | ||
| MMR | C16370 | MYANMAR | A country in Southeastern Asia, bordering the Andaman Sea and the Bay of Bengal, between Bangladesh and Thailand. (NCI) | Myanmar | ||
| MNE | C64378 | MONTENEGRO | A republic in Southeastern Europe, bordering the Adriatic Sea, between Albania and Bosnia and Herzegovina. Formerly part of Serbia and Montenegro (Federation Republic of Yugoslavia). (NCI) | Montenegro | ||
| MNG | C16875 | MONGOLIA | A country in Northern Asia, between China and Russia. (NCI) | Mongolia | ||
| MNP | C17882 | NORTHERN MARIANA ISLANDS | A country in the Pacific, comprising islands in the North Pacific Ocean, about three-quarters of the way from Hawaii to the Philippines. (NCI) | Northern Mariana Islands | ||
| MOZ | C16882 | MOZAMBIQUE | A country in Southern Africa, bordering the Mozambique Channel, between South Africa and Tanzania. (NCI) | Mozambique | ||
| MRT | C16826 | MAURITANIA | A country in Northern Africa, bordering the North Atlantic Ocean, between Senegal and Western Sahara. (NCI) | Mauritania | ||
| MSR | C16876 | MONTSERRAT | A country in the Caribbean, occupying an island in the Caribbean Sea, southeast of Puerto Rico. (NCI) | Montserrat | ||
| MTQ | C16823 | MARTINIQUE | An island in the Caribbean Sea, north of Trinidad and Tobago. (NCI) | Martinique | ||
| MUS | C16827 | MAURITIUS | A country in Southern Africa, occupying an island in the Indian Ocean, east of Madagascar. (NCI) | Mauritius | ||
| MWI | C16813 | MALAWI | A country in Southern Africa, east of Zambia. (NCI) | Malawi | ||
| MYS | C16814 | MALAYSIA | A country in Southeastern Asia, occupying a peninsula and the northern one-third of the island of Borneo, bordering Indonesia and the South China Sea, south of Vietnam. (NCI) | Malaysia | ||
| MYT | C16828 | MAYOTTE | A country in Southern Africa, occupying an island in the Mozambique Channel, about one-half of the way from northern Madagascar to northern Mozambique. (NCI) | Mayotte | ||
| NAM | C16891 | NAMIBIA | A country in Southern Africa, bordering the South Atlantic Ocean, between Angola and South Africa. (NCI) | Namibia | ||
| NCL | C16913 | NEW CALEDONIA | A country in the Pacific, comprised of islands in the South Pacific Ocean, east of Australia. (NCI) | New Caledonia | ||
| NER | C16916 | NIGER | A country in Western Africa, southeast of Algeria. (NCI) | Niger | ||
| NFK | C16919 | NORFOLK ISLAND | A country in the Pacific, occupying an island in the South Pacific Ocean, east of Australia. (NCI) | Norfolk Island | ||
| NGA | C16917 | NIGERIA | A country in Western Africa, bordering the Gulf of Guinea, between Benin and Cameroon. (NCI) | Nigeria | ||
| NIC | C16915 | NICARAGUA | A country in Central America, bordering both the Caribbean Sea and the North Pacific Ocean, between Costa Rica and Honduras. (NCI) | Nicaragua | ||
| NIU | C16918 | NIUE | A country in the Pacific, occupying an island in the South Pacific Ocean, east of Tonga. (NCI) | Niue | ||
| NLD | C16903 | NETHERLANDS | A country in Western Europe, bordering the North Sea, between Belgium and Germany. (NCI) | Netherlands | ||
| NOR | C16920 | NORWAY | A country in Northern Europe, bordering the North Sea and the North Atlantic Ocean, west of Sweden. (NCI) | Norway | ||
| NPL | C16901 | NEPAL | A country in Southern Asia, between China and India. (NCI) | Nepal | ||
| NRU | C16896 | NAURU | A country in Oceania, occupying an island in the South Pacific Ocean, south of the Marshall Islands. (NCI) | Nauru | ||
| NZL | C16914 | NEW ZEALAND | A country in the Pacific, comprised of islands in the South Pacific Ocean, southeast of Australia. (NCI) | New Zealand | ||
| OMN | C16933 | OMAN | A country in the Middle East, bordering the Arabian Sea, Gulf of Oman, and Persian Gulf, between Yemen and the United Arab Emirates. (NCI) | Oman | ||
| PAK | C16949 | PAKISTAN | A country in Southern Asia, bordering the Arabian Sea, between India on the east and Iran and Afghanistan on the west and China in the north. (NCI) | Pakistan | ||
| PAN | C16951 | PANAMA | A country in Central America, bordering both the Caribbean Sea and the North Pacific Ocean, between Colombia and Costa Rica. (NCI) | Panama | ||
| PCN | C16993 | PITCAIRN | A country in the Pacific, comprised of islands in the South Pacific Ocean, about midway between Peru and New Zealand. (NCI) | Pitcairn | ||
| PER | C16972 | PERU | A country in Western South America, bordering the South Pacific Ocean, between Chile and Ecuador. (NCI) | Peru | ||
| PHL | C16978 | PHILIPPINES | A country in Southeastern Asia, comprised of an archipelago between the Philippine Sea and the South China Sea, east of Vietnam. (NCI) | Philippines | ||
| PLW | C17733 | PALAU | A country in the Pacific, comprising a group of islands in the North Pacific Ocean, southeast of the Philippines. (NCI) | Palau | ||
| PNG | C16952 | PAPUA NEW GUINEA | A country in Southeastern Asia, comprising a group of islands and including the eastern half of the island of New Guinea, between the Coral Sea and the South Pacific Ocean, east of Indonesia. (NCI) | Papua New Guinea | ||
| POL | C17002 | POLAND | A country in Central Europe, east of Germany. (NCI) | Poland | ||
| PRI | C17043 | PUERTO RICO | An island between the Caribbean Sea and the North Atlantic Ocean, east of the Dominican Republic. (NCI) | Puerto Rico | ||
| PRK | C16773 | KOREA, DEMOCRATIC PEOPLE'S REPUBLIC OF;NORTH KOREA | A country in Eastern Asia, occupying the northern half of the Korean Peninsula, bordering the Korea Bay and the Sea of Japan, between China and South Korea. (NCI) | Korea, Democratic People's Republic of | ||
| PRT | C17006 | PORTUGAL | A country in Southwestern Europe, bordering the North Atlantic Ocean, west of Spain. (NCI) | Portugal | ||
| PRY | C16953 | PARAGUAY | A country in Central South America, northeast of Argentina. (NCI) | Paraguay | ||
| PSE | C20110 | PALESTINIAN TERRITORY, OCCUPIED | A collective name for the West Bank and the Gaza Strip, two territories in Palestine. (NCI) | Palestinian Territory, Occupied | ||
| PYF | C16594 | FRENCH POLYNESIA | An archipelago in the South Pacific Ocean, about one-half of the way from South America to Australia. (NCI) | French Polynesia | ||
| QAT | C17045 | QATAR | A country in the Middle East, occupying a peninsula bordering the Persian Gulf and Saudi Arabia. (NCI) | Qatar | ||
| REU | C17095 | REUNION | A country in Southern Africa, occupying an island in the Indian Ocean, east of Madagascar. (NCI) | Reunion | ||
| ROU | C17108 | ROMANIA | A country in Southeastern Europe, bordering the Black Sea, between Bulgaria and Ukraine. (NCI) | Romania | ||
| RUS | C17111 | RUSSIAN FEDERATION | A country in Northern Asia (that part west of the Urals is sometimes included with Europe), bordering the Arctic Ocean, between Europe and the North Pacific Ocean. (NCI) | Russian Federation | ||
| RWA | C17112 | RWANDA | A country in Central Africa, east of Democratic Republic of the Congo. (NCI) | Rwanda | ||
| SAU | C17117 | SAUDI ARABIA | A country in the Middle East, bordering the Persian Gulf and the Red Sea, north of Yemen. (NCI) | Saudi Arabia | ||
| SDN | C17170 | SUDAN | A country in Northern Africa, bordering the Red Sea, between Egypt and Eritrea. (NCI) | Sudan | ||
| SEN | C17121 | SENEGAL | A country in Western Africa, bordering the North Atlantic Ocean, between Guinea-Bissau and Mauritania. (NCI) | Senegal | ||
| SGP | C17134 | SINGAPORE | A country in Southeastern Asia, comprised of islands between Malaysia and Indonesia. (NCI) | Singapore | ||
| SGS | C20111 | SOUTH GEORGIA AND THE SOUTH SANDWICH ISLANDS | A group of islands in the South Atlantic Ocean, east of the tip of South America. (NCI) | South Georgia and the South Sandwich Islands | ||
| SHN | C17164 | SAINT HELENA;SAINT HELENA, ASCENSION AND TRISTAN DA CUNHA | Islands in the South Atlantic Ocean, about midway between South America and Africa. (NCI) | Saint Helena, Ascension and Tristan da Cunha | ||
| SJM | C17178 | SVALBARD AND JAN MAYEN | Islands between the Arctic Ocean, Barents Sea, Greenland Sea, and Norwegian Sea, northeast of Iceland and north of Norway. (NCI) | Svalbard and Jan Mayen | ||
| SLB | C17148 | SOLOMON ISLANDS | A group of islands in the South Pacific Ocean, east of Papua New Guinea. (NCI) | Solomon Islands | ||
| SLE | C17130 | SIERRA LEONE | A country in Western Africa, bordering the North Atlantic Ocean, between Guinea and Liberia. (NCI) | Sierra Leone | ||
| SLV | C16532 | EL SALVADOR | A country in Central America, bordering the North Pacific Ocean, between Guatemala and Honduras. (NCI) | El Salvador | ||
| SMR | C17115 | SAN MARINO | A country in Southern Europe, an enclave in central Italy. (NCI) | San Marino | ||
| SOM | C17149 | SOMALIA | A country in Eastern Africa, bordering the Gulf of Aden and the Indian Ocean, east of Ethiopia. (NCI) | Somalia | ||
| SPM | C17165 | SAINT PIERRE AND MIQUELON | A country in Northern North America, comprised of islands in the North Atlantic Ocean, south of Newfoundland (Canada). (NCI) | Saint Pierre and Miquelon | ||
| SRB | C64377 | SERBIA | A republic in Southeastern Europe, bordering the Adriatic Sea, between Albania and Bosnia and Herzegovina. Formerly part of Serbia and Montenegro (Federation Republic of Yugoslavia). (NCI) | Serbia | ||
| SSD | C97351 | SOUTH SUDAN | A northeastern African country located in the Sahel region and bordered by Sudan in the north, Uganda and Kenya in the south and Ethiopia in the west. (NCI) | South Sudan | ||
| STP | C17116 | SAO TOME AND PRINCIPE | A country in Western Africa, comprised of islands in the Gulf of Guinea, straddling the Equator, west of Gabon. (NCI) | Sao Tome and Principe | ||
| SUR | C17175 | SURINAME | A country in Northern South America, bordering the North Atlantic Ocean, between French Guiana and Guyana. (NCI) | Suriname | ||
| SVK | C17669 | SLOVAKIA | A country in Central Europe, south of Poland. (NCI) | Slovakia | ||
| SVN | C17138 | SLOVENIA | A country in Central Europe, bordering the Adriatic Sea, between Austria and Croatia. (NCI) | Slovenia | ||
| SWE | C17180 | SWEDEN | A country in Northern Europe, bordering the Baltic Sea, Gulf of Bothnia, Kattegat, and Skagerrak, between Finland and Norway. (NCI) | Sweden | ||
| SWZ | C17179 | SWAZILAND | A country in Southern Africa, between Mozambique and South Africa. (NCI) | Swaziland | ||
| SXM | C101226 | SINT MAARTEN (DUTCH PART);SINT MAARTEN (DUTCH) | The southern portion of an island in the Caribbean sea, between Anguilla and Saint Barthelemy. (NCI) | Sint Maarten (Dutch Part) | ||
| SYC | C17129 | SEYCHELLES | A country in Eastern Africa, comprised of a group of islands in the Indian Ocean, northeast of Madagascar. (NCI) | Seychelles | ||
| SYR | C17182 | SYRIAN ARAB REPUBLIC | A country in the Middle East, bordering the Mediterranean Sea, between Lebanon and Turkey. (NCI) | Syrian Arab Republic | ||
| TCA | C17224 | TURKS AND CAICOS ISLANDS | Two island groups in the North Atlantic Ocean, southeast of The Bahamas. (NCI) | Turks and Caicos Islands | ||
| TCD | C16412 | CHAD | A country in Central Africa, south of Libya. (NCI) | Chad | ||
| TGO | C17202 | TOGO | A country in Western Africa, bordering the Bight of Benin, between Benin and Ghana. (NCI) | Togo | ||
| THA | C17192 | THAILAND | A country in Southeastern Asia, bordering the Andaman Sea and the Gulf of Thailand, southeast of Burma. (NCI) | Thailand | ||
| TJK | C17183 | TAJIKISTAN | A country in Central Asia, west of China. (NCI) | Tajikistan | ||
| TKL | C17704 | TOKELAU | A group of three atolls in the South Pacific Ocean, about one-half of the way from Hawaii to New Zealand. (NCI) | Tokelau | ||
| TKM | C17223 | TURKMENISTAN | A country in Central Asia, bordering the Caspian Sea, between Iran and Kazakhstan. (NCI) | Turkmenistan | ||
| TLS | C17200 | TIMOR-LESTE | A country in Southeastern Asia, northwest of Australia in the Lesser Sunda Islands at the eastern end of the Indonesian archipelago. East Timor includes the eastern half of the island of Timor, the Oecussi (Ambeno) region on the northwest portion of the island of Timor, and the islands of Pulau Atauro and Pulau Jaco. (NCI) | Timor-Leste | ||
| TON | C17205 | TONGA | An archipelago in the South Pacific Ocean, about two-thirds of the way from Hawaii to New Zealand. (NCI) | Tonga | ||
| TTO | C17217 | TRINIDAD AND TOBAGO | Islands between the Caribbean Sea and the North Atlantic Ocean, northeast of Venezuela. (NCI) | Trinidad and Tobago | ||
| TUN | C17221 | TUNISIA | A country in Northern Africa, bordering the Mediterranean Sea, between Algeria and Libya. (NCI) | Tunisia | ||
| TUR | C17222 | TURKEY | A country in southeastern Europe and southwestern Asia (that portion of Turkey west of the Bosporus is geographically part of Europe), bordering the Black Sea, between Bulgaria and Georgia, and bordering the Aegean Sea and the Mediterranean Sea, between Greece and Syria. (NCI) | Turkey | ||
| TUV | C17225 | TUVALU | An island group consisting of nine coral atolls in the South Pacific Ocean, about one-half of the way from Hawaii to Australia. (NCI) | Tuvalu | ||
| TWN | C17184 | TAIWAN | A group of islands bordering the East China Sea, Philippine Sea, South China Sea, and Taiwan Strait, north of the Philippines, off the southeastern coast of China. (NCI) | Taiwan, Province of China | ||
| TZA | C17185 | TANZANIA, UNITED REPUBLIC OF | A country in Eastern Africa, bordering the Indian Ocean, between Kenya and Mozambique. (NCI) | Tanzania, United Republic of | ||
| UGA | C17228 | UGANDA | A country in Eastern Africa, west of Kenya. (NCI) | Uganda | ||
| UKR | C17229 | UKRAINE | A country in Eastern Europe, bordering the Black Sea, between Poland and Russia. (NCI) | Ukraine | ||
| UMI | C20112 | UNITED STATES MINOR OUTLYING ISLANDS | The U.S. Minor Outlying Islands consist of Baker Island, Howland Island, Jarvis Island, Johnston Atoll, Kingman Reef, Midway Island, Navassa Island, Palmyra Atoll, and Wake Island (Wake Atoll). (NCI) | United States Minor Outlying Islands | ||
| URY | C17244 | URUGUAY | A country in Southern South America, bordering the South Atlantic Ocean, between Argentina and Brazil. (NCI) | Uruguay | ||
| USA | C17234 | UNITED STATES | A country in North America, bordering both the North Atlantic Ocean and the North Pacific Ocean, between Canada and Mexico. (NCI) | United States | ||
| UZB | C17246 | UZBEKISTAN | A country in Central Asia, north of Afghanistan. (NCI) | Uzbekistan | ||
| VAT | C17249 | VATICAN CITY STATE | An enclave of Rome (Italy). (NCI) | Holy See (Vatican City State) | ||
| VCT | C17114 | SAINT VINCENT AND THE GRENADINES | A country in the Caribbean, comprised of islands in the Caribbean Sea, north of Trinidad and Tobago. (NCI) | Saint Vincent and the Grenadines | ||
| VEN | C17250 | VENEZUELA;VENEZUELA, BOLIVARIAN REPUBLIC OF | A country in Northern South America, bordering the Caribbean Sea and the North Atlantic Ocean, between Colombia and Guyana. (NCI) | Venezuela, Bolivian Republic of | ||
| VGB | C17653 | VIRGIN ISLANDS, BRITISH | Islands between the Caribbean Sea and the North Atlantic Ocean, east of Puerto Rico. (NCI) | Virgin Islands, British | ||
| VIR | C17255 | VIRGIN ISLANDS, U.S. | Islands between the Caribbean Sea and the North Atlantic Ocean, east of Puerto Rico. (NCI) | Virgin Islands, U.S. | ||
| VNM | C17252 | VIET NAM;VIETNAM | A country in Southeastern Asia, bordering the Gulf of Thailand, Gulf of Tonkin, and South China Sea, alongside China, Laos, and Cambodia. (NCI) | Viet Nam | ||
| VUT | C17247 | VANUATU | A group of islands in the South Pacific Ocean, about three-quarters of the way from Hawaii to Australia. (NCI) | Vanuatu | ||
| WLF | C17259 | WALLIS AND FUTUNA | Islands in the South Pacific Ocean, about two-thirds of the way from Hawaii to New Zealand. (NCI) | Wallis and Futuna | ||
| WSM | C17740 | SAMOA | A group of islands in the South Pacific Ocean, about one-half of the way from Hawaii to New Zealand. (NCI) | Samoa | ||
| YEM | C17264 | YEMEN | A country in the Middle East, bordering the Arabian Sea, Gulf of Aden, and Red Sea, between Oman and Saudi Arabia. (NCI) | Yemen | ||
| ZAF | C17151 | SOUTH AFRICA | A country in Southern Africa, at the southern tip of the continent of Africa. (NCI) | South Africa | ||
| ZMB | C17267 | ZAMBIA | A country in Southern Africa, east of Angola. (NCI) | Zambia | ||
| ZWE | C17268 | ZIMBABWE | A country in Southern Africa, between South Africa and Zambia. (NCI) | Zimbabwe | ||
| Back to top | ||||||
| CL.C116108.DDTESTCD | Death Details Test Code (DDTESTCD) | text Extensible: Yes | C116108 | Death Details Test Code | Terminology relevant to the death detail assessment short name. | CDISC SDTM Death Details Test Code Terminology |
| PRCDTH | C99531 | Primary Cause of Death | The primary significant event which ultimately led to death. | Primary Cause of Death | ||
| SECDTH | C116142 | Secondary Cause of Death | The secondary significant event which ultimately led to death. | Secondary Cause of Death | ||
| Back to top | ||||||
| CL.C116107.DDTEST | Death Details Test Name (DDTEST) | text Extensible: Yes | C116107 | Death Details Test Name | Terminology relevant to the death detail assessment name. | CDISC SDTM Death Details Test Name Terminology |
| Primary Cause of Death | C99531 | Primary Cause of Death | The primary significant event which ultimately led to death. | Primary Cause of Death | ||
| Secondary Cause of Death | C116142 | Secondary Cause of Death | The secondary significant event which ultimately led to death. | Secondary Cause of Death | ||
| Back to top | ||||||
| CL.C111110.DEACNDEV | Device Events Action Taken with Device (DEACNDEV) | text Extensible: Yes | C111110 | Device Events Action Taken with Device | A terminology codelist based on the action taken with respect to the device. | CDISC SDTM Device Events Action Taken with Device Terminology |
| CALIBRATION | C69187 | The act of checking or adjusting (by comparison with a standard) the accuracy of a measuring instrument. (NCI) | Calibration | |||
| REMOVAL | C61575 | The act of taking out, extracting, or withdrawing an entity from a location. | Extraction | |||
| REPROGRAMMING | C111306 | The act of rewriting program code or application software. (NCI) | Reprogram | |||
| Back to top | ||||||
| CL.C111109.DECAT | Device Events Category (DECAT) | text Extensible: Yes | C111109 | Device Events Category | A terminology codelist based on the category of related records for the device event. | CDISC SDTM Device Events Category Terminology |
| CALIBRATION FAILURE | C62994 | Calibrate, Failure To;Failure to Calibrate | Issue associated with the failure of the device to perform a self-calibration procedure or process designed to assure the accuracy and proper performance of the device. (FDA) | Medical Device Failure to Calibrate | ||
| COMPUTER SOFTWARE ISSUE | C63269 | Software Malfunction | Issue associated with written programs, codes, and/or software system that affects device performance or communication with another device. (NCI) | Computer Software Problem Associated with Medical Device | ||
| DATA STORAGE FAILURE | C116121 | Issue associated with the failure of the software to store collected data. | Data Storage Failure | |||
| DEVICE OPERATIONAL ISSUE | C62954 | Device Operational Malfunction | Issue associated with any deviations from specifications relating to device operations (e.g. deployment, connection, electrical, computer software, infusion/flow, output, protective-measure, and incompatibility issues). | Medical Device Operational Issue | ||
| NON-STUDY EQUIPMENT ISSUE | C112361 | Non-Study Equipment Malfunction | Issue associated with any deviations from specifications relating to non-study device or equipment operations. | Non-Study Device Issue | ||
| SCHEDULED MAINTENANCE | C111309 | An inspection and/or surveillance activity that has been anticipated to occur and was assigned a time or date when that activity is to be performed. (NCI) | Scheduled Maintenance | |||
| SOFTWARE UPDATE | C67227 | All program coding after initial deployment to correct coding errors, enhance the functionality of the software, and perfect the functioning of the software. (NCI) | Software Maintenance | |||
| Back to top | ||||||
| CL.C106480.DIPARM | Device Identifier Long Name (DIPARM) | text Extensible: Yes | C106480 | Device Identifier Long Name | A terminology codelist for the long name of the identifier characteristic of the device. | CDISC SDTM Device Identifier Long Name Terminology |
| Batch Number | C104504 | Batch Identifier;Batch Number | A distinctive alpha-numeric identification code assigned by the manufacturer or distributor to a specific quantity of manufactured material or product that is produced in a manner that is expected to render it homogeneous. | Batch Number | ||
| Device Type | C53265 | Device Type | Generic category of medical device within the device classification established by a regulatory authority. | Type of Device | ||
| FDA Unique Device Identification | C112279 | FDA Unique Device Identification | A UDI is a unique numeric or alphanumeric code that includes a device identifier, which is specific to a device model, and a production identifier, which includes the current production information for that specific device, such as the lot or batch number, the serial number and/or expiration date. (FDA) | FDA Unique Device Identifier | ||
| Lot Number | C70848 | Lot Identifier;Lot Number | A distinctive alpha-numeric identification code assigned by the manufacturer or distributor to a specific quantity of manufactured material or product within a batch. | Lot Number | ||
| Manufacturer | C25392 | Manufacturer | The organization defined as being responsible for creating the product as stated on the package in which the product is supplied. (BRIDG) | Manufacturer | ||
| Model Number | C99285 | Model Identifier;Model Number | The identifier assigned to a particular design of a device, usually an alphanumeric text string. | Model Number | ||
| Secure Lead Type | C111191 | Secure Lead Type | The type of locking device used to securely fasten the electrical leads to the device. (NCI) | Electrical Lead Locking Type | ||
| Serial Number | C73518 | Serial Number | A unique identifier assigned to an individual object. | Serial Number | ||
| Stereotactic Surgery Frame Type | C106570 | Stereotactic Surgery Frame Type | The classification of the cage structure used to immobilize the head or other body part in preparation for stereotactic surgery. (NCI) | Stereotactic Surgery Frame Type | ||
| Back to top | ||||||
| CL.C106481.DIPARMCD | Device Identifier Short Name (DIPARMCD) | text Extensible: Yes | C106481 | Device Identifier Short Name | A terminology codelist for the short name of the identifier characteristic of the device. | CDISC SDTM Device Identifier Short Name Terminology |
| BATCH | C104504 | Batch Identifier;Batch Number | A distinctive alpha-numeric identification code assigned by the manufacturer or distributor to a specific quantity of manufactured material or product that is produced in a manner that is expected to render it homogeneous. | Batch Number | ||
| DEVTYPE | C53265 | Device Type | Generic category of medical device within the device classification established by a regulatory authority. | Type of Device | ||
| FDAUDI | C112279 | FDA Unique Device Identification | A UDI is a unique numeric or alphanumeric code that includes a device identifier, which is specific to a device model, and a production identifier, which includes the current production information for that specific device, such as the lot or batch number, the serial number and/or expiration date. (FDA) | FDA Unique Device Identifier | ||
| LOT | C70848 | Lot Identifier;Lot Number | A distinctive alpha-numeric identification code assigned by the manufacturer or distributor to a specific quantity of manufactured material or product within a batch. | Lot Number | ||
| MANUF | C25392 | Manufacturer | The organization defined as being responsible for creating the product as stated on the package in which the product is supplied. (BRIDG) | Manufacturer | ||
| MODEL | C99285 | Model Identifier;Model Number | The identifier assigned to a particular design of a device, usually an alphanumeric text string. | Model Number | ||
| SECURLD | C111191 | Secure Lead Type | The type of locking device used to securely fasten the electrical leads to the device. (NCI) | Electrical Lead Locking Type | ||
| SERIAL | C73518 | Serial Number | A unique identifier assigned to an individual object. | Serial Number | ||
| SFMTYP | C106570 | Stereotactic Surgery Frame Type | The classification of the cage structure used to immobilize the head or other body part in preparation for stereotactic surgery. (NCI) | Stereotactic Surgery Frame Type | ||
| Back to top | ||||||
| CL.C111111.DOTESTCD | Device Properties Test Code (DOTESTCD) | text Extensible: Yes | C111111 | Device Properties Test Code | A terminology codelist based on the test code used to obtain the device property. | CDISC SDTM Device Properties Test Code Terminology |
| COMPOS | C53414 | Composition | The materials from which something is made. | Composition | ||
| FDADEVCL | C112278 | FDA Device Classification | The class of medical device as determined by the US Food and Drug Administration, based upon the level of control necessary to ensure safety and effectiveness (21 CFR 860). | FDA Device Classification | ||
| INDC | C41184 | Indication for Use | A general description of the disease or condition the product will diagnose, treat, prevent, cure, or mitigate. | Indication | ||
| MRICTYPE | C116119 | MRI Coil Type | The classification of the coil that is used in an magnetic resonance imaging procedure. Usually refers to the anatomical location for where the coil is placed such as head, body or breast. | MRI Coil Type | ||
| MULTPLEX | C116118 | Multiplex Probe Parameter | A descriptor referring to the number of unique molecular probes contained in each assay component from which results are obtained, such as each well in a 96-well plate. | Multiplex Probe Parameter | ||
| PORESIZE | C112332 | Pore Size | A quantitative or qualitative measurement of the physical dimensions of the pores in a material. | Material Pore Size | ||
| REAGLOT | C112406 | Reagent Lot | The lot number of the reagent. | Reagent Lot Number | ||
| SCRYSTYP | C116120 | Scintillation Crystal Type | The classification of the crystalline material, which emits light in response to radiation exposure, used in the imaging procedure. | Scintillation Crystal Type | ||
| SFTWRVER | C111093 | Software Version | A form or variant of software; one of a sequence of copies of a software program, each incorporating new modifications. (NCI) | Software Version | ||
| SHLFLIFE | C70855 | Shelf Life | The period during which a medical product retains its properties and stated performance within specified limits if stored under defined conditions. The stability period is determined from the date the product was manufactured. | Medical Product Shelf Life | ||
| SIZE | C25681 | Size | The physical magnitude of something. (NCI) | Size | ||
| SRGMSHOA | C112421 | Surgical Mesh Open Area | A quantitative or qualitative measurement of the physical dimensions of the open spaces in a loosely woven sheet of inorganic or biological materials, which is used to physically support organs or tissue during a surgical procedure. | Surgical Mesh Open Area | ||
| TEMP | C25206 | Temperature | The property of a body or region of space that determines whether or not there will be a net flow of heat into it or out of it from a neighboring body or region and in which direction (if any) the heat will flow, perceptible by living organism as a somatic sensation of cold or heat. It is a measure of the average translational kinetic energy associated with the disordered microscopic motion of atoms and molecules. Temperature is measured in one of the three standard temperature scales: Celsius, Kelvin, and Fahrenheit. (NCI) | Temperature | ||
| THICKNSS | C41145 | Thickness | The dimension between two surfaces of an object, usually the smallest dimension as opposed to the width or the length. | Thickness | ||
| Back to top | ||||||
| CL.C111112.DOTEST | Device Properties Test Name (DOTEST) | text Extensible: Yes | C111112 | Device Properties Test Name | A terminology codelist based on the test name used to obtain the device property. | CDISC SDTM Device Properties Test Name Terminology |
| Composition | C53414 | Composition | The materials from which something is made. | Composition | ||
| FDA Device Classification | C112278 | FDA Device Classification | The class of medical device as determined by the US Food and Drug Administration, based upon the level of control necessary to ensure safety and effectiveness (21 CFR 860). | FDA Device Classification | ||
| Indication for Use | C41184 | Indication for Use | A general description of the disease or condition the product will diagnose, treat, prevent, cure, or mitigate. | Indication | ||
| MRI Coil Type | C116119 | MRI Coil Type | The classification of the coil that is used in an magnetic resonance imaging procedure. Usually refers to the anatomical location for where the coil is placed such as head, body or breast. | MRI Coil Type | ||
| Multiplex Probe Parameter | C116118 | Multiplex Probe Parameter | A descriptor referring to the number of unique molecular probes contained in each assay component from which results are obtained, such as each well in a 96-well plate. | Multiplex Probe Parameter | ||
| Pore Size | C112332 | Pore Size | A quantitative or qualitative measurement of the physical dimensions of the pores in a material. | Material Pore Size | ||
| Reagent Lot | C112406 | Reagent Lot | The lot number of the reagent. | Reagent Lot Number | ||
| Scintillation Crystal Type | C116120 | Scintillation Crystal Type | The classification of the crystalline material, which emits light in response to radiation exposure, used in the imaging procedure. | Scintillation Crystal Type | ||
| Shelf Life | C70855 | Shelf Life | The period during which a medical product retains its properties and stated performance within specified limits if stored under defined conditions. The stability period is determined from the date the product was manufactured. | Medical Product Shelf Life | ||
| Size | C25681 | Size | The physical magnitude of something. (NCI) | Size | ||
| Software Version | C111093 | Software Version | A form or variant of software; one of a sequence of copies of a software program, each incorporating new modifications. (NCI) | Software Version | ||
| Surgical Mesh Open Area | C112421 | Surgical Mesh Open Area | A quantitative or qualitative measurement of the physical dimensions of the open spaces in a loosely woven sheet of inorganic or biological materials, which is used to physically support organs or tissue during a surgical procedure. | Surgical Mesh Open Area | ||
| Temperature | C25206 | Temperature | The property of a body or region of space that determines whether or not there will be a net flow of heat into it or out of it from a neighboring body or region and in which direction (if any) the heat will flow, perceptible by living organism as a somatic sensation of cold or heat. It is a measure of the average translational kinetic energy associated with the disordered microscopic motion of atoms and molecules. Temperature is measured in one of the three standard temperature scales: Celsius, Kelvin, and Fahrenheit. (NCI) | Temperature | ||
| Thickness | C41145 | Thickness | The dimension between two surfaces of an object, usually the smallest dimension as opposed to the width or the length. | Thickness | ||
| Back to top | ||||||
| CL.C112037.DTDECOD | Device Tracking and Disposition Event Dictionary Derived Term (DTDECOD) | text Extensible: Yes | C112037 | Device Tracking and Disposition Event Dictionary Derived Term | A terminology codelist based on the verbatim or preprinted term for the device tracking and disposition event that occurs. | CDISC SDTM Device Tracking and Disposition Event Dictionary Derived Term Terminology |
| DEPLOYED | C101231 | The act of instantiating, positioning or activating a medical device inside of the body. | Medical Device Deployment | |||
| DESTROYED | C112270 | A finding referring to a product that has been demolished. | Destroyed Medical Device | |||
| EXPLANTED | C114146 | A status indicating that a device is removed from a surgically or naturally formed cavity of the human body. | Explanted Medical Device | |||
| IMPLANTED | C80457 | A status indicating that a device is placed into a surgically or naturally formed cavity of the human body. | Implanted Medical Device | |||
| INTENDED BUT NOT USED | C117758 | A status indicating that a device was introduced to the subject for use but did not meet its intended goal and was removed. (NCI) | Device Intended But Not Used | |||
| LOST | C112329 | A finding referring to a product that is no longer held or possessed; incapable of being recovered or regained. | Lost Medical Device | |||
| RECEIVED | C25639 | The status of coming into possession of or acting as the receptacle or recipient of an item conveyed by an intermediary to the intended destination, from a sender. | Receive | |||
| SHIPPED | C40353 | The status of being transported or conveyed by an intermediary to a destination, from the sender to the intended receiver. | Shipping | |||
| Back to top | ||||||
| CL.C106483.DUTESTCD | Device-In-Use Test Code (DUTESTCD) | text Extensible: Yes | C106483 | Device-In-Use Test Code | A terminology codelist for the test code of the test or examination used to obtain the measurement or finding of the device in use. | CDISC SDTM Device-In-Use Test Code Terminology |
| ANTPLANE | C102516 | Anatomical Plane | The position and orientation of the image slice relative to the patient-based coordinate system. (NCI) | Image Plane | ||
| AQMTRXSZ | C106533 | Image Acquisition Matrix Size | A measurement of the number of data fields, pixels or data points assigned to each linear dimension in a digital image. (NCI) | Image Acquisition Matrix Size | ||
| ATTCRCT | C94862 | Attenuation Correction Type | The adjustment for the effect of tissue thicknesses through which gamma's travel from an activity concentration origin to the scanner's detectors. The count rates of a detector are adjusted to values as if there were no attenuation along the gamma's path. This makes possible accurate quantitation in image analysis. (NCI) | Attenuation Correction | ||
| CHCKSIZE | C117759 | Checkerboard Square Size | A visual stimulus that uses a checkerboard pattern which reverses every half-second (or other specified frequency). The check size can be changed to allow for testing of specific segments of the visual pathway. | Checkerboard Square Size | ||
| COILNUM | C112364 | Number of Coil Channels | The number of channels, or elements, in the coil component of the device. | Number of Coil Channels | ||
| COILSTR | C106510 | Coil Strength | The maximum voltage allowable to pass through an electromagnetic coil. (NCI) | Coil Strength | ||
| DECCORR | C116127 | Decay Correction Indicator | An indication as to whether the image reconstruction took into account the time-activity curve during which the radiolabeled tracer decayed as it spread through the body during the image acquisition. | Decay Correction Indicator | ||
| ECHOTIME | C82331 | Echo Time | The time in milliseconds between the application of the excitation pulse and the recording of the peak echo signal. (NCI) | Echo Time | ||
| FLDVIEW | C74298 | Field of View | The extent of an area that is visible. (NCI) | Field of View | ||
| FLIPANGL | C73792 | Flip Angle | In magnetic resonance imaging, the rotation of the average axis of the protons, relative to the main magnetic field direction, induced by radiofrequency signals. (NCI) | Flip Angle | ||
| IMAQDIM | C116126 | Image Acquisition Dimensionality | The number of dimensions that the acquired image(s) are presented in. | Image Acquisition Dimensionality | ||
| IMWGTTYP | C116122 | Image Weighting Type | A classification of the technique used to enhance image contrast based on differences in magnetic resonance tissue properties. This can be achieved by changing the echo time or repetition time after the tissue has returned to its equilibrium state. | Image Weighting Type | ||
| INTDISTM | C116123 | Interslice Distance | A measurement of the distance between slices within an image sequence, calculated by subtracting the nominal slice thickness from the couch increment. | Interslice Distance Measurement | ||
| INVRTIME | C116124 | Inversion Time | The time between the inversion and excitation pulses in an inversion recovery pulse sequence. | Inversion Time | ||
| NUMSLICE | C116125 | Number of Slices | The number of planar cross-sections in an imaging sequence; each slice corresponds to a single image. | Number of Slices | ||
| PIXSPCX | C69201 | X-axis Pixel Spacing | A measurement of the distance between the centers of two adjacent pixels located along the X-axis. | Horizontal Pixel Spacing | ||
| PIXSPCY | C69210 | Y-axis Pixel Spacing | A measurement of the distance between the centers of two adjacent pixels located along the Y-axis. | Vertical Pixel Spacing | ||
| PULSSEQ | C106562 | Pulse Sequence | A serially recurrent arrangement of radiofrequency pulses that are applied to the sample. (NCI) | Pulse Sequence | ||
| RANDCORR | C116128 | Randoms Correction Indicator | An indication as to whether the device was set to correct for random noise generated by deflected positrons. | Randoms Correction Indicator | ||
| RCBDWDTH | C106563 | Receiver Bandwidth | The range between the minimum and maximum cut-off frequencies for a particular receiver, commonly measured in Hertz. (NCI) | Receiver Bandwidth | ||
| RCFLTRTP | C106564 | Reconstruction Filter Type | A classification of the reconstruction filter used to suppress noise, enhance edges, resolution recovery and smooth an image. | Reconstruction Filter Type | ||
| RECONDAT | C111303 | Reconstruction of Raw Data Type | The type of mathematical process used to produce the displayed image from the raw k-space data obtained from the receiver circuitry. (NCI) | Reconstruction of Raw Data Type | ||
| REPTIME | C82330 | Repetition Time | The amount of time in milliseconds between successive pulse sequences applied to the same slice. | Repetition Time | ||
| SFTWRVER | C111093 | Software Version | A form or variant of software; one of a sequence of copies of a software program, each incorporating new modifications. (NCI) | Software Version | ||
| SIGAMP | C112416 | Signal Amplitude | A measurement of the height of the signal. | Signal Amplitude | ||
| SIGFREQ | C112417 | Signal Frequency | A measurement of the number of cycles of a periodic wave or pulse per unit of time. | Signal Frequency | ||
| SIGW | C112418 | Signal Width | A measurement of the range of values seen in the time interval between the beginning and end of the pulse wave. | Signal Width | ||
| SLICNUM | C111314 | Slice Number | The numeric identifier used to identify an image slice. (NCI) | Slice Number | ||
| STHICK | C106534 | Slice Thickness | The dimension between two surfaces of an imaging plane. (NCI) | Image Slice Thickness | ||
| STIMPARM | C114145 | Stimulation Parameter | The type of electrode (monopolar or bipolar) used on the subject during electrical stimulation of the body or organ. | Electrical Stimulation Electrode Type | ||
| Back to top | ||||||
| CL.C106482.DUTEST | Device-In-Use Test Name (DUTEST) | text Extensible: Yes | C106482 | Device-In-Use Test Name | A terminology codelist for the test name of the test or examination used to obtain the measurement or finding of the device in use. | CDISC SDTM Device-In-Use Test Name Terminology |
| Anatomical Plane | C102516 | Anatomical Plane | The position and orientation of the image slice relative to the patient-based coordinate system. (NCI) | Image Plane | ||
| Attenuation Correction Type | C94862 | Attenuation Correction Type | The adjustment for the effect of tissue thicknesses through which gamma's travel from an activity concentration origin to the scanner's detectors. The count rates of a detector are adjusted to values as if there were no attenuation along the gamma's path. This makes possible accurate quantitation in image analysis. (NCI) | Attenuation Correction | ||
| Checkerboard Square Size | C117759 | Checkerboard Square Size | A visual stimulus that uses a checkerboard pattern which reverses every half-second (or other specified frequency). The check size can be changed to allow for testing of specific segments of the visual pathway. | Checkerboard Square Size | ||
| Coil Strength | C106510 | Coil Strength | The maximum voltage allowable to pass through an electromagnetic coil. (NCI) | Coil Strength | ||
| Decay Correction Indicator | C116127 | Decay Correction Indicator | An indication as to whether the image reconstruction took into account the time-activity curve during which the radiolabeled tracer decayed as it spread through the body during the image acquisition. | Decay Correction Indicator | ||
| Echo Time | C82331 | Echo Time | The time in milliseconds between the application of the excitation pulse and the recording of the peak echo signal. (NCI) | Echo Time | ||
| Field of View | C74298 | Field of View | The extent of an area that is visible. (NCI) | Field of View | ||
| Flip Angle | C73792 | Flip Angle | In magnetic resonance imaging, the rotation of the average axis of the protons, relative to the main magnetic field direction, induced by radiofrequency signals. (NCI) | Flip Angle | ||
| Image Acquisition Dimensionality | C116126 | Image Acquisition Dimensionality | The number of dimensions that the acquired image(s) are presented in. | Image Acquisition Dimensionality | ||
| Image Acquisition Matrix Size | C106533 | Image Acquisition Matrix Size | A measurement of the number of data fields, pixels or data points assigned to each linear dimension in a digital image. (NCI) | Image Acquisition Matrix Size | ||
| Image Weighting Type | C116122 | Image Weighting Type | A classification of the technique used to enhance image contrast based on differences in magnetic resonance tissue properties. This can be achieved by changing the echo time or repetition time after the tissue has returned to its equilibrium state. | Image Weighting Type | ||
| Interslice Distance | C116123 | Interslice Distance | A measurement of the distance between slices within an image sequence, calculated by subtracting the nominal slice thickness from the couch increment. | Interslice Distance Measurement | ||
| Inversion Time | C116124 | Inversion Time | The time between the inversion and excitation pulses in an inversion recovery pulse sequence. | Inversion Time | ||
| Number of Coil Channels | C112364 | Number of Coil Channels | The number of channels, or elements, in the coil component of the device. | Number of Coil Channels | ||
| Number of Slices | C116125 | Number of Slices | The number of planar cross-sections in an imaging sequence; each slice corresponds to a single image. | Number of Slices | ||
| Pulse Sequence | C106562 | Pulse Sequence | A serially recurrent arrangement of radiofrequency pulses that are applied to the sample. (NCI) | Pulse Sequence | ||
| Randoms Correction Indicator | C116128 | Randoms Correction Indicator | An indication as to whether the device was set to correct for random noise generated by deflected positrons. | Randoms Correction Indicator | ||
| Receiver Bandwidth | C106563 | Receiver Bandwidth | The range between the minimum and maximum cut-off frequencies for a particular receiver, commonly measured in Hertz. (NCI) | Receiver Bandwidth | ||
| Reconstruction Filter Type | C106564 | Reconstruction Filter Type | A classification of the reconstruction filter used to suppress noise, enhance edges, resolution recovery and smooth an image. | Reconstruction Filter Type | ||
| Reconstruction of Raw Data Type | C111303 | Reconstruction of Raw Data Type | The type of mathematical process used to produce the displayed image from the raw k-space data obtained from the receiver circuitry. (NCI) | Reconstruction of Raw Data Type | ||
| Repetition Time | C82330 | Repetition Time | The amount of time in milliseconds between successive pulse sequences applied to the same slice. | Repetition Time | ||
| Signal Amplitude | C112416 | Signal Amplitude | A measurement of the height of the signal. | Signal Amplitude | ||
| Signal Frequency | C112417 | Signal Frequency | A measurement of the number of cycles of a periodic wave or pulse per unit of time. | Signal Frequency | ||
| Signal Width | C112418 | Signal Width | A measurement of the range of values seen in the time interval between the beginning and end of the pulse wave. | Signal Width | ||
| Slice Number | C111314 | Slice Number | The numeric identifier used to identify an image slice. (NCI) | Slice Number | ||
| Slice Thickness | C106534 | Slice Thickness | The dimension between two surfaces of an imaging plane. (NCI) | Image Slice Thickness | ||
| Software Version | C111093 | Software Version | A form or variant of software; one of a sequence of copies of a software program, each incorporating new modifications. (NCI) | Software Version | ||
| Stimulation Parameter | C114145 | Stimulation Parameter | The type of electrode (monopolar or bipolar) used on the subject during electrical stimulation of the body or organ. | Electrical Stimulation Electrode Type | ||
| X-axis Pixel Spacing | C69201 | X-axis Pixel Spacing | A measurement of the distance between the centers of two adjacent pixels located along the X-axis. | Horizontal Pixel Spacing | ||
| Y-axis Pixel Spacing | C69210 | Y-axis Pixel Spacing | A measurement of the distance between the centers of two adjacent pixels located along the Y-axis. | Vertical Pixel Spacing | ||
| Back to top | ||||||
| CL.C101857.DIABTHPY | Diabetes Therapy (DIABTHPY) | text Extensible: Yes | C101857 | Diabetes Therapy | A terminology codelist that describes the treatment method for diabetes. | CDISC SDTM Diabetes Therapy Terminology |
| DIET | C15383 | A form of therapy which includes dietary approaches and special diets. | Special Diet Therapy | |||
| INSULIN | C581 | A synthetic or animal-derived form of insulin used in the treatment of diabetes mellitus. | Therapeutic Insulin | |||
| NO TREATMENT | C99994 | No treatment for diabetes. | No Treatment for Diabetes | |||
| ORAL MEDICATION | C102246 | A pharmacological medication intended for administration through the mouth. | Oral Medication | |||
| Back to top | ||||||
| CL.C66787.TDIGRP | Diagnosis Group (TDIGRP) | text Extensible: Yes | C66787 | Diagnosis Group | A grouping of individuals on the basis of a shared procedure or disease, or lack thereof (e.g. healthy volunteers, type 2 diabetic subjects, subjects with renal cell cancer). Standardized naming systems are available that define the groups within which a subject should be placed. (NCI) | CDISC SDTM Diagnosis Group Terminology |
| HEALTHY SUBJECTS | C49651 | An individual who is or becomes a participant in a research study and has no significant health-related issues. (NCI) | Healthy Subject | |||
| Back to top | ||||||
| CL.C66788.DICTNAM | Dictionary Name (DICTNAM) | text Extensible: Yes | C66788 | Dictionary Name | A name given to a reference source that lists words and gives their meaning. (NCI) | CDISC SDTM Dictionary Name Terminology |
| COSTART | C49471 | Coding Symbols for a Thesaurus of Adverse Reaction Terms | A terminology developed and used by the Food and Drug Administration (FDA) for the coding, filing and retrieving of post marketing adverse reaction reports. (NCI) | Thesaurus of Adverse Reaction Term Coding Symbols | ||
| ICD | C49474 | International Classification of Diseases | A system of categories to which morbid entries are assigned according to established criteria. Included is the entire range of conditions in a manageable number of categories, grouped to facilitate mortality reporting. It is produced by the World Health Organization (from ICD-10, p1). The Clinical Modifications, produced by the United States Dept. of Health and Human Services, are larger extensions used for morbidity and general epidemiological purposes, primarily in the U.S. (MSH2005_2004_10_12) | International Classification of Diseases | ||
| LOINC | C49476 | Logical Observation Identifiers Names and Codes | Published by The Regenstrief Institute, the Logical Observation Identifiers Names and Codes covers clinical and clinical laboratory terminology. (NCI) | Logical Observation Identifiers Names and Codes | ||
| MedDRA | C43820 | Medical Dictionary for Regulatory Activities | MedDRA is an international medical terminology designed to support the classification, retrieval, presentation, and communication of medical information throughout the medical product regulatory cycle. MedDRA was developed under the auspices of the International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH). The MedDRA Maintenance and Support Services Organization (MSSO) holds a contract with the International Federation of Pharmaceutical Manufacturers Associations (IFPMA) to maintain and support the implementation of the terminology. (NCI) | MedDRA | ||
| SNOMED | C53489 | Systematized Nomenclature of Medicine | A multiaxial, hierarchical classification system for diseases in man developed by the College of American Pathologists. (NCI) | Systematized Nomenclature of Medicine | ||
| WHOART | C49468 | World Health Organization Adverse Reaction Terms | A terminology implemented by the World Health Organization to describe adverse reactions to a prescribed medication or treatment regimen. (NCI) | World Health Organization Adverse Reaction Terminology | ||
| WHODD | C49475 | World Health Organization Drug Dictionary | A reference source of drugs and drug associated information maintained by the World Health Organization. (NCI) | World Health Organization Drug Dictionary | ||
| Back to top | ||||||
| CL.C99074.DIR | Directionality (DIR) | text Extensible: Yes | C99074 | Directionality | CDISC terminology for anatomical location or specimen further detailing directionality. | CDISC SDTM Directionality Terminology |
| ANTERIOR | C25231 | Denoting the front portion of the body or a structure. | Anterior | |||
| APICAL | C25423 | Relating to or located at the apex. | Apical | |||
| BASAL | C90067 | Relating to or located at the lowest portion of a structure. | Basal | |||
| CAUDAL | C73851 | Toward the tail in a body. | Caudal | |||
| CENTRAL | C25445 | A point or area that is approximately central within some larger region or structure. (NCI) | Center | |||
| CRANIAL | C37936 | Toward the head in a body. | Cranial | |||
| DEEP | C25240 | Extending relatively far inward. (NCI) | Deep | |||
| DISTAL | C25237 | Situated farthest from a point of reference. | Distal | |||
| DORSAL | C45874 | Pertaining to the back or upper surface of the body. | Dorsal | |||
| DORSOLATERAL | C90376 | Toward the back and side of a body. | Dorsolateral | |||
| FORE | C90386 | Of or involving the front of a main body. (NCI) | Fore | |||
| HIND | C90393 | Of or involving the back of a main body. (NCI) | Hind | |||
| INFERIOR | C25353 | Pertaining to a point below a given reference point. | Inferior | |||
| INNER | C37980 | Inside or closer to the inside of the body or object. (NCI) | Inner | |||
| INTERMEDIATE | C73705 | Located between two points or extremes. | Intermediate | |||
| LOWER | C25309 | The bottom one of two. (NCI) | Lower | |||
| MEDIAL | C25232 | Toward the middle or in a limb toward the median plane. | Medial | |||
| MIDLINE | C81170 | A medial line, especially the medial line or medial plane of the body (or some part of the body). | Midline | |||
| NASAL | C27958 | Of, or related to, or in the direction of the nose. | Nasal | |||
| OUTER | C38166 | Being on or toward the outside of the body or object. (NCI) | Outer | |||
| PERIPHERAL | C25233 | On or near an edge or constituting an outer boundary; the outer area. (NCI) | Peripheral | |||
| POSTERIOR | C25622 | Denoting the back portion of the body or a structure. | Posterior | |||
| PROXIMAL | C25236 | Situated nearest to a point of reference. | Proximal | |||
| ROSTRAL | C94393 | Toward the muzzle in the head. | Rostral | |||
| SUPERFICIAL | C25239 | Of or pertaining to the exterior surface. (NCI) | Superficial | |||
| SUPERIOR | C25235 | Pertaining to a point above a given reference point. | Superior | |||
| SURFACE | C25245 | The extended two-dimensional outer layer or area of a three-dimensional object. (NCI) | Surface | |||
| TEMPORAL | C117754 | Of, or related to, anatomic sites that are located in the cranium, brain, and eye. | Temporal Anatomic Qualifier | |||
| TIP | C90069 | The pointed end of a structure. | Tip | |||
| UPPER | C25355 | The top one of two. | Upper | |||
| VENTRAL | C45875 | Pertaining to the front or lower surface of the body. | Ventral | |||
| VENTROLATERAL | C98798 | Of or pertaining to the front and side of a main body. (NCI) | Ventrolateral | |||
| Back to top | ||||||
| CL.C102576.DOBSTLOC | Directly Observed Therapy Location (DOBSTLOC) | text Extensible: No | C102576 | Directly Observed Therapy Location | Terminology relevant to the physical location at which the medication or therapy was observed, by the healthcare provider, as being taken by the subject. | CDISC SDTM Directly Observed Therapy Location Terminology |
| FIELD | C102650 | A setting outside the clinic or a comparable health care facility, e.g. a doctor's office, the subject's home or workplace, a school, a public park, or a restaurant. | In the Field | |||
| HEALTH FACILITY | C21541 | The buildings and organizations where healthcare services are provided. | Healthcare Facility | |||
| Back to top | ||||||
| CL.C101863.DISCHDX | Discharge Disposition (DISCHDX) | text Extensible: Yes | C101863 | Discharge Disposition | The destination or circumstance at the time of discharge. | CDISC SDTM Discharge Disposition Terminology |
| EXPIRED | C28554 | Died | The absence of life or state of being dead. (NCI) | Death | ||
| EXPIRED IN A MEDICAL FACILITY | C99944 | The patient died while in a medical center such as a hospital, skilled nursing facility (SNF), intermediate care facility (ICF), or a freestanding hospice center. | Died in a Medical Facility | |||
| FEDERAL HEALTH CARE FACILITY | C99909 | The patient will be admitted to a medical center that is funded by the federal government (e.g. Veterans Affairs Hospital). | Federal Health Care Facility | |||
| HOME UNDER CARE OF ORGANIZED HOME HEALTH SERVICE ORGANIZATION IN ANTICIPATION OF COVERED SKILLED CARE | C99959 | The patient will return home but personal health maintenance will be administered and monitored by a member of a healthcare organization that is eligible to receive Medicare funding. | Home Under Care of Organized Home Health Service Organization in Anticipation of Covered Skilled Care | |||
| HOME, HOSPICE | C99958 | The patient will receive end-of-life care which will be administered in the patient's home. | Home Hospice | |||
| HOME, SELF CARE | C99957 | A routine discharge where personal health maintenance will be administered and monitored by the patient from their home. | Home Care | |||
| HOSPICE - MEDICAL FACILITY | C99910 | The patient will receive end-of-life care which will be administered in a medical center. | Hospice Care at Medical Facility | |||
| HOSPITAL-BASED MEDICARE-APPROVED SWING BED | C99960 | The patient will be admitted into a medical center and receive a type of hospital bed that will be paid for my Medicare. | Hospital with Medicare Approved Swing Bed | |||
| INPATIENT REHABILITATION FACILITY (IRF) INCLUDING REHABILITATION DISTINCT PART UNITS OF A HOSPITAL | C99911 | The patient will be admitted full time into a free standing rehabilitation center or a rehabilitation center within a general medical facility. | Inpatient Rehabilitation Facility Including Rehabilitation distinct Part Units of a Hospital | |||
| INSTITUTION NOT DEFINED | C102247 | The patient will be admitted into an alternative facility not listed. | Institution Not Defined | |||
| INTERMEDIATE CARE FACILITY | C99912 | The patient will be admitted into a medical center that provides care 24 hours per day. | Intermediate Care Facility | |||
| LEFT AGAINST MEDICAL ADVICE OR DISCONTINUED CARE | C99969 | The patient vacated the medical center or ceased medical care contrary to the recommendation of a trained healthcare provider. | Left Against Medical Advice | |||
| MEDICARE-CERTIFIED LONG TERM CARE HOSPITAL (LTCH) | C99984 | The patient will be admitted into a Medicare funded medical center for a considerable length of time. | Medicare Certified Long Term Care Hospital | |||
| NURSING FACILITY CERTIFIED UNDER MEDICAID BUT NOT CERTIFIED UNDER MEDICARE | C99913 | The patient will be admitted into a medical center which is eligible to receive funding from Medicaid but not Medicare. | Nursing Facility Certified Under Medicaid but Not Certified Under Medicare | |||
| PSYCHIATRIC HOSPITAL OR A PSYCHIATRIC-DISTINCT PART UNIT OF A HOSPITAL | C53536 | The patient will be admitted into a free standing medical facility or a unit within a general medical facility used for the treatment of mental health disorders. | Psychiatric Facility | |||
| SHORT TERM GENERAL HOSPITAL | C102248 | The patient will remain in a basic hospital environment for a brief time. | Short Term General Hospital | |||
| SKILLED NURSING FACILITY (SNF) WITH MEDICARE CERTIFICATION IN ANTICIPATION OF COVERED SKILLED CARE | C99914 | The patient will be admitted into a medical center equipped with a trained nursing staff that is eligible to receive Medicare funding. | Skilled Nursing Facility with Medicare Certification in Anticipation of Covered Skilled Care | |||
| Back to top | ||||||
| CL.C102578.DSSOUT | Disease Outcome (DSSOUT) | text Extensible: Yes | C102578 | Disease Outcome | Terminology relevant to the measurable result or effect of treatment on a disease. | CDISC SDTM Disease Outcome Terminology |
| BACTERIOLOGICAL CURE | C102600 | There are no indicators of bacterial infection in an individual who previously had an infection. | Bacteriological Cure | |||
| BACTERIOLOGICAL FAILURE | C102601 | There are indicators of bacterial infection in the individual who previously had an infection. | Bacteriological Failure | |||
| CLINICAL CURE | C102607 | There are no signs or symptoms of disease in the individual who previously had a disease. | Clinical Cure | |||
| CLINICAL FAILURE | C102608 | There are still signs or symptoms of disease in the individual who previously had an infection. | Clinical Failure | |||
| RECURRENT DISEASE | C38155 | Recurrent Disease | The return of a disease after a period of remission. | Recurrent Disease | ||
| Back to top | ||||||
| CL.C78732.DATESTCD | Drug Accountability Test Code (DATESTCD) | text Extensible: Yes | C78732 | Drug Accountability Test Code | The short name, or code, of the test for the drug accountability assessment. | CDISC SDTM Drug Accountability Test Terminology by Code |
| DISPAMT | C78721 | Dispensed Amount | The quantity of a product that has been dispensed. (NCI) | Dispensed Amount | ||
| RETAMT | C78722 | Returned Amount | The quantity of a product that has been returned. (NCI) | Returned Amount | ||
| Back to top | ||||||
| CL.C78731.DATEST | Drug Accountability Test Name (DATEST) | text Extensible: Yes | C78731 | Drug Accountability Test Name | The name of the test for the drug accountability assessment. | CDISC SDTM Drug Accountability Test Terminology by Name |
| Dispensed Amount | C78721 | Dispensed Amount | The quantity of a product that has been dispensed. (NCI) | Dispensed Amount | ||
| Returned Amount | C78722 | Returned Amount | The quantity of a product that has been returned. (NCI) | Returned Amount | ||
| Back to top | ||||||
| CL.C102577.DRSTAT | Drug Resistance Status (DRSTAT) | text Extensible: Yes | C102577 | Drug Resistance Status | Terminology relevant to the state or condition of the microbe or lesion to indicate whether it is resistant to drugs normally used in treatment. | CDISC SDTM Drug Resistance Status Terminology |
| EXTENSIVE DRUG RESISTANCE | C102633 | XDR | Resistance to nearly all known drugs, particularly the most efficacious or non-first line drugs, used in the treatment of a particular disease. | Extensively Drug Resistance Process | ||
| MULTIPLE DRUG RESISTANCE | C17745 | MDR | Simultaneous resistance to a spectrum of unrelated drugs following exposure to a single agent. Mechanisms involve expression of multidrug efflux pumps (p-glycoprotein), altered glutathione metabolism, decreased topoisomerase II activity, and changes in various cellular proteins. | Multidrug Resistance Process | ||
| SUSCEPTIBLE | C85563 | Susceptible | The growth of microorganisms are inhibited by the usually achievable concentrations of antimicrobial agent when the recommended dosage is used for the site of infection. | Antimicrobial Susceptibility Result | ||
| Back to top | ||||||
| CL.C90013.EGLEAD | ECG Lead (EGLEAD) | text Extensible: Yes | C90013 | ECG Lead | Terminology related to electrocardiogram lead names. | CDISC SDTM Electrocardiogram Lead Terminology |
| LEAD aV6 | C90403 | An augmented unipolar lead placed at the sixth intercostal space on the midaxillary line. (NCI) | Lead Site aV6 | |||
| LEAD aVF | C90360 | An augmented unipolar electrocardiogram limb lead in which the positive (red) electrode is situated on the left pelvic limb and the negative electrode is a combination of the right thoracic limb (white) electrode and the left thoracic limb (black) electrode. Measures the electrical activity of the electrode on the left pelvic limb. | Augmented Vector Foot | |||
| LEAD aVL | C90361 | An augmented unipolar electrocardiogram limb lead in which the positive (black) electrode is situated on the left thoracic limb and the negative electrode is a combination of the right thoracic limb (white) electrode and the left pelvic limb (red) electrode. Measures the electrical activity of the electrode on the left thoracic limb. (NCI) | Augmented Vector Left | |||
| LEAD aVR | C90362 | An augmented unipolar electrocardiogram limb lead in which the positive (white) electrode is situated on the right thoracic limb and the negative electrode is a combination of the left thoracic limb (black) electrode and the left pelvic limb (red) electrode. Measures the electrical activity of the electrode on the right thoracic limb. (NCI) | Augmented Vector Right | |||
| LEAD CM5 | C90404 | A bipolar EKG lead with the right thoracic limb electrode placed on the manubrium and left thoracic limb electrode placed at the surface marking of the V5 position (just above the 5th interspace in the anterior axillary line). The left pelvic limb lead acts as a neutral and may be placed anywhere. The C refers to 'clavicle' where it is often placed. (NCI) | Lead Site CM5 | |||
| LEAD CV5RL | C90405 | A unipolar chest lead used mostly in large animals. Placed on the sixth ICS on the right side of the thorax along a line parallel to the level of the point of the humeralradial joint. | Lead Site CV5RL | |||
| LEAD CV6LL | C90406 | V1 electrode (+) placed in the 6th intercostal space on the left side of the thorax along a line parallel to the level of the point of the humeralradial joint. | Lead Site CV6LL | |||
| LEAD CV6LU | C90407 | V2 electrode (+) placed in the 6th intercostal space on the left side of the thorax along a line parallel to the level of the point of the shoulder. (NCI) | Lead Site CV6LU | |||
| LEAD I | C90408 | A bipolar electrocardiogram limb lead which records the voltage between the negative electrode on the right thoracic limb and the positive electrode on the left thoracic limb. (NCI) | Lead Site I | |||
| LEAD II | C90409 | A bipolar electrocardiogram limb lead which records the voltage between the negative electrode on the right thoracic limb and the positive electrode on the left pelvic limb. (NCI) | Lead Site II | |||
| LEAD III | C90410 | A bipolar electrocardiogram limb lead which records the voltage between the negative electrode on the left thoracic limb and the positive electrode on the left pelvic limb. (NCI) | Lead Site III | |||
| LEAD rV2 | C90411 | A unipolar precordial lead placed at the second intercostal space to the left of the sternum. (NCI) | Lead Site rV2 | |||
| LEAD V1 | C90412 | A unipolar electrocardiogram lead site; the electrode is placed at the fourth intercostal space on the anterior chest wall (between ribs 4 and 5) to the right of the sternal border. In small animals, it is placed at the right fifth intercostal space near the sternum. (NCI) | Lead Site V1 | |||
| LEAD V10 | C90413 | A unipolar chest lead at which the electrode is placed over the dorsal spinous process of 7th thoracic vertebra. (NCI) | Lead Site V10 | |||
| LEAD V2 | C90414 | A unipolar electrocardiogram lead site; the electrode is placed on the anterior chest wall at the fourth intercostal space (between ribs 4 and 5) to the left of the sternal border. In small animals it corresponds to V2-V3 where it is placed at the 6th left intercostal space near the sternum. In large animals it is placed over the 6th rib at the level of the costochondral junction on the left side of the thorax. | Lead Site V2 | |||
| LEAD V3 | C90415 | A unipolar electrocardiogram lead site; the electrode is placed on the anterior chest wall midway between leads V2 and V4. In large and small animals, it is placed over the dorsal spinous process of the 7th thoracic vertebra. (NCI) | Lead Site V3 | |||
| LEAD V4 | C90416 | A unipolar electrocardiogram lead site; the electrode is placed at the fifth intercostal space on the anterior chest wall (between ribs 5 and 6) at the left midclavicular line. In small animals it corresponds to V4-V6 where it is placed at the 6th left intercostal space near the costochondral junction. In large animals it is placed over the 6th rib at the level of a horizontal line drawn through the scapulohumeral articulation on the left side of the thorax. (NCI) | Lead Site V4 | |||
| LEAD V5 | C90417 | A unipolar electrocardiogram lead site; the electrode is placed on the anterior chest wall level with lead V4 at the left anterior axillary line. In large animals it is placed on the sixth ICS on the right side of the thorax along a line parallel to the level of the point of the shoulder corresponding to the electrical center of the heart (central terminal). (NCI) | Lead Site V5 | |||
| LEAD V6 | C90418 | A unipolar electrocardiogram lead site at which the electrode is placed on the anterior chest wall level with lead V5 at the left midaxillary line . | Lead Site V6 | |||
| SML | C117760 | Global Median Beat;Superimposition of Multiple Leads | Measurement methodology using multiple leads for the determination of an ECG parameter. This is often visually represented as a superimposition of the median beats from multiple leads. | Superimposition of Multiple Leads | ||
| Back to top | ||||||
| CL.C71150.EGSTRESC | ECG Result (EGSTRESC) | text Extensible: Yes | C71150 | ECG Result | Terminology codelist used with ECG Findings and Abnormalities within CDISC. | CDISC SDTM ECG Finding Terminology |
| 1ST DEGREE AV BLOCK | C111088 | 1st degree AV block;PR Prolongation;Prolonged PR interval | An electrocardiographic finding of prolonged PR interval for a specific population. For adults one common threshold is a PR interval greater than 0.20 seconds. Note that other thresholds may be applicable. | AV Block First Degree by ECG Finding | ||
| 2:1 AV BLOCK | C71044 | 2:1 AV block | An electrocardiographic finding of a supraventricular rhythm where the ratio of impulses generated above the atrioventricular node to the number of impulses conducted through to the ventricles is 2:1. This is manifest on the ECG as 2 P waves per QRS complex. | 2:1 Atrioventricular Block by ECG Finding | ||
| 2ND DEGREE AV BLOCK | C62016 | Second Degree AV Block | An electrocardiographic finding of intermittent failure of atrial electrical impulse conduction to the ventricles. This is manifest on the ECG by regular P waves which intermittently are not followed by QRS complexes. | AV Block Second Degree by ECG Finding | ||
| 3RD DEGREE AV BLOCK | C111091 | 3rd Degree Heart Block;AV block, complete (third-degree);Complete Heart Block | An electrocardiographic finding of complete failure of atrial electrical impulse conduction to the ventricles. This is manifest on the ECG by disassociation of atrial and ventricular rhythms. The atrial rate must be faster than the ventricular rate. | AV Block Third Degree by ECG Finding | ||
| 50 Hz NOISE | C114165 | 50 Hz Artifact;50 Hz Noise | An electrocardiographic recording showing power line interference with the electrocardiographic signal. The artifact amplitude modulation has the same frequency as the AC power system present (50 Hz). | 50 Hertz Noise by ECG Finding | ||
| 60 Hz NOISE | C114164 | 60 Hz Artifact;60 Hz Noise | An electrocardiographic recording showing power line interference with the electrocardiographic signal. The artifact amplitude modulation has the same frequency as the AC power system present (60 Hz). | 60 Hertz Noise by ECG Finding | ||
| ABERRANTLY CONDUCTED COMPLEXES | C116132 | Aberrantly Conducted Beats | An electrocardiographic finding of abnormal wide QRS complex(es) of supraventricular in origin and wide due to aberrant AV conduction. | Aberrantly Conducted Complexes by ECG Finding | ||
| AC NOISE | C114149 | AC Noise | An electrocardiographic recording showing power line interference with the electrocardiographic signal. The artifact amplitude modulation has the same frequency as the AC power system present (usually 50 Hz or 60 Hz). | Alternating Current Noise by ECG Finding | ||
| ACCELERATED IDIOVENTRICULAR RHYTHM | C62266 | Accelerated idioventricular rhythm | An electrocardiographic finding of idioventricular rhythm with a rate greater than 50 beats per minute. | Accelerated Idioventricular Rhythm by ECG Finding | ||
| ACUTE ANTERIOR WALL MYOCARDIAL INFARCTION | C71065 | Acute Anterior MI;Acute Anterior Wall Myocardial Infarction | An electrocardiographic finding of pathologic Q waves with accompanying ST elevation in leads V3 and V4, which is suggestive of acute myocardial infarction of the anterior wall of the left ventricle. | Acute Anterior Myocardial Infarction by ECG Finding | ||
| ACUTE ANTEROLATERAL WALL MYOCARDIAL INFARCTION | C102591 | Acute Anterolateral Wall Myocardial Infarction | An electrocardiographic finding of pathologic Q waves with accompanying ST elevation in leads V3 through V6, which is suggestive of acute myocardial infarction of the anterolateral wall of the left ventricle. | Acute Anterolateral Myocardial Infarction by ECG Finding | ||
| ACUTE ANTEROSEPTAL WALL MYOCARDIAL INFARCTION | C102592 | Acute Anteroseptal Wall Myocardial Infarction;Acute anteroseptal MI | An electrocardiographic finding of pathologic Q waves with accompanying ST elevation in leads V1 through V4, which is suggestive of acute myocardial infarction of the anteroseptal wall of the left ventricle. | Acute Anteroseptal Myocardial Infarction by ECG Finding | ||
| ACUTE EXTENSIVE ANTERIOR WALL MYOCARDIAL INFARCTION | C106496 | An electrocardiographic finding of pathologic Q waves with accompanying ST elevation in leads V1 to V6, I and aVL, which is suggestive of acute myocardial infarction involving the anterior and anterolateral walls of the left ventricle. | Acute Extensive Anterior Wall Myocardial Infarction by ECG Finding | |||
| ACUTE HIGH LATERAL WALL MYOCARDIAL INFARCTION | C102593 | Acute High Lateral Wall Myocardial Infarction | An electrocardiographic finding of pathologic Q waves with accompanying ST elevation in leads I and aVL, which is suggestive of acute myocardial infarction of the high lateral wall of the left ventricle. | Acute High Lateral Myocardial Infarction by ECG Finding | ||
| ACUTE INFERIOR WALL MYOCARDIAL INFARCTION | C71066 | Acute Inferior MI;Acute Inferior Wall Myocardial Infarction | An electrocardiographic finding of pathologic Q waves with accompanying ST elevation in leads III, aVF and often II, which is suggestive of acute myocardial infarction of the inferior wall of the left ventricle. | Acute Inferior Myocardial Infarction by ECG Finding | ||
| ACUTE LATERAL WALL MYOCARDIAL INFARCTION | C71067 | Acute Lateral MI;Acute Lateral Wall Myocardial Infarction | An electrocardiographic finding of pathologic Q waves with accompanying ST elevation in leads V5, V6, I and aVL, which is suggestive of acute myocardial infarction of the lateral wall of the left ventricle. | Acute Lateral Myocardial Infarction by ECG Finding | ||
| ACUTE MYOCARDIAL INFARCTION | C101596 | Acute Myocardial Infarction | An electrocardiographic finding showing a current of injury with ST elevation. No specification is provided for localization. | Acute Myocardial Infarction by ECG Finding | ||
| ACUTE POSTERIOR WALL MYOCARDIAL INFARCTION | C71068 | Acute Posterior MI;Acute Posterior Wall Myocardial Infarction | An electrocardiographic finding in leads V1 or V2 of an initial R wave duration greater than or equal to 40 ms, R wave greater than S wave, upright T wave, with accompanying ST elevation, which is suggestive of acute myocardial infarction of the posterior wall of the left ventricle. Evidence of inferior or lateral myocardial infarction is usually also present. | Acute Posterior Myocardial Infarction by ECG Finding | ||
| ACUTE RIGHT VENTRICULAR WALL MYOCARDIAL INFARCTION | C102594 | Acute Right Ventricular Wall Myocardial Infarction;Acute Right ventricular MI | An electrocardiographic finding in leads V1 or V2 of an initial R wave duration greater than or equal to 40 ms, R wave greater than S wave, upright T wave, with accompanying ST elevation, which is suggestive of acute myocardial infarction of the ventricular wall of the left ventricle. Evidence of inferior or lateral myocardial infarction is usually also present. Additional criteria include ST elevation > 100 microvolts in the right precordial leads V4R through V6R. | Acute Right Ventricular Myocardial Infarction by ECG Finding | ||
| ACUTE SEPTAL WALL MYOCARDIAL INFARCTION | C102595 | Acute Septal Wall Myocardial Infarction | An electrocardiographic finding of pathologic Q waves with accompanying ST elevation in leads V1, V2 and often V3, which is suggestive of acute myocardial infarction of the intraventricular septum. | Acute Septal Myocardial Infarction by ECG Finding | ||
| ADVANCED/HIGH GRADE AV BLOCK | C102642 | Advanced/High Grade AV Block | An electrocardiographic finding of intermittent failure of atrial electrical impulse conduction to the ventricles, characterized by two or more consecutive non-conducted P waves. | High Grade Atrioventricular Block by ECG Finding | ||
| ALL PRECORDIAL ELECTRODES DISCONNECTED | C114159 | An electrocardiographic recording in which all precordial electrodes are disconnected resulting in missing waveforms (flat line) of all leads V1 - V6. | All Precordial Electrodes Are Disconnected by ECG Finding | |||
| ANTERIOR WALL MYOCARDIAL INFARCTION | C71069 | Anterior MI;Anterior Wall Myocardial Infarction | An electrocardiographic finding of pathologic Q waves in leads V3 and V4, which is suggestive of myocardial infarction of the anterior wall of the left ventricle. | Anterior Myocardial Infarction by ECG Finding | ||
| ANTEROLATERAL WALL MYOCARDIAL INFARCTION | C35303 | Anterolateral Wall Myocardial Infarction | An electrocardiographic finding of pathologic Q waves in leads V3 through V6, which is suggestive of myocardial infarction of the anterolateral wall of the left ventricle. | Anterolateral Myocardial Infarction by ECG Finding | ||
| ANTEROSEPTAL WALL MYOCARDIAL INFARCTION | C35304 | Anteroseptal MI;Anteroseptal Wall Myocardial Infarction | An electrocardiographic finding of pathologic Q waves in leads V1 through V4, which is suggestive of myocardial infarction of the anteroseptal wall of the left ventricle. | Anteroseptal Myocardial Infarction by ECG Finding | ||
| ARTIFACT | C114162 | An electrocardiographic recording in which one or more leads display extraneous signals which do not represent cardiac electrical activity. | Artifact Lead Signal by ECG Finding | |||
| ASYSTOLE | C116130 | An electrocardiographic finding showing no cardiac electrical activity on the ECG for the entire duration of the recording. | Asystole by ECG Finding | |||
| ATRIAL BIGEMINY | C102596 | An electrocardiographic finding of a sinus beat followed by a premature atrial complex for three or more consecutive cycles; a regularly irregular rhythm of normal and abnormal P waves in a 1-1 ratio. | Atrial Bigeminy by ECG Finding | |||
| ATRIAL COUPLETS | C102597 | Atrial Couplets | An electrocardiographic finding in which two premature atrial complexes occur sequentially. | Atrial Couplet by ECG Finding | ||
| ATRIAL ENLARGEMENT | C71039 | Atrial Enlargement | An electrocardiographic finding which comprises left, right or bilateral atrial enlargement. This is may be characterized by prolonged P wave duration, increased P wave amplitude, or multi-component P waves. | Atrial Enlargement by ECG Finding | ||
| ATRIAL FIBRILLATION | C111092 | Atrial fibrillation | An electrocardiographic finding of a supraventricular arrhythmia characterized by the replacement of consistent P waves by rapid oscillations or fibrillatory waves that vary in size, shape and timing and are accompanied by an irregularly irregular ventricular response. | Atrial Fibrillation by ECG Finding | ||
| ATRIAL FLUTTER | C111094 | Atrial flutter | An electrocardiographic finding of an organized, regular atrial rhythm with atrial rate of 240-340 beats per minute. Multiple P waves typically appear in the inferior leads in a saw tooth like pattern between the QRS complexes. | Atrial Flutter by ECG Finding | ||
| ATRIAL TACHYCARDIA | C111105 | Atrial tachycardia | An electrocardiographic finding of an organized, regular atrial rhythm with atrial rate between 101 and 240 beats per minute. The P wave morphology must be distinct from the sinus P wave morphology. | Atrial Tachycardia by ECG Finding | ||
| ATRIAL TACHYCARDIA WITH AV BLOCK | C119249 | An electrocardiographic finding of an atrial tachycardia which does not display 1:1 AV conduction. | Atrial Tachycardia With AV Block by ECG Finding | |||
| ATRIAL TRIGEMINY | C102598 | Atrial Trigeminy | An electrocardiographic finding of two sinus beats followed by a premature atrial complex for 3 or more consecutive cycles; a regularly irregular rhythm of normal and abnormal P waves in a 2-1 ratio. | Atrial Trigeminy by ECG Finding | ||
| ATRIOVENTRICULAR DISSOCIATION | C71045 | AV Dissociation;Atrioventricular dissociation | An electrocardiographic finding in which the electrical activity of the atria and ventricles are independent of one another. | Atrioventricular Dissociation by ECG Finding | ||
| AV MOBITZ I | C111089 | AV Mobitz I;Mobitz I Second Degree AV Block;Second degree AV block- Mobitz type I;Second-degree AV block, Mobitz type I (Wenckebach);Type 1 2nd degree AV Block;Wenckebach | An electrocardiographic finding of intermittent failure of atrial electrical impulse conduction to the ventricles, characterized by a progressively lengthening PR interval prior to the block of an atrial impulse. | AV Block Second Degree Mobitz Type I by ECG Finding | ||
| AV MOBITZ II | C111090 | Mobitz II AV Block;Mobitz II Second Degree AV Block;Type 2 2nd degree AV Block | An electrocardiographic finding of intermittent failure of atrial electrical impulse conduction to the ventricles, characterized by a relatively constant PR interval prior to the block of an atrial impulse. | AV Block Second Degree Mobitz Type II by ECG Finding | ||
| AV NODE RE-ENTRY | C35058 | AV Node Reentrant Supraventricular Tachycardia | An electrocardiographic finding of a regular supraventricular tachycardia due to reentry within the AV node. It is characterized by P waves which typically occurs nearly simultaneously with the QRS complex, resulting in a P wave which is obscured by the QRS, merged with the QRS or which may follow the QRS. | Atrioventricular Nodal Reentry Tachycardia by ECG Finding | ||
| AV RE-ENTRANT TACHYCARDIA | C62261 | AV Reentrant Supraventricular Tachycardia | An electrocardiographic finding of a regular supraventricular tachycardia which utilizes an atrioventricular bypass tract as its retrograde limb (orthodromic tachycardia) or as its antegrade limb (antidromic tachycardia). QRS complexes during sinus rhythm may show preexcitation. During orthodromic tachycardia the preexcitation is not present and a retrograde P wave may appear after the QRS complex. During antidromic tachycardia the QRS complex is preexcited. | Atrioventricular Reentrant Tachycardia by ECG Finding | ||
| BASELINE WANDER | C114147 | An electrocardiographic recording in which the isoelectric line in one or more leads is vertically displaced resulting in low frequency upward and downward movements of the signal with varying amplitudes. | Baseline Wander by ECG Finding | |||
| BIFASCICULAR BLOCK | C71046 | Bifascicular block | An electrocardiographic finding comprising right bundle branch block and left anterior fascicular block, or right bundle branch block and left posterior fascicular block. Defects occurring in two of the three divisions of the conduction system of the heart are considered bifascicular blocks. Technically left bundle branch block may be considered a bifascicular block. (NCI) | Bifascicular Block by ECG Finding | ||
| BIVENTRICULAR HYPERTROPHY | C106502 | An electrocardiographic finding suggestive of enlargement or thickening of both ventricles, with a combination of findings which are related to LVH and RVH, such as voltage criteria for LVH in the presence of marked right axis deviation. | Biventricular Hypertrophy by ECG Finding | |||
| BORDERLINE QTcB | C92228 | Borderline QTcB | An electrocardiographic finding in which the QT interval corrected for heart rate using Bazett's formula is slightly prolonged. Thresholds for different age, gender, and patient populations exist. | Borderline QTcB | ||
| BORDERLINE QTcF | C92229 | Borderline QTcF | An electrocardiographic finding in which the QT interval corrected for heart rate using Fridericia's formula is slightly prolonged. Thresholds for different age, gender, and patient populations exist. | Borderline QTcF | ||
| BRADYCARDIA | C111120 | Bradycardia | An electrocardiographic finding of abnormally slow heart rate. Thresholds for different age, gender, and patient populations exist. | Bradycardia by ECG Finding | ||
| BRUGADA SYNDROME PATTERN | C106503 | An electrocardiographic finding of complete or incomplete right bundle branch block accompanied by ST elevation in leads V1-V3. This may be noted at rest or can be provoked by medication challenge. | Brugada Syndrome Pattern by ECG Finding | |||
| CV ENDPOINTS ISCHEMIC ECG CHANGES | C116138 | An electrocardiographic finding, in the absence of left ventricular hypertrophy (LVH) and left bundle branch block pattern on ECG, of either a) new (or presumed new) ST elevation at the J point in two contiguous leads with the following cut-points: >=0.1 mV in all leads other than leads V2-V3 where the following cut points apply: >=0.2 mV in men >=40 years; >=0.25 mV in men <40 years, or >=0.15 mV in women; or b) new (or presumed new) horizontal or down-sloping ST depression >=0.05 mV in two contiguous leads and/or T inversion >=0.1 mV in two contiguous leads with prominent R wave or R/S ratio >1. (Thygesen K, Alpert JS, Jaffe AS, et al.: the Writing Group on behalf of the Joint ESC/ACCF/AHA/WHF Task Force for the Universal Definition of Myocardial Infarction. J Am Coll Cardiol 60(16):1-18, 2012) | ACC/AHA Ischemic ECG Changes | |||
| DELTA WAVE | C62258 | Delta wave | An electrocardiographic finding of initial slurring (delta wave) of the QRS complex due to the presence of an accessory pathway. This characteristic ECG pattern is typically seen in Wolff-Parkinson-White syndrome. | Delta Wave by ECG Finding | ||
| DEXTROCARDIA | C102623 | Dextrocardia | An electrocardiographic finding suggestive of dextrocardia with situs inversus, characterized by reversal of normal anterior R wave progression and the appearance of reversal of the right and left arm electrodes. | Dextrocardia by ECG Finding | ||
| EARLY R WAVE TRANSITION | C102628 | Early R Wave Progression;Early R Wave Transition | An electrocardiographic finding where the amplitude of the R wave becomes greater than the amplitude of the S wave in the QRS complex at an unusually early point in the precordial leads, usually in leads V1 or V2. | Early R Wave Transition by ECG Finding | ||
| EARLY REPOLARIZATION | C102629 | Early Repolarization | An electrocardiographic finding of J point and ST segment elevation in the absence of other signs of acute ischemia or pericarditis. | Early Repolarization | ||
| ECG ACQUIRED WITH PRECORDIAL ELECTRODES PLACED ON RIGHT CHEST | C114175 | An electrocardiographic recording in which the precordial electrodes have been placed over the right chest and record a right sided ECG. | ECG Acquired with Precordial Electrodes Placed on the Right Chest | |||
| ECG EVALUATION NOT PERFORMED DUE TO CORRUPTED DIGITAL ECG FILE | C114181 | A digital electrocardiographic recording which is corrupted (i.e. ECG signal cannot be restored) such that measurements and/or interpretation cannot be performed. | ECG Evaluation Not Performed Due to Corrupted Digital ECG File | |||
| ECG EVALUATION NOT PERFORMED DUE TO POOR QUALITY OF PRINTED ECG | C114180 | A printed electrocardiographic recording with poor printout quality (e.g. a faded paper ECG tracing or ECG with inconsistent printing speed) such that measurements and/or interpretation cannot be performed. | ECG Evaluation Not Performed Due to Poor Quality of Printed ECG | |||
| ECG EVALUATION NOT PERFORMED DUE TO UNKNOWN ECG AMPLITUDE GAIN OR RECORDING SPEED | C114178 | An electrocardiographic recording in which measurements and/or interpretation are not performed because the ECG amplitude gain and/or recording speed are not known. | ECG Evaluation Not Performed Due to Unknown ECG Amplitude Gain or Recording Speed | |||
| ECTOPIC ATRIAL RHYTHM | C62245 | Ectopic atrial rhythm | An electrocardiographic finding of a regular atrial rhythm with atrial rate of less than 101 beats per minute which does not originate in the sinus node, and which is characterized by P waves whose morphology differs from the P wave morphology during sinus rhythm. | Ectopic Atrial Rhythm by ECG Finding | ||
| ECTOPIC VENTRICULAR RHYTHM | C71042 | Ectopic ventricular rhythm | An electrocardiographic finding of three or more consecutive complexes of ventricular origin. The QRS complexes are wide and have an abnormal morphology. | Ectopic Ventricular Rhythm by ECG Finding | ||
| ELECTRICAL ALTERNANS | C71035 | Electrical alternans | An electrocardiographic finding in which there is an alternating pattern of any of the waveform components. (NCI) | Electrical Alternans by ECG Finding | ||
| EXTENSIVE ANTERIOR WALL MYOCARDIAL INFARCTION | C106520 | An electrocardiographic finding of pathologic Q waves in leads V1 to V6, I and aVL, which is suggestive of myocardial infarction involving the anterior and anterolateral walls of the left ventricle. | Extensive Anterior Wall Myocardial Infarction by ECG Finding | |||
| FUSION COMPLEX | C102639 | Fusion Complex;Fusion complex(es) | An electrocardiographic finding that occurs when electrical activation of the atria or ventricles occurs from two separate sites. This results in a P wave or QRS complex that displays merged characteristics of beats originating from the two different sites. | Fusion Complex | ||
| HIGH LATERAL WALL MYOCARDIAL INFARCTION | C102643 | High Lateral Wall Myocardial Infarction | An electrocardiographic finding of pathologic Q waves in leads I and aVL, which is suggestive of myocardial infarction of the high lateral wall of the left ventricle. | High Lateral Myocardial Infarction by ECG Finding | ||
| IDIOVENTRICULAR RHYTHM | C50599 | Idioventricular Rhythm | An electrocardiographic finding of three or more consecutive complexes of ventricular origin with a rate less than a certain threshold (100 or 120 beats per minute are commonly used). The QRS complexes are wide and have an abnormal morphology. | Idioventricular Rhythm | ||
| INCOMPLETE ECG | C114167 | An electrocardiographic recording which is limited in duration or which does not display all of the expected leads. | Incomplete ECG | |||
| INCOMPLETE LEFT BUNDLE BRANCH BLOCK | C71047 | Incomplete left bundle branch block | An electrocardiographic finding of a wide QRS complex with evidence of delayed conduction to the left ventricle, manifest as a widened initial portion of the QRS complex in leads V5, V6, I and aVL and with QRS duration less than 120 ms. | Incomplete Left Bundle Branch Block by ECG Finding | ||
| INCOMPLETE MEASUREMENTS DUE TO TRUNCATION OF QRS COMPLEXES | C114179 | An electrocardiographic recording in which measurements (particularly of QRS amplitudes) and/or interpretations are not performed because QRS complexes have been truncated. | Incomplete ECG Measurements Due to Truncation of QRS Complexes | |||
| INCOMPLETE RIGHT BUNDLE BRANCH BLOCK | C71048 | Incomplete right bundle branch block;Incomplete right bundle-branch block | An electrocardiographic finding of a wide QRS complex with evidence of delayed conduction to the right ventricle, manifest by a widened initial portion of the QRS in V1 and V2, a widened S wave in V5, V6, I and aVL, and with QRS duration less than 120 ms. | Incomplete Right Bundle Branch Block by ECG Finding | ||
| INCOMPLETELY DIGITIZED ECG LEAD(S) | C114169 | A digital electrocardiographic recording which was digitized from paper ECG tracings and which does not contain all leads present on the original paper printout. | Incompletely Digitized ECG Leads | |||
| INCORRECTLY SCALED ECG | C114168 | An electrocardiographic recording in which the ECG signal is not displayed at the indicated recording speed and/or amplitude resolution. | Incorrectly Scaled ECG | |||
| INDETERMINATE QRS AXIS | C102701 | Indeterminate Axis;Indeterminate QRS Axis;QRS Axis Indeterminate | An electrocardiographic finding in which the frontal plane QRS axis cannot be calculated. | QRS Axis Indeterminate | ||
| INFERIOR WALL MYOCARDIAL INFARCTION | C35398 | Inferior MI;Inferior Wall Myocardial Infarction | An electrocardiographic finding of pathologic Q waves in leads III, aVF and often II, which is suggestive of myocardial infarction of the inferior wall of the left ventricle. | Inferior Myocardial Infarction by ECG Finding | ||
| INSUFFICENT NUMBER OF BEATS TO COMPLETELY EVALUATE ECG | C114177 | An electrocardiographic recording in which fewer than the required number of cardiac complexes are available for measurement and/or interpretation due to a shorter than planned recording or due to cardiac complexes which are present but are not suitable for measurement and/or interpretation. | Insufficient Number of Beats for Complete ECG Evaluation | |||
| INTRAATRIAL CONDUCTION DELAY | C71073 | Intraatrial Conduction Delay | An electrocardiographic finding of a delay in impulse propagation through the atria. This is characterized by broad P waves which are often biphasic in V1. | Intra-Atrial Conduction Delay by ECG Finding | ||
| INTRAVENTRICULAR CONDUCTION DELAY, NONSPECIFIC | C62271 | Intraventricular Conduction Defect;Intraventricular conduction delay | An electrocardiographic finding of a widened QRS duration typically greater than 110 ms which does not meet the morphologic criteria for any of the standard bundle branch or fascicular block patterns. | Nonspecific Intraventricular Conduction Delay by ECG Finding | ||
| INVALID ECG WAVEFORMS | C114171 | An electrocardiographic recording for which the displayed leads do not represent the individual's true ECG lead information. | Invalid ECG Waveforms | |||
| ISORHYTHMIC DISSOCIATION | C62248 | Isorhythmic dissociation | An electrocardiographic finding of a type of atrioventricular dissociation characterized by the atria (P waves) and ventricles (QRS complexes) beating at similar rates, although independently. | Isorhythmic Atrioventricular Dissociation | ||
| J POINT ELEVATION | C71030 | J point elevation | An electrocardiographic finding of a significant elevation above the baseline of the J point. | J Point Elevation | ||
| JUNCTIONAL BRADYCARDIA | C71074 | Junctional bradycardia | An electrocardiographic finding of a junctional rhythm with a heat rate which is abnormally low. | Junctional Bradycardia by ECG Finding | ||
| JUNCTIONAL ESCAPE COMPLEXES | C116129 | Junctional Escape Beats | An electrocardiographic finding of an escape beat following a pause which originates in the AV junction. This is manifest as a QRS complex of supraventricular origin not preceded by a P wave. | Junctional Escape Complexes by ECG Finding | ||
| JUNCTIONAL PREMATURE COMPLEX | C102652 | Junctional Extra Beat;Junctional Premature Complex;Junctional premature complex(es) | An electrocardiographic finding of an ectopic impulse originating in the AV junction presenting as a QRS complex of supraventricular origin which is not preceded by a P wave. | Junctional Premature Complex by ECG Finding | ||
| JUNCTIONAL RHYTHM | C71051 | Junctional rhythm | An electrocardiographic finding of a rhythm which originates in the AV junction and results in a normal heart rate. It is characterized by retrograde P waves which may be obscured by or may follow the QRS complexes. The QRS complexes may be narrow or may demonstrate aberration. | Junctional Rhythm by ECG Finding | ||
| JUNCTIONAL TACHYCARDIA | C35059 | Junctional tachycardia | An electrocardiographic finding of a junctional rhythm with a heart rate which is abnormally elevated. | Junctional Tachycardia by ECG Finding | ||
| LATE R WAVE TRANSITION | C102653 | Late R Wave Transition | An electrocardiographic finding where the amplitude of the R wave does not become greater than the amplitude of the S wave until an unusually late point in the precordial leads, usually in leads V4 to V6. | Late R Wave Transition by ECG Finding | ||
| LATERAL WALL MYOCARDIAL INFARCTION | C35586 | Lateral MI;Lateral Wall Myocardial Infarction | An electrocardiographic finding of pathologic Q waves in leads V5, V6, I and aVL, which is suggestive of myocardial infarction of the lateral wall of the left ventricle. | Lateral Myocardial Infarction by ECG Finding | ||
| LEFT ANTERIOR FASCICULAR BLOCK | C62267 | Left Anterior Hemiblock;Left anterior fascicular block | An electrocardiographic finding of a slightly widened QRS duration (typically less than 120 ms) with leftward frontal plane QRS axis and typically small Q waves in leads I and aVL. | Left Anterior Fascicular Block by ECG Finding | ||
| LEFT ATRIAL ABNORMALITY | C71040 | Left Atrial Enlargement;P-mitrale | An electrocardiographic finding suggesting underlying hypertrophy or dilatation of the left atrium. Electrocardiographic criteria used for the diagnosis of left atrial abnormality may include a bifid p wave, a biphasic p wave and/or a p wave duration of greater than 0.12 seconds. (NCI) | P-mitrale by ECG Finding | ||
| LEFT BUNDLE BRANCH BLOCK | C62269 | Complete LBBB;Left bundle branch block;Left bundle-branch block | An electrocardiographic finding of a wide QRS complex with evidence of delayed conduction to the left ventricle, manifest as a widened initial portion of the QRS complex in leads V5, V6, I and aVL and with QRS duration greater than or equal to 120 ms. | Left Bundle Branch Block by ECG Finding | ||
| LEFT POSTERIOR FASCICULAR BLOCK | C62268 | Left Posterior Hemiblock;Left posterior fascicular block | An electrocardiographic finding of an S1Q3 pattern and QRS axis greater than or equal to 120 degrees. It is usually seen in association with other abnormalities (e.g. RBBB or RVH). | Left Posterior Fascicular Block by ECG Finding | ||
| LEFT VENTRICULAR CONDUCTION DELAY | C92231 | Left Ventricular Conduction Delay | An electrocardiographic finding in which there is evidence that electrical transmission through the left ventricle is impaired. | Left Ventricular Conduction Delay by ECG Finding | ||
| LEFT VENTRICULAR HYPERTROPHY | C71076 | Left Ventricular Hypertrophy | An electrocardiographic finding suggestive of a hypertrophied left ventricle, characterized by large QRS amplitudes and secondary findings of left atrial enlargement, left axis deviation, or typical pattern of ST depression and T wave inversion. | Left Ventricular Hypertrophy by ECG Finding | ||
| LEFT VENTRICULAR HYPERTROPHY WITH STRAIN | C102655 | Left Ventricular Hypertrophy With Strain | An electrocardiographic finding suggestive of a hypertrophied left ventricle, characterized by large QRS amplitudes, ST depression and T wave inversion. | Left Ventricular Hypertrophy with Strain by ECG Finding | ||
| LIMB ELECTRODE(S) DISCONNECTED | C114151 | An electrocardiographic recording in which one or more of the limb electrodes are disconnected resulting in missing waveforms (often flat lines) of the respective leads. | Disconnected Limb Electrodes by ECG Finding | |||
| LIMB ELECTRODES INTERCHANGED | C114150 | Limb Lead Reversal | An electrocardiographic recording in which two or more of the limb electrodes are switched resulting in improper representation of the affected leads. | Interchanged Limb Electrodes by ECG Finding | ||
| LOW AMPLITUDE SIGNAL | C114166 | Low Amplitude QRS Complex | An electrocardiographic recording showing smaller than usual QRS complexes in one or more leads. This may represent a technical issue with the ECG acquisition or characteristics of the individual. | Low Amplitude QRS Complex by ECG Finding | ||
| LOW QRS VOLTAGE | C71078 | Low QRS voltage | An electrocardiographic finding of a QRS amplitude less than or equal to 0.5 mV in the limb leads or QRS amplitude less than or equal to 1 mV in the precordial leads. | Low QRS Voltage by ECG Finding | ||
| LOW VOLTAGE - LIMB LEADS ONLY | C116133 | An electrocardiographic finding of small QRS amplitudes (less than 500 microvolts) in all limb leads. | Low Voltage in Limb Leads Only by ECG Finding | |||
| MULTIFOCAL ATRIAL TACHYCARDIA | C71050 | Multifocal atrial tachycardia | An electrocardiographic finding of a supraventricular arrhythmia characterized by 3 or more distinct P wave morphologies with an isoelectric baseline, variable PR intervals and no predominant atrial rhythm. The ventricular rate is typically 100-150 beats per minute. | Multifocal Atrial Tachycardia by ECG Finding | ||
| MUSCLE TREMOR | C114148 | An electrocardiographic recording with intermittent mid to high frequency artifact in one or more leads due to muscular tremor or movement rather than cardiac activity. | Muscle Tremor Artifact | |||
| MYOCARDIAL INFARCTION | C101589 | Myocardial Infarction | An electrocardiographic finding of pathologic Q waves, which is suggestive of myocardial infarction of one or more regions of the heart. No specification is provided for localization. | Myocardial Infarction by ECG Finding | ||
| NEW ANTERIOR WALL MYOCARDIAL INFARCTION | C102732 | New Anterior MI;New Anterior Wall Myocardial Infarction | An electrocardiographic finding of pathologic Q waves in leads V3 and V4, which is suggestive of myocardial infarction of the anterior wall of the left ventricle and which is new compared to prior ECGs. | New Anterior Myocardial Infarction by ECG Finding | ||
| NEW ANTEROLATERAL WALL MYOCARDIAL INFARCTION | C102733 | New Anterolateral Wall Myocardial Infarction | An electrocardiographic finding of pathologic Q waves in leads V3 through V6, which is suggestive of myocardial infarction of the anterolateral wall of the left ventricle and which is new compared to prior ECGs. | New Anterolateral Myocardial Infarction by ECG Finding | ||
| NEW ANTEROSEPTAL WALL MYOCARDIAL INFARCTION | C102734 | New Anteroseptal Wall Myocardial Infarction | An electrocardiographic finding of pathologic Q waves in leads V1 through V4, which is suggestive of myocardial infarction of the anteroseptal wall of the left ventricle and which is new compared to prior ECGs. | New Anteroseptal Myocardial Infarction by ECG Finding | ||
| NEW EXTENSIVE ANTERIOR WALL MYOCARDIAL INFARCTION | C102735 | New Extensive Anterior Wall Myocardial Infarction | An electrocardiographic finding of pathologic Q waves in leads V1 to V6, I and aVL, which is suggestive of myocardial infarction involving the anterior and anterolateral walls of the left ventricle and which is new compared to prior ECGs. | New Extensive Anterior Myocardial Infarction by ECG Finding | ||
| NEW HIGH LATERAL WALL MYOCARDIAL INFARCTION | C102736 | New High Lateral Wall Myocardial Infarction | An electrocardiographic finding of pathologic Q waves in leads I and aVL, which is suggestive of myocardial infarction of the high lateral wall of the left ventricle and which is new compared to prior ECGs. | New High Lateral Myocardial Infarction by ECG Finding | ||
| NEW INFERIOR WALL MYOCARDIAL INFARCTION | C102737 | New Inferior Wall Myocardial Infarction | An electrocardiographic finding of pathologic Q waves in leads III, aVF and often II, which is suggestive of myocardial infarction of the inferior wall of the left ventricle and which is new compared to prior ECGs. | New Inferior Myocardial Infarction by ECG Finding | ||
| NEW LATERAL WALL MYOCARDIAL INFARCTION | C102738 | New Lateral Wall Myocardial Infarction | An electrocardiographic finding of pathologic Q waves in leads V5, V6, I and aVL, which is suggestive of myocardial infarction of the lateral wall of the left ventricle and which is new compared to prior ECGs. | New Lateral Myocardial Infarction by ECG Finding | ||
| NEW MYOCARDIAL INFARCTION | C102731 | New Myocardial Infarction | An electrocardiographic finding of pathologic Q waves, which is suggestive of myocardial infarction of one or more regions of the heart and which is new compared to prior ECGs. No specification is provided for localization. | New Myocardial Infarction by ECG Finding | ||
| NEW POSTERIOR WALL MYOCARDIAL INFARCTION | C106548 | An electrocardiographic finding in leads V1 or V2 of an initial R wave duration greater than or equal to 40 ms, R wave greater than S wave, and upright T wave, which is suggestive of myocardial infarction of the posterior wall of the left ventricle, and which is new compared to prior ECGs. Evidence of inferior or lateral myocardial infarction is usually also present. | New Posterior Wall Myocardial Infarction by ECG Finding | |||
| NEW SEPTAL WALL MYOCARDIAL INFARCTION | C102739 | New Septal Wall Myocardial Infarction | An electrocardiographic finding of pathologic Q waves in leads V1, V2 and often V3, which is suggestive of myocardial infarction of the intraventricular septum and which is new compared to prior ECGs. | New Septal Myocardial Infarction by ECG Finding | ||
| NO ECG WAVEFORMS PRESENT | C114163 | An electrocardiographic recording that displays flat lines (no waveforms are visible) in all leads present. | ECG Waveforms Not Present | |||
| NON Q WAVE MYOCARDIAL INFARCTION | C71080 | Non Q Wave Myocardial Infarction | An electrocardiographic finding of ST and T wave abnormalities in the absence of pathologic Q waves, which is suggestive of myocardial infarction in one or more regions of the heart. | Non Q Wave Myocardial Infarction by ECG Finding | ||
| NON-DIAGNOSTIC Q WAVES | C116134 | An electrocardiographic finding of Q waves which are insufficient for the diagnosis of myocardial infarction. In such cases a myocardial infarction may be suspected, even though ECG criteria are not met. | Non-Diagnostic Q Waves by ECG Finding | |||
| NON-SPECIFIC ST-T CHANGES | C71031 | Non-specific ST-T changes | An electrocardiographic finding of changes in the ST segment and T wave that do not meet criteria for ischemia or infarction. (NCI) | Non-Specific ST-T Changes by ECG Finding | ||
| NON-SUSTAINED ATRIAL TACHYCARDIA | C102680 | Non-Sustained Atrial Tachycardia | An electrocardiographic finding of an atrial tachycardia which terminates in less than 30 seconds. | Non-Sustained Atrial Tachycardia by ECG Finding | ||
| NON-SUSTAINED VENTRICULAR TACHYCARDIA | C71053 | Non-sustained ventricular tachycardia;Ventricular tachycardia, unsustained | An electrocardiographic finding of ventricular tachycardia less than 30 seconds in duration. (NCI) | Non-Sustained Ventricular Tachycardia by ECG Finding | ||
| NORMAL SINUS RHYTHM | C102681 | Normal Sinus Rhythm | An electrocardiographic finding of an atrial rhythm which originates from the sinoatrial node that is considered normal for the population. There are no extra beats or conduction abnormalities. | Normal Sinus Rhythm | ||
| NORTHWEST AXIS | C102634 | Northwest Axis;Right superior axis | An electrocardiographic finding of a frontal plane QRS axis from -90 to +180 degrees. | Extreme Right Axis Deviation | ||
| NOTCHED T WAVES | C71032 | Notched T Waves | An electrocardiographic finding of an irregular, u or v shaped deflection within the contour of the T wave. | T Wave Notched by ECG Finding | ||
| OLD OR AGE INDETERMINATE ANTERIOR WALL MYOCARDIAL INFARCTION | C102684 | Old Or Age Indeterminate Anterior Wall Myocardial Infarction | An electrocardiographic finding of pathologic Q waves in leads V3 and V4, which is suggestive of myocardial infarction of the anterior wall of the left ventricle, without evidence of current or ongoing acute infarction. | Old or Age Indeterminate Anterior Myocardial Infarction by ECG Finding | ||
| OLD OR AGE INDETERMINATE ANTEROLATERAL WALL MYOCARDIAL INFARCTION | C102685 | Old Or Age Indeterminate Anterolateral Wall Myocardial Infarction | An electrocardiographic finding of pathologic Q waves in leads V3 through V6, which is suggestive of myocardial infarction of the anterolateral wall of the left ventricle, without evidence of current or ongoing acute infarction. | Old or Age Indeterminate Anterolateral Myocardial Infarction by ECG Finding | ||
| OLD OR AGE INDETERMINATE ANTEROSEPTAL WALL MYOCARDIAL INFARCTION | C102686 | Old Or Age Indeterminate Anteroseptal Wall Myocardial Infarction | An electrocardiographic finding of pathologic Q waves in leads V1 through V4, which is suggestive of myocardial infarction of the anteroseptal wall of the left ventricle, without evidence of current or ongoing acute infarction. | Old or Age Indeterminate Anteroseptal Myocardial Infarction by ECG Finding | ||
| OLD OR AGE INDETERMINATE EXTENSIVE ANTERIOR WALL MYOCARDIAL INFARCTION | C102687 | Old Or Age Indeterminate Extensive Anterior Wall Myocardial Infarction | An electrocardiographic finding of pathologic Q waves in leads V1 to V6, I and aVL, which is suggestive of myocardial infarction involving the anterior and anterolateral walls of the left ventricle, without evidence of current or ongoing acute infarction. | Old or Age Indeterminate Extensive Anterior Myocardial Infarction by ECG Finding | ||
| OLD OR AGE INDETERMINATE HIGH LATERAL WALL MYOCARDIAL INFARCTION | C102688 | Old Or Age Indeterminate High Lateral Wall Myocardial Infarction | An electrocardiographic finding of pathologic Q waves in leads I and aVL, which is suggestive of myocardial infarction of the high lateral wall of the left ventricle, without evidence of current or ongoing acute infarction. | Old or Age Indeterminate High Lateral Myocardial Infarction by ECG Finding | ||
| OLD OR AGE INDETERMINATE INFERIOR WALL MYOCARDIAL INFARCTION | C102689 | Old Or Age Indeterminate Inferior Wall Myocardial Infarction | An electrocardiographic finding of pathologic Q waves in leads III, aVF and often II, which is suggestive of myocardial infarction of the inferior wall of the left ventricle, without evidence of current or ongoing acute infarction. | Old or Age Indeterminate Inferior Myocardial Infarction by ECG Finding | ||
| OLD OR AGE INDETERMINATE LATERAL WALL MYOCARDIAL INFARCTION | C102690 | Old Or Age Indeterminate Lateral Wall Myocardial Infarction | An electrocardiographic finding of pathologic Q waves in leads V5, V6, I and aVL, which is suggestive of myocardial infarction of the lateral wall of the left ventricle, without evidence of current or ongoing acute infarction. | Old or Age Indeterminate Lateral Myocardial Infarction by ECG Finding | ||
| OLD OR AGE INDETERMINATE POSTERIOR WALL MYOCARDIAL INFARCTION | C102691 | Old Or Age Indeterminate Posterior Wall Myocardial Infarction | An electrocardiographic finding in leads V1 or V2 of an initial R wave duration greater than or equal to 40 ms, R wave greater than S wave, and upright T wave, which is suggestive of myocardial infarction of the posterior wall of the left ventricle, without evidence of current or ongoing acute infarction. Evidence of inferior or lateral myocardial infarction is usually also present. | Old or Age Indeterminate Posterior Myocardial Infarction by ECG Finding | ||
| OLD OR AGE INDETERMINATE SEPTAL WALL MYOCARDIAL INFARCTION | C102693 | Old Or Age Indeterminate Septal Wall Myocardial Infarction | An electrocardiographic finding of pathologic Q waves in leads V1, V2 and often V3, which is suggestive of myocardial infarction of the intraventricular septum, without evidence of current or ongoing acute infarction. | Old or Age Indeterminate Septal Myocardial Infarction by ECG Finding | ||
| OLD OR AGE INDETERMINATE WALL MYOCARDIAL INFARCTION | C101597 | Old Or Age Indeterminate Wall Myocardial Infarction | An electrocardiographic finding of pathologic Q waves, which is suggestive of myocardial infarction of one or more regions of the heart, without evidence of current or ongoing acute infarction. No specification is provided for localization. | Old Myocardial Infarction by ECG Finding | ||
| OLD OR AGE UNDETERMINED RIGHT VENTRICULAR MYOCARDIAL INFARCTION | C102692 | An electrocardiographic finding, in the presence of an old or age indeterminate inferior wall myocardial infarction, of Q waves greater than or equal to 40 ms in duration in the right ventricular leads V4R through V6R. | Old or Age Indeterminate Right Ventricular Myocardial Infarction by ECG Finding | |||
| OTHER INCORRECT ELECTRODE PLACEMENT | C114176 | An electrocardiographic recording in which one or more electrodes are incorrectly placed but further details are not provided. | Other Incorrect Electrode Placement | |||
| P WAVE ABNORMALITY | C90430 | P Wave Abnormality | An electrocardiographic finding for the P wave that is atypical either for the shape, duration, amplitude, axis or polarity. Abnormality of the P wave signifies aberrant propagation of the electrical impulse through the atria. (NCI) | P Wave Abnormality by ECG Finding | ||
| P WAVE NOTCHED | C90431 | P Wave Notched | An electrocardiographic finding of P waves with two peaks longer in duration than normal and amplitude greater than normal. | P Wave Notched by ECG Finding | ||
| PACED ATRIAL AND VENTRICULAR RHYTHM | C92232 | AV dual-paced complex(es) or rhythm;Paced Atrial And Ventricular Rhythm | An electrocardiographic finding in which both the atrial and ventricular rhythm are controlled by an electrical impulse from an artificial cardiac pacemaker. | Paced Atrial And Ventricular Rhythm | ||
| PACED ATRIAL RHYTHM | C92233 | Atrial-paced complex(es) or rhythm;Paced Atrial Rhythm | An electrocardiographic finding in which the atrial rhythm is controlled by an electrical impulse from an artificial cardiac pacemaker. | Paced Atrial Rhythm | ||
| PACED RHYTHM | C88140 | Atrial and/or Ventricular Paced Rhythm;Paced Rhythm | An electrocardiographic finding in which the cardiac rhythm is controlled by an electrical impulse from an artificial cardiac pacemaker. | Paced Rhythm | ||
| PACED VENTRICULAR RHYTHM | C92234 | Paced Ventricular Rhythm;Ventricular-paced complex(es) or rhythm | An electrocardiographic finding in which the ventricular rhythm is controlled by an electrical impulse from an artificial cardiac pacemaker. | Paced Ventricular Rhythm | ||
| PAROXYSMAL AV BLOCK | C62250 | Paroxysmal AV block | An electrocardiographic finding of the sudden onset of transient AV block, which is often associated with preexisting conduction disorders. | Paroxysmal Atrioventricular Block by ECG Finding | ||
| PAROXYSMAL VENTRICULAR TACHYCARDIA | C34902 | Paroxysmal Ventricular Tachycardia | An episodic form of ventricular tachycardia, with abrupt onset and termination. (NCI) | Paroxysmal Ventricular Tachycardia by ECG Finding | ||
| PAUSE | C119250 | An electrocardiographic finding of an RR interval which exceeds a predefined duration threshold, regardless of the underlying rhythm. | Pause by ECG Finding | |||
| PAUSE GREATER THAN 3.0 SECONDS | C119251 | An electrocardiographic finding of an RR interval with duration greater than 3.0 seconds, regardless of the underlying rhythm. | Pause Greater Than Three Seconds by ECG Finding | |||
| POOR QUALITY ECG | C114172 | An electrocardiographic recording that does not show proper quality for reasons that are not otherwise described. | Poor Quality ECG | |||
| POOR R WAVE PROGRESSION | C71033 | Poor R Wave Progression | An electrocardiographic finding of a lack of progression of R wave height across precordial leads. | Poor R Wave Progression by ECG Finding | ||
| POSTERIOR WALL MYOCARDIAL INFARCTION | C35399 | Posterior MI;Posterior Wall Myocardial Infarction | An electrocardiographic finding in leads V1 or V2 of an initial R wave duration greater than or equal to 40 ms, R wave greater than S wave, and upright T wave, which is suggestive of myocardial infarction of the posterior wall of the left ventricle. Evidence of inferior or lateral myocardial infarction is usually also present. | Posterior Myocardial Infarction by ECG Finding | ||
| PR SEGMENT DEPRESSION | C116135 | PR Depression | An electrocardiographic finding of PR segment depression below the iso-electric line in multiple precordial and/or limb leads. | PR Segment Depression by ECG Finding | ||
| PRE-EXCITATION | C34940 | Pre-excitation;Ventricular preexcitation | An electrocardiographic finding characterized by a premature activation of the whole or some part of the ventricle. The PR interval is usually shortened and delta waves are frequently present. | Pre-Excitation Syndrome | ||
| PRECORDIAL ELECTRODE V1 DISCONNECTED | C114153 | An electrocardiographic recording in which the electrode for lead V1 is disconnected resulting in missing waveforms (flat line) for lead V1. | Disconnected Precordial Electrode V1 by ECG Finding | |||
| PRECORDIAL ELECTRODE V2 DISCONNECTED | C114154 | An electrocardiographic recording in which the electrode for lead V2 is disconnected resulting in missing waveforms (flat line) for lead V2. | Disconnected Precordial Electrode V2 by ECG Finding | |||
| PRECORDIAL ELECTRODE V3 DISCONNECTED | C114155 | An electrocardiographic recording in which the electrode for lead V3 is disconnected resulting in missing waveforms (flat line) for lead V3. | Disconnected Precordial Electrode V3 by ECG Finding | |||
| PRECORDIAL ELECTRODE V4 DISCONNECTED | C114156 | An electrocardiographic recording in which the electrode for lead V4 is disconnected resulting in missing waveforms (flat line) for lead V4. | Disconnected Precordial Electrode V4 by ECG Finding | |||
| PRECORDIAL ELECTRODE V5 DISCONNECTED | C114157 | An electrocardiographic recording in which the electrode for lead V5 is disconnected resulting in missing waveforms (flat line) for lead V5. | Disconnected Precordial Electrode V5 by ECG Finding | |||
| PRECORDIAL ELECTRODE V6 DISCONNECTED | C114158 | An electrocardiographic recording in which the electrode for lead V6 is disconnected resulting in missing waveforms (flat line) for lead V6. | Disconnected Precordial Electrode V6 by ECG Finding | |||
| PRECORDIAL ELECTRODE(S) POSITIONED INCORRECTLY | C114160 | An electrocardiographic recording in which one or more precordial electrodes are placed incorrectly with respect to the standard chest electrode positions resulting in improper representation of the affected leads. | Incorrectly Positioned Precordial Electrodes by ECG Finding | |||
| PRECORDIAL ELECTRODES INTERCHANGED | C114152 | Precordial Lead Reversal | An electrocardiographic recording in which two or more of the precordial electrodes are switched resulting in improper representation of the affected leads. | Interchanged Precordial Electrodes by ECG Finding | ||
| PREMATURE ATRIAL COMPLEXES | C62257 | APC;Atrial premature complex(es);PAC;Premature atrial complex;SVE;Supraventricular Extra Beat | An electrocardiographic finding of an ectopic impulse originating in the atria and not specifically in the sinus node. The P wave morphology of these complexes is often different from a sinus P wave and the RR intervals preceding these complexes is also shorter than those of the regular beats. | Atrial Premature Complex by ECG Finding | ||
| PREMATURE ATRIAL COMPLEXES BLOCKED | C102603 | Atrial premature complexes, nonconducted;Non-conducted SVE;Premature Atrial Complexes Blocked;Premature Atrial Complexes Non-conducted | An electrocardiographic finding of premature atrial complexes which are not conducted to the ventricle, and which are not followed by a QRS complex. | Blocked Atrial Premature Complex by ECG Finding | ||
| PREMATURE ATRIAL COMPLEXES MULTIFOCAL | C102672 | Multifocal SVE;Multifocal Supraventricular Extra Beats;Premature Atrial Complexes Multiform | An electrocardiographic finding of premature atrial complexes which have 2 or more distinct morphologies, suggesting origin at more than one atrial site. | Multifocal Atrial Premature Complex by ECG Finding | ||
| PREMATURE ATRIAL COMPLEXES UNIFOCAL | C102724 | Premature Atrial Complexes Unifocal | An electrocardiographic finding of premature atrial complexes which have a single distinct morphology, suggesting origin at one atrial site. | Unifocal Atrial Premature Complex by ECG Finding | ||
| PREMATURE VENTRICULAR COMPLEX | C62256 | PVC;VE;VPC;Ventricular Extra Beat;Ventricular premature complex(es) | An electrocardiographic finding of an ectopic impulse originating in the ventricles. The QRS morphology of these complexes is different from those of supraventricular origin. The QRS duration is often longer and the RR interval preceding the complexes is usually shorter than that of supraventricular beats. | Ventricular Premature Complex by ECG Finding | ||
| PREMATURE VENTRICULAR COMPLEX INTERPOLATED | C107100 | Interpolated VE;Interpolated VPC;Interpolated Ventricular Extra Beat;Premature Ventricular Complexes Interpolated | An electrocardiographic finding of a premature ventricular complex which occurs between two normal QRS complexes which have normal timing. | Interpolated Premature Ventricular Complex by ECG Finding | ||
| PREMATURE VENTRICULAR COMPLEXES MULTIFOCAL | C102673 | Multifocal VES;Multifocal VPCS;Multifocal Ventricular Extra Beats;Premature Ventricular Complexes Multifocal | An electrocardiographic finding of premature ventricular complexes which have two or more distinct morphologies, suggesting origin at more than one ventricular site. | Multifocal Ventricular Premature Complex by ECG Finding | ||
| PREMATURE VENTRICULAR COMPLEXES UNIFOCAL | C102725 | Premature Ventricular Complexes Unifocal;Unifocal VES;Unifocal VPCS;Unifocal Ventricular Extra Beats | An electrocardiographic finding of premature ventricular complexes which have a single distinct morphology, suggesting origin at one ventricular site. | Unifocal Ventricular Premature Complex by ECG Finding | ||
| PROLONGED QT | C71034 | Prolonged QT;Prolonged QT interval | An electrocardiographic finding in which the QT interval not corrected for heart rate is prolonged. Thresholds for different age, gender, and patient populations exist. | Prolonged QT Interval by ECG Finding | ||
| PROLONGED ST SEGMENT | C116137 | An electrocardiographic finding of a prolonged ST segment, resulting in a long QT interval, without lengthening of the T wave duration. This may be observed in hypocalcemia. | Prolonged ST Segment by ECG Finding | |||
| Q AXIS, LEFT AXIS DEVIATION | C71094 | Left-axis deviation;Q Axis, Left axis deviation;QRS axis, left axis deviation | An electrocardiographic finding of a frontal plane QRS axis from -30 to -90 degrees. | Q Axis Left Axis Deviation | ||
| Q AXIS, RIGHT AXIS DEVIATION | C71095 | Q Axis, Right axis deviation;QRS axis, right axis deviation;Right-axis deviation | An electrocardiographic finding of a frontal plane QRS axis from +90 to +180 degrees. | Q Axis Right Axis Deviation | ||
| QRS COMPLEX ABNORMALITY | C90440 | QRS Complex Abnormality | An electrocardiographic finding of a non-specific abnormality of the QRS complex, which is atypical in shape, duration, amplitude, axis or polarity. | QRS Complex Abnormality by ECG Finding | ||
| QTC PROLONGATION | C83817 | QTc Prolongation | An electrocardiographic finding in which the QTc interval corrected for heart rate is prolonged. Thresholds for different age, gender, and patient populations exist. | Corrected Prolonged QT Interval by ECG Finding | ||
| QTCB PROLONGATION | C107098 | PROLONGED QTcB | An electrocardiographic finding in which the QT interval corrected for heart rate using Bazett's formula is prolonged. Thresholds for different age, gender, and patient populations exist. | QTcB Prolongation | ||
| QTCF PROLONGATION | C107099 | PROLONGED QTcF | An electrocardiographic finding in which the QT interval corrected for heart rate using Fridericia's formula is prolonged. Thresholds for different age, gender, and patient populations exist. | QTcF Prolongation | ||
| QUALITY PROBLEM NOT OTHERWISE SPECIFIED | C114161 | Unknown Quality Problem | An electrocardiographic artifact or recording error with unknown origin or which is not described otherwise. | Quality Problem Not Otherwise Specified by ECG Finding | ||
| R ON T PHENOMENON | C61395 | R on T phenomenon | An electrocardiographic finding in which the R wave of a premature ventricular complex occurs on top of the T wave of the preceding beat. | R On T Phenomenon by ECG Finding | ||
| R WAVE NOTCHED | C90444 | R Wave Notched | An electrocardiographic finding of an R wave variant in which there is a small deflection of the R wave, with changing polarity, within the QRS complex. (NCI) | R Wave Notched by ECG Finding | ||
| REPOLARIZATION ABNORMALITY | C102574 | Repolarization Abnormality | An electrocardiographic finding of an abnormality of T wave duration or morphology or of early repolarization. | Ventricular Repolarization Abnormality | ||
| REPOLARIZATION ABNORMALITY SECONDARY TO VENTRICULAR HYPERTROPHY | C102706 | Repolarization Abnormality Secondary To Ventricular Hypertrophy;ST-T change due to ventricular hypertrophy | An electrocardiographic finding of ST depression and T wave inversion in the presence of increased QRS amplitude which are thought to be due to left ventricular hypertrophy. | Repolarization Abnormality Secondary To Ventricular Hypertrophy | ||
| RIGHT ATRIAL ABNORMALITY | C71041 | P-pulmonale;Right Atrial Enlargement | An electrocardiographic finding suggesting underlying hypertrophy or dilatation of the right atrium. Electrocardiographic criteria used for the diagnosis of right atrial abnormality may include a peaked p wave greater than 2.5 millimeters in amplitude in the inferior leads. (NCI) | P-pulmonale by ECG Finding | ||
| RIGHT BUNDLE BRANCH BLOCK | C62270 | Complete RBBB;Right bundle branch block;Right bundle-branch block | An electrocardiographic finding of a wide QRS complex with evidence of delayed conduction to the right ventricle, manifest by a widened initial portion of the QRS in V1 and V2, a widened S wave in V5, V6, I and aVL, and with QRS duration greater than or equal to 120 ms. An RsR' complex is typically present in leads V1 and V2. | Right Bundle Branch Block by ECG Finding | ||
| RIGHT VENTRICULAR CONDUCTION DELAY | C92235 | Right Ventricular Conduction Delay;Right Ventricular Delay | An electrocardiographic finding in which there is evidence that electrical transmission through the right ventricle is impaired with a maximal QRS duration of 110 ms and which does not meet the criteria for Incomplete Right Bundle Branch Block. | Right Ventricular Conduction Delay by ECG Finding | ||
| RIGHT VENTRICULAR HYPERTROPHY | C71077 | Right ventricular Hypertrophy | An electrocardiographic finding suggestive of a hypertrophied right ventricle, characterized by large R wave amplitudes in the right precordial leads and secondary findings of right atrial enlargement, right axis deviation, and typical pattern of ST depression and T wave inversion in the right precordial leads. | Right Ventricular Hypertrophy by ECG Finding | ||
| RSR PRIME | C92227 | RSR' | An electrocardiographic finding in which there are two R waves, which are two deflections above the baseline resulting from a single ventricular depolarization. The first upward deflection in the complex is the R wave. The S is the first downward deflection. A second upward deflection is called the R-prime wave. | RSR' by ECG Finding | ||
| SEPTAL MYOCARDIAL INFARCTION | C35519 | Septal myocardial infarction | An electrocardiographic finding suggesting an infarction in the anatomic location of the cardiac septum. (NCI) | Septal Myocardial Infarction by ECG Finding | ||
| SHORT PR INTERVAL | C62246 | Short PR interval | An electrocardiographic finding of an abnormally short PR interval. Thresholds for different age, gender, and patient populations exist. | Short PR Interval by ECG Finding | ||
| SHORT QTC INTERVAL | C102709 | Short QTc Interval | An electrocardiographic finding of a QT interval corrected for heart rate that is shorter than the lower limit of normal. Thresholds for different age, gender, and patient populations exist. | Short QTc Interval | ||
| SHORT QTCB | C112402 | An electrocardiographic finding in which the QT interval corrected for heart rate using Bazett's formula is shortened. Thresholds for different age, gender, and patient populations exist. | QTcB Shortened | |||
| SHORT QTCF | C112403 | An electrocardiographic finding in which the QT interval corrected for heart rate using Fridericia's formula is shortened. Thresholds for different age, gender, and patient populations exist. | QTcF Shortened | |||
| SHORT ST SEGMENT | C116136 | An electrocardiographic finding of a short or absent ST segment, resulting in a short QT interval, without changes in T wave morphology. This may be observed in hypercalcemia. | Short ST Segment by ECG Finding | |||
| SINOATRIAL EXIT BLOCK | C50553 | SA Block;Sinoatrial Block;Sinoatrial exit block | An electrocardiographic finding in which impaired conduction or automaticity within the sinus node results in the failure of impulse transmission from the sinoatrial node. This is manifest as dropped P waves during sinus rhythm. | Exit Block by ECG Finding | ||
| SINUS ARREST/PAUSE | C62242 | Sinus arrest/pause;Sinus pause or arrest | An electrocardiographic finding in which a failure of impulse formation or conduction in the sinus node produces prolongation of the P-P interval or dropped P waves. The threshold for the prolongation of the P-P interval is not well defined. | Sinus Arrest by ECG Finding | ||
| SINUS ARRHYTHMIA | C62239 | Respiratory Sinus Arrhythmia;Sinus arrhythmia | An electrocardiographic finding in which the sinus rate fluctuates with the respiratory cycle. | Sinus Arrhythmia by ECG Finding | ||
| SINUS BRADYCARDIA | C111097 | Sinus bradycardia | An electrocardiographic finding of abnormally slow heart rate with its origin in the sinus node. Thresholds for different age, gender, and patient populations exist. | Sinus Bradycardia by ECG Finding | ||
| SINUS RHYTHM | C100076 | Sinus Rhythm | An electrocardiographic finding of an atrial rhythm which originates from the sinoatrial node that is considered normal for the population. | Sinus Rhythm | ||
| SINUS TACHYCARDIA | C111104 | Sinus tachycardia | An electrocardiographic finding of abnormally rapid heart rate with its origin in the sinus node. Thresholds for different age, gender, and patient populations exist. | Sinus Tachycardia by ECG Finding | ||
| ST DEPRESSION | C41330 | ST depression | An electrocardiographic finding of ST segment depression below the baseline, often described as up sloping, down sloping or horizontal. (NCI) | ST Segment Depression by ECG Finding | ||
| ST ELEVATION | C50540 | ST elevation | An electrocardiographic finding of ST segment elevation above the baseline. (NCI) | ST Segment Elevation by ECG Finding | ||
| ST ELEVATION PERICARDITIS | C71029 | ST elevation pericarditis | An electrocardiographic finding of ST elevation which is concave upwards, and which is often accompanied by PR segment depression. | ST Elevation Pericarditis by ECG Finding | ||
| SUPRAVENTRICULAR COUPLET | C119252 | An electrocardiographic finding in which two premature atrial complexes occur sequentially. | Supraventricular Couplet by ECG Finding | |||
| SUPRAVENTRICULAR TACHYCARDIA | C111100 | Supraventricular tachycardia | An electrocardiographic finding of a tachycardia which does not originate in the ventricles or His Purkinje system. There is an abnormally high heart rate and QRS complexes are typically narrow, but aberration or preexcitation may be present. | Supraventricular Tachycardia by ECG Finding | ||
| SUSPECT LIMB ELECTRODES REVERSED, INTERPRETATION ASSUMES NO REVERSAL | C114173 | An electrocardiographic recording in which an interchange of one or more limb lead electrodes is suspected, but for which an interpretation is performed as though the lead placement is correct. | Suspicion of Limb Electrodes Reversal But Interpretation Assumes No Reversal by ECG Finding | |||
| SUSPECT LIMB ELECTRODES REVERSED, INTERPRETATION ASSUMES REVERSAL | C114174 | An electrocardiographic recording in which an interchange of one or more limb lead electrodes is suspected, and for which an interpretation is performed as though the leads have in fact been interchanged. | Suspicion of Limb Electrodes Reversal But Interpretation Assumes Reversal by ECG Finding | |||
| SUSTAINED VENTRICULAR TACHYCARDIA | C71052 | Sustained ventricular tachycardia | An electrocardiographic finding of ventricular tachycardia greater than 30 seconds in duration. (NCI) | Sustained Ventricular Tachycardia by ECG Finding | ||
| T WAVE ALTERNANS | C102718 | T Wave Alternans | An electrocardiographic finding in which there are variations in the shape, amplitude, or direction of the T wave from one beat to the next. | T Wave Alternans by ECG Finding | ||
| T WAVE INVERSION | C71085 | T Wave Inversion | An electrocardiographic finding of an inversion of the T wave from the expected axis. (NCI) | T Wave Inversion by ECG Finding | ||
| T WAVE PEAKED | C71086 | T wave peaked | An electrocardiographic finding in which the T wave appears increased in amplitude and cresting at a point. (NCI) | T Wave Peaked by ECG Finding | ||
| T WAVES BIPHASIC | C71087 | T waves biphasic | An electrocardiographic finding of a T wave with both positive and negative components. | T Waves Biphasic by ECG Finding | ||
| T WAVES FLAT | C71088 | T waves flat | An electrocardiographic finding in which the T wave appears decreased in amplitude. (NCI) | T Waves Flat by ECG Finding | ||
| TACHYCARDIA | C111121 | Tachycardia | An electrocardiographic finding of abnormally rapid heart rate. Thresholds for different age, gender, and patient populations exist. | Tachycardia by ECG Finding | ||
| TORSADES DE POINTES | C50779 | Torsades de pointes;Ventricular tachycardia, torsades de pointes | An electrocardiographic finding of an atypical rapid polymorphic ventricular tachycardia with a characteristic rotation of the QRS complex around the isoelectric baseline, occurring in the setting of a prolonged QT interval. In addition, the QRS complex displays a periodic waxing and waning of amplitude on the electrogram. | Torsades De Pointes by ECG Finding | ||
| U WAVE ABNORMALITY | C106579 | Abnormal U Wave | An electrocardiographic finding of U waves which have increased amplitude, are inverted, or merged with the preceding T wave. | U Wave Abnormality by ECG Finding | ||
| UNABLE TO DIGITIZE ECG LEADS | C114170 | A statement indicating the inability to digitize a paper ECG. | Inability to Digitize ECG Leads | |||
| UNDETERMINED RHYTHM | C116131 | An electrocardiographic finding of a cardiac rhythm whose mechanism cannot be determined from the ECG. | Undetermined Rhythm by ECG Finding | |||
| VENTRICULAR BIGEMINY | C71054 | Bigeminy | An electrocardiographic finding of a normal QRS complex followed by a premature ventricular complex for 3 or more consecutive cycles; a regularly irregular rhythm of normal and abnormal QRS complexes in a 1-1 ratio. | Ventricular Bigeminy by ECG Finding | ||
| VENTRICULAR COUPLET | C62259 | Ventricular Pair;Ventricular couplet | An electrocardiographic finding in which two premature ventricular complexes occur sequentially. | Ventricular Couplet by ECG Finding | ||
| VENTRICULAR ESCAPE BEAT | C90483 | Ventricular Escape Beat;Ventricular escape complex(es) | An electrocardiographic finding of a compensatory ventricular complex that occurs following a prolonged RR interval. | Ventricular Escape Beat by ECG Finding | ||
| VENTRICULAR FIBRILLATION | C111102 | Ventricular fibrillation | An electrocardiographic finding of a rapid grossly irregular ventricular rhythm with marked variability in QRS cycle length, morphology, and amplitude. The rate is typically greater than 300 bpm. | Ventricular Fibrillation by ECG Finding | ||
| VENTRICULAR FLUTTER | C111115 | Ventricular flutter | A ventricular tachyarrhythmia characterized by a high ventricular rate (180 to 250 beats per minute) with a regular rhythm. The electrocardiogram shows large oscillating sine wave-like complexes occurring as a result of QRS complexes and T waves being merged. The P wave is not visible. (NCI) | Ventricular Flutter by ECG Finding | ||
| VENTRICULAR PARASYSTOLE | C102728 | Parasystole;Ventricular Parasystole | An electrocardiographic finding of normal sinus rhythm coexisting with a regular ectopic ventricular rhythm. | Ventricular Parasystole by ECG Finding | ||
| VENTRICULAR TACHYCARDIA | C111103 | Ventricular tachycardia | An electrocardiographic finding of three or more consecutive complexes of ventricular organ with a rate greater than a certain threshold (100 or 120 beats per minute are commonly used). The QRS complexes are wide and have an abnormal morphology. | Ventricular Tachycardia by ECG Finding | ||
| VENTRICULAR TACHYCARDIA, MONOMORPHIC | C62234 | Ventricular tachycardia, monomorphic | An electrocardiographic finding of a ventricular tachycardia in which the QRS complexes have a uniform morphology. | Monomorphic Ventricular Tachycardia by ECG Finding | ||
| VENTRICULAR TACHYCARDIA, POLYMORPHIC | C62236 | Ventricular tachycardia, polymorphic;Ventricular tachycardia, polymorphous | An electrocardiographic finding of a ventricular tachycardia in which the QRS complexes have a variable morphology and often rate. | Polymorphic Ventricular Tachycardia by ECG Finding | ||
| VENTRICULAR TRIGEMINY | C71055 | Trigeminy | An electrocardiographic finding of two normal QRS complexes followed by a premature ventricular complex for 3 or more consecutive cycles; a regularly irregular rhythm of normal and abnormal QRS complexes in a 2-1 ratio. | Ventricular Trigeminy by ECG Finding | ||
| WANDERING ATRIAL PACEMAKER | C62240 | Wandering atrial pacemaker | An electrocardiographic finding of a supraventricular arrhythmia characterized by 3 or more distinct P wave morphologies with an isoelectric baseline, variable PR intervals and no predominant atrial rhythm. The ventricular rate is typically below 100 beats per minute. | Wandering Atrial Pacemaker by ECG Finding | ||
| WIDE QRS TACHYCARDIA | C71090 | Wide QRS tachycardia;Wide-QRS tachycardia | An electrocardiographic finding of three or more consecutive wide QRS complexes of uncertain origin with a rate greater than a certain threshold (100 or 120 beats per minute are commonly used). | Wide QRS Tachycardia by ECG Finding | ||
| WOLFF-PARKINSON-WHITE SYNDROME | C35132 | WPW;Wolff-Parkinson-White syndrome | An electrocardiographic finding of ventricular pre-excitation. The syndrome is characterized by a short PR interval and a long QRS interval with a delta wave. | Wolff-Parkinson-White Syndrome | ||
| Back to top | ||||||
| CL.C71153.EGTESTCD | ECG Test Code (EGTESTCD) | text Extensible: Yes | C71153 | ECG Test Code | Terminology codelist used with ECG Tests within CDISC. | CDISC SDTM ECG Test Terminology by Code |
| AMIEGCHG | C116140 | Acute Myocardial Ischemia ECG Change | An electrocardiographic finding assessment of new or presumed new significant ST-segment-T wave (ST-T) changes or new left bundle branch block consistent with acute myocardial ischemia. (Thygesen K, Alpert JS, Jaffe AS, et al.: the Writing Group on behalf of the Joint ESC/ACCF/AHA/WHF Task Force for the Universal Definition of Myocardial Infarction. J Am Coll Cardiol 60(16):1-18, 2012) | Acute Myocardial Ischemia by ECG Assessment | ||
| AVCOND | C111131 | Atrioventricular Conduction | An electrocardiographic assessment of cardiac atrioventricular conduction. | Atrioventricular Conduction ECG Assessment | ||
| AXISVOLT | C111132 | Axis and Voltage | An electrocardiographic assessment of mean cardiac electrical vector and the ECG voltage. | Axis and Voltage ECG Assessment | ||
| CHYPTENL | C111155 | Chamber Hypertrophy or Enlargement | An electrocardiographic assessment of chamber hypertrophy or enlargement. | Chamber Hypertrophy or Enlargement ECG Assessment | ||
| EGARMAX | C119253 | ECG Maximum Atrial Rate | An electrocardiographic measurement of the maximum rate of atrial depolarizations (P waves) recorded during an interval of time, usually expressed in beats per minute. | Maximum Atrial Rate by Electrocardiogram | ||
| EGARMED | C119254 | ECG Median Atrial Rate | An electrocardiographic measurement of the median rate of atrial depolarizations (P waves) recorded during an interval of time, usually expressed in beats per minute. | Median Atrial Rate by Electrocardiogram | ||
| EGARMIN | C119255 | ECG Minimum Atrial Rate | An electrocardiographic measurement of the minimum rate of atrial depolarizations (P waves) recorded during an interval of time, usually expressed in beats per minute. | Minimum Atrial Rate by Electrocardiogram | ||
| EGARMN | C119256 | ECG Mean Atrial Rate | An electrocardiographic measurement of the average rate of atrial depolarizations (P waves) recorded during an interval of time, usually expressed in beats per minute. | Mean Atrial Rate by Electrocardiogram | ||
| EGCOMP | C117761 | Comparison to a Prior ECG | A comparative interpretation of an ECG relative to a previous (comparator) ECG. The definition of the comparator ECG may be specified elsewhere. Common comparator result values include improved, no change, deteriorated. | Comparison to a Prior ECG | ||
| EGHRMAX | C119257 | ECG Maximum Heart Rate | An electrocardiographic measurement of the maximum rate of depolarization of a specific region of the heart during an interval of time, usually expressed in beats per minute. Unless otherwise specified, this is usually the maximum ventricular rate. | Maximum Heart Rate by Electrocardiogram | ||
| EGHRMIN | C119258 | ECG Minimum Heart Rate | An electrocardiographic measurement of the minimum rate of depolarization of a specific region of the heart during an interval of time, usually expressed in beats per minute. Unless otherwise specified, this is usually the minimum ventricular rate. | Minimum Heart Rate by Electrocardiogram | ||
| EGHRMN | C119259 | ECG Mean Heart Rate | An electrocardiographic measurement of the average rate of depolarization of a specific region of the heart during an interval of time, usually expressed in beats per minute. Unless otherwise specified, this is usually the mean ventricular rate. | Mean Heart Rate by Electrocardiogram | ||
| EGVRMAX | C119260 | ECG Maximum Ventricular Rate | An electrocardiographic measurement of the maximum rate of ventricular depolarizations (QRS complexes) recorded during an interval of time, usually expressed in beats per minute. | Maximum Ventricular Rate by Electrocardiogram | ||
| EGVRMED | C119261 | ECG Median Ventricular Rate | An electrocardiographic measurement of the median rate of ventricular depolarizations (QRS complexes) recorded during an interval of time, usually expressed in beats per minute. | Median Ventricular Rate by Electrocardiogram | ||
| EGVRMIN | C119262 | ECG Minimum Ventricular Rate | An electrocardiographic measurement of the minimum rate of ventricular depolarizations (QRS complexes) recorded during an interval of time, usually expressed in beats per minute. | Minimum Ventricular Rate by Electrocardiogram | ||
| EGVRMN | C119263 | ECG Mean Ventricular Rate | An electrocardiographic measurement of the average rate of ventricular depolarizations (QRS complexes) recorded during an interval of time, usually expressed in beats per minute. | Mean Ventricular Rate by Electrocardiogram | ||
| HRMED | C102249 | Summary (Median) Heart Rate | The median number of cycles of contraction and subsequent relaxation of the heart, usually expressed as beats per minute, obtained from a set of measurements of the heart rate. | Median Heart Rate | ||
| INTP | C41255 | Interpretation | An act or process of elucidation; explication, or explanation of the meaning of the event or thing via the assignment of objects from the domain to the constants of a formal language, truth-values to the proposition symbols, truth-functions to the connectives, other functions to the function symbols, and extensions to the predicates, if any. The assignments are result of human logic application and are not native to the symbols of the formal language. | Interpretation | ||
| IVTIACD | C111238 | Intraventricular-Intraatrial Conduction | An electrocardiographic assessment of intraventricular and intra-atrial conduction. | Intraventricular and Intraatrial Conduction ECG Assessment | ||
| JTAG | C117762 | JT Interval, Aggregate | An aggregate JT value based on the measurement of JT intervals from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean. | Aggregate JT Interval | ||
| JTCB | C62118 | JTcB - Bazett's Correction Formula | A formula which takes into account the physiologic shortening of the JT interval which occurs as the heart rate increases, permitting comparison of the JT interval across a range of rates. It is mathematically defined as: JTcB = JT/SqRootRR(seconds) and theoretically corrects the JT interval to that which would be observed at a heart rate of 1 cycle per second. (NCI) | JTcB - Bazett's Correction Formula | ||
| JTCBAG | C117763 | JTCB Interval, Aggregate | A JTAG interval corrected for heart rate using Bazett's formula. | Aggregate JTCB Interval | ||
| JTCBSB | C117764 | JTCB Interval, Single Beat | A JTSB interval corrected for heart rate using Bazett's formula. | Single Beat JTCB Interval | ||
| JTCF | C62119 | JTcF - Fridericia's Correction Formula | A formula which takes into account the physiologic shortening of the JT interval which occurs as the heart rate increases, permitting comparison of the JT interval across a range of rates. It is mathematically defined as: JTcF = JT/CubeRootRR(seconds) and theoretically corrects the JT interval to that which would be observed at a heart rate of 1 cycle per second. (NCI) | JTcF - Fridericia's Correction Formula | ||
| JTCFAG | C117765 | JTCF Interval, Aggregate | A JTAG interval corrected for heart rate using Fridericia's formula. | Aggregate JTCF Interval | ||
| JTCFSB | C117766 | JTCF Interval, Single Beat | A JTSB interval corrected for heart rate using Fridericia's formula. | Single Beat JTCF Interval | ||
| JTCLC | C62120 | JTcLC - Linear Correction Formula | A formula which takes into account the physiologic shortening of the JT interval which occurs as the heart rate increases, permitting comparison of the JT interval across a range of rates. The linear correction formula uses population-based data obtained and validated using a large cohort of subjects. Using this method, the corrected JT interval is independent of the ventricular rate. (NCI) | JTcLC - Linear Correction Formula | ||
| JTMAX | C62117 | Summary (Max) JT Interval | The maximum duration (time) of the JT interval, obtained from a set of measurements of the JT interval. The JT interval is defined as the time from the J point (end of ventricular depolarization, the point at which the QRS meets the ST segment) to the end of the T wave (representing the end of ventricular repolarization). (NCI) | Maximum JT Duration | ||
| JTMEAN | C62115 | Summary (Mean) JT Interval | The average (mean) duration (time) of the JT interval, obtained from a set of measurements of the JT interval. The JT interval is defined as the time from the J point (end of ventricular depolarization, the point at which the QRS meets the ST segment) to the end of the T wave (representing the end of ventricular repolarization). (NCI) | Mean JT Duration | ||
| JTMIN | C62116 | Summary (Min) JT Interval | The minimum duration (time) of the JT interval, obtained from a set of measurements of the JT interval. The JT interval is defined as the time from the J point (end of ventricular depolarization, the point at which the QRS meets the ST segment) to the end of the T wave (representing the end of ventricular repolarization). (NCI) | Minimum JT Duration | ||
| JTPAG | C117767 | J-Tpeak Interval, Aggregate | An aggregate J-Tpeak value based on the measurement of J-Tpeak intervals from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean. | Aggregate J-T Peak Interval | ||
| JTPSB | C117768 | J-Tpeak Interval, Single Beat | An electrocardiographic interval measured from the J point to the peak of the T wave of a single beat utilizing one or more leads. | Single Beat J-T Peak Interval | ||
| JTSB | C117769 | JT Interval, Single Beat | An electrocardiographic interval measured from the J point to the offset of the T wave of a single beat utilizing one or more leads. | Single Beat JT Interval | ||
| MI | C111280 | Myocardial Infarction | An electrocardiographic assessment of findings suggestive of myocardial infarction. | Myocardial Infarction ECG Assessment | ||
| NEWQWAVE | C117770 | New Q Wave | An electrocardiographic finding assessment of new or presumed new pathologic Q waves suggestive of myocardial infarction. (Thygesen K, Alpert JS, Jaffe AS, et al.: the Writing Group on behalf of the Joint ESC/ACCF/AHA/WHF Task Force for the Universal Definition of Myocardial Infarction. J Am Coll Cardiol 60(16):1-18, 2012). | New Q Wave | ||
| P_AXIS | C118164 | P Wave Axis | A numerical representation of the electrocardiographic vector assessed at maximum deviation of the P wave from the isoelectric baseline, usually reported for the frontal plane. | P Wave Axis | ||
| PACEMAKR | C111285 | Pacemaker | An electrocardiographic assessment of presence of artificial electronic pacing. | Pacemaker ECG Assessment | ||
| PPAG | C117771 | PP Interval, Aggregate | An aggregate PP value based on the measurement of PP intervals from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean. | Aggregate PP Interval | ||
| PPSM | C117772 | PP Interval, Single Measurement | An electrocardiographic measurement of the interval between the onsets of two consecutive P waves. | Single Measurement PP Interval | ||
| PRAG | C117773 | PR Interval, Aggregate | An aggregate PR value based on the measurement of PR intervals from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean. | Aggregate PR Interval | ||
| PRMAX | C62131 | Summary (Max) PR Duration | The maximum duration (time) of the PR interval, obtained from a set of measurements of the PR interval. The PR interval is defined as the time from the beginning of the P wave (representing the onset of atrial depolarization) to the beginning of the R wave (representing the onset of ventricular depolarization). In some cases, a Q wave will precede the R wave, in which case the PR interval is measured from the beginning of the P wave to the beginning of the Q wave. (NCI) | Maximum PR Duration | ||
| PRMEAN | C62086 | Summary (Mean) PR Duration | The average (mean) duration (time) of the PR interval, obtained from a set of measurements of the PR interval. The PR interval is defined as the time from the beginning of the P wave (representing the onset of atrial depolarization) to the beginning of the R wave (representing the onset of ventricular depolarization). In some cases, a Q wave will precede the R wave, in which case the PR interval is measured from the beginning of the P wave to the beginning of the Q wave. (NCI) | Mean PR Duration | ||
| PRMED | C102250 | Summary (Median) PR Duration | The median duration (time) of the PR interval, obtained from a set of measurements of the PR interval. The PR interval is defined as the time from the beginning of the P wave (representing the onset of atrial depolarization) to the beginning of the R wave (representing the onset of ventricular depolarization). In some cases, a Q wave will precede the R wave, in which case the PR interval is measured from the beginning of the P wave to the beginning of the Q wave. | Median PR Duration | ||
| PRMIN | C62125 | Summary (Min) PR Duration | The minimum duration (time) of the PR interval, obtained from a set of measurements of the PR interval. The PR interval is defined as the time from the beginning of the P wave (representing the onset of atrial depolarization) to the beginning of the R wave (representing the onset of ventricular depolarization). In some cases, a Q wave will precede the R wave, in which case the PR interval is measured from the beginning of the P wave to the beginning of the Q wave. (NCI) | Minimum PR Duration | ||
| PRSB | C117774 | PR Interval, Single Beat | An electrocardiographic interval measured from the onset of the P wave to the onset of the QRS complex of a single beat utilizing one or more leads. | Single Beat PR Interval | ||
| PWAVEDUR | C62123 | Summary (Mean) P Wave Duration | The average (mean) duration (time) from the onset of atrial depolarization to the completion of atrial depolarization (length of the P wave), obtained from a set of measurements of the time from beginning to end of atrial depolarization. (NCI) | Mean P Wave Duration | ||
| PWAVEHT | C62124 | Summary (Mean) P Wave Height | The average (mean) height (usually measured in mm) of the maximum deflection from baseline of the P wave (representing atrial depolarization), obtained from a set of measurements of the P wave, from a single lead or set of leads. Typically this measurement is obtained by analysis of Lead II. (NCI) | Mean P Wave Height | ||
| PWDURAG | C117775 | P Wave Duration, Aggregate | An aggregate P wave duration value based on the measurement of P wave duration intervals from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean. | Aggregate P Wave Duration | ||
| PWDURSB | C117776 | P Wave Duration, Single Beat | An electrocardiographic interval measured from the onset of the P wave to the offset of the P wave of a single beat utilizing one or more leads. | Single Beat P Wave Duration | ||
| PWHTAG | C117777 | P Wave Amplitude, Aggregate | An aggregate P wave amplitude value based on the measurement of P wave amplitudes from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean. | Aggregate P Wave Amplitude | ||
| PWHTSB | C117778 | P Wave Amplitude, Single Beat | An electrocardiographic measurement of the mean amplitude (usually measured in mV) of the P wave measured from the isoelectric baseline to the peak of the P wave of a single beat utilizing one or more leads. Based on the recording gain, this measurement may also be reported in mm. | Single Beat P Wave Amplitude | ||
| QRS_AXIS | C118165 | QRS Axis | A numerical representation of the electrocardiographic vector assessed at maximum deviation of the QRS complex from the isoelectric baseline, usually reported for the frontal plane. | QRS Axis | ||
| QRSAG | C117779 | QRS Duration, Aggregate | An aggregate QRS value based on the measurement of QRS intervals from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean. | Aggregate QRS Duration | ||
| QRSDUR | C62087 | Summary (Mean) QRS Duration | The average (mean) duration (time) of the QRS interval, obtained from a set of measurements of the QRS interval. The QRS interval is defined as the time from the beginning of the QRS complex to the end of the QRS complex, representing the time it takes for the ventricles to depolarize. (NCI) | Mean QRS Duration | ||
| QRSDURVP | C100390 | QRS Duration Ventricular Paced | The average (mean) duration (time) of the QRS interval, obtained from a set of measurements of the QRS interval while the ventricle rhythm is controlled by an electrical impulse from a mechanical cardiac pacemaker. The QRS interval is defined as the time from the beginning of the QRS complex to the end of the QRS complex, representing the time it takes for the ventricles to depolarize. | Mean QRS Duration Ventricular Paced | ||
| QRSMED | C102251 | Summary (Median) QRS Duration | The median duration (time) of the QRS interval, obtained from a set of measurements of the QRS interval. The QRS interval is defined as the time from the beginning of the QRS complex to the end of the QRS complex, representing the time it takes for the ventricles to depolarize. | Median QRS Duration | ||
| QRSSB | C117780 | QRS Duration, Single Beat | An electrocardiographic interval measured from the onset of the QRS complex to the offset of the QRS complex of a single beat utilizing one or more leads. | Single Beat QRS Duration | ||
| QRVDVPAG | C117781 | QRS Duration, Ventr. Paced, Aggregate | An aggregate paced QRS duration value based on the measurement of paced QRS duration intervals from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean. | Paced Ventricular Aggregate QRS Duration | ||
| QRVDVPSB | C117782 | QRS Duration, Ventr. Paced, Single Beat | An electrocardiographic interval measured from the onset of the paced QRS complex to the offset of the QRS complex of a single beat utilizing one or more leads. | Paced Ventricular Single Beat QRS Duration | ||
| QTAG | C117783 | QT Interval, Aggregate | An aggregate QT value based on the measurement of QT intervals from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean. | Aggregate QT Interval | ||
| QTC | C100391 | QT Interval, Corrected | The time interval between the start of the Q wave and the end of the T wave in the cardiac cycle as corrected with a non-specified correction formula. | Corrected QT Interval | ||
| QTCB | C62112 | QTcB - Bazett's Correction Formula | A formula which takes into account the physiologic shortening of the QT interval which occurs as the heart rate increases, permitting comparison of the QT interval across a range of rates. It is mathematically defined as: QTcB = QT/SqRootRR(seconds) and theoretically corrects the QT interval to that which would be observed at a heart rate of 1 cycle per second. (NCI) | QTcB - Bazett's Correction Formula | ||
| QTCBAG | C117784 | QTCB Interval, Aggregate | A QTAG interval corrected for heart rate using Bazett's formula. | Aggregate QTCB Interval | ||
| QTCBSB | C117785 | QTCB Interval, Single Beat | A QTSB interval corrected for heart rate using Bazett's formula. | Single Beat QTCB Interval | ||
| QTCF | C62113 | QTcF - Fridericia's Correction Formula | A formula which takes into account the physiologic shortening of the QT interval which occurs as the heart rate increases, permitting comparison of the QT interval across a range of rates. It is mathematically defined as: QTcF = QT/CubeRootRR(seconds) and theoretically corrects the QT interval to that which would be observed at a heart rate of 1 cycle per second. (NCI) | QTcF - Fridericia's Correction Formula | ||
| QTCFAG | C117786 | QTCF Interval, Aggregate | A QTAG interval corrected for heart rate using Fridericia's formula. | Aggregate QTCF Interval | ||
| QTCFMED | C102253 | Summary (Median) QTcF | The median duration (time) of the QTc interval, obtained from a set of measurements of the QT interval and corrected using the Fridericia's correction Formula. | Median QTcF | ||
| QTCFSB | C117787 | QTCF Interval, Single Beat | A QTSB interval corrected for heart rate using Fridericia's formula. | Single Beat QTCF Interval | ||
| QTCLC | C62114 | QTcLC - Linear Correction Formula | A formula which takes into account the physiologic shortening of the QT interval which occurs as the heart rate increases, permitting comparison of the QT interval across a range of rates. The linear correction formula uses population-based data obtained and validated using a large cohort of subjects. This method theoretically corrects the QT interval to that which would be observed at a heart rate of 1 cycle per second. (NCI) | QTcLC - Linear Correction Formula | ||
| QTCV | C90442 | QTcV - Van de Water's Correction Formula | A mathematic formula defined as: QTcV = QT-0.087[(60/Heart Rate)-1](seconds). It permits comparison of the QT interval across a range of rates, while accounting for the progressive shortening of the QT interval which occurs as the heart rate increases. (NCI) | QTcV - Van de Water's Correction Formula | ||
| QTMAX | C62135 | Summary (Max) QT Duration | The maximum duration (time) of the QT interval, obtained from a set of measurements of the QT interval. The QT interval is defined as the time from the beginning of the QRS complex to the end of the T wave, representing the time it takes for the ventricles to depolarize and subsequently repolarize. In some cases, the Q wave will be absent, in which case the QT interval is measured from the beginning of the R wave to the end of the T wave. (NCI) | Maximum QT Duration | ||
| QTMEAN | C62089 | Summary (Mean) QT Duration | The average (mean) duration (time) of the QT interval, obtained from a set of measurements of the QT interval. The QT interval is defined as the time from the beginning of the QRS complex to the end of the T wave, representing the time it takes for the ventricles to depolarize and subsequently repolarize. In some cases, the Q wave will be absent, in which case the QT interval is measured from the beginning of the R wave to the end of the T wave. (NCI) | Mean QT Duration | ||
| QTMED | C102252 | Summary (Median) QT Duration | The median duration (time) of the QT interval, obtained from a set of measurements of the QT interval. The QT interval is defined as the time from the beginning of the QRS complex to the end of the T wave, representing the time it takes for the ventricles to depolarize and subsequently repolarize. In some cases, the Q wave will be absent, in which case the QT interval is measured from the beginning of the R wave to the end of the T wave. | Median QT Duration | ||
| QTMIN | C62133 | Summary (Min) QT Duration | The minimum duration (time) of the QT interval, obtained from a set of measurements of the QT interval. The QT interval is defined as the time from the beginning of the QRS complex to the end of the T wave, representing the time it takes for the ventricles to depolarize and subsequently repolarize. In some cases, the Q wave will be absent, in which case the QT interval is measured from the beginning of the R wave to the end of the T wave. (NCI) | Minimum QT Duration | ||
| QTSB | C117788 | QT Interval, Single Beat | An electrocardiographic interval measured from the onset of the QRS complex to the offset of the T wave of a single beat utilizing one or more leads. | Single Beat QT Interval | ||
| QWAAG | C117789 | Q Wave Amplitude, Aggregate | An aggregate Q wave amplitude value based on the measurement of Q wave amplitudes from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean. | Aggregate Q Wave Amplitude | ||
| QWASB | C117790 | Q Wave Amplitude, Single Beat | An electrocardiographic measurement of the mean amplitude (usually measured in mV) of the Q wave measured from the isoelectric baseline to the peak of the Q wave of a single beat utilizing one or more leads. Based on the recording gain, this measurement may also be reported in mm. | Single Beat Q Wave Amplitude | ||
| RHYNOS | C111307 | Rhythm Not Otherwise Specified | An electrocardiographic assessment of cardiac rhythm not otherwise specified. | Rhythm Not Otherwise Specified ECG Assessment | ||
| RRAG | C117791 | RR Interval, Aggregate | An aggregate RR value based on the measurement of RR intervals from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean. | Aggregate RR Interval | ||
| RRMAX | C62094 | Summary (Max) RR Duration | The maximum duration (time) between successive peaks of R waves in a particular set of RR intervals. (NCI) | Maximum RR Duration | ||
| RRMEAN | C62090 | Summary (Mean) RR Duration | The average (mean) duration (time) of the RR interval, obtained from a set of measurements of the RR interval. The RR interval is defined as the time between successive peaks of the R wave and can be used to measure the ventricular rate. (NCI) | Mean RR Duration | ||
| RRMED | C102254 | Summary (Median) RR Duration | The median duration (time) of the RR interval, obtained from a set of measurements of the RR interval. The RR interval is defined as the time between successive peaks of the R wave and can be used to measure the ventricular rate. | Median RR Duration | ||
| RRMIN | C62093 | Summary (Min) RR Duration | The minimum duration (time) between successive peaks of R waves in a particular set of RR intervals. (NCI) | Minimum RR Duration | ||
| RRSM | C117792 | RR Interval, Single Measurement | An electrocardiographic measurement of the interval between two consecutive R waves. If R waves are not present, this measurement may utilize the interval between the most easily identified components of the QRS complex within two consecutive beats. | RR Interval Single Measurement | ||
| RSAAG | C117793 | RS Wave Amplitude, Aggregate | An aggregate RS wave amplitude value based on measurements from multiple beats from a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean. | RS Wave Amplitude Aggregate | ||
| RSAMP | C62144 | Summary (Mean) R+S Amplitude | The average (mean) amplitude (usually in mm) of the summation of the R and S waves, obtained from a set of measurements of the R and S waves, in a particular lead or set of leads. (NCI) | Mean R+S Amplitude | ||
| RSASB | C117794 | RS Wave Amplitude, Single Beat | An electrocardiographic measurement of the sum of the amplitudes of the R and S waves, obtained from a single beat in one particular lead or set of leads. | RS Wave Amplitude Single Beat | ||
| RWAAG | C117795 | R Wave Amplitude, Aggregate | An aggregate R wave amplitude value based on the measurement of R wave amplitudes from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean. | R Wave Amplitude Aggregate | ||
| RWASB | C117796 | R Wave Amplitude, Single Beat | An electrocardiographic measurement of the mean amplitude (usually measured in mV) of the R wave measured from the isoelectric baseline to the peak of the R wave of a single beat utilizing one or more leads. Based on the recording gain, this measurement may also be reported in mm. | R Wave Amplitude Single Beat | ||
| RWAVEAMP | C62136 | Summary (Mean) R Wave Amplitude | The average (mean) amplitude (usually in mm) of the R wave, obtained from a set of measurements of the R wave, in a particular lead or set of leads. (NCI) | Mean R Wave Amplitude | ||
| SNRARRY | C111312 | Sinus Node Rhythms and Arrhythmias | An electrocardiographic assessment of sinus node rhythms and arrhythmias. | Sinus Node Rhythm and Arrhythmia ECG Assessment | ||
| SPRARRY | C111320 | Supraventricular Arrhythmias | An electrocardiographic assessment of supraventricular arrhythmias excluding tachycardias. | Supraventricular Arrhythmia ECG Assessment | ||
| SPRTARRY | C111321 | Supraventricular Tachyarrhythmias | An electrocardiographic assessment of supraventricular tachyarrhythmias. | Supraventricular Tachyarrhythmia ECG Assessment | ||
| STDAG | C117797 | ST Segment Depression, Aggregate | An aggregate ST segment depression value based on the measurement of ST segment depression from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean. | ST Segment Depression Aggregate | ||
| STDPMAX | C62163 | Summary (Max) ST Depression | The maximum depression (negative deflection from baseline, usually measured in mm) of the ST segment, obtained from a set of measurements of the depression of the ST segment. (NCI) | Maximum ST Segment Depression by ECG Finding | ||
| STDPMEAN | C62161 | Summary (Mean) ST Depression | The average (mean) depression (negative deflection from baseline, usually measured in mm) of the ST segment, obtained from a set of measurements of the depression of the ST segment. (NCI) | Mean ST Segment Depression by ECG Finding | ||
| STDPMIN | C62162 | Summary (Min) ST Depression | The minimum depression (negative deflection from baseline, usually measured in mm) of the ST segment, obtained from a set of measurements of the depression of the ST segment. (NCI) | Minimum ST Segment Depression by ECG Finding | ||
| STDSB | C117798 | ST Segment Depression, Single Beat | An electrocardiographic measurement of the mean amplitude (usually measured in mV) of the ST segment depression below the isoelectric baseline measured from the baseline to the ST segment of a single beat utilizing one or more leads. Based on the recording gain, this measurement may also be reported in mm. | ST Segment Depression Single Beat | ||
| STDVAG | C117799 | ST Segment Deviation, Aggregate | An aggregate ST segment deviation value based on the measurement of ST segment deviation from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean. | ST Segment Deviation Aggregate | ||
| STDVMAX | C62157 | Summary (Max) ST Deviation | The maximum deviation (distance from baseline, positive or negative, usually measured in mm) of the ST segment, obtained from a set of measurements of the deviation of the ST segment. (NCI) | Maximum ST Deviation | ||
| STDVMEAN | C62155 | Summary (Mean) ST Deviation | The average (mean) deviation (distance from baseline, positive or negative, usually measured in mm) of the ST segment, obtained from a set of measurements of the deviation of the ST segment. (NCI) | Mean ST Deviation | ||
| STDVMIN | C62156 | Summary (Min) ST Deviation | The minimum deviation (distance from baseline, positive or negative, usually measured in mm) of the ST segment, obtained from a set of measurements of the deviation of the ST segment. (NCI) | Minimum ST Deviation | ||
| STDVSB | C117800 | ST Segment Deviation, Single Beat | An electrocardiographic measurement of the mean amplitude (usually measured in mV) of the ST segment deviation above or below the isoelectric baseline measured from the baseline to the ST segment of a single beat utilizing one or more leads. Based on the recording gain, this measurement may also be reported in mm. | ST Segment Deviation Single Beat | ||
| STEAG | C117801 | ST Segment Elevation, Aggregate | An aggregate ST segment elevation value based on the measurement of ST segment elevation from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean. | ST Segment Elevation Aggregate | ||
| STELMAX | C62160 | Summary (Max) ST Elevation | The maximum elevation (positive deflection from baseline, usually measured in mm) of the ST segment, obtained from a set of measurements of the elevation of the ST segment. (NCI) | Maximum ST Segment Elevation | ||
| STELMEAN | C62158 | Summary (Mean) ST Elevation | The average (mean) elevation (positive deflection from baseline, usually measured in mm) of the ST segment, obtained from a set of measurements of the elevation of the ST segment. (NCI) | Mean ST Segment Elevation | ||
| STELMIN | C62159 | Summary (Min) ST Elevation | The minimum elevation (positive deflection from baseline, usually measured in mm) of the ST segment, obtained from a set of measurements of the elevation of the ST segment. (NCI) | Minimum ST Segment Elevation | ||
| STESB | C117802 | ST Segment Elevation, Single Beat | An electrocardiographic measurement of the mean amplitude (usually measured in mV) of the ST segment elevation above the isoelectric baseline measured from the baseline to the ST segment of a single beat utilizing one or more leads. Based on the recording gain, this measurement may also be reported in mm. | ST Segment Elevation Single Beat | ||
| STSDURAG | C117803 | ST Segment Duration, Aggregate | An aggregate ST segment duration value based on the measurement of ST segment duration intervals from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean. | ST Segment Duration Aggregate | ||
| STSDURSB | C117804 | ST Segment Duration, Single Beat | An electrocardiographic interval measured from the J point to the onset of the T wave of a single beat utilizing one or more leads. | ST Segment Duration Single Beat | ||
| STSEGDUR | C62145 | Summary (Mean) ST Segment Duration | The average (mean) duration (time) of the ST segment, measured from the J point at the end of the QRS complex to the beginning of the T wave. | Mean ST Segment Duration | ||
| STSTWUW | C111363 | ST Segment, T wave, and U wave | An electrocardiographic assessment of the characteristics of the ST segment, T wave, and U wave. | ST Segment, T wave, and U wave ECG Assessment | ||
| SWAAG | C117805 | S Wave Amplitude, Aggregate | An aggregate S wave amplitude value based on the measurement of S wave amplitudes from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean. | S Wave Amplitude Aggregate | ||
| SWASB | C117806 | S Wave Amplitude, Single Beat | An electrocardiographic measurement of the mean amplitude (usually measured in mV) of the S wave measured from the isoelectric baseline to the peak of the S wave of a single beat utilizing one or more leads. Based on the recording gain, this measurement may also be reported in mm. | S Wave Amplitude Single Beat | ||
| SWAVEAMP | C62137 | Summary (Mean) S Wave Amplitude | The average (mean) amplitude (usually in mm) of the S wave, obtained from a set of measurements of the S wave, in a particular lead or set of leads. (NCI) | Mean S Wave Amplitude | ||
| T_AXIS | C118166 | T Wave Axis | A numerical representation of the electrocardiographic vector assessed at maximum deviation of the T wave from the isoelectric baseline, usually reported for the frontal plane. | T Wave Axis | ||
| TECHQUAL | C117807 | Technical Quality | A statement about an electrocardiographic recording describing technical issues or interference during the recording, processing, or transmission of the data. This does not represent an electrocardiographic diagnosis. | ECG Technical Quality | ||
| TPTEAG | C117808 | Tpeak-Tend Interval, Aggregate | An aggregate Tpeak-Tend value based on the measurement of Tpeak-Tend from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean. | T Peak-T End Interval Aggregate | ||
| TPTESB | C117809 | Tpeak-Tend Interval, Single Beat | An electrocardiographic interval measured from the peak of the T wave to the offset of the T wave of a single beat utilizing one or more leads. | T Peak-T End Interval Single Beat | ||
| TWARAG | C117810 | T Wave Area, Aggregate | An aggregate T wave area value based on the measurement of T wave areas from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean. | T Wave Area Aggregate | ||
| TWARSB | C117811 | T Wave Area, Single Beat | An electrocardiographic measurement of the area of the T wave of a single beat utilizing one or more leads. | T Wave Area Single Beat | ||
| TWAVAREA | C62148 | Summary (Mean) T Wave Area | The average (mean) area under the curve of the deflection from baseline of the T wave (representing ventricular repolarization), obtained from a set of measurements of the T wave, from a single lead or set of leads. (NCI) | Mean T Wave Area | ||
| TWAVEDUR | C62147 | Summary (Mean) T Wave Duration | The average (mean) duration (time) from the onset of ventricular repolarization to the completion of ventricular repolarization (length of the T wave), obtained from a set of measurements of the time from beginning to end of ventricular repolarization. (NCI) | Mean T Wave Duration | ||
| TWAVEHT | C62149 | Summary (Mean) T Wave Height | The average (mean) height (usually measured in mm) of the maximum deflection from baseline of the T wave (representing ventricular repolarization), obtained from a set of measurements of the T wave, from a single lead or set of leads. (NCI) | Mean T Wave Height | ||
| TWDURAG | C117812 | T Wave Duration, Aggregate | An aggregate T wave duration value based on the measurement of T wave duration intervals from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean. | T Wave Duration Aggregate | ||
| TWDURSB | C117813 | T Wave Duration, Single Beat | An electrocardiographic interval measured from the onset of the T wave to the offset of the T wave of a single beat utilizing one or more leads. | T Wave Duration Single Beat | ||
| TWHAG | C117814 | T Wave Amplitude, Aggregate | An aggregate T wave amplitude value based on the measurement of T wave amplitudes from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean. | T Wave Amplitude Aggregate | ||
| TWHSB | C117815 | T Wave Amplitude, Single Beat | An electrocardiographic measurement of the mean amplitude (usually measured in mV) of the T wave measured from the isoelectric baseline to the peak of the T wave of a single beat utilizing one or more leads. Based on the recording gain, this measurement may also be reported in mm. | T Wave Amplitude Single Beat | ||
| VTARRY | C111330 | Ventricular Arrhythmias | An electrocardiographic assessment of ventricular arrhythmias excluding tachycardias. | Ventricular Arrhythmia ECG Assessment | ||
| VTTARRY | C111331 | Ventricular Tachyarrhythmias | An electrocardiographic assessment of supraventricular tachyarrhythmias. | Ventricular Tachyarrhythmia ECG Assessment | ||
| Back to top | ||||||
| CL.C71151.EGMETHOD | ECG Test Method (EGMETHOD) | text Extensible: Yes | C71151 | ECG Test Method | Terminology codelist used with ECG Test Methods within CDISC. | CDISC SDTM ECG Test Method Terminology |
| 10 LEAD STANDARD | C90349 | 10 Lead Standard | An electrocardiogram lead placement on the subject using a ten electrode lead set to synthesize standard 12 lead electrocardiograph data to elicit an electrical view of the heart. | 10 Lead Standard | ||
| 12 LEAD 1 LEAD MISSING | C71125 | 12 Lead 1 Lead Missing | An electrocardiogram (ECG) lead placement whereby 12 leadpoints are recorded but one standard lead position is missing therefore requiring a Mortara source consistency filter. (NCI) | 12 Lead Placement 1 Lead Missing | ||
| 12 LEAD CABRERA | C71116 | 12 Lead Cabrera | An electrocardiogram (ECG) lead placement whereby the display of the 12 standard ECG leads is in an orderly sequence in a single horizontal display of: aVL, I, -aVR, II, aVF, III, V1 to V6. In the Cabrera display the limb lead aVR is inverted (-aVR) to obtain the same positive leftward orientation as the other 5 limbs. (NCI) | 12 Lead Placement Cabrera | ||
| 12 LEAD EASI DOWER TRANSFORMATION | C71123 | 12 Lead EASI Dower Transformation | An electrocardiogram (ECG) lead placement whereby 4 chest electrodes and 1 reference electrode are used to allow for continuous monitoring at the clinical level. This placement creates a 12 lead ECG that allows the acquisition of simultaneous events in the frontal, horizontal and sagittal heart planes with the linear transformation of vectors. This system provides a three-dimensional portrayal of the heart and uses mathematical and fixed coefficients for each lead. (NCI) | Lead Placement EASI Dower Transformation | ||
| 12 LEAD MASON LIKAR | C71103 | 12 Lead Mason Likar | An electrocardiogram (ECG) lead placement whereby 12 leadpoints are recorded but the standard lead positions have been modified for ECG recording during exercise. Exercise stress testing requires moving the limb electrodes to more central positions on the thorax. The electrodes are placed in bony prominences close to the bases of the respective limbs in order to avoid skeletal muscle artifact, provide stability for recording electrodes and to record waveforms similar to the standard limb sites. (NCI) | 12 Lead Placement Mason Likar | ||
| 12 LEAD MODIFIED MASON LIKAR | C71110 | 12 Lead Modified Mason Likar | An electrocardiogram (ECG) lead placement whereby 12 leadpoints are recorded but the Mason Likar lead positions have been modified so that V1 to V6 on the chest are part of a single electrode pad. In addition, lead CM5 is substituted for lead aVR. (NCI) | 12 Lead Placement Mason Likar Modified | ||
| 12 LEAD NON-STANDARD | C71114 | 12 Lead Non-Standard | An electrocardiogram (ECG) lead placement whereby the limb leads are placed on the torso for easier and faster application in emergency situations. (NCI) | 12 Lead Placement Non-Standard | ||
| 12 LEAD RIGHT-SIDED PRECORDIAL LEADS | C116139 | 12 Lead Right-sided Precordial Leads;Right-sided Chest Leads | An electrocardiogram (ECG) lead placement whereby the precordial leads are intentionally placed on the right side of the chest. | 12 Lead Placement Right-sided Precordial Leads | ||
| 12 LEAD SINGLE PAD | C71112 | 12 Lead Single Pad | An electrocardiogram (ECG) lead placement whereby 12 leadpoints are recorded but the standard lead positions have been modified so that all leads on the chest are part of a single electrode pad. (NCI) | 12 Lead Placement Chest | ||
| 12 LEAD STANDARD | C71102 | 12 Lead Standard | An electrocardiogram (ECG) lead placement whereby 12 leads are recorded, with each lead representing an electrical view of the heart. The six leads recorded in the frontal plane are derived from the placement of 3 electrodes (RA or Right Arm, LA, or Left Arm, and LL or Left Leg). These bipolar frontal leads form the basis of Einthoven's triangle, and are represented by leads I, II, and III. Three other derived (or augmented) bipolar frontal vectors are also recorded on a standard 12-lead EKG, aVR, aVF, and aVL. 6 unipolar leads, corresponding to V1 - V6 measure the electrical activity in the horizontal plane. The placement for the V leads is as follows: V1: right 4th intercostal space,V2: left 4th intercostal space, V3: halfway between V2 and V4, V4: left 5th intercostal space, mid-clavicular line, V5: horizontal to V4, anterior axillary line, V6: horizontal to V5, mid-axillary line. (NCI) | 12 Lead Placement Standard | ||
| 12 LEAD UNSPECIFIED | C71101 | 12 Lead Unspecified | An electrocardiogram (ECG) lead placement whereby 12 leadpoints are recorded but the position of the leads is unspecified. (NCI) | 12 Lead Placement Unspecified | ||
| 6 LEAD STANDARD | C90350 | 6 Lead Standard | An electrocardiogram lead placement on the subject using a six electrode lead set with three standard leads and three augmented derived leads to elicit an electrical view of the heart. | 6 Lead Standard | ||
| BIPOLAR UNCORRECTED XYZ LEAD SYSTEM | C71121 | Bipolar uncorrected XYZ lead system | An electrocardiogram (ECG) lead placement whereby the X+ lead is placed at the right mid-axillary line ate the 4th intercostal space, X- at the left mid-axillary line at he 4th intercostal space, Y+ at the proximal left leg, Y- at the superior aspect of the manubrium, Z+ at the direct posterior to Z- and Z- at the 4th intercostal space at the left sternal margin. (NCI) | Lead Placement Bipolar Uncorrected XYZ | ||
| CUBE LEAD SYSTEM | C71120 | Cube lead system | An electrocardiogram (ECG) lead placement that is a type of uncorrected vectorcardiograph. This lead system is based on a rectangular body axis. It uses an extra number of electrodes to make it three-dimensional. (NCI) | Lead Placement Cube | ||
| FRANK LEAD SYSTEM | C71118 | Frank lead system | An electrocardiogram (ECG) lead placement for determining 3 orthogonal components X (right to left direction), Y (foot to head direction) and Z (back to front direction) of the heart. For this method a minimum of 4 electrodes are needed that represent the right arm, left arm, left leg and back. However, usually 7 electrodes are used to avoid dependence on the dipole location and facilitate interpretation. (NCI) | Lead Placement Frank | ||
| MCFEE-PARUNGAO LEAD SYSTEM | C71119 | McFee-Parungao lead system | An electrocardiogram (ECG) lead placement for determining 3 orthogonal components X (back to front), Y (right to left) and Z (foot to head) of the heart. This system places the electrodes closer to the heart to achieve better orthogonality and a homogeneous lead field. (NCI) | Lead Placement McFee-Parungao | ||
| PSEUDO-ORTHOGONAL XYZ LEAD SYSTEM | C71122 | Pseudo-orthogonal XYZ lead system | An electrocardiogram (ECG) lead placement that allows monitoring and recording of cardiac electrical activity. A V1-type lead is used whose positive electrode is localized in the 4th intercostal space, 2.5cm from the sternum. Its negative electrode is placed below the left clavicle. An addition of lead V5 and aVF can be made to facilitate interpretation. (NCI) | Lead Placement Pseudo Orthogonal XYZ | ||
| STANDARD 12-LEAD AND CC5-CM5-ML | C71128 | Standard 12-lead and CC5-CM5-ML | An electrocardiogram (ECG) lead placement whereby 12 leadpoints are recorded but the standard lead positions have been modified so that the negative reference is at CM5 and the active electrode is at the left leg position. (NCI) | 12 Lead Placement Standard And CC5-CM5-ML | ||
| STANDARD 12-LEAD AND CM5-CC5-CH5 | C71126 | Standard 12-lead and CM5-CC5-CH5 | An electrocardiogram (ECG) lead placement whereby 12 leadpoints are recorded but the standard lead positions have been modified so that the bipolar lead groups place the negative of the reference electrode over the manubrium (CM5), the right scapula (CB5), V5R (CC5) or on the forehead (CH5) and the active electrode at V5. (NCI) | 12 Lead Placement Standard And CC5-CM5-CH5 | ||
| STANDARD 12-LEAD EXTENDED LEFT | C71131 | Standard 12-lead extended to the left by V7, V8, V9 | An electrocardiogram (ECG) lead placement whereby the standard lead placement is modified by having leads V7, V8 and V9. (NCI) | 12 Lead Placement Standard Extended Left | ||
| STANDARD 12-LEAD EXTENDED RIGHT | C71130 | Standard 12-lead extended to the right by V5R, V4R, V3R | An electrocardiogram (ECG) lead placement whereby the rightward oriented V leads progress from V1R, placed instead of the standard V2, to V6R. The V3 lead in the standard placement is replaced by V4R. (NCI) | 12 Lead Placement Standard Extended Right | ||
| STANDARD LEADS FOR BICYCLE EXERCISE | C71115 | Standard leads for bicycle exercise. Limb leads on the back (shoulder and on the hips) | Limb leads on the back (shoulder and on the hips). (NCI) | Lead Placement Bicycle | ||
| STANDARD LEADS ONE INTERCOSTAL SPACE HIGHER | C71117 | Standard leads one intercostal space higher | An electrocardiographic lead placement schema in which the V leads are placed one intercostal space cephalad to the position they would have in the standard lead placement schema. (NCI) | Lead Placement Standard Intercostal Space Higher | ||
| VECTORCARDIOGRAPH CORRECTED | C71092 | Vectorcardiograph Corrected | A recording of the electrical activity of the heart displayed in the form of a vector loop, corrected for anatomic inconsistencies. (NCI) | Vectorcardiograph Corrected | ||
| VECTORCARDIOGRAPH UNCORRECTED | C71093 | Vectorcardiograph Uncorrected | A recording of the electrical activity of the heart displayed in the form of a vector loop, uncorrected for anatomic inconsistencies. (NCI) | Vectorcardiograph Uncorrected | ||
| Back to top | ||||||
| CL.C71152.EGTEST | ECG Test Name (EGTEST) | text Extensible: Yes | C71152 | ECG Test Name | Terminology codelist used with ECG Test Names within CDISC. | CDISC SDTM ECG Test Name Terminology |
| Acute Myocardial Ischemia ECG Change | C116140 | Acute Myocardial Ischemia ECG Change | An electrocardiographic finding assessment of new or presumed new significant ST-segment-T wave (ST-T) changes or new left bundle branch block consistent with acute myocardial ischemia. (Thygesen K, Alpert JS, Jaffe AS, et al.: the Writing Group on behalf of the Joint ESC/ACCF/AHA/WHF Task Force for the Universal Definition of Myocardial Infarction. J Am Coll Cardiol 60(16):1-18, 2012) | Acute Myocardial Ischemia by ECG Assessment | ||
| Atrioventricular Conduction | C111131 | Atrioventricular Conduction | An electrocardiographic assessment of cardiac atrioventricular conduction. | Atrioventricular Conduction ECG Assessment | ||
| Axis and Voltage | C111132 | Axis and Voltage | An electrocardiographic assessment of mean cardiac electrical vector and the ECG voltage. | Axis and Voltage ECG Assessment | ||
| Chamber Hypertrophy or Enlargement | C111155 | Chamber Hypertrophy or Enlargement | An electrocardiographic assessment of chamber hypertrophy or enlargement. | Chamber Hypertrophy or Enlargement ECG Assessment | ||
| Comparison to a Prior ECG | C117761 | Comparison to a Prior ECG | A comparative interpretation of an ECG relative to a previous (comparator) ECG. The definition of the comparator ECG may be specified elsewhere. Common comparator result values include improved, no change, deteriorated. | Comparison to a Prior ECG | ||
| ECG Maximum Atrial Rate | C119253 | ECG Maximum Atrial Rate | An electrocardiographic measurement of the maximum rate of atrial depolarizations (P waves) recorded during an interval of time, usually expressed in beats per minute. | Maximum Atrial Rate by Electrocardiogram | ||
| ECG Maximum Heart Rate | C119257 | ECG Maximum Heart Rate | An electrocardiographic measurement of the maximum rate of depolarization of a specific region of the heart during an interval of time, usually expressed in beats per minute. Unless otherwise specified, this is usually the maximum ventricular rate. | Maximum Heart Rate by Electrocardiogram | ||
| ECG Maximum Ventricular Rate | C119260 | ECG Maximum Ventricular Rate | An electrocardiographic measurement of the maximum rate of ventricular depolarizations (QRS complexes) recorded during an interval of time, usually expressed in beats per minute. | Maximum Ventricular Rate by Electrocardiogram | ||
| ECG Mean Atrial Rate | C119256 | ECG Mean Atrial Rate | An electrocardiographic measurement of the average rate of atrial depolarizations (P waves) recorded during an interval of time, usually expressed in beats per minute. | Mean Atrial Rate by Electrocardiogram | ||
| ECG Mean Heart Rate | C119259 | ECG Mean Heart Rate | An electrocardiographic measurement of the average rate of depolarization of a specific region of the heart during an interval of time, usually expressed in beats per minute. Unless otherwise specified, this is usually the mean ventricular rate. | Mean Heart Rate by Electrocardiogram | ||
| ECG Mean Ventricular Rate | C119263 | ECG Mean Ventricular Rate | An electrocardiographic measurement of the average rate of ventricular depolarizations (QRS complexes) recorded during an interval of time, usually expressed in beats per minute. | Mean Ventricular Rate by Electrocardiogram | ||
| ECG Median Atrial Rate | C119254 | ECG Median Atrial Rate | An electrocardiographic measurement of the median rate of atrial depolarizations (P waves) recorded during an interval of time, usually expressed in beats per minute. | Median Atrial Rate by Electrocardiogram | ||
| ECG Median Ventricular Rate | C119261 | ECG Median Ventricular Rate | An electrocardiographic measurement of the median rate of ventricular depolarizations (QRS complexes) recorded during an interval of time, usually expressed in beats per minute. | Median Ventricular Rate by Electrocardiogram | ||
| ECG Minimum Atrial Rate | C119255 | ECG Minimum Atrial Rate | An electrocardiographic measurement of the minimum rate of atrial depolarizations (P waves) recorded during an interval of time, usually expressed in beats per minute. | Minimum Atrial Rate by Electrocardiogram | ||
| ECG Minimum Heart Rate | C119258 | ECG Minimum Heart Rate | An electrocardiographic measurement of the minimum rate of depolarization of a specific region of the heart during an interval of time, usually expressed in beats per minute. Unless otherwise specified, this is usually the minimum ventricular rate. | Minimum Heart Rate by Electrocardiogram | ||
| ECG Minimum Ventricular Rate | C119262 | ECG Minimum Ventricular Rate | An electrocardiographic measurement of the minimum rate of ventricular depolarizations (QRS complexes) recorded during an interval of time, usually expressed in beats per minute. | Minimum Ventricular Rate by Electrocardiogram | ||
| Interpretation | C41255 | Interpretation | An act or process of elucidation; explication, or explanation of the meaning of the event or thing via the assignment of objects from the domain to the constants of a formal language, truth-values to the proposition symbols, truth-functions to the connectives, other functions to the function symbols, and extensions to the predicates, if any. The assignments are result of human logic application and are not native to the symbols of the formal language. | Interpretation | ||
| Intraventricular-Intraatrial Conduction | C111238 | Intraventricular-Intraatrial Conduction | An electrocardiographic assessment of intraventricular and intra-atrial conduction. | Intraventricular and Intraatrial Conduction ECG Assessment | ||
| J-Tpeak Interval, Aggregate | C117767 | J-Tpeak Interval, Aggregate | An aggregate J-Tpeak value based on the measurement of J-Tpeak intervals from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean. | Aggregate J-T Peak Interval | ||
| J-Tpeak Interval, Single Beat | C117768 | J-Tpeak Interval, Single Beat | An electrocardiographic interval measured from the J point to the peak of the T wave of a single beat utilizing one or more leads. | Single Beat J-T Peak Interval | ||
| JT Interval, Aggregate | C117762 | JT Interval, Aggregate | An aggregate JT value based on the measurement of JT intervals from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean. | Aggregate JT Interval | ||
| JT Interval, Single Beat | C117769 | JT Interval, Single Beat | An electrocardiographic interval measured from the J point to the offset of the T wave of a single beat utilizing one or more leads. | Single Beat JT Interval | ||
| JTcB - Bazett's Correction Formula | C62118 | JTcB - Bazett's Correction Formula | A formula which takes into account the physiologic shortening of the JT interval which occurs as the heart rate increases, permitting comparison of the JT interval across a range of rates. It is mathematically defined as: JTcB = JT/SqRootRR(seconds) and theoretically corrects the JT interval to that which would be observed at a heart rate of 1 cycle per second. (NCI) | JTcB - Bazett's Correction Formula | ||
| JTCB Interval, Aggregate | C117763 | JTCB Interval, Aggregate | A JTAG interval corrected for heart rate using Bazett's formula. | Aggregate JTCB Interval | ||
| JTCB Interval, Single Beat | C117764 | JTCB Interval, Single Beat | A JTSB interval corrected for heart rate using Bazett's formula. | Single Beat JTCB Interval | ||
| JTcF - Fridericia's Correction Formula | C62119 | JTcF - Fridericia's Correction Formula | A formula which takes into account the physiologic shortening of the JT interval which occurs as the heart rate increases, permitting comparison of the JT interval across a range of rates. It is mathematically defined as: JTcF = JT/CubeRootRR(seconds) and theoretically corrects the JT interval to that which would be observed at a heart rate of 1 cycle per second. (NCI) | JTcF - Fridericia's Correction Formula | ||
| JTCF Interval, Aggregate | C117765 | JTCF Interval, Aggregate | A JTAG interval corrected for heart rate using Fridericia's formula. | Aggregate JTCF Interval | ||
| JTCF Interval, Single Beat | C117766 | JTCF Interval, Single Beat | A JTSB interval corrected for heart rate using Fridericia's formula. | Single Beat JTCF Interval | ||
| JTcLC - Linear Correction Formula | C62120 | JTcLC - Linear Correction Formula | A formula which takes into account the physiologic shortening of the JT interval which occurs as the heart rate increases, permitting comparison of the JT interval across a range of rates. The linear correction formula uses population-based data obtained and validated using a large cohort of subjects. Using this method, the corrected JT interval is independent of the ventricular rate. (NCI) | JTcLC - Linear Correction Formula | ||
| Myocardial Infarction | C111280 | Myocardial Infarction | An electrocardiographic assessment of findings suggestive of myocardial infarction. | Myocardial Infarction ECG Assessment | ||
| New Q Wave | C117770 | New Q Wave | An electrocardiographic finding assessment of new or presumed new pathologic Q waves suggestive of myocardial infarction. (Thygesen K, Alpert JS, Jaffe AS, et al.: the Writing Group on behalf of the Joint ESC/ACCF/AHA/WHF Task Force for the Universal Definition of Myocardial Infarction. J Am Coll Cardiol 60(16):1-18, 2012). | New Q Wave | ||
| P Wave Amplitude, Aggregate | C117777 | P Wave Amplitude, Aggregate | An aggregate P wave amplitude value based on the measurement of P wave amplitudes from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean. | Aggregate P Wave Amplitude | ||
| P Wave Amplitude, Single Beat | C117778 | P Wave Amplitude, Single Beat | An electrocardiographic measurement of the mean amplitude (usually measured in mV) of the P wave measured from the isoelectric baseline to the peak of the P wave of a single beat utilizing one or more leads. Based on the recording gain, this measurement may also be reported in mm. | Single Beat P Wave Amplitude | ||
| P Wave Axis | C118164 | P Wave Axis | A numerical representation of the electrocardiographic vector assessed at maximum deviation of the P wave from the isoelectric baseline, usually reported for the frontal plane. | P Wave Axis | ||
| P Wave Duration, Aggregate | C117775 | P Wave Duration, Aggregate | An aggregate P wave duration value based on the measurement of P wave duration intervals from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean. | Aggregate P Wave Duration | ||
| P Wave Duration, Single Beat | C117776 | P Wave Duration, Single Beat | An electrocardiographic interval measured from the onset of the P wave to the offset of the P wave of a single beat utilizing one or more leads. | Single Beat P Wave Duration | ||
| Pacemaker | C111285 | Pacemaker | An electrocardiographic assessment of presence of artificial electronic pacing. | Pacemaker ECG Assessment | ||
| PP Interval, Aggregate | C117771 | PP Interval, Aggregate | An aggregate PP value based on the measurement of PP intervals from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean. | Aggregate PP Interval | ||
| PP Interval, Single Measurement | C117772 | PP Interval, Single Measurement | An electrocardiographic measurement of the interval between the onsets of two consecutive P waves. | Single Measurement PP Interval | ||
| PR Interval, Aggregate | C117773 | PR Interval, Aggregate | An aggregate PR value based on the measurement of PR intervals from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean. | Aggregate PR Interval | ||
| PR Interval, Single Beat | C117774 | PR Interval, Single Beat | An electrocardiographic interval measured from the onset of the P wave to the onset of the QRS complex of a single beat utilizing one or more leads. | Single Beat PR Interval | ||
| Q Wave Amplitude, Aggregate | C117789 | Q Wave Amplitude, Aggregate | An aggregate Q wave amplitude value based on the measurement of Q wave amplitudes from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean. | Aggregate Q Wave Amplitude | ||
| Q Wave Amplitude, Single Beat | C117790 | Q Wave Amplitude, Single Beat | An electrocardiographic measurement of the mean amplitude (usually measured in mV) of the Q wave measured from the isoelectric baseline to the peak of the Q wave of a single beat utilizing one or more leads. Based on the recording gain, this measurement may also be reported in mm. | Single Beat Q Wave Amplitude | ||
| QRS Axis | C118165 | QRS Axis | A numerical representation of the electrocardiographic vector assessed at maximum deviation of the QRS complex from the isoelectric baseline, usually reported for the frontal plane. | QRS Axis | ||
| QRS Duration Ventricular Paced | C100390 | QRS Duration Ventricular Paced | The average (mean) duration (time) of the QRS interval, obtained from a set of measurements of the QRS interval while the ventricle rhythm is controlled by an electrical impulse from a mechanical cardiac pacemaker. The QRS interval is defined as the time from the beginning of the QRS complex to the end of the QRS complex, representing the time it takes for the ventricles to depolarize. | Mean QRS Duration Ventricular Paced | ||
| QRS Duration, Aggregate | C117779 | QRS Duration, Aggregate | An aggregate QRS value based on the measurement of QRS intervals from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean. | Aggregate QRS Duration | ||
| QRS Duration, Single Beat | C117780 | QRS Duration, Single Beat | An electrocardiographic interval measured from the onset of the QRS complex to the offset of the QRS complex of a single beat utilizing one or more leads. | Single Beat QRS Duration | ||
| QRS Duration, Ventr. Paced, Aggregate | C117781 | QRS Duration, Ventr. Paced, Aggregate | An aggregate paced QRS duration value based on the measurement of paced QRS duration intervals from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean. | Paced Ventricular Aggregate QRS Duration | ||
| QRS Duration, Ventr. Paced, Single Beat | C117782 | QRS Duration, Ventr. Paced, Single Beat | An electrocardiographic interval measured from the onset of the paced QRS complex to the offset of the QRS complex of a single beat utilizing one or more leads. | Paced Ventricular Single Beat QRS Duration | ||
| QT Interval, Aggregate | C117783 | QT Interval, Aggregate | An aggregate QT value based on the measurement of QT intervals from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean. | Aggregate QT Interval | ||
| QT Interval, Corrected | C100391 | QT Interval, Corrected | The time interval between the start of the Q wave and the end of the T wave in the cardiac cycle as corrected with a non-specified correction formula. | Corrected QT Interval | ||
| QT Interval, Single Beat | C117788 | QT Interval, Single Beat | An electrocardiographic interval measured from the onset of the QRS complex to the offset of the T wave of a single beat utilizing one or more leads. | Single Beat QT Interval | ||
| QTcB - Bazett's Correction Formula | C62112 | QTcB - Bazett's Correction Formula | A formula which takes into account the physiologic shortening of the QT interval which occurs as the heart rate increases, permitting comparison of the QT interval across a range of rates. It is mathematically defined as: QTcB = QT/SqRootRR(seconds) and theoretically corrects the QT interval to that which would be observed at a heart rate of 1 cycle per second. (NCI) | QTcB - Bazett's Correction Formula | ||
| QTCB Interval, Aggregate | C117784 | QTCB Interval, Aggregate | A QTAG interval corrected for heart rate using Bazett's formula. | Aggregate QTCB Interval | ||
| QTCB Interval, Single Beat | C117785 | QTCB Interval, Single Beat | A QTSB interval corrected for heart rate using Bazett's formula. | Single Beat QTCB Interval | ||
| QTcF - Fridericia's Correction Formula | C62113 | QTcF - Fridericia's Correction Formula | A formula which takes into account the physiologic shortening of the QT interval which occurs as the heart rate increases, permitting comparison of the QT interval across a range of rates. It is mathematically defined as: QTcF = QT/CubeRootRR(seconds) and theoretically corrects the QT interval to that which would be observed at a heart rate of 1 cycle per second. (NCI) | QTcF - Fridericia's Correction Formula | ||
| QTCF Interval, Aggregate | C117786 | QTCF Interval, Aggregate | A QTAG interval corrected for heart rate using Fridericia's formula. | Aggregate QTCF Interval | ||
| QTCF Interval, Single Beat | C117787 | QTCF Interval, Single Beat | A QTSB interval corrected for heart rate using Fridericia's formula. | Single Beat QTCF Interval | ||
| QTcLC - Linear Correction Formula | C62114 | QTcLC - Linear Correction Formula | A formula which takes into account the physiologic shortening of the QT interval which occurs as the heart rate increases, permitting comparison of the QT interval across a range of rates. The linear correction formula uses population-based data obtained and validated using a large cohort of subjects. This method theoretically corrects the QT interval to that which would be observed at a heart rate of 1 cycle per second. (NCI) | QTcLC - Linear Correction Formula | ||
| QTcV - Van de Water's Correction Formula | C90442 | QTcV - Van de Water's Correction Formula | A mathematic formula defined as: QTcV = QT-0.087[(60/Heart Rate)-1](seconds). It permits comparison of the QT interval across a range of rates, while accounting for the progressive shortening of the QT interval which occurs as the heart rate increases. (NCI) | QTcV - Van de Water's Correction Formula | ||
| R Wave Amplitude, Aggregate | C117795 | R Wave Amplitude, Aggregate | An aggregate R wave amplitude value based on the measurement of R wave amplitudes from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean. | R Wave Amplitude Aggregate | ||
| R Wave Amplitude, Single Beat | C117796 | R Wave Amplitude, Single Beat | An electrocardiographic measurement of the mean amplitude (usually measured in mV) of the R wave measured from the isoelectric baseline to the peak of the R wave of a single beat utilizing one or more leads. Based on the recording gain, this measurement may also be reported in mm. | R Wave Amplitude Single Beat | ||
| Rhythm Not Otherwise Specified | C111307 | Rhythm Not Otherwise Specified | An electrocardiographic assessment of cardiac rhythm not otherwise specified. | Rhythm Not Otherwise Specified ECG Assessment | ||
| RR Interval, Aggregate | C117791 | RR Interval, Aggregate | An aggregate RR value based on the measurement of RR intervals from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean. | Aggregate RR Interval | ||
| RR Interval, Single Measurement | C117792 | RR Interval, Single Measurement | An electrocardiographic measurement of the interval between two consecutive R waves. If R waves are not present, this measurement may utilize the interval between the most easily identified components of the QRS complex within two consecutive beats. | RR Interval Single Measurement | ||
| RS Wave Amplitude, Aggregate | C117793 | RS Wave Amplitude, Aggregate | An aggregate RS wave amplitude value based on measurements from multiple beats from a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean. | RS Wave Amplitude Aggregate | ||
| RS Wave Amplitude, Single Beat | C117794 | RS Wave Amplitude, Single Beat | An electrocardiographic measurement of the sum of the amplitudes of the R and S waves, obtained from a single beat in one particular lead or set of leads. | RS Wave Amplitude Single Beat | ||
| S Wave Amplitude, Aggregate | C117805 | S Wave Amplitude, Aggregate | An aggregate S wave amplitude value based on the measurement of S wave amplitudes from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean. | S Wave Amplitude Aggregate | ||
| S Wave Amplitude, Single Beat | C117806 | S Wave Amplitude, Single Beat | An electrocardiographic measurement of the mean amplitude (usually measured in mV) of the S wave measured from the isoelectric baseline to the peak of the S wave of a single beat utilizing one or more leads. Based on the recording gain, this measurement may also be reported in mm. | S Wave Amplitude Single Beat | ||
| Sinus Node Rhythms and Arrhythmias | C111312 | Sinus Node Rhythms and Arrhythmias | An electrocardiographic assessment of sinus node rhythms and arrhythmias. | Sinus Node Rhythm and Arrhythmia ECG Assessment | ||
| ST Segment Depression, Aggregate | C117797 | ST Segment Depression, Aggregate | An aggregate ST segment depression value based on the measurement of ST segment depression from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean. | ST Segment Depression Aggregate | ||
| ST Segment Depression, Single Beat | C117798 | ST Segment Depression, Single Beat | An electrocardiographic measurement of the mean amplitude (usually measured in mV) of the ST segment depression below the isoelectric baseline measured from the baseline to the ST segment of a single beat utilizing one or more leads. Based on the recording gain, this measurement may also be reported in mm. | ST Segment Depression Single Beat | ||
| ST Segment Deviation, Aggregate | C117799 | ST Segment Deviation, Aggregate | An aggregate ST segment deviation value based on the measurement of ST segment deviation from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean. | ST Segment Deviation Aggregate | ||
| ST Segment Deviation, Single Beat | C117800 | ST Segment Deviation, Single Beat | An electrocardiographic measurement of the mean amplitude (usually measured in mV) of the ST segment deviation above or below the isoelectric baseline measured from the baseline to the ST segment of a single beat utilizing one or more leads. Based on the recording gain, this measurement may also be reported in mm. | ST Segment Deviation Single Beat | ||
| ST Segment Duration, Aggregate | C117803 | ST Segment Duration, Aggregate | An aggregate ST segment duration value based on the measurement of ST segment duration intervals from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean. | ST Segment Duration Aggregate | ||
| ST Segment Duration, Single Beat | C117804 | ST Segment Duration, Single Beat | An electrocardiographic interval measured from the J point to the onset of the T wave of a single beat utilizing one or more leads. | ST Segment Duration Single Beat | ||
| ST Segment Elevation, Aggregate | C117801 | ST Segment Elevation, Aggregate | An aggregate ST segment elevation value based on the measurement of ST segment elevation from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean. | ST Segment Elevation Aggregate | ||
| ST Segment Elevation, Single Beat | C117802 | ST Segment Elevation, Single Beat | An electrocardiographic measurement of the mean amplitude (usually measured in mV) of the ST segment elevation above the isoelectric baseline measured from the baseline to the ST segment of a single beat utilizing one or more leads. Based on the recording gain, this measurement may also be reported in mm. | ST Segment Elevation Single Beat | ||
| ST Segment, T wave, and U wave | C111363 | ST Segment, T wave, and U wave | An electrocardiographic assessment of the characteristics of the ST segment, T wave, and U wave. | ST Segment, T wave, and U wave ECG Assessment | ||
| Summary (Max) JT Interval | C62117 | Summary (Max) JT Interval | The maximum duration (time) of the JT interval, obtained from a set of measurements of the JT interval. The JT interval is defined as the time from the J point (end of ventricular depolarization, the point at which the QRS meets the ST segment) to the end of the T wave (representing the end of ventricular repolarization). (NCI) | Maximum JT Duration | ||
| Summary (Max) PR Duration | C62131 | Summary (Max) PR Duration | The maximum duration (time) of the PR interval, obtained from a set of measurements of the PR interval. The PR interval is defined as the time from the beginning of the P wave (representing the onset of atrial depolarization) to the beginning of the R wave (representing the onset of ventricular depolarization). In some cases, a Q wave will precede the R wave, in which case the PR interval is measured from the beginning of the P wave to the beginning of the Q wave. (NCI) | Maximum PR Duration | ||
| Summary (Max) QT Duration | C62135 | Summary (Max) QT Duration | The maximum duration (time) of the QT interval, obtained from a set of measurements of the QT interval. The QT interval is defined as the time from the beginning of the QRS complex to the end of the T wave, representing the time it takes for the ventricles to depolarize and subsequently repolarize. In some cases, the Q wave will be absent, in which case the QT interval is measured from the beginning of the R wave to the end of the T wave. (NCI) | Maximum QT Duration | ||
| Summary (Max) RR Duration | C62094 | Summary (Max) RR Duration | The maximum duration (time) between successive peaks of R waves in a particular set of RR intervals. (NCI) | Maximum RR Duration | ||
| Summary (Max) ST Depression | C62163 | Summary (Max) ST Depression | The maximum depression (negative deflection from baseline, usually measured in mm) of the ST segment, obtained from a set of measurements of the depression of the ST segment. (NCI) | Maximum ST Segment Depression by ECG Finding | ||
| Summary (Max) ST Deviation | C62157 | Summary (Max) ST Deviation | The maximum deviation (distance from baseline, positive or negative, usually measured in mm) of the ST segment, obtained from a set of measurements of the deviation of the ST segment. (NCI) | Maximum ST Deviation | ||
| Summary (Max) ST Elevation | C62160 | Summary (Max) ST Elevation | The maximum elevation (positive deflection from baseline, usually measured in mm) of the ST segment, obtained from a set of measurements of the elevation of the ST segment. (NCI) | Maximum ST Segment Elevation | ||
| Summary (Mean) JT Interval | C62115 | Summary (Mean) JT Interval | The average (mean) duration (time) of the JT interval, obtained from a set of measurements of the JT interval. The JT interval is defined as the time from the J point (end of ventricular depolarization, the point at which the QRS meets the ST segment) to the end of the T wave (representing the end of ventricular repolarization). (NCI) | Mean JT Duration | ||
| Summary (Mean) P Wave Duration | C62123 | Summary (Mean) P Wave Duration | The average (mean) duration (time) from the onset of atrial depolarization to the completion of atrial depolarization (length of the P wave), obtained from a set of measurements of the time from beginning to end of atrial depolarization. (NCI) | Mean P Wave Duration | ||
| Summary (Mean) P Wave Height | C62124 | Summary (Mean) P Wave Height | The average (mean) height (usually measured in mm) of the maximum deflection from baseline of the P wave (representing atrial depolarization), obtained from a set of measurements of the P wave, from a single lead or set of leads. Typically this measurement is obtained by analysis of Lead II. (NCI) | Mean P Wave Height | ||
| Summary (Mean) PR Duration | C62086 | Summary (Mean) PR Duration | The average (mean) duration (time) of the PR interval, obtained from a set of measurements of the PR interval. The PR interval is defined as the time from the beginning of the P wave (representing the onset of atrial depolarization) to the beginning of the R wave (representing the onset of ventricular depolarization). In some cases, a Q wave will precede the R wave, in which case the PR interval is measured from the beginning of the P wave to the beginning of the Q wave. (NCI) | Mean PR Duration | ||
| Summary (Mean) QRS Duration | C62087 | Summary (Mean) QRS Duration | The average (mean) duration (time) of the QRS interval, obtained from a set of measurements of the QRS interval. The QRS interval is defined as the time from the beginning of the QRS complex to the end of the QRS complex, representing the time it takes for the ventricles to depolarize. (NCI) | Mean QRS Duration | ||
| Summary (Mean) QT Duration | C62089 | Summary (Mean) QT Duration | The average (mean) duration (time) of the QT interval, obtained from a set of measurements of the QT interval. The QT interval is defined as the time from the beginning of the QRS complex to the end of the T wave, representing the time it takes for the ventricles to depolarize and subsequently repolarize. In some cases, the Q wave will be absent, in which case the QT interval is measured from the beginning of the R wave to the end of the T wave. (NCI) | Mean QT Duration | ||
| Summary (Mean) R Wave Amplitude | C62136 | Summary (Mean) R Wave Amplitude | The average (mean) amplitude (usually in mm) of the R wave, obtained from a set of measurements of the R wave, in a particular lead or set of leads. (NCI) | Mean R Wave Amplitude | ||
| Summary (Mean) R+S Amplitude | C62144 | Summary (Mean) R+S Amplitude | The average (mean) amplitude (usually in mm) of the summation of the R and S waves, obtained from a set of measurements of the R and S waves, in a particular lead or set of leads. (NCI) | Mean R+S Amplitude | ||
| Summary (Mean) RR Duration | C62090 | Summary (Mean) RR Duration | The average (mean) duration (time) of the RR interval, obtained from a set of measurements of the RR interval. The RR interval is defined as the time between successive peaks of the R wave and can be used to measure the ventricular rate. (NCI) | Mean RR Duration | ||
| Summary (Mean) S Wave Amplitude | C62137 | Summary (Mean) S Wave Amplitude | The average (mean) amplitude (usually in mm) of the S wave, obtained from a set of measurements of the S wave, in a particular lead or set of leads. (NCI) | Mean S Wave Amplitude | ||
| Summary (Mean) ST Depression | C62161 | Summary (Mean) ST Depression | The average (mean) depression (negative deflection from baseline, usually measured in mm) of the ST segment, obtained from a set of measurements of the depression of the ST segment. (NCI) | Mean ST Segment Depression by ECG Finding | ||
| Summary (Mean) ST Deviation | C62155 | Summary (Mean) ST Deviation | The average (mean) deviation (distance from baseline, positive or negative, usually measured in mm) of the ST segment, obtained from a set of measurements of the deviation of the ST segment. (NCI) | Mean ST Deviation | ||
| Summary (Mean) ST Elevation | C62158 | Summary (Mean) ST Elevation | The average (mean) elevation (positive deflection from baseline, usually measured in mm) of the ST segment, obtained from a set of measurements of the elevation of the ST segment. (NCI) | Mean ST Segment Elevation | ||
| Summary (Mean) ST Segment Duration | C62145 | Summary (Mean) ST Segment Duration | The average (mean) duration (time) of the ST segment, measured from the J point at the end of the QRS complex to the beginning of the T wave. | Mean ST Segment Duration | ||
| Summary (Mean) T Wave Area | C62148 | Summary (Mean) T Wave Area | The average (mean) area under the curve of the deflection from baseline of the T wave (representing ventricular repolarization), obtained from a set of measurements of the T wave, from a single lead or set of leads. (NCI) | Mean T Wave Area | ||
| Summary (Mean) T Wave Duration | C62147 | Summary (Mean) T Wave Duration | The average (mean) duration (time) from the onset of ventricular repolarization to the completion of ventricular repolarization (length of the T wave), obtained from a set of measurements of the time from beginning to end of ventricular repolarization. (NCI) | Mean T Wave Duration | ||
| Summary (Mean) T Wave Height | C62149 | Summary (Mean) T Wave Height | The average (mean) height (usually measured in mm) of the maximum deflection from baseline of the T wave (representing ventricular repolarization), obtained from a set of measurements of the T wave, from a single lead or set of leads. (NCI) | Mean T Wave Height | ||
| Summary (Median) Heart Rate | C102249 | Summary (Median) Heart Rate | The median number of cycles of contraction and subsequent relaxation of the heart, usually expressed as beats per minute, obtained from a set of measurements of the heart rate. | Median Heart Rate | ||
| Summary (Median) PR Duration | C102250 | Summary (Median) PR Duration | The median duration (time) of the PR interval, obtained from a set of measurements of the PR interval. The PR interval is defined as the time from the beginning of the P wave (representing the onset of atrial depolarization) to the beginning of the R wave (representing the onset of ventricular depolarization). In some cases, a Q wave will precede the R wave, in which case the PR interval is measured from the beginning of the P wave to the beginning of the Q wave. | Median PR Duration | ||
| Summary (Median) QRS Duration | C102251 | Summary (Median) QRS Duration | The median duration (time) of the QRS interval, obtained from a set of measurements of the QRS interval. The QRS interval is defined as the time from the beginning of the QRS complex to the end of the QRS complex, representing the time it takes for the ventricles to depolarize. | Median QRS Duration | ||
| Summary (Median) QT Duration | C102252 | Summary (Median) QT Duration | The median duration (time) of the QT interval, obtained from a set of measurements of the QT interval. The QT interval is defined as the time from the beginning of the QRS complex to the end of the T wave, representing the time it takes for the ventricles to depolarize and subsequently repolarize. In some cases, the Q wave will be absent, in which case the QT interval is measured from the beginning of the R wave to the end of the T wave. | Median QT Duration | ||
| Summary (Median) QTcF | C102253 | Summary (Median) QTcF | The median duration (time) of the QTc interval, obtained from a set of measurements of the QT interval and corrected using the Fridericia's correction Formula. | Median QTcF | ||
| Summary (Median) RR Duration | C102254 | Summary (Median) RR Duration | The median duration (time) of the RR interval, obtained from a set of measurements of the RR interval. The RR interval is defined as the time between successive peaks of the R wave and can be used to measure the ventricular rate. | Median RR Duration | ||
| Summary (Min) JT Interval | C62116 | Summary (Min) JT Interval | The minimum duration (time) of the JT interval, obtained from a set of measurements of the JT interval. The JT interval is defined as the time from the J point (end of ventricular depolarization, the point at which the QRS meets the ST segment) to the end of the T wave (representing the end of ventricular repolarization). (NCI) | Minimum JT Duration | ||
| Summary (Min) PR Duration | C62125 | Summary (Min) PR Duration | The minimum duration (time) of the PR interval, obtained from a set of measurements of the PR interval. The PR interval is defined as the time from the beginning of the P wave (representing the onset of atrial depolarization) to the beginning of the R wave (representing the onset of ventricular depolarization). In some cases, a Q wave will precede the R wave, in which case the PR interval is measured from the beginning of the P wave to the beginning of the Q wave. (NCI) | Minimum PR Duration | ||
| Summary (Min) QT Duration | C62133 | Summary (Min) QT Duration | The minimum duration (time) of the QT interval, obtained from a set of measurements of the QT interval. The QT interval is defined as the time from the beginning of the QRS complex to the end of the T wave, representing the time it takes for the ventricles to depolarize and subsequently repolarize. In some cases, the Q wave will be absent, in which case the QT interval is measured from the beginning of the R wave to the end of the T wave. (NCI) | Minimum QT Duration | ||
| Summary (Min) RR Duration | C62093 | Summary (Min) RR Duration | The minimum duration (time) between successive peaks of R waves in a particular set of RR intervals. (NCI) | Minimum RR Duration | ||
| Summary (Min) ST Depression | C62162 | Summary (Min) ST Depression | The minimum depression (negative deflection from baseline, usually measured in mm) of the ST segment, obtained from a set of measurements of the depression of the ST segment. (NCI) | Minimum ST Segment Depression by ECG Finding | ||
| Summary (Min) ST Deviation | C62156 | Summary (Min) ST Deviation | The minimum deviation (distance from baseline, positive or negative, usually measured in mm) of the ST segment, obtained from a set of measurements of the deviation of the ST segment. (NCI) | Minimum ST Deviation | ||
| Summary (Min) ST Elevation | C62159 | Summary (Min) ST Elevation | The minimum elevation (positive deflection from baseline, usually measured in mm) of the ST segment, obtained from a set of measurements of the elevation of the ST segment. (NCI) | Minimum ST Segment Elevation | ||
| Supraventricular Arrhythmias | C111320 | Supraventricular Arrhythmias | An electrocardiographic assessment of supraventricular arrhythmias excluding tachycardias. | Supraventricular Arrhythmia ECG Assessment | ||
| Supraventricular Tachyarrhythmias | C111321 | Supraventricular Tachyarrhythmias | An electrocardiographic assessment of supraventricular tachyarrhythmias. | Supraventricular Tachyarrhythmia ECG Assessment | ||
| T Wave Amplitude, Aggregate | C117814 | T Wave Amplitude, Aggregate | An aggregate T wave amplitude value based on the measurement of T wave amplitudes from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean. | T Wave Amplitude Aggregate | ||
| T Wave Amplitude, Single Beat | C117815 | T Wave Amplitude, Single Beat | An electrocardiographic measurement of the mean amplitude (usually measured in mV) of the T wave measured from the isoelectric baseline to the peak of the T wave of a single beat utilizing one or more leads. Based on the recording gain, this measurement may also be reported in mm. | T Wave Amplitude Single Beat | ||
| T Wave Area, Aggregate | C117810 | T Wave Area, Aggregate | An aggregate T wave area value based on the measurement of T wave areas from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean. | T Wave Area Aggregate | ||
| T Wave Area, Single Beat | C117811 | T Wave Area, Single Beat | An electrocardiographic measurement of the area of the T wave of a single beat utilizing one or more leads. | T Wave Area Single Beat | ||
| T Wave Axis | C118166 | T Wave Axis | A numerical representation of the electrocardiographic vector assessed at maximum deviation of the T wave from the isoelectric baseline, usually reported for the frontal plane. | T Wave Axis | ||
| T Wave Duration, Aggregate | C117812 | T Wave Duration, Aggregate | An aggregate T wave duration value based on the measurement of T wave duration intervals from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean. | T Wave Duration Aggregate | ||
| T Wave Duration, Single Beat | C117813 | T Wave Duration, Single Beat | An electrocardiographic interval measured from the onset of the T wave to the offset of the T wave of a single beat utilizing one or more leads. | T Wave Duration Single Beat | ||
| Technical Quality | C117807 | Technical Quality | A statement about an electrocardiographic recording describing technical issues or interference during the recording, processing, or transmission of the data. This does not represent an electrocardiographic diagnosis. | ECG Technical Quality | ||
| Tpeak-Tend Interval, Aggregate | C117808 | Tpeak-Tend Interval, Aggregate | An aggregate Tpeak-Tend value based on the measurement of Tpeak-Tend from multiple beats within a single ECG. The method of aggregation, which can vary, is typically a measure of central tendency such as the mean. | T Peak-T End Interval Aggregate | ||
| Tpeak-Tend Interval, Single Beat | C117809 | Tpeak-Tend Interval, Single Beat | An electrocardiographic interval measured from the peak of the T wave to the offset of the T wave of a single beat utilizing one or more leads. | T Peak-T End Interval Single Beat | ||
| Ventricular Arrhythmias | C111330 | Ventricular Arrhythmias | An electrocardiographic assessment of ventricular arrhythmias excluding tachycardias. | Ventricular Arrhythmia ECG Assessment | ||
| Ventricular Tachyarrhythmias | C111331 | Ventricular Tachyarrhythmias | An electrocardiographic assessment of supraventricular tachyarrhythmias. | Ventricular Tachyarrhythmia ECG Assessment | ||
| Back to top | ||||||
| CL.C111108.EMPSTAT | Employment Status (EMPSTAT) | text Extensible: Yes | C111108 | Employment Status | Terminology relevant to the state of being engaged in an activity or service for wages or salary. | CDISC SDTM Employment Status Terminology |
| FULL-TIME | C52658 | Employment involving the standard or customary working time. | Full Time Employment | |||
| NOT EMPLOYED | C75563 | The state of not having a job. | Unemployment | |||
| PART-TIME | C75562 | Employment involving less than the standard or customary working time. | Part Time Employment | |||
| Back to top | ||||||
| CL.C99079.EPOCH | Epoch (EPOCH) | text Extensible: Yes | C99079 | Epoch | The name of the EPOCH. | CDISC SDTM Epoch Terminology |
| BLINDED TREATMENT | C102255 | A period in a clinical study during which subjects receive blinded therapeutic treatment. | Blinded Treatment Epoch | |||
| FOLLOW-UP | C99158 | A period in a clinical study during which information about the health status of an individual is obtained after study procedures and treatments have concluded. | Clinical Study Follow-up | |||
| LONG-TERM FOLLOW-UP | C16032 | A period in a clinical study during which information about the health status of an individual is obtained long after study procedures and treatments have concluded. | Long-term Follow-up | |||
| OPEN LABEL TREATMENT | C102256 | A period in a clinical study during which subjects receive open label therapeutic treatment. | Open Label Treatment Epoch | |||
| RUN-IN | C98779 | A period in a clinical study that occurs before the commencement of the primary clinical study investigation, during which subjects may be assessed for suitability in the clinical study, withdrawn from existing therapy, trained in study methodology or evaluated for any other protocol-specified reason. | Run-in Period | |||
| SCREENING | C48262 | A period in a clinical study during which subjects are evaluated for participation in the study. | Trial Screening | |||
| TREATMENT | C101526 | A period in a clinical study during which subjects receive therapeutic treatment. | Treatment Epoch | |||
| WASHOUT | C42872 | A period of time during a clinical study when a participant is taken off of a study drug or other medication in order to eliminate the effects of the treatment. | Washout Period | |||
| Back to top | ||||||
| CL.C66790.ETHNIC | Ethnic Group (ETHNIC) | text Extensible: No | C66790 | Ethnic Group | A social group characterized by a distinctive social and cultural tradition maintained from generation to generation, a common history and origin and a sense of identification with the group; members of the group have distinctive features in their way of life, shared experiences and often a common genetic heritage; these features may be reflected in their experience of health and disease. (NCI) | CDISC SDTM Ethnic Group Terminology |
| HISPANIC OR LATINO | C17459 | A person of Mexican, Puerto Rican, Cuban, Central or South American or other Spanish culture or origin, regardless of race. (NCI) | Hispanic or Latino | |||
| NOT HISPANIC OR LATINO | C41222 | A person not of Cuban, Mexican, Puerto Rican, South or Central American, or other Spanish culture or origin, regardless of race. An arbitrary ethnic classification. (NCI) | Not Hispanic or Latino | |||
| NOT REPORTED | C43234 | Not reported | Not provided or available. | Not Stated | ||
| UNKNOWN | C17998 | U;Unknown | Not known, not observed, not recorded, or refused. (NCI) | Unknown | ||
| Back to top | ||||||
| CL.C78735.EVAL | Evaluator (EVAL) | text Extensible: Yes | C78735 | Evaluator | The role that the individual or entity plays with respect to a specific situation or person. | CDISC SDTM Evaluator Terminology |
| ADJUDICATION COMMITTEE | C78726 | An external committee whose purpose is to evaluate study data and decide whether a study endpoint or other criterion has been met. (NCI) | Adjudication Committee | |||
| CAREGIVER | C17445 | Caregiver | The primary person in charge of the care of a patient, usually a family member or a designated health care professional. (NCI) | Caregiver | ||
| CHILD | C42708 | A son or a daughter. | Offspring | |||
| CLINICAL RESEARCH ASSOCIATE | C25465 | Research Associate | A person who is employed by a study sponsor or by a contract research organization (CRO), operates independently from the clinical study site and functions as a monitor, and/or auditor, and/or a project director within a particular trial or institution. (NCI) | Clinical Research Associate | ||
| CLINICAL RESEARCH COORDINATOR | C51811 | A person to whom a clinical investigator delegates routine administrative requirements of a protocol. The duties and responsibilities of a clinical research coordinator may vary across different infrastructures. Generally, the coordinator manages the subject's clinical trial participation and provides a vital linkage between the subject, the investigator, and the sponsor. (NCI) | Clinical Coordinator | |||
| CLINICAL STUDY SPONSOR | C70793 | Clinical Study Sponsor;Sponsor;Study Sponsor | An entity that is responsible for the initiation, management, and/or financing of a clinical study. | Clinical Study Sponsor | ||
| DOMESTIC PARTNER | C53262 | Domestic Partner | Person declares that a domestic partnership relationship exists. (HL7) | Domestic Partnership | ||
| FRIEND | C72884 | A person whom an individual knows, likes, and trusts. (NCI) | Friend | |||
| GUARDIAN | C51828 | An individual who is authorized under applicable State or local law to consent on behalf of a child or incapable person to general medical care including participation in clinical research. (NCI) | Guardian | |||
| HEALTH CARE PROFESSIONAL | C53287 | A person qualified to be engaged in activity directed at preservation of mental and physical health by diseases prevention and treatment as a source of livelihood. (NCI) | Health Care Professional | |||
| INDEPENDENT ASSESSOR | C78720 | An individual qualified to perform an evaluation who is masked from a subject's data in order to minimize bias or maximize consistency and quality. (NCI) | Independent Rater | |||
| INTERVIEWER | C63759 | The person who manages an interview and asks the questions. | Interviewer | |||
| INVESTIGATOR | C25936 | A person responsible for the conduct of the clinical trial at a trial site. If a trial is conducted by a team of individuals at the trial site, the investigator is the responsible leader of the team and may be called the principle investigator. | Investigator | |||
| PARENT | C42709 | A mother or a father. | Parent | |||
| PROXY | C119264 | A type of directive that gives a person the authority to make decisions for or provide responses on behalf of another individual. | Proxy | |||
| SIGNIFICANT OTHER | C119265 | A gender-neutral term for a person's partner in an intimate or romantic relationship without disclosing or presuming marital status or sexual orientation. | Significant Other | |||
| SPOUSE | C62649 | Spouse | A person's partner in marriage. (NCI) | Spouse | ||
| STUDY SUBJECT | C41189 | An individual who is observed, analyzed, examined, investigated, experimented upon, or/and treated in the course of a particular study. | Study Subject | |||
| VENDOR | C68608 | A person or agency that promotes or exchanges goods or services for money. (NCI) | Vendor | |||
| Back to top | ||||||
| CL.C101832.FATESTCD | Findings About Test Code (FATESTCD) | text Extensible: Yes | C101832 | Findings About Test Code | Terminology relevant to the test codes that describe findings about an event or intervention. | CDISC SDTM Findings About Test Code Terminology |
| DRSTAT | C102626 | Drug Resistance Status | The state or condition of not responding to a pharmacological agent. | Drug Resistance Status | ||
| Back to top | ||||||
| CL.C101833.FATEST | Findings About Test Name (FATEST) | text Extensible: Yes | C101833 | Findings About Test Name | Terminology relevant to the test names that describe findings about an event or intervention. | CDISC SDTM Findings About Test Name Terminology |
| Drug Resistance Status | C102626 | Drug Resistance Status | The state or condition of not responding to a pharmacological agent. | Drug Resistance Status | ||
| Back to top | ||||||
| CL.C71113.FREQ | Frequency (FREQ) | text Extensible: Yes | C71113 | Frequency | The terminology that includes terms pertaining to frequency within CDISC. | CDISC SDTM Frequency Terminology |
| 1 TIME PER WEEK | C64526 | One Time Per Week | One time per week. (NCI) | Once Weekly | ||
| 2 TIMES PER WEEK | C64497 | BIS;Twice per week | Two times per week. (NCI) | Twice Weekly | ||
| 2 TIMES PER YEAR | C98861 | 2 Times Per Year | Two times per year. (NCI) | Two Times Yearly | ||
| 3 TIMES PER MONTH | C98859 | 3 Times Per Month | Three times per month. (NCI) | Three Times Monthly | ||
| 3 TIMES PER WEEK | C64528 | TIS;Three times a week | Three times per week. (NCI) | Three Times Weekly | ||
| 3 TIMES PER YEAR | C98860 | 3 Times Per Year | Three times per year. (NCI) | Three Times Yearly | ||
| 4 TIMES PER MONTH | C98852 | 4 Times Per Month | Four times per month. (NCI) | Four Times Monthly | ||
| 4 TIMES PER WEEK | C64531 | 4 times per week;QIS | Four times per week. (NCI) | Four Times Weekly | ||
| 4 TIMES PER YEAR | C98853 | 4 Times Per Year | Four times per year. (NCI) | Four Times Yearly | ||
| 5 TIMES PER DAY | C98849 | 5 Times Daily | Five times per day. (NCI) | Five Times Daily | ||
| 5 TIMES PER MONTH | C98850 | 5 Times Per Month | Five times per month. (NCI) | Five Times Monthly | ||
| 5 TIMES PER WEEK | C85552 | 5 Times Per Week | Five times per week. (NCI) | Five Times Weekly | ||
| 5 TIMES PER YEAR | C98851 | 5 Times Per Year | Five times per year. (NCI) | Five Times Yearly | ||
| 6 TIMES PER DAY | C98855 | 6 Times Daily | Six times per day. (NCI) | Six Times Daily | ||
| 6 TIMES PER MONTH | C98856 | 6 Times Per Month | Six times per month. (NCI) | Six Times Monthly | ||
| 6 TIMES PER WEEK | C98857 | 6 Times Per Week | Six times per week. (NCI) | Six Times Weekly | ||
| 6 TIMES PER YEAR | C98858 | 6 Times Per Year | Six times per year. (NCI) | Six Times Yearly | ||
| 7 TIMES PER WEEK | C98854 | 7 Times Per Week | Seven times per week. (NCI) | Seven Times Weekly | ||
| AD LIBITUM | C64636 | Ad Libitum | As much as desired. | As Much as Desired | ||
| BID | C64496 | BD;Twice per day | Two times per day, at unspecified times. (NCI) | Twice Daily | ||
| BIM | C71129 | Twice per month | Twice per month. (NCI) | Twice Per Month | ||
| CONTINUOUS | C53279 | Continuous | Remain in force or carry on without letup; keep or maintain in unaltered condition; exist in time or space without stop or interruption. (NCI) | Continue | ||
| EVERY 2 WEEKS | C71127 | Every 2 weeks;Q2S | Every two weeks. (NCI) | Every Two Weeks | ||
| EVERY 3 WEEKS | C64535 | Every 3 weeks;Q3S | Every three weeks. (NCI) | Every Three Weeks | ||
| EVERY 4 WEEKS | C64529 | Every 4 weeks;Q4S | Every four weeks. (NCI) | Every Four Weeks | ||
| EVERY 5 WEEKS | C103390 | Every 5 weeks;Q5S | Every five weeks. (NCI) | Every Five Weeks | ||
| EVERY 6 WEEKS | C89788 | Every 6 Weeks;Q6S | Every six weeks. (NCI) | Every Six Weeks | ||
| EVERY 7 WEEKS | C116149 | Every 7 weeks;Q7S | Every seven weeks. | Every Seven Weeks | ||
| EVERY 8 WEEKS | C103389 | Every 8 weeks;Q8S | Every eight weeks. (NCI) | Every Eight Weeks | ||
| EVERY WEEK | C67069 | Every week;Per Week;QS | Every week. (NCI) | Weekly | ||
| INTERMITTENT | C71325 | Intermittent | Periodically stopping and starting. (NCI) | Intermittent | ||
| OCCASIONAL | C64954 | Occasional | Not occurring regularly or at short intervals. | Infrequent | ||
| ONCE | C64576 | Once | A one time intervention. (NCI) | Once | ||
| PA | C74924 | /Year;Every Year;Per Annum;Per Year | A frequency rate of occurrences of something within a period of time equal to three hundred sixty-five days. | Per Year | ||
| PRN | C64499 | As needed | As needed. (NCI) | As Necessary | ||
| Q10H | C64500 | Every 10 hours | Every ten hours. (NCI) | Every Ten Hours | ||
| Q11H | C64501 | Every 11 hours | Every eleven hours. (NCI) | Every Eleven Hours | ||
| Q12H | C64502 | Every 12 hours | Every twelve hours. (NCI) | Every Twelve Hours | ||
| Q13H | C64503 | Every 13 hours | Every thirteen hours. (NCI) | Every Thirteen Hours | ||
| Q14H | C64504 | Every 14 hours | Every fourteen hours. (NCI) | Every Fourteen Hours | ||
| Q15H | C64505 | Every 15 hours | Every fifteen hours. (NCI) | Every Fifteen Hours | ||
| Q16H | C64506 | Every 16 hours | Every sixteen hours. (NCI) | Every Sixteen Hours | ||
| Q17H | C64507 | Every 17 hours | Every seventeen hours. (NCI) | Every Seventeen Hours | ||
| Q18H | C64508 | Every 18 hours | Every eighteen hours. (NCI) | Every Eighteen Hours | ||
| Q19H | C64509 | Every 19 hours | Every nineteen hours. (NCI) | Every Nineteen Hours | ||
| Q20H | C64511 | Every 20 hours | Every twenty hours. (NCI) | Every Twenty Hours | ||
| Q21H | C64512 | Every 21 hours | Every twenty-one hours. (NCI) | Every Twenty-One Hours | ||
| Q22H | C64513 | Every 22 hours | Every twenty-two hours. (NCI) | Every Twenty-Two Hours | ||
| Q23H | C64514 | Every 23 hours | Every twenty-three hours. (NCI) | Every Twenty-Three Hours | ||
| Q24H | C64515 | Every 24 hours | Every twenty-four hours. (NCI) | Every Twenty-Four Hours | ||
| Q2H | C64516 | Every 2 hours | Every two hours. (NCI) | Every Two Hours | ||
| Q2M | C64536 | Every two months | Every two months. (NCI) | Every Two Months | ||
| Q3D | C64533 | Every 3 days | Every three days. (NCI) | Every Three Days | ||
| Q3H | C64517 | Every 3 hours | Every three hours. (NCI) | Every Three Hours | ||
| Q3M | C64537 | Every 3 months | Every three months. (NCI) | Every Three Months | ||
| Q4D | C64534 | Every 4 days | Every four days. (NCI) | Every Four Days | ||
| Q4H | C64518 | Every 4 hours | Every four hours. (NCI) | Every Four Hours | ||
| Q4M | C64538 | Every 4 months | Every four months. (NCI) | Every Four Months | ||
| Q5D | C71124 | Every 5 days | Every five days. (NCI) | Every Five Days | ||
| Q5H | C64519 | Every 5 hours | Every five hours. (NCI) | Every Five Hours | ||
| Q6H | C64520 | Every 6 hours | Every six hours. (NCI) | Every Six Hours | ||
| Q6M | C89789 | Every 6 Months | Every six months. (NCI) | Every Six Months | ||
| Q7H | C64521 | Every 7 hours | Every seven hours. (NCI) | Every Seven Hours | ||
| Q8H | C64523 | Every 8 hours | Every eight hours. (NCI) | Every Eight Hours | ||
| Q9H | C64524 | Every 9 hours | Every nine hours. (NCI) | Every Nine Hours | ||
| QD | C25473 | Daily;Per Day | Occurring or done each day. (NCI) | Daily | ||
| QH | C64510 | Every hour | Every hour. (NCI) | Every Hour | ||
| QID | C64530 | 4 times per day | Four times per day. (NCI) | Four Times Daily | ||
| QM | C64498 | Every Month;Per Month | Every month. (NCI) | Monthly | ||
| QOD | C64525 | Every other day | Every other day. (NCI) | Every Other Day | ||
| TID | C64527 | 3 times per day | Three times per day. (NCI) | Three Times Daily | ||
| UNKNOWN | C17998 | U;Unknown | Not known, not observed, not recorded, or refused. (NCI) | Unknown | ||
| Back to top | ||||||
| CL.C103329.GNRLOBSC | General Observation Class (GNRLOBSC) | text Extensible: No | C103329 | General Observation Class | Terminology related to the classification of a CDISC domain. | CDISC SDTM General Observation Class Terminology |
| ADAM OTHER | C103375 | An ADaM analysis dataset that doesn't conform to the ADSL or BDS structure. | CDISC Other ADaM Dataset | |||
| BASIC DATA STRUCTURE | C103371 | BDS | An ADaM BDS dataset contains one or more records per subject, per analysis parameter, per analysis time point. Variables include the value being analyzed (e.g., AVAL) and the description of the value being analyzed (e.g., PARAM). Other variables in the dataset provide more information about the value being analyzed (e.g., the subject identification) or describe and trace the derivation of it (e.g., DTYPE) or support the analysis of it (e.g., treatment variables, covariates). | CDISC Basic Data Structure Dataset | ||
| EVENTS | C103372 | This SDTM class captures planned protocol milestones such as randomization and study completion, and occurrences, conditions, or incidents independent of planned study evaluations occurring during the trial (e.g., adverse events) or prior to the trial (e.g., medical history). | CDISC Events Class | |||
| FINDINGS | C103373 | This SDTM class captures the observations resulting from planned evaluations to address specific tests or questions such as laboratory tests, ECG testing, and questions listed on questionnaires. | CDISC Findings Class | |||
| INTERVENTIONS | C103374 | This SDTM class captures investigational, therapeutic and other treatments that are administered to the subject (with some actual or expected physiological effect) either as specified by the study protocol (e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), or self-administered by the subject (such as use of alcohol, tobacco, or caffeine). | CDISC Interventions Class | |||
| RELATIONSHIP | C103376 | This SDTM class provides a means to link related records between datasets. It includes the RELREC and SUPPQUAL datasets. | CDISC Relationship Class | |||
| SPECIAL PURPOSE | C103377 | This SDTM class contains a set of domains which do not conform to the Findings, Events or Interventions observation classes. The domains included are DM, CO, SE and SV. | CDISC Special Purpose Class | |||
| SUBJECT LEVEL ANALYSIS DATASET | C103378 | ADSL | The Subject-Level Analysis Dataset (ADSL) is a one-record-per-subject dataset which contains variables that describe subject demographic characteristics and group the subjects for analysis. ADSL is the primary source for subject-level variables included in other analysis datasets such as population flags and treatment variables. | CDISC Subject Level Analysis Dataset | ||
| TRIAL DESIGN | C103379 | This SDTM class describes the plan for the procedures to be followed in a clinical trial, including planned and actual timing of events, control group, method of allocating treatments, blinding methods, assignment of epochs that subjects pass through in the course of a trial. | CDISC Trial Design Class | |||
| Back to top | ||||||
| CL.C111114.GENSMP | Genetic Sample Type (GENSMP) | text Extensible: Yes | C111114 | Genetic Sample Type | Terminology relevant to the type of nucleic acid which was derived from the collected sample. | CDISC Genetic Sample Type Terminology |
| 7SK RNA | C95951 | 7SK Small Nuclear RNA;7SK snRNA | 7SK small nuclear RNA is encoded by the human RN7SK gene. This oligoribonucleotide may play a role in the regulation of the enzymatic activity of RNA polymerase II. | 7SK Small Nuclear RNA | ||
| cDNA | C324 | Complementary DNA | Single-stranded DNA that is complementary to messenger RNA or DNA that has been synthesized from messenger RNA by reverse transcriptase. | cDNA | ||
| cpDNA | C111158 | Chloroplast DNA | The DNA that is located in the photosynthetic, chlorophyll-containing organelle in the cells of young leaves and stems of higher plants. (NCI) | Chloroplast DNA | ||
| DNA | C449 | Deoxyribonucleic Acid;Double-stranded DNA;dsDNA | A long linear double-stranded polymer formed from nucleotides attached to a deoxyribose backbone; associated with the transmission of genetic information. | DNA | ||
| dsRNA | C95938 | Double-stranded RNA | An RNA complex consisting of two base-paired strands of complementary RNA. | Double-Stranded RNA | ||
| gDNA | C95940 | Genomic DNA | The DNA that is part of the normal chromosomal complement of an organism. | Genomic DNA | ||
| gRNA | C95952 | Guide RNA | A small RNA involved in post-transcriptional mitochondrial RNA modification (RNA editing) in kinetoplastids. | Guide RNA | ||
| hnRNA | C28454 | Heterogeneous Nuclear RNA | A diverse assortment of nascent, immature, unprocessed RNA transcripts synthesized from DNA templates that are found in eukaryotic nuclei before post-transcriptional modifications. | hnRNA | ||
| miRNA | C25966 | MicroRNA | A sequence of single-stranded RNA which is typically 20-25 nucleotides in length and may regulate the expression of other genes. miRNAs are transcribed from DNA, but are not translated into proteins. | MicroRNA | ||
| mRNA | C813 | Messenger RNA | A class of RNA molecule containing protein-coding information in its nucleotide sequence that can be translated into the amino acid sequence of a protein. | Messenger RNA | ||
| msDNA | C111279 | Multicopy Single-stranded DNA | A DNA/RNA chimera comprised of a single-stranded DNA molecule covalently bound to an internal guanosine of a RNA molecule. (NCI) | Multicopy Single-stranded DNA | ||
| msdRNA | C111278 | MSR | The RNA portion of the msDNA molecule, which contains two stem-loop stuctures and varies widely in length across bacterial species. (NCI) | msdRNA | ||
| mtDNA | C28512 | Mitochondrial DNA;mDNA | Typically small, circular, intronless, and maternally inherited, mitochondrial DNA (mtDNA) is the multicopy deoxyribonucleic acid genome of mitochondria, intracellular organelles responsible for vital respiratory chain and oxidative phosphorylation reactions in higher eukaryotes. Replicated and transcribed by a separate enzymatic machinery from that of nuclear DNA, mtDNA encodes only a subset of mitochondrial functions. | Mitochondrial DNA | ||
| nDNA | C95941 | Nuclear DNA | The DNA that is normally located in the nucleus of a eukaryotic cell. | Nuclear DNA | ||
| pDNA | C754 | Plasmid;Plasmid DNA | A small cellular inclusion consisting of a ring of DNA that is not in a chromosome but is capable of autonomous replication. | Plasmid | ||
| piRNA | C95953 | Piwi-Interacting RNA | Single-stranded RNA molecules that are expressed in animal cells and form complexes with Piwi proteins. They are involved in transcriptional gene silencing. | Piwi-Interacting RNA | ||
| pre-mRNA | C111298 | Precursor mRNA | A primary RNA transcript synthesized from a DNA template in eukaryotic nuclei which is post-transcriptionally modified and spliced to produce a mature mRNA. (NCI) | Precursor mRNA | ||
| pri-miRNA | C25967 | Pri-MIR;Pri-miRNA;Pri-microRNA;Primary MicroRNA | The pri-miRNA is a primary transcript derived from a gene whose sole products are miRNA(s). A unique pathway involving the nuclear microprocessor complex participates in the cleavage of such transcripts, which can be substantially longer than the 65-110 nt pre-miRNA. | Pri-miRNA | ||
| rDNA | C95943 | Ribosomal DNA;Ribosomal RNA Genes | The genomic sequences that code for ribosomal RNA molecules. | Ribosomal RNA Gene | ||
| RIBOZYME | C1292 | Catalytic RNA;Ribonucleic Enzyme | RNA that contains an intron sequence which has an enzyme-like catalytic activity. This intron sequence can function like an enzyme in reactions with other RNA molecules and thus synthesize new molecules even in the absence of protein. | Ribozyme | ||
| RNA | C812 | Ribonucleic Acid | Single-stranded long chain of nucleotides containing ribose. It is the end product of DNA transcription by the enzyme RNA polymerase. It is essential in protein synthesis. | Ribonucleic Acid | ||
| rRNA | C814 | Ribosomal RNA | An RNA molecule that does not contain protein-coding sequence information and constitutes the majority of the cellular RNA (~80%). This nucleic acid associates with multiple proteins to form ribosomes, which are the organelles that drive mRNA-directed protein synthesis. | Ribosomal RNA | ||
| siRNA | C2191 | Small Interfering RNA | A 20 to 25-nucleotide double-stranded RNA which is involved in a sequence-specific messenger RNA degradation process known as RNA interference. | Small Interfering RNA | ||
| snoRNA | C111316 | Small Nucleolar RNA | Small RNA molecules that are present in the nucleolus. They associate with proteins to form small nucleolar ribonucleoprotein particles that are involved in modification of other RNAs. (NCI) | Small Nucleolar RNA | ||
| snRNA | C815 | Small Nuclear RNA;Small Nuclear Ribonucleic Acid;U-RNA | A small RNA molecule (100-300 nucleotides) located in the cell nucleus. This nucleic acid plays a role in RNA splicing, transcriptional regulation, telomere maintenance and rRNA modification. | Small Nuclear RNA | ||
| SRP RNA | C95950 | 7SL RNA;SRP RNA;Signal Recognition Particle RNA;srpRNA | A non-coding RNA that is part of the signal recognition particle. It is involved in the co-translational targeting of proteins to membranes. | Signal Recognition Particle RNA | ||
| ssDNA | C111311 | Single-stranded DNA | A long linear single-stranded polymer formed from nucleotides attached to a deoxyribose backbone. (NCI) | Single-stranded DNA | ||
| tmRNA | C95954 | 10Sa RNA;SsrA;Transfer-Messenger RNA | An RNA encoded by the bacterial ssrA gene. It is involved in the recycling of stalled ribosomes and the targeting of both defective mRNA molecules and incomplete nascent proteins for degradation. | Transfer-Messenger RNA | ||
| TRANSPOSON | C95942 | Jumping Gene;Jumping Genes;Transposable Element | A class of mobile genetic elements that can move from one genomic position to another. | Transposon | ||
| tRNA | C816 | Transfer RNA;Triplet Codon-Amino Acid Adaptor | A class of short adaptor RNAs that transfers a specific amino acid to a growing polypeptide chain at the ribosomal site of protein synthesis during translation. Each transfer RNA comprises a three-nucleotide sequence that is complementary to the triplet nucleotide coding sequence of an mRNA, conferring specificity to the amino acid being incorporated into the assembling protein. | Transfer RNA | ||
| Back to top | ||||||
| CL.C117737.GRAFTTYP | Graft Type (GRAFTTYP) | text Extensible: Yes | C117737 | Graft Type | A terminology codelist relevant to the type of graft implanted in the subject. | CDISC SDTM Graft Type Terminology |
| ARTERIAL GRAFT, FREE | C117816 | A vessel graft comprised of an artery that has been completely detached from its original location. (NCI) | Free Arterial Graft | |||
| ARTERIAL GRAFT, IN-SITU | C117817 | A vessel graft comprised of an artery whose origin remains intact. | In Situ Arterial Graft | |||
| AUTOLOGOUS VEIN GRAFT | C117818 | A vessel graft comprised of a vein harvested from a different anatomical location. | Autologous Vein Graft | |||
| CADAVERIC GRAFT, ARTERIAL | C117819 | An arterial graft harvested from a cadaver. (NCI) | Cadaveric Arterial Graft | |||
| CADAVERIC GRAFT, VENOUS | C117820 | A venous graft harvested from a cadaver. (NCI) | Cadaveric Venous Graft | |||
| COMPOSITE GRAFT | C117821 | A vessel graft comprised of two or more conduit materials. | Composite Vessel Graft | |||
| SAPHENOUS VEIN GRAFT | C117822 | SVG | A vessel graft comprised of the saphenous vein. | Saphenous Vein Graft | ||
| SYNTHETIC GRAFT | C117823 | A vessel graft comprised of non-biological material. | Synthetic Vessel Graft | |||
| Back to top | ||||||
| CL.C117739.HEFATSCD | Hepatic Findings About Test Code (HEFATSCD) | text Extensible: Yes | C117739 | Hepatic Findings About Test Code | Terminology relevant to the test codes that describe hepatic findings. | CDISC SDTM Hepatic Findings About Test Code Terminology |
| WHHEGR | C117747 | West Haven Hepatic Encephalopathy Grade | A grading system to describe the severity of hepatic encephalopathy based on the level of mental status, per the West Haven Criteria. (NCI) | West Haven Hepatic Encephalopathy Grade | ||
| Back to top | ||||||
| CL.C117738.HEFATS | Hepatic Findings About Test Name (HEFATS) | text Extensible: Yes | C117738 | Hepatic Findings About Test Name | Terminology relevant to the test names that describe hepatic findings. | CDISC SDTM Hepatic Findings About Test Name Terminology |
| West Haven Hepatic Encephalopathy Grade | C117747 | West Haven Hepatic Encephalopathy Grade | A grading system to describe the severity of hepatic encephalopathy based on the level of mental status, per the West Haven Criteria. (NCI) | West Haven Hepatic Encephalopathy Grade | ||
| Back to top | ||||||
| CL.C99076.INTMODEL | Intervention Model (INTMODEL) | text Extensible: Yes | C99076 | Intervention Model | The trial design developed to compare treatment groups. | CDISC SDTM Intervention Model Terminology |
| CROSS-OVER | C82637 | Participants receive one of two or more alternative intervention(s) during the initial epoch of the study and receive other intervention(s) during the subsequent epoch(s) of the study. | Crossover Study | |||
| FACTORIAL | C82638 | Two or more interventions, each alone and in combination, are evaluated in parallel against a control group. | Factorial Study | |||
| PARALLEL | C82639 | Participants are assigned to one of two or more arms in parallel for the duration of the study. | Parallel Study | |||
| SINGLE GROUP | C82640 | Single arm study. | Single Group Study | |||
| Back to top | ||||||
| CL.C99078.INTTYPE | Intervention Type (INTTYPE) | text Extensible: No | C99078 | Intervention Type | The kind of product or procedure studied in a trial. | CDISC SDTM Intervention Type Terminology |
| BEHAVIORAL THERAPY | C15184 | A technique used to change subjects' behavior, for example, psychotherapy, lifestyle counseling or hypnosis. | Behavioral Intervention | |||
| BIOLOGIC | C307 | A substance made from living organisms or things they produce, for example: virus, therapeutic serum, toxin, antitoxin, vaccine, blood, blood component or derivative, allergenic product, or analogous product. | Biological Agent | |||
| DEVICE | C16830 | An instrument, apparatus, implement, machine, contrivance, implant, in vitro reagent, or other similar or related article, including any component, part, or accessory, which is recognized in the official National Formulary, or the United States Pharmacopeia, or any supplement to them, intended for use in the diagnosis of disease or other conditions, or in the cure, mitigation, treatment, or prevention of disease, in man or other animals, or intended to affect the structure or any function of the body of man or other animals, and which does not achieve its primary intended purposes through chemical action within or on the body of man or other animals and which is not dependent upon being metabolized for the achievement of its primary intended purposes. (FDA) | Medical Device | |||
| DIETARY SUPPLEMENT | C1505 | Oral preparations containing dietary ingredient(s) intended to supplement the diet. Dietary ingredients include vitamins, minerals, herbs, amino acids, extracts and metabolites. | Dietary Supplement | |||
| DRUG | C1909 | An active natural, synthetic or semi-synthetic ingredient including endogenous body substance that is intended to furnish pharmacological activity or other direct effect in the diagnosis, cure, mitigation, treatment, or prevention of disease or to affect the structure or any function of the human body, but does not include intermediates used in the synthesis of such ingredient (21 CFR 314.3(b)). | Pharmacologic Substance | |||
| GENETIC | C15238 | Application of genetic material into cells in order to correct an inherited or acquired disease. | Gene Therapy | |||
| OTHER | C17649 | Other | Different than the one(s) previously specified or mentioned. (NCI) | Other | ||
| PROCEDURE | C98769 | A treatment procedure performed by manual and/or instrumental means, for example: surgery, lithotripsy, or external manipulation. | Physical Medical Procedure | |||
| RADIATION | C15313 | Treatment of a disease by means of exposure of the target or the whole body to radiation. | Radiation Therapy | |||
| Back to top | ||||||
| CL.C101840.KILLIPC | Killip Class Responses (KILLIPC) | text Extensible: No | C101840 | Killip Class Responses | A terminology codelist based on the classification developed by Killip and Kimball, which classifies patients with myocardial infarction based on routine physical examination parameters, such as the presence or absence of rales, or a decreased systolic blood pressure. | CDISC SDTM Killip Class Responses Terminology |
| KILLIP CLASS I | C77269 | The absence of rales over the lung fields and absence of third heart sound (S3). (ACC/AHA) | Killip Class I | |||
| KILLIP CLASS II | C77270 | The presence of rales over 50% or less of the lung fields or the presence of a third heart sound (S3).(ACC/AHA) | Killip Class II | |||
| KILLIP CLASS III | C77271 | The presence of rales over more than 50% of the lung fields. (ACC/AHA) | Killip Class III | |||
| KILLIP CLASS IV | C77272 | The presence of cardiogenic shock (systolic BP less than 90 mm Hg) for greater than 30 minutes, not responsive to fluid resuscitation alone, and felt to be secondary to cardiac dysfunction. (ACC/AHA) | Killip Class IV | |||
| Back to top | ||||||
| CL.C65047.LBTESTCD | Laboratory Test Code (LBTESTCD) | text Extensible: Yes | C65047 | Laboratory Test Code | Terminology used for laboratory test codes of the CDISC Standard Data Tabulation Model. | CDISC SDTM Laboratory Test Terminology by Code |
| A1AGLP | C100429 | Alpha-1 Acid Glycoprotein | A measurement of the alpha-1 acid glycoprotein in a biological specimen. | Alpha-1 Acid Glycoprotein Measurement | ||
| A1ANTRYP | C80167 | Alpha-1 Antitrypsin;Serum Trypsin Inhibitor | A measurement of the alpha-1 antitrypsin in a biological specimen. | Alpha-1 Antitrypsin Measurement | ||
| A1MCREAT | C100462 | Alpha-1 Microglobulin/Creatinine | A relative measurement (ratio or percentage) of the alpha-1 microglobulin to creatinine in a biological specimen. | Alpha-1 Microglobulin to Creatinine Ratio Measurement | ||
| A1MICG | C100461 | Alpha-1 Microglobulin;Protein HC | A measurement of the alpha-1 microglobulin in a biological specimen. | Alpha-1 Microglobulin Measurement | ||
| A2MACG | C80168 | Alpha-2 Macroglobulin | A measurement of the alpha-2 macroglobulin in a biological specimen. | Alpha-2 Macroglobulin Measurement | ||
| AAP | C100430 | Alanine Aminopeptidase | A measurement of the alanine aminopeptidase in a biological specimen. | Alanine Aminopeptidase Measurement | ||
| ABNCE | C111124 | Abnormal Cells | A measurement of the abnormal cells in a biological specimen. | Abnormal Cell Count | ||
| ACANT | C74699 | Acanthocytes | A measurement of the acanthocytes in a biological specimen. | Acanthocyte Count | ||
| ACANTRBC | C74633 | Acanthocytes/Erythrocytes | A relative measurement (ratio or percentage) of acanthocytes to all erythrocytes in a biological specimen. | Acanthocyte to Erythrocyte Ratio Measurement | ||
| ACE | C80169 | Angiotensin Converting Enzyme | A measurement of the angiotensin converting enzyme in a biological specimen. | Angiotensin Converting Enzyme Measurement | ||
| ACETOAC | C92247 | Acetoacetate;Acetoacetic Acid | A measurement of the acetoacetic acid in a biological specimen. | Acetoacetic Acid Measurement | ||
| ACH | C74838 | Acetylcholine | A measurement of the acetylcholine hormone in a biological specimen. | Acetylcholine Measurement | ||
| ACHE | C96560 | Acetylcholinesterase | A measurement of the acetylcholinesterase in a biological specimen. | Acetylcholinesterase Measurement | ||
| ACHRAB | C96559 | Acetylcholine Receptor Antibody | A measurement of the acetylcholine receptor antibody in a biological specimen. | Acetylcholine Receptor Antibody Measurement | ||
| ACPHOS | C80163 | Acid Phosphatase | A measurement of the acid phosphatase in a biological specimen. | Acid Phosphatase Measurement | ||
| ACT | C103348 | Activated Clot Time;Activated Clotting Time;Coagulation Activated | A measurement of the inhibition of blood coagulation in response to anticoagulant therapies. | Activated Coagulation Time | ||
| ACTH | C74780 | Adrenocorticotropic Hormone | A measurement of the adrenocorticotropic hormone in a biological specimen. | Adrenocorticotropic Hormone Measurement | ||
| ACYLCAOX | C92286 | Acyl CoA Oxidase;Acyl Coenzyme A Oxidase;Fatty Acyl Coenzyme A Oxidase | A measurement of the acyl coenzyme A oxidase in a biological specimen. | Acyl Coenzyme A Oxidase Measurement | ||
| ADENOVAB | C111125 | Adenovirus Antibody | A measurement of the adenovirus antibody in a biological specimen. | Adenovirus Antibody Measurement | ||
| ADH | C74847 | Antidiuretic Hormone;Vasopressin | A measurement of the antidiuretic hormone in a biological specimen. | Antidiuretic Hormone Measurement | ||
| ADP | C102257 | Adenosine Diphosphate | A measurement of the adenosine diphosphate in a biological specimen. | Adenosine Diphosphate Measurement | ||
| ADPNCTN | C74839 | Adiponectin | A measurement of the adiponectin hormone in a biological specimen. | Adiponectin Measurement | ||
| ADSDNA | C74913 | Anti-Double Stranded DNA | A measurement of the anti-double stranded DNA antibody in a biological specimen. | Anti-Double Stranded DNA Measurement | ||
| ADVVLD | C98705 | ADV Viral Load | A measurement of the adenovirus viral load in a biological specimen. | Adenovirus Viral Load Measurement | ||
| AFACTXAA | C98706 | Anti-Factor Xa Activity | A measurement of the anti-activated Factor X in a biological specimen. This test is used to monitor low molecular weight or unfractionated heparin levels in a biological specimen. | Anti-Factor Xa Activity Measurement | ||
| AFP | C74732 | Alpha Fetoprotein | A measurement of the alpha fetoprotein in a biological specimen. | Alpha-fetoprotein Measurement | ||
| AFPA | C106499 | Alpha Fetoprotein Activity | A measurement of the alpha fetoprotein activity in a biological specimen. | Alpha Fetoprotein Activity Measurement | ||
| AFPL1 | C96562 | Alpha Fetoprotein L1 | A measurement of the alpha fetoprotein L1 in a biological specimen. | Alpha Fetoprotein L1 Measurement | ||
| AFPL2 | C96563 | Alpha Fetoprotein L2 | A measurement of the alpha fetoprotein L2 in a biological specimen. | Alpha Fetoprotein L2 Measurement | ||
| AFPL3 | C96564 | Alpha Fetoprotein L3 | A measurement of the alpha fetoprotein L3 in a biological specimen. | Alpha Fetoprotein L3 Measurement | ||
| AFPL3AFP | C96565 | A Fetoprotein L3/A Fetoprotein | A relative measurement (ratio or percentage) of alpha fetoprotein L3 to total alpha fetoprotein in a biological specimen. | Alpha Fetoprotein L3 to Total Alpha Fetoprotein Ratio Measurement | ||
| AHBDH | C111126 | Alpha Hydroxybutyrate Dehydrogenase | A measurement of the alpha-hydroxybutyrate dehydrogenase in a biological specimen. | Alpha Hydroxybutyrate Dehydrogenase Measurement | ||
| ALB | C64431 | Albumin;Microalbumin | A measurement of the albumin protein in a biological specimen. | Albumin Measurement | ||
| ALBCREAT | C74761 | Albumin/Creatinine;Microalbumin/Creatinine Ratio | A relative measurement (ratio or percentage) of the albumin to the creatinine in a biological specimen. | Albumin To Creatinine Protein Ratio Measurement | ||
| ALBEXR | C117829 | Albumin Excretion Rate | A measurement of the amount of albumin being excreted in urine over a defined period of time (e.g. one hour). | Albumin Urine Excretion Rate | ||
| ALBGLOB | C74894 | Albumin/Globulin | The ratio of albumin to globulin in a biological specimen. | Albumin to Globulin Ratio Measurement | ||
| ALBPROT | C103453 | Albumin/Total Protein | A relative measurement (ratio or percentage) of the albumin to total protein in a biological specimen. | Albumin to Total Protein Ratio Measurement | ||
| ALDOLASE | C74731 | Aldolase | A measurement of the aldolase enzyme in a biological specimen. | Aldolase Measurement | ||
| ALDSTRN | C74841 | Aldosterone | A measurement of the aldosterone hormone in a biological specimen. | Aldosterone Measurement | ||
| ALP | C64432 | Alkaline Phosphatase | A measurement of the alkaline phosphatase in a biological specimen. | Alkaline Phosphatase Measurement | ||
| ALPBS | C92287 | Bone Specific Alkaline Phosphatase | A measurement of the bone specific alkaline phosphatase isoform in a biological specimen. | Bone Specific Alkaline Phosphatase Measurement | ||
| ALPCREAT | C79438 | Alkaline Phosphatase/Creatinine | A relative measurement (ratio or percentage) of the alkaline phosphatase to creatinine in a biological specimen. | Alkaline Phosphatase to Creatinine Ratio Measurement | ||
| ALPIS | C119266 | Intestinal Specific Alkaline Phosphatase | A measurement of the intestinal specific alkaline phosphatase isoform in a biological specimen. | Intestinal Specific Alkaline Phosphatase Measurement | ||
| ALPLS | C119267 | Liver Specific Alkaline Phosphatase | A measurement of the liver specific alkaline phosphatase isoform in a biological specimen. | Liver Specific Alkaline Phosphatase Measurement | ||
| ALT | C64433 | Alanine Aminotransferase;SGPT | A measurement of the alanine aminotransferase in a biological specimen. | Alanine Aminotransferase Measurement | ||
| ALTAST | C106498 | ALT/AST | A relative measurement (ratio or percentage) of the alanine aminotransferase (ALT) to aspartate aminotransferase (AST) present in a sample. | Alanine Aminotransferase to Aspartate Aminotransferase Ratio Measurement | ||
| ALTCPHRL | C103349 | Alpha Tocopherol | A measurement of the alpha tocopherol in a biological specimen. | Alpha Tocopherol Measurement | ||
| ALUMINUM | C111127 | Al;Aluminum | A measurement of aluminum in a biological specimen. | Aluminum Measurement | ||
| AMA | C81975 | Antimitochondrial Antibodies;Mitochondrial Antibody | A measurement of the antimitochondrial antibodies in a biological specimen. | Antimitochondrial Antibody Measurement | ||
| AMMONIA | C74799 | Ammonia;NH3 | A measurement of the ammonia in a biological specimen. | Ammonia Measurement | ||
| AMORPHSD | C74666 | Amorphous Debris;Amorphous Sediment | A measurement of the amorphous sediment present in a biological specimen. | Amorphous Sediment Measurement | ||
| AMPHET | C74687 | Amphetamine | A measurement of any amphetamine class drug present in a biological specimen. | Amphetamine Drug Class Measurement | ||
| AMPHETD | C102262 | Dextroamphetamine;d-amphetamine | A measurement of the dextroamphetamine in a biological specimen. | Dextroamphetamine Measurement | ||
| AMYLASE | C64434 | Amylase | A measurement of the total enzyme amylase in a biological specimen. | Amylase Measurement | ||
| AMYLASEM | C111243 | Macroamylase | A measurement of macroamylase in a biological specimen. | Macroamylase Measurement | ||
| AMYLASEP | C98767 | Amylase, Pancreatic | A measurement of the pancreatic enzyme amylase in a biological specimen. | Pancreatic Amylase Measurement | ||
| AMYLASES | C98780 | Amylase, Salivary | A measurement of the salivary enzyme amylase in a biological specimen. | Salivary Amylase Measurement | ||
| AMYLB38 | C103352 | Amyloid Beta 1-38;Amyloid Beta 38;Amyloid Beta 38 Protein | A measurement of amyloid beta protein which is composed of peptides 1 to 38 in a biological specimen. | Amyloid Beta 1-38 Measurement | ||
| AMYLB40 | C103353 | Amyloid Beta 1-40;Amyloid Beta 40;Amyloid Beta 40 Protein | A measurement of amyloid beta protein which is composed of peptides 1 to 40 in a biological specimen. | Amyloid Beta 1-40 Measurement | ||
| AMYLB42 | C84809 | Amyloid Beta 1-42;Amyloid Beta 42;Amyloid Beta 42 Protein | A measurement of amyloid beta protein which is composed of peptides 1 to 42 in a biological specimen. | Beta Amyloid 42 Measurement | ||
| AMYLOIDB | C81999 | Amyloid, Beta;Beta Amyloid | A measurement of the total amyloid beta in a biological specimen. | Beta Amyloid Measurement | ||
| AMYLOIDP | C81998 | Amyloid P | A measurement of the total amyloid P in a biological specimen. | Amyloid P Measurement | ||
| ANA | C74916 | Antinuclear Antibodies | A measurement of the antinuclear antibodies (antibodies that attack the body's own tissue) in a biological specimen. | Antinuclear Antibody Measurement | ||
| ANDSTNDL | C74842 | Androstenediol | A measurement of the androstenediol metabolite in a biological specimen. | Androstenediol Metabolite Measurement | ||
| ANDSTNDN | C74843 | 4-Androstenedione;Androstenedione | A measurement of the androstenedione hormone in a biological specimen. | Androstenedione Measurement | ||
| ANGLBIND | C91372 | Antiglobulin Test, Indirect;Indirect Coombs Test | A test that uses Coombs' reagent to detect the presence of anti-erythrocyte antibodies in a biological specimen. | Indirect Antiglobulin Test | ||
| ANGLOBDR | C81974 | Antiglobulin Test, Direct;Direct Coombs Test | A measurement of the antibody or complement-coated erythrocytes in a biological specimen in vivo. | Direct Antiglobulin Test | ||
| ANGPT1 | C111128 | Angiopoietin 1 | A measurement of angiopoietin 1 in a biological specimen. | Angiopoietin 1 Measurement | ||
| ANGTNS1 | C74844 | Angiotensin I | A measurement of the angiotensin I hormone in a biological specimen. | Angiotensin I Measurement | ||
| ANGTNS2 | C74845 | Angiotensin II | A measurement of the angiotensin II hormone in a biological specimen. | Angiotensin II Measurement | ||
| ANGTNSGN | C74846 | Angiotensin Precursor;Angiotensinogen | A measurement of the angiotensinogen hormone in a biological specimen. | Angiotensinogen Measurement | ||
| ANIONG | C74685 | Anion Gap | A computed estimate of the unmeasured anions (those other than the chloride and bicarbonate anions) in a biological specimen. | Anion Gap Measurement | ||
| ANISO | C74797 | Anisocytes;Anisocytosis | A measurement of the inequality in the size of the red blood cells in a whole blood specimen. | Anisocyte Measurement | ||
| ANP | C74886 | Atrial Natriuretic Peptide;Atriopeptin | A measurement of the atrial natriuretic peptide in a biological specimen. | Atrial Natriuretic Peptide Measurement | ||
| ANTHRM | C81958 | Antithrombin;Antithrombin Activity;Antithrombin III;Antithrombin III Activity | A measurement of the antithrombin activity in a biological specimen. | Antithrombin Activity Measurement | ||
| ANTHRMAG | C81977 | Antithrombin Antigen;Antithrombin III Antigen | A measurement of the antithrombin antigen in a biological specimen. | Antithrombin Antigen Measurement | ||
| ANTIDPRS | C74691 | Antidepressants | A measurement of any antidepressant class drug present in a biological specimen. | Antidepressant Measurement | ||
| APLAB | C102258 | Antiphospholipid Antibodies | A measurement of the antiphospholipid antibodies in a biological specimen. | Antiphospholipid Antibody Measurement | ||
| APLSMA2 | C103351 | Alpha-2 Plasmin Inhibitor | A measurement of the alpha-2 antiplasmin in a biological specimen. | Alpha-2 Antiplasmin Measurement | ||
| APOA1 | C74733 | Apolipoprotein A1 | A measurement of the apolipoprotein A1 in the high density lipoproteins of a biological specimen. | Apolipoprotein A1 Measurement | ||
| APOA2 | C82000 | Apolipoprotein AII | A measurement of the apolipoprotein AII in a biological specimen. | Apolipoprotein AII Measurement | ||
| APOA4 | C103354 | Apolipoprotein A4 | A measurement of the apolipoprotein A4 in a biological specimen. | Apolipoprotein A4 Measurement | ||
| APOA5 | C103355 | Apolipoprotein A5 | A measurement of the apolipoprotein A5 in a biological specimen. | Apolipoprotein A5 Measurement | ||
| APOB | C74734 | Apolipoprotein B | A measurement of the apolipoprotein B in the low density lipoproteins of a biological specimen. | Apolipoprotein B Measurement | ||
| APOBAPA1 | C103356 | Apolipoprotein B/Apolipoprotein A1 | A relative measurement (ratio or percentage) of the Apolipoprotein B to Apolipoprotein A1 in a biological specimen. | Apolipoprotein B to Apolipoprotein A1 Ratio Measurement | ||
| APOC2 | C100427 | Apolipoprotein C2;Apolipoprotein CII | A measurement of the apolipoprotein C2 in a biological specimen. | Apolipoprotein C2 Measurement | ||
| APOC3 | C82001 | Apolipoprotein CIII | A measurement of the apolipoprotein CIII in a biological specimen. | Apolipoprotein CIII Measurement | ||
| APOE | C82002 | Apolipoprotein E | A measurement of the apolipoprotein E in a biological specimen. | Apolipoprotein E Measurement | ||
| APOE4 | C92293 | Apolipoprotein E4 | A measurement of the apolipoprotein E4 in a biological specimen. | Apolipoprotein E4 Measurement | ||
| APOH | C82003 | Apolipoprotein H | A measurement of the apolipoprotein H in a biological specimen. | Apolipoprotein H Measurement | ||
| APOJ | C100428 | Apolipoprotein J;Clusterin | A measurement of the apolipoprotein J in a biological specimen. | Apolipoprotein J Measurement | ||
| APOJCRT | C111130 | Apolipoprotein J/Creatinine;Clusterin/Creatinine | A relative measurement (ratio or percentage) of the apolipoprotein J to creatinine in a biological specimen. | Apolipoprotein J to Creatinine Ratio Measurement | ||
| APPA | C119268 | Amyloid Alpha Precursor Protein | A measurement of the amyloid alpha precursor protein present in a biological specimen. | Amyloid Alpha Precursor Protein Measurement | ||
| APPB | C105438 | Amyloid Beta Precursor;Amyloid Beta Precursor Protein;Amyloid Precursor Beta;Amyloid Precursor Protein | A measurement of the amyloid beta precursor protein present in a biological specimen. | Amyloid Beta Precursor Protein Measurement | ||
| APPEAR | C25377 | Specimen Appearance | The outward or visible aspect of a specimen. | Appearance | ||
| APPT | C119269 | Total Amyloid Precursor Protein | A measurement of the total amyloid precursor protein present in a biological specimen. | Total Amyloid Precursor Protein Measurement | ||
| APRIL | C111123 | A Proliferation-Inducing Ligand;CD256;TNFSF13;Tumor Necrosis Factor Ligand Superfamily Member 13 | A measurement of the a proliferation-inducing ligand in a biological specimen. | A Proliferation-Inducing Ligand Measurement | ||
| APROTCRS | C100471 | Activated Protein C Resistance;Factor V Leiden Screen | A measurement of the resistance in the anticoagulation response to activated protein C in a biological specimen. | Activated Protein C Resistance Measurement | ||
| APTT | C38462 | Activated Partial Thromboplastin Time | A measurement of the length of time that it takes for clotting to occur when reagents are added to a plasma specimen. The test is partial due to the absence of tissue factor (Factor III) from the reaction mixture. | Partial Thromboplastin Time | ||
| APTTLAS | C102277 | APTT-LA;Lupus Anticoagulant Sensitive APTT | A measurement of the length of time that it takes for clotting to occur when a lupus sensitive reagent is added to a plasma specimen. | Lupus Anticoagulant Sensitive APTT Measurement | ||
| APTTSTND | C98862 | Activated PTT/Standard;Activated PTT/Standard PTT;Activated Partial Thromboplastin Time/Standard Thromboplastin Time | A relative measurement (ratio or percentage) of the subject's partial thromboplastin time to a standard or control partial thromboplastin time. | Activated PTT/Standard Ratio Measurement | ||
| ARA | C102259 | Arachidonic Acid | A measurement of the arachidonic acid present in a biological specimen. | Arachidonic Acid Measurement | ||
| ASCAB | C81976 | Anti-Saccharomyces cerevisiae Antibody | A measurement of the anti-Saccharomyces cerevisiae antibody in a biological specimen. | Anti-Saccharomyces cerevisiae Antibody Measurement | ||
| ASSDNA | C92269 | Anti-Single Stranded DNA IgG | A measurement of the anti-single stranded DNA IgG antibody in a biological specimen. | Anti-Single Stranded DNA IgG Measurement | ||
| AST | C64467 | Aspartate Aminotransferase;SGOT | A measurement of the aspartate aminotransferase in a biological specimen. | Aspartate Aminotransferase Measurement | ||
| ASTAG | C81978 | Aspartate Aminotransferase Antigen;SGOT Antigen | A measurement of the aspartate aminotransferase antigen in a biological specimen. | Aspartate Aminotransferase Antigen Measurement | ||
| ASTCREAT | C117830 | Aspartate Aminotransferase/Creatinine | A relative measurement (ratio or percentage) of the aspartate aminotransferase to creatinine in a biological specimen. | Aspartate Aminotransferase to Creatinine Ratio Measurement | ||
| ATPVITE | C103350 | Vitamin E Alpha Tocopherol | A relative measurement (ratio or percentage) of alpha-tocopherol to the total vitamin E in a biological specimen. | Alpha Tocopherol to Vitamin E Ratio Measurement | ||
| AUERRODS | C74657 | Auer Rods | A measurement of the Auer rods (elongated needle structures that are found in the cytoplasm of leukemic blasts and are formed by clumps of azurophilic granular material) in a biological specimen. | Auer Rod Measurement | ||
| AZURGRAN | C116185 | Azurophilic Granulation;Azurophilic Granules | An observation of azurophilic granules in a biological specimen. | Azurophilic Granule Measurement | ||
| B2G1GGAB | C103358 | Beta-2 Glycoprotein 1 IgG Antibody | A measurement of the Beta-2 glycoprotein 1 IgG antibodies in a biological specimen. | Beta-2 Glycoprotein 1 IgG Antibody Measurement | ||
| B2G1GMAB | C103359 | Beta-2 Glycoprotein 1 IgM Antibody | A measurement of the Beta-2 glycoprotein 1 IgM antibodies in a biological specimen. | Beta-2 Glycoprotein 1 IgM Antibody Measurement | ||
| B2GLYAB | C81979 | Beta-2 Glycoprotein Antibody | A measurement of the beta-2 glycoprotein antibody in a biological specimen. | Beta-2 Glycoprotein Antibody Measurement | ||
| B2MICG | C81980 | Beta-2 Microglobulin | A measurement of the beta-2 microglobulin in a biological specimen. | Beta-2 Microglobulin Measurement | ||
| BACT | C64469 | Bacteria | A measurement of the bacteria in a biological specimen. | Bacterial Count | ||
| BAFF | C111135 | B-Cell Activating Factor | A measurement of the B-cell activating factor in a biological specimen. | B-Cell Activating Factor Measurement | ||
| BARB | C74688 | Barbiturates | A measurement of any barbiturate class drug present in a biological specimen. | Barbiturate Drug Class Measurement | ||
| BASEEXCS | C119270 | Base Excess | A measurement of the amount of acid or alkali required to return a biological specimen to a normal pH under standard conditions. | Base Excess Measurement | ||
| BASO | C64470 | Basophils | A measurement of the basophils in a biological specimen. | Total Basophil Count | ||
| BASOCE | C98865 | Basophils/Total Cells | A relative measurement (ratio or percentage) of the basophils to total cells in a biological specimen (for example a bone marrow specimen). | Basophil to Total Cell Ratio Measurement | ||
| BASOIM | C96670 | Immature Basophils | A measurement of the immature basophils in a biological specimen. | Immature Basophil Count | ||
| BASOIMLE | C96671 | Immature Basophils/Leukocytes | A relative measurement (ratio or percentage) of immature basophils to total leukocytes in a biological specimen. | Immature Basophil to Leukocyte Ratio Measurement | ||
| BASOLE | C64471 | Basophils/Leukocytes | A relative measurement (ratio or percentage) of the basophils to leukocytes in a biological specimen. | Basophil to Leukocyte Ratio | ||
| BDNF | C82004 | Brain-Derived Neurotrophic Factor | A measurement of the brain-derived neurotrophic factor in a biological specimen. | Brain-Derived Neurotrophic Factor Measurement | ||
| BETACRTN | C100472 | Beta Carotene;Beta Carotin;b-Carotene | A measurement of the beta carotene in a biological specimen. | Beta Carotene Measurement | ||
| BHYXBTR | C96568 | 3-Hydroxybutyrate;B-Hydroxybutyrate;Beta-Hydroxybutyrate | A measurement of the total Beta-hydroxybutyrate in a biological specimen. | Beta-Hydroxybutyrate Measurement | ||
| BICARB | C74667 | Bicarbonate;HCO3 | A measurement of the bicarbonate in a biological specimen. | Bicarbonate Measurement | ||
| BILDIR | C64481 | Direct Bilirubin | A measurement of the conjugated or water-soluble bilirubin in a biological specimen. | Direct Bilirubin Measurement | ||
| BILEAC | C74800 | Bile Acid;Bile Acids;Bile Salt;Bile Salts | A measurement of the total bile acids in a biological specimen. | Bile Acid Measurement | ||
| BILI | C38037 | Bilirubin;Total Bilirubin | A measurement of the total bilirubin in a biological specimen. | Total Bilirubin Measurement | ||
| BILIND | C64483 | Indirect Bilirubin | A measurement of the unconjugated or non-water-soluble bilirubin in a biological specimen. | Indirect Bilirubin Measurement | ||
| BITECE | C74700 | Bite Cells | A measurement of the bite cells (erythrocytes with the appearance of a bite having been removed, due to oxidative hemolysis) in a biological specimen. | Bite Cell Count | ||
| BJPROT | C111136 | Bence-Jones Protein;Immunoglobulin Light Chains | A measurement of the total Bence-Jones protein in a biological specimen. | Bence-Jones Protein Measurement | ||
| BKVVLD | C98710 | BKV Viral Load | A measurement of the BK virus viral load in a biological specimen. | BK Virus Viral Load Measurement | ||
| BLAST | C74605 | Blasts | A measurement of the blast cells in a biological specimen. | Blast Count | ||
| BLASTIMM | C103407 | Lymphocytes, Immunoblastic | A measurement of the immunoblasts in a biological specimen. | Immunoblast Count | ||
| BLASTLE | C64487 | Blasts/Leukocytes | A relative measurement (ratio or percentage) of the blasts to leukocytes in a biological specimen. | Blast to Leukocyte Ratio | ||
| BLASTLM | C74630 | Leukemic Blasts | A measurement of the leukemic blasts (lymphoblasts that remain in an immature state even when outside the bone marrow) in a biological specimen. | Leukemic Blast Count | ||
| BLSTIMLY | C106535 | Immunoblasts/Lymphocytes;Lymphocytes, Immunoblastic/Lymphocytes | A relative measurement (ratio or percentage) of immunoblasts to all lymphocytes present in a sample. | Immunoblasts to Lymphocytes Ratio Measurement | ||
| BLSTLMLY | C74641 | Leukemic Blasts/Lymphocytes | A relative measurement (ratio or percentage) of the leukemic blasts (immature lymphoblasts) to mature lymphocytes in a biological specimen. | Leukemic Blast to Lymphocyte Ratio Measurement | ||
| BLSTLY | C102278 | Lymphoblasts | A measurement of the lymphoblasts (immature cells that differentiate to form lymphocytes) in a biological specimen. | Lymphoblast Count | ||
| BLSTLYLE | C105444 | Lymphoblasts/Leukocytes | A relative measurement (ratio or percentage) of the lymphoblasts to leukocytes in a biological specimen. | Lymphoblast to Leukocyte Ratio Measurement | ||
| BLSTMBCE | C98761 | Myeloblasts/Total Cells | A relative measurement (ratio or percentage) of the myeloblasts to total cells in a biological specimen (for example a bone marrow specimen). | Myeloblast to Total Cell Ratio Measurement | ||
| BLSTMGK | C98752 | Megakaryoblasts | A measurement of the megakaryoblasts in a biological specimen. | Megakaryoblast Cell Count | ||
| BLSTMKCE | C98753 | Megakaryoblasts/Total Cells | A relative measurement (ratio or percentage) of the megakaryoblasts to total cells in a biological specimen (for example a bone marrow specimen). | Megakaryoblast to Total Cell Ratio Measurement | ||
| BLSTNMCE | C98764 | Normoblasts/Total Cells | A relative measurement (ratio or percentage) of the normoblasts to total cells in a biological specimen (for example a bone marrow specimen). | Normoblast to Total Cell Ratio Measurement | ||
| BLSTPNCE | C98870 | Pronormoblasts/Total Cells | A relative measurement (ratio or percentage) of the pronormoblasts to total cells in a biological specimen (for example a bone marrow specimen). | Pronormoblast to Total Cell Ratio Measurement | ||
| BLSTRSID | C100419 | Ringed Sideroblasts | A measurement of the ringed sideroblasts (abnormal nucleated erythroblasts with a large number of iron deposits in the perinuclear mitochondria, forming a ring around the nucleus) in a biological specimen. | Ringed Sideroblast Measurement | ||
| BLSTSID | C100418 | Sideroblast | A measurement of the sideroblasts (nucleated erythroblasts with iron granules in the cytoplasm) in a biological specimen. | Sideroblast Measurement | ||
| BNP | C74735 | B-Type Natriuretic Peptide;Brain Natriuretic Peptide | A measurement of the brain (B-type) natriuretic peptide in a biological specimen. | Brain Natriuretic Peptide Measurement | ||
| BNPPRO | C82032 | Pro-Brain Natriuretic Peptide;ProB-type Natriuretic Peptide;proBNP | A measurement of the proB-type natriuretic peptide in a biological specimen. | ProB-Type Natriuretic Peptide Measurement | ||
| BNPPRONT | C96610 | N-Terminal ProB-type Natriuretic Peptide;N-terminal pro-Brain Natriuretic Peptide;NT proBNP II | A measurement of the N-terminal proB-type natriuretic peptide in a biological specimen. | N-Terminal ProB-type Natriuretic Peptide Measurement | ||
| BNZDZPN | C74692 | Benzodiazepine | A measurement of any benzodiazepine class drug present in a biological specimen. | Benzodiazepine Measurement | ||
| BNZLCGN | C75350 | Benzoylecgonine;Cocaine Metabolite | A measurement of the benzoylecgonine in a biological specimen. | Benzoylecgonine Measurement | ||
| BTECERBC | C74634 | Bite Cells/Erythrocytes | A relative measurement (ratio or percentage) of bite cells (erythrocytes with the appearance of a bite having been removed, due to oxidative hemolysis) to all erythrocytes in a biological specimen. | Bite Cell to Erythrocyte Ratio Measurement | ||
| BTP | C100426 | Beta-Trace Protein | A measurement of the beta-trace protein in a biological specimen. | Beta-Trace Protein Measurement | ||
| BUCHE | C111142 | Acylcholine Acylhydrolase;Butyrylcholinesterase;Non-neuronal Cholinesterase;Plasma Cholinesterase;Pseudocholinesterase | A measurement of the total butyrylcholinesterase in a biological specimen. | Butyrylcholinesterase Measurement | ||
| BUN | C61019 | Blood Urea Nitrogen | A measurement of the urea nitrogen in a blood specimen. | Blood Urea Nitrogen Measurement | ||
| BUNCREAT | C74753 | BUN/Creatinine | A relative measurement (ratio or percentage) (ratio) of the blood urea nitrogen (BUN) to the creatinine in a biological specimen. | Blood Urea Nitrogen To Creatinine Ratio Measurement | ||
| BURRCE | C74701 | Burr Cells;Keratocytes | A measurement of the Burr cells (erythrocytes characterized by the presence of small, blunt projections evenly distributed across the cell surface) in a biological specimen. | Burr Cell Count | ||
| C1QAB | C80173 | Complement C1q Antibody | A measurement of the complement C1q antibody in a biological specimen. | Complement C1q Antibody Measurement | ||
| C3 | C80174 | Complement C3 | A measurement of the complement C3 in a biological specimen. | Complement C3 Measurement | ||
| C3A | C80175 | ASP, Complement C3 DesArg, Acetylation-stimulating Protein;Complement C3a | A measurement of the complement C3a in a biological specimen. | Complement C3a Measurement | ||
| C3B | C80176 | Complement C3b | A measurement of the complement C3b in a biological specimen. | Complement C3b Measurement | ||
| C3DAB | C119271 | Complement C3d Antibody | A measurement of the complement C3d antibody in a biological specimen. | Complement C3d Antibody Measurement | ||
| C4 | C80177 | Complement C4 | A measurement of the complement C4 in a biological specimen. | Complement C4 Measurement | ||
| C4A | C80178 | Complement C4a | A measurement of the complement C4a in a biological specimen. | Complement C4a Measurement | ||
| C5A | C80179 | Complement C5a | A measurement of the complement C5a in a biological specimen. | Complement C5a Measurement | ||
| CA | C64488 | Calcium | A measurement of the calcium in a biological specimen. | Calcium Measurement | ||
| CA125AG | C79089 | Cancer Antigen 125 | A measurement of the cancer antigen 125 in a biological specimen. | CA-125 Measurement | ||
| CA15_3AG | C103362 | Cancer Antigen 15-3 | A measurement of the cancer antigen 15-3 in a biological specimen. | Cancer Antigen 15-3 Measurement | ||
| CA19_9AG | C81982 | Cancer Antigen 19-9 | A measurement of the cancer antigen 19-9 in a biological specimen. | Cancer Antigen 19-9 Measurement | ||
| CA1AG | C103361 | Cancer Antigen 1 | A measurement of the cancer antigen 1 in a biological specimen. | Cancer Antigen 1 Measurement | ||
| CA2729AG | C111143 | Cancer Antigen 27-29 | A measurement of the cancer antigen 27-29 in a biological specimen. | Cancer Antigen 27-29 Measurement | ||
| CA72_4AG | C106505 | CA 72-4;Cancer Antigen 72-4;Carbohydrate Antigen 72-4 | A measurement of the cancer antigen 72-4 in a biological specimen. | Cancer Antigen 72-4 Measurement | ||
| CABOT | C74702 | Cabot Rings | A measurement of the Cabot rings (red-purple staining, threadlike, ring or figure 8 shaped filaments in an erythrocyte) in a biological specimen. | Cabot Ring Count | ||
| CACLR | C96589 | Calcium Clearance | A measurement of the volume of serum or plasma that would be cleared of calcium by excretion of urine for a specified unit of time (e.g. one minute). | Calcium Clearance Measurement | ||
| CACR | C119272 | Calcium Corrected | A measurement of calcium, which has been corrected for albumin, in a biological specimen. | Calcium Corrected Measurement | ||
| CACREAT | C79439 | Calcium/Creatinine | A relative measurement (ratio or percentage) of the calcium to creatinine in a biological specimen. | Calcium to Creatinine Ratio Measurement | ||
| CAEXR | C117831 | Calcium Excretion Rate | A measurement of the amount of calcium being excreted in urine over a defined period of time (e.g. one hour). | Calcium Urine Excretion Rate | ||
| CAFFEINE | C75346 | Caffeine | A measurement of the caffeine in a biological specimen. | Caffeine Measurement | ||
| CAION | C81948 | Calcium, Ionized | A measurement of the ionized calcium in a biological specimen. | Ionized Calcium Measurement | ||
| CALPRO | C82005 | Calprotectin | A measurement of the calprotectin in a biological specimen. | Calprotectin Measurement | ||
| CANNAB | C74689 | Cannabinoids | A measurement of any cannabinoid class drug present in a biological specimen. | Cannabinoid Drug Class Measurement | ||
| CAPHOSPD | C103360 | Calcium - Phosphorus Product | A measurement of the product of the calcium and phosphate measurements in a biological specimen. | Calcium and Phosphorus Product Measurement | ||
| CARBXHGB | C96591 | Carboxyhemoglobin | A measurement of the carboxyhemoglobin, carbon monoxide-bound hemoglobin, in a biological specimen. | Carboxyhemoglobin Measurement | ||
| CARNIT | C74682 | Carnitine | A measurement of the total carnitine in a biological specimen. | Total Carnitine Measurement | ||
| CARNITAT | C92288 | Carnitine Acetyl Transferase | A measurement of the carnitine acetyl transferase in a biological specimen. | Carnitine Acetyl Transferase Measurement | ||
| CARNITF | C74677 | Carnitine, Free | A measurement of the free carnitine in a biological specimen. | Free Carnitine Measurement | ||
| CASTS | C74763 | Casts | A statement that indicates casts were looked for in a biological specimen. | Cast Present Or Absent | ||
| CASULPH | C96590 | Calcium Sulphate | A measurement of the calcium sulphate in a biological specimen. | Calcium Sulphate Measurement | ||
| CATNINB | C103357 | Beta Catenin | A measurement of the beta catenin in a biological specimen. | Beta Catenin Measurement | ||
| CBB | C80172 | Bb Fragment of Complement Factor B;Bb Fragment of Factor B;Complement Bb | A measurement of the Bb fragment of complement factor B in a biological specimen. | Complement Bb Measurement | ||
| CCK | C74850 | Cholecystokinin;Pancreozymin | A measurement of the cholecystokinin hormone in a biological specimen. | Cholecystokinin Measurement | ||
| CCL17 | C112236 | ABCD-2;Chemokine (C-C Motif) Ligand 17;SCYA17;TARC;Thymus and Activation Regulated Chemokine | A measurement of the CCL17, chemokine (C-C motif) ligand 17, in a biological specimen. | Chemokine (C-C Motif) Ligand 17 Measurement | ||
| CCL18 | C112237 | AMAC-1;AMAC1;CKB7;Chemokine (C-C Motif) Ligand 18;DC-CK1;DCCK1;MIP-4;Macrophage inflammatory protein-4;PARC;Pulmonary and Activation-Regulated Chemokine;SCYA18 | A measurement of the CCL18, chemokine (C-C motif) ligand 18, in a biological specimen. | Chemokine (C-C Motif) Ligand 18 Measurement | ||
| CCPAB | C96595 | Cyclic Citrullinated Peptide Antibody | A measurement of the cyclic citrullinated peptide antibody in a biological specimen. | Cyclic Citrullinated Peptide Antibody Measurement | ||
| CD1 | C103364 | CD1 | A count of the CD1 expressing cells per unit of a biological specimen. | CD1 Expressing Cell Measurement | ||
| CD10 | C111146 | CD10 | A measurement of the CD10 expressing cells per unit in a biological specimen. | CD10 Expressing Cell Count | ||
| CD11A | C105439 | CD11A;CD11a | A count of the CD11a expressing cells per unit of a biological specimen. | CD11A Expressing Cell Count | ||
| CD11B | C105440 | CD11B;CD11b;Complement Component 3 Receptor 3 Subunit;Complement Receptor Type 3 Alpha Subunit;ITGAM Protein;Integrin Alpha-M | A count of the CD11b expressing cells per unit of a biological specimen. | CD11B Expressing Cell Count | ||
| CD13 | C111147 | CD13 | A measurement of the CD13 expressing cells per unit in a biological specimen. | CD13 Expressing Cell Count | ||
| CD14 | C103365 | CD14 | A count of the CD14 expressing cells per unit of a biological specimen. | CD14 Expressing Cell Measurement | ||
| CD19 | C103808 | CD19 | A count of the CD19 expressing cells per unit in a biological specimen. | CD19 Expressing Cell Count | ||
| CD19LY | C103812 | CD19/Lymphocytes | A relative measurement (ratio or percentage) of CD19 expressing cells to all lymphocytes in a biological specimen. | CD19 Cell to Lymphocyte Ratio Measurement | ||
| CD2 | C103366 | CD2 | A count of the CD2 expressing cells per unit of a biological specimen. | CD2 Expressing Cell Measurement | ||
| CD20 | C103368 | CD20 | A count of the CD20 expressing cells per unit of a biological specimen. | CD20 Expressing Cell Measurement | ||
| CD22 | C111148 | CD22 | A measurement of the CD22 expressing cells per unit in a biological specimen. | CD22 Expressing Cell Count | ||
| CD23 | C111149 | CD23 | A measurement of the CD23 expressing cells per unit in a biological specimen. | CD23 Expressing Cell Count | ||
| CD2LY | C103367 | CD2/Lymphocytes | A relative measurement (ratio or percentage) of CD2 expressing cells to all lymphocytes in a biological specimen. | CD2 Expressing Cell to Lymphocyte Ratio Measurement | ||
| CD3 | C103809 | CD3 | A count of the CD3 expressing cells per unit in a biological specimen. | CD3 Expressing Cell Count | ||
| CD33 | C111150 | CD33 | A measurement of the CD33 expressing cells per unit in a biological specimen. | CD33 Expressing Cell Count | ||
| CD34 | C102260 | CD34 | A measurement of the CD34 expressing cells per unit in a biological specimen. | CD34 Measurement | ||
| CD38 | C111151 | CD38 | A measurement of the CD38 expressing cells per unit in a biological specimen. | CD38 Expressing Cell Count | ||
| CD3LY | C103813 | CD3/Lymphocytes | A relative measurement (ratio or percentage) of CD3 expressing cells to all lymphocytes in a biological specimen. | CD3 Cell to Lymphocyte Ratio Measurement | ||
| CD4 | C103810 | CD4 | A count of the CD4 expressing cells per unit in a biological specimen. | CD4 Expressing Cell Count | ||
| CD40 | C82006 | CD40 | A count of the CD40 cells per unit in a biological specimen. | CD40 Measurement | ||
| CD40L | C82007 | CD40 Ligand | A count of the CD40 ligand cells per unit in a biological specimen. | CD40 Ligand Measurement | ||
| CD4CD8 | C103814 | CD4/CD8 | A relative measurement (ratio or percentage) of CD4 expressing cells to the CD8 expressing cells in a biological specimen. | CD4 Cell to CD8 Cell Ratio Measurement | ||
| CD4LY | C103815 | CD4/Lymphocytes | A relative measurement (ratio or percentage) of CD4 expressing cells to all lymphocytes in a biological specimen. | CD4 Cell to Lymphocyte Ratio Measurement | ||
| CD5 | C103369 | CD5 | A count of the CD5 expressing cells per unit of a biological specimen. | CD5 Expressing Cell Measurement | ||
| CD56 | C103370 | CD56 | A count of the CD56 expressing cells per unit of a biological specimen. | CD56 Expressing Cell Measurement | ||
| CD79A | C111152 | CD79A | A measurement of the CD79A expressing cells per unit in a biological specimen. | CD79A Expressing Cell Count | ||
| CD8 | C103811 | CD8 | A count of the CD8 expressing cells per unit in a biological specimen. | CD8 Expressing Cell Count | ||
| CD8LY | C103816 | CD8/Lymphocytes | A relative measurement (ratio or percentage) of CD8 expressing cells to all lymphocytes in a biological specimen. | CD8 Cell to Lymphocyte Ratio Measurement | ||
| CDFTXN | C103381 | Clostridium difficile Toxin | A measurement of the Clostridium difficile toxin in a biological specimen. | Clostridium difficile Toxin Measurement | ||
| CDT | C101016 | Carbohydrate-Deficient Transferrin | A measurement of transferrin with a reduced number of carbohydrate moieties in a biological specimen. | Carbohydrate-Deficient Transferrin Measurement | ||
| CEA | C81983 | Carcinoembryonic Antigen | A measurement of the carcinoembryonic antigen in a biological specimen. | Carcinoembryonic Antigen Measurement | ||
| CEC | C96592 | Circulating Endothelial Cells | A measurement of the circulating endothelial cells in a biological specimen. | Circulating Endothelial Cell Count | ||
| CEIMCE | C111234 | Immature Cells/Total Cells | A relative measurement (ratio or percentage) of the immature hematopoietic cells to total cells in a biological specimen. | Immature Cell to Total Cell Ratio Measurement | ||
| CELLSIM | C96672 | Immature Cells | A measurement of the total immature cells in a blood specimen. | Immature Cell Count | ||
| CELLULAR | C111153 | Cellularity;Cellularity Grade | A measurement of the degree, quality or condition of cells in a biological specimen. | Cellularity Measurement | ||
| CENTROAB | C111154 | Anti-Centromere B Antibodies | A measurement of centromere B antibodies in a biological specimen. | Centromere B Antibody Measurement | ||
| CETPA | C103380 | Cholesteryl Ester Transfer Protein Act | A measurement of the biological activity of cholesteryl ester transfer protein in a biological specimen. | Cholesteryl Ester Transfer Protein Activity Measurement | ||
| CGMP | C111165 | Cyclic Guanosine 3,5-Monophosphate | A measurement of the cyclic guanosine 3,5-monophosphate in a biological specimen. | Cyclic Guanosine Monophosphate Measurement | ||
| CH50 | C100423 | CH50;Complement CH50;Total Hemolytic Complement | A measurement of the complement required to lyse 50 percent of red blood cells in a biological specimen. | CH50 Measurement | ||
| CHOL | C105586 | Cholesterol;Total Cholesterol | A measurement of the cholesterol in a biological specimen. | Cholesterol Measurement | ||
| CHOLHDL | C80171 | Cholesterol/HDL-Cholesterol | A relative measurement (ratio or percentage) of total cholesterol to high-density lipoprotein cholesterol (HDL-C) in a biological specimen. | Cholesterol to HDL-Cholesterol Ratio Measurement | ||
| CHOLINES | C92289 | Cholinesterase | A measurement of the cholinesterase in a biological specimen. | Cholinesterase Measurement | ||
| CHYTRYP | C111159 | Chymotrypsin | A measurement of the total chymotrypsin in a biological specimen. | Chymotrypsin Measurement | ||
| CITRATE | C92248 | Citrate | A measurement of the citrate in a biological specimen. | Citrate Measurement | ||
| CK | C64489 | Creatine Kinase | A measurement of the total creatine kinase in a biological specimen. | Creatine Kinase Measurement | ||
| CKBB | C64490 | Creatine Kinase BB | A measurement of the homozygous B-type creatine kinase in a biological specimen. | Creatine Kinase BB Measurement | ||
| CKBBCK | C79466 | Creatine Kinase BB/Total Creatine Kinase | A relative measurement (ratio or percentage) of the BB-type creatine kinase to total creatine kinase in a biological specimen. | Creatine Kinase BB to Total Creatine Kinase Ratio Measurement | ||
| CKMB | C64491 | Creatine Kinase MB | A measurement of the heterozygous MB-type creatine kinase in a biological specimen. | Creatine Kinase MB Measurement | ||
| CKMBCK | C79441 | Creatine Kinase MB/Total Creatine Kinase | A relative measurement (ratio or percentage) of the MB-type creatine kinase to total creatine kinase in a biological specimen. | Creatine Kinase MB to Total Creatine Kinase Ratio Measurement | ||
| CKMM | C64494 | Creatine Kinase MM | A measurement of the homozygous M-type creatine kinase in a biological specimen. | Creatine Kinase MM Measurement | ||
| CKMMCK | C79442 | Creatine Kinase MM/Total Creatine Kinase | A relative measurement (ratio or percentage) of the MM-type creatine kinase to total creatine kinase in a biological specimen. | Creatine Kinase MM to Total Creatine Kinase Ratio Measurement | ||
| CL | C64495 | Chloride | A measurement of the chloride in a biological specimen. | Chloride Measurement | ||
| CLARITY | C96594 | Clarity | A measurement of the transparency of a biological specimen. | Clarity Measurement | ||
| CLCLR | C106509 | Chloride Clearance | A measurement of the volume of serum or plasma that would be cleared of chloride by excretion of urine for a specified unit of time (e.g. one minute). | Chloride Clearance Measurement | ||
| CLCREAT | C79440 | Chloride/Creatinine | A relative measurement (ratio or percentage) of the chloride to creatinine in a biological specimen. | Chloride to Creatinine Ratio Measurement | ||
| CLCTONN | C74848 | Calcitonin | A measurement of the calcitonin hormone in a biological specimen. | Calcitonin Measurement | ||
| CLCTRIOL | C74849 | Calcitriol | A measurement of the calcitriol hormone in a biological specimen. | Calcitriol Measurement | ||
| CLEXR | C117832 | Chloride Excretion Rate | A measurement of the amount of chloride being excreted in urine over a defined period of time (e.g. one hour). | Chloride Urine Excretion Rate | ||
| CLUECE | C102261 | Clue Cells | A measurement of the clue cells in a biological specimen. | Clue Cell Count | ||
| CMVIGGAB | C96596 | Cytomegalovirus IgG Antibody | A measurement of the cytomegalovirus IgG antibody in a biological specimen. | Cytomegalovirus IgG Antibody Measurement | ||
| CMVIGMAB | C96597 | Cytomegalovirus IgM Antibody | A measurement of the cytomegalovirus IgM antibody in a biological specimen. | Cytomegalovirus IgM Antibody Measurement | ||
| CMVVLD | C98716 | CMV Viral Load | A measurement of the cytomegalovirus viral load in a biological specimen. | Cytomegalovirus Viral Load Measurement | ||
| CO2 | C64545 | Carbon Dioxide | A measurement of the carbon dioxide gas in a biological specimen. | Carbon Dioxide Measurement | ||
| COAGIDX | C112239 | CI;Coagulation Index | A measurement of the efficiency of coagulation of a biological specimen. This is calculated by a mathematical formula that takes into account the R value, K value, angle and maximum amplitude of clot formation. | Coagulation Index Measurement | ||
| COCAINE | C74690 | Cocaine | A measurement of the cocaine present in a biological specimen. | Cocaine Measurement | ||
| COCCAB | C111160 | Coccidioides Antibody | A measurement of the coccidioides antibody in a biological specimen. | Coccidioides Antibody Measurement | ||
| CODEINE | C74877 | Codeine | A measurement of the codeine present in a biological specimen. | Codeine Measurement | ||
| COL4 | C103383 | Collagen Type IV | A measurement of the collagen type IV in a biological specimen. | Collagen Type IV Measurement | ||
| COLOR | C64546 | Color | A measurement of the color of a biological specimen. | Color Assessment | ||
| COMP | C111145 | Cartilage Oligomeric Matrix Protein | A measurement of the cartilage oligomeric matrix protein in a biological specimen. | Cartilage Oligomeric Matrix Protein Measurement | ||
| CONDUCTU | C102282 | Urine Conductivity | A measurement of the urine conductivity which is a non-linear function of the electrolyte concentration in the urine. | Urine Conductivity | ||
| COPPER | C111161 | Copper;Cu | A measurement of copper in a biological specimen. | Copper Measurement | ||
| CORCREAT | C106512 | Cortisol/Creatinine | A relative measurement (ratio or percentage) of the cortisol to creatinine present in a sample. | Cortisol to Creatinine Ratio Measurement | ||
| CORTFR | C88113 | Cortisol, Free | A measurement of the free, unbound cortisol in a biological specimen. | Free Cortisol Measurement | ||
| CORTISOL | C74781 | Cortisol;Total Cortisol | A measurement of the cortisol in a biological specimen. | Cortisol Measurement | ||
| COTININE | C92249 | Cotinine | A measurement of the cotinine in a biological specimen. | Cotinine Measurement | ||
| CPEPTIDE | C74736 | C-peptide | A measurement of the C (connecting) peptide of insulin in a biological specimen. | C-peptide Measurement | ||
| CPNIGAAB | C92432 | Chlamydia pneumoniae IgA Antibody | A measurement of the Chlamydia pneumoniae IgA antibody in a biological specimen. | Chlamydia pneumoniae IgA Antibody Measurement | ||
| CPNIGMAB | C92433 | Chlamydia pneumoniae IgM Antibody | A measurement of the Chlamydia pneumoniae IgM in a biological specimen. | Chlamydia pneumoniae IgM Antibody Measurement | ||
| CRDIGGAB | C111144 | Anti-Cardiolipin IgG Antibody;Cardiolipin IgG Antibody | A measurement of the cardiolipin IgG antibody in a biological specimen. | Cardiolipin IgG Antibody Measurement | ||
| CRDIGMAB | C103363 | Cardiolipin IgM Antibody | A measurement of the cardiolipin IgM antibodies in a biological specimen. | Cardiolipin IgM Antibody Measurement | ||
| CREAT | C64547 | Creatinine | A measurement of the creatinine in a biological specimen. | Creatinine Measurement | ||
| CREATCLR | C25747 | Creatinine Clearance | A measurement of the volume of serum or plasma that would be cleared of creatinine by excretion of urine for a specified unit of time (e.g. one minute). | Creatinine Clearance | ||
| CREATEXR | C117833 | Creatinine Excretion Rate | A measurement of the amount of creatinine being excreted in urine over a defined amount of time (e.g. one hour). | Creatinine Urine Excretion Rate | ||
| CRENCE | C74703 | Crenated Cells;Echinocytes | A measurement of the Burr cells (erythrocytes characterized by the presence of multiple small, sharp projections evenly distributed across the cell surface) in a biological specimen. | Crenated Cell Measurement | ||
| CRH | C74851 | Corticotropin Releasing Factor;Corticotropin Releasing Hormone | A measurement of the corticotropin releasing hormone in a biological specimen. | Corticotropin Releasing Hormone Measurement | ||
| CRLPLSMN | C100432 | Caeruloplasmin;Ceruloplasmin | A measurement of ceruloplasmin in a biological specimen. | Ceruloplasmin Measurement | ||
| CRP | C64548 | C Reactive Protein | A measurement of the C reactive protein in a biological specimen. | C-Reactive Protein Measurement | ||
| CRTCREAT | C106511 | Corticosterone/Creatinine | A relative measurement (ratio or percentage) of the corticosterone to creatinine present in a sample. | Corticosterone to Creatinine Ratio Measurement | ||
| CRTRONE | C79434 | Corticosterone | A measurement of corticosterone in a biological specimen. | Corticosterone Measurement | ||
| CRYOGLBN | C111164 | Cryoglobulin | A measurement of cryoglobulin in a biological specimen. | Cryoglobulin Measurement | ||
| CRYSTALS | C74673 | Crystals | A statement that indicates crystals were looked for in a biological specimen. | Crystal Present Or Absent | ||
| CSBACT | C74762 | Bacterial Casts | A measurement of the bacterial casts present in a biological specimen. | Bacterial Cast Measurement | ||
| CSBROAD | C96588 | Broad Casts | A measurement of the broad casts in a biological specimen. | Broad Casts Measurement | ||
| CSCELL | C74764 | Cellular Casts | A measurement of the cellular (white blood cell, red blood cell, epithelial and bacterial) casts present in a biological specimen. | Cellular Cast Measurement | ||
| CSEPI | C74779 | Epithelial Casts | A measurement of the epithelial cell casts present in a biological specimen. | Epithelial-Cast Measurement | ||
| CSEPI846 | C112220 | 846-Epitope;Aggrecan Chondroitin Sulfate Epitope 846;CS846;Chondroitin Sulfate Epitope 846;Chondroitin Sulfate Proteoglycan 1 Epitope 846 | A measurement of the 846 epitope present on the chondroitin sulfate chains of aggrecan in a biological specimen. | Aggrecan Chondroitin Sulfate Epitope 846 Measurement | ||
| CSFAT | C74766 | Fatty Casts | A measurement of the fatty casts present in a biological specimen. | Fatty Cast Measurement | ||
| CSGRAN | C74768 | Granular Casts | A measurement of the granular (coarse and fine) casts present in a biological specimen. | Granular Cast Measurement | ||
| CSGRANC | C74765 | Granular Coarse Casts | A measurement of the coarse granular casts present in a biological specimen. | Coarse Granular Cast Measurement | ||
| CSGRANF | C74769 | Granular Fine Casts | A measurement of the fine granular casts present in a biological specimen. | Granular Fine Cast Measurement | ||
| CSHYAL | C74770 | Hyaline Casts | A measurement of the hyaline casts present in a biological specimen. | Hyaline Cast Measurement | ||
| CSMIX | C74771 | Mixed Casts | A measurement of the mixed (the cast contains a mixture of cell types) casts present in a biological specimen. | Mixed Cast Count | ||
| CSRBC | C74772 | RBC Casts | A measurement of the red blood cell casts present in a biological specimen. | Red Blood Cell Cast Measurement | ||
| CSUNCLA | C74776 | Unclassified Casts | A measurement of the unclassifiable casts present in a biological specimen. | Unclassified Cast Measurement | ||
| CSWAX | C74777 | Waxy Casts | A measurement of the waxy casts present in a biological specimen. | Waxy Cell Cast Measurement | ||
| CSWBC | C74778 | WBC Casts | A measurement of the white blood cell casts present in a biological specimen. | White Blood Cell Cast Measurement | ||
| CTBIGGAB | C116194 | Cholera Toxin B Subunit IgG Antibody | A measurement of the cholera toxin B subunit IgG antibody in a biological specimen. | Cholera Toxin B Subunit IgG Antibody Measurement | ||
| CTC | C96593 | Circulating Tumor Cells | A measurement of the circulating tumor cells in a biological specimen. | Circulating Tumor Cell Count | ||
| CTOT | C80160 | Complement Total | A measurement of the total complement in a biological specimen. | Complement Measurement | ||
| CTRIGAAB | C100464 | Chlamydia trachomatis IgA Antibody | A measurement of the Chlamydia trachomatis IgA antibody in a biological specimen. | Chlamydia trachomatis IgA Antibody Measurement | ||
| CTRIGGAB | C100466 | Chlamydia trachomatis IgG Antibody | A measurement of the Chlamydia trachomatis IgG antibody in a biological specimen. | Chlamydia trachomatis IgG Antibody Measurement | ||
| CTRIGMAB | C100465 | Chlamydia trachomatis IgM Antibody | A measurement of the Chlamydia trachomatis IgM antibody in a biological specimen. | Chlamydia trachomatis IgM Antibody Measurement | ||
| CTTIGGAB | C103382 | Clostridium tetani IgG Antibody | A measurement of the Clostridium tetani IgG antibody in a biological specimen. | Clostridium tetani IgG Antibody Measurement | ||
| CTXI | C82038 | Type I Collagen C-Telopeptides;Type I Collagen X-linked C-telopeptide | A measurement of the type I collagen C-telopeptides in a biological specimen. | Type I Collagen C-Telopeptide Measurement | ||
| CTXII | C82040 | Type II Collagen C-Telopeptides | A measurement of the type II collagen C-telopeptides in a biological specimen. | Type II Collagen C-Telopeptide Measurement | ||
| CXCL10 | C112238 | Chemokine (C-X-C Motif) Ligand 10;IP-10;Interferon Gamma-induced Protein 10;Small-inducible Cytokine B10 | A measurement of the CXCL10, chemokine (C-X-C motif) ligand 10, in a biological specimen. | Chemokine (C-X-C Motif) Ligand 10 Measurement | ||
| CXCR3 | C100431 | CD183;CXCR3;Chemokine (C-X-C Motif) Receptor 3;GPR9 | A measurement of the CXCR3, chemokine (C-X-C motif) receptor 3, in a biological specimen. | Chemokine Receptor CXCR3 Measurement | ||
| CYACIDU | C74912 | Acid Urate Crystals | A measurement of the acid urate crystals present in a biological specimen. | Acid Urate Crystal Measurement | ||
| CYAMMBIU | C105590 | Acid Ammonium Urate Crystals;Ammonium Biurate Crystals;Ammonium Urate Crystals | A measurement of the ammonium biurate crystals present in a biological specimen. | Ammonium Biurate Crystals Measurement | ||
| CYAMMOX | C74759 | Ammonium Oxalate Crystals | A measurement of the ammonium oxalate crystals present in a urine specimen. | Urine Ammonium Oxalate Crystal Measurement | ||
| CYAMORPH | C74665 | Amorphous Crystals | A measurement of the amorphous (Note: phosphate or urate, depending on pH) crystals present in a biological specimen. | Amorphous Crystal Measurement | ||
| CYAMPPH | C92243 | Amorphous Phosphate Crystals | A measurement of the amorphous phosphate crystals in a biological specimen. | Amorphous Phosphate Crystals Measurement | ||
| CYAMPURT | C92244 | Amorphous Urate Crystals | A measurement of the amorphous urate crystals in a biological specimen. | Amorphous Urate Crystals Measurement | ||
| CYBILI | C74668 | Bilirubin Crystals | A measurement of the bilirubin crystals present in a biological specimen. | Bilirubin Crystal Measurement | ||
| CYCACAR | C74669 | Calcium Carbonate Crystals | A measurement of the calcium carbonate crystals present in a biological specimen. | Calcium Carbonate Crystal Measurement | ||
| CYCAOXA | C74670 | Calcium Oxalate Crystals | A measurement of the calcium oxalate crystals present in a biological specimen. | Calcium Oxalate Crystal Measurement | ||
| CYCAPHOS | C74671 | Calcium Phosphate Crystals | A measurement of the calcium phosphate crystals present in a biological specimen. | Calcium Phosphate Crystal Measurement | ||
| CYCHOL | C74672 | Cholesterol Crystals | A measurement of the cholesterol crystals present in a biological specimen. | Cholesterol Crystal Measurement | ||
| CYCYSTIN | C74674 | Cystine Crystals | A measurement of the cystine crystals present in a biological specimen. | Cystine Crystal Measurement | ||
| CYFRA211 | C106514 | CYFRA21-1;Cytokeratin 19 Fragment;Cytokeratin Fragment 21-1 | A measurement of the cytokeratin 19 fragment 21-1 in a biological specimen. | Cytokeratin Fragment 21-1 Measurement | ||
| CYHGBC | C112288 | Hemoglobin C Crystals | A measurement of hemoglobin C crystals in a biological specimen. | Hemoglobin C Crystals Measurement | ||
| CYHIPPAC | C74754 | Hippuric Acid Crystals | A measurement of the hippuric acid crystals present in a biological specimen. | Hippuric Acid Crystal Measurement | ||
| CYLEUC | C74680 | Leucine Crystals | A measurement of the leucine crystals present in a biological specimen. | Leucine Crystal Measurement | ||
| CYMSU | C74681 | Monosodium Urate Crystals | A measurement of the monosodium urate crystals present in a biological specimen. | Monosodium Urate Crystal Measurement | ||
| CYSCREAT | C106513 | Cystatin C/Creatinine | A relative measurement (ratio or percentage) of the cystatin C to creatinine present in a sample. | Cystatin C to Creatinine Ratio Measurement | ||
| CYSTARCH | C81951 | Starch Crystals | A measurement of the starch crystals in a biological specimen. | Starch Crystal Measurement | ||
| CYSTATC | C92290 | Cystatin C | A measurement of the cystatin C in a biological specimen. | Cystatin C Measurement | ||
| CYSTINE | C105441 | Cystine | A measurement of the cystine in a biological specimen. | Cystine Measurement | ||
| CYSULFA | C74755 | Sulfa Crystals | A measurement of the sulfa crystals present in a biological specimen. | Sulfa Crystal Measurement | ||
| CYTRPHOS | C74756 | Triple Phosphate Crystals | A measurement of the triple phosphate crystals present in a biological specimen. | Triple Phosphate Crystal Measurement | ||
| CYTYRO | C74683 | Tyrosine Crystals | A measurement of the tyrosine crystals present in a biological specimen. | Tyrosine Crystal Measurement | ||
| CYUNCLA | C74757 | Unclassified Crystals | A measurement of the unclassifiable crystals present in a biological specimen. | Unclassified Crystal Measurement | ||
| CYURIAC | C74684 | Uric Acid Crystals | A measurement of the uric acid crystals present in a biological specimen. | Uric Acid Crystal Measurement | ||
| DDIMER | C82621 | D-Dimer | A measurement of the d-dimers in a biological specimen. | D-Dimer Measurement | ||
| DENSITY | C45781 | Density | A measurement of the compactness of a biological specimen expressed in mass per unit volume. | Density | ||
| DGNWBC | C111190 | Degenerated Leukocytes;Degenerated WBC;Degenerated White Blood Cells | A measurement of the degenerated leukocytes (leukocytes that show deterioration in form or function) in a biological specimen. | Degenerated Leukocyte Count | ||
| DHEA | C74852 | Dehydroepiandrosterone;Dehydroisoandrosterone | A measurement of the dehydroepiandrosterone hormone in a biological specimen. | Dehydroepiandrosterone Measurement | ||
| DHEAS | C96629 | DHEA Sulfate;DHEA-S;Dehydroepiandrosterone Sulfate;sDHEA | A measurement of the sulfated Dehydroepiandrosterone in a biological specimen. | Sulfated DHEA Measurement | ||
| DHPG | C101017 | 3,4-Dihydroxyphenylglycol;3.4 Dihydroxyphenylglycol | A measurement of the catecholamine metabolite, 3,4-Dihydroxyphenylglycol in a biological specimen. | 3,4-Dihydroxyphenylglycol Measurement | ||
| DHT | C74853 | Androstanalone;Dihydrotestosterone | A measurement of the dihydrotestosterone hormone in a biological specimen. | Dihydrotestosterone Measurement | ||
| DIHYDCDN | C74878 | Dihydrocodeine | A measurement of the dihydrocodeine present in a biological specimen. | Dihydrocodeine Measurement | ||
| DNAAB | C81973 | Anti-DNA Antibodies;Anti-ds-DNA Antibodies | A measurement of the anti-DNA antibodies in a biological specimen. | Anti-DNA Antibody Measurement | ||
| DNASEBAB | C100463 | Anti-Dnase B;DNase-B Antibody | A measurement of Dnase-B antibody in a biological specimen. | DNase-B Antibody Measurement | ||
| DOHLE | C74610 | Dohle Bodies | A measurement of the Dohle bodies (blue-gray, basophilic, leukocyte inclusions located in the peripheral cytoplasm of neutrophils) in a biological specimen. | Dohle Body Measurement | ||
| DOPAC | C103345 | 3,4-Dihydroxyphenylacetic Acid | A measurement of the 3,4-dihydroxyphenylacetic acid in a biological specimen. | 3,4-Dihydroxyphenylacetic Acid Measurement | ||
| DOPAMINE | C74854 | Dopamine | A measurement of the dopamine hormone in a biological specimen. | Dopamine Measurement | ||
| DPD | C79443 | Deoxypyridinoline | A measurement of the deoxypyridinoline in a biological specimen. | Deoxypyridinoline Measurement | ||
| DPDCREAT | C79444 | Deoxypyridinoline/Creatinine | A relative measurement (ratio or percentage) of the deoxypyridinoline to creatinine in a biological specimen. | Deoxypyridinoline to Creatinine Ratio Measurement | ||
| DPPIVA | C103387 | DPPIV Activity | A measurement of the biological activity of dipeptidyl peptidase-4 in a biological specimen. | Dipeptidyl Peptidase-4 Activity Measurement | ||
| DPTIGGAB | C103388 | Diphtheria IgG Antibody | A measurement of the Diphtheria IgG antibodies in a biological specimen. | Diphtheria IgG Antibody Measurement | ||
| DRUGSCR | C78139 | Drug Screen | An indication of the presence or absence of recreational drugs or drugs of abuse in a biological specimen. | Drug Test | ||
| DRVVT | C96696 | Dilute Russell's Viper Venom Time;Lupus Anticoagulant Test | A measurement of the time it takes a plasma sample to clot after adding dilute Russell's viper venom. | Dilute Russell's Viper Venom Time Measurement | ||
| DRVVTRT | C103386 | Lupus Anticoagulant Ratio | A relative measurement (ratio or percentage) of the dilute Russell's viper venom time in a subject sample to a control sample. | Dilute Russell's Viper Venom Time to Control Ratio Measurement | ||
| DTPACLR | C100441 | DTPA Clearance | A measurement of the volume of serum or plasma that would be cleared of Diethylenetriamine pentaacetate (DTPA) through its excretion for a specified unit of time. | Diethylene Triamine Pentaacetic Acid Clearance | ||
| EBCIGGAB | C96600 | Epstein-Barr Capsid IgG Antibody | A measurement of the Epstein-Barr capsid IgG antibody in a biological specimen. | Epstein-Barr Capsid IgG Antibody Measurement | ||
| EBCIGMAB | C96601 | Epstein-Barr Capsid IgM Antibody | A measurement of the Epstein-Barr capsid IgM antibody in a biological specimen. | Epstein-Barr Capsid IgM Antibody Measurement | ||
| EBEAG | C96602 | Epstein-Barr Early Antigen | A measurement of the Epstein-Barr early antigen in a biological specimen. | Epstein-Barr Early Antigen Measurement | ||
| EBN1IGAB | C106518 | Epstein-Barr Nuclear Antigen 1 IgG Ab | A measurement of the Epstein-Barr nuclear antigen 1 IgG antibody in a biological specimen. | Epstein-Barr Nuclear Antigen 1 IgG Ab Measurement | ||
| EBNAB | C96603 | Epstein-Barr Nuclear Antibody;Epstein-Barr Nuclear Antigen Antibody | A measurement of the Epstein-Barr nuclear antibody in a biological specimen. | Epstein-Barr Nuclear Antibody Measurement | ||
| EBNAG | C96604 | Epstein-Barr Nuclear Antigen | A measurement of the Epstein-Barr nuclear antigen in a biological specimen. | Epstein-Barr Nuclear Antigen Measurement | ||
| EBVINTP | C106519 | EBV Profile Interpretation;Epstein-Barr Virus Antibody Profile;Epstein-Barr Virus Panel;Epstein-Barr Virus Profile Interpretation | An assessment of Epstein-Barr virus infection based on a panel of EBV antigen antibody tests. | Epstein-Barr Virus Profile Interpretation | ||
| EBVVLD | C98721 | EBV Viral Load | A measurement of the Epstein-Barr virus viral load in a biological specimen. | Epstein-Barr Virus Viral Load Measurement | ||
| ECCENTCY | C96598 | Eccentrocytes | A measurement of the eccentrocytes (erythrocytes in which the hemoglobin is localized to a particular portion of the cell, noticeable as localized staining) in a biological specimen. | Eccentrocyte Count | ||
| ECT | C100422 | Ecarin Clotting Time | A measurement of the activity of thrombin inhibitors in a biological specimen based on the generation of meizothrombin. | Ecarin Clotting Time Measurement | ||
| EDTACLR | C100440 | EDTA Clearance | A measurement of the volume of serum or plasma that would be cleared of Ethylenediamine tetraacetic acid (EDTA) through its excretion for a specified unit of time. | EDTA Clearance | ||
| EGF | C82009 | Epidermal Growth Factor | A measurement of the epidermal growth factor in a biological specimen. | Epidermal Growth Factor Measurement | ||
| EGFR | C112273 | ERBB1;Epidermal Growth Factor Receptor;HER1 | A measurement of the cells with positive expression of EGFR in a biological specimen. | Epidermal Growth Factor Receptor Measurement | ||
| ELA1 | C82028 | Pancreatic Elastase 1 | A measurement of the pancreatic elastase 1 in a biological specimen. | Pancreatic Elastase Measurement | ||
| ELA1PMN | C82029 | Pancreatic Elastase 1, Polymorphonuclear | A measurement of the polymorphonuclear pancreatic elastase 1 in a biological specimen. | Polymorphonuclear Pancreatic Elastase Measurement | ||
| ELA2 | C82026 | Neutrophil Elastase | A measurement of the neutrophil elastase in a biological specimen. | Neutrophil Elastase Measurement | ||
| ELA2PMN | C82027 | Neutrophil Elastase, Polymorphonuclear | A measurement of the polymorphonuclear neutrophil elastase in a biological specimen. | Polymorphonuclear Neutrophil Elastase Measurement | ||
| ELLIPCY | C64549 | Elliptocytes;Ovalocytes | A measurement of the elliptically shaped erythrocytes in a biological specimen. | Elliptocyte Count | ||
| ENA78 | C82010 | Epith Neutrophil-Activating Peptide 78 | A measurement of the epithelial neutrophil-activating peptide in a biological specimen. | Epithelial Neutrophil-Activating Peptide 78 Measurement | ||
| ENAAB | C92270 | Anti-ENA;Extractable Nuclear Antigen Antibody | A measurement of the extractable nuclear antigen antibody in a biological specimen. | Extractable Nuclear Antigen Antibody Measurement | ||
| ENDOTH1 | C82008 | Endothelin-1 | A measurement of the endothelin-1 in a biological specimen. | Endothelin-1 Measurement | ||
| ENRAGE | C82011 | Extracell Newly Ident RAGE Bind Protein;S100 Calcium Binding Protein A12 | A measurement of the extracellular newly identified RAGE (receptor for advanced glycation end products) binding protein in a biological specimen. | Extracell Newly Ident RAGE Bind Protein Measurement | ||
| EOS | C64550 | Eosinophils | A measurement of the eosinophils in a biological specimen. | Eosinophil Count | ||
| EOSB | C114216 | Eosinophils Band Form | A measurement of the banded eosinophils in a biological specimen. | Eosinophil Band Form Count | ||
| EOSBLE | C114217 | Eosinophils Band Form/Leukocytes | A relative measurement (ratio or percentage) of the banded eosinophils to leukocytes in a biological specimen. | Eosinophil Band Form to Leukocyte Ratio | ||
| EOSCE | C98720 | Eosinophils/Total Cells | A relative measurement (ratio or percentage) of the eosinophils to total cells in a biological specimen (for example a bone marrow specimen). | Eosinophils to Total Cell Ratio Measurement | ||
| EOSIM | C96673 | Immature Eosinophils | A measurement of the immature eosinophils in a biological specimen. | Immature Eosinophil Count | ||
| EOSIMLE | C96674 | Immature Eosinophils/Leukocytes | A relative measurement (ratio or percentage) of immature eosinophils to total leukocytes in a biological specimen. | Immature Eosinophil to Leukocyte Ratio Measurement | ||
| EOSLE | C64604 | Eosinophils/Leukocytes | A relative measurement (ratio or percentage) of the eosinophils to leukocytes in a biological specimen. | Eosinophil to Leukocyte Ratio | ||
| EOSMM | C84819 | Eosinophilic Metamyelocytes | A measurement of the eosinphilic metamyelocytes in a biological specimen. | Eosinophilic Metamyelocyte Count | ||
| EOSMYL | C84821 | Eosinophilic Myelocytes | A measurement of the eosinophilic myelocytes in a biological specimen. | Eosinophilic Myelocyte Count | ||
| EOTAXIN1 | C81952 | Chemokine Ligand 11;Eotaxin-1 | A measurement of the eotaxin-1 in a biological specimen. | Eotaxin-1 Measurement | ||
| EOTAXIN2 | C81953 | Chemokine Ligand 24;Eotaxin-2 | A measurement of the eotaxin-2 in a biological specimen. | Eotaxin-2 Measurement | ||
| EOTAXIN3 | C81954 | CCL26;Chemokine (C-C Motif) Ligand 26;Chemokine Ligand 26;Eotaxin-3 | A measurement of the eotaxin-3 in a biological specimen. | Eotaxin-3 Measurement | ||
| EPIC | C64605 | Epithelial Cells | A measurement of the epithelial cells in a biological specimen. | Epithelial Cell Count | ||
| EPIN | C79445 | Adrenaline;Epinephrine | A measurement of the epinephrine hormone in a biological specimen. | Epinephrine Measurement | ||
| EPIROCE | C74698 | Round Epithelial Cells | A measurement of the round epithelial cells present in a biological specimen. | Round Epithelial Cell Count | ||
| EPISQCE | C74773 | Squamous Epithelial Cells | A measurement of the squamous epithelial cells present in a biological specimen. | Squamous Epithelial Cell Count | ||
| EPISQTCE | C74774 | Epithelial Cells;Squamous Transitional Epithelial Cells | A measurement of the squamous transitional epithelial cells present in a biological specimen. | Squamous Transitional Epithelial Cell Count | ||
| EPITCE | C92251 | Transitional Epithelial Cells | A measurement of the transitional epithelial cells present in a biological specimen. | Transitional Epithelial Cells Measurement | ||
| EPITUCE | C74775 | Renal Tubular Epithelial Cells;Tubular Epithelial Cells | A measurement of the tubular epithelial cells present in a biological specimen. | Tubular Epithelial Cell Count | ||
| EPO | C74855 | Erythropoietin;Hematopoietin | A measurement of the erythropoietin hormone in a biological specimen. | Erythropoietin Measurement | ||
| ESELS | C119273 | Soluble E-Selectin;sE-selectin | A measurement of the soluble E-Selectin activity in a biological specimen. | Soluble E-Selectin Measurement | ||
| ESR | C74611 | Biernacki Reaction;Erythrocyte Sedimentation Rate | The distance (e.g. millimeters) that red blood cells settle in unclotted blood over a specified unit of time (e.g. one hour). | Erythrocyte Sedimentation Rate Measurement | ||
| ESTRCPT | C112274 | ER;ESR;Estrogen Receptor;Oestrogen Receptor | A measurement of the cells with positive expression of estrogen receptor in a biological specimen. | Estrogen Receptor Measurement | ||
| ESTRDIOL | C74782 | Estradiol;Oestradiol | A measurement of the estradiol in a biological specimen. | Estradiol Measurement | ||
| ESTRIOL | C74856 | Estriol;Oestriol | A measurement of the estriol hormone in a biological specimen. | Estriol Measurement | ||
| ESTRIOLF | C81963 | Estriol, Free | A measurement of the free estriol in a biological specimen. | Free Estriol Measurement | ||
| ESTRONE | C74857 | Estrone;Oestrone | A measurement of the estrone hormone in a biological specimen. | Estrone Measurement | ||
| ETHANOL | C74693 | Alcohol;Ethanol | A measurement of the ethanol present in a biological specimen. | Ethanol Measurement | ||
| ETP | C102266 | Endogenous Thrombin Potential | A measurement of the total concentration of thrombin generated in the presence of a substrate in a plasma or blood sample. | Endogenous Thrombin Potential Measurement | ||
| ETPAUC | C102263 | ETP Area Under Curve;Endogenous Thrombin Potential Area Under Curve | A measurement of the area under the thrombin generation curve. | Endogenous Thrombin Potential Area Under Curve Measurement | ||
| ETPLT | C102264 | ETP Lag Time;Endogenous Thrombin Potential Lag Time | A measurement of time from the start of the thrombin generation test to the point where a predetermined amount of thrombin is generated. | Endogenous Thrombin Potential Lag Time Measurement | ||
| ETPLTR | C102265 | ETP Lag Time Relative;Endogenous Thrombin Potential Lag Time Relative | A relative measurement (ratio or percentage) of time from the start of the thrombin generation test to the point where a predetermined amount of thrombin is generated. | Endogenous Thrombin Potential Lag Time Relative Measurement | ||
| ETPPH | C102267 | ETP Peak Height;Endogenous Thrombin Potential Peak Height | A measurement of the maximum concentration of thrombin generated during a thrombin generation test. | Endogenous Thrombin Potential Peak Height Measurement | ||
| ETPPHR | C102268 | ETP Peak Height Relative;Endogenous Thrombin Potential Peak Height Relative | A relative (ratio or percentage) of the maximum concentration of thrombin generated during a thrombin generation test. | Endogenous Thrombin Potential Peak Height Relative Measurement | ||
| ETPTP | C102269 | ETP Time to Peak;Endogenous Thrombin Potential Time to Peak | A measurement of the time it takes to generate the maximum concentration of thrombin. | Endogenous Thrombin Potential Time to Peak Measurement | ||
| ETPTPR | C102270 | ETP Time to Peak Relative;Endogenous Thrombin Potential Time to Peak Relative | A relative (ratio or percentage) measurement of the time it takes to generate the maximum concentration of thrombin. | Endogenous Thrombin Potential Time to Peak Relative Measurement | ||
| FABP1 | C82012 | Fatty Acid Binding Protein 1 | A measurement of the fatty acid binding protein 1 in a biological specimen. | Fatty Acid Binding Protein 1 Measurement | ||
| FABP3 | C106521 | Fatty Acid Binding Protein 3 | A measurement of the fatty acid binding protein 3 in a biological specimen. | Fatty Acid Binding Protein 3 Measurement | ||
| FACTII | C96626 | Factor II;Prothrombin | A measurement of the Factor II in a biological specimen. | Prothrombin Measurement | ||
| FACTIII | C81959 | Factor III;Tissue Factor, CD142 | A measurement of the factor III in a biological specimen. | Factor III Measurement | ||
| FACTIX | C98725 | Christmas Factor;Factor IX | A measurement of the factor IX in a biological specimen. | Factor IX Measurement | ||
| FACTIXA | C103395 | Christmas Factor Activity | A measurement of the biological activity of factor IX in a biological specimen. | Factor IX Activity Measurement | ||
| FACTV | C98726 | Factor V;Labile Factor | A measurement of the factor V in a biological specimen. | Factor V Measurement | ||
| FACTVA | C103396 | Labile Factor Activity | A measurement of the biological activity of factor V in a biological specimen. | Factor V Activity Measurement | ||
| FACTVII | C81960 | Factor VII;Proconvertin;Stable Factor | A measurement of the factor VII in a biological specimen. | Factor VII Measurement | ||
| FACTVIIA | C103397 | Proconvertin Activity;Stable Factor Activity | A measurement of the biological activity of factor VII in a biological specimen. | Factor VII Activity Measurement | ||
| FACTVIII | C81961 | Anti-hemophilic Factor;Factor VIII | A measurement of the factor VIII in a biological specimen. | Factor VIII Measurement | ||
| FACTVL | C102271 | Factor V Leiden | A measurement of the Factor V Leiden in a biological specimen. | Factor V Leiden Measurement | ||
| FACTVW | C98799 | von Willebrand Factor;von Willebrand Factor Antigen | A measurement of the von Willebrand factor in a biological specimen. | von Willebrand Factor Measurement | ||
| FACTX | C98727 | Factor X | A measurement of the factor X in a biological specimen. | Factor X Measurement | ||
| FACTXIII | C112277 | Factor XIII;Fibrin Stablizing Factor | A measurement of the factor XIII in a biological specimen. | Factor XIII Measurement | ||
| FACTXIV | C102272 | Autoprothrombin IIA;Factor XIV;Protein C;Protein C Antigen | A measurement of the factor XIV in a biological specimen. | Factor XIV Measurement | ||
| FACTXIVA | C105442 | Factor XIV Activity;Protein C Activity;Protein C Function | A measurement of the factor XIV activity in a biological specimen. | Factor XIV Activity Measurement | ||
| FAT | C96648 | Fat | A measurement of the fat in a biological specimen. | Fat Measurement | ||
| FATACFR | C80200 | Free Fatty Acid;Non-Esterified Fatty Acid, Free | A measurement of the total non-esterified fatty acids in a biological specimen. | Non-esterified Fatty Acids Measurement | ||
| FATACFRS | C80206 | Free Fatty Acid, Saturated;Non-esterified Fatty Acid, Saturated | A measurement of the saturated non-esterified fatty acids in a biological specimen. | Saturated Non-esterified Fatty Acids Measurement | ||
| FATACFRU | C80209 | Free Fatty Acid, Unsaturated;Non-esterified Fatty Acid, Unsaturated | A measurement of the unsaturated non-esterified fatty acids in a biological specimen. | Unsaturated Non-esterified Fatty Acids Measurement | ||
| FATBODOV | C81947 | Fat Bodies, Oval | A measurement of the oval-shaped fat bodies, usually renal proximal tubular cells with lipid aggregates in the cytoplasm, in a biological specimen. | Oval Fat Body Measurement | ||
| FATDROP | C98728 | Fat Droplet | A measurement of the triglyceride aggregates within a biological specimen. | Fat Droplet Measurement | ||
| FBRTST | C105443 | FibroSURE Score;FibroTest Score | A biomarker test that measures liver pathology through the assessment of a six-parameter blood test (for Alpha-2-macroglobulin, Haptoglobin, Apolipoprotein A1, Gamma-glutamyl transpeptidase (GGT), Total bilirubin, and Alanine aminotransferase (ALT)), taking into account the age and gender of the patient. | FibroTest Score Measurement | ||
| FCTVIIAA | C103398 | Factor VIIa Activity | A measurement of the biological activity of factor VIIa in a biological specimen. | Factor VIIa Activity Measurement | ||
| FCTVIIIA | C103399 | Anti-hemophilic Factor Activity | A measurement of the biological activity of factor VIII in a biological specimen. | Factor VIII Activity Measurement | ||
| FDP | C82013 | Fibrin Degradation Products | A measurement of the fibrin degradation products in a biological specimen. | Fibrin Degradation Products Measurement | ||
| FECA | C114219 | Fractional Calcium Excretion | A measurement of the fractional excretion of calcium that is computed based upon the concentrations of calcium and creatinine in both blood and urine. | Fractional Excretion of Calcium | ||
| FECL | C114220 | Fractional Chloride Excretion | A measurement of the fractional excretion of chloride that is computed based upon the concentrations of chloride and creatinine in both blood and urine. | Fractional Excretion of Chloride | ||
| FEK | C114222 | Fractional Potassium Excretion | A measurement of the fractional excretion of potassium that is computed based upon the concentrations of potassium and creatinine in both blood and urine. | Fractional Excretion of Potassium | ||
| FENA | C107435 | Fractional Sodium Excretion | A measurement of the fractional excretion of sodium that is computed based upon the concentrations of sodium and creatinine in both blood and urine. | Fractional Excretion of Sodium | ||
| FEPI | C114221 | Fractional Inorganic Phosphate Excretion;Fractional Phosphorus Excretion | A measurement of the fractional excretion of phosphorus that is computed based upon the concentrations of phosphorus and creatinine in both blood and urine. | Fractional Excretion of Phosphate | ||
| FERRITIN | C74737 | Ferritin | A measurement of the ferritin in a biological specimen. | Ferritin Measurement | ||
| FGF21 | C112280 | FGF 21;Fibroblast Growth Factor 21 | A measurement of the fibroblast growth factor 21 in a biological specimen. | Fibroblast Growth Factor 21 Measurement | ||
| FGF23 | C96650 | Fibroblast Growth Factor 23;Phosphatonin | A measurement of the fibroblast growth factor 23 in a biological specimen. | Fibroblast Growth Factor 23 Measurement | ||
| FGFBF | C82014 | FGF2;Fibroblast Growth Factor Basic Form | A measurement of the basic form of fibroblast growth factor in a biological specimen. | Fibroblast Growth Factor Basic Form Measurement | ||
| FIBRINO | C64606 | Fibrinogen | A measurement of the fibrinogen in a biological specimen. | Fibrinogen Measurement | ||
| FRUCT | C74678 | Fructosamine;Glycated Serum Protein | A measurement of the fructosamine in a biological specimen. | Fructosamine Measurement | ||
| FSH | C74783 | Follicle Stimulating Hormone | A measurement of the follicle stimulating hormone (FSH) in a biological specimen. | Follicle Stimulating Hormone Measurement | ||
| G6PD | C80184 | Glucose-6-Phosphate Dehydrogenase | A measurement of the glucose-6-phosphate dehydrogenase in a biological specimen. | Glucose-6-Phosphate Dehydrogenase Measurement | ||
| GAD1 | C82015 | Glutamic Acid Decarboxylase 1;Glutamic Acid Decarboxylase 67 | A measurement of the glutamic acid decarboxylase 1 in a biological specimen. | Glutamic Acid Decarboxylase 1 Measurement | ||
| GAD2 | C82016 | Glutamic Acid Decarboxylase 2;Glutamic Acid Decarboxylase 65 | A measurement of the glutamic acid decarboxylase 2 in a biological specimen. | Glutamic Acid Decarboxylase 2 Measurement | ||
| GAD2AB | C82017 | Glutamic Acid Decarboxylase 2 Antibody;Glutamic Acid Decarboxylase 65 Antibody | A measurement of the glutamic acid decarboxylase 2 antibody in a biological specimen. | Glutamic Acid Decarboxylase 2 Antibody Measurement | ||
| GADAB | C96653 | GAD Antibody;Glutamic Acid Decarboxylase Antibody | A measurement of the glutamic acid decarboxylase antibody in a biological specimen. | Glutamic Acid Decarboxylase Antibody Measurement | ||
| GALANIN | C80182 | Galanin | A measurement of the galanin in a biological specimen. | Galanin Measurement | ||
| GASTRIN | C74858 | Gastrin | A measurement of the gastrin hormone in a biological specimen. | Gastrin Measurement | ||
| GATCPHRL | C116211 | Gamma Tocopherol | A measurement of the gamma tocopherol in a biological specimen. | Gamma Tocopherol Measurement | ||
| GCSF | C82018 | Granulocyte Colony Stimulating Factor | A measurement of the granulocyte colony stimulating factor in a biological specimen. | Granulocyte Colony Stimulating Factor Measurement | ||
| GFR | C90505 | Glomerular Filtration Rate | A kidney function test that measures the fluid volume that is filtered from the kidney glomeruli to the Bowman's capsule per unit of time. | Glomerular Filtration Rate | ||
| GFRBSA | C98734 | Glomerular Filtration Rate Adj for BSA | A measurement of the glomerular filtration rate adjusted for body size. | Glomerular Filtration Rate Adjusted for BSA | ||
| GFRBSB2M | C100450 | GFR from B-2 Microglobulin Adj for BSA | A measurement of the glomerular filtration rate (GFR) based on the clearance of beta-2 microglobulin after adjusting it for the body surface area. | Glomerular Filtration Rate from B-2 Microglobulin Adjusted for BSA Measurement | ||
| GFRBSBTP | C100449 | GFR from Beta-Trace Protein Adj for BSA | A measurement of the glomerular filtration rate (GFR) based on the clearance of beta-trace protein after adjusting it for the body surface area. | Glomerular Filtration Rate from Beta-Trace Protein Adjusted for BSA Measurement | ||
| GFRBSCRT | C98735 | GFR from Creatinine Adjusted for BSA | An estimation of the glomerular filtration rate adjusted for body size based on creatinine. | Glomerular Filtration Rate from Creatinine Adjusted for BSA | ||
| GFRBSCYC | C98736 | GFR from Cystatin C Adjusted for BSA | An estimation of the glomerular filtration rate adjusted for body size based on cystatin C. | Glomerular Filtration Rate from Cystatin C Adjusted for BSA | ||
| GGT | C64847 | Gamma Glutamyl Transferase | A measurement of the gamma glutamyl transferase in a biological specimen. | Gamma Glutamyl Transpeptidase Measurement | ||
| GGTCREAT | C79446 | Gamma Glutamyl Transferase/Creatinine | A relative measurement (ratio or percentage) of the gamma glutamyl transferase to creatinine in a biological specimen. | Gamma Glutamyl Transferase to Creatinine Ratio Measurement | ||
| GHRELIN | C112286 | Ghrelin;Growth Hormone Secretagogue Receptor Ligand;Motilin-related Peptide;Total Ghrelin | A measurement of total ghrelin in a biological specimen. | Ghrelin Measurement | ||
| GHRELINA | C112219 | Active Ghrelin;Ghrelin | A measurement of active ghrelin in a biological specimen. | Active Ghrelin Measurement | ||
| GIPI | C106537 | Glucose-dep Insulinotropic Pep, Intact;Intact GIP;Intact Gastric Inhibitory Polypeptide;Intact Glucose-dependent Insulinotropic Peptide | A measurement of the intact (containing amino acids 1-42) glucose-dependent insulinotropic peptide in a biological specimen. | Intact Glucose-dependent Insulinotropic Peptide Measurement | ||
| GLDH | C79448 | Glutamate Dehydrogenase | A measurement of the glutamate dehydrogenase in a biological specimen. | Glutamate Dehydrogenase Measurement | ||
| GLOBA1 | C92252 | A1-Globulin;Alpha-1 Globulin | A measurement of the proteins contributing to the alpha 1 fraction in a biological specimen. | Alpha-1 Globulin Measurement | ||
| GLOBA1PT | C92253 | Alpha-1 Globulin/Total Protein | A relative measurement (ratio or percentage) of alpha-1-fraction proteins to total proteins in a biological specimen. | Alpha-1 Globulin to Total Protein Ratio Measurement | ||
| GLOBA2 | C92254 | A2-Globulin;Alpha-2 Globulin | A measurement of the proteins contributing to the alpha 2 fraction in a biological specimen. | Alpha-2 Globulin Measurement | ||
| GLOBA2PT | C92255 | Alpha-2 Globulin/Total Protein | A relative measurement (ratio or percentage) of alpha-2-fraction proteins to total proteins in a biological specimen. | Alpha-2 Globulin to Total Protein Ratio Measurement | ||
| GLOBB | C92256 | Beta Globulin | A measurement of the proteins contributing to the beta fraction in a biological specimen. | Beta Globulin Measurement | ||
| GLOBB1 | C119274 | Beta-1 Globulin | A measurement of the beta-1 globulin in a biological specimen. | Beta-1 Globulin Measurement | ||
| GLOBB1PT | C119275 | Beta-1 Globulin/Total Protein | A relative measurement (ratio or percentage) of beta-1-fraction proteins to total proteins in a biological specimen. | Beta-1 Globulin to Total Protein Ratio Measurement | ||
| GLOBB2 | C119276 | Beta-2 Globulin | A measurement of the beta-2 globulin in a biological specimen. | Beta-2 Globulin Measurement | ||
| GLOBB2PT | C119277 | Beta-2 Globulin/Total Protein | A relative measurement (ratio or percentage) of beta-2-fraction proteins to total proteins in a biological specimen. | Beta-2 Globulin to Total Protein Ratio Measurement | ||
| GLOBBPT | C92294 | Beta Globulin/Total Protein | A relative measurement (ratio or percentage) of beta fraction proteins to total proteins in a biological specimen. | Beta Globulin to Total Protein Ratio Measurement | ||
| GLOBG | C92257 | Gamma Globulin | A measurement of the proteins contributing to the gamma fraction in a biological specimen. | Gamma Globulin Measurement | ||
| GLOBGPT | C92295 | Gamma Globulin/Total Protein | A relative measurement (ratio or percentage) of gamma fraction proteins to total proteins in a biological specimen. | Gamma Globulin to Total Protein Ratio Measurement | ||
| GLOBUL | C74738 | Globulin | A measurement of the globulin protein in a biological specimen. | Globulin Protein Measurement | ||
| GLP1 | C80183 | Glucagon-Like Peptide-1;Total Glucagon-Like Peptide-1 | A measurement of the total glucagon-like peptide-1 in a biological specimen. | Glucagon-like Peptide-1 Measurement | ||
| GLP1AC | C80164 | Glucagon-Like Peptide-1, Active Form | A measurement of the active form of glucagon-like peptide-1 in a biological specimen. | Active Glucagon-like Peptide-1 Measurement | ||
| GLUC | C105585 | Glucose | A measurement of the glucose in a biological specimen. | Glucose Measurement | ||
| GLUCAGON | C74859 | Glucagon | A measurement of the glucagon hormone in a biological specimen. | Glucagon Measurement | ||
| GLUCCLR | C96652 | Glucose Clearance | A measurement of the volume of serum or plasma that would be cleared of glucose by excretion of urine for a specified unit of time (e.g. one minute). | Glucose Clearance Measurement | ||
| GLUCCRT | C79447 | Glucose/Creatinine | A relative measurement (ratio or percentage) of the glucose to creatinine in a biological specimen. | Glucose to Creatinine Ratio Measurement | ||
| GLUCEXR | C117834 | Glucose Excretion Rate | A measurement of the amount of glucose being excreted in urine over a defined amount of time (e.g. one hour). | Glucose Urine Excretion Rate | ||
| GLUTAM | C74739 | Glutamate;Glutamic Acid | A measurement of the glutamate in a biological specimen. | Glutamate Measurement | ||
| GLYCRLFR | C100448 | Free Glycerin;Free Glycerol | A measurement of the amount of unbound glycerol in a biological specimen. | Free Glycerol Measurement | ||
| GMCSF | C82019 | Granulocyte Macrophage Colony Stm Factor | A measurement of the granulocyte macrophage colony stimulating factor in a biological specimen. | Granulocyte Macrophage Colony Stm Factor Measurement | ||
| GNRH | C74860 | Gonadotropin Releasing Hormone;Luteinising Hormone Releasing Hormone | A measurement of the gonadotropin releasing hormone in a biological specimen. | Gonadotropin Releasing Hormone Measurement | ||
| GOLD | C80186 | Gold | A measurement of the gold in a biological specimen. | Gold Measurement | ||
| GRAN | C96654 | Granulocytes | A measurement of the granulocytes in a biological specimen. | Granulocyte Count | ||
| GRANCE | C98866 | Granulocytes/Total Cells | A relative measurement (ratio or percentage) of the granulocytes to total cells in a biological specimen (for example a bone marrow specimen). | Granulocyte to Total Cell Ratio Measurement | ||
| GRANIM | C96675 | Immature Granulocytes | A measurement of the total immature granulocytes in a biological specimen. | Immature Granulocyte Count | ||
| GRANIMLE | C100445 | Immature Granulocytes/Leukocytes | A relative measurement (ratio or percentage) of the immature granulocytes to leukocytes in a biological specimen (for example a bone marrow specimen). | Immature Granulocytes to Leukocytes Ratio Measurement | ||
| GRWHIH | C74861 | Growth Hormone Inhibiting Hormone;Somatostatin | A measurement of the growth hormone inhibiting hormone in a biological specimen. | Growth Hormone Inhibiting Hormone Measurement | ||
| GRWHRH | C74862 | Growth Hormone Releasing Hormone;Somatocrinin | A measurement of the growth hormone releasing hormone in a biological specimen. | Growth Hormone Releasing Hormone Measurement | ||
| GST | C80185 | Glutathione S-Transferase, Total | A measurement of the total glutathione-s-transferase in a biological specimen. | Glutathione-S-Transferase Measurement | ||
| GSTAL | C79433 | Alpha Glutathione-S-Transferase | A measurement of the alpha form of glutathione S-transferase in a biological specimen. | Alpha Glutathione-S-Transferase Measurement | ||
| GSTALCRT | C80166 | Glutathione S-Transferase, Alpha/Creat | A relative measurement (ratio or percentage) of the alpha glutathione-S-transferase to creatinine in a biological specimen. | Alpha Glutathione-S-Transferase to Creatinine Ratio Measurement | ||
| GSTALEXR | C119278 | Alpha-GST Excretion Rate | A measurement of the amount of Alpha Glutathione-S-Transferase being excreted in urine over a defined period of time (e.g. one hour). | Alpha-GST Excretion Rate | ||
| GSTCREAT | C79435 | Glutathione-S-Transferase/Creatinine | A relative measurement (ratio or percentage) of the glutathione S-transferase to creatinine in a biological specimen. | Glutathione-S-Transferase to Creatinine Ratio Measurement | ||
| GSTMU | C79457 | Mu Glutathione-S-Transferase | A measurement of the mu form of glutathione S-transferase in a biological specimen. | Mu Glutathione-S-Transferase Measurement | ||
| GSTMUCRT | C79458 | Mu Glutathione-S-Transferase/Creatinine | A relative measurement (ratio or percentage) of the mu gamma glutamyl transpeptidase to creatinine in a biological specimen. | Mu Glutathione-S-Transferase to Creatinine Ratio Measurement | ||
| GSTPI | C80203 | Glutathione S-Transferase, Pi | A measurement of the Pi glutathione-s-transferase in a biological specimen. | Pi Glutathione S-Transferase Measurement | ||
| GSTPIEXR | C119279 | Pi-GST Excretion Rate | A measurement of the amount of Pi Glutathione-S-Transferase being excreted in urine over a defined period of time (e.g. one hour). | Pi-GST Excretion Rate | ||
| GSTTH | C80207 | Glutathione S-Transferase, Theta | A measurement of the theta glutathione-s-transferase in a biological specimen. | Theta Glutathione S-Transferase Measurement | ||
| GUSA | C80165 | Glucuronidase, Alpha | A measurement of the alpha glucuronidase in a biological specimen. | Alpha Glucuronidase Measurement | ||
| GUSB | C80170 | Glucuronidase, Beta | A measurement of the beta glucuronidase in a biological specimen. | Beta Glucuronidase Measurement | ||
| HAAB | C92534 | Hepatitis A Virus Antibody | A measurement of the antibody reaction of a biological specimen to the Hepatitis A virus. | Hepatitis A Antibody Measurement | ||
| HAABIGM | C92271 | Hepatitis A Virus Antibody IgM | A measurement of hepatitis A virus antibody IgM in a biological specimen. | Hepatitis A Virus Antibody IgM Measurement | ||
| HAIRYCE | C74604 | Hairy Cells | A measurement of the hairy cells (b-cell lymphocytes with hairy projections from the cytoplasm) in a biological specimen. | Hairy Cell Count | ||
| HALBAB | C103405 | Human Albumin Antibody | A measurement of the human albumin antibody in a biological specimen. | Human Albumin Antibody Measurement | ||
| HAMAB | C103406 | HAMA | A measurement of the human anti-mouse antibody in a biological specimen. | Human Anti-Mouse Antibody Measurement | ||
| HAPTOG | C74740 | Haptoglobin | A measurement of the haptoglobin protein in a biological specimen. | Haptoglobin Protein Measurement | ||
| HASIGEAB | C98740 | Human Anti-Sheep IgE Antibody | A measurement of the human anti-sheep IgE antibodies in a biological specimen. | Human Anti-Sheep IgE Antibody Measurement | ||
| HASIGGAB | C98741 | Human Anti-Sheep IgG Antibody | A measurement of the human anti-sheep IgG antibodies in a biological specimen. | Human Anti-Sheep IgG Antibody Measurement | ||
| HASIGMAB | C98742 | Human Anti-Sheep IgM Antibody | A measurement of the human anti-sheep IgM antibodies in a biological specimen. | Human Anti-Sheep IgM Antibody Measurement | ||
| HAVVLD | C92541 | HAV Viral Load | A measurement of the hepatitis A viral load in a biological specimen. | Hepatitis A Viral Load Measurement | ||
| HBA1C | C64849 | Glycosylated Hemoglobin;Hemoglobin A1C | A measurement of the glycosylated hemoglobin in a biological specimen. | Glycosylated Hemoglobin Measurement | ||
| HBA1CHGB | C111207 | Hemoglobin A1C/Hemoglobin | A relative measurement (ratio or percentage) of the glycosylated hemoglobin to total hemoglobin in a biological specimen. | Hemoglobin A1C to Hemoglobin Ratio Measurement | ||
| HBCAB | C96660 | Hepatitis B Virus Core Antibody | A measurement of the hepatitis B virus core antibody in a biological specimen. | Hepatitis B Virus Core Antibody Measurement | ||
| HBCIGGAB | C119280 | Hepatitis B Virus Core IgG Antibody | A measurement of the hepatitis B virus core IgG antibody in a biological specimen. | Hepatitis B Virus Core IgG Antibody Measurement | ||
| HBCIGMAB | C96661 | Hepatitis B Virus Core IgM Antibody | A measurement of the hepatitis B virus core IgM antibody in a biological specimen. | Hepatitis B Virus Core IgM Antibody Measurement | ||
| HBDNA | C103404 | Hepatitis B DNA | A measurement of hepatitis B virus DNA in a biological specimen. | Hepatitis B DNA Measurement | ||
| HBEAB | C96662 | Hepatitis B Virus e Antibody | A measurement of the hepatitis B e antibody in a biological specimen. | Hepatitis B Virus e Antibody Measurement | ||
| HBEAG | C96663 | Hepatitis B Virus e Antigen | A measurement of the hepatitis B e antigen in a biological specimen. | Hepatitis B Virus e Antigen Measurement | ||
| HBSAB | C74711 | Anti-HBs;HBsAb;Hepatitis B Virus Surface Antibody | A measurement of the surface antibody reaction of a biological specimen to the Hepatitis B virus. | Hepatitis B Surface Antibody Measurement | ||
| HBSAG | C64850 | HBsAg;Hepatitis B Virus Surface Antigen | A measurement of the surface antigen reaction of a biological specimen to the Hepatitis B virus. | Hepatitis B Virus Surface Antigen Measurement | ||
| HBVVLD | C92542 | HBV Viral Load | A measurement of the hepatitis B viral load in a biological specimen. | Hepatitis B Viral Load Measurement | ||
| HCAB | C92535 | Hepatitis C Virus Antibody | A measurement of the antibody reaction of a biological specimen to the Hepatitis C virus. | Hepatitis C Antibody Measurement | ||
| HCAG | C116196 | Hepatitis C Virus Antigen | A measurement of the hepatitis C virus antigen in a biological specimen. | Hepatitis C Virus Antigen Measurement | ||
| HCG | C64851 | Choriogonadotropin Beta;Pregnancy Test | A measurement of the Choriogonadotropin Beta in a biological specimen. | Choriogonadotropin Beta Measurement | ||
| HCT | C64796 | EVF;Erythrocyte Volume Fraction;Hematocrit;PCV;Packed Cell Volume | The percentage of a whole blood specimen that is composed of red blood cells (erythrocytes). | Hematocrit Measurement | ||
| HCVVLD | C92543 | HCV RNA;HCV Viral Load;Hepatitis C RNA | A measurement of the hepatitis C viral load in a biological specimen. | Hepatitis C Viral Load Measurement | ||
| HDAB | C96664 | Hepatitis D Virus Antibody;Hepatitis Delta Antibody | A measurement of the hepatitis D virus antibody in a biological specimen. | Hepatitis D Virus Antibody Measurement | ||
| HDIGGAB | C119281 | Hepatitis D Virus IgG Antibody | A measurement of the hepatitis D virus IgG antibody in a biological specimen. | Hepatitis D Virus IgG Antibody Measurement | ||
| HDIGMAB | C119282 | Hepatitis D Virus IgM Antibody | A measurement of the hepatitis D virus IgM antibody in a biological specimen. | Hepatitis D Virus IgM Antibody Measurement | ||
| HDL | C105587 | HDL Cholesterol | A measurement of the high density lipoprotein cholesterol in a biological specimen. | High Density Lipoprotein Cholesterol Measurement | ||
| HDL2 | C80187 | HDL-Cholesterol Subclass 2 | A measurement of the high-density lipoprotein (HDL) cholesterol subclass 2 in a biological specimen. | HDL-Cholesterol Subclass 2 Measurement | ||
| HDL3 | C80188 | HDL-Cholesterol Subclass 3 | A measurement of the high-density lipoprotein (HDL) cholesterol subclass 3 in a biological specimen. | HDL-Cholesterol Subclass 3 Measurement | ||
| HDLCLDLC | C100425 | HDL Cholesterol/LDL Cholesterol Ratio | A relative measurement (ratio or percentage) of the amount of HDL cholesterol compared to LDL cholesterol in a biological specimen. | HDL Cholesterol to LDL Cholesterol Ratio Measurement | ||
| HDLPSZ | C103402 | HDL Particle Size | A measurement of the average particle size of high-density lipoprotein in a biological specimen. | HDL Particle Size Measurement | ||
| HDW | C106525 | Hemoglobin Distribution Width | A measurement of the distribution of the hemoglobin concentration in red blood cells. | Hemoglobin Distribution Width Measurement | ||
| HEAB | C119283 | Hepatitis E Virus Antibody | A measurement of the antibody reaction of a biological specimen to the Hepatitis E virus. | Hepatitis E Virus Antibody Measurement | ||
| HEIGGAB | C106526 | Hepatitis E Virus IgG Antibody | A measurement of IgG antibody to the hepatitis E virus in a biological specimen. | Hepatitis E Virus IgG Antibody Measurement | ||
| HEIGMAB | C96665 | Hepatitis E Virus IgM Antibody | A measurement of the hepatitis E virus IgM antibody in a biological specimen. | Hepatitis E Virus IgM Antibody Measurement | ||
| HEINZ | C74709 | Heinz Bodies;Heinz-Erhlich Bodies | A measurement of the Heinz bodies (small round inclusions within the body of a red blood cell) in a biological specimen. | Heinz-Ehrlich Body Measurement | ||
| HEINZRBC | C111206 | Heinz Bodies/Erythrocytes | A relative measurement (ratio or percentage) of the erythrocytes that contain heinz bodies to total erythrocytes in a biological specimen. | Heinz Body to Erythrocyte Ratio Measurement | ||
| HELMETCE | C74658 | Helmet Cells | A measurement of the Helmet cells (specialized Keratocytes with two projections on either end that are tapered and hornlike) in a biological specimen. | Helmet Cell Count | ||
| HEMOLYSI | C111208 | Hemolysis;Hemolytic Index | A measurement of the destruction of red blood cells in a biological specimen. | Hemolytic Index | ||
| HER2 | C112312 | ERBB2;HER2/NEU;Human Epidermal Growth Factor Receptor 2 | A measurement of the cells with positive expression of HER2 in a biological specimen. | Human Epidermal Growth Factor Receptor 2 Measurement | ||
| HER2AG | C112291 | HER2 Antigen;HER2/NEU Antigen | A measurement of the HER2 antigen in a biological specimen. | HER2 Antigen Measurement | ||
| HETRPH | C116186 | Heterophils | A measurement of heterophils (granular leukocytes) in a biological specimen from avian species. | Heterophil Measurement | ||
| HETRPHLE | C116187 | Heterophils/Leukocytes | A relative measurement (ratio or percentage) of heterophils to leukocytes in a biological specimen from avian species. | Heterophils to Leukocytes Ratio Measurement | ||
| HEXK | C96668 | Hexokinase | A measurement of the hexokinase in a biological specimen. | Hexokinase Measurement | ||
| HGB | C64848 | FHGB;Free Hemoglobin;Hemoglobin | A measurement of the non-cellular hemoglobin in a biological specimen. | Hemoglobin Measurement | ||
| HGBA | C92258 | Hemoglobin A | A measurement of the hemoglobin A in a biological specimen. | Hemoglobin A Measurement | ||
| HGBA2 | C92259 | Hemoglobin A2 | A measurement of the hemoglobin A2 in a biological specimen. | Hemoglobin A2 Measurement | ||
| HGBB | C92260 | Hemoglobin B | A measurement of the hemoglobin B in a biological specimen. | Hemoglobin B Measurement | ||
| HGBC | C92261 | Hemoglobin C | A measurement of the hemoglobin C in a biological specimen. | Hemoglobin C Measurement | ||
| HGBF | C92262 | Fetal Hemoglobin;Hemoglobin F | A measurement of the hemoglobin F in a biological specimen. | Hemoglobin F Measurement | ||
| HGBMET | C96689 | Methemoglobin | A measurement of the methemoglobin in a biological specimen. | Methemoglobin Measurement | ||
| HGBOXY | C96616 | Oxyhemoglobin | A measurement of the oxyhemoglobin, oxygen-bound hemoglobin, in a biological specimen. | Oxyhemoglobin Measurement | ||
| HGRNA | C92272 | Hepatitis G RNA | A measurement of the Hepatitis G RNA in a biological specimen. | Hepatitis G RNA Measurement | ||
| HIST1AB | C112293 | Histone 1 Antibody | A measurement of the total histone 1 antibodies in a biological specimen. | Histone 1 Antibody Measurement | ||
| HIST2AAB | C112294 | Histone 2A Antibody | A measurement of the total histone 2A antibodies in a biological specimen. | Histone 2A Antibody Measurement | ||
| HIST2BAB | C112295 | Histone 2B Antibody | A measurement of the total histone 2B antibodies in a biological specimen. | Histone 2B Antibody Measurement | ||
| HIST3AB | C112296 | Histone 3 Antibody | A measurement of the total histone 3 antibodies in a biological specimen. | Histone 3 Antibody Measurement | ||
| HIST4AB | C112297 | Histone 4 Antibody | A measurement of the total histone 4 antibodies in a biological specimen. | Histone 4 Antibody Measurement | ||
| HISTAB | C111209 | Anti-Histone Antibodies;Histone Antibodies | A measurement of histone antibodies in a biological specimen. | Histone Antibody Measurement | ||
| HISTAMIN | C80189 | Histamine | A measurement of the histamine in a biological specimen. | Histamine Measurement | ||
| HIV124AG | C92265 | HIV-1 p24 Antigen | A measurement of the HIV-1 p24 antigen in a biological specimen. | HIV-1 p24 Antigen Measurement | ||
| HIV12AB | C74714 | HIV-1/2 Antibody | A measurement of the antibody reaction of a biological specimen to the either the HIV-1 or HIV-2 virus. | HIV-1 HIV-2 Antibody Measurement | ||
| HIV1AB | C74713 | HIV-1 Antibody | A measurement of the antibody reaction of a biological specimen to the HIV-1 virus. | HIV-1 Antibody Measurement | ||
| HIV1MONA | C92263 | HIV-1 Group M and O Nucleic Acid | A measurement of the HIV-1 group M and O nucleic acids in a biological specimen. | HIV-1 Group M and O Nucleic Acid Measurement | ||
| HIV1OAB | C92264 | HIV-1 Group O Antibody | A measurement of the HIV-1 group O antibody in a biological specimen. | HIV-1 Group O Antibody Measurement | ||
| HIV2AB | C74715 | HIV-2 Antibody | A measurement of the antibody reaction of a biological specimen to the HIV-2 virus. | HIV-2 Antibody Measurement | ||
| HIV2NUAC | C92266 | HIV-2 Nucleic Acid | A measurement of the HIV-2 nucleic acids in a biological specimen. | HIV-2 Nucleic Acid Measurement | ||
| HIVAB | C106527 | HIV Antibody | A measurement of the antibody reaction of a biological specimen to the HIV virus. | HIV Antibody Measurement | ||
| HIVVLD | C92544 | HIV Viral Load | A measurement of the HIV viral load in a biological specimen. | HIV Viral Load Measurement | ||
| HLAB27AG | C100460 | HLA-B27 Antigen;Human Leukocyte Antigen B27 | A measurement of the human leukocyte antigen B27 (HLA-B27) in a biological specimen. | HLA-B27 Antigen Measurement | ||
| HMOSIDRN | C96659 | Hemosiderin | A measurement of the hemosiderin complex in a biological specimen. | Hemosiderin Measurement | ||
| HOMAIR | C100447 | Homeostatic Model Assessment of Insulin Resistance;Homostat Model Assess of Insulin Rstn | An assessment of beta-cell function and insulin resistance based on fasting blood glucose and insulin concentrations. | Homeostatic Model Assessment of Insulin Resistance | ||
| HOMOCY | C74741 | Homocysteine | A measurement of the homocysteine amino acid in a biological specimen. | Homocysteine Acid Measurement | ||
| HOWJOL | C74704 | Howell-Jolly Bodies | A measurement of the Howell-Jolly bodies (spherical, blue-black condensed DNA inclusions within the body of a red blood cell that appear under Wright-stain) in a biological specimen. | Howell-Jolly Body Measurement | ||
| HPLIGGAB | C103403 | Helicobacter pylori IgG Antibody | A measurement of the Helicobacter pylori IgG antibody in a biological specimen. | Helicobacter pylori IgG Antibody Measurement | ||
| HPOCROM | C64802 | Hypochromia | An observation which indicates that the hemoglobin concentration in a red blood cell specimen has fallen below a specified level. | Hypochromia | ||
| HRYCELY | C74640 | Hairy Cells/Lymphocytes | A relative measurement (ratio or percentage) of the hairy cells (b-cell lymphocytes with hairy projections from the cytoplasm) to all lymphocytes in a biological specimen . | Hairy Cell to Lymphocyte Ratio Measurement | ||
| HS12GGAB | C96697 | HSV-1/2 IgG Ab;Herpes Simplex Virus 1/2 IgG Antibody | A measurement of the herpes simplex virus 1 and 2 IgG antibody in a biological specimen. | Herpes Simplex Virus 1/2 IgG Antibody Measurement | ||
| HS12GMAB | C96698 | HSV-1/2 IgM Ab;Herpes Simplex Virus 1/2 IgM Antibody | A measurement of the herpes simplex virus 1 and 2 IgM antibody in a biological specimen. | Herpes Simplex Virus 1/2 IgM Antibody Measurement | ||
| HS1IGGAB | C96666 | HSV-1 IgG Antibody;Herpes Simplex Virus 1 IgG Antibody | A measurement of the herpes simplex virus 1 IgG antibody in a biological specimen. | Herpes Simplex Virus 1 IgG Antibody Measurement | ||
| HS1IGMAB | C98738 | Herpes Simplex Virus 1 IgM Antibody | A measurement of the Herpes Simplex virus 1 IgM antibodies in a biological specimen. | Herpes Simplex Virus 1 IgM Antibody Measurement | ||
| HS2IGGAB | C96667 | HSV-2 IgG Antibody;Herpes Simplex Virus 2 IgG Antibody | A measurement of the herpes simplex virus 2 IgG antibody in a biological specimen. | Herpes Simplex Virus 2 IgG Antibody Measurement | ||
| HS2IGMAB | C98739 | Herpes Simplex Virus 2 IgM Antibody | A measurement of the Herpes Simplex virus 2 IgM antibodies in a biological specimen. | Herpes Simplex Virus 2 IgM Antibody Measurement | ||
| HS6AB | C112292 | Herpes Simplex Virus 6 Antibody | A measurement of the herpes simplex virus 6 antibody in a biological specimen. | Herpes Simplex Virus 6 Antibody Measurement | ||
| HTPHAB | C81984 | Heterophile Antibodies | A measurement of the heterophile antibodies in a biological specimen. | Heterophile Antibody Measurement | ||
| HVA | C74863 | Homovanillic Acid | A measurement of the homovanillic acid metabolite in a biological specimen. | Homovanillic Acid Measurement | ||
| HYALUAC | C112319 | Hyaluronic Acid | A measurement of hyaluronic acid in a biological specimen. | Hyaluronic Acid Measurement | ||
| HYDCDN | C74879 | Hydrocodone | A measurement of the hydrocodone present in a biological specimen. | Hydrocodone Measurement | ||
| HYDMRPHN | C74880 | Hydromorphone | A measurement of the hydromorphone present in a biological specimen. | Hydromorphone Measurement | ||
| HYDROGEN | C102275 | Hydrogen | A measurement of the hydrogen in a biological specimen. | Hydrogen Measurement | ||
| HYPERCHR | C96669 | Hyperchromia | A measurement of the prevalence of the erthrocytes with an elevated hemoglobin concentration. | Hyperchromia Measurement | ||
| HYPRLN | C80190 | Hydroxyproline | A measurement of the total hydroxyproline in a biological specimen. | Hydroxyproline Measurement | ||
| HYPSEGCE | C74612 | Hypersegmented Cells | A measurement of the hypersegmented (more than five lobes) neutrophils in a biological specimen. | Hypersegmented Neutrophil Measurement | ||
| IA2AB | C119284 | Insulinoma-Associated Protein 2 Antibody | A measurement of the insulinoma-associated protein 2 antibody in a biological specimen. | Insulinoma-Associated Protein 2 Antibody Measurement | ||
| IAA5OH | C112217 | 5-Hydroxyindoleacetic Acid | A measurement of 5-hydroxyindoleacetic acid in a biological specimen. | 5-Hydroxyindoleacetic Acid Measurement | ||
| IAH1N1VL | C92273 | Influenza A H1N1 Viral Load | A measurement of the Influenza A H1N1 viral load in a biological specimen. | Influenza A H1N1 Viral Load Measurement | ||
| IAIGGAB | C103408 | Influenza A IgG Antibody | A measurement of the Influenza A IgG antibody in a biological specimen. | Influenza A IgG Antibody Measurement | ||
| IBCT | C74718 | Total Iron Binding Capacity | A measurement of the amount of iron needed to fully saturate the transferrin in a biological specimen. | Total Iron Binding Capacity | ||
| IBCU | C74719 | Unsaturated Iron Binding Capacity | A measurement of the binding capacity of unsaturated iron in a biological specimen. | Unsaturated Iron Binding Capacity Measurement | ||
| IBIGGAB | C103409 | Influenza B IgG Antibody | A measurement of the Influenza B IgG antibody in a biological specimen. | Influenza B IgG Antibody Measurement | ||
| IC512AB | C81985 | Islet Cell 512 Antibody | A measurement of the islet cell 512 antibody in a biological specimen. | Islet Cell 512 Antibody Measurement | ||
| IC512AG | C81986 | Islet Cell 512 Antigen | A measurement of the islet cell 512 antigen in a biological specimen. | Islet Cell 512 Antigen Measurement | ||
| ICTERUSI | C111232 | Icteric Index;Icterus | A measurement of the yellow color of a biological specimen, due to the presence of bile pigments. | Icteric Index | ||
| IDL | C112325 | IDL Cholesterol;Intermediate Density Lipoprotein | A measurement of the intermediate density lipoprotein in a biological specimen. | Intermediate Density Lipoprotein Cholesterol Measurement | ||
| IDLP | C116197 | IDL Particles;Intermediate Density Lipoproteins Particles | A measurement of the concentration of IDL particles in a biological specimen. | IDL Particles Measurement | ||
| IFNA | C81994 | Interferon Alpha | A measurement of the interferon alpha in a biological specimen. | Interferon Alpha Measurement | ||
| IFNB | C81995 | Interferon Beta | A measurement of the interferon beta in a biological specimen. | Interferon Beta Measurement | ||
| IFNG | C81996 | Interferon Gamma | A measurement of the interferon gamma in a biological specimen. | Interferon Gamma Measurement | ||
| IGA | C81969 | Immunoglobulin A | A measurement of the Immunoglobulin A in a biological specimen. | Immunoglobulin A Measurement | ||
| IGAGM | C111233 | IgG IgM IgA Total | A measurement of the total IgG, IgM, and IgA in a biological specimen. | IgG IgM IgA Total Measurement | ||
| IGD | C98745 | Immunoglobulin D | A measurement of the Immunoglobulin D in a biological specimen. | Immunoglobulin D Measurement | ||
| IGE | C81970 | Immunoglobulin E | A measurement of the Immunoglobulin E in a biological specimen. | Immunoglobulin E Measurement | ||
| IGF1 | C74864 | Insulin-like Growth Factor-1 | A measurement of the insulin-like growth factor-1 in a biological specimen. | Insulin Like Growth Factor-1 Measurement | ||
| IGF2 | C74865 | Insulin-like Growth Factor-2 | A measurement of the insulin-like growth factor-2 in a biological specimen. | Insulin Like Growth Factor-2 Measurement | ||
| IGFBP3 | C112322 | Insulin-Like Growth Factor Binding Prot3;Insulin-Like Growth Factor Binding Protein 3 | A measurement of the insulin-like growth factor binding protein 3 in a biological specimen. | Insulin-Like Growth Factor Binding Protein 3 Measurement | ||
| IGG | C81971 | Immunoglobulin G | A measurement of the Immunoglobulin G in a biological specimen. | Immunoglobulin G Measurement | ||
| IGGCREAT | C119285 | Immunoglobulin G/Creatinine | A relative measurement (ratio or percentage) of the immunoglobulin G to creatinine in a biological specimen. | Immunoglobulin G to Creatinine Ratio Measurement | ||
| IGM | C81972 | Immunoglobulin M | A measurement of the Immunoglobulin M in a biological specimen. | Immunoglobulin M Measurement | ||
| IGSOL | C117835 | Soluble Immunoglobulin | A measurement of the soluble total immunoglobulin in a biological specimen. | Soluble Immunoglobulin Measurement | ||
| IL1SR1 | C117836 | Soluble Interleukin-1 Receptor Type I | A measurement of the soluble interleukin-1 receptor type I in a biological specimen. | Soluble Interleukin-1 Receptor Type I Measurement | ||
| IL2SRA | C102280 | Soluble Interleukin 2 Receptor Activity | A measurement of the soluble interleukin 2 receptor activity in a biological specimen. | Soluble Interleukin 2 Receptor Activity Measurement | ||
| IL6SR | C117837 | Soluble Interleukin 6 Receptor | A measurement of the soluble interleukin 6 receptor in a biological specimen. | Soluble Interleukin 6 Receptor Measurement | ||
| ILE | C103410 | Isoleucine | A measurement of the isoleucine in a biological specimen. | Isoleucine Measurement | ||
| INCLBOD | C116184 | Inclusion Bodies | A measurement of the inclusion bodies in a biological specimen. | Inclusion Body Measurement | ||
| INDICAN | C82044 | Indican | A measurement of the indican present in a biological specimen. | Indican Measurement | ||
| INFAVLD | C92274 | Influenza A Viral Load | A measurement of the Influenza A viral load in a biological specimen. | Influenza A Viral Load Measurement | ||
| INGAPAB | C81987 | Islet Neogenesis Assoc Protein Antibody | A measurement of the islet neogenesis associated protein antibody in a biological specimen. | Islet Neogenesis Associated Protein Antibody Measurement | ||
| INHIBINA | C82020 | Inhibin A | A measurement of the inhibin A in a biological specimen. | Inhibin A Measurement | ||
| INHIBINB | C96681 | Inhibin B | A measurement of the inhibin B in a biological specimen. | Inhibin B Measurement | ||
| INLCLR | C98748 | Inulin Clearance | A measurement of the volume of serum or plasma that would be cleared of inulin by excretion of urine for a specified unit of time (e.g. one minute). | Inulin Clearance | ||
| INR | C64805 | Prothrombin Intl. Normalized Ratio | A ratio that represents the prothrombin time for a plasma specimen, divided by the result for a control plasma specimen, further standardized for the International Sensitivity Index of the tissue factor (thromboplastin) used in the test. | International Normalized Ratio of Prothrombin Time | ||
| INSAAB | C119286 | Insulin Autoantibody | A measurement of the antibody to endogenous insulin in a biological specimen. | Insulin Autoantibody Measurement | ||
| INSAB | C119287 | Insulin Antibody | A measurement of the antibody to therapeutic insulin in a biological specimen. | Insulin Antibody Measurement | ||
| INSULIN | C74788 | Insulin | A measurement of the insulin in a biological specimen. | Insulin Measurement | ||
| INTLK1 | C74805 | Interleukin 1 | A measurement of the interleukin 1 in a biological specimen. | Interleukin 1 Measurement | ||
| INTLK10 | C74806 | Interleukin 10 | A measurement of the interleukin 10 in a biological specimen. | Interleukin 10 Measurement | ||
| INTLK11 | C74807 | Interleukin 11 | A measurement of the interleukin 11 in a biological specimen. | Interleukin 11 Measurement | ||
| INTLK12 | C74808 | Interleukin 12 | A measurement of the interleukin 12 in a biological specimen. | Interleukin 12 Measurement | ||
| INTLK13 | C74809 | Interleukin 13 | A measurement of the interleukin 13 in a biological specimen. | Interleukin 13 Measurement | ||
| INTLK14 | C74810 | Interleukin 14 | A measurement of the interleukin 14 in a biological specimen. | Interleukin 14 Measurement | ||
| INTLK15 | C74811 | Interleukin 15 | A measurement of the interleukin 15 in a biological specimen. | Interleukin 15 Measurement | ||
| INTLK16 | C74812 | Interleukin 16 | A measurement of the interleukin 16 in a biological specimen. | Interleukin 16 Measurement | ||
| INTLK17 | C74813 | Interleukin 17 | A measurement of the interleukin 17 in a biological specimen. | Interleukin 17 Measurement | ||
| INTLK18 | C74814 | Interleukin 18 | A measurement of the interleukin 18 in a biological specimen. | Interleukin 18 Measurement | ||
| INTLK19 | C74815 | Interleukin 19 | A measurement of the interleukin 19 in a biological specimen. | Interleukin 19 Measurement | ||
| INTLK1B | C112323 | IL-1B;IL1Beta;Interleukin 1 Beta;Interleukin 1B | A measurement of interleukin 1 beta in a biological specimen. | Interleukin 1 Beta Measurement | ||
| INTLK1RA | C112324 | IL-1RA;Interleukin 1 Receptor Antagonist | A measurement of the interleukin 1 receptor antagonist in a biological specimen. | Interleukin 1 Receptor Antagonist Measurement | ||
| INTLK2 | C74816 | Interleukin 2 | A measurement of the interleukin 2 in a biological specimen. | Interleukin 2 Measurement | ||
| INTLK20 | C74817 | Interleukin 20 | A measurement of the interleukin 20 in a biological specimen. | Interleukin 20 Measurement | ||
| INTLK21 | C74818 | Interleukin 21 | A measurement of the interleukin 21 in a biological specimen. | Interleukin 21 Measurement | ||
| INTLK22 | C74819 | Interleukin 22 | A measurement of the interleukin 22 in a biological specimen. | Interleukin 22 Measurement | ||
| INTLK23 | C74820 | Interleukin 23 | A measurement of the interleukin 23 in a biological specimen. | Interleukin 23 Measurement | ||
| INTLK24 | C74821 | Interleukin 24 | A measurement of the interleukin 24 in a biological specimen. | Interleukin 24 Measurement | ||
| INTLK25 | C74822 | Interleukin 25 | A measurement of the interleukin 25 in a biological specimen. | Interleukin 25 Measurement | ||
| INTLK26 | C74823 | Interleukin 26 | A measurement of the interleukin 26 in a biological specimen. | Interleukin 26 Measurement | ||
| INTLK27 | C74824 | Interleukin 27 | A measurement of the interleukin 27 in a biological specimen. | Interleukin 27 Measurement | ||
| INTLK28 | C74825 | Interleukin 28 | A measurement of the interleukin 28 in a biological specimen. | Interleukin 28 Measurement | ||
| INTLK29 | C74826 | Interleukin 29 | A measurement of the interleukin 29 in a biological specimen. | Interleukin 29 Measurement | ||
| INTLK3 | C74827 | Interleukin 3 | A measurement of the interleukin 3 in a biological specimen. | Interleukin 3 Measurement | ||
| INTLK30 | C74828 | Interleukin 30 | A measurement of the interleukin 30 in a biological specimen. | Interleukin 30 Measurement | ||
| INTLK31 | C74829 | Interleukin 31 | A measurement of the interleukin 31 in a biological specimen. | Interleukin 31 Measurement | ||
| INTLK32 | C74830 | Interleukin 32 | A measurement of the interleukin 32 in a biological specimen. | Interleukin 32 Measurement | ||
| INTLK33 | C74831 | Interleukin 33 | A measurement of the interleukin 33 in a biological specimen. | Interleukin 33 Measurement | ||
| INTLK4 | C74832 | Interleukin 4 | A measurement of the interleukin 4 in a biological specimen. | Interleukin 4 Measurement | ||
| INTLK5 | C74833 | Interleukin 5 | A measurement of the interleukin 5 in a biological specimen. | Interleukin 5 Measurement | ||
| INTLK6 | C74834 | Interleukin 6 | A measurement of the interleukin 6 in a biological specimen. | Interleukin 6 Measurement | ||
| INTLK7 | C74835 | Interleukin 7 | A measurement of the interleukin 7 in a biological specimen. | Interleukin 7 Measurement | ||
| INTLK8 | C74836 | Interleukin 8 | A measurement of the interleukin 8 in a biological specimen. | Interleukin 8 Measurement | ||
| INTLK9 | C74837 | Interleukin 9 | A measurement of the interleukin 9 in a biological specimen. | Interleukin 9 Measurement | ||
| IOHEXCLR | C100439 | Iohexol Clearance | A measurement of the volume of serum or plasma that would be cleared of Iohexol through excretion for a specified unit of time. | Iohexol Clearance | ||
| IOTCLR | C98749 | Iothalamate Clearance | A measurement of the volume of serum or plasma that would be cleared of iothalamate by excretion of urine for a specified unit of time (e.g. one minute). | Iothalamate Clearance | ||
| IOTCLRBS | C98750 | Iothalamate Clearance Adjusted for BSA | A measurement of the volume of serum or plasma that would be cleared of iothalamate by excretion of urine for a specified unit of time (e.g. one minute), adjusted for body size. | Iothalamate Clearance Adjusted for BSA | ||
| IRF | C102276 | Immature Reticulocyte Fraction | A measurement of the immature reticulocyte fraction present in a biological specimen. | Immature Reticulocyte Fraction Measurement | ||
| IRON | C74679 | FE;Iron | A measurement of the iron in a biological specimen. | Iron Measurement | ||
| IRONEXR | C117838 | Iron Excretion Rate | A measurement of the amount of iron being excreted in urine over a defined amount of time (e.g. one hour). | Iron Urine Excretion Rate | ||
| ISOPRF2 | C80180 | F2-Isoprostane | A measurement of the F2-isoprostane in a biological specimen. | F2 Isoprostane Measurement | ||
| JCVAB | C112326 | JC Polyomavirus Antibody;JC Virus Antibody;JCV Antibody;John Cunningham Virus Antibody | A measurement of the JC virus antibody in a biological specimen. | JC Virus Antibody Measurement | ||
| JO1AB | C100459 | Jo-1 Antibody | A measurement of the Jo-1 antibody in a biological specimen. | Jo-1 Antibody Measurement | ||
| K | C64853 | Potassium | A measurement of the potassium in a biological specimen. | Potassium Measurement | ||
| KCLR | C106560 | Potassium Clearance | A measurement of the volume of serum or plasma that would be cleared of potassium by excretion of urine for a specified unit of time (e.g. one minute). | Potassium Clearance Measurement | ||
| KCREAT | C79462 | Potassium/Creatinine | A relative measurement (ratio or percentage) of the potassium to creatinine in a biological specimen. | Potassium to Creatinine Ratio Measurement | ||
| KETONEBD | C111239 | Ketone Bodies | A measurement of the ketone bodies (acetone, acetoacetic acid, beta-hydroxybutyric acid, beta-ketopentanoate and beta-hydroxypentanoate) in a biological specimen. | Ketone Body Measurement | ||
| KETONES | C64854 | Ketones | A measurement of the ketones in a biological specimen. | Ketone Measurement | ||
| KEXR | C117839 | Potassium Excretion Rate | A measurement of the amount of potassium being excreted in urine over a defined amount of time (e.g. one hour). | Potassium Urine Excretion Rate | ||
| KIM1 | C100433 | Hepatitis A Virus Cellular Receptor 1;KIM-1;Kidney Injury Molecule-1 | A measurement of the kidney injury molecule-1 (Kim-1) in a biological specimen. | Kidney Injury Molecule-1 Measurement | ||
| KLCFR | C98730 | Kappa Light Chain, Free | A measurement of the free kappa light chain in a biological specimen. | Free Kappa Light Chain Measurement | ||
| KLCLLCFR | C98731 | Kappa Lt Chain,Free/Lambda Lt Chain,Free | A relative measurement (ratio or percentage) of the free kappa light chain to the free lambda light chain in a biological specimen. | Free Kappa Light Chain to Free Lambda Light Chain Ratio Measurement | ||
| KRCYMG | C96688 | Megakaryocytes | A measurement of the megakaryocytes per unit of a biological specimen. | Megakaryocyte Count | ||
| KRCYMGCE | C98867 | Megakaryocytes/Total Cells | A relative measurement (ratio or percentage) of the megakaryocytes to total cells in a biological specimen (for example a bone marrow specimen). | Megakaryocyte to Total Cell Ratio Measurement | ||
| KURLOFCE | C96682 | Kurloff Cells | A measurement of the large secretory granule-containing immune cells in a biological specimen taken from members of certain genera of the Caviidae family. | Kurloff Cells Measurement | ||
| LACTICAC | C79450 | 2-hydroxypropanoic acid;Lactate;Lactic Acid | A measurement of the lactic acid in a biological specimen. | Lactic Acid Measurement | ||
| LCN2 | C106539 | Lipocalin-2 | A measurement of lipocalin-2 in a biological specimen. | Lipocalin-2 Measurement | ||
| LCN2CREA | C106540 | Lipocalin-2/Creatinine | A relative measurement (ratio or percentage) of the lipocalin-2 to creatinine present in a sample. | Lipocalin-2 to Creatinine Ratio Measurement | ||
| LDH | C64855 | Lactate Dehydrogenase | A measurement of the lactate dehydrogenase in a biological specimen. | Lactate Dehydrogenase Measurement | ||
| LDH1 | C74887 | LDH Isoenzyme 1 | A measurement of the lactate dehydrogenase isoenzyme 1 in a biological specimen. | Lactate Dehydrogenase Isoenzyme 1 Measurement | ||
| LDH1LDH | C79451 | LDH Isoenzyme 1/LDH | A relative measurement (ratio or percentage) of the lactate dehydrogenase isoenzyme 1 to total lactate dehydrogenase in a biological specimen. | LDH Isoenzyme 1 to LDH Ratio Measurement | ||
| LDH2 | C74888 | LDH Isoenzyme 2 | A measurement of the lactate dehydrogenase isoenzyme 2 in a biological specimen. | Lactate Dehydrogenase Isoenzyme 2 Measurement | ||
| LDH2LDH | C79452 | LDH Isoenzyme 2/LDH | A relative measurement (ratio or percentage) of the lactate dehydrogenase isoenzyme 2 to total lactate dehydrogenase in a biological specimen. | LDH Isoenzyme 2 to LDH Ratio Measurement | ||
| LDH3 | C74889 | LDH Isoenzyme 3 | A measurement of the lactate dehydrogenase isoenzyme 3 in a biological specimen. | Lactate Dehydrogenase Isoenzyme 3 Measurement | ||
| LDH3LDH | C79453 | LDH Isoenzyme 3/LDH | A relative measurement (ratio or percentage) of the lactate dehydrogenase isoenzyme 3 to total lactate dehydrogenase in a biological specimen. | LDH Isoenzyme 3 to LDH Ratio Measurement | ||
| LDH4 | C74890 | LDH Isoenzyme 4 | A measurement of the lactate dehydrogenase isoenzyme 4 in a biological specimen. | Lactate Dehydrogenase Isoenzyme 4 Measurement | ||
| LDH4LDH | C79454 | LDH Isoenzyme 4/LDH | A relative measurement (ratio or percentage) of the lactate dehydrogenase isoenzyme 4 to total lactate dehydrogenase in a biological specimen. | LDH Isoenzyme 4 to LDH Ratio Measurement | ||
| LDH5 | C74891 | LDH Isoenzyme 5 | A measurement of the lactate dehydrogenase isoenzyme 5 in a biological specimen. | Lactate Dehydrogenase Isoenzyme 5 Measurement | ||
| LDH5LDH | C79455 | LDH Isoenzyme 5/LDH | A relative measurement (ratio or percentage) of the lactate dehydrogenase isoenzyme 5 to total lactate dehydrogenase in a biological specimen. | LDH Isoenzyme 5 to LDH Ratio Measurement | ||
| LDHCREAT | C79449 | Lactate Dehydrogenase/Creatinine | A relative measurement (ratio or percentage) of the lactate dehydrogenase to creatinine in a biological specimen. | Lactate Dehydrogenase to Creatinine Ratio Measurement | ||
| LDL | C105588 | LDL Cholesterol | A measurement of the low density lipoprotein cholesterol in a biological specimen. | Low Density Lipoprotein Cholesterol Measurement | ||
| LDLOXAB | C119288 | Oxidized LDL Cholesterol Antibody | A measurement of the total oxidized low density lipoprotein cholesterol antibody in a biological specimen. | Oxidized LDL Cholesterol Antibody Measurement | ||
| LDLPSZ | C103412 | LDL Particle Size | A measurement of the average particle size of low-density lipoprotein in a biological specimen. | LDL Particle Size Measurement | ||
| LEPTIN | C74866 | Leptin | A measurement of the leptin hormone in a biological specimen. | Leptin Measurement | ||
| LEUKASE | C64856 | Leukocyte Esterase | A measurement of the enzyme which indicates the presence of white blood cells in a biological specimen. | Leukocyte Esterase Measurement | ||
| LEUKCE | C116195 | Leukemic Cells;Residual Leukemic Cells | A measurement of the leukemic cells in a biological specimen. | Leukemic Cells Measurement | ||
| LGLUCLE | C79467 | Large Unstained Cells/Leukocytes | A relative measure (ratio or percentage) of the large unstained cells to leukocytes in a biological specimen. | Large Unstained Cells to Leukocytes Ratio Measurement | ||
| LGUNSCE | C74659 | Large Unstained Cells | A measurement of the large, peroxidase-negative cells which cannot be further characterized (i.e. as large lymphocytes, virocytes, or stem cells) present in a biological specimen. | Large Unstained Cell Count | ||
| LH | C74790 | Luteinizing Hormone | A measurement of the luteinizing hormone in a biological specimen. | Luteinizing Hormone Measurement | ||
| LIPASEG | C117840 | Gastric Triacylglycerol Lipase;LIPF;Lipase, Gastric | A measurement of the gastric triacylglycerol lipase in a biological specimen. | Gastric Lipase Measurement | ||
| LIPASEP | C117841 | Lipase, Pancreatic;PNLIP;Pancreatic Triacylglycerol Lipase | A measurement of the pancreatic triacylglycerol lipase in a biological specimen. | Pancreatic Lipase Measurement | ||
| LIPASET | C117748 | Lipase;Total Lipase | A measurement of the total lipase in a biological specimen. | Lipase Measurement | ||
| LIPASLAL | C117842 | Acid Cholesteryl Ester Hydrolase;LAL;LIPA;Lipase, Lysosomal Acid;Lysosomal Lipase | A measurement of the lysosomal acid lipase in a biological specimen. | Lysosomal Acid Lipase Measurement | ||
| LIPEMIAI | C111242 | Lipemia;Lipemic Index | A measurement of the abnormally high concentration of lipid in a biological specimen. | Lipemic Index | ||
| LKM1AB | C96683 | LKM-1;Liver Kidney Microsomal Type 1 Antibody | A measurement of the liver kidney microsomal type 1 antibody in a biological specimen. | Liver Kidney Microsomal Type 1 Antibody Measurement | ||
| LKM1IAAB | C100456 | Liver Kidney Microsomal Type 1 IgA Ab | A measurement of the liver kidney microsomal type 1 IgA antibodies in a biological specimen. | Liver Kidney Microsomal Type 1 IgA Antibody Measurement | ||
| LKM1IGAB | C100454 | Liver Kidney Microsomal Type 1 IgG Ab | A measurement of the liver kidney microsomal type 1 IgG antibodies in a biological specimen. | Liver Kidney Microsomal Type 1 IgG Antibody Measurement | ||
| LKM1IMAB | C100455 | Liver Kidney Microsomal Type 1 IgM Ab | A measurement of the liver kidney microsomal type 1 IgM antibodies in a biological specimen. | Liver Kidney Microsomal Type 1 IgM Antibody Measurement | ||
| LLCFR | C98732 | Lambda Light Chain, Free | A measurement of the free lambda light chain in a biological specimen. | Free Lambda Light Chain Measurement | ||
| LPA | C82022 | Lipoprotein-a | A measurement of the lipoprotein-a in a biological specimen. | Lipoprotein a Measurement | ||
| LPNAG | C92275 | Legionella pneumophila Antigen | A measurement of the Legionella pneumophila antigen in a biological specimen. | Legionella pneumophila Antigen Measurement | ||
| LPNGMAB | C92277 | Legionella pneumophila IgG IgM Antibody | A measurement of the Legionella pneumophila IgG and IgM in a biological specimen. | Legionella pneumophila IgG IgM Antibody Measurement | ||
| LPNIGGAB | C92276 | Legionella pneumophila IgG Antibody | A measurement of the Legionella pneumophila IgG antibody in a biological specimen. | Legionella pneumophila IgG Antibody Measurement | ||
| LPNIGMAB | C92278 | Legionella pneumophila IgM Antibody | A measurement of the Legionella pneumophila IgM antibody in a biological specimen. | Legionella pneumophila IgM Antibody Measurement | ||
| LSD | C75354 | Acid;Lysergic Acid Diethylamide | A measurement of the lysergic acid diethylamine (LSD) in a biological specimen. | Lysergide Measurement | ||
| LTB4 | C103413 | Leukotriene B4 | A measurement of the leukotriene B4 in a biological specimen. | Leukotriene B4 Measurement | ||
| LTD4 | C103414 | Leukotriene D4 | A measurement of the leukotriene D4 in a biological specimen. | Leukotriene D4 Measurement | ||
| LTE4 | C103415 | Leukotriene E4 | A measurement of the leukotriene E4 in a biological specimen. | Leukotriene E4 Measurement | ||
| LTF | C82021 | Lactoferrin;Lactotransferrin | A measurement of the lactoferrin in a biological specimen. | Lactoferrin Measurement | ||
| LYM | C51949 | Lymphocytes | A measurement of the lymphocytes in a biological specimen. | Lymphocyte Count | ||
| LYMA | C119289 | Lymphocytes Activated | A measurement of the total activated lymphocytes in a biological specimen. | Activated Lymphocytes Measurement | ||
| LYMAT | C64818 | Lymphocytes Atypical | A measurement of the atypical lymphocytes in a biological specimen. | Atypical Lymphocyte Count | ||
| LYMATLE | C64819 | Lymphocytes Atypical/Leukocytes | A relative measurement (ratio or percentage) of the atypical lymphocytes to leukocytes in a biological specimen. | Atypical Lymphocyte to Leukocyte Ratio | ||
| LYMCE | C98751 | Lymphocytes/Total Cells | A relative measurement (ratio or percentage) of the lymphocytes to total cells in a biological specimen (for example a bone marrow specimen). | Lymphocyte to Total Cell Ratio Measurement | ||
| LYMIM | C100444 | Immature Lymphocytes | A measurement of the immature lymphocytes in a biological specimen. | Immature Lymphocytes Measurement | ||
| LYMIMLE | C100443 | Immature Lymphocytes/Leukocytes | A relative measurement (ratio or percentage) of the immature lymphocytes to leukocytes in a biological specimen. | Immature Lymphocytes to Leukocytes Ratio Measurement | ||
| LYMLE | C64820 | Lymphocytes/Leukocytes | A relative measurement (ratio or percentage) of the lymphocytes to leukocytes in a biological specimen. | Lymphocyte to Leukocyte Ratio | ||
| LYMMCE | C74613 | Lymphoma Cells | A measurement of the malignant lymphocytes in a biological specimen. | Lymphoma Cell Count | ||
| LYMMCELY | C74910 | Lymphoma Cells/Lymphocytes | A relative measurement (ratio or percentage) of the malignant lymphocytes to all lymphocytes in a biological specimen. | Lymphoma Cell to Lymphocyte Ratio Measurement | ||
| LYMPHOTC | C81955 | Chemokine Ligand 1;Lymphotactin | A measurement of the lymphotactin in a biological specimen. | Lymphotactin Measurement | ||
| LYMPL | C74618 | Plasmacytoid Lymphocytes;Plymphocytes | A measurement of the plasmacytoid lymphocytes (lymphocytes with peripherally clumped chromatin and often deep blue cytoplasm, and that appear similar to plasma cells) in a biological specimen. | Plasmacytoid Lymphocyte Count | ||
| LYMPLLY | C74648 | Plasmacytoid Lymphocytes/Lymphocytes | A relative measurement (ratio or percentage) of the plasmacytoid lymphocytes (lymphocytes with peripherally clumped chromatin and often deep blue cytoplasm, and that appear similar to plasma cells) to all lymphocytes in a biological specimen. | Plasmacytoid Lymphocyte to Lymphocyte Ratio Measurement | ||
| LYMRCT | C74629 | Reactive Lymphocytes | A measurement of the reactive lymphocytes (lymphocytes which have become large due to an antigen reaction) in a biological specimen. | Reactive Lymphocyte Count Measurement | ||
| LYMRCTLY | C74654 | Reactive Lymphocytes/Lymphocytes | A relative measurement (ratio or percentage) of the reactive lymphocytes (lymphocytes which have become large due to an antigen reaction) to all lymphocytes in a biological specimen. | Reactive Lymphocyte to Lymphocyte Ratio Measurement | ||
| LYMVAC | C111329 | Vacuolated Lymphocytes | A measurement of the vacuolated lymphocytes in a biological specimen. | Vacuolated Lymphocyte Count | ||
| MACROCY | C64821 | Macrocytes | A measurement of the macrocytes in a biological specimen. | Macrocyte Count | ||
| MASTCE | C111246 | Mast Cells;Mastocytes | A measurement of the mast cells in a biological specimen. | Mast Cell Count | ||
| MASTCECE | C111247 | Mast Cells/Total Cells | A relative measurement (ratio or percentage) of the mast cells to total cells in a biological specimen. | Mast Cell to Total Cell Ratio Measurement | ||
| MAYHEG | C74614 | May-Hegglin Anomaly | A measurement of the May-Hegglin anomaly in a blood sample. This anomaly is characterized by large, misshapen platelets and the presence of Dohle bodies in leukocytes. | May-Hegglin Anomaly Measurement | ||
| MCH | C64797 | Ery. Mean Corpuscular Hemoglobin | A quantitative measurement of the mean amount of hemoglobin per erythrocyte in a biological specimen. | Erythrocyte Mean Corpuscular Hemoglobin | ||
| MCHC | C64798 | Ery. Mean Corpuscular HGB Concentration | A quantitative measurement of the mean amount of hemoglobin per erythrocytes in a specified volume of a biological specimen. | Erythrocyte Mean Corpuscular Hemoglobin Concentration | ||
| MCP1 | C82025 | Monocyte Chemotactic Protein 1 | A measurement of the monocyte chemotactic protein 1 in a biological specimen. | Monocyte Chemotactic Protein 1 Measurement | ||
| MCPHG | C74798 | Macrophages | A measurement of the macrophages in a biological specimen. | Macrophage Count | ||
| MCPHGCE | C111244 | Macrophages/Total Cells | A relative measurement (ratio or percentage) of the macrophages to total cells in a biological specimen. | Macrophage to Total Cell Ratio Measurement | ||
| MCPROT | C92291 | Monoclonal Immunoglobulin Protein;Paraprotein | A measurement of homogenous immunoglobulin resulting from the proliferation of a single clone of plasma cells in a biological specimen. | Monoclonal Protein Measurement | ||
| MCSF | C80191 | Macrophage Colony Stimulating Factor | A measurement of the macrophage colony stimulating factor in a biological specimen. | Macrophage Colony Stimulating Factor Measurement | ||
| MCV | C64799 | Ery. Mean Corpuscular Volume;Erythrocytes Mean Corpuscular Volume;RBC Mean Corpuscular Volume | A quantitative measurement of the mean volume of erythrocytes in a biological specimen. | Erythrocyte Mean Corpuscular Volume | ||
| MCVRETIC | C114215 | MCV Reticulocytes;Mean Corpuscular Volume Reticulocytes | A measurement of the mean volume of reticulocytes in a biological specimen. | Reticulocyte Mean Corpuscular Volume | ||
| MDC | C81956 | Chemokine Ligand 22;Macrophage-Derived Chemokine | A measurement of the macrophage-derived chemokine in a biological specimen. | Macrophage-Derived Chemokine Measurement | ||
| MDMA | C75359 | 3,4-methylenedioxymethamphetamine;Ecstasy | A measurement of the 3,4-methylenedioxymethamphetamine (MDMA) in a biological specimen. | 3,4-Methylenedioxymethamphetamine Measurement | ||
| MENGL | C111250 | Meningeal Cells | A measurement of the mengingeal cells in a biological specimen. | Meningeal Cell Count | ||
| MENGLCE | C111251 | Meningeal Cells/Total Cells | A relative measurement (ratio or percentage) of the meningeal cells to total cells in a biological specimen. | Meningeal Cell to Total Cell Ratio Measurement | ||
| METAMY | C74615 | Metamyelocytes | A measurement of the metamyelocytes (small, myelocytic neutrophils with an indented nucleus) in a biological specimen. | Metamyelocyte Count | ||
| METAMYCE | C98754 | Metamyelocytes/Total Cells | A relative measurement (ratio or percentage ) of the metamyelocytes (small, myelocytic neutrophils with an indented nucleus) to total cells in a biological specimen (for example a bone marrow specimen). | Metamyelocyte to Total Cell Ratio Measurement | ||
| METAMYLE | C74645 | Metamyelocytes/Leukocytes | A relative measurement (ratio or percentage) of the metamyelocytes (small, myelocytic neutrophils with an indented nucleus) to all leukocytes in a biological specimen. | Metamyelocyte to Leukocyte Ratio Measurement | ||
| METANEPH | C116198 | Metadrenaline;Metanephrine | A measurement of the metanephrine in a biological specimen. | Metanephrine Measurement | ||
| METHAMPH | C75348 | Methamphetamine | A measurement of the methamphetamine drug present in a biological specimen. | Methamphetamine Measurement | ||
| METHDN | C74881 | Methadone | A measurement of the methadone present in a biological specimen. | Methadone Measurement | ||
| METHQLDN | C74882 | Methaqualone | A measurement of the methaqualone present in a biological specimen. | Methaqualone Measurement | ||
| MFILARIA | C117843 | Microfilaria | Presence of microfilaria stage of filarial nematodes in smears prepared from whole blood or other body fluids. | Microfilaria Measurement | ||
| MG | C64840 | Magnesium | A measurement of the magnesium in a biological specimen. | Magnesium Measurement | ||
| MGB | C79436 | Myoglobin | A measurement of myoglobin in a biological specimen. | Myoglobin Measurement | ||
| MGBCREAT | C106546 | Myoglobin/Creatinine | A relative measurement (ratio or percentage) of the myoglobin to creatinine present in a sample. | Myoglobin to Creatinine Ratio Measurement | ||
| MGCREAT | C79456 | Magnesium/Creatinine | A relative measurement (ratio or percentage) of the magnesium to creatinine in a biological specimen. | Magnesium to Creatinine Ratio Measurement | ||
| MICROCY | C64822 | Microcytes | A measurement of the microcytes in a biological specimen. | Microcyte Count | ||
| MIDCEF | C116199 | Mid Cell Fraction;Mid Cells | A measurement of the mid cell fraction, including eosinophils, basophils, monocytes and other precursor white blood cells, in a biological specimen. | Mid Cell Fraction Measurement | ||
| MIP1A | C82023 | Chemokine Ligand 3;Macrophage Inflammatory Protein 1 Alpha | A measurement of the macrophage inflammatory protein 1 alpha in a biological specimen. | Macrophage Inflammatory Protein 1 Alpha Measurement | ||
| MIP1B | C82024 | Chemokine Ligand 4;Macrophage Inflammatory Protein 1 Beta | A measurement of the macrophage inflammatory protein 1 beta in a biological specimen. | Macrophage Inflammatory Protein 1 Beta Measurement | ||
| MLATONIN | C74867 | Melatonin | A measurement of the melatonin hormone in a biological specimen. | Melatonin Measurement | ||
| MLIGCE | C74660 | Malignant Cells, NOS | A measurement of the malignant cells of all types in a biological specimen. | Malignant Cell Count | ||
| MLIGCEBC | C74643 | Malignant Cells, NOS/Blood Cells | A relative measurement (ratio or percentage) of the malignant cells of all types to all blood cells in a biological specimen. | Malignant Cell to Blood Cell Ratio Measurement | ||
| MLR | C16790 | Mixed Leukocyte Reaction;Mixed Lymphocyte Reaction | A measurement of the histocompatibility at the HL-A locus between two populations of lymphocytes taken from two separate individuals. | Mixed Lymphocyte Reaction Test | ||
| MMA | C96690 | Methylmalonic Acid | A measurement of the methylmalonic acid in a biological specimen. | Methylmalonic Acid Measurement | ||
| MMP1 | C80192 | Interstitial Collagenase;Matrix Metalloproteinase 1 | A measurement of the matrix metalloproteinase 1 in a biological specimen. | Matrix Metalloproteinase 1 Measurement | ||
| MMP2 | C80193 | Gelatinase A;Matrix Metalloproteinase 2 | A measurement of the matrix metalloproteinase 2 in a biological specimen. | Matrix Metalloproteinase 2 Measurement | ||
| MMP3 | C80194 | Matrix Metalloproteinase 3;Stromelysin 1 | A measurement of the matrix metalloproteinase 3 in a biological specimen. | Matrix Metalloproteinase 3 Measurement | ||
| MMP7 | C80195 | Matrilysin;Matrix Metalloproteinase 7 | A measurement of the matrix metalloproteinase 7 in a biological specimen. | Matrix Metalloproteinase 7 Measurement | ||
| MMP8 | C80196 | Matrix Metalloproteinase 8;Neutrophil Collagenase | A measurement of the matrix metalloproteinase 8 in a biological specimen. | Matrix Metalloproteinase 8 Measurement | ||
| MMP9 | C80197 | Gelatinase B;Matrix Metalloproteinase 9 | A measurement of the matrix metalloproteinase 9 in a biological specimen. | Matrix Metalloproteinase 9 Measurement | ||
| MOCYCE | C111276 | Monocytoid Cells | A measurement of the monocytoid cells in a biological specimen. | Monocytoid Cell Count | ||
| MOCYCECE | C111277 | Monocytoid Cells/Total Cells | A relative measurement (ratio or percentage) of the monocytoid cells to total cells in a biological specimen. | Monocytoid Cell to Total Cell Ratio Measurement | ||
| MONO | C64823 | Monocytes | A measurement of the monocytes in a biological specimen. | Monocyte Count | ||
| MONOBL | C74631 | Monoblasts | A measurement of the monoblast cells in a biological specimen. | Monoblast Count | ||
| MONOBLLE | C74646 | Monoblasts/Leukocytes | A relative measurement (ratio or percentage) of the monoblasts to leukocytes in a biological specimen. | Monoblast to Leukocyte Ratio Measurement | ||
| MONOCE | C98872 | Monocytes/Total Cells | A relative measurement (ratio or percentage) of the monocytes to total cells in a biological specimen (for example a bone marrow specimen). | Monocytes to Total Cell Ratio Measurement | ||
| MONOIM | C96676 | Immature Monocytes | A measurement of the immature monocytes in a biological specimen. | Immature Monocyte Count | ||
| MONOIMLE | C96677 | Immature Monocytes/Leukocytes | A relative measurement (ratio or percentage) of immature monocytes to total leukocytes in a biological specimen. | Immature Monocyte to Leukocyte Ratio Measurement | ||
| MONOLE | C64824 | Monocytes/Leukocytes | A relative measurement (ratio or percentage) of the monocytes to leukocytes in a biological specimen. | Monocyte to Leukocyte Ratio | ||
| MONOMA | C106544 | Monocytes/Macrocytes | A relative measurement (ratio or percentage) of the monocytes to macrocytes present in a sample. | Monocytes to Macrocytes Ratio Measurement | ||
| MORPHINE | C74883 | Morphine | A measurement of the morphine present in a biological specimen. | Morphine Measurement | ||
| MPC | C96686 | Mean Platelet Component | A measurement of the mean platelet component (platelet activity) in a blood specimen. | Mean Platelet Component Measurement | ||
| MPM | C114214 | Mean Platelet Dry Mass | A measurement of the mean platelet dry mass in a biological specimen. | Mean Platelet Dry Mass | ||
| MPO | C80198 | Myeloperoxidase | A measurement of the myeloperoxidase in a biological specimen. | Myeloperoxidase Measurement | ||
| MPOAB | C92280 | Myeloperoxidase Antibody | A measurement of the myeloperoxidase antibody in a biological specimen. | Myeloperoxidase Antibody Measurement | ||
| MPV | C74730 | Mean Platelet Volume | A measurement of the average size of the platelets present in a blood sample. | Mean Platelet Volume Measurement | ||
| MPXI | C119290 | Myeloperoxidase Index | The mean peroxidase activity index or staining intensity of the neutrophil population relative to the archetype. | Neutrophil Myeloperoxidase Index | ||
| MSPIKE | C117844 | Monoclonal Protein Spike | A measurement of the monoclonal protein in the region of the electrophoresis field containing a spike (increase) in protein. | Monoclonal Protein Spike Measurement | ||
| MUCTHR | C74721 | Mucous Threads | A measurement of the mucous threads present in a biological specimen. | Mucous Thread Measurement | ||
| MYBLA | C74632 | Myeloblasts | A measurement of the myeloblast cells in a biological specimen. | Myeloblast Count | ||
| MYBLALE | C64825 | Myeloblasts/Leukocytes | A relative measurement (ratio or percentage) of the myeloblasts to leukocytes in a biological specimen. | Myeloblast to Leukocyte Ratio | ||
| MYBLAT1 | C92283 | Type I Myeloblasts | A measurement of type I myeloblast cells per unit of a biological specimen. | Type I Myeloblasts Measurement | ||
| MYBLAT2 | C92284 | Type II Myeloblasts | A measurement of type II myeloblast cells per unit of a biological specimen. | Type II Myeloblasts Measurement | ||
| MYBLAT3 | C92285 | Type III Myeloblasts | A measurement of type III myeloblast cells per unit of a biological specimen. | Type III Myeloblasts Measurement | ||
| MYCY | C74662 | Myelocytes | A measurement of the myelocytes in a biological specimen. | Myelocyte Count | ||
| MYCYCE | C98868 | Myelocytes/Total Cells | A relative measurement (ratio or percentage) of the myelocytes to total cells in a biological specimen (for example a bone marrow specimen). | Myelocyte to Total Cell Ratio Measurement | ||
| MYCYLE | C64826 | Myelocytes/Leukocytes | A relative measurement (ratio or percentage) of the myelocytes to leukocytes in a biological specimen. | Myelocyte to Leukocyte Ratio | ||
| MYELINAB | C103418 | Myelin Antibodies | A measurement of the myelin antibodies in a biological specimen. | Myelin Antibodies Measurement | ||
| MYL3 | C106547 | Cardiac myosin light chain 1;Myosin Light Chain 3;Myosin light chain 1, slow-twitch muscle B/ventricular isoform | A measurement of myosin light chain 3 in a biological specimen. | Myosin Light Chain 3 Measurement | ||
| MYPCERPC | C92242 | Myeloid/Erythroid Ratio | A relative measurement (ratio or percentage) of myeloid progenitor cells to erythrocyte precursor cells in a biological specimen. | Myeloid to Erythroid Ratio Measurement | ||
| MYTBGIR | C92241 | Mycobacterium tuberculosis IFN Gamma Response | A measurement of the amount of interferon gamma that is released when Mycobacterium tuberculosis antigen is incubated with a biological specimen, usually blood. Increased amounts of interferon gamma suggests a prior or existing M. tuberculosis infection. | Mycobacterium tuberculosis Interferon Gamma Response | ||
| MYTBNUAC | C92279 | Mycobacterium tuberculosis Nucleic Acid | A measurement of the Mycobacterium tuberculosis nucleic acid in a biological specimen. | Mycobacterium tuberculosis Nucleic Acid Measurement | ||
| NACLR | C106568 | Sodium Clearance | A measurement of the volume of serum or plasma that would be cleared of sodium by excretion of urine for a specified unit of time (e.g. one minute). | Sodium Clearance Measurement | ||
| NACREAT | C79464 | Sodium/Creatinine | A relative measurement (ratio or percentage) of the sodium to creatinine in a biological specimen. | Sodium to Creatinine Ratio Measurement | ||
| NAG | C79459 | N-Acetyl Glucosamide;N-Acetyl Glucosamine | A measurement of N-acetyl glucosamide (sugar derivative) in a biological specimen. | N-Acetyl Glucosamide Measurement | ||
| NAGASE | C103419 | Beta-N-acetyl-D-glucosaminidase | A measurement of the N-acetyl-beta-D-glucosaminidase (enzyme) in a biological specimen. | N-acetyl-beta-D-glucosaminidase Measurement | ||
| NAGCREAT | C79460 | N-Acetyl Glucosamide/Creatinine | A relative measurement (ratio or percentage) of the N-acetyl glucosamide to creatinine in a biological specimen. | N-Acetyl Glucosamide to Creatinine Ratio Measurement | ||
| NCTD5P | C79437 | 5 Prime Nucleotidase;5'-Ribonucleotide Phosphohydrolase | A measurement of the 5'-nucleotidase in a biological specimen. | 5 Prime Nucleotidase Measurement | ||
| NEOPTERN | C80199 | Neopterin | A measurement of the neopterin in a biological specimen. | Neopterin Measurement | ||
| NEUT | C63321 | Neutrophils | A measurement of the neutrophils in a biological specimen. | Absolute Neutrophil Count | ||
| NEUTAGR | C116200 | Agranular Neutrophils | A measurement of the agranular neutrophils in a biological specimen. | Agranular Neutrophils Measurement | ||
| NEUTB | C64830 | Neutrophils Band Form | A measurement of the banded neutrophils in a biological specimen. | Neutrophil Band Form Count | ||
| NEUTBLE | C64831 | Neutrophils Band Form/Leukocytes | A relative measurement (ratio or percentage) of the banded neutrophils to leukocytes in a biological specimen. | Neutrophil Band Form to Leukocyte Ratio | ||
| NEUTCE | C98763 | Neutrophils/Total Cells | A relative measurement (ratio or percentage) of the neutrophils to total cells in a biological specimen (for example a bone marrow specimen). | Neutrophil to Total Cell Ratio Measurement | ||
| NEUTCYBS | C111166 | Cytoplasmic Basophilia Neutrophil | A measurement of the neutrophils in a biological specimen showing a dark staining pattern in the cytoplasm due to increased acidic content. | Cytoplasmic Basophilia Neutrophil Count | ||
| NEUTGT | C96651 | Giant Neutrophils | A measurement of the giant neutrophils in a biological specimen. | Giant Neutrophil Count | ||
| NEUTHYGR | C116201 | Hypogranular Neutrophils | A measurement of the hypogranular neutrophils in a biological specimen. | Hypogranular Neutrophil Measurement | ||
| NEUTIM | C96678 | Immature Neutrophils | A measurement of the total immature neutrophils in a biological specimen. | Immature Neutrophil Count | ||
| NEUTIMLE | C100442 | Immature Neutrophils/Leukocytes | A relative measurement (ratio or percentage) of the immature neutrophils to leukocytes in a biological specimen. | Immature Neutrophils to Leukocytes Ratio Measurement | ||
| NEUTLE | C64827 | Neutrophils/Leukocytes | A relative measurement (ratio or percentage) of the neutrophils to leukocytes in a biological specimen. | Neutrophil to Leukocyte Ratio | ||
| NEUTLS | C116202 | Left Shift Neutrophils | An observation of the above normal incidence of immature neutrophils, including band neutrophils and neutrophil precursors in a biological specimen. | Left Shift Neutrophil Measurement | ||
| NEUTMM | C84822 | Neutrophilic Metamyelocytes | A measurement of the neutrophilic metamyelocytes in a biological specimen. | Neutrophilic Metamyelocyte Count | ||
| NEUTMY | C84823 | Neutrophilic Myelocytes | A measurement of the neutrophilic myelocytes in a biological specimen. | Neutrophilic Myelocyte Count | ||
| NEUTSG | C81997 | Neutrophils, Segmented | A measurement of the segmented neutrophils in a biological specimen. | Segmented Neutrophil Count | ||
| NEUTSGLE | C82045 | Neutrophils, Segmented/Leukocytes | A relative measurement (ratio or percentage) of segmented neutrophils to leukocytes in a biological specimen. | Segmented Neutrophil to Leukocyte Ratio Measurement | ||
| NEUTVAC | C74628 | Vacuolated Neutrophils | A measurement of the neutrophils containing small vacuoles in a biological specimen. | Vacuolated Neutrophil Count | ||
| NGON | C92298 | Neisseria gonorrhoeae Screening | Examination of a biological specimen to detect the presence of Neisseria gonorrhoeae. | Neisseria gonorrhoeae Screening | ||
| NITRICOX | C112360 | NO;Nitric Oxide | A measurement of the nitric oxide in a biological specimen. | Nitric Oxide Measurement | ||
| NITRITE | C64810 | Nitrite | A measurement of the nitrite in a urine specimen. | Nitrite Measurement | ||
| NKCE | C98762 | Natural Killer Cells | A measurement of the total natural killer cells in a biological specimen. | Natural Killer Cell Count | ||
| NKCEFUNC | C116203 | Natural Killer Cell Activity;Natural Killer Cell Function | A measurement of the natural killer cell function in a biological specimen. | Natural Killer Cell Activity Measurement | ||
| NONHDL | C116204 | Non-HDL Cholesterol;Non-High Density Lipoprotein | A measurement of the non-high density lipoprotein cholesterol in a biological specimen. | Non-High Density Lipoprotein Cholesterol Measurement | ||
| NOREPIN | C74868 | Noradrenaline;Norepinephrine | A measurement of the norepinephrine hormone in a biological specimen. | Noradrenaline Measurement | ||
| NPAP | C100434 | Non-Prostatic Acid Phosphatase | A measurement of the non-prostatic acid phosphatase in a biological specimen. | Non-Prostatic Acid Phosphatase Measurement | ||
| NPY | C74892 | Neuropeptide Y | A measurement of the neuropeptide Y in a biological specimen. | Neuropeptide Y Measurement | ||
| NSE | C116205 | Enolase 2;Gamma-enolase;Neuron Specific Enolase | A measurement of the neuron specific enolase in a biological specimen. | Neuron Specific Enolase Measurement | ||
| NTELOP | C74743 | N-telopeptide | A measurement of the N-telopeptide in a biological specimen. | N-Telopeptide Measurement | ||
| NTXI | C82039 | Type I Collagen N-Telopeptides | A measurement of the type I collagen N-telopeptides in a biological specimen. | Type I Collagen N-Telopeptide Measurement | ||
| NTXII | C82041 | Type II Collagen N-Telopeptides | A measurement of the type II collagen N-telopeptides in a biological specimen. | Type II Collagen N-Telopeptide Measurement | ||
| NUCSWELL | C114213 | Nuclear Swelling | A measurement of the expansion of the nucleus of the cells in a biological specimen. | Nuclear Swelling Measurement | ||
| O2CT | C111284 | Oxygen Content | A measurement of the amount of oxygen content in a biological specimen. | Oxygen Measurement | ||
| OCCBLD | C74686 | Occult Blood | A measurement of the blood in body products such as a urine or stool sample, not detectable on gross examination. | Occult Blood Measurement | ||
| OPG | C116206 | OCIF;Osteoclastogenesis Inhibitory Factor;Osteoprotegerin;TNFRS11B;Tumor Necrosis Factor Receptor Superfamily Member 11b | A measurement of the osteoprotegerin in a biological specimen. | Osteoprotegerin Measurement | ||
| OPIATE | C74796 | Opiate | A measurement of any opiate class drug present in a biological specimen. | Opiate Measurement | ||
| OSMLTY | C74801 | Osmolality | A measurement of the osmoles of solute per unit of biological specimen. | Osmolality Measurement | ||
| OSMRTY | C74802 | Osmolarity | A measurement of the osmoles of solute per liter of solution. | Osmolarity Measurement | ||
| OSTEOC | C74744 | Osteocalcin | A measurement of the osteocalcin in a biological specimen. | Osteocalcin Measurement | ||
| OVAPARS | C100452 | Ova and Parasite | A measurement of the parasites and ova in a biological specimen. | Ova and Parasite Measurement | ||
| OXACREAT | C117983 | Oxalate/Creatinine | A relative measurement (ratio or percentage) of the oxalate to creatinine in a biological specimen. | Oxalate to Creatinine Ratio Measurement | ||
| OXALATE | C92250 | Ethanedioate;Oxalate | A measurement of the oxalate in a biological specimen. | Oxalate Measurement | ||
| OXYCAP | C96614 | Oxygen Capacity | A measurement of the maximum amount of oxygen that can be combined chemically with hemoglobin in a volume of blood. | Oxygen Capacity Measurement | ||
| OXYCDN | C74884 | Oxycodone;Oxycontin | A measurement of the oxycodone present in a biological specimen. | Oxycodone Measurement | ||
| OXYSAT | C60832 | Oxygen Saturation | A measurement of the oxygen-hemoglobin saturation of a volume of blood. | Oxygen Saturation Measurement | ||
| OXYTOCIN | C74869 | Oxytocin;Oxytoxin | A measurement of the oxytocin hormone in a biological specimen. | Oxytocin Measurement | ||
| P1NP | C96625 | Amino-terminal propeptide of type 1 procollagen;P1NP Aminoterm Type 1;Procollagen 1 N-Terminal Propeptide | A measurement of the procollagen 1 N-terminal propeptide in a biological specimen. | Procollagen 1 N-Terminal Propeptide Measurement | ||
| P50OXYGN | C102279 | P50 Oxygen | A measurement of the partial pressure of oxygen when hemoglobin is half saturated in a biological specimen. | P50 Oxygen Measurement | ||
| PAF | C111292 | Platelet Activating Factor | A measurement of the platelet activating factor in a biological specimen. | Platelet Activating Factor Measurement | ||
| PAI1 | C82030 | Plasminogen Activator Inhibitor-1 | A measurement of the plasminogen activator inhibitor-1 in a biological specimen. | Plasminogen Activator Inhibitor-1 Measurement | ||
| PAI1AG | C81989 | Plasminogen Activator Inhibitor-1 AG | A measurement of the plasminogen activator inhibitor-1 antigen in a biological specimen. | Plasminogen Activator Inhibitor-1 Antigen Measurement | ||
| PAP | C80204 | Prostatic Acid Phosphatase | A measurement of the prostatic acid phosphatase in a biological specimen. | Prostatic Acid Phosphatase Measurement | ||
| PAPPA | C82031 | Pregnancy-Associated Plasma Protein-A | A measurement of the pregnancy-associated plasma protein-A in a biological specimen. | Pregnancy-Associated Plasma Protein-A Measurement | ||
| PAPPEN | C74616 | Pappenheimer Bodies | A measurement of the cells containing Pappenheimer Bodies (violet or blue staining ferritin granules usually found along the periphery of the red blood cells) in a biological specimen. | Pappenheimer Body Count | ||
| PARICEAB | C116207 | Anti-Parietal Cell Antibody;Parietal Cell Antibody | A measurement of the parietal cell antibody in a biological specimen. | Parietal Cell Antibody Measurement | ||
| PB19GGAB | C96617 | Parvovirus B19 IgG Antibody | A measurement of the Parvovirus B19 IgG antibody in a biological specimen. | Parvovirus B19 IgG Antibody Measurement | ||
| PB19GMAB | C96618 | Parvovirus B19 IgM Antibody | A measurement of the Parvovirus B19 IgM antibody in a biological specimen. | Parvovirus B19 IgM Antibody Measurement | ||
| PCDW | C111294 | Platelet Component Distribution Width | A measurement of a marker of platelet shape change in a biological specimen. | Platelet Component Distribution Width Measurement | ||
| PCO2 | C82625 | Partial Pressure Carbon Dioxide | A measurement of the pressure of carbon dioxide in a biological specimen. | Partial Pressure of Carbon Dioxide Measurement | ||
| PCP | C74694 | Phencyclidine;Phenylcyclohexylpiperidine | A measurement of the phencyclidine present in a biological specimen. | Phencyclidine Measurement | ||
| PCT | C103430 | Procalcitonin | A measurement of the procalcitonin in a biological specimen. | Procalcitonin Measurement | ||
| PDGFAB | C116208 | PDGF Isoform AB;Platelet Derived Growth Factor Isoform AB;Platelet Derived Growth Factor-AB Isoform | A measurement of the platelet derived growth factor isoform AB in a biological specimen. | Platelet Derived Growth Factor Isoform AB Measurement | ||
| PDW | C81962 | Platelet Distribution Width | A measurement of the range of platelet sizes in a biological specimen. | Platelet Distribution Width | ||
| PELGERH | C74617 | Pelger Huet Anomaly | A measurement of the Pelger Huet Anomaly (nuclei of neutrophils and eosinophils appear rod-like, spherical or dumbbell shaped) in a biological specimen. | Pelger Huet Anomaly Measurement | ||
| PEMAB | C81988 | Pemphigoid Antibodies | A measurement of the pemphigoid antibodies in a biological specimen. | Pemphigoid Antibody Measurement | ||
| PEPSNG | C100122 | Pepsinogen | A measurement of the pepsinogen in a biological specimen. | Pepsinogen Measurement | ||
| PEPSNGA | C100469 | PGA;Pepsinogen A | A measurement of the pepsinogen A in a biological specimen. | Pepsinogen A Measurement | ||
| PEPSNGC | C100470 | PGC;Pepsinogen C | A measurement of the pepsinogen C in a biological specimen. | Pepsinogen C Measurement | ||
| PEPSNGI | C100467 | PGI;Pepsinogen I | A measurement of the pepsinogen I in a biological specimen. | Pepsinogen I Measurement | ||
| PEPSNGII | C100468 | PGII;Pepsinogen II | A measurement of the pepsinogen II in a biological specimen. | Pepsinogen II Measurement | ||
| PERIOSTN | C112395 | OSF2;Osteoblast Specific Factor 2;POSTN;Periostin | A measurement of the periostin in a biological specimen. | Periostin Measurement | ||
| PERTHRBL | C100446 | Proerythroblast | A measurement of the proerythroblasts in a biological specimen. | Proerythroblast Measurement | ||
| PF2AI8CR | C119291 | 8-Iso-PGF2alpha/Creatinine | A relative measurement (ratio or percentage) of the prostaglandin F2 alpha isoform 8 to creatinine in a biological specimen. | 8-Iso-Prostaglandin F2 Alpha to Creatinine Ratio Measurement | ||
| PFCT | C111295 | PFCT;Platelet Function Closure Time | A measurement of the platelet function closure time in a biological specimen. | Platelet Function Closure Time Measurement | ||
| PG | C103343 | Total Prostaglandin | A measurement of the total prostaglandin in a biological specimen. | Prostaglandin Measurement | ||
| PGD2 | C103431 | Prostaglandin D2 | A measurement of the prostaglandin D2 in a biological specimen. | Prostaglandin D2 Measurement | ||
| PGD2S | C103432 | Prostaglandin D2 Synthase | A measurement of the prostaglandin D2 synthase in a biological specimen. | Prostaglandin D2 Synthase Measurement | ||
| PGE1 | C103434 | Prostaglandin E1 | A measurement of the prostaglandin E1 in a biological specimen. | Prostaglandin E1 Measurement | ||
| PGE2 | C103435 | Prostaglandin E2 | A measurement of the prostaglandin E2 in a biological specimen. | Prostaglandin E2 Measurement | ||
| PGES | C103433 | Prostaglandin E Synthase | A measurement of the prostaglandin E synthase in a biological specimen. | Prostaglandin E Synthase Measurement | ||
| PGF1A | C103436 | Prostaglandin F1 Alpha | A measurement of the prostaglandin F1 alpha in a biological specimen. | Prostaglandin F1 Alpha Measurement | ||
| PGF2A | C103437 | Prostaglandin F2 Alpha | A measurement of the prostaglandin F2 alpha in a biological specimen. | Prostaglandin F2 Alpha Measurement | ||
| PGF2AI8 | C119292 | 8-Iso-Prostaglandin F2 Alpha | A measurement of the prostaglandin F2 alpha isoform 8 in a biological specimen. | 8-Iso-Prostaglandin F2 Alpha Measurement | ||
| PH | C45997 | pH | The negative logarithm (base 10) of the concentration of hydronium ions, which is used as a measure of the acidity or alkalinity of a fluid. | pH | ||
| PHENTHZ | C74695 | Dibenzothiazine;Phenothiazine | A measurement of the phenothiazine present in a biological specimen. | Phenothiazine Measurement | ||
| PHOS | C64857 | Inorganic Phosphate;Phosphate;Phosphorus | A measurement of the phosphate in a biological specimen. | Phosphate Measurement | ||
| PHOSCLR | C106553 | Phosphate Clearance | A measurement of the volume of serum or plasma that would be cleared of phosphate by excretion of urine for a specified unit of time (e.g. one minute). | Phosphate Clearance Measurement | ||
| PHOSCRT | C79461 | Phosphate/Creatinine | A relative measurement (ratio or percentage) of the phosphate to creatinine in a biological specimen. | Phosphate to Creatinine Ratio Measurement | ||
| PHOSEXR | C117845 | Phosphorus Excretion Rate | A measurement of the amount of phosphorus being excreted in urine over a defined amount of time (e.g. one hour). | Phosphorus Urine Excretion Rate | ||
| PHOSLPD | C96623 | Phospholipid | A measurement of the phospholipids in a biological specimen. | Phospholipid Measurement | ||
| PICP | C82033 | Procollagen Type I Carboxy Term Peptide | A measurement of the procollagen-1 carboxy-terminal peptide in a biological specimen. | Procollagen Type I Carboxy Terminal Peptide Measurement | ||
| PLAGGCVT | C114210 | Platelet Aggregation Curve Type | The classification of the curve pattern that is formed as a result of platelet aggregation. | Platelet Aggregometry Curve Type | ||
| PLAGMAMP | C114211 | Platelet Aggregation Mean Amplitude | An average of the measurements of the magnitude of the platelet aggregation in a biological specimen. | Platelet Aggregometry Mean Amplitude | ||
| PLAGMCVT | C114212 | Platelet Aggregation Mean Curve Type | The classification of the curve pattern that is formed as the average result of the platelet aggregation curve measurements. | Platelet Aggregometry Mean Curve Type | ||
| PLAT | C51951 | Platelets | A measurement of the platelets (non-nucleated thrombocytes) in a biological specimen. | Platelet Count | ||
| PLATAGGR | C103427 | Platelet Aggregation;Platelet Function | A measurement of the association of platelets to one another via adhesion molecules in a biological sample. | Platelet Aggregation Measurement | ||
| PLATCLMP | C96624 | PLT Clumps;Platelet Clumps | A measurement of the platelet clumps in a biological specimen. | Platelet Clumps Count | ||
| PLATGNT | C74728 | Giant Platelets | A measurement of the giant (larger than 7um in diameter) platelets in a biological specimen. | Giant Platelet Count | ||
| PLATHCT | C100424 | Platelet Hematocrit;Thrombocytocrit | A relative measurement (ratio or percentage) of the proportion of the volume of blood taken up by platelets. | Platelet Hematocrit Measurement | ||
| PLATLRG | C74729 | Large Platelets | A measurement of the large (between 4 um and 7um in diameter) platelets in a biological specimen. | Large Platelet Count | ||
| PLATSAT | C116209 | Platelet Satellitism | An examination or assessment of the platelet satellitism (platelet rosetting around cells) in a biological specimen. | Platelet Satellitism Assessment | ||
| PLSCECE | C98869 | Plasma Cells/Total Cells | A relative measurement (ratio or percentage) of the mature plasma cells (plasmacytes) to total cells in a biological specimen (for example a bone marrow specimen). | Plasma Cell to Total Cell Ratio Measurement | ||
| PLSIMCE | C96679 | Immature Plasma Cells | A measurement of the immature plasma cells in a biological specimen. | Immature Plasma Cell Count | ||
| PLSIMCLY | C96680 | Immature Plasma Cells/Lymphocytes | A relative measurement (ratio or percentage) of immature plasma cells to total lymphocytes in a biological specimen. | Immature Plasma Cell to Lymphocyte Ratio Measurement | ||
| PLSMCE | C74661 | Mature Plasma Cells;Plasmacytes | A measurement of the mature plasma cells (plasmacytes) in a biological specimen. | Mature Plasma Cell Count | ||
| PLSMCELY | C74911 | Mature Plasma Cells/Lymphocytes | A relative measurement (ratio or percentage) of the mature plasma cells (plasmacytes) to all lymphocytes in a biological specimen. | Mature Plasma Cell to Lymphocyte Ratio Measurement | ||
| PLSMDM | C100453 | Malaria;Plasmodium | Examination of a biological specimen to detect the presence of any protozoan belonging to the Plasmodium genus. | Plasmodium Measurement | ||
| PLSPCE | C74619 | Plasmablast;Precursor Plasma Cells | A measurement of the precursor (blast stage) plasma cells (antibody secreting cells derived from B cells via antigen stimulation) in a biological specimen. | Precursor Plasma Cell Count | ||
| PLSPCELY | C74650 | Precursor Plasma Cells/Lymphocytes | A relative measurement (ratio or percentage) of the precursor (blast stage) plasma cells (antibody secreting cells derived from B cells via antigen stimulation) to all lymphocytes in a biological specimen. | Precursor Plasma Cell to Lymphocyte Ratio Measurement | ||
| PLTAGAMP | C111293 | Platelet Aggregation Amplitude | A measurement of the magnitude of the platelet aggregation in a biological specimen. | Platelet Aggregation Amplitude Measurement | ||
| PLTMORPH | C111296 | Platelet Morphology | An examination or assessment of the form and structure of platelets. | Platelet Morphology Measurement | ||
| PNCTPP | C80201 | Pancreatic Polypeptide | A measurement of the pancreatic polypeptide in a biological specimen. | Pancreatic Polypeptide Measurement | ||
| PO2 | C71251 | Partial Pressure Oxygen | A measurement of the pressure of oxygen in a biological specimen. | Partial Pressure of Oxygen Measurement | ||
| PO2FIO2 | C119293 | PAO2/FIO2;PP Arterial O2/Fraction Inspired O2 | A relative measurement (ratio or percentage) of the force per unit area (pressure) of oxygen dissolved in arterial blood to the percentage oxygen of an inhaled mixture of gasses. | Partial Pressure Arterial Oxygen to Fraction Inspired Oxygen Ratio Measurement | ||
| POIKILO | C79602 | Poikilocytes | A measurement of the odd-shaped erythrocytes in a whole blood specimen. | Poikilocyte Measurement | ||
| POIKRBC | C74649 | Poikilocytes/Erythrocytes | A relative measurement (ratio or percentage) of the poikilocytes, or irregularly shaped erythrocytes, to all erythrocytes in a biological specimen. | Poikilocyte to Erythrocyte Ratio Measurement | ||
| POLYCHR | C64803 | Polychromasia | A measurement of the blue-staining characteristic of newly generated erythrocytes. | Polychromasia | ||
| PRA | C116210 | PRA Score;Panel Reactive Antibody;Percent Panel Reactive Antibody;Percent Reactive Antibody | A measurement of the panel reactive antibody (the reactivity between host immune cells and donor human leukocyte antigen) in a biological specimen. | Panel Reactive Antibody Test | ||
| PREALB | C100435 | Prealbumin;Thyroxine-binding Prealbumin;Transthyretin | A measurement of the prealbumin in a biological specimen. | Prealbumin Measurement | ||
| PRINSINS | C111299 | Proinsulin/Insulin Ratio | A relative measurement (ratio or percentage) of the proinsulin to insulin in a biological specimen. | Proinsulin to Insulin Ratio Measurement | ||
| PRLYMLE | C64829 | Prolymphocytes/Leukocytes | A relative measurement (ratio or percentage) of prolymphocytes to leukocytes in a biological specimen. | Prolymphocyte to Leukocyte Ratio | ||
| PROGEST | C74791 | Progesterone | A measurement of the progesterone hormone in a biological specimen. | Progesterone Measurement | ||
| PROGESTR | C117846 | NR3C3;PR;Progesterone Receptor | A measurement of the progesterone receptor in a biological specimen. | Progesterone Receptor Measurement | ||
| PROINSUL | C81967 | Proinsulin | A measurement of the proinsulin in a biological specimen. | Proinsulin Measurement | ||
| PROLCTN | C74870 | Prolactin | A measurement of the prolactin hormone in a biological specimen. | Prolactin Measurement | ||
| PROLYM | C74620 | Prolymphocytes | A measurement of the prolymphocytes in a biological specimen. | Prolymphocyte Count | ||
| PROLYMLY | C74651 | Prolymphocytes/Lymphocytes | A relative measurement (ratio or percentage) of the prolymphocytes to all lymphocytes in a biological specimen. | Prolymphocyte to Lymphocyte Ratio Measurement | ||
| PROMONLE | C74652 | Promonocytes/Leukocytes | A relative measurement (ratio or percentage) of the promonocytes to all leukocytes in a biological specimen. | Promonocyte to Lymphocyte Ratio Measurement | ||
| PROMONO | C74621 | Promonocytes | A measurement of the promonocytes in a biological specimen. | Promonocyte Count | ||
| PROMY | C74622 | Promyelocytes | A measurement of the promyelocytes (immature myelocytes) in a biological specimen. | Promyelocyte Count | ||
| PROMYB | C117847 | Promyeloblasts | A measurement of the promyeloblasts in a biological specimen. | Promyeloblasts Measurement | ||
| PROMYCE | C98773 | Promyelocytes/Total Cells | A relative measurement (ratio or percentage) of the promyelocytes (immature myelocytes) to total cells in a biological specimen (for example a bone marrow specimen). | Promyelocyte to Total Cell Ratio Measurement | ||
| PROMYLE | C74653 | Promyelocytes/Leukocytes | A relative measurement (ratio or percentage) of the promyelocytes (immature myelocytes) to all leukocytes in a biological specimen. | Promyelocyte to Lymphocyte Ratio Measurement | ||
| PROPOX | C74885 | Propoxyphene | A measurement of the propoxyphene present in a biological specimen. | Propoxyphene Measurement | ||
| PROT | C64858 | Protein | A measurement of the total protein in a biological specimen. | Total Protein Measurement | ||
| PROTCRT | C79463 | Protein/Creatinine | A relative measurement (ratio or percentage) of the protein to creatinine in a biological specimen. | Protein to Creatinine Ratio Measurement | ||
| PROTEXR | C117848 | Protein Excretion Rate | A measurement of the amount of total protein being excreted in urine over a defined amount of time (e.g. one hour). | Total Protein Urine Excretion Rate | ||
| PROTOSML | C92240 | Protein/Osmolality;Protein/Osmolality Ratio | A relative measurement (ratio or percentage) of total proteins to the osmolality of a biological specimen. | Protein to Osmolality Ratio Measurement | ||
| PROTOZOA | C117849 | Protozoa | Examination of a biological specimen to detect the presence of protozoa in a biological specimen. | Protozoa Measurement | ||
| PROTS | C100436 | Protein S | A measurement of the protein S in a biological specimen. | Protein S Measurement | ||
| PSA | C17634 | Prostate Specific Antigen | A measurement of the prostate specific antigen in a biological specimen. | Prostate Specific Antigen Measurement | ||
| PSDEPHD | C74696 | Pseudoephedrine | A measurement of the pseudoephedrine present in a biological specimen. | Pseudoephedrine Measurement | ||
| PSELECT | C117850 | GMP-140;P-Selectin | A measurement of total P-selectin in a biological specimen. | P-Selectin Measurement | ||
| PT | C62656 | Prothrombin Time | A blood clotting measurement that evaluates the extrinsic pathway of coagulation. | Prothrombin Time | ||
| PTA | C98774 | Factor II Activity;Prothrombin Activity | A measurement of the biological activity of prothrombin in a biological specimen. | Prothrombin Activity Measurement | ||
| PTF1_2 | C82034 | Prothrombin Fragments 1 + 2 | A measurement of the prothrombin fragments 1 and 2 in a biological specimen. | Prothrombin Fragments 1 and 2 Measurement | ||
| PTHCT | C81964 | Parathyroid Hormone, C-Terminal | A measurement of the C-terminal fragment of parathyroid hormone in a biological specimen. | C-Terminal Parathyroid Hormone Measurement | ||
| PTHFG | C74784 | Parathyroid Hormone, Fragmented | A measurement of the fragmented parathyroid hormone in a biological specimen. | Fragmented Parathyroid Hormone Measurement | ||
| PTHI | C74789 | Parathyroid Hormone, Intact | A measurement of the intact parathyroid hormone (consisting of amino acids 1-84 or 7-84) in a biological specimen. | Intact Parathyroid Hormone Measurement | ||
| PTHMM | C81965 | Parathyroid Hormone, Mid-Molecule | A measurement of the mid-molecule fragment of parathyroid hormone in a biological specimen. | Mid-Molecule Parathyroid Hormone Measurement | ||
| PTHNT | C81966 | Parathyroid Hormone, N-Terminal | A measurement of the N-terminal fragment of parathyroid hormone in a biological specimen. | N-Terminal Parathyroid Hormone Measurement | ||
| PTHRP | C117851 | Parathyroid Hormone-related Peptide;Parathyroid Hormone-related Protein | A measurement of parathyroid hormone-related protein in a biological specimen. | Parathyroid Hormone-related Protein Measurement | ||
| PTHW | C103451 | Parathyroid Hormone, Whole | A measurement of the whole parathyroid hormone (consisting of amino acids 1-84) in a biological specimen. | Whole Parathyroid Hormone Measurement | ||
| PYRIDNLN | C80211 | Pyridinoline | A measurement of the pyridinoline in a biological specimen. | Pyridinoline Measurement | ||
| PYY | C80202 | Peptide Tyrosine Tyrosine;Peptide YY | A measurement of the peptide YY in a biological specimen. | Peptide YY Measurement | ||
| RANKL | C117852 | Receptor Activator Nuclear KappaB Ligand;Receptor Activator of Nuclear Kappa-B Ligand | A measurement of the receptor activator of nuclear kappa-B ligand in a biological specimen. | Receptor Activator Nuclear KappaB Ligand Measurement | ||
| RANTES | C81957 | Chemokine Ligand 5;Reg upon Act Normal T-cell Exprd Secrtd | A measurement of the RANTES (regulated on activation, normally, T-cell expressed, and secreted) chemokine in a biological specimen. | Reg upon Act Normal T-cell Exprd Secrtd Measurement | ||
| RBC | C51946 | Erythrocytes;Red Blood Cells | A measurement of the total erythrocytes in a biological specimen. | Erythrocyte Count | ||
| RBCAGGLU | C111197 | Autoagglutination;Erythrocyte Agglutination;RBC Agglutination | A measurement of the erythrocyte agglutination in a biological specimen. | Erythrocyte Agglutination Measurement | ||
| RBCCLMP | C92245 | Erythrocyte Cell Clumps;RBC Clumps;Red Blood Cell Clumps | A measurement of red blood cell clumps in a biological specimen. | Erythrocyte Cell Clumps Measurement | ||
| RBCDIPOP | C117853 | Dimorphic Erythrocyte Population;Dimorphic RBC Population | Examination of a biological specimen to detect the presence of dimorphic erythrocyte population. | Dimorphic Erythrocyte Population | ||
| RBCFRAG | C116212 | Erythrocyte Fragment;RBC Fragment | A measurement of the red blood cell fragments (red cell fragments that have a reticular-like shape with rounded ends and no spicules, differentiating them from schistocytes and acanthocytes) in a biological specimen. | Erythrocyte Fragment Measurement | ||
| RBCGHOST | C96605 | Erythrocyte Ghosts;RBC Ghosts | A measurement of the erythrocyte ghosts (erythrocytes in which hemoglobin has been removed through hemolysis) in a biological specimen. | Erythrocyte Ghost Count | ||
| RBCMORPH | C92296 | Erythrocyte Cell Morphology;RBC Morphology;Red Blood Cell Morphology | An examination or assessment of the form and structure of red blood cells. | Erythrocyte Cell Morphology | ||
| RBCNUC | C74705 | Nucleated Erythrocytes;Nucleated Red Blood Cells | A measurement of the nucleated erythrocytes (large, immature nucleated erythrocytes) in a biological specimen. | Nucleated Red Blood Cell Count | ||
| RBCNUCLE | C82046 | Nucleated Erythrocytes/Leukocytes | A relative measurement (ratio or percentage) of nucleated erythrocytes to leukocytes in a biological specimen. | Nucleated Erythrocyte to Leukocyte Ratio Measurement | ||
| RBCNURBC | C74647 | Nucleated Erythrocytes/Erythrocytes;Nucleated Red Blood Cells/Erythrocytes | A relative measurement (ratio or percentage) of the nucleated erythrocytes (large, immature nucleated erythrocytes) to all erythrocytes in a biological specimen. | Nucleated Red Blood Cell to Erythrocyte Ratio Measurement | ||
| RBOIGGAB | C112412 | Measles IgG Antibody;Rubeola IgG Antibody | A measurement of the Measles (Rubeola) virus IgG antibody in a biological specimen. | Rubeola IgG Antibody Measurement | ||
| RBOIGMAB | C112413 | Measles IgM Antibody;Rubeola IgM Antibody | A measurement of the Measles (Rubeola) virus IgM antibody in a biological specimen. | Rubeola IgM Antibody Measurement | ||
| RBP | C100437 | Retinol Binding Protein | A measurement of the total retinol binding protein in a biological specimen. | Retinol Binding Protein Measurement | ||
| RDW | C64800 | Erythrocytes Distribution Width;Red Blood Cell Distribution Width | A value derived from mean corpuscular volume and the standard deviation of the red blood cell volume in a whole blood specimen. | Erythrocyte Distribution Width Measurement | ||
| RENIN | C74893 | Active Renin;Angiotensinogenase;Direct Renin;Renin | A measurement of the renin in a biological specimen. | Renin Measurement | ||
| RENINA | C111305 | PRA;Plasma Renin Activity;Renin Activity;URA;Urinary Renin Activity | A measurement of the renin activity in a biological specimen. | Renin Activity Measurement | ||
| RESISTIN | C80205 | Resistin | A measurement of the resistin in a biological specimen. | Resistin Measurement | ||
| RETCRRBC | C102274 | HCT Corrected Reticulocytes/Erythrocytes | A relative measurement (ratio or percentage) of the hematocrit corrected reticulocytes to erythrocytes in a biological specimen. | Hematocrit Corrected Reticulocytes to Erythrocytes Ratio Measurement | ||
| RETI | C51947 | Reticulocytes | A measurement of the reticulocytes in a biological specimen. | Reticulocyte Count | ||
| RETICDW | C114218 | Reticulocyte Distribution Width | A measurement of the range of reticulocyte sizes in a biological specimen. | Reticulocyte Distribution Width | ||
| RETICH | C117854 | CHr;Ret. Corpuscular Hemoglobin Content | A quantitative measurement of the total amount of hemoglobin in the reticulocyte population. | Total Reticulocyte Corpuscular Hemoglobin Content Measurement | ||
| RETIH | C116188 | High Absorption Reticulocytes | A measurement of the high absorption reticulocytes in a biological specimen. | High Absorption Reticulocyte Measurement | ||
| RETIHCR | C102273 | Hematocrit Corrected Reticulocytes | A measurement of the hematocrit corrected reticulocytes in a biological specimen. | Hematocrit Corrected Reticulocyte Count | ||
| RETIHGB | C98776 | Reticulocyte Hemoglobin | A measurement of the amount of hemoglobin in reticulocytes. | Reticulocyte Hemoglobin Measurement | ||
| RETIHRTC | C116189 | High Absorption Retic/Reticulocytes | A relative measurement (ratio or percentage) of the high absorption reticulocytes to total reticulocytes in a biological specimen. | High Absorption Reticulocytes to Total Reticulocytes Ratio Measurement | ||
| RETIL | C116190 | Low Absorption Reticulocytes | A measurement of the low absorption reticulocytes in a biological specimen. | Low Absorption Reticulocyte Measurement | ||
| RETILRTC | C116191 | Low Absorption Retic/Reticulocytes | A relative measurement (ratio or percentage) of the low absorption reticulocytes to total reticulocytes in a biological specimen. | Low Absorption Reticulocytes to Total Reticulocytes Ratio Measurement | ||
| RETIM | C116192 | Medium Absorption Reticulocytes | A measurement of the medium absorption reticulocytes in a biological specimen. | Medium Absorption Reticulocyte Measurement | ||
| RETIMCH | C117855 | CHCMr;Ret. Mean Corpuscular Hemoglobin | A quantitative measurement of the mean amount of hemoglobin per reticulocyte in a biological specimen. | Reticulocyte Mean Corpuscular Hemoglobin Measurement | ||
| RETIMRTC | C116193 | Medium Absorption Retic/Reticulocytes | A relative measurement (ratio or percentage) of the medium absorption reticulocytes to total reticulocytes in a biological specimen. | Medium Absorption Reticulocytes to Total Reticulocytes Ratio Measurement | ||
| RETIRBC | C64828 | Reticulocytes/Erythrocytes | A relative measurement (ratio or percentage) of reticulocytes to erythrocytes in a biological specimen. | Reticulocyte to Erythrocyte Ratio | ||
| RF | C74717 | Rheumatoid Factor | A measurement of the rheumatoid factor antibody in a biological specimen. | Rheumatoid Factor Measurement | ||
| RNPAB | C100457 | RNP Antibody;Ribonucleoprotein Antibody | A measurement of the ribonucleoprotein antibody in a biological specimen. | Ribonucleoprotein Antibody Measurement | ||
| ROULEAUX | C74624 | Rouleaux Formation | A measurement of the number of stacking red blood cells within a biological specimen. | Rouleaux Formation Count | ||
| RPR | C74716 | Rapid Plasma Reagin | A measurement of the antibodies produced by cellular damage caused by Treponema pallidum (syphilis) in a biological specimen. | Rapid Plasma Reagin Measurement | ||
| RPTLTIME | C96628 | Reptilase Time | A measurement of the time it takes a plasma sample to clot after adding the active enzyme reptilase. | Reptilase Time Measurement | ||
| RT3 | C81968 | Triiodothyronine, Reverse | A measurement of the reverse triiodothyronine in a biological specimen. | Reverse Triiodothyronine Measurement | ||
| RUBIGGAB | C103440 | Rubella IgG Antibody | A measurement of the Rubella IgG antibody in a biological specimen. | Rubella IgG Antibody Measurement | ||
| SCF | C82035 | KIT Ligand;Stem Cell Factor | A measurement of the stem cell factor in a biological specimen. | Stem Cell Factor Measurement | ||
| SCHISTO | C74706 | Schistocytes | A measurement of the schistocytes (fragmented red blood cells) in a biological specimen. | Schistocyte Count | ||
| SCKCERBC | C74656 | Sickle Cells/Erythrocytes | A relative measurement (ratio or percentage) of the sickle cells (sickle shaped red blood cells) to all erythrocytes in a biological specimen. | Sickle Cell to Erythrocyte Ratio Measurement | ||
| SCKLCE | C74626 | Sickle Cells | A measurement of the sickle cells (sickle shaped red blood cells) in a biological specimen. | Sickle Cell Count | ||
| SCL70AB | C100458 | Scl-70 Antibody;Scleroderma-70 Antibody | A measurement of the Scl-70 antibody in a biological specimen. | Scl-70 Antibody Measurement | ||
| SDH | C79465 | Sorbitol Dehydrogenase | A measurement of the sorbitol dehydrogenase in a biological specimen. | Sorbitol Dehydrogenase Measurement | ||
| SECRETIN | C74871 | Secretin | A measurement of the secretin hormone in a biological specimen. | Secretin Measurement | ||
| SEDEXAM | C105744 | Microscopic Sediment Analysis;Sediment Analysis;Sediment Examination | An observation, assessment or examination of the sediment in a biological specimen. | Sediment Analysis | ||
| SEZCE | C74625 | Sezary Cells | A measurement of the Sezary cells (atypical lymphocytes with cerebriform nuclei) in a biological specimen. | Sezary Cell Count | ||
| SEZCELY | C74655 | Sezary Cells/Lymphocytes | A relative measurement (ratio or percentage of the Sezary cells (atypical lymphocytes with cerebriform nuclei) to all lymphocytes in a biological specimen. | Sezary Cell to Lymphocyte Ratio Measurement | ||
| SFTPD | C111322 | SP-D;Surfactant Protein D | A measurement of the surfactant protein D in a biological specimen. | Surfactant Protein D Measurement | ||
| SHBG | C74745 | Sex Hormone Binding Globulin;Sex Hormone Binding Protein | A measurement of the sex hormone binding (globulin) protein in a biological specimen. | Sex Hormone Binding Protein Measurement | ||
| SIXMAM | C74876 | 6-Monoacetylmorphine | A measurement of the 6-monoacetylmorphine present in a biological specimen. | 6-Monoacetylmorphine Measurement | ||
| SJSSAAB | C92236 | Ro Antibody;Sjogrens SS-A Antibody | A measurement of the Sjogrens SS-A antibody in a biological specimen. | Sjogren's SS-A Antibody Measurement | ||
| SJSSBAB | C92237 | La Antibody;Sjogrens SS-B Antibody | A measurement of the Sjogrens SS-B antibody in a biological specimen. | Sjogren's SS-B Antibody Measurement | ||
| SLTFRNRC | C100438 | Soluble Transferrin Receptor | A measurement of the soluble transferrin receptor in a biological specimen. | Soluble Transferrin Receptor Measurement | ||
| SLXAG | C114223 | SLeX;Sialyl Lewis X Antigen;Sialyl Lex;Sialyl SSEA-1 Antigen;Sialyl-CD15 | A measurement of the sialyl stage-specific embryonic antigen-1 in a biological specimen. | Sialyl SSEA-1 Antigen Measurement | ||
| SMDGCE | C74627 | Basket Cells;Gumprecht Shadow Cells;Shadow Cells;Smudge Cells | A measurement of the smudge cells (the nuclear remnant of a ruptured white blood cell) in a biological specimen. | Smudge Cell Count | ||
| SMDGCELE | C119294 | Basket Cells/Leukocytes;Gumprecht Shadow Cells/Leukocytes;Shadow Cells/Leukocytes;Smudge Cells/Leukocytes | A relative measurement (ratio or percentage) of smudge cells to leukocytes in a biological specimen. | Smudge Cells to Leukocytes Ratio Measurement | ||
| SMTHAB | C92281 | Smith Antibody | A measurement of the Smith antibody in a biological specimen. | Smith Antibody Measurement | ||
| SMUSCAB | C111317 | Actin Antibody;Anti-Smooth Muscle Antibody;Smooth Muscle Antibody | A measurement of the smooth muscle antibody in a biological specimen. | Smooth Muscle Antibody Measurement | ||
| SO2 | C114224 | Sulfur Dioxide | A measurement of the sulfur dioxide in a biological specimen. | Sulfur Dioxide Measurement | ||
| SODIUM | C64809 | Sodium | A measurement of the sodium in a biological specimen. | Sodium Measurement | ||
| SODMEXR | C117856 | Sodium Excretion Rate | A measurement of the amount of sodium being excreted in urine over a defined amount of time (e.g. one hour). | Sodium Urine Excretion Rate | ||
| SOMATRO | C80360 | Growth Hormone;Somatotrophin | A measurement of the somatotrophin (growth) hormone in a biological specimen. | Somatotrophin Measurement | ||
| SOST | C117857 | Sclerostin | A measurement of the sclerostin in a biological specimen. | Sclerostin Measurement | ||
| SPERM | C74663 | Spermatozoa | A measurement of the spermatozoa cells present in a biological specimen. | Spermatozoa Cell Count | ||
| SPERMMTL | C102281 | Sperm Motility | A measurement of the sperm capable of forward, progressive movement in a semen specimen. | Sperm Motility Measurement | ||
| SPGRAV | C64832 | Specific Gravity | A ratio of the density of a fluid to the density of water. | Specific Gravity | ||
| SPHERO | C74707 | Spherocytes | A measurement of the spherocytes (small, sphere-shaped red blood cells) in a biological specimen. | Spherocyte Count | ||
| SPWEIGHT | C106569 | Specimen Weight | A measurement of the weight of a biological specimen. | Specimen Weight Measurement | ||
| SRTONIN | C74872 | Serotonin | A measurement of the serotonin hormone in a biological specimen. | Serotonin Measurement | ||
| STIPBASO | C96567 | Basophilic Stippling | A measurement of the basophilic stippling in a biological specimen. | Basophilic Stippling Measurement | ||
| STOMCY | C74708 | Stomatocytes | A measurement of the stomatocytes (red blood cells with an oval or rectangular area of central pallor, producing the appearance of a cell mouth) in a biological specimen. | Stomatocyte Count | ||
| STRIGGAB | C117858 | Strongyloides IgG Antibody | A measurement of strongyloides IgG antibody in a biological specimen. | Strongyloides IgG Antibody Measurement | ||
| STRPLOAB | C92282 | Antistreptolysin O;Streptolysin O Antibody | A measurement of Streptolysin O Antibody in a biological specimen. | Streptolysin O Antibody Measurement | ||
| SVCAM1 | C92533 | Soluble Vascular Cell Adhesion Molecule 1 | A measurement of the soluble vascular cell adhesion molecule 1 in a biological specimen. | Soluble Vascular Cell Adhesion Molecule 1 | ||
| T3 | C74747 | Total T3;Triiodothyronine | A measurement of the total (free and bound) triiodothyronine in a biological specimen. | Triiodothyronine Measurement | ||
| T3FR | C74787 | Free T3;Triiodothyronine, Free | A measurement of the free triiodothyronine in a biological specimen. | Free Triiodothyronine Measurement | ||
| T3UP | C74748 | Triiodothyronine Uptake | A measurement of the binding of triiodothyonine to thyroxine binding globulin protein in a biological specimen. | Triiodothyronine Uptake Measurement | ||
| T4 | C74794 | Thyroxine;Total T4 | A measurement of the total (free and bound) thyroxine in a biological specimen. | Total Thyroxine Measurement | ||
| T4FR | C74786 | Free T4;Thyroxine, Free | A measurement of the free thyroxine in a biological specimen. | Free Thyroxine Measurement | ||
| TAT | C106574 | Thrombin/Antithrombin;Thrombin/Antithrombin III | A relative measurement (ratio or percentage) of the thrombin to antithrombin present in a sample. | Thrombin to Antithrombin Ratio Measurement | ||
| TBG | C74746 | Thyroxine Binding Globulin | A measurement of the thyroxine binding globulin protein in a biological specimen. | Thyroxine Binding Globulin Protein Measurement | ||
| TDTAG | C117859 | Terminal Deoxynucleotidyl Transferase Ag;Terminal Deoxynucleotidyl Transferase Antigen | A measurement of the terminal deoxynucleotidyl transferase antigen in a biological specimen. | Terminal Deoxynucleotidyl Transferase Antigen Measurement | ||
| TEARDCY | C64801 | Dacryocytes;Tear Shaped Erythrocytes;Teardrop Cells | A measurement of dacryocytes in a biological specimen. | Dacryocyte Analysis | ||
| TESTOS | C74793 | Testosterone;Total Testosterone | A measurement of the total (free and bound) testosterone in a biological specimen. | Total Testosterone Measurement | ||
| TESTOSBA | C117860 | Bioavailable Testosterone | A measurement of bioavailable testosterone in a biological specimen. | Bioavailable Testosterone Measurement | ||
| TESTOSFR | C74785 | Testosterone, Free | A measurement of the free testosterone in a biological specimen. | Free Testosterone Measurement | ||
| TFERRIN | C82037 | Transferrin | A measurement of the transferrin in a biological specimen. | Transferrin Measurement | ||
| TFRRNSAT | C98792 | Iron Binding Capacity Saturation;Iron Saturation;Iron Saturation Percent;Serum Iron to TIBC Ratio;Transferrin Iron Saturation;Transferrin Saturation | A measurement of the iron bound to transferrin in a biological specimen. | Transferrin Saturation Measurement | ||
| TGFB1 | C117861 | Transforming Growth Factor Beta 1 | A measurement of the transforming growth factor beta 1 in a biological specimen. | Transforming Growth Factor Beta 1 Measurement | ||
| TGLOB | C103446 | TG;Thyroglobulin | A measurement of the thyroglobulin in a biological specimen. | Thyroglobulin Measurement | ||
| THEOPHYL | C105445 | Theophylline | A measurement of the Theophylline present in a biological specimen. | Theophylline Measurement | ||
| THRMPTN | C74873 | Thrombopoietin | A measurement of the thrombopoietin hormone in a biological specimen. | Thrombopoietin Measurement | ||
| THROMNUC | C111283 | Nucleated Thrombocytes;Thrombocytes | A measurement of the nucleated platelets, namely thrombocytes, in a biological specimen. This is typically measured in birds and other non-mammalian vertebrates. | Nucleated Thrombocyte Count | ||
| THYAB | C81990 | Thyroid Antibodies | A measurement of the thyroid antibodies in a biological specimen. | Thyroid Antibody Measurement | ||
| THYAMAB | C81991 | Thyroid Antimicrosomal Antibodies | A measurement of the thyroid antimicrosomal antibodies in a biological specimen. | Thyroid Antimicrosomal Antibody Measurement | ||
| THYATAB | C81992 | Thyroid Antithyroglobulin Antibodies | A measurement of the thyroid antithyroglobulin antibodies in a biological specimen. | Thyroid Antithyroglobulin Antibody Measurement | ||
| THYPXD | C96639 | Thyroid Peroxidase;Thyroperoxidase | A measurement of the thyroperoxidase in a biological specimen. | Thyroperoxidase Measurement | ||
| THYPXDAB | C96638 | Thyroperoxidase Antibody | A measurement of the thyroperoxidase antibody in a biological specimen. | Thyroperoxidase Antibody Measurement | ||
| TIMP1 | C82036 | Tissue Inhibitor of Metalloproteinase 1 | A measurement of the tissue inhibitor of metalloproteinase 1 in a biological specimen. | Tissue Inhibitor of Metalloproteinase 1 Measurement | ||
| TIMP1CRE | C106575 | TIMP1/Creatinine;Tissue Inhibitor of Metalloproteinase 1/Creatinine | A relative measurement (ratio or percentage) of the tissue inhibitor of metalloproteinase 1 to creatinine present in a sample. | Tissue Inhibitor of Metalloproteinase 1 to Creatinine Ratio Measurement | ||
| TNF | C74751 | Tumor Necrosis Factor;Tumor Necrosis Factor alpha | A measurement of the total tumor necrosis factor (cachexin) cytokine in a biological specimen. | Tumor Necrosis Factor Measurement | ||
| TNFAPIA | C117862 | TNF-a Production Inhibitory Activity | A measurement of TNF-a production inhibitory activity in a biological specimen. | TNF-a Production Inhibitory Activity Measurement | ||
| TNFSR | C117749 | Soluble Tumor Necrosis Factor Receptor | A measurement of the total soluble tumor necrosis factor receptor in a biological specimen. | Soluble Tumor Necrosis Factor Receptor Measurement | ||
| TNFSR1 | C117863 | Soluble TNF Receptor Type I | A measurement of the soluble tumor necrosis factor receptor type I in a biological specimen. | Soluble Tumor Necrosis Factor Receptor Type I Measurement | ||
| TNFSR2 | C117864 | Soluble TNF Receptor Type II | A measurement of the soluble tumor necrosis factor receptor type II in a biological specimen. | Soluble Tumor Necrosis Factor Receptor Type II Measurement | ||
| TOXGRAN | C96641 | Toxic Granulation | A measurement of the toxic granulation in neutrophilic blood cells. | Toxic Granulation Measurement | ||
| TPAAG | C81993 | Tissue Plasminogen Activator Antigen | A measurement of the tissue plasminogen activator antigen in a biological specimen. | Tissue Plasminogen Activator Antigen Measurement | ||
| TPRONP | C84811 | Non-Phosphorylated Tau Protein | A measurement of the non-phosphorylated Tau protein in a biological specimen. | Nonphosphorylated Tau Protein Measurement | ||
| TPROT | C84810 | Tau Protein;Total Tau Protein | A measurement of the total Tau protein in a biological specimen. | Tau Protein Measurement | ||
| TPROTP | C84812 | Phosphorylated Tau Protein | A measurement of the phosphorylated Tau protein in a biological specimen. | Phosphorylated Tau Protein Measurement | ||
| TRACP5B | C117865 | TRAP5B;Tartrate-Resistant Acid Phosphatase 5b | A measurement of tartrate-resistant acid phosphatase 5b in a biological specimen. | Tartrate-Resistant Acid Phosphatase 5b Measurement | ||
| TRAP | C80208 | Total Radical-Trap Antioxidant Potential | A measurement of the ability of the antioxidants in a biological specimen to buffer free radicals in a suspension. | Total Radical-Trap Antioxidant Potential Measurement | ||
| TRCYANDP | C100420 | Tricyclic Antidepressants | A measurement of tricyclic antidepressants in a biological specimen. | Tricyclic Antidepressant Measurement | ||
| TRGTCE | C96636 | Codocytes;Leptocytes;Mexican Hat Cells;Target Cells | A measurement of the target cells in a biological specimen. | Target Cell Count | ||
| TRH | C74874 | Thyrotropin Releasing Factor;Thyrotropin Releasing Hormone | A measurement of the thyrotropin releasing hormone in a biological specimen. | Thyrotropin Releasing Hormone Measurement | ||
| TRICH | C92238 | Trichomonas | Examination of a biological specimen to detect the presence of any protozoan belonging to the Trichomonas genus. | Trichomonas Screening | ||
| TRIG | C64812 | Triglycerides | A measurement of the triglycerides in a biological specimen. | Triglyceride Measurement | ||
| TROPONI | C74749 | Troponin I | A measurement of the actin binding troponin in a biological specimen. | Troponin I Measurement | ||
| TROPONIN | C111327 | Troponin | A measurement of the total troponin in a biological specimen. | Troponin Measurement | ||
| TROPONT | C74750 | Troponin T | A measurement of the tropomyosin binding troponin in a biological specimen. | Troponin T Measurement | ||
| TRYPTASE | C92292 | Tryptase | A measurement of the tryptase in a biological specimen. | Tryptase Measurement | ||
| TSH | C64813 | Thyroid Stimulating Hormone;Thyrotropin | A measurement of the thyrotropin in a biological specimen. | Thyrotropin Measurement | ||
| TT | C80365 | Thrombin Time | A measurement of the time it takes a plasma sample to clot after adding the active enzyme thrombin. (NCI) | Thrombin Time | ||
| TURB | C74723 | Turbidity | A measurement of the opacity of a biological specimen. | Turbidity Measurement | ||
| TXB2 | C103445 | Thromboxane B2 | A measurement of the thromboxane B2 in a biological specimen. | Thromboxane B2 Measurement | ||
| TXB2_D11 | C103344 | 11-Dehydro-Thromboxane B2 | A measurement of the 11-dehydro-thromboxane B2 in a biological specimen. | 11-Dehydro-Thromboxane B2 Measurement | ||
| UNSPCE | C112241 | Unspecified Cells | A measurement of the cells not otherwise identified or specified in a biological specimen. | Count of Unspecified Cells | ||
| UNSPCECE | C114225 | Unspecified Cells/Total Cells | A relative measurement (ratio or percentage) of the cells not otherwise identified or specified to total cells in a biological specimen. | Unspecified Cells to Total Cell Ratio Measurement | ||
| URATE | C64814 | Urate;Uric Acid | A measurement of the urate in a biological specimen. | Urate Measurement | ||
| URATECRT | C117866 | Urate/Creatinine | A relative measurement (ratio or percentage) of the urate to creatinine in a biological specimen. | Urate to Creatinine Ratio Measurement | ||
| UREA | C64815 | Urea | A measurement of the urea in a biological specimen. | Urea Measurement | ||
| UREACRT | C96645 | Urea/Creatinine | A relative measurement (ratio or percentage) of the urea to creatinine in a biological specimen. | Urea to Creatinine Ratio Measurement | ||
| UROBIL | C64816 | Urobilinogen | A measurement of the urobilinogen in a biological specimen. | Urobilinogen Measurement | ||
| VCAM1 | C82042 | Vascular Cell Adhesion Molecule 1 | A measurement of the vascular cell adhesion molecule 1 in a biological specimen. | Vascular Cell Adhesion Molecule 1 Measurement | ||
| VEGF | C92514 | Vascular Endothelial Growth Factor | A measurement of the vascular endothelial growth factor in a biological specimen. | Vascular Endothelial Growth Factor Measurement | ||
| VISC | C75912 | Viscosity | The resistance of a liquid to sheer forces and flow. (NCI) | Viscosity | ||
| VITA | C74895 | Retinol;Vitamin A | A measurement of the Vitamin A in a biological specimen. | Vitamin A Measurement | ||
| VITB1 | C74896 | Thiamine;Vitamin B1 | A measurement of the thiamine in a biological specimen. | Vitamin B1 Measurement | ||
| VITB12 | C64817 | Vitamin B12 | A measurement of the Vitamin B12 in a serum specimen. | Vitamin B12 Measurement | ||
| VITB17 | C74897 | Amygdalin;Vitamin B17 | A measurement of the Vitamin B17 in a biological specimen. | Vitamin B17 Measurement | ||
| VITB2 | C74898 | Riboflavin;Vitamin B2 | A measurement of the riboflavin in a biological specimen. | Vitamin B2 Measurement | ||
| VITB3 | C74899 | Niacin;Vitamin B3 | A measurement of the niacin in a biological specimen. | Vitamin B3 Measurement | ||
| VITB5 | C74900 | Pantothenic Acid;Vitamin B5 | A measurement of the Vitamin B5 in a biological specimen. | Vitamin B5 Measurement | ||
| VITB6 | C74901 | Pyridoxine;Vitamin B6 | A measurement of the Vitamin B6 in a biological specimen. | Vitamin B6 Measurement | ||
| VITB7 | C74902 | Biotin;Vitamin B7 | A measurement of the Vitamin B7 in a biological specimen. | Vitamin B7 Measurement | ||
| VITB9 | C74676 | Folic Acid;Vitamin B9 | A measurement of the folic acid in a biological specimen. | Folic Acid Measurement | ||
| VITC | C74903 | Ascorbic Acid;Vitamin C | A measurement of the Vitamin C in a biological specimen. | Vitamin C Measurement | ||
| VITD | C84818 | Total Vitamin D;Vitamin D | A measurement of the total Vitamin D in a biological specimen. | Vitamin D Measurement | ||
| VITD2 | C74904 | Ergocalciferol;Vitamin D2 | A measurement of the Vitamin D2 in a biological specimen. | Vitamin D2 Measurement | ||
| VITD3 | C74905 | Cholecalciferol;Vitamin D3 | A measurement of the Vitamin D3 in a biological specimen. | Vitamin D3 Measurement | ||
| VITDAT | C92267 | 1, 25-Dihydroxyvitamin D;Active Vitamin D | A measurement of the total active Vitamin D in a biological specimen. | 1, 25-Dihydroxyvitamin D Measurement | ||
| VITDIT | C92268 | 25-Hydroxyvitamin D;Inactive Vitamin D | A measurement of the total inactive Vitamin D in a biological specimen. | 25-Hydroxyvitamin D Measurement | ||
| VITE | C74906 | Vitamin E | A measurement of the Vitamin E in a biological specimen. | Vitamin E Measurement | ||
| VITECHOL | C103448 | Vitamin E/Cholesterol | A relative measurement (ratio or percentage) of vitamin E to total cholesterol in a biological specimen. | Vitamin E to Cholesterol Ratio Measurement | ||
| VITK | C74907 | Naphthoquinone;Vitamin K | A measurement of the total Vitamin K in a biological specimen. | Vitamin K Measurement | ||
| VITK1 | C103449 | Phylloquinone;Phytomenadione | A measurement of the Vitamin K1 in a biological specimen. | Vitamin K1 Measurement | ||
| VLDL | C105589 | VLDL Cholesterol | A measurement of the very low density lipoprotein cholesterol in a biological specimen. | Very Low Density Lipoprotein Cholesterol Measurement | ||
| VLDLPSZ | C103450 | VLDL Particle Size | A measurement of the average particle size of very-low-density lipoprotein in a biological specimen. | VLDL Particle Size Measurement | ||
| VMA | C74875 | Vanillyl Mandelic Acid;Vanilmandelic Acid | A measurement of the vanillyl mandelic acid metabolite in a biological specimen. | Vanillyl Mandelic Acid Measurement | ||
| VOLUME | C74720 | Volume | A measurement of the volume of a biological specimen. | Volume Measurement | ||
| VZVAB | C117867 | Varicella Zoster Virus Antibody | A measurement of the total varicella zoster virus antibody in a biological specimen. | Varicella Zoster Virus Antibody Measurement | ||
| VZVIGAAB | C98795 | Varicella Zoster Virus IgA Antibody | A measurement of the Varicella Zoster virus IgA antibodies in a biological specimen. | Varicella Zoster Virus IgA Antibody Measurement | ||
| VZVIGGAB | C98796 | Varicella Zoster Virus IgG Antibody | A measurement of the Varicella Zoster virus IgG antibodies in a biological specimen. | Varicella Zoster Virus IgG Antibody Measurement | ||
| VZVIGMAB | C98797 | Varicella Zoster Virus IgM Antibody | A measurement of the Varicella Zoster virus IgM antibodies in a biological specimen. | Varicella Zoster Virus IgM Antibody Measurement | ||
| WBC | C51948 | Leukocytes;White Blood Cells | A measurement of the leukocytes in a biological specimen. | Leukocyte Count | ||
| WBCCLMP | C92246 | Leukocyte Cell Clumps;WBC Clumps;White Blood Cell Clumps | A measurement of white blood cell clumps in a biological specimen. | Leukocyte Cell Clumps Measurement | ||
| WBCMORPH | C92297 | Leukocyte Cell Morphology;WBC Morphology;White Blood Cell Morphology | An examination or assessment of the form and structure of white blood cells. | Leukocyte Cell Morphology | ||
| YEAST | C74664 | Yeast Cells | A measurement of the yeast cells present in a biological specimen. | Yeast Cell Measurement | ||
| YEASTBUD | C106504 | Budding Yeast;Yeast Budding | A measurement of the budding yeast present in a biological specimen. | Budding Yeast Measurement | ||
| YEASTHYP | C92239 | Yeast Hyphae | A measurement of the yeast hyphae present in a biological specimen. | Yeast Hyphae Screening | ||
| ZINC | C80210 | Zinc | A measurement of the zinc in a biological specimen. | Zinc Measurement | ||
| Back to top | ||||||
| CL.C67154.LBTEST | Laboratory Test Name (LBTEST) | text Extensible: Yes | C67154 | Laboratory Test Name | Terminology used for laboratory test names of the CDISC Standard Data Tabulation Model. | CDISC SDTM Laboratory Test Terminology by Name |
| 1, 25-Dihydroxyvitamin D | C92267 | 1, 25-Dihydroxyvitamin D;Active Vitamin D | A measurement of the total active Vitamin D in a biological specimen. | 1, 25-Dihydroxyvitamin D Measurement | ||
| 11-Dehydro-Thromboxane B2 | C103344 | 11-Dehydro-Thromboxane B2 | A measurement of the 11-dehydro-thromboxane B2 in a biological specimen. | 11-Dehydro-Thromboxane B2 Measurement | ||
| 25-Hydroxyvitamin D | C92268 | 25-Hydroxyvitamin D;Inactive Vitamin D | A measurement of the total inactive Vitamin D in a biological specimen. | 25-Hydroxyvitamin D Measurement | ||
| 3,4-Dihydroxyphenylacetic Acid | C103345 | 3,4-Dihydroxyphenylacetic Acid | A measurement of the 3,4-dihydroxyphenylacetic acid in a biological specimen. | 3,4-Dihydroxyphenylacetic Acid Measurement | ||
| 3,4-Dihydroxyphenylglycol | C101017 | 3,4-Dihydroxyphenylglycol;3.4 Dihydroxyphenylglycol | A measurement of the catecholamine metabolite, 3,4-Dihydroxyphenylglycol in a biological specimen. | 3,4-Dihydroxyphenylglycol Measurement | ||
| 3,4-methylenedioxymethamphetamine | C75359 | 3,4-methylenedioxymethamphetamine;Ecstasy | A measurement of the 3,4-methylenedioxymethamphetamine (MDMA) in a biological specimen. | 3,4-Methylenedioxymethamphetamine Measurement | ||
| 5 Prime Nucleotidase | C79437 | 5 Prime Nucleotidase;5'-Ribonucleotide Phosphohydrolase | A measurement of the 5'-nucleotidase in a biological specimen. | 5 Prime Nucleotidase Measurement | ||
| 5-Hydroxyindoleacetic Acid | C112217 | 5-Hydroxyindoleacetic Acid | A measurement of 5-hydroxyindoleacetic acid in a biological specimen. | 5-Hydroxyindoleacetic Acid Measurement | ||
| 6-Monoacetylmorphine | C74876 | 6-Monoacetylmorphine | A measurement of the 6-monoacetylmorphine present in a biological specimen. | 6-Monoacetylmorphine Measurement | ||
| 8-Iso-PGF2alpha/Creatinine | C119291 | 8-Iso-PGF2alpha/Creatinine | A relative measurement (ratio or percentage) of the prostaglandin F2 alpha isoform 8 to creatinine in a biological specimen. | 8-Iso-Prostaglandin F2 Alpha to Creatinine Ratio Measurement | ||
| 8-Iso-Prostaglandin F2 Alpha | C119292 | 8-Iso-Prostaglandin F2 Alpha | A measurement of the prostaglandin F2 alpha isoform 8 in a biological specimen. | 8-Iso-Prostaglandin F2 Alpha Measurement | ||
| A Fetoprotein L3/A Fetoprotein | C96565 | A Fetoprotein L3/A Fetoprotein | A relative measurement (ratio or percentage) of alpha fetoprotein L3 to total alpha fetoprotein in a biological specimen. | Alpha Fetoprotein L3 to Total Alpha Fetoprotein Ratio Measurement | ||
| A Proliferation-Inducing Ligand | C111123 | A Proliferation-Inducing Ligand;CD256;TNFSF13;Tumor Necrosis Factor Ligand Superfamily Member 13 | A measurement of the a proliferation-inducing ligand in a biological specimen. | A Proliferation-Inducing Ligand Measurement | ||
| Abnormal Cells | C111124 | Abnormal Cells | A measurement of the abnormal cells in a biological specimen. | Abnormal Cell Count | ||
| Acanthocytes | C74699 | Acanthocytes | A measurement of the acanthocytes in a biological specimen. | Acanthocyte Count | ||
| Acanthocytes/Erythrocytes | C74633 | Acanthocytes/Erythrocytes | A relative measurement (ratio or percentage) of acanthocytes to all erythrocytes in a biological specimen. | Acanthocyte to Erythrocyte Ratio Measurement | ||
| Acetoacetic Acid | C92247 | Acetoacetate;Acetoacetic Acid | A measurement of the acetoacetic acid in a biological specimen. | Acetoacetic Acid Measurement | ||
| Acetylcholine | C74838 | Acetylcholine | A measurement of the acetylcholine hormone in a biological specimen. | Acetylcholine Measurement | ||
| Acetylcholine Receptor Antibody | C96559 | Acetylcholine Receptor Antibody | A measurement of the acetylcholine receptor antibody in a biological specimen. | Acetylcholine Receptor Antibody Measurement | ||
| Acetylcholinesterase | C96560 | Acetylcholinesterase | A measurement of the acetylcholinesterase in a biological specimen. | Acetylcholinesterase Measurement | ||
| Acid Phosphatase | C80163 | Acid Phosphatase | A measurement of the acid phosphatase in a biological specimen. | Acid Phosphatase Measurement | ||
| Acid Urate Crystals | C74912 | Acid Urate Crystals | A measurement of the acid urate crystals present in a biological specimen. | Acid Urate Crystal Measurement | ||
| Activated Coagulation Time | C103348 | Activated Clot Time;Activated Clotting Time;Coagulation Activated | A measurement of the inhibition of blood coagulation in response to anticoagulant therapies. | Activated Coagulation Time | ||
| Activated Partial Thromboplastin Time | C38462 | Activated Partial Thromboplastin Time | A measurement of the length of time that it takes for clotting to occur when reagents are added to a plasma specimen. The test is partial due to the absence of tissue factor (Factor III) from the reaction mixture. | Partial Thromboplastin Time | ||
| Activated Protein C Resistance | C100471 | Activated Protein C Resistance;Factor V Leiden Screen | A measurement of the resistance in the anticoagulation response to activated protein C in a biological specimen. | Activated Protein C Resistance Measurement | ||
| Activated PTT/Standard | C98862 | Activated PTT/Standard;Activated PTT/Standard PTT;Activated Partial Thromboplastin Time/Standard Thromboplastin Time | A relative measurement (ratio or percentage) of the subject's partial thromboplastin time to a standard or control partial thromboplastin time. | Activated PTT/Standard Ratio Measurement | ||
| Active Ghrelin | C112219 | Active Ghrelin;Ghrelin | A measurement of active ghrelin in a biological specimen. | Active Ghrelin Measurement | ||
| Acyl Coenzyme A Oxidase | C92286 | Acyl CoA Oxidase;Acyl Coenzyme A Oxidase;Fatty Acyl Coenzyme A Oxidase | A measurement of the acyl coenzyme A oxidase in a biological specimen. | Acyl Coenzyme A Oxidase Measurement | ||
| Adenosine Diphosphate | C102257 | Adenosine Diphosphate | A measurement of the adenosine diphosphate in a biological specimen. | Adenosine Diphosphate Measurement | ||
| Adenovirus Antibody | C111125 | Adenovirus Antibody | A measurement of the adenovirus antibody in a biological specimen. | Adenovirus Antibody Measurement | ||
| Adiponectin | C74839 | Adiponectin | A measurement of the adiponectin hormone in a biological specimen. | Adiponectin Measurement | ||
| Adrenocorticotropic Hormone | C74780 | Adrenocorticotropic Hormone | A measurement of the adrenocorticotropic hormone in a biological specimen. | Adrenocorticotropic Hormone Measurement | ||
| ADV Viral Load | C98705 | ADV Viral Load | A measurement of the adenovirus viral load in a biological specimen. | Adenovirus Viral Load Measurement | ||
| Aggrecan Chondroitin Sulfate Epitope 846 | C112220 | 846-Epitope;Aggrecan Chondroitin Sulfate Epitope 846;CS846;Chondroitin Sulfate Epitope 846;Chondroitin Sulfate Proteoglycan 1 Epitope 846 | A measurement of the 846 epitope present on the chondroitin sulfate chains of aggrecan in a biological specimen. | Aggrecan Chondroitin Sulfate Epitope 846 Measurement | ||
| Agranular Neutrophils | C116200 | Agranular Neutrophils | A measurement of the agranular neutrophils in a biological specimen. | Agranular Neutrophils Measurement | ||
| Alanine Aminopeptidase | C100430 | Alanine Aminopeptidase | A measurement of the alanine aminopeptidase in a biological specimen. | Alanine Aminopeptidase Measurement | ||
| Alanine Aminotransferase | C64433 | Alanine Aminotransferase;SGPT | A measurement of the alanine aminotransferase in a biological specimen. | Alanine Aminotransferase Measurement | ||
| Albumin | C64431 | Albumin;Microalbumin | A measurement of the albumin protein in a biological specimen. | Albumin Measurement | ||
| Albumin Excretion Rate | C117829 | Albumin Excretion Rate | A measurement of the amount of albumin being excreted in urine over a defined period of time (e.g. one hour). | Albumin Urine Excretion Rate | ||
| Albumin/Creatinine | C74761 | Albumin/Creatinine;Microalbumin/Creatinine Ratio | A relative measurement (ratio or percentage) of the albumin to the creatinine in a biological specimen. | Albumin To Creatinine Protein Ratio Measurement | ||
| Albumin/Globulin | C74894 | Albumin/Globulin | The ratio of albumin to globulin in a biological specimen. | Albumin to Globulin Ratio Measurement | ||
| Albumin/Total Protein | C103453 | Albumin/Total Protein | A relative measurement (ratio or percentage) of the albumin to total protein in a biological specimen. | Albumin to Total Protein Ratio Measurement | ||
| Aldolase | C74731 | Aldolase | A measurement of the aldolase enzyme in a biological specimen. | Aldolase Measurement | ||
| Aldosterone | C74841 | Aldosterone | A measurement of the aldosterone hormone in a biological specimen. | Aldosterone Measurement | ||
| Alkaline Phosphatase | C64432 | Alkaline Phosphatase | A measurement of the alkaline phosphatase in a biological specimen. | Alkaline Phosphatase Measurement | ||
| Alkaline Phosphatase/Creatinine | C79438 | Alkaline Phosphatase/Creatinine | A relative measurement (ratio or percentage) of the alkaline phosphatase to creatinine in a biological specimen. | Alkaline Phosphatase to Creatinine Ratio Measurement | ||
| Alpha Fetoprotein | C74732 | Alpha Fetoprotein | A measurement of the alpha fetoprotein in a biological specimen. | Alpha-fetoprotein Measurement | ||
| Alpha Fetoprotein Activity | C106499 | Alpha Fetoprotein Activity | A measurement of the alpha fetoprotein activity in a biological specimen. | Alpha Fetoprotein Activity Measurement | ||
| Alpha Fetoprotein L1 | C96562 | Alpha Fetoprotein L1 | A measurement of the alpha fetoprotein L1 in a biological specimen. | Alpha Fetoprotein L1 Measurement | ||
| Alpha Fetoprotein L2 | C96563 | Alpha Fetoprotein L2 | A measurement of the alpha fetoprotein L2 in a biological specimen. | Alpha Fetoprotein L2 Measurement | ||
| Alpha Fetoprotein L3 | C96564 | Alpha Fetoprotein L3 | A measurement of the alpha fetoprotein L3 in a biological specimen. | Alpha Fetoprotein L3 Measurement | ||
| Alpha Glutathione-S-Transferase | C79433 | Alpha Glutathione-S-Transferase | A measurement of the alpha form of glutathione S-transferase in a biological specimen. | Alpha Glutathione-S-Transferase Measurement | ||
| Alpha Hydroxybutyrate Dehydrogenase | C111126 | Alpha Hydroxybutyrate Dehydrogenase | A measurement of the alpha-hydroxybutyrate dehydrogenase in a biological specimen. | Alpha Hydroxybutyrate Dehydrogenase Measurement | ||
| Alpha Tocopherol | C103349 | Alpha Tocopherol | A measurement of the alpha tocopherol in a biological specimen. | Alpha Tocopherol Measurement | ||
| Alpha Tocopherol/Vitamin E | C103350 | Vitamin E Alpha Tocopherol | A relative measurement (ratio or percentage) of alpha-tocopherol to the total vitamin E in a biological specimen. | Alpha Tocopherol to Vitamin E Ratio Measurement | ||
| Alpha-1 Acid Glycoprotein | C100429 | Alpha-1 Acid Glycoprotein | A measurement of the alpha-1 acid glycoprotein in a biological specimen. | Alpha-1 Acid Glycoprotein Measurement | ||
| Alpha-1 Antitrypsin | C80167 | Alpha-1 Antitrypsin;Serum Trypsin Inhibitor | A measurement of the alpha-1 antitrypsin in a biological specimen. | Alpha-1 Antitrypsin Measurement | ||
| Alpha-1 Globulin | C92252 | A1-Globulin;Alpha-1 Globulin | A measurement of the proteins contributing to the alpha 1 fraction in a biological specimen. | Alpha-1 Globulin Measurement | ||
| Alpha-1 Globulin/Total Protein | C92253 | Alpha-1 Globulin/Total Protein | A relative measurement (ratio or percentage) of alpha-1-fraction proteins to total proteins in a biological specimen. | Alpha-1 Globulin to Total Protein Ratio Measurement | ||
| Alpha-1 Microglobulin | C100461 | Alpha-1 Microglobulin;Protein HC | A measurement of the alpha-1 microglobulin in a biological specimen. | Alpha-1 Microglobulin Measurement | ||
| Alpha-1 Microglobulin/Creatinine | C100462 | Alpha-1 Microglobulin/Creatinine | A relative measurement (ratio or percentage) of the alpha-1 microglobulin to creatinine in a biological specimen. | Alpha-1 Microglobulin to Creatinine Ratio Measurement | ||
| Alpha-2 Antiplasmin | C103351 | Alpha-2 Plasmin Inhibitor | A measurement of the alpha-2 antiplasmin in a biological specimen. | Alpha-2 Antiplasmin Measurement | ||
| Alpha-2 Globulin | C92254 | A2-Globulin;Alpha-2 Globulin | A measurement of the proteins contributing to the alpha 2 fraction in a biological specimen. | Alpha-2 Globulin Measurement | ||
| Alpha-2 Globulin/Total Protein | C92255 | Alpha-2 Globulin/Total Protein | A relative measurement (ratio or percentage) of alpha-2-fraction proteins to total proteins in a biological specimen. | Alpha-2 Globulin to Total Protein Ratio Measurement | ||
| Alpha-2 Macroglobulin | C80168 | Alpha-2 Macroglobulin | A measurement of the alpha-2 macroglobulin in a biological specimen. | Alpha-2 Macroglobulin Measurement | ||
| Alpha-GST Excretion Rate | C119278 | Alpha-GST Excretion Rate | A measurement of the amount of Alpha Glutathione-S-Transferase being excreted in urine over a defined period of time (e.g. one hour). | Alpha-GST Excretion Rate | ||
| ALT/AST | C106498 | ALT/AST | A relative measurement (ratio or percentage) of the alanine aminotransferase (ALT) to aspartate aminotransferase (AST) present in a sample. | Alanine Aminotransferase to Aspartate Aminotransferase Ratio Measurement | ||
| Aluminum | C111127 | Al;Aluminum | A measurement of aluminum in a biological specimen. | Aluminum Measurement | ||
| Ammonia | C74799 | Ammonia;NH3 | A measurement of the ammonia in a biological specimen. | Ammonia Measurement | ||
| Ammonium Biurate Crystals | C105590 | Acid Ammonium Urate Crystals;Ammonium Biurate Crystals;Ammonium Urate Crystals | A measurement of the ammonium biurate crystals present in a biological specimen. | Ammonium Biurate Crystals Measurement | ||
| Ammonium Oxalate Crystals | C74759 | Ammonium Oxalate Crystals | A measurement of the ammonium oxalate crystals present in a urine specimen. | Urine Ammonium Oxalate Crystal Measurement | ||
| Amorphous Crystals | C74665 | Amorphous Crystals | A measurement of the amorphous (Note: phosphate or urate, depending on pH) crystals present in a biological specimen. | Amorphous Crystal Measurement | ||
| Amorphous Phosphate Crystals | C92243 | Amorphous Phosphate Crystals | A measurement of the amorphous phosphate crystals in a biological specimen. | Amorphous Phosphate Crystals Measurement | ||
| Amorphous Sediment | C74666 | Amorphous Debris;Amorphous Sediment | A measurement of the amorphous sediment present in a biological specimen. | Amorphous Sediment Measurement | ||
| Amorphous Urate Crystals | C92244 | Amorphous Urate Crystals | A measurement of the amorphous urate crystals in a biological specimen. | Amorphous Urate Crystals Measurement | ||
| Amphetamine | C74687 | Amphetamine | A measurement of any amphetamine class drug present in a biological specimen. | Amphetamine Drug Class Measurement | ||
| Amylase | C64434 | Amylase | A measurement of the total enzyme amylase in a biological specimen. | Amylase Measurement | ||
| Amylase, Pancreatic | C98767 | Amylase, Pancreatic | A measurement of the pancreatic enzyme amylase in a biological specimen. | Pancreatic Amylase Measurement | ||
| Amylase, Salivary | C98780 | Amylase, Salivary | A measurement of the salivary enzyme amylase in a biological specimen. | Salivary Amylase Measurement | ||
| Amyloid Alpha Precursor Protein | C119268 | Amyloid Alpha Precursor Protein | A measurement of the amyloid alpha precursor protein present in a biological specimen. | Amyloid Alpha Precursor Protein Measurement | ||
| Amyloid Beta 1-38 | C103352 | Amyloid Beta 1-38;Amyloid Beta 38;Amyloid Beta 38 Protein | A measurement of amyloid beta protein which is composed of peptides 1 to 38 in a biological specimen. | Amyloid Beta 1-38 Measurement | ||
| Amyloid Beta 1-40 | C103353 | Amyloid Beta 1-40;Amyloid Beta 40;Amyloid Beta 40 Protein | A measurement of amyloid beta protein which is composed of peptides 1 to 40 in a biological specimen. | Amyloid Beta 1-40 Measurement | ||
| Amyloid Beta 1-42 | C84809 | Amyloid Beta 1-42;Amyloid Beta 42;Amyloid Beta 42 Protein | A measurement of amyloid beta protein which is composed of peptides 1 to 42 in a biological specimen. | Beta Amyloid 42 Measurement | ||
| Amyloid Beta Precursor Protein | C105438 | Amyloid Beta Precursor;Amyloid Beta Precursor Protein;Amyloid Precursor Beta;Amyloid Precursor Protein | A measurement of the amyloid beta precursor protein present in a biological specimen. | Amyloid Beta Precursor Protein Measurement | ||
| Amyloid P | C81998 | Amyloid P | A measurement of the total amyloid P in a biological specimen. | Amyloid P Measurement | ||
| Amyloid, Beta | C81999 | Amyloid, Beta;Beta Amyloid | A measurement of the total amyloid beta in a biological specimen. | Beta Amyloid Measurement | ||
| Androstenediol | C74842 | Androstenediol | A measurement of the androstenediol metabolite in a biological specimen. | Androstenediol Metabolite Measurement | ||
| Androstenedione | C74843 | 4-Androstenedione;Androstenedione | A measurement of the androstenedione hormone in a biological specimen. | Androstenedione Measurement | ||
| Angiopoietin 1 | C111128 | Angiopoietin 1 | A measurement of angiopoietin 1 in a biological specimen. | Angiopoietin 1 Measurement | ||
| Angiotensin Converting Enzyme | C80169 | Angiotensin Converting Enzyme | A measurement of the angiotensin converting enzyme in a biological specimen. | Angiotensin Converting Enzyme Measurement | ||
| Angiotensin I | C74844 | Angiotensin I | A measurement of the angiotensin I hormone in a biological specimen. | Angiotensin I Measurement | ||
| Angiotensin II | C74845 | Angiotensin II | A measurement of the angiotensin II hormone in a biological specimen. | Angiotensin II Measurement | ||
| Angiotensinogen | C74846 | Angiotensin Precursor;Angiotensinogen | A measurement of the angiotensinogen hormone in a biological specimen. | Angiotensinogen Measurement | ||
| Anion Gap | C74685 | Anion Gap | A computed estimate of the unmeasured anions (those other than the chloride and bicarbonate anions) in a biological specimen. | Anion Gap Measurement | ||
| Anisocytes | C74797 | Anisocytes;Anisocytosis | A measurement of the inequality in the size of the red blood cells in a whole blood specimen. | Anisocyte Measurement | ||
| Anti-DNA Antibodies | C81973 | Anti-DNA Antibodies;Anti-ds-DNA Antibodies | A measurement of the anti-DNA antibodies in a biological specimen. | Anti-DNA Antibody Measurement | ||
| Anti-Double Stranded DNA | C74913 | Anti-Double Stranded DNA | A measurement of the anti-double stranded DNA antibody in a biological specimen. | Anti-Double Stranded DNA Measurement | ||
| Anti-Factor Xa Activity | C98706 | Anti-Factor Xa Activity | A measurement of the anti-activated Factor X in a biological specimen. This test is used to monitor low molecular weight or unfractionated heparin levels in a biological specimen. | Anti-Factor Xa Activity Measurement | ||
| Anti-Saccharomyces cerevisiae Antibody | C81976 | Anti-Saccharomyces cerevisiae Antibody | A measurement of the anti-Saccharomyces cerevisiae antibody in a biological specimen. | Anti-Saccharomyces cerevisiae Antibody Measurement | ||
| Anti-Single Stranded DNA IgG | C92269 | Anti-Single Stranded DNA IgG | A measurement of the anti-single stranded DNA IgG antibody in a biological specimen. | Anti-Single Stranded DNA IgG Measurement | ||
| Antidepressants | C74691 | Antidepressants | A measurement of any antidepressant class drug present in a biological specimen. | Antidepressant Measurement | ||
| Antidiuretic Hormone | C74847 | Antidiuretic Hormone;Vasopressin | A measurement of the antidiuretic hormone in a biological specimen. | Antidiuretic Hormone Measurement | ||
| Antiglobulin Test, Direct | C81974 | Antiglobulin Test, Direct;Direct Coombs Test | A measurement of the antibody or complement-coated erythrocytes in a biological specimen in vivo. | Direct Antiglobulin Test | ||
| Antiglobulin Test, Indirect | C91372 | Antiglobulin Test, Indirect;Indirect Coombs Test | A test that uses Coombs' reagent to detect the presence of anti-erythrocyte antibodies in a biological specimen. | Indirect Antiglobulin Test | ||
| Antimitochondrial Antibodies | C81975 | Antimitochondrial Antibodies;Mitochondrial Antibody | A measurement of the antimitochondrial antibodies in a biological specimen. | Antimitochondrial Antibody Measurement | ||
| Antinuclear Antibodies | C74916 | Antinuclear Antibodies | A measurement of the antinuclear antibodies (antibodies that attack the body's own tissue) in a biological specimen. | Antinuclear Antibody Measurement | ||
| Antiphospholipid Antibodies | C102258 | Antiphospholipid Antibodies | A measurement of the antiphospholipid antibodies in a biological specimen. | Antiphospholipid Antibody Measurement | ||
| Antithrombin | C81958 | Antithrombin;Antithrombin Activity;Antithrombin III;Antithrombin III Activity | A measurement of the antithrombin activity in a biological specimen. | Antithrombin Activity Measurement | ||
| Antithrombin Antigen | C81977 | Antithrombin Antigen;Antithrombin III Antigen | A measurement of the antithrombin antigen in a biological specimen. | Antithrombin Antigen Measurement | ||
| Apolipoprotein A1 | C74733 | Apolipoprotein A1 | A measurement of the apolipoprotein A1 in the high density lipoproteins of a biological specimen. | Apolipoprotein A1 Measurement | ||
| Apolipoprotein A4 | C103354 | Apolipoprotein A4 | A measurement of the apolipoprotein A4 in a biological specimen. | Apolipoprotein A4 Measurement | ||
| Apolipoprotein A5 | C103355 | Apolipoprotein A5 | A measurement of the apolipoprotein A5 in a biological specimen. | Apolipoprotein A5 Measurement | ||
| Apolipoprotein AII | C82000 | Apolipoprotein AII | A measurement of the apolipoprotein AII in a biological specimen. | Apolipoprotein AII Measurement | ||
| Apolipoprotein B | C74734 | Apolipoprotein B | A measurement of the apolipoprotein B in the low density lipoproteins of a biological specimen. | Apolipoprotein B Measurement | ||
| Apolipoprotein B/Apolipoprotein A1 | C103356 | Apolipoprotein B/Apolipoprotein A1 | A relative measurement (ratio or percentage) of the Apolipoprotein B to Apolipoprotein A1 in a biological specimen. | Apolipoprotein B to Apolipoprotein A1 Ratio Measurement | ||
| Apolipoprotein C2 | C100427 | Apolipoprotein C2;Apolipoprotein CII | A measurement of the apolipoprotein C2 in a biological specimen. | Apolipoprotein C2 Measurement | ||
| Apolipoprotein CIII | C82001 | Apolipoprotein CIII | A measurement of the apolipoprotein CIII in a biological specimen. | Apolipoprotein CIII Measurement | ||
| Apolipoprotein E | C82002 | Apolipoprotein E | A measurement of the apolipoprotein E in a biological specimen. | Apolipoprotein E Measurement | ||
| Apolipoprotein E4 | C92293 | Apolipoprotein E4 | A measurement of the apolipoprotein E4 in a biological specimen. | Apolipoprotein E4 Measurement | ||
| Apolipoprotein H | C82003 | Apolipoprotein H | A measurement of the apolipoprotein H in a biological specimen. | Apolipoprotein H Measurement | ||
| Apolipoprotein J | C100428 | Apolipoprotein J;Clusterin | A measurement of the apolipoprotein J in a biological specimen. | Apolipoprotein J Measurement | ||
| Apolipoprotein J/Creatinine | C111130 | Apolipoprotein J/Creatinine;Clusterin/Creatinine | A relative measurement (ratio or percentage) of the apolipoprotein J to creatinine in a biological specimen. | Apolipoprotein J to Creatinine Ratio Measurement | ||
| Arachidonic Acid | C102259 | Arachidonic Acid | A measurement of the arachidonic acid present in a biological specimen. | Arachidonic Acid Measurement | ||
| Aspartate Aminotransferase | C64467 | Aspartate Aminotransferase;SGOT | A measurement of the aspartate aminotransferase in a biological specimen. | Aspartate Aminotransferase Measurement | ||
| Aspartate Aminotransferase Antigen | C81978 | Aspartate Aminotransferase Antigen;SGOT Antigen | A measurement of the aspartate aminotransferase antigen in a biological specimen. | Aspartate Aminotransferase Antigen Measurement | ||
| Aspartate Aminotransferase/Creatinine | C117830 | Aspartate Aminotransferase/Creatinine | A relative measurement (ratio or percentage) of the aspartate aminotransferase to creatinine in a biological specimen. | Aspartate Aminotransferase to Creatinine Ratio Measurement | ||
| Atrial Natriuretic Peptide | C74886 | Atrial Natriuretic Peptide;Atriopeptin | A measurement of the atrial natriuretic peptide in a biological specimen. | Atrial Natriuretic Peptide Measurement | ||
| Auer Rods | C74657 | Auer Rods | A measurement of the Auer rods (elongated needle structures that are found in the cytoplasm of leukemic blasts and are formed by clumps of azurophilic granular material) in a biological specimen. | Auer Rod Measurement | ||
| Azurophilic Granules | C116185 | Azurophilic Granulation;Azurophilic Granules | An observation of azurophilic granules in a biological specimen. | Azurophilic Granule Measurement | ||
| B-Cell Activating Factor | C111135 | B-Cell Activating Factor | A measurement of the B-cell activating factor in a biological specimen. | B-Cell Activating Factor Measurement | ||
| Bacteria | C64469 | Bacteria | A measurement of the bacteria in a biological specimen. | Bacterial Count | ||
| Bacterial Casts | C74762 | Bacterial Casts | A measurement of the bacterial casts present in a biological specimen. | Bacterial Cast Measurement | ||
| Barbiturates | C74688 | Barbiturates | A measurement of any barbiturate class drug present in a biological specimen. | Barbiturate Drug Class Measurement | ||
| Base Excess | C119270 | Base Excess | A measurement of the amount of acid or alkali required to return a biological specimen to a normal pH under standard conditions. | Base Excess Measurement | ||
| Basophilic Stippling | C96567 | Basophilic Stippling | A measurement of the basophilic stippling in a biological specimen. | Basophilic Stippling Measurement | ||
| Basophils | C64470 | Basophils | A measurement of the basophils in a biological specimen. | Total Basophil Count | ||
| Basophils/Leukocytes | C64471 | Basophils/Leukocytes | A relative measurement (ratio or percentage) of the basophils to leukocytes in a biological specimen. | Basophil to Leukocyte Ratio | ||
| Basophils/Total Cells | C98865 | Basophils/Total Cells | A relative measurement (ratio or percentage) of the basophils to total cells in a biological specimen (for example a bone marrow specimen). | Basophil to Total Cell Ratio Measurement | ||
| Bence-Jones Protein | C111136 | Bence-Jones Protein;Immunoglobulin Light Chains | A measurement of the total Bence-Jones protein in a biological specimen. | Bence-Jones Protein Measurement | ||
| Benzodiazepine | C74692 | Benzodiazepine | A measurement of any benzodiazepine class drug present in a biological specimen. | Benzodiazepine Measurement | ||
| Benzoylecgonine | C75350 | Benzoylecgonine;Cocaine Metabolite | A measurement of the benzoylecgonine in a biological specimen. | Benzoylecgonine Measurement | ||
| Beta Carotene | C100472 | Beta Carotene;Beta Carotin;b-Carotene | A measurement of the beta carotene in a biological specimen. | Beta Carotene Measurement | ||
| Beta Catenin | C103357 | Beta Catenin | A measurement of the beta catenin in a biological specimen. | Beta Catenin Measurement | ||
| Beta Globulin | C92256 | Beta Globulin | A measurement of the proteins contributing to the beta fraction in a biological specimen. | Beta Globulin Measurement | ||
| Beta Globulin/Total Protein | C92294 | Beta Globulin/Total Protein | A relative measurement (ratio or percentage) of beta fraction proteins to total proteins in a biological specimen. | Beta Globulin to Total Protein Ratio Measurement | ||
| Beta-1 Globulin | C119274 | Beta-1 Globulin | A measurement of the beta-1 globulin in a biological specimen. | Beta-1 Globulin Measurement | ||
| Beta-1 Globulin/Total Protein | C119275 | Beta-1 Globulin/Total Protein | A relative measurement (ratio or percentage) of beta-1-fraction proteins to total proteins in a biological specimen. | Beta-1 Globulin to Total Protein Ratio Measurement | ||
| Beta-2 Globulin | C119276 | Beta-2 Globulin | A measurement of the beta-2 globulin in a biological specimen. | Beta-2 Globulin Measurement | ||
| Beta-2 Globulin/Total Protein | C119277 | Beta-2 Globulin/Total Protein | A relative measurement (ratio or percentage) of beta-2-fraction proteins to total proteins in a biological specimen. | Beta-2 Globulin to Total Protein Ratio Measurement | ||
| Beta-2 Glycoprotein 1 IgG Antibody | C103358 | Beta-2 Glycoprotein 1 IgG Antibody | A measurement of the Beta-2 glycoprotein 1 IgG antibodies in a biological specimen. | Beta-2 Glycoprotein 1 IgG Antibody Measurement | ||
| Beta-2 Glycoprotein 1 IgM Antibody | C103359 | Beta-2 Glycoprotein 1 IgM Antibody | A measurement of the Beta-2 glycoprotein 1 IgM antibodies in a biological specimen. | Beta-2 Glycoprotein 1 IgM Antibody Measurement | ||
| Beta-2 Glycoprotein Antibody | C81979 | Beta-2 Glycoprotein Antibody | A measurement of the beta-2 glycoprotein antibody in a biological specimen. | Beta-2 Glycoprotein Antibody Measurement | ||
| Beta-2 Microglobulin | C81980 | Beta-2 Microglobulin | A measurement of the beta-2 microglobulin in a biological specimen. | Beta-2 Microglobulin Measurement | ||
| Beta-Hydroxybutyrate | C96568 | 3-Hydroxybutyrate;B-Hydroxybutyrate;Beta-Hydroxybutyrate | A measurement of the total Beta-hydroxybutyrate in a biological specimen. | Beta-Hydroxybutyrate Measurement | ||
| Beta-Trace Protein | C100426 | Beta-Trace Protein | A measurement of the beta-trace protein in a biological specimen. | Beta-Trace Protein Measurement | ||
| Bicarbonate | C74667 | Bicarbonate;HCO3 | A measurement of the bicarbonate in a biological specimen. | Bicarbonate Measurement | ||
| Bile Acid | C74800 | Bile Acid;Bile Acids;Bile Salt;Bile Salts | A measurement of the total bile acids in a biological specimen. | Bile Acid Measurement | ||
| Bilirubin | C38037 | Bilirubin;Total Bilirubin | A measurement of the total bilirubin in a biological specimen. | Total Bilirubin Measurement | ||
| Bilirubin Crystals | C74668 | Bilirubin Crystals | A measurement of the bilirubin crystals present in a biological specimen. | Bilirubin Crystal Measurement | ||
| Bioavailable Testosterone | C117860 | Bioavailable Testosterone | A measurement of bioavailable testosterone in a biological specimen. | Bioavailable Testosterone Measurement | ||
| Bite Cells | C74700 | Bite Cells | A measurement of the bite cells (erythrocytes with the appearance of a bite having been removed, due to oxidative hemolysis) in a biological specimen. | Bite Cell Count | ||
| Bite Cells/Erythrocytes | C74634 | Bite Cells/Erythrocytes | A relative measurement (ratio or percentage) of bite cells (erythrocytes with the appearance of a bite having been removed, due to oxidative hemolysis) to all erythrocytes in a biological specimen. | Bite Cell to Erythrocyte Ratio Measurement | ||
| BKV Viral Load | C98710 | BKV Viral Load | A measurement of the BK virus viral load in a biological specimen. | BK Virus Viral Load Measurement | ||
| Blasts | C74605 | Blasts | A measurement of the blast cells in a biological specimen. | Blast Count | ||
| Blasts/Leukocytes | C64487 | Blasts/Leukocytes | A relative measurement (ratio or percentage) of the blasts to leukocytes in a biological specimen. | Blast to Leukocyte Ratio | ||
| Blood Urea Nitrogen | C61019 | Blood Urea Nitrogen | A measurement of the urea nitrogen in a blood specimen. | Blood Urea Nitrogen Measurement | ||
| Bone Specific Alkaline Phosphatase | C92287 | Bone Specific Alkaline Phosphatase | A measurement of the bone specific alkaline phosphatase isoform in a biological specimen. | Bone Specific Alkaline Phosphatase Measurement | ||
| Brain Natriuretic Peptide | C74735 | B-Type Natriuretic Peptide;Brain Natriuretic Peptide | A measurement of the brain (B-type) natriuretic peptide in a biological specimen. | Brain Natriuretic Peptide Measurement | ||
| Brain-Derived Neurotrophic Factor | C82004 | Brain-Derived Neurotrophic Factor | A measurement of the brain-derived neurotrophic factor in a biological specimen. | Brain-Derived Neurotrophic Factor Measurement | ||
| Broad Casts | C96588 | Broad Casts | A measurement of the broad casts in a biological specimen. | Broad Casts Measurement | ||
| BUN/Creatinine | C74753 | BUN/Creatinine | A relative measurement (ratio or percentage) (ratio) of the blood urea nitrogen (BUN) to the creatinine in a biological specimen. | Blood Urea Nitrogen To Creatinine Ratio Measurement | ||
| Burr Cells | C74701 | Burr Cells;Keratocytes | A measurement of the Burr cells (erythrocytes characterized by the presence of small, blunt projections evenly distributed across the cell surface) in a biological specimen. | Burr Cell Count | ||
| Butyrylcholinesterase | C111142 | Acylcholine Acylhydrolase;Butyrylcholinesterase;Non-neuronal Cholinesterase;Plasma Cholinesterase;Pseudocholinesterase | A measurement of the total butyrylcholinesterase in a biological specimen. | Butyrylcholinesterase Measurement | ||
| C Reactive Protein | C64548 | C Reactive Protein | A measurement of the C reactive protein in a biological specimen. | C-Reactive Protein Measurement | ||
| C-peptide | C74736 | C-peptide | A measurement of the C (connecting) peptide of insulin in a biological specimen. | C-peptide Measurement | ||
| Cabot Rings | C74702 | Cabot Rings | A measurement of the Cabot rings (red-purple staining, threadlike, ring or figure 8 shaped filaments in an erythrocyte) in a biological specimen. | Cabot Ring Count | ||
| Caffeine | C75346 | Caffeine | A measurement of the caffeine in a biological specimen. | Caffeine Measurement | ||
| Calcitonin | C74848 | Calcitonin | A measurement of the calcitonin hormone in a biological specimen. | Calcitonin Measurement | ||
| Calcitriol | C74849 | Calcitriol | A measurement of the calcitriol hormone in a biological specimen. | Calcitriol Measurement | ||
| Calcium | C64488 | Calcium | A measurement of the calcium in a biological specimen. | Calcium Measurement | ||
| Calcium - Phosphorus Product | C103360 | Calcium - Phosphorus Product | A measurement of the product of the calcium and phosphate measurements in a biological specimen. | Calcium and Phosphorus Product Measurement | ||
| Calcium Carbonate Crystals | C74669 | Calcium Carbonate Crystals | A measurement of the calcium carbonate crystals present in a biological specimen. | Calcium Carbonate Crystal Measurement | ||
| Calcium Clearance | C96589 | Calcium Clearance | A measurement of the volume of serum or plasma that would be cleared of calcium by excretion of urine for a specified unit of time (e.g. one minute). | Calcium Clearance Measurement | ||
| Calcium Corrected | C119272 | Calcium Corrected | A measurement of calcium, which has been corrected for albumin, in a biological specimen. | Calcium Corrected Measurement | ||
| Calcium Excretion Rate | C117831 | Calcium Excretion Rate | A measurement of the amount of calcium being excreted in urine over a defined period of time (e.g. one hour). | Calcium Urine Excretion Rate | ||
| Calcium Oxalate Crystals | C74670 | Calcium Oxalate Crystals | A measurement of the calcium oxalate crystals present in a biological specimen. | Calcium Oxalate Crystal Measurement | ||
| Calcium Phosphate Crystals | C74671 | Calcium Phosphate Crystals | A measurement of the calcium phosphate crystals present in a biological specimen. | Calcium Phosphate Crystal Measurement | ||
| Calcium Sulphate | C96590 | Calcium Sulphate | A measurement of the calcium sulphate in a biological specimen. | Calcium Sulphate Measurement | ||
| Calcium, Ionized | C81948 | Calcium, Ionized | A measurement of the ionized calcium in a biological specimen. | Ionized Calcium Measurement | ||
| Calcium/Creatinine | C79439 | Calcium/Creatinine | A relative measurement (ratio or percentage) of the calcium to creatinine in a biological specimen. | Calcium to Creatinine Ratio Measurement | ||
| Calprotectin | C82005 | Calprotectin | A measurement of the calprotectin in a biological specimen. | Calprotectin Measurement | ||
| Cancer Antigen 1 | C103361 | Cancer Antigen 1 | A measurement of the cancer antigen 1 in a biological specimen. | Cancer Antigen 1 Measurement | ||
| Cancer Antigen 125 | C79089 | Cancer Antigen 125 | A measurement of the cancer antigen 125 in a biological specimen. | CA-125 Measurement | ||
| Cancer Antigen 15-3 | C103362 | Cancer Antigen 15-3 | A measurement of the cancer antigen 15-3 in a biological specimen. | Cancer Antigen 15-3 Measurement | ||
| Cancer Antigen 19-9 | C81982 | Cancer Antigen 19-9 | A measurement of the cancer antigen 19-9 in a biological specimen. | Cancer Antigen 19-9 Measurement | ||
| Cancer Antigen 27-29 | C111143 | Cancer Antigen 27-29 | A measurement of the cancer antigen 27-29 in a biological specimen. | Cancer Antigen 27-29 Measurement | ||
| Cancer Antigen 72-4 | C106505 | CA 72-4;Cancer Antigen 72-4;Carbohydrate Antigen 72-4 | A measurement of the cancer antigen 72-4 in a biological specimen. | Cancer Antigen 72-4 Measurement | ||
| Cannabinoids | C74689 | Cannabinoids | A measurement of any cannabinoid class drug present in a biological specimen. | Cannabinoid Drug Class Measurement | ||
| Carbohydrate-Deficient Transferrin | C101016 | Carbohydrate-Deficient Transferrin | A measurement of transferrin with a reduced number of carbohydrate moieties in a biological specimen. | Carbohydrate-Deficient Transferrin Measurement | ||
| Carbon Dioxide | C64545 | Carbon Dioxide | A measurement of the carbon dioxide gas in a biological specimen. | Carbon Dioxide Measurement | ||
| Carboxyhemoglobin | C96591 | Carboxyhemoglobin | A measurement of the carboxyhemoglobin, carbon monoxide-bound hemoglobin, in a biological specimen. | Carboxyhemoglobin Measurement | ||
| Carcinoembryonic Antigen | C81983 | Carcinoembryonic Antigen | A measurement of the carcinoembryonic antigen in a biological specimen. | Carcinoembryonic Antigen Measurement | ||
| Cardiolipin IgG Antibody | C111144 | Anti-Cardiolipin IgG Antibody;Cardiolipin IgG Antibody | A measurement of the cardiolipin IgG antibody in a biological specimen. | Cardiolipin IgG Antibody Measurement | ||
| Cardiolipin IgM Antibody | C103363 | Cardiolipin IgM Antibody | A measurement of the cardiolipin IgM antibodies in a biological specimen. | Cardiolipin IgM Antibody Measurement | ||
| Carnitine | C74682 | Carnitine | A measurement of the total carnitine in a biological specimen. | Total Carnitine Measurement | ||
| Carnitine Acetyl Transferase | C92288 | Carnitine Acetyl Transferase | A measurement of the carnitine acetyl transferase in a biological specimen. | Carnitine Acetyl Transferase Measurement | ||
| Carnitine, Free | C74677 | Carnitine, Free | A measurement of the free carnitine in a biological specimen. | Free Carnitine Measurement | ||
| Cartilage Oligomeric Matrix Protein | C111145 | Cartilage Oligomeric Matrix Protein | A measurement of the cartilage oligomeric matrix protein in a biological specimen. | Cartilage Oligomeric Matrix Protein Measurement | ||
| Casts | C74763 | Casts | A statement that indicates casts were looked for in a biological specimen. | Cast Present Or Absent | ||
| CD1 | C103364 | CD1 | A count of the CD1 expressing cells per unit of a biological specimen. | CD1 Expressing Cell Measurement | ||
| CD10 | C111146 | CD10 | A measurement of the CD10 expressing cells per unit in a biological specimen. | CD10 Expressing Cell Count | ||
| CD11A | C105439 | CD11A;CD11a | A count of the CD11a expressing cells per unit of a biological specimen. | CD11A Expressing Cell Count | ||
| CD11B | C105440 | CD11B;CD11b;Complement Component 3 Receptor 3 Subunit;Complement Receptor Type 3 Alpha Subunit;ITGAM Protein;Integrin Alpha-M | A count of the CD11b expressing cells per unit of a biological specimen. | CD11B Expressing Cell Count | ||
| CD13 | C111147 | CD13 | A measurement of the CD13 expressing cells per unit in a biological specimen. | CD13 Expressing Cell Count | ||
| CD14 | C103365 | CD14 | A count of the CD14 expressing cells per unit of a biological specimen. | CD14 Expressing Cell Measurement | ||
| CD19 | C103808 | CD19 | A count of the CD19 expressing cells per unit in a biological specimen. | CD19 Expressing Cell Count | ||
| CD19/Lymphocytes | C103812 | CD19/Lymphocytes | A relative measurement (ratio or percentage) of CD19 expressing cells to all lymphocytes in a biological specimen. | CD19 Cell to Lymphocyte Ratio Measurement | ||
| CD2 | C103366 | CD2 | A count of the CD2 expressing cells per unit of a biological specimen. | CD2 Expressing Cell Measurement | ||
| CD2/Lymphocytes | C103367 | CD2/Lymphocytes | A relative measurement (ratio or percentage) of CD2 expressing cells to all lymphocytes in a biological specimen. | CD2 Expressing Cell to Lymphocyte Ratio Measurement | ||
| CD20 | C103368 | CD20 | A count of the CD20 expressing cells per unit of a biological specimen. | CD20 Expressing Cell Measurement | ||
| CD22 | C111148 | CD22 | A measurement of the CD22 expressing cells per unit in a biological specimen. | CD22 Expressing Cell Count | ||
| CD23 | C111149 | CD23 | A measurement of the CD23 expressing cells per unit in a biological specimen. | CD23 Expressing Cell Count | ||
| CD3 | C103809 | CD3 | A count of the CD3 expressing cells per unit in a biological specimen. | CD3 Expressing Cell Count | ||
| CD3/Lymphocytes | C103813 | CD3/Lymphocytes | A relative measurement (ratio or percentage) of CD3 expressing cells to all lymphocytes in a biological specimen. | CD3 Cell to Lymphocyte Ratio Measurement | ||
| CD33 | C111150 | CD33 | A measurement of the CD33 expressing cells per unit in a biological specimen. | CD33 Expressing Cell Count | ||
| CD34 | C102260 | CD34 | A measurement of the CD34 expressing cells per unit in a biological specimen. | CD34 Measurement | ||
| CD38 | C111151 | CD38 | A measurement of the CD38 expressing cells per unit in a biological specimen. | CD38 Expressing Cell Count | ||
| CD4 | C103810 | CD4 | A count of the CD4 expressing cells per unit in a biological specimen. | CD4 Expressing Cell Count | ||
| CD4/CD8 | C103814 | CD4/CD8 | A relative measurement (ratio or percentage) of CD4 expressing cells to the CD8 expressing cells in a biological specimen. | CD4 Cell to CD8 Cell Ratio Measurement | ||
| CD4/Lymphocytes | C103815 | CD4/Lymphocytes | A relative measurement (ratio or percentage) of CD4 expressing cells to all lymphocytes in a biological specimen. | CD4 Cell to Lymphocyte Ratio Measurement | ||
| CD40 | C82006 | CD40 | A count of the CD40 cells per unit in a biological specimen. | CD40 Measurement | ||
| CD40 Ligand | C82007 | CD40 Ligand | A count of the CD40 ligand cells per unit in a biological specimen. | CD40 Ligand Measurement | ||
| CD5 | C103369 | CD5 | A count of the CD5 expressing cells per unit of a biological specimen. | CD5 Expressing Cell Measurement | ||
| CD56 | C103370 | CD56 | A count of the CD56 expressing cells per unit of a biological specimen. | CD56 Expressing Cell Measurement | ||
| CD79A | C111152 | CD79A | A measurement of the CD79A expressing cells per unit in a biological specimen. | CD79A Expressing Cell Count | ||
| CD8 | C103811 | CD8 | A count of the CD8 expressing cells per unit in a biological specimen. | CD8 Expressing Cell Count | ||
| CD8/Lymphocytes | C103816 | CD8/Lymphocytes | A relative measurement (ratio or percentage) of CD8 expressing cells to all lymphocytes in a biological specimen. | CD8 Cell to Lymphocyte Ratio Measurement | ||
| Cellular Casts | C74764 | Cellular Casts | A measurement of the cellular (white blood cell, red blood cell, epithelial and bacterial) casts present in a biological specimen. | Cellular Cast Measurement | ||
| Cellularity | C111153 | Cellularity;Cellularity Grade | A measurement of the degree, quality or condition of cells in a biological specimen. | Cellularity Measurement | ||
| Centromere B Antibodies | C111154 | Anti-Centromere B Antibodies | A measurement of centromere B antibodies in a biological specimen. | Centromere B Antibody Measurement | ||
| Ceruloplasmin | C100432 | Caeruloplasmin;Ceruloplasmin | A measurement of ceruloplasmin in a biological specimen. | Ceruloplasmin Measurement | ||
| Chemokine (C-C Motif) Ligand 17 | C112236 | ABCD-2;Chemokine (C-C Motif) Ligand 17;SCYA17;TARC;Thymus and Activation Regulated Chemokine | A measurement of the CCL17, chemokine (C-C motif) ligand 17, in a biological specimen. | Chemokine (C-C Motif) Ligand 17 Measurement | ||
| Chemokine (C-C Motif) Ligand 18 | C112237 | AMAC-1;AMAC1;CKB7;Chemokine (C-C Motif) Ligand 18;DC-CK1;DCCK1;MIP-4;Macrophage inflammatory protein-4;PARC;Pulmonary and Activation-Regulated Chemokine;SCYA18 | A measurement of the CCL18, chemokine (C-C motif) ligand 18, in a biological specimen. | Chemokine (C-C Motif) Ligand 18 Measurement | ||
| Chemokine (C-X-C Motif) Ligand 10 | C112238 | Chemokine (C-X-C Motif) Ligand 10;IP-10;Interferon Gamma-induced Protein 10;Small-inducible Cytokine B10 | A measurement of the CXCL10, chemokine (C-X-C motif) ligand 10, in a biological specimen. | Chemokine (C-X-C Motif) Ligand 10 Measurement | ||
| Chemokine (C-X-C Motif) Receptor 3 | C100431 | CD183;CXCR3;Chemokine (C-X-C Motif) Receptor 3;GPR9 | A measurement of the CXCR3, chemokine (C-X-C motif) receptor 3, in a biological specimen. | Chemokine Receptor CXCR3 Measurement | ||
| Chlamydia pneumoniae IgA Antibody | C92432 | Chlamydia pneumoniae IgA Antibody | A measurement of the Chlamydia pneumoniae IgA antibody in a biological specimen. | Chlamydia pneumoniae IgA Antibody Measurement | ||
| Chlamydia pneumoniae IgM Antibody | C92433 | Chlamydia pneumoniae IgM Antibody | A measurement of the Chlamydia pneumoniae IgM in a biological specimen. | Chlamydia pneumoniae IgM Antibody Measurement | ||
| Chlamydia trachomatis IgA Antibody | C100464 | Chlamydia trachomatis IgA Antibody | A measurement of the Chlamydia trachomatis IgA antibody in a biological specimen. | Chlamydia trachomatis IgA Antibody Measurement | ||
| Chlamydia trachomatis IgG Antibody | C100466 | Chlamydia trachomatis IgG Antibody | A measurement of the Chlamydia trachomatis IgG antibody in a biological specimen. | Chlamydia trachomatis IgG Antibody Measurement | ||
| Chlamydia trachomatis IgM Antibody | C100465 | Chlamydia trachomatis IgM Antibody | A measurement of the Chlamydia trachomatis IgM antibody in a biological specimen. | Chlamydia trachomatis IgM Antibody Measurement | ||
| Chloride | C64495 | Chloride | A measurement of the chloride in a biological specimen. | Chloride Measurement | ||
| Chloride Clearance | C106509 | Chloride Clearance | A measurement of the volume of serum or plasma that would be cleared of chloride by excretion of urine for a specified unit of time (e.g. one minute). | Chloride Clearance Measurement | ||
| Chloride Excretion Rate | C117832 | Chloride Excretion Rate | A measurement of the amount of chloride being excreted in urine over a defined period of time (e.g. one hour). | Chloride Urine Excretion Rate | ||
| Chloride/Creatinine | C79440 | Chloride/Creatinine | A relative measurement (ratio or percentage) of the chloride to creatinine in a biological specimen. | Chloride to Creatinine Ratio Measurement | ||
| Cholecystokinin | C74850 | Cholecystokinin;Pancreozymin | A measurement of the cholecystokinin hormone in a biological specimen. | Cholecystokinin Measurement | ||
| Cholera Toxin B Subunit IgG Antibody | C116194 | Cholera Toxin B Subunit IgG Antibody | A measurement of the cholera toxin B subunit IgG antibody in a biological specimen. | Cholera Toxin B Subunit IgG Antibody Measurement | ||
| Cholesterol | C105586 | Cholesterol;Total Cholesterol | A measurement of the cholesterol in a biological specimen. | Cholesterol Measurement | ||
| Cholesterol Crystals | C74672 | Cholesterol Crystals | A measurement of the cholesterol crystals present in a biological specimen. | Cholesterol Crystal Measurement | ||
| Cholesterol/HDL-Cholesterol | C80171 | Cholesterol/HDL-Cholesterol | A relative measurement (ratio or percentage) of total cholesterol to high-density lipoprotein cholesterol (HDL-C) in a biological specimen. | Cholesterol to HDL-Cholesterol Ratio Measurement | ||
| Cholesteryl Ester Transfer Protein Act | C103380 | Cholesteryl Ester Transfer Protein Act | A measurement of the biological activity of cholesteryl ester transfer protein in a biological specimen. | Cholesteryl Ester Transfer Protein Activity Measurement | ||
| Cholinesterase | C92289 | Cholinesterase | A measurement of the cholinesterase in a biological specimen. | Cholinesterase Measurement | ||
| Choriogonadotropin Beta | C64851 | Choriogonadotropin Beta;Pregnancy Test | A measurement of the Choriogonadotropin Beta in a biological specimen. | Choriogonadotropin Beta Measurement | ||
| Chymotrypsin | C111159 | Chymotrypsin | A measurement of the total chymotrypsin in a biological specimen. | Chymotrypsin Measurement | ||
| Circulating Endothelial Cells | C96592 | Circulating Endothelial Cells | A measurement of the circulating endothelial cells in a biological specimen. | Circulating Endothelial Cell Count | ||
| Circulating Tumor Cells | C96593 | Circulating Tumor Cells | A measurement of the circulating tumor cells in a biological specimen. | Circulating Tumor Cell Count | ||
| Citrate | C92248 | Citrate | A measurement of the citrate in a biological specimen. | Citrate Measurement | ||
| Clarity | C96594 | Clarity | A measurement of the transparency of a biological specimen. | Clarity Measurement | ||
| Clostridium difficile Toxin | C103381 | Clostridium difficile Toxin | A measurement of the Clostridium difficile toxin in a biological specimen. | Clostridium difficile Toxin Measurement | ||
| Clostridium tetani IgG Antibody | C103382 | Clostridium tetani IgG Antibody | A measurement of the Clostridium tetani IgG antibody in a biological specimen. | Clostridium tetani IgG Antibody Measurement | ||
| Clue Cells | C102261 | Clue Cells | A measurement of the clue cells in a biological specimen. | Clue Cell Count | ||
| CMV Viral Load | C98716 | CMV Viral Load | A measurement of the cytomegalovirus viral load in a biological specimen. | Cytomegalovirus Viral Load Measurement | ||
| Coagulation Index | C112239 | CI;Coagulation Index | A measurement of the efficiency of coagulation of a biological specimen. This is calculated by a mathematical formula that takes into account the R value, K value, angle and maximum amplitude of clot formation. | Coagulation Index Measurement | ||
| Cocaine | C74690 | Cocaine | A measurement of the cocaine present in a biological specimen. | Cocaine Measurement | ||
| Coccidioides Antibody | C111160 | Coccidioides Antibody | A measurement of the coccidioides antibody in a biological specimen. | Coccidioides Antibody Measurement | ||
| Codeine | C74877 | Codeine | A measurement of the codeine present in a biological specimen. | Codeine Measurement | ||
| Collagen Type IV | C103383 | Collagen Type IV | A measurement of the collagen type IV in a biological specimen. | Collagen Type IV Measurement | ||
| Color | C64546 | Color | A measurement of the color of a biological specimen. | Color Assessment | ||
| Complement Bb | C80172 | Bb Fragment of Complement Factor B;Bb Fragment of Factor B;Complement Bb | A measurement of the Bb fragment of complement factor B in a biological specimen. | Complement Bb Measurement | ||
| Complement C1q Antibody | C80173 | Complement C1q Antibody | A measurement of the complement C1q antibody in a biological specimen. | Complement C1q Antibody Measurement | ||
| Complement C3 | C80174 | Complement C3 | A measurement of the complement C3 in a biological specimen. | Complement C3 Measurement | ||
| Complement C3a | C80175 | ASP, Complement C3 DesArg, Acetylation-stimulating Protein;Complement C3a | A measurement of the complement C3a in a biological specimen. | Complement C3a Measurement | ||
| Complement C3b | C80176 | Complement C3b | A measurement of the complement C3b in a biological specimen. | Complement C3b Measurement | ||
| Complement C3d Antibody | C119271 | Complement C3d Antibody | A measurement of the complement C3d antibody in a biological specimen. | Complement C3d Antibody Measurement | ||
| Complement C4 | C80177 | Complement C4 | A measurement of the complement C4 in a biological specimen. | Complement C4 Measurement | ||
| Complement C4a | C80178 | Complement C4a | A measurement of the complement C4a in a biological specimen. | Complement C4a Measurement | ||
| Complement C5a | C80179 | Complement C5a | A measurement of the complement C5a in a biological specimen. | Complement C5a Measurement | ||
| Complement CH50 | C100423 | CH50;Complement CH50;Total Hemolytic Complement | A measurement of the complement required to lyse 50 percent of red blood cells in a biological specimen. | CH50 Measurement | ||
| Complement Total | C80160 | Complement Total | A measurement of the total complement in a biological specimen. | Complement Measurement | ||
| Copper | C111161 | Copper;Cu | A measurement of copper in a biological specimen. | Copper Measurement | ||
| Corticosterone | C79434 | Corticosterone | A measurement of corticosterone in a biological specimen. | Corticosterone Measurement | ||
| Corticosterone/Creatinine | C106511 | Corticosterone/Creatinine | A relative measurement (ratio or percentage) of the corticosterone to creatinine present in a sample. | Corticosterone to Creatinine Ratio Measurement | ||
| Corticotropin Releasing Hormone | C74851 | Corticotropin Releasing Factor;Corticotropin Releasing Hormone | A measurement of the corticotropin releasing hormone in a biological specimen. | Corticotropin Releasing Hormone Measurement | ||
| Cortisol | C74781 | Cortisol;Total Cortisol | A measurement of the cortisol in a biological specimen. | Cortisol Measurement | ||
| Cortisol, Free | C88113 | Cortisol, Free | A measurement of the free, unbound cortisol in a biological specimen. | Free Cortisol Measurement | ||
| Cortisol/Creatinine | C106512 | Cortisol/Creatinine | A relative measurement (ratio or percentage) of the cortisol to creatinine present in a sample. | Cortisol to Creatinine Ratio Measurement | ||
| Cotinine | C92249 | Cotinine | A measurement of the cotinine in a biological specimen. | Cotinine Measurement | ||
| Creatine Kinase | C64489 | Creatine Kinase | A measurement of the total creatine kinase in a biological specimen. | Creatine Kinase Measurement | ||
| Creatine Kinase BB | C64490 | Creatine Kinase BB | A measurement of the homozygous B-type creatine kinase in a biological specimen. | Creatine Kinase BB Measurement | ||
| Creatine Kinase BB/Total Creatine Kinase | C79466 | Creatine Kinase BB/Total Creatine Kinase | A relative measurement (ratio or percentage) of the BB-type creatine kinase to total creatine kinase in a biological specimen. | Creatine Kinase BB to Total Creatine Kinase Ratio Measurement | ||
| Creatine Kinase MB | C64491 | Creatine Kinase MB | A measurement of the heterozygous MB-type creatine kinase in a biological specimen. | Creatine Kinase MB Measurement | ||
| Creatine Kinase MB/Total Creatine Kinase | C79441 | Creatine Kinase MB/Total Creatine Kinase | A relative measurement (ratio or percentage) of the MB-type creatine kinase to total creatine kinase in a biological specimen. | Creatine Kinase MB to Total Creatine Kinase Ratio Measurement | ||
| Creatine Kinase MM | C64494 | Creatine Kinase MM | A measurement of the homozygous M-type creatine kinase in a biological specimen. | Creatine Kinase MM Measurement | ||
| Creatine Kinase MM/Total Creatine Kinase | C79442 | Creatine Kinase MM/Total Creatine Kinase | A relative measurement (ratio or percentage) of the MM-type creatine kinase to total creatine kinase in a biological specimen. | Creatine Kinase MM to Total Creatine Kinase Ratio Measurement | ||
| Creatinine | C64547 | Creatinine | A measurement of the creatinine in a biological specimen. | Creatinine Measurement | ||
| Creatinine Clearance | C25747 | Creatinine Clearance | A measurement of the volume of serum or plasma that would be cleared of creatinine by excretion of urine for a specified unit of time (e.g. one minute). | Creatinine Clearance | ||
| Creatinine Excretion Rate | C117833 | Creatinine Excretion Rate | A measurement of the amount of creatinine being excreted in urine over a defined amount of time (e.g. one hour). | Creatinine Urine Excretion Rate | ||
| Crenated Cells | C74703 | Crenated Cells;Echinocytes | A measurement of the Burr cells (erythrocytes characterized by the presence of multiple small, sharp projections evenly distributed across the cell surface) in a biological specimen. | Crenated Cell Measurement | ||
| Cryoglobulin | C111164 | Cryoglobulin | A measurement of cryoglobulin in a biological specimen. | Cryoglobulin Measurement | ||
| Crystals | C74673 | Crystals | A statement that indicates crystals were looked for in a biological specimen. | Crystal Present Or Absent | ||
| Cyclic Citrullinated Peptide Antibody | C96595 | Cyclic Citrullinated Peptide Antibody | A measurement of the cyclic citrullinated peptide antibody in a biological specimen. | Cyclic Citrullinated Peptide Antibody Measurement | ||
| Cyclic Guanosine Monophosphate | C111165 | Cyclic Guanosine 3,5-Monophosphate | A measurement of the cyclic guanosine 3,5-monophosphate in a biological specimen. | Cyclic Guanosine Monophosphate Measurement | ||
| Cystatin C | C92290 | Cystatin C | A measurement of the cystatin C in a biological specimen. | Cystatin C Measurement | ||
| Cystatin C/Creatinine | C106513 | Cystatin C/Creatinine | A relative measurement (ratio or percentage) of the cystatin C to creatinine present in a sample. | Cystatin C to Creatinine Ratio Measurement | ||
| Cystine | C105441 | Cystine | A measurement of the cystine in a biological specimen. | Cystine Measurement | ||
| Cystine Crystals | C74674 | Cystine Crystals | A measurement of the cystine crystals present in a biological specimen. | Cystine Crystal Measurement | ||
| Cytokeratin Fragment 21-1 | C106514 | CYFRA21-1;Cytokeratin 19 Fragment;Cytokeratin Fragment 21-1 | A measurement of the cytokeratin 19 fragment 21-1 in a biological specimen. | Cytokeratin Fragment 21-1 Measurement | ||
| Cytomegalovirus IgG Antibody | C96596 | Cytomegalovirus IgG Antibody | A measurement of the cytomegalovirus IgG antibody in a biological specimen. | Cytomegalovirus IgG Antibody Measurement | ||
| Cytomegalovirus IgM Antibody | C96597 | Cytomegalovirus IgM Antibody | A measurement of the cytomegalovirus IgM antibody in a biological specimen. | Cytomegalovirus IgM Antibody Measurement | ||
| Cytoplasmic Basophilia Neutrophil | C111166 | Cytoplasmic Basophilia Neutrophil | A measurement of the neutrophils in a biological specimen showing a dark staining pattern in the cytoplasm due to increased acidic content. | Cytoplasmic Basophilia Neutrophil Count | ||
| D-Dimer | C82621 | D-Dimer | A measurement of the d-dimers in a biological specimen. | D-Dimer Measurement | ||
| Dacryocytes | C64801 | Dacryocytes;Tear Shaped Erythrocytes;Teardrop Cells | A measurement of dacryocytes in a biological specimen. | Dacryocyte Analysis | ||
| Degenerated Leukocytes | C111190 | Degenerated Leukocytes;Degenerated WBC;Degenerated White Blood Cells | A measurement of the degenerated leukocytes (leukocytes that show deterioration in form or function) in a biological specimen. | Degenerated Leukocyte Count | ||
| Dehydroepiandrosterone | C74852 | Dehydroepiandrosterone;Dehydroisoandrosterone | A measurement of the dehydroepiandrosterone hormone in a biological specimen. | Dehydroepiandrosterone Measurement | ||
| Dehydroepiandrosterone Sulfate | C96629 | DHEA Sulfate;DHEA-S;Dehydroepiandrosterone Sulfate;sDHEA | A measurement of the sulfated Dehydroepiandrosterone in a biological specimen. | Sulfated DHEA Measurement | ||
| Density | C45781 | Density | A measurement of the compactness of a biological specimen expressed in mass per unit volume. | Density | ||
| Deoxypyridinoline | C79443 | Deoxypyridinoline | A measurement of the deoxypyridinoline in a biological specimen. | Deoxypyridinoline Measurement | ||
| Deoxypyridinoline/Creatinine | C79444 | Deoxypyridinoline/Creatinine | A relative measurement (ratio or percentage) of the deoxypyridinoline to creatinine in a biological specimen. | Deoxypyridinoline to Creatinine Ratio Measurement | ||
| Dextroamphetamine | C102262 | Dextroamphetamine;d-amphetamine | A measurement of the dextroamphetamine in a biological specimen. | Dextroamphetamine Measurement | ||
| Dihydrocodeine | C74878 | Dihydrocodeine | A measurement of the dihydrocodeine present in a biological specimen. | Dihydrocodeine Measurement | ||
| Dihydrotestosterone | C74853 | Androstanalone;Dihydrotestosterone | A measurement of the dihydrotestosterone hormone in a biological specimen. | Dihydrotestosterone Measurement | ||
| Dilute Russell's Viper Venom Time | C96696 | Dilute Russell's Viper Venom Time;Lupus Anticoagulant Test | A measurement of the time it takes a plasma sample to clot after adding dilute Russell's viper venom. | Dilute Russell's Viper Venom Time Measurement | ||
| Dilute Russell's Viper Venom Time Ratio | C103386 | Lupus Anticoagulant Ratio | A relative measurement (ratio or percentage) of the dilute Russell's viper venom time in a subject sample to a control sample. | Dilute Russell's Viper Venom Time to Control Ratio Measurement | ||
| Dimorphic Erythrocyte Population | C117853 | Dimorphic Erythrocyte Population;Dimorphic RBC Population | Examination of a biological specimen to detect the presence of dimorphic erythrocyte population. | Dimorphic Erythrocyte Population | ||
| Dipeptidyl Peptidase-4 Activity | C103387 | DPPIV Activity | A measurement of the biological activity of dipeptidyl peptidase-4 in a biological specimen. | Dipeptidyl Peptidase-4 Activity Measurement | ||
| Diphtheria IgG Antibody | C103388 | Diphtheria IgG Antibody | A measurement of the Diphtheria IgG antibodies in a biological specimen. | Diphtheria IgG Antibody Measurement | ||
| Direct Bilirubin | C64481 | Direct Bilirubin | A measurement of the conjugated or water-soluble bilirubin in a biological specimen. | Direct Bilirubin Measurement | ||
| DNase-B Antibody | C100463 | Anti-Dnase B;DNase-B Antibody | A measurement of Dnase-B antibody in a biological specimen. | DNase-B Antibody Measurement | ||
| Dohle Bodies | C74610 | Dohle Bodies | A measurement of the Dohle bodies (blue-gray, basophilic, leukocyte inclusions located in the peripheral cytoplasm of neutrophils) in a biological specimen. | Dohle Body Measurement | ||
| Dopamine | C74854 | Dopamine | A measurement of the dopamine hormone in a biological specimen. | Dopamine Measurement | ||
| Drug Screen | C78139 | Drug Screen | An indication of the presence or absence of recreational drugs or drugs of abuse in a biological specimen. | Drug Test | ||
| DTPA Clearance | C100441 | DTPA Clearance | A measurement of the volume of serum or plasma that would be cleared of Diethylenetriamine pentaacetate (DTPA) through its excretion for a specified unit of time. | Diethylene Triamine Pentaacetic Acid Clearance | ||
| EBV Profile Interpretation | C106519 | EBV Profile Interpretation;Epstein-Barr Virus Antibody Profile;Epstein-Barr Virus Panel;Epstein-Barr Virus Profile Interpretation | An assessment of Epstein-Barr virus infection based on a panel of EBV antigen antibody tests. | Epstein-Barr Virus Profile Interpretation | ||
| EBV Viral Load | C98721 | EBV Viral Load | A measurement of the Epstein-Barr virus viral load in a biological specimen. | Epstein-Barr Virus Viral Load Measurement | ||
| Ecarin Clotting Time | C100422 | Ecarin Clotting Time | A measurement of the activity of thrombin inhibitors in a biological specimen based on the generation of meizothrombin. | Ecarin Clotting Time Measurement | ||
| Eccentrocytes | C96598 | Eccentrocytes | A measurement of the eccentrocytes (erythrocytes in which the hemoglobin is localized to a particular portion of the cell, noticeable as localized staining) in a biological specimen. | Eccentrocyte Count | ||
| EDTA Clearance | C100440 | EDTA Clearance | A measurement of the volume of serum or plasma that would be cleared of Ethylenediamine tetraacetic acid (EDTA) through its excretion for a specified unit of time. | EDTA Clearance | ||
| Elliptocytes | C64549 | Elliptocytes;Ovalocytes | A measurement of the elliptically shaped erythrocytes in a biological specimen. | Elliptocyte Count | ||
| Endogenous Thrombin Potential | C102266 | Endogenous Thrombin Potential | A measurement of the total concentration of thrombin generated in the presence of a substrate in a plasma or blood sample. | Endogenous Thrombin Potential Measurement | ||
| Endothelin-1 | C82008 | Endothelin-1 | A measurement of the endothelin-1 in a biological specimen. | Endothelin-1 Measurement | ||
| Eosinophilic Metamyelocytes | C84819 | Eosinophilic Metamyelocytes | A measurement of the eosinphilic metamyelocytes in a biological specimen. | Eosinophilic Metamyelocyte Count | ||
| Eosinophilic Myelocytes | C84821 | Eosinophilic Myelocytes | A measurement of the eosinophilic myelocytes in a biological specimen. | Eosinophilic Myelocyte Count | ||
| Eosinophils | C64550 | Eosinophils | A measurement of the eosinophils in a biological specimen. | Eosinophil Count | ||
| Eosinophils Band Form | C114216 | Eosinophils Band Form | A measurement of the banded eosinophils in a biological specimen. | Eosinophil Band Form Count | ||
| Eosinophils Band Form/Leukocytes | C114217 | Eosinophils Band Form/Leukocytes | A relative measurement (ratio or percentage) of the banded eosinophils to leukocytes in a biological specimen. | Eosinophil Band Form to Leukocyte Ratio | ||
| Eosinophils/Leukocytes | C64604 | Eosinophils/Leukocytes | A relative measurement (ratio or percentage) of the eosinophils to leukocytes in a biological specimen. | Eosinophil to Leukocyte Ratio | ||
| Eosinophils/Total Cells | C98720 | Eosinophils/Total Cells | A relative measurement (ratio or percentage) of the eosinophils to total cells in a biological specimen (for example a bone marrow specimen). | Eosinophils to Total Cell Ratio Measurement | ||
| Eotaxin-1 | C81952 | Chemokine Ligand 11;Eotaxin-1 | A measurement of the eotaxin-1 in a biological specimen. | Eotaxin-1 Measurement | ||
| Eotaxin-2 | C81953 | Chemokine Ligand 24;Eotaxin-2 | A measurement of the eotaxin-2 in a biological specimen. | Eotaxin-2 Measurement | ||
| Eotaxin-3 | C81954 | CCL26;Chemokine (C-C Motif) Ligand 26;Chemokine Ligand 26;Eotaxin-3 | A measurement of the eotaxin-3 in a biological specimen. | Eotaxin-3 Measurement | ||
| Epidermal Growth Factor | C82009 | Epidermal Growth Factor | A measurement of the epidermal growth factor in a biological specimen. | Epidermal Growth Factor Measurement | ||
| Epidermal Growth Factor Receptor | C112273 | ERBB1;Epidermal Growth Factor Receptor;HER1 | A measurement of the cells with positive expression of EGFR in a biological specimen. | Epidermal Growth Factor Receptor Measurement | ||
| Epinephrine | C79445 | Adrenaline;Epinephrine | A measurement of the epinephrine hormone in a biological specimen. | Epinephrine Measurement | ||
| Epith Neutrophil-Activating Peptide 78 | C82010 | Epith Neutrophil-Activating Peptide 78 | A measurement of the epithelial neutrophil-activating peptide in a biological specimen. | Epithelial Neutrophil-Activating Peptide 78 Measurement | ||
| Epithelial Casts | C74779 | Epithelial Casts | A measurement of the epithelial cell casts present in a biological specimen. | Epithelial-Cast Measurement | ||
| Epithelial Cells | C64605 | Epithelial Cells | A measurement of the epithelial cells in a biological specimen. | Epithelial Cell Count | ||
| Epstein-Barr Capsid IgG Antibody | C96600 | Epstein-Barr Capsid IgG Antibody | A measurement of the Epstein-Barr capsid IgG antibody in a biological specimen. | Epstein-Barr Capsid IgG Antibody Measurement | ||
| Epstein-Barr Capsid IgM Antibody | C96601 | Epstein-Barr Capsid IgM Antibody | A measurement of the Epstein-Barr capsid IgM antibody in a biological specimen. | Epstein-Barr Capsid IgM Antibody Measurement | ||
| Epstein-Barr Early Antigen | C96602 | Epstein-Barr Early Antigen | A measurement of the Epstein-Barr early antigen in a biological specimen. | Epstein-Barr Early Antigen Measurement | ||
| Epstein-Barr Nuclear Antibody | C96603 | Epstein-Barr Nuclear Antibody;Epstein-Barr Nuclear Antigen Antibody | A measurement of the Epstein-Barr nuclear antibody in a biological specimen. | Epstein-Barr Nuclear Antibody Measurement | ||
| Epstein-Barr Nuclear Antigen | C96604 | Epstein-Barr Nuclear Antigen | A measurement of the Epstein-Barr nuclear antigen in a biological specimen. | Epstein-Barr Nuclear Antigen Measurement | ||
| Epstein-Barr Nuclear Antigen 1 IgG Ab | C106518 | Epstein-Barr Nuclear Antigen 1 IgG Ab | A measurement of the Epstein-Barr nuclear antigen 1 IgG antibody in a biological specimen. | Epstein-Barr Nuclear Antigen 1 IgG Ab Measurement | ||
| Ery. Mean Corpuscular Hemoglobin | C64797 | Ery. Mean Corpuscular Hemoglobin | A quantitative measurement of the mean amount of hemoglobin per erythrocyte in a biological specimen. | Erythrocyte Mean Corpuscular Hemoglobin | ||
| Ery. Mean Corpuscular HGB Concentration | C64798 | Ery. Mean Corpuscular HGB Concentration | A quantitative measurement of the mean amount of hemoglobin per erythrocytes in a specified volume of a biological specimen. | Erythrocyte Mean Corpuscular Hemoglobin Concentration | ||
| Ery. Mean Corpuscular Volume | C64799 | Ery. Mean Corpuscular Volume;Erythrocytes Mean Corpuscular Volume;RBC Mean Corpuscular Volume | A quantitative measurement of the mean volume of erythrocytes in a biological specimen. | Erythrocyte Mean Corpuscular Volume | ||
| Erythrocyte Agglutination | C111197 | Autoagglutination;Erythrocyte Agglutination;RBC Agglutination | A measurement of the erythrocyte agglutination in a biological specimen. | Erythrocyte Agglutination Measurement | ||
| Erythrocyte Cell Clumps | C92245 | Erythrocyte Cell Clumps;RBC Clumps;Red Blood Cell Clumps | A measurement of red blood cell clumps in a biological specimen. | Erythrocyte Cell Clumps Measurement | ||
| Erythrocyte Cell Morphology | C92296 | Erythrocyte Cell Morphology;RBC Morphology;Red Blood Cell Morphology | An examination or assessment of the form and structure of red blood cells. | Erythrocyte Cell Morphology | ||
| Erythrocyte Fragment | C116212 | Erythrocyte Fragment;RBC Fragment | A measurement of the red blood cell fragments (red cell fragments that have a reticular-like shape with rounded ends and no spicules, differentiating them from schistocytes and acanthocytes) in a biological specimen. | Erythrocyte Fragment Measurement | ||
| Erythrocyte Ghosts | C96605 | Erythrocyte Ghosts;RBC Ghosts | A measurement of the erythrocyte ghosts (erythrocytes in which hemoglobin has been removed through hemolysis) in a biological specimen. | Erythrocyte Ghost Count | ||
| Erythrocyte Sedimentation Rate | C74611 | Biernacki Reaction;Erythrocyte Sedimentation Rate | The distance (e.g. millimeters) that red blood cells settle in unclotted blood over a specified unit of time (e.g. one hour). | Erythrocyte Sedimentation Rate Measurement | ||
| Erythrocytes | C51946 | Erythrocytes;Red Blood Cells | A measurement of the total erythrocytes in a biological specimen. | Erythrocyte Count | ||
| Erythrocytes Distribution Width | C64800 | Erythrocytes Distribution Width;Red Blood Cell Distribution Width | A value derived from mean corpuscular volume and the standard deviation of the red blood cell volume in a whole blood specimen. | Erythrocyte Distribution Width Measurement | ||
| Erythropoietin | C74855 | Erythropoietin;Hematopoietin | A measurement of the erythropoietin hormone in a biological specimen. | Erythropoietin Measurement | ||
| Estradiol | C74782 | Estradiol;Oestradiol | A measurement of the estradiol in a biological specimen. | Estradiol Measurement | ||
| Estriol | C74856 | Estriol;Oestriol | A measurement of the estriol hormone in a biological specimen. | Estriol Measurement | ||
| Estriol, Free | C81963 | Estriol, Free | A measurement of the free estriol in a biological specimen. | Free Estriol Measurement | ||
| Estrogen Receptor | C112274 | ER;ESR;Estrogen Receptor;Oestrogen Receptor | A measurement of the cells with positive expression of estrogen receptor in a biological specimen. | Estrogen Receptor Measurement | ||
| Estrone | C74857 | Estrone;Oestrone | A measurement of the estrone hormone in a biological specimen. | Estrone Measurement | ||
| Ethanol | C74693 | Alcohol;Ethanol | A measurement of the ethanol present in a biological specimen. | Ethanol Measurement | ||
| ETP Area Under Curve | C102263 | ETP Area Under Curve;Endogenous Thrombin Potential Area Under Curve | A measurement of the area under the thrombin generation curve. | Endogenous Thrombin Potential Area Under Curve Measurement | ||
| ETP Lag Time | C102264 | ETP Lag Time;Endogenous Thrombin Potential Lag Time | A measurement of time from the start of the thrombin generation test to the point where a predetermined amount of thrombin is generated. | Endogenous Thrombin Potential Lag Time Measurement | ||
| ETP Lag Time Relative | C102265 | ETP Lag Time Relative;Endogenous Thrombin Potential Lag Time Relative | A relative measurement (ratio or percentage) of time from the start of the thrombin generation test to the point where a predetermined amount of thrombin is generated. | Endogenous Thrombin Potential Lag Time Relative Measurement | ||
| ETP Peak Height | C102267 | ETP Peak Height;Endogenous Thrombin Potential Peak Height | A measurement of the maximum concentration of thrombin generated during a thrombin generation test. | Endogenous Thrombin Potential Peak Height Measurement | ||
| ETP Peak Height Relative | C102268 | ETP Peak Height Relative;Endogenous Thrombin Potential Peak Height Relative | A relative (ratio or percentage) of the maximum concentration of thrombin generated during a thrombin generation test. | Endogenous Thrombin Potential Peak Height Relative Measurement | ||
| ETP Time to Peak | C102269 | ETP Time to Peak;Endogenous Thrombin Potential Time to Peak | A measurement of the time it takes to generate the maximum concentration of thrombin. | Endogenous Thrombin Potential Time to Peak Measurement | ||
| ETP Time to Peak Relative | C102270 | ETP Time to Peak Relative;Endogenous Thrombin Potential Time to Peak Relative | A relative (ratio or percentage) measurement of the time it takes to generate the maximum concentration of thrombin. | Endogenous Thrombin Potential Time to Peak Relative Measurement | ||
| Extracell Newly Ident RAGE Bind Protein | C82011 | Extracell Newly Ident RAGE Bind Protein;S100 Calcium Binding Protein A12 | A measurement of the extracellular newly identified RAGE (receptor for advanced glycation end products) binding protein in a biological specimen. | Extracell Newly Ident RAGE Bind Protein Measurement | ||
| Extractable Nuclear Antigen Antibody | C92270 | Anti-ENA;Extractable Nuclear Antigen Antibody | A measurement of the extractable nuclear antigen antibody in a biological specimen. | Extractable Nuclear Antigen Antibody Measurement | ||
| F2-Isoprostane | C80180 | F2-Isoprostane | A measurement of the F2-isoprostane in a biological specimen. | F2 Isoprostane Measurement | ||
| Factor II | C96626 | Factor II;Prothrombin | A measurement of the Factor II in a biological specimen. | Prothrombin Measurement | ||
| Factor III | C81959 | Factor III;Tissue Factor, CD142 | A measurement of the factor III in a biological specimen. | Factor III Measurement | ||
| Factor IX | C98725 | Christmas Factor;Factor IX | A measurement of the factor IX in a biological specimen. | Factor IX Measurement | ||
| Factor IX Activity | C103395 | Christmas Factor Activity | A measurement of the biological activity of factor IX in a biological specimen. | Factor IX Activity Measurement | ||
| Factor V | C98726 | Factor V;Labile Factor | A measurement of the factor V in a biological specimen. | Factor V Measurement | ||
| Factor V Activity | C103396 | Labile Factor Activity | A measurement of the biological activity of factor V in a biological specimen. | Factor V Activity Measurement | ||
| Factor V Leiden | C102271 | Factor V Leiden | A measurement of the Factor V Leiden in a biological specimen. | Factor V Leiden Measurement | ||
| Factor VII | C81960 | Factor VII;Proconvertin;Stable Factor | A measurement of the factor VII in a biological specimen. | Factor VII Measurement | ||
| Factor VII Activity | C103397 | Proconvertin Activity;Stable Factor Activity | A measurement of the biological activity of factor VII in a biological specimen. | Factor VII Activity Measurement | ||
| Factor VIIa Activity | C103398 | Factor VIIa Activity | A measurement of the biological activity of factor VIIa in a biological specimen. | Factor VIIa Activity Measurement | ||
| Factor VIII | C81961 | Anti-hemophilic Factor;Factor VIII | A measurement of the factor VIII in a biological specimen. | Factor VIII Measurement | ||
| Factor VIII Activity | C103399 | Anti-hemophilic Factor Activity | A measurement of the biological activity of factor VIII in a biological specimen. | Factor VIII Activity Measurement | ||
| Factor X | C98727 | Factor X | A measurement of the factor X in a biological specimen. | Factor X Measurement | ||
| Factor XIII | C112277 | Factor XIII;Fibrin Stablizing Factor | A measurement of the factor XIII in a biological specimen. | Factor XIII Measurement | ||
| Factor XIV | C102272 | Autoprothrombin IIA;Factor XIV;Protein C;Protein C Antigen | A measurement of the factor XIV in a biological specimen. | Factor XIV Measurement | ||
| Factor XIV Activity | C105442 | Factor XIV Activity;Protein C Activity;Protein C Function | A measurement of the factor XIV activity in a biological specimen. | Factor XIV Activity Measurement | ||
| Fat | C96648 | Fat | A measurement of the fat in a biological specimen. | Fat Measurement | ||
| Fat Bodies, Oval | C81947 | Fat Bodies, Oval | A measurement of the oval-shaped fat bodies, usually renal proximal tubular cells with lipid aggregates in the cytoplasm, in a biological specimen. | Oval Fat Body Measurement | ||
| Fat Droplet | C98728 | Fat Droplet | A measurement of the triglyceride aggregates within a biological specimen. | Fat Droplet Measurement | ||
| Fatty Acid Binding Protein 1 | C82012 | Fatty Acid Binding Protein 1 | A measurement of the fatty acid binding protein 1 in a biological specimen. | Fatty Acid Binding Protein 1 Measurement | ||
| Fatty Acid Binding Protein 3 | C106521 | Fatty Acid Binding Protein 3 | A measurement of the fatty acid binding protein 3 in a biological specimen. | Fatty Acid Binding Protein 3 Measurement | ||
| Fatty Casts | C74766 | Fatty Casts | A measurement of the fatty casts present in a biological specimen. | Fatty Cast Measurement | ||
| Ferritin | C74737 | Ferritin | A measurement of the ferritin in a biological specimen. | Ferritin Measurement | ||
| Fibrin Degradation Products | C82013 | Fibrin Degradation Products | A measurement of the fibrin degradation products in a biological specimen. | Fibrin Degradation Products Measurement | ||
| Fibrinogen | C64606 | Fibrinogen | A measurement of the fibrinogen in a biological specimen. | Fibrinogen Measurement | ||
| Fibroblast Growth Factor 21 | C112280 | FGF 21;Fibroblast Growth Factor 21 | A measurement of the fibroblast growth factor 21 in a biological specimen. | Fibroblast Growth Factor 21 Measurement | ||
| Fibroblast Growth Factor 23 | C96650 | Fibroblast Growth Factor 23;Phosphatonin | A measurement of the fibroblast growth factor 23 in a biological specimen. | Fibroblast Growth Factor 23 Measurement | ||
| Fibroblast Growth Factor Basic Form | C82014 | FGF2;Fibroblast Growth Factor Basic Form | A measurement of the basic form of fibroblast growth factor in a biological specimen. | Fibroblast Growth Factor Basic Form Measurement | ||
| FibroTest Score | C105443 | FibroSURE Score;FibroTest Score | A biomarker test that measures liver pathology through the assessment of a six-parameter blood test (for Alpha-2-macroglobulin, Haptoglobin, Apolipoprotein A1, Gamma-glutamyl transpeptidase (GGT), Total bilirubin, and Alanine aminotransferase (ALT)), taking into account the age and gender of the patient. | FibroTest Score Measurement | ||
| Follicle Stimulating Hormone | C74783 | Follicle Stimulating Hormone | A measurement of the follicle stimulating hormone (FSH) in a biological specimen. | Follicle Stimulating Hormone Measurement | ||
| Fractional Calcium Excretion | C114219 | Fractional Calcium Excretion | A measurement of the fractional excretion of calcium that is computed based upon the concentrations of calcium and creatinine in both blood and urine. | Fractional Excretion of Calcium | ||
| Fractional Chloride Excretion | C114220 | Fractional Chloride Excretion | A measurement of the fractional excretion of chloride that is computed based upon the concentrations of chloride and creatinine in both blood and urine. | Fractional Excretion of Chloride | ||
| Fractional Phosphorus Excretion | C114221 | Fractional Inorganic Phosphate Excretion;Fractional Phosphorus Excretion | A measurement of the fractional excretion of phosphorus that is computed based upon the concentrations of phosphorus and creatinine in both blood and urine. | Fractional Excretion of Phosphate | ||
| Fractional Potassium Excretion | C114222 | Fractional Potassium Excretion | A measurement of the fractional excretion of potassium that is computed based upon the concentrations of potassium and creatinine in both blood and urine. | Fractional Excretion of Potassium | ||
| Fractional Sodium Excretion | C107435 | Fractional Sodium Excretion | A measurement of the fractional excretion of sodium that is computed based upon the concentrations of sodium and creatinine in both blood and urine. | Fractional Excretion of Sodium | ||
| Free Fatty Acid | C80200 | Free Fatty Acid;Non-Esterified Fatty Acid, Free | A measurement of the total non-esterified fatty acids in a biological specimen. | Non-esterified Fatty Acids Measurement | ||
| Free Fatty Acid, Saturated | C80206 | Free Fatty Acid, Saturated;Non-esterified Fatty Acid, Saturated | A measurement of the saturated non-esterified fatty acids in a biological specimen. | Saturated Non-esterified Fatty Acids Measurement | ||
| Free Fatty Acid, Unsaturated | C80209 | Free Fatty Acid, Unsaturated;Non-esterified Fatty Acid, Unsaturated | A measurement of the unsaturated non-esterified fatty acids in a biological specimen. | Unsaturated Non-esterified Fatty Acids Measurement | ||
| Free Glycerol | C100448 | Free Glycerin;Free Glycerol | A measurement of the amount of unbound glycerol in a biological specimen. | Free Glycerol Measurement | ||
| Fructosamine | C74678 | Fructosamine;Glycated Serum Protein | A measurement of the fructosamine in a biological specimen. | Fructosamine Measurement | ||
| Galanin | C80182 | Galanin | A measurement of the galanin in a biological specimen. | Galanin Measurement | ||
| Gamma Globulin | C92257 | Gamma Globulin | A measurement of the proteins contributing to the gamma fraction in a biological specimen. | Gamma Globulin Measurement | ||
| Gamma Globulin/Total Protein | C92295 | Gamma Globulin/Total Protein | A relative measurement (ratio or percentage) of gamma fraction proteins to total proteins in a biological specimen. | Gamma Globulin to Total Protein Ratio Measurement | ||
| Gamma Glutamyl Transferase | C64847 | Gamma Glutamyl Transferase | A measurement of the gamma glutamyl transferase in a biological specimen. | Gamma Glutamyl Transpeptidase Measurement | ||
| Gamma Glutamyl Transferase/Creatinine | C79446 | Gamma Glutamyl Transferase/Creatinine | A relative measurement (ratio or percentage) of the gamma glutamyl transferase to creatinine in a biological specimen. | Gamma Glutamyl Transferase to Creatinine Ratio Measurement | ||
| Gamma Tocopherol | C116211 | Gamma Tocopherol | A measurement of the gamma tocopherol in a biological specimen. | Gamma Tocopherol Measurement | ||
| Gastrin | C74858 | Gastrin | A measurement of the gastrin hormone in a biological specimen. | Gastrin Measurement | ||
| GFR from B-2 Microglobulin Adj for BSA | C100450 | GFR from B-2 Microglobulin Adj for BSA | A measurement of the glomerular filtration rate (GFR) based on the clearance of beta-2 microglobulin after adjusting it for the body surface area. | Glomerular Filtration Rate from B-2 Microglobulin Adjusted for BSA Measurement | ||
| GFR from Beta-Trace Protein Adj for BSA | C100449 | GFR from Beta-Trace Protein Adj for BSA | A measurement of the glomerular filtration rate (GFR) based on the clearance of beta-trace protein after adjusting it for the body surface area. | Glomerular Filtration Rate from Beta-Trace Protein Adjusted for BSA Measurement | ||
| GFR from Creatinine Adjusted for BSA | C98735 | GFR from Creatinine Adjusted for BSA | An estimation of the glomerular filtration rate adjusted for body size based on creatinine. | Glomerular Filtration Rate from Creatinine Adjusted for BSA | ||
| GFR from Cystatin C Adjusted for BSA | C98736 | GFR from Cystatin C Adjusted for BSA | An estimation of the glomerular filtration rate adjusted for body size based on cystatin C. | Glomerular Filtration Rate from Cystatin C Adjusted for BSA | ||
| Ghrelin | C112286 | Ghrelin;Growth Hormone Secretagogue Receptor Ligand;Motilin-related Peptide;Total Ghrelin | A measurement of total ghrelin in a biological specimen. | Ghrelin Measurement | ||
| Giant Neutrophils | C96651 | Giant Neutrophils | A measurement of the giant neutrophils in a biological specimen. | Giant Neutrophil Count | ||
| Giant Platelets | C74728 | Giant Platelets | A measurement of the giant (larger than 7um in diameter) platelets in a biological specimen. | Giant Platelet Count | ||
| Globulin | C74738 | Globulin | A measurement of the globulin protein in a biological specimen. | Globulin Protein Measurement | ||
| Glomerular Filtration Rate | C90505 | Glomerular Filtration Rate | A kidney function test that measures the fluid volume that is filtered from the kidney glomeruli to the Bowman's capsule per unit of time. | Glomerular Filtration Rate | ||
| Glomerular Filtration Rate Adj for BSA | C98734 | Glomerular Filtration Rate Adj for BSA | A measurement of the glomerular filtration rate adjusted for body size. | Glomerular Filtration Rate Adjusted for BSA | ||
| Glucagon | C74859 | Glucagon | A measurement of the glucagon hormone in a biological specimen. | Glucagon Measurement | ||
| Glucagon-Like Peptide-1 | C80183 | Glucagon-Like Peptide-1;Total Glucagon-Like Peptide-1 | A measurement of the total glucagon-like peptide-1 in a biological specimen. | Glucagon-like Peptide-1 Measurement | ||
| Glucagon-Like Peptide-1, Active Form | C80164 | Glucagon-Like Peptide-1, Active Form | A measurement of the active form of glucagon-like peptide-1 in a biological specimen. | Active Glucagon-like Peptide-1 Measurement | ||
| Glucose | C105585 | Glucose | A measurement of the glucose in a biological specimen. | Glucose Measurement | ||
| Glucose Clearance | C96652 | Glucose Clearance | A measurement of the volume of serum or plasma that would be cleared of glucose by excretion of urine for a specified unit of time (e.g. one minute). | Glucose Clearance Measurement | ||
| Glucose Excretion Rate | C117834 | Glucose Excretion Rate | A measurement of the amount of glucose being excreted in urine over a defined amount of time (e.g. one hour). | Glucose Urine Excretion Rate | ||
| Glucose-6-Phosphate Dehydrogenase | C80184 | Glucose-6-Phosphate Dehydrogenase | A measurement of the glucose-6-phosphate dehydrogenase in a biological specimen. | Glucose-6-Phosphate Dehydrogenase Measurement | ||
| Glucose-dep Insulinotropic Pep, Intact | C106537 | Glucose-dep Insulinotropic Pep, Intact;Intact GIP;Intact Gastric Inhibitory Polypeptide;Intact Glucose-dependent Insulinotropic Peptide | A measurement of the intact (containing amino acids 1-42) glucose-dependent insulinotropic peptide in a biological specimen. | Intact Glucose-dependent Insulinotropic Peptide Measurement | ||
| Glucose/Creatinine | C79447 | Glucose/Creatinine | A relative measurement (ratio or percentage) of the glucose to creatinine in a biological specimen. | Glucose to Creatinine Ratio Measurement | ||
| Glucuronidase, Alpha | C80165 | Glucuronidase, Alpha | A measurement of the alpha glucuronidase in a biological specimen. | Alpha Glucuronidase Measurement | ||
| Glucuronidase, Beta | C80170 | Glucuronidase, Beta | A measurement of the beta glucuronidase in a biological specimen. | Beta Glucuronidase Measurement | ||
| Glutamate | C74739 | Glutamate;Glutamic Acid | A measurement of the glutamate in a biological specimen. | Glutamate Measurement | ||
| Glutamate Dehydrogenase | C79448 | Glutamate Dehydrogenase | A measurement of the glutamate dehydrogenase in a biological specimen. | Glutamate Dehydrogenase Measurement | ||
| Glutamic Acid Decarboxylase 1 | C82015 | Glutamic Acid Decarboxylase 1;Glutamic Acid Decarboxylase 67 | A measurement of the glutamic acid decarboxylase 1 in a biological specimen. | Glutamic Acid Decarboxylase 1 Measurement | ||
| Glutamic Acid Decarboxylase 2 | C82016 | Glutamic Acid Decarboxylase 2;Glutamic Acid Decarboxylase 65 | A measurement of the glutamic acid decarboxylase 2 in a biological specimen. | Glutamic Acid Decarboxylase 2 Measurement | ||
| Glutamic Acid Decarboxylase 2 Antibody | C82017 | Glutamic Acid Decarboxylase 2 Antibody;Glutamic Acid Decarboxylase 65 Antibody | A measurement of the glutamic acid decarboxylase 2 antibody in a biological specimen. | Glutamic Acid Decarboxylase 2 Antibody Measurement | ||
| Glutamic Acid Decarboxylase Antibody | C96653 | GAD Antibody;Glutamic Acid Decarboxylase Antibody | A measurement of the glutamic acid decarboxylase antibody in a biological specimen. | Glutamic Acid Decarboxylase Antibody Measurement | ||
| Glutathione S-Transferase, Alpha/Creat | C80166 | Glutathione S-Transferase, Alpha/Creat | A relative measurement (ratio or percentage) of the alpha glutathione-S-transferase to creatinine in a biological specimen. | Alpha Glutathione-S-Transferase to Creatinine Ratio Measurement | ||
| Glutathione S-Transferase, Pi | C80203 | Glutathione S-Transferase, Pi | A measurement of the Pi glutathione-s-transferase in a biological specimen. | Pi Glutathione S-Transferase Measurement | ||
| Glutathione S-Transferase, Theta | C80207 | Glutathione S-Transferase, Theta | A measurement of the theta glutathione-s-transferase in a biological specimen. | Theta Glutathione S-Transferase Measurement | ||
| Glutathione S-Transferase, Total | C80185 | Glutathione S-Transferase, Total | A measurement of the total glutathione-s-transferase in a biological specimen. | Glutathione-S-Transferase Measurement | ||
| Glutathione-S-Transferase/Creatinine | C79435 | Glutathione-S-Transferase/Creatinine | A relative measurement (ratio or percentage) of the glutathione S-transferase to creatinine in a biological specimen. | Glutathione-S-Transferase to Creatinine Ratio Measurement | ||
| Gold | C80186 | Gold | A measurement of the gold in a biological specimen. | Gold Measurement | ||
| Gonadotropin Releasing Hormone | C74860 | Gonadotropin Releasing Hormone;Luteinising Hormone Releasing Hormone | A measurement of the gonadotropin releasing hormone in a biological specimen. | Gonadotropin Releasing Hormone Measurement | ||
| Granular Casts | C74768 | Granular Casts | A measurement of the granular (coarse and fine) casts present in a biological specimen. | Granular Cast Measurement | ||
| Granular Coarse Casts | C74765 | Granular Coarse Casts | A measurement of the coarse granular casts present in a biological specimen. | Coarse Granular Cast Measurement | ||
| Granular Fine Casts | C74769 | Granular Fine Casts | A measurement of the fine granular casts present in a biological specimen. | Granular Fine Cast Measurement | ||
| Granulocyte Colony Stimulating Factor | C82018 | Granulocyte Colony Stimulating Factor | A measurement of the granulocyte colony stimulating factor in a biological specimen. | Granulocyte Colony Stimulating Factor Measurement | ||
| Granulocyte Macrophage Colony Stm Factor | C82019 | Granulocyte Macrophage Colony Stm Factor | A measurement of the granulocyte macrophage colony stimulating factor in a biological specimen. | Granulocyte Macrophage Colony Stm Factor Measurement | ||
| Granulocytes | C96654 | Granulocytes | A measurement of the granulocytes in a biological specimen. | Granulocyte Count | ||
| Granulocytes/Total Cells | C98866 | Granulocytes/Total Cells | A relative measurement (ratio or percentage) of the granulocytes to total cells in a biological specimen (for example a bone marrow specimen). | Granulocyte to Total Cell Ratio Measurement | ||
| Growth Hormone Inhibiting Hormone | C74861 | Growth Hormone Inhibiting Hormone;Somatostatin | A measurement of the growth hormone inhibiting hormone in a biological specimen. | Growth Hormone Inhibiting Hormone Measurement | ||
| Growth Hormone Releasing Hormone | C74862 | Growth Hormone Releasing Hormone;Somatocrinin | A measurement of the growth hormone releasing hormone in a biological specimen. | Growth Hormone Releasing Hormone Measurement | ||
| Hairy Cells | C74604 | Hairy Cells | A measurement of the hairy cells (b-cell lymphocytes with hairy projections from the cytoplasm) in a biological specimen. | Hairy Cell Count | ||
| Hairy Cells/Lymphocytes | C74640 | Hairy Cells/Lymphocytes | A relative measurement (ratio or percentage) of the hairy cells (b-cell lymphocytes with hairy projections from the cytoplasm) to all lymphocytes in a biological specimen . | Hairy Cell to Lymphocyte Ratio Measurement | ||
| Haptoglobin | C74740 | Haptoglobin | A measurement of the haptoglobin protein in a biological specimen. | Haptoglobin Protein Measurement | ||
| HAV Viral Load | C92541 | HAV Viral Load | A measurement of the hepatitis A viral load in a biological specimen. | Hepatitis A Viral Load Measurement | ||
| HBV Viral Load | C92542 | HBV Viral Load | A measurement of the hepatitis B viral load in a biological specimen. | Hepatitis B Viral Load Measurement | ||
| HCT Corrected Reticulocytes/Erythrocytes | C102274 | HCT Corrected Reticulocytes/Erythrocytes | A relative measurement (ratio or percentage) of the hematocrit corrected reticulocytes to erythrocytes in a biological specimen. | Hematocrit Corrected Reticulocytes to Erythrocytes Ratio Measurement | ||
| HCV Viral Load | C92543 | HCV RNA;HCV Viral Load;Hepatitis C RNA | A measurement of the hepatitis C viral load in a biological specimen. | Hepatitis C Viral Load Measurement | ||
| HDL Cholesterol | C105587 | HDL Cholesterol | A measurement of the high density lipoprotein cholesterol in a biological specimen. | High Density Lipoprotein Cholesterol Measurement | ||
| HDL Cholesterol/LDL Cholesterol Ratio | C100425 | HDL Cholesterol/LDL Cholesterol Ratio | A relative measurement (ratio or percentage) of the amount of HDL cholesterol compared to LDL cholesterol in a biological specimen. | HDL Cholesterol to LDL Cholesterol Ratio Measurement | ||
| HDL Particle Size | C103402 | HDL Particle Size | A measurement of the average particle size of high-density lipoprotein in a biological specimen. | HDL Particle Size Measurement | ||
| HDL-Cholesterol Subclass 2 | C80187 | HDL-Cholesterol Subclass 2 | A measurement of the high-density lipoprotein (HDL) cholesterol subclass 2 in a biological specimen. | HDL-Cholesterol Subclass 2 Measurement | ||
| HDL-Cholesterol Subclass 3 | C80188 | HDL-Cholesterol Subclass 3 | A measurement of the high-density lipoprotein (HDL) cholesterol subclass 3 in a biological specimen. | HDL-Cholesterol Subclass 3 Measurement | ||
| Heinz Bodies | C74709 | Heinz Bodies;Heinz-Erhlich Bodies | A measurement of the Heinz bodies (small round inclusions within the body of a red blood cell) in a biological specimen. | Heinz-Ehrlich Body Measurement | ||
| Heinz Bodies/Erythrocytes | C111206 | Heinz Bodies/Erythrocytes | A relative measurement (ratio or percentage) of the erythrocytes that contain heinz bodies to total erythrocytes in a biological specimen. | Heinz Body to Erythrocyte Ratio Measurement | ||
| Helicobacter pylori IgG Antibody | C103403 | Helicobacter pylori IgG Antibody | A measurement of the Helicobacter pylori IgG antibody in a biological specimen. | Helicobacter pylori IgG Antibody Measurement | ||
| Helmet Cells | C74658 | Helmet Cells | A measurement of the Helmet cells (specialized Keratocytes with two projections on either end that are tapered and hornlike) in a biological specimen. | Helmet Cell Count | ||
| Hematocrit | C64796 | EVF;Erythrocyte Volume Fraction;Hematocrit;PCV;Packed Cell Volume | The percentage of a whole blood specimen that is composed of red blood cells (erythrocytes). | Hematocrit Measurement | ||
| Hematocrit Corrected Reticulocytes | C102273 | Hematocrit Corrected Reticulocytes | A measurement of the hematocrit corrected reticulocytes in a biological specimen. | Hematocrit Corrected Reticulocyte Count | ||
| Hemoglobin | C64848 | FHGB;Free Hemoglobin;Hemoglobin | A measurement of the non-cellular hemoglobin in a biological specimen. | Hemoglobin Measurement | ||
| Hemoglobin A | C92258 | Hemoglobin A | A measurement of the hemoglobin A in a biological specimen. | Hemoglobin A Measurement | ||
| Hemoglobin A1C | C64849 | Glycosylated Hemoglobin;Hemoglobin A1C | A measurement of the glycosylated hemoglobin in a biological specimen. | Glycosylated Hemoglobin Measurement | ||
| Hemoglobin A1C/Hemoglobin | C111207 | Hemoglobin A1C/Hemoglobin | A relative measurement (ratio or percentage) of the glycosylated hemoglobin to total hemoglobin in a biological specimen. | Hemoglobin A1C to Hemoglobin Ratio Measurement | ||
| Hemoglobin A2 | C92259 | Hemoglobin A2 | A measurement of the hemoglobin A2 in a biological specimen. | Hemoglobin A2 Measurement | ||
| Hemoglobin B | C92260 | Hemoglobin B | A measurement of the hemoglobin B in a biological specimen. | Hemoglobin B Measurement | ||
| Hemoglobin C | C92261 | Hemoglobin C | A measurement of the hemoglobin C in a biological specimen. | Hemoglobin C Measurement | ||
| Hemoglobin C Crystals | C112288 | Hemoglobin C Crystals | A measurement of hemoglobin C crystals in a biological specimen. | Hemoglobin C Crystals Measurement | ||
| Hemoglobin Distribution Width | C106525 | Hemoglobin Distribution Width | A measurement of the distribution of the hemoglobin concentration in red blood cells. | Hemoglobin Distribution Width Measurement | ||
| Hemoglobin F | C92262 | Fetal Hemoglobin;Hemoglobin F | A measurement of the hemoglobin F in a biological specimen. | Hemoglobin F Measurement | ||
| Hemolytic Index | C111208 | Hemolysis;Hemolytic Index | A measurement of the destruction of red blood cells in a biological specimen. | Hemolytic Index | ||
| Hemosiderin | C96659 | Hemosiderin | A measurement of the hemosiderin complex in a biological specimen. | Hemosiderin Measurement | ||
| Hepatitis A Virus Antibody | C92534 | Hepatitis A Virus Antibody | A measurement of the antibody reaction of a biological specimen to the Hepatitis A virus. | Hepatitis A Antibody Measurement | ||
| Hepatitis A Virus Antibody IgM | C92271 | Hepatitis A Virus Antibody IgM | A measurement of hepatitis A virus antibody IgM in a biological specimen. | Hepatitis A Virus Antibody IgM Measurement | ||
| Hepatitis B DNA | C103404 | Hepatitis B DNA | A measurement of hepatitis B virus DNA in a biological specimen. | Hepatitis B DNA Measurement | ||
| Hepatitis B Virus Core Antibody | C96660 | Hepatitis B Virus Core Antibody | A measurement of the hepatitis B virus core antibody in a biological specimen. | Hepatitis B Virus Core Antibody Measurement | ||
| Hepatitis B Virus Core IgG Antibody | C119280 | Hepatitis B Virus Core IgG Antibody | A measurement of the hepatitis B virus core IgG antibody in a biological specimen. | Hepatitis B Virus Core IgG Antibody Measurement | ||
| Hepatitis B Virus Core IgM Antibody | C96661 | Hepatitis B Virus Core IgM Antibody | A measurement of the hepatitis B virus core IgM antibody in a biological specimen. | Hepatitis B Virus Core IgM Antibody Measurement | ||
| Hepatitis B Virus e Antibody | C96662 | Hepatitis B Virus e Antibody | A measurement of the hepatitis B e antibody in a biological specimen. | Hepatitis B Virus e Antibody Measurement | ||
| Hepatitis B Virus e Antigen | C96663 | Hepatitis B Virus e Antigen | A measurement of the hepatitis B e antigen in a biological specimen. | Hepatitis B Virus e Antigen Measurement | ||
| Hepatitis B Virus Surface Antibody | C74711 | Anti-HBs;HBsAb;Hepatitis B Virus Surface Antibody | A measurement of the surface antibody reaction of a biological specimen to the Hepatitis B virus. | Hepatitis B Surface Antibody Measurement | ||
| Hepatitis B Virus Surface Antigen | C64850 | HBsAg;Hepatitis B Virus Surface Antigen | A measurement of the surface antigen reaction of a biological specimen to the Hepatitis B virus. | Hepatitis B Virus Surface Antigen Measurement | ||
| Hepatitis C Virus Antibody | C92535 | Hepatitis C Virus Antibody | A measurement of the antibody reaction of a biological specimen to the Hepatitis C virus. | Hepatitis C Antibody Measurement | ||
| Hepatitis C Virus Antigen | C116196 | Hepatitis C Virus Antigen | A measurement of the hepatitis C virus antigen in a biological specimen. | Hepatitis C Virus Antigen Measurement | ||
| Hepatitis D Virus Antibody | C96664 | Hepatitis D Virus Antibody;Hepatitis Delta Antibody | A measurement of the hepatitis D virus antibody in a biological specimen. | Hepatitis D Virus Antibody Measurement | ||
| Hepatitis D Virus IgG Antibody | C119281 | Hepatitis D Virus IgG Antibody | A measurement of the hepatitis D virus IgG antibody in a biological specimen. | Hepatitis D Virus IgG Antibody Measurement | ||
| Hepatitis D Virus IgM Antibody | C119282 | Hepatitis D Virus IgM Antibody | A measurement of the hepatitis D virus IgM antibody in a biological specimen. | Hepatitis D Virus IgM Antibody Measurement | ||
| Hepatitis E Virus Antibody | C119283 | Hepatitis E Virus Antibody | A measurement of the antibody reaction of a biological specimen to the Hepatitis E virus. | Hepatitis E Virus Antibody Measurement | ||
| Hepatitis E Virus IgG Antibody | C106526 | Hepatitis E Virus IgG Antibody | A measurement of IgG antibody to the hepatitis E virus in a biological specimen. | Hepatitis E Virus IgG Antibody Measurement | ||
| Hepatitis E Virus IgM Antibody | C96665 | Hepatitis E Virus IgM Antibody | A measurement of the hepatitis E virus IgM antibody in a biological specimen. | Hepatitis E Virus IgM Antibody Measurement | ||
| Hepatitis G RNA | C92272 | Hepatitis G RNA | A measurement of the Hepatitis G RNA in a biological specimen. | Hepatitis G RNA Measurement | ||
| HER2 Antigen | C112291 | HER2 Antigen;HER2/NEU Antigen | A measurement of the HER2 antigen in a biological specimen. | HER2 Antigen Measurement | ||
| Herpes Simplex Virus 1 IgG Antibody | C96666 | HSV-1 IgG Antibody;Herpes Simplex Virus 1 IgG Antibody | A measurement of the herpes simplex virus 1 IgG antibody in a biological specimen. | Herpes Simplex Virus 1 IgG Antibody Measurement | ||
| Herpes Simplex Virus 1 IgM Antibody | C98738 | Herpes Simplex Virus 1 IgM Antibody | A measurement of the Herpes Simplex virus 1 IgM antibodies in a biological specimen. | Herpes Simplex Virus 1 IgM Antibody Measurement | ||
| Herpes Simplex Virus 1/2 IgG Antibody | C96697 | HSV-1/2 IgG Ab;Herpes Simplex Virus 1/2 IgG Antibody | A measurement of the herpes simplex virus 1 and 2 IgG antibody in a biological specimen. | Herpes Simplex Virus 1/2 IgG Antibody Measurement | ||
| Herpes Simplex Virus 1/2 IgM Antibody | C96698 | HSV-1/2 IgM Ab;Herpes Simplex Virus 1/2 IgM Antibody | A measurement of the herpes simplex virus 1 and 2 IgM antibody in a biological specimen. | Herpes Simplex Virus 1/2 IgM Antibody Measurement | ||
| Herpes Simplex Virus 2 IgG Antibody | C96667 | HSV-2 IgG Antibody;Herpes Simplex Virus 2 IgG Antibody | A measurement of the herpes simplex virus 2 IgG antibody in a biological specimen. | Herpes Simplex Virus 2 IgG Antibody Measurement | ||
| Herpes Simplex Virus 2 IgM Antibody | C98739 | Herpes Simplex Virus 2 IgM Antibody | A measurement of the Herpes Simplex virus 2 IgM antibodies in a biological specimen. | Herpes Simplex Virus 2 IgM Antibody Measurement | ||
| Herpes Simplex Virus 6 Antibody | C112292 | Herpes Simplex Virus 6 Antibody | A measurement of the herpes simplex virus 6 antibody in a biological specimen. | Herpes Simplex Virus 6 Antibody Measurement | ||
| Heterophile Antibodies | C81984 | Heterophile Antibodies | A measurement of the heterophile antibodies in a biological specimen. | Heterophile Antibody Measurement | ||
| Heterophils | C116186 | Heterophils | A measurement of heterophils (granular leukocytes) in a biological specimen from avian species. | Heterophil Measurement | ||
| Heterophils/Leukocytes | C116187 | Heterophils/Leukocytes | A relative measurement (ratio or percentage) of heterophils to leukocytes in a biological specimen from avian species. | Heterophils to Leukocytes Ratio Measurement | ||
| Hexokinase | C96668 | Hexokinase | A measurement of the hexokinase in a biological specimen. | Hexokinase Measurement | ||
| High Absorption Retic/Reticulocytes | C116189 | High Absorption Retic/Reticulocytes | A relative measurement (ratio or percentage) of the high absorption reticulocytes to total reticulocytes in a biological specimen. | High Absorption Reticulocytes to Total Reticulocytes Ratio Measurement | ||
| High Absorption Reticulocytes | C116188 | High Absorption Reticulocytes | A measurement of the high absorption reticulocytes in a biological specimen. | High Absorption Reticulocyte Measurement | ||
| Hippuric Acid Crystals | C74754 | Hippuric Acid Crystals | A measurement of the hippuric acid crystals present in a biological specimen. | Hippuric Acid Crystal Measurement | ||
| Histamine | C80189 | Histamine | A measurement of the histamine in a biological specimen. | Histamine Measurement | ||
| Histone 1 Antibody | C112293 | Histone 1 Antibody | A measurement of the total histone 1 antibodies in a biological specimen. | Histone 1 Antibody Measurement | ||
| Histone 2A Antibody | C112294 | Histone 2A Antibody | A measurement of the total histone 2A antibodies in a biological specimen. | Histone 2A Antibody Measurement | ||
| Histone 2B Antibody | C112295 | Histone 2B Antibody | A measurement of the total histone 2B antibodies in a biological specimen. | Histone 2B Antibody Measurement | ||
| Histone 3 Antibody | C112296 | Histone 3 Antibody | A measurement of the total histone 3 antibodies in a biological specimen. | Histone 3 Antibody Measurement | ||
| Histone 4 Antibody | C112297 | Histone 4 Antibody | A measurement of the total histone 4 antibodies in a biological specimen. | Histone 4 Antibody Measurement | ||
| Histone Antibodies | C111209 | Anti-Histone Antibodies;Histone Antibodies | A measurement of histone antibodies in a biological specimen. | Histone Antibody Measurement | ||
| HIV Antibody | C106527 | HIV Antibody | A measurement of the antibody reaction of a biological specimen to the HIV virus. | HIV Antibody Measurement | ||
| HIV Viral Load | C92544 | HIV Viral Load | A measurement of the HIV viral load in a biological specimen. | HIV Viral Load Measurement | ||
| HIV-1 Antibody | C74713 | HIV-1 Antibody | A measurement of the antibody reaction of a biological specimen to the HIV-1 virus. | HIV-1 Antibody Measurement | ||
| HIV-1 Group M and O Nucleic Acid | C92263 | HIV-1 Group M and O Nucleic Acid | A measurement of the HIV-1 group M and O nucleic acids in a biological specimen. | HIV-1 Group M and O Nucleic Acid Measurement | ||
| HIV-1 Group O Antibody | C92264 | HIV-1 Group O Antibody | A measurement of the HIV-1 group O antibody in a biological specimen. | HIV-1 Group O Antibody Measurement | ||
| HIV-1 p24 Antigen | C92265 | HIV-1 p24 Antigen | A measurement of the HIV-1 p24 antigen in a biological specimen. | HIV-1 p24 Antigen Measurement | ||
| HIV-1/2 Antibody | C74714 | HIV-1/2 Antibody | A measurement of the antibody reaction of a biological specimen to the either the HIV-1 or HIV-2 virus. | HIV-1 HIV-2 Antibody Measurement | ||
| HIV-2 Antibody | C74715 | HIV-2 Antibody | A measurement of the antibody reaction of a biological specimen to the HIV-2 virus. | HIV-2 Antibody Measurement | ||
| HIV-2 Nucleic Acid | C92266 | HIV-2 Nucleic Acid | A measurement of the HIV-2 nucleic acids in a biological specimen. | HIV-2 Nucleic Acid Measurement | ||
| HLA-B27 Antigen | C100460 | HLA-B27 Antigen;Human Leukocyte Antigen B27 | A measurement of the human leukocyte antigen B27 (HLA-B27) in a biological specimen. | HLA-B27 Antigen Measurement | ||
| Homocysteine | C74741 | Homocysteine | A measurement of the homocysteine amino acid in a biological specimen. | Homocysteine Acid Measurement | ||
| Homostat Model Assess of Insulin Rstn | C100447 | Homeostatic Model Assessment of Insulin Resistance;Homostat Model Assess of Insulin Rstn | An assessment of beta-cell function and insulin resistance based on fasting blood glucose and insulin concentrations. | Homeostatic Model Assessment of Insulin Resistance | ||
| Homovanillic Acid | C74863 | Homovanillic Acid | A measurement of the homovanillic acid metabolite in a biological specimen. | Homovanillic Acid Measurement | ||
| Howell-Jolly Bodies | C74704 | Howell-Jolly Bodies | A measurement of the Howell-Jolly bodies (spherical, blue-black condensed DNA inclusions within the body of a red blood cell that appear under Wright-stain) in a biological specimen. | Howell-Jolly Body Measurement | ||
| Human Albumin Antibody | C103405 | Human Albumin Antibody | A measurement of the human albumin antibody in a biological specimen. | Human Albumin Antibody Measurement | ||
| Human Anti-Mouse Antibody | C103406 | HAMA | A measurement of the human anti-mouse antibody in a biological specimen. | Human Anti-Mouse Antibody Measurement | ||
| Human Anti-Sheep IgE Antibody | C98740 | Human Anti-Sheep IgE Antibody | A measurement of the human anti-sheep IgE antibodies in a biological specimen. | Human Anti-Sheep IgE Antibody Measurement | ||
| Human Anti-Sheep IgG Antibody | C98741 | Human Anti-Sheep IgG Antibody | A measurement of the human anti-sheep IgG antibodies in a biological specimen. | Human Anti-Sheep IgG Antibody Measurement | ||
| Human Anti-Sheep IgM Antibody | C98742 | Human Anti-Sheep IgM Antibody | A measurement of the human anti-sheep IgM antibodies in a biological specimen. | Human Anti-Sheep IgM Antibody Measurement | ||
| Human Epidermal Growth Factor Receptor 2 | C112312 | ERBB2;HER2/NEU;Human Epidermal Growth Factor Receptor 2 | A measurement of the cells with positive expression of HER2 in a biological specimen. | Human Epidermal Growth Factor Receptor 2 Measurement | ||
| Hyaline Casts | C74770 | Hyaline Casts | A measurement of the hyaline casts present in a biological specimen. | Hyaline Cast Measurement | ||
| Hyaluronic Acid | C112319 | Hyaluronic Acid | A measurement of hyaluronic acid in a biological specimen. | Hyaluronic Acid Measurement | ||
| Hydrocodone | C74879 | Hydrocodone | A measurement of the hydrocodone present in a biological specimen. | Hydrocodone Measurement | ||
| Hydrogen | C102275 | Hydrogen | A measurement of the hydrogen in a biological specimen. | Hydrogen Measurement | ||
| Hydromorphone | C74880 | Hydromorphone | A measurement of the hydromorphone present in a biological specimen. | Hydromorphone Measurement | ||
| Hydroxyproline | C80190 | Hydroxyproline | A measurement of the total hydroxyproline in a biological specimen. | Hydroxyproline Measurement | ||
| Hyperchromia | C96669 | Hyperchromia | A measurement of the prevalence of the erthrocytes with an elevated hemoglobin concentration. | Hyperchromia Measurement | ||
| Hypersegmented Cells | C74612 | Hypersegmented Cells | A measurement of the hypersegmented (more than five lobes) neutrophils in a biological specimen. | Hypersegmented Neutrophil Measurement | ||
| Hypochromia | C64802 | Hypochromia | An observation which indicates that the hemoglobin concentration in a red blood cell specimen has fallen below a specified level. | Hypochromia | ||
| Hypogranular Neutrophils | C116201 | Hypogranular Neutrophils | A measurement of the hypogranular neutrophils in a biological specimen. | Hypogranular Neutrophil Measurement | ||
| Icteric Index | C111232 | Icteric Index;Icterus | A measurement of the yellow color of a biological specimen, due to the presence of bile pigments. | Icteric Index | ||
| IDL Cholesterol | C112325 | IDL Cholesterol;Intermediate Density Lipoprotein | A measurement of the intermediate density lipoprotein in a biological specimen. | Intermediate Density Lipoprotein Cholesterol Measurement | ||
| IDL Particles | C116197 | IDL Particles;Intermediate Density Lipoproteins Particles | A measurement of the concentration of IDL particles in a biological specimen. | IDL Particles Measurement | ||
| IgG IgM IgA Total | C111233 | IgG IgM IgA Total | A measurement of the total IgG, IgM, and IgA in a biological specimen. | IgG IgM IgA Total Measurement | ||
| Immature Basophils | C96670 | Immature Basophils | A measurement of the immature basophils in a biological specimen. | Immature Basophil Count | ||
| Immature Basophils/Leukocytes | C96671 | Immature Basophils/Leukocytes | A relative measurement (ratio or percentage) of immature basophils to total leukocytes in a biological specimen. | Immature Basophil to Leukocyte Ratio Measurement | ||
| Immature Cells | C96672 | Immature Cells | A measurement of the total immature cells in a blood specimen. | Immature Cell Count | ||
| Immature Cells/Total Cells | C111234 | Immature Cells/Total Cells | A relative measurement (ratio or percentage) of the immature hematopoietic cells to total cells in a biological specimen. | Immature Cell to Total Cell Ratio Measurement | ||
| Immature Eosinophils | C96673 | Immature Eosinophils | A measurement of the immature eosinophils in a biological specimen. | Immature Eosinophil Count | ||
| Immature Eosinophils/Leukocytes | C96674 | Immature Eosinophils/Leukocytes | A relative measurement (ratio or percentage) of immature eosinophils to total leukocytes in a biological specimen. | Immature Eosinophil to Leukocyte Ratio Measurement | ||
| Immature Granulocytes | C96675 | Immature Granulocytes | A measurement of the total immature granulocytes in a biological specimen. | Immature Granulocyte Count | ||
| Immature Granulocytes/Leukocytes | C100445 | Immature Granulocytes/Leukocytes | A relative measurement (ratio or percentage) of the immature granulocytes to leukocytes in a biological specimen (for example a bone marrow specimen). | Immature Granulocytes to Leukocytes Ratio Measurement | ||
| Immature Lymphocytes | C100444 | Immature Lymphocytes | A measurement of the immature lymphocytes in a biological specimen. | Immature Lymphocytes Measurement | ||
| Immature Lymphocytes/Leukocytes | C100443 | Immature Lymphocytes/Leukocytes | A relative measurement (ratio or percentage) of the immature lymphocytes to leukocytes in a biological specimen. | Immature Lymphocytes to Leukocytes Ratio Measurement | ||
| Immature Monocytes | C96676 | Immature Monocytes | A measurement of the immature monocytes in a biological specimen. | Immature Monocyte Count | ||
| Immature Monocytes/Leukocytes | C96677 | Immature Monocytes/Leukocytes | A relative measurement (ratio or percentage) of immature monocytes to total leukocytes in a biological specimen. | Immature Monocyte to Leukocyte Ratio Measurement | ||
| Immature Neutrophils | C96678 | Immature Neutrophils | A measurement of the total immature neutrophils in a biological specimen. | Immature Neutrophil Count | ||
| Immature Neutrophils/Leukocytes | C100442 | Immature Neutrophils/Leukocytes | A relative measurement (ratio or percentage) of the immature neutrophils to leukocytes in a biological specimen. | Immature Neutrophils to Leukocytes Ratio Measurement | ||
| Immature Plasma Cells | C96679 | Immature Plasma Cells | A measurement of the immature plasma cells in a biological specimen. | Immature Plasma Cell Count | ||
| Immature Plasma Cells/Lymphocytes | C96680 | Immature Plasma Cells/Lymphocytes | A relative measurement (ratio or percentage) of immature plasma cells to total lymphocytes in a biological specimen. | Immature Plasma Cell to Lymphocyte Ratio Measurement | ||
| Immature Reticulocyte Fraction | C102276 | Immature Reticulocyte Fraction | A measurement of the immature reticulocyte fraction present in a biological specimen. | Immature Reticulocyte Fraction Measurement | ||
| Immunoblasts | C103407 | Lymphocytes, Immunoblastic | A measurement of the immunoblasts in a biological specimen. | Immunoblast Count | ||
| Immunoblasts/Lymphocytes | C106535 | Immunoblasts/Lymphocytes;Lymphocytes, Immunoblastic/Lymphocytes | A relative measurement (ratio or percentage) of immunoblasts to all lymphocytes present in a sample. | Immunoblasts to Lymphocytes Ratio Measurement | ||
| Immunoglobulin A | C81969 | Immunoglobulin A | A measurement of the Immunoglobulin A in a biological specimen. | Immunoglobulin A Measurement | ||
| Immunoglobulin D | C98745 | Immunoglobulin D | A measurement of the Immunoglobulin D in a biological specimen. | Immunoglobulin D Measurement | ||
| Immunoglobulin E | C81970 | Immunoglobulin E | A measurement of the Immunoglobulin E in a biological specimen. | Immunoglobulin E Measurement | ||
| Immunoglobulin G | C81971 | Immunoglobulin G | A measurement of the Immunoglobulin G in a biological specimen. | Immunoglobulin G Measurement | ||
| Immunoglobulin G/Creatinine | C119285 | Immunoglobulin G/Creatinine | A relative measurement (ratio or percentage) of the immunoglobulin G to creatinine in a biological specimen. | Immunoglobulin G to Creatinine Ratio Measurement | ||
| Immunoglobulin M | C81972 | Immunoglobulin M | A measurement of the Immunoglobulin M in a biological specimen. | Immunoglobulin M Measurement | ||
| Inclusion Bodies | C116184 | Inclusion Bodies | A measurement of the inclusion bodies in a biological specimen. | Inclusion Body Measurement | ||
| Indican | C82044 | Indican | A measurement of the indican present in a biological specimen. | Indican Measurement | ||
| Indirect Bilirubin | C64483 | Indirect Bilirubin | A measurement of the unconjugated or non-water-soluble bilirubin in a biological specimen. | Indirect Bilirubin Measurement | ||
| Influenza A H1N1 Viral Load | C92273 | Influenza A H1N1 Viral Load | A measurement of the Influenza A H1N1 viral load in a biological specimen. | Influenza A H1N1 Viral Load Measurement | ||
| Influenza A IgG Antibody | C103408 | Influenza A IgG Antibody | A measurement of the Influenza A IgG antibody in a biological specimen. | Influenza A IgG Antibody Measurement | ||
| Influenza A Viral Load | C92274 | Influenza A Viral Load | A measurement of the Influenza A viral load in a biological specimen. | Influenza A Viral Load Measurement | ||
| Influenza B IgG Antibody | C103409 | Influenza B IgG Antibody | A measurement of the Influenza B IgG antibody in a biological specimen. | Influenza B IgG Antibody Measurement | ||
| Inhibin A | C82020 | Inhibin A | A measurement of the inhibin A in a biological specimen. | Inhibin A Measurement | ||
| Inhibin B | C96681 | Inhibin B | A measurement of the inhibin B in a biological specimen. | Inhibin B Measurement | ||
| Insulin | C74788 | Insulin | A measurement of the insulin in a biological specimen. | Insulin Measurement | ||
| Insulin Antibody | C119287 | Insulin Antibody | A measurement of the antibody to therapeutic insulin in a biological specimen. | Insulin Antibody Measurement | ||
| Insulin Autoantibody | C119286 | Insulin Autoantibody | A measurement of the antibody to endogenous insulin in a biological specimen. | Insulin Autoantibody Measurement | ||
| Insulin-Like Growth Factor Binding Prot3 | C112322 | Insulin-Like Growth Factor Binding Prot3;Insulin-Like Growth Factor Binding Protein 3 | A measurement of the insulin-like growth factor binding protein 3 in a biological specimen. | Insulin-Like Growth Factor Binding Protein 3 Measurement | ||
| Insulin-like Growth Factor-1 | C74864 | Insulin-like Growth Factor-1 | A measurement of the insulin-like growth factor-1 in a biological specimen. | Insulin Like Growth Factor-1 Measurement | ||
| Insulin-like Growth Factor-2 | C74865 | Insulin-like Growth Factor-2 | A measurement of the insulin-like growth factor-2 in a biological specimen. | Insulin Like Growth Factor-2 Measurement | ||
| Insulinoma-Associated Protein 2 Antibody | C119284 | Insulinoma-Associated Protein 2 Antibody | A measurement of the insulinoma-associated protein 2 antibody in a biological specimen. | Insulinoma-Associated Protein 2 Antibody Measurement | ||
| Interferon Alpha | C81994 | Interferon Alpha | A measurement of the interferon alpha in a biological specimen. | Interferon Alpha Measurement | ||
| Interferon Beta | C81995 | Interferon Beta | A measurement of the interferon beta in a biological specimen. | Interferon Beta Measurement | ||
| Interferon Gamma | C81996 | Interferon Gamma | A measurement of the interferon gamma in a biological specimen. | Interferon Gamma Measurement | ||
| Interleukin 1 | C74805 | Interleukin 1 | A measurement of the interleukin 1 in a biological specimen. | Interleukin 1 Measurement | ||
| Interleukin 1 Beta | C112323 | IL-1B;IL1Beta;Interleukin 1 Beta;Interleukin 1B | A measurement of interleukin 1 beta in a biological specimen. | Interleukin 1 Beta Measurement | ||
| Interleukin 1 Receptor Antagonist | C112324 | IL-1RA;Interleukin 1 Receptor Antagonist | A measurement of the interleukin 1 receptor antagonist in a biological specimen. | Interleukin 1 Receptor Antagonist Measurement | ||
| Interleukin 10 | C74806 | Interleukin 10 | A measurement of the interleukin 10 in a biological specimen. | Interleukin 10 Measurement | ||
| Interleukin 11 | C74807 | Interleukin 11 | A measurement of the interleukin 11 in a biological specimen. | Interleukin 11 Measurement | ||
| Interleukin 12 | C74808 | Interleukin 12 | A measurement of the interleukin 12 in a biological specimen. | Interleukin 12 Measurement | ||
| Interleukin 13 | C74809 | Interleukin 13 | A measurement of the interleukin 13 in a biological specimen. | Interleukin 13 Measurement | ||
| Interleukin 14 | C74810 | Interleukin 14 | A measurement of the interleukin 14 in a biological specimen. | Interleukin 14 Measurement | ||
| Interleukin 15 | C74811 | Interleukin 15 | A measurement of the interleukin 15 in a biological specimen. | Interleukin 15 Measurement | ||
| Interleukin 16 | C74812 | Interleukin 16 | A measurement of the interleukin 16 in a biological specimen. | Interleukin 16 Measurement | ||
| Interleukin 17 | C74813 | Interleukin 17 | A measurement of the interleukin 17 in a biological specimen. | Interleukin 17 Measurement | ||
| Interleukin 18 | C74814 | Interleukin 18 | A measurement of the interleukin 18 in a biological specimen. | Interleukin 18 Measurement | ||
| Interleukin 19 | C74815 | Interleukin 19 | A measurement of the interleukin 19 in a biological specimen. | Interleukin 19 Measurement | ||
| Interleukin 2 | C74816 | Interleukin 2 | A measurement of the interleukin 2 in a biological specimen. | Interleukin 2 Measurement | ||
| Interleukin 20 | C74817 | Interleukin 20 | A measurement of the interleukin 20 in a biological specimen. | Interleukin 20 Measurement | ||
| Interleukin 21 | C74818 | Interleukin 21 | A measurement of the interleukin 21 in a biological specimen. | Interleukin 21 Measurement | ||
| Interleukin 22 | C74819 | Interleukin 22 | A measurement of the interleukin 22 in a biological specimen. | Interleukin 22 Measurement | ||
| Interleukin 23 | C74820 | Interleukin 23 | A measurement of the interleukin 23 in a biological specimen. | Interleukin 23 Measurement | ||
| Interleukin 24 | C74821 | Interleukin 24 | A measurement of the interleukin 24 in a biological specimen. | Interleukin 24 Measurement | ||
| Interleukin 25 | C74822 | Interleukin 25 | A measurement of the interleukin 25 in a biological specimen. | Interleukin 25 Measurement | ||
| Interleukin 26 | C74823 | Interleukin 26 | A measurement of the interleukin 26 in a biological specimen. | Interleukin 26 Measurement | ||
| Interleukin 27 | C74824 | Interleukin 27 | A measurement of the interleukin 27 in a biological specimen. | Interleukin 27 Measurement | ||
| Interleukin 28 | C74825 | Interleukin 28 | A measurement of the interleukin 28 in a biological specimen. | Interleukin 28 Measurement | ||
| Interleukin 29 | C74826 | Interleukin 29 | A measurement of the interleukin 29 in a biological specimen. | Interleukin 29 Measurement | ||
| Interleukin 3 | C74827 | Interleukin 3 | A measurement of the interleukin 3 in a biological specimen. | Interleukin 3 Measurement | ||
| Interleukin 30 | C74828 | Interleukin 30 | A measurement of the interleukin 30 in a biological specimen. | Interleukin 30 Measurement | ||
| Interleukin 31 | C74829 | Interleukin 31 | A measurement of the interleukin 31 in a biological specimen. | Interleukin 31 Measurement | ||
| Interleukin 32 | C74830 | Interleukin 32 | A measurement of the interleukin 32 in a biological specimen. | Interleukin 32 Measurement | ||
| Interleukin 33 | C74831 | Interleukin 33 | A measurement of the interleukin 33 in a biological specimen. | Interleukin 33 Measurement | ||
| Interleukin 4 | C74832 | Interleukin 4 | A measurement of the interleukin 4 in a biological specimen. | Interleukin 4 Measurement | ||
| Interleukin 5 | C74833 | Interleukin 5 | A measurement of the interleukin 5 in a biological specimen. | Interleukin 5 Measurement | ||
| Interleukin 6 | C74834 | Interleukin 6 | A measurement of the interleukin 6 in a biological specimen. | Interleukin 6 Measurement | ||
| Interleukin 7 | C74835 | Interleukin 7 | A measurement of the interleukin 7 in a biological specimen. | Interleukin 7 Measurement | ||
| Interleukin 8 | C74836 | Interleukin 8 | A measurement of the interleukin 8 in a biological specimen. | Interleukin 8 Measurement | ||
| Interleukin 9 | C74837 | Interleukin 9 | A measurement of the interleukin 9 in a biological specimen. | Interleukin 9 Measurement | ||
| Intestinal Specific Alkaline Phosphatase | C119266 | Intestinal Specific Alkaline Phosphatase | A measurement of the intestinal specific alkaline phosphatase isoform in a biological specimen. | Intestinal Specific Alkaline Phosphatase Measurement | ||
| Inulin Clearance | C98748 | Inulin Clearance | A measurement of the volume of serum or plasma that would be cleared of inulin by excretion of urine for a specified unit of time (e.g. one minute). | Inulin Clearance | ||
| Iohexol Clearance | C100439 | Iohexol Clearance | A measurement of the volume of serum or plasma that would be cleared of Iohexol through excretion for a specified unit of time. | Iohexol Clearance | ||
| Iothalamate Clearance | C98749 | Iothalamate Clearance | A measurement of the volume of serum or plasma that would be cleared of iothalamate by excretion of urine for a specified unit of time (e.g. one minute). | Iothalamate Clearance | ||
| Iothalamate Clearance Adjusted for BSA | C98750 | Iothalamate Clearance Adjusted for BSA | A measurement of the volume of serum or plasma that would be cleared of iothalamate by excretion of urine for a specified unit of time (e.g. one minute), adjusted for body size. | Iothalamate Clearance Adjusted for BSA | ||
| Iron | C74679 | FE;Iron | A measurement of the iron in a biological specimen. | Iron Measurement | ||
| Iron Excretion Rate | C117838 | Iron Excretion Rate | A measurement of the amount of iron being excreted in urine over a defined amount of time (e.g. one hour). | Iron Urine Excretion Rate | ||
| Islet Cell 512 Antibody | C81985 | Islet Cell 512 Antibody | A measurement of the islet cell 512 antibody in a biological specimen. | Islet Cell 512 Antibody Measurement | ||
| Islet Cell 512 Antigen | C81986 | Islet Cell 512 Antigen | A measurement of the islet cell 512 antigen in a biological specimen. | Islet Cell 512 Antigen Measurement | ||
| Islet Neogenesis Assoc Protein Antibody | C81987 | Islet Neogenesis Assoc Protein Antibody | A measurement of the islet neogenesis associated protein antibody in a biological specimen. | Islet Neogenesis Associated Protein Antibody Measurement | ||
| Isoleucine | C103410 | Isoleucine | A measurement of the isoleucine in a biological specimen. | Isoleucine Measurement | ||
| JC Virus Antibody | C112326 | JC Polyomavirus Antibody;JC Virus Antibody;JCV Antibody;John Cunningham Virus Antibody | A measurement of the JC virus antibody in a biological specimen. | JC Virus Antibody Measurement | ||
| Jo-1 Antibody | C100459 | Jo-1 Antibody | A measurement of the Jo-1 antibody in a biological specimen. | Jo-1 Antibody Measurement | ||
| Kappa Light Chain, Free | C98730 | Kappa Light Chain, Free | A measurement of the free kappa light chain in a biological specimen. | Free Kappa Light Chain Measurement | ||
| Kappa Lt Chain,Free/Lambda Lt Chain,Free | C98731 | Kappa Lt Chain,Free/Lambda Lt Chain,Free | A relative measurement (ratio or percentage) of the free kappa light chain to the free lambda light chain in a biological specimen. | Free Kappa Light Chain to Free Lambda Light Chain Ratio Measurement | ||
| Ketone Bodies | C111239 | Ketone Bodies | A measurement of the ketone bodies (acetone, acetoacetic acid, beta-hydroxybutyric acid, beta-ketopentanoate and beta-hydroxypentanoate) in a biological specimen. | Ketone Body Measurement | ||
| Ketones | C64854 | Ketones | A measurement of the ketones in a biological specimen. | Ketone Measurement | ||
| Kidney Injury Molecule-1 | C100433 | Hepatitis A Virus Cellular Receptor 1;KIM-1;Kidney Injury Molecule-1 | A measurement of the kidney injury molecule-1 (Kim-1) in a biological specimen. | Kidney Injury Molecule-1 Measurement | ||
| Kurloff Cells | C96682 | Kurloff Cells | A measurement of the large secretory granule-containing immune cells in a biological specimen taken from members of certain genera of the Caviidae family. | Kurloff Cells Measurement | ||
| Lactate Dehydrogenase | C64855 | Lactate Dehydrogenase | A measurement of the lactate dehydrogenase in a biological specimen. | Lactate Dehydrogenase Measurement | ||
| Lactate Dehydrogenase/Creatinine | C79449 | Lactate Dehydrogenase/Creatinine | A relative measurement (ratio or percentage) of the lactate dehydrogenase to creatinine in a biological specimen. | Lactate Dehydrogenase to Creatinine Ratio Measurement | ||
| Lactic Acid | C79450 | 2-hydroxypropanoic acid;Lactate;Lactic Acid | A measurement of the lactic acid in a biological specimen. | Lactic Acid Measurement | ||
| Lactoferrin | C82021 | Lactoferrin;Lactotransferrin | A measurement of the lactoferrin in a biological specimen. | Lactoferrin Measurement | ||
| Lambda Light Chain, Free | C98732 | Lambda Light Chain, Free | A measurement of the free lambda light chain in a biological specimen. | Free Lambda Light Chain Measurement | ||
| Large Platelets | C74729 | Large Platelets | A measurement of the large (between 4 um and 7um in diameter) platelets in a biological specimen. | Large Platelet Count | ||
| Large Unstained Cells | C74659 | Large Unstained Cells | A measurement of the large, peroxidase-negative cells which cannot be further characterized (i.e. as large lymphocytes, virocytes, or stem cells) present in a biological specimen. | Large Unstained Cell Count | ||
| Large Unstained Cells/Leukocytes | C79467 | Large Unstained Cells/Leukocytes | A relative measure (ratio or percentage) of the large unstained cells to leukocytes in a biological specimen. | Large Unstained Cells to Leukocytes Ratio Measurement | ||
| LDH Isoenzyme 1 | C74887 | LDH Isoenzyme 1 | A measurement of the lactate dehydrogenase isoenzyme 1 in a biological specimen. | Lactate Dehydrogenase Isoenzyme 1 Measurement | ||
| LDH Isoenzyme 1/LDH | C79451 | LDH Isoenzyme 1/LDH | A relative measurement (ratio or percentage) of the lactate dehydrogenase isoenzyme 1 to total lactate dehydrogenase in a biological specimen. | LDH Isoenzyme 1 to LDH Ratio Measurement | ||
| LDH Isoenzyme 2 | C74888 | LDH Isoenzyme 2 | A measurement of the lactate dehydrogenase isoenzyme 2 in a biological specimen. | Lactate Dehydrogenase Isoenzyme 2 Measurement | ||
| LDH Isoenzyme 2/LDH | C79452 | LDH Isoenzyme 2/LDH | A relative measurement (ratio or percentage) of the lactate dehydrogenase isoenzyme 2 to total lactate dehydrogenase in a biological specimen. | LDH Isoenzyme 2 to LDH Ratio Measurement | ||
| LDH Isoenzyme 3 | C74889 | LDH Isoenzyme 3 | A measurement of the lactate dehydrogenase isoenzyme 3 in a biological specimen. | Lactate Dehydrogenase Isoenzyme 3 Measurement | ||
| LDH Isoenzyme 3/LDH | C79453 | LDH Isoenzyme 3/LDH | A relative measurement (ratio or percentage) of the lactate dehydrogenase isoenzyme 3 to total lactate dehydrogenase in a biological specimen. | LDH Isoenzyme 3 to LDH Ratio Measurement | ||
| LDH Isoenzyme 4 | C74890 | LDH Isoenzyme 4 | A measurement of the lactate dehydrogenase isoenzyme 4 in a biological specimen. | Lactate Dehydrogenase Isoenzyme 4 Measurement | ||
| LDH Isoenzyme 4/LDH | C79454 | LDH Isoenzyme 4/LDH | A relative measurement (ratio or percentage) of the lactate dehydrogenase isoenzyme 4 to total lactate dehydrogenase in a biological specimen. | LDH Isoenzyme 4 to LDH Ratio Measurement | ||
| LDH Isoenzyme 5 | C74891 | LDH Isoenzyme 5 | A measurement of the lactate dehydrogenase isoenzyme 5 in a biological specimen. | Lactate Dehydrogenase Isoenzyme 5 Measurement | ||
| LDH Isoenzyme 5/LDH | C79455 | LDH Isoenzyme 5/LDH | A relative measurement (ratio or percentage) of the lactate dehydrogenase isoenzyme 5 to total lactate dehydrogenase in a biological specimen. | LDH Isoenzyme 5 to LDH Ratio Measurement | ||
| LDL Cholesterol | C105588 | LDL Cholesterol | A measurement of the low density lipoprotein cholesterol in a biological specimen. | Low Density Lipoprotein Cholesterol Measurement | ||
| LDL Particle Size | C103412 | LDL Particle Size | A measurement of the average particle size of low-density lipoprotein in a biological specimen. | LDL Particle Size Measurement | ||
| Left Shift Neutrophils | C116202 | Left Shift Neutrophils | An observation of the above normal incidence of immature neutrophils, including band neutrophils and neutrophil precursors in a biological specimen. | Left Shift Neutrophil Measurement | ||
| Legionella pneumophila Antigen | C92275 | Legionella pneumophila Antigen | A measurement of the Legionella pneumophila antigen in a biological specimen. | Legionella pneumophila Antigen Measurement | ||
| Legionella pneumophila IgG Antibody | C92276 | Legionella pneumophila IgG Antibody | A measurement of the Legionella pneumophila IgG antibody in a biological specimen. | Legionella pneumophila IgG Antibody Measurement | ||
| Legionella pneumophila IgG IgM Antibody | C92277 | Legionella pneumophila IgG IgM Antibody | A measurement of the Legionella pneumophila IgG and IgM in a biological specimen. | Legionella pneumophila IgG IgM Antibody Measurement | ||
| Legionella pneumophila IgM Antibody | C92278 | Legionella pneumophila IgM Antibody | A measurement of the Legionella pneumophila IgM antibody in a biological specimen. | Legionella pneumophila IgM Antibody Measurement | ||
| Leptin | C74866 | Leptin | A measurement of the leptin hormone in a biological specimen. | Leptin Measurement | ||
| Leucine Crystals | C74680 | Leucine Crystals | A measurement of the leucine crystals present in a biological specimen. | Leucine Crystal Measurement | ||
| Leukemic Blasts | C74630 | Leukemic Blasts | A measurement of the leukemic blasts (lymphoblasts that remain in an immature state even when outside the bone marrow) in a biological specimen. | Leukemic Blast Count | ||
| Leukemic Blasts/Lymphocytes | C74641 | Leukemic Blasts/Lymphocytes | A relative measurement (ratio or percentage) of the leukemic blasts (immature lymphoblasts) to mature lymphocytes in a biological specimen. | Leukemic Blast to Lymphocyte Ratio Measurement | ||
| Leukemic Cells | C116195 | Leukemic Cells;Residual Leukemic Cells | A measurement of the leukemic cells in a biological specimen. | Leukemic Cells Measurement | ||
| Leukocyte Cell Clumps | C92246 | Leukocyte Cell Clumps;WBC Clumps;White Blood Cell Clumps | A measurement of white blood cell clumps in a biological specimen. | Leukocyte Cell Clumps Measurement | ||
| Leukocyte Cell Morphology | C92297 | Leukocyte Cell Morphology;WBC Morphology;White Blood Cell Morphology | An examination or assessment of the form and structure of white blood cells. | Leukocyte Cell Morphology | ||
| Leukocyte Esterase | C64856 | Leukocyte Esterase | A measurement of the enzyme which indicates the presence of white blood cells in a biological specimen. | Leukocyte Esterase Measurement | ||
| Leukocytes | C51948 | Leukocytes;White Blood Cells | A measurement of the leukocytes in a biological specimen. | Leukocyte Count | ||
| Leukotriene B4 | C103413 | Leukotriene B4 | A measurement of the leukotriene B4 in a biological specimen. | Leukotriene B4 Measurement | ||
| Leukotriene D4 | C103414 | Leukotriene D4 | A measurement of the leukotriene D4 in a biological specimen. | Leukotriene D4 Measurement | ||
| Leukotriene E4 | C103415 | Leukotriene E4 | A measurement of the leukotriene E4 in a biological specimen. | Leukotriene E4 Measurement | ||
| Lipase | C117748 | Lipase;Total Lipase | A measurement of the total lipase in a biological specimen. | Lipase Measurement | ||
| Lipase, Gastric | C117840 | Gastric Triacylglycerol Lipase;LIPF;Lipase, Gastric | A measurement of the gastric triacylglycerol lipase in a biological specimen. | Gastric Lipase Measurement | ||
| Lipase, Lysosomal Acid | C117842 | Acid Cholesteryl Ester Hydrolase;LAL;LIPA;Lipase, Lysosomal Acid;Lysosomal Lipase | A measurement of the lysosomal acid lipase in a biological specimen. | Lysosomal Acid Lipase Measurement | ||
| Lipase, Pancreatic | C117841 | Lipase, Pancreatic;PNLIP;Pancreatic Triacylglycerol Lipase | A measurement of the pancreatic triacylglycerol lipase in a biological specimen. | Pancreatic Lipase Measurement | ||
| Lipemic Index | C111242 | Lipemia;Lipemic Index | A measurement of the abnormally high concentration of lipid in a biological specimen. | Lipemic Index | ||
| Lipocalin-2 | C106539 | Lipocalin-2 | A measurement of lipocalin-2 in a biological specimen. | Lipocalin-2 Measurement | ||
| Lipocalin-2/Creatinine | C106540 | Lipocalin-2/Creatinine | A relative measurement (ratio or percentage) of the lipocalin-2 to creatinine present in a sample. | Lipocalin-2 to Creatinine Ratio Measurement | ||
| Lipoprotein-a | C82022 | Lipoprotein-a | A measurement of the lipoprotein-a in a biological specimen. | Lipoprotein a Measurement | ||
| Liver Kidney Microsomal Type 1 Antibody | C96683 | LKM-1;Liver Kidney Microsomal Type 1 Antibody | A measurement of the liver kidney microsomal type 1 antibody in a biological specimen. | Liver Kidney Microsomal Type 1 Antibody Measurement | ||
| Liver Kidney Microsomal Type 1 IgA Ab | C100456 | Liver Kidney Microsomal Type 1 IgA Ab | A measurement of the liver kidney microsomal type 1 IgA antibodies in a biological specimen. | Liver Kidney Microsomal Type 1 IgA Antibody Measurement | ||
| Liver Kidney Microsomal Type 1 IgG Ab | C100454 | Liver Kidney Microsomal Type 1 IgG Ab | A measurement of the liver kidney microsomal type 1 IgG antibodies in a biological specimen. | Liver Kidney Microsomal Type 1 IgG Antibody Measurement | ||
| Liver Kidney Microsomal Type 1 IgM Ab | C100455 | Liver Kidney Microsomal Type 1 IgM Ab | A measurement of the liver kidney microsomal type 1 IgM antibodies in a biological specimen. | Liver Kidney Microsomal Type 1 IgM Antibody Measurement | ||
| Liver Specific Alkaline Phosphatase | C119267 | Liver Specific Alkaline Phosphatase | A measurement of the liver specific alkaline phosphatase isoform in a biological specimen. | Liver Specific Alkaline Phosphatase Measurement | ||
| Low Absorption Retic/Reticulocytes | C116191 | Low Absorption Retic/Reticulocytes | A relative measurement (ratio or percentage) of the low absorption reticulocytes to total reticulocytes in a biological specimen. | Low Absorption Reticulocytes to Total Reticulocytes Ratio Measurement | ||
| Low Absorption Reticulocytes | C116190 | Low Absorption Reticulocytes | A measurement of the low absorption reticulocytes in a biological specimen. | Low Absorption Reticulocyte Measurement | ||
| Lupus Anticoagulant Sensitive APTT | C102277 | APTT-LA;Lupus Anticoagulant Sensitive APTT | A measurement of the length of time that it takes for clotting to occur when a lupus sensitive reagent is added to a plasma specimen. | Lupus Anticoagulant Sensitive APTT Measurement | ||
| Luteinizing Hormone | C74790 | Luteinizing Hormone | A measurement of the luteinizing hormone in a biological specimen. | Luteinizing Hormone Measurement | ||
| Lymphoblasts | C102278 | Lymphoblasts | A measurement of the lymphoblasts (immature cells that differentiate to form lymphocytes) in a biological specimen. | Lymphoblast Count | ||
| Lymphoblasts/Leukocytes | C105444 | Lymphoblasts/Leukocytes | A relative measurement (ratio or percentage) of the lymphoblasts to leukocytes in a biological specimen. | Lymphoblast to Leukocyte Ratio Measurement | ||
| Lymphocytes | C51949 | Lymphocytes | A measurement of the lymphocytes in a biological specimen. | Lymphocyte Count | ||
| Lymphocytes Activated | C119289 | Lymphocytes Activated | A measurement of the total activated lymphocytes in a biological specimen. | Activated Lymphocytes Measurement | ||
| Lymphocytes Atypical | C64818 | Lymphocytes Atypical | A measurement of the atypical lymphocytes in a biological specimen. | Atypical Lymphocyte Count | ||
| Lymphocytes Atypical/Leukocytes | C64819 | Lymphocytes Atypical/Leukocytes | A relative measurement (ratio or percentage) of the atypical lymphocytes to leukocytes in a biological specimen. | Atypical Lymphocyte to Leukocyte Ratio | ||
| Lymphocytes/Leukocytes | C64820 | Lymphocytes/Leukocytes | A relative measurement (ratio or percentage) of the lymphocytes to leukocytes in a biological specimen. | Lymphocyte to Leukocyte Ratio | ||
| Lymphocytes/Total Cells | C98751 | Lymphocytes/Total Cells | A relative measurement (ratio or percentage) of the lymphocytes to total cells in a biological specimen (for example a bone marrow specimen). | Lymphocyte to Total Cell Ratio Measurement | ||
| Lymphoma Cells | C74613 | Lymphoma Cells | A measurement of the malignant lymphocytes in a biological specimen. | Lymphoma Cell Count | ||
| Lymphoma Cells/Lymphocytes | C74910 | Lymphoma Cells/Lymphocytes | A relative measurement (ratio or percentage) of the malignant lymphocytes to all lymphocytes in a biological specimen. | Lymphoma Cell to Lymphocyte Ratio Measurement | ||
| Lymphotactin | C81955 | Chemokine Ligand 1;Lymphotactin | A measurement of the lymphotactin in a biological specimen. | Lymphotactin Measurement | ||
| Lysergic Acid Diethylamide | C75354 | Acid;Lysergic Acid Diethylamide | A measurement of the lysergic acid diethylamine (LSD) in a biological specimen. | Lysergide Measurement | ||
| M. tuberculosis IFN Gamma Response | C92241 | Mycobacterium tuberculosis IFN Gamma Response | A measurement of the amount of interferon gamma that is released when Mycobacterium tuberculosis antigen is incubated with a biological specimen, usually blood. Increased amounts of interferon gamma suggests a prior or existing M. tuberculosis infection. | Mycobacterium tuberculosis Interferon Gamma Response | ||
| Macroamylase | C111243 | Macroamylase | A measurement of macroamylase in a biological specimen. | Macroamylase Measurement | ||
| Macrocytes | C64821 | Macrocytes | A measurement of the macrocytes in a biological specimen. | Macrocyte Count | ||
| Macrophage Colony Stimulating Factor | C80191 | Macrophage Colony Stimulating Factor | A measurement of the macrophage colony stimulating factor in a biological specimen. | Macrophage Colony Stimulating Factor Measurement | ||
| Macrophage Inflammatory Protein 1 Alpha | C82023 | Chemokine Ligand 3;Macrophage Inflammatory Protein 1 Alpha | A measurement of the macrophage inflammatory protein 1 alpha in a biological specimen. | Macrophage Inflammatory Protein 1 Alpha Measurement | ||
| Macrophage Inflammatory Protein 1 Beta | C82024 | Chemokine Ligand 4;Macrophage Inflammatory Protein 1 Beta | A measurement of the macrophage inflammatory protein 1 beta in a biological specimen. | Macrophage Inflammatory Protein 1 Beta Measurement | ||
| Macrophage-Derived Chemokine | C81956 | Chemokine Ligand 22;Macrophage-Derived Chemokine | A measurement of the macrophage-derived chemokine in a biological specimen. | Macrophage-Derived Chemokine Measurement | ||
| Macrophages | C74798 | Macrophages | A measurement of the macrophages in a biological specimen. | Macrophage Count | ||
| Macrophages/Total Cells | C111244 | Macrophages/Total Cells | A relative measurement (ratio or percentage) of the macrophages to total cells in a biological specimen. | Macrophage to Total Cell Ratio Measurement | ||
| Magnesium | C64840 | Magnesium | A measurement of the magnesium in a biological specimen. | Magnesium Measurement | ||
| Magnesium/Creatinine | C79456 | Magnesium/Creatinine | A relative measurement (ratio or percentage) of the magnesium to creatinine in a biological specimen. | Magnesium to Creatinine Ratio Measurement | ||
| Malignant Cells, NOS | C74660 | Malignant Cells, NOS | A measurement of the malignant cells of all types in a biological specimen. | Malignant Cell Count | ||
| Malignant Cells, NOS/Blood Cells | C74643 | Malignant Cells, NOS/Blood Cells | A relative measurement (ratio or percentage) of the malignant cells of all types to all blood cells in a biological specimen. | Malignant Cell to Blood Cell Ratio Measurement | ||
| Mast Cells | C111246 | Mast Cells;Mastocytes | A measurement of the mast cells in a biological specimen. | Mast Cell Count | ||
| Mast Cells/Total Cells | C111247 | Mast Cells/Total Cells | A relative measurement (ratio or percentage) of the mast cells to total cells in a biological specimen. | Mast Cell to Total Cell Ratio Measurement | ||
| Matrix Metalloproteinase 1 | C80192 | Interstitial Collagenase;Matrix Metalloproteinase 1 | A measurement of the matrix metalloproteinase 1 in a biological specimen. | Matrix Metalloproteinase 1 Measurement | ||
| Matrix Metalloproteinase 2 | C80193 | Gelatinase A;Matrix Metalloproteinase 2 | A measurement of the matrix metalloproteinase 2 in a biological specimen. | Matrix Metalloproteinase 2 Measurement | ||
| Matrix Metalloproteinase 3 | C80194 | Matrix Metalloproteinase 3;Stromelysin 1 | A measurement of the matrix metalloproteinase 3 in a biological specimen. | Matrix Metalloproteinase 3 Measurement | ||
| Matrix Metalloproteinase 7 | C80195 | Matrilysin;Matrix Metalloproteinase 7 | A measurement of the matrix metalloproteinase 7 in a biological specimen. | Matrix Metalloproteinase 7 Measurement | ||
| Matrix Metalloproteinase 8 | C80196 | Matrix Metalloproteinase 8;Neutrophil Collagenase | A measurement of the matrix metalloproteinase 8 in a biological specimen. | Matrix Metalloproteinase 8 Measurement | ||
| Matrix Metalloproteinase 9 | C80197 | Gelatinase B;Matrix Metalloproteinase 9 | A measurement of the matrix metalloproteinase 9 in a biological specimen. | Matrix Metalloproteinase 9 Measurement | ||
| Mature Plasma Cells | C74661 | Mature Plasma Cells;Plasmacytes | A measurement of the mature plasma cells (plasmacytes) in a biological specimen. | Mature Plasma Cell Count | ||
| Mature Plasma Cells/Lymphocytes | C74911 | Mature Plasma Cells/Lymphocytes | A relative measurement (ratio or percentage) of the mature plasma cells (plasmacytes) to all lymphocytes in a biological specimen. | Mature Plasma Cell to Lymphocyte Ratio Measurement | ||
| May-Hegglin Anomaly | C74614 | May-Hegglin Anomaly | A measurement of the May-Hegglin anomaly in a blood sample. This anomaly is characterized by large, misshapen platelets and the presence of Dohle bodies in leukocytes. | May-Hegglin Anomaly Measurement | ||
| MCV Reticulocytes | C114215 | MCV Reticulocytes;Mean Corpuscular Volume Reticulocytes | A measurement of the mean volume of reticulocytes in a biological specimen. | Reticulocyte Mean Corpuscular Volume | ||
| Mean Platelet Component | C96686 | Mean Platelet Component | A measurement of the mean platelet component (platelet activity) in a blood specimen. | Mean Platelet Component Measurement | ||
| Mean Platelet Dry Mass | C114214 | Mean Platelet Dry Mass | A measurement of the mean platelet dry mass in a biological specimen. | Mean Platelet Dry Mass | ||
| Mean Platelet Volume | C74730 | Mean Platelet Volume | A measurement of the average size of the platelets present in a blood sample. | Mean Platelet Volume Measurement | ||
| Medium Absorption Retic/Reticulocytes | C116193 | Medium Absorption Retic/Reticulocytes | A relative measurement (ratio or percentage) of the medium absorption reticulocytes to total reticulocytes in a biological specimen. | Medium Absorption Reticulocytes to Total Reticulocytes Ratio Measurement | ||
| Medium Absorption Reticulocytes | C116192 | Medium Absorption Reticulocytes | A measurement of the medium absorption reticulocytes in a biological specimen. | Medium Absorption Reticulocyte Measurement | ||
| Megakaryoblasts | C98752 | Megakaryoblasts | A measurement of the megakaryoblasts in a biological specimen. | Megakaryoblast Cell Count | ||
| Megakaryoblasts/Total Cells | C98753 | Megakaryoblasts/Total Cells | A relative measurement (ratio or percentage) of the megakaryoblasts to total cells in a biological specimen (for example a bone marrow specimen). | Megakaryoblast to Total Cell Ratio Measurement | ||
| Megakaryocytes | C96688 | Megakaryocytes | A measurement of the megakaryocytes per unit of a biological specimen. | Megakaryocyte Count | ||
| Megakaryocytes/Total Cells | C98867 | Megakaryocytes/Total Cells | A relative measurement (ratio or percentage) of the megakaryocytes to total cells in a biological specimen (for example a bone marrow specimen). | Megakaryocyte to Total Cell Ratio Measurement | ||
| Melatonin | C74867 | Melatonin | A measurement of the melatonin hormone in a biological specimen. | Melatonin Measurement | ||
| Meningeal Cells | C111250 | Meningeal Cells | A measurement of the mengingeal cells in a biological specimen. | Meningeal Cell Count | ||
| Meningeal Cells/Total Cells | C111251 | Meningeal Cells/Total Cells | A relative measurement (ratio or percentage) of the meningeal cells to total cells in a biological specimen. | Meningeal Cell to Total Cell Ratio Measurement | ||
| Metamyelocytes | C74615 | Metamyelocytes | A measurement of the metamyelocytes (small, myelocytic neutrophils with an indented nucleus) in a biological specimen. | Metamyelocyte Count | ||
| Metamyelocytes/Leukocytes | C74645 | Metamyelocytes/Leukocytes | A relative measurement (ratio or percentage) of the metamyelocytes (small, myelocytic neutrophils with an indented nucleus) to all leukocytes in a biological specimen. | Metamyelocyte to Leukocyte Ratio Measurement | ||
| Metamyelocytes/Total Cells | C98754 | Metamyelocytes/Total Cells | A relative measurement (ratio or percentage ) of the metamyelocytes (small, myelocytic neutrophils with an indented nucleus) to total cells in a biological specimen (for example a bone marrow specimen). | Metamyelocyte to Total Cell Ratio Measurement | ||
| Metanephrine | C116198 | Metadrenaline;Metanephrine | A measurement of the metanephrine in a biological specimen. | Metanephrine Measurement | ||
| Methadone | C74881 | Methadone | A measurement of the methadone present in a biological specimen. | Methadone Measurement | ||
| Methamphetamine | C75348 | Methamphetamine | A measurement of the methamphetamine drug present in a biological specimen. | Methamphetamine Measurement | ||
| Methaqualone | C74882 | Methaqualone | A measurement of the methaqualone present in a biological specimen. | Methaqualone Measurement | ||
| Methemoglobin | C96689 | Methemoglobin | A measurement of the methemoglobin in a biological specimen. | Methemoglobin Measurement | ||
| Methylmalonic Acid | C96690 | Methylmalonic Acid | A measurement of the methylmalonic acid in a biological specimen. | Methylmalonic Acid Measurement | ||
| Microcytes | C64822 | Microcytes | A measurement of the microcytes in a biological specimen. | Microcyte Count | ||
| Microfilaria | C117843 | Microfilaria | Presence of microfilaria stage of filarial nematodes in smears prepared from whole blood or other body fluids. | Microfilaria Measurement | ||
| Mid Cell Fraction | C116199 | Mid Cell Fraction;Mid Cells | A measurement of the mid cell fraction, including eosinophils, basophils, monocytes and other precursor white blood cells, in a biological specimen. | Mid Cell Fraction Measurement | ||
| Mixed Casts | C74771 | Mixed Casts | A measurement of the mixed (the cast contains a mixture of cell types) casts present in a biological specimen. | Mixed Cast Count | ||
| Mixed Lymphocyte Reaction | C16790 | Mixed Leukocyte Reaction;Mixed Lymphocyte Reaction | A measurement of the histocompatibility at the HL-A locus between two populations of lymphocytes taken from two separate individuals. | Mixed Lymphocyte Reaction Test | ||
| Monoblasts | C74631 | Monoblasts | A measurement of the monoblast cells in a biological specimen. | Monoblast Count | ||
| Monoblasts/Leukocytes | C74646 | Monoblasts/Leukocytes | A relative measurement (ratio or percentage) of the monoblasts to leukocytes in a biological specimen. | Monoblast to Leukocyte Ratio Measurement | ||
| Monoclonal Protein | C92291 | Monoclonal Immunoglobulin Protein;Paraprotein | A measurement of homogenous immunoglobulin resulting from the proliferation of a single clone of plasma cells in a biological specimen. | Monoclonal Protein Measurement | ||
| Monoclonal Protein Spike | C117844 | Monoclonal Protein Spike | A measurement of the monoclonal protein in the region of the electrophoresis field containing a spike (increase) in protein. | Monoclonal Protein Spike Measurement | ||
| Monocyte Chemotactic Protein 1 | C82025 | Monocyte Chemotactic Protein 1 | A measurement of the monocyte chemotactic protein 1 in a biological specimen. | Monocyte Chemotactic Protein 1 Measurement | ||
| Monocytes | C64823 | Monocytes | A measurement of the monocytes in a biological specimen. | Monocyte Count | ||
| Monocytes/Leukocytes | C64824 | Monocytes/Leukocytes | A relative measurement (ratio or percentage) of the monocytes to leukocytes in a biological specimen. | Monocyte to Leukocyte Ratio | ||
| Monocytes/Macrocytes | C106544 | Monocytes/Macrocytes | A relative measurement (ratio or percentage) of the monocytes to macrocytes present in a sample. | Monocytes to Macrocytes Ratio Measurement | ||
| Monocytes/Total Cells | C98872 | Monocytes/Total Cells | A relative measurement (ratio or percentage) of the monocytes to total cells in a biological specimen (for example a bone marrow specimen). | Monocytes to Total Cell Ratio Measurement | ||
| Monocytoid Cells | C111276 | Monocytoid Cells | A measurement of the monocytoid cells in a biological specimen. | Monocytoid Cell Count | ||
| Monocytoid Cells/Total Cells | C111277 | Monocytoid Cells/Total Cells | A relative measurement (ratio or percentage) of the monocytoid cells to total cells in a biological specimen. | Monocytoid Cell to Total Cell Ratio Measurement | ||
| Monosodium Urate Crystals | C74681 | Monosodium Urate Crystals | A measurement of the monosodium urate crystals present in a biological specimen. | Monosodium Urate Crystal Measurement | ||
| Morphine | C74883 | Morphine | A measurement of the morphine present in a biological specimen. | Morphine Measurement | ||
| Mu Glutathione-S-Transferase | C79457 | Mu Glutathione-S-Transferase | A measurement of the mu form of glutathione S-transferase in a biological specimen. | Mu Glutathione-S-Transferase Measurement | ||
| Mu Glutathione-S-Transferase/Creatinine | C79458 | Mu Glutathione-S-Transferase/Creatinine | A relative measurement (ratio or percentage) of the mu gamma glutamyl transpeptidase to creatinine in a biological specimen. | Mu Glutathione-S-Transferase to Creatinine Ratio Measurement | ||
| Mucous Threads | C74721 | Mucous Threads | A measurement of the mucous threads present in a biological specimen. | Mucous Thread Measurement | ||
| Mycobacterium tuberculosis Nucleic Acid | C92279 | Mycobacterium tuberculosis Nucleic Acid | A measurement of the Mycobacterium tuberculosis nucleic acid in a biological specimen. | Mycobacterium tuberculosis Nucleic Acid Measurement | ||
| Myelin Antibodies | C103418 | Myelin Antibodies | A measurement of the myelin antibodies in a biological specimen. | Myelin Antibodies Measurement | ||
| Myeloblasts | C74632 | Myeloblasts | A measurement of the myeloblast cells in a biological specimen. | Myeloblast Count | ||
| Myeloblasts/Leukocytes | C64825 | Myeloblasts/Leukocytes | A relative measurement (ratio or percentage) of the myeloblasts to leukocytes in a biological specimen. | Myeloblast to Leukocyte Ratio | ||
| Myeloblasts/Total Cells | C98761 | Myeloblasts/Total Cells | A relative measurement (ratio or percentage) of the myeloblasts to total cells in a biological specimen (for example a bone marrow specimen). | Myeloblast to Total Cell Ratio Measurement | ||
| Myelocytes | C74662 | Myelocytes | A measurement of the myelocytes in a biological specimen. | Myelocyte Count | ||
| Myelocytes/Leukocytes | C64826 | Myelocytes/Leukocytes | A relative measurement (ratio or percentage) of the myelocytes to leukocytes in a biological specimen. | Myelocyte to Leukocyte Ratio | ||
| Myelocytes/Total Cells | C98868 | Myelocytes/Total Cells | A relative measurement (ratio or percentage) of the myelocytes to total cells in a biological specimen (for example a bone marrow specimen). | Myelocyte to Total Cell Ratio Measurement | ||
| Myeloid/Erythroid Ratio | C92242 | Myeloid/Erythroid Ratio | A relative measurement (ratio or percentage) of myeloid progenitor cells to erythrocyte precursor cells in a biological specimen. | Myeloid to Erythroid Ratio Measurement | ||
| Myeloperoxidase | C80198 | Myeloperoxidase | A measurement of the myeloperoxidase in a biological specimen. | Myeloperoxidase Measurement | ||
| Myeloperoxidase Antibody | C92280 | Myeloperoxidase Antibody | A measurement of the myeloperoxidase antibody in a biological specimen. | Myeloperoxidase Antibody Measurement | ||
| Myeloperoxidase Index | C119290 | Myeloperoxidase Index | The mean peroxidase activity index or staining intensity of the neutrophil population relative to the archetype. | Neutrophil Myeloperoxidase Index | ||
| Myoglobin | C79436 | Myoglobin | A measurement of myoglobin in a biological specimen. | Myoglobin Measurement | ||
| Myoglobin/Creatinine | C106546 | Myoglobin/Creatinine | A relative measurement (ratio or percentage) of the myoglobin to creatinine present in a sample. | Myoglobin to Creatinine Ratio Measurement | ||
| Myosin Light Chain 3 | C106547 | Cardiac myosin light chain 1;Myosin Light Chain 3;Myosin light chain 1, slow-twitch muscle B/ventricular isoform | A measurement of myosin light chain 3 in a biological specimen. | Myosin Light Chain 3 Measurement | ||
| N-Acetyl Glucosamide | C79459 | N-Acetyl Glucosamide;N-Acetyl Glucosamine | A measurement of N-acetyl glucosamide (sugar derivative) in a biological specimen. | N-Acetyl Glucosamide Measurement | ||
| N-Acetyl Glucosamide/Creatinine | C79460 | N-Acetyl Glucosamide/Creatinine | A relative measurement (ratio or percentage) of the N-acetyl glucosamide to creatinine in a biological specimen. | N-Acetyl Glucosamide to Creatinine Ratio Measurement | ||
| N-acetyl-beta-D-glucosaminidase | C103419 | Beta-N-acetyl-D-glucosaminidase | A measurement of the N-acetyl-beta-D-glucosaminidase (enzyme) in a biological specimen. | N-acetyl-beta-D-glucosaminidase Measurement | ||
| N-telopeptide | C74743 | N-telopeptide | A measurement of the N-telopeptide in a biological specimen. | N-Telopeptide Measurement | ||
| N-Terminal ProB-type Natriuretic Peptide | C96610 | N-Terminal ProB-type Natriuretic Peptide;N-terminal pro-Brain Natriuretic Peptide;NT proBNP II | A measurement of the N-terminal proB-type natriuretic peptide in a biological specimen. | N-Terminal ProB-type Natriuretic Peptide Measurement | ||
| Natural Killer Cell Function | C116203 | Natural Killer Cell Activity;Natural Killer Cell Function | A measurement of the natural killer cell function in a biological specimen. | Natural Killer Cell Activity Measurement | ||
| Natural Killer Cells | C98762 | Natural Killer Cells | A measurement of the total natural killer cells in a biological specimen. | Natural Killer Cell Count | ||
| Neisseria gonorrhoeae Screening | C92298 | Neisseria gonorrhoeae Screening | Examination of a biological specimen to detect the presence of Neisseria gonorrhoeae. | Neisseria gonorrhoeae Screening | ||
| Neopterin | C80199 | Neopterin | A measurement of the neopterin in a biological specimen. | Neopterin Measurement | ||
| Neuron Specific Enolase | C116205 | Enolase 2;Gamma-enolase;Neuron Specific Enolase | A measurement of the neuron specific enolase in a biological specimen. | Neuron Specific Enolase Measurement | ||
| Neuropeptide Y | C74892 | Neuropeptide Y | A measurement of the neuropeptide Y in a biological specimen. | Neuropeptide Y Measurement | ||
| Neutrophil Elastase | C82026 | Neutrophil Elastase | A measurement of the neutrophil elastase in a biological specimen. | Neutrophil Elastase Measurement | ||
| Neutrophil Elastase, Polymorphonuclear | C82027 | Neutrophil Elastase, Polymorphonuclear | A measurement of the polymorphonuclear neutrophil elastase in a biological specimen. | Polymorphonuclear Neutrophil Elastase Measurement | ||
| Neutrophilic Metamyelocytes | C84822 | Neutrophilic Metamyelocytes | A measurement of the neutrophilic metamyelocytes in a biological specimen. | Neutrophilic Metamyelocyte Count | ||
| Neutrophilic Myelocytes | C84823 | Neutrophilic Myelocytes | A measurement of the neutrophilic myelocytes in a biological specimen. | Neutrophilic Myelocyte Count | ||
| Neutrophils | C63321 | Neutrophils | A measurement of the neutrophils in a biological specimen. | Absolute Neutrophil Count | ||
| Neutrophils Band Form | C64830 | Neutrophils Band Form | A measurement of the banded neutrophils in a biological specimen. | Neutrophil Band Form Count | ||
| Neutrophils Band Form/Leukocytes | C64831 | Neutrophils Band Form/Leukocytes | A relative measurement (ratio or percentage) of the banded neutrophils to leukocytes in a biological specimen. | Neutrophil Band Form to Leukocyte Ratio | ||
| Neutrophils, Segmented | C81997 | Neutrophils, Segmented | A measurement of the segmented neutrophils in a biological specimen. | Segmented Neutrophil Count | ||
| Neutrophils, Segmented/Leukocytes | C82045 | Neutrophils, Segmented/Leukocytes | A relative measurement (ratio or percentage) of segmented neutrophils to leukocytes in a biological specimen. | Segmented Neutrophil to Leukocyte Ratio Measurement | ||
| Neutrophils/Leukocytes | C64827 | Neutrophils/Leukocytes | A relative measurement (ratio or percentage) of the neutrophils to leukocytes in a biological specimen. | Neutrophil to Leukocyte Ratio | ||
| Neutrophils/Total Cells | C98763 | Neutrophils/Total Cells | A relative measurement (ratio or percentage) of the neutrophils to total cells in a biological specimen (for example a bone marrow specimen). | Neutrophil to Total Cell Ratio Measurement | ||
| Niacin | C74899 | Niacin;Vitamin B3 | A measurement of the niacin in a biological specimen. | Vitamin B3 Measurement | ||
| Nitric Oxide | C112360 | NO;Nitric Oxide | A measurement of the nitric oxide in a biological specimen. | Nitric Oxide Measurement | ||
| Nitrite | C64810 | Nitrite | A measurement of the nitrite in a urine specimen. | Nitrite Measurement | ||
| Non-HDL Cholesterol | C116204 | Non-HDL Cholesterol;Non-High Density Lipoprotein | A measurement of the non-high density lipoprotein cholesterol in a biological specimen. | Non-High Density Lipoprotein Cholesterol Measurement | ||
| Non-Phosphorylated Tau Protein | C84811 | Non-Phosphorylated Tau Protein | A measurement of the non-phosphorylated Tau protein in a biological specimen. | Nonphosphorylated Tau Protein Measurement | ||
| Non-Prostatic Acid Phosphatase | C100434 | Non-Prostatic Acid Phosphatase | A measurement of the non-prostatic acid phosphatase in a biological specimen. | Non-Prostatic Acid Phosphatase Measurement | ||
| Norepinephrine | C74868 | Noradrenaline;Norepinephrine | A measurement of the norepinephrine hormone in a biological specimen. | Noradrenaline Measurement | ||
| Normoblasts/Total Cells | C98764 | Normoblasts/Total Cells | A relative measurement (ratio or percentage) of the normoblasts to total cells in a biological specimen (for example a bone marrow specimen). | Normoblast to Total Cell Ratio Measurement | ||
| Nuclear Swelling | C114213 | Nuclear Swelling | A measurement of the expansion of the nucleus of the cells in a biological specimen. | Nuclear Swelling Measurement | ||
| Nucleated Erythrocytes | C74705 | Nucleated Erythrocytes;Nucleated Red Blood Cells | A measurement of the nucleated erythrocytes (large, immature nucleated erythrocytes) in a biological specimen. | Nucleated Red Blood Cell Count | ||
| Nucleated Erythrocytes/Erythrocytes | C74647 | Nucleated Erythrocytes/Erythrocytes;Nucleated Red Blood Cells/Erythrocytes | A relative measurement (ratio or percentage) of the nucleated erythrocytes (large, immature nucleated erythrocytes) to all erythrocytes in a biological specimen. | Nucleated Red Blood Cell to Erythrocyte Ratio Measurement | ||
| Nucleated Erythrocytes/Leukocytes | C82046 | Nucleated Erythrocytes/Leukocytes | A relative measurement (ratio or percentage) of nucleated erythrocytes to leukocytes in a biological specimen. | Nucleated Erythrocyte to Leukocyte Ratio Measurement | ||
| Occult Blood | C74686 | Occult Blood | A measurement of the blood in body products such as a urine or stool sample, not detectable on gross examination. | Occult Blood Measurement | ||
| Opiate | C74796 | Opiate | A measurement of any opiate class drug present in a biological specimen. | Opiate Measurement | ||
| Osmolality | C74801 | Osmolality | A measurement of the osmoles of solute per unit of biological specimen. | Osmolality Measurement | ||
| Osmolarity | C74802 | Osmolarity | A measurement of the osmoles of solute per liter of solution. | Osmolarity Measurement | ||
| Osteocalcin | C74744 | Osteocalcin | A measurement of the osteocalcin in a biological specimen. | Osteocalcin Measurement | ||
| Osteoprotegerin | C116206 | OCIF;Osteoclastogenesis Inhibitory Factor;Osteoprotegerin;TNFRS11B;Tumor Necrosis Factor Receptor Superfamily Member 11b | A measurement of the osteoprotegerin in a biological specimen. | Osteoprotegerin Measurement | ||
| Ova and Parasite | C100452 | Ova and Parasite | A measurement of the parasites and ova in a biological specimen. | Ova and Parasite Measurement | ||
| Oxalate | C92250 | Ethanedioate;Oxalate | A measurement of the oxalate in a biological specimen. | Oxalate Measurement | ||
| Oxalate/Creatinine | C117983 | Oxalate/Creatinine | A relative measurement (ratio or percentage) of the oxalate to creatinine in a biological specimen. | Oxalate to Creatinine Ratio Measurement | ||
| Oxidized LDL Cholesterol Antibody | C119288 | Oxidized LDL Cholesterol Antibody | A measurement of the total oxidized low density lipoprotein cholesterol antibody in a biological specimen. | Oxidized LDL Cholesterol Antibody Measurement | ||
| Oxycodone | C74884 | Oxycodone;Oxycontin | A measurement of the oxycodone present in a biological specimen. | Oxycodone Measurement | ||
| Oxygen Capacity | C96614 | Oxygen Capacity | A measurement of the maximum amount of oxygen that can be combined chemically with hemoglobin in a volume of blood. | Oxygen Capacity Measurement | ||
| Oxygen Content | C111284 | Oxygen Content | A measurement of the amount of oxygen content in a biological specimen. | Oxygen Measurement | ||
| Oxygen Saturation | C60832 | Oxygen Saturation | A measurement of the oxygen-hemoglobin saturation of a volume of blood. | Oxygen Saturation Measurement | ||
| Oxyhemoglobin | C96616 | Oxyhemoglobin | A measurement of the oxyhemoglobin, oxygen-bound hemoglobin, in a biological specimen. | Oxyhemoglobin Measurement | ||
| Oxytocin | C74869 | Oxytocin;Oxytoxin | A measurement of the oxytocin hormone in a biological specimen. | Oxytocin Measurement | ||
| P-Selectin | C117850 | GMP-140;P-Selectin | A measurement of total P-selectin in a biological specimen. | P-Selectin Measurement | ||
| P50 Oxygen | C102279 | P50 Oxygen | A measurement of the partial pressure of oxygen when hemoglobin is half saturated in a biological specimen. | P50 Oxygen Measurement | ||
| Pancreatic Elastase 1 | C82028 | Pancreatic Elastase 1 | A measurement of the pancreatic elastase 1 in a biological specimen. | Pancreatic Elastase Measurement | ||
| Pancreatic Elastase 1, Polymorphonuclear | C82029 | Pancreatic Elastase 1, Polymorphonuclear | A measurement of the polymorphonuclear pancreatic elastase 1 in a biological specimen. | Polymorphonuclear Pancreatic Elastase Measurement | ||
| Pancreatic Polypeptide | C80201 | Pancreatic Polypeptide | A measurement of the pancreatic polypeptide in a biological specimen. | Pancreatic Polypeptide Measurement | ||
| Panel Reactive Antibody | C116210 | PRA Score;Panel Reactive Antibody;Percent Panel Reactive Antibody;Percent Reactive Antibody | A measurement of the panel reactive antibody (the reactivity between host immune cells and donor human leukocyte antigen) in a biological specimen. | Panel Reactive Antibody Test | ||
| Pappenheimer Bodies | C74616 | Pappenheimer Bodies | A measurement of the cells containing Pappenheimer Bodies (violet or blue staining ferritin granules usually found along the periphery of the red blood cells) in a biological specimen. | Pappenheimer Body Count | ||
| Parathyroid Hormone, C-Terminal | C81964 | Parathyroid Hormone, C-Terminal | A measurement of the C-terminal fragment of parathyroid hormone in a biological specimen. | C-Terminal Parathyroid Hormone Measurement | ||
| Parathyroid Hormone, Fragmented | C74784 | Parathyroid Hormone, Fragmented | A measurement of the fragmented parathyroid hormone in a biological specimen. | Fragmented Parathyroid Hormone Measurement | ||
| Parathyroid Hormone, Intact | C74789 | Parathyroid Hormone, Intact | A measurement of the intact parathyroid hormone (consisting of amino acids 1-84 or 7-84) in a biological specimen. | Intact Parathyroid Hormone Measurement | ||
| Parathyroid Hormone, Mid-Molecule | C81965 | Parathyroid Hormone, Mid-Molecule | A measurement of the mid-molecule fragment of parathyroid hormone in a biological specimen. | Mid-Molecule Parathyroid Hormone Measurement | ||
| Parathyroid Hormone, N-Terminal | C81966 | Parathyroid Hormone, N-Terminal | A measurement of the N-terminal fragment of parathyroid hormone in a biological specimen. | N-Terminal Parathyroid Hormone Measurement | ||
| Parathyroid Hormone, Whole | C103451 | Parathyroid Hormone, Whole | A measurement of the whole parathyroid hormone (consisting of amino acids 1-84) in a biological specimen. | Whole Parathyroid Hormone Measurement | ||
| Parathyroid Hormone-related Protein | C117851 | Parathyroid Hormone-related Peptide;Parathyroid Hormone-related Protein | A measurement of parathyroid hormone-related protein in a biological specimen. | Parathyroid Hormone-related Protein Measurement | ||
| Parietal Cell Antibody | C116207 | Anti-Parietal Cell Antibody;Parietal Cell Antibody | A measurement of the parietal cell antibody in a biological specimen. | Parietal Cell Antibody Measurement | ||
| Partial Pressure Carbon Dioxide | C82625 | Partial Pressure Carbon Dioxide | A measurement of the pressure of carbon dioxide in a biological specimen. | Partial Pressure of Carbon Dioxide Measurement | ||
| Partial Pressure Oxygen | C71251 | Partial Pressure Oxygen | A measurement of the pressure of oxygen in a biological specimen. | Partial Pressure of Oxygen Measurement | ||
| Parvovirus B19 IgG Antibody | C96617 | Parvovirus B19 IgG Antibody | A measurement of the Parvovirus B19 IgG antibody in a biological specimen. | Parvovirus B19 IgG Antibody Measurement | ||
| Parvovirus B19 IgM Antibody | C96618 | Parvovirus B19 IgM Antibody | A measurement of the Parvovirus B19 IgM antibody in a biological specimen. | Parvovirus B19 IgM Antibody Measurement | ||
| Pelger Huet Anomaly | C74617 | Pelger Huet Anomaly | A measurement of the Pelger Huet Anomaly (nuclei of neutrophils and eosinophils appear rod-like, spherical or dumbbell shaped) in a biological specimen. | Pelger Huet Anomaly Measurement | ||
| Pemphigoid Antibodies | C81988 | Pemphigoid Antibodies | A measurement of the pemphigoid antibodies in a biological specimen. | Pemphigoid Antibody Measurement | ||
| Pepsinogen | C100122 | Pepsinogen | A measurement of the pepsinogen in a biological specimen. | Pepsinogen Measurement | ||
| Pepsinogen A | C100469 | PGA;Pepsinogen A | A measurement of the pepsinogen A in a biological specimen. | Pepsinogen A Measurement | ||
| Pepsinogen C | C100470 | PGC;Pepsinogen C | A measurement of the pepsinogen C in a biological specimen. | Pepsinogen C Measurement | ||
| Pepsinogen I | C100467 | PGI;Pepsinogen I | A measurement of the pepsinogen I in a biological specimen. | Pepsinogen I Measurement | ||
| Pepsinogen II | C100468 | PGII;Pepsinogen II | A measurement of the pepsinogen II in a biological specimen. | Pepsinogen II Measurement | ||
| Peptide YY | C80202 | Peptide Tyrosine Tyrosine;Peptide YY | A measurement of the peptide YY in a biological specimen. | Peptide YY Measurement | ||
| Periostin | C112395 | OSF2;Osteoblast Specific Factor 2;POSTN;Periostin | A measurement of the periostin in a biological specimen. | Periostin Measurement | ||
| pH | C45997 | pH | The negative logarithm (base 10) of the concentration of hydronium ions, which is used as a measure of the acidity or alkalinity of a fluid. | pH | ||
| Phencyclidine | C74694 | Phencyclidine;Phenylcyclohexylpiperidine | A measurement of the phencyclidine present in a biological specimen. | Phencyclidine Measurement | ||
| Phenothiazine | C74695 | Dibenzothiazine;Phenothiazine | A measurement of the phenothiazine present in a biological specimen. | Phenothiazine Measurement | ||
| Phosphate | C64857 | Inorganic Phosphate;Phosphate;Phosphorus | A measurement of the phosphate in a biological specimen. | Phosphate Measurement | ||
| Phosphate Clearance | C106553 | Phosphate Clearance | A measurement of the volume of serum or plasma that would be cleared of phosphate by excretion of urine for a specified unit of time (e.g. one minute). | Phosphate Clearance Measurement | ||
| Phosphate/Creatinine | C79461 | Phosphate/Creatinine | A relative measurement (ratio or percentage) of the phosphate to creatinine in a biological specimen. | Phosphate to Creatinine Ratio Measurement | ||
| Phospholipid | C96623 | Phospholipid | A measurement of the phospholipids in a biological specimen. | Phospholipid Measurement | ||
| Phosphorus Excretion Rate | C117845 | Phosphorus Excretion Rate | A measurement of the amount of phosphorus being excreted in urine over a defined amount of time (e.g. one hour). | Phosphorus Urine Excretion Rate | ||
| Phosphorylated Tau Protein | C84812 | Phosphorylated Tau Protein | A measurement of the phosphorylated Tau protein in a biological specimen. | Phosphorylated Tau Protein Measurement | ||
| Pi-GST Excretion Rate | C119279 | Pi-GST Excretion Rate | A measurement of the amount of Pi Glutathione-S-Transferase being excreted in urine over a defined period of time (e.g. one hour). | Pi-GST Excretion Rate | ||
| Plasma Cells/Total Cells | C98869 | Plasma Cells/Total Cells | A relative measurement (ratio or percentage) of the mature plasma cells (plasmacytes) to total cells in a biological specimen (for example a bone marrow specimen). | Plasma Cell to Total Cell Ratio Measurement | ||
| Plasmacytoid Lymphocytes | C74618 | Plasmacytoid Lymphocytes;Plymphocytes | A measurement of the plasmacytoid lymphocytes (lymphocytes with peripherally clumped chromatin and often deep blue cytoplasm, and that appear similar to plasma cells) in a biological specimen. | Plasmacytoid Lymphocyte Count | ||
| Plasmacytoid Lymphocytes/Lymphocytes | C74648 | Plasmacytoid Lymphocytes/Lymphocytes | A relative measurement (ratio or percentage) of the plasmacytoid lymphocytes (lymphocytes with peripherally clumped chromatin and often deep blue cytoplasm, and that appear similar to plasma cells) to all lymphocytes in a biological specimen. | Plasmacytoid Lymphocyte to Lymphocyte Ratio Measurement | ||
| Plasminogen Activator Inhibitor-1 | C82030 | Plasminogen Activator Inhibitor-1 | A measurement of the plasminogen activator inhibitor-1 in a biological specimen. | Plasminogen Activator Inhibitor-1 Measurement | ||
| Plasminogen Activator Inhibitor-1 AG | C81989 | Plasminogen Activator Inhibitor-1 AG | A measurement of the plasminogen activator inhibitor-1 antigen in a biological specimen. | Plasminogen Activator Inhibitor-1 Antigen Measurement | ||
| Plasmodium | C100453 | Malaria;Plasmodium | Examination of a biological specimen to detect the presence of any protozoan belonging to the Plasmodium genus. | Plasmodium Measurement | ||
| Platelet Activating Factor | C111292 | Platelet Activating Factor | A measurement of the platelet activating factor in a biological specimen. | Platelet Activating Factor Measurement | ||
| Platelet Aggregation | C103427 | Platelet Aggregation;Platelet Function | A measurement of the association of platelets to one another via adhesion molecules in a biological sample. | Platelet Aggregation Measurement | ||
| Platelet Aggregation Amplitude | C111293 | Platelet Aggregation Amplitude | A measurement of the magnitude of the platelet aggregation in a biological specimen. | Platelet Aggregation Amplitude Measurement | ||
| Platelet Aggregation Curve Type | C114210 | Platelet Aggregation Curve Type | The classification of the curve pattern that is formed as a result of platelet aggregation. | Platelet Aggregometry Curve Type | ||
| Platelet Aggregation Mean Amplitude | C114211 | Platelet Aggregation Mean Amplitude | An average of the measurements of the magnitude of the platelet aggregation in a biological specimen. | Platelet Aggregometry Mean Amplitude | ||
| Platelet Aggregation Mean Curve Type | C114212 | Platelet Aggregation Mean Curve Type | The classification of the curve pattern that is formed as the average result of the platelet aggregation curve measurements. | Platelet Aggregometry Mean Curve Type | ||
| Platelet Clumps | C96624 | PLT Clumps;Platelet Clumps | A measurement of the platelet clumps in a biological specimen. | Platelet Clumps Count | ||
| Platelet Component Distribution Width | C111294 | Platelet Component Distribution Width | A measurement of a marker of platelet shape change in a biological specimen. | Platelet Component Distribution Width Measurement | ||
| Platelet Derived Growth Factor Isoform AB | C116208 | PDGF Isoform AB;Platelet Derived Growth Factor Isoform AB;Platelet Derived Growth Factor-AB Isoform | A measurement of the platelet derived growth factor isoform AB in a biological specimen. | Platelet Derived Growth Factor Isoform AB Measurement | ||
| Platelet Distribution Width | C81962 | Platelet Distribution Width | A measurement of the range of platelet sizes in a biological specimen. | Platelet Distribution Width | ||
| Platelet Function Closure Time | C111295 | PFCT;Platelet Function Closure Time | A measurement of the platelet function closure time in a biological specimen. | Platelet Function Closure Time Measurement | ||
| Platelet Hematocrit | C100424 | Platelet Hematocrit;Thrombocytocrit | A relative measurement (ratio or percentage) of the proportion of the volume of blood taken up by platelets. | Platelet Hematocrit Measurement | ||
| Platelet Morphology | C111296 | Platelet Morphology | An examination or assessment of the form and structure of platelets. | Platelet Morphology Measurement | ||
| Platelet Satellitism | C116209 | Platelet Satellitism | An examination or assessment of the platelet satellitism (platelet rosetting around cells) in a biological specimen. | Platelet Satellitism Assessment | ||
| Platelets | C51951 | Platelets | A measurement of the platelets (non-nucleated thrombocytes) in a biological specimen. | Platelet Count | ||
| Poikilocytes | C79602 | Poikilocytes | A measurement of the odd-shaped erythrocytes in a whole blood specimen. | Poikilocyte Measurement | ||
| Poikilocytes/Erythrocytes | C74649 | Poikilocytes/Erythrocytes | A relative measurement (ratio or percentage) of the poikilocytes, or irregularly shaped erythrocytes, to all erythrocytes in a biological specimen. | Poikilocyte to Erythrocyte Ratio Measurement | ||
| Polychromasia | C64803 | Polychromasia | A measurement of the blue-staining characteristic of newly generated erythrocytes. | Polychromasia | ||
| Potassium | C64853 | Potassium | A measurement of the potassium in a biological specimen. | Potassium Measurement | ||
| Potassium Clearance | C106560 | Potassium Clearance | A measurement of the volume of serum or plasma that would be cleared of potassium by excretion of urine for a specified unit of time (e.g. one minute). | Potassium Clearance Measurement | ||
| Potassium Excretion Rate | C117839 | Potassium Excretion Rate | A measurement of the amount of potassium being excreted in urine over a defined amount of time (e.g. one hour). | Potassium Urine Excretion Rate | ||
| Potassium/Creatinine | C79462 | Potassium/Creatinine | A relative measurement (ratio or percentage) of the potassium to creatinine in a biological specimen. | Potassium to Creatinine Ratio Measurement | ||
| PP Arterial O2/Fraction Inspired O2 | C119293 | PAO2/FIO2;PP Arterial O2/Fraction Inspired O2 | A relative measurement (ratio or percentage) of the force per unit area (pressure) of oxygen dissolved in arterial blood to the percentage oxygen of an inhaled mixture of gasses. | Partial Pressure Arterial Oxygen to Fraction Inspired Oxygen Ratio Measurement | ||
| Prealbumin | C100435 | Prealbumin;Thyroxine-binding Prealbumin;Transthyretin | A measurement of the prealbumin in a biological specimen. | Prealbumin Measurement | ||
| Precursor Plasma Cells | C74619 | Plasmablast;Precursor Plasma Cells | A measurement of the precursor (blast stage) plasma cells (antibody secreting cells derived from B cells via antigen stimulation) in a biological specimen. | Precursor Plasma Cell Count | ||
| Precursor Plasma Cells/Lymphocytes | C74650 | Precursor Plasma Cells/Lymphocytes | A relative measurement (ratio or percentage) of the precursor (blast stage) plasma cells (antibody secreting cells derived from B cells via antigen stimulation) to all lymphocytes in a biological specimen. | Precursor Plasma Cell to Lymphocyte Ratio Measurement | ||
| Pregnancy-Associated Plasma Protein-A | C82031 | Pregnancy-Associated Plasma Protein-A | A measurement of the pregnancy-associated plasma protein-A in a biological specimen. | Pregnancy-Associated Plasma Protein-A Measurement | ||
| ProB-type Natriuretic Peptide | C82032 | Pro-Brain Natriuretic Peptide;ProB-type Natriuretic Peptide;proBNP | A measurement of the proB-type natriuretic peptide in a biological specimen. | ProB-Type Natriuretic Peptide Measurement | ||
| Procalcitonin | C103430 | Procalcitonin | A measurement of the procalcitonin in a biological specimen. | Procalcitonin Measurement | ||
| Procollagen 1 N-Terminal Propeptide | C96625 | Amino-terminal propeptide of type 1 procollagen;P1NP Aminoterm Type 1;Procollagen 1 N-Terminal Propeptide | A measurement of the procollagen 1 N-terminal propeptide in a biological specimen. | Procollagen 1 N-Terminal Propeptide Measurement | ||
| Procollagen Type I Carboxy Term Peptide | C82033 | Procollagen Type I Carboxy Term Peptide | A measurement of the procollagen-1 carboxy-terminal peptide in a biological specimen. | Procollagen Type I Carboxy Terminal Peptide Measurement | ||
| Proerythroblast | C100446 | Proerythroblast | A measurement of the proerythroblasts in a biological specimen. | Proerythroblast Measurement | ||
| Progesterone | C74791 | Progesterone | A measurement of the progesterone hormone in a biological specimen. | Progesterone Measurement | ||
| Progesterone Receptor | C117846 | NR3C3;PR;Progesterone Receptor | A measurement of the progesterone receptor in a biological specimen. | Progesterone Receptor Measurement | ||
| Proinsulin | C81967 | Proinsulin | A measurement of the proinsulin in a biological specimen. | Proinsulin Measurement | ||
| Proinsulin/Insulin Ratio | C111299 | Proinsulin/Insulin Ratio | A relative measurement (ratio or percentage) of the proinsulin to insulin in a biological specimen. | Proinsulin to Insulin Ratio Measurement | ||
| Prolactin | C74870 | Prolactin | A measurement of the prolactin hormone in a biological specimen. | Prolactin Measurement | ||
| Prolymphocytes | C74620 | Prolymphocytes | A measurement of the prolymphocytes in a biological specimen. | Prolymphocyte Count | ||
| Prolymphocytes/Leukocytes | C64829 | Prolymphocytes/Leukocytes | A relative measurement (ratio or percentage) of prolymphocytes to leukocytes in a biological specimen. | Prolymphocyte to Leukocyte Ratio | ||
| Prolymphocytes/Lymphocytes | C74651 | Prolymphocytes/Lymphocytes | A relative measurement (ratio or percentage) of the prolymphocytes to all lymphocytes in a biological specimen. | Prolymphocyte to Lymphocyte Ratio Measurement | ||
| Promonocytes | C74621 | Promonocytes | A measurement of the promonocytes in a biological specimen. | Promonocyte Count | ||
| Promonocytes/Leukocytes | C74652 | Promonocytes/Leukocytes | A relative measurement (ratio or percentage) of the promonocytes to all leukocytes in a biological specimen. | Promonocyte to Lymphocyte Ratio Measurement | ||
| Promyeloblasts | C117847 | Promyeloblasts | A measurement of the promyeloblasts in a biological specimen. | Promyeloblasts Measurement | ||
| Promyelocytes | C74622 | Promyelocytes | A measurement of the promyelocytes (immature myelocytes) in a biological specimen. | Promyelocyte Count | ||
| Promyelocytes/Leukocytes | C74653 | Promyelocytes/Leukocytes | A relative measurement (ratio or percentage) of the promyelocytes (immature myelocytes) to all leukocytes in a biological specimen. | Promyelocyte to Lymphocyte Ratio Measurement | ||
| Promyelocytes/Total Cells | C98773 | Promyelocytes/Total Cells | A relative measurement (ratio or percentage) of the promyelocytes (immature myelocytes) to total cells in a biological specimen (for example a bone marrow specimen). | Promyelocyte to Total Cell Ratio Measurement | ||
| Pronormoblasts/Total Cells | C98870 | Pronormoblasts/Total Cells | A relative measurement (ratio or percentage) of the pronormoblasts to total cells in a biological specimen (for example a bone marrow specimen). | Pronormoblast to Total Cell Ratio Measurement | ||
| Propoxyphene | C74885 | Propoxyphene | A measurement of the propoxyphene present in a biological specimen. | Propoxyphene Measurement | ||
| Prostaglandin | C103343 | Total Prostaglandin | A measurement of the total prostaglandin in a biological specimen. | Prostaglandin Measurement | ||
| Prostaglandin D2 | C103431 | Prostaglandin D2 | A measurement of the prostaglandin D2 in a biological specimen. | Prostaglandin D2 Measurement | ||
| Prostaglandin D2 Synthase | C103432 | Prostaglandin D2 Synthase | A measurement of the prostaglandin D2 synthase in a biological specimen. | Prostaglandin D2 Synthase Measurement | ||
| Prostaglandin E Synthase | C103433 | Prostaglandin E Synthase | A measurement of the prostaglandin E synthase in a biological specimen. | Prostaglandin E Synthase Measurement | ||
| Prostaglandin E1 | C103434 | Prostaglandin E1 | A measurement of the prostaglandin E1 in a biological specimen. | Prostaglandin E1 Measurement | ||
| Prostaglandin E2 | C103435 | Prostaglandin E2 | A measurement of the prostaglandin E2 in a biological specimen. | Prostaglandin E2 Measurement | ||
| Prostaglandin F1 Alpha | C103436 | Prostaglandin F1 Alpha | A measurement of the prostaglandin F1 alpha in a biological specimen. | Prostaglandin F1 Alpha Measurement | ||
| Prostaglandin F2 Alpha | C103437 | Prostaglandin F2 Alpha | A measurement of the prostaglandin F2 alpha in a biological specimen. | Prostaglandin F2 Alpha Measurement | ||
| Prostate Specific Antigen | C17634 | Prostate Specific Antigen | A measurement of the prostate specific antigen in a biological specimen. | Prostate Specific Antigen Measurement | ||
| Prostatic Acid Phosphatase | C80204 | Prostatic Acid Phosphatase | A measurement of the prostatic acid phosphatase in a biological specimen. | Prostatic Acid Phosphatase Measurement | ||
| Protein | C64858 | Protein | A measurement of the total protein in a biological specimen. | Total Protein Measurement | ||
| Protein Excretion Rate | C117848 | Protein Excretion Rate | A measurement of the amount of total protein being excreted in urine over a defined amount of time (e.g. one hour). | Total Protein Urine Excretion Rate | ||
| Protein S | C100436 | Protein S | A measurement of the protein S in a biological specimen. | Protein S Measurement | ||
| Protein/Creatinine | C79463 | Protein/Creatinine | A relative measurement (ratio or percentage) of the protein to creatinine in a biological specimen. | Protein to Creatinine Ratio Measurement | ||
| Protein/Osmolality | C92240 | Protein/Osmolality;Protein/Osmolality Ratio | A relative measurement (ratio or percentage) of total proteins to the osmolality of a biological specimen. | Protein to Osmolality Ratio Measurement | ||
| Prothrombin Activity | C98774 | Factor II Activity;Prothrombin Activity | A measurement of the biological activity of prothrombin in a biological specimen. | Prothrombin Activity Measurement | ||
| Prothrombin Fragments 1 + 2 | C82034 | Prothrombin Fragments 1 + 2 | A measurement of the prothrombin fragments 1 and 2 in a biological specimen. | Prothrombin Fragments 1 and 2 Measurement | ||
| Prothrombin Intl. Normalized Ratio | C64805 | Prothrombin Intl. Normalized Ratio | A ratio that represents the prothrombin time for a plasma specimen, divided by the result for a control plasma specimen, further standardized for the International Sensitivity Index of the tissue factor (thromboplastin) used in the test. | International Normalized Ratio of Prothrombin Time | ||
| Prothrombin Time | C62656 | Prothrombin Time | A blood clotting measurement that evaluates the extrinsic pathway of coagulation. | Prothrombin Time | ||
| Protozoa | C117849 | Protozoa | Examination of a biological specimen to detect the presence of protozoa in a biological specimen. | Protozoa Measurement | ||
| Pseudoephedrine | C74696 | Pseudoephedrine | A measurement of the pseudoephedrine present in a biological specimen. | Pseudoephedrine Measurement | ||
| Pyridinoline | C80211 | Pyridinoline | A measurement of the pyridinoline in a biological specimen. | Pyridinoline Measurement | ||
| Rapid Plasma Reagin | C74716 | Rapid Plasma Reagin | A measurement of the antibodies produced by cellular damage caused by Treponema pallidum (syphilis) in a biological specimen. | Rapid Plasma Reagin Measurement | ||
| RBC Casts | C74772 | RBC Casts | A measurement of the red blood cell casts present in a biological specimen. | Red Blood Cell Cast Measurement | ||
| Reactive Lymphocytes | C74629 | Reactive Lymphocytes | A measurement of the reactive lymphocytes (lymphocytes which have become large due to an antigen reaction) in a biological specimen. | Reactive Lymphocyte Count Measurement | ||
| Reactive Lymphocytes/Lymphocytes | C74654 | Reactive Lymphocytes/Lymphocytes | A relative measurement (ratio or percentage) of the reactive lymphocytes (lymphocytes which have become large due to an antigen reaction) to all lymphocytes in a biological specimen. | Reactive Lymphocyte to Lymphocyte Ratio Measurement | ||
| Receptor Activator Nuclear KappaB Ligand | C117852 | Receptor Activator Nuclear KappaB Ligand;Receptor Activator of Nuclear Kappa-B Ligand | A measurement of the receptor activator of nuclear kappa-B ligand in a biological specimen. | Receptor Activator Nuclear KappaB Ligand Measurement | ||
| Reg upon Act Normal T-cell Exprd Secrtd | C81957 | Chemokine Ligand 5;Reg upon Act Normal T-cell Exprd Secrtd | A measurement of the RANTES (regulated on activation, normally, T-cell expressed, and secreted) chemokine in a biological specimen. | Reg upon Act Normal T-cell Exprd Secrtd Measurement | ||
| Renin | C74893 | Active Renin;Angiotensinogenase;Direct Renin;Renin | A measurement of the renin in a biological specimen. | Renin Measurement | ||
| Renin Activity | C111305 | PRA;Plasma Renin Activity;Renin Activity;URA;Urinary Renin Activity | A measurement of the renin activity in a biological specimen. | Renin Activity Measurement | ||
| Reptilase Time | C96628 | Reptilase Time | A measurement of the time it takes a plasma sample to clot after adding the active enzyme reptilase. | Reptilase Time Measurement | ||
| Resistin | C80205 | Resistin | A measurement of the resistin in a biological specimen. | Resistin Measurement | ||
| Ret. Corpuscular Hemoglobin Content | C117854 | CHr;Ret. Corpuscular Hemoglobin Content | A quantitative measurement of the total amount of hemoglobin in the reticulocyte population. | Total Reticulocyte Corpuscular Hemoglobin Content Measurement | ||
| Ret. Mean Corpuscular Hemoglobin | C117855 | CHCMr;Ret. Mean Corpuscular Hemoglobin | A quantitative measurement of the mean amount of hemoglobin per reticulocyte in a biological specimen. | Reticulocyte Mean Corpuscular Hemoglobin Measurement | ||
| Reticulocyte Distribution Width | C114218 | Reticulocyte Distribution Width | A measurement of the range of reticulocyte sizes in a biological specimen. | Reticulocyte Distribution Width | ||
| Reticulocyte Hemoglobin | C98776 | Reticulocyte Hemoglobin | A measurement of the amount of hemoglobin in reticulocytes. | Reticulocyte Hemoglobin Measurement | ||
| Reticulocytes | C51947 | Reticulocytes | A measurement of the reticulocytes in a biological specimen. | Reticulocyte Count | ||
| Reticulocytes/Erythrocytes | C64828 | Reticulocytes/Erythrocytes | A relative measurement (ratio or percentage) of reticulocytes to erythrocytes in a biological specimen. | Reticulocyte to Erythrocyte Ratio | ||
| Retinol Binding Protein | C100437 | Retinol Binding Protein | A measurement of the total retinol binding protein in a biological specimen. | Retinol Binding Protein Measurement | ||
| Rheumatoid Factor | C74717 | Rheumatoid Factor | A measurement of the rheumatoid factor antibody in a biological specimen. | Rheumatoid Factor Measurement | ||
| Riboflavin | C74898 | Riboflavin;Vitamin B2 | A measurement of the riboflavin in a biological specimen. | Vitamin B2 Measurement | ||
| Ribonucleoprotein Antibody | C100457 | RNP Antibody;Ribonucleoprotein Antibody | A measurement of the ribonucleoprotein antibody in a biological specimen. | Ribonucleoprotein Antibody Measurement | ||
| Ringed Sideroblasts | C100419 | Ringed Sideroblasts | A measurement of the ringed sideroblasts (abnormal nucleated erythroblasts with a large number of iron deposits in the perinuclear mitochondria, forming a ring around the nucleus) in a biological specimen. | Ringed Sideroblast Measurement | ||
| Rouleaux Formation | C74624 | Rouleaux Formation | A measurement of the number of stacking red blood cells within a biological specimen. | Rouleaux Formation Count | ||
| Round Epithelial Cells | C74698 | Round Epithelial Cells | A measurement of the round epithelial cells present in a biological specimen. | Round Epithelial Cell Count | ||
| Rubella IgG Antibody | C103440 | Rubella IgG Antibody | A measurement of the Rubella IgG antibody in a biological specimen. | Rubella IgG Antibody Measurement | ||
| Rubeola IgG Antibody | C112412 | Measles IgG Antibody;Rubeola IgG Antibody | A measurement of the Measles (Rubeola) virus IgG antibody in a biological specimen. | Rubeola IgG Antibody Measurement | ||
| Rubeola IgM Antibody | C112413 | Measles IgM Antibody;Rubeola IgM Antibody | A measurement of the Measles (Rubeola) virus IgM antibody in a biological specimen. | Rubeola IgM Antibody Measurement | ||
| Schistocytes | C74706 | Schistocytes | A measurement of the schistocytes (fragmented red blood cells) in a biological specimen. | Schistocyte Count | ||
| Scl-70 Antibody | C100458 | Scl-70 Antibody;Scleroderma-70 Antibody | A measurement of the Scl-70 antibody in a biological specimen. | Scl-70 Antibody Measurement | ||
| Sclerostin | C117857 | Sclerostin | A measurement of the sclerostin in a biological specimen. | Sclerostin Measurement | ||
| Secretin | C74871 | Secretin | A measurement of the secretin hormone in a biological specimen. | Secretin Measurement | ||
| Sediment Examination | C105744 | Microscopic Sediment Analysis;Sediment Analysis;Sediment Examination | An observation, assessment or examination of the sediment in a biological specimen. | Sediment Analysis | ||
| Serotonin | C74872 | Serotonin | A measurement of the serotonin hormone in a biological specimen. | Serotonin Measurement | ||
| Sex Hormone Binding Globulin | C74745 | Sex Hormone Binding Globulin;Sex Hormone Binding Protein | A measurement of the sex hormone binding (globulin) protein in a biological specimen. | Sex Hormone Binding Protein Measurement | ||
| Sezary Cells | C74625 | Sezary Cells | A measurement of the Sezary cells (atypical lymphocytes with cerebriform nuclei) in a biological specimen. | Sezary Cell Count | ||
| Sezary Cells/Lymphocytes | C74655 | Sezary Cells/Lymphocytes | A relative measurement (ratio or percentage of the Sezary cells (atypical lymphocytes with cerebriform nuclei) to all lymphocytes in a biological specimen. | Sezary Cell to Lymphocyte Ratio Measurement | ||
| Sialyl SSEA-1 Antigen | C114223 | SLeX;Sialyl Lewis X Antigen;Sialyl Lex;Sialyl SSEA-1 Antigen;Sialyl-CD15 | A measurement of the sialyl stage-specific embryonic antigen-1 in a biological specimen. | Sialyl SSEA-1 Antigen Measurement | ||
| Sickle Cells | C74626 | Sickle Cells | A measurement of the sickle cells (sickle shaped red blood cells) in a biological specimen. | Sickle Cell Count | ||
| Sickle Cells/Erythrocytes | C74656 | Sickle Cells/Erythrocytes | A relative measurement (ratio or percentage) of the sickle cells (sickle shaped red blood cells) to all erythrocytes in a biological specimen. | Sickle Cell to Erythrocyte Ratio Measurement | ||
| Sideroblast | C100418 | Sideroblast | A measurement of the sideroblasts (nucleated erythroblasts with iron granules in the cytoplasm) in a biological specimen. | Sideroblast Measurement | ||
| Sjogrens SS-A Antibody | C92236 | Ro Antibody;Sjogrens SS-A Antibody | A measurement of the Sjogrens SS-A antibody in a biological specimen. | Sjogren's SS-A Antibody Measurement | ||
| Sjogrens SS-B Antibody | C92237 | La Antibody;Sjogrens SS-B Antibody | A measurement of the Sjogrens SS-B antibody in a biological specimen. | Sjogren's SS-B Antibody Measurement | ||
| Smith Antibody | C92281 | Smith Antibody | A measurement of the Smith antibody in a biological specimen. | Smith Antibody Measurement | ||
| Smooth Muscle Antibody | C111317 | Actin Antibody;Anti-Smooth Muscle Antibody;Smooth Muscle Antibody | A measurement of the smooth muscle antibody in a biological specimen. | Smooth Muscle Antibody Measurement | ||
| Smudge Cells | C74627 | Basket Cells;Gumprecht Shadow Cells;Shadow Cells;Smudge Cells | A measurement of the smudge cells (the nuclear remnant of a ruptured white blood cell) in a biological specimen. | Smudge Cell Count | ||
| Smudge Cells/Leukocytes | C119294 | Basket Cells/Leukocytes;Gumprecht Shadow Cells/Leukocytes;Shadow Cells/Leukocytes;Smudge Cells/Leukocytes | A relative measurement (ratio or percentage) of smudge cells to leukocytes in a biological specimen. | Smudge Cells to Leukocytes Ratio Measurement | ||
| Sodium | C64809 | Sodium | A measurement of the sodium in a biological specimen. | Sodium Measurement | ||
| Sodium Clearance | C106568 | Sodium Clearance | A measurement of the volume of serum or plasma that would be cleared of sodium by excretion of urine for a specified unit of time (e.g. one minute). | Sodium Clearance Measurement | ||
| Sodium Excretion Rate | C117856 | Sodium Excretion Rate | A measurement of the amount of sodium being excreted in urine over a defined amount of time (e.g. one hour). | Sodium Urine Excretion Rate | ||
| Sodium/Creatinine | C79464 | Sodium/Creatinine | A relative measurement (ratio or percentage) of the sodium to creatinine in a biological specimen. | Sodium to Creatinine Ratio Measurement | ||
| Soluble E-Selectin | C119273 | Soluble E-Selectin;sE-selectin | A measurement of the soluble E-Selectin activity in a biological specimen. | Soluble E-Selectin Measurement | ||
| Soluble Immunoglobulin | C117835 | Soluble Immunoglobulin | A measurement of the soluble total immunoglobulin in a biological specimen. | Soluble Immunoglobulin Measurement | ||
| Soluble Interleukin 2 Receptor Activity | C102280 | Soluble Interleukin 2 Receptor Activity | A measurement of the soluble interleukin 2 receptor activity in a biological specimen. | Soluble Interleukin 2 Receptor Activity Measurement | ||
| Soluble Interleukin 6 Receptor | C117837 | Soluble Interleukin 6 Receptor | A measurement of the soluble interleukin 6 receptor in a biological specimen. | Soluble Interleukin 6 Receptor Measurement | ||
| Soluble Interleukin-1 Receptor Type I | C117836 | Soluble Interleukin-1 Receptor Type I | A measurement of the soluble interleukin-1 receptor type I in a biological specimen. | Soluble Interleukin-1 Receptor Type I Measurement | ||
| Soluble TNF Receptor Type I | C117863 | Soluble TNF Receptor Type I | A measurement of the soluble tumor necrosis factor receptor type I in a biological specimen. | Soluble Tumor Necrosis Factor Receptor Type I Measurement | ||
| Soluble TNF Receptor Type II | C117864 | Soluble TNF Receptor Type II | A measurement of the soluble tumor necrosis factor receptor type II in a biological specimen. | Soluble Tumor Necrosis Factor Receptor Type II Measurement | ||
| Soluble Transferrin Receptor | C100438 | Soluble Transferrin Receptor | A measurement of the soluble transferrin receptor in a biological specimen. | Soluble Transferrin Receptor Measurement | ||
| Soluble Tumor Necrosis Factor Receptor | C117749 | Soluble Tumor Necrosis Factor Receptor | A measurement of the total soluble tumor necrosis factor receptor in a biological specimen. | Soluble Tumor Necrosis Factor Receptor Measurement | ||
| Soluble Vasc Cell Adhesion Molecule 1 | C92533 | Soluble Vascular Cell Adhesion Molecule 1 | A measurement of the soluble vascular cell adhesion molecule 1 in a biological specimen. | Soluble Vascular Cell Adhesion Molecule 1 | ||
| Somatotrophin | C80360 | Growth Hormone;Somatotrophin | A measurement of the somatotrophin (growth) hormone in a biological specimen. | Somatotrophin Measurement | ||
| Sorbitol Dehydrogenase | C79465 | Sorbitol Dehydrogenase | A measurement of the sorbitol dehydrogenase in a biological specimen. | Sorbitol Dehydrogenase Measurement | ||
| Specific Gravity | C64832 | Specific Gravity | A ratio of the density of a fluid to the density of water. | Specific Gravity | ||
| Specimen Appearance | C25377 | Specimen Appearance | The outward or visible aspect of a specimen. | Appearance | ||
| Specimen Weight | C106569 | Specimen Weight | A measurement of the weight of a biological specimen. | Specimen Weight Measurement | ||
| Sperm Motility | C102281 | Sperm Motility | A measurement of the sperm capable of forward, progressive movement in a semen specimen. | Sperm Motility Measurement | ||
| Spermatozoa | C74663 | Spermatozoa | A measurement of the spermatozoa cells present in a biological specimen. | Spermatozoa Cell Count | ||
| Spherocytes | C74707 | Spherocytes | A measurement of the spherocytes (small, sphere-shaped red blood cells) in a biological specimen. | Spherocyte Count | ||
| Squamous Epithelial Cells | C74773 | Squamous Epithelial Cells | A measurement of the squamous epithelial cells present in a biological specimen. | Squamous Epithelial Cell Count | ||
| Squamous Transitional Epithelial Cells | C74774 | Epithelial Cells;Squamous Transitional Epithelial Cells | A measurement of the squamous transitional epithelial cells present in a biological specimen. | Squamous Transitional Epithelial Cell Count | ||
| Starch Crystals | C81951 | Starch Crystals | A measurement of the starch crystals in a biological specimen. | Starch Crystal Measurement | ||
| Stem Cell Factor | C82035 | KIT Ligand;Stem Cell Factor | A measurement of the stem cell factor in a biological specimen. | Stem Cell Factor Measurement | ||
| Stomatocytes | C74708 | Stomatocytes | A measurement of the stomatocytes (red blood cells with an oval or rectangular area of central pallor, producing the appearance of a cell mouth) in a biological specimen. | Stomatocyte Count | ||
| Streptolysin O Antibody | C92282 | Antistreptolysin O;Streptolysin O Antibody | A measurement of Streptolysin O Antibody in a biological specimen. | Streptolysin O Antibody Measurement | ||
| Strongyloides IgG Antibody | C117858 | Strongyloides IgG Antibody | A measurement of strongyloides IgG antibody in a biological specimen. | Strongyloides IgG Antibody Measurement | ||
| Sulfa Crystals | C74755 | Sulfa Crystals | A measurement of the sulfa crystals present in a biological specimen. | Sulfa Crystal Measurement | ||
| Sulfur Dioxide | C114224 | Sulfur Dioxide | A measurement of the sulfur dioxide in a biological specimen. | Sulfur Dioxide Measurement | ||
| Surfactant Protein D | C111322 | SP-D;Surfactant Protein D | A measurement of the surfactant protein D in a biological specimen. | Surfactant Protein D Measurement | ||
| Target Cells | C96636 | Codocytes;Leptocytes;Mexican Hat Cells;Target Cells | A measurement of the target cells in a biological specimen. | Target Cell Count | ||
| Tartrate-Resistant Acid Phosphatase 5b | C117865 | TRAP5B;Tartrate-Resistant Acid Phosphatase 5b | A measurement of tartrate-resistant acid phosphatase 5b in a biological specimen. | Tartrate-Resistant Acid Phosphatase 5b Measurement | ||
| Tau Protein | C84810 | Tau Protein;Total Tau Protein | A measurement of the total Tau protein in a biological specimen. | Tau Protein Measurement | ||
| Terminal Deoxynucleotidyl Transferase Ag | C117859 | Terminal Deoxynucleotidyl Transferase Ag;Terminal Deoxynucleotidyl Transferase Antigen | A measurement of the terminal deoxynucleotidyl transferase antigen in a biological specimen. | Terminal Deoxynucleotidyl Transferase Antigen Measurement | ||
| Testosterone | C74793 | Testosterone;Total Testosterone | A measurement of the total (free and bound) testosterone in a biological specimen. | Total Testosterone Measurement | ||
| Testosterone, Free | C74785 | Testosterone, Free | A measurement of the free testosterone in a biological specimen. | Free Testosterone Measurement | ||
| Theophylline | C105445 | Theophylline | A measurement of the Theophylline present in a biological specimen. | Theophylline Measurement | ||
| Thiamine | C74896 | Thiamine;Vitamin B1 | A measurement of the thiamine in a biological specimen. | Vitamin B1 Measurement | ||
| Thrombin Time | C80365 | Thrombin Time | A measurement of the time it takes a plasma sample to clot after adding the active enzyme thrombin. (NCI) | Thrombin Time | ||
| Thrombin/Antithrombin | C106574 | Thrombin/Antithrombin;Thrombin/Antithrombin III | A relative measurement (ratio or percentage) of the thrombin to antithrombin present in a sample. | Thrombin to Antithrombin Ratio Measurement | ||
| Thrombocytes | C111283 | Nucleated Thrombocytes;Thrombocytes | A measurement of the nucleated platelets, namely thrombocytes, in a biological specimen. This is typically measured in birds and other non-mammalian vertebrates. | Nucleated Thrombocyte Count | ||
| Thrombopoietin | C74873 | Thrombopoietin | A measurement of the thrombopoietin hormone in a biological specimen. | Thrombopoietin Measurement | ||
| Thromboxane B2 | C103445 | Thromboxane B2 | A measurement of the thromboxane B2 in a biological specimen. | Thromboxane B2 Measurement | ||
| Thyroglobulin | C103446 | TG;Thyroglobulin | A measurement of the thyroglobulin in a biological specimen. | Thyroglobulin Measurement | ||
| Thyroid Antibodies | C81990 | Thyroid Antibodies | A measurement of the thyroid antibodies in a biological specimen. | Thyroid Antibody Measurement | ||
| Thyroid Antimicrosomal Antibodies | C81991 | Thyroid Antimicrosomal Antibodies | A measurement of the thyroid antimicrosomal antibodies in a biological specimen. | Thyroid Antimicrosomal Antibody Measurement | ||
| Thyroid Antithyroglobulin Antibodies | C81992 | Thyroid Antithyroglobulin Antibodies | A measurement of the thyroid antithyroglobulin antibodies in a biological specimen. | Thyroid Antithyroglobulin Antibody Measurement | ||
| Thyroperoxidase | C96639 | Thyroid Peroxidase;Thyroperoxidase | A measurement of the thyroperoxidase in a biological specimen. | Thyroperoxidase Measurement | ||
| Thyroperoxidase Antibody | C96638 | Thyroperoxidase Antibody | A measurement of the thyroperoxidase antibody in a biological specimen. | Thyroperoxidase Antibody Measurement | ||
| Thyrotropin | C64813 | Thyroid Stimulating Hormone;Thyrotropin | A measurement of the thyrotropin in a biological specimen. | Thyrotropin Measurement | ||
| Thyrotropin Releasing Hormone | C74874 | Thyrotropin Releasing Factor;Thyrotropin Releasing Hormone | A measurement of the thyrotropin releasing hormone in a biological specimen. | Thyrotropin Releasing Hormone Measurement | ||
| Thyroxine | C74794 | Thyroxine;Total T4 | A measurement of the total (free and bound) thyroxine in a biological specimen. | Total Thyroxine Measurement | ||
| Thyroxine Binding Globulin | C74746 | Thyroxine Binding Globulin | A measurement of the thyroxine binding globulin protein in a biological specimen. | Thyroxine Binding Globulin Protein Measurement | ||
| Thyroxine, Free | C74786 | Free T4;Thyroxine, Free | A measurement of the free thyroxine in a biological specimen. | Free Thyroxine Measurement | ||
| TIMP1/Creatinine | C106575 | TIMP1/Creatinine;Tissue Inhibitor of Metalloproteinase 1/Creatinine | A relative measurement (ratio or percentage) of the tissue inhibitor of metalloproteinase 1 to creatinine present in a sample. | Tissue Inhibitor of Metalloproteinase 1 to Creatinine Ratio Measurement | ||
| Tissue Inhibitor of Metalloproteinase 1 | C82036 | Tissue Inhibitor of Metalloproteinase 1 | A measurement of the tissue inhibitor of metalloproteinase 1 in a biological specimen. | Tissue Inhibitor of Metalloproteinase 1 Measurement | ||
| Tissue Plasminogen Activator Antigen | C81993 | Tissue Plasminogen Activator Antigen | A measurement of the tissue plasminogen activator antigen in a biological specimen. | Tissue Plasminogen Activator Antigen Measurement | ||
| TNF-a Production Inhibitory Activity | C117862 | TNF-a Production Inhibitory Activity | A measurement of TNF-a production inhibitory activity in a biological specimen. | TNF-a Production Inhibitory Activity Measurement | ||
| Total Amyloid Precursor Protein | C119269 | Total Amyloid Precursor Protein | A measurement of the total amyloid precursor protein present in a biological specimen. | Total Amyloid Precursor Protein Measurement | ||
| Total Iron Binding Capacity | C74718 | Total Iron Binding Capacity | A measurement of the amount of iron needed to fully saturate the transferrin in a biological specimen. | Total Iron Binding Capacity | ||
| Total Radical-Trap Antioxidant Potential | C80208 | Total Radical-Trap Antioxidant Potential | A measurement of the ability of the antioxidants in a biological specimen to buffer free radicals in a suspension. | Total Radical-Trap Antioxidant Potential Measurement | ||
| Toxic Granulation | C96641 | Toxic Granulation | A measurement of the toxic granulation in neutrophilic blood cells. | Toxic Granulation Measurement | ||
| Transferrin | C82037 | Transferrin | A measurement of the transferrin in a biological specimen. | Transferrin Measurement | ||
| Transferrin Saturation | C98792 | Iron Binding Capacity Saturation;Iron Saturation;Iron Saturation Percent;Serum Iron to TIBC Ratio;Transferrin Iron Saturation;Transferrin Saturation | A measurement of the iron bound to transferrin in a biological specimen. | Transferrin Saturation Measurement | ||
| Transforming Growth Factor Beta 1 | C117861 | Transforming Growth Factor Beta 1 | A measurement of the transforming growth factor beta 1 in a biological specimen. | Transforming Growth Factor Beta 1 Measurement | ||
| Transitional Epithelial Cells | C92251 | Transitional Epithelial Cells | A measurement of the transitional epithelial cells present in a biological specimen. | Transitional Epithelial Cells Measurement | ||
| Trichomonas | C92238 | Trichomonas | Examination of a biological specimen to detect the presence of any protozoan belonging to the Trichomonas genus. | Trichomonas Screening | ||
| Tricyclic Antidepressants | C100420 | Tricyclic Antidepressants | A measurement of tricyclic antidepressants in a biological specimen. | Tricyclic Antidepressant Measurement | ||
| Triglycerides | C64812 | Triglycerides | A measurement of the triglycerides in a biological specimen. | Triglyceride Measurement | ||
| Triiodothyronine | C74747 | Total T3;Triiodothyronine | A measurement of the total (free and bound) triiodothyronine in a biological specimen. | Triiodothyronine Measurement | ||
| Triiodothyronine Uptake | C74748 | Triiodothyronine Uptake | A measurement of the binding of triiodothyonine to thyroxine binding globulin protein in a biological specimen. | Triiodothyronine Uptake Measurement | ||
| Triiodothyronine, Free | C74787 | Free T3;Triiodothyronine, Free | A measurement of the free triiodothyronine in a biological specimen. | Free Triiodothyronine Measurement | ||
| Triiodothyronine, Reverse | C81968 | Triiodothyronine, Reverse | A measurement of the reverse triiodothyronine in a biological specimen. | Reverse Triiodothyronine Measurement | ||
| Triple Phosphate Crystals | C74756 | Triple Phosphate Crystals | A measurement of the triple phosphate crystals present in a biological specimen. | Triple Phosphate Crystal Measurement | ||
| Troponin | C111327 | Troponin | A measurement of the total troponin in a biological specimen. | Troponin Measurement | ||
| Troponin I | C74749 | Troponin I | A measurement of the actin binding troponin in a biological specimen. | Troponin I Measurement | ||
| Troponin T | C74750 | Troponin T | A measurement of the tropomyosin binding troponin in a biological specimen. | Troponin T Measurement | ||
| Tryptase | C92292 | Tryptase | A measurement of the tryptase in a biological specimen. | Tryptase Measurement | ||
| Tubular Epithelial Cells | C74775 | Renal Tubular Epithelial Cells;Tubular Epithelial Cells | A measurement of the tubular epithelial cells present in a biological specimen. | Tubular Epithelial Cell Count | ||
| Tumor Necrosis Factor | C74751 | Tumor Necrosis Factor;Tumor Necrosis Factor alpha | A measurement of the total tumor necrosis factor (cachexin) cytokine in a biological specimen. | Tumor Necrosis Factor Measurement | ||
| Turbidity | C74723 | Turbidity | A measurement of the opacity of a biological specimen. | Turbidity Measurement | ||
| Type I Collagen C-Telopeptides | C82038 | Type I Collagen C-Telopeptides;Type I Collagen X-linked C-telopeptide | A measurement of the type I collagen C-telopeptides in a biological specimen. | Type I Collagen C-Telopeptide Measurement | ||
| Type I Collagen N-Telopeptides | C82039 | Type I Collagen N-Telopeptides | A measurement of the type I collagen N-telopeptides in a biological specimen. | Type I Collagen N-Telopeptide Measurement | ||
| Type I Myeloblasts | C92283 | Type I Myeloblasts | A measurement of type I myeloblast cells per unit of a biological specimen. | Type I Myeloblasts Measurement | ||
| Type II Collagen C-Telopeptides | C82040 | Type II Collagen C-Telopeptides | A measurement of the type II collagen C-telopeptides in a biological specimen. | Type II Collagen C-Telopeptide Measurement | ||
| Type II Collagen N-Telopeptides | C82041 | Type II Collagen N-Telopeptides | A measurement of the type II collagen N-telopeptides in a biological specimen. | Type II Collagen N-Telopeptide Measurement | ||
| Type II Myeloblasts | C92284 | Type II Myeloblasts | A measurement of type II myeloblast cells per unit of a biological specimen. | Type II Myeloblasts Measurement | ||
| Type III Myeloblasts | C92285 | Type III Myeloblasts | A measurement of type III myeloblast cells per unit of a biological specimen. | Type III Myeloblasts Measurement | ||
| Tyrosine Crystals | C74683 | Tyrosine Crystals | A measurement of the tyrosine crystals present in a biological specimen. | Tyrosine Crystal Measurement | ||
| Unclassified Casts | C74776 | Unclassified Casts | A measurement of the unclassifiable casts present in a biological specimen. | Unclassified Cast Measurement | ||
| Unclassified Crystals | C74757 | Unclassified Crystals | A measurement of the unclassifiable crystals present in a biological specimen. | Unclassified Crystal Measurement | ||
| Unsaturated Iron Binding Capacity | C74719 | Unsaturated Iron Binding Capacity | A measurement of the binding capacity of unsaturated iron in a biological specimen. | Unsaturated Iron Binding Capacity Measurement | ||
| Unspecified Cells | C112241 | Unspecified Cells | A measurement of the cells not otherwise identified or specified in a biological specimen. | Count of Unspecified Cells | ||
| Unspecified Cells/Total Cells | C114225 | Unspecified Cells/Total Cells | A relative measurement (ratio or percentage) of the cells not otherwise identified or specified to total cells in a biological specimen. | Unspecified Cells to Total Cell Ratio Measurement | ||
| Urate | C64814 | Urate;Uric Acid | A measurement of the urate in a biological specimen. | Urate Measurement | ||
| Urate/Creatinine | C117866 | Urate/Creatinine | A relative measurement (ratio or percentage) of the urate to creatinine in a biological specimen. | Urate to Creatinine Ratio Measurement | ||
| Urea | C64815 | Urea | A measurement of the urea in a biological specimen. | Urea Measurement | ||
| Urea/Creatinine | C96645 | Urea/Creatinine | A relative measurement (ratio or percentage) of the urea to creatinine in a biological specimen. | Urea to Creatinine Ratio Measurement | ||
| Uric Acid Crystals | C74684 | Uric Acid Crystals | A measurement of the uric acid crystals present in a biological specimen. | Uric Acid Crystal Measurement | ||
| Urine Conductivity | C102282 | Urine Conductivity | A measurement of the urine conductivity which is a non-linear function of the electrolyte concentration in the urine. | Urine Conductivity | ||
| Urobilinogen | C64816 | Urobilinogen | A measurement of the urobilinogen in a biological specimen. | Urobilinogen Measurement | ||
| Vacuolated Lymphocytes | C111329 | Vacuolated Lymphocytes | A measurement of the vacuolated lymphocytes in a biological specimen. | Vacuolated Lymphocyte Count | ||
| Vacuolated Neutrophils | C74628 | Vacuolated Neutrophils | A measurement of the neutrophils containing small vacuoles in a biological specimen. | Vacuolated Neutrophil Count | ||
| Vanillyl Mandelic Acid | C74875 | Vanillyl Mandelic Acid;Vanilmandelic Acid | A measurement of the vanillyl mandelic acid metabolite in a biological specimen. | Vanillyl Mandelic Acid Measurement | ||
| Varicella Zoster Virus Antibody | C117867 | Varicella Zoster Virus Antibody | A measurement of the total varicella zoster virus antibody in a biological specimen. | Varicella Zoster Virus Antibody Measurement | ||
| Varicella Zoster Virus IgA Antibody | C98795 | Varicella Zoster Virus IgA Antibody | A measurement of the Varicella Zoster virus IgA antibodies in a biological specimen. | Varicella Zoster Virus IgA Antibody Measurement | ||
| Varicella Zoster Virus IgG Antibody | C98796 | Varicella Zoster Virus IgG Antibody | A measurement of the Varicella Zoster virus IgG antibodies in a biological specimen. | Varicella Zoster Virus IgG Antibody Measurement | ||
| Varicella Zoster Virus IgM Antibody | C98797 | Varicella Zoster Virus IgM Antibody | A measurement of the Varicella Zoster virus IgM antibodies in a biological specimen. | Varicella Zoster Virus IgM Antibody Measurement | ||
| Vascular Cell Adhesion Molecule 1 | C82042 | Vascular Cell Adhesion Molecule 1 | A measurement of the vascular cell adhesion molecule 1 in a biological specimen. | Vascular Cell Adhesion Molecule 1 Measurement | ||
| Vascular Endothelial Growth Factor | C92514 | Vascular Endothelial Growth Factor | A measurement of the vascular endothelial growth factor in a biological specimen. | Vascular Endothelial Growth Factor Measurement | ||
| Viscosity | C75912 | Viscosity | The resistance of a liquid to sheer forces and flow. (NCI) | Viscosity | ||
| Vitamin A | C74895 | Retinol;Vitamin A | A measurement of the Vitamin A in a biological specimen. | Vitamin A Measurement | ||
| Vitamin B12 | C64817 | Vitamin B12 | A measurement of the Vitamin B12 in a serum specimen. | Vitamin B12 Measurement | ||
| Vitamin B17 | C74897 | Amygdalin;Vitamin B17 | A measurement of the Vitamin B17 in a biological specimen. | Vitamin B17 Measurement | ||
| Vitamin B5 | C74900 | Pantothenic Acid;Vitamin B5 | A measurement of the Vitamin B5 in a biological specimen. | Vitamin B5 Measurement | ||
| Vitamin B6 | C74901 | Pyridoxine;Vitamin B6 | A measurement of the Vitamin B6 in a biological specimen. | Vitamin B6 Measurement | ||
| Vitamin B7 | C74902 | Biotin;Vitamin B7 | A measurement of the Vitamin B7 in a biological specimen. | Vitamin B7 Measurement | ||
| Vitamin B9 | C74676 | Folic Acid;Vitamin B9 | A measurement of the folic acid in a biological specimen. | Folic Acid Measurement | ||
| Vitamin C | C74903 | Ascorbic Acid;Vitamin C | A measurement of the Vitamin C in a biological specimen. | Vitamin C Measurement | ||
| Vitamin D | C84818 | Total Vitamin D;Vitamin D | A measurement of the total Vitamin D in a biological specimen. | Vitamin D Measurement | ||
| Vitamin D2 | C74904 | Ergocalciferol;Vitamin D2 | A measurement of the Vitamin D2 in a biological specimen. | Vitamin D2 Measurement | ||
| Vitamin D3 | C74905 | Cholecalciferol;Vitamin D3 | A measurement of the Vitamin D3 in a biological specimen. | Vitamin D3 Measurement | ||
| Vitamin E | C74906 | Vitamin E | A measurement of the Vitamin E in a biological specimen. | Vitamin E Measurement | ||
| Vitamin E/Cholesterol | C103448 | Vitamin E/Cholesterol | A relative measurement (ratio or percentage) of vitamin E to total cholesterol in a biological specimen. | Vitamin E to Cholesterol Ratio Measurement | ||
| Vitamin K | C74907 | Naphthoquinone;Vitamin K | A measurement of the total Vitamin K in a biological specimen. | Vitamin K Measurement | ||
| Vitamin K1 | C103449 | Phylloquinone;Phytomenadione | A measurement of the Vitamin K1 in a biological specimen. | Vitamin K1 Measurement | ||
| VLDL Cholesterol | C105589 | VLDL Cholesterol | A measurement of the very low density lipoprotein cholesterol in a biological specimen. | Very Low Density Lipoprotein Cholesterol Measurement | ||
| VLDL Particle Size | C103450 | VLDL Particle Size | A measurement of the average particle size of very-low-density lipoprotein in a biological specimen. | VLDL Particle Size Measurement | ||
| Volume | C74720 | Volume | A measurement of the volume of a biological specimen. | Volume Measurement | ||
| von Willebrand Factor | C98799 | von Willebrand Factor;von Willebrand Factor Antigen | A measurement of the von Willebrand factor in a biological specimen. | von Willebrand Factor Measurement | ||
| Waxy Casts | C74777 | Waxy Casts | A measurement of the waxy casts present in a biological specimen. | Waxy Cell Cast Measurement | ||
| WBC Casts | C74778 | WBC Casts | A measurement of the white blood cell casts present in a biological specimen. | White Blood Cell Cast Measurement | ||
| Yeast Budding | C106504 | Budding Yeast;Yeast Budding | A measurement of the budding yeast present in a biological specimen. | Budding Yeast Measurement | ||
| Yeast Cells | C74664 | Yeast Cells | A measurement of the yeast cells present in a biological specimen. | Yeast Cell Measurement | ||
| Yeast Hyphae | C92239 | Yeast Hyphae | A measurement of the yeast hyphae present in a biological specimen. | Yeast Hyphae Screening | ||
| Zinc | C80210 | Zinc | A measurement of the zinc in a biological specimen. | Zinc Measurement | ||
| Back to top | ||||||
| CL.C102580.LBSTRESC | Laboratory Test Standard Character Result (LBSTRESC) | text Extensible: Yes | C102580 | Laboratory Test Standard Character Result | Terminology relevant to the standardized results, in character format, for laboratory tests. | CDISC SDTM Laboratory Test Standard Character Result Terminology |
| BORDERLINE | C14157 | Straddling the dividing line between two categories. | Borderline | |||
| INDETERMINATE | C48658 | Inconclusive | Cannot distinguish between two or more possible values in the current context. (NCI) | Indeterminate | ||
| INVALID | C50913 | Not valid data. | Invalid Data | |||
| NEGATIVE | C38757 | A finding of normality following an examination or investigation looking for the presence of a microorganism, disease, or condition. | Negative Finding | |||
| POSITIVE | C38758 | An observation confirming something, such as the presence of a disease, condition, or microorganism. | Positive Finding | |||
| Back to top | ||||||
| CL.C99073.LAT | Laterality (LAT) | text Extensible: Yes | C99073 | Laterality | CDISC terminology for anatomical location or specimen further detailing the side(s) of interest. | CDISC SDTM Laterality Terminology |
| BILATERAL | C13332 | Affecting both sides of the body, or a pair of organs. | Bilateral | |||
| CONTRALATERAL | C25307 | Having to do with the opposite side of the body, in relation to a pre-existing reference point. | Contralateral | |||
| IPSILATERAL | C25308 | Having to do with the same side of the body, in relation to a pre-existing reference point. | Ipsilateral | |||
| LATERAL | C25230 | Situated at or extending to the side. | Lateral | |||
| LEFT | C25229 | Being or located on or directed toward the side of the body to the west when facing north. | Left | |||
| RIGHT | C25228 | Being or located on or directed toward the side of the body to the east when facing north. | Right | |||
| UNILATERAL | C68598 | Affecting one side of the body or one of a pair of organs. | Unilateral | |||
| Back to top | ||||||
| CL.C101862.LEADABN | Lead Abnormality (LEADABN) | text Extensible: Yes | C101862 | Lead Abnormality | Terminology related to the complications of cardiac lead systems. | CDISC SDTM Lead Abnormality Terminology |
| CONDUCTOR FAILURE | C99924 | Conductor failure manifests by high lead impedance either absolutely (above manufacturer's product specifications) or by a significant increase from previously stable chronic values. | Cardiac Device Conductor Failure | |||
| DEFIBRILLATION ISSUES | C99922 | The cardiac lead is not performing as expected with issues such as oversensing with or without shock or ATP, or failed shocks or inadequate DFT safety margins defibrillation activity. | Cardiac Defibrillator Issue | |||
| EXTRACARDIAC STIMULATION | C99951 | This manifests as stimulation by the lead of non-cardiac structures such as the diaphragm, chest wall, or pectoral muscle. | Extracardiac Stimulation | |||
| FAILED TO SHOCK WITH INADEQUATE DFT SAFETY MARGIN | C99954 | The cardiac lead failed to administer a shock and had an inadequate defibrillator threshold safety margin. | Failure to Shock with Inadequate Defibrillator Threshold Safety Margin | |||
| FAILURE TO CAPTURE WITH ACCEPTABLE SAFETY MARGIN | C99953 | Failure to capture manifests as a high pacing threshold that results in either intermittent failure to capture at maximal programmed output or excessive battery drain leading to premature battery exhaustion. | Failure to Capture with Acceptable Safety Margin | |||
| FAILURE TO PACE | C99528 | Failure to pace manifests as absence of pacemaker stimulation artifacts on electrocardiographic recordings despite rates below pacemaker programmed rate. | Failure of Cardiac Pacemaker to Pace | |||
| INSULATION FAILURE | C99932 | Insulation failure manifests as low lead impedance either absolutely (below manufacturer's product specifications) or by a significant decrease from previously stable chronic values. | Cardiac Lead Insulation Failure | |||
| LEAD DISLODGEMENT REQUIRING REPOSITION/REOPERATION | C100034 | The movement (macroscopic or microscopic) of an existing lead within the heart or vascular tree away from the original implantation site. | Cardiac Lead Dislodgement Requiring Reposition/Reoperation | |||
| OVERSENSING | C99926 | Oversensing manifests as sensing of electrical signals not related to cardiac depolarization of the lead chamber that cannot be resolved acceptably by device reprogramming. | Cardiac Device Oversensing | |||
| OVERSENSING WITH SHOCK OR ATP | C99927 | This manifests as sensing of non-cardiac depolarization signals that met arrhythmia detection criteria and elicited programmed tachyarrhythmia therapy. | Cardiac Device Oversensing with Shock or Anti-Tachycardia Pacing | |||
| OVERSENSING WITHOUT SHOCK OR ATP | C99928 | This manifests as sensing of non-cardiac depolarization signals that did not meet arrhythmia detection criteria and do not elicit programmed tachyarrhythmia therapy. | Cardiac Device Oversensing without Shock or Anti-Tachycardia Pacing | |||
| SET SCREW PROBLEM | C99929 | The pacing and/or sensing problem associated with high impedance due to a poor connection between a lead and generator caused by a loose set screw. | Cardiac Device Set Screw Problem | |||
| UNDERSENSING | C99930 | Undersensing manifests as failure to sense appropriate cardiac depolarizations that cannot be resolved with reprogramming. | Cardiac Device Undersensing | |||
| Back to top | ||||||
| CL.C101867.LEADSTAT | Lead Status (LEADSTAT) | text Extensible: Yes | C101867 | Lead Status | The status of the lead. | CDISC SDTM Lead Status Terminology |
| ABANDONED | C99906 | The lead has been left in situ but is not in use. | Abandoned Lead | |||
| EXTRACTED | C102283 | The lead has been removed from the body. | Extracted Lead | |||
| REUSED | C102284 | The lead has been left in situ and reused. | Reused Lead | |||
| Back to top | ||||||
| CL.C101868.LVEFMRE | Left Ventricular Ejection Fraction Measurement Result (LVEFMRE) | text Extensible: Yes | C101868 | Left Ventricular Ejection Fraction Measurement Result | Terminology for results of left ventricular ejection fraction assessments. | CDISC SDTM Left Ventricular Ejection Fraction Measurement Result Terminology |
| HYPERDYNAMIC | C99512 | A pathologically high percentage of blood that is forced from the heart ventricle to produce cardiac output. This is often the result of ventricular dilation due to hypertrophic cardiomyopathy. Quantitatively, the ejection fraction is considered higher than 70%. | Hyperdynamic Ventricular Ejection Fraction | |||
| MILD DYSFUNCTION | C99507 | Slightly less than normal amount of blood that is forced from the heart ventricle to produce cardiac output. Quantitatively, the ejection fraction is considered between 40% to 49%. | Mildly Abnormal Ejection Fraction | |||
| MODERATE DYSFUNCTION | C99508 | Moderately less than normal amount of blood that is forced from the heart ventricle to produce cardiac output. Quantitatively, the ejection fraction is considered between 30% to 39%. | Moderately Abnormal Ejection Fraction | |||
| NORMAL EJECTION FRACTION | C99513 | The usual amount of blood that is forced from the heart ventricle to produce cardiac output. Quantitatively, the ejection fraction is considered between 50% to 70%. | Normal Ventricular Ejection Fraction | |||
| SEVERE DYSFUNCTION | C99509 | Severely less than normal amount of blood that is forced from the heart ventricle to produce cardiac output. Quantitatively, the ejection fraction is considered less than 30%. | Severely Abnormal Ventricular Ejection Fraction | |||
| Back to top | ||||||
| CL.C101861.LSNCMPX | Lesion Complexity (LSNCMPX) | text Extensible: No | C101861 | Lesion Complexity | Terminology related to the risk of percutaneous coronary intervention for a particular lesion. | CDISC SDTM Lesion Complexity Terminology |
| ACC/AHA LESION COMPLEXITY SCORE A | C100037 | Low Risk | Discrete (less than 10 mm length) and concentric and readily accessible and non-angulated segment less than 45 degrees and smooth contour and little or no calcification and less than totally occlusive and not ostial in location and no major branch involvement and absence of thrombus. | American College of Cardiology/American Heart Association Lesion Complexity Score A | ||
| ACC/AHA LESION COMPLEXITY SCORE B | C100038 | Medium Risk | Tubular (10-20 mm length) or eccentric or moderate tortuosity of proximal segment or moderately angulated segment, 45-90 degrees or irregular contour or moderate to heavy calcification or ostial in location or bifurcation lesions requiring double guidewires or some thrombus present or total occlusion less than3 months old. | American College of Cardiology/American Heart Association Lesion Complexity Score B | ||
| ACC/AHA LESION COMPLEXITY SCORE C | C100039 | High Risk | Diffuse (length greater than 2cm) or excessive tortuosity of proximal segment or extremely angulated segments greater than 90 degrees or total occlusions greater than 3 months old and/or bridging collaterals or inability to protect major side branches or degenerated vein grafts with friable lesions. | American College of Cardiology/American Heart Association Lesion Complexity Score C | ||
| Back to top | ||||||
| CL.C101851.GRSTNLOC | Location of Most Severe Stenosis Within a Graft (GRSTNLOC) | text Extensible: No | C101851 | Location of Most Severe Stenosis Within a Graft | Terminology used to describe the part of the graft that is most severely stenotic. | CDISC SDTM Location of Most Severe Stenosis Within a Graft Terminology |
| AORTIC ANASTOMOSIS OF THE GRAFT | C99915 | The connection where the graft joins the aorta usually less than or equal to 3 mm from insertion point. | Aortic Anastomosis of Graft | |||
| BODY OF THE GRAFT | C99918 | The portion of the graft that lies between its anastomoses. | Body of Graft | |||
| CORONARY ANASTOMOSIS OF THE GRAFT | C80476 | Coronary Graft Anastomoses | The connection where the graft joins the coronary artery usually less than or equal to 3 mm from insertion point. | Coronary Graft Anastomoses | ||
| Back to top | ||||||
| CL.C76348.MARISTAT | Marital Status (MARISTAT) | text Extensible: Yes | C76348 | Marital Status | A demographic parameter indicating a person's current conjugal status. | CDISC SDTM Marital Status Terminology |
| ANNULLED | C76240 | Marriage contract has been declared null and to not have existed. (HL7) | Annulled | |||
| DIVORCED | C51776 | Marriage contract has been declared dissolved and inactive. (HL7) | Divorced | |||
| DOMESTIC PARTNER | C53262 | Domestic Partner | Person declares that a domestic partnership relationship exists. (HL7) | Domestic Partnership | ||
| INTERLOCUTORY | C76241 | Temporary order issued during the course of litigation. (HL7) | Interlocutory Marital Status | |||
| LEGALLY SEPARATED | C51777 | A person living apart from his/her spouse by legal arrangement. (HL7) | Separated | |||
| MARRIED | C51773 | A current marriage contract is active. (HL7) | Married | |||
| NEVER MARRIED | C51774 | No marriage contract has ever been entered. (HL7) | Never Married | |||
| POLYGAMOUS | C76242 | More than 1 current spouse. (HL7) | Polygamous | |||
| WIDOWED | C51775 | The spouse has died. (HL7) | Widowed | |||
| Back to top | ||||||
| CL.C101845.MCRCSPTM | Mechanical Circulatory Support Placement Timing (MCRCSPTM) | text Extensible: No | C101845 | Mechanical Circulatory Support Placement Timing | A terminology codelist to describe the timing of mechanical circulatory support placement. | CDISC SDTM Mechanical Circulatory Support Placement Timing Terminology |
| IN PLACE AT START OF PROCEDURE | C99981 | In Place at Start of Procedure | Mechanical Circulatory Support was in place at the start of the procedure. | Mechanical Circulatory Support in Place at Start of Procedure | ||
| INSERTED DURING A NON-PERCUTANEOUS CORONARY INTERVENTION PROCEDURE | C99962 | Inserted during a Non PCI Procedure | Mechanical Circulatory Support was inserted during a non-Percutaneous Coronary Intervention (PCI) procedure. | Inserted During a Non-Percutaneous Coronary Intervention | ||
| INSERTED DURING PROCEDURE AND AFTER PERCUTANEOUS CORONARY INTERVENTION STARTED | C99964 | Inserted during Procedure and after PCI Started | Mechanical Circulatory Support was inserted during the procedure after Percutaneous Coronary Intervention (PCI) started. | Inserted During Procedure and After Percutaneous Coronary Intervention Began | ||
| INSERTED DURING PROCEDURE BUT PRIOR TO PERCUTANEOUS CORONARY INTERVENTION | C99963 | Inserted during Procedure but Prior to PCI | Mechanical Circulatory Support was inserted during the procedure prior to percutaneous coronary intervention (PCI). | Inserted During a Procedure but Prior to Percutaneous Coronary Intervention | ||
| Back to top | ||||||
| CL.C96777.MEDEVAL | Medical Evaluator (MEDEVAL) | text Extensible: Yes | C96777 | Medical Evaluator | The individual responsible for the medical assessment. | CDISC SDTM Medical Evaluator Terminology |
| ADJUDICATOR | C96561 | An individual that presides over and arbitrates between individuals or organizations. | Adjudicator | |||
| NEUROLOGIST | C17721 | A physician who specializes in diagnosing and treating diseases and disorders of the nervous system. | Neurologist | |||
| NEUROLOGIST 1 | C96692 | A neurologist performing the assessment that is given the designation of one. | Neurologist 1 | |||
| NEUROLOGIST 2 | C96606 | A neurologist performing the assessment that is given the designation of two. | Neurologist 2 | |||
| ONCOLOGIST | C17821 | A physician who specializes in diagnosing and treating cancer. (NCI) | Oncologist | |||
| ONCOLOGIST 1 | C96611 | An oncologist performing the assessment that is given the designation of one. | Oncologist 1 | |||
| ONCOLOGIST 2 | C96612 | An oncologist performing the assessment that is given the designation of two. | Oncologist 2 | |||
| RADIOLOGIST | C17824 | A physician who specializes in the diagnostic and/or therapeutic uses of radiation. (NCI) | Radiologist | |||
| RADIOLOGIST 1 | C94530 | A radiologist performing the assessment that is given the designation of one. | Radiologist 1 | |||
| RADIOLOGIST 2 | C94531 | A radiologist performing the assessment that is given the designation of two. | Radiologist 2 | |||
| READER | C28747 | An individual who takes non-quantifiable data and provides quantifiable assessments for that data. | Reader | |||
| READER 1 | C94532 | A reader performing the assessment that is given the designation of one. | Reader 1 | |||
| READER 2 | C94533 | A reader performing the assessment that is given the designation of two. | Reader 2 | |||
| Back to top | ||||||
| CL.C85492.METHOD | Method (METHOD) | text Extensible: Yes | C85492 | Method | Method is any technique or procedure (an action) that determines how an observation or clinical finding was made. | CDISC SDTM Method Terminology |
| ACID FAST STAIN | C23015 | A microscopy staining method used to examine a specimen for the presence of acid-fast microorganisms, specifically mycobacteria. | Acid Fast Bacillae Staining Method | |||
| ACRIDINE ORANGE STAIN | C85554 | A microscopy staining method that utilizes acridine orange, a fluorescent cationic dye that is selective for nucleic acids, to determine the presence of viable cells or microorganisms in a sample. Acridine orange interacts with RNA and DNA and the lysosomal compartment of cells. | Acridine Orange Staining Method | |||
| AGAR DILUTION | C85555 | A method to determine microbial susceptibility to antibiotics in which test bacteria is inoculated onto agar plates with serial dilutions of know quantities of antibiotics. The minimum inhibitory concentration of antibiotic is assessed. | Agar Dilution Method | |||
| ALCIAN BLUE AND PERIODIC ACID SCHIFF STAIN | C92304 | A microscopy staining method that utilizes periodic acid, an oxoacid of iodine, Schiff reagent, the reaction product of fuchsine and sodium bisulfite, and Alcian blue, a water soluble copper phthalocyanine dye. This staining method is used to differentially stain glycoproteins. | Alcian Blue and Periodic Acid Schiff Staining Method | |||
| ALCIAN BLUE STAIN | C92299 | A microscopy staining method that utilizes alcian blue, a cationic, water soluble copper-containing phthalocyanine dye to determine the presence of acid mucopolysaccharides and glycosaminoglycans. | Alcian Blue Staining Method | |||
| ANGIOGRAPHY | C20080 | A method used to create an image of blood vessels. | Angiography | |||
| ANTIBIOTIC AGAR SCREEN | C85557 | A method used to detect organisms that have resistance to a single concentration of antibiotics in an agar matrix. | Antibiotic Agar Screening Method | |||
| ANTIMICROBIAL COMBINATION TESTING | C85558 | A method to determine the microbial susceptibility to two or more antibiotics. Numerical result translated into indifference, antagonism, synergism, or additive. | Antimicrobial Combination Testing Method | |||
| ATOMIC ABSORPTION SPECTROMETRY | C85574 | A spectrometric method that determines the type and concentration of metal elements in a sample, based upon the principle that each elemental metal absorbs a particular wavelength of ultraviolet light when exposed to heat. | Atomic Absorption Spectroscopy | |||
| AUDIOMETRY | C38036 | Testing conducted utilizing a manual or microprocessor audiometer to test for hearing loss. | Audiometric Test | |||
| AURAMINE STAIN | C102599 | Auramine O | A microscopy acid fast staining method that utilizes auramine O, a bright yellow ketonimine dye, which binds to the mycolic acid in the cell walls of acid fast microorganisms. | Auramine Staining Method | ||
| AUSCULTATION | C85573 | Listening with a device, such as a stethoscope, to anatomical locations that produce audible sounds like the heart, lungs and abdomen. | Auscultation | |||
| BAC ACGH | C116157 | BAC Array-based CGH;Bacterial Artificial Chromosome Array-based CGH;Bacterial Artificial Chromosome Array-based Comparative Genomic Hybridization | A molecular cytogenetic method combining chromosomal comparative genomic hybridization technique and microarray to detect chromosomal aberrations and changes in DNA copy numbers, using bacterial artificial chromosome clones containing target DNA fragments for hybridization. | Bacterial Artificial Chromosome Array-based Comparative Genomic Hybridization | ||
| BETA LACTAMASE | C85576 | A test that detects beta lactamase produced by Staphylococcus species, Haemophilus species, Moraxella catarrhalis, and Neisseria gonorrhoeae. | Beta Lactamase Screening Method | |||
| BIOPSY | C15189 | The removal of tissue specimens or fluid from the living body for microscopic examination, performed to establish a diagnosis. | Biopsy | |||
| CALCOFLUOR WHITE STAIN | C85577 | A microscopy staining method that utilizes calcofluor, a fluorescent dye that preferentially stains chitin and cellulose on the cell walls of fungi, parasites, and some cysts of the Pneumocystis genus. | Calcofluor White Staining Method | |||
| CALCULATION | C54125 | The procedure or activity of determining a result by mathematical or logical methods. (NCI) | Calculation | |||
| CELLULOSE TAPE | C85578 | A microbiological technique for specimen collection and mounting for microscopic examination that utilizes a cellulose-based adhesive ribbon. | Cellulose Tape Method | |||
| CHROMATOGRAPHY | C16431 | A technique for the separation of complex mixtures that relies on the differential affinities of substances for a gas or liquid mobile medium and for a stationary adsorbing medium through which they pass. | Chromatography | |||
| CISH | C40960 | Chromogenic in Situ Hybridization | A laboratory procedure that combines the sequence-specific detection aspects of FISH with the simple detection methods of immunohistochemistry. Briefly, sequence-specific probes are hybridized to cells fixed on slides and the sequestered probe is visualized by a peroxidase reaction. It has the advantage of being a less costly assay that does not require fluorescence microscopy with results that are stable over time. | Chromogenic In Situ Hybridization | ||
| CLIP | C111163 | Cross-Linking and Immunoprecipitation | A type of immunoprecipitation protocol that employs UV-light induced covalent cross-linking of molecules (for instance protein and RNA) prior to the immunoprecipitation and purification steps. | Cross-Linking and Immunoprecipitation | ||
| CLIP SEQUENCING | C116152 | CLIP-Seq;Cross-linking Immunoprecipitation High-throughput Sequencing;HITS-CLIP | A molecular biology method combining crosslinking-immunoprecipitation and high-throughput sequencing techniques to detect and map RNA-protein interactions. | Cross-linking Immunoprecipitation High-throughput Sequencing | ||
| CLOT DETECTION | C111095 | Any of several methods used to detect the presence of or quantify the formation of a thrombus in a specimen. (NCI) | Clot Detection | |||
| COLORIMETRY | C111096 | A method to measure the absorbance of visible wavelengths of light using a colorimeter. | Colorimetry | |||
| CONTRAST ENHANCED MRI | C46087 | A technique that uses radiofrequency waves and a magnet to image the body. The images are enhanced by the addition of contrast agents which selectively intensify anatomical regions to intensify the clarity of the image for diagnostic purposes. (NCI) | Contrast-enhanced Magnetic Resonance Imaging | |||
| CORONARY ANGIOGRAPHY | C100085 | A procedure in which the catheter is passed into the aortic root or other great vessels for the purpose of angiography of the native coronary arteries or bypass grafts supplying native coronary arteries. | Coronary Angiography | |||
| CT SCAN | C17204 | CT;Computed Tomography | A series of detailed pictures of areas inside the body; the pictures are created by a computer linked to an x-ray machine. | Computed Tomography | ||
| DARK FIELD MICROSCOPY | C85837 | A microscopic technique in which the light that does not come into contact with the structure or details of interest is subtracted from the ocular image. This yields an image in which the structure or details are alight while the areas where the structures or details are absent are dark. | Dark Field Microscopy | |||
| DIGITAL PCR ARRAY | C116158 | Digital PCR;Digital Polymerase Chain Reaction;dPCR | A technique used to deliver high-throughput digital PCR. The digital array partitions a sample premixed with PCR reagents into hundreds of individual PCR reactions, which allows the absolute quantification of target sequences and rare allele detection, as compared to conventional real-time quantitative PCR. | Digital Array | ||
| DIPSTICK | C106516 | A strip of composite material that is coated or impregnated with reagents designed to detect the presence of an analyte in a liquid by producing a color change. | Dipstick | |||
| DIRECT SEQUENCING | C116154 | A technique used to identify the sequence of individual nucleotides in a single strand of DNA fragment template which does not require subcloning and can be a plasmid insert, genomic DNA or a PCR product. | Direct Sequencing | |||
| DISK DIFFUSION | C85595 | A method to determine microbial susceptibility to antibiotics in which filter paper disks containing known concentrations of antibiotics are placed on the agar surface that has been previously inoculated with the bacteria of interest. Microbial susceptibility is assessed by measuring the area around the disk that is free of microbial growth. | Disk Diffusion Method | |||
| DNA MICROARRAY | C18158 | DNA Chip;Gene Chip;Gene Expression Array | An orderly array of DNA samples affixed to a support. The chip is used in various types of hybridization experiments. Used when a more specific microarray methodology is not specified. | DNA Microarray Chip | ||
| DXA SCAN | C48789 | A technique for scanning bone and measuring bone mineral density (BMD). | Dual X-ray Absorptiometry | |||
| DYNAMIC CONTRAST ENHANCED MRI | C62665 | A type of contrast-enhanced MRI that allows observation of functional properties in addition to structural properties. | Dynamic Contrast-Enhanced Magnetic Resonance Imaging | |||
| DYNAMIC LIGHT SCATTERING | C62329 | Photon Correlation Spectroscopy;Quasi-elastic Light Scattering | A type of spectroscopy that utilizes a laser beam to irradiate a sample containing particles in suspension, resulting in light scattering. | Photon Correlation Spectroscopy | ||
| ECHOCARDIOGRAM | C16525 | A procedure that uses high-frequency sound waves (ultrasound) to create an image of the heart. | Echocardiography | |||
| EEG | C38054 | ELECTROENCEPHALOGRAPHY | A technique used to capture and record spontaneous electrical activity of the brain by the application of electrodes to the scalp. | Electroencephalography | ||
| EIA | C17455 | Enzyme Immunoassay | Any of several immunoassay methods that use an enzyme covalently linked to an antigen or antibody as a label; the most common types are enzyme-linked immunosorbent assay (ELISA) and enzyme-multiplied immunoassay technique (EMIT). | Enzyme Immunoassay | ||
| ELASTOGRAPHY | C106517 | An ultrasound-based imaging technique used to examine the stiffness or elasticity of a tissue by applying mechanical compression or vibration to the tissue being imaged. (NCI) | Elastography | |||
| ELECTROCHEMILUMINESCENCE | C111193 | A method in which electromagnetic radiation, in the form of light emission, is generated from an electrochemical reaction in a solution. (NCI) | Electrochemiluminescence | |||
| ELECTROCHEMILUMINESCENCE IMMUNOASSAY | C111194 | A method in which electromagnetic radiation, in the form of light emission, is generated from an electrochemical reaction in a solution due to the formation of antigen-antibody complexes. | Electrochemiluminescence Immunoassay | |||
| ELECTROPHORESIS | C16536 | The motion of charged particles in a colloid under the influence of an electric field; particles with a positive charge go to the cathode and negative to the anode. | Electrophoresis | |||
| ELISA | C16553 | Enzyme-linked Immunosorbent Assay | An immunoassay for detecting and measuring antigens or antibodies in a solution; the solution is run over a surface to which immobilized antibodies specific to the substance have been attached, and if the substance is present, it will bind to the antibody layer, and its presence is verified and visualized with an application of antibodies that have been tagged in some way. | ELISA | ||
| ELISPOT | C102632 | Enzyme-linked Immunosorbent Spot Assay | A highly sensitive immunoassay capable of detecting secreted materials from individuals cells upon activation. If the material of interest is secreted in response to a particular stimulus, then the material will bind to a specific immobilized antibody. Binding is then verified and visualized by applying other antibodies that have been tagged in some way. | Enzyme-linked Immunosorbent Spot Assay | ||
| ENDOSCOPY | C16546 | An examination of the body using an endoscope. | Endoscopic Procedure | |||
| ENZYMATIC COLORIMETRY | C111195 | A type of colorimetry that makes use of an enzymatic reaction to induce a color change. (NCI) | Enzymatic Colorimetry | |||
| ENZYME MULTIPLIED IMMUNOASSAY TECHNIQUE | C111196 | EMIT | A type of homogenous immunoassay in which sample is applied to a reagent mixture of enzyme-labeled ligand, antibody, and substrate. Substrate binding to enzyme leads to inactivation and unlabeled-ligand in the sample can be quantified by colorimetric analysis. | Enzyme Multiplied Immunoassay Technique | ||
| EPSILOMETER | C85596 | A method to determine microbial susceptibility to antibiotics in which a plastic strip impregnated with the antibiotic of interest is placed on an agar plate that has been inoculated with bacteria. The antibiotic diffuses from the strip producing a concentration gradient of drug on the agar. The point at which the elliptical shaped area of growth inhibition meets the strip is the minimum inhibitory concentration of the drug of interest. | Epsilometry | |||
| ETDRS EYE CHART | C117877 | A diagrammatic method to test visual acuity which incorporates the Bailey-Lovie layout in conjunction with Sloan optotypes. | Early Treatment of Diabetic Retinopathy Study Eye Chart | |||
| FDGPET | C103400 | FDG-PET Scan | An imaging technique that utilizes positron emission tomography to produce a three-dimensional image of functional processes in the body. The system detects pairs of gamma rays emitted indirectly by a positron-emitting radionuclide (tracer), which is introduced into the body on the biologically active molecule (fludeoxyglucose) FDG. FDG is an analogue of glucose which when imaged will give tissue metabolic activity, in terms of regional glucose uptake. | FDG-Positron Emission Tomography | ||
| FISH | C17563 | Fluorescence in Situ Hybridization | A physical mapping approach that uses fluorescent tags to detect hybridization of probes within metaphase chromosomes or less condensed somatic interphase chromatin. This technique can be used for identification of chromosomal abnormalities and for gene mapping. | Fluorescence In Situ Hybridization | ||
| FLAME PHOTOMETRY | C106523 | A type of atomic spectroscopy that qualitatively or quantitatively measures select cations (particularly Na, K, Rb, Cs, Ca, Ba, Cu) by utilizing a low temperature flame capable of exciting a valence electron to an upper energy state which emits light at a wavelength unique to each cation as the electron returns to its ground state. (NCI) | Flame Photometry | |||
| FLOW CYTOMETRY | C16585 | A technique for counting, examining or sorting microscopic particles suspended in a stream of fluid. | Flow Cytometry | |||
| FLOW MICROSCOPY | C112284 | A method of measuring the number of cells in a sample by placing the cells in a fluid and passing them, in a stream, through a special light microscope that can record and analyze images of the cells to determine the presence of foreign particles, cell counts, protein aggregates and morphology information. | Flow Microscopy | |||
| FLTPET | C103401 | FLT-PET Scan | An imaging technique that utilizes positron emission tomography to produce a three-dimensional image of functional processes in the body. The system detects pairs of gamma rays emitted indirectly by a positron-emitting radionuclide (tracer), which is introduced into the body on the biologically active molecule fluoro-L-thymidine (FLT). FLT when imaged will give tissue metabolic activity, in terms of cell proliferation. | FLT-Positron Emission Tomography | ||
| FLUORESCENT IMMUNOASSAY | C17370 | Fluorescent Antibody Assay;Immunofluorescence Assay | A bioassay in which fluorescent-coupled antibodies or antigens are used to quantify or qualify a biological response to a stimulus. | Fluorescent Antibody Procedure | ||
| FLUORESCENT MICROSCOPY | C16856 | Microscopy of specimens stained with fluorescent dye (usually fluorescein isothiocyanate) or of naturally fluorescent materials, which emit light when exposed to ultraviolet or blue light. | Fluorescence Microscopy | |||
| FLUORIMETRY | C62322 | An analytical method that utilizes ultraviolet light to excite the sample and detects the fluorescence emitted during the return of the sample to its ground state. (NCI) | Fluorimetry | |||
| FUNCTIONAL MRI | C17958 | fMRI | A type of MRI that takes a series of images of an organ in quick succession and statistically analyzes the differences between the images. | Functional Magnetic Resonance Imaging | ||
| GC/MS | C111203 | Gas Chromatography/Mass Spectrometry | An analytical technique where gas chromatography is coupled with mass spectrometry in order to separate, identify, and quantify substances in a sample. (NCI) | Gas Chromatography Mass Spectrometry | ||
| GEL ELECTROPHORESIS | C18091 | A method of separating large molecules (such as DNA fragments or proteins) from a mixture of similar molecules by electrophoretic filtration through a gelatinous matrix. Subject to an electric field, each molecule in the sample mixture migrates through the matrix at a different rate, depending mainly on electrical charge and size, resulting in spatial separation within the matrix of each molecular species in the sample mixture. Agarose and acrylamide in a cylindrical tube or slab gel are commonly used media for electrophoresis of proteins and nucleic acids. | Gel Electrophoresis | |||
| GIEMSA STAIN | C85598 | A microscopy staining method that utilizes Giemsa, a mixture of ethylene blue and eosin, which forms purplish-black crystals when dried. This stain preferentially binds to the phosphate groups of DNA and aggregates at areas with an increase in adenine-thymine binding, thus leading to chromosomal staining patterns that lend themselves to g-banding analysis. Additionally Giemsa can be used as a differential stain to determine microbial cell adherence to human cells as well as in the diagnosis of malaria, spirochete, and protozoal infections. | Giemsa Staining Method | |||
| GRADIENT DIFFUSION | C85599 | A method to determine microbial susceptibility to antibiotics in which an agar plate, which has a concentration gradient of the drug within the agar, is streaked with the microorganism of interest. Microbial susceptibility as well as minimum inhibitory concentration of antibiotic is assessed. | Gradient Diffusion Method | |||
| GRAM STAIN | C23014 | A microscopy staining method for staining and identifying bacteria, based on the differential retention of a crystal violet-iodine complex within the cell membrane. Gram-positive organisms will appear blue-black or purple while Gram-negative organisms will appear red. | Gram Staining Method | |||
| HANSEL STAIN | C111205 | A microscopy staining method that uses Hansel reagent to differentiate eosinophils and neutrophils in a specimen. (NCI) | Hansel Staining Method | |||
| HEMATOXYLIN AND EOSIN STAIN | C23011 | H&E Stain | A microscopy staining method that utilizes two separate dyes, one staining the nucleus and the other staining the cytoplasm and connective tissue. Hematoxylin is a dark purplish dye that stains the chromatin (nuclear material) within the nucleus. Eosin is an orangish-pink to red dye that stains the cytoplasmic material including connective tissue and collagen. | Hematoxylin and Eosin Staining Method | ||
| HEPATITIS C VIRUS RECOMBINANT IMMUNOBLOT ASSAY | C95525 | An assay used to verify the presence of anti-HCV antibodies in a blood sample. Serum is incubated with a membrane strip on which four recombinant viral proteins are attached. The immunoblot is considered positive if two or more proteins react, and indeterminate if only one positive band is detected. (NCI) | Hepatitis C Virus Recombinant Immunoblot Assay | |||
| HIGH LEVEL AMINOGLYCOSIDE SCREEN | C85556 | A method to determine microbial susceptibility to high concentrations of aminoglycoside antibiotics. | Aminoglycoside Screening Method | |||
| HPLC | C16434 | High Performance Liquid Chromatography | Frequently referred to simply as HPLC, this form of column chromatography is used frequently in biochemistry. The analyte is forced through a column by liquid at high pressure, which decreases the time the separated components remain on the stationary phase. Less time on the column then translates to narrower peaks in the resulting chromatogram and thence to better selectivity and sensitivity. | High Performance Liquid Chromatography | ||
| HPLC/MS | C103513 | High Performance Liquid Chromatography/Mass Spectrometry | An analytical technique wherein high performance liquid chromatography is coupled to mass spectrometry in order to separate, identify, and quantify substances in a sample. | High Performance Liquid Chromatography Mass Spectrometry | ||
| IHC | C23020 | Immunohistochemistry | Immunohistochemical staining techniques allow for the visualization of antigens via the sequential application of a specific antibody to the antigen (primary antibody), a secondary antibody to the primary antibody and an enzyme complex with a chromogenic substrate. The enzymatic activation of the chromogen results in a visible reaction product at the antigen site. The specimen may then be counterstained and coverslipped. Results are interpreted using a light microscope and aid in the differential diagnosis of pathophysiological processes, which may or may not be associated with a particular antigen. | Immunohistochemistry Staining Method | ||
| IMMUNOASSAY | C16714 | An immunological procedure involving the usage of enzyme-antibody or enzyme-antigen conjugates, antienzyme antibodies, or enzyme-antienzyme complexes. | Immunoenzyme Procedure | |||
| IMMUNOBLOT | C17638 | A technique for analyzing or identifying proteins immobilized on a filter by complementary reaction with specific antibodies. (NCI) | Immunoblot Analysis | |||
| IMMUNOCHEMILUMINOMETRIC ASSAY | C111235 | Chemiluminesence Immunoassay;ICMA | An immunoassay in which the antigen-antibody complex is quantified using light emission, which is generated from a chemical reaction. | Immunochemiluminometric Assay | ||
| IMMUNOPRECIPITATION | C16724 | Antigen aggregation with antibody, in the right ratios, to cause precipitation. (NCI) | Immunoprecipitation | |||
| IMMUNORADIOMETRIC ASSAY | C111236 | IRMA | An antibody-excess, non-competition radioimmunometric assay in which ligand is sandwiched between an immobilized antibody on a solid phase and a radiolabeled antibody raised against a different epitope of the ligand. | Immunoradiometric Assay | ||
| IMMUNOTURBIDIMETRY | C106536 | A method that measures the absorbance of light from a sample which is used for quantifying an amount of analyte based on the level of turbidity produced by the formation and precipitation of an immune complex containing the analyte. (NCI) | Immunoturbidimetry | |||
| IN SITU HYBRIDIZATION | C17562 | Use of a DNA or RNA probe to detect the presence of complementary sequences in chromosomes, cells, or tissues. (NCI) | In Situ Hybridization | |||
| INDIA INK STAIN | C85642 | A microscopy staining method that utilizes India Ink, a water soluble carbon-based black ink, to determine the presence of microorganisms that are surrounded by a gelatinous capsule. This is a negative staining method in which background is stained in black and the microbes and microscopic structures of interest remain white. | India Ink Staining Method | |||
| INFRARED SPECTROMETRY | C85643 | A spectrometric method that determines the type and concentration of elements or chemicals in a sample, based upon the principle that the atoms in a sample will vibrate or rotate at a specific frequency when exposed to infrared light. | Infrared Spectrometry | |||
| INTRAVASCULAR ULTRASOUND | C99535 | IVUS | An invasive procedure in which sound waves (called ultrasound) are bounced off of vascular tissues from within the vessel and the echoes produce a picture (sonogram). | Intravascular Ultrasound | ||
| IODINE STAIN | C85649 | A microscopy staining method that utilizes Iodine, an element belonging to the halogen group, which specifically stains polysaccharides such as cellulose, chitin, glycogen, and starch a blue color. | Iodine Staining Method | |||
| IRON HEMATOXYLIN STAIN | C85650 | A microscopy staining method that utilizes a mixture of iron and hematoxylin to visualize intracellular structures in a microscopic sample. In this dye system, iron acts as a mordant to hematoxylin rendering it insoluble, thereby allowing irreversible blue-black colored dyeing to the cell nucleus. | Iron Hematoxylin Staining Method | |||
| KARYOTYPING | C16768 | The preparation, analysis, and interpretation of a karyotype, the representation of the chromosome set of a cell sample. | Karyotyping | |||
| KINETIC MICROPARTICLE IMMUNOASSAY | C111240 | A type of immunoassay in which the antigen of interest found in a biological specimen competes with a lattice of antigen-antibody complexes. Competing antigen inhibits lattice formation and decreases absorbance in proportion to the amount of antigen present in a biological specimen. (NCI) | Kinetic Microparticle Immunoassay | |||
| KINYOUN STAIN | C85651 | A microscopy acid fast staining method that utilizes kinyoun carbol fuchsin, a dye containing basic fuchsin in solution with ethyl alcohol and aqueous phenol. This acid fast staining technique does not require heating during the primary staining step involving the carbol fuchsin. | Kinyoun Staining Method | |||
| LASER CAPTURE MICRODISSECTION | C19263 | LCM;LMD;Laser Microdissection | A technique used for the highly specific and selective capture and isolation of a cell population from a heterogeneous tissue section, cytological preparation, or live cell culture. This technique uses direct visualization of the cells via microscopy as well as a laser energy source for cutting and extraction of the cells. | Laser Capture Microdissection | ||
| LC/MS | C18475 | Liquid Chromatography/Mass Spectrometry | An analytical technique wherein liquid chromatography is coupled to mass spectrometry in order to separate, identify, and quantify substances in a sample. | Liquid Chromatography Mass Spectrometry | ||
| LEAD CITRATE STAIN | C92301 | A microscopy staining method that utilizes lead citrate, a mixture of lead nitrate and sodium citrate, and has applications for electron microscopy staining. | Lead Citrate Staining Method | |||
| LIGHT MICROSCOPY | C17995 | Light microscopy is a technique for producing visible images of structures or details which are too small to be otherwise seen by the human eye. It involves passing light transmitted through or reflected from the subject through a series of lenses to be detected directly by the eye, imaged on a photographic plate, or captured digitally. | Light Microscopy | |||
| LIGHT SCATTERING SPECTROSCOPY | C20059 | LiSSP | A type of spectroscopy that measures power spectral density of surface morphology by exploiting the tendency of light to disperse into a range of directions as a result of physical interaction. | Light-Scattering Spectroscopy | ||
| LINE PROBE ASSAY | C102656 | LPA;LiPA | A microbial identification technique in which polymerase chain reaction is used to amplify specific nucleic acid sequences in a biospecimen. The product of this reaction is then applied to a nitrocellulose test strip containing complementary DNA probes. | Line Probe Assay | ||
| LOOP-MEDIATED ISOTHERMAL AMPLIFICATION | C102661 | LAMP | A type of nucleic acid amplification test in which sample DNA is exposed to a single temperature in the presence of multiple sets of primers and a polymerase with replication and high strand displacement activity. This test negates the need for thermal cyclers and may be a low cost alternative to PCR. | Loop-mediated Isothermal Amplification | ||
| LUXOL FAST BLUE AND CRESYL VIOLET STAIN | C92300 | A microscopy staining method that utilizes luxol fast blue, an alcohol soluble copper phthalocyanine dye, and cresyl violet, an organic compound that is commonly used as a counter stain, to determine the presence of myelin as well as helicobacter and campylobacter bacterial species. | Luxol Fast Blue and Cresyl Violet Staining Method | |||
| MACRO BROTH DILUTION | C85697 | A method to determine the minimum inhibitory concentration (MIC) of antibiotics in which growth media is pipetted into a test tube. Each tube contains a known concentration of drug and is inoculated with a known quantity of bacteria. The tubes are incubated for a specified period of time and each is assessed for bacterial cell growth. The drug concentration in the first tube showing no growth is known as the MIC for that antibiotic. | Macro Broth Dilution Method | |||
| MALDI | C48040 | Matrix-Assisted Laser Desorption Ionization Mass Spectrometry | A mass spectrometric technique that is used for the analysis of large biomolecules. Analyte molecules are embedded in an excess matrix of small organic molecules that show a high resonant absorption at the laser wavelength used. The matrix absorbs the laser energy, thus inducing a soft disintegration of the sample- matrix mixture into free (gas phase) matrix and analyte molecules and molecular ions. In general, only molecular ions of the analyte molecules are produced and almost no fragmentation occurs. This makes the method well suited for molecular weight determinations and mixture analysis. (CHI) | Matrix-Assisted Laser Desorption Ionization Mass Spectrometry | ||
| MALDI-TOF | C19935 | Matrix-Assisted Laser Desorption/Ionization-Time of Flight Mass Spectrometry | In MALDI-TOF, a laser pulse is fired into a protein or peptide sample contained in a light-absorbing matrix. A small explosion vaporizes and ionizes the sample. In the presence of a high electric field, peptide ions are accelerated down an evacuated flight tube. Because large particles travel more slowly than small ones, the masses of the ionized particles are determined by measuring their arrival time at the end of the tube. | Matrix-Assisted Laser Desorption/Ionization-Time of Flight Mass Spectrometry | ||
| MAMMOGRAPHY | C16818 | A type of radiography used specifically to examine breast tissue. The procedure utilizes a low-dose of x-rays or radiation to generate an image. | Mammography | |||
| MANUAL CLOT DETECTION | C111245 | A clot detection method that uses a manual means (visual discernment) to detect the presence and/or quantify the formation of a thrombus in a specimen. (NCI) | Manual Clot Detection | |||
| MAPH | C116159 | Multiplex Amplifiable Probe Hybridization | A screening method used to determine changes in complex genomes. This method uses unique short probes which are quantitatively recovered and amplified after hybridization to genomic DNA. | Multiplex Amplifiable Probe Hybridization | ||
| MASS SPECTROMETRY | C17156 | MassSpec | An analytical technique wherein ions are separated according to their ratio of charge to mass. From the mass spectrum produced, the atomic weight of the particle can be deduced. | Mass Spectrometry | ||
| MECHANICAL CLOT DETECTION | C111249 | A clot detection method that uses a mechanical means (electromagnetic mechanical or electromechanical) to detect the presence of or quantify the formation of a thrombus in a specimen. (NCI) | Mechanical Clot Detection | |||
| MICRO BROTH DILUTION | C85701 | A method to determine the minimum inhibitory concentration (MIC) of antibiotics in which growth media is pipetted into a multi-well plate. Each well contains a known concentration of drug which is inoculated with a known quantity of bacteria. The plate is incubated for a specified period of time and each well is assessed for bacterial cell growth. The drug concentration in the first well showing no growth is known as the MIC for that antibiotic. | Micro Broth Dilution Method | |||
| MICROARRAY | C44282 | A piece of glass or plastic on which different samples have been affixed at separate locations in an ordered manner thus forming a microscopic array. The samples are usually DNA fragments but may also be antibodies, other proteins, or tissues. | Microarray | |||
| MICROBIAL BIOCHEMICAL IDENTIFICATION | C51955 | Any of a number of biochemical tests performed to identify the genus and/or species of a microorganism. These may include the assessment of gram reaction or metabolic characteristics. | Bacterial Typing Procedure | |||
| MICROBIAL CONCENTRATION | C85702 | Any technique in which a sample is condensed in order to afford greater sensitivity for the detection of microorganisms. | Microbial Concentration Method | |||
| MICROBIAL CULTURE | C25300 | Culture Procedure | Any method for growing microorganisms. | Microbial Culture Procedure | ||
| MICROBIAL CULTURE, LIQUID | C102668 | A method for growing microorganisms in liquid culture media. | Microbial Liquid Culture | |||
| MICROBIAL CULTURE, SOLID | C102669 | A method for growing microorganisms in solid culture media. | Microbial Solid Culture | |||
| MICROPARTICLE ENZYME IMMUNOASSAY | C111252 | MEIA | An enzyme immunoassay that uses antigen-coated microparticles as a substrate for antibody binding. | Microparticle Enzyme Immunoassay | ||
| MICROSCOPY | C16853 | The application of microscope magnification to the study of materials that cannot be properly seen by the unaided eye. (NCI) | Microscopy | |||
| MODIFIED ACID FAST STAIN | C85736 | A microscopy staining method, that does not utilize heat in the slide preparation, used to examine a specimen for the presence of acid-fast microorganisms, specifically nocardia. | Modified Acid Fast Staining Method | |||
| MRI | C16809 | Magnetic Resonance Imaging | Imaging that uses radiofrequency waves and a strong magnetic field rather than x-rays to provide amazingly clear and detailed pictures of internal organs and tissues. The technique is valuable for the diagnosis of many pathologic conditions, including cancer, heart and vascular disease, stroke, and joint and musculoskeletal disorders. | Magnetic Resonance Imaging | ||
| MRI WITHOUT CONTRAST | C114184 | A technique that uses radiofrequency waves and a magnet to image the body, in which the images are not enhanced by the addition of contrast agents. | MRI Without Contrast | |||
| MRS | C29934 | Magnetic Resonance Spectroscopy | Magnetic resonance spectroscopy is a noninvasive imaging technique that operates by exciting and recording signals from a range of magnetic resonance frequencies, allowing the identification and quantification of several biologically significant molecules containing proton groups that resonate in the appropriate frequency range. The technique facilitates observation of the spatial distribution of metabolic patterns over a region of interest and surrounding tissue at a high spatial resolution. (NCI) | Magnetic Resonance Spectroscopic Imaging | ||
| MUGA | C38073 | A multi-gated acquisition (MUGA) scan and a form of radionuclide imaging that provides a comprehensive look at blood flow and the function of the lower chambers of the heart ventricles. (NCI) | Radionuclide Ventriculogram Scan | |||
| MULTI-SLICE SPIRAL CT | C106545 | A type of spiral computed tomography that employs multiple rows of detectors, each capable of producing a simultaneous image (slice). (NCI) | Multi-slice Spiral Computed Tomography | |||
| MULTIPLE-COMPLETE-DIGEST RESTRICTION FRAGMENT MAPPING | C116160 | Multiple Complete Digestion | A DNA mapping technique based on complete restriction enzyme digestion of a set of overlapping clones that provides highly redundant coverage of the mapping target. | Multiple Complete Digest Restriction Fragment Mapping | ||
| MULTIPLEX LIGATION-DEPENDENT PROBE AMPLIFICATION | C116161 | MLPA | A type of high-throughput , multiplex PCR method that uses a single pair of PCR primers to amplify multiple targets and to determine changes in complex genomes. | Multiplex Ligation-dependent Probe Amplification | ||
| NEPHELOMETRY | C111281 | A method to quantify the concentration of particulate matter suspended in a liquid or gas using a nephelometer. | Nephelometry | |||
| NEXT GENERATION SEQUENCING | C101293 | Massively Parallel Sequencing | Technologies that facilitate the rapid determination of the DNA sequence of large numbers of strands or segments of DNA, using spatially separated, clonally amplified DNA templates or molecules in a flow cell. | Next Generation Sequencing | ||
| NUCLEIC ACID AMPLIFICATION TEST | C20055 | NAAT | Any of a number of molecular biological techniques that are used to copy nucleic acid sequences within a specimen, leading to an increase in the number of copies of that sequence of interest. These techniques may be used for detection of a particular gene or microorganism of interest. | Nucleic Acid Amplification Test | ||
| NUCLEIC ACID HYBRIDIZATION | C16924 | A method in which single stranded nucleic acids are allowed to interact so that complexes, or hybrids, are formed by molecules with sufficiently similar, complementary sequences. By this means the degree of sequence identity can be assessed and specific sequences detected. (From Biology-online) | Nucleic Acid Hybridization | |||
| NUCLEIC ACID SEQUENCING | C18881 | The process of determining the sequence of purines and pyrimidines in nucleic acids and polynucleotides. | Nucleic Acid Sequencing | |||
| OBSERVATION | C25598 | Watching something and taking note of what happens. | Observation | |||
| OLIGO ACGH | C116156 | Oligonucleotide Array-based CGH;Oligonucleotide Array-based Comparative Genomic Hybridization | A molecular cytogenetic method combining chromosomal comparative genomic hybridization technique and microarray to detect chromosomal aberrations and changes in DNA copy numbers in the genome, using oligonucleotides as targets for hybridization. | Oligonucleotide Array-based Comparative Genomic Hybridization | ||
| OPTICAL COHERENCE TOMOGRAPHY | C20828 | Optical Coherence Tomography (OCT) combines the principles of ultrasound with the imaging performance of a microscope. OCT uses infrared light waves that reflect off the internal microstructure within the biological tissues. The frequencies and bandwidths of infrared light are orders of magnitude higher than medical ultrasound signals, resulting in greatly increased image resolution, 8-25 times greater than any existing modality. In addition to providing high-level resolutions for the evaluation of microanatomic structures OCT is also able to provide information regarding tissue composition. (NCI) | Optical Coherence Tomography | |||
| OPTICAL DENSITY MEASUREMENT | C85776 | A quantification of the amount of light that is absorbed by or transmitted through a substance. | Optical Density Measurement | |||
| OPTICAL MAPPING | C116162 | Optical Map | A technique used for constructing the ordered and high-resolution genome or chromosome sized restriction enzyme map of an organism from a single, stained DNA molecule, digested by the restriction enzyme and imaged by an optical microscope. | Optical Mapping | ||
| PALPATION | C16950 | A method of feeling with the hands during a physical examination. The health care provider touches and feels the patient's body to examine the size, consistency, texture, location and tenderness of an organ or body part. | Palpation | |||
| PANENDOSCOPY | C94528 | An endoscopic examination of the pharynx, larynx, trachea and esophagus. | Panendoscopy | |||
| PELLI-ROBSON EYE CHART | C117878 | A diagrammatic method to test visual acuity and contrast sensitivity, which uses large letters (at a 20/60 acuity) that decrease in contrast from right to left and top to bottom. | Pelli-Robson Contrast Sensitivity Eye Chart | |||
| PERCUSSION | C62298 | A diagnostic test performed on a tooth by tapping on the crown with a dental instrument. | Dental Percussion | |||
| PERIODIC ACID SCHIFF STAIN | C23019 | A microscopy staining method that utilizes Schiff's reagent, a solution composed of pararosanilin treated with sulfurous acid, which selectively reacts with and stains aldehydes pink to determine the presence of glycogen, mucin, mucoprotein, glycoprotein, as well as fungi. Periodic Acid Schiff staining is useful for outlining tissue structures such as basement membranes, capsules and blood vessels. | Periodic Acid Schiff Staining Method | |||
| PERIPHERAL ANGIOGRAPHY | C117879 | A procedure in which the catheter is passed into a peripheral vessel (usually in the groin) for the purpose of angiography of the abdomen, hands, arms, feet and legs. | Peripheral Angiography | |||
| PET SCAN | C17007 | An imaging technique for measuring the gamma radiation produced by collisions of electrons and positrons (anti-electrons) within living tissue. In positron emission tomography (PET), a subject is given a dose of a positron-emitting radionuclide attached to a metabolically active substance. A scanner reveals the tissue location of the metabolically-active substance administered. | Positron Emission Tomography | |||
| PET/CT SCAN | C103512 | An imaging technique that utilizes positron emission tomography and computed tomography in a single machine. | Positron Emission Tomography and Computed Tomography Scan | |||
| PET/MRI SCAN | C103514 | An imaging technique that utilizes positron emission tomography and magnetic resonance imaging in a single machine. | Positron Emission Tomography and Magnetic Resonance Imaging | |||
| PET/SPECT SCAN | C111297 | An imaging technique that utilizes positron emission tomography and single-photon emission computed tomography in a single machine. | Positron Emission Tomography and Single Photon Emission Computed Tomography Scan | |||
| PHASE CONTRAST MICROSCOPY | C16857 | A microscopic technique in which the amplitude shift that occurs when light passes through a specimen highlights structures or details within the specimen. | Phase-Contrast Microscopy | |||
| PHOTOGRAPHY | C94527 | The process by which an image is acquired by recording light emissions. | Photography | |||
| PHOTOMETRIC CLOT DETECTION | C111291 | A clot detection method that uses a photometric means (measuring the absorbancy of monochromatic light) to detect the presence and/or quantify the formation of a thrombus in a specimen. (NCI) | Photometric Clot Detection | |||
| PHOTOMETRY | C65109 | Measurement of the properties of light, especially luminous intensity. (NCI) | Photometry | |||
| PHYSICAL EXAMINATION | C20989 | Physical Exam | A systemic evaluation of the body and its functions using visual inspection, palpation, percussion and auscultation. The purpose is to determine the presence or absence of physical signs of disease or abnormality for an individual's health assessment. | Physical Examination | ||
| POLYMERASE CHAIN REACTION | C17003 | PCR | A method for amplifying a DNA base sequence using multiple rounds of heat denaturation of the DNA and annealing of oligonucleotide primers complementary to flanking regions in the presence of a heat-stable polymerase. This results in duplication of the targeted DNA region. Newly synthesized DNA strands can subsequently serve as additional templates for the same primer sequences, so that successive rounds of primer annealing, strand elongation, and dissociation produce rapid and highly specific amplification of the desired sequence. PCR also can be used to detect the existence of the defined sequence in a DNA sample. | Polymerase Chain Reaction | ||
| POLYSOMNOGRAPHY | C114185 | PSG | A group of tests taken during sleep to capture and record brain wave changes, eye movements, breathing rate, blood pressure, heart rate, and the electrical activity of the heart and other muscles. | Polysomnography | ||
| PYROSEQUENCING | C99481 | A DNA sequencing technique that is based on the detection of released pyrophosphate during DNA synthesis. | Pyrosequencing | |||
| QUANTITATIVE REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION | C28408 | qRT-PCR | A modified polymerase chain reaction (PCR) technique in which RNA sequences are reverse transcribed into complementary DNA (cDNA) transcripts by the enzyme reverse transcriptase. The cDNA is then amplified by a PCR reaction and quantified by comparing to a standard, using fluorescent probes. | Quantitative Reverse Transcriptase PCR | ||
| RADIAL IMMUNODIFFUSION | C119296 | A quantitative technique used to detect and estimate the concentration of an antigen by measuring the diameter of the ring of precipitation (precipitin ring) which is formed as a result of the interaction of the antigen and an antibody at optimal concentration. (NCI) | Radial Immunodiffusion | |||
| REAL-TIME POLYMERASE CHAIN REACTION ASSAY | C51962 | Quantitative PCR;Real Time-PCR;qPCR | A modified polymerase chain reaction (PCR) technique in which DNA amplification is detected and quantified as the PCR reaction progresses, through the use of fluorescent DNA probes in the reaction mixture. | Real Time PCR | ||
| REFLECTANCE SPECTROSCOPY | C19340 | The spectroscopic analysis of light reflected from a polished sample. | Reflectance or Transmission Spectroscopy | |||
| REFRACTOMETRY | C111304 | A method to measure the refractive index (propensity for light to bend) of a sample. (NCI) | Refractometry | |||
| REPRESENTATIONAL OLIGONUCLEOTIDE MICROARRAY ANALYSIS | C40211 | ROMA | A genomic microarray-based method that analyzes two restriction enzyme digested full genomes to identify regions in the genome that have undergone large scale variation. | Representational Oligonucleotide Microarray Analysis | ||
| REVERSE TRANSCRIPTASE PCR | C18136 | RT-PCR;Reverse Transcription Polymerase Chain Reaction | A molecular biology technique used to recreate and amplify complimentary DNA (cDNA) from total RNA or messenger RNA (mRNA). | Reverse Transcriptase-Polymerase Chain Reaction | ||
| RIA | C17057 | Radioimmunoassay | Radioimmunoassay (RIA) is an immunological technique, which quantitatively determines antigen and antibody concentrations, using a radioactively labeled substance (radioligand), either directly or indirectly. | Radioimmunoassay | ||
| RYAN BLUE STAIN | C85801 | A microscopy staining method that utilizes a modified trichrome stain to determine the presence of microspordial, sporulating species. This staining technique substitutes aniline blue for the fast green counterstain of the original trichrome staining method and decreased levels of phosphotungstic acid in the reagent. | Ryan Blue Staining Method | |||
| SCANNING ELECTRON MICROSCOPY | C16855 | An electron microscopy imaging technique that is utilized to examine structural components of a sample by passing electrons through a specimen that has been coated with a heavy metal. | Scanning Electron Microscopy | |||
| SCINTIGRAPHY | C62667 | An imaging technique that uses a small dose of a radioactive chemical (isotope) called a tracer that can detect sites of cancer growth, trauma, infection or degenerative disorders. The tracer, which is either injected into a vein or swallowed, travels through the bloodstream to the target organ, and emits gamma rays, which are detected by a gamma camera and analyzed by a computer to form an image of the target organ. (NCI) | Radionuclide Imaging | |||
| SEQUENCING | C116155 | A process to identify and determine the primary structure of, and the order of constituents in a biopolymer. Used when a more specific sequencing methodology is not specified. | Biopolymer Sequencing | |||
| SINGLE-SLICE SPIRAL CT | C106567 | A type of spiral computed tomography that employs only one detector and produces one image (slice). (NCI) | Single-slice Spiral Computed Tomography | |||
| SLIT LAMP | C75583 | Examination of the anterior segment of the eye using a medical instrument called a slit lamp. | Slit-lamp Examination | |||
| SLOAN LETTER EYE CHART 1.25% | C117880 | A diagrammatic method to test visual acuity that uses the Sloan optotypes and a 1.25% contrast level. | Sloan Letter Eye Chart 1.25 Percent | |||
| SLOAN LETTER EYE CHART 2.5% | C117881 | A diagrammatic method to test visual acuity that uses the Sloan optotypes and a 2.5% contrast level. | Sloan Letter Eye Chart 2.5 Percent | |||
| SMEAR | C65126 | The action of spreading a thin layer of material across a surface. | Smear | |||
| SNP ARRAY | C116151 | Genotype Chip;SNP Genotyping;SNP Probe;Single Nucleotide Polymorphism Array | A genomic microarray-based method able to detect single nucleotide polymorphisms. | Single Nucleotide Polymorphism Array | ||
| SPIRAL CT | C20645 | Spiral Computed Tomography | A method of examining body organs by scanning them with X rays and using a computer to construct a series of cross-sectional scans along a single axis. | Spiral CT | ||
| TEST STRIP | C50322 | A piece of chemically treated medium designed to react in the presence of specific amounts of a trigger substance. | Test Strip Device Component | |||
| THICK SMEAR | C85819 | A blood smear technique used to make a thick blood smear on a microscope slide which is generally used to look for blood parasites such as those causing malaria. | Thick Smear Technique | |||
| THIN SMEAR | C85820 | A blood smear technique used to make a thin blood smear on a microscope slide which is generally used to look for blood parasites such as those causing malaria. | Thin Smear Technique | |||
| TOLUIDINE BLUE STAIN | C92302 | A microscopy staining method that utilizes toluidine blue, a solution composed of tolonium chloride, to determine the presence of mast cells, lignin, proteoglycans and glycosaminoglycans. | Toluidine Blue Staining Method | |||
| TOTAL BODY IRRADIATION | C15350 | A therapeutic procedure that involves the irradiation of the whole body with ionizing or non-ionizing radiation. (NCI) | Total-Body Irradiation | |||
| TOTAL BODY RADIOGRAPHY | C96640 | A diagnostic radiologic test that involves the examination of the entire body in a single procedure. | Total Body Radiography | |||
| TRANSMISSION ELECTRON MICROSCOPY | C18216 | An electron microscopy imaging technique that is utilized to examine structural components of a sample by passing electrons through the specimen. | Transmission Electron Microscopy | |||
| TRICHROME STAIN | C23012 | A microscopy staining method that utilizes two or more colored, acidic dyes of contrasting colors. Masson trichrome is a mixture of three dyes including aniline blue, Beibrich scarlet and Weigert's iron hematoxylin. Other related, modified trichrome staining methods include Lillie's trichrome, Gomori's trichrome and Mallory's trichrome. | Trichrome Staining Method | |||
| TURBIDIMETRY | C111328 | A method to quantify the opaqueness of a liquid using a turbidimeter, by measuring the decrease in light intensity due to the scattering effect of suspended particles in the liquid sample. | Turbidimetry | |||
| TWO-COLOR MICROARRAY | C116153 | Dual-channel Microarray;Two-channel Expression Array;Two-channel Microarray;Two-color Microarray-based Gene Expression | A genomic microarray-based method using cDNA from two samples, labeled with two separate fluorophores/dyes at different emission wavelengths, and hybridized to a single microarray. The relative fluorescence intensity of each dye is being measured. | Two Color Microarray | ||
| ULTRASOUND | C17230 | A technique in which high-frequency sound waves are bounced off internal organs and the echo pattern is converted into a 2 dimensional picture of the structures beneath the transducer. | Ultrasonography | |||
| URANYL ACETATE STAIN | C92303 | A microscopy staining method that utilizes uranyl acetate, a water insoluble yellow crystalline solid, which is used as a negative stain in electron microscopy. | Uranyl Acetate Staining Method | |||
| WEBER GREEN STAIN | C85828 | A microscopy staining method that utilizes a modified trichrome stain to determine the presence of microspordial, sporulating species. The staining method utilizes chromotrope 2R, a red acidic dye, the counterstain fast green, and phosphotungstic acid. | Weber Green Staining Method | |||
| WESTERN BLOT | C16357 | A method for the detection or identification of proteins or peptides that have been separated by gel electrophoresis and transferred onto nitrocellulose or other type of paper or nylon membrane. The proteins are then detected by reaction with enzymatically labeled or radiolabeled antibody probes. | Western Blotting | |||
| WRIGHT STAIN | C85829 | A microscopy staining method that utilizes the Romanowsky stains, eosin and methylene blue, solubilized in methanol. In this staining protocol, methanol is also utilized as a fixative agent prior to staining. | Wright Staining Method | |||
| WRIGHT-GIEMSA STAIN | C23041 | A microscopy staining method that is a combination of the Wright and Giemsa staining protocols and utilizes the Romanowsky stains, which are mixtures of eosin and thiazine dyes such as methylene blue. It produces darker blue and magenta shades than the giemsa stain alone, which may provide better contrast in microscopy. | Wright-Giemsa Staining Method | |||
| X-RAY | C38101 | Radiography | A radiographic procedure using the emission of x-rays to form an image of the structure penetrated by the radiation. | Radiography | ||
| X-RAY FLUORESCENCE SPECTROMETRY | C85830 | A spectrometric method that determines the type and concentration of elements or chemicals in a sample, based upon the principle that each element emits fluorescent light of a particular wavelength when exposed to an X-ray. | X-Ray Fluorescence Spectrometry | |||
| ZIEHL NEELSEN ACID FAST STAIN | C85831 | A microscopy acid fast staining method that utilizes Ziehl-Neelsen carbol fuchsin, acid alcohol and methylene blue, to determine the presence of acid fast microorganisms. This acid fast staining technique requires heating during the primary staining step involving the carbol fuchsin. | Ziehl Neelsen Acid Fast Staining Method | |||
| Back to top | ||||||
| CL.C102581.MCIDCERT | Microbial Identification Certainty (MCIDCERT) | text Extensible: No | C102581 | Microbial Identification Certainty | Terminology relevant to the degree of certainty of the correctness of a microbial identification test result. | CDISC SDTM Microbial Identification Certainty Terminology |
| DEFINITIVE | C62607 | Supplying or being a final or conclusive settlement or result. | Definitive | |||
| PRESUMPTIVE | C102697 | Supplying or being a probable or reasonable settlement or result. | Presumptive | |||
| Back to top | ||||||
| CL.C85495.MSRESCAT | Microbiology Susceptibility Testing Result Category (MSRESCAT) | text Extensible: No | C85495 | Microbiology Susceptibility Testing Result Category | Used to categorize the result of a finding in a standard format. | CDISC SDTM Microbiology Susceptibility Testing Result Category Terminology |
| INTERMEDIATE | C85560 | Intermediate | The growth of microorganisms may be inhibited by antimicrobials that approach usually attainable blood and tissue concentrations. The response rates may be lower than for susceptible isolates. This category also includes a buffer zone, which should prevent small, uncontrolled, technical factors from causing major discrepancies in interpretations, especially for drugs with narrow pharmacotoxicity margins. | Antimicrobial Intermediate Susceptibility Result | ||
| NONSUSCEPTIBLE | C85561 | Non Susceptible | A category used for microorganisms that have only a susceptible interpretive criteria, but not an intermediate or resistant interpretive category (i.e., susceptible-only interpretive category). This category may be applied to new antimicrobial agents for which no resistant microorganisms have been encountered at the time the initial interpretive criteria are determined. Microorganisms that test with an MIC above or a zone measurement below the susceptible interpretive criteria are designated as nonsusceptible. A designation of nonsusceptible does not necessarily mean that a resistance mechanism(s) exists in the microorganism. | Antimicrobial Nonsusceptibility Result | ||
| NOT APPLICABLE | C48660 | NA;Not Applicable | Determination of a value is not relevant in the current context. (NCI) | Not Applicable | ||
| RESISTANT | C85562 | Resistant | The growth of microorganisms are not inhibited by the usually achievable concentrations of the antimicrobial agent with normal dosages, and/or microorganisms demonstrate MICs or zone diameters that fall in the range where specific microbial resistance mechanisms (e.g. Beta-lactamases) are likely, and clinical efficacy of the agent against the microorganism has not been reliably shown in treatment studies. | Antimicrobial Resistance Result | ||
| SUSCEPTIBLE | C85563 | Susceptible | The growth of microorganisms are inhibited by the usually achievable concentrations of antimicrobial agent when the recommended dosage is used for the site of infection. | Antimicrobial Susceptibility Result | ||
| SUSCEPTIBLE-DOSE DEPENDENT | C85559 | Susceptible-Dose Dependent | The growth of microorganisms may be inhibited when higher than normal dosages of an antimicrobial agent are used and maximal possible blood concentration of the antimicrobial agent is achieved. | Antimicrobial Dose Dependent Susceptibility Result | ||
| UNKNOWN | C17998 | U;Unknown | Not known, not observed, not recorded, or refused. (NCI) | Unknown | ||
| Back to top | ||||||
| CL.C85491.MICROORG | Microorganism (MICROORG) | text Extensible: Yes | C85491 | Microorganism | Microorganisms, bacteria, fungi and other organisms. | CDISC SDTM Microorganism Terminology |
| ABIOTROPHIA | C86077 | Any bacteria that is not assigned to the species level but can be assigned to the Abiotrophia genus level. | Abiotrophia | |||
| ABIOTROPHIA DEFECTIVA | C86078 | Any bacterial organism that can be assigned to the species Abiotrophia defectiva. | Abiotrophia defectiva | |||
| ABSIDIA | C119580 | Any fungal organism that is not assigned to the species level but can be assigned to the Absidia genus level. | Absidia | |||
| ACANTHAMOEBA | C118934 | Any amoebic organism that is not assigned to the species level but can be assigned to the Acanthamoeba genus level. | Acanthamoeba | |||
| ACANTHAMOEBA ASTRONYXIS | C119297 | Any amoebic organism that can be assigned to the species Acanthamoeba astronyxis. | Acanthamoeba astronyxis | |||
| ACANTHAMOEBA CASTELLANII | C119298 | Any amoebic organism that can be assigned to the species Acanthamoeba castellanii. | Acanthamoeba castellanii | |||
| ACANTHAMOEBA CULBERTSONI | C119299 | Any amoebic organism that can be assigned to the species Acanthamoeba culbertsoni. | Acanthamoeba culbertsoni | |||
| ACANTHAMOEBA GRIFFINI | C119300 | Any amoebic organism that can be assigned to the species Acanthamoeba griffini. | Acanthamoeba griffini | |||
| ACANTHAMOEBA HATCHETTI | C119301 | Any amoebic organism that can be assigned to the species Acanthamoeba hatchetti. | Acanthamoeba hatchetti | |||
| ACANTHAMOEBA LUGDUNENSIS | C119302 | Any amoebic organism that can be assigned to the species Acanthamoeba lugdunensis. | Acanthamoeba lugdunensis | |||
| ACANTHAMOEBA PALESTINENSIS | C119303 | Any amoebic organism that can be assigned to the species Acanthamoeba palestinensis. | Acanthamoeba palestinensis | |||
| ACANTHAMOEBA POLYPHAGA | C119304 | Any amoebic organism that can be assigned to the species Acanthamoeba polyphaga. | Acanthamoeba polyphaga | |||
| ACANTHAMOEBA QUINA | C119305 | Any amoebic organism that can be assigned to the species Acanthamoeba quina. | Acanthamoeba quina | |||
| ACANTHAMOEBA RHYSODES | C119306 | Any amoebic organism that can be assigned to the species Acanthamoeba rhysodes. | Acanthamoeba rhysodes | |||
| ACHROMOBACTER | C86079 | Any bacteria that is not assigned to the species level but can be assigned to the Achromobacter genus level. | Achromobacter | |||
| ACHROMOBACTER DENITRIFICANS | C86080 | ALCALIGENES DENITRIFICANS | Any bacterial organism that can be assigned to the species Achromobacter denitrificans. | Achromobacter denitrificans | ||
| ACHROMOBACTER PIECHAUDII | C86081 | Any bacterial organism that can be assigned to the species Achromobacter piechaudii. | Achromobacter piechaudii | |||
| ACHROMOBACTER RUHLANDII | C119307 | Alcaligenes ruhlandii;Hydrogenomonas ruhlandii;Pseudomonas ruhlandii | Any bacterial organism that can be assigned to the species Achromobacter ruhlandii. | Achromobacter ruhlandii | ||
| ACHROMOBACTER XYLOSOXIDANS | C86082 | ALCALIGENES XYLOSOXIDANS | Any bacterial organism that can be assigned to the species Achromobacter xylosoxidans. | Achromobacter xylosoxidans | ||
| ACIDAMINOCOCCUS | C86083 | Any bacteria that is not assigned to the species level but can be assigned to the Acidaminococcus genus level. | Acidaminococcus | |||
| ACIDAMINOCOCCUS FERMENTANS | C86084 | Any bacterial organism that can be assigned to the species Acidaminococcus fermentans. | Acidaminococcus fermentans | |||
| ACIDOVORAX | C86085 | Any bacteria that is not assigned to the species level but can be assigned to the Acidovorax genus level. | Acidovorax | |||
| ACIDOVORAX DELAFIELDII | C86086 | Any bacterial organism that can be assigned to the species Acidovorax delafieldii. | Acidovorax delafieldii | |||
| ACIDOVORAX FACILIS | C86087 | Any bacterial organism that can be assigned to the species Acidovorax facilis. | Acidovorax facilis | |||
| ACIDOVORAX TEMPERANS | C86088 | Any bacterial organism that can be assigned to the species Acidovorax temperans. | Acidovorax temperans | |||
| ACINETOBACTER | C76200 | Any bacteria that is not assigned to the species level but can be assigned to the Acinetobacter genus level. | Acinetobacter | |||
| ACINETOBACTER ANITRATUS | C86089 | ACINETOBACTER BAUMANNII;ACINETOBACTER CALCOACETICUS SUBSP. ANITRATUS | Any bacterial organism that can be assigned to the species Acinetobacter anitratus. | Acinetobacter anitratus | ||
| ACINETOBACTER CALCOACETICUS | C86090 | Any bacterial organism that can be assigned to the species Acinetobacter calcoaceticus. | Acinetobacter calcoaceticus | |||
| ACINETOBACTER CALCOACETICUS-BAUMANNII COMPLEX | C86091 | A non-taxonomic grouping of bacteria assigned to the Acinetobacter genus that include the A. calcoaceticus and A. baumannii species. | Acinetobacter calcoaceticus/baumannii Complex | |||
| ACINETOBACTER HAEMOLYTICUS | C86092 | Any bacterial organism that can be assigned to the species Acinetobacter haemolyticus. | Acinetobacter haemolyticus | |||
| ACINETOBACTER JOHNSONII | C86093 | Any bacterial organism that can be assigned to the species Acinetobacter johnsonii. | Acinetobacter johnsonii | |||
| ACINETOBACTER JUNII | C86094 | Any bacterial organism that can be assigned to the species Acinetobacter junii. | Acinetobacter junii | |||
| ACINETOBACTER LWOFFII | C86095 | ACINETOBACTER CALCOACETICUS SUBSP. LWOFFII | Any bacterial organism that can be assigned to the species Acinetobacter lwoffii. | Acinetobacter lwoffii | ||
| ACINETOBACTER PARVUS | C119308 | Acinetobacter sp. phenon 4 | Any bacterial organism that can be assigned to the species Acinetobacter parvus. | Acinetobacter parvus | ||
| ACINETOBACTER RADIORESISTENS | C86096 | Any bacterial organism that can be assigned to the species Acinetobacter radioresistens. | Acinetobacter radioresistens | |||
| ACINETOBACTER URSINGII | C119309 | Acinetobacter sp. phenon 1 | Any bacterial organism that can be assigned to the species Acinetobacter ursingii. | Acinetobacter ursingii | ||
| ACREMONIUM | C118935 | Cephalosporium | Any fungal organism that is not assigned to the species level but can be assigned to the Acremonium genus level. | Acremonium | ||
| ACREMONIUM ATROGRISEUM | C119310 | Gliomastix atrogriseum;Phaeoscopulariopsis atrogrisea | Any fungal organism that can be assigned to the species Acremonium atrogriseum. | Acremonium atrogriseum | ||
| ACTINOBACILLUS | C86097 | Any bacteria that is not assigned to the species level but can be assigned to the Actinobacillus genus level. | Actinobacillus | |||
| ACTINOBACILLUS ACTINOMYCETEMCOMITANS | C86098 | CDC GROUP HB-3 | Any bacterial organism that can be assigned to the species Actinobacillus actinomycetemcomitans. | Actinobacillus actinomycetemcomitans | ||
| ACTINOBACILLUS EQUULI | C86099 | Any bacterial organism that can be assigned to the species Actinobacillus equuli. | Actinobacillus equuli | |||
| ACTINOBACILLUS LIGNIERESII | C86100 | Any bacterial organism that can be assigned to the species Actinobacillus ligniersii. | Actinobacillus lignieresii | |||
| ACTINOBACILLUS PLEUROPNEUMONIAE | C86101 | HAEMOPHILUS PLEUROPNEUMONIAE | Any bacterial organism that can be assigned to the species Actinobacillus pleuropneumoniae. | Actinobacillus pleuropneumoniae | ||
| ACTINOBACILLUS SUIS | C86102 | Any bacterial organism that can be assigned to the species Actinobacillus suis. | Actinobacillus suis | |||
| ACTINOBACILLUS UREAE | C86103 | PASTEURELLA UREAE | Any bacterial organism that can be assigned to the species Actinobacillus ureae. | Actinobacillus ureae | ||
| ACTINOBACULUM SCHAALII | C119311 | Any bacterial organism that can be assigned to the species Actinobaculum schaalii. | Actinobaculum schaalii | |||
| ACTINOMADURA | C86104 | Any bacteria that is not assigned to the species level but can be assigned to the Actinomadura genus level. | Actinomadura | |||
| ACTINOMADURA MADURAE | C86105 | Any bacterial organism that can be assigned to the species Actinomadura madurae. | Actinomadura madurae | |||
| ACTINOMADURA PELLETIERI | C86106 | Any bacterial organism that can be assigned to the species Actinomadura pelletieri. | Actinomadura pelletieri | |||
| ACTINOMYCES | C76201 | Any bacteria that is not assigned to the species level but can be assigned to the Actinomyces genus level. | Actinomyces | |||
| ACTINOMYCES BOVIS | C86107 | ACTINOCLADOTHRIX BOVIS;CLADOTHRIX BOVIS;DISCOMYCES BOVIS;NOCARDIA BOVIS;OOSPORA BOVIS;PROACTINOMYCES BOVIS;SARCOMYCES BOVIS;SPHAEROTILUS BOVIS;STREPTOTHRIX BOVIS | Any bacterial organism that can be assigned to the species Actinomyces bovis. | Actinomyces bovis | ||
| ACTINOMYCES EUROPAEUS | C119312 | Any bacterial organism that can be assigned to the species Actinomyces europaeus. | Actinomyces europaeus | |||
| ACTINOMYCES ISRAELII | C86108 | Any bacterial organism that can be assigned to the species Actinomyces israelii. | Actinomyces israelii | |||
| ACTINOMYCES MEYERII | C86109 | Any bacterial organism that can be assigned to the species Actinomyces meyerii. | Actinomyces meyerii | |||
| ACTINOMYCES NAESLUNDII | C86110 | Any bacterial organism that can be assigned to the species Actinomyces naseslundii. | Actinomyces naeslundii | |||
| ACTINOMYCES NEUII | C86111 | Any bacterial organism that can be assigned to the species Actinomyces neuii. | Actinomyces neuii | |||
| ACTINOMYCES NEUII SUBSP. NEUII | C119313 | CDC coryneform group 1 | Any bacterial organism that can be assigned to the species Actinomyces neuii subspecies neuii. | Actinomyces neuii Subspecies neuii | ||
| ACTINOMYCES ODONTOLYTICUS | C86112 | Any bacterial organism that can be assigned to the species Actinomyces odontolyticus. | Actinomyces odontolyticus | |||
| ACTINOMYCES RADINGAE | C86113 | Any bacterial organism that can be assigned to the species Actinomyces radingae. | Actinomyces radingae | |||
| ACTINOMYCES TURICENSIS | C86114 | Any bacterial organism that can be assigned to the species Actinomyces turicensis. | Actinomyces turicensis | |||
| ACTINOMYCES VISCOSUS | C86115 | Any bacterial organism that can be assigned to the species Actinomyces viscosus. | Actinomyces viscosus | |||
| ADENOVIRUS | C14179 | Adenoviridae | Any viral organism that can be assigned to the family Adenoviridae. | Adenovirus | ||
| AEROBIC GRAM-NEGATIVE BACILLUS | C86116 | AEROBIC GRAM-NEGATIVE ROD | Any rod-shaped bacteria with an oxygen-based metabolism and has a cell wall that contains low levels of peptidoglycan and stains pink with the Gram staining technique. | Aerobic Gram Negative Bacillus | ||
| AEROBIC GRAM-NEGATIVE COCCUS | C86117 | Any spherical-shaped bacteria with an oxygen-based metabolism and a cell wall that contains low levels of peptidoglycan and stains pink with the Gram staining technique. | Aerobic Gram Negative Coccus | |||
| AEROBIC GRAM-POSITIVE BACILLUS | C86118 | AEROBIC GRAM-POSITIVE ROD | Any rod-shaped bacteria with an oxygen-based metabolism and has a peptidoglycan-rich cell wall that stains dark purple with the Gram staining technique. | Aerobic Gram Positive Bacillus | ||
| AEROBIC GRAM-POSITIVE COCCUS | C86119 | Any spherical-shaped bacteria with an oxygen-based metabolism and a peptidoglycan-rich cell wall that stains dark purple with the Gram staining technique. | Aerobic Gram Positive Coccus | |||
| AEROBIC STREPTOCOCCUS | C86120 | Any bacteria assigned to the genus Streptococcus that requires oxygen to grow or respirate. | Aerobic Streptococcus | |||
| AEROCOCCUS | C86121 | GAFFKYA SPECIES | Any bacteria that is not assigned to the species level but can be assigned to the Aerococcus genus level. | Aerococcus | ||
| AEROCOCCUS SANGUINICOLA | C119314 | Any bacterial organism that can be assigned to the species Aerococcus sanguinicola. | Aerococcus sanguinicola | |||
| AEROCOCCUS URINAE | C86122 | Any bacterial organism that can be assigned to the species Aerococcus urinae. | Aerococcus urinae | |||
| AEROCOCCUS VIRIDANS | C86123 | Any bacterial organism that can be assigned to the species Aerococcus viridans. | Aerococcus viridans | |||
| AEROMONAS | C86124 | Any bacteria that is not assigned to the species level but can be assigned to the Aeromonas genus level. | Aeromonas | |||
| AEROMONAS HYDROPHILA | C86125 | AEROMONAS HYDROPHILA GROUP | Any bacterial organism that can be assigned to the species Aeromonas hydrophila. | Aeromonas hydrophila | ||
| AEROMONAS JANDAEI | C86126 | Any bacterial organism that can be assigned to the species Aeromonas jandaei. | Aeromonas jandaei | |||
| AEROMONAS PUNCTATA | C86127 | AEROMONAS CAVIAE | Any bacterial organism that can be assigned to the species Aeromonas punctata. | Aeromonas punctata | ||
| AEROMONAS SALMONICIDA | C86128 | Any bacterial organism that can be assigned to the species Aeromonas salmonicida. | Aeromonas salmonicida | |||
| AEROMONAS SCHUBERTII | C86129 | Any bacterial organism that can be assigned to the species Aeromonas schubertii. | Aeromonas schubertii | |||
| AEROMONAS SOBRIA | C86130 | Any bacterial organism that can be assigned to the species Aeromonas sobria. | Aeromonas sobria | |||
| AEROMONAS VERONII | C86131 | Any bacterial organism that can be assigned to the species Aeromonas veronii. | Aeromonas veronii | |||
| AGGREGATIBACTER | C86132 | Any bacteria that is not assigned to the species level but can be assigned to the Aggregatibacter genus level. | Aggregatibacter | |||
| AGGREGATIBACTER ACTINOMYCETEMCOMITANS | C86133 | HAEMOPHILUS ACTINOMYCETEMCOMITANS | Any bacterial organism that can be assigned to the species Aggregatibacter actinomycetemcomitans. | Aggregatibacter actinomycetemcomitans | ||
| AGGREGATIBACTER APHROPHILUS | C86134 | BETA-LACTAMASE NEGATIVE HAEMOPHILUS PARAPHROPHILUS;CDC GROUP HB-2;HAEMOPHILUS APHROPHILUS;HAEMOPHILUS PARAPHROPHILUS | Any bacterial organism that can be assigned to the species Aggregatibacter aphrophilus. | Aggregatibacter aphrophilus | ||
| AGGREGATIBACTER APHROPHILUS, BETA-LACTAMASE NEGATIVE | C119315 | Haemophilus Aphrophilus, Beta-Lactamase Negative | Any bacterial organism that can be assigned to the species Aggregatibacter aphrophilus and is beta-lactamase negative. | Aggregatibacter aphrophilus, Beta-lactamase Negative | ||
| AGGREGATIBACTER APHROPHILUS, BETA-LACTAMASE POSITIVE | C119316 | Haemophilus Aphrophilus, Beta-Lactamase Positive | Any bacterial organism that can be assigned to the species Aggregatibacter aphrophilus and is beta-lactamase positive. | Aggregatibacter aphrophilus, Beta-lactamase Positive | ||
| AGGREGATIBACTER APHROPHILUS, PENICILLINASE NEGATIVE | C119317 | Haemophilus Aphrophilus, Penicillinase Negative | Any bacterial organism that can be assigned to the species Aggregatibacter aphrophilus and is penicillinase negative. | Aggregatibacter aphrophilus, Penicillinase Negative | ||
| AGGREGATIBACTER APHROPHILUS, PENICILLINASE POSITIVE | C119318 | Haemophilus Aphrophilus, Penicillinase Positive | Any bacterial organism that can be assigned to the species Aggregatibacter aphrophilus and is penicillinase positive. | Aggregatibacter aphrophilus, Penicillinase Positive | ||
| AGGREGATIBACTER SEGNIS | C86135 | HAEMOPHILUS SEGNIS | Any bacterial organism that can be assigned to the species Aggregatibacter segnis. | Aggregatibacter segnis | ||
| AGROBACTERIUM | C86011 | Any bacteria that is not assigned to the species level but can be assigned to the Agrobacterium genus level. | Agrobacterium | |||
| AGROBACTERIUM RADIOBACTER | C86137 | Any bacterial organism that can be assigned to the species Agrobacterium radiobacter. | Agrobacterium radiobacter | |||
| AGROBACTERIUM TUMEFACIENS | C86138 | CDC GROUP VD-3;RHIZOBIUM RADIOBACTER | Any bacterial organism that can be assigned to the species Agrobacterium tumefaciens. | Agrobacterium tumefaciens | ||
| AJELLOMYCES CAPSULATUS | C77186 | Any fungal organism that can be assigned to the species Ajellomyces capsulatus. | Ajellomyces capsulatus | |||
| ALCALIGENES | C86012 | Any bacteria that is not assigned to the species level but can be assigned to the Alcaligenes genus level. | Alcaligenes | |||
| ALCALIGENES FAECALIS | C86140 | ALCALIGENES ODORANS | Any bacterial organism that can be assigned to the species Alcaligenes faecalis. | Alcaligenes faecalis | ||
| ALISTIPES | C86870 | Any bacterial organism that is not assigned to the species level but can be assigned to the Alistipes genus level. | Alistipes | |||
| ALISTIPES PUTREDINIS | C86871 | BACTEROIDES PUTREDINIS | Any bacterial organism that can be assigned to the species Alistipes putredinis. | Alistipes putredinis | ||
| ALISTIPES SHAHII | C114246 | Any bacterial organism that can be assigned to the species Alistipes shahii. | Alistipes shahii | |||
| ALPHACORONAVIRUS | C119319 | Coronavirus Group 1 | Any viral organism that is not assigned to the species level but can be assigned to the Alphacoronavirus genus level. | Alphacoronavirus | ||
| ALPHAVIRUS | C112030 | Arboviruses Group A | Any viral organism that can be assigned to the genus Alphavirus. | Alphavirus | ||
| ALTERNARIA | C119320 | Any fungal organism that is not assigned to the species level but can be assigned to the Alternaria genus level. | Alternaria | |||
| AMOEBA | C119581 | Ameba | Any protozoan organism that is not assigned to the species level but can be assigned to the Amoeba genus level. | Amoeba | ||
| ANAEROBIC BACTERIA | C119321 | Anaerobe | Any bacterial organism that does not require oxygen to grow or respirate and cannot be assigned to a specific genus or species. | Anaerobic Bacteria | ||
| ANAEROBIC COCCUS | C119322 | Any spherical shaped bacterial organism that does not require oxygen to grow or respirate and cannot be assigned to a specific genus or species. | Anaerobic Coccus | |||
| ANAEROBIC GRAM-NEGATIVE BACILLUS | C86142 | ANAEROBIC GRAM-NEGATIVE ROD | Any rod-shaped bacteria that does not require oxygen to grow or respirate and has a cell wall that contains low levels of peptidoglycan and stains pink with the Gram staining technique. | Anaerobic Gram Negative Bacillus | ||
| ANAEROBIC GRAM-NEGATIVE BACTERIA | C119323 | Gram-negative Anaerobe | Any bacterial organism that does not require oxygen to grow or respirate, cannot be assigned to a specific genus or species, and has a cell wall that contains low levels of peptidoglycan and stains pink with the Gram staining technique. | Anaerobic Gram-negative Bacteria | ||
| ANAEROBIC GRAM-NEGATIVE COCCUS | C86143 | Any spherical-shaped bacteria that does not require oxygen to grow or respirate and has a cell wall that contains low levels of peptidoglycan and stains pink with the Gram staining technique. | Anaerobic Gram Negative Coccus | |||
| ANAEROBIC GRAM-POSITIVE BACILLUS | C86144 | ANAEROBIC GRAM-POSITIVE ROD | Any rod-shaped bacteria that does not require oxygen to grow or respirate and has a peptidoglycan-rich cell wall that stains dark purple with the Gram staining technique. | Anaerobic Gram Positive Bacillus | ||
| ANAEROBIC GRAM-POSITIVE COCCUS | C86145 | Any spherical-shaped bacteria that does not require oxygen to grow or respirate and has a peptidoglycan-rich cell wall that stains dark purple with the Gram staining technique. | Anaerobic Gram Positive Coccus | |||
| ANAEROBIC STREPTOCOCCUS | C86146 | Any bacteria assigned to the genus Streptococcus that does not require oxygen to grow or respirate. | Anaerobic Streptococcus | |||
| ANAEROCOCCUS | C86872 | Any bacteria that is not assigned to the species level but can be assigned to the Anaerococcus genus level. | Anaerococcus | |||
| ANAEROCOCCUS HYDROGENALIS | C86874 | PEPTOSTREPTOCOCCUS HYDROGENALIS | Any bacterial organism that can be assigned to the species Anaerococcus hydrogenalis. | Anaerococcus hydrogenalis | ||
| ANAEROCOCCUS PREVOTII | C86875 | Any bacterial organism that can be assigned to the species Anaerococcus prevotii. | Anaerococcus prevotii | |||
| ANAEROCOCCUS TETRADIUS | C86876 | GAFFKYA ANAEROBIA;PEPTOSTREPTOTOCCUS TETRADIUS | Any bacterial organism that can be assigned to the species Anaerococcus tetradius. | Anaerococcus tetradius | ||
| ANAEROCOCCUS VAGINALIS | C86877 | Any bacterial organism that can be assigned to the species Anaerococcus vaginalis. | Anaerococcus vaginalis | |||
| APHTHOVIRUS | C112229 | Any viral organism that can be assigned to the genus Aphthovirus. | Aphthovirus | |||
| ARBOVIRUS | C112230 | Arthropod-Borne Virus | A non-taxonomic grouping of viruses that are transmitted through an arthropod vector and replicate in a vertebrate host. | Arbovirus | ||
| ARCANOBACTERIUM | C86147 | Any bacteria that is not assigned to the species level but can be assigned to the Arcanobacterium genus level. | Arcanobacterium | |||
| ARCANOBACTERIUM BERNARDIAE | C86148 | Any bacterial organism that can be assigned to the species Arcanobacterium bernardiae. | Arcanobacterium bernardiae | |||
| ARCANOBACTERIUM HAEMOLYTICUM | C86149 | CORYNEBACTERIUM HAEMOLYTICUM;CORYNEBACTERIUM HAEMOLYTICUS | Any bacterial organism that can be assigned to the species Arcanobacterium haemolyticum. | Arcanobacterium haemolyticum | ||
| ARCANOBACTERIUM PYOGENES | C86150 | ACTINOMYCES PYOGENES;CORYNEBACTERIUM PYOGENES | Any bacterial organism that can be assigned to the species Arcanobacterium pyogenes. | Arcanobacterium pyogenes | ||
| ARCOBACTER | C86152 | Any bacteria that is not assigned to the species level but can be assigned to the Arcobacter genus level. | Arcobacter | |||
| ARCOBACTER BUTZLERI | C86153 | CAMPYLOBACTER BUTZLERI | Any bacterial organism that can be assigned to the species Arcobacter butzleri. | Arcobacter butzleri | ||
| ARCOBACTER CRYAEROPHILUS | C86154 | CAMPYLOBACTER CRYAEROPHILUS | Any bacterial organism that can be assigned to the species Arcobacter cryaerophilus. | Arcobacter cryaerophilus | ||
| ARENAVIRUS | C14306 | Any viral organism that can be assigned to the genus Arenavirus. | Arenavirus | |||
| ARTHROBACTER | C86155 | Any bacteria that is not assigned to the species level but can be assigned to the Arthrobacter genus level. | Arthrobacter | |||
| ARTHROBACTER CUMMINSII | C114248 | Any bacterial organism that can be assigned to the species Arthrobacter cumminsii. | Arthrobacter cumminsii | |||
| ASTROVIRUS | C112231 | Astroviridae | Any viral organism that can be assigned to the family Astroviridae. | Astroviridae | ||
| ATOPOBIUM MINUTUM | C86156 | LACTOBACILLUS MINUTIS;LACTOBACILLUS MINUTUS | Any bacterial organism that can be assigned to the species Atopobium minutum. | Atopobium minutum | ||
| ATOPOBIUM PARVULUM | C86157 | STREPTOCOCCUS PARVULUS | Any bacterial organism that can be assigned to the species Atopobium parvulum. | Atopobium parvulum | ||
| ATOPOBIUM RIMAE | C114244 | Lactobacillus rimae | Any bacterial organism that can be assigned to the species Atopobium rimae. | Atopobium rimae | ||
| AVIBACTERIUM PARAGALLINARUM | C86158 | HAEMOPHILUS PARAGALLINARUM | Any bacterial organism that can be assigned to the species Avibacterium paragallinarum. | Avibacterium paragallinarum | ||
| BACILLUS | C76202 | Any bacteria that is not assigned to the species level but can be assigned to the Bacillus genus level. | Bacillus | |||
| BACILLUS ALVEI | C86159 | Any bacterial organism that can be assigned to the species Bacillus alvei. | Bacillus alvei | |||
| BACILLUS ANTHRACIS | C86160 | Any bacterial organism that can be assigned to the species Bacillus anthracis. | Bacillus anthracis | |||
| BACILLUS CEREUS | C86161 | Any bacterial organism that can be assigned to the species Bacillus cereus. | Bacillus cereus | |||
| BACILLUS LENTUS | C86162 | Any bacterial organism that can be assigned to the species Bacillus lentus. | Bacillus lentus | |||
| BACILLUS LICHENIFORMIS | C86163 | Any bacterial organism that can be assigned to the species Bacillus licheniformis. | Bacillus licheniformis | |||
| BACILLUS MEGATERIUM | C86164 | Any bacterial organism that can be assigned to the species Bacillus megaterium. | Bacillus megaterium | |||
| BACILLUS MYCOIDES | C86165 | Any bacterial organism that can be assigned to the species Bacillus mycoides. | Bacillus mycoides | |||
| BACILLUS POLYMYXA | C86166 | Any bacterial organism that can be assigned to the species Bacillus polymyxa. | Bacillus polymyxa | |||
| BACILLUS SUBTILIS | C86167 | Any bacterial organism that can be assigned to the species Bacillus subtilis. | Bacillus subtilis | |||
| BACTERIA | C14187 | BACTERIUM;EUBACTERIA | Any organism assigned to the kingdom Bacteria. | Bacteria | ||
| BACTEROIDES | C76204 | Any bacteria that is not assigned to the species level but can be assigned to the Bacteroides genus level. | Bacteroides | |||
| BACTEROIDES CACCAE | C86168 | BACTEROIDES FRAGILIS GROUP 3452A | Any bacterial organism that can be assigned to the species Bacteroides caccae. | Bacteroides caccae | ||
| BACTEROIDES CAPILLOSUS | C86169 | Any bacterial organism that can be assigned to the species Bacteroides capillosus. | Bacteroides capillosus | |||
| BACTEROIDES CELLULOSOLVENS | C86170 | Any bacterial organism that can be assigned to the species Bacteroides cellulosolvens. | Bacteroides cellulosolvens | |||
| BACTEROIDES DOREI | C111133 | Any bacterial organism that can be assigned to the species Bacteroides dorei. | Bacteroides dorei | |||
| BACTEROIDES EGGERTHII | C86171 | Any bacterial organism that can be assigned to the species Bacteroides eggerthii. | Bacteroides eggerthii | |||
| BACTEROIDES FAECIS | C111134 | Any bacterial organism that can be assigned to the species Bacteroides faecis. | Bacteroides faecis | |||
| BACTEROIDES FRAGILIS | C86172 | Any bacterial organism that can be assigned to the species Bacteroides fragilis. | Bacteroides fragilis | |||
| BACTEROIDES FRAGILIS GROUP | C86173 | A bacteria that belongs to the Fragilis group of the genus Bacteroides. | Bacteroides fragilis Group | |||
| BACTEROIDES INTESTINALIS | C119324 | Any bacterial organism that can be assigned to the species Bacteroides intestinalis. | Bacteroides intestinalis | |||
| BACTEROIDES NORDII | C86174 | Any bacterial organism that can be assigned to the species Bacteroides nordii. | Bacteroides nordii | |||
| BACTEROIDES OVATUS | C86175 | Any bacterial organism that can be assigned to the species Bacteroides ovatus. | Bacteroides ovatus | |||
| BACTEROIDES STERCORIS | C86177 | BACTEROIDES FRAGILIS SUBSP. A | Any bacterial organism that can be assigned to the species Bacteroides stercoris. | Bacteroides stercoris | ||
| BACTEROIDES TECTUS | C86178 | BACTEROIDES TECTUM | Any bacterial organism that can be assigned to the species Bacteroides tectus. | Bacteroides tectus | ||
| BACTEROIDES THETAIOTAOMICRON | C86179 | Any bacterial organism that can be assigned to the species Bacteroides thetaiotamicron. | Bacteroides thetaiotaomicron | |||
| BACTEROIDES UNIFORMIS | C86180 | Any bacterial organism that can be assigned to the species Bacteroides uniformis. | Bacteroides uniformis | |||
| BACTEROIDES UREOLYTICUS | C86181 | BACTEROIDES CORRODENS | Any bacterial organism that can be assigned to the species Bacteroides ureolyticus. | Bacteroides ureolyticus | ||
| BACTEROIDES VULGATUS | C86182 | Any bacterial organism that can be assigned to the species Bacteroides vulgatus. | Bacteroides vulgatus | |||
| BARMAH FOREST VIRUS | C112232 | Any viral organism that can be assigned to the species Barmah Forest virus. | Barmah Forest Virus | |||
| BARTONELLA | C86184 | Any bacteria that is not assigned to the species level but can be assigned to the Bartonella genus level. | Bartonella | |||
| BARTONELLA ELIZABETHAE | C86185 | ROCHALIMAEA ELIZABETHAE | Any bacterial organism that can be assigned to the species Bartonella elizabethae. | Bartonella elizabethae | ||
| BARTONELLA HENSELAE | C86186 | ROCHALIMAEA HENSELAE | Any bacterial organism that can be assigned to the species Bartonella henselae. | Bartonella henselae | ||
| BARTONELLA QUINTANA | C86187 | ROCHALIMAEA QUINTANA | Any bacterial organism that can be assigned to the species Bartonella quintana. | Bartonella quintana | ||
| BERGEYELLA | C86188 | Any bacteria that is not assigned to the species level but can be assigned to the Bergeyella genus level. | Bergeyella | |||
| BERGEYELLA ZOOHELCUM | C86189 | WEEKSELLA ZOOHELCUM | Any bacterial organism that can be assigned to the species Bergeyella zoohelcum. | Bergeyella zoohelcum | ||
| BETA STREPTOCOCCUS, GROUP C | C86191 | A non-taxonomic grouping of beta-hemolytic species within the Streptococcus genus that are assigned to the C group. | Beta Streptococcus Group C | |||
| BETA STREPTOCOCCUS, GROUP F | C86192 | A non-taxonomic grouping of beta-hemolytic species within the Streptococcus genus that are assigned to the F group. | Beta Streptococcus Group F | |||
| BETA STREPTOCOCCUS, GROUP G | C86193 | A non-taxonomic grouping of beta-hemolytic species within the Streptococcus genus that are assigned to the G group. | Beta Streptococcus Group G | |||
| BIFIDOBACTERIUM | C86194 | Any bacteria that is not assigned to the species level but can be assigned to the Bifidobacterium genus level. | Bifidobacterium | |||
| BIFIDOBACTERIUM ADOLESCENTIS | C86195 | Any bacterial organism that can be assigned to the species Bifidobacterium adolescentis. | Bifidobacterium adolescentis | |||
| BIFIDOBACTERIUM ANGULATUM | C86196 | Any bacterial organism that can be assigned to the species Bifidobacterium angulatum. | Bifidobacterium angulatum | |||
| BIFIDOBACTERIUM BIFIDUM | C86197 | Any bacterial organism that can be assigned to the species Bifidobacterium bifidum. | Bifidobacterium bifidum | |||
| BIFIDOBACTERIUM DENTIUM | C86198 | BIFIDOBACTERIUM APPENDICITIS | Any bacterial organism that can be assigned to the species Bifidobacterium dentium. | Bifidobacterium dentium | ||
| BIFIDOBACTERIUM LONGUM | C86199 | Any bacterial organism that can be assigned to the species Bifidobacterium longum. | Bifidobacterium longum | |||
| BILOPHILA | C86200 | Any bacteria that is not assigned to the species level but can be assigned to the Bilophila genus level. | Bilophila | |||
| BILOPHILA WADSWORTHIA | C86201 | Any bacterial organism that can be assigned to the species Bilophila wadsworthia. | Bilophila wadsworthia | |||
| BK POLYOMAVIRUS | C89820 | BK Virus | Any viral organism that can be assigned to the species BK polyomavirus. | BK Virus | ||
| BORDETELLA | C86202 | Any bacteria that is not assigned to the species level but can be assigned to the Bordetella genus level. | Bordetella | |||
| BORDETELLA AVIUM | C86203 | Any bacterial organism that can be assigned to the species Bordetella avium. | Bordetella avium | |||
| BORDETELLA BRONCHISEPTICA | C86204 | BORDETELLA BRONCHICANIS | Any bacterial organism that can be assigned to the species Bordetella bronchiseptica. | Bordetella bronchiseptica | ||
| BORDETELLA PARAPERTUSSIS | C86205 | Any bacterial organism that can be assigned to the species Bordetella parapertussis. | Bordetella parapertussis | |||
| BORDETELLA PERTUSSIS | C76205 | Any bacterial organism that can be assigned to the species Bordetella pertussis. | Bordetella pertussis | |||
| BORRELIA | C86206 | Any bacteria that is not assigned to the species level but can be assigned to the Borrelia genus level. | Borrelia | |||
| BORRELIA BURGDORFERI | C76208 | Any bacterial organism that can be assigned to the species Borrelia burgdorferi. | Borrelia burgdorferi | |||
| BREVIBACILLUS | C86207 | Any bacteria that is not assigned to the species level but can be assigned to the Brevibacillus genus level. | Brevibacillus | |||
| BREVIBACILLUS LATEROSPORUS | C86208 | Any bacterial organism that can be assigned to the species Brevibacillus laterosporus. | Brevibacillus laterosporus | |||
| BREVIBACTERIUM | C86209 | Any bacteria that is not assigned to the species level but can be assigned to the Brevibacterium genus level. | Brevibacterium | |||
| BREVIBACTERIUM CASEI | C86210 | Any bacterial organism that can be assigned to the species Brevibacterium casei. | Brevibacterium casei | |||
| BREVIBACTERIUM EPIDERMIDIS | C86211 | Any bacterial organism that can be assigned to the species Brevibacterium epidermidis. | Brevibacterium epidermidis | |||
| BREVUNDIMONAS | C86212 | Any bacteria that is not assigned to the species level but can be assigned to the Brevundimonas genus level. | Brevundimonas | |||
| BREVUNDIMONAS DIMINUTA | C86213 | PSEUDOMONAS DIMINUTA | Any bacterial organism that can be assigned to the species Brevundimonas diminuta. | Brevundimonas diminuta | ||
| BREVUNDIMONAS VESICULARIS | C86214 | PSEUDOMONAS VESICULARIS | Any bacterial organism that can be assigned to the species Brevundimonas vesicularis. | Brevundimonas vesicularis | ||
| BRUCELLA | C86215 | Any bacteria that is not assigned to the species level but can be assigned to the Brucella genus level. | Brucella | |||
| BRUCELLA ABORTUS | C86216 | Any bacterial organism that can be assigned to the species Brucella abortus. | Brucella abortus | |||
| BRUCELLA CANIS | C86217 | Any bacterial organism that can be assigned to the species Brucella canis. | Brucella canis | |||
| BRUCELLA MELITENSIS | C86218 | Any bacterial organism that can be assigned to the species Brucella melitensis. | Brucella melitensis | |||
| BRUCELLA SUIS | C86219 | Any bacterial organism that can be assigned to the species Brucella suis. | Brucella suis | |||
| BUDVICIA | C86220 | Any bacteria that is not assigned to the species level but can be assigned to the Budvicia genus level. | Budvicia | |||
| BUDVICIA AQUATICA | C86221 | Any bacterial organism that can be assigned to the species Budvicia aquatica. | Budvicia aquatica | |||
| BURKHOLDERIA | C86222 | Any bacteria that is not assigned to the species level but can be assigned to the Burkholderia genus level. | Burkholderia | |||
| BURKHOLDERIA CENOCEPACIA | C86223 | Any bacterial organism that can be assigned to the species Burkholderia cenocepacia. | Burkholderia cenocepacia | |||
| BURKHOLDERIA CEPACIA | C76376 | CDC GROUP EO-1;PSEUDOMONAS CEPACIA | Any bacterial organism that can be assigned to the species Burkholderia cepacia. | Burkholderia cepacia | ||
| BURKHOLDERIA CEPACIA COMPLEX | C86224 | A non-taxonomic grouping of bacteria assigned to and including at least nine related species from the Burkholderia genus. | Burkholderia cepacia Complex | |||
| BURKHOLDERIA GLADIOLI | C86225 | PSEUDOMONAS GLADIOLI | Any bacterial organism that can be assigned to the species Burkholderia gladioli. | Burkholderia gladioli | ||
| BURKHOLDERIA MALLEI | C86226 | ACTINOBACILLUS MALLEI | Any bacterial organism that can be assigned to the species Burkholderia mallei. | Burkholderia mallei | ||
| BURKHOLDERIA PSEUDOMALLEI | C86227 | BURKHOLDERIA PSEUDOMALLE;PSEUDOMONAS PSEUDOMALLEI | Any bacterial organism that can be assigned to the species Burkholderia pseudomallei. | Burkholderia pseudomallei | ||
| BUTTIAUXELLA | C86228 | Any bacteria that is not assigned to the species level but can be assigned to the Buttiauxella genus level. | Buttiauxella | |||
| BUTTIAUXELLA AGRESTIS | C86229 | Any bacterial organism that can be assigned to the species Buttiauxella agrestis. | Buttiauxella agrestis | |||
| CALICIVIRUS | C14304 | Caliciviridae | Any viral organism that can be assigned to the family Caliciviridae. | Calicivirus | ||
| CAMPYLOBACTER | C76211 | Any bacteria that is not assigned to the species level but can be assigned to the Campylobacter genus level. | Campylobacter | |||
| CAMPYLOBACTER COLI | C86230 | Any bacterial organism that can be assigned to the species Campylobacter coli. | Campylobacter coli | |||
| CAMPYLOBACTER CONCISUS | C86231 | CDC GROUP EF-22 | Any bacterial organism that can be assigned to the species Campylobacter concisus. | Campylobacter concisus | ||
| CAMPYLOBACTER CURVUS | C86232 | WOLINELLA CURVA | Any bacterial organism that can be assigned to the species Campylobacter curvus. | Campylobacter curvus | ||
| CAMPYLOBACTER FETUS | C86233 | VIBRIO FETUS | Any bacterial organism that can be assigned to the species Campylobacter fetus. | Campylobacter fetus | ||
| CAMPYLOBACTER GRACILIS | C86234 | BACTEROIDES GRACILIS | Any bacterial organism that can be assigned to the species Campylobacter gracilis. | Campylobacter gracilis | ||
| CAMPYLOBACTER JEJUNI | C86235 | Any bacterial organism that can be assigned to the species Campylobacter jejuni. | Campylobacter jejuni | |||
| CAMPYLOBACTER LARI | C86236 | CAMPYLOBACTER LARIDIS | Any bacterial organism that can be assigned to the species Campylobacter lari. | Campylobacter lari | ||
| CAMPYLOBACTER RECTUS | C86237 | WOLINELLA RECTA | Any bacterial organism that can be assigned to the species Campylobacter rectus. | Campylobacter rectus | ||
| CAMPYLOBACTER UPSALIENSIS | C86238 | Any bacterial organism that can be assigned to the species Campylobacter upsaliensis. | Campylobacter upsaliensis | |||
| CANDIDA ALBICANS | C77170 | C. albicans | Any fungal organism that can be assigned to the species Candida albicans. | Candida albicans | ||
| CANDIDA DUBLINIENSIS | C114255 | C. dubliniensis | Any fungal organism that can be assigned to the species Candida dubliniensis. | Candida dubliniensis | ||
| CANDIDA GLABRATA | C77179 | C. glabrata;Torulopsis glabrata | Any fungal organism that can be assigned to the species Candida glabrata. | Candida glabrata | ||
| CANDIDA ORTHOPSILOSIS | C114260 | C. orthopsilosis;Candida parapsilosis group II | Any fungal organism that can be assigned to the species Candida orthopsilosis. | Candida orthopsilosis | ||
| CANDIDA PARAPSILOSIS | C77176 | C. parapsilosis | Any fungal organism that can be assigned to the species Candida parapsilosis. | Candida parapsilosis | ||
| CANDIDA PARARUGOSA | C114258 | C. pararugosa | Any fungal organism that can be assigned to the species Candida pararugosa. | Candida pararugosa | ||
| CANDIDA RUGOSA | C114254 | C. rugosa | Any fungal organism that can be assigned to the species Candida rugosa. | Candida rugosa | ||
| CANDIDA TROPICALIS | C77177 | C. tropicalis | Any fungal organism that can be assigned to the species Candida tropicalis. | Candida tropicalis | ||
| CANDIDA ZEYLANOIDES | C114261 | C. krissii;C. zeylanoides;Candida krissii | Any fungal organism that can be assigned to the species Candida zeylanoides. | Candida zeylanoides | ||
| CAPNOCYTOPHAGA | C76269 | Any bacteria that is not assigned to the species level but can be assigned to the Capnocytophaga genus level. | Capnocytophaga | |||
| CAPNOCYTOPHAGA CANIMORSUS | C86239 | CDC GROUP DF-2 | Any bacterial organism that can be assigned to the species Capnocytophaga canimorsus. | Capnocytophaga canimorsus | ||
| CAPNOCYTOPHAGA GINGIVALIS | C86240 | Any bacterial organism that can be assigned to the species Capnocytophaga gingivalis. | Capnocytophaga gingivalis | |||
| CAPNOCYTOPHAGA OCHRACEA | C86241 | Any bacterial organism that can be assigned to the species Capnocytophaga ochracea. | Capnocytophaga ochracea | |||
| CAPNOCYTOPHAGA SPUTIGENA | C86242 | Any bacterial organism that can be assigned to the species Capnocytophaga sputigena. | Capnocytophaga sputigena | |||
| CARDIOBACTERIUM | C86243 | Any bacteria that is not assigned to the species level but can be assigned to the Cardiobacterium genus level. | Cardiobacterium | |||
| CARDIOBACTERIUM HOMINIS | C86244 | CDC GROUP IID | Any bacterial organism that can be assigned to the species Cardiobacterium hominis. | Cardiobacterium hominis | ||
| CEDECEA | C86245 | Any bacteria that is not assigned to the species level but can be assigned to the Cedecea genus level. | Cedecea | |||
| CEDECEA DAVISAE | C86246 | CDC ENTERIC GROUP 15 | Any bacterial organism that can be assigned to the species Cedecea davisae. | Cedecea davisae | ||
| CEDECEA LAPAGEI | C86247 | Any bacterial organism that can be assigned to the species Cedecea lapagei. | Cedecea lapagei | |||
| CEDECEA NETERI | C86248 | CEDECEA SPECIES 4 | Any bacterial organism that can be assigned to the species Cedecea neteri. | Cedecea neteri | ||
| CELLULOMONAS | C86249 | Any bacteria that is not assigned to the species level but can be assigned to the Cellulomonas genus level. | Cellulomonas | |||
| CELLULOMONAS HOMINIS | C86250 | Any bacterial organism that can be assigned to the species Cellulomonas hominis. | Cellulomonas hominis | |||
| CELLULOSIMICROBIUM | C86251 | Any bacteria that is not assigned to the species level but can be assigned to the Cellulosimicrobium genus level. | Cellulosimicrobium | |||
| CELLULOSIMICROBIUM CELLULANS | C86252 | ARTHROBACTER LUTEUS;CELLULOMONAS CELLULANS;NOCARDIA CELLULANS;OERSKOVIA XANTHINEOLYTICA | Any bacterial organism that can be assigned to the species Cellulosimicrobium cellulans. | Cellulosimicrobium cellulans | ||
| CHLAMYDIA | C76271 | Any bacteria that is not assigned to the species level but can be assigned to the Chlamydia genus level. | Chlamydia | |||
| CHLAMYDIA TRACHOMATIS | C86253 | Any bacterial organism that can be assigned to the species Chlamydia trachomatis. | Chlamydia trachomatis | |||
| CHLAMYDOPHILA | C86254 | Any bacteria that is not assigned to the species level but can be assigned to the Chlamydophila genus level. | Chlamydophila | |||
| CHLAMYDOPHILA PNEUMONIAE | C76272 | CHLAMYDIA PNEUMONIAE | Any bacterial organism that can be assigned to the species Chlamydophila pneumoniae. | Chlamydophila pneumoniae | ||
| CHLAMYDOPHILA PSITTACI | C86255 | CHLAMYDIA PSITTACI | Any bacterial organism that can be assigned to the species Chlamydophila psittaci. | Chlamydophila psittaci | ||
| CHROMOBACTERIUM | C86256 | Any bacteria that is not assigned to the species level but can be assigned to the Chromobacterium genus level. | Chromobacterium | |||
| CHROMOBACTERIUM VIOLACEUM | C86257 | Any bacterial organism that can be assigned to the species Chromobacterium violaceum. | Chromobacterium violaceum | |||
| CHRYSEOBACTERIUM | C86258 | Any bacteria that is not assigned to the species level but can be assigned to the Chryseobacterium genus level. | Chryseobacterium | |||
| CHRYSEOBACTERIUM GLEUM | C86259 | FLAVOBACTERIUM GLEUM | Any bacterial organism that can be assigned to the species Chryseobacterium gleum. | Chryseobacterium gleum | ||
| CHRYSEOBACTERIUM INDOLOGENES | C86260 | FLAVOBACTERIUM INDOLOGENES | Any bacterial organism that can be assigned to the species Chryseobacterium indologenes. | Chryseobacterium indologenes | ||
| CHRYSEOMONAS | C86261 | Any bacteria that is not assigned to the species level but can be assigned to the Chryseomonas genus level. | Chryseomonas | |||
| CITROBACTER | C76273 | Any bacteria that is not assigned to the species level but can be assigned to the Citrobacter genus level. | Citrobacter | |||
| CITROBACTER AMALONATICUS | C86262 | LEVINEA AMALONATICA | Any bacterial organism that can be assigned to the species Citrobacter amalonaticus. | Citrobacter amalonaticus | ||
| CITROBACTER BRAAKII | C86263 | Any bacterial organism that can be assigned to the species Citrobacter braakii. | Citrobacter braakii | |||
| CITROBACTER FARMERI | C86264 | CITROBACTER AMALONATICUS BIOGROUP 1 | Any bacterial organism that can be assigned to the species Citrobacter farmeri. | Citrobacter farmeri | ||
| CITROBACTER FREUNDII | C86265 | COLOBACTRUM FREUNDII | Any bacterial organism that can be assigned to the species Citrobacter freundii. | Citrobacter freundii | ||
| CITROBACTER FREUNDII COMPLEX | C86266 | A non-taxonomic grouping of bacteria assigned to and including eight related species from the Citrobacter genus. | Citrobacter freundii Complex | |||
| CITROBACTER KOSERI | C86267 | CITROBACTER DIVERSUS | Any bacterial organism that can be assigned to the species Citrobacter koseri. | Citrobacter koseri | ||
| CITROBACTER YOUNGAE | C86268 | Any bacterial organism that can be assigned to the species Citrobacter youngae. | Citrobacter youngae | |||
| CLAVISPORA LUSITANIAE | C77174 | C. lusitaniae;Candida lusitaniae | Any fungal organism that can be assigned to the species Clavispora lusitaniae. | Clavispora lusitaniae | ||
| CLOSTRIDIUM | C76275 | Any bacteria that is not assigned to the species level but can be assigned to the Clostridium genus level. | Clostridium | |||
| CLOSTRIDIUM ACETOBUTYLICUM | C86269 | Any bacterial organism that can be assigned to the species Clostridium acetobutylicum. | Clostridium acetobutylicum | |||
| CLOSTRIDIUM BARATII | C86270 | CLOSTRIDIUM BARATI | Any bacterial organism that can be assigned to the species Clostridium baratii. | Clostridium baratii | ||
| CLOSTRIDIUM BEIJERINCKII | C86271 | Any bacterial organism that can be assigned to the species Clostridium beijerinckii. | Clostridium beijerinckii | |||
| CLOSTRIDIUM BIFERMENTANS | C86272 | Any bacterial organism that can be assigned to the species Clostridium bifermentans. | Clostridium bifermentans | |||
| CLOSTRIDIUM BOLTEAE | C114250 | Any bacterial organism that can be assigned to the species Clostridium bolteae. | Clostridium bolteae | |||
| CLOSTRIDIUM BUTYRICUM | C86273 | CLOSTRIDIUM PSEUDOTETANICUM | Any bacterial organism that can be assigned to the species Clostridium butyricum. | Clostridium butyricum | ||
| CLOSTRIDIUM CADAVERIS | C86274 | Any bacterial organism that can be assigned to the species Clostridium cadaveris. | Clostridium cadaveris | |||
| CLOSTRIDIUM CELATUM | C86275 | Any bacterial organism that can be assigned to the species Clostridium celatum. | Clostridium celatum | |||
| CLOSTRIDIUM CLOSTRIDIOFORME | C86276 | CLOSTRIDIUM CLOSTRIDIIFORME | Any bacterial organism that can be assigned to the species Clostridium clostridioforme. | Clostridium clostridioforme | ||
| CLOSTRIDIUM COCHLEARIUM | C86277 | Any bacterial organism that can be assigned to the species Clostridium cochlearium. | Clostridium cochlearium | |||
| CLOSTRIDIUM COCLEATUM | C86278 | Any bacterial organism that can be assigned to the species Clostridium cocleatum. | Clostridium cocleatum | |||
| CLOSTRIDIUM DIFFICILE | C76276 | CLOSTRIDIUM DIFFICILIS | Any bacterial organism that can be assigned to the species Clostridium difficile. | Clostridium difficile | ||
| CLOSTRIDIUM FALLAX | C86279 | CLOSTRIDIUM PSEUDOFALLAX | Any bacterial organism that can be assigned to the species Clostridium fallax. | Clostridium fallax | ||
| CLOSTRIDIUM GLYCOLICUM | C86280 | Any bacterial organism that can be assigned to the species Clostridium glycolicum. | Clostridium glycolicum | |||
| CLOSTRIDIUM HAEMOLYTICUM | C86281 | Any bacterial organism that can be assigned to the species Clostridium haemolyticum. | Clostridium haemolyticum | |||
| CLOSTRIDIUM HATHEWAYI | C114251 | Any bacterial organism that can be assigned to the species Clostridium hathewayi. | Clostridium hathewayi | |||
| CLOSTRIDIUM HISTOLYTICUM | C86282 | Any bacterial organism that can be assigned to the species Clostridium histolyticum. | Clostridium histolyticum | |||
| CLOSTRIDIUM INNOCUUM | C86283 | Any bacterial organism that can be assigned to the species Clostridium innocuum. | Clostridium innocuum | |||
| CLOSTRIDIUM LIMOSUM | C86284 | CLOSTRIDIUM SPECIES CDC GROUP P-1 | Any bacterial organism that can be assigned to the species Clostridium limosum. | Clostridium limosum | ||
| CLOSTRIDIUM NOVYI | C86285 | Any bacterial organism that can be assigned to the species Clostridium novyi. | Clostridium novyi | |||
| CLOSTRIDIUM OCEANICUM | C86286 | Any bacterial organism that can be assigned to the species Clostridium oceanicum. | Clostridium oceanicum | |||
| CLOSTRIDIUM PARAPUTRIFICUM | C86287 | Any bacterial organism that can be assigned to the species Clostridium paraputrificum. | Clostridium paraputrificum | |||
| CLOSTRIDIUM PERFRINGENS | C86288 | CLOSTRIDIUM WELCHII | Any bacterial organism that can be assigned to the species Clostridium perfringens. | Clostridium perfringens | ||
| CLOSTRIDIUM PUTRIFICUM | C86289 | CLOSTRIDIUM LENTOPUTRESCENS | Any bacterial organism that can be assigned to the species Clostridium putrificum. | Clostridium putrificum | ||
| CLOSTRIDIUM RAMOSUM | C86290 | ACTINOMYCES RAMOSUS | Any bacterial organism that can be assigned to the species Clostridium ramosum. | Clostridium ramosum | ||
| CLOSTRIDIUM RECTUM | C86291 | Any bacterial organism that can be assigned to the species Clostridium rectum. | Clostridium rectum | |||
| CLOSTRIDIUM SARTAGOFORME | C119325 | Any bacterial organism that can be assigned to the species Clostridium sartagoforme. | Clostridium sartagoforme | |||
| CLOSTRIDIUM SEPTICUM | C86292 | Any bacterial organism that can be assigned to the species Clostridium septicum. | Clostridium septicum | |||
| CLOSTRIDIUM SORDELLII | C86293 | Any bacterial organism that can be assigned to the species Clostridium sordellii. | Clostridium sordellii | |||
| CLOSTRIDIUM SPOROGENES | C86294 | Any bacterial organism that can be assigned to the species Clostridium sporogenes. | Clostridium sporogenes | |||
| CLOSTRIDIUM SUBTERMINALE | C86295 | Any bacterial organism that can be assigned to the species Clostridium subterminale. | Clostridium subterminale | |||
| CLOSTRIDIUM SYMBIOSUM | C86296 | BACTEROIDES SYMBIOSUS | Any bacterial organism that can be assigned to the species Clostridium symbiosum. | Clostridium symbiosum | ||
| CLOSTRIDIUM TERTIUM | C86297 | Any bacterial organism that can be assigned to the species Clostridium tertium. | Clostridium tertium | |||
| CLOSTRIDIUM TETANI | C86298 | Any bacterial organism that can be assigned to the species Clostridium tetani. | Clostridium tetani | |||
| CLOSTRIDIUM TYROBUTYRICUM | C86299 | Any bacterial organism that can be assigned to the species Clostridium tyrobutyricum. | Clostridium tyrobutyricum | |||
| COAGULASE NEGATIVE STAPHYLOCOCCUS | C62584 | Any bacteria assigned to the genus Staphylococcus that does not express the enzyme coagulase. | Coagulase-Negative Staphylococcus | |||
| COAGULASE POSITIVE STAPHYLOCOCCUS | C62585 | Any bacteria assigned to the genus Staphylococcus that expresses the enzyme coagulase. | Coagulase-Positive Staphylococcus | |||
| COLLINSELLA | C86300 | Any bacteria that is not assigned to the species level but can be assigned to the Collinsella genus level. | Collinsella | |||
| COLLINSELLA AEROFACIENS | C86301 | EUBACTERIUM AEROFACIENS | Any bacterial organism that can be assigned to the species Collinsella aerofaciens. | Collinsella aerofaciens | ||
| COLLINSELLA INTESTINALIS | C86302 | Any bacterial organism that can be assigned to the species Collinsella intestinalis. | Collinsella intestinalis | |||
| COLORADO TICK FEVER VIRUS | C112240 | CTFV | Any viral organism that can be assigned to the species Colorado tick fever virus. | Colorado Tick Fever Virus | ||
| COMAMONAS | C86303 | Any bacteria that is not assigned to the species level but can be assigned to the Comamonas genus level. | Comamonas | |||
| COMAMONAS TERRIGENA | C86304 | CDC GROUP EF-19 | Any bacterial organism that can be assigned to the species Comamonas terrigena. | Comamonas terrigena | ||
| COMAMONAS TESTOSTERONI | C86305 | PSEUDOMONAS TESTOSTERONI | Any bacterial organism that can be assigned to the species Comamonas testosteroni. | Comamonas testosteroni | ||
| CORONAVIRUS | C113205 | Coronaviridae | Any viral organism that can be assigned to the family Coronaviridae. | Coronaviridae | ||
| CORYNEBACTERIUM | C76308 | Any bacteria that is not assigned to the species level but can be assigned to the Corynebacterium genus level. | Corynebacterium | |||
| CORYNEBACTERIUM ACCOLENS | C86306 | CORYNEBACTERIUM GROUP G-1 | Any bacterial organism that can be assigned to the species Corynebacterium accolens. | Corynebacterium accolens | ||
| CORYNEBACTERIUM AFERMENTANS | C86307 | CORYNEBACTERIUM ANF-1 | Any bacterial organism that can be assigned to the species Corynebacterium afermentans. | Corynebacterium afermentans | ||
| CORYNEBACTERIUM AMYCOLATUM | C86308 | Any bacterial organism that can be assigned to the species Corynebacterium amycolatum. | Corynebacterium amycolatum | |||
| CORYNEBACTERIUM ARGENTORATENSE | C86309 | Any bacterial organism that can be assigned to the species Corynebacterium argentoratense. | Corynebacterium argentoratense | |||
| CORYNEBACTERIUM AURIS | C86310 | Any bacterial organism that can be assigned to the species Corynebacterium auris. | Corynebacterium auris | |||
| CORYNEBACTERIUM BOVIS | C86311 | Any bacterial organism that can be assigned to the species Corynebacterium bovis. | Corynebacterium bovis | |||
| CORYNEBACTERIUM DIPHTHERIAE | C86312 | Any bacterial organism that can be assigned to the species Corynebacterium diphtheriae. | Corynebacterium diphtheriae | |||
| CORYNEBACTERIUM GENITALIUM | C86313 | Any bacterial organism that can be assigned to the species Corynebacterium genitalium. | Corynebacterium genitalium | |||
| CORYNEBACTERIUM GLUCURONOLYTICUM | C86955 | Any bacterial organism that can be assigned to the species Corynebacterium glucuronolyticum. | Corynebacterium glucuronolyticum | |||
| CORYNEBACTERIUM JEIKEIUM | C76307 | CDC GROUP JK;CORYNEBACTERIUM GROUP JK | Any bacterial organism that can be assigned to the species Corynebacterium jeikeium. | Corynebacterium jeikeium | ||
| CORYNEBACTERIUM KUTSCHERI | C86314 | Any bacterial organism that can be assigned to the species Corynebacterium kutscheri. | Corynebacterium kutscheri | |||
| CORYNEBACTERIUM MACGINLEYI | C86315 | Any bacterial organism that can be assigned to the species Corynebacterium macginleyi. | Corynebacterium macginleyi | |||
| CORYNEBACTERIUM MATRUCHOTII | C86316 | BACTERIONEMA MATRUCHOTII | Any bacterial organism that can be assigned to the species Corynebacterium matruchotii. | Corynebacterium matruchotii | ||
| CORYNEBACTERIUM MINUTISSIMUM | C86317 | Any bacterial organism that can be assigned to the species Corynebacterium minutissimum. | Corynebacterium minutissimum | |||
| CORYNEBACTERIUM PILOSUM | C86318 | Any bacterial organism that can be assigned to the species Corynebacterium pilosum. | Corynebacterium pilosum | |||
| CORYNEBACTERIUM PROPINQUUM | C86319 | Any bacterial organism that can be assigned to the species Corynebacterium propinquum. | Corynebacterium propinquum | |||
| CORYNEBACTERIUM PSEUDODIPHTHERITICUM | C86320 | CORYNEBACTERIUM HOFMANNII | Any bacterial organism that can be assigned to the species Corynebacterium pseudodiphtheriticum. | Corynebacterium pseudodiphtheriticum | ||
| CORYNEBACTERIUM PSEUDOTUBERCULOSIS | C86321 | Any bacterial organism that can be assigned to the species Corynebacterium pseudotuberculosis. | Corynebacterium pseudotuberculosis | |||
| CORYNEBACTERIUM RENALE | C86322 | Any bacterial organism that can be assigned to the species Corynebacterium renale. | Corynebacterium renale | |||
| CORYNEBACTERIUM STRIATUM | C86323 | Any bacterial organism that can be assigned to the species Corynebacterium striatum. | Corynebacterium striatum | |||
| CORYNEBACTERIUM TUBERCULOSTEARICUM | C114249 | Any bacterial organism that can be assigned to the species Corynebacterium tuberculostearicum. | Corynebacterium tuberculostearicum | |||
| CORYNEBACTERIUM ULCERANS | C86324 | Any bacterial organism that can be assigned to the species Corynebacterium ulcerans. | Corynebacterium ulcerans | |||
| CORYNEBACTERIUM UREALYTICUM | C86325 | CDC GROUP D2;CORYNEBACTERIUM GROUP D-2 | Any bacterial organism that can be assigned to the species Corynebacterium urealyticum. | Corynebacterium urealyticum | ||
| CORYNEBACTERIUM XEROSIS | C86326 | Any bacterial organism that can be assigned to the species Corynebacterium xerosis. | Corynebacterium xerosis | |||
| CORYNEFORM GRAM-POSITIVE BACILLUS | C86327 | CORYNEFORM GRAM-POSITIVE ROD | Any bacteria whose shape is similar to those bacteria assigned to the Corynebacterium genus and have a cell wall that contains low levels of peptidoglycan and stains pink with the Gram staining technique. | Coryneform Gram Positive Bacillus | ||
| COXIELLA | C76309 | Any bacteria that is not assigned to the species level but can be assigned to the Coxiella genus level. | Coxiella | |||
| COXIELLA BURNETII | C86328 | Any bacterial organism that can be assigned to the species Coxiella burnetii. | Coxiella burnetii | |||
| COXSACKIE A VIRUS | C112242 | Coxsackie Virus A | Any viral organism that can be assigned to the Enterovirus A species subtype Coxsackie A virus. | Coxsackie A Virus | ||
| COXSACKIE B VIRUS | C112243 | Coxsackie Virus B | Any viral organism that can be assigned to the Enterovirus B species subtype Coxsackie B virus. | Coxsackie B Virus | ||
| CRONOBACTER SAKAZAKII | C86329 | ENTEROBACTER SAKAZAKII | Any bacterial organism that can be assigned to the species Cronobacter sakazakii. | Cronobacter sakazakii | ||
| CRYPTOCOCCUS ALBIDUS | C114267 | C. albidus;R. albida;Rhodotorula albida;T. albida;T. nadaensis;T. neoformans var. albida;Torula albida;Torulopsis albida;Torulopsis nadaensis;Torulopsis neoformans var. albida | Any fungal organism that can be assigned to the species Cryptococcus albidus. | Cryptococcus albidus | ||
| CRYPTOCOCCUS GATTII | C114268 | C. bacillisporus;C. gattii;Cryptococcus bacillisporus | Any fungal organism that can be assigned to the species Cryptococcus gattii. | Cryptococcus gattii | ||
| CRYPTOCOCCUS LAURENTII | C114269 | C. laurentii | Any fungal organism that can be assigned to the species Cryptococcus laurentii. | Cryptococcus laurentii | ||
| CRYPTOCOCCUS NEOFORMANS | C14195 | B. neoformans;Blastomyces neoformans;C. neoformans;D. neoformans;Debaryomyces neoformans;L. neoformans;Lipomyces neoformans;S. neoformans;Saccharomyces neoformans;T. neoformans;Torula neoformans;Torulopsis neoformans | Any fungal organism that can be assigned to the species Cryptococcus neoformans. | Cryptococcus neoformans | ||
| CRYPTOCOCCUS RANDHAWII | C114266 | C. randhawii | Any fungal organism that can be assigned to the species Cryptococcus randhawii. | Cryptococcus randhawii | ||
| CUPRIAVIDUS | C86330 | Any bacteria that is not assigned to the species level but can be assigned to the Cupriavidus genus level. | Cupriavidus | |||
| CUPRIAVIDUS PAUCULUS | C86331 | CDC GROUP IVC-2;RALSTONIA PAUCULA;WAUTERSIA PAUCULA | Any bacterial organism that can be assigned to the species Cupriavidus pauculus. | Cupriavidus pauculus | ||
| CYTOMEGALOVIRUS | C14196 | Any viral organism that can be assigned to the genus Cytomegalovirus. | Cytomegalovirus | |||
| DELFTIA | C86332 | Any bacteria that is not assigned to the species level but can be assigned to the Delftia genus level. | Delftia | |||
| DELFTIA ACIDOVORANS | C86333 | COMAMONAS ACIDOVORANS;PSEUDOMONAS ACIDOVORANS | Any bacterial organism that can be assigned to the species Delftia acidovorans. | Delftia acidovorans | ||
| DELTARETROVIRUS | C14347 | Any viral organism that can be assigned to the genus Deltaretrovirus. | Deltaretrovirus | |||
| DENGUE VIRUS | C112036 | Any viral organism that can be assigned to the species Dengue virus. | Dengue Virus | |||
| DENGUE VIRUS 1 | C112266 | DEN-1;DENV-1;Dengue Virus Type 1 | Any viral organism that can be assigned to the Dengue virus serotype 1. | Dengue Virus 1 | ||
| DENGUE VIRUS 2 | C112267 | DEN-2;DENV-2;Dengue Virus Type 2 | Any viral organism that can be assigned to the Dengue virus serotype 2. | Dengue Virus 2 | ||
| DENGUE VIRUS 3 | C112268 | DEN-3;DENV-3;Dengue Virus Type 3 | Any viral organism that can be assigned to the Dengue virus serotype 3. | Dengue Virus 3 | ||
| DENGUE VIRUS 4 | C112269 | DEN-4;DENV-4;Dengue Virus Type 4 | Any viral organism that can be assigned to the Dengue virus serotype 4. | Dengue Virus 4 | ||
| DERMABACTER | C86334 | Any bacteria that is not assigned to the species level but can be assigned to the Dermabacter genus level. | Dermabacter | |||
| DERMABACTER HOMINIS | C86335 | Any bacterial organism that can be assigned to the species Dermabacter hominis. | Dermabacter hominis | |||
| DERMACOCCUS NISHINOMIYAENSIS | C86336 | MICROCOCCUS NISHINOMIYAENSIS | Any bacterial organism that can be assigned to the species Dermacoccus nishinomiyaensis. | Dermacoccus nishinomiyaensis | ||
| DERMATOPHILUS | C86337 | Any bacteria that is not assigned to the species level but can be assigned to the Dermatophilus genus level. | Dermatophilus | |||
| DERMATOPHILUS CONGOLENSIS | C86338 | Any bacterial organism that can be assigned to the species Dermatophilus congolensis. | Dermatophilus congolensis | |||
| DESULFOVIBRIO | C86339 | DESULFOMONAS SPECIES | Any bacteria that is not assigned to the species level but can be assigned to the Desulfovibrio genus level. | Desulfovibrio | ||
| DESULFOVIBRIO DESULFURICANS | C86340 | Any bacterial organism that can be assigned to the species Desulfovibrio desulfuricans. | Desulfovibrio desulfuricans | |||
| DESULFOVIBRIO FAIRFIELDENSIS | C86341 | Any bacterial organism that can be assigned to the species Desulfovibrio fairfieldensis. | Desulfovibrio fairfieldensis | |||
| DESULFOVIBRIO PIGER | C86342 | DESULFOMONAS PIGRA | Any bacterial organism that can be assigned to the species Desulfovibrio piger. | Desulfovibrio piger | ||
| DIPHTHEROID BACILLUS | C86343 | Any of a number of rod-shaped bacteria that resemble Corynebacterium diphtheriae, either in morphology or etiology. | Diptheroid Bacillus | |||
| EBOLA VIRUS | C112271 | EBOV | Any viral organism that can be assigned to the genus Ebola virus. | Ebola Virus | ||
| ECHOVIRUS | C112272 | Any viral organism that can be assigned to the species Echovirus. | Echovirus | |||
| EDWARDSIELLA | C86344 | Any bacteria that is not assigned to the species level but can be assigned to the Edwardsiella genus level. | Edwardsiella | |||
| EDWARDSIELLA HOSHINAE | C86345 | Any bacterial organism that can be assigned to the species Edwardsiella hoshinae. | Edwardsiella hoshinae | |||
| EDWARDSIELLA ICTALURI | C86346 | Any bacterial organism that can be assigned to the species Edwardsiella ictaluri. | Edwardsiella ictaluri | |||
| EDWARDSIELLA TARDA | C86347 | Any bacterial organism that can be assigned to the species Edwardsiella tarda. | Edwardsiella tarda | |||
| EGGERTHELLA | C86348 | Any bacteria that is not assigned to the species level but can be assigned to the Eggerthella genus level. | Eggerthella | |||
| EGGERTHELLA LENTA | C86349 | EUBACTERIUM LENTUM | Any bacterial organism that can be assigned to the species Eggerthella lenta. | Eggerthella lenta | ||
| EIKENELLA | C86350 | Any bacteria that is not assigned to the species level but can be assigned to the Eikenella genus level. | Eikenella | |||
| EIKENELLA CORRODENS | C86351 | CDC GROUP HB-1 | Any bacterial organism that can be assigned to the species Eikenella corrodens. | Eikenella corrodens | ||
| ELIZABETHKINGIA | C86352 | Any bacteria that is not assigned to the species level but can be assigned to the Elizabethkingia genus level. | Elizabethkingia | |||
| ELIZABETHKINGIA MENINGOCEPTICA | C86353 | CHRYSEOBACTERIUM MENINGOSEPTICUM;FLAVOBACTERIUM MENINGOSEPTICUM | Any bacterial organism that can be assigned to the species Elizabethkingia meningoceptica. | Elizabethkingia meningoceptica | ||
| EMPEDOBACTER | C86354 | Any bacteria that is not assigned to the species level but can be assigned to the Empedobacter genus level. | Empedobacter | |||
| EMPEDOBACTER BREVIS | C86355 | FLAVOBACTERIUM BREVE | Any bacterial organism that can be assigned to the species Empedobacter brevis. | Empedobacter brevis | ||
| ENTEROBACTER | C76310 | Any bacteria that is not assigned to the species level but can be assigned to the Enterobacter genus level. | Enterobacter | |||
| ENTEROBACTER AEROGENES | C86356 | AEROBACTER AEROGENES | Any bacterial organism that can be assigned to the species Enterobacter aerogenes. | Enterobacter aerogenes | ||
| ENTEROBACTER AMNIGENUS | C86357 | ENTEROBACTER AMNIGENUS I | Any bacterial organism that can be assigned to the species Enterobacter amnigenus. | Enterobacter amnigenus | ||
| ENTEROBACTER ASBURIAE | C86358 | CDC ENTERIC GROUP 17 | Any bacterial organism that can be assigned to the species Enterobacter asburiae. | Enterobacter asburiae | ||
| ENTEROBACTER CANCEROGENUS | C86359 | CDC ENTERIC GROUP 19;ENTEROBACTER TAYLORAE | Any bacterial organism that can be assigned to the species Enterobacter cancerogenus. | Enterobacter cancerogenus | ||
| ENTEROBACTER CLOACAE | C86360 | ENTEROBACTER CLOACAE STRAIN 1 | Any bacterial organism that can be assigned to the species Enterobacter cloacae. | Enterobacter cloacae | ||
| ENTEROBACTER GERGOVIAE | C86361 | Any bacterial organism that can be assigned to the species Enterobacter gergoviae. | Enterobacter gergoviae | |||
| ENTEROBACTER HORMAECHEI | C86362 | CDC ENTERIC GROUP 75 | Any bacterial organism that can be assigned to the species Enterobacter hormaechei. | Enterobacter hormaechei | ||
| ENTEROCOCCUS | C76311 | PRESUMPTIVE ENTEROCOCCUS | Any bacteria that is not assigned to the species level but can be assigned to the Enterococcus genus level. | Enterococcus | ||
| ENTEROCOCCUS AVIUM | C86364 | STREPTOCOCCUS AVIUM | Any bacterial organism that can be assigned to the species Enterococcus avium. | Enterococcus avium | ||
| ENTEROCOCCUS CASSELIFLAVUS | C86365 | Any bacterial organism that can be assigned to the species Enterococcus casseliflavus. | Enterococcus casseliflavus | |||
| ENTEROCOCCUS DISPAR | C86366 | Any bacterial organism that can be assigned to the species Enterococcus dispar. | Enterococcus dispar | |||
| ENTEROCOCCUS DURANS | C86367 | STREPTOCOCCUS DURANS | Any bacterial organism that can be assigned to the species Enterococcus durans. | Enterococcus durans | ||
| ENTEROCOCCUS FAECALIS | C86368 | STREPTOCOCCUS FAECALIS | Any bacterial organism that can be assigned to the species Enterococcus faecalis. | Enterococcus faecalis | ||
| ENTEROCOCCUS FAECIUM | C86369 | STREPTOCOCCUS FAECIUM | Any bacterial organism that can be assigned to the species Enterococcus faecium. | Enterococcus faecium | ||
| ENTEROCOCCUS GALLINARUM | C86370 | Any bacterial organism that can be assigned to the species Enterococcus gallinarum. | Enterococcus gallinarum | |||
| ENTEROCOCCUS HIRAE | C86371 | Any bacterial organism that can be assigned to the species Enterococcus hirae. | Enterococcus hirae | |||
| ENTEROCOCCUS MALODORATUS | C86372 | Any bacterial organism that can be assigned to the species Enterococcus malodoratus. | Enterococcus malodoratus | |||
| ENTEROCOCCUS MUNDTII | C86373 | Any bacterial organism that can be assigned to the species Enterococcus mundtii. | Enterococcus mundtii | |||
| ENTEROCOCCUS PSEUDOAVIUM | C86374 | Any bacterial organism that can be assigned to the species Enterococcus pseudoavium. | Enterococcus pseudoavium | |||
| ENTEROCOCCUS RAFFINOSUS | C86375 | Any bacterial organism that can be assigned to the species Enterococcus raffinosus. | Enterococcus raffinosus | |||
| ENTEROCOCCUS THAILANDICUS | C114243 | Enterococcus sanguinicola | Any bacterial organism that can be assigned to the species Enterococcus thailandicus. | Enterococcus thailandicus | ||
| ENTEROVIRUS | C14203 | Any viral organism that can be assigned to the genus Enterovirus. | Enterovirus | |||
| ERYSIPELOTHRIX | C86376 | ERYSIPELOTHRIX INSIDIOSA | Any bacteria that is not assigned to the species level but can be assigned to the Erysipelothrix genus level. | Erysipelothrix | ||
| ERYSIPELOTHRIX RHUSIOPATHIAE | C86377 | Any bacterial organism that can be assigned to the species Erysipelothrix rhusiopathiae. | Erysipelothrix rhusiopathiae | |||
| ESCHERICHIA | C77208 | Any bacteria that is not assigned to the species level but can be assigned to the Escherichia genus level. | Escherichia | |||
| ESCHERICHIA ALBERTII | C86378 | Any bacterial organism that can be assigned to the species Escherichia albertii. | Escherichia albertii | |||
| ESCHERICHIA BLATTAE | C86379 | Any bacterial organism that can be assigned to the species Escherichia blattae. | Escherichia blattae | |||
| ESCHERICHIA COLI | C14206 | E. COLI | Any bacterial organism that can be assigned to the species Escherichia coli. | Escherichia coli | ||
| ESCHERICHIA COLI O111 | C86881 | Any bacterial organism that can be assigned to the species Escherichia coli and strain O111. | Escherichia coli strain O111 | |||
| ESCHERICHIA COLI O157 (NOT H7) | C86882 | Any bacterial organism that can be assigned to the species Escherichia coli and strain O157. | Escherichia coli strain O157 | |||
| ESCHERICHIA COLI O157:H7 | C86883 | Any bacterial organism that can be assigned to the species Escherichia coli and strain O157:H7. | Escherichia coli strain O157:H7 | |||
| ESCHERICHIA COLI O26 | C86884 | Any bacterial organism that can be assigned to the species Escherichia coli and strain O26. | Escherichia coli strain O26 | |||
| ESCHERICHIA FERGUSONII | C86380 | CDC ENTERIC GROUP 10 | Any bacterial organism that can be assigned to the species Escherichia fergusonii. | Escherichia fergusonii | ||
| ESCHERICHIA HERMANNII | C86381 | CDC ENTERIC GROUP 11 | Any bacterial organism that can be assigned to the species Escherichia hermannii. | Escherichia hermannii | ||
| ESCHERICHIA VULNERIS | C86382 | CDC ENTERIC GROUP 1 | Any bacterial organism that can be assigned to the species Escherichia vulneris. | Escherichia vulneris | ||
| EUBACTERIUM | C86383 | Any bacteria that is not assigned to the species level but can be assigned to the Eubacterium genus level. | Eubacterium | |||
| EUBACTERIUM ALACTOLYTICUM | C86384 | Any bacterial organism that can be assigned to the species Eubacterium adactolyticum. | Eubacterium alactolyticum | |||
| EUBACTERIUM CONTORTUM | C86385 | Any bacterial organism that can be assigned to the species Eubacterium contortum. | Eubacterium contortum | |||
| EUBACTERIUM LIMOSUM | C86386 | Any bacterial organism that can be assigned to the species Eubacterium limosum. | Eubacterium limosum | |||
| EUBACTERIUM NODATUM | C86387 | Any bacterial organism that can be assigned to the species Eubacterium nodatum. | Eubacterium nodatum | |||
| EUBACTERIUM RECTALE | C86388 | Any bacterial organism that can be assigned to the species Eubacterium rectale. | Eubacterium rectale | |||
| EUBACTERIUM VENTRIOSUM | C86389 | Any bacterial organism that can be assigned to the species Eubacterium ventriosum. | Eubacterium ventriosum | |||
| EWINGELLA | C86390 | Any bacteria that is not assigned to the species level but can be assigned to the Ewingella genus level. | Ewingella | |||
| EWINGELLA AMERICANA | C86391 | CDC ENTERIC GROUP 40 | Any bacterial organism that can be assigned to the species Ewingella americana. | Ewingella americana | ||
| EXIGUOBACTERIUM | C86885 | Any bacteria that is not assigned to the species level but can be assigned to the Exiguobacterium genus level. | Exiguobacterium | |||
| EXIGUOBACTERIUM ACETYLICUM | C86886 | BREVIBACTERIUM ACETYLICUM | Any bacterial organism that can be assigned to the species Exiguobacterium acetylicum. | Exiguobacterium acetylicum | ||
| FACKLAMIA | C86392 | Any bacteria that is not assigned to the species level but can be assigned to the Facklamia genus level. | Facklamia | |||
| FAECALIBACTERIUM | C86393 | Any bacteria that is not assigned to the species level but can be assigned to the Faecalibacterium genus level. | Faecalibacterium | |||
| FAECALIBACTERIUM PRAUSNITZII | C86394 | FUSOBACTERIUM PRAUSNITZII | Any bacterial organism that can be assigned to the species Faecalibacterium prausnitzii. | Faecalibacterium prausnitzii | ||
| FERMENTATIVE GRAM-NEGATIVE BACILLUS | C86395 | FERMENTATIVE GRAM-NEGATIVE ROD | Any rod-shaped, anaerobic bacteria that can convert carbohydrates into acids and alcohols and has a cell wall contains low levels of peptidoglycan and stains pink with the Gram staining technique. | Fermentative Gram Negative Bacillus | ||
| FILOBASIDIUM UNIGUTTULATUM | C114265 | C. neoformans var. uniguttulatus;C. uniguttulatus;Cryptococcus neoformans var. uniguttulatus;Cryptococcus uniguttulatus;E. uniguttulata;Eutorulopsis uniguttulata;F. uniguttulatum | Any fungal organism that can be assigned to the species Filobasidium uniguttulatum. | Filobasidium uniguttulatum | ||
| FILOVIRUS | C112031 | Filoviridae | Any viral organism that can be assigned to the family Filoviridae. | Filoviridae | ||
| FINEGOLDIA | C86887 | Any bacteria that is not assigned to the species level but can be assigned to the Finegoldia genus level. | Finegoldia | |||
| FINEGOLDIA MAGNA | C86888 | PEPTOSTREPTOCOCCUS MAGNUS | Any bacterial organism that can be assigned to the species Finegoldia magna. | Finegoldia magna | ||
| FLAVIVIRUS | C14208 | Any viral organism that can be assigned to the genus Flavivirus. | Flavivirus | |||
| FLAVOBACTERIUM | C76320 | Any bacteria that is not assigned to the species level but can be assigned to the Flavobacterium genus level. | Flavobacterium | |||
| FRANCISELLA | C86396 | Any bacteria that is not assigned to the species level but can be assigned to the Francisella genus level. | Francisella | |||
| FRANCISELLA TULARENSIS | C86397 | PASTEURELLA TULARENSIS | Any bacterial organism that can be assigned to the species Francisella tularensis. | Francisella tularensis | ||
| FUSOBACTERIUM | C76323 | Any bacteria that is not assigned to the species level but can be assigned to the Fusobacterium genus level. | Fusobacterium | |||
| FUSOBACTERIUM GONIDIAFORMANS | C86398 | Any bacterial organism that can be assigned to the species Fusobacterium gonidiaformans. | Fusobacterium gonidiaformans | |||
| FUSOBACTERIUM MORTIFERUM | C86399 | Any bacterial organism that can be assigned to the species Fusobacterium mortiferum. | Fusobacterium mortiferum | |||
| FUSOBACTERIUM NAVIFORME | C114252 | Bacillus naviformis;Fusibacterium naviforme;Pseudobacterium naviformis;Ristella naviformis | Any bacterial organism that can be assigned to the species Fusobacterium naviforme. | Fusobacterium naviforme | ||
| FUSOBACTERIUM NECROGENES | C86400 | Any bacterial organism that can be assigned to the species Fusobacterium necrogenes. | Fusobacterium necrogenes | |||
| FUSOBACTERIUM NECROPHORUM | C86401 | Any bacterial organism that can be assigned to the species Fusobacterium necrophorum. | Fusobacterium necrophorum | |||
| FUSOBACTERIUM NUCLEATUM | C86404 | Any bacterial organism that can be assigned to the species Fusobacterium nucleatum. | Fusobacterium nucleatum | |||
| FUSOBACTERIUM RUSSII | C86405 | Any bacterial organism that can be assigned to the species Fusobacterium russii. | Fusobacterium russii | |||
| FUSOBACTERIUM ULCERANS | C86406 | Any bacterial organism that can be assigned to the species Fusobacterium ulcerans. | Fusobacterium ulcerans | |||
| FUSOBACTERIUM VARIUM | C86407 | FUSOBACTERIUM NECROPHORUM BIOVAR C;FUSOBACTERIUM PSEUDONECROPHORUM | Any bacterial organism that can be assigned to the species Fusobacterium varium. | Fusobacterium varium | ||
| GARDNERELLA | C86409 | Any bacteria that is not assigned to the species level but can be assigned to the Gardnerella genus level. | Gardnerella | |||
| GARDNERELLA VAGINALIS | C86410 | CORYNEBACTERIUM VAGINALIS | Any bacterial organism that can be assigned to the species Gardnerella vaginalis. | Gardnerella vaginalis | ||
| GEMELLA | C86889 | Any bacteria that is not assigned to the species level but can be assigned to the Gemella genus level. | Gemella | |||
| GEMELLA BERGERI | C86890 | Any bacterial organism that can be assigned to the species Gemella bergeri. | Gemella bergeri | |||
| GEMELLA HAEMOLYSANS | C86891 | NEISSERIA HAEMOLYSANS | Any bacterial organism that can be assigned to the species Gemella haemolysans. | Gemella haemolysans | ||
| GEMELLA MORBILLORUM | C86892 | STREPTOCOCCUS MORBILLORUM | Any bacterial organism that can be assigned to the species Gemella morbillorum. | Gemella morbillorum | ||
| GEMELLA SANGUINIS | C86893 | Any bacterial organism that can be assigned to the species Gemella sanguinis. | Gemella sanguinis | |||
| GLOBICATELLA | C86411 | Any bacteria that is not assigned to the species level but can be assigned to the Globicatella genus level. | Globicatella | |||
| GLOBICATELLA SANGUINIS | C86412 | GLOBICATELLA SANGUIS | Any bacterial organism that can be assigned to the species Globicatella sanguinis. | Globicatella sanguinis | ||
| GLOBICATELLA SULFIDIFACIENS | C86413 | Any bacterial organism that can be assigned to the species Globicatella sulfidifaciens. | Globicatella sulfidifaciens | |||
| GORDONIA | C86414 | Any bacteria that is not assigned to the species level but can be assigned to the Gordonia genus level. | Gordonia | |||
| GORDONIA AICHIENSIS | C86415 | GORDONA AICHIENSIS;TSUKAMURELLA AICHIENSIS | Any bacterial organism that can be assigned to the species Gordonia aichiensis. | Gordonia aichiensis | ||
| GORDONIA BRONCHIALIS | C86416 | GORDONA BRONCHIALIS;RHODOCOCCUS BRONCHIALIS | Any bacterial organism that can be assigned to the species Gordonia bronchialis. | Gordonia bronchialis | ||
| GORDONIA RUBRIPERTINCTA | C86417 | GORDONA RUBROPERTINCTA;RHODOCOCCUS RUBRIPERTINCTA | Any bacterial organism that can be assigned to the species Gordonia rubripertincta. | Gordonia rubripertincta | ||
| GORDONIA SPUTI | C86418 | GORDONA SPUTI | Any bacterial organism that can be assigned to the species Gordonia sputi. | Gordonia sputi | ||
| GORDONIA TERRAE | C86419 | GORDONA TERRAE;RHODOCOCCUS TERRAE | Any bacterial organism that can be assigned to the species Gordonia terrae. | Gordonia terrae | ||
| GRACILIBACILLUS | C86420 | Any bacteria that is not assigned to the species level but can be assigned to the Gracilibacillus genus level. | Gracilibacillus | |||
| GRAM-NEGATIVE BACILLUS | C86421 | Any rod-shaped bacteria that contains low levels of peptidoglycan in its cell wall and stains pink with the Gram staining technique. | Gram Negative Bacillus | |||
| GRAM-NEGATIVE COCCUS | C86422 | Any spherical-shaped bacteria that contains low levels of peptidoglycan in its cell wall and stains pink with the Gram staining technique. | Gram Negative Coccus | |||
| GRAM-POSITIVE BACILLUS | C62589 | Any rod-shaped bacteria that has a peptidoglycan-rich cell wall that stains dark purple with the Gram staining technique. | Gram-Positive Rod | |||
| GRAM-POSITIVE COCCUS | C86424 | Any spherical-shaped bacteria that has a peptidoglycan-rich cell wall that stains dark purple with the Gram staining technique. | Gram Positive Coccus | |||
| GRANULICATELLA | C86425 | Any bacteria that is not assigned to the species level but can be assigned to the Granulicatella genus level. | Granulicatella | |||
| GRANULICATELLA ADIACENS | C86426 | ABIOTROPHIA ADJACENS;STREPTOCOCCUS ADJACENS | Any bacterial organism that can be assigned to the species Granulicatella adiacens. | Granulicatella adiacens | ||
| GRANULICATELLA ELEGANS | C111204 | ABIOTROPHIA ELEGANS | Any bacterial organism that can be assigned to the species Granulicatella elegans. | Granulicatella elegans | ||
| GRIMONTIA HOLLISAE | C86427 | VIBRIO HOLLISAE | Any bacterial organism that can be assigned to the species Grimontia hollisae. | Grimontia hollisae | ||
| HAEMOPHILUS | C76324 | Any bacteria that is not assigned to the species level but can be assigned to the Haemophilus genus level. | Haemophilus | |||
| HAEMOPHILUS AEGYPTIUS | C86428 | Any bacterial organism that can be assigned to the species Haemophilus aegyptius. | Haemophilus aegyptius | |||
| HAEMOPHILUS HAEMOGLOBINOPHILUS | C86429 | Any bacterial organism that can be assigned to the species Haemophilus haemoglobinophilus. | Haemophilus haemoglobinophilus | |||
| HAEMOPHILUS HAEMOLYTICUS | C86430 | Any bacterial organism that can be assigned to the species Haemophilus haemolyticus. | Haemophilus haemolyticus | |||
| HAEMOPHILUS INFLUENZAE | C86431 | H-FLU | Any bacterial organism that can be assigned to the species Haemophilus influenzae. | Haemophilus influenzae | ||
| HAEMOPHILUS PARAHAEMOLYTICUS | C86432 | Any bacterial organism that can be assigned to the species Haemophilus parahaemolyticus. | Haemophilus parahaemolyticus | |||
| HAEMOPHILUS PARAINFLUENZAE | C86433 | HEMOPHILUS PARAINFLUENZAE | Any bacterial organism that can be assigned to the species Haemophilus parainfluenzae. | Haemophilus parainfluenzae | ||
| HAFNIA | C86434 | Any bacteria that is not assigned to the species level but can be assigned to the Hafnia genus level. | Hafnia | |||
| HAFNIA ALVEI | C86435 | ENTEROBACTER ALVEI | Any bacterial organism that can be assigned to the species Hafnia alvei. | Hafnia alvei | ||
| HALOBACILLUS | C86436 | Any bacteria that is not assigned to the species level but can be assigned to the Halobacillus genus level. | Halobacillus | |||
| HANTAVIRUS | C14213 | Any viral organism that can be assigned to the genus Hantavirus. | Hantavirus | |||
| HELCOCOCCUS | C86873 | Any bacteria that is not assigned to the species level but can be assigned to the Helcococcus genus level. | Helcococcus | |||
| HELCOCOCCUS KUNZII | C86878 | Any bacterial organism that can be assigned to the species Helcococcus kunzii. | Helcococcus kunzii | |||
| HELCOCOCCUS PYOGENES | C86879 | Any bacterial organism that can be assigned to the species Helcococcus pyogenes. | Helcococcus pyogenes | |||
| HELCOCOCCUS SUECIENSIS | C86880 | Any bacterial organism that can be assigned to the species Helcococcus sueciensis. | Helcococcus sueciensis | |||
| HELICOBACTER | C14296 | Any bacteria that is not assigned to the species level but can be assigned to the Helicobacter genus level. | Helicobacter | |||
| HELICOBACTER CINAEDI | C86437 | CAMPYLOBACTER CINAEDI | Any bacterial organism that can be assigned to the species Helicobacter cinaedi. | Helicobacter cinaedi | ||
| HELICOBACTER FELIS | C14330 | H. FELIS | Any bacterial organism that can be assigned to the species Helicobacter felis. | Helicobacter felis | ||
| HELICOBACTER FENNELLIAE | C86438 | CAMPYLOBACTER FENNELLIAE | Any bacterial organism that can be assigned to the species Helicobacter fennelliae. | Helicobacter fennelliae | ||
| HELICOBACTER MUSTELAE | C86439 | CAMPYLOBACTER MUSTELAE | Any bacterial organism that can be assigned to the species Helicobacter mustelae. | Helicobacter mustelae | ||
| HELICOBACTER PYLORI | C14289 | CAMPYLOBACTER PYLORI;H. PYLORI | Any bacterial organism that can be assigned to the species Helicobacter pylori. | Helicobacter pylori | ||
| HELICOBACTER RAPPINI | C86440 | FLEXISPIRA RAPPINI | Any bacterial organism that can be assigned to the species Helicobacter rappini. | Helicobacter rappini | ||
| HENDRA VIRUS | C112289 | Any viral organism that can be assigned to the species Hendra virus. | Hendra Virus | |||
| HENIPAVIRUS | C112290 | Any viral organism that can be assigned to the genus Henipavirus. | Henipavirus | |||
| HEPATITIS A VIRUS | C14325 | HAV | Any viral organism that can be assigned to the species Hepatitis A virus. | Hepatitis A Virus | ||
| HEPATITIS B VIRUS | C14215 | HBV | Any viral organism that can be assigned to the species Hepatitis B virus. | Hepatitis B Virus | ||
| HEPATITIS C VIRUS | C14312 | HCV | Any viral organism that can be assigned to the species Hepatitis C virus. | Hepatitis C Virus | ||
| HEPATITIS D VIRUS | C93324 | HDV | Any viral organism that can be assigned to the species Hepatitis D virus. | Hepatitis D Virus | ||
| HEPATITIS E VIRUS | C14295 | HEV | Any viral organism that can be assigned to the species Hepatitis E virus. | Hepatitis E Virus | ||
| HEPATITIS G VIRUS | C14328 | GBV-C;HGV | Any viral organism that can be assigned to the species Hepatitis G virus. | GB virus C | ||
| HISTOPHILUS SOMNI | C86441 | HAEMOPHILUS SOMNUS | Any bacterial organism that can be assigned to the species Histophilus somni. | Histophilus somni | ||
| HOLDEMANIA | C86442 | Any bacteria that is not assigned to the species level but can be assigned to the Holdemania genus level. | Holdemania | |||
| HOLDEMANIA FILIFORMIS | C86443 | Any bacterial organism that can be assigned to the species Holdemania filiformis. | Holdemania filiformis | |||
| HUMAN HERPESVIRUS 1 | C14311 | HHV-1;HSV-1;Herpes Simplex Virus type 1 | Any viral organism that can be assigned to the species Human Herpesvirus 1 within the genus Simplexvirus. | Human Herpesvirus 1 | ||
| HUMAN HERPESVIRUS 2 | C112313 | HHV-2;HSV-2;Herpes Simplex Virus type 2 | Any viral organism that can be assigned to the species Human Herpesvirus 2 within the genus Simplexvirus. | Human Herpesvirus 2 | ||
| HUMAN HERPESVIRUS 3 | C71091 | HHV-3;VZV;Varicella Zoster Virus | Any viral organism that can be assigned to the species Human Herpesvirus 3. | Varicella Zoster Virus | ||
| HUMAN HERPESVIRUS 4 | C14204 | EBV;Epstein-Barr Virus;HHV-4 | Any viral organism that can be assigned to the species Human Herpesvirus 4. | Epstein-Barr Virus | ||
| HUMAN HERPESVIRUS 5 | C112314 | HCMV;HHV-5;Human Cytomegalovirus | Any viral organism that can be assigned to the species Human Herpesvirus 5. | Human Herpesvirus 5 | ||
| HUMAN HERPESVIRUS 6 | C14218 | HHV-6 | Any viral organism that can be assigned to the species Human Herpesvirus 6. | Human Herpesvirus 6 | ||
| HUMAN HERPESVIRUS 7 | C112315 | HHV-7 | Any viral organism that can be assigned to the species Human Herpesvirus 7. | Human Herpesvirus 7 | ||
| HUMAN HERPESVIRUS 8 | C14327 | HHV-8;KSHV;Kaposi's sarcoma-associated herpesvirus | Any viral organism that can be assigned to the species Human herpesvirus 8. | Human Herpesvirus 8 | ||
| HUMAN IMMUNODEFICIENCY VIRUS 1 | C14220 | HIV-1;LAV-1 | Any viral organism that can be assigned to the species Human Immunodeficiency virus 1. | Human Immunodeficiency Virus 1 | ||
| HUMAN IMMUNODEFICIENCY VIRUS 2 | C14221 | HIV-2;LAV-2 | Any viral organism that can be assigned to the species Human Immunodeficiency virus 2. | Human Immunodeficiency Virus 2 | ||
| HUMAN PAPILLOMAVIRUS | C14226 | HPV;Human Papilloma Virus | Any viral organism in humans that can be assigned to the family Papillomaviridae. | Human Papillomavirus | ||
| HUMAN PARAINFLUENZA VIRUS 1 | C14254 | HPIV-1;Human Parainfluenza Virus Type 1;hPIV-1 | Any viral organism that can be assigned to the Human Parainfluenza virus 1 serotype. | Human Parainfluenza Virus 1 | ||
| HUMAN PARAINFLUENZA VIRUS 2 | C112316 | HPIV-2;Human Parainfluenza Virus Type 2;hPIV-2 | Any viral organism that can be assigned to the Human Parainfluenza virus 2 serotype. | Human Parainfluenza Virus 2 | ||
| HUMAN PARAINFLUENZA VIRUS 3 | C112317 | HPIV-3;Human Parainfluenza Virus Type 3;hPIV-3 | Any viral organism that can be assigned to the Human Parainfluenza virus 3 serotype. | Human Parainfluenza Virus 3 | ||
| HUMAN PARAINFLUENZA VIRUS 4 | C112318 | HPIV-4;Human Parainfluenza Virus Type 4;hPIV-4 | Any viral organism that can be assigned to the Human Parainfluenza virus 4 serotype. | Human Parainfluenza Virus 4 | ||
| HUMAN PARVOVIRUS B19 | C89772 | B19 Virus;Human Erythrovirus B19;Parvovirus B19 | Any viral organism that can be assigned to the species Human Parvovirus B19. | Parvovirus B19 | ||
| HUMAN RESPIRATORY SYNCYTIAL VIRUS | C14267 | Human RSV;RSV;hRSV | Any viral organism that can be assigned to the species Human Respiratory Syncitial virus. | Human Respiratory Syncytial Virus | ||
| HUMAN T-LYMPHOTROPIC VIRUS 1 | C14223 | Adult T-cell leukemia lymphoma ATLL;Adult T-cell lymphoma virus type 1;HTLV-1 | Any viral organism that can be assigned to the Human T-lymphotrophic virus serotype 1. | HTLV-1 | ||
| HUMAN T-LYMPHOTROPIC VIRUS 2 | C14224 | HTLV-2;HTLV-II | Any viral organism that can be assigned to the Human T-lymphotrophic virus serotype 2. | HTLV-2 | ||
| INFLUENZA A VIRUS | C53454 | FLUAV;Influenza Virus Type A | Any viral organism that can be assigned to the species Influenza A virus. | Influenza A Virus | ||
| INFLUENZA B VIRUS | C53468 | FLUBV;Influenza Virus Type B | Any viral organism that can be assigned to the species Influenza B virus. | Influenza B Virus | ||
| INFLUENZA C VIRUS | C97157 | FLUCV;Influenza Virus Type C | Any viral organism that can be assigned to the species Influenza C virus. | Influenza C Virus | ||
| INQUILINUS | C86444 | Any bacteria that is not assigned to the species level but can be assigned to the Inquilinus genus level. | Inquilinus | |||
| INQUILINUS LIMOSUS | C86445 | Any bacterial organism that can be assigned to the species Inquilinus limosus. | Inquilinus limosus | |||
| JC VIRUS | C14229 | Human polyomavirus (type JC);Polyomavirus hominis 2;polyomavirus JC | Any viral organism that can be assigned to the species JC polyomavirus. | JC Virus | ||
| JEOTGALIBACILLUS | C86446 | Any bacteria that is not assigned to the species level but can be assigned to the Jeotgalibacillus genus level. | Jeotgalibacillus | |||
| JOHNSONELLA | C86447 | Any bacteria that is not assigned to the species level but can be assigned to the Johnsonella genus level. | Johnsonella | |||
| JOHNSONELLA IGNAVA | C86448 | Any bacterial organism that can be assigned to the species Johnsonella ignava. | Johnsonella ignava | |||
| KINGELLA | C86449 | Any bacteria that is not assigned to the species level but can be assigned to the Kingella genus level. | Kingella | |||
| KINGELLA DENITRIFICANS | C86450 | CDC GROUP TM-1 | Any bacterial organism that can be assigned to the species Kingella denitrificans. | Kingella denitrificans | ||
| KINGELLA KINGAE | C86451 | MORAXELLA KINGAE | Any bacterial organism that can be assigned to the species Kingella kingae. | Kingella kingae | ||
| KINGELLA ORALIS | C86452 | Any bacterial organism that can be assigned to the species Kingella oralis. | Kingella oralis | |||
| KINGELLA POTUS | C86453 | Any bacterial organism that can be assigned to the species Kingella potus. | Kingella potus | |||
| KLEBSIELLA | C28165 | Any bacteria that is not assigned to the species level but can be assigned to the Klebsiella genus level. | Klebsiella | |||
| KLEBSIELLA GRANULOMATIS | C86454 | Any bacterial organism that can be assigned to the species Klebsiella granulomatis. | Klebsiella granulomatis | |||
| KLEBSIELLA OXYTOCA | C86455 | K. OXYTOCA | Any bacterial organism that can be assigned to the species Klebsiella oxytoca. | Klebsiella oxytoca | ||
| KLEBSIELLA OZAENAE | C86456 | KLEBSIELLA PNEUMONIAE SUBSP. OZAENAE | Any bacterial organism that can be assigned to the species Klebsiella ozaenae. | Klebsiella ozaenae | ||
| KLEBSIELLA PNEUMONIAE | C86457 | K. PNEUMONIAE | Any bacterial organism that can be assigned to the species Klebsiella pneumoniae. | Klebsiella pneumoniae | ||
| KLEBSIELLA RHINOSCLEROMATIS | C86458 | KLEBSIELLA PNEUMONIAE SUBSP. RHINOSCLEROMATIS | Any bacterial organism that can be assigned to the species Klebsiella rhinoscleromatis. | Klebsiella rhinoscleromatis | ||
| KLEBSIELLA SINGAPORENSIS | C86459 | Any bacterial organism that can be assigned to the species Klebsiella singaporensis. | Klebsiella singaporensis | |||
| KLEBSIELLA VARIICOLA | C86460 | Any bacterial organism that can be assigned to the species Klebsiella variicola. | Klebsiella variicola | |||
| KLUYVERA | C86461 | Any bacteria that is not assigned to the species level but can be assigned to the Kluyvera genus level. | Kluyvera | |||
| KLUYVERA ASCORBATA | C86462 | CDC ENTERIC GROUP 8 | Any bacterial organism that can be assigned to the species Kluyvera ascorbata. | Kluyvera ascorbata | ||
| KLUYVERA CRYOCRESCENS | C86463 | Any bacterial organism that can be assigned to the species Kluyvera cryocrescens. | Kluyvera cryocrescens | |||
| KLUYVERA GEORGIANA | C86464 | Any bacterial organism that can be assigned to the species Kluyvera georgiana. | Kluyvera georgiana | |||
| KLUYVERA INTERMEDIA | C86465 | ENTEROBACTER INTERMEDIUM;ENTEROBACTER INTERMEDIUS;KLUYVERA COCHLEAE | Any bacterial organism that can be assigned to the species Kluyvera intermedia. | Kluyvera intermedia | ||
| KLUYVEROMYCES MARXIANUS | C114256 | C. pseudotropicalis;Candida pseudotropicalis;K. cicerisporus;K. fragilis;Kluyveromyces cicerisporus;Kluyveromyces fragilis | Any fungal organism that can be assigned to the species Kluyveromyces marxianus. | Kluyveromyces marxianus | ||
| KNOELLIA | C86466 | Any bacteria that is not assigned to the species level but can be assigned to the Knoellia genus level. | Knoellia | |||
| KOCURIA | C86467 | Any bacteria that is not assigned to the species level but can be assigned to the Kocuria genus level. | Kocuria | |||
| KOCURIA KRISTINAE | C86468 | MICROCOCCUS KRISTINAE | Any bacterial organism that can be assigned to the species Kocuria kristinae. | Kocuria kristinae | ||
| KOCURIA RHIZOPHILA | C86513 | MICROCOCCUS LUTEUS;SARCINA LUTEA | Any bacterial organism that can be assigned to the species Kocuria rhizophila. | Micrococcus luteus | ||
| KOCURIA ROSEA | C86469 | Any bacterial organism that can be assigned to the species Kocuria rosea. | Kocuria rosea | |||
| KOCURIA VARIANS | C86470 | Any bacterial organism that can be assigned to the species Kocuria varians. | Kocuria varians | |||
| KURTHIA | C86471 | Any bacteria that is not assigned to the species level but can be assigned to the Kurthia genus level. | Kurthia | |||
| KYTOCOCCUS | C86472 | Any bacteria that is not assigned to the species level but can be assigned to the Kytococcus genus level. | Kytococcus | |||
| KYTOCOCCUS SEDENTARIUS | C86473 | Any bacterial organism that can be assigned to the species Kytococcus sedentarius. | Kytococcus sedentarius | |||
| LACTOBACILLUS | C76352 | Any bacteria that is not assigned to the species level but can be assigned to the Lactobacillus genus level. | Lactobacillus | |||
| LACTOBACILLUS ACIDOPHILUS | C86474 | Any bacterial organism that can be assigned to the species Lactobacillus acidophilus. | Lactobacillus acidophilus | |||
| LACTOBACILLUS BREVIS | C86475 | Any bacterial organism that can be assigned to the species Lactobacillus brevis. | Lactobacillus brevis | |||
| LACTOBACILLUS CASEI | C86476 | Any bacterial organism that can be assigned to the species Lactobacillus casei. | Lactobacillus casei | |||
| LACTOBACILLUS CATENAFORMIS | C86477 | LACTOBACILLUS CATENAFORME | Any bacterial organism that can be assigned to the species Lactobacillus catenaformis. | Lactobacillus catenaformis | ||
| LACTOBACILLUS FERMENTUM | C86478 | Any bacterial organism that can be assigned to the species Lactobacillus fermentum. | Lactobacillus fermentum | |||
| LACTOBACILLUS GALLINARUM | C86479 | Any bacterial organism that can be assigned to the species Lactobacillus gallinarum. | Lactobacillus gallinarum | |||
| LACTOBACILLUS JENSENII | C86480 | Any bacterial organism that can be assigned to the species Lactobacillus jensenii. | Lactobacillus jensenii | |||
| LACTOBACILLUS JOHNSONII | C86481 | Any bacterial organism that can be assigned to the species Lactobacillus johnsonii. | Lactobacillus johnsonii | |||
| LACTOBACILLUS SALIVARIUS | C86482 | Any bacterial organism that can be assigned to the species Lactobacillus salivarius. | Lactobacillus salivarius | |||
| LACTOCOCCUS | C86483 | DOEDERLEIN BACILLUS | Any bacteria that is not assigned to the species level but can be assigned to the Lactococcus genus level. | Lactococcus | ||
| LACTOCOCCUS GARVIEAE | C86484 | Any bacterial organism that can be assigned to the species Lactococcus garvieae. | Lactococcus garvieae | |||
| LACTOCOCCUS LACTIS | C86485 | Any bacterial organism that can be assigned to the species Lactococcus lactis. | Lactococcus lactis | |||
| LECLERCIA | C86486 | Any bacteria that is not assigned to the species level but can be assigned to the Leclercia genus level. | Leclercia | |||
| LECLERCIA ADECARBOXYLATA | C86487 | CDC ENTERIC GROUP 41 | Any bacterial organism that can be assigned to the species Leclercia adecarboxylata. | Leclercia adecarboxylata | ||
| LEGIONELLA | C76353 | Any bacteria that is not assigned to the species level but can be assigned to the Legionella genus level. | Legionella | |||
| LEGIONELLA LONGBEACHAE | C86488 | Any bacterial organism that can be assigned to the species Legionella longbeachae. | Legionella longbeachae | |||
| LEGIONELLA PNEUMOPHILA | C86489 | Any bacterial organism that can be assigned to the species Legionella pneumophila. | Legionella pneumophila | |||
| LEIFSONIA | C86490 | Any bacteria that is not assigned to the species level but can be assigned to the Leifsonia genus level. | Leifsonia | |||
| LEIFSONIA AQUATICA | C86491 | CORYNEBACTERIUM AQUATICUM | Any bacterial organism that can be assigned to the species Leifsonia aquatica. | Leifsonia aquatica | ||
| LEMINORELLA | C86492 | Any bacteria that is not assigned to the species level but can be assigned to the Leminorella genus level. | Leminorella | |||
| LEMINORELLA GRIMONTII | C86493 | CDC ENTERIC GROUP 57 | Any bacterial organism that can be assigned to the species Leminorella grimontii. | Leminorella grimontii | ||
| LEMINORELLA RICHARDII | C86494 | Any bacterial organism that can be assigned to the species Leminorella richardii. | Leminorella richardii | |||
| LENTIVIRUS | C14290 | Lentivirinae | Any viral organism that can be assigned to the genus Lentivirus. | Lentivirus | ||
| LEPTOSPIRA | C76355 | Any bacteria that is not assigned to the species level but can be assigned to the Leptospira genus level. | Leptospira | |||
| LEUCONOSTOC | C76357 | Any bacteria that is not assigned to the species level but can be assigned to the Leuconostoc genus level. | Leuconostoc | |||
| LEUCONOSTOC CITREUM | C86495 | Any bacterial organism that can be assigned to the species Leuconostoc citreum. | Leuconostoc citreum | |||
| LEUCONOSTOC LACTIS | C86496 | Any bacterial organism that can be assigned to the species Leuconostoc lactis. | Leuconostoc lactis | |||
| LEUCONOSTOC MESENTEROIDES | C86497 | Any bacterial organism that can be assigned to the species Leuconostoc mesenteroides. | Leuconostoc mesenteroides | |||
| LEUCONOSTOC PSEUDOMESENTEROIDES | C86498 | Any bacterial organism that can be assigned to the species Leuconostoc pseudomesenteroides. | Leuconostoc pseudomesenteroides | |||
| LISTERIA | C76359 | Any bacteria that is not assigned to the species level but can be assigned to the Listeria genus level. | Listeria | |||
| LISTERIA GRAYI | C86499 | Any bacterial organism that can be assigned to the species Listeria grayi. | Listeria grayi | |||
| LISTERIA INNOCUA | C86500 | Any bacterial organism that can be assigned to the species Listeria innocua. | Listeria innocua | |||
| LISTERIA IVANOVII | C86501 | LISTERIA MONOCYTOGENES SEROVAR 5 | Any bacterial organism that can be assigned to the species Listeria ivanovii. | Listeria ivanovii | ||
| LISTERIA MONOCYTOGENES | C86502 | Any bacterial organism that can be assigned to the species Listeria monocytogenes. | Listeria monocytogenes | |||
| LISTERIA SEELIGERI | C86503 | Any bacterial organism that can be assigned to the species Listeria seeligeri. | Listeria seeligeri | |||
| LISTERIA WELSHIMERI | C86504 | Any bacterial organism that can be assigned to the species Listeria welshimeri. | Listeria welshimeri | |||
| LYSSAVIRUS | C112330 | Any viral organism that can be assigned to the genus Lyssavirus. | Lyssavirus | |||
| MACROCOCCUS | C86505 | Any bacteria that is not assigned to the species level but can be assigned to the Macrococcus genus level. | Macrococcus | |||
| MACROCOCCUS CASEOLYTICUS | C86506 | STAPHYLOCOCCUS CASEOLYTICUS | Any bacterial organism that can be assigned to the species Macrococcus caseolyticus. | Macrococcus caseolyticus | ||
| MAGNUSIOMYCES CAPITATUS | C114263 | M. capitatus | Any fungal organism that can be assigned to the species Magnusiomyces capitatus. | Magnusiomyces capitatus | ||
| MANNHEIMIA | C86507 | Any bacteria that is not assigned to the species level but can be assigned to the Mannheimia genus level. | Mannheimia | |||
| MANNHEIMIA HAEMOLYTICA | C86508 | PASTEURELLA HAEMOLYTICA | Any bacterial organism that can be assigned to the species Mannheimia haemolytica. | Mannheimia haemolytica | ||
| MANSONELLA PERSTANS | C119326 | Dipetalonema perstans | Any parasitic organism that can be assigned to the species Mansonella perstans. | Mansonella perstans | ||
| MARBURGVIRUS | C112331 | Marburg Virus | Any viral organism that can be assigned to the genus Marburgvirus. | Marburgvirus | ||
| MEASLES VIRUS | C14237 | Rubeola Virus;SSPEV;rougeole virus;subacute sclerosing panencephalitis virus | Any viral organism that can be assigned to the species Measles virus. | Measles Virus | ||
| MEGAMONAS FUNIFORMIS | C114247 | Any bacterial organism that can be assigned to the species Megamonas funiformis. | Megamonas funiformis | |||
| MEGASPHAERA | C86895 | Any bacteria that is not assigned to the species level but can be assigned to the Megasphaera genus level. | Megasphaera | |||
| MEGASPHAERA ELSDENII | C86896 | PEPTOSTREPTOCOCCUS ELSDENII | Any bacterial organism that can be assigned to the species Megasphaera elsdenii. | Megasphaera elsdenii | ||
| METHYLOBACTERIUM | C76361 | Any bacteria that is not assigned to the species level but can be assigned to the Methylobacterium genus level. | Methylobacterium | |||
| METHYLOBACTERIUM MESOPHILICUM | C86510 | PSEUDOMONAS MESOPHILICA | Any bacterial organism that can be assigned to the species Methylobacterium mesophilicum. | Methylobacterium mesophilicum | ||
| MEYEROZYMA GUILLIERMONDII | C77172 | C. guilliermondii;Candida guilliermondii;M. guillliermondii | Any fungal organism that can be assigned to the species Meyerozyma guilliermondii. | Pichia guilliermondii | ||
| MICROBACTERIUM | C85511 | CDC CORYNEFORM GROUP A-4, A-5 | Any bacteria that is not assigned to the species level but can be assigned to the Microbacterium genus level. | Microbacterium | ||
| MICROBACTERIUM PARAOXYDANS | C86512 | Any bacterial organism that can be assigned to the species Microbacterium paraoxydans. | Microbacterium paraoxydans | |||
| MICROCOCCUS | C77086 | Any bacteria that is not assigned to the species level but can be assigned to the Micrococcus genus level. | Micrococcus | |||
| MICROCOCCUS LYLAE | C86514 | Any bacterial organism that can be assigned to the species Micrococcus lylae. | Micrococcus lylae | |||
| MITSUOKELLA | C86515 | Any bacteria that is not assigned to the species level but can be assigned to the Mitsuokella genus level. | Mitsuokella | |||
| MITSUOKELLA MULTACIDA | C86516 | Any bacterial organism that can be assigned to the species Mitsuokella multacida. | Mitsuokella multacida | |||
| MOBILUNCUS | C86517 | Any bacteria that is not assigned to the species level but can be assigned to the Mobiluncus genus level. | Mobiluncus | |||
| MOBILUNCUS CURTISII | C86518 | Any bacterial organism that can be assigned to the species Mobiluncus curtisii. | Mobiluncus curtisii | |||
| MOBILUNCUS MULIERIS | C86519 | Any bacterial organism that can be assigned to the species Mobiluncus mulieris. | Mobiluncus mulieris | |||
| MOELLERELLA | C86520 | Any bacteria that is not assigned to the species level but can be assigned to the Moellerella genus level. | Moellerella | |||
| MOELLERELLA WISCONSENSIS | C86521 | CDC ENTERIC GROUP 46 | Any bacterial organism that can be assigned to the species Moellerella wisconsensis. | Moellerella wisconsensis | ||
| MOGIBACTERIUM | C86898 | Any bacteria that is not assigned to the species level but can be assigned to the Mogibacterium genus level. | Mogibacterium | |||
| MOGIBACTERIUM TIMIDUM | C86899 | EUBACTERIUM TIMIDUM | Any bacterial organism that can be assigned to the species Mogibacterium timidum. | Mogibacterium timidum | ||
| MOLLUSCIPOXVIRUS | C112356 | Molluscipox Virus | Any viral organism that can be assigned to the genus Molluscipoxvirus. | Molluscipoxvirus | ||
| MOLLUSCUM CONTAGIOSUM VIRUS | C112357 | MCV;MOCV | Any viral organism that can be assigned to the species Molluscum contagiosum virus. | Molluscum Contagiosum Virus | ||
| MORAXELLA | C86009 | BRANHAMELLA SPECIES | Any bacteria that is not assigned to the species level but can be assigned to the Moraxella genus level. | Moraxella | ||
| MORAXELLA ATLANTAE | C86523 | CDC GROUP M-3 | Any bacterial organism that can be assigned to the species Moraxella atlantae. | Moraxella atlantae | ||
| MORAXELLA BOVIS | C86524 | Any bacterial organism that can be assigned to the species Moraxella bovis. | Moraxella bovis | |||
| MORAXELLA CANIS | C86525 | Any bacterial organism that can be assigned to the species Moraxella canis. | Moraxella canis | |||
| MORAXELLA CATARRHALIS | C76210 | BRANHAMELLA CATARRHALIS | Any bacterial organism that can be assigned to the species Moraxella catarrhalis. | Moraxella catarrhalis | ||
| MORAXELLA LACUNATA | C86526 | MORAXELLA LIQUEFACIENS | Any bacterial organism that can be assigned to the species Moraxella lacunata. | Moraxella lacunata | ||
| MORAXELLA LINCOLNII | C86527 | Any bacterial organism that can be assigned to the species Moraxella lincolnii. | Moraxella lincolnii | |||
| MORAXELLA NONLIQUEFACIENS | C86528 | Any bacterial organism that can be assigned to the species Moraxella nonliquefaciens. | Moraxella nonliquefaciens | |||
| MORAXELLA OBLONGA | C86529 | Any bacterial organism that can be assigned to the species Moraxella oblonga. | Moraxella oblonga | |||
| MORAXELLA OSLOENSIS | C86530 | Any bacterial organism that can be assigned to the species Moraxella osloensis. | Moraxella osloensis | |||
| MORBILLIVIRUS | C14309 | Any viral organism that can be assigned to the genus Morbillivirus. | Morbillivirus | |||
| MORGANELLA | C86531 | Any bacteria that is not assigned to the species level but can be assigned to the Morganella genus level. | Morganella | |||
| MORGANELLA MORGANII | C86015 | PROTEUS MORGANII | Any bacterial organism that can be assigned to the species Morganella morganii. | Morganella morganii | ||
| MYCOBACTERIUM | C76369 | Any bacteria that is not assigned to the species level but can be assigned to the Mycobacterium genus level. | Mycobacterium | |||
| MYCOBACTERIUM ABSCESSUS | C86533 | MYCOBACTERIUM CHELONAE SUBSP. ABSCESSUS | Any bacterial organism that can be assigned to the species Mycobacterium abscessus. | Mycobacterium abscessus | ||
| MYCOBACTERIUM AFRICANUM | C85544 | Any bacterial organism that can be assigned to the species Mycobacterium africanum. | Mycobacterium africanum | |||
| MYCOBACTERIUM AVIUM | C86535 | Any bacterial organism that can be assigned to the species Mycobacterium avium. | Mycobacterium avium | |||
| MYCOBACTERIUM AVIUM COMPLEX | C76368 | A non-taxonomic grouping of bacteria assigned to and including at least three related subspecies from the Mycobacterium avium species. | Mycobacterium avium complex | |||
| MYCOBACTERIUM BOVIS | C85545 | Any bacterial organism that can be assigned to the species Mycobacterium bovis. | Mycobacterium bovis | |||
| MYCOBACTERIUM BOVIS BCG | C85546 | An attenuated form of Mycobacterium bovis that is used to generate the Bacillus Calmette-Guerin vaccine. | Mycobacterium bovis BCG | |||
| MYCOBACTERIUM CANETTII | C85547 | Any bacterial organism that can be assigned to the species Mycobacterium canettii. | Mycobacterium canetti | |||
| MYCOBACTERIUM CHELONAE | C86536 | MYCOBACTERIUM CHELONAE SUBSP. CHELONAE | Any bacterial organism that can be assigned to the species Mycobacterium chelonae. | Mycobacterium chelonae | ||
| MYCOBACTERIUM FLAVESCENS | C86537 | Any bacterial organism that can be assigned to the species Mycobacterium flavescens. | Mycobacterium flavescens | |||
| MYCOBACTERIUM FORTUITUM | C86538 | Any bacterial organism that can be assigned to the species Mycobacterium fortuitum. | Mycobacterium fortuitum | |||
| MYCOBACTERIUM FORTUITUM COMPLEX | C86539 | A non-taxonomic grouping of bacteria assigned to the Mycobacterium genus, which includes the related species and subspecies M. chelonei subsp. chelonei, M. chelonei subsp. abscessus, M. fortuitum, and M. peregrinum. | Mycobacterium fortuitum Complex | |||
| MYCOBACTERIUM GASTRI | C86540 | Any bacterial organism that can be assigned to the species Mycobacterium gastri. | Mycobacterium gastri | |||
| MYCOBACTERIUM GORDONAE | C86541 | MYCOBACTERIUM AQUAE | Any bacterial organism that can be assigned to the species Mycobacterium gordonae. | Mycobacterium gordonae | ||
| MYCOBACTERIUM HAEMOPHILUM | C86542 | Any bacterial organism that can be assigned to the species Mycobacterium haemophilum. | Mycobacterium haemophilum | |||
| MYCOBACTERIUM INTRACELLULARE | C91843 | Any bacterial organism that can be assigned to the species Mycobacterium intracellulare. | Mycobacterium intracellulare | |||
| MYCOBACTERIUM KANSASII | C85543 | Any bacterial organism that can be assigned to the species Mycobacterium kansasii. | Mycobacterium kansasii | |||
| MYCOBACTERIUM LEPRAE | C86544 | Any bacterial organism that can be assigned to the species Mycobacterium leprae. | Mycobacterium leprae | |||
| MYCOBACTERIUM MARINUM | C86545 | MYCOBACTERIUM BALNEI | Any bacterial organism that can be assigned to the species Mycobacterium marinum. | Mycobacterium marinum | ||
| MYCOBACTERIUM MICROTI | C85548 | Any bacterial organism that can be assigned to the species Mycobacterium microti. | Mycobacterium microti | |||
| MYCOBACTERIUM PEREGRINUM | C86546 | Any bacterial organism that can be assigned to the species Mycobacterium peregrinum. | Mycobacterium peregrinum | |||
| MYCOBACTERIUM SCROFULACEUM | C86547 | Any bacterial organism that can be assigned to the species Mycobacterium scrofulaceum. | Mycobacterium scrofulaceum | |||
| MYCOBACTERIUM SIMIAE | C86548 | MYCOBACTERIUM HABANA | Any bacterial organism that can be assigned to the species Mycobacterium simiae. | Mycobacterium simiae | ||
| MYCOBACTERIUM SMEGMATIS | C86590 | Any bacterial organism that can be assigned to the species Mycobacterium smegmatis. | Mycobacterium smegmatis | |||
| MYCOBACTERIUM SZULGAI | C86591 | Any bacterial organism that can be assigned to the species Mycobacterium szulgai. | Mycobacterium szulgai | |||
| MYCOBACTERIUM TERRAE | C86592 | Any bacterial organism that can be assigned to the species Mycobacterium terrae. | Mycobacterium terrae | |||
| MYCOBACTERIUM THERMORESISTIBILE | C86593 | Any bacterial organism that can be assigned to the species Mycobacterium thermoresistibile. | Mycobacterium thermoresistibile | |||
| MYCOBACTERIUM TUBERCULOSIS | C76370 | Any bacterial organism that can be assigned to the species Mycobacterium tuberculosis. | Mycobacterium tuberculosis | |||
| MYCOBACTERIUM TUBERCULOSIS COMPLEX | C86594 | A non-taxonomic grouping of bacteria assigned to the Mycobacterium genus, which includes the related species M. tuberculosis, M. africanum, M. bovis, and M. microti. | Mycobacterium tuberculosis Complex | |||
| MYCOBACTERIUM ULCERANS | C86595 | MYCOBACTERIUM BURULI | Any bacterial organism that can be assigned to the species Mycobacterium ulcerans. | Mycobacterium ulcerans | ||
| MYCOPLASMA | C73540 | Any bacteria that is not assigned to the species level but can be assigned to the Mycoplasma genus level. | Mycoplasma | |||
| MYCOPLASMA HOMINIS | C86597 | Any bacterial organism that can be assigned to the species Mycoplasma hominis. | Mycoplasma hominis | |||
| MYCOPLASMA ORALE | C86598 | Any bacterial organism that can be assigned to the species Mycoplasma orale. | Mycoplasma orale | |||
| MYCOPLASMA PNEUMONIAE | C86599 | Any bacterial organism that can be assigned to the species Mycoplasma pneumoniae. | Mycoplasma pneumoniae | |||
| MYROIDES | C86953 | Any bacteria that is not assigned to the species level but can be assigned to the Myroides genus level. | Myroides | |||
| MYROIDES ODORATUS | C86954 | FLAVOBACTERIUM ODORATUM | Any bacterial organism that can be assigned to the species Myroides odoratus. | Myroides odoratus | ||
| NAIROVIRUS | C112358 | Any viral organism that can be assigned to the genus Nairovirus. | Nairovirus | |||
| NEISSERIA | C76371 | Any bacteria that is not assigned to the species level but can be assigned to the Neisseria genus level. | Neisseria | |||
| NEISSERIA CANIS | C86600 | Any bacterial organism that can be assigned to the species Neisseria canis. | Neisseria canis | |||
| NEISSERIA CINEREA | C86601 | MICROCOCCUS CINEREUS | Any bacterial organism that can be assigned to the species Neisseria cinerea. | Neisseria cinerea | ||
| NEISSERIA FLAVESCENS | C86602 | Any bacterial organism that can be assigned to the species Neisseria flavescens. | Neisseria flavescens | |||
| NEISSERIA GONORRHOEAE | C86603 | Any bacterial organism that can be assigned to the species Neisseria gonorrhoeae. | Neisseria gonorrhoeae | |||
| NEISSERIA LACTAMICA | C86604 | Any bacterial organism that can be assigned to the species Neisseria lactamica. | Neisseria lactamica | |||
| NEISSERIA MENINGITIDIS | C86605 | BETA-LACTAMASE NEGATIVE NEISSERIA MENINGITIDIS | Any bacterial organism that can be assigned to the species Neisseria meningitidis. | Neisseria meningitidis | ||
| NEISSERIA MUCOSA | C86606 | Any bacterial organism that can be assigned to the species Neisseria mucosa. | Neisseria mucosa | |||
| NEISSERIA POLYSACCHAREA | C86607 | Any bacterial organism that can be assigned to the species Neisseria polysaccharea. | Neisseria polysaccharea | |||
| NEISSERIA SICCA | C86608 | Any bacterial organism that can be assigned to the species Neisseria sicca. | Neisseria sicca | |||
| NEISSERIA SUBFLAVA | C86609 | Any bacterial organism that can be assigned to the species Neisseria subflava. | Neisseria subflava | |||
| NEISSERIA WEAVERII | C86610 | CDC GROUP M-5 | Any bacterial organism that can be assigned to the species Neisseria weaverii. | Neisseria weaverii | ||
| NEWCASTLE DISEASE VIRUS | C93023 | Avian Paramyxovirus Type 1;NDV | Any viral organism that can be assigned to the species Newcastle disease virus. | Newcastle Disease Virus | ||
| NIPAH VIRUS | C112359 | NiV | Any viral organism that can be assigned to the species Nipah virus. | Nipah Virus | ||
| NOCARDIA | C76372 | Any bacteria that is not assigned to the species level but can be assigned to the Nocardia genus level. | Nocardia | |||
| NOCARDIA ASTEROIDES | C86611 | Any bacterial organism that can be assigned to the species Nocardia asteroides. | Nocardia asteroides | |||
| NOCARDIA ASTEROIDES COMPLEX | C86612 | A non-taxonomic grouping of bacteria assigned to and including at least four related species from the Nocardia genus. | Nocardia asteroides Complex | |||
| NOCARDIA BRASILIENSIS | C86613 | Any bacterial organism that can be assigned to the species Nocardia brasiliensis. | Nocardia brasiliensis | |||
| NOCARDIA DASSONVILLEI | C86614 | Any bacterial organism that can be assigned to the species Nocardia dassonvillei. | Nocardia dassonvillei | |||
| NOCARDIA FARCINICA | C86615 | Any bacterial organism that can be assigned to the species Nocardia farcinica. | Nocardia farcinica | |||
| NOCARDIA NOVA | C86616 | Any bacterial organism that can be assigned to the species Nocardia nova. | Nocardia nova | |||
| NOCARDIA OTITIDISCAVIARUM | C86617 | NOCARDIA CAVIAE | Any bacterial organism that can be assigned to the species Nocardia otitidiscaviarum. | Nocardia otitidiscaviarum | ||
| NON-FERMENTATIVE GRAM-NEGATIVE BACILLUS | C86618 | NON-FERMENTATIVE GRAM-NEGATIVE ROD | Any rod-shaped, anaerobic bacteria that cannot convert carbohydrates into acids and alcohols and has a cell wall that contains low levels of peptidoglycan and stains pink with the Gram staining technique. | Non-Fermentative Gram Negative Bacillus | ||
| NOROVIRUS | C112362 | NoV;Norwalk-like virus | Any viral organism that can be assigned to the genus Norovirus. | Norovirus | ||
| NORWALK VIRUS | C112363 | NV;Norwalk calicivirus | Any viral organism that can be assigned to the species Norwalk virus. | Norwalk Virus | ||
| OCHROBACTRUM | C86619 | Any bacteria that is not assigned to the species level but can be assigned to the Ochrobactrum genus level. | Ochrobactrum | |||
| OCHROBACTRUM ANTHROPI | C86620 | ACHROMOBACTER SUBSP. BIOTYPE 1 | Any bacterial organism that can be assigned to the species Ochrobactrum anthropi. | Ochrobactrum anthropi | ||
| OCHROBACTRUM INTERMEDIUM | C86621 | Any bacterial organism that can be assigned to the species Ochrobactrum intermedium. | Ochrobactrum intermedium | |||
| ODORIBACTER SPLANCHNICUS | C86176 | BACTEROIDES SPLANCHNICUS | Any bacterial organism that can be assigned to the species Odoribacter splanchnicus. | Bacteroides splanchnicus | ||
| OERSKOVIA | C86622 | Any bacteria that is not assigned to the species level but can be assigned to the Oerskovia genus level. | Oerskovia | |||
| OERSKOVIA TURBATA | C86623 | Any bacterial organism that can be assigned to the species Oerskovia turbata. | Oerskovia turbata | |||
| OLIGELLA | C86624 | Any bacteria that is not assigned to the species level but can be assigned to the Oligella genus level. | Oligella | |||
| OLIGELLA UREOLYTICA | C86625 | CDC GROUP IVE | Any bacterial organism that can be assigned to the species Oligella ureolytica. | Oligella ureolytica | ||
| OLIGELLA URETHRALIS | C86626 | CDC GROUP M-4 | Any bacterial organism that can be assigned to the species Oligella urethralis. | Oligella urethralis | ||
| OLSENELLA | C86627 | Any bacteria that is not assigned to the species level but can be assigned to the Olsenella genus level. | Olsenella | |||
| OLSENELLA ULI | C86628 | LACTOBACILLUS ULI | Any bacterial organism that can be assigned to the species Olsenella uli. | Olsenella uli | ||
| ORBIVIRUS | C112365 | Any viral organism that can be assigned to the genus Orbivirus. | Orbivirus | |||
| ORTHOBUNYAVIRUS | C112366 | Bunyavirus | Any viral organism that can be assigned to the genus Orthobunyavirus. | Orthobunyavirus | ||
| ORTHOPOXVIRUS | C96524 | Any viral organism that can be assigned to the genus Orthopoxvirus. | Orthopoxvirus | |||
| PANDORAEA | C86629 | Any bacteria that is not assigned to the species level but can be assigned to the Pandoraea genus level. | Pandoraea | |||
| PANDORAEA PNOMENUSA | C86630 | Any bacterial organism that can be assigned to the species Pandoraea pnomenusa. | Pandoraea pnomenusa | |||
| PANDORAEA SPUTORUM | C119327 | Any bacterial organism that can be assigned to the species Pandoraea sputorum. | Pandoraea sputorum | |||
| PANNONIBACTER PHRAGMITETUS | C119328 | Achromobacter group B;Achromobacter group E | Any bacterial organism that can be assigned to the species Pannonibacter phragmitetus. | Pannonibacter phragmitetus | ||
| PANTOEA | C86631 | Any bacteria that is not assigned to the species level but can be assigned to the Pantoea genus level. | Pantoea | |||
| PANTOEA AGGLOMERANS | C86632 | ENTEROBACTER AGGLOMERANS | Any bacterial organism that can be assigned to the species Pantoea agglomerans. | Pantoea agglomerans | ||
| PARABACTEROIDES | C86633 | Any bacteria that is not assigned to the species level but can be assigned to the Parabacteroides genus level. | Parabacteroides | |||
| PARABACTEROIDES DISTASONIS | C86634 | BACTEROIDES DISTASONIS | Any bacterial organism that can be assigned to the species Parabacteroides distasonis. | Parabacteroides distasonis | ||
| PARABACTEROIDES MERDAE | C86635 | BACTEROIDES FRAGILIS T4-1;BACTEROIDES MERDAE | Any bacterial organism that can be assigned to the species Parabacteroides merdae. | Parabacteroides merdae | ||
| PARAPOXVIRUS | C112367 | Any viral organism that can be assigned to the genus Parapoxvirus. | Parapoxvirus | |||
| PARVIMONAS | C86900 | Any bacteria that is not assigned to the species level but can be assigned to the Parvimonas genus level. | Parvimonas | |||
| PARVIMONAS MICRA | C86901 | MICROMONAS MICROS;PEPTOSTREPTOCOCCUS MICROS | Any bacterial organism that can be assigned to the species Parvimonas micra. | Parvimonas micra | ||
| PASTEURELLA | C86636 | Any bacteria that is not assigned to the species level but can be assigned to the Pasteurella genus level. | Pasteurella | |||
| PASTEURELLA AEROGENES | C86637 | Any bacterial organism that can be assigned to the species Pasteurella aerogenes. | Pasteurella aerogenes | |||
| PASTEURELLA BETTYAE | C86638 | CDC GROUP HB-5 | Any bacterial organism that can be assigned to the species Pasteurella bettyae. | Pasteurella bettyae | ||
| PASTEURELLA CANIS | C86639 | PASTEURELLA MULTOCIDA BIOTYPE 6 | Any bacterial organism that can be assigned to the species Pasteurella canis. | Pasteurella canis | ||
| PASTEURELLA MULTOCIDA | C76373 | PASTEURELLA SEPTICA | Any bacterial organism that can be assigned to the species Pasteurella multocida. | Pasteurella multocida | ||
| PASTEURELLA PNEUMOTROPICA | C86640 | Any bacterial organism that can be assigned to the species Pasteurella pneumotropica. | Pasteurella pneumotropica | |||
| PEDIOCOCCUS | C86641 | Any bacteria that is not assigned to the species level but can be assigned to the Pediococcus genus level. | Pediococcus | |||
| PEPTOCOCCUS | C86642 | Any bacteria that is not assigned to the species level but can be assigned to the Peptococcus genus level. | Peptococcus | |||
| PEPTOCOCCUS NIGER | C86643 | MICROCOCCUS NIGER | Any bacterial organism that can be assigned to the species Peptococcus niger. | Peptococcus niger | ||
| PEPTONIPHILUS | C86902 | Any bacteria that is not assigned to the species level but can be assigned to the Peptoniphilus genus level. | Peptoniphilus | |||
| PEPTONIPHILUS ASACCHAROLYTICUS | C86903 | PEPTOCOCCUS ASACCHAROLYTICUS;PEPTOSTREPTOCOCCUS ASACCHAROLYTICUS | Any bacterial organism that can be assigned to the species Peptoniphilus asaccharolyticus. | Peptoniphilus asaccharolyticus | ||
| PEPTONIPHILUS HAREI | C114245 | Peptostreptococcus harei;Schleiferella harei | Any bacterial organism that can be assigned to the species Peptoniphilus harei. | Peptoniphilus harei | ||
| PEPTONIPHILUS INDOLICUS | C86904 | PEPTOSTREPTOCOCCUS INDOLICUS | Any bacterial organism that can be assigned to the species Peptoniphilus indolicus. | Peptoniphilus indolicus | ||
| PEPTOSTREPTOCOCCUS | C86644 | Any bacteria that is not assigned to the species level but can be assigned to the Peptostreptococcus genus level. | Peptostreptococcus | |||
| PEPTOSTREPTOCOCCUS ANAEROBIUS | C86645 | Any bacterial organism that can be assigned to the species Peptostreptococcus anaerobius. | Peptostreptococcus anaerobius | |||
| PEPTOSTREPTOCOCCUS STOMATIS | C119329 | Any bacterial organism that can be assigned to the species Peptostreptococcus stomatis. | Peptostreptococcus stomatis | |||
| PHLEBOVIRUS | C112397 | Any viral organism that can be assigned to the genus Phlebovirus. | Phlebovirus | |||
| PHOTOBACTERIUM | C86646 | Any bacteria that is not assigned to the species level but can be assigned to the Photobacterium genus level. | Photobacterium | |||
| PHOTOBACTERIUM DAMSELAE | C86647 | CDC GROUP EF-5;PHOTOBACTERIUM DAMSELAE SUBSP. DAMSELAE;VIBRIO DAMSELA | Any bacterial organism that can be assigned to the species Photobacterium damselae. | Photobacterium damselae | ||
| PHOTORHABDUS | C86648 | Any bacteria that is not assigned to the species level but can be assigned to the Photorhabdus genus level. | Photorhabdus | |||
| PHOTORHABDUS LUMINESCENS | C86649 | Any bacterial organism that can be assigned to the species Photorhabdus luminescens. | Photorhabdus luminescens | |||
| PICHIA KLUYVERI | C114270 | P. kluyveri | Any fungal organism that can be assigned to the species Pichia kluyveri. | Pichia kluyveri | ||
| PICHIA KUDRIAVZEVII | C77173 | C. krusei;Candida krusei;I. orientalis;Issatchenkia orientalis;P. kudriavzevii | Any fungal organism that can be assigned to the species Pichia kudriavzevii. | Candida krusei | ||
| PICHIA NORVEGENSIS | C114259 | C. mycoderma var. annulata;Candida mycoderma var. annulata;P. norvegensis | Any fungal organism that can be assigned to the species Pichia norvegensis. | Pichia norvegensis | ||
| PLANOCOCCUS | C86650 | Any bacteria that is not assigned to the species level but can be assigned to the Planococcus genus level. | Planococcus | |||
| PLESIOMONAS | C86651 | Any bacteria that is not assigned to the species level but can be assigned to the Plesiomonas genus level. | Plesiomonas | |||
| PLESIOMONAS SHIGELLOIDES | C86652 | AEROMONAS SHIGELLOIDES | Any bacterial organism that can be assigned to the species Plesiomonas shigelloides. | Plesiomonas shigelloides | ||
| PNEUMOVIRUS | C112398 | Any viral organism that can be assigned to the genus Pneumovirus. | Pneumovirus | |||
| POLIOVIRUS | C14259 | Enterovirus C;Human enterovirus C | Any viral organism that can be assigned to the species Poliovirus. | Poliovirus | ||
| POLYOMAVIRUS | C14260 | Any viral organism that can be assigned to the genus Polyomavirus. | Polyomavirus | |||
| PORPHYROMONAS | C86653 | Any bacteria that is not assigned to the species level but can be assigned to the Porphyromonas genus level. | Porphyromonas | |||
| PORPHYROMONAS ASACCHAROLYTICA | C86654 | BACTEROIDES ASACCHAROLYTICUS | Any bacterial organism that can be assigned to the species Porphyromonas asaccharolytica. | Porphyromonas asaccharolytica | ||
| PORPHYROMONAS CATONIAE | C86655 | Any bacterial organism that can be assigned to the species Porphyromonas catoniae. | Porphyromonas catoniae | |||
| PORPHYROMONAS ENDODONTALIS | C86656 | BACTEROIDES ENDODONTALIS | Any bacterial organism that can be assigned to the species Porphyromonas endodontalis. | Porphyromonas endodontalis | ||
| PORPHYROMONAS GINGIVALIS | C86657 | BACTEROIDES GINGIVALIS | Any bacterial organism that can be assigned to the species Porphyromonas gingivalis. | Porphyromonas gingivalis | ||
| PORPHYROMONAS LEVII | C86658 | BACTEROIDES LEVII;BACTEROIDES MELANINOGENICUS SUBSP. LEVII | Any bacterial organism that can be assigned to the species Porphyromonas levii. | Porphyromonas levii | ||
| PORPHYROMONAS SOMERAE | C86659 | Any bacterial organism that can be assigned to the species Porphyromonas somerae. | Porphyromonas somerae | |||
| PREVOTELLA | C86660 | Any bacteria that is not assigned to the species level but can be assigned to the Prevotella genus level. | Prevotella | |||
| PREVOTELLA BERGENSIS | C119330 | Any bacterial organism that can be assigned to the species Prevotella bergensis. | Prevotella bergensis | |||
| PREVOTELLA BIVIA | C86661 | BACTEROIDES BIVIA | Any bacterial organism that can be assigned to the species Prevotella bivia. | Prevotella bivia | ||
| PREVOTELLA BREVIS | C86662 | BACTEROIDES RUMINICOLA SUBSP. BREVIS;BACTEROIDES RUMINICOLA SUBSP. BREVUS | Any bacterial organism that can be assigned to the species Prevotella brevis. | Prevotella brevis | ||
| PREVOTELLA BUCCAE | C86663 | BACTEROIDES BUCCAE | Any bacterial organism that can be assigned to the species Prevotella buccae. | Prevotella buccae | ||
| PREVOTELLA BUCCALIS | C86664 | Any bacterial organism that can be assigned to the species Prevotella buccalis. | Prevotella buccalis | |||
| PREVOTELLA CORPORIS | C86665 | Any bacterial organism that can be assigned to the species Prevotella corporis. | Prevotella corporis | |||
| PREVOTELLA DENTALIS | C86666 | Any bacterial organism that can be assigned to the species Prevotella dentalis. | Prevotella dentalis | |||
| PREVOTELLA DENTICOLA | C86667 | BACTEROIDES DENTICOLA | Any bacterial organism that can be assigned to the species Prevotella denticola. | Prevotella denticola | ||
| PREVOTELLA DISIENS | C86668 | BACTEROIDES DISIENS | Any bacterial organism that can be assigned to the species Prevotella disiens. | Prevotella disiens | ||
| PREVOTELLA HEPARINOLYTICA | C86669 | BACTEROIDES HEPARINOLYTICUS | Any bacterial organism that can be assigned to the species Prevotella heparinolytica. | Prevotella heparinolytica | ||
| PREVOTELLA INTERMEDIA | C86670 | BACTEROIDES INTERMEDIA | Any bacterial organism that can be assigned to the species Prevotella intermedia. | Prevotella intermedia | ||
| PREVOTELLA INTERMEDIA/NIGRESCENS GROUP | C86671 | A non-taxonomic grouping of bacteria assigned to the Prevotella genus that include the P. intermedia and P. nigrescens species. | Prevotella intermedia/nigrescens Group | |||
| PREVOTELLA LOESCHEII | C86672 | Any bacterial organism that can be assigned to the species Prevotella loescheii. | Prevotella loescheii | |||
| PREVOTELLA MELANINOGENICA | C86673 | BACTEROIDES MELANINOGENICUS | Any bacterial organism that can be assigned to the species Prevotella melaninogenica. | Prevotella melaninogenica | ||
| PREVOTELLA NIGRESCENS | C86674 | Any bacterial organism that can be assigned to the species Prevotella nigrescens. | Prevotella nigrescens | |||
| PREVOTELLA ORALIS | C86675 | BACTEROIDES ORALIS | Any bacterial organism that can be assigned to the species Prevotella oralis. | Prevotella oralis | ||
| PREVOTELLA ORIS | C86676 | BACTEROIDES ORIS | Any bacterial organism that can be assigned to the species Prevotella oris. | Prevotella oris | ||
| PREVOTELLA RUMINICOLA | C86677 | BACTEROIDES RUMINICOLA | Any bacterial organism that can be assigned to the species Prevotella ruminicola. | Prevotella ruminicola | ||
| PREVOTELLA TANNERAE | C86678 | Any bacterial organism that can be assigned to the species Prevotella tannerae. | Prevotella tannerae | |||
| PREVOTELLA VERORALIS | C86679 | Any bacterial organism that can be assigned to the species Prevotella veroralis. | Prevotella veroralis | |||
| PROPIONIBACTERIUM | C86013 | Any bacteria that is not assigned to the species level but can be assigned to the Propionibacterium genus level. | Propionibacterium | |||
| PROPIONIBACTERIUM ACNES | C14378 | BACILLUS ACNES;C. PARVUM;CORYNEBACTERIUM ACNES;CORYNEBACTERIUM PARVUM;CPARV | Any bacterial organism that can be assigned to the species Propionibacterium acnes. | Propionibacterium acnes | ||
| PROPIONIBACTERIUM AVIDUM | C86681 | Any bacterial organism that can be assigned to the species Propionibacterium avidum. | Propionibacterium avidum | |||
| PROPIONIBACTERIUM GRANULOSUM | C86682 | CORYNEBACTERIUM GRANULOSUM | Any bacterial organism that can be assigned to the species Propionibacterium granulosum. | Propionibacterium granulosum | ||
| PROPIONIBACTERIUM PROPIONICUM | C86683 | ACTINOMYCES PROPIONICUS | Any bacterial organism that can be assigned to the species Propionibacterium propionicum. | Propionibacterium propionicum | ||
| PROTEUS | C76374 | Any bacteria that is not assigned to the species level but can be assigned to the Proteus genus level. | Proteus | |||
| PROTEUS HAUSERI | C86684 | Any bacterial organism that can be assigned to the species Proteus hauseri. | Proteus hauseri | |||
| PROTEUS INCONSTANS | C84582 | PROVIDENCIA INCONSTANS | Any bacterial organism that can be assigned to the species Proteus inconstans. | Proteus inconstans | ||
| PROTEUS MIRABILIS | C86019 | Any bacterial organism that can be assigned to the species Proteus mirabilis. | Proteus mirabilis | |||
| PROTEUS MYXOFACIENS | C86687 | Any bacterial organism that can be assigned to the species Proteus myxofaciens. | Proteus myxofaciens | |||
| PROTEUS PENNERI | C86688 | INDOLE NEGATIVE PROTEUS VULGARIS | Any bacterial organism that can be assigned to the species Proteus penneri. | Proteus penneri | ||
| PROTEUS VULGARIS | C85250 | Any bacterial organism that can be assigned to the species Proteus vulgaris. | Proteus vulgaris | |||
| PROTOTHECA WICKERHAMII | C114271 | P. wickerhamii | Any algal organism that can be assigned to the species Prototheca wickerhamii. | Prototheca wickerhamii | ||
| PROVIDENCIA | C86690 | Any bacteria that is not assigned to the species level but can be assigned to the Providencia genus level. | Providencia | |||
| PROVIDENCIA ALCALIFACIENS | C86691 | Any bacterial organism that can be assigned to the species Providencia alcalifaciens. | Providencia alcalifaciens | |||
| PROVIDENCIA HEIMBACHAE | C86692 | Any bacterial organism that can be assigned to the species Providencia heimbachae. | Providencia heimbachae | |||
| PROVIDENCIA RETTGERI | C86693 | Any bacterial organism that can be assigned to the species Providencia rettgeri. | Proteus rettgeri | |||
| PROVIDENCIA RUSTIGIANII | C86694 | PROVIDENCIA ALCALIFACIENS BIOGROUP 3 | Any bacterial organism that can be assigned to the species Providencia rustigianii. | Providencia rustigianii | ||
| PROVIDENCIA STUARTII | C86695 | Any bacterial organism that can be assigned to the species Providencia stuartii. | Providencia stuartii | |||
| PSEUDOCOWPOX VIRUS | C112401 | Paravaccinia virus;Pseudocowpoxvirus | Any viral organism that can be assigned to the species Pseudocowpox virus. | Pseudocowpox Virus | ||
| PSEUDOMONAS | C76375 | Any bacteria that is not assigned to the species level but can be assigned to the Pseudomonas genus level. | Pseudomonas | |||
| PSEUDOMONAS AERUGINOSA | C86696 | Any bacterial organism that can be assigned to the species Pseudomonas aeruginosa. | Pseudomonas aeruginosa | |||
| PSEUDOMONAS ALCALIGENES | C86697 | Any bacterial organism that can be assigned to the species Pseudomonas alcaligenes. | Pseudomonas alcaligenes | |||
| PSEUDOMONAS CHLORORAPHIS | C86699 | Any bacterial organism that can be assigned to the species Pseudomonas chlororaphis. | Pseudomonas chlororaphis | |||
| PSEUDOMONAS FLUORESCENS/PUTIDA GROUP | C86962 | A non-taxonomic grouping of bacteria assigned to the Pseudomonas genus that include the P. fluorescens and P. putida species. | Pseudomonas fluorescens/putida Group | |||
| PSEUDOMONAS LUTEOLA | C86701 | CHRYSEOMONAS LUTEOLA | Any bacterial organism that can be assigned to the species Pseudomonas luteola. | Pseudomonas luteola | ||
| PSEUDOMONAS MENDOCINA | C86702 | CDC GROUP VB-2 | Any bacterial organism that can be assigned to the species Pseudomonas mendocina. | Pseudomonas mendocina | ||
| PSEUDOMONAS MOSSELII | C86703 | Any bacterial organism that can be assigned to the species Pseudomonas mosselii. | Pseudomonas mosselii | |||
| PSEUDOMONAS ORYZIHABITANS | C76319 | FLAVIMONAS ORYZIHABITANS | Any bacterial organism that can be assigned to the species Pseudomonas oryzihabitans. | Pseudomonas oryzihabitans | ||
| PSEUDOMONAS PSEUDOALCALIGENES | C86704 | PSEUDOMONAS ALCALIGENES BIOTYPE B | Any bacterial organism that can be assigned to the species Pseudomonas pseudoalcaligenes. | Pseudomonas pseudoalcaligenes | ||
| PSEUDOMONAS PUTIDA | C86705 | Any bacterial organism that can be assigned to the species Pseudomonas putida. | Pseudomonas putida | |||
| PSEUDOMONAS STUTZERI | C86706 | PSEUDOMONAS GROUP VB-1 | Any bacterial organism that can be assigned to the species Pseudomonas stutzeri. | Pseudomonas stutzeri | ||
| PSYCHROBACTER | C86707 | Any bacteria that is not assigned to the species level but can be assigned to the Psychrobacter genus level. | Psychrobacter | |||
| PSYCHROBACTER IMMOBILIS | C86708 | Any bacterial organism that can be assigned to the species Psychrobacter immobilis. | Psychrobacter immobilis | |||
| PSYCHROBACTER PHENYLPYRUVICUS | C86709 | CDC GROUP M-2;MORAXELLA PHENYLPYRUVICA | Any bacterial organism that can be assigned to the species Psychrobacter phenylpyruvicus. | Psychrobacter phenylpyruvicus | ||
| RABIES VIRUS | C112405 | Any viral organism that can be assigned to the species Rabies virus. | Rabies Virus | |||
| RAHNELLA | C86710 | Any bacteria that is not assigned to the species level but can be assigned to the Rahnella genus level. | Rahnella | |||
| RAHNELLA AQUATILIS | C86711 | Any bacterial organism that can be assigned to the species Rahnella aquatilis. | Rahnella aquatilis | |||
| RALSTONIA | C86712 | Any bacteria that is not assigned to the species level but can be assigned to the Ralstonia genus level. | Ralstonia | |||
| RALSTONIA MANNITOLILYTICA | C111302 | Any bacterial organism that can be assigned to the species Ralstonia mannitolilytica. | Ralstonia mannitolilytica | |||
| RALSTONIA PICKETTII | C86713 | BURKHOLDERIA PICKETTII;PSEUDOMONAS PICKETTII | Any bacterial organism that can be assigned to the species Ralstonia pickettii. | Ralstonia pickettii | ||
| RAOULTELLA | C86714 | Any bacteria that is not assigned to the species level but can be assigned to the Raoultella genus level. | Raoultella | |||
| RAOULTELLA ORNITHINOLYTICA | C86715 | KLEBSIELLA ORNITHINOLYTICA | Any bacterial organism that can be assigned to the species Raoultella ornithinolytica. | Raoultella ornithinolytica | ||
| RAOULTELLA PLANTICOLA | C86716 | Any bacterial organism that can be assigned to the species Raoultella planticola. | Raoultella planticola | |||
| RAOULTELLA TERRIGENA | C86717 | KLEBSIELLA TERRIGENA | Any bacterial organism that can be assigned to the species Raoultella terrigena. | Raoultella terrigena | ||
| RESPIROVIRUS | C14310 | Paramyxovirus | Any viral organism that can be assigned to the genus Paramyxovirus. | Paramyxovirus | ||
| RHINOVIRUS A | C112407 | Human Rhinovirus A | Any viral organism that can be assigned to the species Rhinovirus A. | Rhinovirus A | ||
| RHINOVIRUS B | C112408 | Human Rhinovirus B | Any viral organism that can be assigned to the species Rhinovirus B. | Rhinovirus B | ||
| RHINOVIRUS C | C112409 | Human Rhinovirus C | Any viral organism that can be assigned to the species Rhinovirus C. | Rhinovirus C | ||
| RHIZOBIUM | C86718 | Any bacteria that is not assigned to the species level but can be assigned to the Rhizobium genus level. | Rhizobium | |||
| RHODOCOCCUS | C76378 | Any bacteria that is not assigned to the species level but can be assigned to the Rhodococcus genus level. | Rhodococcus | |||
| RHODOCOCCUS EQUI | C86719 | CORYNEBACTERIUM EQUI | Any bacterial organism that can be assigned to the species Rhodococcus equi. | Rhodococcus equi | ||
| RHODOTORULA GLUTINIS | C114264 | R. glutinis | Any fungal organism that can be assigned to the species Rhodotorula glutinis. | Rhodotorula glutinis | ||
| RHODOTORULA MUCILAGINOSA | C86027 | R. mucilaginosa;R. pilimanae;R. rubra;Rhodotorula pilimanae;Rhodotorula rubra;S. albo-rubescens;Sporobolomyces albo-rubescens | Any fungal organism that can be assigned to the species Rhodotorula mucilaginosa. | Rhodotorula mucilaginosa | ||
| RICKETTSIA | C76379 | Any bacteria that is not assigned to the species level but can be assigned to the Rickettsia genus level. | Rickettsia | |||
| RICKETTSIA AFRICAE | C86720 | Any bacterial organism that can be assigned to the species Rickettsia africae. | Rickettsia africae | |||
| RICKETTSIA FELIS | C86721 | Any bacterial organism that can be assigned to the species Rickettsia felis. | Rickettsia felis | |||
| RICKETTSIA JAPONICA | C86722 | Any bacterial organism that can be assigned to the species Rickettsia japonica. | Rickettsia japonica | |||
| RICKETTSIA PROWAZEKII | C86723 | Any bacterial organism that can be assigned to the species Rickettsia prowazekii. | Rickettsia prowazekii | |||
| RICKETTSIA RICKETTSII | C86724 | Any bacterial organism that can be assigned to the species Rickettsia rickettsii. | Rickettsia rickettsii | |||
| RICKETTSIA TYPHI | C86725 | Any bacterial organism that can be assigned to the species Rickettsia typhi. | Rickettsia typhi | |||
| ROSEOLOVIRUS | C112410 | Any viral organism that can be assigned to the genus Roseolovirus. | Roseolovirus | |||
| ROSEOMONAS | C86726 | Any bacteria that is not assigned to the species level but can be assigned to the Roseomonas genus level. | Roseomonas | |||
| ROSS RIVER VIRUS | C112411 | RRV | Any viral organism that can be assigned to the species Ross River virus. | Ross River Virus | ||
| ROTAVIRUS | C77199 | Any viral organism that can be assigned to the genus Rotavirus. | Rotavirus | |||
| ROTHIA | C86727 | Any bacteria that is not assigned to the species level but can be assigned to the Rothia genus level. | Rothia | |||
| ROTHIA DENTOCARIOSA | C86728 | NOCARDIA DENTOCARIOSA | Any bacterial organism that can be assigned to the species Rothia dentocariosa. | Rothia dentocariosa | ||
| ROTHIA MUCILAGINOSA | C76382 | STOMATOCOCCUS MUCILAGINOSUS | Any bacterial organism that can be assigned to the species Rothia mucilaginosa. | Rothia mucilaginosa | ||
| RUBELLA VIRUS | C77198 | German Measles Virus | Any viral organism that can be assigned to the species Rubella virus. | Rubella Virus | ||
| RUBIVIRUS | C112414 | Any viral organism that can be assigned to the genus Rubivirus. | Rubivirus | |||
| RUBULAVIRUS | C14326 | Any viral organism that can be assigned to the genus Rubulavirus. | Rubulavirus | |||
| RUMINOCOCCUS | C86729 | Any bacteria that is not assigned to the species level but can be assigned to the Ruminococcus genus level. | Ruminococcus | |||
| RUMINOCOCCUS PRODUCTUS | C86730 | PEPTOSTREPTOCOCCUS PRODUCTUS | Any bacterial organism that can be assigned to the species Ruminococcus productus. | Ruminococcus productus | ||
| SACCHAROMYCES CEREVISIAE | C14271 | Bakers Yeast;Brewers Yeast;S. capensis;S. cerevisiae;S. italicus;S. oviformis;S. uvarum var. melibiosus;Saccharomyces capensis;Saccharomyces italicus;Saccharomyces oviformis;Saccharomyces uvarum var. melibiosus | Any fungal organism that can be assigned to the species Saccharomyces cerevisiae. | Saccharomyces cerevisiae | ||
| SALMONELLA | C76380 | SALMONELLA SEROGROUP D (NOT S. TYPHI) | Any bacteria that is not assigned to the species level but can be assigned to the Salmonella genus level. | Salmonella | ||
| SALMONELLA BONGORI | C91842 | Any bacterial organism that can be assigned to the species Salmonella bongori. | Salmonella bongori | |||
| SALMONELLA ENTERICA | C86731 | Any bacterial organism that can be assigned to the species Salmonella enterica. | Salmonella enterica | |||
| SALMONELLA ENTERICA SUBSP. ARIZONAE | C86910 | Any bacterial organism that can be assigned to the species Salmonella enterica subspecies arizonae. | Salmonella enterica subsp arizonae | |||
| SALMONELLA ENTERICA SUBSP. DIARIZONAE | C91844 | Any bacterial organism that can be assigned to the species Salmonella enterica subspecies diarizonae. | Salmonella enterica subsp diarizonae | |||
| SALMONELLA ENTERICA SUBSP. ENTERICA | C86913 | Any bacterial organism that can be assigned to the species Salmonella enterica subspecies enterica. | Salmonella enterica subsp enterica | |||
| SALMONELLA ENTERICA SUBSP. HOUTENAE | C91845 | Any bacterial organism that can be assigned to the species Salmonella enterica subspecies houtenae. | Salmonella enterica subsp houtenae | |||
| SALMONELLA ENTERICA SUBSP. INDICA | C91846 | Any bacterial organism that can be assigned to the species Salmonella enterica subspecies indica. | Salmonella enterica subsp indica | |||
| SALMONELLA ENTERICA SUBSP. SALAMAE | C91847 | Any bacterial organism that can be assigned to the species Salmonella enterica subspecies salamae. | Salmonella enterica subsp salamae | |||
| SALMONELLA SEROTYPE CHOLERAESUIS | C86915 | Any bacterial organism that can be assigned to the genus Salmonella with serotype Choleraesuis. | Salmonella Serotype Choleraesuis | |||
| SALMONELLA SEROTYPE DUBLIN | C86918 | Any bacterial organism that can be assigned to the genus Salmonella with serotype Dublin. | Salmonella Serotype Dublin | |||
| SALMONELLA SEROTYPE ENTERITIDIS | C86919 | Any bacterial organism that can be assigned to the genus Salmonella with serotype Enteritidis. | Salmonella Serotype Enteritidis | |||
| SALMONELLA SEROTYPE NEWPORT | C86921 | Any bacterial organism that can be assigned to the genus Salmonella with serotype Newport. | Salmonella Serotype Newport | |||
| SALMONELLA SEROTYPE PARATYPHI A | C86922 | Any bacterial organism that can be assigned to the genus Salmonella with serotype Paratyphi A. | Salmonella Serotype Paratyphi A | |||
| SALMONELLA SEROTYPE PARATYPHI B | C86924 | Any bacterial organism that can be assigned to the genus Salmonella with serotype Paratyphi B. | Salmonella Serotype Paratyphi B | |||
| SALMONELLA SEROTYPE PARATYPHI C | C86925 | Any bacterial organism that can be assigned to the genus Salmonella with serotype Paratyphi C. | Salmonella Serotype Paratyphi C | |||
| SALMONELLA SEROTYPE TYPHI | C86926 | Any bacterial organism that can be assigned to the genus Salmonella with serotype Typhi. | Salmonella Serotype Typhi | |||
| SALMONELLA SEROTYPE TYPHIMURIUM | C86927 | Any bacterial organism that can be assigned to the genus Salmonella with serotype Typhimurium. | Salmonella Serotype Typhimurium | |||
| SAPOVIRUS | C112029 | Any viral organism that can be assigned to the genus Sapovirus. | Sapovirus | |||
| SAPPORO VIRUS | C112415 | Human calicivirus SLV;Human calicivirus Sapporo-like Virus | Any viral organism that can be assigned to the species Sapporo virus. | Sapporo Virus | ||
| SARS CORONAVIRUS | C112432 | HCoV-SARS;SARS;Severe Acute Respiratory Syndrome Coronavirus | Any viral organism that can be assigned to the species SARS coronavirus. | SARS Coronavirus | ||
| SELENOMONAS | C86732 | Any bacteria that is not assigned to the species level but can be assigned to the Selenomonas genus level. | Selenomonas | |||
| SELENOMONAS NOXIA | C86733 | Any bacterial organism that can be assigned to the species Selenomonas noxia. | Selenomonas noxia | |||
| SELENOMONAS SPUTIGENA | C86734 | Any bacterial organism that can be assigned to the species Selenomonas sputigena. | Selenomonas sputigena | |||
| SERRATIA | C86010 | SERRATIA | Any bacteria that is not assigned to the species level but can be assigned to the Serratia genus level. | Serratia | ||
| SERRATIA FICARIA | C86736 | Any bacterial organism that can be assigned to the species Serratia ficaria. | Serratia ficaria | |||
| SERRATIA FONTICOLA | C86737 | Any bacterial organism that can be assigned to the species Serratia fonticola. | Serratia fonticola | |||
| SERRATIA LIQUEFACIENS | C86738 | ENTEROBACTER LIQUEFACIENS | Any bacterial organism that can be assigned to the species Serratia liquefaciens. | Serratia liquefaciens | ||
| SERRATIA MARCESCENS | C14272 | S. MARCESCENS | Any bacterial organism that can be assigned to the species Serratia marcescens. | Serratia marcescens | ||
| SERRATIA ODORIFERA | C86739 | Any bacterial organism that can be assigned to the species Serratia odorifera. | Serratia odorifera | |||
| SERRATIA PLYMUTHICA | C86740 | Any bacterial organism that can be assigned to the species Serratia plymuthica. | Serratia plymuthica | |||
| SERRATIA RUBIDAEA | C86741 | SERRATIA MARINORUBRA | Any bacterial organism that can be assigned to the species Serratia rubidaea. | Serratia rubidaea | ||
| SHEWANELLA | C86742 | Any bacteria that is not assigned to the species level but can be assigned to the Shewanella genus level. | Shewanella | |||
| SHEWANELLA PUTREFACIENS | C86743 | ALTEROMONAS PUTREFACIENS;PSEUDOMONAS PUTREFACIENS | Any bacterial organism that can be assigned to the species Shewanella putrefaciens. | Shewanella putrefaciens | ||
| SHIGELLA | C76381 | Any bacteria that is not assigned to the species level but can be assigned to the Shigella genus level. | Shigella | |||
| SHIGELLA BOYDII | C86744 | SHIGELLA BIOGROUP C | Any bacterial organism that can be assigned to the species Shigella boydii. | Shigella boydii | ||
| SHIGELLA DYSENTERIAE | C86745 | SHIGELLA BIOGROUP A | Any bacterial organism that can be assigned to the species Shigella dysenteriae. | Shigella dysenteriae | ||
| SHIGELLA FLEXNERI | C86746 | SHIGELLA BIOGROUP B | Any bacterial organism that can be assigned to the species Shigella flexneri. | Shigella flexneri | ||
| SHIGELLA SONNEI | C86747 | SHIGELLA BIOGROUP D | Any bacterial organism that can be assigned to the species Shigella sonnei. | Shigella sonnei | ||
| SIMPLEXVIRUS | C112419 | Human Herpes Simplex Virus | Any viral organism that can be assigned to the genus Simplexvirus. | Simplexvirus | ||
| SLACKIA EXIGUA | C111313 | EUBACTERIUM EXIGUUM | Any bacterial organism that can be assigned to the species Slackia exigua. | Slackia exigua | ||
| SPHINGOBACTERIUM | C86957 | Any bacteria that is not assigned to the species level but can be assigned to the Sphingobacterium genus level. | Sphingobacterium | |||
| SPHINGOBACTERIUM MIZUTAII | C86958 | FLAVOBACTERIUM MIZUTAE | Any bacterial organism that can be assigned to the species Sphingobacterium mizutaii. | Sphingobacterium mizutaii | ||
| SPHINGOBACTERIUM MULTIVORUM | C86959 | CDC GROUP IIK-2 | Any bacterial organism that can be assigned to the species Sphingobacterium multivorum. | Sphingobacterium multivorum | ||
| SPHINGOBACTERIUM SPIRITIVORUM | C86960 | CDC GROUP IIK-3 | Any bacterial organism that can be assigned to the species Sphingobacterium spiritivorum. | Sphingobacterium spiritivorum | ||
| SPHINGOBACTERIUM THALPOPHILUM | C86961 | FLAVOBACTERIUM THALPOPHILUM | Any bacterial organism that can be assigned to the species Sphingobacterium thalpophilum. | Sphingobacterium thalpophilum | ||
| SPHINGOMONAS | C86748 | Any bacteria that is not assigned to the species level but can be assigned to the Sphingomonas genus level. | Sphingomonas | |||
| SPHINGOMONAS PAUCIMOBILIS | C86749 | CDC GROUP IIK-1;PSEUDOMONAS PAUCIMOBILIS | Any bacterial organism that can be assigned to the species Sphingomonas paucimobilis. | Sphingomonas paucimobilis | ||
| STAPHYLOCOCCUS | C62583 | Any bacteria that is not assigned to the species level but can be assigned to the Staphylococcus genus level. | Staphylococcus | |||
| STAPHYLOCOCCUS ARLETTAE | C86750 | Any bacterial organism that can be assigned to the species Staphylococcus arlettae. | Staphylococcus arlettae | |||
| STAPHYLOCOCCUS AUREUS | C50921 | STAPH. AUREUS | Any bacterial organism that can be assigned to the species Staphylococcus aureus. | Staphylococcus aureus | ||
| STAPHYLOCOCCUS AURICULARIS | C86751 | Any bacterial organism that can be assigned to the species Staphylococcus auricularis. | Staphylococcus auricularis | |||
| STAPHYLOCOCCUS CAPITIS | C86752 | Any bacterial organism that can be assigned to the species Staphylococcus capitis. | Staphylococcus capitis | |||
| STAPHYLOCOCCUS CAPRAE | C86753 | Any bacterial organism that can be assigned to the species Staphylococcus caprae. | Staphylococcus caprae | |||
| STAPHYLOCOCCUS CARNOSUS | C86754 | Any bacterial organism that can be assigned to the species Staphylococcus carnosus. | Staphylococcus carnosus | |||
| STAPHYLOCOCCUS CHROMOGENES | C86755 | Any bacterial organism that can be assigned to the species Staphylococcus chromogenes. | Staphylococcus chromogenes | |||
| STAPHYLOCOCCUS COHNII | C86756 | Any bacterial organism that can be assigned to the species Staphylococcus cohnii. | Staphylococcus cohnii | |||
| STAPHYLOCOCCUS EPIDERMIDIS | C86757 | STAPHYLOCOCCUS ALBUS | Any bacterial organism that can be assigned to the species Staphylococcus epidermidis. | Staphylococcus epidermidis | ||
| STAPHYLOCOCCUS EQUORUM | C86758 | Any bacterial organism that can be assigned to the species Staphylococcus equorum. | Staphylococcus equorum | |||
| STAPHYLOCOCCUS FELIS | C86759 | Any bacterial organism that can be assigned to the species Staphylococcus felis. | Staphylococcus felis | |||
| STAPHYLOCOCCUS GALLINARUM | C86760 | Any bacterial organism that can be assigned to the species Staphylococcus gallinarum. | Staphylococcus gallinarum | |||
| STAPHYLOCOCCUS HAEMOLYTICUS | C86761 | STAPH. HAEMOLYTICUS | Any bacterial organism that can be assigned to the species Staphylococcus haemolyticus. | Staphylococcus haemolyticus | ||
| STAPHYLOCOCCUS HOMINIS | C86762 | COAGULASE NEGATIVE STAPHYLOCOCCUS HOMINIS | Any bacterial organism that can be assigned to the species Staphylococcus hominis. | Staphylococcus hominis | ||
| STAPHYLOCOCCUS HYICUS | C86763 | Any bacterial organism that can be assigned to the species Staphylococcus hyicus. | Staphylococcus hyicus | |||
| STAPHYLOCOCCUS INTERMEDIUS | C86764 | Any bacterial organism that can be assigned to the species Staphylococcus intermedius. | Staphylococcus intermedius | |||
| STAPHYLOCOCCUS KLOOSII | C86765 | Any bacterial organism that can be assigned to the species Staphylococcus kloosii. | Staphylococcus kloosii | |||
| STAPHYLOCOCCUS LENTUS | C86766 | Any bacterial organism that can be assigned to the species Staphylococcus lentus. | Staphylococcus lentus | |||
| STAPHYLOCOCCUS LUGDUNENSIS | C86767 | Any bacterial organism that can be assigned to the species Staphylococcus lugdunensis. | Staphylococcus lugdunensis | |||
| STAPHYLOCOCCUS PASTEURI | C86768 | Any bacterial organism that can be assigned to the species Staphylococcus pasteuri. | Staphylococcus pasteuri | |||
| STAPHYLOCOCCUS SACCHAROLYTICUS | C86769 | PEPTOCOCCUS SACCHAROLYTICUS | Any bacterial organism that can be assigned to the species Staphylococcus saccharolyticus. | Staphylococcus saccharolyticus | ||
| STAPHYLOCOCCUS SAPROPHYTICUS | C86770 | MICROCOCCUS SUBGROUP 3 | Any bacterial organism that can be assigned to the species Staphylococcus saprophyticus. | Staphylococcus saprophyticus | ||
| STAPHYLOCOCCUS SCHLEIFERI | C86771 | Any bacterial organism that can be assigned to the species Staphylococcus schleiferi. | Staphylococcus schleiferi | |||
| STAPHYLOCOCCUS SCIURI | C86772 | Any bacterial organism that can be assigned to the species Staphylococcus sciuri. | Staphylococcus sciuri | |||
| STAPHYLOCOCCUS SIMULANS | C86773 | Any bacterial organism that can be assigned to the species Staphylococcus simulans. | Staphylococcus simulans | |||
| STAPHYLOCOCCUS WARNERI | C86774 | Any bacterial organism that can be assigned to the species Staphylococcus warneri. | Staphylococcus warneri | |||
| STAPHYLOCOCCUS XYLOSUS | C86775 | Any bacterial organism that can be assigned to the species Staphylococcus xylosus. | Staphylococcus xylosus | |||
| STENOTROPHOMONAS | C86776 | STENOTROPHOMONAS | Any bacteria that is not assigned to the species level but can be assigned to the Stenotrophomonas genus level. | Stenotrophomonas | ||
| STENOTROPHOMONAS MALTOPHILIA | C76377 | PSEUDOMONAS MALTOPHILIA;XANTHOMONAS MALTOPHILIA | Any bacterial organism that can be assigned to the species Stenotrophomonas maltophilia. | Stenotrophomonas maltophilia | ||
| STREPTOBACILLUS | C86777 | Any bacteria that is not assigned to the species level but can be assigned to the Streptobacillus genus level. | Streptobacillus | |||
| STREPTOBACILLUS MONILIFORMIS | C86778 | HAVERHILLIA MULTIFORMIS | Any bacterial organism that can be assigned to the species Streptobacillus moniliformis. | Streptobacillus moniliformis | ||
| STREPTOCOCCUS | C76383 | STREPTOCOCCI SP. | Any bacteria that is not assigned to the species level but can be assigned to the Streptococcus genus level. | Streptococcus | ||
| STREPTOCOCCUS ACIDOMINIMUS | C86779 | Any bacterial organism that can be assigned to the species Streptococcus acidominimus. | Streptococcus acidominimus | |||
| STREPTOCOCCUS AGALACTIAE | C86780 | STREPT. GP B(AGALACT) | Any bacterial organism that can be assigned to the species Streptococcus agalactiae. | Streptococcus agalactiae | ||
| STREPTOCOCCUS ALACTOLYTICUS | C86781 | Any bacterial organism that can be assigned to the species Streptococcus alactolyticus. | Streptococcus alactolyticus | |||
| STREPTOCOCCUS ALPHA-HEMOLYTIC | C86141 | ALPHA-HEMOLYTIC STREPTOCOCCUS | A bacteria that is assigned to the genus Streptococcus that is able to reduce the iron content in hemoglobin in red blood cells, thus producing green-colored colonies on blood agar plates. | Alpha-Hemolytic Streptococcus | ||
| STREPTOCOCCUS ANGINOSIS | C86782 | Any bacterial organism that can be assigned to the species Streptococcus anginosis. | Streptococcus anginosis | |||
| STREPTOCOCCUS ANGINOSUS GROUP | C86783 | A bacteria that belongs to the Anginosus group of the genus Streptococcus. | Streptococcus anginosus Group | |||
| STREPTOCOCCUS BETA-HEMOLYTIC | C86190 | BETA-HEMOLYTIC STREPTOCOCCUS | A bacteria that is assigned to the genus Streptococcus that is able to facilitate the complete rupturing of red blood cells, thus producing wide, clear, zones around colonies on blood agar plates. | Beta-Hemolytic Streptococcus | ||
| STREPTOCOCCUS BOVIS | C86784 | Any bacterial organism that can be assigned to the species Streptococcus bovis. | Streptococcus bovis | |||
| STREPTOCOCCUS BOVIS GROUP | C86785 | A bacteria that belongs to the Bovis group of the genus Streptococcus. | Streptococcus bovis Group | |||
| STREPTOCOCCUS CANIS | C86786 | STREPTOCOCCUS DYSGALACTIAE | Any bacterial organism that can be assigned to the species Streptococcus canis. | Streptococcus canis | ||
| STREPTOCOCCUS CONSTELLATUS | C86787 | Any bacterial organism that can be assigned to the species Streptococcus constellatus. | Streptococcus constellatus | |||
| STREPTOCOCCUS CRISTATUS | C86788 | Any bacterial organism that can be assigned to the species Streptococcus cristatus. | Streptococcus cristatus | |||
| STREPTOCOCCUS DYSGALACTIAE SUBSP. DYSGALACTIAE | C91848 | Any bacterial organism that can be assigned to the species Streptococcus dysgalactiae subspecies dysgalactiae. | Streptococcus dysgalactiae subsp dysgalactiae | |||
| STREPTOCOCCUS DYSGALACTIAE SUBSP. EQUISIMILIS | C86906 | STREPTOCOCCUS EQUISIMILIS | Any bacterial organism that can be assigned to the species Streptococcus dysgalactiae subspecies equisimilis. | Streptococcus dysgalactiae subsp equisimilis | ||
| STREPTOCOCCUS EQUI | C86789 | Any bacterial organism that can be assigned to the species Streptococcus equi. | Streptococcus equi | |||
| STREPTOCOCCUS EQUINUS | C86790 | Any bacterial organism that can be assigned to the species Streptococcus equinus. | Streptococcus equinus | |||
| STREPTOCOCCUS GALLOLYTICUS | C86791 | Any bacterial organism that can be assigned to the species Streptococcus gallolyticus. | Streptococcus gallolyticus | |||
| STREPTOCOCCUS GAMMA-HEMOLYTIC | C86408 | GAMMA-HEMOLYTIC STREPTOCOCCUS | A bacteria that is assigned to the genus Streptococcus that is unable to facilitate red blood cell lysis. | Gamma-Hemolytic Streptococcus | ||
| STREPTOCOCCUS GORDONII | C86792 | Any bacterial organism that can be assigned to the species Streptococcus gordonii. | Streptococcus gordonii | |||
| STREPTOCOCCUS INFANTARIUS | C86793 | Any bacterial organism that can be assigned to the species Streptococcus infantarius. | Streptococcus infantarius | |||
| STREPTOCOCCUS INTERMEDIUS | C86794 | Any bacterial organism that can be assigned to the species Streptococcus intermedius. | Streptococcus intermedius | |||
| STREPTOCOCCUS MILLERI | C86795 | STREPTOCOCCUS MILLERI I | Any bacterial organism that can be assigned to the species Streptococcus milleri. | Streptococcus milleri | ||
| STREPTOCOCCUS MILLERI GROUP | C86796 | A bacteria that belongs to the Milleri group of the genus Streptococcus. | Streptococcus milleri Group | |||
| STREPTOCOCCUS MITIS GROUP | C86797 | A bacteria that belongs to the Mitis group of the genus Streptococcus. | Streptococcus mitis Group | |||
| STREPTOCOCCUS MUTANS GROUP | C86798 | A bacteria that belongs to the Mutans group of the genus Streptococcus. | Streptococcus mutans Group | |||
| STREPTOCOCCUS ORALIS | C86799 | Any bacterial organism that can be assigned to the species Streptococcus oralis. | Streptococcus oralis | |||
| STREPTOCOCCUS PARASANGUINIS | C86800 | STREPTOCOCCUS PARASANGUIS | Any bacterial organism that can be assigned to the species Streptococcus parasanguinis. | Streptococcus parasanguinis | ||
| STREPTOCOCCUS PNEUMONIAE | C76384 | DIPLOCOCCUS PNEUMONIAE | Any bacterial organism that can be assigned to the species Streptococcus pneumoniae. | Streptococcus pneumoniae | ||
| STREPTOCOCCUS PORCINUS | C86802 | Any bacterial organism that can be assigned to the species Streptococcus porcinus. | Streptococcus porcinus | |||
| STREPTOCOCCUS PYOGENES | C86803 | GROUP A BETA-HEMOLYTIC STREPTOCOCCUS PYOGENES | Any bacterial organism that can be assigned to the species Streptococcus pyogenes. | Streptococcus pyogenes | ||
| STREPTOCOCCUS SALIVARIUS | C86804 | Any bacterial organism that can be assigned to the species Streptococcus salivarius. | Streptococcus salivarius | |||
| STREPTOCOCCUS SALIVARIUS GROUP | C86805 | A bacteria that belongs to the Salivarius group of the genus Streptococcus. | Streptococcus salivarius Group | |||
| STREPTOCOCCUS SANGUINIS | C86806 | STREPTOCOCCUS SANGUIS | Any bacterial organism that can be assigned to the species Streptococcus sanguinis. | Streptococcus sanguinis | ||
| STREPTOCOCCUS SUIS | C86807 | Any bacterial organism that can be assigned to the species Streptococcus suis. | Streptococcus suis | |||
| STREPTOCOCCUS THERMOPHILUS | C86808 | Any bacterial organism that can be assigned to the species Streptococcus thermophilus. | Streptococcus thermophilus | |||
| STREPTOCOCCUS UBERIS | C86809 | Any bacterial organism that can be assigned to the species Streptococcus uberis. | Streptococcus uberis | |||
| STREPTOCOCCUS VESTIBULARIS | C86810 | Any bacterial organism that can be assigned to the species Streptococcus vestibularis. | Streptococcus vestibularis | |||
| STREPTOCOCCUS VIRIDANS GROUP | C86811 | STREPTOCOCCUS VIRIDANS;VIRIDANS STREPTOCOCCUS | A non-taxonomic grouping of species within the Streptococcus genus that are alpha-hemolytic and do not express Lancefield antigens. | Streptococcus viridans Group | ||
| STREPTOMYCES | C14278 | Any bacteria that is not assigned to the species level but can be assigned to the Streptomyces genus level. | Streptomyces | |||
| STREPTOMYCES ALBUS | C86812 | Any bacterial organism that can be assigned to the species Streptomyces albus. | Streptomyces albus | |||
| STREPTOMYCES GRISEUS | C86813 | Any bacterial organism that can be assigned to the species Streptomyces griseus. | Streptomyces griseus | |||
| STREPTOMYCES SOMALIENSIS | C86814 | Any bacterial organism that can be assigned to the species Streptomyces somaliensis. | Streptomyces somaliensis | |||
| SUTTERELLA | C86956 | Any bacteria that is not assigned to the species level but can be assigned to the Sutterella genus level. | Sutterella | |||
| SUTTONELLA | C86815 | Any bacteria that is not assigned to the species level but can be assigned to the Suttonella genus level. | Suttonella | |||
| SUTTONELLA INDOLOGENES | C86816 | KINGELLA INDOLOGENES | Any bacterial organism that can be assigned to the species Suttonella indologenes. | Suttonella indologenes | ||
| TATLOCKIA MICDADEI | C86817 | LEGIONELLA MICDADEI | Any bacterial organism that can be assigned to the species Legionella micdadei. | Tatlockia micdadei | ||
| TATUMELLA | C86818 | Any bacteria that is not assigned to the species level but can be assigned to the Tatumella genus level. | Tatumella | |||
| TATUMELLA PTYSEOS | C86819 | CDC GROUP EF-9 | Any bacterial organism that can be assigned to the species Tatumella ptyseos. | Tatumella ptyseos | ||
| TETRAGENOCOCCUS | C86820 | Any bacteria that is not assigned to the species level but can be assigned to the Tetragenococcus genus level. | Tetragenococcus | |||
| TETRAGENOCOCCUS SOLITARIUS | C86821 | ENTEROCOCCUS SOLITARIUS | Any bacterial organism that can be assigned to the species Tetragenococcus solitarius. | Tetragenococcus solitarius | ||
| TICK-BORNE ENCEPHALITIS VIRUS | C112422 | FSME virus;TBEV | Any viral organism that can be assigned to the species Tick-borne encephalitis virus. | Tick-Borne Encephalitis Virus | ||
| TISSIERELLA | C86907 | Any bacteria that is not assigned to the species level but can be assigned to the Tissierella genus level. | Tissierella | |||
| TISSIERELLA PRAEACUTA | C86908 | Any bacterial organism that can be assigned to the species Tissierella praeacuta. | Tissierella praeacuta | |||
| TRABULSIELLA | C86822 | Any bacteria that is not assigned to the species level but can be assigned to the Trabulsiella genus level. | Trabulsiella | |||
| TRABULSIELLA GUAMENSIS | C86823 | CDC ENTERIC GROUP 90 | Any bacterial organism that can be assigned to the species Trabulsiella guamensis. | Trabulsiella guamensis | ||
| TREPONEMA | C76385 | Any bacteria that is not assigned to the species level but can be assigned to the Treponema genus level. | Treponema | |||
| TREPONEMA PALLIDUM | C86825 | Any bacterial organism that can be assigned to the species Treponema pallidum. | Treponema pallidum | |||
| TREPONEMA PALLIDUM SUBSP. ENDEMICUM | C91850 | Any bacterial organism that can be assigned to the species Treponema pallidum subspecies endemicum. | Treponema pallidum subsp endemicum | |||
| TREPONEMA PALLIDUM SUBSP. PALLIDUM | C91849 | Any bacterial organism that can be assigned to the species Treponema pallidum subspecies pallidum. | Treponema pallidum subsp pallidum | |||
| TREPONEMA PALLIDUM SUBSP. PERTENUE | C86909 | TREPONEMA PERTENUE | Any bacterial organism that can be assigned to the species Treponema pallidum and subspecies pertenue. | Treponema pallidum subsp pertenue | ||
| TRICHOSPORON ASAHII | C114272 | T. asahii | Any fungal organism that can be assigned to the species Trichosporon asahii. | Trichosporon asahii | ||
| TROPHERYMA | C86826 | Any bacteria that is not assigned to the species level but can be assigned to the Tropheryma genus level. | Tropheryma | |||
| TROPHERYMA WHIPPLEI | C86827 | Any bacterial organism that can be assigned to the species Tropheryma whipplei. | Tropheryma whipplei | |||
| TSUKAMURELLA | C86828 | Any bacteria that is not assigned to the species level but can be assigned to the Tsukamurella genus level. | Tsukamurella | |||
| TSUKAMURELLA PAUROMETABOLUM | C86829 | GORDONA AURANTIACA | Any bacterial organism that can be assigned to the species Tsukamurella paurometabolum. | Tsukamurella paurometabolum | ||
| TSUKAMURELLA PULMONIS | C114253 | Any bacterial organism that can be assigned to the species Tsukamurella pulmonis. | Tsukamurella pulmonis | |||
| TURICELLA | C86830 | Any bacteria that is not assigned to the species level but can be assigned to the Turicella genus level. | Turicella | |||
| TURICELLA OTITIDIS | C86831 | RHODOCOCCUS AURANTIAZUS | Any bacterial organism that can be assigned to the species Turicella otitidis. | Turicella otitidis | ||
| UREAPLASMA | C86832 | Any bacteria that is not assigned to the species level but can be assigned to the Ureaplasma genus level. | Ureaplasma | |||
| UREAPLASMA UREALYTICUM | C86833 | T-MYCOPLASMA | Any bacterial organism that can be assigned to the species Ureaplasma urealyticum. | Ureaplasma urealyticum | ||
| VACCINIA VIRUS | C14281 | VV | Any viral organism that can be assigned to the species Vaccinia virus. | Vaccinia Virus | ||
| VAGOCOCCUS | C86834 | Any bacteria that is not assigned to the species level but can be assigned to the Vagococcus genus level. | Vagococcus | |||
| VARIBACULUM | C86835 | Any bacteria that is not assigned to the species level but can be assigned to the Varibaculum genus level. | Varibaculum | |||
| VARIBACULUM CAMBRIENSE | C86836 | Any bacterial organism that can be assigned to the species Varibaculum cambriense. | Varibaculum cambriense | |||
| VARICELLOVIRUS | C112426 | Varicellavirus | Any viral organism that can be assigned to the genus Varicellovirus. | Varicellovirus | ||
| VARIOLA VIRUS | C96527 | Smallpox Virus;Variola Virus VAR | Any viral organism that can be assigned to the species Variola virus. | Variola Virus | ||
| VEILLONELLA | C86837 | Any bacteria that is not assigned to the species level but can be assigned to the Veillonella genus level. | Veillonella | |||
| VEILLONELLA DISPAR | C86838 | Any bacterial organism that can be assigned to the species Veillonella dispar. | Veillonella dispar | |||
| VEILLONELLA PARVULA | C86839 | Any bacterial organism that can be assigned to the species Veillonella parvula. | Veillonella parvula | |||
| VIBRIO | C76386 | Any bacteria that is not assigned to the species level but can be assigned to the Vibrio genus level. | Vibrio | |||
| VIBRIO ALGINOLYTICUS | C86840 | Any bacterial organism that can be assigned to the species Vibrio alginolyticus. | Vibrio alginolyticus | |||
| VIBRIO CHOLERAE | C86841 | VIBRIO COMMA | Any bacterial organism that can be assigned to the species Vibrio cholerae. | Vibrio cholerae | ||
| VIBRIO FLUVIALIS | C86842 | CDC GROUP EF-6 | Any bacterial organism that can be assigned to the species Vibrio fluvialis. | Vibrio fluvialis | ||
| VIBRIO FURNISSII | C86843 | VIBRIO FLUVIALIS BIOGROUP 2 | Any bacterial organism that can be assigned to the species Vibrio furnissii. | Vibrio furnissii | ||
| VIBRIO METSCHNIKOVII | C86844 | CDC ENTERIC GROUP 16 | Any bacterial organism that can be assigned to the species Vibrio metschnikovii. | Vibrio metschnikovii | ||
| VIBRIO MIMICUS | C86845 | SUCROSE NEGATIVE VIBRIO CHOLERAE | Any bacterial organism that can be assigned to the species Vibrio mimicus. | Vibrio mimicus | ||
| VIBRIO PARAHAEMOLYTICUS | C86846 | Any bacterial organism that can be assigned to the species Vibrio parahaemolyticus. | Vibrio parahaemolyticus | |||
| VIBRIO VULNIFICUS | C86847 | BENECKEA VULNIFICA | Any bacterial organism that can be assigned to the species Vibrio vulnificus. | Vibrio vulnificus | ||
| WAUTERSIELLA FALSENII | C111334 | Any bacterial organism that can be assigned to the species Wautersiella falsenii. | Wautersiella falsenii | |||
| WEEKSELLA | C86848 | Any bacteria that is not assigned to the species level but can be assigned to the Weeksella genus level. | Weeksella | |||
| WEEKSELLA VIROSA | C86849 | CDC GROUP IIF | Any bacterial organism that can be assigned to the species Weeksella virosa. | Weeksella virosa | ||
| WEST NILE VIRUS | C71877 | WNV | Any viral organism that can be assigned to the species West Nile virus. | West Nile Virus | ||
| WICKERHAMOMYCES ANOMALUS | C114262 | C. pelliculosa;Candida pelliculosa;H. anomala;Hansenula anomala;P. anomala;Pichia anomala;W. anomalus | Any fungal organism that can be assigned to the species Wickerhamomyces anomalus. | Wickerhamomyces anomalus | ||
| WOLINELLA | C86850 | Any bacteria that is not assigned to the species level but can be assigned to the Wolinella genus level. | Wolinella | |||
| WOLINELLA SUCCINOGENES | C86851 | Any bacterial organism that can be assigned to the species Wolinella succinogenes. | Wolinella succinogenes | |||
| YARROWIA LIPOLYTICA | C114257 | M. lipolytica;Mycotorula lipolytica;Y. lipolytica | Any fungal organism that can be assigned to the species Yarrowia lipolytica. | Yarrowia lipolytica | ||
| YELLOW FEVER VIRUS | C97156 | Flavivirus febricis;YFV | Any viral organism that can be assigned to the species Yellow fever virus. | Yellow Fever Virus | ||
| YERSINIA | C86852 | Any bacteria that is not assigned to the species level but can be assigned to the Yersinia genus level. | Yersinia | |||
| YERSINIA ALDOVAE | C86853 | Any bacterial organism that can be assigned to the species Yersinia aldovae. | Yersinia aldovae | |||
| YERSINIA BERCOVIERI | C86854 | YERSINIA ENTEROLITICA BIOGROUP 3B | Any bacterial organism that can be assigned to the species Yersinia bercovieri. | Yersinia bercovieri | ||
| YERSINIA ENTEROCOLITICA | C86855 | PASTEURELLA ENTEROCOLITICA | Any bacterial organism that can be assigned to the species Yersinia enterocolitica. | Yersinia enterocolitica | ||
| YERSINIA FREDERIKSENII | C86856 | Any bacterial organism that can be assigned to the species Yersinia frederiksenii. | Yersinia frederiksenii | |||
| YERSINIA INTERMEDIA | C86857 | Any bacterial organism that can be assigned to the species Yersinia intermedia. | Yersinia intermedia | |||
| YERSINIA KRISTENSENII | C86858 | Any bacterial organism that can be assigned to the species Yersinia kristensenii. | Yersinia kristensenii | |||
| YERSINIA MOLLARETII | C86859 | YERSINIA ENTEROLITICA BIOGROUP 3A | Any bacterial organism that can be assigned to the species Yersinia mollaretii. | Yersinia mollaretii | ||
| YERSINIA PESTIS | C86860 | PASTEURELLA PESTIS | Any bacterial organism that can be assigned to the species Yersinia pestis. | Yersinia pestis | ||
| YERSINIA PSEUDOTUBERCULOSIS | C86861 | PASTEURELLA PSEUDOTUBERCULOSIS | Any bacterial organism that can be assigned to the species Yersinia pseudotuberculosis. | Yersinia pseudotuberculosis | ||
| YERSINIA ROHDEI | C86862 | Any bacterial organism that can be assigned to the species Yersinia rohdei. | Yersinia rohdei | |||
| YERSINIA RUCKERI | C86863 | Any bacterial organism that can be assigned to the species Yersinia ruckeri. | Yersinia ruckeri | |||
| YOKENELLA | C86864 | Any bacteria that is not assigned to the species level but can be assigned to the Yokenella genus level. | Yokenella | |||
| YOKENELLA REGENSBURGEI | C86865 | CDC ENTERIC GROUP 45 | Any bacterial organism that can be assigned to the species Yokenella regensburgei. | Yokenella regensburgei | ||
| ZIMMERMANNELLA | C86866 | Any bacteria that is not assigned to the species level but can be assigned to the Zimmermannella genus level. | Zimmermannella | |||
| ZIMMERMANNELLA ALBA | C86867 | Any bacterial organism that can be assigned to the species Zimmermannella alba. | Zimmermannella alba | |||
| ZIMMERMANNELLA BIFIDA | C86868 | Any bacterial organism that can be assigned to the species Zimmermannella bifida. | Zimmermannella bifida | |||
| Back to top | ||||||
| CL.C89974.MITESTCD | Microscopic Findings Test Code (MITESTCD) | text Extensible: Yes | C89974 | Microscopic Findings Test Code | Terminology for the test codes concerned with the findings from a specimen that are visible by microscopic analysis. | CDISC SEND Microscopic Findings Test Code Terminology |
| FIBSCBAL | C119570 | Batts-Ludwig Fibrosis Score | The histopathological evaluation of the liver based on the Batts-Ludwig scoring system. | Batts-Ludwig Fibrosis Score | ||
| FIBSCISH | C95149 | Ishak Fibrosis Score | The histopathological evaluation of the liver based on the Ishak scoring system. | Ishak Score | ||
| FIBSCKNO | C119571 | Knodell Fibrosis Score | The histopathological evaluation of the liver based on the Knodell scoring system. | Knodell Fibrosis Score | ||
| FIBSCMET | C119572 | Metavir Fibrosis Score | The histopathological evaluation of the liver based on the Meta-analysis of Histological Data in Viral Hepatitis (Metavir) scoring system. | METAVIR Fibrosis Score | ||
| FIBSCSCH | C119573 | Scheuer Fibrosis Score | The histopathological evaluation of the liver based on the Scheuer scoring system. | Scheuer Fibrosis Score | ||
| MIEXAM | C90424 | Microscopic Examination | An assessment by microscope (e.g., light, electron, confocal, etc.). | Microscopic Examination | ||
| Back to top | ||||||
| CL.C89973.MITEST | Microscopic Findings Test Name (MITEST) | text Extensible: Yes | C89973 | Microscopic Findings Test Name | Terminology for the test names concerned with the findings from a specimen that are visible by microscopic analysis. | CDISC SEND Microscopic Findings Test Name Terminology |
| Batts-Ludwig Fibrosis Score | C119570 | Batts-Ludwig Fibrosis Score | The histopathological evaluation of the liver based on the Batts-Ludwig scoring system. | Batts-Ludwig Fibrosis Score | ||
| Ishak Fibrosis Score | C95149 | Ishak Fibrosis Score | The histopathological evaluation of the liver based on the Ishak scoring system. | Ishak Score | ||
| Knodell Fibrosis Score | C119571 | Knodell Fibrosis Score | The histopathological evaluation of the liver based on the Knodell scoring system. | Knodell Fibrosis Score | ||
| Metavir Fibrosis Score | C119572 | Metavir Fibrosis Score | The histopathological evaluation of the liver based on the Meta-analysis of Histological Data in Viral Hepatitis (Metavir) scoring system. | METAVIR Fibrosis Score | ||
| Microscopic Examination | C90424 | Microscopic Examination | An assessment by microscope (e.g., light, electron, confocal, etc.). | Microscopic Examination | ||
| Scheuer Fibrosis Score | C119573 | Scheuer Fibrosis Score | The histopathological evaluation of the liver based on the Scheuer scoring system. | Scheuer Fibrosis Score | ||
| Back to top | ||||||
| CL.C114117.MOTESTCD | Morphology Test Code (MOTESTCD) | text Extensible: Yes | C114117 | Morphology Test Code | A terminology codelist based on the test codes for macroscopic assessments that are seen by the naked eye or observed via procedures such as imaging modalities, endoscopy, or other technologies. | CDISC SDTM Morphology Test Code Terminology |
| BSI | C114183 | Boundary Shift Integral | A measurement of change in volume of an organ or anatomical feature as determined by a shift in tissue boundary over time. | Boundary Shift Integral | ||
| CANRFIND | C119331 | Coronary Artery No Reflow Indicator | An indication as to whether there is a new acute reduction in coronary flow (TIMI grade 0-1) in the absence of dissection, thrombus, spasm, or high-grade residual stenosis at the original PCI lesion site. | Coronary No Reflow at PCI Site Indicator | ||
| DEPTH | C25333 | Depth | The extent downward or inward; the perpendicular measurement from the surface downward to determine deepness. (NCI) | Depth | ||
| ELASTIC | C119332 | Elasticity | A quantitative measurement of an organ's ability to deform in response to physiological force and return to its normal shape by passive elastic recoil. | Organ Elasticity | ||
| INRSTIND | C116148 | In-Stent Restenosis Indicator | An indication as to whether there is re-narrowing of a stent implanted at a lesion site to treat a prior stenosis, to a diameter stenosis of greater than 50% within the stent. | In-Stent Restenosis Indicator | ||
| INTP | C41255 | Interpretation | An act or process of elucidation; explication, or explanation of the meaning of the event or thing via the assignment of objects from the domain to the constants of a formal language, truth-values to the proposition symbols, truth-functions to the connectives, other functions to the function symbols, and extensions to the predicates, if any. The assignments are result of human logic application and are not native to the symbols of the formal language. | Interpretation | ||
| LATELOSS | C116146 | Late Loss | The difference between the mean minimum lumen diameter (MLD) assessed immediately after an index procedure and the MLD assessed at follow-up angiography. | Late Lumen Loss Measurement | ||
| LENGTH | C25334 | Length | The linear extent in space from one end of something to the other end, or the extent of something from beginning to end. (NCI) | Length | ||
| LRSTIND | C116147 | Lesion Restenosis Indicator | An indication as to whether there is re-narrowing of a lesion site following treatment of a prior stenosis, to a diameter stenosis of greater than 50% at the previously treated lesion site. | Lesion Restenosis Indicator | ||
| MASS | C43246 | Mass | The amount of matter in an object. | Mass | ||
| MEANVDIA | C116143 | Mean Vessel Diameter | The mean of the inside diameters of the normal blood vessel segments. | Mean Vessel Diameter | ||
| MINLDIAM | C116144 | Minimum Vessel Lumen Diameter | The minimum diameter of the inside of a blood vessel (lumen) derived quantitatively in a single view. | Minimum Vessel Lumen Diameter | ||
| PCTDIAST | C116145 | Percent Diameter Stenosis | The value calculated as 100 x (1 - MLD/RVD), using the mean quantitative values for minimum lumen diameter (MLD) and reference vessel diameter (RVD). | Percent Diameter Stenosis Measurement | ||
| THICK | C41145 | Thickness | The dimension between two surfaces of an object, usually the smallest dimension as opposed to the width or the length. | Thickness | ||
| VOLUME | C25335 | Volume | The amount of three dimensional space occupied by an object or the capacity of a space or container. (NCI) | Volume | ||
| WEIGHT | C25208 | Weight | The vertical force exerted by a mass as a result of gravity. (NCI) | Weight | ||
| WIDTH | C25345 | Width | The extent or measurement of something from side to side. (NCI) | Width | ||
| Back to top | ||||||
| CL.C114116.MOTEST | Morphology Test Name (MOTEST) | text Extensible: Yes | C114116 | Morphology Test Name | A terminology codelist based on the test names for macroscopic assessments that are seen by the naked eye or observed via procedures such as imaging modalities, endoscopy, or other technologies. | CDISC SDTM Morphology Test Name Terminology |
| Boundary Shift Integral | C114183 | Boundary Shift Integral | A measurement of change in volume of an organ or anatomical feature as determined by a shift in tissue boundary over time. | Boundary Shift Integral | ||
| Coronary Artery No Reflow Indicator | C119331 | Coronary Artery No Reflow Indicator | An indication as to whether there is a new acute reduction in coronary flow (TIMI grade 0-1) in the absence of dissection, thrombus, spasm, or high-grade residual stenosis at the original PCI lesion site. | Coronary No Reflow at PCI Site Indicator | ||
| Depth | C25333 | Depth | The extent downward or inward; the perpendicular measurement from the surface downward to determine deepness. (NCI) | Depth | ||
| Elasticity | C119332 | Elasticity | A quantitative measurement of an organ's ability to deform in response to physiological force and return to its normal shape by passive elastic recoil. | Organ Elasticity | ||
| In-Stent Restenosis Indicator | C116148 | In-Stent Restenosis Indicator | An indication as to whether there is re-narrowing of a stent implanted at a lesion site to treat a prior stenosis, to a diameter stenosis of greater than 50% within the stent. | In-Stent Restenosis Indicator | ||
| Interpretation | C41255 | Interpretation | An act or process of elucidation; explication, or explanation of the meaning of the event or thing via the assignment of objects from the domain to the constants of a formal language, truth-values to the proposition symbols, truth-functions to the connectives, other functions to the function symbols, and extensions to the predicates, if any. The assignments are result of human logic application and are not native to the symbols of the formal language. | Interpretation | ||
| Late Loss | C116146 | Late Loss | The difference between the mean minimum lumen diameter (MLD) assessed immediately after an index procedure and the MLD assessed at follow-up angiography. | Late Lumen Loss Measurement | ||
| Length | C25334 | Length | The linear extent in space from one end of something to the other end, or the extent of something from beginning to end. (NCI) | Length | ||
| Lesion Restenosis Indicator | C116147 | Lesion Restenosis Indicator | An indication as to whether there is re-narrowing of a lesion site following treatment of a prior stenosis, to a diameter stenosis of greater than 50% at the previously treated lesion site. | Lesion Restenosis Indicator | ||
| Mass | C43246 | Mass | The amount of matter in an object. | Mass | ||
| Mean Vessel Diameter | C116143 | Mean Vessel Diameter | The mean of the inside diameters of the normal blood vessel segments. | Mean Vessel Diameter | ||
| Minimum Vessel Lumen Diameter | C116144 | Minimum Vessel Lumen Diameter | The minimum diameter of the inside of a blood vessel (lumen) derived quantitatively in a single view. | Minimum Vessel Lumen Diameter | ||
| Percent Diameter Stenosis | C116145 | Percent Diameter Stenosis | The value calculated as 100 x (1 - MLD/RVD), using the mean quantitative values for minimum lumen diameter (MLD) and reference vessel diameter (RVD). | Percent Diameter Stenosis Measurement | ||
| Thickness | C41145 | Thickness | The dimension between two surfaces of an object, usually the smallest dimension as opposed to the width or the length. | Thickness | ||
| Volume | C25335 | Volume | The amount of three dimensional space occupied by an object or the capacity of a space or container. (NCI) | Volume | ||
| Weight | C25208 | Weight | The vertical force exerted by a mass as a result of gravity. (NCI) | Weight | ||
| Width | C25345 | Width | The extent or measurement of something from side to side. (NCI) | Width | ||
| Back to top | ||||||
| CL.C117741.MSFATSCD | Multiple Sclerosis Findings About Test Code (MSFATSCD) | text Extensible: Yes | C117741 | Multiple Sclerosis Findings About Test Code | Terminology relevant to the test codes that describe multiple sclerosis findings. | CDISC SDTM Multiple Sclerosis Findings About Test Code Terminology |
| DXCRITMT | C117883 | Diagnostic Criteria Met | A description of the diagnostic criteria that the subject fulfilled in order to establish a medical diagnosis. | Which Diagnostic Criteria Met | ||
| LOCONSET | C117884 | Localization of Onset | The anatomical location of the beginning or early stages of a disease. | Location of Disease Onset | ||
| OUNIMULT | C117885 | Onset Unifocal or Multifocal | A categorization of the number of lesions present in the Central Nervous System at the time of diagnosis of a specific disease. | Focality of Disease Onset | ||
| Back to top | ||||||
| CL.C117740.MSFATS | Multiple Sclerosis Findings About Test Name (MSFATS) | text Extensible: Yes | C117740 | Multiple Sclerosis Findings About Test Name | Terminology relevant to the test names that describe multiple sclerosis findings. | CDISC SDTM Multiple Sclerosis Findings About Test Name Terminology |
| Diagnostic Criteria Met | C117883 | Diagnostic Criteria Met | A description of the diagnostic criteria that the subject fulfilled in order to establish a medical diagnosis. | Which Diagnostic Criteria Met | ||
| Localization of Onset | C117884 | Localization of Onset | The anatomical location of the beginning or early stages of a disease. | Location of Disease Onset | ||
| Onset Unifocal or Multifocal | C117885 | Onset Unifocal or Multifocal | A categorization of the number of lesions present in the Central Nervous System at the time of diagnosis of a specific disease. | Focality of Disease Onset | ||
| Back to top | ||||||
| CL.C88025.NEOPLASM | Neoplasm Type (NEOPLASM) | text Extensible: Yes | C88025 | Neoplasm Type | The terminology that includes concepts relevant to benign or malignant tissue growth. | CDISC SEND Tumor Findings Results Terminology |
| ACINAR-ISLET CELL TUMOR, BENIGN | C116215 | A benign tumor of the pancreas with morphologic characteristics of endocrine, acinar and ductal cells. (INHAND) | Experimental Organism Benign Acinar-islet Cell Tumor | |||
| ACINAR-ISLET CELL TUMOR, MALIGNANT | C6878 | A malignant pancreatic neoplasm characterized by the presence of a mixture of acinar and islet cell elements. | Mixed Acinar-Neuroendocrine Carcinoma of the Pancreas | |||
| ADAMANTINOMA, MALIGNANT | C7644 | Adamantinoma | A low-grade malignant neoplasm composed of epithelial cells and a spindle cell osteo-fibrous proliferation. | Adamantinoma | ||
| ADENOACANTHOMA, MALIGNANT | C4200 | Adenoacanthoma | A malignant neoplasm arising from glandular cells that includes focal or extensive areas of squamous metaplasia. | Adenocarcinoma with Squamous Metaplasia | ||
| ADENOCARCINOMA, CLEAR CELL, MALIGNANT | C3766 | Clear Cell Carcinoma;Mesonephroid Clear Cell Adenocarcinoma;Mesonephroid Clear Cell Carcinoma | A malignant neoplasm comprising glandular epithelial clear cells. | Clear Cell Adenocarcinoma | ||
| ADENOCARCINOMA, ENDOMETRIAL, MALIGNANT | C7359 | Adenocarcinoma of Endometrium;Adenocarcinoma of the Endometrium | A malignant glandular neoplasm of the uterine lining. | Endometrial Adenocarcinoma | ||
| ADENOCARCINOMA, MALIGNANT | C2852 | A malignant neoplasm arising from glandular cells. | Adenocarcinoma | |||
| ADENOCARCINOMA, MUCINOUS, MALIGNANT | C26712 | Colloid Adenocarcinoma;Colloid Carcinoma;Gelatinous Adenocarcinoma;Gelatinous Carcinoma;Mucinous Carcinoma;Mucoid Adenocarcinoma;Mucoid Carcinoma;Mucous Adenocarcinoma;Mucous Carcinoma | An adenocarcinoma comprising neoplastic glandular cells containing intracytoplasmic mucin. | Mucinous Adenocarcinoma | ||
| ADENOCARCINOMA, PAPILLARY, MALIGNANT | C2853 | An adenocarcinoma with papillary growth pattern. | Papillary Adenocarcinoma | |||
| ADENOCARCINOMA, SEBACEOUS, MALIGNANT | C40310 | Carcinoma of Sebaceous Gland;Carcinoma of the Sebaceous Gland;Sebaceous Gland Carcinoma | An adenocarcinoma with sebaceous differentiation. | Sebaceous Carcinoma | ||
| ADENOFIBROMA, BENIGN | C8984 | Benign Mixed Muellerian Tumor | Benign mixed neoplasm comprised of epithelial/glandular and mesenchymal structures. | Adenofibroma | ||
| ADENOLIPOMA, BENIGN | C4159 | Benign mixed neoplasm comprised of epithelial/glandular and lipomatous structures. | Lipoadenoma | |||
| ADENOMA, ACINAR CELL, BENIGN | C4196 | Acinar Adenoma;Acinic Cell Adenoma | A benign glandular epithelial neoplasm comprising secretory cells forming acinar patterns. | Acinar Cell Adenoma | ||
| ADENOMA, ADNEXAL, BENIGN | C7580 | Adenoma of Adnexa;Adenoma of Skin Appendage;Adnexal Adenoma | A benign epithelial neoplasm arising from the sebaceous or sweat glands. | Skin Appendage Adenoma | ||
| ADENOMA, ADRENOCORTICAL, BENIGN | C9003 | Adenoma of Adrenal Cortex;Adenoma of Adrenal Gland;Adenoma of the Adrenal Cortex;Adenoma of the Adrenal Gland;Adrenal Adenoma;Adrenal Cortical Adenoma;Adrenal Gland Adenoma;Adrenocortical Adenoma;Benign Adenoma of Adrenal Gland;Benign Adenoma of the Adrenal Gland;Benign Adrenal Adenoma;Benign Adrenal Gland Adenoma;Cortical Cell Adenoma | A benign neoplasm arising from any of the adrenal cortical layers. | Adrenal Cortex Adenoma | ||
| ADENOMA, ANTERIOR LOBE PITUITARY GLAND, BENIGN | C3329 | Adenoma of Pituitary;Adenoma of Pituitary Gland;Adenoma of the Pituitary;Adenoma of the Pituitary Gland;Pituitary Adenoma | A benign neoplasm of the anterior lobe of the pituitary gland. | Pituitary Gland Adenoma | ||
| ADENOMA, BENIGN | C2855 | A benign neoplasm arising from epithelium. | Adenoma | |||
| ADENOMA, BRONCHIAL, BENIGN | C3494 | A benign neoplasia of the lung, arising from bronchial epithelium. | Lung Papillary Adenoma | |||
| ADENOMA, BRONCHIOLOALVEOLAR, BENIGN | C4140 | Adenoma of Alveoli;Adenoma of the Alveoli | A benign lung neoplasm arising from the alveolar/bronchiolar epithelium. | Alveolar Adenoma | ||
| ADENOMA, C-CELL, BENIGN | C46101 | Parafollicular Cell Adenoma | A benign neoplasm arising from C-cells of the thyroid gland. | Neoplastic C-Cell Hyperplasia | ||
| ADENOMA, CERUMINOUS GLAND, BENIGN | C6088 | Ceruminoma;Ceruminous Adenoma;Ceruminous Adenoma of External Auditory Canal;Ceruminous Adenoma of the External Auditory Canal | A benign epithelial neoplasm derived from ceruminous glands in the external auditory canal. | External Auditory Canal Ceruminous Adenoma | ||
| ADENOMA, CLEAR CELL, BENIGN | C4151 | A benign neoplasm comprising glands containing epithelial clear cells. | Clear Cell Adenoma | |||
| ADENOMA, FOLLICULAR CELL, BENIGN | C3502 | Adenoma of Thyroid;Adenoma of Thyroid Gland;Adenoma of the Thyroid;Adenoma of the Thyroid Gland;Follicular Adenoma;Follicular Adenoma of Thyroid;Follicular Adenoma of Thyroid Gland;Follicular Adenoma of the Thyroid;Follicular Adenoma of the Thyroid Gland;Thyroid Adenoma;Thyroid Follicular Adenoma;Thyroid Gland Adenoma | A benign neoplasm arising from follicular cells of the thyroid gland. | Thyroid Gland Follicular Adenoma | ||
| ADENOMA, HEPATOCELLULAR, BENIGN | C3758 | Adenoma of Liver Cells;Adenoma of the Liver Cells;HCA;Liver Cell Adenoma | A benign epithelial neoplasm arising from hepatocytes. | Hepatocellular Adenoma | ||
| ADENOMA, HEPATOCHOLANGIOCELLULAR, BENIGN | C7126 | A benign neoplasm arising from the intrahepatic bile duct. | Intrahepatic Bile Duct Adenoma | |||
| ADENOMA, ISLET CELL, BENIGN | C114108 | Islet Cell Adenoma | A benign neoplasm arising from the islet cells of the pancreas. | Experimental Organism Islet Cell Adenoma Neoplasm | ||
| ADENOMA, LIGHT CELL, BENIGN | C46119 | A benign epithelial neoplasm of the thyroid gland comprising follicular cells with cytoplasmic clearing. | Thyroid Gland Clear Cell Follicular Adenoma | |||
| ADENOMA, MUCINOUS, BENIGN | C2973 | Mucinous Adenoma;Mucinous Cystoma;Pseudomucinous Cystadenoma | A benign, cystic epithelial neoplasm comprising cells containing intracytoplasmic mucin. | Mucinous Cystadenoma | ||
| ADENOMA, PAPILLARY, BENIGN | C79951 | A benign epithelial neoplasm characterized by the presence of papillary epithelial patterns. | Papillary Adenoma | |||
| ADENOMA, PARS DISTALIS, BENIGN | C60490 | Rat Pars Distalis Adenoma | A benign epithelial neoplasm arising from the pars distalis of the anterior pituitary gland. | Rat Pars Distalis Adenoma | ||
| ADENOMA, PARS INTERMEDIA, BENIGN | C60493 | Rat Pars Intermedia Adenoma | A benign epithelial neoplasm arising from the pars intermedia of the anterior pituitary gland. | Rat Pars Intermedia Adenoma | ||
| ADENOMA, PITUITARY GLAND, BENIGN | C98723 | A benign neoplasm of the pituitary gland. | Experimental Organism Pituitary Gland Adenoma | |||
| ADENOMA, RENAL CELL, BENIGN | C8383 | Renal Tubule Adenoma | A benign neoplasm arising from the renal cortex. | Renal Adenoma | ||
| ADENOMA, RETE TESTIS, BENIGN | C39956 | A benign epithelial neoplasm arising from the rete testis. | Rete Testis Adenoma | |||
| ADENOMA, SEBACEOUS, BENIGN | C4174 | Adenoma of Sebaceous Gland;Adenoma of the Sebaceous Gland;Sebaceous Gland Adenoma;Skin Appendage Sebaceous Adenoma | A benign neoplasm arising from sebaceous glands. | Sebaceous Adenoma | ||
| ADENOMA, SERTOLIFORM TUBULAR, BENIGN | C92180 | Rat Sertoliform Tubular Adenoma | A benign tubular adenoma with Sertoli cell differentiation. | Rat Sertoliform Tubular Adenoma | ||
| ADENOMA, SWEAT GLAND, BENIGN | C7560 | Adenoma of Sweat Gland;Adenoma of the Sweat Gland | A benign epithelias neoplasm arising from sweat glands. | Sweat Gland Adenoma | ||
| ADENOMA, TUBULAR CELL, BENIGN | C4133 | A benign neoplasm arising from glandular epithelium, characterized by a tubular architectural pattern. | Tubular Adenoma | |||
| ADENOMA, TUBULOSTROMAL, BENIGN | C79953 | A benign ovarian epithelial neoplasm characterized by the presence of tubular structures and interstitial stroma. | Tubulostromal Adenoma | |||
| ADENOMA, ZYMBAL'S GLAND, BENIGN | C98800 | A benign neoplasm of the rodent Zymbal's gland with sebaceous and/or squamous differentiation. | Zymbal's Gland Adenoma | |||
| ADENOMYOMA, BENIGN | C3726 | A benign neoplasm characterized by the presence of a glandular and a mesenchymal component. | Adenomyoma | |||
| ADRENAL TUMOR, SUBCAPSULAR, BENIGN | C83488 | Subcapsular Single Cell Adenoma, Adrenal | A benign neoplasm located beneath the adrenal capsule. | Benign Subcapsular Adrenal Tumor | ||
| ADRENAL TUMOR, SUBCAPSULAR, MALIGNANT | C83489 | Subcapsular Single Cell Carcinoma, Adrenal | A malignant neoplasm located beneath the adrenal capsule. | Malignant Subcapsular Adrenal Tumor | ||
| ADRENAL TUMOR, SUBCAPSULAR, UNDETERMINED | C82973 | Subcapsular Cell Tumor, Adrenal | A neoplasm located beneath the adrenal capsule in which the malignancy status has not been established. | Subcapsular Adrenal Tumor | ||
| ADRENOCORTICAL NEOPLASM, UNDETERMINED | C2858 | Adrenal Cortex Tumor;Adrenocortical Neoplasm;Adrenocortical Tumor | A neoplasm of the adrenal cortex in which the malignancy status has not been established. | Adrenal Cortex Neoplasm | ||
| AMELOBLASTOMA, BENIGN | C7111 | A benign odontogenic neoplasm arising from the epithelial component of the embryonic tooth. | Benign Ameloblastoma | |||
| AMELOBLASTOMA, MALIGNANT | C54297 | Malignant Ameloblastoma | A malignant odontogenic neoplasm arising from the epithelial component of the embryonic tooth. | Metastasizing Ameloblastoma | ||
| AMELOBLASTOMA, UNDETERMINED | C4313 | A odontogenic neoplasm arising from the epithelial component of the embryonic tooth of undetermined malignancy status. | Ameloblastoma | |||
| ANGIOFIBROMA, BENIGN | C3799 | Angiofibromatous Hyperplasia;Fibroangioma, Benign;Fibrous Papule;Telangiectatic Fibroma | A benign, morphologic variant of fibroma characterized by the presence of numerous dilated vascular channels. | Angiofibroma | ||
| ANGIOLIPOMA, BENIGN | C3733 | Angiolipoma | A lipoma characterized by prominent vascularization. | Angiolipoma | ||
| ARRHENOBLASTOMA, BENIGN | C4209 | Arrhenoblastoma, Benign | A benign Sertoli-Leydig neoplasm of the ovary characterized by the presence of Sertoli cells in tubules without evidence of significant nuclear atypia or mitotic activity. | Well Differentiated Ovarian Sertoli-Leydig Cell Tumor | ||
| ARRHENOBLASTOMA, MALIGNANT | C4210 | Arrhenoblastoma, Malignant | A malignant Sertoli-Leydig neoplasm of the ovary characterized by the presence of a sarcomatoid stroma which contains primitive gonadal stromal cells. | Poorly Differentiated Ovarian Sertoli-Leydig Cell Tumor | ||
| ASTROCYTOMA, ANAPLASTIC, MALIGNANT | C9477 | Grade III Astrocytic Neoplasm;Grade III Astrocytic Tumor;Grade III Astrocytoma;Malignant Astrocytoma | A malignant neoplasm of the brain or spinal cord originating from astrocytes, exhibiting poor differentiation (anaplasia). | Anaplastic Astrocytoma | ||
| ASTROCYTOMA, DIFFUSE, MALIGNANT | C7173 | Astrocytoma, Diffuse | A malignant astrocytic neoplasm characterized by a high degree of cellular differentiation, slow growth, and diffuse infiltration of neighboring brain structures. | Diffuse Astrocytoma | ||
| ASTROCYTOMA, MALIGNANT | C119574 | A malignant neoplasm of the brain or spinal cord originating from astrocytes. | Experimental Organism Malignant Astrocytoma | |||
| ASTROCYTOMA, PILOCYTIC, BENIGN | C4047 | Astrocytoma, Benign;Grade I Astrocytic Neoplasm;Grade I Astrocytic Tumor;Grade I Astrocytoma | A benign neoplasm of the brain or spinal cord arising from astrocytes associated with single or multiple cysts. | Pilocytic Astrocytoma | ||
| ASTROCYTOMA, UNDETERMINED | C60781 | A neoplasm of the brain or spinal cord exhibiting astrocytic differentiation, but in which the malignancy status has not been established. | Astrocytoma | |||
| BASAL CELL TUMOR, BENIGN | C111198 | Adenoma, Basal Cell, Benign | A benign epithelial neoplasm with a uniform, monomorphic appearance that is dominated by basal cells. | Experimental Organism Basal Cell Adenoma | ||
| BASALIOMA, BENIGN | C103391 | Basalioma | A benign epithelial neoplasm arising from primary epithelial germ cells of the piliary complex. | Experimental Organism Benign Basalioma | ||
| BASOSQUAMOUS TUMOR, BENIGN | C4614 | Cutaneous Papilloma;Papilloma of Skin;Papilloma of the Skin | A benign papillary neoplasm of the skin. | Skin Papilloma | ||
| BASOSQUAMOUS TUMOR, MALIGNANT | C2922 | Basosquamous Carcinoma;Basosquamous Cell Carcinoma;Skin Mixed Basal and Squamous Cell Carcinoma | A basal cell carcinoma (skin neoplasm) which displays squamous differentiation. | Skin Basosquamous Cell Carcinoma | ||
| CARCINOID TUMOR, MALIGNANT | C72074 | Malignant Carcinoid Tumor | A malignant neuroendocrine neoplasm arising from enterochromaffin cells in the gastrointestinal tract and (less common) in the bronchi. | Atypical Carcinoid Tumor | ||
| CARCINOID TUMOR, UNDETERMINED | C2915 | Carcinoid;Carcinoid Neoplasm;Well-differentiated Endocrine Neoplasm | A neuroendocrine neoplasm arising from enterochromaffin cells in the gastrointestinal tract and (less common) the bronchi with undetermined malignancy status. | Carcinoid Tumor | ||
| CARCINOMA, ACIDOPHIL, MALIGNANT | C114109 | Acidophil Adenocarcinoma;Acidophil Carcinoma;Eosinophil Adenocarcinoma;Eosinophil Carcinoma | A malignant epithelial neoplasm of the anterior pituitary gland in which the neoplastic cells stain positive with acidic dyes. | Experimental Organism Acidophil Carcinoma Neoplasm | ||
| CARCINOMA, ACINAR CELL, MALIGNANT | C3768 | Acinar Adenocarcinoma;Acinar Carcinoma;Acinar Cell Adenocarcinoma;Acinic Cell Adenocarcinoma;Acinic Cell Carcinoma | A malignant glandular epithelial neoplasm comprising secretory cells forming acinar patterns. | Acinar Cell Carcinoma | ||
| CARCINOMA, ADENOSQUAMOUS, MALIGNANT | C3727 | Mixed Adenocarcinoma and Epidermoid Carcinoma;Mixed Adenocarcinoma and Epidermoid Cell Carcinoma;Mixed Adenocarcinoma and Squamous Carcinoma;Mixed Adenocarcinoma and Squamous Cell Carcinoma | An epithelial neoplasm composed of malignant glandular and malignant squamous cells. | Adenosquamous Carcinoma | ||
| CARCINOMA, ADNEXAL, MALIGNANT | C3775 | Carcinoma of Adnexa;Carcinoma of Skin Appendage;Skin Appendage Carcinoma | A malignant epithelial neoplasm arising from sebaceous or sweat glands or from hair follicles. | Adnexal Carcinoma | ||
| CARCINOMA, ADRENOCORTICAL, MALIGNANT | C9325 | Adenocarcinoma, Adrenocortical, Malignant;Adrenal Cortex Adenocarcinoma;Adrenal Cortex Cancer;Adrenal Cortical Adenocarcinoma;Adrenal Cortical Carcinoma;Adrenocortical Carcinoma;Cortical Cell Carcinoma | A malignant epithelial neoplasm arising from adrenal cortical cells. | Adrenal Cortex Carcinoma | ||
| CARCINOMA, BASAL CELL, MALIGNANT | C111199 | BCC;Basal Cell Cancer;Basal Cell Carcinoma;Basal Cell Epithelioma;Basal Cell Skin Carcinoma | A malignant epithelial neoplasm arising from basal cells. | Experimental Organism Basal Cell Carcinoma | ||
| CARCINOMA, BRONCHIAL, MALIGNANT | C35875 | A malignant neoplasia of the lung, arising from bronchial epithelium. | Bronchogenic Carcinoma | |||
| CARCINOMA, BRONCHIOLOALVEOLAR, MALIGNANT | C2923 | BAC;Bronchioalveolar Adenocarcinoma of Lung;Bronchioalveolar Adenocarcinoma of the Lung;Bronchioalveolar Lung Carcinoma;Bronchiolo-Alveolar Carcinoma of Lung;Bronchiolo-Alveolar Carcinoma of the Lung;Bronchiolo-Alveolar Lung Carcinoma;Bronchioloalveolar Adenocarcinoma of Lung;Bronchioloalveolar Adenocarcinoma of the Lung;Bronchioloalveolar Lung Adenocarcinoma | A malignant lung neoplasm originating from the alveolar/bronchiolar epithelium. | Bronchioloalveolar Carcinoma | ||
| CARCINOMA, C-CELL, MALIGNANT | C3879 | C Cell Carcinoma;MTC;Medullary Carcinoma;Medullary Carcinoma of Thyroid;Medullary Carcinoma of Thyroid Gland;Medullary Carcinoma of the Thyroid;Medullary Carcinoma of the Thyroid Gland;Medullary Thyroid Cancer;Medullary Thyroid Carcinoma;Medullary Thyroid Gland Carcinoma;Parafollicular Cell Carcinoma;Thyroid Gland Neuroendocrine Carcinoma;Thyroid Medullary Carcinoma | A neuroendocrine malignant epithelial neoplasm arising from C-cells of the thyroid gland. | Thyroid Gland Medullary Carcinoma | ||
| CARCINOMA, CERUMINOUS GLAND, MALIGNANT | C4176 | A malignant neoplasm derived from ceruminous glands in the external auditory canal. | Ceruminous Adenocarcinoma | |||
| CARCINOMA, CHOROID PLEXUS, MALIGNANT | C4715 | Anaplastic Choroid Plexus Papilloma;Cancer of Choroid Plexus;Cancer of the Choroid Plexus;Carcinoma of Choroid Plexus;Carcinoma of the Choroid Plexus;Choroid Plexus Cancer | A malignant neoplasm arising from the choroid plexus of the brain. | Choroid Plexus Carcinoma | ||
| CARCINOMA, EMBRYONAL, MALIGNANT | C3752 | Carcinoma, Embryonal, Malignant | A non-seminomatous malignant germ cell neoplasm of the testis or ovary. | Embryonal Carcinoma | ||
| CARCINOMA, ENDOMETRIAL, MALIGNANT | C7558 | Carcinoma of Endometrium;Carcinoma of the Endometrium | A malignant epithelial neoplasm arising from the lining of the uterine body cavity. | Endometrial Carcinoma | ||
| CARCINOMA, FOLLICULAR CELL, MALIGNANT | C8054 | Follicular Adenocarcinoma;Follicular Cancer of Thyroid;Follicular Cancer of Thyroid Gland;Follicular Cancer of the Thyroid;Follicular Cancer of the Thyroid Gland;Follicular Carcinoma;Follicular Carcinoma of Thyroid;Follicular Carcinoma of Thyroid Gland;Follicular Carcinoma of the Thyroid;Follicular Carcinoma of the Thyroid Gland;Follicular Thyroid Cancer;Follicular Thyroid Carcinoma;Follicular Thyroid Gland Carcinoma;Thyroid Follicular Carcinoma;Well-differentiated Follicular Adenocarcinoma;Well-differentiated Follicular Carcinoma | A malignant neoplasia arising from follicular cells of the thyroid gland. | Thyroid Gland Follicular Carcinoma | ||
| CARCINOMA, HEPATOCELLULAR, MALIGNANT | C3099 | Carcinoma of Liver Cells;Carcinoma of the Liver Cells;HCC;Hepatoma;Liver Cell Carcinoma;Primary Carcinoma of Liver Cells;Primary Carcinoma of the Liver Cells | A malignant neoplasm arising from hepatocytes. | Hepatocellular Carcinoma | ||
| CARCINOMA, HEPATOCHOLANGIOCELLULAR, MALIGNANT | C103393 | Hepatocholangiocellular Carcinoma | A malignant mixed neoplasm of the liver comprising neoplastic hepatocytes and bile duct epithelial cells; both elements displaying evidence of malignancy. | Experimental Organism Malignant Hepatocholangiocellular Carcinoma | ||
| CARCINOMA, IN SITU, MALIGNANT | C2917 | CIS;Epithelial Tumor, In situ, Malignant;Intraepithelial Carcinoma;Non-invasive Carcinoma | A malignant epithelial neoplasm confined to the epithelial layer and without evidence of further tissue invasion. | Carcinoma In Situ | ||
| CARCINOMA, ISLET CELL, MALIGNANT | C3770 | Islet Cell Cancer;Islet Cell Carcinoma;Malignant Islet Cell Tumor;Malignant Pancreatic Endocrine Tumor;Pancreatic Neuroendocrine Carcinoma | A malignant endocrine neoplasm arising from islets of Langerhans of the pancreas. | Pancreatic Neuroendocrine Carcinoma | ||
| CARCINOMA, MALIGNANT | C2916 | Epithelial Carcinoma;Epithelioma Malignant;Malignant Epithelial Neoplasm;Malignant Epithelial Tumor;Malignant Epithelioma | A malignant epithelial neoplasm. | Carcinoma | ||
| CARCINOMA, NEUROENDOCRINE CELL, MALIGNANT | C3773 | Neuroendocrine Carcinoma;Neuroendocrine Cell Carcinoma;Neuroendocrine Tumor, Malignant | A malignant neuroendocrine neoplasm comprising cells containing secretory granules. | Neuroendocrine Carcinoma | ||
| CARCINOMA, PARS DISTALIS, MALIGNANT | C60491 | Rat Pars Distalis Carcinoma | A malignant epithelial neoplasm arising from the pars distalis of the pituitary gland. | Rat Pars Distalis Carcinoma | ||
| CARCINOMA, PARS INTERMEDIA, MALIGNANT | C92183 | Rat Pars Intermedia Carcinoma | A malignant epithelial neoplasm arising from the pars intermedia of the pituitary gland. | Rat Pars Intermedia Carcinoma | ||
| CARCINOMA, RENAL CELL, MALIGNANT | C9385 | Adenocarcinoma of Kidney;Adenocarcinoma of the Kidney;Kidney Adenocarcinoma;RCC;Renal Cell Adenocarcinoma;Renal Cell Cancer;Renal Cell Carcinoma, Stage Unspecified | A malignant neoplasm arising from renal parenchyma. | Renal Cell Carcinoma | ||
| CARCINOMA, RENAL, TUBULAR, MALIGNANT | C39807 | Mucinous Tubular and Spindle Cell Carcinoma of the Kidney | A malignant neoplasm of the kidney, characterized by the presence of tubules. | Mucinous Tubular and Spindle Cell Carcinoma of the Kidney | ||
| CARCINOMA, SPINDLE CELL, MALIGNANT | C27004 | Pseudosarcomatous Carcinoma;Spindle Cell Carcinoma | A malignant epithelial neoplasm characterized by the presence of spindle cells. | Sarcomatoid Carcinoma | ||
| CARCINOMA, SQUAMOUS CELL, IN SITU, MALIGNANT | C27093 | Epidermoid Carcinoma In situ;Epidermoid Cell Carcinoma In situ;Grade 3 Squamous Intraepithelial Neoplasia;Grade III Squamous Intraepithelial Neoplasia;Intraepithelial Squamous Cell Carcinoma;Squamous Carcinoma In situ;Squamous Cell Carcinoma In situ | A malignant epithelial neoplasm confined to the squamous epithelium, without invasion of underlying tissues. | Stage 0 Squamous Cell Carcinoma | ||
| CARCINOMA, SQUAMOUS CELL, MALIGNANT | C2929 | Epidermoid Carcinoma;Epidermoid Cell Cancer;Malignant Epidermoid Cell Neoplasm;Malignant Epidermoid Cell Tumor;Malignant Squamous Cell Neoplasm;Malignant Squamous Cell Tumor;Squamous Carcinoma;Squamous Cell Cancer;Squamous Cell Epithelioma | A malignant neoplasm arising from squamous epithelial cells. | Squamous Cell Carcinoma | ||
| CARCINOMA, SWEAT GLAND, MALIGNANT | C6938 | Carcinoma of Sweat Gland;Carcinoma of the Sweat Gland | A malignant neoplasm arising from sweat glands. | Sweat Gland Carcinoma | ||
| CARCINOMA, TRANSITIONAL CELL, MALIGNANT | C2930 | Transitional Carcinoma | A malignant neoplasm arising from transitional epithelium, usually affecting the urinary bladder, ureter, or renal pelvis. | Transitional Cell Carcinoma | ||
| CARCINOMA, TUBULAR CELL, MALIGNANT | C65192 | A malignant glandular neoplasm exhibiting tubular structures. | Tubular Adenocarcinoma | |||
| CARCINOMA, TUBULOSTROMAL, MALIGNANT | C80356 | A malignant epithelial neoplasm of the ovary with tubular and stromal neoplastic components. | Tubulostromal Adenocarcinoma | |||
| CARCINOMA, UNDIFFERENTIATED, MALIGNANT | C3692 | Anaplastic Carcinoma;Carcinoma, Undifferentiated | A malignant epithelial neoplasm exhibiting poor differentiation (anaplasia). | Undifferentiated Carcinoma | ||
| CARCINOMA, ZYMBAL'S GLAND | C98801 | A malignant neoplasm of the rodent Zymbal's gland with sebaceous and/or squamous differentiation. | Zymbal's Gland Carcinoma | |||
| CARCINOSARCOMA, MALIGNANT | C34448 | A malignant neoplasm comprising a mixture of carcinomatous and sarcomatous elements. | Carcinosarcoma | |||
| CARDIAC SCHWANNOMA, BENIGN | C5358 | Schwannoma, Endocardial, Benign | A benign peripheral nervous system neoplasm that is composed of well-differentiated Schwann cells and affects the heart. | Benign Cardiac Schwannoma | ||
| CHEMODECTOMA, BENIGN | C79950 | Benign Chemodectoma | A benign neoplasm of the chemoreceptor system (e.g. carotid body, glomus jugulare, glomus vagale). | Benign Carotid Body Paraganglioma | ||
| CHEMODECTOMA, MALIGNANT | C3574 | Malignant Carotid Body Neoplasm;Malignant Carotid Body Tumor;Malignant Neoplasm of Carotid Body;Malignant Neoplasm of the Carotid Body;Malignant Tumor of Carotid Body;Malignant Tumor of the Carotid Body | A malignant neoplasm of the chemoreceptor system (e.g. carotid body, glomus jugulare, glomus vagale). | Malignant Carotid Body Paraganglioma | ||
| CHEMODECTOMA, UNDETERMINED | C2932 | Carotid Body Chemodectoma;Carotid Body Tumor;Chemodectoma;Paraganglioma of Carotid Body;Paraganglioma of the Carotid Body;Tumor of Carotid Body;Tumor of the Carotid Body | A neoplasm of the chemoreceptor system (e.g. carotid body, glomus jugulare, glomus vagale) for which the malignancy status has not be established. | Carotid Body Paraganglioma | ||
| CHOLANGIOCARCINOMA, INTRAHEPATIC, MALIGNANT | C35417 | Intrahepatic Bile Duct Carcinoma;Intrahepatic Carcinoma of Bile Duct;Intrahepatic Carcinoma of the Bile Duct | A malignant neoplasm of the liver arising from/comprising cells resembling those of bile ducts. | Intrahepatic Cholangiocarcinoma | ||
| CHOLANGIOCARCINOMA, MALIGNANT | C4436 | Cholangiocellular Carcinoma | A malignant neoplasm arising from/comprising cells resembling those of bile ducts. | Cholangiocarcinoma | ||
| CHOLANGIOMA, BENIGN | C2942 | Adenoma of Bile Duct;Adenoma of the Bile Duct;Cholangioadenoma;Cholangioma;Hepatocholangiocellular Adenoma;Hepatocholangioma | A benign neoplasm arising from/comprising cells resembling those of bile ducts. | Bile Duct Adenoma | ||
| CHONDROMA, BENIGN | C53459 | A benign, well circumscribed neoplasm arising from the hyaline cartilage in soft tissue or bone. It is characterized by the presence of chondrocytes. | Chondroma | |||
| CHONDROSARCOMA, MALIGNANT | C2946 | A malignant mesenchymal neoplasm arising from cartilage-forming tissues. | Chondrosarcoma | |||
| CHORDOMA, BENIGN | C60334 | A benign bone neoplasm arising from the remnants of the fetal notochord. | Rat Benign Chordoma | |||
| CHORDOMA, MALIGNANT | C2947 | A malignant bone neoplasm arising from the remnants of the fetal notochord. | Chordoma | |||
| CHORIOCARCINOMA, MALIGNANT | C2948 | Chorioepithelioma | A malignant neoplasm arising from placental trophoblast cells. They generally arise in the uterus. | Choriocarcinoma | ||
| CONNECTIVE AND SOFT TISSUE NEOPLASM, BENIGN | C53684 | Benign Connective and Soft Tissue Neoplasm;Benign Connective and Soft Tissue Tumor;Benign Mesenchymal Cell Neoplasm;Benign Neoplasm of the Soft Tissue and Bone;Benign Tumor of the Soft Tissue and Bone | A benign neoplasm arising from connective and soft tissues that does not invade adjacent tissues or metastasize to other anatomic sites. | Benign Connective and Soft Tissue Neoplasm | ||
| CRANIOPHARYNGIOMA, BENIGN | C2964 | Cystoma;Neoplasm of Rathke's Pouch;Rathke Pouch Neoplasm;Rathke Pouch Tumor;Rathke's Pouch Neoplasm;Rathke's Pouch Tumor;Tumor of Rathke's Pouch | A benign epithelial neoplasm of the sellar region, presumably derived from Rathke pouch epithelium. | Craniopharyngioma | ||
| CRANIOPHARYNGIOMA, MALIGNANT | C79949 | Carcinoma Arising From Craniopharyngioma | A malignant epithelial neoplasm of the sellar region, presumably derived from Rathke pouch epithelium. | Carcinoma Arising from Craniopharyngioma | ||
| CYSTADENOCARCINOMA, MALIGNANT | C2971 | A malignant cystic epithelial neoplasm arising from glandular epithelium. | Cystadenocarcinoma | |||
| CYSTADENOCARCINOMA, PAPILLARY, MALIGNANT | C3777 | A malignant cystic epithelial neoplasm arising from glandular epithelium exhibiting papillary structures. | Papillary Cystadenocarcinoma | |||
| CYSTADENOMA, BENIGN | C2972 | Cystoma | A benign cystic epithelial neoplasm arising from glandular epithelium. | Cystadenoma | ||
| CYSTADENOMA, PAPILLARY, BENIGN | C2974 | A benign cystic epithelial neoplasm arising from glandular epithelium exhibiting papillary structures. | Papillary Cystadenoma | |||
| DECIDUOMA, MALIGNANT | C3555 | Malignant Neoplasm of Placenta;Malignant Neoplasm of the Placenta;Malignant Placental Neoplasm;Malignant Placental Tumor;Malignant Tumor of Placenta;Malignant Tumor of the Placenta | A malignant neoplasm arising from decidua (placental) cells. | Malignant Placental Neoplasm | ||
| DECIDUOMA, UNDETERMINED | C4858 | Neoplasm of Placenta;Neoplasm of the Placenta;Placenta Neoplasm;Placenta Neoplasms;Placenta Tumor;Placenta Tumors;Placental Tumor;Placental Tumors;Tumor Of the Placenta;Tumor of Placenta;Tumor of the Placenta | A neoplasm arising from decidua (placental) cells in which the malignancy status has not been established. | Placental Neoplasm | ||
| DERMOID CYST, BENIGN | C9011 | Benign Cystic Teratoma;Dermoid;Mature Cystic Teratoma | A benign neoplasm comprised of a cyst, lined by mature epidermis-like tissue with dermal appendages. | Dermoid Cyst | ||
| DYSGERMINOMA, MALIGNANT | C2996 | A malignant germ cell neoplasm characterized by the presence of a monotonous primitive germ cell population, primarily in the ovary. | Dysgerminoma | |||
| EPENDYMOMA, ANAPLASTIC, MALIGNANT | C4049 | Anaplastic Ependymal Neoplasm;Anaplastic Ependymal Tumor;Malignant Ependymoma;Undifferentiated Ependymal Neoplasm;Undifferentiated Ependymal Tumor;Undifferentiated Ependymoma;Who Grade III Ependymal Neoplasm;Who Grade III Ependymal Tumor | A malignant neoplasm of ependymal origin with anaplastic cellular morphology. | Anaplastic Ependymoma | ||
| EPENDYMOMA, BENIGN | C3697 | A benign neoplasm of ependymal origin. | Myxopapillary Ependymoma | |||
| EPENDYMOMA, MALIGNANT | C119575 | A malignant neoplasm of ependymal origin. | Experimental Organism Malignant Ependymoma | |||
| EPENDYMOMA, UNDETERMINED | C3017 | Who Grade II Ependymal Neoplasm;Who Grade II Ependymal Tumor | A neoplasm of ependymal origin, for which the malignancy status has not been established. | Ependymoma | ||
| EPITHELIOMA, BENIGN | C4092 | Benign Epithelial Tumor;Benign Epithelioma;Benign Neoplasm of Epithelium;Benign Neoplasm of the Epithelium;Benign Tumor of Epithelium;Benign Tumor of the Epithelium | A benign neoplasm arising from epithelial cells of the skin. | Benign Epithelial Neoplasm | ||
| EPITHELIOMA, CYSTIC KERATINIZING, BENIGN | C80349 | A benign cystic epithelial neoplasm featuring a central keratin mass surrounded by squamous epithelium. | Cystic Keratinizing Epithelioma | |||
| EPITHELIOMA, NON-KERATINIZING, BENIGN | C84356 | A benign cystic epithelial neoplasm characterized by the absence of keratin production. | Non-Keratinizing Epithelioma | |||
| FIBROADENOCARCINOMA, MALIGNANT | C2928 | Adenocarcinoma With Productive Fibrosis;Fibrocarcinoma;Scirrhous Carcinoma | A malignant neoplasm originating from glandular cells with a fibrous or fibroblastic component. | Scirrhous Adenocarcinoma | ||
| FIBROADENOMA, BENIGN | C3744 | Breast Fibroadenoma;Fibroadenoma of Breast;Fibroadenoma of the Breast | A benign neoplasm originating from glandular cells with a fibrous or fibroblastic component. | Fibroadenoma | ||
| FIBROLIPOMA, BENIGN | C4249 | A benign neoplasm comprising mature adipocytes, characterized by areas of abundant fibrous tissue. | Fibrolipoma | |||
| FIBROMA, BENIGN | C3041 | A benign neoplasm arising from fibrous tissue. | Fibroma | |||
| FIBROMA, ODONTOGENIC, BENIGN | C4314 | Central Odontogenic Fibroma | A benign intraosseous neoplasm arising from tooth-forming tissues in the mandible and maxilla, characterized by the presence of islands of odontogenic epithelium. | Odontogenic Fibroma | ||
| FIBROMA, OSSIFYING, BENIGN | C8422 | Cementifying Fibroma;Cemento-Ossifying Fibroma;Ossifying Fibroma | A benign fibrous neoplasm characterized by a mineralized component (woven bone, lamellar bone, or cementum-like material). | Ossifying Fibroma | ||
| FIBROMYXOMA, BENIGN | C66760 | Fibromyxoma | A benign soft-tissue neoplasm of uncertain lineage, characterized by the presence of neoplastic spindle-shaped to round cells and a fibromyxoid stroma. | Fibromyxoid Neoplasm | ||
| FIBROPAPILLOMA, BENIGN | C3337 | A benign polypoid tumor comprising fibrous tissue and epithelium. | Fibroepithelial Polyp | |||
| FIBROSARCOMA, MALIGNANT | C3043 | A malignant mesenchymal neoplasm of the soft tissue and bone. | Fibrosarcoma | |||
| GANGLIOGLIOMA, BENIGN | C119576 | A benign neoplasm comprised of ganglion and glial cells. | Experimental Organism Benign Ganglioglioma | |||
| GANGLIOGLIOMA, UNDETERMINED | C3788 | A neuroepithelial neoplasm comprised of neoplastic ganglion cells and neoplastic glial cells, in which the malignancy status has not been established. | Ganglioglioma | |||
| GANGLIONEUROBLASTOMA, MALIGNANT | C3790 | A malignant neoplasm characterized by the presence of neuroblastic and ganglion cells and a stroma with Schwannian differentiation. | Ganglioneuroblastoma | |||
| GANGLIONEUROMA, BENIGN | C3049 | Neural Crest Tumor, Benign | A benign neoplasm characterized by the presence of ganglion cells and spindle cell proliferation, located primarily in the brain, ganglia, or adrenal medulla. | Ganglioneuroma | ||
| GIANT CELL TUMOR, BENIGN | C27477 | Benign Bone Giant Cell Tumor;Osteoclastoma, Benign | A benign neoplasm of bone comprised of giant cells (osteoclast-like) and mononuclear cells. | Benign Giant Cell Tumor of Bone | ||
| GIANT CELL TUMOR, MALIGNANT | C4090 | Malignant Giant Cell Tumor | A malignant neoplasm of bone comprised of giant cells (osteoclast-like) and mononuclear cells. | Malignant Giant Cell Neoplasm | ||
| GIANT CELL TUMOR, UNDETERMINED | C3055 | Tumor of Giant Cell;Tumor of the Giant Cell | A neoplasm of bone comprised of giant cells (osteoclast-like) and mononuclear cells, for which the malignancy status has not been established. | Giant Cell Tumor | ||
| GLIOMA, MALIGNANT | C4822 | Malignant Glial Neoplasm;Malignant Glial Tumor;Malignant Neuroglial Neoplasm;Malignant Neuroglial Tumor | A malignant neuroglial neoplasm. The term can apply to several primary neoplasm of the brain and spinal cord, including astrocytoma and oligodendroglioma in addition to others. | Malignant Glioma | ||
| GLIOMA, MIXED, MALIGNANT | C3903 | Glioma, Mixed;Mixed Glial Neoplasm;Mixed Glial Tumor;Mixed Neuroglial Neoplasm;Mixed Neuroglial Tumor | A malignant neoplasm comprising two or more glial cell types (e.g., astrocytes, ependymal cells, oligodendrocytes). | Mixed Glioma | ||
| GRANULAR CELL TUMOR, BENIGN | C3252 | Benign Granular Cell Myoblastoma;Benign Granular Cell Neoplasm;Benign Granular Cell Tumor;Myoblastoma | A benign neoplasm, comprised of large cells with cytoplasmatic granules, occurring in various organs/tissues. | Benign Granular Cell Tumor | ||
| GRANULAR CELL TUMOR, MALIGNANT | C4336 | Malignant Granular Cell Myoblastoma;Malignant Granular Cell Neoplasm;Myoblastoma, Malignant | A malignant neoplasm, comprised of large cells with cytoplasmatic granules, occurring in various organs/tissues. | Malignant Granular Cell Tumor | ||
| GRANULOSA CELL TUMOR, BENIGN | C60340 | A benign neoplasm of the ovary, originating from granulosa cells. | Rat Benign Granulosa Cell Tumor | |||
| GRANULOSA CELL TUMOR, MALIGNANT | C4205 | Malignant Granulosa Cell Tumor | A malignant neoplasm of the ovary, originating from granulosa cells. | Malignant Granulosa Cell Tumor | ||
| GRANULOSA CELL TUMOR, UNDETERMINED | C3070 | Granulosa Cell Neoplasm | A neoplasm of the ovary (or testis), originating from granulosa cells for which the malignancy status has not been established. | Granulosa Cell Tumor | ||
| HAIR FOLLICLE NEOPLASM, BENIGN | C27520 | Benign Follicular Neoplasm;Benign Follicular Tumor;Benign Hair Follicle Tumor | A benign neoplasm that arises from the hair follicle. | Benign Hair Follicle Neoplasm | ||
| HAIR FOLLICLE NEOPLASM, MALIGNANT | C43310 | Malignant Hair Follicle Tumor | A malignant neoplasm that arises from the hair follicle. | Malignant Hair Follicle Neoplasm | ||
| HAIR FOLLICLE NEOPLASM, UNDETERMINED | C7367 | Hair Follicle Tumor;Hair Matrix Neoplasm;Hair Matrix Tumor;Neoplasm of Hair Follicle;Neoplasm of the Hair Follicle | A neoplasm that arises from the hair follicle, for which the malignancy status has not been established. | Hair Follicle Neoplasm | ||
| HEMANGIOMA, BENIGN | C3085 | Angioma;Benign Angioma;Benign Hemangioma | A benign vascular neoplasm characterized by the formation of capillary-sized or cavernous vascular channels. | Hemangioma | ||
| HEMANGIOPERICYTOMA, BENIGN | C4300 | A benign neoplasm originating from vascular pericytes (cells in the periphery of vessels). | Benign Hemangiopericytoma | |||
| HEMANGIOPERICYTOMA, MALIGNANT | C4301 | Malignant Hemangiopericytoma NOS | A malignant neoplasm originating from vascular pericytes (cells in the periphery of vessels). | Malignant Hemangiopericytoma | ||
| HEMANGIOPERICYTOMA, UNDETERMINED | C3087 | A neoplasm originating from vascular pericytes (cells in the periphery of vessels), for which the malignancy status has not been established. | Hemangiopericytoma | |||
| HEMANGIOSARCOMA, MALIGNANT | C3088 | Hemangiosarcoma | A malignant vascular neoplasm arising from endothelial cells. | Angiosarcoma | ||
| HEPATOBLASTOMA, MALIGNANT | C3728 | HBL;Pediatric Embryonal Hepatoma;Pediatric Hepatoblastoma | A malignant liver neoplasm composed of immature hepatocytic elements. | Hepatoblastoma | ||
| HIBERNOMA, BENIGN | C3702 | Brown Fat Neoplasm;Brown Fat Tumor;Fetal Fat Cell Lipoma | A benign neoplasm of the brown adipose tissue. | Hibernoma | ||
| HIBERNOMA, MALIGNANT | C103394 | Malignant Hibernoma | A malignant neoplasm arising from the brown adipose tissue in animals, usually in the subcutis and the thoracic cavity. | Experimental Organism Malignant Hibernoma | ||
| HISTIOCYTOMA, BENIGN | C98708 | A benign dermal neoplasm comprising of round cells, resembling histiocytes. The tumor commonly occurs in young dogs and may regress spontaneously. | Benign Histiocytoma | |||
| HISTIOCYTOMA, FIBROUS, BENIGN | C3739 | Fibrous Histiocytoma | A benign neoplasm composed of a fibroblastic and a histiocytic component. | Benign Fibrous Histiocytoma | ||
| HISTIOCYTOMA, FIBROUS, MALIGNANT | C4247 | Fibroxanthosarcoma;MFH;Malignant Fibrous Histiocytoma of Soft Tissue and Bone;Malignant Fibrous Histiocytoma of the Soft Tissue and Bone;Malignant Fibroxanthoma | A malignant neoplasm composed of a fibroblastic and a histiocytic component. | Unclassified Pleomorphic Sarcoma | ||
| HISTIOCYTOMA, FIBROUS, UNDETERMINED | C8402 | Fibrohistiocytic Tumor | A neoplasm composed of a fibroblastic and a histiocytic component, for which the malignancy status has not been established. | Fibrohistiocytic Neoplasm | ||
| HISTIOCYTOMA, UNDETERMINED | C35765 | A neoplasm composed of histiocytic cells, for which the malignancy status has not been established. | Histiocytoma | |||
| ITO CELL TUMOR, BENIGN | C80351 | Benign Spongiotic Pericytoma | A benign neoplasm of the liver composed of hepatic stellate cells (Ito cells). | Benign Ito Cell Tumor | ||
| ITO CELL TUMOR, MALIGNANT | C80352 | Malignant Spongiotic Pericytoma | A malignant neoplasm of the liver composed of hepatic stellate cells (Ito cells). | Malignant Ito Cell Tumor | ||
| KERATOACANTHOMA, BENIGN | C117977 | A benign neoplasm in the superficial dermis with direct association to the epidermis, composed of well differentiated squamous epithelium and a central cavity filled with concentric layers of keratin; a pore (opening in the epidermis) may be present. | Experimental Organism Benign Keratoacanthoma | |||
| KERATOACANTHOMA, UNDETERMINED | C3146 | An epithelial skin neoplasm, composed of squamous cells, for which the malignancy status has not been established. | Keratoacanthoma | |||
| LEIOMYOBLASTOMA, BENIGN | C81854 | A benign neoplasm of the gastro-intestinal tract, originating from smooth muscle cells. | Benign Epithelioid Cell Type Gastrointestinal Stromal Tumor | |||
| LEIOMYOBLASTOMA, MALIGNANT | C81855 | A malignant neoplasm of the gastro-intestinal tract, originating from smooth muscle cells. | Malignant Epithelioid Cell Type Gastrointestinal Stromal Tumor | |||
| LEIOMYOBLASTOMA, UNDETERMINED | C3486 | Epithelioid Cell Type GIST;Leiomyoblastoma;Stout's Leiomyoblastoma | A neoplasm of the gastro-intestinal tract, originating from smooth muscle cells, for which the malignancy status has not been established. | Epithelioid Cell Type Gastrointestinal Stromal Tumor | ||
| LEIOMYOMA, BENIGN | C3157 | Fibroid;Fibroid Neoplasm;Fibroid Tumor;Leiomyomatous Neoplasm;Leiomyomatous Tumor | A benign neoplasm, originating from smooth muscle cells. | Leiomyoma | ||
| LEIOMYOSARCOMA, MALIGNANT | C3158 | Leiomyosarcomas | A malignant neoplasm, originating from smooth muscle cells. | Leiomyosarcoma | ||
| LEUKEMIA, ERYTHROID, MALIGNANT | C8923 | Acute Erythroblastic Leukemia;Erythroblastic Leukemia;Fab M6;M6 Acute Myeloid Leukemia | A progressive, proliferative disease of blood cells, originating from immature erythroid cells. | Acute Erythroid Leukemia | ||
| LEUKEMIA, GRANULOCYTIC, MALIGNANT | C3172 | Leukemia Granulocytic;Leukemia Myeloid;Myelocytic Leukemia;Myelogenous Leukemia;Non-lymphoblastic Leukemia;Non-lymphocytic Leukemia | A progressive, proliferative disease of blood cells, originating from immature granulocytes. | Myeloid Leukemia | ||
| LEUKEMIA, LARGE GRANULAR LYMPHOCYTIC, MALIGNANT | C4664 | LGLL;Large Cell Granular Lymphogenous Leukemia;Large Cell Granular Lymphoid Leukemia;Large Granular Lymphocytic Leukemia;Large Granular Lymphocytosis;T Gamma Lymphoproliferative Disorder;T-Cell Large Granular Lymphocytic Leukemia;T-Gamma Lymphoproliferative Disorder;Tgamma Large Granular Lymphocyte Leukemia | A progressive, proliferative disease of blood cells which are large and granular, originating from lymphoid cells. | T-Cell Large Granular Lymphocyte Leukemia | ||
| LEUKEMIA, LYMPHOBLASTIC, MALIGNANT | C3167 | ALL;ALL - Acute Lymphocytic Leukemia;Acute Lymphocytic Leukaemia;Acute Lymphocytic Leukemias;Acute Lymphogenous Leukemia;Acute Lymphoid Leukemia;Lymphoblastic Leukemia;Precursor Cell Lymphoblastic Leukemia;Precursor Lymphoblasic Leukemia | A progressive, proliferative disease of blood cells, originating from immature lymphoid cells. | Acute Lymphoblastic Leukemia | ||
| LEUKEMIA, LYMPHOCYTIC, MALIGNANT | C7539 | Lymphocytic Leukemia;Lymphogenous Leukemia | A progressive, proliferative disease of blood cells, originating from lymphoid cells. | Lymphoid Leukemia | ||
| LEUKEMIA, MALIGNANT | C3161 | Blood (Leukemia);Leukemia NOS;Leukemias;Leukemias, General | A progressive, proliferative disease of blood cells, originating from myeloid or lymphoid stem cells. | Leukemia | ||
| LEUKEMIA, MEGAKARYOCYTIC, MALIGNANT | C3170 | Acute M7 Myeloid Leukemia;Acute Megakaryoblastic Leukemia (Fab Type M7);Acute Megakaryocytic Leukemia;Fab M7 | A progressive, proliferative disease of blood cells, originating from immature megakaryocytes. | Acute Megakaryoblastic Leukemia | ||
| LEUKEMIA, MONOCYTIC, MALIGNANT | C4861 | Acute Monocytic Leukemia (Fab M5B);Monocytic Leukemia | A progressive, proliferative disease of blood cells, originating from immature monocytes. | Acute Monocytic Leukemia | ||
| LEYDIG CELL TUMOR, BENIGN | C4212 | Adenoma, Interstitial;Benign Interstitial Cell Neoplasm;Benign Interstitial Cell Tumor;Benign Leydig Cell Neoplasm | A benign neoplasm of the testis originating from interstitial (Leydig) cells. | Benign Leydig Cell Tumor | ||
| LEYDIG CELL TUMOR, MALIGNANT | C4213 | Malignant Interstitial Cell Neoplasm;Malignant Interstitial Cell Tumor;Malignant Leydig Cell Neoplasm | A malignant neoplasm of the testis originating from interstitial (Leydig) cells. | Malignant Leydig Cell Tumor | ||
| LEYDIG CELL TUMOR, UNDETERMINED | C3188 | Interstitial Cell Neoplasm;Interstitial Cell Tumor;Leydig Cell Neoplasm;Leydig Cell Tumor | A neoplasm of the testis originating from interstitial (Leydig) cells, for which the malignancy status has not been established. | Leydig Cell Tumor | ||
| LIPOMA, BENIGN | C3192 | A benign neoplasm composed of adipose tissue. | Lipoma | |||
| LIPOSARCOMA, MALIGNANT | C3194 | A malignant neoplasm composed of adipose tissue. | Liposarcoma | |||
| LUTEOMA, BENIGN | C3202 | Luteal Cell Neoplasm;Luteal Cell Tumor;Luteinoma;Luteoma;Ovarian Stroma Luteoma | A benign neoplasm of the ovary, composed of leuteinized granulosa-theca cells. | Ovarian Stromal Luteoma | ||
| LYMPHANGIOMA, BENIGN | C8965 | A benign neoplasm arising from the lymphatics. | Lymphangioma | |||
| LYMPHANGIOSARCOMA, MALIGNANT | C3205 | Lymphangioendothelial Sarcoma;Malignant Lymphangioendothelioma | A malignant neoplasm arising from the endothelial cells of the lymphatic vessels. | Lymphangiosarcoma | ||
| LYMPHOMA, FOLLICULAR, MALIGNANT | C3209 | Follicle Center Lymphoma;Follicular Centre Cell Lymphoma;Follicular Non-Hodgkin Lymphoma;Follicular Non-Hodgkin's Lymphoma;Lymphoma, Follicular Centre Cell | A neoplasm of lymphoid cells which has at least a partial follicular pattern. | Follicular Lymphoma | ||
| LYMPHOMA, HISTIOCYTIC, MALIGNANT | C114110 | Lymphoma, Large Cell, Malignant | A malignant neoplasm of large lymphocytes, which resemble histiocytes. | Experimental Organism Histiocytic Lymphoma Neoplasm | ||
| LYMPHOMA, IMMUNOBLASTIC, MALIGNANT | C3461 | A malignant neoplasm composed of immunoblasts (large B cells). | Immunoblastic Lymphoma | |||
| LYMPHOMA, LYMPHOBLASTIC, MALIGNANT | C9360 | Precursor Cell Lymphoblastic Lymphoma;Precursor Lymphoblastic Lymphoma | A malignant neoplasm composed of lymphoblasts (lymphoid precursor cells). | Lymphoblastic Lymphoma | ||
| LYMPHOMA, LYMPHOPLASMACYTIC, MALIGNANT | C3212 | Immunocytoma, Lymphoplasmacytic Type;Lymphoma, Plasmacytic;Lymphoplasmacytoid Lymphoma | A malignant neoplasm composed of lymphocytes (B-cells), lymphoplasmacytoid cells, and plasma cells. | Lymphoplasmacytic Lymphoma | ||
| LYMPHOMA, MALIGNANT | C3208 | Lymphoma (Hodgkin and Non-Hodgkin);Lymphoma (Hodgkin's and Non-Hodgkin's);Malignant Lymphoma | A malignant neoplasm composed of lymphocytes of B- or T/NK-cell phenotype. | Lymphoma | ||
| LYMPHOMA, MIXED, MALIGNANT | C114111 | Diffuse Mixed Large and Small Cell Lymphoma | A malignant neoplasm composed of a mixed lymphocyte population. | Experimental Organism Mixed Lymphoma Neoplasm | ||
| LYMPHOMA, SMALL LYMPHOCYTIC, MALIGNANT | C7540 | B-Cell Small Lymphocytic Lymphoma;Lymphoma, Lymphocytic, Malignant;SLL;Small B-Cell Lymphocytic Lymphoma | A malignant neoplasm composed of small lymphocytes. | Small Lymphocytic Lymphoma | ||
| LYMPHOSARCOMA, MALIGNANT | C114112 | An antiquated term referring to a malignant lymphoma that is diffused and composed of small and large lymphocytes. | Experimental Organism Lymphosarcoma Neoplasm | |||
| MAST CELL TUMOR, BENIGN | C3217 | A benign neoplasm composed of mast cells. | Benign Mastocytoma | |||
| MAST CELL TUMOR, MALIGNANT | C8991 | A malignant neoplasm composed of mast cells. | Malignant Mastocytosis | |||
| MAST CELL TUMOR, UNDETERMINED | C9295 | Mast Cell Proliferative Disease;Mast Cell Tumor;Neoplasm of Mast Cells;Neoplasm of the Mast Cells;Tumor of Mast Cells;Tumor of the Mast Cells | A neoplasm composed of mast cells, for which the malignancy status has not been determined. | Mast Cell Neoplasm | ||
| MEDULLOBLASTOMA, MALIGNANT | C3222 | Medulloblastomas | A malignant, invasive embryonal neoplasm arising from the cerebellum. | Medulloblastoma | ||
| MELANOMA, AMELANOTIC, MALIGNANT | C3802 | A malignant neoplasm composed of melanocytes, which lack melanin. | Amelanotic Melanoma | |||
| MELANOMA, BENIGN | C98709 | Benign Melanocytoma;Melanocytoma, Benign | A benign neoplasm or hamartoma composed of melanocytes. | Benign Melanocytoma | ||
| MELANOMA, MALIGNANT | C3224 | Malignant Melanoma | A malignant neoplasm composed of melanocytes. | Melanoma | ||
| MELANOMA, UVEAL, MALIGNANT | C7712 | Intraocular Melanoma;Melanoma of Uvea;Melanoma of the Uvea | A malignant neoplasm of the uvea composed of melanocytes. | Uveal Melanoma | ||
| MENINGIOMA, ANAPLASTIC, MALIGNANT | C4051 | Anaplastic Meningioma;Malignant Meningioma;Meningioma, Malignant | A malignant neoplasm of the meninges, exhibiting poor differentiation (anaplasia). | Anaplastic (Malignant) Meningioma | ||
| MENINGIOMA, BENIGN | C4055 | Meningioma, Benign | A benign neoplasm of the meninges. | Benign Meningioma | ||
| MENINGIOMA, MALIGNANT | C38938 | Grade 3 Meningioma;Grade III Meningioma;Who Grade III Meningioma | A malignant neoplasm of the meninges. | Grade III Meningioma | ||
| MENINGIOMA, UNDETERMINED | C3230 | A neoplasm of the meninges, for which the status of malignancy has not been determined. | Meningioma | |||
| MESENCHYMAL TUMOR, BENIGN | C4267 | A benign soft-tissue neoplasm comprising two or more non-fibroblastic mesenchymal lines of differentiation. | Benign Mesenchymoma | |||
| MESENCHYMAL TUMOR, MALIGNANT | C64118 | A malignant soft-tissue neoplasm comprising two or more non-fibroblastic mesenchymal lines of differentiation. | Malignant Mesenchymal Tumor of the Rat Kidney | |||
| MESOTHELIOMA, BENIGN | C3762 | Adenomatoid Tumor, Benign;Benign Localized Epithelial Mesothelioma;Benign Mesothelial Neoplasm;Benign Mesothelial Tumor;Benign Mesothelioma;Benign Neoplasm of Mesothelium;Benign Neoplasm of the Mesothelium;Benign Tumor of Mesothelium;Benign Tumor of the Mesothelium;Mesothelioma, Benign | A benign neoplasm arising from mesothelial cells. | Adenomatoid Tumor | ||
| MESOTHELIOMA, MALIGNANT | C4456 | Malignant Mesothelial Neoplasm;Malignant Mesothelial Tumor;Malignant Neoplasm of Mesothelium;Malignant Neoplasm of the Mesothelium;Malignant Tumor of Mesothelium;Malignant Tumor of the Mesothelium | A malignant neoplasm originating from mesothelial cells of the pleura or peritoneum. | Malignant Mesothelioma | ||
| MESOTHELIOMA, UNDETERMINED | C3234 | A neoplasm originating from mesothelial cells of the pleura or peritoneum, for which the malignancy status has not been established. | Mesothelioma | |||
| MIXED GLIOMA, BENIGN | C4050 | A benign neoplasm of the central nervous system with an astrocytic and oligodendrocytic component. | Oligoastrocytoma | |||
| MIXED TUMOR, BENIGN | C8602 | A benign neoplasm composed of epithelial and/or myoepithelial cells and a mesenchymal component. | Pleomorphic Adenoma | |||
| MIXED TUMOR, MALIGNANT | C3729 | Malignant Mixed Tumor | A malignant neoplasm composed of epithelial and/or myoepithelial cells and a mesenchymal component. A general term for which the transformed cell types have not been specified. | Malignant Mixed Neoplasm | ||
| MIXED TUMOR, UNDETERMINED | C6930 | Mixed Tumor;Tumor, Mixed | A neoplasm composed of an epithelial component and/or a mesenchymal component, for which the malignancy status has not been established. A general term for which the transformed cell types have not been specified. | Mixed Neoplasm | ||
| MUELLERIAN TUMOR, MIXED, MALIGNANT | C8975 | Malignant Mixed Mesodermal Tumor;Malignant Mixed Mullerian Tumor;Mmmt | A malignant neoplasm of the female reproductive system (mostly uterus and ovaries) originating from the Muellerian ducts and composed of carcinomatous and sarcomatous elements. | Malignant Mixed Mesodermal (Mullerian) Tumor | ||
| MYELOLIPOMA, BENIGN | C3736 | Myelolipoma | A benign tumor of the adrenal gland composed of adipocytes and hematopoietic/lymphoid cells. | Adrenal Gland Myelolipoma | ||
| MYELOMA, PLASMA CELL, MALIGNANT | C3242 | Multiple Myeloma;Myeloma | A malignant neoplasm of the bone marrow composed of plasma cells. | Plasma Cell Myeloma | ||
| MYOEPITHELIOMA, BENIGN | C7442 | A benign neoplasm composed of myoepithelial cells. | Benign Myoepithelioma | |||
| MYOEPITHELIOMA, MALIGNANT | C7596 | Malignant Myoepithelioma;Myoepithelial Carcinoma | A malignant neoplasm composed of myoepithelial cells. | Malignant Myoepithelioma | ||
| MYXOMA, BENIGN | C6577 | A benign soft tissue neoplasm with a myxoid stroma formation. | Myxoma | |||
| MYXOSARCOMA, MALIGNANT | C3255 | A malignant soft tissue neoplasm with a myxoid stroma formation. | Myxosarcoma | |||
| NEOPLASM, BENIGN | C3677 | Benign Tumor;Benign Unclassifiable Tumor | A general term used to describe autonomous growth of tissue where the originating cell type has not been characterized. The term benign indicates the absence of morphologic features associated with malignancy (for instance severe atypia, nuclear pleomorphism, tumor cell necrosis, and abnormal mitoses). | Benign Neoplasm | ||
| NEOPLASM, MALIGNANT | C9305 | CA;Cancer;Malignancy;Malignant Tumor | A general term for autonomous tissue growth exhibiting morphologic features of malignancy (e.g. severe atypia, nuclear pleomorphism, tumor cell necrosis, abnormal mitoses, tissue invasiveness) and for which the transformed cell type has not been specifically identified. | Malignant Neoplasm | ||
| NEOPLASM, UNDETERMINED | C3262 | A general term for autonomous tissue growth in which the malignancy status has not been established and for which the transformed cell type has not been specifically identified. | Neoplasm | |||
| NEPHROBLASTOMA, BENIGN | C114235 | A benign embryonal neoplasm of the kidney. | Experimental Organism Benign Nephroblastoma Neoplasm | |||
| NEPHROBLASTOMA, MALIGNANT | C40407 | Embryonal Nephroma;Nephroblastoma;Renal Wilms' Tumor;Wilms Tumor of the Kidney;Wilms' Tumor of the Kidney | A malignant embryonal neoplasm of the kidney. | Nephroblastoma | ||
| NEURAL CREST TUMOR, UNDETERMINED | C6963 | A neoplasm composed of cells of neuroendocrine origin for which the malignancy status has not been established. | Neuroblastic Tumor | |||
| NEUROBLASTOMA, MALIGNANT | C3270 | Neural Crest Tumor, Malignant;Neuroblastoma (Schwannian Stroma-poor) | A malignant neoplasm composed of neuroblastic cells. | Neuroblastoma | ||
| NEUROBLASTOMA, OLFACTORY, MALIGNANT | C3789 | Esthesioneuroblastoma;Esthesioneuroepithelioma;Olfactory Esthesioneuroblastoma;Olfactory Neuroepithelioma | A malignant neoplasm of the olfactory receptor cells, composed of neuroblastic cells. | Olfactory Neuroblastoma | ||
| NEUROFIBROMA, BENIGN | C3272 | An intraneural or extraneural neoplasm arising from nerve tissues and neural sheaths, composed of perineurial-like fibroblasts and Schwann cells. | Neurofibroma | |||
| NEUROGLIAL TUMOR, UNDETERMINED | C3059 | Glial Neoplasm;Glial Tumor;Glioma;Neoplasm of Neuroglia;Neoplasm of the Neuroglia;Neoplasms of Neuroglia;Neuroglial Neoplasm;Neuroglial Neoplasms;Tumor of Neuroglia;Tumor of the Neuroglia;Tumors of Neuroglia | A neoplasm of the central nervous system composed of glial cells (astrocytes, oligodendrocytes, ependymal cells), for which the malignancy status has not been determined. | Glioma | ||
| NEUROMYOBLASTOMA, MALIGNANT | C116214 | A malignant tumor that arises in the brain stem or adjacent cranial nerves, consisting of variable populations of cells with neuronal and myoblast differentiation. (INHAND) | Experimental Organism Malignant Neuromyoblastoma | |||
| ODONTOGENIC TUMOR, BENIGN | C4306 | Benign Odontogenic Tumor | A benign neoplasm arising from tooth-forming tissues. | Benign Odontogenic Neoplasm | ||
| ODONTOGENIC TUMOR, UNDETERMINED | C3286 | Odontogenic Tumor | A neoplasm arising from tooth-forming tissues, for which the malignancy status has not been established. | Odontogenic Neoplasm | ||
| ODONTOMA, AMELOBLASTIC, BENIGN | C3710 | Ameloblastic Fibroodontoma;Fibroameloblastic Odontoma | A benign neoplasm arising from tooth-forming tissues with-enamel organ differentiation (but without enamel formation). | Ameloblastic Fibro-Odontoma | ||
| ODONTOMA, AMELOBLASTIC, MALIGNANT | C7492 | A malignant neoplasm arising from tooth-forming tissues with-enamel organ differentiation (but without enamel formation). | Ameloblastic Carcinoma | |||
| ODONTOMA, BENIGN | C3287 | Fibro-Odontoma;Fibroodontoma | A benign neoplasm of tooth origin. | Odontoma | ||
| ODONTOMA, MALIGNANT | C4812 | Malignant Odontogenic Tumor;Odontogenic Carcinoma;Odontogenic Carcinosarcoma | A malignant neoplasm of tooth origin. | Malignant Odontogenic Neoplasm | ||
| OLIGODENDROGLIOMA, ANAPLASTIC, MALIGNANT | C4326 | Malignant;Malignant Oligodendroglioma;Oligodendroglioma;Undifferentiated Oligodendroglioma;Who Grade III Oligodendroglial Neoplasm;Who Grade III Oligodendroglial Tumor | A malignant neoplasm of the central nervous system arising from oligodendrocytes, exhibiting poor differentiation (anaplasia). | Anaplastic Oligodendroglioma | ||
| OLIGODENDROGLIOMA, MALIGNANT | C119577 | A malignant neoplasm of the brain or spinal cord originating from oligodendrocytes. | Experimental Organism Malignant Oligodendroglioma | |||
| OLIGODENDROGLIOMA, UNDETERMINED | C3288 | Well Differentiated Oligodendroglial Tumor;Well Differentiated Oligodendroglioma;Who Grade II Oligodendroglial Neoplasm;Who Grade II Oligodendroglial Tumor | A neoplasm of the central nervous system arising from oligodendrocytes, for which the malignancy status has not been determined. | Oligodendroglioma | ||
| ONCOCYTOMA, BENIGN | C7072 | Oncocytic Tumor;Oncocytoma | A benign neoplasm composed of large cells with abundant eosinophilic granular cytoplasm (oncocytes). | Oncocytic Neoplasm | ||
| ONCOCYTOMA, MALIGNANT | C3679 | Hurthle Cell Adenocarcinoma;Hurthle Cell Carcinoma;Oncocytic Adenocarcinoma;Oncocytic Carcinoma | A malignant neoplasm composed of large epithelial cells with abundant granular eosinophilic cytoplasm (oncocytes). | Oxyphilic Adenocarcinoma | ||
| OSTEOBLASTOMA, BENIGN | C3294 | Giant Osteoid Osteoma;Ossifying Giant Cell Tumor | A benign neoplasm of bone, characterized by the formation of osteoid tissue and large osteoblast-like cells. | Osteoblastoma | ||
| OSTEOCHONDROMA, BENIGN | C3295 | A benign cartiliginous neoplasm arising from the metaphysis of bone. | Osteochondroma | |||
| OSTEOCHONDROSARCOMA, MALIGNANT | C7155 | Conventional Chondrosarcoma of Bone;Primary Bone Chondrosarcoma;Primary Chondrosarcoma;Primary Chondrosarcoma of Bone;Primary Chondrosarcoma of the Bone | A malignant cartiliginous neoplasm of bone. | Conventional Chondrosarcoma | ||
| OSTEOCLASTOMA, MALIGNANT | C4304 | Dedifferentiated Giant Cell Tumor;Giant Cell Bone Sarcoma;Giant Cell Sarcoma of Bone;Giant Cell Sarcoma of the Bone | A malignant neoplasm of bone comprised of osteoclast-like giant cells and mononuclear cells. | Malignant Giant Cell Tumor of Bone | ||
| OSTEOCLASTOMA, UNDETERMINED | C3738 | Bone Giant Cell Neoplasm;Bone Giant Cell Tumor;Giant Cell Neoplasm of Bone | A neoplasm of bone comprised of osteoclast-like giant cells and mononuclear cells, for which the malignancy status has not been established. | Giant Cell Tumor of Bone | ||
| OSTEOFIBROMA, BENIGN | C3740 | Desmoid Tumor of Bone;Desmoplastic Fibroma;Desmoplastic Fibroma of Bone;Desmoplastic Fibroma of the Bone;Osseous Desmoplastic Fibroma | A benign neoplasm characterized by osteolysis and the presence of a rich collagenous stroma and spindle cells. | Bone Desmoplastic Fibroma | ||
| OSTEOFIBROMA, BONE, BENIGN | C103392 | Osteofibroma, Bone | A benign neoplasm, morphologically a fibroma with osseous components. | Experimental Organism Benign Bone Osteofibroma | ||
| OSTEOMA, BENIGN | C3296 | A benign well-differentiated neoplasm of bone. | Osteoma | |||
| OSTEOSARCOMA, EXTRASKELETAL, MALIGNANT | C8810 | Extraosseous Osteosarcoma;Extraskeletal Osteogenic Sarcoma;Soft Tissue Osteosarcoma | A malignant bone-forming neoplasm, arising in tissue other than bone. | Extraskeletal Osteosarcoma | ||
| OSTEOSARCOMA, MALIGNANT | C9145 | Osteogenic Sarcoma | A malignant neoplasm usually arising from bone. | Osteosarcoma | ||
| OVARIAN SEX CORD-STROMAL TUMOR, BENIGN | C6803 | Benign Ovarian Sex Cord-Stromal Neoplasm;Benign Sex Cord-Stromal Neoplasm of Ovary;Benign Sex Cord-Stromal Neoplasm of the Ovary;Benign Sex Cord-Stromal Tumor of Ovary;Benign Sex Cord-Stromal Tumor of the Ovary;Sex Cord Stromal Tumor, Benign | A benign neoplasm of the ovary, originating from the sex-cord stroma. | Benign Ovarian Sex Cord-Stromal Tumor | ||
| PAPILLOMA, BENIGN | C7440 | A benign epithelial neoplasm that projects above the surrounding epithelial surface. | Papilloma | |||
| PAPILLOMA, CHOROID PLEXUS, BENIGN | C3698 | Papilloma of Choroid Plexus;Papilloma of the Choroid Plexus | A benign neoplasm of the choroid plexus of the central nervous system. | Choroid Plexus Papilloma | ||
| PAPILLOMA, SQUAMOUS CELL, BENIGN | C3712 | Epidermoid Cell Papilloma;Epidermoid Papilloma;Keratotic Papilloma;Squamous Cell Papilloma | A benign epithelial neoplasm characterized by a papillary growth pattern and a proliferation of neoplastic squamous cells. | Squamous Papilloma | ||
| PAPILLOMA, TRANSITIONAL CELL, BENIGN | C4115 | Transitional Papilloma | A benign papillary neoplasm composed of transitional cells. | Transitional Cell Papilloma | ||
| PARAGANGLIOMA, BENIGN | C48314 | Benign Neuroendocrine Cell Tumor;Benign Paraganglionic Neoplasm | A benign neoplasm arising from paraganglia located along nerves composed of neoplastic neuroectodermal chromaffin cells. | Benign Paraganglioma | ||
| PARAGANGLIOMA, MALIGNANT | C8559 | Malignant;Malignant Neoplasm of Paraganglion;Malignant Neoplasm of the Paraganglion;Malignant Paraganglion Neoplasm;Malignant Paraganglion Tumor;Malignant Paraganglionic Neoplasm;Malignant Paraganglionic Tumor;Malignant Tumor of Paraganglion;Malignant Tumor of the Paraganglion;Paraganglion Neoplasm | A malignant neoplasm arising from paraganglia located along nerves composed of neoplastic neuroectodermal chromaffin cells. | Malignant Paraganglioma | ||
| PARAGANGLIOMA, UNDETERMINED | C3308 | Neoplasm of Paraganglion;Neoplasm of the Paraganglion;Paraganglion Neoplasm;Paraganglion Tumor;Paraganglionic Neoplasm;Paraganglionic Tumor;Tumor of Paraganglion;Tumor of the Paraganglion | A neoplasm arising from paraganglia located along nerves composed of neoplastic neuroectodermal chromaffin cells, for which the malignancy status has not been established. | Paraganglioma | ||
| PERIPHERAL CHOLANGIOCARCINOMA, MALIGNANT | C96805 | Peripheral Cholangiocarcinoma | A malignant intrahepatic neoplasm arising from the small interlobular bile ducts. | Peripheral Intrahepatic Cholangiocarcinoma | ||
| PERIPHERAL NERVE SHEATH TUMOR, MALIGNANT | C3798 | MPNST;Malignant Neoplasm of Peripheral Nerve Sheath;Malignant Neoplasm of the Peripheral Nerve Sheath;Malignant Neurilemmoma;Malignant Neurilemoma;Malignant Peripheral Nerve Sheath Neoplasm;Malignant Peripheral Nerve Sheath Tumour;Malignant Schwannoma;Malignant Tumor of Peripheral Nerve Sheath;Malignant Tumor of the Peripheral Nerve Sheath;Neurofibrosarcoma, Malignant | A malignant neoplasm, originating from the sheaths of the peripheral nerve. | Malignant Peripheral Nerve Sheath Tumor | ||
| PHEOCHROMOCYTOMA, BENIGN | C48305 | A benign neoplasm of the adrenal gland medulla. | Benign Adrenal Gland Pheochromocytoma | |||
| PHEOCHROMOCYTOMA, COMPLEX, BENIGN | C92181 | A benign neoplasm of the adrenal gland medulla, composed of medullary and neuroectodermal components. | Benign Adrenal Gland Composite Pheochromocytoma | |||
| PHEOCHROMOCYTOMA, COMPLEX, MALIGNANT | C92184 | A malignant neoplasm of the adrenal gland medulla, composed of medullary and neuroectodermal components. | Malignant Adrenal Gland Composite Pheochromocytoma | |||
| PHEOCHROMOCYTOMA, COMPLEX, UNDETERMINED | C48306 | A neoplasm of the adrenal gland medulla, composed of medullary and neuroectodermal components, for which the malignancy status has not been established. | Adrenal Gland Composite Pheochromocytoma | |||
| PHEOCHROMOCYTOMA, MALIGNANT | C4220 | Malignant Adrenal Gland Chromaffin Neoplasm;Malignant Adrenal Gland Chromaffin Paraganglioma;Malignant Adrenal Gland Chromaffin Tumor;Malignant Adrenal Gland Chromaffinoma;Malignant Adrenal Gland Paraganglioma;Malignant Adrenal Medullary Paraganglioma;Malignant Adrenal Medullary Pheochromocytoma;Malignant Adrenal Pheochromocytoma;Malignant Pheochromocytoma;Pheochromoblastoma | A malignant neoplasm of the adrenal gland medulla. | Malignant Adrenal Gland Pheochromocytoma | ||
| PHEOCHROMOCYTOMA, UNDETERMINED | C3326 | Adrenal Gland Chromaffin Paraganglioma;Adrenal Gland Chromaffinoma;Adrenal Gland Paraganglioma;Adrenal Medullary Paraganglioma;Adrenal Medullary Pheochromocytoma;Adrenal Pheochromocytoma;Chromaffin Paraganglioma of the Adrenal Gland;Intraadrenal Paraganglioma;PCC;Phaeochromocytoma;Pheochromocytoma | A neoplasm of the adrenal gland medulla, for which the malignancy status has not been established. | Adrenal Gland Pheochromocytoma | ||
| PILOMATRIXOMA, BENIGN | C7368 | Benign Hair Follicle Neoplasm;Benign Pilomatricoma;Benign Pilomatrixoma;Calcifying Epitherlioma of Malherbe;Pilomatrixoma | A benign adnexal neoplasm arising from hair-bearing skin surfaces. | Pilomatricoma | ||
| PINEOBLASTOMA, MALIGNANT | C9344 | PNET of Pineal Gland;PNET of the Pineal Gland;Pineal Gland PNET;Pineal Gland Primitive Neuroectodermal Neoplasm;Pineal Gland Primitive Neuroectodermal Tumor;Pineal PNET;Pineal Primitive Neuroectodermal Neoplasm;Pineal Primitive Neuroectodermal Tumor;Primitive Neuroectodermal Neoplasm of Pineal Gland;Primitive Neuroectodermal Neoplasm of the Pineal Gland;Primitive Neuroectodermal Tumor of Pineal Gland;Primitive Neuroectodermal Tumor of the Pineal Gland | A poorly differentiated malignant embryonal neoplasm arising from the pineal region of the brain. | Pineoblastoma | ||
| PINEOCYTOMA, BENIGN | C6966 | Benign Pinealoma;Pinealoma | A benign neoplasm of the brain arising from the pineal gland. | Pineocytoma | ||
| PITUICYTOMA, BENIGN | C7157 | Neurohypophysis Neoplasm;Neurohypophysis Tumor;Posterior Pituitary Gland Tumor;Posterior Pituitary Neoplasm;Posterior Pituitary Tumor | A neoplasm arising from the posterior lobe of the pituitary gland. | Posterior Pituitary Gland Neoplasm | ||
| PLASMA CELL TUMOR, MALIGNANT | C4665 | Plasma Cell Dyscrasia;Plasma Cell Tumor;Plasmacytic Neoplasm;Plasmacytic Tumor | A malignant neoplasm composed of plasma cells. | Plasma Cell Neoplasm | ||
| POLYP, ADENOMATOUS, UNDETERMINED | C3764 | Polypoid Adenoma | A neoplasm, originating from glandular epithelium, exhibiting polypoid growth, for which the malignancy status has not been determined. | Adenomatous Polyp | ||
| POLYP, BENIGN | C112275 | A benign polypoid neoplasm of an epithelial lining projecting into a lumen or cavity. | Experimental Organism Benign Polyp | |||
| POLYP, ENDOMETRIAL STROMAL, BENIGN | C6433 | Adenoma, Endometrial;Endometrial Adenoma;Endometrial Stromal Polyp;Glandular Endometrial Polyp;Polyp of Endometrium;Polyp of the Endometrium;Polyp, Stromal | A benign polypoid neoplasm of the endometrium projecting into the endometrial cavity. | Endometrial Polyp | ||
| POLYP, UNDETERMINED | C3340 | A protruding growth attached to the underlying tissue by a broad base or a thin stalk, which can be either inflammatory, hamartomatous, or neoplastic. | Polyp | |||
| POLYP, VAGINAL, BENIGN | C3664 | Polyp of Vagina;Polyp of the Vagina | A benign polypoid growth arising from the vaginal wall. | Vaginal Polyp | ||
| RETICULOSIS, MALIGNANT | C4684 | Angiocentric T-Cell Lymphoma | A malignant lymphoid neoplasm composed of EBV-positive NK/T cells arranged in an angiocentric pattern. | Nasal Type Extranodal NK/T-Cell Lymphoma | ||
| RETINOBLASTOMA, MALIGNANT | C7541 | RB | A malignant neoplasm originating in the nuclear layer of the retina. | Retinoblastoma | ||
| RHABDOMYOMA, BENIGN | C3358 | A benign neoplasm arising from skeletal muscle, characterized by the presence of rhabdomyoblasts. | Rhabdomyoma | |||
| RHABDOMYOSARCOMA, MALIGNANT | C3359 | A malignant mesenchymal neoplasm arising from skeletal muscle. | Rhabdomyosarcoma | |||
| SARCOMA, GRANULOCYTIC, MALIGNANT | C35815 | A malignant neoplasm composed of myeloblasts, neutrophils and neutrophil precursors. | Granulocytic Sarcoma | |||
| SARCOMA, HISTIOCYTIC, MALIGNANT | C27349 | A malignant neoplasm composed of cells resembling histiocytes. | Histiocytic Sarcoma | |||
| SARCOMA, LEPTOMENINGEAL, MALIGNANT | C8312 | Sarcoma of Leptomeninges;Sarcoma of the Leptomeninges;Sarcoma, Meningeal | A malignant mesenchymal neoplasm arising from the leptomeninges. | Leptomeningeal Sarcoma | ||
| SARCOMA, MALIGNANT | C9118 | Mesenchymal Tumor, Malignant;Sarcoma;Sarcoma of Soft Tissue and Bone;Sarcoma of the Soft Tissue and Bone | A malignant mesenchymal neoplasm. A general term for which the transformed cell type has not been specified. | Sarcoma | ||
| SARCOMA, MYELOID, MALIGNANT | C3520 | Chloroma;Extramedullary Myeloid Tumor | A malignant neoplasm composed of myeloblasts or immature myeloid cells. It occurs in extramedullary sites or the bone. | Myeloid Sarcoma | ||
| SARCOMA, SYNOVIAL, MALIGNANT | C3400 | SS | A malignant neoplasm that usually arises in the synovial membranes of the joints and the synovial cells of the tendons and bursae. | Synovial Sarcoma | ||
| SARCOMA, UNDIFFERENTIATED, MALIGNANT | C27096 | Embryonal Sarcoma, Undifferentiated | A rare malignant neoplasm of the liver that is most common in youth. | Undifferentiated (Embryonal) Sarcoma | ||
| SCHWANNOMA, BENIGN | C3269 | Neurilemmoma;Neurinoma;Schwannoma;Schwannoma (Who Grade I) | A benign neoplasm of the peripheral nervous system composed of well-differentiated Schwann cells. | Schwannoma | ||
| SEMINOMA, BENIGN | C112276 | A benign germ cell neoplasm of the testis. | Experimental Organism Benign Seminoma | |||
| SEMINOMA, MALIGNANT | C9309 | Seminoma;Seminoma, Pure | A malignant germ cell neoplasm of the testis. | Seminoma | ||
| SERTOLI CELL TUMOR, BENIGN | C67012 | Benign Androblastoma | A benign neoplasm of the testis or ovary, originating from Sertoli cells. | Benign Sertoli Cell Tumor | ||
| SERTOLI CELL TUMOR, MALIGNANT | C67006 | Malignant Androblastoma | A malignant neoplasm of the testis or ovary, originating from Sertoli cells. | Malignant Sertoli Cell Tumor | ||
| SERTOLI CELL TUMOR, UNDETERMINED | C98794 | An ovarian neoplasm comprising Sertoli cells in which the malignancy status has not been established. | Undetermined Sertoli Cell Tumor | |||
| STROMAL NEPHROMA, MALIGNANT | C6569 | Cmn;Mesoblastic Nephroma | A congenital malignant neoplasm of the kidney characterized by the presence of fibroblastic cells. | Congenital Mesoblastic Nephroma | ||
| STROMAL SARCOMA, ENDOMETRIAL, MALIGNANT | C8973 | ESS | A malignant, mesenchymal tumor of the uterine stroma. | Endometrioid Stromal Sarcoma | ||
| STROMAL SARCOMA, MALIGNANT | C6926 | Stromal Tumor, Malignant | A malignant neoplasm characterized by the presence of atypical mesenchymal-stromal cells. | Stromal Sarcoma | ||
| STROMAL TUMOR, BENIGN | C114113 | A benign neoplasm composed of mesenchymal stromal cells. | Experimental Organism Benign Stromal Tumor Neoplasm | |||
| STROMAL TUMOR, GONADAL, MALIGNANT | C67561 | Sex Cord Stromal Tumor, Malignant | A malignant neoplasm originating from the gonadal sex cord stroma. | Malignant Sex Cord-Stromal Tumor | ||
| STROMAL TUMOR, GONADAL, UNDETERMINED | C3794 | Sex Cord-Stromal Neoplasm;Sex Cord-Stromal Tumor, Undetermined | A neoplasm originating from the gonadal sex cord stroma, for which the status of malignancy has not been determined. | Sex Cord-Stromal Tumor | ||
| SUBEPENDYMOMA, BENIGN | C3795 | Subependymal Glioma;Who Grade I Ependymal Neoplasm;Who Grade I Ependymal Tumor | A benign neoplasm of the brain localized in the vicinity of a ventricular wall and is composed of glial tumor cell clusters embedded in an abundant fibrillary matrix with frequent microcystic changes. | Subependymoma | ||
| SYNOVIOMA, BENIGN | C3829 | Benign Neoplasm of Synovium;Benign Neoplasm of the Synovium;Benign Synovial Tumor;Benign Synovioma;Benign Tumor of Synovium;Benign Tumor of the Synovium | A benign neoplasm arising from the synovial membrane. | Benign Synovial Neoplasm | ||
| TERATOMA, BENIGN | C114114 | A benign germ-cell neoplasm derived from pluripotent cells and consisting of components from one or more of the three germ-cell layers. | Experimental Organism Benign Teratoma Neoplasm | |||
| TERATOMA, MALIGNANT | C4286 | Immature Teratoma | A malignant germ-cell neoplasm derived from pluripotent cells and consisting of components from one or more of the three germ-cell layers. | Immature Teratoma | ||
| TERATOMA, UNDETERMINED | C3403 | A germ-cell neoplasm derived from pluripotent cells and consisting of components from one or more of the three germ-cell layers, for which the malignancy status has not been established. | Teratoma | |||
| THECOMA, BENIGN | C5219 | Benign Ovarian Thecal Cell Neoplasm;Benign Ovarian Thecal Cell Tumor;Benign Thecal Cell Neoplasm of Ovary;Benign Thecal Cell Neoplasm of the Ovary;Benign Thecal Cell Tumor of Ovary;Benign Thecal Cell Tumor of the Ovary;Benign Thecoma of Ovary;Benign Thecoma of the Ovary;Thecal Cell Tumor, Benign | A benign sex-cord neoplasm of the ovary, originating from theca cells. | Benign Ovarian Thecoma | ||
| THECOMA, OVARIAN, MALIGNANT | C6929 | Malignant Ovarian Thecal Cell Neoplasm;Malignant Ovarian Thecal Cell Tumor;Malignant Thecal Cell Neoplasm of Ovary;Malignant Thecal Cell Neoplasm of the Ovary;Malignant Thecal Cell Tumor of Ovary;Malignant Thecal Cell Tumor of the Ovary;Malignant Thecoma of Ovary;Malignant Thecoma of the Ovary;Thecoma, Malignant | A malignant sex-cord neoplasm of the ovary, originating from theca cells. | Malignant Ovarian Thecoma | ||
| THYMOMA, BENIGN | C114115 | A benign neoplasm of the thymus, originating from epithelial thymus cells. | Experimental Organism Benign Thymoma Neoplasm | |||
| THYMOMA, MALIGNANT | C7612 | A malignant neoplasm of the thymus, originating from epithelial thymus cells. | Malignant Thymoma | |||
| THYMOMA, UNDETERMINED | C3411 | A neoplasm of the thymus, originating from epithelial thymus cells, for which the malignancy status has not been established. | Thymoma | |||
| TRICHOEPITHELIOMA, BENIGN | C27132 | Brooke's Tumor;Trichoepithelioma;Trichogenic Adnexal Tumor;Trichogenic Trichoblastoma | A benign hair follicle neoplasm with trichoblastic differentiation. | Trichoblastoma | ||
| YOLK SAC TUMOR, BENIGN | C84357 | A benign epithelial neoplasm arising from the yolk sac. | Yolk Sac Adenoma | |||
| YOLK SAC TUMOR, MALIGNANT | C3011 | Endodermal Sinus Neoplasm;Endodermal Sinus Tumor;Yolk Sac Neoplasm;Yolk Sac Tumor Site Unspecified | A non-seminomatous malignant germ cell tumor composed of primitive germ cells and which produce an eosinophilic substance (alpha-fetoprotein). | Yolk Sac Tumor | ||
| Back to top | ||||||
| CL.C116104.NVTESTCD | Nervous System Physiology Test Code (NVTESTCD) | text Extensible: Yes | C116104 | Nervous System Physiology Test Code | Terminology relevant to the test codes that describe nervous system physiology findings. | CDISC SDTM Nervous System Physiology Test Code Terminology |
| N145LAT | C117886 | N145 Latency | An assessment of the latency of the N145 or N2 wave of the visual evoked potential assessment waveform. | N145 Latency | ||
| P100AMP | C117887 | P100 Amplitude | The magnitude, or height, of the P100 wave of the visual evoked potential assessment waveform. This assessment calculates the height from the N75 negative peak to the P100 positive peak. | N75 to P100 Peak to Peak Amplitude | ||
| P100LAT | C117888 | P100 Latency | An assessment of the latency of the P100 or P1 wave of the visual evoked potential assessment waveform. | P100 Latency | ||
| SUVR | C116141 | Standard Uptake Value Ratio | The ratio between the uptake or binding of a radiopharmaceutical agent in an anatomical region of interest and a context-defined reference anatomical region. | Standard Uptake Value Ratio | ||
| Back to top | ||||||
| CL.C116103.NVTEST | Nervous System Physiology Test Name (NVTEST) | text Extensible: Yes | C116103 | Nervous System Physiology Test Name | Terminology relevant to the test names that describe nervous system physiology findings. | CDISC SDTM Nervous System Physiology Test Name Terminology |
| N145 Latency | C117886 | N145 Latency | An assessment of the latency of the N145 or N2 wave of the visual evoked potential assessment waveform. | N145 Latency | ||
| P100 Amplitude | C117887 | P100 Amplitude | The magnitude, or height, of the P100 wave of the visual evoked potential assessment waveform. This assessment calculates the height from the N75 negative peak to the P100 positive peak. | N75 to P100 Peak to Peak Amplitude | ||
| P100 Latency | C117888 | P100 Latency | An assessment of the latency of the P100 or P1 wave of the visual evoked potential assessment waveform. | P100 Latency | ||
| Standard Uptake Value Ratio | C116141 | Standard Uptake Value Ratio | The ratio between the uptake or binding of a radiopharmaceutical agent in an anatomical region of interest and a context-defined reference anatomical region. | Standard Uptake Value Ratio | ||
| Back to top | ||||||
| CL.C78738.NCF | Never/Current/Former Classification (NCF) | text Extensible: Yes | C78738 | Never/Current/Former Classification | A classification of usage or experience that falls into three categories; never, current, or former. | CDISC SDTM Never/Current/Former Classification Terminology |
| CURRENT | C25471 | Occurring in or belonging to the present time. (NCI) | Current | |||
| FORMER | C25627 | Previous | Occurring prior to something else. (NCI) | Previous | ||
| NEVER | C70543 | Not ever; at no time in the past. | Never | |||
| Back to top | ||||||
| CL.C101839.NYHAC | New York Heart Association Classification (NYHAC) | text Extensible: No | C101839 | New York Heart Association Classification | A terminology codelist based on the functional classification developed by the New York Heart Association (NYHA), for categorizing patients with defined or presumed cardiac disease. | CDISC SDTM New York Heart Association Class Responses Terminology |
| NYHA CLASS I | C66904 | New York Heart Association Class I | Without limitations of physical activity. Ordinary physical activity does not cause undue fatigue, palpitations, or dyspnea. | New York Heart Association Class I | ||
| NYHA CLASS II | C66905 | New York Heart Association Class II | Slight limitation of physical activity. The patient is comfortable at rest. Ordinary physical activity results in fatigue, palpitations, or dyspnea. | New York Heart Association Class II | ||
| NYHA CLASS III | C66907 | New York Heart Association Class III | Marked limitation of physical activity. The patient is comfortable at rest. Less than ordinary activity causes fatigue, palpitations, or dyspnea. | New York Heart Association Class III | ||
| NYHA CLASS IV | C66908 | New York Heart Association Class IV | Inability to carry on any physical activity without discomfort. Heart failure symptoms are present even at rest or with minimal exertion. | New York Heart Association Class IV | ||
| Back to top | ||||||
| CL.C66742.NY | No Yes Response (NY) | text Extensible: No | C66742 | No Yes Response | A term that is used to indicate a question with permissible values of yes/no/unknown/not applicable. | CDISC SDTM Yes No Unknown or Not Applicable Response Terminology |
| N | C49487 | No | The non-affirmative response to a question. (NCI) | No | ||
| NA | C48660 | NA;Not Applicable | Determination of a value is not relevant in the current context. (NCI) | Not Applicable | ||
| U | C17998 | U;Unknown | Not known, not observed, not recorded, or refused. (NCI) | Unknown | ||
| Y | C49488 | Yes | The affirmative response to a question. (NCI) | Yes | ||
| Back to top | ||||||
| CL.C101855.NSYSPCID | Non-system Reason for PCI Delay (NSYSPCID) | text Extensible: No | C101855 | Non-system Reason for PCI Delay | A terminology codelist that contains reasons for non-system PCI delay. | CDISC SDTM Non-system Reason for PCI Delay Terminology |
| CARDIAC ARREST BEFORE PCI | C99920 | Cardiac arrest which occurs before a percutaneous coronary intervention can take place. | Cardiac Arrest Prior to Percutaneous Coronary Intervention | |||
| DIFFICULT VASCULAR ACCESS | C99945 | Access to the subject's vasculature is troublesome or formidable. | Difficult Vascular Access | |||
| DIFFICULTY CROSSING THE CULPRIT LESION DURING THE PCI PROCEDURE | C99946 | Placement of intracoronary devices across the coronary stenosis is troublesome or formidable. | Difficulty Crossing Culprit Lesion During Percutaneous Coronary Intervention | |||
| ENDOTRACHEAL INTUBATION BEFORE PCI | C99950 | Intubation before PCI | Endotracheal intubation which occurs before a percutaneous coronary intervention can take place. | Endotracheal Intubation before Percutaneous Coronary Intervention | ||
| OTHER | C17649 | Other | Different than the one(s) previously specified or mentioned. (NCI) | Other | ||
| SUBJECT DELAY IN PROVIDING CONSENT | C100016 | Patient Delay in Providing Consent | The subject has not provided consent in a timely manner for the procedure to take place. | Subject Delay in Providing Consent | ||
| Back to top | ||||||
| CL.C101834.NORMABNM | Normal Abnormal Response (NORMABNM) | text Extensible: No | C101834 | Normal Abnormal Response | A terminology codelist to describe a normal or abnormal response. | CDISC SDTM Normal Abnormal Response Terminology |
| ABNORMAL | C25401 | Deviating in any way from the state, position, structure, condition, behavior, or rule which is considered a norm. (NCI) | Abnormal | |||
| INDETERMINATE | C48658 | Inconclusive | Cannot distinguish between two or more possible values in the current context. (NCI) | Indeterminate | ||
| NORMAL | C14165 | Being approximately average or within certain limits; conforming with or constituting a norm or standard or level or type or social norm. (NCI) | Normal | |||
| NOT EVALUABLE | C62222 | Not Evaluable | Unable to be evaluated. (NCI) | Unevaluable | ||
| UNKNOWN | C17998 | U;Unknown | Not known, not observed, not recorded, or refused. (NCI) | Unknown | ||
| Back to top | ||||||
| CL.C66789.ND | Not Done (ND) | text Extensible: No | C66789 | Not Done | Indicates a task, process or examination that has either not been initiated or completed. (NCI) | CDISC SDTM Not Done Terminology |
| NOT DONE | C49484 | Indicates a task, process or examination that has either not been initiated or completed. (NCI) | Not Done | |||
| Back to top | ||||||
| CL.C117743.OETESTCD | Ophthalmic Exam Test Code (OETESTCD) | text Extensible: Yes | C117743 | Ophthalmic Exam Test Code | Terminology relevant to the test codes that describe findings from ophthalmic examinations. | CDISC SDTM Ophthalmic Exam Test Code Terminology |
| ASTAXIS | C117889 | Astigmatism Axis | A measurement of the location, in degrees, of the flatter principal meridian on a 180-degree scale, where 90 degrees designates the vertical meridian and 180 degrees designates the horizontal meridian. | Astigmatism Axis | ||
| LOGSCORE | C117890 | Log Score | A number or range of numeric values on the log scale that measures performance, function, quality, or ability. | Log Score | ||
| NUMLCOR | C117891 | Number of Letters Correct | The integer that describes the number of letters correctly identified by the subject during an eye chart assessment. | Number of Correct Eye Chart Letters | ||
| RECYLDR | C117892 | Cylindrical Refraction Error | A measurement of the extent of defect in vision caused by a mismatch of optical power between the cylindrical and horizontal meridians, resulting in sub-optimal reflection of light onto the retina. (NCI) | Cylindrical Refractive Error | ||
| RESPHERE | C117893 | Spherical Refractive Error | A measurement of the extent of defect in vision caused by a mismatch of optimal power between the cornea and/or lens and the length of the eyeball, resulting in sub-optimal reflection of light onto the retina. (NCI) | Spherical Refractive Error | ||
| Back to top | ||||||
| CL.C117742.OETEST | Ophthalmic Exam Test Name (OETEST) | text Extensible: Yes | C117742 | Ophthalmic Exam Test Name | Terminology relevant to the test names that describe findings from ophthalmic examinations. | CDISC SDTM Ophthalmic Exam Test Name Terminology |
| Astigmatism Axis | C117889 | Astigmatism Axis | A measurement of the location, in degrees, of the flatter principal meridian on a 180-degree scale, where 90 degrees designates the vertical meridian and 180 degrees designates the horizontal meridian. | Astigmatism Axis | ||
| Cylindrical Refraction Error | C117892 | Cylindrical Refraction Error | A measurement of the extent of defect in vision caused by a mismatch of optical power between the cylindrical and horizontal meridians, resulting in sub-optimal reflection of light onto the retina. (NCI) | Cylindrical Refractive Error | ||
| Log Score | C117890 | Log Score | A number or range of numeric values on the log scale that measures performance, function, quality, or ability. | Log Score | ||
| Number of Letters Correct | C117891 | Number of Letters Correct | The integer that describes the number of letters correctly identified by the subject during an eye chart assessment. | Number of Correct Eye Chart Letters | ||
| Spherical Refractive Error | C117893 | Spherical Refractive Error | A measurement of the extent of defect in vision caused by a mismatch of optimal power between the cornea and/or lens and the length of the eyeball, resulting in sub-optimal reflection of light onto the retina. (NCI) | Spherical Refractive Error | ||
| Back to top | ||||||
| CL.C119013.OEFOCUS | Ophthalmic Focus of Study Specific Interest (OEFOCUS) | text Extensible: No | C119013 | Ophthalmic Focus of Study Specific Interest | Terminology relevant to the identification of a focus of ophthalmic observations. | CDISC SDTM Ophthalmic Focus of Study Specific Interest Terminology |
| OD | C119333 | The eye positioned in the right orbit, Oculus Dexter. | Right Eye | |||
| OS | C119334 | The eye positioned in the left orbit, Oculus Sinister. | Left Eye | |||
| OU | C119335 | Of or pertaining to both the left and right eyes, Oculus Uterque. | Both Eyes | |||
| Back to top | ||||||
| CL.C66768.OUT | Outcome of Event (OUT) | text Extensible: No | C66768 | Outcome of Event | A condition or event that is attributed to the adverse event and is the result or conclusion of the adverse event. (NCI) | CDISC SDTM Adverse Event Outcome Terminology |
| FATAL | C48275 | 5;FATAL;Grade 5 | The termination of life as a result of an adverse event. (NCI) | Death Related to Adverse Event | ||
| NOT RECOVERED/NOT RESOLVED | C49494 | One of the possible results of an adverse event outcome that indicates that the event has not improved or recuperated. (NCI) | Not Recovered or Not Resolved | |||
| RECOVERED/RESOLVED | C49498 | One of the possible results of an adverse event outcome that indicates that the event has improved or recuperated. (NCI) | Recovered or Resolved | |||
| RECOVERED/RESOLVED WITH SEQUELAE | C49495 | One of the possible results of an adverse event outcome where the subject recuperated but retained pathological conditions resulting from the prior disease or injury. (NCI) | Recovered or Resolved with Sequelae | |||
| RECOVERING/RESOLVING | C49496 | One of the possible results of an adverse event outcome that indicates that the event is improving. (NCI) | Recovering or Resolving | |||
| UNKNOWN | C17998 | U;Unknown | Not known, not observed, not recorded, or refused. (NCI) | Unknown | ||
| Back to top | ||||||
| CL.C66726.FRM | Pharmaceutical Dosage Form (FRM) | text Extensible: Yes | C66726 | Pharmaceutical Dosage Form | The form of the completed pharmaceutical product, e.g. tablet, capsule, injection, elixir, suppository. Dosage form can have a significant effect on the onset, duration and intensity of the pharmacological action of a drug. A pharmaceutical dosage form controls the rate at which the drug is released into the biological fluids. This release rate affects its intrinsic absorption pattern and therefore, the bioavailability of the drug. | CDISC SDTM Pharmaceutical Dosage Form Terminology |
| AEROSOL | C42887 | aer | A product that is packaged under pressure and contains therapeutically active ingredients that are released upon activation of an appropriate valve system; it is intended for topical application to the skin as well as local application into the nose (nasal aerosols), mouth (lingual aerosols), or lungs (inhalation aerosols). | Aerosol Dosage Form | ||
| AEROSOL, FOAM | C42888 | A dosage form containing one or more active ingredients, surfactants, aqueous or non-aqueous liquids, and the propellants; if the propellant is in the internal (discontinuous) phase (i.e., of the oil-in-water type), a stable foam is discharged, and if the propellant is in the external (continuous) phase (i.e., of the water-in-oil type), a spray or a quick-breaking foam is discharged. | Aerosol Foam Dosage Form | |||
| AEROSOL, METERED | C42960 | A pressurized dosage form consisting of metered dose valves which allow for the delivery of a uniform quantity of spray upon each activation. (NCI) | Metered Aerosol Dosage Form | |||
| AEROSOL, POWDER | C42971 | A product that is packaged under pressure and contains therapeutically active ingredients, in the form of a powder, that are released upon activation of an appropriate valve system. (NCI) | Powder Aerosol Dosage Form | |||
| AEROSOL, SPRAY | C42889 | An aerosol product which utilizes a compressed gas as the propellant to provide the force necessary to expel the product as a wet spray; it is applicable to solutions of medicinal agents in aqueous solvents. (NCI) | Aerosol Spray Dosage Form | |||
| BAR, CHEWABLE | C42892 | A solid dosage form usually in the form of a rectangle that is meant to be chewed. (NCI) | Chewable Bar Dosage Form | |||
| BEAD | C42890 | A solid dosage form in the shape of a small ball. (NCI) | Bead Dosage Form | |||
| BEAD, IMPLANT, EXTENDED RELEASE | C43451 | A small sterile solid mass consisting of a highly purified drug intended for implantation in the body which would allow at least a reduction in dosing frequency as compared to that drug presented as a conventional dosage form. (NCI) | Extended Release Bead Implant Dosage Form | |||
| BLOCK | C42891 | Solid dosage form, usually in the shape of a square or rectangle. (NCI) | Block Dosage Form | |||
| CAPLET | C97197 | A solid dosage form in which a tablet has been compacted into capsule shape. | Caplet Dosage Form | |||
| CAPSULE | C25158 | cap | A solid pharmaceutical dosage form that contains medicinal agent within either a hard or soft soluble container or shell, usually used for the oral administration of medicine. The shells are made of a suitable form of gelatin or other substance. (NCI) | Capsule Dosage Form | ||
| CAPSULE, COATED | C42895 | A solid dosage form in which the drug is enclosed within either a hard or soft soluble container or "shell" made from a suitable form of gelatin; additionally, the capsule is covered in a designated coating. | Coated Capsule Dosage Form | |||
| CAPSULE, COATED PELLETS | C42896 | A solid dosage form in which the drug is enclosed within either a hard or soft soluble container or 'shell' made from a suitable form of gelatin; the drug itself is in the form of granules to which varying amounts of coating have been applied. (NCI) | Coated Pellet in Capsule Dosage Form | |||
| CAPSULE, COATED, EXTENDED RELEASE | C42917 | A solid dosage form in which the drug is enclosed within either a hard or soft soluble container or "shell" made from a suitable form of gelatin; additionally, the capsule is covered in a designated coating, and which releases a drug (or drugs) in such a manner to allow at least a reduction in dosing frequency as compared to that drug (or drugs) presented as a conventional dosage form. | Extended Release Coated Capsule Dosage Form | |||
| CAPSULE, DELAYED RELEASE | C42902 | A solid dosage form in which the drug is enclosed within either a hard or soft soluble container made from a suitable form of gelatin, and which releases a drug (or drugs) at a time other than promptly after administration. Enteric-coated articles are delayed release dosage forms. (NCI) | Delayed Release Capsule Dosage Form | |||
| CAPSULE, DELAYED RELEASE PELLETS | C42904 | A solid dosage form in which the drug is enclosed within either a hard or soft soluble container or "shell" made from a suitable form of gelatin; the drug itself is in the form of granules to which enteric coating has been applied, thus delaying release of the drug until its passage into the intestines. | Delayed Release Pellet in Capsule Dosage Form | |||
| CAPSULE, EXTENDED RELEASE | C42916 | A solid dosage form in which the drug is enclosed within either a hard or soft soluble container made from a suitable form of gelatin, and which releases a drug (or drugs) in such a manner to allow a reduction in dosing frequency as compared to that drug (or drugs) presented as a conventional dosage form. (NCI) | Extended Release Capsule Dosage Form | |||
| CAPSULE, FILM COATED, EXTENDED RELEASE | C42928 | A solid dosage form in which the drug is enclosed within either a hard or soft soluble container or 'shell' made from a suitable form of gelatin; additionally, the capsule is covered in a designated film coating, and which releases a drug (or drugs) in such a manner to allow at least a reduction in dosing frequency as compared to that drug (or drugs) presented as a conventional dosage form. | Extended Release Film Coated Capsule Dosage Form | |||
| CAPSULE, GELATIN COATED | C42936 | A solid dosage form in which the drug is enclosed within either a hard or soft soluble container made from a suitable form of gelatin; through a banding process, the capsule is coated with additional layers of gelatin so as to form a complete seal. (NCI) | Gelatin Coated Capsule Dosage Form | |||
| CAPSULE, LIQUID FILLED | C42954 | A solid dosage form in which the drug is enclosed within a soluble, gelatin shell which is plasticized by the addition of a polyol, such as sorbitol or glycerin, and is therefore of a somewhat thicker consistency than that of a hard shell capsule; typically, the active ingredients are dissolved or suspended in a liquid vehicle. (NCI) | Liquid Filled Capsule Dosage Form | |||
| CEMENT | C45414 | A substance that serves to produce solid union between two surfaces. (NCI) | Cement Dosage Form | |||
| CIGARETTE | C42678 | A narrow tube filled with material that is capable to burn with release of therapeutically-active substance(s) during the process of smoking. Cigarette is a very efficient drug-delivery inhaler system for fast-acting substances. | Cigarette Dosage Form | |||
| CLOTH | C60884 | A large piece of relatively flat, absorbent material that contains a drug. It is typically used for applying medication or for cleansing. | Cloth Dosage Form | |||
| CONCENTRATE | C60891 | A liquid preparation of increased strength and reduced volume which is usually diluted prior to administration. (NCI) | Concentrated Dosage Form | |||
| CONE | C42900 | A solid dosage form bounded by a circular base and the surface formed by line segments joining every point of the boundary of the base to a common vertex. A cone (usually containing antibiotics) is normally placed below the gingiva after a dental extraction. (NCI) | Cone Dosage Form | |||
| CORE, EXTENDED RELEASE | C42919 | An ocular system placed in the eye from which the drug diffuses through a membrane at a constant rate over a specified period. (NCI) | Extended Release Core Dosage Form | |||
| CREAM | C28944 | A semisolid emulsion of either the oil-in-water or the water-in-oil type, ordinarily intended for topical use. (NCI) | Cream Dosage Form | |||
| CREAM, AUGMENTED | C60897 | A cream dosage form that enhances drug delivery. Augmentation does not refer to the strength of the drug in the dosage form. NOTE: CDER has decided to refrain from expanding the use of this dosage form due to difficulties in setting specific criteria that must be met to be considered augmented. | Augmented Cream Dosage Form | |||
| CRYSTAL | C42901 | A naturally produced angular solid of definite form in which the ultimate units from which it is built up are systematically arranged; they are usually evenly spaced on a regular space lattice. | Crystal Dosage Form | |||
| CULTURE | C45415 | The propagation of microorganisms or of living tissue cells in special media conducive to their growth. (NCI) | Culture Dosage Form | |||
| DIAPHRAGM | C47890 | A device usually dome-shaped, worn during copulation over the cervical mouth for prevention of conception or infection. (NCI) | Vaginal Diaphragm Dosage Form | |||
| DISC | C43525 | A circular plate-like organ or structure. | Disc Dosage Form | |||
| DOUCHE | C42679 | A liquid preparation, intended for the irrigative cleansing of the vagina, that is prepared from powders, liquid solutions, or liquid concentrates and contains one or more chemical substances dissolved in a suitable solvent or mutually miscible solvents. (NCI) | Douche Dosage Form | |||
| DRESSING | C42763 | The application of various materials for protecting a wound. | Dressing Dosage Form | |||
| DRUG DELIVERY SYSTEM | C17423 | Modern technology, distributed with or as a part of a drug product that allows for the uniform release or targeting of drugs to the body. | Drug Delivery System | |||
| ELIXIR | C42912 | A clear, pleasantly flavored, sweetened hydroalcoholic liquid containing dissolved medicinal agents; it is intended for oral use. (NCI) | Elixir Dosage Form | |||
| EMULSION | C42913 | A dosage form consisting of a two-phase system comprised of at least two immiscible liquids (1), one of which is dispersed as droplets (internal or dispersed phase) within the other liquid (external or continuous phase), generally stabilized with one or more emulsifying agents. Note 1: A liquid is pourable; it flows and conforms to its container at room temperature. It displays Newtonian or pseudoplastic flow behavior. Note 2: Emulsion is used as a dosage form term unless a more specific term is applicable, e.g. cream, lotion, ointment. (NCI) | Emulsion Dosage Form | |||
| ENEMA | C42915 | A rectal preparation for therapeutic, diagnostic, or nutritive purposes. (NCI) | Enema Dosage Form | |||
| EXTRACT | C42929 | A concentrated preparation of vegetable or animal drugs obtained by removal of the active constituents of the respective drugs with a suitable menstrua, evaporation of all or nearly all of the solvent, and adjustment of the residual masses or powders to the prescribed standards. (NCI) | Extract Dosage Form | |||
| FIBER, EXTENDED RELEASE | C60926 | A slender and elongated solid thread-like substance that delivers drug in such a manner to allow a reduction in dosing frequency as compared to that drug (or drugs) presented as a conventional dosage form. | Extended Release Fiber Dosage Form | |||
| FILM | C42932 | A thin layer or coating. (NCI) | Film Dosage Form | |||
| FILM, EXTENDED RELEASE | C42920 | A drug delivery system in the form of a film that releases the drug over an extended period in such a way as to maintain constant drug levels in the blood or target tissue. (NCI) | Extended Release Film Dosage Form | |||
| FILM, SOLUBLE | C42984 | A thin layer or coating which is susceptible to being dissolved when in contact with a liquid. (NCI) | Soluble Film Dosage Form | |||
| FOR SOLUTION | C60927 | A product, usually a solid, intended for solution prior to administration. | Dosage Form for Solution | |||
| FOR SUSPENSION | C60928 | A product, usually a solid, intended for suspension prior to administration. | Dosage Form for Suspension | |||
| FOR SUSPENSION, EXTENDED RELEASE | C60929 | A product, usually a solid, intended for suspension prior to administration; once the suspension is administered, the drug will be released at a constant rate over a specified period. | Extended Release Dosage Form for Suspension | |||
| GAS | C42933 | Any elastic aeriform fluid in which the molecules are separated from one another and have free paths. (NCI) | Gas Dosage Form | |||
| GEL | C42934 | A semisolid (1) dosage form that contains a gelling agent to provide stiffness to a solution or a colloidal dispersion (2). A gel may contain suspended particles. Note 1: A semisolid is not pourable; it does not flow or conform to its container at room temperature. It does not flow at low shear stress and generally exhibits plastic flow behavior. Note 2: A colloidal dispersion is a system in which particles of colloidal dimension (i.e., typically between 1 nm and 1 micrometer) are distributed uniformly throughout a liquid. | Gel Dosage Form | |||
| GEL, DENTIFRICE | C42906 | A combination of a dentifrice (formulation intended to clean and/or polish the teeth, and which may contain certain additional agents), and a gel. It is used with a toothbrush for the purpose of cleaning and polishing the teeth. (NCI) | Dentifrice Gel Dosage Form | |||
| GEL, METERED | C60930 | A gel preparation, with metered dose valves, which allow for the delivery of a uniform quantity of gel upon each activation. | Metered Gel Dosage Form | |||
| GENERATOR | C48193 | An apparatus for the formation of vapor or gas from a liquid or solid by heat or chemical action. The term GENERATOR also applies to radioactive columns from which radionuclides are provided. (NCI) | Generator Dosage Form | |||
| GLOBULE | C42937 | Also called pellets or pilules, are made of pure sucrose, lactose, or other polysaccharides. They are formed into small globular masses of various sizes, and are medicated by placing them in a vial and adding the liquid drug attenuation in the proportion not less than one percent (v/w). After shaking, the medicated globules are dried at temperatures not to exceed 40 degrees Centigrade. (NCI) | Globule Dosage Form | |||
| GRAFT | C45416 | A slip of skin or of other tissue for implantation. (NCI) | Graft Dosage Form | |||
| GRANULE | C42938 | A small particle or grain. (NCI) | Granule Dosage Form | |||
| GRANULE, DELAYED RELEASE | C42903 | A small medicinal particle or grain to which an enteric or other coating has been applied, thus delaying release of the drug until its passage into the intestines. (NCI) | Delayed Release Granule Dosage Form | |||
| GRANULE, EFFERVESCENT | C42909 | A small particle or grain containing a medicinal agent in a dry mixture usually composed of sodium bicarbonate, citric acid, and tartaric acid which, when in contact with water, has the capability to release gas, resulting in effervescence. (NCI) | Effervescent Granule Dosage Form | |||
| GRANULE, FOR SOLUTION | C42939 | A small medicinal particle or grain made available in its more stable dry form, to be reconstituted with solvent just before dispensing; the granules are so prepared to contain not only the medicinal agent, but the colorants, flavorants, and any other desired pharmaceutic ingredient. (NCI) | Granule for Solution Dosage Form | |||
| GRANULE, FOR SUSPENSION | C42940 | A small medicinal particle or grain made available in its more stable dry form, to be reconstituted with solvent just before dispensing to form a suspension; the granules are so prepared to contain not only the medicinal agent, but the colorants, flavorants, and any other desired pharmaceutic ingredient. (NCI) | Granule for Suspension Dosage Form | |||
| GRANULE, FOR SUSPENSION, EXTENDED RELEASE | C42921 | A small medicinal particle or grain made available in its more stable dry form, to be reconstituted with solvent just before dispensing to form a suspension; the extended release system achieves slow release of the drug over an extended period of time and maintains constant drug levels in the blood or target tissue. (NCI) | Extended Release Granule for Suspension Dosage Form | |||
| GUM | C42941 | A mucilaginous excretion from various plants. (NCI) | Gum Dosage Form | |||
| GUM, CHEWING | C42894 | A sweetened and flavored insoluble plastic material of various shapes which when chewed, releases a drug substance into the oral cavity. (NCI) | Chewing Gum Dosage Form | |||
| GUM, RESIN | C42978 | Natural mixture of gum and resin, usually obtained as exudations from plants. (NCI) | Resin Gum Dosage Form | |||
| IMPLANT | C42942 | A material containing drug intended to be inserted securely and deeply in a living site for growth, slow release, or formation of an organic union. (NCI) | Implant Dosage Form | |||
| INHALANT | C42944 | A special class of inhalations consisting of a drug or combination of drugs, that by virtue of their high vapor pressure, can be carried by an air current into the nasal passage where they exert their effect; the container from which the inhalant generally is administered is known as an inhaler. (NCI) | Inhalant Dosage Form | |||
| INJECTABLE, LIPOSOMAL | C60931 | An injection, which either consists of or forms liposomes (a lipid bilayer vesicle usually composed of phospholipids which is used to encapsulate an active drug substance). | Liposomal Injection Dosage Form | |||
| INJECTION | C42946 | A sterile preparation intended for parenteral use; five distinct classes of injections exist as defined by the USP. (NCI) | Injectable Dosage Form | |||
| INJECTION, EMULSION | C42914 | An emulsion consisting of a sterile, pyrogen-free preparation intended to be administered parenterally. | Emulsion for Injection Dosage Form | |||
| INJECTION, LIPID COMPLEX | C42950 | [definition pending] | Injectable Lipid Complex Dosage Form | |||
| INJECTION, POWDER, FOR SOLUTION | C42974 | A sterile preparation intended for reconstitution to form a solution for parenteral use. (NCI) | Powder for Injectable Solution Dosage Form | |||
| INJECTION, POWDER, FOR SUSPENSION | C42976 | A sterile preparation intended for reconstitution to form a suspension for parenteral use. (NCI) | Powder for Injectable Suspension Dosage Form | |||
| INJECTION, POWDER, FOR SUSPENSION, EXTENDED RELEASE | C42977 | A dried preparation intended for reconstitution to form a suspension for parenteral use which has been formulated in a manner to allow at least a reduction in dosing frequency as compared to that drug presented as a conventional dosage form (e.g., as a solution). | Powder for Injectable Extended Release Suspension Dosage Form | |||
| INJECTION, POWDER, LYOPHILIZED, FOR LIPOSOMAL SUSPENSION | C42959 | A sterile freeze dried preparation intended for reconstitution for parenteral use which has been formulated in a manner that would allow liposomes (a lipid bilayer vesicle usually composed of phospholipids which is used to encapsulate an active drug substance, either within a lipid bilayer or in an aqueous space) to be formed upon reconstitution. (NCI) | Lyophilized Powder for Injectable Liposomal Suspension Dosage Form | |||
| INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | C42957 | A dosage form intended for the solution prepared by lyophilization ('freeze drying'), a process which involves the removal of water from products in the frozen state at extremely low pressures; this is intended for subsequent addition of liquid to create a solution that conforms in all respects to the requirements for Injections. (NCI) | Lyophilized Powder for Injectable Solution Dosage Form | |||
| INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION | C42958 | A liquid preparation, intended for parenteral use, that contains solids suspended in a suitable fluid medium and conforms in all respects to the requirements for Sterile Suspensions; the medicinal agents intended for the suspension are prepared by lyophilization ("freeze drying"), a process which involves the removal of water from products in the frozen state at extremely low pressures. | Lyophilized Powder for Injectable Suspension Dosage Form | |||
| INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION, EXTENDED RELEASE | C42956 | A sterile freeze dried preparation intended for reconstitution for parenteral use which has been formulated in a manner to allow at least a reduction in dosing frequency as compared to that drug presented as a conventional dosage form (e.g., as a solution). (NCI) | Lyophilized Powder for Extended Release Injectable Suspension Dosage Form | |||
| INJECTION, SOLUTION | C42945 | A liquid preparation containing one or more drug substances dissolved in a suitable solvent or mixture of mutually miscible solvents that is suitable for injection. (NCI) | Injectable Solution Dosage Form | |||
| INJECTION, SOLUTION, CONCENTRATE | C42899 | A sterile preparation for parenteral use which, upon the addition of suitable solvents, yields a solution conforming in all respects to the requirements for Injections. (NCI) | Concentrated Injectable Solution Dosage Form | |||
| INJECTION, SUSPENSION | C42995 | A liquid preparation, suitable for injection, which consists of solid particles dispersed throughout a liquid phase in which the particles are not soluble. It can also consist of an oil phase dispersed throughout an aqueous phase, or vice-versa. (NCI) | Injectable Suspension Dosage Form | |||
| INJECTION, SUSPENSION, EXTENDED RELEASE | C42926 | A sterile preparation intended for parenteral use which has been formulated in a manner to allow at least a reduction in dosing frequency as compared to that drug presented as a conventional dosage form (e.g., as a solution or a prompt drug-releasing, conventional solid dosage form). (NCI) | Injectable Extended Release Suspension Dosage Form | |||
| INJECTION, SUSPENSION, LIPOSOMAL | C42951 | A liquid parenteral pharmaceutical dosage form structured as a multilamellar composition of concentric phospholipid spheres that encapsulate the drug (drug delivery systems) separated by layers of water. Drug release is facilitated and controlled by in vivo erosion of the liposomes. To further increase the in vivo circulation time, liposomes in some preparations are covalently derivatized with PEG to produce PEGylated or stealth liposomes. Covalent attachment of drugs to the outer surface of liposomes can potentially serve as a delayed-release product. (NCI) | Injectable Liposomal Suspension Dosage Form | |||
| INJECTION, SUSPENSION, SONICATED | C42988 | A liquid preparation, suitable for injection, which consists of solid particles dispersed throughout a liquid phase in which the particles are not soluble. In addition, the product is sonicated while a gas is bubbled through the suspension, and this results in the formation of microspheres by the solid particles. (NCI) | Injectable Sonicated Suspension Dosage Form | |||
| INSERT | C60933 | A specially formulated and shaped non-encapsulated solid preparation intended to be placed into a non-rectal orifice of the body, where drug is released, generally for localized effects. | Insert Dosage Form | |||
| INSERT, EXTENDED RELEASE | C42922 | A specially formulated and shaped solid preparation (e.g., ring, tablet, or stick) intended to be placed in the vagina by special inserters, where the medication is released, generally for localized effects; the extended release preparation is designed to allow a reduction in dosing frequency. (NCI) | Extended Release Insert Dosage Form | |||
| INTRAUTERINE DEVICE | C47915 | A device inserted and left in the uterus to prevent effective conception. (NCI) | Intrauterine Device Dosage Form | |||
| IRRIGANT | C42947 | A sterile solution intended to bathe or flush open wounds or body cavities; they're used topically, never parenterally. (NCI) | Irrigant Dosage Form | |||
| JELLY | C42948 | A class of gels--semisolid systems which consist of suspensions made up of either small inorganic particles or large organic molecules interpenetrated by a liquid--in which the structural coherent matrix contains a high portion of liquid, usually water. (NCI) | Jelly Dosage Form | |||
| KIT | C47916 | A packaged collection of related material. (NCI) | Kit Dosage Form | |||
| LINER, DENTAL | C45413 | A material applied to the inside of the dental cavity, for protection or insulation of the surface. | Dental Liner Dosage Form | |||
| LINIMENT | C42949 | A solution or mixture of various substances in oil, alcoholic solutions of soap, or emulsions intended for external application. (NCI) | Liniment Dosage Form | |||
| LIPSTICK | C42952 | A waxy solid, usually colored cosmetic, in stick form for the lips. (NCI) | Lipstick Dosage Form | |||
| LIQUID | C42953 | A dosage form consisting of a pure chemical in its liquid state. This dosage form term should not be applied to solutions. Note: A liquid is pourable; it flows and conforms to its container at room temperature. It displays Newtonian or pseudoplastic flow behavior. | Liquid Dosage Form | |||
| LIQUID, EXTENDED RELEASE | C60934 | A liquid that delivers a drug in such a manner to allow a reduction in dosing frequency as compared to that drug (or drugs) presented as a conventional dosage form. | Extended Release Liquid Dosage Form | |||
| LOTION | C29167 | An emulsion, liquid (1) dosage form. This dosage form is generally for external application to the skin (2). Note 1: A liquid is pourable; it flows and conforms to its container at room temperature. It displays Newtonian or pseudoplastic flow behavior. Note 2: Previously the definition of a lotion was: The term lotion has been used to categorize many topical suspensions, solutions, and emulsions intended for application to the skin. The current definition of a lotion is restricted to an emulsion. | Lotion Dosage Form | |||
| LOTION, AUGMENTED | C60957 | A lotion dosage form that enhances drug delivery. Augmentation does not refer to the strength of the drug in the dosage form. NOTE: CDER has decided to refrain from expanding the use of this dosage form due to difficulties in setting specific criteria that must be met to be considered augmented. | Augmented Lotion Dosage Form | |||
| LOTION/SHAMPOO | C60958 | A lotion dosage form which has a soap or detergent that is usually used to clean the hair and scalp; it is often used as a vehicle for dermatologic agents. | Lotion Shampoo Dosage Form | |||
| LOZENGE | C42955 | A solid preparation containing one or more medicaments, usually in a flavored, sweetened base which is intended to dissolve or disintegrate slowly in the mouth. A lollipop is a lozenge on a stick. | Lozenge Dosage Form | |||
| MOUTHWASH | C29269 | An aqueous solution which is most often used for its deodorant, refreshing, or antiseptic effect. (NCI) | Mouthwash Dosage Form | |||
| NOT APPLICABLE | C48624 | The use of a dosage form term is not relevant or appropriate. (NCI) | Dosage Form Not Applicable | |||
| OIL | C42965 | An unctuous, combustible substance which is liquid, or easily liquefiable, on warming, and is soluble in ether but insoluble in water. Such substances, depending on their origin, are classified as animal, mineral, or vegetable oils. (NCI) | Oil Dosage Form | |||
| OINTMENT | C42966 | oint | A suspension or emulsion, semisolid (1) dosage form, usually containing < 20% water and volatiles (2) and > 50% hydrocarbons, waxes, or polyols as the vehicle. This dosage form is generally for external application to the skin or mucous membranes. Note 1: A semisolid is not pourable; it does not flow or conform to its container at room temperature. It does not flow at low shear stress and generally exhibits plastic flow behavior. Note 2: Percent water and volatiles are measured by a loss on drying test in which the sample is heated at 105 degrees C until constant weight is achieved. | Ointment Dosage Form | ||
| OINTMENT, AUGMENTED | C60984 | An ointment dosage form that enhances drug delivery. Augmentation does not refer to the strength of the drug in the dosage form. NOTE: CDER has decided to refrain from expanding the use of this dosage form due to difficulties in setting specific criteria that must be met to be considered augmented. | Augmented Ointment Dosage Form | |||
| PACKING | C47887 | A material, usually covered by or impregnated with a drug, that is inserted into a body cavity or between the tooth enamel and the gingival margin. | Packing Dosage Form | |||
| PASTE | C42967 | A semisolid dosage form, containing a large proportion (20 - 50%) of solids finely dispersed in a fatty vehicle. This dosage form is generally for external application to the skin or mucous membranes. Note: A semisolid is not pourable; it does not flow or conform to its container at room temperature. It does not flow at low shear stress and generally exhibits plastic flow behavior. (NCI) | Paste Dosage Form | |||
| PASTE, DENTIFRICE | C42907 | A paste formulation intended to clean and/or polish the teeth, and which may contain certain additional agents. (NCI) | Dentifrice Paste Dosage Form | |||
| PASTILLE | C60985 | An aromatic preparation, often with a pleasing flavor, usually intended to dissolve in the mouth. | Pastille Dosage Form | |||
| PATCH | C42968 | A drug delivery system that often contains an adhesive backing that is usually applied to an external site on the body. Its ingredients either passively diffuse from, or are actively transported from, some portion of the patch. Depending upon the patch, the ingredients are either delivered to the outer surface of the body or into the body. A patch is sometimes synonymous with the terms Extended Release Film and System. | Patch Dosage Form | |||
| PATCH, EXTENDED RELEASE | C42923 | A drug delivery system in the form of a patch that releases the drug in such a manner that a reduction in dosing frequency compared to that drug presented as a conventional dosage form (e.g., a solution or a prompt drug-releasing, conventional solid dosage form). (NCI) | Extended Release Patch Dosage Form | |||
| PATCH, EXTENDED RELEASE, ELECTRICALLY CONTROLLED | C42911 | A drug delivery system in the form of a patch which is controlled by an electric current that releases the drug in such a manner that a reduction in dosing frequency compared to that drug presented as a conventional dosage form (e.g., a solution or a prompt drug-releasing, conventional solid dosage form). (NCI) | Electrically Controlled Extended Release Patch Dosage Form | |||
| PELLET | C42969 | A small sterile solid mass consisting of a highly purified drug (with or without excipients) made by the formation of granules, or by compression and molding. (NCI) | Pellet Dosage Form | |||
| PELLET, IMPLANTABLE | C42943 | A small sterile solid mass consisting of a highly purified drug (with or without excipients) made by the formation of granules, or by compression and molding; they are intended for implantation in the body (usually subcutaneously) for the purpose of providing continuous release of the drug over long periods of time. | Implantable Pellet Dosage Form | |||
| PELLETS, COATED, EXTENDED RELEASE | C42918 | A solid dosage form in which the drug itself is in the form of granules to which varying amounts of coating have been applied, and which releases a drug (or drugs) in such a manner to allow a reduction in dosing frequency as compared to that drug (or drugs) presented as a conventional dosage form. (NCI) | Extended Release Coated Pellet Dosage Form | |||
| PILL | C25394 | A dose of medicine in the form of a small pellet. (NCI) | Pill Dosage Form | |||
| PLASTER | C42970 | Substance intended for external application made of such materials and of such consistency as to adhere to the skin and attach to a dressing; plasters are intended to afford protection and support and/or to furnish an occlusion and macerating action and to bring medication into close contact with the skin. | Plaster Dosage Form | |||
| POULTICE | C47913 | A soft, moist mass of meal, herbs, seed, etc., usually applied hot in cloth that consists of gruel-like consistency. (NCI) | Poultice Dosage Form | |||
| POWDER | C42972 | An intimate mixture of dry, finely divided drugs and/or chemicals that may be intended for internal or external use. (NCI) | Powder Dosage Form | |||
| POWDER, DENTIFRICE | C42908 | A powder formulation intended to clean and/or polish the teeth, and which may contain certain additional agents. (NCI) | Dentifrice Powder Dosage Form | |||
| POWDER, FOR SOLUTION | C42973 | An intimate mixture of dry, finely divided drugs and/or chemicals, which, upon the addition of suitable vehicles, yields a solution. (NCI) | Powder for Solution Dosage Form | |||
| POWDER, FOR SUSPENSION | C42975 | An intimate mixture of dry, finely divided drugs and/or chemicals, which, upon the addition of suitable vehicles, yields a suspension (a liquid preparation containing the solid particles dispersed in the liquid vehicle). (NCI) | Powder for Suspension Dosage Form | |||
| POWDER, METERED | C42961 | A powder dosage form that is situated inside a container that has a mechanism to deliver a specified quantity. (NCI) | Metered Powder Dosage Form | |||
| RING | C60988 | A small circular object with a vacant circular center that is usually intended to be placed in the body by special inserters, where the medication is released, generally for localized effects. | Ring Dosage Form | |||
| RINSE | C42979 | A liquid used to cleanse by flushing. (NCI) | Rinse Dosage Form | |||
| SALVE | C42980 | A thick ointment or cerate (a fat or wax based preparation with a consistency between an ointment and a plaster). (NCI) | Salve Dosage Form | |||
| SHAMPOO | C42981 | A liquid soap or detergent used to clean the hair and scalp and is often used as a vehicle for dermatologic agents. (NCI) | Shampoo Dosage Form | |||
| SHAMPOO, SUSPENSION | C42982 | A liquid soap or detergent containing one or more solid, insoluble substances dispersed in a liquid vehicle that is used to clean the hair and scalp and is often used as a vehicle for dermatologic agents. (NCI) | Shampoo Suspension Dosage Form | |||
| SOAP | C42983 | Any compound of one or more fatty acids, or their equivalents, with an alkali; soap is detergent and is much employed in liniments, enemas, and in making pills. It is also a mild aperient, antacid and antiseptic. (NCI) | Soap Dosage Form | |||
| SOLUTION | C42986 | A clear, homogeneous liquid dosage form that contains one or more chemical substances dissolved in a solvent or mixture of mutually miscible solvents. Note: A liquid is pourable; it flows and conforms to its container at room temperature. It displays Newtonian or pseudoplastic flow behavior. | Solution Dosage Form | |||
| SOLUTION, CONCENTRATE | C42898 | A liquid preparation (i.e., a substance that flows readily in its natural state) that contains a drug dissolved in a suitable solvent or mixture of mutually miscible solvents; the drug has been strengthened by the evaporation of its non-active parts. (NCI) | Concentrated Solution Dosage Form | |||
| SOLUTION, FOR SLUSH | C42987 | A solution for the preparation of an iced saline slush, which is administered by irrigation and used to induce regional hypothermia (in conditions such as certain open heart and kidney surgical procedures) by its direct application. (NCI) | Solution for Slush Dosage Form | |||
| SOLUTION, GEL FORMING / DROPS | C60994 | A solution, which after usually being administered in a drop-wise fashion, forms a gel. | Gel Forming Drop Solution Dosage Form | |||
| SOLUTION, GEL FORMING, EXTENDED RELEASE | C42935 | A solution that forms a gel when it comes in contact with ocular fluid, and which allows at least a reduction in dosing frequency. | Extended Release Gel Forming Solution Dosage Form | |||
| SOLUTION/ DROPS | C60992 | A solution which is usually administered in a drop-wise fashion. | Drop Solution Dosage Form | |||
| SPONGE | C47912 | A porous, interlacing, absorbent material that contains a drug. It is typically used for applying or introducing medication, or for cleansing. A sponge usually retains its shape. | Sponge Dosage Form | |||
| SPRAY | C42989 | A liquid minutely divided as by a jet of air or steam. (NCI) | Spray Dosage Form | |||
| SPRAY, METERED | C42962 | A non-pressurized dosage form consisting of valves which allow the dispensing of a specified quantity of spray upon each activation. (NCI) | Metered Spray Dosage Form | |||
| SPRAY, SUSPENSION | C42990 | A liquid preparation containing solid particles dispersed in a liquid vehicle and in the form of coarse droplets or as finely divided solids to be applied locally, most usually to the nasal-pharyngeal tract, or topically to the skin. (NCI) | Spray Suspension Dosage Form | |||
| STICK | C42991 | A dosage form prepared in a relatively long and slender often cylindrical form. (NCI) | Stick Dosage Form | |||
| STRIP | C47914 | A long narrow piece of material. | Strip Dosage Form | |||
| SUPPOSITORY | C42993 | supp | A solid body of various weights and shapes, adapted for introduction into the rectal, vaginal, or urethral orifice of the human body; they usually melt, soften, or dissolve at body temperature. | Suppository Dosage Form | ||
| SUPPOSITORY, EXTENDED RELEASE | C42924 | A drug delivery system in the form of a suppository that allows at least a reduction in dosing frequency. (NCI) | Extended Release Suppository Dosage Form | |||
| SUSPENSION | C42994 | susp | A liquid dosage form that contains solid particles dispersed in a liquid vehicle. Note: A liquid is pourable; it flows and conforms to its container at room temperature. It displays Newtonian or pseudoplastic flow behavior. | Suspension Dosage Form | ||
| SUSPENSION, EXTENDED RELEASE | C42925 | A liquid preparation consisting of solid particles dispersed throughout a liquid phase in which the particles are not soluble; the suspension has been formulated in a manner to allow at least a reduction in dosing frequency as compared to that drug presented as a conventional dosage form (e.g., as a solution or a prompt drug-releasing, conventional solid dosage form). (NCI) | Extended Release Suspension Dosage Form | |||
| SUSPENSION/DROPS | C60995 | A suspension which is usually administered in a dropwise fashion. | Drop Suspension Dosage Form | |||
| SUTURE | C47889 | A strand or fiber used to hold wound edges in apposition during healing. (NCI) | Suture Dosage Form | |||
| SWAB | C47898 | A small piece of relatively flat absorbent material that contains a drug. A swab may also be attached to one end of a small stick. A swab is typically used for applying medication or for cleansing. | Swab Dosage Form | |||
| SYRUP | C42996 | An oral solution containing high concentrations of sucrose or other sugars; the term has also been used to include any other liquid dosage form prepared in a sweet and viscid vehicle, including oral suspensions. (NCI) | Syrup Dosage Form | |||
| TABLET | C42998 | tab | A solid dosage form containing medicinal substances with or without suitable diluents. (NCI) | Tablet Dosage Form | ||
| TABLET, CHEWABLE | C42893 | A solid dosage form containing medicinal substances with or without suitable diluents that is intended to be chewed, producing a pleasant tasting residue in the oral cavity that is easily swallowed and does not leave a bitter or unpleasant after-taste. (NCI) | Chewable Tablet Dosage Form | |||
| TABLET, COATED | C42897 | A solid dosage form that contains medicinal substances with or without suitable diluents and is covered with a designated coating. (NCI) | Coated Tablet Dosage Form | |||
| TABLET, COATED PARTICLES | C60997 | A solid dosage form containing a conglomerate of medicinal particles that have each been covered with a coating. | Tablet Coated Particle Dosage Form | |||
| TABLET, DELAYED RELEASE | C42905 | A solid dosage form which releases a drug (or drugs) at a time other than promptly after administration. Enteric-coated articles are delayed release dosage forms. (NCI) | Delayed Release Tablet Dosage Form | |||
| TABLET, DELAYED RELEASE PARTICLES | C42997 | A solid dosage form containing a conglomerate of medicinal particles that have been covered with a coating which releases a drug (or drugs) at a time other than promptly after administration. Enteric-coated articles are delayed release dosage forms. (NCI) | Delayed Release Particle Tablet Dosage Form | |||
| TABLET, EFFERVESCENT | C42910 | A solid dosage form containing mixtures of acids (e.g., citric acid, tartaric acid) and sodium bicarbonate, which release carbon dioxide when dissolved in water; it is intended to be dissolved or dispersed in water before administration. | Effervescent Tablet Dosage Form | |||
| TABLET, EXTENDED RELEASE | C42927 | A solid dosage form containing a drug which allows at least a reduction in dosing frequency as compared to that drug presented in conventional dosage form. (NCI) | Extended Release Tablet Dosage Form | |||
| TABLET, FILM COATED | C42931 | A solid dosage form that contains medicinal substances with or without suitable diluents and is coated with a thin layer of a water-insoluble or water-soluble polymer. (NCI) | Film Coated Tablet Dosage Form | |||
| TABLET, FILM COATED, EXTENDED RELEASE | C42930 | A solid dosage form that contains medicinal substances with or without suitable diluents and is coated with a thin layer of a water-insoluble or water-soluble polymer; the tablet is formulated in such manner as to make the contained medicament available over an extended period of time following ingestion. | Film Coated Extended Release Tablet Dosage Form | |||
| TABLET, FOR SOLUTION | C61004 | A tablet that forms a solution when placed in a liquid. | Tablet for Solution Dosage Form | |||
| TABLET, FOR SUSPENSION | C61005 | A tablet that forms a suspension when placed in a liquid (formerly referred to as a Dispersible Tablet). | Tablet for Suspension Dosage Form | |||
| TABLET, MULTILAYER | C42964 | A solid dosage form containing medicinal substances that have been compressed to form a multiple-layered tablet or a tablet-within-a-tablet, the inner tablet being the core and the outer portion being the shell. (NCI) | Multilayered Tablet Dosage Form | |||
| TABLET, MULTILAYER, EXTENDED RELEASE | C42963 | A solid dosage form containing medicinal substances that have been compressed to form a multiple-layered tablet or a tablet-within-a-tablet, the inner tablet being the core and the outer portion being the shell, which, additionally, is covered in a designated coating; the tablet is formulated in such manner as to allow at least a reduction in dosing frequency as compared to that drug presented as a conventional dosage form. (NCI) | Multilayered Extended Release Tablet Dosage Form | |||
| TABLET, ORALLY DISINTEGRATING | C42999 | A solid dosage form containing medicinal substances which disintegrates rapidly, usually within a matter of seconds, when placed upon the tongue. (NCI) | Orally Disintegrating Tablet Dosage Form | |||
| TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE | C61006 | A solid dosage form containing medicinal substances which disintegrates rapidly, usually within a matter of seconds, when placed upon the tongue, but which releases a drug (or drugs) at a time other than promptly after administration. | Orally Disintegrating Delayed Release Tablet Dosage Form | |||
| TABLET, SOLUBLE | C42985 | A solid dosage form that contains medicinal substances with or without suitable diluents and possesses the ability to dissolve in fluids. (NCI) | Soluble Tablet Dosage Form | |||
| TABLET, SUGAR COATED | C42992 | A solid dosage form that contains medicinal substances with or without suitable diluents and is coated with a colored or an uncolored water-soluble sugar. (NCI) | Sugar Coated Tablet Dosage Form | |||
| TAMPON | C47892 | A plug made of cotton, sponge, or oakum variously used in surgery to plug the nose, vagina, etc., for the control of hemorrhage or the absorption of secretions. (NCI) | Tampon Dosage Form | |||
| TAPE | C47897 | A narrow woven fabric, or a narrow extruded synthetic (such as plastic), usually with an adhesive on one or both sides. (NCI) | Tape Dosage Form | |||
| TINCTURE | C43000 | An alcoholic or hydroalcoholic solution prepared from vegetable materials or from chemical substances. (NCI) | Tincture Dosage Form | |||
| TROCHE | C43001 | A discoid-shaped solid containing the medicinal agent in a suitably flavored base; troches are placed in the mouth where they slowly dissolve, liberating the active ingredients. (NCI) | Troche Dosage Form | |||
| UNASSIGNED | C43002 | A dosage form has yet to be assigned. (NCI) | Unassigned Dosage Form | |||
| WAFER | C43003 | A thin slice of material containing a medicinal agent. (NCI) | Wafer Dosage Form | |||
| Back to top | ||||||
| CL.C114119.PBSTMT | Pharmacogenomics Biomarker Medical Statement (PBSTMT) | text Extensible: Yes | C114119 | Pharmacogenomics Biomarker Medical Statement | A terminology codelist relevant to the medical conclusion such as confirmation of a diagnosis or drug resistance based on genetic biological markers. | CDISC SDTM Pharmacogenomics Biomarker Medical Statement Terminology |
| NEGATIVE | C38757 | A finding of normality following an examination or investigation looking for the presence of a microorganism, disease, or condition. | Negative Finding | |||
| POSITIVE | C38758 | An observation confirming something, such as the presence of a disease, condition, or microorganism. | Positive Finding | |||
| RESISTANT | C85562 | Resistant | The growth of microorganisms are not inhibited by the usually achievable concentrations of the antimicrobial agent with normal dosages, and/or microorganisms demonstrate MICs or zone diameters that fall in the range where specific microbial resistance mechanisms (e.g. Beta-lactamases) are likely, and clinical efficacy of the agent against the microorganism has not been reliably shown in treatment studies. | Antimicrobial Resistance Result | ||
| SUSCEPTIBLE | C85563 | Susceptible | The growth of microorganisms are inhibited by the usually achievable concentrations of antimicrobial agent when the recommended dosage is used for the site of infection. | Antimicrobial Susceptibility Result | ||
| Back to top | ||||||
| CL.C116106.PFTESTCD | Pharmacogenomics Findings Test Code (PFTESTCD) | text Extensible: Yes | C116106 | Pharmacogenomics Findings Test Code | Terminology relevant to the test codes that describe pharmacogenomics findings. | CDISC SDTM Pharmacogenomics Findings Test Code Terminology |
| ALLELE | C16277 | Allele | Mutually exclusive alternative forms of the same gene occupying the same locus on homologous chromosomes, differing in nucleotide sequence and governing the same biochemical and developmental process. (NCI) | Allele | ||
| Back to top | ||||||
| CL.C116105.PFTEST | Pharmacogenomics Findings Test Name (PFTEST) | text Extensible: Yes | C116105 | Pharmacogenomics Findings Test Name | Terminology relevant to the test names that describe pharmacogenomics findings. | CDISC SDTM Pharmacogenomics Findings Test Name Terminology |
| Allele | C16277 | Allele | Mutually exclusive alternative forms of the same gene occupying the same locus on homologous chromosomes, differing in nucleotide sequence and governing the same biochemical and developmental process. (NCI) | Allele | ||
| Back to top | ||||||
| CL.C95121.PHSPRPCD | Physical Properties Test Code (PHSPRPCD) | text Extensible: Yes | C95121 | Physical Properties Test Code | Terminology relevant to the test codes that describe the physical characteristics of an entity. | CDISC SDTM Physical Properties Test Code Terminology |
| COLOR | C37927 | Color | The appearance of objects (or light sources) described in terms of a person's perception of their hue and lightness (or brightness) and saturation. (NCI) | Color | ||
| CONSIST | C95110 | Consistency | A description about the firmness or make-up of an entity. | Consistency | ||
| DEPTH | C25333 | Depth | The extent downward or inward; the perpendicular measurement from the surface downward to determine deepness. (NCI) | Depth | ||
| DESCR | C25365 | Description | A written or verbal account, representation, statement, or explanation of something. (NCI) | Description | ||
| DIAMETER | C25285 | Diameter | The length of a straight line passing through the center of a circle or sphere and connecting two points on the circumference. (NCI) | Diameter | ||
| HAIRCOV | C95109 | Hair Cover | A description of the quantity or quality of the hair or fur covering a biological entity. (NCI) | Hair or Fur Cover | ||
| LENGTH | C25334 | Length | The linear extent in space from one end of something to the other end, or the extent of something from beginning to end. (NCI) | Length | ||
| SHAPE | C25677 | Shape | The spatial arrangement of something as distinct from its substance. (NCI) | Shape | ||
| ULCER | C25757 | Ulceration | The formation or development of an ulcer. (NCI) | Ulceration | ||
| WIDTH | C25345 | Width | The extent or measurement of something from side to side. (NCI) | Width | ||
| Back to top | ||||||
| CL.C95120.PHSPRP | Physical Properties Test Name (PHSPRP) | text Extensible: Yes | C95120 | Physical Properties Test Name | Terminology relevant to the test names that describe the physical characteristics of an entity. | CDISC SDTM Physical Properties Test Name Terminology |
| Color | C37927 | Color | The appearance of objects (or light sources) described in terms of a person's perception of their hue and lightness (or brightness) and saturation. (NCI) | Color | ||
| Consistency | C95110 | Consistency | A description about the firmness or make-up of an entity. | Consistency | ||
| Depth | C25333 | Depth | The extent downward or inward; the perpendicular measurement from the surface downward to determine deepness. (NCI) | Depth | ||
| Description | C25365 | Description | A written or verbal account, representation, statement, or explanation of something. (NCI) | Description | ||
| Diameter | C25285 | Diameter | The length of a straight line passing through the center of a circle or sphere and connecting two points on the circumference. (NCI) | Diameter | ||
| Hair Cover | C95109 | Hair Cover | A description of the quantity or quality of the hair or fur covering a biological entity. (NCI) | Hair or Fur Cover | ||
| Length | C25334 | Length | The linear extent in space from one end of something to the other end, or the extent of something from beginning to end. (NCI) | Length | ||
| Shape | C25677 | Shape | The spatial arrangement of something as distinct from its substance. (NCI) | Shape | ||
| Ulceration | C25757 | Ulceration | The formation or development of an ulcer. (NCI) | Ulceration | ||
| Width | C25345 | Width | The extent or measurement of something from side to side. (NCI) | Width | ||
| Back to top | ||||||
| CL.C85493.PKPARM | PK Parameters (PKPARM) | text Extensible: Yes | C85493 | PK Parameters | Parameters used to describe the time-concentration curve. | CDISC SDTM Pharmacokinetic Parameter Terminology |
| Accumulation Index using Lambda z | C114234 | Accumulation Index using Lambda z | Predicted accumulation ratio for area under the curve (AUC) calculated using the Lambda z estimated from single dose data. | Accumulation Index using Lambda z | ||
| Accumulation Ratio AUC | C102356 | Accumulation Ratio AUC | The area under the curve (AUCTAU) at steady state divided by the area under the curve over the initial dosing interval. | Accumulation Ratio Area Under the Curve | ||
| Accumulation Ratio Cmax | C102357 | Accumulation Ratio Cmax | The maximum concentration at steady state divided by the maximum concentration during the initial dosing interval. | Accumulation Ratio Cmax | ||
| Accumulation Ratio Cmin | C102358 | Accumulation Ratio Cmin | The minimum concentration at steady state divided by the minimum concentration during the initial dosing interval. | Accumulation Ratio Cmin | ||
| Accumulation Ratio Ctrough | C102426 | Accumulation Ratio Ctrough | The trough concentration at steady state divided by the trough concentration during the initial dosing interval. | Accumulation Ratio Ctrough | ||
| Amt Rec from T1 to T2 | C102359 | Amt Rec from T1 to T2 | The cumulative amount recovered from the specimen type specified in PPSPEC over the interval from T1 to T2. | Amount Recovered from T1 to T2 | ||
| Amt Rec from T1 to T2 Norm by BMI | C102360 | Amt Rec from T1 to T2 Norm by BMI | The cumulative amount recovered from the specimen type specified in PPSPEC over the interval from T1 to T2 divided by body mass index. | Amount Recovered from T1 to T2 Normalized by Body Mass Index | ||
| Amt Rec from T1 to T2 Norm by SA | C102361 | Amt Rec from T1 to T2 Norm by SA | The cumulative amount recovered from the specimen type specified in PPSPEC over the interval from T1 to T2 divided by surface area. | Amount Recovered from T1 to T2 Normalized by Surface Area | ||
| Amt Rec from T1 to T2 Norm by WT | C102362 | Amt Rec from T1 to T2 Norm by WT | The cumulative amount recovered from the specimen type specified in PPSPEC over the interval from T1 to T2 divided by weight. | Amount Recovered from T1 to T2 Normalized by Weight | ||
| Amt Rec Infinity Obs | C112032 | Amt Rec Infinity Obs | The cumulative amount recovered from the specimen type specified in PPSPEC extrapolated to infinity, calculated using the observed value of the last non-zero concentration. | Amount Recovered Infinity Observed | ||
| Amt Rec Infinity Obs Norm by BMI | C112223 | Amt Rec Infinity Obs Norm by BMI | The cumulative amount recovered from the specimen type specified in PPSPEC extrapolated to infinity, calculated using the observed value of the last non-zero concentration, divided by the body mass index. | Amount Recovered Infinity Observed Normalized by Body Mass Index | ||
| Amt Rec Infinity Obs Norm by SA | C112224 | Amt Rec Infinity Obs Norm by SA | The cumulative amount recovered from the specimen type specified in PPSPEC extrapolated to infinity, calculated using the observed value of the last non-zero concentration, divided by the surface area. | Amount Recovered Infinity Observed Normalized by Surface Area | ||
| Amt Rec Infinity Obs Norm by WT | C112225 | Amt Rec Infinity Obs Norm by WT | The cumulative amount recovered from the specimen type specified in PPSPEC extrapolated to infinity, calculated using the observed value of the last non-zero concentration, divided by the weight. | Amount Recovered Infinity Observed Normalized by Weight | ||
| Amt Rec Infinity Pred | C112033 | Amt Rec Infinity Pred | The cumulative amount recovered from the specimen type specified in PPSPEC extrapolated to infinity, calculated using the predicted value of the last non-zero concentration. | Amount Recovered Infinity Predicted | ||
| Amt Rec Infinity Pred Norm by BMI | C112226 | Amt Rec Infinity Pred Norm by BMI | The cumulative amount recovered from the specimen type specified in PPSPEC extrapolated to infinity, calculated using the predicted value of the last non-zero concentration, divided by the body mass index. | Amount Recovered Infinity Predicted Normalized by Body Mass Index | ||
| Amt Rec Infinity Pred Norm by SA | C112227 | Amt Rec Infinity Pred Norm by SA | The cumulative amount recovered from the specimen type specified in PPSPEC extrapolated to infinity, calculated using the predicted value of the last non-zero concentration, divided by the surface area. | Amount Recovered Infinity Predicted Normalized by Surface Area | ||
| Amt Rec Infinity Pred Norm by WT | C112228 | Amt Rec Infinity Pred Norm by WT | The cumulative amount recovered from the specimen type specified in PPSPEC extrapolated to infinity, calculated using the predicted value of the last non-zero concentration, divided by the weight. | Amount Recovered Infinity Predicted Normalized by Weight | ||
| Amt Rec Over Dosing Interval | C102363 | Amt Rec Over Dosing Interval | The cumulative amount recovered from the specimen type specified in PPSPEC between doses (TAU). | Amount Recovered Over Dosing Interval | ||
| Amt Rec Over Dosing Interval Norm by BMI | C102364 | Amt Rec Over Dosing Interval Norm by BMI | The cumulative amount recovered from the specimen type specified in PPSPEC between doses (TAU) divided by body mass index. | Amount Recovered Over Dosing Interval Normalized by Body Mass Index | ||
| Amt Rec Over Dosing Interval Norm by SA | C102365 | Amt Rec Over Dosing Interval Norm by SA | The cumulative amount recovered from the specimen type specified in PPSPEC between doses (TAU) divided by surface area. | Amount Recovered Over Dosing Interval Normalized by Surface Area | ||
| Amt Rec Over Dosing Interval Norm by WT | C102366 | Amt Rec Over Dosing Interval Norm by WT | The cumulative amount recovered from the specimen type specified in PPSPEC between doses (TAU) divided by weight. | Amount Recovered Over Dosing Interval Normalized by Weight | ||
| AUC %Back Extrapolation Obs | C85763 | AUC %Back Extrapolation Obs | Applies only for intravascular bolus dosing. The area under the curve (AUC) from the first measured concentration value back extrapolated to the concentration value at time zero as a percentage of the area under the curve extrapolated to infinity using the observed value of the last non-zero concentration. | Observed Area Under the Curve Percent Back Extrapolation | ||
| AUC %Back Extrapolation Pred | C85787 | AUC %Back Extrapolation Pred | Applies only for intravascular bolus dosing. The area under the curve (AUC) from the first measured concentration value back extrapolated to the concentration value at time zero as a percentage of the area under the curve extrapolated to infinity using the predicted value of the last non-zero concentration. | Predicted Area Under the Curve Percent Back Extrapolation | ||
| AUC %Extrapolation Obs | C85764 | AUC %Extrapolation Obs | The area under the curve (AUC) from the last observed non-zero concentration value to infinity as a percentage of the area under the curve extrapolated to infinity. | Observed Area Under the Curve Percent Extrapolation | ||
| AUC %Extrapolation Pred | C85788 | AUC %Extrapolation Pred | The area under the curve (AUC) from the last predicted non-zero concentration value to infinity as a percentage of the area under the curve extrapolated to infinity. | Predicted Area Under the Curve Percent Extrapolation | ||
| AUC All | C85564 | AUC All | The area under the curve (AUC) from the time of dosing to the time of the last observation, regardless of whether the last concentration is measurable or not. | Area Under the Curve All | ||
| AUC All Norm by BMI | C92362 | AUC All Norm by BMI | The area under the curve (AUC) from the time of dosing to the time of the last observation divided by the body mass index, regardless of whether the last concentration is measurable or not. | AUC All Normalized by Body Mass Index | ||
| AUC All Norm by Dose | C92306 | AUC All Norm by Dose | The area under the curve (AUC) from the time of dosing to the time of the last observation divided by the dose, regardless of whether the last concentration is measurable or not. | AUC All Normalized by Dose | ||
| AUC All Norm by SA | C92307 | AUC All Norm by SA | The area under the curve (AUC) from the time of dosing to the time of the last observation divided by the surface area, regardless of whether the last concentration is measurable or not. | AUC All Normalized by Surface Area | ||
| AUC All Norm by WT | C92308 | AUC All Norm by WT | The area under the curve (AUC) from the time of dosing to the time of the last observation divided by the weight, regardless of whether the last concentration is measurable or not. | AUC All Normalized by Weight | ||
| AUC from T1 to T2 | C85566 | AUC from T1 to T2 | The area under the curve (AUC) over the interval from T1 to T2. | Area Under the Curve from T1 to T2 | ||
| AUC from T1 to T2 Norm by BMI | C92312 | AUC from T1 to T2 Norm by BMI | The area under the curve (AUC) over the interval from T1 to T2 divided by the body mass index. | AUC from T1 to T2 Normalized by Body Mass Index | ||
| AUC from T1 to T2 Norm by Dose | C92313 | AUC from T1 to T2 Norm by Dose | The area under the curve (AUC) over the interval from T1 to T2 divided by the dose. | AUC from T1 to T2 Normalized by Dose | ||
| AUC from T1 to T2 Norm by SA | C92314 | AUC from T1 to T2 Norm by SA | The area under the curve (AUC) over the interval from T1 to T2 divided by the surface area. | AUC from T1 to T2 Normalized by Surface Area | ||
| AUC from T1 to T2 Norm by WT | C92315 | AUC from T1 to T2 Norm by WT | The area under the curve (AUC) over the interval from T1 to T2 divided by the weight. | AUC from T1 to T2 Normalized by Weight | ||
| AUC Infinity Obs | C85761 | AUC Infinity Obs | The area under the curve (AUC) extrapolated to infinity, calculated using the observed value of the last non-zero concentration. | Observed Area Under the Curve Infinity | ||
| AUC Infinity Obs Norm by BMI | C92316 | AUC Infinity Obs Norm by BMI | The area under the curve (AUC) extrapolated to infinity, calculated using the observed value of the last non-zero concentration, divided by the body mass index. | AUC Infinity Observed Normalized by Body Mass Index | ||
| AUC Infinity Obs Norm by Dose | C96695 | AUC Infinity Obs Norm by Dose | The area under the curve (AUC) extrapolated to infinity, calculated using the observed value of the last non-zero concentration, divided by the dose. | AUC Infinity Observed Normalized by Dose | ||
| AUC Infinity Obs Norm by SA | C92317 | AUC Infinity Obs Norm by SA | The area under the curve (AUC) extrapolated to infinity, calculated using the observed value of the last non-zero concentration, divided by the surface area. | AUC Infinity Observed Normalized by Surface Area | ||
| AUC Infinity Obs Norm by WT | C92318 | AUC Infinity Obs Norm by WT | The area under the curve (AUC) extrapolated to infinity, calculated using the observed value of the last non-zero concentration, divided by the weight. | AUC Infinity Observed Normalized by Weight | ||
| AUC Infinity Pred | C85785 | AUC Infinity Pred | The area under the curve (AUC) extrapolated to infinity, calculated using the predicted value of the last non-zero concentration. | Predicted Area Under the Curve Infinity | ||
| AUC Infinity Pred Norm by BMI | C92319 | AUC Infinity Pred Norm by BMI | The area under the curve (AUC) extrapolated to infinity, calculated using the predicted value of the last non-zero concentration, divided by the body mass index. | AUC Infinity Predicted Normalized by Body Mass Index | ||
| AUC Infinity Pred Norm by Dose | C85786 | AUC Infinity Pred Norm by Dose | The area under the curve (AUC) extrapolated to infinity, calculated using the predicted value of the last non-zero concentration, divided by the dose. | Predicted Area Under the Curve Infinity by Dose | ||
| AUC Infinity Pred Norm by SA | C92320 | AUC Infinity Pred Norm by SA | The area under the curve (AUC) extrapolated to infinity, calculated using the predicted value of the last non-zero concentration, divided by the surface area. | AUC Infinity Predicted Normalized by Surface Area | ||
| AUC Infinity Pred Norm by WT | C92321 | AUC Infinity Pred Norm by WT | The area under the curve (AUC) extrapolated to infinity, calculated using the predicted value of the last non-zero concentration, divided by the weight. | AUC Infinity Predicted Normalized by Weight | ||
| AUC Over Dosing Interval | C85567 | AUC Over Dosing Interval | The area under the curve (AUC) for the defined interval between doses (TAU). | Area Under the Curve Over Dosing Interval | ||
| AUC Over Dosing Interval Norm by BMI | C92322 | AUC Over Dosing Interval Norm by BMI | The area under the curve (AUC) for the defined interval between doses (TAU) divided by the body mass index. | AUC Over Dosing Interval Normalized by Body Mass Index | ||
| AUC Over Dosing Interval Norm by Dose | C92323 | AUC Over Dosing Interval Norm by Dose | The area under the curve (AUC) for the defined interval between doses (TAU) divided by the dose. | AUC Over Dosing Interval Normalized by Dose | ||
| AUC Over Dosing Interval Norm by SA | C92324 | AUC Over Dosing Interval Norm by SA | The area under the curve (AUC) for the defined interval between doses (TAU) divided by the surface area. | AUC Over Dosing Interval Normalized by Surface Area | ||
| AUC Over Dosing Interval Norm by WT | C92325 | AUC Over Dosing Interval Norm by WT | The area under the curve (AUC) for the defined interval between doses (TAU) divided by the weight. | AUC Over Dosing Interval Normalized by Weight | ||
| AUC to Last Nonzero Conc | C85565 | AUC to Last Nonzero Conc | The area under the curve (AUC) from the time of dosing to the last measurable concentration. | Area Under the Curve From Dosing to Last Concentration | ||
| AUC to Last Nonzero Conc Norm by BMI | C92309 | AUC to Last Nonzero Conc Norm by BMI | The area under the curve (AUC) from the time of dosing to the last measurable concentration divided by the body mass index. | AUC Dosing to Last Concentration Normalized by Body Mass Index | ||
| AUC to Last Nonzero Conc Norm by Dose | C92310 | AUC to Last Nonzero Conc Norm by Dose | The area under the curve (AUC) from the time of dosing to the last measurable concentration divided by the dose. | AUC Dosing to Last Concentration Normalized by Dose | ||
| AUC to Last Nonzero Conc Norm by SA | C92311 | AUC to Last Nonzero Conc Norm by SA | The area under the curve (AUC) from the time of dosing to the last measurable concentration divided by the surface area. | AUC Dosing to Last Concentration Normalized by Surface Area | ||
| AUC to Last Nonzero Conc Norm by WT | C92305 | AUC to Last Nonzero Conc Norm by WT | The area under the curve (AUC) from the time of dosing to the last measurable concentration divided by the weight. | AUC Dosing to Last Concentration Normalized by Weight | ||
| AUMC % Extrapolation Obs | C85766 | AUMC % Extrapolation Obs | The area under the moment curve (AUMC) from the last observed non-zero concentration value to infinity as a percentage of the area under the moment curve extrapolated to infinity. | Observed Area Under the First Moment Curve Percent Extrapolation | ||
| AUMC % Extrapolation Pred | C85790 | AUMC % Extrapolation Pred | The area under the moment curve (AUMC) from the last predicted non-zero concentration value to infinity as a percentage of the area under the moment curve extrapolated to infinity. | Predicted Area Under the First Moment Curve Percent Extrapolation | ||
| AUMC Infinity Obs | C85765 | AUMC Infinity Obs | The area under the moment curve (AUMC) extrapolated to infinity, calculated using the observed value of the last non-zero concentration. | Observed Area Under the First Moment Curve Infinity | ||
| AUMC Infinity Obs Norm by BMI | C92330 | AUMC Infinity Obs Norm by BMI | The area under the moment curve (AUMC) extrapolated to infinity, calculated using the observed value of the last non-zero concentration, divided by the body mass index. | AUMC Infinity Observed Normalized by Body Mass Index | ||
| AUMC Infinity Obs Norm by Dose | C92331 | AUMC Infinity Obs Norm by Dose | The area under the moment curve (AUMC) extrapolated to infinity, calculated using the observed value of the last non-zero concentration, divided by the dose. | AUMC Infinity Observed Normalized by Dose | ||
| AUMC Infinity Obs Norm by SA | C92332 | AUMC Infinity Obs Norm by SA | The area under the moment curve (AUMC) extrapolated to infinity, calculated using the observed value of the last non-zero concentration, divided by the surface area. | AUMC Infinity Observed Normalized by Surface Area | ||
| AUMC Infinity Obs Norm by WT | C92333 | AUMC Infinity Obs Norm by WT | The area under the moment curve (AUMC) extrapolated to infinity, calculated using the observed value of the last non-zero concentration, divided by the weight. | AUMC Infinity Observed Normalized by Weight | ||
| AUMC Infinity Pred | C85789 | AUMC Infinity Pred | The area under the moment curve (AUMC) extrapolated to infinity, calculated using the predicted value of the last non-zero concentration. | Predicted Area Under the First Moment Curve Infinity | ||
| AUMC Infinity Pred Norm by BMI | C92334 | AUMC Infinity Pred Norm by BMI | The area under the moment curve (AUMC) extrapolated to infinity, calculated using the predicted value of the last non-zero concentration, divided by the body mass index. | AUMC Infinity Predicted Normalized by Body Mass Index | ||
| AUMC Infinity Pred Norm by Dose | C92335 | AUMC Infinity Pred Norm by Dose | The area under the moment curve (AUMC) extrapolated to infinity, calculated using the predicted value of the last non-zero concentration, divided by the dose. | AUMC Infinity Predicted Normalized by Dose | ||
| AUMC Infinity Pred Norm by SA | C92336 | AUMC Infinity Pred Norm by SA | The area under the moment curve (AUMC) extrapolated to infinity, calculated using the predicted value of the last non-zero concentration, divided by the surface area. | AUMC Infinity Predicted Normalized by Surface Area | ||
| AUMC Infinity Pred Norm by WT | C92337 | AUMC Infinity Pred Norm by WT | The area under the moment curve (AUMC) extrapolated to infinity, calculated using the predicted value of the last non-zero concentration, divided by the weight. | AUMC Infinity Predicted Normalized by Weight | ||
| AUMC Over Dosing Interval | C85570 | AUMC Over Dosing Interval | The area under the first moment curve (AUMC) for the defined interval between doses (TAU). | Area Under the First Moment Curve Over Dosing Interval | ||
| AUMC Over Dosing Interval Norm by BMI | C92338 | AUMC Over Dosing Interval Norm by BMI | The area under the first moment curve (AUMC) for the defined interval between doses (TAU) divided by the body mass index. | AUMC Over Dosing Interval Normalized by Body Mass Index | ||
| AUMC Over Dosing Interval Norm by Dose | C92339 | AUMC Over Dosing Interval Norm by Dose | The area under the first moment curve (AUMC) for the defined interval between doses (TAU) divided by the dose. | AUMC Over Dosing Interval Normalized by Dose | ||
| AUMC Over Dosing Interval Norm by SA | C92340 | AUMC Over Dosing Interval Norm by SA | The area under the first moment curve (AUMC) for the defined interval between doses (TAU) divided by the surface area. | AUMC Over Dosing Interval Normalized by Surface Area | ||
| AUMC Over Dosing Interval Norm by WT | C92341 | AUMC Over Dosing Interval Norm by WT | The area under the first moment curve (AUMC) for the defined interval between doses (TAU) divided by the weight. | AUMC Over Dosing Interval Normalized by Weight | ||
| AUMC to Last Nonzero Conc | C85569 | AUMC to Last Nonzero Conc | The area under the moment curve (AUMC) from the time of dosing to the last measurable concentration. | Area Under the First Moment Curve From Dosing to Last Concentration | ||
| AUMC to Last Nonzero Conc Norm by BMI | C92326 | AUMC to Last Nonzero Conc Norm by BMI | The area under the moment curve (AUMC) from the time of dosing to the last measurable concentration divided by the body mass index. | AUMC Dosing to Last Concentration Normalized by Body Mass Index | ||
| AUMC to Last Nonzero Conc Norm by Dose | C92327 | AUMC to Last Nonzero Conc Norm by Dose | The area under the moment curve (AUMC) from the time of dosing to the last measurable concentration divided by the dose. | AUMC Dosing to Last Concentration Normalized by Dose | ||
| AUMC to Last Nonzero Conc Norm by SA | C92328 | AUMC to Last Nonzero Conc Norm by SA | The area under the moment curve (AUMC) from the time of dosing to the last measurable concentration divided by the surface area. | AUMC Dosing to Last Concentration Normalized by Surface Area | ||
| AUMC to Last Nonzero Conc Norm by WT | C92329 | AUMC to Last Nonzero Conc Norm by WT | The area under the moment curve (AUMC) from the time of dosing to the last measurable concentration divided by the weight. | AUMC Dosing to Last Concentration Normalized by Weight | ||
| AURC % Extrapolation Obs | C85768 | AURC % Extrapolation Obs | The area under the urinary excretion rate curve (AURC) from the last observed non-zero rate value to infinity as a percentage of the area under the urinary excretion rate curve extrapolated to infinity. | Observed Area Under the Urinary Excretion Rate Curve Percent Extrapolation | ||
| AURC % Extrapolation Pred | C85792 | AURC % Extrapolation Pred | The area under the urinary excretion rate curve (AURC) from the last predicted non-zero rate value to infinity as a percentage of the area under the urinary excretion rate curve extrapolated to infinity. | Predicted Area Under the Urinary Excretion Rate Curve Percent Extrapolation | ||
| AURC All | C85841 | AURC All | The area under the urinary excretion rate curve (AURC) from time zero to the time of the last observation, regardless of whether the last observation is a measurable concentration or not. | Area Under Urinary Excretion Rate Curve All | ||
| AURC All Norm by BMI | C92342 | AURC All Norm by BMI | The area under the urinary excretion rate curve (AURC) from time zero to the last measurable rate divided by the body mass index. | AURC All Normalized by Body Mass Index | ||
| AURC All Norm by Dose | C92343 | AURC All Norm by Dose | The area under the urinary excretion rate curve (AURC) from time zero to the last measurable rate divided by the dose. | AURC All Normalized by Dose | ||
| AURC All Norm by SA | C92344 | AURC All Norm by SA | The area under the urinary excretion rate curve (AURC) from time zero to the last measurable rate divided by the surface area. | AURC All Normalized by Surface Area | ||
| AURC All Norm by WT | C92345 | AURC All Norm by WT | The area under the urinary excretion rate curve (AURC) from time zero to the last measurable rate divided by the weight. | AURC All Normalized by Weight | ||
| AURC Dosing to Last Conc Norm by BMI | C92346 | AURC to Last Nonzero Rate Norm by BMI | The area under the urinary excretion rate curve (AURC) from time zero to the last measurable rate, divided by the body mass index. | AURC Dosing to Last Concentration Normalized by Body Mass Index | ||
| AURC Dosing to Last Conc Norm by Dose | C92347 | AURC to Last Nonzero Rate Norm by Dose | The area under the urinary excretion rate curve (AURC) from time zero to the last measurable rate, divided by the dose. | AURC Dosing to Last Concentration Normalized by Dose | ||
| AURC Dosing to Last Conc Norm by SA | C92348 | AURC to Last Nonzero Rate Norm by SA | The area under the urinary excretion rate curve (AURC) from time zero to the last measurable rate, divided by the surface area. | AURC Dosing to Last Concentration Normalized by Surface Area | ||
| AURC Dosing to Last Conc Norm by WT | C92349 | AURC to Last Nonzero Rate Norm by WT | The area under the urinary excretion rate curve (AURC) from time zero to the last measurable rate, divided by the weight. | AURC Dosing to Last Concentration Normalized by Weight | ||
| AURC from T1 to T2 | C85572 | AURC from T1 to T2 | The area under the urinary excretion rate curve (AURC) over the interval from T1 to T2. | Area Under the Urinary Excretion Rate Curve from T1 to T2 | ||
| AURC from T1 to T2 Norm by BMI | C92350 | AURC from T1 to T2 Norm by BMI | The area under the urinary excretion rate curve (AURC) over the interval from T1 to T2 divided by the body mass index. | AURC from T1 to T2 Normalized by Body Mass Index | ||
| AURC from T1 to T2 Norm by Dose | C92351 | AURC from T1 to T2 Norm by Dose | The area under the urinary excretion rate curve (AURC) over the interval from T1 to T2 divided by the dose. | AURC from T1 to T2 Normalized by Dose | ||
| AURC from T1 to T2 Norm by SA | C92352 | AURC from T1 to T2 Norm by SA | The area under the urinary excretion rate curve (AURC) over the interval from T1 to T2 divided by the surface area. | AURC from T1 to T2 Normalized by Surface Area | ||
| AURC from T1 to T2 Norm by WT | C92353 | AURC from T1 to T2 Norm by WT | The area under the urinary excretion rate curve (AURC) over the interval from T1 to T2 divided by the weight. | AURC from T1 to T2 Normalized by Weight | ||
| AURC Infinity Obs | C85767 | AURC Infinity Obs | The area under the urinary excretion rate curve (AURC) extrapolated to infinity, calculated using the observed value of the last excretion rate. | Observed Area Under the Urinary Excretion Rate Curve infinity | ||
| AURC Infinity Obs Norm by BMI | C92354 | AURC Infinity Obs Norm by BMI | The area under the urinary excretion rate curve (AURC) extrapolated to infinity, calculated using the observed value of the last excretion rate, divided by the body mass index. | AURC Infinity Observed Normalized by Body Mass Index | ||
| AURC Infinity Obs Norm by Dose | C92355 | AURC Infinity Obs Norm by Dose | The area under the urinary excretion rate curve (AURC) extrapolated to infinity, calculated using the observed value of the last excretion rate, divided by the dose. | AURC Infinity Observed Normalized by Dose | ||
| AURC Infinity Obs Norm by SA | C92356 | AURC Infinity Obs Norm by SA | The area under the urinary excretion rate curve (AURC) extrapolated to infinity, calculated using the observed value of the last excretion rate, divided by the surface area. | AURC Infinity Observed Normalized by Surface Area | ||
| AURC Infinity Obs Norm by WT | C92357 | AURC Infinity Obs Norm by WT | The area under the urinary excretion rate curve (AURC) extrapolated to infinity, calculated using the observed value of the last excretion rate, divided by the weight. | AURC Infinity Observed Normalized by Weight | ||
| AURC Infinity Pred | C85791 | AURC Infinity Pred | The area under the urinary excretion rate curve (AURC) extrapolated to infinity, calculated using the predicted value of the last non-zero excretion rate. | Predicted Area Under the Urinary Excretion Rate Curve Infinity | ||
| AURC Infinity Pred Norm by BMI | C92358 | AURC Infinity Pred Norm by BMI | The area under the urinary excretion rate curve (AURC) extrapolated to infinity, calculated using the predicted value of the last non-zero excretion rate, divded by the body mass index. | AURC Infinity Predicted Normalized by Body Mass Index | ||
| AURC Infinity Pred Norm by Dose | C92359 | AURC Infinity Pred Norm by Dose | The area under the urinary excretion rate curve (AURC) extrapolated to infinity, calculated using the predicted value of the last non-zero excretion rate, divded by the dose. | AURC Infinity Predicted Normalized by Dose | ||
| AURC Infinity Pred Norm by SA | C92360 | AURC Infinity Pred Norm by SA | The area under the urinary excretion rate curve (AURC) extrapolated to infinity, calculated using the predicted value of the last non-zero excretion rate, divded by the surface area. | AURC Infinity Predicted Normalized by Surface Area | ||
| AURC Infinity Pred Norm by WT | C92361 | AURC Infinity Pred Norm by WT | The area under the urinary excretion rate curve (AURC) extrapolated to infinity, calculated using the predicted value of the last non-zero excretion rate, divded by the weight. | AURC Infinity Predicted Normalized by Weight | ||
| AURC to Last Nonzero Rate | C85571 | AURC to Last Nonzero Rate | The area under the urinary excretion rate curve (AURC) from time zero to the time of the last measurable concentration. | Area Under the Urinary Excretion Rate Curve From Dosing to Last Concentration | ||
| Average Conc Norm by BMI | C92367 | Average Conc Norm by BMI | AUCTAU divided by TAU and then divided by the body mass index. | Average Concentration Normalized by Body Mass Index | ||
| Average Conc Norm by Dose | C92368 | Average Conc Norm by Dose | AUCTAU divided by TAU and then divided by the dose. | Average Concentration Normalized by Dose | ||
| Average Conc Norm by SA | C92369 | Average Conc Norm by SA | AUCTAU divided by TAU and then divided by the surface area. | Average Concentration Normalized by Surface Area | ||
| Average Conc Norm by WT | C92370 | Average Conc Norm by WT | AUCTAU divided by TAU and then divided by the weight. | Average Concentration Normalized by Weight | ||
| Average Concentration | C85575 | Average Concentration | AUCTAU divided by TAU. | Average Concentration | ||
| Conc by BMI | C102367 | Conc by BMI | The concentration divided by body mass index. | Concentration Divided by Body Mass Index | ||
| Conc by Dose | C102368 | Conc by Dose | The concentration divided by dose. | Concentration Divided by Dose | ||
| Conc by SA | C102369 | Conc by SA | The concentration divided by surface area. | Concentration Divided by Surface Area | ||
| Conc by WT | C102370 | Conc by WT | The concentration divided by weight. | Concentration Divided by Weight | ||
| Conc Trough | C102394 | Conc Trough | Concentration at end of dosing interval. | Trough Concentration | ||
| Conc Trough by BMI | C102395 | Conc Trough by BMI | The trough concentration divided by body mass index. | Trough Concentration Divided by Body Mass Index | ||
| Conc Trough by Dose | C102396 | Conc Trough by Dose | The trough concentration divided by dose. | Trough Concentration Divided by Dose | ||
| Conc Trough by SA | C102397 | Conc Trough by SA | The trough concentration divided by surface area. | Trough Concentration Divided by Surface Area | ||
| Conc Trough by WT | C102398 | Conc Trough by WT | The trough concentration divided by weight. | Trough Concentration Divided by Weight | ||
| Concentration | C41185 | Concentration | The quantity of a specified substance in a unit volume or weight of another substance. | Concentration | ||
| Correlation Between TimeX and Log ConcY | C85821 | Correlation Between TimeX and Log ConcY | The correlation between time (X) and log concentration (Y) for the points used in the estimation of lambda z. | Time and Log Concentration Correlation | ||
| Effective Half-Life | C95007 | Effective Half-Life | The drug half-life that quantifies the accumulation ratio of a drug following multiple dosing. | Effective Half-life | ||
| Excret Rate from T1 to T2 | C105449 | Excret Rate from T1 to T2 | The excretion rate over the interval from T1 to T2, determined for the specimen type specified in PPSPEC. | Excretion Rate From T1 to T2 | ||
| Excret Rate from T1 to T2 Norm by BMI | C105450 | Excret Rate from T1 to T2 Norm by BMI | The excretion rate over the interval from T1 to T2 divided by the body mass index, determined for the specimen type specified in PPSPEC. | Excretion Rate From T1 to T2 Normalized by BMI | ||
| Excret Rate from T1 to T2 Norm by Dose | C105451 | Excret Rate from T1 to T2 Norm by Dose | The excretion rate over the interval from T1 to T2 divided by the dose, determined for the specimen type specified in PPSPEC. | Excretion Rate From T1 to T2 Normalized by Dose | ||
| Excret Rate from T1 to T2 Norm by SA | C105452 | Excret Rate from T1 to T2 Norm by SA | The excretion rate over the interval from T1 to T2 divided by the surface area, determined for the specimen type specified in PPSPEC. | Excretion Rate From T1 to T2 Normalized by SA | ||
| Excret Rate from T1 to T2 Norm by WT | C105453 | Excret Rate from T1 to T2 Norm by WT | The excretion rate over the interval from T1 to T2 divided by the weight, determined for the specimen type specified in PPSPEC. | Excretion Rate From T1 to T2 Normalized by WT | ||
| Fluctuation% | C85581 | Fluctuation% | The difference between Cmin and Cmax standardized to Cavg, between dose time and Tau. | Concentration Variability Between Dose Time and Tau | ||
| Half-Life Lambda z | C85818 | Half-Life Lambda z | Terminal half-life. | Terminal Half Life | ||
| Hemodialysis Clearance | C112287 | Hemodialysis Clearance | The clearance of a substance from the blood during a hemodialysis session. | Hemodialysis Clearance | ||
| Hemodialysis Extraction Ratio | C116213 | Hemodialysis Extraction Ratio | The fractional content of a substance removed from the blood during a hemodialysis session. | Hemodialysis Extraction Ratio | ||
| Initial Conc | C85644 | Initial Conc | Initial concentration. Given only for bolus IV models. | Initial Concentration | ||
| Initial Conc Norm by BMI | C92383 | Initial Conc Norm by BMI | Initial concentration divided by the body mass index. Given only for bolus IV models. | Initial Concentration Normalized by Body Mass Index | ||
| Initial Conc Norm by Dose | C92384 | Initial Conc Norm by Dose | Initial concentration divided by the dose. Given only for bolus IV models. | Initial Concentration Normalized by Dose | ||
| Initial Conc Norm by SA | C92385 | Initial Conc Norm by SA | Initial concentration divided by the surface area. Given only for bolus IV models. | Initial Concentration Normalized by Surface Area | ||
| Initial Conc Norm by WT | C92386 | Initial Conc Norm by WT | Initial concentration divided by the weight. Given only for bolus IV models. | Initial Concentration Normalized by Weight | ||
| Lambda z | C85652 | Lambda z | The first order rate constant associated with the terminal (log-linear) portion of the curve. | Lambda Z | ||
| Lambda z Lower Limit | C85653 | Lambda z Lower Limit | The lower limit on time for values to be included in the calculation of Lambda z. | Lambda Z Time Lower Limit | ||
| Lambda z Upper Limit | C85654 | Lambda z Upper Limit | The upper limit on time for values to be included in the calculation of Lambda z. | Lambda Z Time Upper Limit | ||
| Last Meas Excretion Rate | C85656 | Last Meas Excretion Rate | The last measurable (positive) excretion rate determined for the specimen type specified in PPSPEC. | Last Measurable Observed Excretion Rate | ||
| Last Meas Excretion Rate Norm by BMI | C92391 | Last Meas Excretion Rate Norm by BMI | The last measurable (positive) excretion rate divided by the body mass index. | Last Measurable Excretion Rate Normalized by Body Mass Index | ||
| Last Meas Excretion Rate Norm by Dose | C92392 | Last Meas Excretion Rate Norm by Dose | The last measurable (positive) excretion rate divided by the dose. | Last Measurable Excretion Rate Normalized by Dose | ||
| Last Meas Excretion Rate Norm by SA | C92393 | Last Meas Excretion Rate Norm by SA | The last measurable (positive) excretion rate divided by the surface area. | Last Measurable Excretion Rate Normalized by Surface Area | ||
| Last Meas Excretion Rate Norm by WT | C92394 | Last Meas Excretion Rate Norm by WT | The last measurable (positive) excretion rate divided by the weight. | Last Measurable Excretion Rate Normalized by Weight | ||
| Last Nonzero Conc | C85655 | Last Nonzero Conc | The concentration corresponding to Tlast. | Last Concentration | ||
| Last Nonzero Conc Norm by BMI | C92387 | Last Nonzero Conc Norm by BMI | The concentration corresponding to Tlast divided by the body mass index. | Last Concentration Normalized by Body Mass Index | ||
| Last Nonzero Conc Norm by Dose | C92388 | Last Nonzero Conc Norm by Dose | The concentration corresponding to Tlast divided by the dose. | Last Concentration Normalized by Dose | ||
| Last Nonzero Conc Norm by SA | C92389 | Last Nonzero Conc Norm by SA | The concentration corresponding to Tlast divided by the surface area. | Last Concentration Normalized by Surface Area | ||
| Last Nonzero Conc Norm by WT | C92390 | Last Nonzero Conc Norm by WT | The concentration corresponding to Tlast divided by the weight. | Last Concentration Normalized by Weight | ||
| Max Conc | C70918 | Max Conc | The maximum concentration occurring at Tmax. | Cmax | ||
| Max Conc Norm by BMI | C92371 | Max Conc Norm by BMI | The maximum concentration occurring at Tmax, divided by the body mass index. | Maximum Concentration Normalized by Body Mass Index | ||
| Max Conc Norm by Dose | C85698 | Max Conc Norm by Dose | The maximum concentration occurring at Tmax, divided by the dose. | Maximum Concentration Dose Normalized | ||
| Max Conc Norm by SA | C92372 | Max Conc Norm by SA | The maximum concentration occurring at Tmax, divided by the surface area. | Maximum Concentration Normalized by Surface Area | ||
| Max Conc Norm by WT | C92373 | Max Conc Norm by WT | The maximum concentration occurring at Tmax, divided by the weight. | Maximum Concentration Normalized by Weight | ||
| Max Excretion Rate | C85699 | Max Excretion Rate | The maximum excretion rate determined for the specimen type specified in PPSPEC. | Maximum Observed Excretion Rate | ||
| Max Excretion Rate Norm by BMI | C92395 | Max Excretion Rate Norm by BMI | The maximum excretion rate divided by the body mass index. | Maximum Observed Excretion Rate Normalized by Body Mass Index | ||
| Max Excretion Rate Norm by Dose | C92396 | Max Excretion Rate Norm by Dose | The maximum excretion rate divided by the dose. | Maximum Observed Excretion Rate Normalized by Dose | ||
| Max Excretion Rate Norm by SA | C92397 | Max Excretion Rate Norm by SA | The maximum excretion rate divided by the surface area. | Maximum Observed Excretion Rate Normalized by Surface Area | ||
| Max Excretion Rate Norm by WT | C92398 | Max Excretion Rate Norm by WT | The maximum excretion rate divided by the weight. | Maximum Observed Excretion Rate Normalized by Weight | ||
| Midpoint of Collection Interval | C85580 | Midpoint of Collection Interval | The midpoint of collection interval, which is associated with last Measurable rate. | Collection Interval Midpoint | ||
| Min Conc | C85579 | Min Conc | The minimum concentration between dose time and dose time plus Tau (at Tmin). | Cmin | ||
| Min Conc Norm by BMI | C92374 | Min Conc Norm by BMI | The minimum concentration between dose time and dose time plus Tau (at Tmin) divided by the body mass index. | Minimum Concentration Normalized by Body Mass Index | ||
| Min Conc Norm by Dose | C92375 | Min Conc Norm by Dose | The minimum concentration between dose time and dose time plus Tau (at Tmin) divided by the dose. | Minimum Concentration Normalized by Dose | ||
| Min Conc Norm by SA | C92376 | Min Conc Norm by SA | The minimum concentration between dose time and dose time plus Tau (at Tmin) divided by the surface area. | Minimum Concentration Normalized by Surface Area | ||
| Min Conc Norm by WT | C92377 | Min Conc Norm by WT | The minimum concentration between dose time and dose time plus Tau (at Tmin) divided by the weight. | Minimum Concentration Normalized by Weight | ||
| MRT Infinity Obs | C85769 | MRT Infinity Obs | The mean residence time (MRT) extrapolated to infinity, calculated using the observed value of the last non-zero concentration. | Observed Mean Residence Time Infinity | ||
| MRT Infinity Pred | C85793 | MRT Infinity Pred | The mean residence time (MRT) extrapolated to infinity, calculated using the predicted value of the last non-zero concentration. | Predicted Mean Residence Time Infinity | ||
| MRT to Last Nonzero Conc | C85700 | MRT to Last Nonzero Conc | Mean residence time (MRT) from the time of dosing to the time of the last measurable concentration. | Mean Residence Time Last | ||
| Nonrenal CL | C102376 | Nonrenal CL | The total clearance of a substance from the blood less the renal clearance. | Nonrenal Clearance | ||
| Nonrenal CL Norm by BMI | C105454 | Nonrenal CL Norm by BMI | The total clearance of a substance from the blood minus the renal clearance divided by the body mass index. | Nonrenal Clearance Normalized by BMI | ||
| Nonrenal CL Norm by Dose | C105455 | Nonrenal CL Norm by Dose | The total clearance of a substance from the blood minus the renal clearance divided by the dose. | Nonrenal Clearance Normalized by Dose | ||
| Nonrenal CL Norm by SA | C105456 | Nonrenal CL Norm by SA | The total clearance of a substance from the blood minus the renal clearance divided by the surface area. | Nonrenal Clearance Normalized by SA | ||
| Nonrenal CL Norm by WT | C105457 | Nonrenal CL Norm by WT | The total clearance of a substance from the blood minus the renal clearance divided by the weight. | Nonrenal Clearance Normalized by WT | ||
| Number of Points for Lambda z | C85816 | Number of Points for Lambda z | The number of time points used in computing Lambda z. | Sum of Lambda Z Timepoints | ||
| Pct Rec from T1 to T2 | C102382 | Pct Rec from T1 to T2 | The percentage of the administered dose that is recovered from the specimen type specified in PPSPEC, over the interval between T1 and T2. | Percent Recovered from T1 to T2 | ||
| Pct Rec from T1 to T2 Norm by BMI | C102383 | Pct Rec from T1 to T2 Norm by BMI | The percentage of the administered dose that is recovered from the specimen type specified in PPSPEC, over the interval between T1 and T2 divided by body mass index. | Percent Recovered from T1 to T2 Normalized by Body Mass Index | ||
| Pct Rec from T1 to T2 Norm by SA | C102384 | Pct Rec from T1 to T2 Norm by SA | The percentage of the administered dose that is recovered from the specimen type specified in PPSPEC, over the interval between T1 and T2 divided by surface area. | Percent Recovered from T1 to T2 Normalized by Surface Area | ||
| Pct Rec from T1 to T2 Norm by WT | C102385 | Pct Rec from T1 to T2 Norm by WT | The percentage of the administered dose that is recovered from the specimen type specified in PPSPEC, over the interval between T1 and T2 divided by weight. | Percent Recovered from T1 to T2 Normalized by Weight | ||
| Pct Rec Infinity Obs | C112034 | Pct Rec Infinity Obs | The percentage of the administered dose that is recovered from the specimen type specified in PPSPEC extrapolated to infinity, calculated using the observed value of the last non-zero concentration. | Percent Recovered Infinity Observed | ||
| Pct Rec Infinity Obs Norm by BMI | C112389 | Pct Rec Infinity Obs Norm by BMI | The percentage of the administered dose that is recovered from the specimen type specified in PPSPEC extrapolated to infinity, calculated using the observed value of the last non-zero concentration, divided by the body mass index. | Percent Recovered Infinity Observed Normalized by Body Mass Index | ||
| Pct Rec Infinity Obs Norm by SA | C112390 | Pct Rec Infinity Obs Norm by SA | The percentage of the administered dose that is recovered from the specimen type specified in PPSPEC extrapolated to infinity, calculated using the observed value of the last non-zero concentration, divided by the surface area. | Percent Recovered Infinity Observed Normalized by Surface Area | ||
| Pct Rec Infinity Obs Norm by WT | C112391 | Pct Rec Infinity Obs Norm by WT | The percentage of the administered dose that is recovered from the specimen type specified in PPSPEC extrapolated to infinity, calculated using the observed value of the last non-zero concentration, divided by the weight. | Percent Recovered Infinity Observed Normalized by Weight | ||
| Pct Rec Infinity Pred | C112035 | Pct Rec Infinity Pred | The percentage of the administered dose that is recovered from the specimen type specified in PPSPEC extrapolated to infinity, calculated using the predicted value of the last non-zero concentration. | Percent Recovered Infinity Predicted | ||
| Pct Rec Infinity Pred Norm by BMI | C112392 | Pct Rec Infinity Pred Norm by BMI | The percentage of the administered dose that is recovered from the specimen type specified in PPSPEC extrapolated to infinity, calculated using the predicted value of the last non-zero concentration, divided by the body mass index. | Percent Recovered Infinity Predicted Normalized by Body Mass Index | ||
| Pct Rec Infinity Pred Norm by SA | C112393 | Pct Rec Infinity Pred Norm by SA | The percentage of the administered dose that is recovered from the specimen type specified in PPSPEC extrapolated to infinity, calculated using the predicted value of the last non-zero concentration, divided by the surface area. | Percent Recovered Infinity Predicted Normalized by Surface Area | ||
| Pct Rec Infinity Pred Norm by WT | C112394 | Pct Rec Infinity Pred Norm by WT | The percentage of the administered dose that is recovered from the specimen type specified in PPSPEC extrapolated to infinity, calculated using the predicted value of the last non-zero concentration, divided by the weight. | Percent Recovered Infinity Predicted Normalized by Weight | ||
| Pct Rec Over Dosing Interval | C102386 | Pct Rec Over Dosing Interval | The percentage of the administered dose that is recovered from the specimen type specified in PPSPEC, between doses (TAU). | Percent Recovered Over Dosing Interval | ||
| Pct Rec Over Dosing Interval Norm by BMI | C102387 | Pct Rec Over Dosing Interval Norm by BMI | The percentage of the administered dose that is recovered from the specimen type specified in PPSPEC, between doses (TAU) divided by the body mass index. | Percent Recovered Over Dosing Interval Normalized by Body Mass Index | ||
| Pct Rec Over Dosing Interval Norm by SA | C102388 | Pct Rec Over Dosing Interval Norm by SA | The percentage of the administered dose that is recovered from the specimen type specified in PPSPEC, between doses (TAU) divided by surface area. | Percent Recovered Over Dosing Interval Normalized by Surface Area | ||
| Pct Rec Over Dosing Interval Norm by WT | C102389 | Pct Rec Over Dosing Interval Norm by WT | The percentage of the administered dose that is recovered from the specimen type specified in PPSPEC, between doses (TAU) divided by weight. | Percent Recovered Over Dosing Interval Normalized by Weight | ||
| Peak Trough Ratio | C102381 | Peak Trough Ratio | The ratio of Cmax to Ctrough during a dosing interval. | Peak Trough Ratio | ||
| R Squared | C85542 | R Squared | The goodness of fit statistic for the terminal elimination phase. | R Squared | ||
| R Squared Adjusted | C85553 | R Squared Adjusted | The goodness of fit statistic for the terminal elimination phase, adjusted for the number of time points used in the estimation of Lambda z. | Adjusted R Squared | ||
| Renal CL | C75913 | Renal CL | The clearance of a substance from the blood by the kidneys. | Renal Clearance | ||
| Renal CL Norm by BMI | C105458 | Renal CL Norm by BMI | The clearance of a substance from the blood by the kidneys divided by the body mass index. | Renal Clearance Normalized by BMI | ||
| Renal CL Norm by Dose | C105459 | Renal CL Norm by Dose | The clearance of a substance from the blood by the kidneys divided by the dose. | Renal Clearance Normalized by Dose | ||
| Renal CL Norm by SA | C105460 | Renal CL Norm by SA | The clearance of a substance from the blood by the kidneys divided by the surface area. | Renal Clearance Normalized by SA | ||
| Renal CL Norm by WT | C105461 | Renal CL Norm by WT | The clearance of a substance from the blood by the kidneys divided by the weight. | Renal Clearance Normalized by WT | ||
| Sum of Urine Vol | C85817 | Sum of Urine Vol | The sum of urine volumes that are used for PK parameters. | Sum Urine Volume | ||
| Time of CMAX | C70919 | Time of CMAX | The time of maximum observed concentration sampled during a dosing interval. | Tmax | ||
| Time of CMIN Observation | C85825 | Time of CMIN Observation | The time of minimum concentration sampled during a dosing interval. | Tmin | ||
| Time of Last Nonzero Conc | C85822 | Time of Last Nonzero Conc | The time of the last measurable (positive) concentration. | Time of Last Nonzero Concentration | ||
| Time of Max Excretion Rate | C85823 | Time of Max Excretion Rate | The midpoint of collection interval associated with the maximum excretion rate. | Time of Maximum Observed Excretion Rate | ||
| Time Until First Nonzero Conc | C85824 | Time Until First Nonzero Conc | The time prior to the first measurable (non-zero) concentration. | Time until First Nonzero Concentration | ||
| Total CL by F for Dose Int | C114121 | Total CL by F for Dose Int | The total body clearance for extravascular administration divided by the fraction of dose absorbed, calculated using AUCTAU. | Total Body Clearance by Fraction of Dose for Dose Interval | ||
| Total CL by F for Dose Int Norm by BMI | C114227 | Total CL by F for Dose Int Norm by BMI | The total body clearance for extravascular administration divided by the fraction of dose absorbed, calculated using AUCTAU, divided by the body mass index. | Total Body Clearance by Fraction of Dose for Dose Interval Normalized by Body Mass Index | ||
| Total CL by F for Dose Int Norm by Dose | C114226 | Total CL by F for Dose Int Norm by Dose | The total body clearance for extravascular administration divided by the fraction of dose absorbed, calculated using AUCTAU, divided by the dose. | Total Body Clearance by Fraction of Dose for Dose Interval Normalized by Dose | ||
| Total CL by F for Dose Int Norm by SA | C114228 | Total CL by F for Dose Int Norm by SA | The total body clearance for extravascular administration divided by the fraction of dose absorbed, calculated using AUCTAU, divided by the surface area. | Total Body Clearance by Fraction of Dose for Dose Interval Normalized by Surface Area | ||
| Total CL by F for Dose Int Norm by WT | C114229 | Total CL by F for Dose Int Norm by WT | The total body clearance for extravascular administration divided by the fraction of dose absorbed, calculated using AUCTAU, divided by the weight. | Total Body Clearance by Fraction of Dose for Dose Interval Normalized by Weight | ||
| Total CL for Dose Int | C114122 | Total CL for Dose Int | The total body clearance for intravascular administration, calculated using AUCTAU. | Total Body Clearance for Dose Interval | ||
| Total CL for Dose Int Norm by BMI | C114231 | Total CL for Dose Int Norm by BMI | The total body clearance for intravascular administration, calculated using AUCTAU, divided by the body mass index. | Total Body Clearance for Dose Interval Normalized by Body Mass Index | ||
| Total CL for Dose Int Norm by Dose | C114230 | Total CL for Dose Int Norm by Dose | The total body clearance for intravascular administration, calculated using AUCTAU, divided by the dose. | Total Body Clearance for Dose Interval Normalized by Dose | ||
| Total CL for Dose Int Norm by SA | C114232 | Total CL for Dose Int Norm by SA | The total body clearance for intravascular administration, calculated using AUCTAU, divided by the surface area. | Total Body Clearance for Dose Interval Normalized by Surface Area | ||
| Total CL for Dose Int Norm by WT | C114233 | Total CL for Dose Int Norm by WT | The total body clearance for intravascular administration, calculated using AUCTAU, divided by the weight. | Total Body Clearance for Dose Interval Normalized by Weight | ||
| Total CL Obs | C85773 | Total CL Obs | The total body clearance for intravascular administration, calculated using the observed value of the last non-zero concentration. | Observed Total Body Clearance Rate | ||
| Total CL Obs by F | C85772 | Total CL Obs by F | The total body clearance for extravascular administration divided by the fraction of dose absorbed, calculated using the observed value of the last non-zero concentration. | Observed Total Body Clearance by Fraction of Dose Absorbed | ||
| Total CL Obs by F Norm by BMI | C92399 | Total CL Obs by F Norm by BMI | The total body clearance for extravascular administration divided by the fraction of dose absorbed, calculated using the observed value of the last non-zero concentration, divided by the body mass index. | Total Clearance Observed by Fraction Dose Normalized by Body Mass Index | ||
| Total CL Obs by F Norm by Dose | C92400 | Total CL Obs by F Norm by Dose | The total body clearance for extravascular administration divided by the fraction of dose absorbed, calculated using the observed value of the last non-zero concentration, divided by the dose. | Total Clearance Observed by Fraction Dose Normalized by Dose | ||
| Total CL Obs by F Norm by SA | C92401 | Total CL Obs by F Norm by SA | The total body clearance for extravascular administration divided by the fraction of dose absorbed, calculated using the observed value of the last non-zero concentration, divided by the surface area. | Total Clearance Observed by Fraction Dose Normalized by Surface Area | ||
| Total CL Obs by F Norm by WT | C92402 | Total CL Obs by F Norm by WT | The total body clearance for extravascular administration divided by the fraction of dose absorbed, calculated using the observed value of the last non-zero concentration, divided by the weight. | Total Clearance Observed by Fraction Dose Normalized by Weight | ||
| Total CL Obs Norm by BMI | C92403 | Total CL Obs Norm by BMI | The total body clearance for intravascular administration, calculated using the observed value of the last non-zero concentration, divided by the body mass index. | Total Clearance Observed Normalized by Body Mass Index | ||
| Total CL Obs Norm by Dose | C92404 | Total CL Obs Norm by Dose | The total body clearance for intravascular administration, calculated using the observed value of the last non-zero concentration, divided by the dose. | Total Clearance Observed Normalized by Dose | ||
| Total CL Obs Norm by SA | C92405 | Total CL Obs Norm by SA | The total body clearance for intravascular administration, calculated using the observed value of the last non-zero concentration, divided by the surface area. | Total Clearance Observed Normalized by Surface Area | ||
| Total CL Obs Norm by WT | C92406 | Total CL Obs Norm by WT | The total body clearance for intravascular administration, calculated using the observed value of the last non-zero concentration, divided by the weight. | Total Clearance Observed Normalized by Weight | ||
| Total CL Pred | C85797 | Total CL Pred | The total body clearance for intravascular administration, calculated using the predicted value of the last non-zero concentration. | Predicted Total Body Clearance Rate | ||
| Total CL Pred by F | C85796 | Total CL Pred by F | The total body clearance for extravascular administration divided by the fraction of dose absorbed, calculated using the predicted value of the last non-zero concentration. | Predicted Total Body Clearance by Fraction of Dose Absorbed | ||
| Total CL Pred by F Norm by BMI | C92417 | Total CL Pred by F Norm by BMI | The total body clearance for extravascular administration divided by the fraction of dose absorbed, calculated using the predicted value of the last non-zero concentration, divided by body mass index. | Total Clearance Predicted by Fraction Dose Normalized by Body Mass Index | ||
| Total CL Pred by F Norm by Dose | C92418 | Total CL Pred by F Norm by Dose | The total body clearance for extravascular administration divided by the fraction of dose absorbed, calculated using the predicted value of the last non-zero concentration, divided by the dose. | Total Clearance Predicted by Fraction Dose Normalized by Dose | ||
| Total CL Pred by F Norm by SA | C92419 | Total CL Pred by F Norm by SA | The total body clearance for extravascular administration divided by the fraction of dose absorbed, calculated using the predicted value of the last non-zero concentration, divided by the surface area. | Total Clearance Predicted by Fraction Dose Normalized by Surface Area | ||
| Total CL Pred by F Norm by WT | C92420 | Total CL Pred by F Norm by WT | The total body clearance for extravascular administration divided by the fraction of dose absorbed, calculated using the predicted value of the last non-zero concentration, divided by the weight. | Total Clearance Predicted by Fraction Dose Normalized by Weight | ||
| Total CL Pred Norm by BMI | C92421 | Total CL Pred Norm by BMI | The total body clearance for intravascular administration, calculated using the predicted value of the last non-zero concentration, divided by the body mass index. | Total Clearance Predicted Normalized by Body Mass Index | ||
| Total CL Pred Norm by Dose | C92422 | Total CL Pred Norm by Dose | The total body clearance for intravascular administration, calculated using the predicted value of the last non-zero concentration, divided by the dose. | Total Clearance Predicted Normalized by Dose | ||
| Total CL Pred Norm by SA | C92423 | Total CL Pred Norm by SA | The total body clearance for intravascular administration, calculated using the predicted value of the last non-zero concentration, divided by the surface area. | Total Clearance Predicted Normalized by Surface Area | ||
| Total CL Pred Norm by WT | C92424 | Total CL Pred Norm by WT | The total body clearance for intravascular administration, calculated using the predicted value of the last non-zero concentration, divided by the weight. | Total Clearance Predicted Normalized by Weight | ||
| Vol Dist Initial | C102371 | Vol Dist Initial | The initial volume of distribution for a substance administered by bolus intravascular dosing. | Initial Volume of Distribution | ||
| Vol Dist Initial Norm by BMI | C102372 | Vol Dist Initial Norm by BMI | The initial volume of distribution for a substance administered by bolus intravascular dosing divided by the body mass index. | Initial Volume of Distribution Normalized by Body Mass Index | ||
| Vol Dist Initial Norm by Dose | C102373 | Vol Dist Initial Norm by Dose | The initial volume of distribution for a substance administered by bolus intravascular dosing divided by the dose. | Initial Volume of Distribution Normalized by Dose | ||
| Vol Dist Initial Norm by SA | C102374 | Vol Dist Initial Norm by SA | The initial volume of distribution for a substance administered by bolus intravascular dosing divided by the surface area. | Initial Volume of Distribution Normalized by Surface Area | ||
| Vol Dist Initial Norm by WT | C102375 | Vol Dist Initial Norm by WT | The initial volume of distribution for a substance administered by bolus intravascular dosing divided by the weight. | Initial Volume of Distribution Normalized by Weight | ||
| Vol Dist Steady State Obs | C85770 | Vol Dist Steady State Obs | The volume of distribution at steady state based on the observed CLST for a substance administered by intravascular dosing. | Observed Steady State Volume of Distribution | ||
| Vol Dist Steady State Obs Norm by BMI | C102377 | Vol Dist Steady State Obs Norm by BMI | The volume of distribution at steady state based on the observed CLST for a substance administered by intravascular dosing divided by the body mass index. | Observed Steady State Volume of Distribution Normalized by Body Mass Index | ||
| Vol Dist Steady State Obs Norm by Dose | C102378 | Vol Dist Steady State Obs Norm by Dose | The volume of distribution at steady state based on the observed CLST for a substance administered by intravascular dosing divided by the dose. | Observed Steady State Volume of Distribution Normalized by Dose | ||
| Vol Dist Steady State Obs Norm by SA | C102379 | Vol Dist Steady State Obs Norm by SA | The volume of distribution at steady state based on the observed CLST for a substance administered by intravascular dosing divided by the surface area. | Observed Steady State Volume of Distribution Normalized by Surface Area | ||
| Vol Dist Steady State Obs Norm by WT | C102380 | Vol Dist Steady State Obs Norm by WT | The volume of distribution at steady state based on the observed CLST for a substance administered by intravascular dosing divided by the weight. | Observed Steady State Volume of Distribution Normalized by Weight | ||
| Vol Dist Steady State Pred | C85794 | Vol Dist Steady State Pred | The volume of distribution at steady state based on the predicted CLST for a substance administered by intravascular dosing. | Predicted Steady State Volume of Distribution | ||
| Vol Dist Steady State Pred Norm by BMI | C102390 | Vol Dist Steady State Pred Norm by BMI | The volume of distribution at steady state based on the predicted CLST for a substance administered by intravascular dosing divided by the body mass index. | Predicted Steady State Volume of Distribution Normalized by Body Mass Index | ||
| Vol Dist Steady State Pred Norm by Dose | C102391 | Vol Dist Steady State Pred Norm by Dose | The volume of distribution at steady state based on the predicted CLST for a substance administered by intravascular dosing divided by the dose. | Predicted Steady State Volume of Distribution Normalized by Dose | ||
| Vol Dist Steady State Pred Norm by SA | C102392 | Vol Dist Steady State Pred Norm by SA | The volume of distribution at steady state based on the predicted CLST for a substance administered by intravascular dosing divided by the surface area. | Predicted Steady State Volume of Distribution Normalized by Surface Area | ||
| Vol Dist Steady State Pred Norm by WT | C102393 | Vol Dist Steady State Pred Norm by WT | The volume of distribution at steady state based on the predicted CLST for a substance administered by intravascular dosing divided by the weight. | Predicted Steady State Volume of Distribution Normalized by Weight | ||
| Vz for Dose Int | C111333 | Vz for Dose Int | The volume of distribution associated with the terminal slope following intravascular administration, calculated using AUCTAU. | Volume of Distribution for Dosing Interval | ||
| Vz for Dose Int by F | C111364 | Vz for Dose Int by F | The volume of distribution associated with the terminal slope following extravascular administration divided by the fraction of dose absorbed, calculated using AUCTAU. | Volume of Distribution for Dosing Interval by Fraction | ||
| Vz for Dose Int by F Norm by BMI | C111365 | Vz for Dose Int by F Norm by BMI | The volume of distribution associated with the terminal slope following extravascular administration divided by the fraction of dose absorbed, calculated using AUCTAU, divided by the body mass index. | Volume of Distribution for Dosing Interval by Fraction Normalized by Body Mass Index | ||
| Vz for Dose Int by F Norm by Dose | C111366 | Vz for Dose Int by F Norm by Dose | The volume of distribution associated with the terminal slope following extravascular administration divided by the fraction of dose absorbed, calculated using AUCTAU, divided by the dose. | Volume of Distribution for Dosing Interval by Fraction Normalized by Dose | ||
| Vz for Dose Int by F Norm by SA | C111367 | Vz for Dose Int by F Norm by SA | The volume of distribution associated with the terminal slope following extravascular administration divided by the fraction of dose absorbed, calculated using AUCTAU, divided by the surface area. | Volume of Distribution for Dosing Interval by Fraction Normalized by Surface Area | ||
| Vz for Dose Int by F Norm by WT | C111368 | Vz for Dose Int by F Norm by WT | The volume of distribution associated with the terminal slope following extravascular administration divided by the fraction of dose absorbed, calculated using AUCTAU, divided by the weight. | Volume of Distribution for Dosing Interval by Fraction Normalized by Weight | ||
| Vz for Dose Int Norm by BMI | C111369 | Vz for Dose Int Norm by BMI | The volume of distribution associated with the terminal slope following intravascular administration, calculated using AUCTAU, divided by the body mass index. | Volume of Distribution for Dosing Interval Normalized by Body Mass Index | ||
| Vz for Dose Int Norm by Dose | C111370 | Vz for Dose Int Norm by Dose | The volume of distribution associated with the terminal slope following intravascular administration, calculated using AUCTAU, divided by the dose. | Volume of Distribution for Dosing Interval Normalized by Dose | ||
| Vz for Dose Int Norm by SA | C111371 | Vz for Dose Int Norm by SA | The volume of distribution associated with the terminal slope following intravascular administration, calculated using AUCTAU, divided by the surface area. | Volume of Distribution for Dosing Interval Normalized by Surface Area | ||
| Vz for Dose Int Norm by WT | C111372 | Vz for Dose Int Norm by WT | The volume of distribution associated with the terminal slope following intravascular administration, calculated using AUCTAU, divided by the weight. | Volume of Distribution for Dosing Interval Normalized by Weight | ||
| Vz Obs | C85774 | Vz Obs | The volume of distribution associated with the terminal slope following intravascular administration, calculated using the observed value of the last non-zero concentration. | Observed Volume of Distribution | ||
| Vz Obs by F | C85775 | Vz Obs by F | The volume of distribution associated with the terminal slope following extravascular administration divided by the fraction of dose absorbed, calculated using the observed value of the last non-zero concentration. | Observed Volume of Distribution of Absorbed Fraction | ||
| Vz Obs by F Norm by BMI | C92410 | Vz Obs by F Norm by BMI | The volume of distribution associated with the terminal slope following extravascular administration divided by the fraction of dose absorbed, calculated using the observed value of the last non-zero concentration, divided by the body mass index. | Volume of Distribution of Fraction Dose Observed Normalized by Body Mass Index | ||
| Vz Obs by F Norm by Dose | C102729 | Vz Obs by F Norm by Dose | The volume of distribution associated with the terminal slope following extravascular administration divided by the fraction of dose absorbed, calculated using the observed value of the last non-zero concentration, divided by the dose. | Volume of Distribution of Fraction Dose Observed Normalized by Dose | ||
| Vz Obs by F Norm by SA | C92411 | Vz Obs by F Norm by SA | The volume of distribution associated with the terminal slope following extravascular administration divided by the fraction of dose absorbed, calculated using the observed value of the last non-zero concentration, divided by the surface area. | Volume of Distribution of Fraction Dose Observed Normalized by Surface Area | ||
| Vz Obs by F Norm by WT | C92412 | Vz Obs by F Norm by WT | The volume of distribution associated with the terminal slope following extravascular administration divided by the fraction of dose absorbed, calculated using the observed value of the last non-zero concentration, divided by the weight. | Volume of Distribution of Fraction Dose Observed Normalized by Weight | ||
| Vz Obs Norm by BMI | C92407 | Vz Obs Norm by BMI | The volume of distribution associated with the terminal slope following intravascular administration, calculated using the observed value of the last non-zero concentration, divided by the body mass index. | Volume of Distribution Observed Normalized by Body Mass Index | ||
| Vz Obs Norm by Dose | C102683 | Vz Obs Norm by Dose | The volume of distribution associated with the terminal slope following intravascular administration, calculated using the observed value of the last non-zero concentration, divided by the dose. | Observed Volume of Distribution Normalized by Dose | ||
| Vz Obs Norm by SA | C92408 | Vz Obs Norm by SA | The volume of distribution associated with the terminal slope following intravascular administration, calculated using the observed value of the last non-zero concentration, divided by the surface area. | Volume of Distribution Observed Normalized by Surface Area | ||
| Vz Obs Norm by WT | C92409 | Vz Obs Norm by WT | The volume of distribution associated with the terminal slope following intravascular administration, calculated using the observed value of the last non-zero concentration, divided by the weight. | Volume of Distribution Observed Normalized by Weight | ||
| Vz Pred | C85798 | Vz Pred | The volume of distribution associated with the terminal slope following intravascular administration, calculated using the predicted value of the last non-zero concentration. | Predicted Volume of Distribution | ||
| Vz Pred by F | C85799 | Vz Pred by F | The volume of distribution associated with the terminal slope following extravascular administration divided by the fraction of dose absorbed, calculated using the predicted value of the last non-zero concentration. | Predicted Volume of Distribution of Absorbed Fraction | ||
| Vz Pred by F Norm by BMI | C92428 | Vz Pred by F Norm by BMI | The volume of distribution associated with the terminal slope following extravascular administration divided by the fraction of dose absorbed, calculated using the predicted value of the last non-zero concentration, divided by the body mass index. | Volume of Distribution of Fraction Dose Predicted Normalized by Body Mass Index | ||
| Vz Pred by F Norm by Dose | C102730 | Vz Pred by F Norm by Dose | The volume of distribution associated with the terminal slope following extravascular administration divided by the fraction of dose absorbed, calculated using the predicted value of the last non-zero concentration, divided by the dose. | Volume of Distribution of Fraction Dose Predicted Normalized by Dose | ||
| Vz Pred by F Norm by SA | C92429 | Vz Pred by F Norm by SA | The volume of distribution associated with the terminal slope following extravascular administration divided by the fraction of dose absorbed, calculated using the predicted value of the last non-zero concentration, divided by the surface area. | Volume of Distribution of Fraction Dose Predicted Normalized by Surface Area | ||
| Vz Pred by F Norm by WT | C92430 | Vz Pred by F Norm by WT | The volume of distribution associated with the terminal slope following extravascular administration divided by the fraction of dose absorbed, calculated using the predicted value of the last non-zero concentration, divided by the weight. | Volume of Distribution of Fraction Dose Predicted Normalized by Weight | ||
| Vz Pred Norm by BMI | C92425 | Vz Pred Norm by BMI | The volume of distribution associated with the terminal slope following intravascular administration, calculated using the predicted value of the last non-zero concentration, divided by the body mass index. | Volume of Distribution Predicted Normalized by Body Mass Index | ||
| Vz Pred Norm by Dose | C102696 | Vz Pred Norm by Dose | The volume of distribution associated with the terminal slope following intravascular administration, calculated using the predicted value of the last non-zero concentration, divided by the dose. | Predicted Volume of Distribution Normalized by Dose | ||
| Vz Pred Norm by SA | C92426 | Vz Pred Norm by SA | The volume of distribution associated with the terminal slope following intravascular administration, calculated using the predicted value of the last non-zero concentration, divided by the surface area. | Volume of Distribution Predicted Normalized by Surface Area | ||
| Vz Pred Norm by WT | C92427 | Vz Pred Norm by WT | The volume of distribution associated with the terminal slope following intravascular administration, calculated using the predicted value of the last non-zero concentration, divided by the weight. | Volume of Distribution Predicted Normalized by Weight | ||
| Back to top | ||||||
| CL.C85839.PKPARMCD | PK Parameters Code (PKPARMCD) | text Extensible: Yes | C85839 | PK Parameters Code | Parameter codes used to describe the time-concentration curve. | CDISC SDTM Pharmacokinetic Parameter Terminology by Code |
| AILAMZ | C114234 | Accumulation Index using Lambda z | Predicted accumulation ratio for area under the curve (AUC) calculated using the Lambda z estimated from single dose data. | Accumulation Index using Lambda z | ||
| ARAUC | C102356 | Accumulation Ratio AUC | The area under the curve (AUCTAU) at steady state divided by the area under the curve over the initial dosing interval. | Accumulation Ratio Area Under the Curve | ||
| ARCMAX | C102357 | Accumulation Ratio Cmax | The maximum concentration at steady state divided by the maximum concentration during the initial dosing interval. | Accumulation Ratio Cmax | ||
| ARCMIN | C102358 | Accumulation Ratio Cmin | The minimum concentration at steady state divided by the minimum concentration during the initial dosing interval. | Accumulation Ratio Cmin | ||
| ARCTROUG | C102426 | Accumulation Ratio Ctrough | The trough concentration at steady state divided by the trough concentration during the initial dosing interval. | Accumulation Ratio Ctrough | ||
| AUCALL | C85564 | AUC All | The area under the curve (AUC) from the time of dosing to the time of the last observation, regardless of whether the last concentration is measurable or not. | Area Under the Curve All | ||
| AUCALLB | C92362 | AUC All Norm by BMI | The area under the curve (AUC) from the time of dosing to the time of the last observation divided by the body mass index, regardless of whether the last concentration is measurable or not. | AUC All Normalized by Body Mass Index | ||
| AUCALLD | C92306 | AUC All Norm by Dose | The area under the curve (AUC) from the time of dosing to the time of the last observation divided by the dose, regardless of whether the last concentration is measurable or not. | AUC All Normalized by Dose | ||
| AUCALLS | C92307 | AUC All Norm by SA | The area under the curve (AUC) from the time of dosing to the time of the last observation divided by the surface area, regardless of whether the last concentration is measurable or not. | AUC All Normalized by Surface Area | ||
| AUCALLW | C92308 | AUC All Norm by WT | The area under the curve (AUC) from the time of dosing to the time of the last observation divided by the weight, regardless of whether the last concentration is measurable or not. | AUC All Normalized by Weight | ||
| AUCIFO | C85761 | AUC Infinity Obs | The area under the curve (AUC) extrapolated to infinity, calculated using the observed value of the last non-zero concentration. | Observed Area Under the Curve Infinity | ||
| AUCIFOB | C92316 | AUC Infinity Obs Norm by BMI | The area under the curve (AUC) extrapolated to infinity, calculated using the observed value of the last non-zero concentration, divided by the body mass index. | AUC Infinity Observed Normalized by Body Mass Index | ||
| AUCIFOD | C96695 | AUC Infinity Obs Norm by Dose | The area under the curve (AUC) extrapolated to infinity, calculated using the observed value of the last non-zero concentration, divided by the dose. | AUC Infinity Observed Normalized by Dose | ||
| AUCIFOS | C92317 | AUC Infinity Obs Norm by SA | The area under the curve (AUC) extrapolated to infinity, calculated using the observed value of the last non-zero concentration, divided by the surface area. | AUC Infinity Observed Normalized by Surface Area | ||
| AUCIFOW | C92318 | AUC Infinity Obs Norm by WT | The area under the curve (AUC) extrapolated to infinity, calculated using the observed value of the last non-zero concentration, divided by the weight. | AUC Infinity Observed Normalized by Weight | ||
| AUCIFP | C85785 | AUC Infinity Pred | The area under the curve (AUC) extrapolated to infinity, calculated using the predicted value of the last non-zero concentration. | Predicted Area Under the Curve Infinity | ||
| AUCIFPB | C92319 | AUC Infinity Pred Norm by BMI | The area under the curve (AUC) extrapolated to infinity, calculated using the predicted value of the last non-zero concentration, divided by the body mass index. | AUC Infinity Predicted Normalized by Body Mass Index | ||
| AUCIFPD | C85786 | AUC Infinity Pred Norm by Dose | The area under the curve (AUC) extrapolated to infinity, calculated using the predicted value of the last non-zero concentration, divided by the dose. | Predicted Area Under the Curve Infinity by Dose | ||
| AUCIFPS | C92320 | AUC Infinity Pred Norm by SA | The area under the curve (AUC) extrapolated to infinity, calculated using the predicted value of the last non-zero concentration, divided by the surface area. | AUC Infinity Predicted Normalized by Surface Area | ||
| AUCIFPW | C92321 | AUC Infinity Pred Norm by WT | The area under the curve (AUC) extrapolated to infinity, calculated using the predicted value of the last non-zero concentration, divided by the weight. | AUC Infinity Predicted Normalized by Weight | ||
| AUCINT | C85566 | AUC from T1 to T2 | The area under the curve (AUC) over the interval from T1 to T2. | Area Under the Curve from T1 to T2 | ||
| AUCINTB | C92312 | AUC from T1 to T2 Norm by BMI | The area under the curve (AUC) over the interval from T1 to T2 divided by the body mass index. | AUC from T1 to T2 Normalized by Body Mass Index | ||
| AUCINTD | C92313 | AUC from T1 to T2 Norm by Dose | The area under the curve (AUC) over the interval from T1 to T2 divided by the dose. | AUC from T1 to T2 Normalized by Dose | ||
| AUCINTS | C92314 | AUC from T1 to T2 Norm by SA | The area under the curve (AUC) over the interval from T1 to T2 divided by the surface area. | AUC from T1 to T2 Normalized by Surface Area | ||
| AUCINTW | C92315 | AUC from T1 to T2 Norm by WT | The area under the curve (AUC) over the interval from T1 to T2 divided by the weight. | AUC from T1 to T2 Normalized by Weight | ||
| AUCLST | C85565 | AUC to Last Nonzero Conc | The area under the curve (AUC) from the time of dosing to the last measurable concentration. | Area Under the Curve From Dosing to Last Concentration | ||
| AUCLSTB | C92309 | AUC to Last Nonzero Conc Norm by BMI | The area under the curve (AUC) from the time of dosing to the last measurable concentration divided by the body mass index. | AUC Dosing to Last Concentration Normalized by Body Mass Index | ||
| AUCLSTD | C92310 | AUC to Last Nonzero Conc Norm by Dose | The area under the curve (AUC) from the time of dosing to the last measurable concentration divided by the dose. | AUC Dosing to Last Concentration Normalized by Dose | ||
| AUCLSTS | C92311 | AUC to Last Nonzero Conc Norm by SA | The area under the curve (AUC) from the time of dosing to the last measurable concentration divided by the surface area. | AUC Dosing to Last Concentration Normalized by Surface Area | ||
| AUCLSTW | C92305 | AUC to Last Nonzero Conc Norm by WT | The area under the curve (AUC) from the time of dosing to the last measurable concentration divided by the weight. | AUC Dosing to Last Concentration Normalized by Weight | ||
| AUCPBEO | C85763 | AUC %Back Extrapolation Obs | Applies only for intravascular bolus dosing. The area under the curve (AUC) from the first measured concentration value back extrapolated to the concentration value at time zero as a percentage of the area under the curve extrapolated to infinity using the observed value of the last non-zero concentration. | Observed Area Under the Curve Percent Back Extrapolation | ||
| AUCPBEP | C85787 | AUC %Back Extrapolation Pred | Applies only for intravascular bolus dosing. The area under the curve (AUC) from the first measured concentration value back extrapolated to the concentration value at time zero as a percentage of the area under the curve extrapolated to infinity using the predicted value of the last non-zero concentration. | Predicted Area Under the Curve Percent Back Extrapolation | ||
| AUCPEO | C85764 | AUC %Extrapolation Obs | The area under the curve (AUC) from the last observed non-zero concentration value to infinity as a percentage of the area under the curve extrapolated to infinity. | Observed Area Under the Curve Percent Extrapolation | ||
| AUCPEP | C85788 | AUC %Extrapolation Pred | The area under the curve (AUC) from the last predicted non-zero concentration value to infinity as a percentage of the area under the curve extrapolated to infinity. | Predicted Area Under the Curve Percent Extrapolation | ||
| AUCTAU | C85567 | AUC Over Dosing Interval | The area under the curve (AUC) for the defined interval between doses (TAU). | Area Under the Curve Over Dosing Interval | ||
| AUCTAUB | C92322 | AUC Over Dosing Interval Norm by BMI | The area under the curve (AUC) for the defined interval between doses (TAU) divided by the body mass index. | AUC Over Dosing Interval Normalized by Body Mass Index | ||
| AUCTAUD | C92323 | AUC Over Dosing Interval Norm by Dose | The area under the curve (AUC) for the defined interval between doses (TAU) divided by the dose. | AUC Over Dosing Interval Normalized by Dose | ||
| AUCTAUS | C92324 | AUC Over Dosing Interval Norm by SA | The area under the curve (AUC) for the defined interval between doses (TAU) divided by the surface area. | AUC Over Dosing Interval Normalized by Surface Area | ||
| AUCTAUW | C92325 | AUC Over Dosing Interval Norm by WT | The area under the curve (AUC) for the defined interval between doses (TAU) divided by the weight. | AUC Over Dosing Interval Normalized by Weight | ||
| AUMCIFO | C85765 | AUMC Infinity Obs | The area under the moment curve (AUMC) extrapolated to infinity, calculated using the observed value of the last non-zero concentration. | Observed Area Under the First Moment Curve Infinity | ||
| AUMCIFOB | C92330 | AUMC Infinity Obs Norm by BMI | The area under the moment curve (AUMC) extrapolated to infinity, calculated using the observed value of the last non-zero concentration, divided by the body mass index. | AUMC Infinity Observed Normalized by Body Mass Index | ||
| AUMCIFOD | C92331 | AUMC Infinity Obs Norm by Dose | The area under the moment curve (AUMC) extrapolated to infinity, calculated using the observed value of the last non-zero concentration, divided by the dose. | AUMC Infinity Observed Normalized by Dose | ||
| AUMCIFOS | C92332 | AUMC Infinity Obs Norm by SA | The area under the moment curve (AUMC) extrapolated to infinity, calculated using the observed value of the last non-zero concentration, divided by the surface area. | AUMC Infinity Observed Normalized by Surface Area | ||
| AUMCIFOW | C92333 | AUMC Infinity Obs Norm by WT | The area under the moment curve (AUMC) extrapolated to infinity, calculated using the observed value of the last non-zero concentration, divided by the weight. | AUMC Infinity Observed Normalized by Weight | ||
| AUMCIFP | C85789 | AUMC Infinity Pred | The area under the moment curve (AUMC) extrapolated to infinity, calculated using the predicted value of the last non-zero concentration. | Predicted Area Under the First Moment Curve Infinity | ||
| AUMCIFPB | C92334 | AUMC Infinity Pred Norm by BMI | The area under the moment curve (AUMC) extrapolated to infinity, calculated using the predicted value of the last non-zero concentration, divided by the body mass index. | AUMC Infinity Predicted Normalized by Body Mass Index | ||
| AUMCIFPD | C92335 | AUMC Infinity Pred Norm by Dose | The area under the moment curve (AUMC) extrapolated to infinity, calculated using the predicted value of the last non-zero concentration, divided by the dose. | AUMC Infinity Predicted Normalized by Dose | ||
| AUMCIFPS | C92336 | AUMC Infinity Pred Norm by SA | The area under the moment curve (AUMC) extrapolated to infinity, calculated using the predicted value of the last non-zero concentration, divided by the surface area. | AUMC Infinity Predicted Normalized by Surface Area | ||
| AUMCIFPW | C92337 | AUMC Infinity Pred Norm by WT | The area under the moment curve (AUMC) extrapolated to infinity, calculated using the predicted value of the last non-zero concentration, divided by the weight. | AUMC Infinity Predicted Normalized by Weight | ||
| AUMCLST | C85569 | AUMC to Last Nonzero Conc | The area under the moment curve (AUMC) from the time of dosing to the last measurable concentration. | Area Under the First Moment Curve From Dosing to Last Concentration | ||
| AUMCLSTB | C92326 | AUMC to Last Nonzero Conc Norm by BMI | The area under the moment curve (AUMC) from the time of dosing to the last measurable concentration divided by the body mass index. | AUMC Dosing to Last Concentration Normalized by Body Mass Index | ||
| AUMCLSTD | C92327 | AUMC to Last Nonzero Conc Norm by Dose | The area under the moment curve (AUMC) from the time of dosing to the last measurable concentration divided by the dose. | AUMC Dosing to Last Concentration Normalized by Dose | ||
| AUMCLSTS | C92328 | AUMC to Last Nonzero Conc Norm by SA | The area under the moment curve (AUMC) from the time of dosing to the last measurable concentration divided by the surface area. | AUMC Dosing to Last Concentration Normalized by Surface Area | ||
| AUMCLSTW | C92329 | AUMC to Last Nonzero Conc Norm by WT | The area under the moment curve (AUMC) from the time of dosing to the last measurable concentration divided by the weight. | AUMC Dosing to Last Concentration Normalized by Weight | ||
| AUMCPEO | C85766 | AUMC % Extrapolation Obs | The area under the moment curve (AUMC) from the last observed non-zero concentration value to infinity as a percentage of the area under the moment curve extrapolated to infinity. | Observed Area Under the First Moment Curve Percent Extrapolation | ||
| AUMCPEP | C85790 | AUMC % Extrapolation Pred | The area under the moment curve (AUMC) from the last predicted non-zero concentration value to infinity as a percentage of the area under the moment curve extrapolated to infinity. | Predicted Area Under the First Moment Curve Percent Extrapolation | ||
| AUMCTAU | C85570 | AUMC Over Dosing Interval | The area under the first moment curve (AUMC) for the defined interval between doses (TAU). | Area Under the First Moment Curve Over Dosing Interval | ||
| AUMCTAUB | C92338 | AUMC Over Dosing Interval Norm by BMI | The area under the first moment curve (AUMC) for the defined interval between doses (TAU) divided by the body mass index. | AUMC Over Dosing Interval Normalized by Body Mass Index | ||
| AUMCTAUD | C92339 | AUMC Over Dosing Interval Norm by Dose | The area under the first moment curve (AUMC) for the defined interval between doses (TAU) divided by the dose. | AUMC Over Dosing Interval Normalized by Dose | ||
| AUMCTAUS | C92340 | AUMC Over Dosing Interval Norm by SA | The area under the first moment curve (AUMC) for the defined interval between doses (TAU) divided by the surface area. | AUMC Over Dosing Interval Normalized by Surface Area | ||
| AUMCTAUW | C92341 | AUMC Over Dosing Interval Norm by WT | The area under the first moment curve (AUMC) for the defined interval between doses (TAU) divided by the weight. | AUMC Over Dosing Interval Normalized by Weight | ||
| AURCALL | C85841 | AURC All | The area under the urinary excretion rate curve (AURC) from time zero to the time of the last observation, regardless of whether the last observation is a measurable concentration or not. | Area Under Urinary Excretion Rate Curve All | ||
| AURCALLB | C92342 | AURC All Norm by BMI | The area under the urinary excretion rate curve (AURC) from time zero to the last measurable rate divided by the body mass index. | AURC All Normalized by Body Mass Index | ||
| AURCALLD | C92343 | AURC All Norm by Dose | The area under the urinary excretion rate curve (AURC) from time zero to the last measurable rate divided by the dose. | AURC All Normalized by Dose | ||
| AURCALLS | C92344 | AURC All Norm by SA | The area under the urinary excretion rate curve (AURC) from time zero to the last measurable rate divided by the surface area. | AURC All Normalized by Surface Area | ||
| AURCALLW | C92345 | AURC All Norm by WT | The area under the urinary excretion rate curve (AURC) from time zero to the last measurable rate divided by the weight. | AURC All Normalized by Weight | ||
| AURCIFO | C85767 | AURC Infinity Obs | The area under the urinary excretion rate curve (AURC) extrapolated to infinity, calculated using the observed value of the last excretion rate. | Observed Area Under the Urinary Excretion Rate Curve infinity | ||
| AURCIFOB | C92354 | AURC Infinity Obs Norm by BMI | The area under the urinary excretion rate curve (AURC) extrapolated to infinity, calculated using the observed value of the last excretion rate, divided by the body mass index. | AURC Infinity Observed Normalized by Body Mass Index | ||
| AURCIFOD | C92355 | AURC Infinity Obs Norm by Dose | The area under the urinary excretion rate curve (AURC) extrapolated to infinity, calculated using the observed value of the last excretion rate, divided by the dose. | AURC Infinity Observed Normalized by Dose | ||
| AURCIFOS | C92356 | AURC Infinity Obs Norm by SA | The area under the urinary excretion rate curve (AURC) extrapolated to infinity, calculated using the observed value of the last excretion rate, divided by the surface area. | AURC Infinity Observed Normalized by Surface Area | ||
| AURCIFOW | C92357 | AURC Infinity Obs Norm by WT | The area under the urinary excretion rate curve (AURC) extrapolated to infinity, calculated using the observed value of the last excretion rate, divided by the weight. | AURC Infinity Observed Normalized by Weight | ||
| AURCIFP | C85791 | AURC Infinity Pred | The area under the urinary excretion rate curve (AURC) extrapolated to infinity, calculated using the predicted value of the last non-zero excretion rate. | Predicted Area Under the Urinary Excretion Rate Curve Infinity | ||
| AURCIFPB | C92358 | AURC Infinity Pred Norm by BMI | The area under the urinary excretion rate curve (AURC) extrapolated to infinity, calculated using the predicted value of the last non-zero excretion rate, divded by the body mass index. | AURC Infinity Predicted Normalized by Body Mass Index | ||
| AURCIFPD | C92359 | AURC Infinity Pred Norm by Dose | The area under the urinary excretion rate curve (AURC) extrapolated to infinity, calculated using the predicted value of the last non-zero excretion rate, divded by the dose. | AURC Infinity Predicted Normalized by Dose | ||
| AURCIFPS | C92360 | AURC Infinity Pred Norm by SA | The area under the urinary excretion rate curve (AURC) extrapolated to infinity, calculated using the predicted value of the last non-zero excretion rate, divded by the surface area. | AURC Infinity Predicted Normalized by Surface Area | ||
| AURCIFPW | C92361 | AURC Infinity Pred Norm by WT | The area under the urinary excretion rate curve (AURC) extrapolated to infinity, calculated using the predicted value of the last non-zero excretion rate, divded by the weight. | AURC Infinity Predicted Normalized by Weight | ||
| AURCINT | C85572 | AURC from T1 to T2 | The area under the urinary excretion rate curve (AURC) over the interval from T1 to T2. | Area Under the Urinary Excretion Rate Curve from T1 to T2 | ||
| AURCINTB | C92350 | AURC from T1 to T2 Norm by BMI | The area under the urinary excretion rate curve (AURC) over the interval from T1 to T2 divided by the body mass index. | AURC from T1 to T2 Normalized by Body Mass Index | ||
| AURCINTD | C92351 | AURC from T1 to T2 Norm by Dose | The area under the urinary excretion rate curve (AURC) over the interval from T1 to T2 divided by the dose. | AURC from T1 to T2 Normalized by Dose | ||
| AURCINTS | C92352 | AURC from T1 to T2 Norm by SA | The area under the urinary excretion rate curve (AURC) over the interval from T1 to T2 divided by the surface area. | AURC from T1 to T2 Normalized by Surface Area | ||
| AURCINTW | C92353 | AURC from T1 to T2 Norm by WT | The area under the urinary excretion rate curve (AURC) over the interval from T1 to T2 divided by the weight. | AURC from T1 to T2 Normalized by Weight | ||
| AURCLST | C85571 | AURC to Last Nonzero Rate | The area under the urinary excretion rate curve (AURC) from time zero to the time of the last measurable concentration. | Area Under the Urinary Excretion Rate Curve From Dosing to Last Concentration | ||
| AURCLSTB | C92346 | AURC to Last Nonzero Rate Norm by BMI | The area under the urinary excretion rate curve (AURC) from time zero to the last measurable rate, divided by the body mass index. | AURC Dosing to Last Concentration Normalized by Body Mass Index | ||
| AURCLSTD | C92347 | AURC to Last Nonzero Rate Norm by Dose | The area under the urinary excretion rate curve (AURC) from time zero to the last measurable rate, divided by the dose. | AURC Dosing to Last Concentration Normalized by Dose | ||
| AURCLSTS | C92348 | AURC to Last Nonzero Rate Norm by SA | The area under the urinary excretion rate curve (AURC) from time zero to the last measurable rate, divided by the surface area. | AURC Dosing to Last Concentration Normalized by Surface Area | ||
| AURCLSTW | C92349 | AURC to Last Nonzero Rate Norm by WT | The area under the urinary excretion rate curve (AURC) from time zero to the last measurable rate, divided by the weight. | AURC Dosing to Last Concentration Normalized by Weight | ||
| AURCPEO | C85768 | AURC % Extrapolation Obs | The area under the urinary excretion rate curve (AURC) from the last observed non-zero rate value to infinity as a percentage of the area under the urinary excretion rate curve extrapolated to infinity. | Observed Area Under the Urinary Excretion Rate Curve Percent Extrapolation | ||
| AURCPEP | C85792 | AURC % Extrapolation Pred | The area under the urinary excretion rate curve (AURC) from the last predicted non-zero rate value to infinity as a percentage of the area under the urinary excretion rate curve extrapolated to infinity. | Predicted Area Under the Urinary Excretion Rate Curve Percent Extrapolation | ||
| C0 | C85644 | Initial Conc | Initial concentration. Given only for bolus IV models. | Initial Concentration | ||
| C0B | C92383 | Initial Conc Norm by BMI | Initial concentration divided by the body mass index. Given only for bolus IV models. | Initial Concentration Normalized by Body Mass Index | ||
| C0D | C92384 | Initial Conc Norm by Dose | Initial concentration divided by the dose. Given only for bolus IV models. | Initial Concentration Normalized by Dose | ||
| C0S | C92385 | Initial Conc Norm by SA | Initial concentration divided by the surface area. Given only for bolus IV models. | Initial Concentration Normalized by Surface Area | ||
| C0W | C92386 | Initial Conc Norm by WT | Initial concentration divided by the weight. Given only for bolus IV models. | Initial Concentration Normalized by Weight | ||
| CAVG | C85575 | Average Concentration | AUCTAU divided by TAU. | Average Concentration | ||
| CAVGB | C92367 | Average Conc Norm by BMI | AUCTAU divided by TAU and then divided by the body mass index. | Average Concentration Normalized by Body Mass Index | ||
| CAVGD | C92368 | Average Conc Norm by Dose | AUCTAU divided by TAU and then divided by the dose. | Average Concentration Normalized by Dose | ||
| CAVGS | C92369 | Average Conc Norm by SA | AUCTAU divided by TAU and then divided by the surface area. | Average Concentration Normalized by Surface Area | ||
| CAVGW | C92370 | Average Conc Norm by WT | AUCTAU divided by TAU and then divided by the weight. | Average Concentration Normalized by Weight | ||
| CLFO | C85772 | Total CL Obs by F | The total body clearance for extravascular administration divided by the fraction of dose absorbed, calculated using the observed value of the last non-zero concentration. | Observed Total Body Clearance by Fraction of Dose Absorbed | ||
| CLFOB | C92399 | Total CL Obs by F Norm by BMI | The total body clearance for extravascular administration divided by the fraction of dose absorbed, calculated using the observed value of the last non-zero concentration, divided by the body mass index. | Total Clearance Observed by Fraction Dose Normalized by Body Mass Index | ||
| CLFOD | C92400 | Total CL Obs by F Norm by Dose | The total body clearance for extravascular administration divided by the fraction of dose absorbed, calculated using the observed value of the last non-zero concentration, divided by the dose. | Total Clearance Observed by Fraction Dose Normalized by Dose | ||
| CLFOS | C92401 | Total CL Obs by F Norm by SA | The total body clearance for extravascular administration divided by the fraction of dose absorbed, calculated using the observed value of the last non-zero concentration, divided by the surface area. | Total Clearance Observed by Fraction Dose Normalized by Surface Area | ||
| CLFOW | C92402 | Total CL Obs by F Norm by WT | The total body clearance for extravascular administration divided by the fraction of dose absorbed, calculated using the observed value of the last non-zero concentration, divided by the weight. | Total Clearance Observed by Fraction Dose Normalized by Weight | ||
| CLFP | C85796 | Total CL Pred by F | The total body clearance for extravascular administration divided by the fraction of dose absorbed, calculated using the predicted value of the last non-zero concentration. | Predicted Total Body Clearance by Fraction of Dose Absorbed | ||
| CLFPB | C92417 | Total CL Pred by F Norm by BMI | The total body clearance for extravascular administration divided by the fraction of dose absorbed, calculated using the predicted value of the last non-zero concentration, divided by body mass index. | Total Clearance Predicted by Fraction Dose Normalized by Body Mass Index | ||
| CLFPD | C92418 | Total CL Pred by F Norm by Dose | The total body clearance for extravascular administration divided by the fraction of dose absorbed, calculated using the predicted value of the last non-zero concentration, divided by the dose. | Total Clearance Predicted by Fraction Dose Normalized by Dose | ||
| CLFPS | C92419 | Total CL Pred by F Norm by SA | The total body clearance for extravascular administration divided by the fraction of dose absorbed, calculated using the predicted value of the last non-zero concentration, divided by the surface area. | Total Clearance Predicted by Fraction Dose Normalized by Surface Area | ||
| CLFPW | C92420 | Total CL Pred by F Norm by WT | The total body clearance for extravascular administration divided by the fraction of dose absorbed, calculated using the predicted value of the last non-zero concentration, divided by the weight. | Total Clearance Predicted by Fraction Dose Normalized by Weight | ||
| CLFTAU | C114121 | Total CL by F for Dose Int | The total body clearance for extravascular administration divided by the fraction of dose absorbed, calculated using AUCTAU. | Total Body Clearance by Fraction of Dose for Dose Interval | ||
| CLFTAUB | C114227 | Total CL by F for Dose Int Norm by BMI | The total body clearance for extravascular administration divided by the fraction of dose absorbed, calculated using AUCTAU, divided by the body mass index. | Total Body Clearance by Fraction of Dose for Dose Interval Normalized by Body Mass Index | ||
| CLFTAUD | C114226 | Total CL by F for Dose Int Norm by Dose | The total body clearance for extravascular administration divided by the fraction of dose absorbed, calculated using AUCTAU, divided by the dose. | Total Body Clearance by Fraction of Dose for Dose Interval Normalized by Dose | ||
| CLFTAUS | C114228 | Total CL by F for Dose Int Norm by SA | The total body clearance for extravascular administration divided by the fraction of dose absorbed, calculated using AUCTAU, divided by the surface area. | Total Body Clearance by Fraction of Dose for Dose Interval Normalized by Surface Area | ||
| CLFTAUW | C114229 | Total CL by F for Dose Int Norm by WT | The total body clearance for extravascular administration divided by the fraction of dose absorbed, calculated using AUCTAU, divided by the weight. | Total Body Clearance by Fraction of Dose for Dose Interval Normalized by Weight | ||
| CLO | C85773 | Total CL Obs | The total body clearance for intravascular administration, calculated using the observed value of the last non-zero concentration. | Observed Total Body Clearance Rate | ||
| CLOB | C92403 | Total CL Obs Norm by BMI | The total body clearance for intravascular administration, calculated using the observed value of the last non-zero concentration, divided by the body mass index. | Total Clearance Observed Normalized by Body Mass Index | ||
| CLOD | C92404 | Total CL Obs Norm by Dose | The total body clearance for intravascular administration, calculated using the observed value of the last non-zero concentration, divided by the dose. | Total Clearance Observed Normalized by Dose | ||
| CLOS | C92405 | Total CL Obs Norm by SA | The total body clearance for intravascular administration, calculated using the observed value of the last non-zero concentration, divided by the surface area. | Total Clearance Observed Normalized by Surface Area | ||
| CLOW | C92406 | Total CL Obs Norm by WT | The total body clearance for intravascular administration, calculated using the observed value of the last non-zero concentration, divided by the weight. | Total Clearance Observed Normalized by Weight | ||
| CLP | C85797 | Total CL Pred | The total body clearance for intravascular administration, calculated using the predicted value of the last non-zero concentration. | Predicted Total Body Clearance Rate | ||
| CLPB | C92421 | Total CL Pred Norm by BMI | The total body clearance for intravascular administration, calculated using the predicted value of the last non-zero concentration, divided by the body mass index. | Total Clearance Predicted Normalized by Body Mass Index | ||
| CLPD | C92422 | Total CL Pred Norm by Dose | The total body clearance for intravascular administration, calculated using the predicted value of the last non-zero concentration, divided by the dose. | Total Clearance Predicted Normalized by Dose | ||
| CLPS | C92423 | Total CL Pred Norm by SA | The total body clearance for intravascular administration, calculated using the predicted value of the last non-zero concentration, divided by the surface area. | Total Clearance Predicted Normalized by Surface Area | ||
| CLPW | C92424 | Total CL Pred Norm by WT | The total body clearance for intravascular administration, calculated using the predicted value of the last non-zero concentration, divided by the weight. | Total Clearance Predicted Normalized by Weight | ||
| CLST | C85655 | Last Nonzero Conc | The concentration corresponding to Tlast. | Last Concentration | ||
| CLSTB | C92387 | Last Nonzero Conc Norm by BMI | The concentration corresponding to Tlast divided by the body mass index. | Last Concentration Normalized by Body Mass Index | ||
| CLSTD | C92388 | Last Nonzero Conc Norm by Dose | The concentration corresponding to Tlast divided by the dose. | Last Concentration Normalized by Dose | ||
| CLSTS | C92389 | Last Nonzero Conc Norm by SA | The concentration corresponding to Tlast divided by the surface area. | Last Concentration Normalized by Surface Area | ||
| CLSTW | C92390 | Last Nonzero Conc Norm by WT | The concentration corresponding to Tlast divided by the weight. | Last Concentration Normalized by Weight | ||
| CLTAU | C114122 | Total CL for Dose Int | The total body clearance for intravascular administration, calculated using AUCTAU. | Total Body Clearance for Dose Interval | ||
| CLTAUB | C114231 | Total CL for Dose Int Norm by BMI | The total body clearance for intravascular administration, calculated using AUCTAU, divided by the body mass index. | Total Body Clearance for Dose Interval Normalized by Body Mass Index | ||
| CLTAUD | C114230 | Total CL for Dose Int Norm by Dose | The total body clearance for intravascular administration, calculated using AUCTAU, divided by the dose. | Total Body Clearance for Dose Interval Normalized by Dose | ||
| CLTAUS | C114232 | Total CL for Dose Int Norm by SA | The total body clearance for intravascular administration, calculated using AUCTAU, divided by the surface area. | Total Body Clearance for Dose Interval Normalized by Surface Area | ||
| CLTAUW | C114233 | Total CL for Dose Int Norm by WT | The total body clearance for intravascular administration, calculated using AUCTAU, divided by the weight. | Total Body Clearance for Dose Interval Normalized by Weight | ||
| CMAX | C70918 | Max Conc | The maximum concentration occurring at Tmax. | Cmax | ||
| CMAXB | C92371 | Max Conc Norm by BMI | The maximum concentration occurring at Tmax, divided by the body mass index. | Maximum Concentration Normalized by Body Mass Index | ||
| CMAXD | C85698 | Max Conc Norm by Dose | The maximum concentration occurring at Tmax, divided by the dose. | Maximum Concentration Dose Normalized | ||
| CMAXS | C92372 | Max Conc Norm by SA | The maximum concentration occurring at Tmax, divided by the surface area. | Maximum Concentration Normalized by Surface Area | ||
| CMAXW | C92373 | Max Conc Norm by WT | The maximum concentration occurring at Tmax, divided by the weight. | Maximum Concentration Normalized by Weight | ||
| CMIN | C85579 | Min Conc | The minimum concentration between dose time and dose time plus Tau (at Tmin). | Cmin | ||
| CMINB | C92374 | Min Conc Norm by BMI | The minimum concentration between dose time and dose time plus Tau (at Tmin) divided by the body mass index. | Minimum Concentration Normalized by Body Mass Index | ||
| CMIND | C92375 | Min Conc Norm by Dose | The minimum concentration between dose time and dose time plus Tau (at Tmin) divided by the dose. | Minimum Concentration Normalized by Dose | ||
| CMINS | C92376 | Min Conc Norm by SA | The minimum concentration between dose time and dose time plus Tau (at Tmin) divided by the surface area. | Minimum Concentration Normalized by Surface Area | ||
| CMINW | C92377 | Min Conc Norm by WT | The minimum concentration between dose time and dose time plus Tau (at Tmin) divided by the weight. | Minimum Concentration Normalized by Weight | ||
| CONC | C41185 | Concentration | The quantity of a specified substance in a unit volume or weight of another substance. | Concentration | ||
| CONCB | C102367 | Conc by BMI | The concentration divided by body mass index. | Concentration Divided by Body Mass Index | ||
| CONCD | C102368 | Conc by Dose | The concentration divided by dose. | Concentration Divided by Dose | ||
| CONCS | C102369 | Conc by SA | The concentration divided by surface area. | Concentration Divided by Surface Area | ||
| CONCW | C102370 | Conc by WT | The concentration divided by weight. | Concentration Divided by Weight | ||
| CORRXY | C85821 | Correlation Between TimeX and Log ConcY | The correlation between time (X) and log concentration (Y) for the points used in the estimation of lambda z. | Time and Log Concentration Correlation | ||
| CTROUGH | C102394 | Conc Trough | Concentration at end of dosing interval. | Trough Concentration | ||
| CTROUGHB | C102395 | Conc Trough by BMI | The trough concentration divided by body mass index. | Trough Concentration Divided by Body Mass Index | ||
| CTROUGHD | C102396 | Conc Trough by Dose | The trough concentration divided by dose. | Trough Concentration Divided by Dose | ||
| CTROUGHS | C102397 | Conc Trough by SA | The trough concentration divided by surface area. | Trough Concentration Divided by Surface Area | ||
| CTROUGHW | C102398 | Conc Trough by WT | The trough concentration divided by weight. | Trough Concentration Divided by Weight | ||
| EFFHL | C95007 | Effective Half-Life | The drug half-life that quantifies the accumulation ratio of a drug following multiple dosing. | Effective Half-life | ||
| ERINT | C105449 | Excret Rate from T1 to T2 | The excretion rate over the interval from T1 to T2, determined for the specimen type specified in PPSPEC. | Excretion Rate From T1 to T2 | ||
| ERINTB | C105450 | Excret Rate from T1 to T2 Norm by BMI | The excretion rate over the interval from T1 to T2 divided by the body mass index, determined for the specimen type specified in PPSPEC. | Excretion Rate From T1 to T2 Normalized by BMI | ||
| ERINTD | C105451 | Excret Rate from T1 to T2 Norm by Dose | The excretion rate over the interval from T1 to T2 divided by the dose, determined for the specimen type specified in PPSPEC. | Excretion Rate From T1 to T2 Normalized by Dose | ||
| ERINTS | C105452 | Excret Rate from T1 to T2 Norm by SA | The excretion rate over the interval from T1 to T2 divided by the surface area, determined for the specimen type specified in PPSPEC. | Excretion Rate From T1 to T2 Normalized by SA | ||
| ERINTW | C105453 | Excret Rate from T1 to T2 Norm by WT | The excretion rate over the interval from T1 to T2 divided by the weight, determined for the specimen type specified in PPSPEC. | Excretion Rate From T1 to T2 Normalized by WT | ||
| ERLST | C85656 | Last Meas Excretion Rate | The last measurable (positive) excretion rate determined for the specimen type specified in PPSPEC. | Last Measurable Observed Excretion Rate | ||
| ERLSTB | C92391 | Last Meas Excretion Rate Norm by BMI | The last measurable (positive) excretion rate divided by the body mass index. | Last Measurable Excretion Rate Normalized by Body Mass Index | ||
| ERLSTD | C92392 | Last Meas Excretion Rate Norm by Dose | The last measurable (positive) excretion rate divided by the dose. | Last Measurable Excretion Rate Normalized by Dose | ||
| ERLSTS | C92393 | Last Meas Excretion Rate Norm by SA | The last measurable (positive) excretion rate divided by the surface area. | Last Measurable Excretion Rate Normalized by Surface Area | ||
| ERLSTW | C92394 | Last Meas Excretion Rate Norm by WT | The last measurable (positive) excretion rate divided by the weight. | Last Measurable Excretion Rate Normalized by Weight | ||
| ERMAX | C85699 | Max Excretion Rate | The maximum excretion rate determined for the specimen type specified in PPSPEC. | Maximum Observed Excretion Rate | ||
| ERMAXB | C92395 | Max Excretion Rate Norm by BMI | The maximum excretion rate divided by the body mass index. | Maximum Observed Excretion Rate Normalized by Body Mass Index | ||
| ERMAXD | C92396 | Max Excretion Rate Norm by Dose | The maximum excretion rate divided by the dose. | Maximum Observed Excretion Rate Normalized by Dose | ||
| ERMAXS | C92397 | Max Excretion Rate Norm by SA | The maximum excretion rate divided by the surface area. | Maximum Observed Excretion Rate Normalized by Surface Area | ||
| ERMAXW | C92398 | Max Excretion Rate Norm by WT | The maximum excretion rate divided by the weight. | Maximum Observed Excretion Rate Normalized by Weight | ||
| ERTMAX | C85823 | Time of Max Excretion Rate | The midpoint of collection interval associated with the maximum excretion rate. | Time of Maximum Observed Excretion Rate | ||
| FLUCP | C85581 | Fluctuation% | The difference between Cmin and Cmax standardized to Cavg, between dose time and Tau. | Concentration Variability Between Dose Time and Tau | ||
| HDCL | C112287 | Hemodialysis Clearance | The clearance of a substance from the blood during a hemodialysis session. | Hemodialysis Clearance | ||
| HDER | C116213 | Hemodialysis Extraction Ratio | The fractional content of a substance removed from the blood during a hemodialysis session. | Hemodialysis Extraction Ratio | ||
| LAMZ | C85652 | Lambda z | The first order rate constant associated with the terminal (log-linear) portion of the curve. | Lambda Z | ||
| LAMZHL | C85818 | Half-Life Lambda z | Terminal half-life. | Terminal Half Life | ||
| LAMZLL | C85653 | Lambda z Lower Limit | The lower limit on time for values to be included in the calculation of Lambda z. | Lambda Z Time Lower Limit | ||
| LAMZNPT | C85816 | Number of Points for Lambda z | The number of time points used in computing Lambda z. | Sum of Lambda Z Timepoints | ||
| LAMZUL | C85654 | Lambda z Upper Limit | The upper limit on time for values to be included in the calculation of Lambda z. | Lambda Z Time Upper Limit | ||
| MIDPTLST | C85580 | Midpoint of Collection Interval | The midpoint of collection interval, which is associated with last Measurable rate. | Collection Interval Midpoint | ||
| MRTIFO | C85769 | MRT Infinity Obs | The mean residence time (MRT) extrapolated to infinity, calculated using the observed value of the last non-zero concentration. | Observed Mean Residence Time Infinity | ||
| MRTIFP | C85793 | MRT Infinity Pred | The mean residence time (MRT) extrapolated to infinity, calculated using the predicted value of the last non-zero concentration. | Predicted Mean Residence Time Infinity | ||
| MRTLST | C85700 | MRT to Last Nonzero Conc | Mean residence time (MRT) from the time of dosing to the time of the last measurable concentration. | Mean Residence Time Last | ||
| NRENALCL | C102376 | Nonrenal CL | The total clearance of a substance from the blood less the renal clearance. | Nonrenal Clearance | ||
| NRENLCLB | C105454 | Nonrenal CL Norm by BMI | The total clearance of a substance from the blood minus the renal clearance divided by the body mass index. | Nonrenal Clearance Normalized by BMI | ||
| NRENLCLD | C105455 | Nonrenal CL Norm by Dose | The total clearance of a substance from the blood minus the renal clearance divided by the dose. | Nonrenal Clearance Normalized by Dose | ||
| NRENLCLS | C105456 | Nonrenal CL Norm by SA | The total clearance of a substance from the blood minus the renal clearance divided by the surface area. | Nonrenal Clearance Normalized by SA | ||
| NRENLCLW | C105457 | Nonrenal CL Norm by WT | The total clearance of a substance from the blood minus the renal clearance divided by the weight. | Nonrenal Clearance Normalized by WT | ||
| PTROUGHR | C102381 | Peak Trough Ratio | The ratio of Cmax to Ctrough during a dosing interval. | Peak Trough Ratio | ||
| R2 | C85542 | R Squared | The goodness of fit statistic for the terminal elimination phase. | R Squared | ||
| R2ADJ | C85553 | R Squared Adjusted | The goodness of fit statistic for the terminal elimination phase, adjusted for the number of time points used in the estimation of Lambda z. | Adjusted R Squared | ||
| RCAMIFO | C112032 | Amt Rec Infinity Obs | The cumulative amount recovered from the specimen type specified in PPSPEC extrapolated to infinity, calculated using the observed value of the last non-zero concentration. | Amount Recovered Infinity Observed | ||
| RCAMIFOB | C112223 | Amt Rec Infinity Obs Norm by BMI | The cumulative amount recovered from the specimen type specified in PPSPEC extrapolated to infinity, calculated using the observed value of the last non-zero concentration, divided by the body mass index. | Amount Recovered Infinity Observed Normalized by Body Mass Index | ||
| RCAMIFOS | C112224 | Amt Rec Infinity Obs Norm by SA | The cumulative amount recovered from the specimen type specified in PPSPEC extrapolated to infinity, calculated using the observed value of the last non-zero concentration, divided by the surface area. | Amount Recovered Infinity Observed Normalized by Surface Area | ||
| RCAMIFOW | C112225 | Amt Rec Infinity Obs Norm by WT | The cumulative amount recovered from the specimen type specified in PPSPEC extrapolated to infinity, calculated using the observed value of the last non-zero concentration, divided by the weight. | Amount Recovered Infinity Observed Normalized by Weight | ||
| RCAMIFP | C112033 | Amt Rec Infinity Pred | The cumulative amount recovered from the specimen type specified in PPSPEC extrapolated to infinity, calculated using the predicted value of the last non-zero concentration. | Amount Recovered Infinity Predicted | ||
| RCAMIFPB | C112226 | Amt Rec Infinity Pred Norm by BMI | The cumulative amount recovered from the specimen type specified in PPSPEC extrapolated to infinity, calculated using the predicted value of the last non-zero concentration, divided by the body mass index. | Amount Recovered Infinity Predicted Normalized by Body Mass Index | ||
| RCAMIFPS | C112227 | Amt Rec Infinity Pred Norm by SA | The cumulative amount recovered from the specimen type specified in PPSPEC extrapolated to infinity, calculated using the predicted value of the last non-zero concentration, divided by the surface area. | Amount Recovered Infinity Predicted Normalized by Surface Area | ||
| RCAMIFPW | C112228 | Amt Rec Infinity Pred Norm by WT | The cumulative amount recovered from the specimen type specified in PPSPEC extrapolated to infinity, calculated using the predicted value of the last non-zero concentration, divided by the weight. | Amount Recovered Infinity Predicted Normalized by Weight | ||
| RCAMINT | C102359 | Amt Rec from T1 to T2 | The cumulative amount recovered from the specimen type specified in PPSPEC over the interval from T1 to T2. | Amount Recovered from T1 to T2 | ||
| RCAMINTB | C102360 | Amt Rec from T1 to T2 Norm by BMI | The cumulative amount recovered from the specimen type specified in PPSPEC over the interval from T1 to T2 divided by body mass index. | Amount Recovered from T1 to T2 Normalized by Body Mass Index | ||
| RCAMINTS | C102361 | Amt Rec from T1 to T2 Norm by SA | The cumulative amount recovered from the specimen type specified in PPSPEC over the interval from T1 to T2 divided by surface area. | Amount Recovered from T1 to T2 Normalized by Surface Area | ||
| RCAMINTW | C102362 | Amt Rec from T1 to T2 Norm by WT | The cumulative amount recovered from the specimen type specified in PPSPEC over the interval from T1 to T2 divided by weight. | Amount Recovered from T1 to T2 Normalized by Weight | ||
| RCAMTAU | C102363 | Amt Rec Over Dosing Interval | The cumulative amount recovered from the specimen type specified in PPSPEC between doses (TAU). | Amount Recovered Over Dosing Interval | ||
| RCAMTAUB | C102364 | Amt Rec Over Dosing Interval Norm by BMI | The cumulative amount recovered from the specimen type specified in PPSPEC between doses (TAU) divided by body mass index. | Amount Recovered Over Dosing Interval Normalized by Body Mass Index | ||
| RCAMTAUS | C102365 | Amt Rec Over Dosing Interval Norm by SA | The cumulative amount recovered from the specimen type specified in PPSPEC between doses (TAU) divided by surface area. | Amount Recovered Over Dosing Interval Normalized by Surface Area | ||
| RCAMTAUW | C102366 | Amt Rec Over Dosing Interval Norm by WT | The cumulative amount recovered from the specimen type specified in PPSPEC between doses (TAU) divided by weight. | Amount Recovered Over Dosing Interval Normalized by Weight | ||
| RCPCIFO | C112034 | Pct Rec Infinity Obs | The percentage of the administered dose that is recovered from the specimen type specified in PPSPEC extrapolated to infinity, calculated using the observed value of the last non-zero concentration. | Percent Recovered Infinity Observed | ||
| RCPCIFOB | C112389 | Pct Rec Infinity Obs Norm by BMI | The percentage of the administered dose that is recovered from the specimen type specified in PPSPEC extrapolated to infinity, calculated using the observed value of the last non-zero concentration, divided by the body mass index. | Percent Recovered Infinity Observed Normalized by Body Mass Index | ||
| RCPCIFOS | C112390 | Pct Rec Infinity Obs Norm by SA | The percentage of the administered dose that is recovered from the specimen type specified in PPSPEC extrapolated to infinity, calculated using the observed value of the last non-zero concentration, divided by the surface area. | Percent Recovered Infinity Observed Normalized by Surface Area | ||
| RCPCIFOW | C112391 | Pct Rec Infinity Obs Norm by WT | The percentage of the administered dose that is recovered from the specimen type specified in PPSPEC extrapolated to infinity, calculated using the observed value of the last non-zero concentration, divided by the weight. | Percent Recovered Infinity Observed Normalized by Weight | ||
| RCPCIFP | C112035 | Pct Rec Infinity Pred | The percentage of the administered dose that is recovered from the specimen type specified in PPSPEC extrapolated to infinity, calculated using the predicted value of the last non-zero concentration. | Percent Recovered Infinity Predicted | ||
| RCPCIFPB | C112392 | Pct Rec Infinity Pred Norm by BMI | The percentage of the administered dose that is recovered from the specimen type specified in PPSPEC extrapolated to infinity, calculated using the predicted value of the last non-zero concentration, divided by the body mass index. | Percent Recovered Infinity Predicted Normalized by Body Mass Index | ||
| RCPCIFPS | C112393 | Pct Rec Infinity Pred Norm by SA | The percentage of the administered dose that is recovered from the specimen type specified in PPSPEC extrapolated to infinity, calculated using the predicted value of the last non-zero concentration, divided by the surface area. | Percent Recovered Infinity Predicted Normalized by Surface Area | ||
| RCPCIFPW | C112394 | Pct Rec Infinity Pred Norm by WT | The percentage of the administered dose that is recovered from the specimen type specified in PPSPEC extrapolated to infinity, calculated using the predicted value of the last non-zero concentration, divided by the weight. | Percent Recovered Infinity Predicted Normalized by Weight | ||
| RCPCINT | C102382 | Pct Rec from T1 to T2 | The percentage of the administered dose that is recovered from the specimen type specified in PPSPEC, over the interval between T1 and T2. | Percent Recovered from T1 to T2 | ||
| RCPCINTB | C102383 | Pct Rec from T1 to T2 Norm by BMI | The percentage of the administered dose that is recovered from the specimen type specified in PPSPEC, over the interval between T1 and T2 divided by body mass index. | Percent Recovered from T1 to T2 Normalized by Body Mass Index | ||
| RCPCINTS | C102384 | Pct Rec from T1 to T2 Norm by SA | The percentage of the administered dose that is recovered from the specimen type specified in PPSPEC, over the interval between T1 and T2 divided by surface area. | Percent Recovered from T1 to T2 Normalized by Surface Area | ||
| RCPCINTW | C102385 | Pct Rec from T1 to T2 Norm by WT | The percentage of the administered dose that is recovered from the specimen type specified in PPSPEC, over the interval between T1 and T2 divided by weight. | Percent Recovered from T1 to T2 Normalized by Weight | ||
| RCPCTAU | C102386 | Pct Rec Over Dosing Interval | The percentage of the administered dose that is recovered from the specimen type specified in PPSPEC, between doses (TAU). | Percent Recovered Over Dosing Interval | ||
| RCPCTAUB | C102387 | Pct Rec Over Dosing Interval Norm by BMI | The percentage of the administered dose that is recovered from the specimen type specified in PPSPEC, between doses (TAU) divided by the body mass index. | Percent Recovered Over Dosing Interval Normalized by Body Mass Index | ||
| RCPCTAUS | C102388 | Pct Rec Over Dosing Interval Norm by SA | The percentage of the administered dose that is recovered from the specimen type specified in PPSPEC, between doses (TAU) divided by surface area. | Percent Recovered Over Dosing Interval Normalized by Surface Area | ||
| RCPCTAUW | C102389 | Pct Rec Over Dosing Interval Norm by WT | The percentage of the administered dose that is recovered from the specimen type specified in PPSPEC, between doses (TAU) divided by weight. | Percent Recovered Over Dosing Interval Normalized by Weight | ||
| RENALCL | C75913 | Renal CL | The clearance of a substance from the blood by the kidneys. | Renal Clearance | ||
| RENALCLB | C105458 | Renal CL Norm by BMI | The clearance of a substance from the blood by the kidneys divided by the body mass index. | Renal Clearance Normalized by BMI | ||
| RENALCLD | C105459 | Renal CL Norm by Dose | The clearance of a substance from the blood by the kidneys divided by the dose. | Renal Clearance Normalized by Dose | ||
| RENALCLS | C105460 | Renal CL Norm by SA | The clearance of a substance from the blood by the kidneys divided by the surface area. | Renal Clearance Normalized by SA | ||
| RENALCLW | C105461 | Renal CL Norm by WT | The clearance of a substance from the blood by the kidneys divided by the weight. | Renal Clearance Normalized by WT | ||
| TLAG | C85824 | Time Until First Nonzero Conc | The time prior to the first measurable (non-zero) concentration. | Time until First Nonzero Concentration | ||
| TLST | C85822 | Time of Last Nonzero Conc | The time of the last measurable (positive) concentration. | Time of Last Nonzero Concentration | ||
| TMAX | C70919 | Time of CMAX | The time of maximum observed concentration sampled during a dosing interval. | Tmax | ||
| TMIN | C85825 | Time of CMIN Observation | The time of minimum concentration sampled during a dosing interval. | Tmin | ||
| V0 | C102371 | Vol Dist Initial | The initial volume of distribution for a substance administered by bolus intravascular dosing. | Initial Volume of Distribution | ||
| V0B | C102372 | Vol Dist Initial Norm by BMI | The initial volume of distribution for a substance administered by bolus intravascular dosing divided by the body mass index. | Initial Volume of Distribution Normalized by Body Mass Index | ||
| V0D | C102373 | Vol Dist Initial Norm by Dose | The initial volume of distribution for a substance administered by bolus intravascular dosing divided by the dose. | Initial Volume of Distribution Normalized by Dose | ||
| V0S | C102374 | Vol Dist Initial Norm by SA | The initial volume of distribution for a substance administered by bolus intravascular dosing divided by the surface area. | Initial Volume of Distribution Normalized by Surface Area | ||
| V0W | C102375 | Vol Dist Initial Norm by WT | The initial volume of distribution for a substance administered by bolus intravascular dosing divided by the weight. | Initial Volume of Distribution Normalized by Weight | ||
| VOLPK | C85817 | Sum of Urine Vol | The sum of urine volumes that are used for PK parameters. | Sum Urine Volume | ||
| VSSO | C85770 | Vol Dist Steady State Obs | The volume of distribution at steady state based on the observed CLST for a substance administered by intravascular dosing. | Observed Steady State Volume of Distribution | ||
| VSSOB | C102377 | Vol Dist Steady State Obs Norm by BMI | The volume of distribution at steady state based on the observed CLST for a substance administered by intravascular dosing divided by the body mass index. | Observed Steady State Volume of Distribution Normalized by Body Mass Index | ||
| VSSOD | C102378 | Vol Dist Steady State Obs Norm by Dose | The volume of distribution at steady state based on the observed CLST for a substance administered by intravascular dosing divided by the dose. | Observed Steady State Volume of Distribution Normalized by Dose | ||
| VSSOS | C102379 | Vol Dist Steady State Obs Norm by SA | The volume of distribution at steady state based on the observed CLST for a substance administered by intravascular dosing divided by the surface area. | Observed Steady State Volume of Distribution Normalized by Surface Area | ||
| VSSOW | C102380 | Vol Dist Steady State Obs Norm by WT | The volume of distribution at steady state based on the observed CLST for a substance administered by intravascular dosing divided by the weight. | Observed Steady State Volume of Distribution Normalized by Weight | ||
| VSSP | C85794 | Vol Dist Steady State Pred | The volume of distribution at steady state based on the predicted CLST for a substance administered by intravascular dosing. | Predicted Steady State Volume of Distribution | ||
| VSSPB | C102390 | Vol Dist Steady State Pred Norm by BMI | The volume of distribution at steady state based on the predicted CLST for a substance administered by intravascular dosing divided by the body mass index. | Predicted Steady State Volume of Distribution Normalized by Body Mass Index | ||
| VSSPD | C102391 | Vol Dist Steady State Pred Norm by Dose | The volume of distribution at steady state based on the predicted CLST for a substance administered by intravascular dosing divided by the dose. | Predicted Steady State Volume of Distribution Normalized by Dose | ||
| VSSPS | C102392 | Vol Dist Steady State Pred Norm by SA | The volume of distribution at steady state based on the predicted CLST for a substance administered by intravascular dosing divided by the surface area. | Predicted Steady State Volume of Distribution Normalized by Surface Area | ||
| VSSPW | C102393 | Vol Dist Steady State Pred Norm by WT | The volume of distribution at steady state based on the predicted CLST for a substance administered by intravascular dosing divided by the weight. | Predicted Steady State Volume of Distribution Normalized by Weight | ||
| VZFO | C85775 | Vz Obs by F | The volume of distribution associated with the terminal slope following extravascular administration divided by the fraction of dose absorbed, calculated using the observed value of the last non-zero concentration. | Observed Volume of Distribution of Absorbed Fraction | ||
| VZFOB | C92410 | Vz Obs by F Norm by BMI | The volume of distribution associated with the terminal slope following extravascular administration divided by the fraction of dose absorbed, calculated using the observed value of the last non-zero concentration, divided by the body mass index. | Volume of Distribution of Fraction Dose Observed Normalized by Body Mass Index | ||
| VZFOD | C102729 | Vz Obs by F Norm by Dose | The volume of distribution associated with the terminal slope following extravascular administration divided by the fraction of dose absorbed, calculated using the observed value of the last non-zero concentration, divided by the dose. | Volume of Distribution of Fraction Dose Observed Normalized by Dose | ||
| VZFOS | C92411 | Vz Obs by F Norm by SA | The volume of distribution associated with the terminal slope following extravascular administration divided by the fraction of dose absorbed, calculated using the observed value of the last non-zero concentration, divided by the surface area. | Volume of Distribution of Fraction Dose Observed Normalized by Surface Area | ||
| VZFOW | C92412 | Vz Obs by F Norm by WT | The volume of distribution associated with the terminal slope following extravascular administration divided by the fraction of dose absorbed, calculated using the observed value of the last non-zero concentration, divided by the weight. | Volume of Distribution of Fraction Dose Observed Normalized by Weight | ||
| VZFP | C85799 | Vz Pred by F | The volume of distribution associated with the terminal slope following extravascular administration divided by the fraction of dose absorbed, calculated using the predicted value of the last non-zero concentration. | Predicted Volume of Distribution of Absorbed Fraction | ||
| VZFPB | C92428 | Vz Pred by F Norm by BMI | The volume of distribution associated with the terminal slope following extravascular administration divided by the fraction of dose absorbed, calculated using the predicted value of the last non-zero concentration, divided by the body mass index. | Volume of Distribution of Fraction Dose Predicted Normalized by Body Mass Index | ||
| VZFPD | C102730 | Vz Pred by F Norm by Dose | The volume of distribution associated with the terminal slope following extravascular administration divided by the fraction of dose absorbed, calculated using the predicted value of the last non-zero concentration, divided by the dose. | Volume of Distribution of Fraction Dose Predicted Normalized by Dose | ||
| VZFPS | C92429 | Vz Pred by F Norm by SA | The volume of distribution associated with the terminal slope following extravascular administration divided by the fraction of dose absorbed, calculated using the predicted value of the last non-zero concentration, divided by the surface area. | Volume of Distribution of Fraction Dose Predicted Normalized by Surface Area | ||
| VZFPW | C92430 | Vz Pred by F Norm by WT | The volume of distribution associated with the terminal slope following extravascular administration divided by the fraction of dose absorbed, calculated using the predicted value of the last non-zero concentration, divided by the weight. | Volume of Distribution of Fraction Dose Predicted Normalized by Weight | ||
| VZFTAU | C111364 | Vz for Dose Int by F | The volume of distribution associated with the terminal slope following extravascular administration divided by the fraction of dose absorbed, calculated using AUCTAU. | Volume of Distribution for Dosing Interval by Fraction | ||
| VZFTAUB | C111365 | Vz for Dose Int by F Norm by BMI | The volume of distribution associated with the terminal slope following extravascular administration divided by the fraction of dose absorbed, calculated using AUCTAU, divided by the body mass index. | Volume of Distribution for Dosing Interval by Fraction Normalized by Body Mass Index | ||
| VZFTAUD | C111366 | Vz for Dose Int by F Norm by Dose | The volume of distribution associated with the terminal slope following extravascular administration divided by the fraction of dose absorbed, calculated using AUCTAU, divided by the dose. | Volume of Distribution for Dosing Interval by Fraction Normalized by Dose | ||
| VZFTAUS | C111367 | Vz for Dose Int by F Norm by SA | The volume of distribution associated with the terminal slope following extravascular administration divided by the fraction of dose absorbed, calculated using AUCTAU, divided by the surface area. | Volume of Distribution for Dosing Interval by Fraction Normalized by Surface Area | ||
| VZFTAUW | C111368 | Vz for Dose Int by F Norm by WT | The volume of distribution associated with the terminal slope following extravascular administration divided by the fraction of dose absorbed, calculated using AUCTAU, divided by the weight. | Volume of Distribution for Dosing Interval by Fraction Normalized by Weight | ||
| VZO | C85774 | Vz Obs | The volume of distribution associated with the terminal slope following intravascular administration, calculated using the observed value of the last non-zero concentration. | Observed Volume of Distribution | ||
| VZOB | C92407 | Vz Obs Norm by BMI | The volume of distribution associated with the terminal slope following intravascular administration, calculated using the observed value of the last non-zero concentration, divided by the body mass index. | Volume of Distribution Observed Normalized by Body Mass Index | ||
| VZOD | C102683 | Vz Obs Norm by Dose | The volume of distribution associated with the terminal slope following intravascular administration, calculated using the observed value of the last non-zero concentration, divided by the dose. | Observed Volume of Distribution Normalized by Dose | ||
| VZOS | C92408 | Vz Obs Norm by SA | The volume of distribution associated with the terminal slope following intravascular administration, calculated using the observed value of the last non-zero concentration, divided by the surface area. | Volume of Distribution Observed Normalized by Surface Area | ||
| VZOW | C92409 | Vz Obs Norm by WT | The volume of distribution associated with the terminal slope following intravascular administration, calculated using the observed value of the last non-zero concentration, divided by the weight. | Volume of Distribution Observed Normalized by Weight | ||
| VZP | C85798 | Vz Pred | The volume of distribution associated with the terminal slope following intravascular administration, calculated using the predicted value of the last non-zero concentration. | Predicted Volume of Distribution | ||
| VZPB | C92425 | Vz Pred Norm by BMI | The volume of distribution associated with the terminal slope following intravascular administration, calculated using the predicted value of the last non-zero concentration, divided by the body mass index. | Volume of Distribution Predicted Normalized by Body Mass Index | ||
| VZPD | C102696 | Vz Pred Norm by Dose | The volume of distribution associated with the terminal slope following intravascular administration, calculated using the predicted value of the last non-zero concentration, divided by the dose. | Predicted Volume of Distribution Normalized by Dose | ||
| VZPS | C92426 | Vz Pred Norm by SA | The volume of distribution associated with the terminal slope following intravascular administration, calculated using the predicted value of the last non-zero concentration, divided by the surface area. | Volume of Distribution Predicted Normalized by Surface Area | ||
| VZPW | C92427 | Vz Pred Norm by WT | The volume of distribution associated with the terminal slope following intravascular administration, calculated using the predicted value of the last non-zero concentration, divided by the weight. | Volume of Distribution Predicted Normalized by Weight | ||
| VZTAU | C111333 | Vz for Dose Int | The volume of distribution associated with the terminal slope following intravascular administration, calculated using AUCTAU. | Volume of Distribution for Dosing Interval | ||
| VZTAUB | C111369 | Vz for Dose Int Norm by BMI | The volume of distribution associated with the terminal slope following intravascular administration, calculated using AUCTAU, divided by the body mass index. | Volume of Distribution for Dosing Interval Normalized by Body Mass Index | ||
| VZTAUD | C111370 | Vz for Dose Int Norm by Dose | The volume of distribution associated with the terminal slope following intravascular administration, calculated using AUCTAU, divided by the dose. | Volume of Distribution for Dosing Interval Normalized by Dose | ||
| VZTAUS | C111371 | Vz for Dose Int Norm by SA | The volume of distribution associated with the terminal slope following intravascular administration, calculated using AUCTAU, divided by the surface area. | Volume of Distribution for Dosing Interval Normalized by Surface Area | ||
| VZTAUW | C111372 | Vz for Dose Int Norm by WT | The volume of distribution associated with the terminal slope following intravascular administration, calculated using AUCTAU, divided by the weight. | Volume of Distribution for Dosing Interval Normalized by Weight | ||
| Back to top | ||||||
| CL.C85494.PKUNIT | PK Units of Measure (PKUNIT) | text Extensible: Yes | C85494 | PK Units of Measure | Units of measure for pharmacokinetic data and parameters. | CDISC SDTM Pharmacokinetic Parameter Unit of Measure Terminology |
| % | C25613 | Percentage | A fraction or ratio with 100 understood as the denominator. (NCI) | Percentage | ||
| (L/day)/g | C85657 | L/g/d;mL/mg/day;uL/ug/day | Liters per day (flow), divided by grams (weight). | Liter per Gram per Day | ||
| (L/day)/mg | C85672 | L/day/mg;L/mg/d;mL/day/ug;mL/ug/day | Liters per day (flow), divided by milligrams (dose). | Liter per Milligram per Day | ||
| (L/day)/ug | C85665 | L/day/mcg;L/day/ug;L/mcg/day;mL/day/ng;mL/ng/day | Liters per day (flow), divided by micrograms (dose). | Liter per Microgram per Day | ||
| (L/h)/g | C85658 | L/g/h;L/h/g;mL/h/mg;mL/mg/h;uL/h/ug;uL/ug/h | Liters per hour (flow), divided by grams (weight). | Liter per Gram per Hour | ||
| (L/h)/mg | C85673 | L/h/mg;L/mg/h;mL/h/ug;mL/ug/h | Liters per hour (flow), divided by milligrams (dose). | Liter per Milligram per Hour | ||
| (L/h)/ug | C85662 | L/h/mcg;L/h/ug;L/mcg/h;L/ug/h;mL/h/ng;mL/ng/h | Liters per hour (flow), divided by micrograms (dose). | Liter per Microgram per Hour | ||
| (L/min)/g | C85659 | L/g/min;L/min/g;mL/mg/min;uL/ug/min | Liters per minute (flow), divided by grams (weight). | Liter per Gram per Minute | ||
| (L/min)/mg | C85674 | L/mg/min;L/min/mg;mL/min/ug;mL/ug/min | Liters per minute (flow), divided by milligrams (dose). | Liter per Milligram per Minute | ||
| (L/min)/ug | C85666 | L/mcg/min;L/min/mcg;L/min/ug;mL/min/ng;mL/ng/min | Liters per minute (flow), divided by micrograms (dose). | Liter per Microgram per Minute | ||
| /h | C66966 | Per Hour | A rate of occurrences of something within a period of time equal to sixty minutes. | Per Hour | ||
| day | C25301 | Day | The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours. This also refers to a specific day. (NCI) | Day | ||
| day*fg/mL | C85583 | Days times femtograms per milliliter (area under the curve). | Day Times Femtogram per Milliliter | |||
| day*fg/mL/(kg/m2) | C111167 | Days times femtograms per milliliter (area under the curve), divided by kilograms per meter squared (body mass index). | Day Times Femtogram per Milliliter per Kilogram per Meter Squared | |||
| day*fg/mL/(mg/g) | C117894 | Days times femtograms per milliliter (area under the curve), divided by milligrams per gram (dose normalized by body weight). | Day Times Femtogram Per Milliliter Per Milligram Per Gram | |||
| day*fg/mL/(mg/g/day) | C117895 | Days times femtograms per milliliter (area under the curve), divided by milligrams per gram per day (daily dose normalized by body weight). | Day Times Femtogram Per Milliliter Per Milligram Per Gram Per Day | |||
| day*fg/mL/g | C112244 | Days times femtograms per milliliter (area under the curve), divided by grams (weight). | Day Times Femtogram Per Milliliter Per Gram | |||
| day*fg/mL/kg | C112245 | Days times femtograms per milliliter (area under the curve), divided by kilograms (weight). | Day Times Femtogram Per Milliliter Per Kilogram | |||
| day*fg/mL/m2 | C111168 | Days times femtograms per milliliter (area under the curve), divided by meters squared (surface area). | Day Times Femtogram per Milliliter per Meter Squared | |||
| day*g/mL | C85584 | Days times grams per milliliter (area under the curve). | Day Times Gram per Milliliter | |||
| day*g/mL/(kg/m2) | C111169 | Days times grams per milliliter (area under the curve), divided by kilograms per meter squared (body mass index). | Day Times Gram per Milliliter per Kilogram per Meter Squared | |||
| day*g/mL/(mg/g) | C117896 | Days times grams per milliliter (area under the curve), divided by milligrams per gram (dose normalized by body weight). | Day Times gram Per Milliliter Per Milligram Per Gram | |||
| day*g/mL/(mg/g/day) | C117897 | Days times grams per milliliter (area under the curve), divided by milligrams per gram per day (daily dose normalized by body weight). | Day Times gram Per Milliliter Per Milligram Per Gram Per Day | |||
| day*g/mL/g | C112246 | Days times grams per milliliter (area under the curve), divided by grams (weight). | Day Times Gram Per Milliliter Per Gram | |||
| day*g/mL/kg | C112247 | Days times grams per milliliter (area under the curve), divided by kilograms (weight). | Day Times Gram Per Milliliter Per Kilogram | |||
| day*g/mL/m2 | C111170 | Days times grams per milliliter (area under the curve), divided by meters squared (surface area). | Day Times Gram per Milliliter per Meter Squared | |||
| day*mg/mL | C85588 | Days times milligrams per milliliter (area under the curve). | Day Times Milligram per Milliliter | |||
| day*mg/mL/(kg/m2) | C111175 | Days times milligrams per milliliter (area under the curve), divided by kilograms per meter squared (body mass index). | Day Times Milligram per Milliliter per Kilogram per Meter Squared | |||
| day*mg/mL/(mg/g) | C117898 | Days times milligrams per milliliter (area under the curve), divided by milligrams per gram (dose normalized by body weight). | Day Times Milligram Per Milliliter Per Milligram Per Gram | |||
| day*mg/mL/(mg/g/day) | C117899 | Days times milligrams per milliliter (area under the curve), divided by milligrams per gram per day (daily dose normalized by body weight). | Day Times Milligram Per Milliliter Per Milligram Per Gram Per Day | |||
| day*mg/mL/g | C112252 | Days times milligrams per milliliter (area under the curve), divided by grams (weight). | Day Times Milligram Per Milliliter Per Gram | |||
| day*mg/mL/kg | C112253 | Days times milligrams per milliliter (area under the curve), divided by kilograms (weight). | Day Times Milligram Per Milliliter Per Kilogram | |||
| day*mg/mL/m2 | C111176 | Days times milligrams per milliliter (area under the curve), divided by meters squared (surface area). | Day Times Milligram per Milliliter per Meter Squared | |||
| day*mmol/L | C85587 | Days times millimoles per liter (area under the curve). | Day Times Micromole per Milliliter | |||
| day*mmol/L/(kg/m2) | C111177 | Days times millimoles per liter (area under the curve), divided by kilograms per meter squared (body mass index). | Day Times Millimole per Liter per Kilogram per Meter Squared | |||
| day*mmol/L/(mg/g) | C117900 | Days times millimoles per liter (area under the curve), divided by milligrams per gram (dose normalized by body weight). | Day Times Millimole Per Liter Per Milligram Per Gram | |||
| day*mmol/L/(mg/g/day) | C117901 | Days times millimoles per liter (area under the curve), divided by milligrams per gram per day (daily dose normalized by body weight). | Day Times Millimole Per Liter Per Milligram Per Gram Per Day | |||
| day*mmol/L/g | C112254 | Days times millimoles per liter (area under the curve), divided by grams (weight). | Day Times Millimole Per Liter Per Gram | |||
| day*mmol/L/kg | C112255 | Days times millimoles per liter (area under the curve), divided by kilograms (weight). | Day Times Millimole Per Liter Per Kilogram | |||
| day*mmol/L/m2 | C111178 | Days times millimoles per liter (area under the curve), divided by meters squared (surface area). | Day Times Millimole per Liter per Meter Squared | |||
| day*mol/L | C85589 | Days times moles per liter (area under the curve). | Day Times Millimole per Milliliter | |||
| day*mol/L/(kg/m2) | C111179 | Days times moles per liter (area under the curve), divided by kilograms per meter squared (body mass index). | Day Times Mole per Liter per Kilogram per Meter Squared | |||
| day*mol/L/(mg/g) | C117902 | Days times moles per liter (area under the curve), divided by milligrams per gram (dose normalized by body weight). | Day Times mole Per Liter Per Milligram Per Gram | |||
| day*mol/L/(mg/g/day) | C117903 | Days times moles per liter (area under the curve), divided by milligrams per gram per day (daily dose normalized by body weight). | Day Times mole Per Liter Per Milligram Per Gram Per Day | |||
| day*mol/L/g | C112256 | Days times moles per liter (area under the curve), divided by grams (weight). | Day Times Mole Per Liter Per Gram | |||
| day*mol/L/kg | C112257 | Days times moles per liter (area under the curve), divided by kilograms (weight). | Day Times Mole Per Liter Per Kilogram | |||
| day*mol/L/m2 | C111180 | Days times moles per liter (area under the curve), divided by meters squared (surface area). | Day Times Mole per Liter per Meter Squared | |||
| day*ng/mL | C85591 | Days times nanograms per milliliter (area under the curve). | Day Times Nanogram per Milliliter | |||
| day*ng/mL/(kg/m2) | C111181 | Days times nanograms per milliliter (area under the curve), divided by kilograms per meter squared (body mass index). | Day Times Nanogram per Milliliter per Kilogram per Meter Squared | |||
| day*ng/mL/(mg/g) | C117904 | Days times nanograms per milliliter (area under the curve), divided by milligrams per gram (dose normalized by body weight). | Day Times Nanogram Per Milliliter Per Milligram Per Gram | |||
| day*ng/mL/(mg/g/day) | C117905 | Days times nanograms per milliliter (area under the curve), divided by milligrams per gram per day (daily dose normalized by body weight). | Day Times Nanogram Per Milliliter Per Milligram Per Gram Per Day | |||
| day*ng/mL/g | C112258 | Days times nanograms per milliliter (area under the curve), divided by grams (weight). | Day Times Nanogram Per Milliliter Per Gram | |||
| day*ng/mL/kg | C112259 | Days times nanograms per milliliter (area under the curve), divided by kilograms (weight). | Day Times Nanogram Per Milliliter Per Kilogram | |||
| day*ng/mL/m2 | C111182 | Days times nanograms per milliliter (area under the curve), divided by meters squared (surface area). | Day Times Nanogram per Milliliter per Meter Squared | |||
| day*nmol/L | C85594 | Days times nanomoles per liter (area under the curve). | Day Times Picomole per Milliliter | |||
| day*nmol/L/(kg/m2) | C111183 | Days times nanomoles per liter (area under the curve), divided by kilograms per meter squared (body mass index). | Day Times Nanomole per Liter per Kilogram per Meter Squared | |||
| day*nmol/L/(mg/g) | C117906 | Days times nanomoles per liter (area under the curve), divided by milligrams per gram (dose normalized by body weight). | Day Times Nanomole Per Liter Per Milligram Per Gram | |||
| day*nmol/L/(mg/g/day) | C117907 | Days times nanomoles per liter (area under the curve), divided by milligrams per gram per day (daily dose normalized by body weight). | Day Times Nanomole Per Liter Per Milligram Per Gram Per Day | |||
| day*nmol/L/g | C112260 | Days times nanomoles per liter (area under the curve), divided by grams (weight). | Day Times Nanomole Per Liter Per Gram | |||
| day*nmol/L/kg | C112261 | Days times nanomoles per liter (area under the curve), divided by kilograms (weight). | Day Times Nanomole Per Liter Per Kilogram | |||
| day*nmol/L/m2 | C111184 | Days times nanomoles per liter (area under the curve), divided by meters squared (surface area). | Day Times Nanomole per Liter per Meter Squared | |||
| day*pg/mL | C85593 | Days times picograms per milliliter (area under the curve). | Day Times Picogram per Milliliter | |||
| day*pg/mL/(kg/m2) | C111185 | Days times picograms per milliliter (area under the curve), divided by kilograms per meter squared (body mass index). | Day Times Picogram per Milliliter per Kilogram per Meter Squared | |||
| day*pg/mL/(mg/g) | C117908 | Days times picograms per milliliter (area under the curve), divided by milligrams per gram (dose normalized by body weight). | Day Times Picogram Per Milliliter Per Milligram Per Gram | |||
| day*pg/mL/(mg/g/day) | C117909 | Days times picograms per milliliter (area under the curve), divided by milligrams per gram per day (daily dose normalized by body weight). | Day Times Picogram Per Milliliter Per Milligram Per Gram Per Day | |||
| day*pg/mL/g | C112262 | Days times picograms per milliliter (area under the curve), divided by grams (weight). | Day Times Picogram Per Milliliter Per Gram | |||
| day*pg/mL/kg | C112263 | Days times picograms per milliliter (area under the curve), divided by kilograms (weight). | Day Times Picogram Per Milliliter Per Kilogram | |||
| day*pg/mL/m2 | C111186 | Days times picograms per milliliter (area under the curve), divided by meters squared (surface area). | Day Times Picogram per Milliliter per Meter Squared | |||
| day*pmol/L | C111187 | Days times picomoles per liter (area under the curve). | Day Times Picomole per Liter | |||
| day*pmol/L/(kg/m2) | C111188 | Days times picomoles per liter (area under the curve), divided by kilograms per meter squared (body mass index). | Day Times Picomole per Liter per Kilogram per Meter Squared | |||
| day*pmol/L/(mg/g) | C117910 | Days times picomoles per liter (area under the curve), divided by milligrams per gram (dose normalized by body weight). | Day Times Picomole Per Liter Per Milligram Per Gram | |||
| day*pmol/L/(mg/g/day) | C117911 | Days times picomoles per liter (area under the curve), divided by milligrams per gram per day (daily dose normalized by body weight). | Day Times Picomole Per Liter Per Milligram Per Gram Per Day | |||
| day*pmol/L/g | C112264 | Days times picomoles per liter (area under the curve), divided by grams (weight). | Day Times Picomole Per Liter Per Gram | |||
| day*pmol/L/kg | C112265 | Days times picomoles per liter (area under the curve), divided by kilograms (weight). | Day Times Picomole Per Liter Per Kilogram | |||
| day*pmol/L/m2 | C111189 | Days times picomoles per liter (area under the curve), divided by meters squared (surface area). | Day Times Picomole per Liter per Meter Squared | |||
| day*ug/mL | C85586 | Days times micrograms per milliliter (area under the curve). | Day Times Microgram per Milliliter | |||
| day*ug/mL/(kg/m2) | C111171 | Days times micrograms per milliliter (area under the curve), divided by kilograms per meter squared (body mass index). | Day Times Microgram per Milliliter per Kilogram per Meter Squared | |||
| day*ug/mL/(mg/g) | C117912 | Days times micrograms per milliliter (area under the curve), divided by milligrams per gram (dose normalized by body weight). | Day Times Microgram Per Milliliter Per Milligram Per Gram | |||
| day*ug/mL/(mg/g/day) | C117913 | Days times micrograms per milliliter (area under the curve), divided by milligrams per gram per day (daily dose normalized by body weight). | Day Times Microgram Per Milliliter Per Milligram Per Gram Per Day | |||
| day*ug/mL/g | C112248 | Days times micrograms per milliliter (area under the curve), divided by grams (weight). | Day Times Microgram Per Milliliter Per Gram | |||
| day*ug/mL/kg | C112249 | Days times micrograms per milliliter (area under the curve), divided by kilograms (weight). | Day Times Microgram Per Milliliter Per Kilogram | |||
| day*ug/mL/m2 | C111172 | Days times micrograms per milliliter (area under the curve), divided by meters squared (surface area). | Day Times Microgram per Milliliter per Meter Squared | |||
| day*umol/L | C85592 | Days times micromoles per liter (area under the curve). | Day Times Nanomole per Milliliter | |||
| day*umol/L/(kg/m2) | C111173 | Days times micromoles per liter (area under the curve), divided by kilograms per meter squared (body mass index). | Day Times Micromole per Liter per Kilogram per Meter Squared | |||
| day*umol/L/(mg/g) | C117914 | Days times micromoles per liter (area under the curve), divided by milligrams per gram (dose normalized by body weight). | Day Times Micromole Per Liter Per Milligram Per Gram | |||
| day*umol/L/(mg/g/day) | C117915 | Days times micromoles per liter (area under the curve), divided by milligrams per gram per day (daily dose normalized by body weight). | Day Times Micromole Per Liter Per Milligram Per Gram Per Day | |||
| day*umol/L/g | C112250 | Days times micromoles per liter (area under the curve), divided by grams (weight). | Day Times Micromole Per Liter Per Gram | |||
| day*umol/L/kg | C112251 | Days times micromoles per liter (area under the curve), divided by kilograms (weight). | Day Times Micromole Per Liter Per Kilogram | |||
| day*umol/L/m2 | C111174 | Days times micromoles per liter (area under the curve), divided by meters squared (surface area). | Day Times Micromole per Liter per Meter Squared | |||
| fg/mL | C85597 | fg/mL;pg/L | A unit of concentration or mass density equal to one femtogram of substance per milliliter of solution or one picogram of substance per liter of solution. | Femtogram per Milliliter | ||
| fg/mL/(kg/m2) | C119336 | Femtograms per milliliter (concentration), divided by kilograms per meter squared (body mass index). | Femtogram per Milliliter per Kilogram per Meter Squared | |||
| fg/mL/(mg/day) | C119337 | Femtograms per milliliter (concentration), divided by milligrams per day (daily dose). | Femtogram per Milliliter per Milligram per Day | |||
| fg/mL/(mg/kg) | C119338 | Femtograms per milliliter (concentration), divided by milligrams per kilogram. | Femtogram per Milliliter per Milligram per Kilogram | |||
| fg/mL/(mg/kg/day) | C119339 | Femtograms per milliliter (concentration), divided by milligrams per kilogram per day. | Femtogram per Milliliter per Milligram per Kilogram per Day | |||
| fg/mL/(mg/m2) | C119340 | Femtograms per milliliter (concentration), divided by milligrams per meter squared. | Femtogram per Milliliter per Milligram per Meter Squared | |||
| fg/mL/(mg/m2/day) | C119341 | Femtograms per milliliter (concentration), divided by milligrams per meter squared per day (daily dose normalized by surface area). | Femtogram per Milliliter per Milligram per Meter Squared per Day | |||
| fg/mL/(ug/day) | C119342 | Femtograms per milliliter (concentration), divided by micrograms per day (daily dose). | Femtogram per Milliliter per Microgram per Day | |||
| fg/mL/(ug/kg) | C119343 | Femtograms per milliliter (concentration), divided by micrograms per kilogram. | Femtogram per Milliliter per Microgram per Kilogram | |||
| fg/mL/(ug/kg/day) | C119344 | Femtograms per milliliter (concentration), divided by micrograms per kilogram per day. | Femtogram per Milliliter per Microgram per Kilogram per Day | |||
| fg/mL/(ug/m2) | C119345 | Femtograms per milliliter (concentration), divided by micrograms per meter squared. | Femtogram per Milliliter per Microgram per Meter Squared | |||
| fg/mL/(ug/m2/day) | C119346 | Femtograms per milliliter (concentration), divided by micrograms per meter squared per day (daily dose normalized by surface area). | Femtogram per Milliliter per Microgram per Meter Squared per Day | |||
| fg/mL/g | C119347 | Femtograms per milliliter (concentration), divided by grams (weight). | Femtogram per Milliliter per Gram | |||
| fg/mL/kg | C119348 | Femtograms per milliliter (concentration), divided by kilograms (weight). | Femtogram per Milliliter per Kilogram | |||
| fg/mL/m2 | C119349 | Femtograms per milliliter (concentration), divided by meters squared (surface area). | Femtogram per Milliliter per Meter Square | |||
| fg/mL/mg | C119350 | Femtograms per milliliter (concentration), divided by milligrams (dose). | Femtogram per Milliliter per Milligram | |||
| fg/mL/ug | C119351 | Femtograms per milliliter (concentration), divided by micrograms (dose). | Femtogram per Milliliter per Microgram | |||
| g | C48155 | Gram | A metric unit of mass equal to one one thousandth of a kilogram. (NCI) | Gram | ||
| g/day | C67372 | Gram per Day;g/24h;g/d;gram/24 Hours;gram/day | A dose calculation unit expressed in gram(s) per period of time equal to twenty-four hours. | Gram per 24 Hours | ||
| g/h | C85601 | g/h;gram/h | Grams per hour. | Gram per Hour | ||
| g/min | C85602 | g/min;gram/min | Grams per minute. | Gram per Minute | ||
| g/mL | C64566 | Gram per Milliliter;Kilogram per Liter;g/mL;gram/mL;kg/L;mg/uL | A unit of concentration or mass density equal to one gram of substance per milliliter of solution or one kilogram of substance per liter of solution. | Kilogram per Liter | ||
| g/mL/(kg/m2) | C119352 | Grams per milliliter (concentration), divided by kilograms per meter squared (body mass index). | Gram per Milliliter per Kilogram per Meter Squared | |||
| g/mL/(mg/day) | C119353 | Grams per milliliter (concentration), divided by milligrams per day (daily dose). | Gram per Milliliter per Milligram per Day | |||
| g/mL/(mg/kg) | C105462 | Grams per milliliter (concentration), divided by milligrams per kilogram (dose normalized by body weight). | Gram Per Milliliter Per Milligram Per Kilogram | |||
| g/mL/(mg/kg/day) | C105463 | Grams per milliliter (concentration), divided by milligrams per kilogram per day (daily dose normalized by body weight). | Gram Per Milliliter Per Milligram Per Kilogram Per Day | |||
| g/mL/(mg/m2) | C119354 | Grams per milliliter (concentration), divided by milligrams per meter squared. | Gram per Milliliter per Milligram per Meter Squared | |||
| g/mL/(mg/m2/day) | C119355 | Grams per milliliter (concentration), divided by milligrams per meter squared per day (daily dose normalized by surface area). | Gram per Milliliter per Milligram per Meter Squared per Day | |||
| g/mL/(ug/day) | C119356 | Grams per milliliter (concentration), divided by micrograms per day (daily dose). | Gram per Milliliter per Microgram per Day | |||
| g/mL/(ug/kg) | C119357 | Grams per milliliter (concentration), divided by micrograms per kilogram. | Gram per Milliliter per Microgram per Kilogram | |||
| g/mL/(ug/kg/day) | C119358 | Grams per milliliter (concentration), divided by micrograms per kilogram per day. | Gram per Milliliter per Microgram per Kilogram per Day | |||
| g/mL/(ug/m2) | C119359 | Grams per milliliter (concentration), divided by micrograms per meter squared. | Gram per Milliliter per Microgram per Meter Squared | |||
| g/mL/(ug/m2/day) | C119360 | Grams per milliliter (concentration), divided by micrograms per meter squared per day (daily dose normalized by surface area). | Gram per Milliliter per Microgram per Meter Squared per Day | |||
| g/mL/g | C119361 | Grams per milliliter (concentration), divided by grams (weight). | Gram per Milliliter per Gram | |||
| g/mL/kg | C119362 | Grams per milliliter (concentration), divided by kilograms (weight). | Gram per Milliliter per Kilogram | |||
| g/mL/m2 | C119363 | Grams per milliliter (concentration), divided by meters squared (surface area). | Gram per Milliliter per Meter Squared | |||
| g/mL/mg | C119364 | Grams per milliliter (concentration), divided by milligrams (dose). | Gram per Milliliter per Milligram | |||
| g/mL/ug | C119365 | Grams per milliliter (concentration), divided by micrograms (dose). | Gram per Milliliter per Microgram | |||
| h | C25529 | Hour;hr | A unit measure of time equal to 3,600 seconds or 60 minutes. It is approximately 1/24 of a median day. (NCI) | Hour | ||
| h*fg/mL | C85611 | Hours times femtograms per milliliter (area under the curve). | Hour Times Femtogram per Milliliter | |||
| h*fg/mL/(kg/m2) | C111210 | Hours times femtograms per milliliter (area under the curve), divided by kilograms per meter squared (body mass index). | Hour Times Femtogram per Milliliter per Kilogram per Meter Squared | |||
| h*fg/mL/(mg/g) | C117916 | Hours times femtograms per milliliter (area under the curve), divided by milligrams per gram (dose normalized by body weight). | Hour Times Femtogram Per Milliliter Per Milligram Per Gram | |||
| h*fg/mL/(mg/g/day) | C117917 | Hours times femtograms per milliliter (area under the curve), divided by milligrams per gram per day (daily dose normalized by body weight). | Hour Times Femtogram Per Milliliter Per Milligram Per Gram Per Day | |||
| h*fg/mL/g | C112298 | Hours times femtograms per milliliter (area under the curve), divided by grams (weight). | Hour Times Femtogram Per Milliliter Per Gram | |||
| h*fg/mL/kg | C112299 | Hours times femtograms per milliliter (area under the curve), divided by kilograms (weight). | Hour Times Femtogram Per Milliliter Per Kilogram | |||
| h*fg/mL/m2 | C111211 | Hours times femtograms per milliliter (area under the curve), divided by meters squared (surface area). | Hour Times Femtogram per Milliliter per Meter Squared | |||
| h*g/mL | C85613 | Hours times grams per milliliter (area under the curve). | Hour Times Gram per Milliliter | |||
| h*g/mL/(kg/m2) | C111212 | Hours times grams per milliliter (area under the curve), divided by kilograms per meter squared (body mass index). | Hour Times Gram per Milliliter per Kilogram per Meter Squared | |||
| h*g/mL/(mg/g) | C117918 | Hours times grams per milliliter (area under the curve), divided by milligrams per gram (dose normalized by body weight). | Hour Times gram Per Milliliter Per Milligram Per Gram | |||
| h*g/mL/(mg/g/day) | C117919 | Hours times grams per milliliter (area under the curve), divided by milligrams per gram per day (daily dose normalized by body weight). | Hour Times gram Per Milliliter Per Milligram Per Gram Per Day | |||
| h*g/mL/(mg/kg) | C105464 | h*g/mL/(ug/g) | Hours times grams per milliliter (area under the curve), divided by milligrams per kilogram (dose normalized by body weight). | Hour Times Gram Per Milliliter Per Milligram Per Kilogram | ||
| h*g/mL/(mg/kg/day) | C105465 | h*g/mL/(ug/g/day) | Hours times grams per milliliter (area under the curve), divided by milligrams per kilogram per day (daily dose normalized by body weight). | Hour Times Gram Per Milliliter Per Milligram Per Kilogram Per Day | ||
| h*g/mL/g | C112300 | Hours times grams per milliliter (area under the curve), divided by grams (weight). | Hour Times Gram Per Milliliter Per Gram | |||
| h*g/mL/kg | C112301 | Hours times grams per milliliter (area under the curve), divided by kilograms (weight). | Hour Times Gram Per Milliliter Per Kilogram | |||
| h*g/mL/m2 | C111213 | Hours times grams per milliliter (area under the curve), divided by meters squared (surface area). | Hour Times Gram per Milliliter per Meter Squared | |||
| h*mg/mL | C85621 | Hours times milligrams per milliliter (area under the curve). | Hour Times Milligram per Milliliter | |||
| h*mg/mL/(kg/m2) | C111218 | Hours times milligrams per milliliter (area under the curve), divided by kilograms per meter squared (body mass index). | Hour Times Milligram per Milliliter per Kilogram per Meter Squared | |||
| h*mg/mL/(mg/g) | C117920 | Hours times milligrams per milliliter (area under the curve), divided by milligrams per gram (dose normalized by body weight). | Hour Times Milligram Per Milliliter Per Milligram Per Gram | |||
| h*mg/mL/(mg/g/day) | C117921 | Hours times milligrams per milliliter (area under the curve), divided by milligrams per gram per day (daily dose normalized by body weight). | Hour Times Milligram Per Milliliter Per Milligram Per Gram Per Day | |||
| h*mg/mL/(mg/kg) | C105468 | h*mg/mL/(ug/g) | Hours times milligrams per milliliter (area under the curve), divided by milligrams per kilogram (dose normalized by body weight). | Hour Times Milligram Per Milliliter Per Milligram Per Kilogram | ||
| h*mg/mL/(mg/kg/day) | C105469 | h*mg/mL/(ug/g/day) | Hours times milligrams per milliliter (area under the curve), divided by milligrams per kilogram per day (daily dose normalized by body weight). | Hour Times Milligram Per Milliliter Per Milligram Per Kilogram Per Day | ||
| h*mg/mL/g | C112305 | Hours times milligrams per milliliter (area under the curve), divided by grams (weight). | Hour Times Milligram Per Milliliter Per Gram | |||
| h*mg/mL/kg | C112306 | Hours times milligrams per milliliter (area under the curve), divided by kilograms (weight). | Hour Times Milligram Per Milliliter Per Kilogram | |||
| h*mg/mL/m2 | C111219 | Hours times milligrams per milliliter (area under the curve), divided by meters squared (surface area). | Hour Times Milligram per Milliliter per Meter Squared | |||
| h*mmol/L | C85618 | Hours times millimoles per liter (area under the curve). | Hour Times Micromole per Milliliter | |||
| h*mmol/L/(kg/m2) | C111220 | Hours times millimoles per liter (area under the curve), divided by kilograms per meter squared (body mass index). | Hour Times Millimole per Liter per Kilogram per Meter Squared | |||
| h*mmol/L/(mg/g) | C117922 | Hours times millimoles per liter (area under the curve), divided by milligrams per gram (dose normalized by body weight). | Hour Times Millimole Per Liter Per Milligram Per Gram | |||
| h*mmol/L/(mg/g/day) | C117923 | Hours times millimoles per liter (area under the curve), divided by milligrams per gram per day (daily dose normalized by body weight). | Hour Times Millimole Per Liter Per Milligram Per Gram Per Day | |||
| h*mmol/L/g | C106530 | Hours times millimoles per liter (area under the curve), divided by grams (weight). | Hour times Millimole Per Liter Per Gram | |||
| h*mmol/L/kg | C112307 | Hours times millimoles per liter (area under the curve), divided by kilograms (weight). | Hour Times Millimole Per Liter Per Kilogram | |||
| h*mmol/L/m2 | C111221 | Hours times millimoles per liter (area under the curve), divided by meters squared (surface area). | Hour Times Millimole per Liter per Meter Squared | |||
| h*mol/L | C85622 | Hours times moles per liter (area under the curve). | Hour Times Millimole per Milliliter | |||
| h*mol/L/(kg/m2) | C111222 | Hours times moles per liter (area under the curve), divided by kilograms per meter squared (body mass index). | Hour Times Mole per Liter per Kilogram per Meter Squared | |||
| h*mol/L/(mg/g) | C117924 | Hours times moles per liter (area under the curve), divided by milligrams per gram (dose normalized by body weight). | Hour Times mole Per Liter Per Milligram Per Gram | |||
| h*mol/L/(mg/g/day) | C117925 | Hours times moles per liter (area under the curve), divided by milligrams per gram per day (daily dose normalized by body weight). | Hour Times mole Per Liter Per Milligram Per Gram Per Day | |||
| h*mol/L/g | C106531 | Hours times moles per liter (area under the curve), divided by grams (weight). | Hour times Mole Per Liter Per Gram | |||
| h*mol/L/kg | C112308 | Hours times moles per liter (area under the curve), divided by kilograms (weight). | Hour Times Mole Per Liter Per Kilogram | |||
| h*mol/L/m2 | C111223 | Hours times moles per liter (area under the curve), divided by meters squared (surface area). | Hour Times Mole per Liter per Meter Squared | |||
| h*ng/mL | C85624 | Hours times nanograms per milliliter (area under the curve). | Hour Times Nanogram per Milliliter | |||
| h*ng/mL/(kg/m2) | C111224 | Hours times nanograms per milliliter (area under the curve), divided by kilograms per meter squared (body mass index). | Hour Times Nanogram per Milliliter per Kilogram per Meter Squared | |||
| h*ng/mL/(mg/g) | C117926 | Hours times nanograms per milliliter (area under the curve), divided by milligrams per gram (dose normalized by body weight). | Hour Times Nanogram Per Milliliter Per Milligram Per Gram | |||
| h*ng/mL/(mg/g/day) | C117927 | Hours times nanograms per milliliter (area under the curve), divided by milligrams per gram per day (daily dose normalized by body weight). | Hour Times Nanogram Per Milliliter Per Milligram Per Gram Per Day | |||
| h*ng/mL/(mg/kg) | C85628 | h*ng/mL/(ug/g) | Hours times nanograms per milliliter (area under the curve), divided by milligrams per kilogram (dose normalized by body weight). | Hour Times Nanogram per Milliliter per Milligram per Kilogram | ||
| h*ng/mL/(mg/kg/day) | C105470 | h*ng/mL/(ug/g/day) | Hours times nanograms per milliliter (area under the curve), divided by milligrams per kilogram per day (daily dose normalized by body weight). | Hour Times Nanogram Per Milliliter Per Milligram Per Kilogram Per Day | ||
| h*ng/mL/(mg/m2) | C85629 | Hours times nanograms per milliliter (area under the curve), divided by milligrams per meter squared (dose normalized by surface area). | Hour Times Nanogram per Milliliter per Milligram per Meter Squared | |||
| h*ng/mL/g | C85625 | Hours times nanograms per milliliter (area under the curve), divided by grams (weight). | Hour Times Nanogram per Milliliter per Gram | |||
| h*ng/mL/kg | C85626 | Hours times nanograms per milliliter (area under the curve), divided by kilograms (weight). | Hour Times Nanogram per Milliliter per Kilogram | |||
| h*ng/mL/m2 | C111225 | Hours times nanograms per milliliter (area under the curve), divided by meters squared (surface area). | Hour Times Nanogram per Milliliter per Meter Squared | |||
| h*ng/mL/mg | C85627 | h*ng/mL/mg;h*ng/mg/mL;ng*h/mL/mg;ng*h/mg/mL | Hours times nanograms per milliliter (area under the curve), divided by milligrams (dose). | Hour Times Nanogram per Milliliter per Milligram | ||
| h*nmol/L | C85640 | Hours times nanomoles per liter (area under the curve). | Hour Times Picomole per Milliliter | |||
| h*nmol/L/(kg/m2) | C111226 | Hours times nanomoles per liter (area under the curve), divided by kilograms per meter squared (body mass index). | Hour Times Nanomole per Liter per Kilogram per Meter Squared | |||
| h*nmol/L/(mg/g) | C117928 | Hours times nanomoles per liter (area under the curve), divided by milligrams per gram (dose normalized by body weight). | Hour Times Nanomole Per Liter Per Milligram Per Gram | |||
| h*nmol/L/(mg/g/day) | C117929 | Hours times nanomoles per liter (area under the curve), divided by milligrams per gram per day (daily dose normalized by body weight). | Hour Times Nanomole Per Liter Per Milligram Per Gram Per Day | |||
| h*nmol/L/g | C116062 | Hours times nanomoles per liter (area under the curve), divided by grams (dose or weight). | Hour Times Nanomole per Liter per Gram | |||
| h*nmol/L/kg | C112309 | Hours times nanomoles per liter (area under the curve), divided by kilograms (weight). | Hour Times Nanomole Per Liter Per Kilogram | |||
| h*nmol/L/m2 | C111227 | Hours times nanomoles per liter (area under the curve), divided by meters squared (surface area). | Hour Times Nanomole per Liter per Meter Squared | |||
| h*nmol/L/umol | C85631 | h*nmol/L/mcmol;h*nmol/umol/L;nmol*h/L/umol;nmol*h/umol/L | Hours times nanomoles per liter per micromole. | Hour Times Nanomole per Liter per Micromole | ||
| h*pg/mL | C85635 | Hours times picograms per milliliter (area under the curve). | Hour Times Picogram per Milliliter | |||
| h*pg/mL/(kg/m2) | C111228 | Hours times picograms per milliliter (area under the curve), divided by kilograms per meter squared (body mass index). | Hour Times Picogram per Milliliter per Kilogram per Meter Squared | |||
| h*pg/mL/(mg/g) | C117930 | Hours times picograms per milliliter (area under the curve), divided by milligrams per gram (dose normalized by body weight). | Hour Times Picogram Per Milliliter Per Milligram Per Gram | |||
| h*pg/mL/(mg/g/day) | C117931 | Hours times picograms per milliliter (area under the curve), divided by milligrams per gram per day (daily dose normalized by body weight). | Hour Times Picogram Per Milliliter Per Milligram Per Gram Per Day | |||
| h*pg/mL/(mg/kg) | C105471 | h*pg/mL/(ug/g) | Hours times picograms per milliliter (area under the curve), divided by milligrams per kilogram (dose normalized by body weight). | Hour Times Picogram Per Milliliter Per Milligram Per Kilogram | ||
| h*pg/mL/(mg/kg/day) | C105472 | h*pg/mL/(ug/g/day) | Hours times picograms per milliliter (area under the curve), divided by milligrams per kilogram per day (daily dose normalized by body weight). | Hour Times Picogram Per Milliliter Per Milligram Per Kilogram Per Day | ||
| h*pg/mL/g | C112310 | Hours times picograms per milliliter (area under the curve), divided by grams (weight). | Hour Times Picogram Per Milliliter Per Gram | |||
| h*pg/mL/kg | C85636 | Hours times picograms per milliliter (area under the curve), divided by kilograms (weight). | Hour Times Picogram per Milliliter per Kilogram | |||
| h*pg/mL/m2 | C111229 | Hours times picograms per milliliter (area under the curve), divided by meters squared (surface area). | Hour Times Picogram per Milliliter per Meter Squared | |||
| h*pg/mL/mg | C85638 | h*pg/mL/mg;h*pg/mg/mL;pg*h/mL/mg;pg*h/mg/mL | Hours times picograms per milliliter (area under the curve), divided by milligrams (dose). | Hour Times Picogram per Milliliter per Milligram | ||
| h*pmol/L | C85612 | Hours times picomoles per liter (area under the curve). | Hour Times Femtomole per Milliliter | |||
| h*pmol/L/(kg/m2) | C111230 | Hours times picomoles per liter (area under the curve), divided by kilograms per meter squared (body mass index). | Hour Times Picomole per Liter per Kilogram per Meter Squared | |||
| h*pmol/L/(mg/g) | C117932 | Hours times picomoles per liter (area under the curve), divided by milligrams per gram (dose normalized by body weight). | Hour Times Picomole Per Liter Per Milligram Per Gram | |||
| h*pmol/L/(mg/g/day) | C117933 | Hours times picomoles per liter (area under the curve), divided by milligrams per gram per day (daily dose normalized by body weight). | Hour Times Picomole Per Liter Per Milligram Per Gram Per Day | |||
| h*pmol/L/g | C106532 | Hours times picomoles per liter (area under the curve), divided by grams (weight). | Hour times Picomole Per Liter Per Gram | |||
| h*pmol/L/kg | C112311 | Hours times picomoles per liter (area under the curve), divided by kilograms (weight). | Hour Times Picomole Per Liter Per Kilogram | |||
| h*pmol/L/m2 | C111231 | Hours times picomoles per liter (area under the curve), divided by meters squared (surface area). | Hour Times Picomole per Liter per Meter Squared | |||
| h*ug/mL | C85615 | Hours times micrograms per milliliter (area under the curve). | Hour Times Microgram per Milliliter | |||
| h*ug/mL/(kg/m2) | C111214 | Hours times micrograms per milliliter (area under the curve), divided by kilograms per meter squared (body mass index). | Hour Times Microgram per Milliliter per Kilogram per Meter Squared | |||
| h*ug/mL/(mg/g) | C117934 | Hours times micrograms per milliliter (area under the curve), divided by milligrams per gram (dose normalized by body weight). | Hour Times Microgram Per Milliliter Per Milligram Per Gram | |||
| h*ug/mL/(mg/g/day) | C117935 | Hours times micrograms per milliliter (area under the curve), divided by milligrams per gram per day (daily dose normalized by body weight). | Hour Times Microgram Per Milliliter Per Milligram Per Gram Per Day | |||
| h*ug/mL/(mg/kg) | C105466 | h*ug/mL/(ug/g) | Hours times micrograms per milliliter (area under the curve), divided by milligrams per kilogram (dose normalized by body weight). | Hour Times Microgram Per Milliliter Per Milligram Per Kilogram | ||
| h*ug/mL/(mg/kg/day) | C105467 | h*ug/mL/(ug/g/day) | Hours times micrograms per milliliter (area under the curve), divided by milligrams per kilogram per day (daily dose normalized by body weight). | Hour Times Microgram Per Milliliter Per Milligram Per Kilogram Per Day | ||
| h*ug/mL/g | C112302 | Hours times micrograms per milliliter (area under the curve), divided by grams (weight). | Hour Times Microgram Per Milliliter Per Gram | |||
| h*ug/mL/kg | C112303 | Hours times micrograms per milliliter (area under the curve), divided by kilograms (weight). | Hour Times Microgram Per Milliliter Per Kilogram | |||
| h*ug/mL/m2 | C111215 | Hours times micrograms per milliliter (area under the curve), divided by meters squared (surface area). | Hour Times Microgram per Milliliter per Meter Squared | |||
| h*ug/mL/mg | C85617 | h*mcg/mL/mg;h*ug/mg/mL;ug*h/mL/mg;ug*h/mg/mL | Hours times micrograms per milliliter (area under the curve), divided by milligrams (dose). | Hour Times Microgram per Milliliter per Milligram | ||
| h*umol/L | C85632 | Hours times micromoles per liter (area under the curve). | Hour Times Nanomole per Milliliter | |||
| h*umol/L/(kg/m2) | C111216 | Hours times micromoles per liter (area under the curve), divided by kilograms per meter squared (body mass index). | Hour Times Micromole per Liter per Kilogram per Meter Squared | |||
| h*umol/L/(mg/g) | C117936 | Hours times micromoles per liter (area under the curve), divided by milligrams per gram (dose normalized by body weight). | Hour Times Micromole Per Liter Per Milligram Per Gram | |||
| h*umol/L/(mg/g/day) | C117937 | Hours times micromoles per liter (area under the curve), divided by milligrams per gram per day (daily dose normalized by body weight). | Hour Times Micromole Per Liter Per Milligram Per Gram Per Day | |||
| h*umol/L/g | C116063 | Hours times micromoles per liter (area under the curve), divided by grams (dose or weight). | Hour Times Micromole per liter per Gram | |||
| h*umol/L/kg | C112304 | Hours times micromoles per liter (area under the curve), divided by kilograms (weight). | Hour Times Micromole Per Liter Per Kilogram | |||
| h*umol/L/m2 | C111217 | Hours times micromoles per liter (area under the curve), divided by meters squared (surface area). | Hour Times Micromole per Liter per Meter Squared | |||
| h2*mg/mL | C85606 | h*h*mg/mL;h2*g/L;h2*ug/uL;h^2*mg/mL;mg*h2/mL | Hours squared times milligrams per milliliter. | Hour Squared Times Milligram per Milliliter | ||
| h2*mmol/L | C85605 | Hours squared times millimoles per liter (area under the moment curve). | Hour Squared Times Micromole per Milliliter | |||
| h2*mol/L | C85607 | Hours squared times moles per liter (area under the moment curve). | Hour Squared Times Millimole per Milliliter | |||
| h2*ng/mL | C85608 | h*h*ng/mL;h2*ug/L;h^2*ng/mL;ng*h2/mL | Hours squared times nanograms per milliliter. | Hour Squared Times Nanogram per Milliliter | ||
| h2*nmol/L | C85610 | Hours squared times nanomoles per liter (area under the moment curve). | Hour Squared Times Picomole per Milliliter | |||
| h2*pg/mL | C85609 | h*h*pg/mL;h2*ng/L;h^2*pg/mL;pg*h2/mL | Hours squared times picogram per milliliter. | Hour Squared Times Picogram per Milliliter | ||
| h2*pmol/L | C106529 | Hours squared times picomoles per liter (area under the moment curve). | Hour Squared Times Picomole Per Liter | |||
| h2*ug/mL | C85604 | h*h*ug/mL;h2*mcg/mL;h2*mg/L;h^2*ug/mL;ug*h2/mL | Hours squared times micrograms per milliliter. | Hour Squared Times Microgram per Milliliter | ||
| h2*umol/L | C106528 | Hours squared times micromoles per liter (area under the moment curve). | Hour Squared Times Micromole Per Liter | |||
| IU/day | C85645 | IU/d | International units per day. | International Unit per Day | ||
| IU/h | C85646 | IU/h | International units per hour. | International Unit per Hour | ||
| IU/min | C85647 | IU/min | International units per minute. | International Unit per Minute | ||
| IU/mL | C67377 | IE/mL;International Unit per Milliliter;Kilo International Unit per Liter;kIU/L | A unit of concentration (biologic activity) equal to one international unit of substance per milliliter of solution. | International Unit per Milliliter | ||
| IU/mL/(kg/m2) | C119366 | International units per milliliter (concentration), divided by kilograms per meter squared (body mass index). | International Unit per Milliliter per Kilogram per Meter Squared | |||
| IU/mL/(mg/day) | C119367 | International units per milliliter (concentration), divided by milligrams per day (daily dose). | International Unit per Milliliter per Milligram per Day | |||
| IU/mL/(mg/kg) | C119368 | International units per milliliter (concentration), divided by milligrams per kilogram. | International Unit per Milliliter per Milligram per Kilogram | |||
| IU/mL/(mg/kg/day) | C119369 | International units per milliliter (concentration), divided by milligrams per kilogram per day. | International Unit per Milliliter per Milligram per Kilogram per Day | |||
| IU/mL/(mg/m2) | C119370 | International units per milliliter (concentration), divided by milligrams per meter squared. | International Unit per Milliliter per Milligram per Meter Squared | |||
| IU/mL/(mg/m2/day) | C119371 | International units per milliliter (concentration), divided by milligrams per meter squared per day (daily dose normalized by surface area). | International Unit per Milliliter per Milligram per Meter Squared per Day | |||
| IU/mL/(ug/day) | C119372 | International units per milliliter (concentration), divided by micrograms per day (daily dose). | International Unit per Milliliter per Microgram per Day | |||
| IU/mL/(ug/kg) | C119373 | International units per milliliter (concentration), divided by micrograms per kilogram. | International Unit per Milliliter per Microgram per Kilogram | |||
| IU/mL/(ug/kg/day) | C119374 | International units per milliliter (concentration), divided by micrograms per kilogram per day. | International Unit per Milliliter per Microgram per Kilogram per Day | |||
| IU/mL/(ug/m2) | C119375 | International units per milliliter (concentration), divided by micrograms per meter squared. | International Unit per Milliliter per Microgram per Meter Squared | |||
| IU/mL/(ug/m2/day) | C119376 | International units per milliliter (concentration), divided by micrograms per meter squared per day (daily dose normalized by surface area). | International Unit per Milliliter per Microgram per Meter Squared per Day | |||
| IU/mL/g | C119377 | International units per milliliter (concentration), divided by grams (weight). | International Unit per Milliliter per Gram | |||
| IU/mL/kg | C119378 | International units per milliliter (concentration), divided by kilograms (weight). | International Unit per Milliliter per Kilogram | |||
| IU/mL/m2 | C119379 | International units per milliliter (concentration), divided by meters squared (surface area). | International Unit per Milliliter per Meter Squared | |||
| IU/mL/mg | C119380 | International units per milliliter (concentration), divided by milligrams (dose). | International Unit per Milliliter per Milligram | |||
| IU/mL/ug | C119381 | International units per milliliter (concentration), divided by micrograms (dose). | International Unit per Milliliter per Microgram | |||
| L | C48505 | Liter | A unit of volume equal to a cubic decimeter, or one thousandth of cubic meter, or 1000 cubic centimeters, or approximately 61.023 744 cubic inches.(NCI) | Liter | ||
| L/day | C69110 | Liters per day. | Liter per Day | |||
| L/h | C69160 | L/h | Liters per hour. | Liter per Hour | ||
| L/kg/day | C73755 | L/day/kg;L/kg/d;Milliliter per Gram per Day;mL/day/g;mL/g/day;uL/day/mg;uL/mg/day | Liters per kilogram per day. | Milliliter per Gram per Day | ||
| L/kg/h | C73756 | Milliliter per Gram per Hour | Milliliters per gram per hour. | Milliliter per Gram per Hour | ||
| L/kg/min | C73757 | Milliliter per Gram per Minute | Milliliters per gram per minute. | Milliliter per Gram per Minute | ||
| L/min | C67388 | Liters per Minute | A unit of volumetric flow rate defined as the rate at which one liter of matter travels during the period of time equal to one minute.(NCI) | Liter per Minute | ||
| L/mmol/day | C85676 | L/day/mmol;L/mmol/d;mL/day/umol;mL/umol/day | Liters per millimole per day. | Liter per Millimole per Day | ||
| L/mmol/h | C85677 | L/h/mmol;L/mmol/h;mL/h/umol;mL/umol/h | Liters per millimole per hour. | Liter per Millimole per Hour | ||
| L/mmol/min | C85678 | L/min/mmol;L/mmol/min;mL/min/umol;mL/umol/min | Liters per millimole per minute. | Liter per Millimole per Minute | ||
| L/mol | C85680 | L/mol;mL/mmol;uL/umol | Liters per mole. | Liter per Mole | ||
| L/mol/day | C85681 | L/day/mol;L/mol/d;mL/day/mmol;mL/mmol/day;uL/day/umol;uL/umol/day | Liters per mole per day. | Liter per Mole per Day | ||
| L/mol/h | C85682 | L/h/mol;L/mol/h;mL/h/mmol;mL/mmol/h;uL/h/umol;uL/umol/h | Liters per mole per hour. | Liter per Mole per Hour | ||
| L/mol/min | C85683 | L/min/mol;L/mol/min;mL/min/mmol;mL/mmol/min;uL/min/umol;uL/umol/min | Liters per mole per minute. | Liter per Mole per Minute | ||
| L/ng/day | C85685 | L/day/ng;L/ng/d;mL/day/pg;mL/pg/day | Liters per nanogram per day. | Liter per Nanogram per Day | ||
| L/ng/h | C85686 | L/h/ng;L/ng/h;mL/h/pg;mL/pg/h | Liters per nanogram per hour. | Liter per Nanogram per Hour | ||
| L/ng/min | C85687 | L/min/ng;L/ng/min;mL/min/pg;mL/pg/min | Liters per nanogram per minute. | Liter per Nanogram per Minute | ||
| L/nmol/day | C85689 | L/day/nmol;L/nmol/d;mL/day/pmol;mL/pmol/day | Liters per nanomole per day. | Liter per Nanomole per Day | ||
| L/nmol/h | C85690 | L/h/nmol;L/nmol/h;mL/h/pmol;mL/pmol/h | Liters per nanomole per hour. | Liter per Nanomole per Hour | ||
| L/nmol/min | C85691 | L/min/nmol;L/nmol/min;mL/min/pmol;mL/pmol/min | Liters per nanomole per minute. | Liter per Nanomole per Minute | ||
| L/pg/day | C85693 | L/day/pg;L/pg/d | Liters per picogram per day. | Liter per Picogram per Day | ||
| L/pg/h | C85694 | L/h/pg;L/pg/h | Liters per picogram per hour. | Liter per Picogram per Hour | ||
| L/pg/min | C85695 | L/min/pg;L/pg/min | Liters per picogram per minute. | Liter per Picogram per Minute | ||
| L/umol/day | C85668 | L/day/mcmol;L/day/umol;L/mcmol/day;L/umol/d | Liters per micromole per day. | Liter per Micromole per Day | ||
| L/umol/h | C85669 | L/h/mcmol;L/h/umol;L/mcmol/h;L/umol/h | Liters per micromole per hour. | Liter per Micromole per Hour | ||
| L/umol/min | C85670 | L/mcmol/min;L/min/mcmol;L/min/umol;L/umol/min | Liters per micromole per minute. | Liter per Micromole per Minute | ||
| mg | C28253 | Milligram | The unit of mass equal to one thousandth of a gram or 1000 micrograms. One milligram equals approximately 0.015432 grain or 35.274 x 10E-6 ounce.(NCI) | Milligram | ||
| mg/day | C67399 | Milligram per Day | A unit of measure referring to the ratio between mass expressed in milligrams per day.(NCI) | Milligram per 24 Hours | ||
| mg/h | C66969 | Milligram per Hour | A unit of mass flow rate equivalent to the rate at which one thousandth of a gram of matter travels to a given object or space over a period of time equal to one hour.(NCI) | Milligram per Hour | ||
| mg/min | C73742 | Milligram per Minute | Milligrams per minute. | Milligram per Minute | ||
| mg/mL | C42576 | Gram per Liter;Kilogram per Cubic Meter;Microgram per Microliter;Milligram per Milliliter;g/L;kg/m3;mg/mL;ug/uL | A unit of concentration or mass density equal to one milligram of substance per milliliter of solution or one gram of substance per liter of solution. | Kilogram per Cubic Meter | ||
| mg/mL/(kg/m2) | C119382 | Milligrams per milliliter (concentration), divided by kilograms per meter squared (body mass index). | Milligram per Milliliter per Kilogram per Meter Squared | |||
| mg/mL/(mg/day) | C119383 | Milligrams per milliliter (concentration), divided by milligrams per day (daily dose). | Milligram per Milliliter per Milligram per Day | |||
| mg/mL/(mg/kg) | C105475 | Milligrams per milliliter (concentration), divided by milligrams per kilogram (dose normalized by body weight). | Milligram Per Milliliter Per Milligram Per Kilogram | |||
| mg/mL/(mg/kg/day) | C105476 | Milligrams per milliliter (concentration), divided by milligrams per kilogram per day (daily dose normalized by body weight). | Milligram Per Milliliter Per Milligram Per Kilogram Per Day | |||
| mg/mL/(mg/m2) | C119384 | Milligrams per milliliter (concentration), divided by milligrams per meter squared. | Milligram per Milliliter per Milligram per Meter Squared | |||
| mg/mL/(mg/m2/day) | C119385 | Milligrams per milliliter (concentration), divided by milligrams per meter squared per day (daily dose normalized by surface area). | Milligram per Milliliter per Milligram per Meter Squared per Day | |||
| mg/mL/(ug/day) | C119386 | Milligrams per milliliter (concentration), divided by micrograms per day (daily dose). | Milligram per Milliliter per Microgram per Day | |||
| mg/mL/(ug/kg) | C119387 | Milligrams per milliliter (concentration), divided by micrograms per kilogram. | Milligram per Milliliter per Microgram per Kilogram | |||
| mg/mL/(ug/kg/day) | C119388 | Milligrams per milliliter (concentration), divided by micrograms per kilogram per day. | Milligram per Milliliter per Microgram per Kilogram per Day | |||
| mg/mL/(ug/m2) | C119389 | Milligrams per milliliter (concentration), divided by micrograms per meter squared. | Milligram per Milliliter per Microgram per Meter Squared | |||
| mg/mL/(ug/m2/day) | C119390 | Milligrams per milliliter (concentration), divided by micrograms per meter squared per day (daily dose normalized by surface area). | Milligram per Milliliter per Microgram per Meter Squared per Day | |||
| mg/mL/g | C119391 | Milligrams per milliliter (concentration), divided by grams (weight). | Milligram per Milliliter per Gram | |||
| mg/mL/h | C85711 | g/L/h;g/h/L;mg/h/mL;ug/h/uL;ug/uL/h | Milligrams per milliliter per hour. | Milligram per Milliliter per Hour | ||
| mg/mL/kg | C119392 | Milligrams per milliliter (concentration), divided by kilograms (weight). | Milligram per Milliliter per Kilogram | |||
| mg/mL/m2 | C119393 | Milligrams per milliliter (concentration), divided by meters squared (surface area). | Milligram per Milliliter per Meter Squared | |||
| mg/mL/mg | C119394 | Milligrams per milliliter (concentration), divided by milligrams (dose). | Milligram per Milliliter per Milligram | |||
| mg/mL/ug | C119395 | Milligrams per milliliter (concentration), divided by micrograms (dose). | Milligram per Milliliter per Microgram | |||
| min | C48154 | Minute Unit of Time | A unit measure of time equal to 60 seconds.(NCI) | Minute | ||
| min*fg/mL | C85724 | Minutes times femtograms per milliliter (area under the curve). | Minute Times Femtogram per Milliliter | |||
| min*fg/mL/(kg/m2) | C111254 | Minutes times femtograms per milliliter (area under the curve), divided by kilograms per meter squared (body mass index). | Minute Times Femtogram per Milliliter per Kilogram per Meter Squared | |||
| min*fg/mL/(mg/g) | C117938 | Minutes times femtograms per milliliter (area under the curve), divided by milligrams per gram (dose normalized by body weight). | Minute Times Femtogram Per Milliliter Per Milligram Per Gram | |||
| min*fg/mL/(mg/g/day) | C117939 | Minutes times femtograms per milliliter (area under the curve), divided by milligrams per gram per day (daily dose normalized by body weight). | Minute Times Femtogram Per Milliliter Per Milligram Per Gram Per Day | |||
| min*fg/mL/g | C112334 | Minutes times femtograms per milliliter (area under the curve), divided by grams (weight). | Minute Times Femtogram Per Milliliter Per Gram | |||
| min*fg/mL/kg | C112335 | Minutes times femtograms per milliliter (area under the curve), divided by kilograms (weight). | Minute Times Femtogram Per Milliliter Per Kilogram | |||
| min*fg/mL/m2 | C111255 | Minutes times femtograms per milliliter (area under the curve), divided by meters squared (surface area). | Minute Times Femtogram per Milliliter per Meter Squared | |||
| min*g/mL | C85725 | Minutes times grams per milliliter (area under the curve). | Minute Times Gram per Milliliter | |||
| min*g/mL/(kg/m2) | C111256 | Minutes times grams per milliliter (area under the curve), divided by kilograms per meter squared (body mass index). | Minute Times Gram per Milliliter per Kilogram per Meter Squared | |||
| min*g/mL/(mg/g) | C117940 | Minutes times grams per milliliter (area under the curve), divided by milligrams per gram (dose normalized by body weight). | Minute Times gram Per Milliliter Per Milligram Per Gram | |||
| min*g/mL/(mg/g/day) | C117941 | Minutes times grams per milliliter (area under the curve), divided by milligrams per gram per day (daily dose normalized by body weight). | Minute Times gram Per Milliliter Per Milligram Per Gram Per Day | |||
| min*g/mL/g | C112336 | Minutes times grams per milliliter (area under the curve), divided by grams (weight). | Minute Times Gram Per Milliliter Per Gram | |||
| min*g/mL/kg | C112337 | Minutes times grams per milliliter (area under the curve), divided by kilograms (weight). | Minute Times Gram Per Milliliter Per Kilogram | |||
| min*g/mL/m2 | C111257 | Minutes times grams per milliliter (area under the curve), divided by meters squared (surface area). | Minute Times Gram per Milliliter per Meter Squared | |||
| min*mg/mL | C85729 | Minutes times milligrams per milliliter (area under the curve). | Minute Times Milligram per Milliliter | |||
| min*mg/mL/(kg/m2) | C111262 | Minutes times milligrams per milliliter (area under the curve), divided by kilograms per meter squared (body mass index). | Minute Times Milligram per Milliliter per Kilogram per Meter Squared | |||
| min*mg/mL/(mg/g) | C117942 | Minutes times milligrams per milliliter (area under the curve), divided by milligrams per gram (dose normalized by body weight). | Minute Times Milligram Per Milliliter Per Milligram Per Gram | |||
| min*mg/mL/(mg/g/day) | C117943 | Minutes times milligrams per milliliter (area under the curve), divided by milligrams per gram per day (daily dose normalized by body weight). | Minute Times Milligram Per Milliliter Per Milligram Per Gram Per Day | |||
| min*mg/mL/g | C112342 | Minutes times milligrams per milliliter (area under the curve), divided by grams (weight). | Minute Times Milligram Per Milliliter Per Gram | |||
| min*mg/mL/kg | C112343 | Minutes times milligrams per milliliter (area under the curve), divided by kilograms (weight). | Minute Times Milligram Per Milliliter Per Kilogram | |||
| min*mg/mL/m2 | C111263 | Minutes times milligrams per milliliter (area under the curve), divided by meters squared (surface area). | Minute Times Milligram per Milliliter per Meter Squared | |||
| min*mmol/L | C85728 | Minutes times millimoles per liter (area under the curve). | Minute Times Micromole per Milliliter | |||
| min*mmol/L/(kg/m2) | C111264 | Minutes times millimoles per liter (area under the curve), divided by kilograms per meter squared (body mass index). | Minute Times Millimole per Liter per Kilogram per Meter Squared | |||
| min*mmol/L/(mg/g) | C117944 | Minutes times millimoles per liter (area under the curve), divided by milligrams per gram (dose normalized by body weight). | Minute Times Millimole Per Liter Per Milligram Per Gram | |||
| min*mmol/L/(mg/g/day) | C117945 | Minutes times millimoles per liter (area under the curve), divided by milligrams per gram per day (daily dose normalized by body weight). | Minute Times Millimole Per Liter Per Milligram Per Gram Per Day | |||
| min*mmol/L/g | C112344 | Minutes times millimoles per liter (area under the curve), divided by grams (weight). | Minute Times Millimole Per Liter Per Gram | |||
| min*mmol/L/kg | C112345 | Minutes times millimoles per liter (area under the curve), divided by kilograms (weight). | Minute Times Millimole Per Liter Per Kilogram | |||
| min*mmol/L/m2 | C111265 | Minutes times millimoles per liter (area under the curve), divided by meters squared (surface area). | Minute Times Millimole per Liter per Meter Squared | |||
| min*mol/L | C85730 | Minutes times moles per liter (area under the curve). | Minute Times Millimole per Milliliter | |||
| min*mol/L/(kg/m2) | C111266 | Minutes times moles per liter (area under the curve), divided by kilograms per meter squared (body mass index). | Minute Times Mole per Liter per Kilogram per Meter Squared | |||
| min*mol/L/(mg/g) | C117946 | Minutes times moles per liter (area under the curve), divided by milligrams per gram (dose normalized by body weight). | Minute Times mole Per Liter Per Milligram Per Gram | |||
| min*mol/L/(mg/g/day) | C117947 | Minutes times moles per liter (area under the curve), divided by milligrams per gram per day (daily dose normalized by body weight). | Minute Times mole Per Liter Per Milligram Per Gram Per Day | |||
| min*mol/L/g | C112346 | Minutes times moles per liter (area under the curve), divided by grams (weight). | Minute Times Mole Per Liter Per Gram | |||
| min*mol/L/kg | C112347 | Minutes times moles per liter (area under the curve), divided by kilograms (weight). | Minute Times Mole Per Liter Per Kilogram | |||
| min*mol/L/m2 | C111267 | Minutes times moles per liter (area under the curve), divided by meters squared (surface area). | Minute Times Mole per Liter per Meter Squared | |||
| min*ng/mL | C85732 | Minutes times nanograms per milliliter (area under the curve). | Minute Times Nanogram per Milliliter | |||
| min*ng/mL/(kg/m2) | C111268 | Minutes times nanograms per milliliter (area under the curve), divided by kilograms per meter squared (body mass index). | Minute Times Nanogram per Milliliter per Kilogram per Meter Squared | |||
| min*ng/mL/(mg/g) | C117948 | Minutes times nanograms per milliliter (area under the curve), divided by milligrams per gram (dose normalized by body weight). | Minute Times Nanogram Per Milliliter Per Milligram Per Gram | |||
| min*ng/mL/(mg/g/day) | C117949 | Minutes times nanograms per milliliter (area under the curve), divided by milligrams per gram per day (daily dose normalized by body weight). | Minute Times Nanogram Per Milliliter Per Milligram Per Gram Per Day | |||
| min*ng/mL/g | C112348 | Minutes times nanograms per milliliter (area under the curve), divided by grams (weight). | Minute Times Nanogram Per Milliliter Per Gram | |||
| min*ng/mL/kg | C112349 | Minutes times nanograms per milliliter (area under the curve), divided by kilograms (weight). | Minute Times Nanogram Per Milliliter Per Kilogram | |||
| min*ng/mL/m2 | C111269 | Minutes times nanograms per milliliter (area under the curve), divided by meters squared (surface area). | Minute Times Nanogram per Milliliter per Meter Squared | |||
| min*nmol/L | C85735 | Minutes times nanomoles per liter (area under the curve). | Minute Times Picomole per Milliliter | |||
| min*nmol/L/(kg/m2) | C111270 | Minutes times nanomoles per liter (area under the curve), divided by kilograms per meter squared (body mass index). | Minute Times Nanomole per Liter per Kilogram per Meter Squared | |||
| min*nmol/L/(mg/g) | C117950 | Minutes times nanomoles per liter (area under the curve), divided by milligrams per gram (dose normalized by body weight). | Minute Times Nanomole Per Liter Per Milligram Per Gram | |||
| min*nmol/L/(mg/g/day) | C117951 | Minutes times nanomoles per liter (area under the curve), divided by milligrams per gram per day (daily dose normalized by body weight). | Minute Times Nanomole Per Liter Per Milligram Per Gram Per Day | |||
| min*nmol/L/g | C112350 | Minutes times nanomoles per liter (area under the curve), divided by grams (weight). | Minute Times Nanomole Per Liter Per Gram | |||
| min*nmol/L/kg | C112351 | Minutes times nanomoles per liter (area under the curve), divided by kilograms (weight). | Minute Times Nanomole Per Liter Per Kilogram | |||
| min*nmol/L/m2 | C111271 | Minutes times nanomoles per liter (area under the curve), divided by meters squared (surface area). | Minute Times Nanomole per Liter per Meter Squared | |||
| min*pg/mL | C85734 | Minutes times picograms per milliliter (area under the curve). | Minute Times Picogram per Milliliter | |||
| min*pg/mL/(kg/m2) | C111272 | Minutes times picograms per milliliter (area under the curve), divided by kilograms per meter squared (body mass index). | Minute Times Picogram per Milliliter per Kilogram per Meter Squared | |||
| min*pg/mL/(mg/g) | C117952 | Minutes times picograms per milliliter (area under the curve), divided by milligrams per gram (dose normalized by body weight). | Minute Times Picogram Per Milliliter Per Milligram Per Gram | |||
| min*pg/mL/(mg/g/day) | C117953 | Minutes times picograms per milliliter (area under the curve), divided by milligrams per gram per day (daily dose normalized by body weight). | Minute Times Picogram Per Milliliter Per Milligram Per Gram Per Day | |||
| min*pg/mL/g | C112352 | Minutes times picograms per milliliter (area under the curve), divided by grams (weight). | Minute Times Picogram Per Milliliter Per Gram | |||
| min*pg/mL/kg | C112353 | Minutes times picograms per milliliter (area under the curve), divided by kilograms (weight). | Minute Times Picogram Per Milliliter Per Kilogram | |||
| min*pg/mL/m2 | C111273 | Minutes times picograms per milliliter (area under the curve), divided by meters squared (surface area). | Minute Times Picogram per Milliliter per Meter Squared | |||
| min*pmol/L | C106543 | Minutes times picomoles per liter (area under the curve). | Minute Times Picomole Per Liter | |||
| min*pmol/L/(kg/m2) | C111274 | Minutes times picomoles per liter (area under the curve), divided by kilograms per meter squared (body mass index). | Minute Times Picomole per Liter per Kilogram per Meter Squared | |||
| min*pmol/L/(mg/g) | C117954 | Minutes times picomoles per liter (area under the curve), divided by milligrams per gram (dose normalized by body weight). | Minute Times Picomole Per Liter Per Milligram Per Gram | |||
| min*pmol/L/(mg/g/day) | C117955 | Minutes times picomoles per liter (area under the curve), divided by milligrams per gram per day (daily dose normalized by body weight). | Minute Times Picomole Per Liter Per Milligram Per Gram Per Day | |||
| min*pmol/L/g | C112354 | Minutes times picomoles per liter (area under the curve), divided by grams (weight). | Minute Times Picomole Per Liter Per Gram | |||
| min*pmol/L/kg | C112355 | Minutes times picomoles per liter (area under the curve), divided by kilograms (weight). | Minute Times Picomole Per Liter Per Kilogram | |||
| min*pmol/L/m2 | C111275 | Minutes times picomoles per liter (area under the curve), divided by meters squared (surface area). | Minute Times Picomole per Liter per Meter Squared | |||
| min*ug/mL | C85727 | Minutes times micrograms per milliliter (area under the curve). | Minute Times Microgram per Milliliter | |||
| min*ug/mL/(kg/m2) | C111258 | Minutes times micrograms per milliliter (area under the curve), divided by kilograms per meter squared (body mass index). | Minute Times Microgram per Milliliter per Kilogram per Meter Squared | |||
| min*ug/mL/(mg/g) | C117956 | Minutes times micrograms per milliliter (area under the curve), divided by milligrams per gram (dose normalized by body weight). | Minute Times Microgram Per Milliliter Per Milligram Per Gram | |||
| min*ug/mL/(mg/g/day) | C117957 | Minutes times micrograms per milliliter (area under the curve), divided by milligrams per gram per day (daily dose normalized by body weight). | Minute Times Microgram Per Milliliter Per Milligram Per Gram Per Day | |||
| min*ug/mL/g | C112338 | Minutes times micrograms per milliliter (area under the curve), divided by grams (weight). | Minute Times Microgram Per Milliliter Per Gram | |||
| min*ug/mL/kg | C112339 | Minutes times micrograms per milliliter (area under the curve), divided by kilograms (weight). | Minute Times Microgram Per Milliliter Per Kilogram | |||
| min*ug/mL/m2 | C111259 | Minutes times micrograms per milliliter (area under the curve), divided by meters squared (surface area). | Minute Times Microgram per Milliliter per Meter Squared | |||
| min*umol/L | C85733 | Minutes times micromoles per liter (area under the curve). | Minute Times Nanomole per Milliliter | |||
| min*umol/L/(kg/m2) | C111260 | Minutes times micromoles per liter (area under the curve), divided by kilograms per meter squared (body mass index). | Minute Times Micromole per Liter per Kilogram per Meter Squared | |||
| min*umol/L/(mg/g) | C117958 | Minutes times micromoles per liter (area under the curve), divided by milligrams per gram (dose normalized by body weight). | Minute Times Micromole Per Liter Per Milligram Per Gram | |||
| min*umol/L/(mg/g/day) | C117959 | Minutes times micromoles per liter (area under the curve), divided by milligrams per gram per day (daily dose normalized by body weight). | Minute Times Micromole Per Liter Per Milligram Per Gram Per Day | |||
| min*umol/L/g | C112340 | Minutes times micromoles per liter (area under the curve), divided by grams (weight). | Minute Times Micromole Per Liter Per Gram | |||
| min*umol/L/kg | C112341 | Minutes times micromoles per liter (area under the curve), divided by kilograms (weight). | Minute Times Micromole Per Liter Per Kilogram | |||
| min*umol/L/m2 | C111261 | Minutes times micromoles per liter (area under the curve), divided by meters squared (surface area). | Minute Times Micromole per Liter per Meter Squared | |||
| mIU/mL | C67376 | IE/L;IU/L;International Unit per Liter;mIU/mL | A unit of concentration (biologic activity) equal to one milli-international unit of substance per milliliter of solution or one international unit of substance per liter of solution. | International Unit per Liter | ||
| mIU/mL/(kg/m2) | C119396 | Milli-international units per milliliter (concentration), divided by kilograms per meter squared (body mass index). | Milli-International Unit per Milliliter per Kilogram per Meter Squared | |||
| mIU/mL/(mg/day) | C119397 | Milli-international units per milliliter (concentration), divided by milligrams per day (daily dose). | Milli-International Unit per Milliliter per Milligram per Day | |||
| mIU/mL/(mg/kg) | C119398 | Milli-international units per milliliter (concentration), divided by milligrams per kilogram. | Milli-International Unit per Milliliter per Milligram per Kilogram | |||
| mIU/mL/(mg/kg/day) | C119399 | Milli-international units per milliliter (concentration), divided by milligrams per kilogram per day. | Milli-International Unit per Milliliter per Milligram per Kilogram per Day | |||
| mIU/mL/(mg/m2) | C119400 | Milli-international units per milliliter (concentration), divided by milligrams per meter squared. | Milli-International Unit per Milliliter per Milligram per Meter Squared | |||
| mIU/mL/(mg/m2/day) | C119401 | Milli-international units per milliliter (concentration), divided by milligrams per meter squared per day (daily dose normalized by surface area). | Milli-International Unit per Milliliter per Milligram per Meter Squared per Day | |||
| mIU/mL/(ug/day) | C119402 | Milli-international units per milliliter (concentration), divided by micrograms per day (daily dose). | Milli-International Unit per Milliliter per Microgram per Day | |||
| mIU/mL/(ug/kg) | C119403 | Milli-international units per milliliter (concentration), divided by micrograms per kilogram. | Milli-International Unit per Milliliter per Microgram per Kilogram | |||
| mIU/mL/(ug/kg/day) | C119404 | Milli-international units per milliliter (concentration), divided by micrograms per kilogram per day. | Milli-International Unit per Milliliter per Microgram per Kilogram per Day | |||
| mIU/mL/(ug/m2) | C119405 | Milli-international units per milliliter (concentration), divided by micrograms per meter squared. | Milli-International Unit per Milliliter per Microgram per Meter Squared | |||
| mIU/mL/(ug/m2/day) | C119406 | Milli-international units per milliliter (concentration), divided by micrograms per meter squared per day (daily dose normalized by surface area). | Milli-International Unit per Milliliter per Microgram per Meter Squared per Day | |||
| mIU/mL/g | C119407 | Milli-international units per milliliter (concentration), divided by grams (weight). | Milli-International Unit per Milliliter per Gram | |||
| mIU/mL/kg | C119408 | Milli-international units per milliliter (concentration), divided by kilograms (weight). | Milli-International Unit per Milliliter per Kilogram | |||
| mIU/mL/m2 | C119409 | Milli-international units per milliliter (concentration), divided by meters squared (surface area). | Milli-International Unit per Milliliter per Meter Squared | |||
| mIU/mL/mg | C119410 | Milli-international units per milliliter (concentration), divided by milligrams (dose). | Milli-International Unit per Milliliter per Milligram | |||
| mIU/mL/ug | C119411 | Milli-international units per milliliter (concentration), divided by micrograms (dose). | Milli-International Unit per Milliliter per Microgram | |||
| mL | C28254 | Milliliter;cm3 | The unit of volume equal to one thousandth of a liter, one cubic centimeter, 10E-6 cubic meter, or approximately to 0.061 023 7 cubic inch.(NCI) | Milliliter | ||
| mL/day | C67410 | Milliliter per Day | Milliliters per day. | Milliliter per 24 Hours | ||
| mL/h | C66962 | Milliliters per Hour | A unit of volumetric flow rate defined as the rate at which one milliliter of matter travels during the period of time equal to one hour.(NCI) | Milliliter per Hour | ||
| mL/kg/day | C73758 | Milliliter per Kilogram per Day | Milliliters per kilogram per day. | Milliliter per Kilogram per Day | ||
| mL/kg/h | C73759 | Milliliter per Kilogram per Hour | Milliliters per kilogram per hour. | Milliliter per Kilogram per Hour | ||
| mL/kg/min | C73760 | Milliliter per Kilogram per Minute;mL/kg/min;mL/min/kg;uL/g/min;uL/min/g | Milliliters per kilogram per minute. | Milliliter per Kilogram per Minute | ||
| mL/min | C64777 | Milliliters per Minute | A metric unit of volumetric flow rate defined as the rate at which one milliliter of matter travels during the period of time equal to one minute.(NCI) | Milliliter per Minute | ||
| mL/mol/day | C85716 | mL/day/mol;mL/mol/d;uL/day/mmol;uL/mmol/day | Milliliters per mole per day. | Milliliter per Mole per Day | ||
| mL/mol/h | C85717 | mL/h/mol;mL/mol/h;uL/h/mmol;uL/mmol/h | Milliliters per mole per hour. | Milliliter per Mole per Hour | ||
| mL/mol/min | C85718 | mL/min/mol;mL/mol/min;uL/min/mmol;uL/mmol/min | Milliliters per mole per minute. | Milliliter per Mole per Minute | ||
| mmol | C48513 | Millimole | A unit of amount of substance equal to 0.001 mole.(NCI) | Millimole | ||
| mmol/h | C85720 | Millimoles per hour. | Millimole per Hour | |||
| mmol/L | C64387 | Micromole per Milliliter;Millimole per Liter;Mole per Cubic Meter;mcmol/mL;mmol/L;mol/m3;nmol/uL;umol/mL | A unit of concentration (molarity unit) equal to one millimole of solute per liter of solution. | Millimole per Liter | ||
| mmol/L/(kg/m2) | C119412 | Millimoles per liter (concentration), divided by kilograms per meter squared (body mass index). | Millimole per Liter per Kilogram per Meter Squared | |||
| mmol/L/(mg/day) | C119413 | Millimoles per liter (concentration), divided by milligrams per day (daily dose). | Millimole per Liter per Milligram per Day | |||
| mmol/L/(mg/kg) | C119414 | Millimoles per liter (concentration), divided by milligrams per kilogram. | Millimole per Liter per Milligram per Kilogram | |||
| mmol/L/(mg/kg/day) | C119415 | Millimoles per liter (concentration), divided by milligrams per kilogram per day. | Millimole per Liter per Milligram per Kilogram per Day | |||
| mmol/L/(mg/m2) | C119416 | Millimoles per liter (concentration), divided by milligrams per meter squared. | Millimole per Liter per Milligram per Meter Squared | |||
| mmol/L/(mg/m2/day) | C119417 | Millimoles per liter (concentration), divided by milligrams per meter squared per day (daily dose normalized by surface area). | Millimole per Liter per Milligram per Meter Squared per Day | |||
| mmol/L/(ug/day) | C119418 | Millimoles per liter (concentration), divided by micrograms per day (daily dose). | Millimole per Liter per Microgram per Day | |||
| mmol/L/(ug/kg) | C119419 | Millimoles per liter (concentration), divided by micrograms per kilogram. | Millimole per Liter per Microgram per Kilogram | |||
| mmol/L/(ug/kg/day) | C119420 | Millimoles per liter (concentration), divided by micrograms per kilogram per day. | Millimole per Liter per Microgram per Kilogram per Day | |||
| mmol/L/(ug/m2) | C119421 | Millimoles per liter (concentration), divided by micrograms per meter squared. | Millimole per Liter per Microgram per Meter Squared | |||
| mmol/L/(ug/m2/day) | C119422 | Millimoles per liter (concentration), divided by micrograms per meter squared per day (daily dose normalized by surface area). | Millimole per Liter per Microgram per Meter Squared per Day | |||
| mmol/L/g | C119423 | Millimoles per liter (concentration), divided by grams (weight). | Millimole per Liter per Gram | |||
| mmol/L/kg | C119424 | Millimoles per liter (concentration), divided by kilograms (weight). | Millimole per Liter per Kilogram | |||
| mmol/L/m2 | C119425 | Millimoles per liter (concentration), divided by meters squared (surface area). | Millimole per Liter per Meter Squared | |||
| mmol/L/mg | C119426 | Millimoles per liter (concentration), divided by milligrams (dose). | Millimole per Liter per Milligram | |||
| mmol/L/ug | C119427 | Millimoles per liter (concentration), divided by micrograms (dose). | Millimole per Liter per Microgram | |||
| mmol/min | C85722 | Millimoles per minute. | Millimole per Minute | |||
| mmol/mL/h | C85721 | mmol/h/mL;mmol/mL/h;mol/L/h;mol/h/L;umol/h/uL;umol/uL/h | Millimoles per milliliter per hour. | Millimole per Milliliter per Hour | ||
| mol | C42539 | Mole | A unit defined as the amount of substance that contains as many elementary units as there are atoms in 0.012 kg of carbon-12. When the mole is used, the elementary entities must be specified and may be atoms, molecules, ions, electrons, other particles, or specified groups of such particles.(NCI) | Mole | ||
| mol/day | C85737 | mol/d | Moles per day. | Mole per Day | ||
| mol/h | C85738 | Moles per hour. | Mole per Hour | |||
| mol/L | C48555 | Mole per Liter;mmol/mL;mol/L | A unit of concentration (molarity unit) equal to one mole of solute in one liter of solution.(NCI) | Mole per Liter | ||
| mol/L/(kg/m2) | C119428 | Moles per liter (concentration), divided by kilograms per meter squared (body mass index). | Mole per Liter per Kilogram per Meter Squared | |||
| mol/L/(mg/day) | C119429 | Moles per liter (concentration), divided by milligrams per day (daily dose). | Mole per Liter per Milligram per Day | |||
| mol/L/(mg/kg) | C119430 | Moles per liter (concentration), divided by milligrams per kilogram. | Mole per Liter per Milligram per Kilogram | |||
| mol/L/(mg/kg/day) | C119431 | Moles per liter (concentration), divided by milligrams per kilogram per day. | Mole per Liter per Milligram per Kilogram per Day | |||
| mol/L/(mg/m2) | C119432 | Moles per liter (concentration), divided by milligrams per meter squared. | Mole per Liter per Milligram per Meter Squared | |||
| mol/L/(mg/m2/day) | C119433 | Moles per liter (concentration), divided by milligrams per meter squared per day (daily dose normalized by surface area). | Mole per Liter per Milligram per Meter Squared per Day | |||
| mol/L/(ug/day) | C119434 | Moles per liter (concentration), divided by micrograms per day (daily dose). | Mole per Liter per Microgram per Day | |||
| mol/L/(ug/kg) | C119435 | Moles per liter (concentration), divided by micrograms per kilogram. | Mole per Liter per Microgram per Kilogram | |||
| mol/L/(ug/kg/day) | C119436 | Moles per liter (concentration), divided by micrograms per kilogram per day. | Mole per Liter per Microgram per Kilogram per Day | |||
| mol/L/(ug/m2) | C119437 | Moles per liter (concentration), divided by micrograms per meter squared. | Mole per Liter per Microgram per Meter Squared | |||
| mol/L/(ug/m2/day) | C119438 | Moles per liter (concentration), divided by micrograms per meter squared per day (daily dose normalized by surface area). | Mole per Liter per Microgram per Meter Squared per Day | |||
| mol/L/g | C119439 | Moles per liter (concentration), divided by grams (weight). | Mole per Liter per Gram | |||
| mol/L/kg | C119440 | Moles per liter (concentration), divided by kilograms (weight). | Mole per Liter per Kilogram | |||
| mol/L/m2 | C119441 | Moles per liter (concentration), divided by meters squared (surface area). | Mole per Liter per Meter Squared | |||
| mol/L/mg | C119442 | Moles per liter (concentration), divided by milligrams (dose). | Mole per Liter per Milligram | |||
| mol/L/ug | C119443 | Moles per liter (concentration), divided by micrograms (dose). | Mole per Liter per Microgram | |||
| mol/min | C85739 | Moles per minute. | Mole per Minute | |||
| ng | C48516 | Nanogram | A unit of mass equal to one billionth (10E-9) of a gram, or one millionth (10E-6) of a milligram.(NCI) | Nanogram | ||
| ng/day | C85741 | ng/d | Nanograms per day. | Nanogram per Day | ||
| ng/h | C85742 | Nanograms per hour. | Nanogram per Hour | |||
| ng/kg/min | C85743 | ng/kg/min;ng/min/kg;pg/g/min;pg/min/g | Nanograms per kilogram per minute. | Nanogram per Kilogram per Minute | ||
| ng/mg of Creatinine | C85744 | ng/mg of Creatinine;ug/g of Creatinine | Nanograms per milligram of creatinine. | Nanogram per Milligram of Creatinine | ||
| ng/min | C85749 | Nanograms per minute. | Nanogram per Minute | |||
| ng/mL | C67306 | Microgram per Liter;Milligram per Cubic Meter;Nanogram per Milliliter;mcg/L;mg/m3;ng/mL;ug/L | A unit of concentration or mass density equal to one nanogram of substance per milliliter of solution or one microgram of substance per liter of solution. | Microgram per Liter | ||
| ng/mL/(kg/m2) | C119444 | Nanograms per milliliter (concentration), divided by kilograms per meter squared (body mass index). | Nanogram per Milliliter per Kilogram per Meter Squared | |||
| ng/mL/(mg/day) | C119445 | Nanograms per milliliter (concentration), divided by milligrams per day (daily dose). | Nanogram per Milliliter per Milligram per Day | |||
| ng/mL/(mg/kg) | C105477 | Nanograms per milliliter (concentration), divided by milligrams per kilogram (dose normalized by body weight). | Nanogram Per Milliliter Per Milligram Per Kilogram | |||
| ng/mL/(mg/kg/day) | C105478 | Nanograms per milliliter (concentration), divided by milligrams per kilogram per day (daily dose normalized by body weight). | Nanogram Per Milliliter Per Milligram Per Kilogram Per Day | |||
| ng/mL/(mg/m2) | C119446 | Nanograms per milliliter (concentration), divided by milligrams per meter squared. | Nanogram per Milliliter per Milligram per Meter Squared | |||
| ng/mL/(mg/m2/day) | C119447 | Nanograms per milliliter (concentration), divided by milligrams per meter squared per day (daily dose normalized by surface area). | Nanogram per Milliliter per Milligram per Meter Squared per Day | |||
| ng/mL/(ug/day) | C119448 | Nanograms per milliliter (concentration), divided by micrograms per day (daily dose). | Nanogram per Milliliter per Microgram per Day | |||
| ng/mL/(ug/kg) | C119449 | Nanograms per milliliter (concentration), divided by micrograms per kilogram. | Nanogram per Milliliter per Microgram per Kilogram | |||
| ng/mL/(ug/kg/day) | C119450 | Nanograms per milliliter (concentration), divided by micrograms per kilogram per day. | Nanogram per Milliliter per Microgram per Kilogram per Day | |||
| ng/mL/(ug/m2) | C119451 | Nanograms per milliliter (concentration), divided by micrograms per meter squared. | Nanogram per Milliliter per Microgram per Meter Squared | |||
| ng/mL/(ug/m2/day) | C119452 | Nanograms per milliliter (concentration), divided by micrograms per meter squared per day (daily dose normalized by surface area). | Nanogram per Milliliter per Microgram per Meter Squared per Day | |||
| ng/mL/g | C119453 | Nanograms per milliliter (concentration), divided by grams (weight). | Nanogram per Milliliter per Gram | |||
| ng/mL/h | C67430 | ng/h/mL;ng/mL/h;ug/L/h | Nanograms per milliliter per hour. | Nanogram per Milliliter per Hour | ||
| ng/mL/kg | C85746 | Nanograms per milliliter (concentration), divided by kilograms (weight). | Nanogram per Milliliter per Kilogram | |||
| ng/mL/m2 | C119454 | Nanograms per milliliter (concentration), divided by meters squared (surface area). | Nanogram per Milliliter per Meter Squared | |||
| ng/mL/mg | C85747 | Nanograms per milliliter (concentration), divided by milligrams (dose). | Nanogram per Milliliter per Milligram | |||
| ng/mL/ug | C119455 | Nanograms per milliliter (concentration), divided by micrograms (dose). | Nanogram per Milliliter per Microgram | |||
| nL | C69188 | Nanoliter | A unit of volume equal to one billionth of a liter (10E-9 liter).(NCI) | Nanoliter | ||
| nmol | C48517 | Nanomole | A unit of amount of substance equal to one billionth (10E-9) of a mole.(NCI) | Nanomole | ||
| nmol/day | C85751 | nmol/d | Nanomoles per day. | Nanomole per Day | ||
| nmol/g | C85752 | nmol/g;pmol/mg;umol/kg | Nanomoles per gram. | Nanomole per Gram | ||
| nmol/h | C85753 | Nanomoles per hour. | Nanomole per Hour | |||
| nmol/kg | C85754 | nmol/kg;pmol/g | Nanomoles per kilogram. | Nanomole per Kilogram | ||
| nmol/L | C67432 | Nanomole per Liter | A unit of concentration (molarity unit) equal to one nanomole of solute per liter of solution. | Nanomole per Liter | ||
| nmol/L/(kg/m2) | C119456 | Nanomoles per liter (concentration), divided by kilograms per meter squared (body mass index). | Nanomole per Liter per Kilogram per Meter Squared | |||
| nmol/L/(mg/day) | C119457 | Nanomoles per liter (concentration), divided by milligrams per day (daily dose). | Nanomole per Liter per Milligram per Day | |||
| nmol/L/(mg/kg) | C119458 | Nanomoles per liter (concentration), divided by milligrams per kilogram. | Nanomole per Liter per Milligram per Kilogram | |||
| nmol/L/(mg/kg/day) | C119459 | Nanomoles per liter (concentration), divided by milligrams per kilogram per day. | Nanomole per Liter per Milligram per Kilogram per Day | |||
| nmol/L/(mg/m2) | C119460 | Nanomoles per liter (concentration), divided by milligrams per meter squared. | Nanomole per Liter per Milligram per Meter Squared | |||
| nmol/L/(mg/m2/day) | C119461 | Nanomoles per liter (concentration), divided by milligrams per meter squared per day (daily dose normalized by surface area). | Nanomole per Liter per Milligram per Meter Squared per Day | |||
| nmol/L/(ug/day) | C119462 | Nanomoles per liter (concentration), divided by micrograms per day (daily dose). | Nanomole per Liter per Microgram per Day | |||
| nmol/L/(ug/kg) | C119463 | Nanomoles per liter (concentration), divided by micrograms per kilogram. | Nanomole per Liter per Microgram per Kilogram | |||
| nmol/L/(ug/kg/day) | C119464 | Nanomoles per liter (concentration), divided by micrograms per kilogram per day. | Nanomole per Liter per Microgram per Kilogram per Day | |||
| nmol/L/(ug/m2) | C119465 | Nanomoles per liter (concentration), divided by micrograms per meter squared. | Nanomole per Liter per Microgram per Meter Squared | |||
| nmol/L/(ug/m2/day) | C119466 | Nanomoles per liter (concentration), divided by micrograms per meter squared per day (daily dose normalized by surface area). | Nanomole per Liter per Microgram per Meter Squared per Day | |||
| nmol/L/g | C119467 | Nanomoles per liter (concentration), divided by grams (weight). | Nanomole per Liter per Gram | |||
| nmol/L/kg | C119468 | Nanomoles per liter (concentration), divided by kilograms (weight). | Nanomole per Liter per Kilogram | |||
| nmol/L/m2 | C119469 | Nanomoles per liter (concentration), divided by meters squared (surface area). | Nanomole per Liter per Meter Squared | |||
| nmol/L/mg | C119470 | Nanomoles per liter (concentration), divided by milligrams (dose). | Nanomole per Liter per Milligram | |||
| nmol/L/ug | C119471 | Nanomoles per liter (concentration), divided by micrograms (dose). | Nanomole per Liter per Microgram | |||
| nmol/min | C85758 | Nanomoles per minute. | Nanomole per Minute | |||
| nmol/mL/h | C85757 | nmol/h/mL;nmol/mL/h;umol/L/h | Nanomoles per milliliter per hour. | Nanomole per Milliliter per Hour | ||
| nU/mL | C85760 | mcU/L;nU/mL;uU/L | Nanounits per milliliter. | Nanounit per Milliliter | ||
| pg/day | C85778 | pg/d | Picograms per day. | Picogram per Day | ||
| pg/dL | C67331 | Picogram per Deciliter | Picograms per deciliter. | Picogram per Deciliter | ||
| pg/h | C85779 | Picograms per hour. | Picogram per Hour | |||
| pg/mg | C67396 | Microgram per Kilogram;mcg/kg;ng/g;ug/kg | A unit of a mass fraction expressed as a number of micrograms of substance per kilogram of mixture. The unit is also used as a dose calculation unit.(NCI) | Microgram per Kilogram | ||
| pg/mg Creatinine | C85780 | ng/g of Creatinine;pg/mg of Creatinine | Picograms per milligram creatinine. | Picogram per Milligram of Creatinine | ||
| pg/min | C85782 | Picograms per minute. | Picogram per Minute | |||
| pg/mL | C67327 | Microgram per Cubic Meter;ng/L;pg/mL;ug/m3 | A unit of concentration or mass density equal to one picogram of substance per milliliter of solution or one nanogram of substance per liter of solution. | Nanogram per Liter | ||
| pg/mL/(kg/m2) | C119472 | Picograms per milliliter (concentration), divided by kilograms per meter squared (body mass index). | Picogram per Milliliter per Kilogram per Meter Squared | |||
| pg/mL/(mg/day) | C119473 | Picograms per milliliter (concentration), divided by milligrams per day (daily dose). | Picogram per Milliliter per Milligram per Day | |||
| pg/mL/(mg/kg) | C105479 | Picograms per milliliter (concentration), divided by milligrams per kilogram (dose normalized by body weight). | Picogram Per Milliliter Per Milligram Per Kilogram | |||
| pg/mL/(mg/kg/day) | C105480 | Picograms per milliliter (concentration), divided by milligrams per kilogram per day (daily dose normalized by body weight). | Picogram Per Milliliter Per Milligram Per Kilogram Per Day | |||
| pg/mL/(mg/m2) | C119474 | Picograms per milliliter (concentration), divided by milligrams per meter squared. | Picogram per Milliliter per Milligram per Meter Squared | |||
| pg/mL/(mg/m2/day) | C119475 | Picograms per milliliter (concentration), divided by milligrams per meter squared per day (daily dose normalized by surface area). | Picogram per Milliliter per Milligram per Meter Squared per Day | |||
| pg/mL/(ug/day) | C119476 | Picograms per milliliter (concentration), divided by micrograms per day (daily dose). | Picogram per Milliliter per Microgram per Day | |||
| pg/mL/(ug/kg) | C119477 | Picograms per milliliter (concentration), divided by micrograms per kilogram. | Picogram per Milliliter per Microgram per Kilogram | |||
| pg/mL/(ug/kg/day) | C119478 | Picograms per milliliter (concentration), divided by micrograms per kilogram per day. | Picogram per Milliliter per Microgram per Kilogram per Day | |||
| pg/mL/(ug/m2) | C119479 | Picograms per milliliter (concentration), divided by micrograms per meter squared. | Picogram per Milliliter per Microgram per Meter Squared | |||
| pg/mL/(ug/m2/day) | C119480 | Picograms per milliliter (concentration), divided by micrograms per meter squared per day (daily dose normalized by surface area). | Picogram per Milliliter per Microgram per Meter Squared per Day | |||
| pg/mL/g | C119481 | Picograms per milliliter (concentration), divided by grams (weight). | Picogram per Milliliter per Gram | |||
| pg/mL/kg | C119482 | Picograms per milliliter (concentration), divided by kilograms (weight). | Picogram per Milliliter per Kilogram | |||
| pg/mL/m2 | C119483 | Picograms per milliliter (concentration), divided by meters squared (surface area). | Picogram per Milliliter per Meter Squared | |||
| pg/mL/mg | C119484 | Picograms per milliliter (concentration), divided by milligrams (dose). | Picogram per Milliliter per Milligram | |||
| pg/mL/ug | C85781 | pg/mL/mcg | Picograms per milliliter (concentration), divided by micrograms (dose). | Picogram per Milliliter per Microgram | ||
| pmol/L | C67434 | Femtomole per Milliliter;Picomole per Liter;fmol/mL | A unit of concentration (molarity unit) equal to one picomole of solute per liter of solution. | Picomole per Liter | ||
| pmol/L/(kg/m2) | C119485 | Picomoles per liter (concentration), divided by kilograms per meter squared (body mass index). | Picomole per Liter per Kilogram per Meter Squared | |||
| pmol/L/(mg/day) | C119486 | Picomoles per liter (concentration), divided by milligrams per day (daily dose). | Picomole per Liter per Milligram per Day | |||
| pmol/L/(mg/kg) | C119487 | Picomoles per liter (concentration), divided by milligrams per kilogram. | Picomole per Liter per Milligram per Kilogram | |||
| pmol/L/(mg/kg/day) | C119488 | Picomoles per liter (concentration), divided by milligrams per kilogram per day. | Picomole per Liter per Milligram per Kilogram per Day | |||
| pmol/L/(mg/m2) | C119489 | Picomoles per liter (concentration), divided by milligrams per meter squared. | Picomole per Liter per Milligram per Meter Squared | |||
| pmol/L/(mg/m2/day) | C119490 | Picomoles per liter (concentration), divided by milligrams per meter squared per day (daily dose normalized by surface area). | Picomole per Liter per Milligram per Meter Squared per Day | |||
| pmol/L/(ug/day) | C119491 | Picomoles per liter (concentration), divided by micrograms per day (daily dose). | Picomole per Liter per Microgram per Day | |||
| pmol/L/(ug/kg) | C119492 | Picomoles per liter (concentration), divided by micrograms per kilogram. | Picomole per Liter per Microgram per Kilogram | |||
| pmol/L/(ug/kg/day) | C119493 | Picomoles per liter (concentration), divided by micrograms per kilogram per day. | Picomole per Liter per Microgram per Kilogram per Day | |||
| pmol/L/(ug/m2) | C119494 | Picomoles per liter (concentration), divided by micrograms per meter squared. | Picomole per Liter per Microgram per Meter Squared | |||
| pmol/L/(ug/m2/day) | C119495 | Picomoles per liter (concentration), divided by micrograms per meter squared per day (daily dose normalized by surface area). | Picomole per Liter per Microgram per Meter Squared per Day | |||
| pmol/L/g | C119496 | Picomoles per liter (concentration), divided by grams (weight). | Picomole per Liter per Gram | |||
| pmol/L/kg | C119497 | Picomoles per liter (concentration), divided by kilograms (weight). | Picomole per Liter per Kilogram | |||
| pmol/L/m2 | C119498 | Picomoles per liter (concentration), divided by meters squared (surface area). | Picomole per Liter per Meter Squared | |||
| pmol/L/mg | C119499 | Picomoles per liter (concentration), divided by milligrams (dose). | Picomole per Liter per Milligram | |||
| pmol/L/ug | C85784 | Picomoles per liter (concentration), divided by micrograms (dose). | Picomole per Liter per Microgram | |||
| RATIO | C44256 | A unit of measurement for the quotient of the amount of one entity to another. | Ratio | |||
| ug | C48152 | Microgram;mcg | The unit of mass equal to one millionth of a gram or one thousandth of a milligram.(NCI) | Microgram | ||
| ug/day | C71205 | Microgram per Day;mcg/day | A unit of mass flow rate equivalent to the rate at which one millionth of a gram of matter travels to a given object or space over a period of time equal to twenty four hours. Microgram per day is also a dose administration rate unit equal to the rate at which one millionth of a gram of a product is administered per unit of time equal to twenty four hours.(NCI) | Microgram per Day | ||
| ug/h | C67394 | Micrograms per Hour;mcg/h | A unit of mass flow rate equivalent to the rate at which one millionth of a gram of matter travels to a given object or space over a period of time equal to one hour.(NCI) | Microgram per Hour | ||
| ug/inh | C85703 | mcg/inh | Micrograms per inhalation. | Microgram per Inhalation | ||
| ug/min | C71211 | Micrograms per Minute;mcg/min | A unit of mass flow rate equivalent to the rate at which one millionth of a gram of matter travels to a given object or space over a period of time equal to one minute. Microgram per minute is also a dose administration rate unit equal to the rate at which one millionth of a gram of a product is administered per unit of time equal to one minute.(NCI) | Microgram per Minute | ||
| ug/mL | C64572 | Gram per Cubic Meter;Microgram per Milliliter;Milligram per Liter;g/m3;mcg/mL;mg/L;ng/uL;ug/mL | A unit of concentration or mass density equal to one microgram of substance per milliliter of solution or one milligram of substance per liter of solution. | Microgram per Milliliter | ||
| ug/mL/(kg/m2) | C119500 | Micrograms per milliliter (concentration), divided by kilograms per meter squared (body mass index). | Microgram per Milliliter per Kilogram per Meter Squared | |||
| ug/mL/(mg/day) | C119501 | Micrograms per milliliter (concentration), divided by milligrams per day (daily dose). | Microgram per Milliliter per Milligram per Day | |||
| ug/mL/(mg/kg) | C105473 | Micrograms per milliliter (concentration), divided by milligrams per kilogram (dose normalized by body weight). | Microgram Per Milliliter Per Milligram Per Kilogram | |||
| ug/mL/(mg/kg/day) | C105474 | Micrograms per milliliter (concentration), divided by milligrams per kilogram per day (daily dose normalized by body weight). | Microgram Per Milliliter Per Milligram Per Kilogram Per Day | |||
| ug/mL/(mg/m2) | C119502 | Micrograms per milliliter (concentration), divided by milligrams per meter squared. | Microgram per Milliliter per Milligram per Meter Squared | |||
| ug/mL/(mg/m2/day) | C119503 | Micrograms per milliliter (concentration), divided by milligrams per meter squared per day (daily dose normalized by surface area). | Microgram per Milliliter per Milligram per Meter Squared per Day | |||
| ug/mL/(ug/day) | C119504 | Micrograms per milliliter (concentration), divided by micrograms per day (daily dose). | Microgram per Milliliter per Microgram per Day | |||
| ug/mL/(ug/kg) | C119505 | Micrograms per milliliter (concentration), divided by micrograms per kilogram. | Microgram per Milliliter per Microgram per Kilogram | |||
| ug/mL/(ug/kg/day) | C119506 | Micrograms per milliliter (concentration), divided by micrograms per kilogram per day. | Microgram per Milliliter per Microgram per Kilogram per Day | |||
| ug/mL/(ug/m2) | C119507 | Micrograms per milliliter (concentration), divided by micrograms per meter squared. | Microgram per Milliliter per Microgram per Meter Squared | |||
| ug/mL/(ug/m2/day) | C119508 | Micrograms per milliliter (concentration), divided by micrograms per meter squared per day (daily dose normalized by surface area). | Microgram per Milliliter per Microgram per Meter Squared per Day | |||
| ug/mL/g | C119509 | Micrograms per milliliter (concentration), divided by grams (weight). | Microgram per Milliliter per Gram | |||
| ug/mL/kg | C119510 | Micrograms per milliliter (concentration), divided by kilograms (weight). | Microgram per Milliliter per Kilogram | |||
| ug/mL/m2 | C119511 | Micrograms per milliliter (concentration), divided by meters squared (surface area). | Microgram per Milliliter per Meter Squared | |||
| ug/mL/mg | C85710 | Micrograms per milliliter (concentration), divided by milligrams (dose). | Milligram per Liter per Milligram | |||
| ug/mL/ug | C119512 | Micrograms per milliliter (concentration), divided by micrograms (dose). | Microgram per Milliliter per Microgram | |||
| ug/puff | C85704 | mcg/puff | Micrograms per puff. | Microgram per Puff | ||
| uIU/mL | C67405 | Micro-International Unit per milliliter;mIE/L;mIU/L;mcIU/mL;uIU/mL | A unit of concentration (biologic activity) equal to one micro-international unit of substance per milliliter of solution or one milli-international unit of substance per liter of solution. | Microinternational Unit per Milliliter | ||
| uIU/mL/(kg/m2) | C119513 | Micro-international units per milliliter (concentration), divided by kilograms per meter squared (body mass index). | Micro-International Units per Milliliter per Kilogram per Meter Squared | |||
| uIU/mL/(mg/day) | C119514 | Micro-international units per milliliter (concentration), divided by milligrams per day (daily dose). | Micro-International Units per Milliliter per Milligram per Day | |||
| uIU/mL/(mg/kg) | C119515 | Micro-international units per milliliter (concentration), divided by milligrams per kilogram. | Micro-International Units per Milliliter per Milligram per Kilogram | |||
| uIU/mL/(mg/kg/day) | C119516 | Micro-international units per milliliter (concentration), divided by milligrams per kilogram per day. | Micro-International Units per Milliliter per Milligram per Kilogram per Day | |||
| uIU/mL/(mg/m2) | C119517 | Micro-international units per milliliter (concentration), divided by milligrams per meter squared. | Micro-International Units per Milliliter per Milligram per Meter Squared | |||
| uIU/mL/(mg/m2/day) | C119518 | Micro-international units per milliliter (concentration), divided by milligrams per meter squared per day (daily dose normalized by surface area). | Micro-International Units per Milliliter per Milligram per Meter Squared per Day | |||
| uIU/mL/(ug/day) | C119519 | Micro-international units per milliliter (concentration), divided by micrograms per day (daily dose). | Micro-International Units per Milliliter per Microgram per Day | |||
| uIU/mL/(ug/kg) | C119520 | Micro-international units per milliliter (concentration), divided by micrograms per kilogram. | Micro-International Units per Milliliter per Microgram per Kilogram | |||
| uIU/mL/(ug/kg/day) | C119521 | Micro-international units per milliliter (concentration), divided by micrograms per kilogram per day. | Micro-International Units per Milliliter per Microgram per Kilogram per Day | |||
| uIU/mL/(ug/m2) | C119522 | Micro-international units per milliliter (concentration), divided by micrograms per meter squared. | Micro-International Units per Milliliter per Microgram per Meter Squared | |||
| uIU/mL/(ug/m2/day) | C119523 | Micro-international units per milliliter (concentration), divided by micrograms per meter squared per day (daily dose normalized by surface area). | Micro-International Units per Milliliter per Microgram per Meter Squared per Day | |||
| uIU/mL/g | C119524 | Micro-international units per milliliter (concentration), divided by grams (weight). | Micro-International Units per Milliliter per Gram | |||
| uIU/mL/kg | C119525 | Micro-international units per milliliter (concentration), divided by kilograms (weight). | Micro-International Units per Milliliter per Kilogram | |||
| uIU/mL/m2 | C119526 | Micro-international units per milliliter (concentration), divided by meters squared (surface area). | Micro-International Units per Milliliter per Meter Squared | |||
| uIU/mL/mg | C119527 | Micro-international units per milliliter (concentration), divided by milligrams (dose). | Micro-International Units per Milliliter per Milligram | |||
| uIU/mL/ug | C119528 | Micro-international units per milliliter (concentration), divided by micrograms (dose). | Micro-International Units per Milliliter per Microgram | |||
| uL | C48153 | Microliter;mcL;mm3 | A unit of volume accepted for use with the SI and equal to one millionth of a liter (10E-6 liter).(NCI) | Microliter | ||
| umol | C48509 | Micromole;mcmol | A unit of amount of substance equal to one millionth (10E-6) of a mole.(NCI) | Micromole | ||
| umol/day | C67406 | Micromoles per Day;mcmol/day | A unit of amount of substance flow rate equivalent to the rate at which one millionth of a mole of substance travels to a given object or space over a period of time equal to 24 hours.(NCI) | Micromole per 24 Hours | ||
| umol/h | C85707 | mcmol/h;umol/h | Micromoles per hour. | Micromole per Hour | ||
| umol/L | C48508 | Micromole per Liter | A unit of concentration (molarity unit) equal to one micromole of solute per liter of solution. | Micromole per Liter | ||
| umol/L/(kg/m2) | C119529 | Micromoles per liter (concentration), divided by kilograms per meter squared (body mass index). | Micromole per Liter per Kilogram per Meter Squared | |||
| umol/L/(mg/day) | C119530 | Micromoles per liter (concentration), divided by milligrams per day (daily dose). | Micromole per Liter per Milligram per Day | |||
| umol/L/(mg/kg) | C119531 | Micromoles per liter (concentration), divided by milligrams per kilogram. | Micromole per Liter per Milligram per Kilogram | |||
| umol/L/(mg/kg/day) | C119532 | Micromoles per liter (concentration), divided by milligrams per kilogram per day. | Micromole per Liter per Milligram per Kilogram per Day | |||
| umol/L/(mg/m2) | C119533 | Micromoles per liter (concentration), divided by milligrams per meter squared. | Micromole per Liter per Milligram per Meter Squared | |||
| umol/L/(mg/m2/day) | C119534 | Micromoles per liter (concentration), divided by milligrams per meter squared per day (daily dose normalized by surface area). | Micromole per Liter per Milligram per Meter Squared per Day | |||
| umol/L/(ug/day) | C119535 | Micromoles per liter (concentration), divided by micrograms per day (daily dose). | Micromole per Liter per Microgram per Day | |||
| umol/L/(ug/kg) | C119536 | Micromoles per liter (concentration), divided by micrograms per kilogram. | Micromole per Liter per Microgram per Kilogram | |||
| umol/L/(ug/kg/day) | C119537 | Micromoles per liter (concentration), divided by micrograms per kilogram per day. | Micromole per Liter per Microgram per Kilogram per Day | |||
| umol/L/(ug/m2) | C119538 | Micromoles per liter (concentration), divided by micrograms per meter squared. | Micromole per Liter per Microgram per Meter Squared | |||
| umol/L/(ug/m2/day) | C119539 | Micromoles per liter (concentration), divided by micrograms per meter squared per day (daily dose normalized by surface area). | Micromole per Liter per Microgram per Meter Squared per Day | |||
| umol/L/g | C119540 | Micromoles per liter (concentration), divided by grams (weight). | Micromole per Liter per Gram | |||
| umol/L/kg | C119541 | Micromoles per liter (concentration), divided by kilograms (weight). | Micromole per Liter per Kilogram | |||
| umol/L/m2 | C119542 | Micromoles per liter (concentration), divided by meters squared (surface area). | Micromole per Liter per Meter Squared | |||
| umol/L/mg | C119543 | Micromoles per liter (concentration), divided by milligrams (dose). | Micromole per Liter per Milligram | |||
| umol/L/ug | C119544 | Micromoles per liter (concentration), divided by micrograms (dose). | Micromole per Liter per Microgram | |||
| umol/min | C85708 | mcmol/min;umol/min | Micromoles per minute. | Micromole per Minute | ||
| Back to top | ||||||
| CL.C99075.PORTOT | Portion/Totality (PORTOT) | text Extensible: Yes | C99075 | Portion/Totality | Qualifier for anatomical location or specimen further detailing the portion or totality, which means arrangement of, or apportioning of an entity. | CDISC SDTM Portion/Totality Terminology |
| ALL | C64916 | Being or representing the total number of individual entities. | All | |||
| ENTIRE | C25326 | Whole | Being or representing the complete extent of a single entity. | Whole | ||
| MULTIPLE | C78728 | Many;Several | More than one. (NCI) | Many | ||
| PARTIAL | C25378 | Being or representing an incomplete extent of a single entity. | Partial | |||
| SEGMENT | C45312 | One of the parts into which something is divided. | Segment | |||
| SINGLE | C48440 | One. | Single | |||
| Back to top | ||||||
| CL.C71148.POSITION | Position (POSITION) | text Extensible: Yes | C71148 | Position | Terminology codelist used with Body Position within CDISC. | CDISC SDTM Body Position Terminology |
| DECUBITUS | C77532 | Recumbent | Lying down. (NCI) | Recumbent Position | ||
| FOWLERS | C62173 | Fowlers | A semi-sitting position whereby the head of an adjustable bed is elevated to the desired height, about 60-90 cm, to produce angulation of the body, usually 45 degrees to 60 degrees. Knees may or may not be bent. (NCI) | Fowler's Position | ||
| LATERAL DECUBITUS | C100758 | Lateral Decubitus | Lying down on one side. | Lateral Decubitus Position | ||
| LEFT LATERAL DECUBITUS | C62172 | Left lateral decubitus | A recumbent left lateral side position. (NCI) | Left Lateral Decubitus Position | ||
| PRONE | C62165 | Prone | An anterior recumbent body position whereby the person lies on its stomach and faces downward. (NCI) | Prone Position | ||
| REVERSE TRENDELENBURG | C62169 | Reverse Trendelenburg | A supine position with the person inclined at an angle of 45 degrees so that the head is higher than the pelvis. (NCI) | Reverse Trendelenburg | ||
| RIGHT LATERAL DECUBITUS | C62171 | Right lateral decubitus | A recumbent right lateral side position. (NCI) | Right Lateral Decubitus Position | ||
| SEMI-FOWLERS | C62174 | Semi-Fowlers | A semi-sitting or semi-reclined body position whereby the head is elevated on an angle of approximately 30 degrees. (NCI) | Semi-Fowler's Position | ||
| SEMI-RECUMBENT | C111310 | A semi-sitting or semi-reclined body position in which the head is elevated above horizontal. (NCI) | Semi-Recumbent | |||
| SITTING | C62122 | Sitting | The state or act of one who sits; the posture of one who occupies a seat. (NCI) | Sitting | ||
| SLING | C92604 | Sling | A position in which the subject's body is supported by a sling. | Patient in Body Sling | ||
| STANDING | C62166 | Standing | The act of assuming or maintaining an erect upright position. (NCI) | Standing | ||
| SUPINE | C62167 | Supine | A posterior recumbent body position whereby the person lies on its back and faces upward. (NCI) | Supine Position | ||
| TRENDELENBURG | C62168 | Trendelenburg | A supine position with the person inclined at an angle of 45 degrees so that the pelvis is higher than the head. (NCI) | Trendelenburg | ||
| UNCONSTRAINED | C90480 | Unconstrained | The ability to move body parts and limbs without physical restriction. (NCI) | Unconstrained Body Movement | ||
| Back to top | ||||||
| CL.C102582.PRITBCON | Priority of Tuberculosis Contact (PRITBCON) | text Extensible: Yes | C102582 | Priority of Tuberculosis Contact | Terminology relevant to the prioritization of tuberculosis contacts. | CDISC SDTM Priority of Tuberculosis Contact Terminology |
| HIGH-PRIORITY TUBERCULOSIS CONTACT | C102644 | An individual that has tested positive for pulmonary, laryngeal, or pleural tuberculosis and may or may not present with cavitary disease. | High-priority Tuberculosis Subject | |||
| LOW-PRIORITY TUBERCULOSIS CONTACT | C102662 | An individual that has had limited exposure to an individual with tuberculosis and has a low probability of having had a recent infection. | Low-priority Tuberculosis Subject | |||
| MEDIUM-PRIORITY TUBERCULOSIS CONTACT | C102665 | An individual that has tested negative for pulmonary, laryngeal, or pleural tuberculosis but has had a non-cavitary chest x-ray that is consistent with tuberculosis. | Medium-priority Tuberculosis Subject | |||
| Back to top | ||||||
| CL.C101858.PROCEDUR | Procedure (PROCEDUR) | text Extensible: Yes | C101858 | Procedure | A terminology codelist to describe any activity considered to be a therapeutic or diagnostic procedure. | CDISC SDTM Procedure Terminology |
| ABLATION | C20985 | Removal, separation, detachment, extirpation or eradication of a body part, pathway or function by surgery, chemical destruction, morbid process, or noxious substance. (NCI) | Ablation Therapy | |||
| ABLATION, ACCESSORY PATHWAYS | C99907 | An invasive therapeutic procedure to destroy tissue in an accessory pathways in the atrioventricular conduction system that contributes to arrhythmia. | Ablation of Cardiac Accessory Pathway | |||
| ABLATION, ATRIAL | C80432 | An invasive therapeutic procedure to destroy tissue in the cardiac atria that is the source of an arrhythmia. | Atrial Ablation | |||
| ABLATION, AV NODE | C99908 | An invasive therapeutic procedure to destroy tissue in the AV-node that contributes to arrhythmia. | Ablation of Cardiac Atrioventricular Node | |||
| ABLATION, CHEMICAL | C111157 | Removal, separation, detachment, extirpation or eradication of a body part, pathway or function by chemical means. (NCI) | Chemical Ablation | |||
| ABLATION, LASER | C111241 | Removal, separation, detachment, extirpation or eradication of a body part, pathway or function by light amplification by stimulated emission of radiation. (NCI) | Laser Ablation | |||
| ABLATION, VENTRICULAR | C80433 | An invasive therapeutic procedure to destroy tissue in the cardiac ventricles that is the source of an arrhythmia. | Ventricular Ablation | |||
| AORTIC BALLOON VALVOTOMY | C99916 | Dilation of the valve between the left ventricle of the heart and the aorta by inflating a balloon. | Aortic Balloon Valvotomy | |||
| AORTIC VALVE REPLACEMENT | C50815 | Surgery performed with the purpose of replacing a degenerated, calcified, malformed, dysfunctional, etc. aortic valve with a bioprosthetic, homograft, or autograft valve. | Aortic Valve Replacement | |||
| ATRIAL SEPTAL CLOSURE | C99939 | Repair of atrial septum. | Closure of Cardiac Atrial Septum | |||
| CARDIAC RESYNCHRONIZATION THERAPY | C80436 | An invasive procedure that includes an electronic device that stimulates both right and left cardiac ventricles to improve coordination of ventricular contraction. | Cardiac Resynchronization Therapy | |||
| CARDIAC STENT PLACEMENT | C100080 | A procedure performed during a percutaneous coronary intervention in which a device is deployed into the lumen of a coronary artery to expand and support the vessel wall such that the vessel remains patent and blood flow is uninhibited. | Cardiac Stent Placement | |||
| CARDIAC TRANSPLANT | C15246 | Heart Transplant | A surgical procedure in which a damaged heart is removed and replaced by another heart from a suitable donor. | Heart Transplantation | ||
| CARDIOVERSION, CHEMICAL | C99937 | CHEMICAL CARDIOVERSION | The administration of pharmacologic agents to correct abnormal heart rhythm. | Chemical Cardioversion | ||
| CARDIOVERSION, ELECTRICAL | C99948 | ELECTRICAL CARDIOVERSION | The administration of electric current to correct abnormal heart rhythm. | Electric Cardioversion | ||
| CORONARY ARTERY BYPASS GRAFT | C51998 | Aortocoronary Bypass;CAB;CABG;Coronary Artery Bypass;Coronary Artery Bypass Graft;Coronary Artery Bypass Graft Surgery;Coronary Artery Bypass Grafting;Heart Bypass | A procedure performed to bypass partially or completely occluded coronary arteries with veins and/or arteries harvested from elsewhere in the body, thereby improving the blood supply to the coronary circulation supplying the myocardium (heart muscle). | Coronary Artery Bypass Surgery | ||
| CRYOABLATION | C15215 | Removal, separation, detachment, extirpation or eradication of a body part, pathway or function by freezing. (NCI) | Cryosurgery | |||
| CRYOTHERAPY | C40030 | The therapeutic use of cold or refrigeration. | Cryotherapy | |||
| ELECTROCAUTERIZATION | C111192 | A procedure for destroying tissue using an electrical current. | Electrocauterization | |||
| ENDARTERECTOMY | C52002 | Excision of an atheromatous plaque. (NCI) | Endarterectomy | |||
| EXCISION | C15232 | The act of cutting out; the surgical removal of part or all of a structure or organ. (NCI) | Excision | |||
| IMMUNOTHERAPY | C15262 | A therapy designed to induce changes in a patient's immune status. | Immunotherapy | |||
| IMPLANTABLE CARDIOVERTER DEFIBRILLATOR | C80435 | Implantable Cardioverter Defibrillator Procedure | A procedure involving an electronic device implanted in the body that delivers electrical stimulation to the heart to treat tachycardia. It may also have the capability to treat bradycardia. | Implantable Cardioverter-Defibrillator Placement | ||
| INFRARED PHOTO COAGULATION | C62730 | Infrared Coagulation | The use of an intense beam of light, such as a laser, to seal off blood vessels or destroy tissue. (NCI) | Infrared Photocoagulation Therapy | ||
| LEAD | C99934 | Lead Procedure | A procedure involving one or more wires used for pacemaker or implantable defibrillator devices. | Cardiac Lead Procedure | ||
| LEFT ATRIAL APPENDAGE OCCLUSION | C99965 | The therapeutic blockage of the muscular pouch in the left atrium. | Intentional Left Cardiac Atrial Appendage Occlusion Procedure | |||
| LEFT VENTRICULAR ASSIST DEVICE | C80473 | LVAD | A procedure involving a mechanical cardiac pump which receives blood from the left ventricle and delivers it to the aorta. | Left Ventricular Assist Device | ||
| LEFT VENTRICULAR SYSTOLIC DYSFUNCTION EVALUATION | C99975 | An examination and assessment of the inability of the left ventricle to effectively pump blood to the body. | Left Cardiac Ventricular Systolic Dysfunction Evaluation | |||
| MITRAL BALLOON VALVOTOMY | C99987 | Dilation of the valve between the left atrium and the left ventricle of the heart by inflating a balloon. | Mitral Balloon Valvotomy | |||
| MITRAL COMMISSUROTOMY | C99988 | Dilation of the valve between the left atrium and the left ventricle of the heart by use of a surgeon's finger or rigid instrument. | Mitral Commissurotomy | |||
| MITRAL VALVE REPAIR | C80449 | Surgery performed for the purpose of reducing regurgitation of the mitral valve. | Mitral Valve Repair | |||
| MITRAL VALVE REPLACEMENT | C50825 | Surgery performed with the purpose of replacing a degenerated, calcified, malformed, dysfunctional, etc. mitral valve with bioprosthetic, homograft or autograft valve. | Mitral Valve Replacement | |||
| NON-CARDIOVASCULAR SURGERY | C99995 | An operative procedure that does not involve the heart or the blood vessels. | Non-Cardiovascular Surgery | |||
| PACEMAKER | C99998 | Pacemaker Procedure | A procedure involving an electronic device that delivers electrical stimulation to the heart to treat bradycardia. | Pacemaker Procedure | ||
| PERCUTANEOUS CORONARY INTERVENTION | C99521 | PCI | A percutaneous coronary intervention (PCI) is the placement of an angioplasty guide wire, balloon, or other device (e.g. stent, atherectomy, brachytherapy, or thrombectomy catheter) into a native coronary artery or coronary artery bypass graft for the purpose of mechanical coronary revascularization. Examples of things not considered to be PCI procedures include intravascular ultrasound, measurements of coronary flow reserve, or measurements of fractional flow reserve. | Percutaneous Coronary Intervention | ||
| PERCUTANEOUS MITRAL REPAIR | C100003 | Invasive procedure through a puncture in the skin, performed for the purpose of reducing regurgitation of the mitral valve. | Percutaneous Mitral Valve Repair | |||
| PERICARDIAL STRIPPING | C100004 | Removal or resection of the pericardium. | Pericardial Stripping | |||
| PERICARDIAL WINDOW | C51618 | A procedure in which an opening is made in the pericardium. | Pericardial Window Procedure | |||
| PERICARDIOCENTESIS | C52010 | The aspiration of excess fluid between the pericardium and the heart. | Pericardiocentesis | |||
| PERIPHERAL VASCULAR INTERVENTION | C116150 | PVI | A peripheral vascular intervention is a catheter-based or open surgical procedure designed to improve arterial or venous blood flow or otherwise modify or revise vascular conduits. In general, the intention to perform percutaneous vascular intervention is denoted by the insertion of a guide wire into an artery or vein. For the sake of simplicity, this definition applies to the extracranial carotid artery and other non-cardiac arteries and veins, while it excludes the lymphatics and intracranial vessels. | Peripheral Vascular Intervention | ||
| PULMONARY VALVE REPLACEMENT | C50817 | Surgery performed with the purpose of replacing a degenerated, calcified, malformed, dysfunctional, etc. pulmonary valve with bioprosthetic, homograft or autograft valve. | Pulmonary Valve Replacement | |||
| PULMONIC VALVULOPLASTY | C100044 | Dilation of the valve between the right ventricle and the pulmonary artery of the heart by inflating a balloon. | Pulmonic Valvuloplasty | |||
| RIGHT VENTRICULAR ASSIST DEVICE | C100010 | RVAD | A procedure involving a mechanical pump which receives blood from the right ventricle and delivers it to the pulmonary artery. | Right Cardiac Ventricle Assist Device Procedure | ||
| SEPTAL ABLATION | C80439 | A cardiac catheterization procedure to relieve symptoms in patients with severe obstructive hypertrophic cardiomyopathy. A catheter is used to inject alcohol into a septal artery supplying the heart muscle responsible for the obstruction, destroying the muscle tissue and relieving the obstruction. | Septal Ablation | |||
| SURGICAL MAZE | C100017 | Cox Maze | A cardiac procedure intended to inhibit atrial fibrillation, in which a series of incisions are made in the atria to block abnormal electrical circuits that contribute to atrial fibrillation. | Surgical Maze Procedure | ||
| TRANSCATHETER AORTIC VALVE IMPLANT | C100022 | Use of a thin tube to deliver an artificial valve apparatus between the left ventricle of the heart and the aorta. | Transcatheter Aortic Valve Implantation | |||
| TRICUSPID VALVE REPAIR | C99935 | Surgery performed for the purpose of reducing regurgitation of the cardiac valve between the right atrium and right ventricle. | Cardiac Tricuspid Valve Repair | |||
| TRICUSPID VALVE REPLACEMENT | C50816 | Surgery performed with the purpose of replacing a degenerated, calcified, malformed, dysfunctional, etc. tricuspid valve with bioprosthetic, homograft or autograft valve. | Tricuspid Valve Replacement | |||
| VENTRICULAR ANEURYSM RESECTION | C80451 | Cardiac surgical procedure performed for the removal of an aneurysm from the ventricular wall. | Ventricular Aneurysm Resection | |||
| VENTRICULAR SEPTAL CLOSURE | C99940 | Repair of ventricular septum. | Closure of Cardiac Ventricle Septum | |||
| Back to top | ||||||
| CL.C101856.PRURGNCY | Procedure Urgency Status (PRURGNCY) | text Extensible: No | C101856 | Procedure Urgency Status | A terminology codelist that describes the degree of urgency for a procedure. | CDISC SDTM Procedure Urgency Status Terminology |
| ELECTIVE | C51996 | Elective procedures can be deferred without increased risk of compromised outcome. Patient's clinical condition is currently stable and has been stable in the days/weeks prior. The clinical situation does not demand that the procedure take place at a specified time. | Elective Surgical Procedure | |||
| EMERGENCY | C62648 | Emergency procedures must be performed as soon as possible because of substantial concerns that delay could lead to death. Clinical situation demands that procedure should be performed immediately or in next available room, even if it means another case must be rescheduled. | Emergency | |||
| SALVAGE | C15359 | Performing a salvage procedure is the last resort. The clinical situation involves either ongoing life support measures, life support measures for more than 60 seconds during the prior 10 minutes, or unanticipated institution of extracorporeal circulatory support. | Salvage Therapy | |||
| URGENT | C100031 | Deferring an urgent procedure increases risk of adverse outcome or clinical deterioration. Clinical situation warrants performing urgent procedures during the current episode of care to avoid compromising patient safety. | Urgent Procedure | |||
| Back to top | ||||||
| CL.C114118.PROTMLST | Protocol Milestone (PROTMLST) | text Extensible: Yes | C114118 | Protocol Milestone | A terminology codelist relevant to protocol-specified, point-in-time events during a study. | CDISC SDTM Protocol Milestone Terminology |
| INFORMED CONSENT OBTAINED | C16735 | Consent by a patient for participation in a clinical study after achieving an understanding of the relevant medical facts and the risks involved. | Informed Consent | |||
| RANDOMIZED | C114209 | Participants are assigned to arms of a clinical trial by chance. | Subject is Randomized | |||
| Back to top | ||||||
| CL.C74457.RACE | Race (RACE) | text Extensible: No | C74457 | Race | Terminology codelist used to identify the race of an individual within the Clinical Data Interchange Standards Consortium Study Data Tabulation Model. | CDISC SDTM Race Terminology |
| AMERICAN INDIAN OR ALASKA NATIVE | C41259 | A person having origins in any of the original peoples of North and South America (including Central America), and who maintains tribal affiliation or community attachment. (FDA) | American Indian or Alaska Native | |||
| ASIAN | C41260 | A person having origins in any of the original peoples of the Far East, Southeast Asia, or the Indian subcontinent including, for example, Cambodia, China, India, Japan, Korea, Malaysia, Pakistan, the Philippine Islands, Thailand, and Vietnam. (FDA) | Asian | |||
| BLACK OR AFRICAN AMERICAN | C16352 | A person having origins in any of the black racial groups of Africa. Terms such as "Haitian" or "Negro" can be used in addition to "Black or African American." (FDA) | African American | |||
| NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER | C41219 | Denotes a person having origins in any of the original peoples of Hawaii, Guam, Samoa, or other Pacific Islands. The term covers particularly people who identify themselves as part-Hawaiian, Native Hawaiian, Guamanian or Chamorro, Carolinian, Samoan, Chuu. (FDA) | Native Hawaiian or Other Pacific Islander | |||
| WHITE | C41261 | Denotes a person with European, Middle Eastern, or North African ancestral origin who identifies, or is identified, as White. (FDA) | White | |||
| Back to top | ||||||
| CL.C101864.CSLVLNIM | Reason CS/LV Lead Not Implanted (CSLVLNIM) | text Extensible: No | C101864 | Reason CS/LV Lead Not Implanted | The reason that a Coronary Sinus Access or Left Ventricular (CS/LV) lead was not implanted. | CDISC SDTM Reason Coronary Sinus Access or Left Ventricular Lead Not Implanted Terminology |
| COULD NOT OBTAIN ACCEPTABLE PACING THRESHOLDS | C100025 | The coronary sinus/left ventricular lead was not implanted because the operator was unable to obtain acceptable pacing thresholds. | Unable to Obtain Acceptable Pacing Thresholds | |||
| LEAD POSITION RESULTS IN UNDESIRABLE STIMULATION OF THE DIAPHRAGM | C99933 | The coronary sinus/left ventricular lead was not implanted because the lead position resulted in undesirable stimulation of the diaphragm. | Cardiac Lead Position Results in Undesirable Stimulation of Diaphragm | |||
| PREVIOUSLY IMPLANTED | C100007 | The coronary sinus/left ventricular lead was not implanted because a lead had been previously implanted. | Previously Implanted Cardiac Lead | |||
| UNABLE TO OBTAIN SATISFACTORY CORONARY SINUS ACCESS | C100026 | The coronary sinus/left ventricular lead was not implanted because the operator was unable to obtain satisfactory coronary sinus access. | Unable to Obtain Satisfactory Coronary Sinus Access | |||
| UNABLE TO OBTAIN SATISFACTORY VASCULAR ACCESS | C100027 | The coronary sinus/left ventricular lead was not implanted because the operator was unable to obtain satisfactory vascular access. | Unable to Obtain Satisfactory Vascular Access | |||
| UNABLE TO POSITION LEAD DUE TO CORONARY SINUS DISSECTION | C100028 | The coronary sinus/left ventricular lead was not implanted because the coronary sinus was dissected. | Unable to Position Lead Due to Coronary Sinus Dissection | |||
| UNABLE TO POSITION LEAD IN TRIBUTARY VEIN OF CORONARY SINUS | C100029 | The coronary sinus/left ventricular lead was not implanted because the operator was unable to position the lead in the tributary vein of the coronary sinus. | Unable to Position Lead In tributary Vein of Coronary Sinus | |||
| Back to top | ||||||
| CL.C102584.REASTRT | Reason For Treatment (REASTRT) | text Extensible: Yes | C102584 | Reason For Treatment | Terminology relevant to the reason the treatment was administered. | CDISC SDTM Reason For Treatment Terminology |
| FAILURE AFTER FIRST TREATMENT | C102635 | A lack of response to the first cycle of therapy. | Failure After First Treatment | |||
| FAILURE AFTER MULTIPLE TREATMENTS | C102636 | A lack of response to more than one cycle of therapy. | Failure After Multiple Treatments | |||
| PREVIOUS PATIENT NONCOMPLIANCE | C102698 | A previous episode of failure by a patient to follow medical advice, take medication as directed, or adhere to a prescribed course of treatment. | Previous Patient Noncompliance | |||
| RECURRENT DISEASE | C38155 | Recurrent Disease | The return of a disease after a period of remission. | Recurrent Disease | ||
| Back to top | ||||||
| CL.C102583.REASTINT | Reason for Treatment Interruption (REASTINT) | text Extensible: Yes | C102583 | Reason for Treatment Interruption | Terminology relevant to the reason the drug or therapy was temporarily ceased. | CDISC SDTM Reason for Treatment Interruption Terminology |
| FORGOT TO TAKE MEDICATION DOSE | C102638 | A patient's failure to remember to take a dose of medication. | Forgot to Take Medication Dose | |||
| INTOLERANCE | C71437 | An inability to absorb or metabolize certain substances in the normal way. | Intolerance | |||
| MEDICATION MISPLACED | C102664 | Medications that were lost because they were put in the wrong place. | Medication Misplaced | |||
| PATIENT NONCOMPLIANCE | C91752 | Failure of a patient to follow medical advice, take medication as directed, or adhere to a prescribed course of treatment. | Patient Noncompliance | |||
| TREATMENT FAILURE | C48226 | The lack of expected or desired effect related to a therapy. (NCI) | Lack of Efficacy | |||
| VACATION | C80227 | Leisure time away from work devoted to rest or pleasure. | Vacation | |||
| Back to top | ||||||
| CL.C102586.RSTRTNA | Reason Treatment Not Administered (RSTRTNA) | text Extensible: Yes | C102586 | Reason Treatment Not Administered | Terminology relevant to the reason the treatment was not administered. | CDISC SDTM Reason Treatment Not Administered Terminology |
| MEDICATION LOST | C102663 | The medication is no longer held or possessed by the subject and is incapable of being recovered or regained. | Medication Lost | |||
| NOT OFFERED | C102682 | Is not an option. | Not Offered | |||
| REFUSE | C49161 | To decline to do, accept, give, or allow something. | Refuse | |||
| RELOCATION | C77951 | The act of changing your residence or place of business. | Relocation | |||
| Back to top | ||||||
| CL.C78736.NRIND | Reference Range Indicator (NRIND) | text Extensible: Yes | C78736 | Reference Range Indicator | A description of the results relative to the normal or expected range of values. | CDISC SDTM Reference Range Indicator |
| ABNORMAL | C78802 | Reported values outside the typical or expected range. (NCI) | Abnormal Reference Range | |||
| HIGH | C78800 | Reported values above the typical or expected range. (NCI) | Value Above Reference Range | |||
| LOW | C78801 | Reported values below the typical or expected range. (NCI) | Value Below Reference Range | |||
| NORMAL | C78727 | Reported values within the typical or expected range. (NCI) | Normal Reference Range | |||
| Back to top | ||||||
| CL.C66728.STENRF | Relation to Reference Period (STENRF) | text Extensible: No | C66728 | Relation to Reference Period | The relative relationship of a timepoint to a reference timepoint. | CDISC SDTM Relation to Reference Period Terminology |
| AFTER | C38008 | The time period following a point or another period of time. (NCI) | Post | |||
| BEFORE | C25629 | Earlier in time or order. (NCI) | Prior | |||
| COINCIDENT | C25456 | Occurring or operating at the same time. | Concurrent | |||
| DURING | C25490 | At some point in a given period of time. (NCI) | During | |||
| DURING/AFTER | C49640 | Within a certain period of time or after a certain point or period in time. (NCI) | During or After | |||
| ONGOING | C53279 | Continuous | Remain in force or carry on without letup; keep or maintain in unaltered condition; exist in time or space without stop or interruption. (NCI) | Continue | ||
| UNKNOWN | C17998 | U;Unknown | Not known, not observed, not recorded, or refused. (NCI) | Unknown | ||
| Back to top | ||||||
| CL.C100130.RELSUB | Relationship to Subject (RELSUB) | text Extensible: Yes | C100130 | Relationship to Subject | The relationship of a person to a study subject. | CDISC SDTM Relationship to Subject Terminology |
| AUNT, BIOLOGICAL | C96569 | Biological Aunt | A female relative who is a sibling of either of the biological parents, and who share a common ancestor. (NCI) | Biological Aunt | ||
| AUNT, BIOLOGICAL MATERNAL | C96575 | Biological Maternal Aunt | A female relative who is a sibling of the biological mother, and who both share a common ancestor. (NCI) | Biological Maternal Aunt | ||
| AUNT, BIOLOGICAL PATERNAL | C96581 | Biological Paternal Aunt | A female relative who is a sibling of the biological father, and who both share a common ancestor. (NCI) | Biological Paternal Aunt | ||
| BROTHER, BIOLOGICAL | C96570 | Biological Brother | A male who shares with his sibling the genetic makeup inherited from one or both of their shared biological parents. | Biological Brother | ||
| BROTHER, BIOLOGICAL MATERNAL HALF | C96656 | Half-brother with Mother as Common Parent | A male who shares with his sibling the genetic makeup inherited from only the biological mother. | Half-brother with Mother as Common Parent | ||
| BROTHER, BIOLOGICAL PATERNAL HALF | C96655 | Half-brother with Father as Common Parent | A male who shares with his sibling the genetic makeup inherited from only the biological father. | Half-brother with Father as Common Parent | ||
| BROTHER, FULL | C111201 | A male who shares with his sibling the genetic makeup inherited from both of the biological parents. | Full Brother | |||
| BROTHER, HALF | C71402 | Half Brother | A male who shares with his sibling the genetic makeup inherited from only one of the biological parents. | Half Brother | ||
| CAREGIVER | C17445 | Caregiver | The primary person in charge of the care of a patient, usually a family member or a designated health care professional. (NCI) | Caregiver | ||
| CHILD, BIOLOGICAL | C100807 | Biological Child | A son or daughter with genetic makeup inherited from the parent. | Biological Child | ||
| CLINICIAN | C85499 | Clinician | An individual, such as a physician, nurse practitioner or other health care professional, who takes responsibility for a subject's care. | Clinician | ||
| COUSIN, BIOLOGICAL | C96571 | Biological Cousin | A relative who is the offspring of a sibling of either of the biological parents, and who share a common ancestor. (NCI) | Biological Cousin | ||
| COUSIN, BIOLOGICAL MATERNAL | C96576 | Biological Maternal Cousin | A relative who is the offspring of a sibling of the biological mother and share a common ancestor. | Biological Maternal Cousin | ||
| COUSIN, BIOLOGICAL PATERNAL | C96582 | Biological Paternal Cousin | A relative who is the offspring of a sibling of the biological father and share a common ancestor. | Biological Paternal Cousin | ||
| DOMESTIC PARTNER | C53262 | Domestic Partner | Person declares that a domestic partnership relationship exists. (HL7) | Domestic Partnership | ||
| DONOR | C48284 | Donor | One that contributes something. (NCI) | Donor | ||
| DONOR, ORGAN | C100810 | Organ Donor | Someone from whom an organ is removed for transplantation or other purpose. | Organ Donor | ||
| DONOR, TISSUE | C25168 | Tissue Donor | Someone from whom tissue is removed for transplantation or other purpose. | Tissue Donor | ||
| FAMILY MEMBER | C41256 | Family Member | Any of the individuals who are descended from a common progenitor, related by marriage or other legal tie. | Family Member | ||
| FATHER, BIOLOGICAL | C96572 | Biological Father | A male who contributes to the genetic makeup of his offspring through the fertilization of an ovum by his sperm. (NCI) | Biological Father | ||
| GRANDCHILD, BIOLOGICAL | C100805 | Biological Grandchild | A biological child of an individual's biological child. | Biological Grandchild | ||
| GRANDFATHER, BIOLOGICAL | C96573 | Biological Grandfather | A male relative who is the biological father of either the biological mother or the biological father. (NCI) | Biological Grandfather | ||
| GRANDFATHER, BIOLOGICAL MATERNAL | C96577 | Biological Maternal Grandfather | A male relative who is the biological father of the biological mother. (NCI) | Biological Maternal Grandfather | ||
| GRANDFATHER, BIOLOGICAL PATERNAL | C96583 | Biological Paternal Grandfather | A male relative who is the biological father of the biological father. (NCI) | Biological Paternal Grandfather | ||
| GRANDMOTHER, BIOLOGICAL | C96574 | Biological Grandmother | A female relative who is the biological mother of either the biological mother or the biological father. (NCI) | Biological Grandmother | ||
| GRANDMOTHER, BIOLOGICAL MATERNAL | C96578 | Biological Maternal Grandmother | A female relative who is the biological mother of the biological mother. (NCI) | Biological Maternal Grandmother | ||
| GRANDMOTHER, BIOLOGICAL PATERNAL | C96584 | Biological Paternal Grandmother | A female relative who is the biological mother of the biological father. (NCI) | Biological Paternal Grandmother | ||
| GRANDPARENT, BIOLOGICAL | C100806 | Biological Grandparent | A biological parent of the biological father or biological mother. | Biological Grandparent | ||
| GRANDPARENT, BIOLOGICAL MATERNAL | C111248 | A relative who is the biological parent of the biological mother. | Maternal Biological Grandparent | |||
| GRANDPARENT, BIOLOGICAL PATERNAL | C111286 | A relative who is the biological parent of the biological father. | Paternal Biological Grandparent | |||
| MOTHER, BIOLOGICAL | C96580 | Biological Mother | A female who contributes to the genetic makeup of her offspring from the fertilization of her ovum. (NCI) | Biological Mother | ||
| NURSE | C20821 | Nurse | A professional healthcare provider who has graduated from a nursing program. | Nurse | ||
| PREGNANCY PARTNER | C100811 | Pregnancy Partner | An individual who provides support to a pregnant individual. | Pregnancy Partner | ||
| RELATIVE, FIRST DEGREE | C21481 | First Degree Relative | Any individual related biologically or legally to another individual and considered immediate family as in the case of a spouse, parent, sibling or child. | First Degree Relative | ||
| RELATIVE, SECOND DEGREE | C19811 | Second Degree Relative | Any individual related biologically or legally to another individual and considered one degree removed from the immediate family as in the case of in-laws, grandparents, aunts and uncles. | Second Degree Relative | ||
| RELATIVE, THIRD DEGREE | C100808 | Third Degree Relative | Any individual related biologically or legally to another individual and considered two degrees removed from the immediate family as in the case of cousins. | Third Degree Relative | ||
| SEXUAL PARTNER | C100812 | Sexual Partner | A person with whom one has had sexual relations. | Sexual Partner | ||
| SIBLING, BIOLOGICAL | C100809 | Biological Sibling | A person's brother or sister with whom they share a genetic makeup inherited from their shared biological parents. | Biological Sibling | ||
| SIBLING, FULL | C71390 | A person's brother or sister with whom they share a genetic makeup inherited from both of their shared biological parents. | Full Sibling | |||
| SIBLING, HALF | C71391 | A person's brother or sister with whom they share a genetic makeup inherited from one of their shared biological parents. | Half Sibling | |||
| SISTER, BIOLOGICAL | C96586 | Biological Sister | A female who shares with her sibling the genetic makeup inherited from one or both of their shared biological parents. | Biological Sister | ||
| SISTER, BIOLOGICAL MATERNAL HALF | C96658 | Half-sister with Mother as Common Parent | A female who shares with her sibling the genetic makeup inherited from only the biological mother. | Half-sister with Mother as Common Parent | ||
| SISTER, BIOLOGICAL PATERNAL HALF | C96657 | Half-sister with Father as Common Parent | A female who shares with her sibling the genetic makeup inherited from only the biological father. | Half-sister with Father as Common Parent | ||
| SISTER, FULL | C111202 | A female who shares with her sibling the genetic makeup inherited from both of the biological parents. | Full Sister | |||
| SISTER, HALF | C71403 | Half Sister | A female who shares with her sibling the genetic makeup inherited from only one of the biological parents. | Half Sister | ||
| SPOUSE | C62649 | Spouse | A person's partner in marriage. (NCI) | Spouse | ||
| TECHNICIAN | C63861 | Technician | A person skilled in the performance of the technical or procedural aspects of a profession. (NCI) | Technician | ||
| TWIN | C73427 | Twin | Either of two offspring born from the same pregnancy. (NCI) | Twin | ||
| TWIN, DIZYGOTIC | C73428 | Dizygotic Twin | Either of the two offspring resulting from two separately fertilized ovums during the same pregnancy. | Fraternal Twin | ||
| TWIN, MONOZYGOTIC | C73429 | Monozygotic Twin | Either of the two offspring resulting from a shared ovum. (NCI) | Identical Twin | ||
| UNCLE, BIOLOGICAL | C96587 | Biological Uncle | A male relative who is a sibling of either of the biological parents, and who share a common ancestor. (NCI) | Biological Uncle | ||
| UNCLE, BIOLOGICAL MATERNAL | C96579 | Biological Maternal Uncle | A male relative who is a sibling of the biological mother, and who both share a common ancestor. (NCI) | Biological Maternal Uncle | ||
| UNCLE, BIOLOGICAL PATERNAL | C96585 | Biological Paternal Uncle | A male relative who is a sibling of the biological father, and who both share a common ancestor. (NCI) | Biological Paternal Uncle | ||
| Back to top | ||||||
| CL.C78737.RELTYPE | Relationship Type (RELTYPE) | text Extensible: No | C78737 | Relationship Type | The description of relationship types between a record or set of records. | CDISC SDTM Relationship Type Terminology |
| MANY | C78728 | Many;Several | More than one. (NCI) | Many | ||
| ONE | C66832 | A textual representation of the numeral 1. | One | |||
| Back to top | ||||||
| CL.C106479.RPTESTCD | Reproductive System Findings Test Code (RPTESTCD) | text Extensible: Yes | C106479 | Reproductive System Findings Test Code | A terminology codelist for the physiological test codes related to the male and female reproductive systems. | CDISC SDTM Reproductive System Findings Test Code Terminology |
| ABORTN | C106550 | Number of Abortions | A measurement of the total number of instances in which there has been a spontaneous termination of pregnancy (miscarriage) or elective termination of pregnancy. | Number of Abortions | ||
| BCMETHOD | C106501 | Birth Control Method | The method by which conception or impregnation is prevented. | Birth Control Method | ||
| BRTHLVN | C16955 | Number of Live Births | A measurement of the total number of live-born offspring a female has delivered. | Parity | ||
| CHILDPOT | C106508 | Childbearing Potential | An indicator as to whether the female subject has the potential to become pregnant. (NCI) | Childbearing Potential | ||
| MENARAGE | C19666 | Menarche Age | The age at which the first menstruation event occurred. (NCI) | Age at Menarche | ||
| MENOAGE | C106497 | Menopause Age | The age at which permanent cessation of menses occurred. (NCI) | Age at Menopause | ||
| MENOSTAT | C106541 | Menopause Status | The status of a female with respect to menopause. | Menopause Status | ||
| MENSDUR | C119549 | Menstrual Cycle Duration | The length of time of the menses cycle, measured from the beginning of one menstrual period to the beginning of the next. | Menstrual Cycle Duration | ||
| PREGNN | C106551 | Number of Pregnancies | A measurement of the total number of pregnancy events experienced by a female. | Number of Pregnancies | ||
| PREGST | C106561 | Pregnant During the Study | An indicator as to whether a female is pregnant during the study period. (NCI) | Pregnant During the Study | ||
| Back to top | ||||||
| CL.C106478.RPTEST | Reproductive System Findings Test Name (RPTEST) | text Extensible: Yes | C106478 | Reproductive System Findings Test Name | A terminology codelist for the physiological test names related to the male and female reproductive systems. | CDISC SDTM Reproductive System Findings Test Name Terminology |
| Birth Control Method | C106501 | Birth Control Method | The method by which conception or impregnation is prevented. | Birth Control Method | ||
| Childbearing Potential | C106508 | Childbearing Potential | An indicator as to whether the female subject has the potential to become pregnant. (NCI) | Childbearing Potential | ||
| Menarche Age | C19666 | Menarche Age | The age at which the first menstruation event occurred. (NCI) | Age at Menarche | ||
| Menopause Age | C106497 | Menopause Age | The age at which permanent cessation of menses occurred. (NCI) | Age at Menopause | ||
| Menopause Status | C106541 | Menopause Status | The status of a female with respect to menopause. | Menopause Status | ||
| Menstrual Cycle Duration | C119549 | Menstrual Cycle Duration | The length of time of the menses cycle, measured from the beginning of one menstrual period to the beginning of the next. | Menstrual Cycle Duration | ||
| Number of Abortions | C106550 | Number of Abortions | A measurement of the total number of instances in which there has been a spontaneous termination of pregnancy (miscarriage) or elective termination of pregnancy. | Number of Abortions | ||
| Number of Live Births | C16955 | Number of Live Births | A measurement of the total number of live-born offspring a female has delivered. | Parity | ||
| Number of Pregnancies | C106551 | Number of Pregnancies | A measurement of the total number of pregnancy events experienced by a female. | Number of Pregnancies | ||
| Pregnant During the Study | C106561 | Pregnant During the Study | An indicator as to whether a female is pregnant during the study period. (NCI) | Pregnant During the Study | ||
| Back to top | ||||||
| CL.C111106.RETESTCD | Respiratory Test Code (RETESTCD) | text Extensible: Yes | C111106 | Respiratory Test Code | A terminology codelist based on the test codes for physiological findings related to the respiratory system, including the organs that are involved in breathing such as the nose, throat, larynx, trachea, bronchi and lungs. | CDISC SDTM Respiratory Test Code Terminology |
| ERV | C111200 | Expiratory Reserve Volume | The maximum volume of air a subject can exhale from the lungs after a tidal exhalation. | Expiratory Reserve Volume | ||
| ERVPP | C112375 | Percent Predicted ERV | The maximum volume of air a subject can exhale from the lungs after a tidal exhalation as a proportion of the predicted normal value. | Percent Predicted Expiratory Reserve Volume | ||
| FEF2575 | C119545 | Forced Expiratory Flow 25-75% | The mean forced expiratory flow rate at 25-75% of the forced vital capacity. (NCI) | Forced Expiratory Flow at 25-75 Percent | ||
| FEF2575P | C119546 | Percent Predicted FEF25-75 | The mean forced expiratory flow rate at 25-75% of the forced vital capacity as a proportion of the predicted normal value. (NCI) | Percent Predicted Forced Expiratory Flow at 25-75 Percent | ||
| FEV1 | C38084 | Forced Expiratory Volume in 1 Second | The volume of air that a subject can breathe out during the first second of exhalation after maximum inhalation. | Forced Expiratory Volume in 1 Second | ||
| FEV1FVC | C111359 | FEV1/FVC | The proportion of total forced vital capacity that is expelled during the first second of a forced exhalation. | Forced Expiratory Volume in 1 Second to Forced Vital Capacity Ratio Measurement | ||
| FEV1FVCP | C112377 | Percent Predicted FEV1/FVC | The proportion of total forced vital capacity that is expelled during the first second of a forced exhalation as a proportion of the predicted normal value. | Percent Predicted Forced Expiratory Volume in 1 Second Divided by Forced Vital Capacity | ||
| FEV1PP | C112376 | Percent Predicted FEV1 | Forced expiratory volume in one second as a proportion of the predicted normal value. | Percent Predicted Forced Expiratory Volume in 1 Second | ||
| FEV1REV | C112285 | FEV1 Reversibility | The change in FEV1 following administration of a bronchodilator relative to the pre-treatment FEV1 value. | Forced Expiratory Volume in 1 Second Reversibility | ||
| FEV6 | C47843 | Forced Expiratory Volume in 6 Seconds | The volume of air that a subject can breathe out during the first 6 seconds of exhalation after maximum inhalation. | Forced Expiratory Volume in 6 Seconds | ||
| FEV6PP | C112378 | Percent Predicted FEV6 | Forced expiratory volume in six seconds as a proportion of the predicted normal value. | Percent Predicted Forced Expiratory Volume in 6 Seconds | ||
| FIFMAX | C112333 | Maximum Forced Inspiratory Flow | Forced inspiratory flow for a portion of the FVC curve at the point where the maximum portion of FVC is already inhaled. | Maximum Forced Inspiratory Flow | ||
| FIFMAXPP | C112379 | Percent Predicted FIFmax | Forced inspiratory flow for a portion of the FVC curve at the point where the maximum portion of FVC is already inhaled as a proportion of the predicted normal value. | Percent Predicted Forced Inspiratory Flow Maximum | ||
| FIV1 | C111360 | Forced Inspiratory Volume in 1 Second | The volume of air that a subject can breathe in during the first second of inhalation after maximum exhalation. | Forced Inspiratory Volume in 1 Second | ||
| FIV1PP | C112380 | Percent Predicted FIV1 | The volume of air that a subject can breathe in during the first second of inhalation after maximum exhalation as a proportion of the predicted normal value. | Percent Predicted Forced Inspiratory Volume in 1 Second | ||
| FVC | C111361 | Forced Vital Capacity | The maximum volume of air that can be exhaled after forced maximum inhalation. | Forced Vital Capacity | ||
| FVCPP | C112381 | Percent Predicted Forced Vital Capacity | Forced vital capacity as a proportion of the predicted normal value. | Percent Predicted Forced Vital Capacity | ||
| IC | C111362 | Inspiratory Capacity | The maximum volume of air a subject can inhale into the lungs after a tidal exhalation (IRV plus TV). | Inspiratory Capacity | ||
| ICPP | C112382 | Percent Predicted Inspiratory Capacity | The maximum volume of air a subject can inhale into the lungs after a tidal exhalation (IRV plus TV) as a proportion of the predicted normal value. | Percent Predicted Inspiratory Capacity | ||
| ICREV | C112321 | IC Reversibility | The change in IC following administration of a bronchodilator relative to the pre-treatment IC value. | Inspiratory Capacity Reversibility | ||
| IRV | C111237 | Inspiratory Reserve Volume | The maximum volume of air a subject can inhale into the lungs after a tidal inhalation. | Inspiratory Reserve Volume | ||
| IRVPP | C112383 | Percent Predicted IRV | The maximum volume of air a subject can inhale into the lungs after a tidal inhalation as a proportion of the predicted normal value. | Percent Predicted Inspiratory Reserve Volume | ||
| PEF | C41372 | Peak Expiratory Flow | The maximal flow achieved during the maximally forced expiration initiated at maximum inhalation. | Peak Expiratory Flow | ||
| PEFPP | C112384 | Percent Predicted Peak Expiratory Flow | The maximal flow achieved during the maximally forced expiration initiated at maximum inhalation as a proportion of the predicted normal value. | Percent Predicted Peak Expiratory Flow | ||
| PEFREV | C112368 | PEF Reversibility | The change in PEF following administration of a bronchodilator relative to the pre-treatment PEF value. | Peak Expiratory Flow Reversibility | ||
| PNIF | C119547 | Peak Nasal Inspiratory Flow | The maximal flow achieved during the maximally forced inspiration through the nose initiated at maximum exhalation. (NCI) | Peak Nasal Inspiratory Flow | ||
| RV | C89836 | Residual Volume | The volume of air remaining in the lungs after maximum exhalation. | Residual Volume | ||
| RVPP | C112385 | Percent Predicted Residual Volume | The volume of air remaining in the lungs after maximum exhalation as a proportion of the predicted normal value. | Percent Predicted Residual Volume | ||
| SVC | C111315 | Slow Vital Capacity | The maximum volume of air that can be exhaled after slow maximum inhalation. | Slow Vital Capacity | ||
| SVCPP | C112386 | Percent Predicted Slow Vital Capacity | The maximum volume of air that can be exhaled after slow maximum inhalation as a proportion of the predicted normal value. | Percent Predicted Slow Vital Capacity | ||
| TLC | C111325 | Total Lung Capacity | The total volume of air in the lungs after maximum inhalation. | Total Lung Capacity | ||
| TLCPP | C112388 | Percent Predicted Total Lung Capacity | The total volume of air in the lungs after maximum inhalation as a proportion of the predicted normal value. | Percent Predicted Total Lung Capacity | ||
| TV | C111324 | Tidal Volume | The volume of air moved into and out of the lungs during breathing at rest. | Tidal Volume | ||
| TVPP | C112387 | Percent Predicted Tidal Volume | The volume of air moved into and out of the lungs during breathing at rest as a proportion of the predicted normal value. | Percent Predicted Tidal Volume | ||
| Back to top | ||||||
| CL.C111107.RETEST | Respiratory Test Name (RETEST) | text Extensible: Yes | C111107 | Respiratory Test Name | A terminology codelist based on the test names for physiological findings related to the respiratory system, including the organs that are involved in breathing such as the nose, throat, larynx, trachea, bronchi and lungs. | CDISC SDTM Respiratory Test Name Terminology |
| Expiratory Reserve Volume | C111200 | Expiratory Reserve Volume | The maximum volume of air a subject can exhale from the lungs after a tidal exhalation. | Expiratory Reserve Volume | ||
| FEV1 Reversibility | C112285 | FEV1 Reversibility | The change in FEV1 following administration of a bronchodilator relative to the pre-treatment FEV1 value. | Forced Expiratory Volume in 1 Second Reversibility | ||
| FEV1/FVC | C111359 | FEV1/FVC | The proportion of total forced vital capacity that is expelled during the first second of a forced exhalation. | Forced Expiratory Volume in 1 Second to Forced Vital Capacity Ratio Measurement | ||
| Forced Expiratory Flow 25-75% | C119545 | Forced Expiratory Flow 25-75% | The mean forced expiratory flow rate at 25-75% of the forced vital capacity. (NCI) | Forced Expiratory Flow at 25-75 Percent | ||
| Forced Expiratory Volume in 1 Second | C38084 | Forced Expiratory Volume in 1 Second | The volume of air that a subject can breathe out during the first second of exhalation after maximum inhalation. | Forced Expiratory Volume in 1 Second | ||
| Forced Expiratory Volume in 6 Seconds | C47843 | Forced Expiratory Volume in 6 Seconds | The volume of air that a subject can breathe out during the first 6 seconds of exhalation after maximum inhalation. | Forced Expiratory Volume in 6 Seconds | ||
| Forced Inspiratory Volume in 1 Second | C111360 | Forced Inspiratory Volume in 1 Second | The volume of air that a subject can breathe in during the first second of inhalation after maximum exhalation. | Forced Inspiratory Volume in 1 Second | ||
| Forced Vital Capacity | C111361 | Forced Vital Capacity | The maximum volume of air that can be exhaled after forced maximum inhalation. | Forced Vital Capacity | ||
| IC Reversibility | C112321 | IC Reversibility | The change in IC following administration of a bronchodilator relative to the pre-treatment IC value. | Inspiratory Capacity Reversibility | ||
| Inspiratory Capacity | C111362 | Inspiratory Capacity | The maximum volume of air a subject can inhale into the lungs after a tidal exhalation (IRV plus TV). | Inspiratory Capacity | ||
| Inspiratory Reserve Volume | C111237 | Inspiratory Reserve Volume | The maximum volume of air a subject can inhale into the lungs after a tidal inhalation. | Inspiratory Reserve Volume | ||
| Maximum Forced Inspiratory Flow | C112333 | Maximum Forced Inspiratory Flow | Forced inspiratory flow for a portion of the FVC curve at the point where the maximum portion of FVC is already inhaled. | Maximum Forced Inspiratory Flow | ||
| Peak Expiratory Flow | C41372 | Peak Expiratory Flow | The maximal flow achieved during the maximally forced expiration initiated at maximum inhalation. | Peak Expiratory Flow | ||
| Peak Nasal Inspiratory Flow | C119547 | Peak Nasal Inspiratory Flow | The maximal flow achieved during the maximally forced inspiration through the nose initiated at maximum exhalation. (NCI) | Peak Nasal Inspiratory Flow | ||
| PEF Reversibility | C112368 | PEF Reversibility | The change in PEF following administration of a bronchodilator relative to the pre-treatment PEF value. | Peak Expiratory Flow Reversibility | ||
| Percent Predicted ERV | C112375 | Percent Predicted ERV | The maximum volume of air a subject can exhale from the lungs after a tidal exhalation as a proportion of the predicted normal value. | Percent Predicted Expiratory Reserve Volume | ||
| Percent Predicted FEF25-75 | C119546 | Percent Predicted FEF25-75 | The mean forced expiratory flow rate at 25-75% of the forced vital capacity as a proportion of the predicted normal value. (NCI) | Percent Predicted Forced Expiratory Flow at 25-75 Percent | ||
| Percent Predicted FEV1 | C112376 | Percent Predicted FEV1 | Forced expiratory volume in one second as a proportion of the predicted normal value. | Percent Predicted Forced Expiratory Volume in 1 Second | ||
| Percent Predicted FEV1/FVC | C112377 | Percent Predicted FEV1/FVC | The proportion of total forced vital capacity that is expelled during the first second of a forced exhalation as a proportion of the predicted normal value. | Percent Predicted Forced Expiratory Volume in 1 Second Divided by Forced Vital Capacity | ||
| Percent Predicted FEV6 | C112378 | Percent Predicted FEV6 | Forced expiratory volume in six seconds as a proportion of the predicted normal value. | Percent Predicted Forced Expiratory Volume in 6 Seconds | ||
| Percent Predicted FIFmax | C112379 | Percent Predicted FIFmax | Forced inspiratory flow for a portion of the FVC curve at the point where the maximum portion of FVC is already inhaled as a proportion of the predicted normal value. | Percent Predicted Forced Inspiratory Flow Maximum | ||
| Percent Predicted FIV1 | C112380 | Percent Predicted FIV1 | The volume of air that a subject can breathe in during the first second of inhalation after maximum exhalation as a proportion of the predicted normal value. | Percent Predicted Forced Inspiratory Volume in 1 Second | ||
| Percent Predicted Forced Vital Capacity | C112381 | Percent Predicted Forced Vital Capacity | Forced vital capacity as a proportion of the predicted normal value. | Percent Predicted Forced Vital Capacity | ||
| Percent Predicted Inspiratory Capacity | C112382 | Percent Predicted Inspiratory Capacity | The maximum volume of air a subject can inhale into the lungs after a tidal exhalation (IRV plus TV) as a proportion of the predicted normal value. | Percent Predicted Inspiratory Capacity | ||
| Percent Predicted IRV | C112383 | Percent Predicted IRV | The maximum volume of air a subject can inhale into the lungs after a tidal inhalation as a proportion of the predicted normal value. | Percent Predicted Inspiratory Reserve Volume | ||
| Percent Predicted Peak Expiratory Flow | C112384 | Percent Predicted Peak Expiratory Flow | The maximal flow achieved during the maximally forced expiration initiated at maximum inhalation as a proportion of the predicted normal value. | Percent Predicted Peak Expiratory Flow | ||
| Percent Predicted Residual Volume | C112385 | Percent Predicted Residual Volume | The volume of air remaining in the lungs after maximum exhalation as a proportion of the predicted normal value. | Percent Predicted Residual Volume | ||
| Percent Predicted Slow Vital Capacity | C112386 | Percent Predicted Slow Vital Capacity | The maximum volume of air that can be exhaled after slow maximum inhalation as a proportion of the predicted normal value. | Percent Predicted Slow Vital Capacity | ||
| Percent Predicted Tidal Volume | C112387 | Percent Predicted Tidal Volume | The volume of air moved into and out of the lungs during breathing at rest as a proportion of the predicted normal value. | Percent Predicted Tidal Volume | ||
| Percent Predicted Total Lung Capacity | C112388 | Percent Predicted Total Lung Capacity | The total volume of air in the lungs after maximum inhalation as a proportion of the predicted normal value. | Percent Predicted Total Lung Capacity | ||
| Residual Volume | C89836 | Residual Volume | The volume of air remaining in the lungs after maximum exhalation. | Residual Volume | ||
| Slow Vital Capacity | C111315 | Slow Vital Capacity | The maximum volume of air that can be exhaled after slow maximum inhalation. | Slow Vital Capacity | ||
| Tidal Volume | C111324 | Tidal Volume | The volume of air moved into and out of the lungs during breathing at rest. | Tidal Volume | ||
| Total Lung Capacity | C111325 | Total Lung Capacity | The total volume of air in the lungs after maximum inhalation. | Total Lung Capacity | ||
| Back to top | ||||||
| CL.C101848.RSKASMT | Risk Assessment (RSKASMT) | text Extensible: No | C101848 | Risk Assessment | A terminology codelist to describe the risk of a disease, disorder or abnormal condition. | CDISC SDTM Risk Assessment Terminology |
| HIGH RISK | C102401 | The potential future harm that may arise from some present action or attribute or condition is almost certain. | High Risk | |||
| INTERMEDIATE RISK | C102402 | The potential future harm that may arise from some present action or attribute or condition is moderate. | Intermediate Risk | |||
| LOW RISK | C102403 | The potential future harm that may arise from some present action or attribute or condition is small. | Low Risk | |||
| UNKNOWN | C17998 | U;Unknown | Not known, not observed, not recorded, or refused. (NCI) | Unknown | ||
| Back to top | ||||||
| CL.C66729.ROUTE | Route of Administration (ROUTE) | text Extensible: Yes | C66729 | Route of Administration | The course by which a substance was administered in order to reach the site of action in the body. | CDISC SDTM Route of Administration Terminology |
| AURICULAR (OTIC) | C38192 | Administration to or by way of the ear. (FDA) | Auricular Route of Administration | |||
| BUCCAL | C38193 | Administration directed toward the cheek, generally from within the mouth. (FDA) | Buccal Route of Administration | |||
| CONJUNCTIVAL | C38194 | Administration to the conjunctiva, the delicate membrane that lines the eyelids and covers the exposed surface of the eyeball. (FDA) | Conjunctival Route of Administration | |||
| CUTANEOUS | C38675 | Administration to the skin. (FDA) | Cutaneous Route of Administration | |||
| DENTAL | C38197 | Administration to a tooth or teeth. (FDA) | Dental Route of Administration | |||
| DIETARY | C78373 | Administration by way of food stuff. (NCI) | Dietary Route of Administration | |||
| ELECTRO-OSMOSIS | C38633 | Administration of through the diffusion of substance through a membrane in an electric field. (FDA) | Electro-osmosis Route of Administration | |||
| ENDOCERVICAL | C38205 | Intracervical Route of Administration | Administration within the canal of the cervix uteri. Synonymous with the term intracervical. (FDA) | Endocervical Route of Administration | ||
| ENDOSINUSIAL | C38206 | Administration within the nasal sinuses of the head. (FDA) | Endosinusial Route of Administration | |||
| ENDOTRACHEAL | C38208 | Intratracheal Route of Administration | Administration directly into the trachea. Synonymous with the term intratracheal. (FDA) | Endotracheal Route of Administration | ||
| ENTERAL | C38209 | Administration directly into the intestines. (FDA) | Enteral Route of Administration | |||
| EPIDURAL | C38210 | Administration upon or over the dura mater. (FDA) | Epidural Route of Administration | |||
| EXTRA-AMNIOTIC | C38211 | Administration to the outside of the membrane enveloping the fetus. (FDA) | Extraamniotic Route of Administration | |||
| EXTRACORPOREAL | C38212 | Administration outside of the body. (FDA) | Extracorporeal Circulation Route of Administration | |||
| HEMODIALYSIS | C38200 | Administration through hemodialysate fluid. (FDA) | Administration via Hemodialysis | |||
| INFILTRATION | C38215 | Administration that results in substances passing into tissue spaces or into cells. (FDA) | Infiltration Route of Administration | |||
| INTERSTITIAL | C38219 | Administration to or in the interstices of a tissue. (FDA) | Interstitial Route of Administration | |||
| INTRA-ABDOMINAL | C38220 | Administration within the abdomen. (FDA) | Intraabdominal Route of Administration | |||
| INTRA-AMNIOTIC | C38221 | Administration within the amnion. (FDA) | Intraamniotic Route of Administration | |||
| INTRA-ARTERIAL | C38222 | Administration within an artery or arteries. (FDA) | Intraarterial Route of Administration | |||
| INTRA-ARTICULAR | C38223 | Administration within a joint. (FDA) | Intraarticular Route of Administration | |||
| INTRABILIARY | C38224 | Administration within the bile, bile ducts or gallbladder. (FDA) | Intrabiliary Route of Administration | |||
| INTRABRONCHIAL | C38225 | Administration within a bronchus. (FDA) | Intrabronchial Route of Administration | |||
| INTRABURSAL | C38226 | Administration within a bursa. (FDA) | Intrabursal Route of Administration | |||
| INTRACAMERAL | C64984 | Administration by injection directly into the anterior chamber of the eye. | Intracameral Route of Administration | |||
| INTRACARDIAC | C38227 | Administration within the heart. (FDA) | Intracardiac Route of Administration | |||
| INTRACARTILAGINOUS | C38228 | Administration within a cartilage; endochondral. (FDA) | Intracartilaginous Route of Administration | |||
| INTRACAUDAL | C38229 | Administration within the cauda equina. (FDA) | Intracaudal Route of Administration | |||
| INTRACAVERNOUS | C38230 | Administration within a pathologic cavity, such as occurs in the lung in tuberculosis. (FDA) | Intracavernous Route of Administration | |||
| INTRACAVITARY | C38231 | Administration within a non-pathologic cavity, such as that of the cervix, uterus, or penis, or such as that is formed as the result of a wound. (FDA) | Intracavitary Route of Administration | |||
| INTRACEREBRAL | C38232 | Administration within the cerebrum. (FDA) | Intracerebral Route of Administration | |||
| INTRACISTERNAL | C38233 | Administration within the cisterna magna cerebellomedularis. (FDA) | Intracisternal Route of Administration | |||
| INTRACORNEAL | C38234 | Administration within the cornea (the transparent structure forming the anterior part of the fibrous tunic of the eye). (FDA) | Intracorneal Route of Administration | |||
| INTRACORONAL, DENTAL | C38217 | Administration of a drug within a portion of a tooth which is covered by enamel and which is separated from the roots by a slightly constricted region known as the neck. (FDA) | Intracoronal Dental Route of Administration | |||
| INTRACORONARY | C38218 | Administration within the coronary arteries. (FDA) | Intracoronary Route of Administration | |||
| INTRACORPORUS CAVERNOSUM | C38235 | Administration within the dilatable spaces of the corporus cavernosa of the penis. (FDA) | Intracorporus Cavernosum Route of Administration | |||
| INTRADERMAL | C38238 | Administration within the dermis. (FDA) | Intradermal Route of Administration | |||
| INTRADISCAL | C38239 | Administration within a disc. (FDA) | Intradiscal Route of Administration | |||
| INTRADUCTAL | C38240 | Administration within the duct of a gland. (FDA) | Intraductal Route of Administration | |||
| INTRADUODENAL | C38241 | Administration within the duodenum. (FDA) | Intraduodenal Route of Administration | |||
| INTRADURAL | C38242 | Administration within or beneath the dura. (FDA) | Intradural Route of Administration | |||
| INTRAEPIDERMAL | C38243 | Administration within the epidermis. (FDA) | Intraepidermal Route of Administration | |||
| INTRAESOPHAGEAL | C38245 | Administration within the esophagus. (FDA) | Intraesophageal Route of Administration | |||
| INTRAGASTRIC | C38246 | Administration within the stomach. (FDA) | Intragastric Route of Administration | |||
| INTRAGINGIVAL | C38247 | Administration within the gingivae. (FDA) | Intragingival Route of Administration | |||
| INTRAHEPATIC | C38248 | Administration into the liver. | Intrahepatic Route of Administration | |||
| INTRAILEAL | C38249 | Administration within the distal portion of the small intestine, from the jejunum to the cecum. (FDA) | Intraileal Route of Administration | |||
| INTRAJEJUNAL | C102399 | Administration into the jejunum. | Intrajejunal Route of Administration | |||
| INTRALESIONAL | C38250 | Administration within or introduced directly into a localized lesion. (FDA) | Intralesional Route of Administration | |||
| INTRALUMINAL | C38251 | Administration within the lumen of a tube. (FDA) | Intraluminal Route of Administration | |||
| INTRALYMPHATIC | C38252 | Administration within the lymph. (FDA) | Intralymphatic Route of Administration | |||
| INTRAMEDULLARY | C38253 | Administration within the marrow cavity of a bone. (FDA) | Intramedullary Route of Administration | |||
| INTRAMENINGEAL | C38254 | Administration within the meninges (the three membranes that envelope the brain and spinal cord). (FDA) | Intrameningeal Route of Administration | |||
| INTRAMUSCULAR | C28161 | Administration within a muscle. (FDA) | Intramuscular Route of Administration | |||
| INTRAOCULAR | C38255 | Administration within the eye. (FDA) | Intraocular Route of Administration | |||
| INTRAOVARIAN | C38256 | Administration within the ovary. (FDA) | Intraovarian Route of Administration | |||
| INTRAPALATAL | C102400 | Administration into the palate. | Intrapalatal Route of Administration | |||
| INTRAPARENCHYMAL | C119548 | Administration within or into the parenchyma of a targeted organ. | Intraparenchymal Route of Administration | |||
| INTRAPERICARDIAL | C38257 | Administration within the pericardium. (FDA) | Intrapericardial Route of Administration | |||
| INTRAPERITONEAL | C38258 | Administration within the peritoneal cavity. (FDA) | Intraperitoneal Route of Administration | |||
| INTRAPLEURAL | C38259 | Administration within the pleura. (FDA) | Intrapleural Route of Administration | |||
| INTRAPROSTATIC | C38260 | Administration within the prostate gland. (FDA) | Intraprostatic Route of Administration | |||
| INTRAPULMONARY | C38261 | Administration within the lungs or its bronchi. (FDA) | Intrapulmonary Route of Administration | |||
| INTRASINAL | C38262 | Administration within the nasal or periorbital sinuses. (FDA) | Intrasinal Route of Administration | |||
| INTRASPINAL | C38263 | Administration within the vertebral column. (FDA) | Intraspinal Route of Administration | |||
| INTRASTOMAL | C65138 | Administration into a stoma. | Administration via Stoma | |||
| INTRASYNOVIAL | C38264 | Administration within the synovial cavity of a joint. (FDA) | Intrasynovial Route of Administration | |||
| INTRATENDINOUS | C38265 | Administration within a tendon. (FDA) | Intratendinous Route of Administration | |||
| INTRATESTICULAR | C38266 | Administration within the testicle. (FDA) | Intratesticular Route of Administration | |||
| INTRATHECAL | C38267 | Administration within the cerebrospinal fluid at any level of the cerebrospinal axis, including injection into the cerebral ventricles. (FDA) | Intrathecal Route of Administration | |||
| INTRATHORACIC | C38207 | Administration within the thorax (internal to the ribs); synonymous with the term endothoracic. (FDA) | Endothoracic Route of Administration | |||
| INTRATUBULAR | C38268 | Administration within the tubules of an organ. (FDA) | Intratubular Route of Administration | |||
| INTRATUMOR | C38269 | Intratumor Route of Administration | Administration within a tumor. (FDA) | Intratumoral Route of Administration | ||
| INTRATYMPANIC | C38270 | Administration within the auris media. (FDA) | Intratympanic Route of Administration | |||
| INTRAUTERINE | C38272 | Administration within the uterus. (FDA) | Intrauterine Route of Administration | |||
| INTRAVASCULAR | C38273 | Administration within a vessel or vessels. (FDA) | Intravascular Route of Administration | |||
| INTRAVENOUS | C38276 | Administration within or into a vein or veins. (FDA) | Intravenous Route of Administration | |||
| INTRAVENOUS BOLUS | C38274 | Administration within or into a vein or veins all at once. (FDA) | Intravenous Bolus | |||
| INTRAVENOUS DRIP | C38279 | Administration within or into a vein or veins over a sustained period of time. (FDA) | Intravenous Drip | |||
| INTRAVENTRICULAR | C38277 | Administration within a ventricle. (FDA) | Intraventricular Route of Administration | |||
| INTRAVESICAL | C38278 | Administration within the bladder. (FDA) | Intravesical Route of Administration | |||
| INTRAVITREAL | C38280 | Administration within the vitreous body of the eye. (FDA) | Intravitreal Route of Administration | |||
| IONTOPHORESIS | C38203 | Administration by means of an electric current where ions of soluble salts migrate into the tissues of the body. (FDA) | Iontophoresis Route of Administration | |||
| IRRIGATION | C38281 | Administration to bathe or flush open wounds or body cavities. (FDA) | Irrigation-Route of Administration | |||
| LARYNGEAL | C38282 | Administration directly upon the larynx. (FDA) | Laryngeal Route of Administration | |||
| NASAL | C38284 | Intranasal Route of Administration | Administration to the nose; administered by way of the nose. (FDA) | Nasal Route of Administration | ||
| NASOGASTRIC | C38285 | Administration through the nose and into the stomach, usually by means of a tube. (FDA) | Nasogastric Route of Administration | |||
| NOT APPLICABLE | C48623 | Routes of administration are not applicable. (FDA) | Route of Administration Not Applicable | |||
| OCCLUSIVE DRESSING TECHNIQUE | C38286 | Administration by the topical route which is then covered by a dressing which occludes the area. (FDA) | Occlusive Dressing Technique | |||
| OPHTHALMIC | C38287 | Administration to the external eye. (FDA) | Ophthalmic Route of Administration | |||
| ORAL | C38288 | Intraoral Route of Administration;PO | Administration to or by way of the mouth. (FDA) | Oral Route of Administration | ||
| ORAL GAVAGE | C78374 | Administration through the mouth and into the stomach, usually by means of a tube. (NCI) | Oral Gavage Route of Administration | |||
| OROMUCOSAL | C64906 | Administration across the mucosa of the oral cavity. | Oromucosal Route of Administration | |||
| OROPHARYNGEAL | C38289 | Administration directly to the mouth and pharynx. (FDA) | Oropharyngeal Route of Administration | |||
| PARENTERAL | C38291 | Administration by injection, infusion, or implantation. (FDA) | Parenteral Route of Administration | |||
| PERCUTANEOUS | C38676 | Administration through the skin. (FDA) | Percutaneous Route of Administration | |||
| PERIARTICULAR | C38292 | Administration around a joint. (FDA) | Periarticular Route of Administration | |||
| PERIDURAL | C38677 | Administration to the outside of the dura mater of the spinal cord. (FDA) | Peridural Route of Administration | |||
| PERINEURAL | C38293 | Administration surrounding a nerve or nerves. (FDA) | Perineural Route of Administration | |||
| PERIODONTAL | C38294 | Administration around a tooth. (FDA) | Periodontal Route of Administration | |||
| PERIVENOUS | C112396 | Administration into the area surrounding a vein. (NCI) | Perivenous Route of Administration | |||
| RECTAL | C38295 | Administration to the rectum. (FDA) | Rectal Route of Administration | |||
| RESPIRATORY (INHALATION) | C38216 | Administration within the respiratory tract by inhaling orally or nasally for local or systemic effect. (FDA) | Inhalation Route of Administration | |||
| RETROBULBAR | C38296 | Administration behind the pons or behind the eyeball. (FDA) | Retrobulbar Route of Administration | |||
| SOFT TISSUE | C38198 | Administration into any soft tissue. (FDA) | Soft Tissue Route of Administration | |||
| SUBARACHNOID | C38297 | Administration beneath the arachnoid. (FDA) | Subarachnoid Route of Administration | |||
| SUBCONJUNCTIVAL | C38298 | Administration beneath the conjunctiva. (FDA) | Subconjunctival Route of Administration | |||
| SUBCUTANEOUS | C38299 | SC;Subdermal Route of Administration | Administration beneath the skin; hypodermic. Synonymous with the term SUBDERMAL. (FDA) | Subcutaneous Route of Administration | ||
| SUBLINGUAL | C38300 | Administration beneath the tongue. (FDA) | Sublingual Route of Administration | |||
| SUBMUCOSAL | C38301 | Administration beneath the mucous membrane. (FDA) | Submucosal Route of Administration | |||
| SUBTENON | C94636 | Administration by injection through the membrane covering the muscles and nerves at the back of the eyeball. | Subtenon Route of Administration | |||
| TOPICAL | C38304 | TOP | Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL. (FDA) | Topical Route of Administration | ||
| TRANSDERMAL | C38305 | Administration through the dermal layer of the skin to the systemic circulation by diffusion. (FDA) | Transdermal Route of Administration | |||
| TRANSMAMMARY | C111326 | Administration by ingestion of colostrum or breast milk. | Transmammary Route of Administration | |||
| TRANSMUCOSAL | C38283 | Administration across the mucosa. (FDA) | Mucosal Route of Administration | |||
| TRANSPLACENTAL | C38307 | Administration through or across the placenta. (FDA) | Transplacental Route of Administration | |||
| TRANSTRACHEAL | C38308 | Administration through the wall of the trachea. (FDA) | Transtracheal Route of Administration | |||
| TRANSTYMPANIC | C38309 | Administration across or through the tympanic cavity. (FDA) | Transtympanic Route of Administration | |||
| UNASSIGNED | C38310 | Route of administration has not yet been assigned. (FDA) | Unassigned Route of Administration | |||
| UNKNOWN | C38311 | Route of administration is unknown. (FDA) | Unknown Route of Administration | |||
| URETERAL | C38312 | Administration into the ureter. (FDA) | Ureteral Route of Administration | |||
| URETHRAL | C38271 | Administration into the urethra. (FDA) | Intraurethral Route of Administration | |||
| VAGINAL | C38313 | Administration into the vagina. (FDA) | Vaginal Route of Administration | |||
| Back to top | ||||||
| CL.C66734.DOMAIN | SDTM Domain Abbreviation (DOMAIN) | text Extensible: Yes | C66734 | SDTM Domain Abbreviation | A unique, 2-character domain code used in the regulatory submission process. The domain abbreviation is used consistently throughout the submission, i.e. in the dataset name, as the value of the domain variable within the dataset, and as a prefix for most variable names in the dataset. (CDISC Glossary) | CDISC SDTM Submission Domain Abbreviation Terminology |
| AD | C49563 | Analysis Dataset | Datasets used for statistical analysis and reporting by the sponsor. These are submitted in addition to the data tabulation datasets. | Analysis Dataset Domain | ||
| AE | C49562 | Adverse Events | Adverse events may be captured either as free text or a pre-specified list of terms. | Adverse Event Domain | ||
| AG | C117755 | Procedure Agents | A domain for the agents administered to the subject as part of a procedure or assessment as opposed to drugs, medications and therapies administered with therapeutic intent. | Procedure Agents Domain | ||
| AU | C49565 | Autopsy | Additional data about deaths, specific to findings from autopsies. | Autopsy Domain | ||
| AX | C111282 | Non-Compliant ADaM Datasets | Prefix to indicate an analysis dataset that is not compliant with a defined ADaM structure. | Non-Compliant ADaM Datasets Domain | ||
| BE | C111138 | Biospecimen Events | An events domain that documents biospecimen collection and storage information. | Biospecimen Events Domain | ||
| BM | C49566 | Bone Measurements | Findings resulting from evaluations of bone mineral density. | Bone Measurements Domain | ||
| BR | C49567 | Biopsy | Findings resulting from biopsies. | Biopsy Domain | ||
| BS | C111137 | Biospecimen | A findings domain that documents biospecimen handling information. | Biospecimen Domain | ||
| CE | C85441 | Clinical Events | A dataset used to capture clinical events of interest that would not be classified as adverse events. | Clinical Events Domain | ||
| CM | C49568 | Concomitant Meds | Case report form (CRF) data that captures the Concomitant and Prior Medications/Therapies used by the subject. Examples are the Concomitant Medications/Therapies given on an as needed basis and the usual Background Medications/Therapies given for a condition. | Concomitant Medication Domain | ||
| CO | C49569 | Comments | The Comments dataset accommodates two sources of comments: 1) those collected alongside other data on topical case report form (CRF) pages such as Adverse Events and 2) those collected on a separate page specifically dedicated to comments. | Comment Domain | ||
| CV | C102605 | Cardiovascular System Findings | A domain for physiological findings related to the cardiovascular system, including the heart, blood vessels and lymphatic vessels. | Cardiovascular System Findings Domain | ||
| DA | C49578 | Drug Accountability | Data regarding the accountability of study drug, such as information on the receipt, dispensing, return, and packaging. | Drug Accountability Domain | ||
| DD | C95087 | Death Diagnosis | This domain captures the diagnosis of the cause of death for a subject. | Death Diagnosis Domain | ||
| DE | C102616 | Device Events | A domain for device-related events. | Device Events Domain | ||
| DI | C102618 | Device Identifiers | A domain for the submission of information that identifies a specific device unit. | Device Identifiers Domain | ||
| DM | C49572 | Demographics | The Demographics domain includes a set of essential standard variables that describe each subject in a clinical study. It is the parent domain for all other observations for human clinical subjects. | Demographics Domain | ||
| DO | C102619 | Device Properties | A domain for the characteristics of the device that do not vary over the course of the study. | Device Properties Domain | ||
| DP | C95088 | Developmental Milestone | This domain captures the outcome of developmental milestone testing during a scheduled period of observation. | Developmental Milestone Domain | ||
| DR | C102620 | Device to Subject Relationship | A domain for the linkage of each subject to the device(s) to which they may have been exposed. | Device to Subject Relationship Domain | ||
| DS | C49576 | Disposition | A subject domain utilized for the submission of information encompassing and representing data, vocabulary or records related to disposition. (NCI) | Disposition Domain | ||
| DT | C102621 | Device Tracking and Disposition | A domain for logistics and disposition information specific to a given device. | Device Tracking and Disposition Domain | ||
| DU | C102622 | Device-In-Use | A domain for the findings for the values of measurements and settings that are intentionally set on a device when it is in use. These are characteristics that exist for the device, and have a specific setting for a use instance. | Device-In-Use Domain | ||
| DV | C49585 | Protocol Deviations | The intent of the domain is to capture protocol violations and deviations during the course of the study and will store only those criteria violation by or deviated from by the subject and not a response to each violation or deviation. | Protocol Deviations Domain | ||
| DX | C102617 | Device Exposure | A domain for a subject's exposure to a medical device under study. | Device Exposure Domain | ||
| ED | C102630 | Endocrine System Findings | A domain for physiological findings related to the endocrine system, including the glands and cells that make hormones that are released directly into the blood and travel to tissues and organs all over the body. | Endocrine System Findings Domain | ||
| EG | C49626 | Electrocardiogram | Findings related to the collection of ECG data, including position of the subject, method of evaluation, all cycle measurements and all findings from the ECG including an overall interpretation if collected or derived. | Electrocardiogram Domain | ||
| EX | C49587 | Exposure | The Exposure domain model records the details of a subject's exposure to protocol-specified study treatment. Study treatment may be any intervention that is prospectively defined as a test material within a study, and is typically but not always supplied to the subject. | Exposure Domain | ||
| FA | C85442 | Findings About Events or Interventions | A dataset used to capture the findings about an event or intervention that cannot be represented within an event or intervention record or as a supplemental qualifier. | Findings About Events or Interventions Domain | ||
| FH | C49588 | Family History | A subject domain utilized for the submission of information encompassing and representing data, vocabulary or records related to family history. (NCI) | Family History Domain | ||
| FT | C117756 | Functional Tests | A domain for named, stand-alone task-based evaluations designed to provide an assessment of mobility, dexterity, or cognitive ability. | Functional Tests Domain | ||
| GI | C102640 | Gastrointestinal System Findings | A domain for physiological findings related to the gastrointestinal system, including the esophagus, stomach, small and large intestine, anus, liver, biliary tract and pancreas. | Gastrointestinal System Findings Domain | ||
| HM | C102641 | Hematopoietic System Findings | A domain for physiological findings related to the hematopoietic system, including the bone marrow and lymph nodes involved in the production of blood. | Hematopoietic System Findings Domain | ||
| HO | C117757 | Healthcare Encounters | A domain for inpatient and outpatient healthcare events. | Healthcare Encounters Domain | ||
| HU | C49589 | Healthcare Resource Utilization | Healthcare resource utilization data such as subject visits to physicians, hospitalizations, and nursing home stays. | Healthcare Resource Utilization Domain | ||
| IE | C61536 | Inclusion/Exclusion | The intent of the domain model is to only collect those criteria that cause the subject to be in violation of the inclusion/exclusion criteria not a response to each criterion. | Inclusion Exclusion Domain | ||
| IG | C102651 | Integumentary System Findings | A domain for physiological findings related to the integumentary system, including the epidermis, dermis, all of the derivatives of the epidermis, hairs, nails, sudoriferous and sebaceous glands, and mammary glands. | Integumentary System Findings Domain | ||
| IM | C102649 | Immune System Findings | A domain for physiological findings related to the immune system, including the thymus, spleen and tonsils. | Immune System Findings Domain | ||
| IS | C112320 | Immunogenicity Specimen Assessments | A findings domain for assessments that determine whether a therapy induced an immune response. | Immunogenicity Specimen Assessments Domain | ||
| LB | C49592 | Laboratory Data | Laboratory test findings including, but is not limited to hematology, clinical chemistry and urinalysis data. This domain does not include microbiology or pharmacokinetic data, which are stored in separate domains. | Laboratory Data Domain | ||
| MB | C49602 | Microbiology | Microbiology specimen findings, including gram stain results, and organisms found. | Microbiology Specimen Domain | ||
| MH | C49603 | Medical History | The medical history dataset includes the subject's prior history at the start of the trial. Examples of subject medical history information could include general medical history, gynecological history, and primary diagnosis. | Medical History Domain | ||
| MI | C95095 | Microscopic Findings | The histopathology findings and microscopic evaluations recorded. | Microscopic Findings Domain | ||
| MK | C102674 | Musculoskeletal Findings, Connective and Soft Tissue Findings | A domain for physiological findings related to the system of muscles, tendons, ligaments, bones, joints and associated tissues. | Musculoskeletal Findings, Connective and Soft Tissue Findings Domain | ||
| ML | C49604 | Meal Data | Information regarding the subject's meal consumption, such as fluid intake, amounts, form (solid or liquid state), frequency, etc., typically used for pharmacokinetic analysis. | Meal Data Domain | ||
| MO | C102671 | Morphology Findings | A domain relevant to the science of the form and structure of an organism or of its parts. | Morphology Findings Domain | ||
| MS | C61531 | Microbiology Susceptibility | This includes microbiology susceptibility test results, plus results of any other organism-related tests. | Microbiology Susceptibility Domain | ||
| NV | C102677 | Nervous System Findings | A domain for physiological findings related to the nervous system, including the brain, spinal cord, the cranial and spinal nerves, autonomic ganglia and plexuses. | Nervous System Findings Domain | ||
| PB | C106552 | Pharmacogenomics Biomarker | A special-purpose domain that relates a set of genetic variations to an inference about the medical meaning of that set of genetic variations. | Pharmacogenomics Biomarker Domain | ||
| PC | C49606 | Pharmacokinetic Concentration | Concentrations of drugs/metabolites in fluids or tissues as a function of time. | Pharmacokinetic Concentration Domain | ||
| PE | C49608 | Physical Exam | Findings collected during a physical examination of the subject. It has findings that are discovered that are related to body systems. Does not include vital signs measurements, which are stored in the vital signs domain. | Physical Exam Domain | ||
| PF | C111289 | Pharmacogenomics Findings | A findings domain for gene expression and genetic variation assessments. | Pharmacogenomics Findings Domain | ||
| PG | C61529 | Pharmacogenomics/Genetics Methods and Supporting Information | Pharmacogenomics findings that initially focus on genotype and gene expression data. | Pharmacogenomics Domain | ||
| PP | C49607 | Pharmacokinetic Parameters | Pharmacokinetic parameters derived from pharmacokinetic concentration-time (PC) data. | Pharmacokinetic Parameters Domain | ||
| PR | C102700 | Procedure | A domain relevant to an interventional activity that is intended to have diagnostic, preventive, therapeutic, or palliative effects. | Procedure Domain | ||
| PS | C111300 | Protocol Summary for PGx | A special purpose domain that contains the protocol summary information for pharmacogenomics assessments. | Protocol Summary for Pharmacogenomic Assessments Domain | ||
| PT | C111290 | Pharmacogenomics Trial Characteristics | A special purpose domain that contains design parameters used in performing pharmacogenomic assessments. | Pharmacogenomics Trial Characteristics Domain | ||
| QS | C49609 | Questionnaires | Questionnaires are named, stand-alone instruments designed to provide an assessment of a concept. Questionnaires have a defined standard structure, format, and content; consist of conceptually related items that are typically scored; and have documented methods for administration and analysis. Most often, questionnaires have as their primary purpose the generation of a quantitative statistic to assess a qualitative concept. | Questionnaire Domain | ||
| RE | C95098 | Respiratory System Findings | A domain for physiological findings related to the respiratory system, including the organs that are involved in breathing such as the nose, throat, larynx, trachea, bronchi and lungs. | Respiratory Domain | ||
| RP | C102707 | Reproductive System Findings | A domain for physiological findings related to the male and female reproductive systems. | Reproductive System Findings Domain | ||
| RS | C107097 | Disease Response | The disease response (RS) domain represents disease response evaluations determined from collected data in the tumor results (TR) domain and/or other SDTM domains. | Disease Response Domain | ||
| SB | C106571 | Subject Biomarker | A special purpose domain that associates the subject with the medical conclusions contained in the pharmacogenomics biological state (PB) domain based on the observations reported in pharmacogenomics findings (PF) domain. | Subject Biomarker Domain | ||
| SC | C49610 | Subject Characteristics | The subject characteristics domain is for data not collected in other domains that is subject-related. | Subject Characteristics Domain | ||
| SE | C49616 | Subject Element | The subject element table describes the actual order of elements followed by the subject, together with the start date/time and end date/time for each element. | Subject Element Domain | ||
| SG | C49611 | Surgery | Surgical information. | Surgery Domain | ||
| SK | C49612 | Skin Test | Findings from diagnostic skin tests. | Skin Test Domain | ||
| SL | C49613 | Sleep Polysomnography Data | Findings from diagnostic sleep tests (polysomnography). | Sleep Polysomnography Domain | ||
| SR | C112420 | Skin Response | A findings about domain for submitting dermal responses to antigens. | Skin Response Domain | ||
| SU | C49615 | Substance Use | The intent of the domain is to capture substance use information that may be used to assess the efficacy and/or safety of therapies that look to mitigate the effects of chronic substance use. | Substance Use Domain | ||
| SV | C49617 | Subject Visits | The subject visits table describes the actual start and end data/time for each visit of each individual subject. | Subject Visits Domain | ||
| TA | C49618 | Trial Arms | The trial arms table describes each planned arm in the trial. An arm is described as an ordered sequence of elements. | Trial Arms Domain | ||
| TE | C49619 | Trial Elements | The trial elements table describes the element code that is unique for each element, the element description, and the rules for starting and ending an element. | Trial Elements Domain | ||
| TF | C95100 | Tumor Findings | This domain captures the tumor findings of the nonclinical subject. | Tumor Findings Domain | ||
| TI | C49620 | Trial Inclusion/Exclusion Criteria | The trial summary information domain is not subject oriented. It contains one record for each of the inclusion and exclusion criteria for the trial. | Trial Inclusion and Exclusion Criteria Domain | ||
| TP | C95101 | Trial Paths | The trial paths domain is not subject oriented. This domain provides the complete planned non-treatment related sequences of stages for each path in a study. | Trial Paths Domain | ||
| TR | C106578 | Tumor Results | This domain represents quantitative measurements and/or qualitative assessments of the tumors identified in the tumor identifier (TU) domain. | Tumor Results Domain | ||
| TS | C53483 | Trial Summary | The trial summary information domain is not subject oriented. It contains one record for each trial summary characteristic. | Trial Summary Domain | ||
| TU | C106577 | Tumor Identifier | This domain represents data that uniquely identifies tumors. | Tumor Identifier Domain | ||
| TV | C49621 | Trial Visits | The trial visits table describes the planned order and number of visits in the study within each arm. | Trial Visits Domain | ||
| TX | C95103 | Trial Sets | The trial stages domain is not subject oriented. It contains one record for each trial set characteristic including experimental factors, treatment factors, inherent characteristics, or distinct sponsor designations. | Trial Sets Domain | ||
| UR | C102726 | Urinary System Findings | A domain for physiological findings related to the urinary tract, including the organs involved in the creation and excretion of urine such as the kidneys, ureters, bladder and urethra. | Urinary System Findings Domain | ||
| VR | C106581 | Viral Resistance Findings | A findings domain that contains information about virus drug-resistance. | Viral Resistance Domain | ||
| VS | C49622 | Vital Signs | Measurements including but not limited to blood pressure, temperature, respiration, body surface area, BMI, height and weight. | Vital Signs Domain | ||
| Back to top | ||||||
| CL.C116111.SPCIES | SDTM Species (SPCIES) | text Extensible: Yes | C116111 | SDTM Species | Terminology relevant to the species of the pathogen to which the subject is a host when the pathogen is the focus of the test or interpretation. | CDISC SDTM Species Terminology |
| ACINETOBACTER LWOFFII | C86095 | ACINETOBACTER CALCOACETICUS SUBSP. LWOFFII | Any bacterial organism that can be assigned to the species Acinetobacter lwoffii. | Acinetobacter lwoffii | ||
| ACTINOBACILLUS PLEUROPNEUMONIAE | C86101 | HAEMOPHILUS PLEUROPNEUMONIAE | Any bacterial organism that can be assigned to the species Actinobacillus pleuropneumoniae. | Actinobacillus pleuropneumoniae | ||
| BACILLUS ANTHRACIS | C86160 | Any bacterial organism that can be assigned to the species Bacillus anthracis. | Bacillus anthracis | |||
| BARMAH FOREST VIRUS | C112232 | Any viral organism that can be assigned to the species Barmah Forest virus. | Barmah Forest Virus | |||
| BK POLYOMAVIRUS | C89820 | BK Virus | Any viral organism that can be assigned to the species BK polyomavirus. | BK Virus | ||
| BORDETELLA PERTUSSIS | C76205 | Any bacterial organism that can be assigned to the species Bordetella pertussis. | Bordetella pertussis | |||
| BUTTIAUXELLA AGRESTIS | C86229 | Any bacterial organism that can be assigned to the species Buttiauxella agrestis. | Buttiauxella agrestis | |||
| CHLAMYDIA TRACHOMATIS | C86253 | Any bacterial organism that can be assigned to the species Chlamydia trachomatis. | Chlamydia trachomatis | |||
| CHLAMYDOPHILA PNEUMONIAE | C76272 | CHLAMYDIA PNEUMONIAE | Any bacterial organism that can be assigned to the species Chlamydophila pneumoniae. | Chlamydophila pneumoniae | ||
| CLOSTRIDIUM GLYCOLICUM | C86280 | Any bacterial organism that can be assigned to the species Clostridium glycolicum. | Clostridium glycolicum | |||
| CLOSTRIDIUM HISTOLYTICUM | C86282 | Any bacterial organism that can be assigned to the species Clostridium histolyticum. | Clostridium histolyticum | |||
| CLOSTRIDIUM NOVYI | C86285 | Any bacterial organism that can be assigned to the species Clostridium novyi. | Clostridium novyi | |||
| CLOSTRIDIUM TERTIUM | C86297 | Any bacterial organism that can be assigned to the species Clostridium tertium. | Clostridium tertium | |||
| COLORADO TICK FEVER VIRUS | C112240 | CTFV | Any viral organism that can be assigned to the species Colorado tick fever virus. | Colorado Tick Fever Virus | ||
| CORYNEBACTERIUM AMYCOLATUM | C86308 | Any bacterial organism that can be assigned to the species Corynebacterium amycolatum. | Corynebacterium amycolatum | |||
| CORYNEBACTERIUM DIPHTHERIAE | C86312 | Any bacterial organism that can be assigned to the species Corynebacterium diphtheriae. | Corynebacterium diphtheriae | |||
| CORYNEBACTERIUM MACGINLEYI | C86315 | Any bacterial organism that can be assigned to the species Corynebacterium macginleyi. | Corynebacterium macginleyi | |||
| CORYNEBACTERIUM UREALYTICUM | C86325 | CDC GROUP D2;CORYNEBACTERIUM GROUP D-2 | Any bacterial organism that can be assigned to the species Corynebacterium urealyticum. | Corynebacterium urealyticum | ||
| CORYNEBACTERIUM XEROSIS | C86326 | Any bacterial organism that can be assigned to the species Corynebacterium xerosis. | Corynebacterium xerosis | |||
| COXIELLA BURNETII | C86328 | Any bacterial organism that can be assigned to the species Coxiella burnetii. | Coxiella burnetii | |||
| DENGUE VIRUS | C112036 | Any viral organism that can be assigned to the species Dengue virus. | Dengue Virus | |||
| ECHOVIRUS | C112272 | Any viral organism that can be assigned to the species Echovirus. | Echovirus | |||
| ENTEROBACTER AEROGENES | C86356 | AEROBACTER AEROGENES | Any bacterial organism that can be assigned to the species Enterobacter aerogenes. | Enterobacter aerogenes | ||
| ENTEROBACTER ASBURIAE | C86358 | CDC ENTERIC GROUP 17 | Any bacterial organism that can be assigned to the species Enterobacter asburiae. | Enterobacter asburiae | ||
| ESCHERICHIA COLI | C14206 | E. COLI | Any bacterial organism that can be assigned to the species Escherichia coli. | Escherichia coli | ||
| ESCHERICHIA FERGUSONII | C86380 | CDC ENTERIC GROUP 10 | Any bacterial organism that can be assigned to the species Escherichia fergusonii. | Escherichia fergusonii | ||
| ESCHERICHIA VULNERIS | C86382 | CDC ENTERIC GROUP 1 | Any bacterial organism that can be assigned to the species Escherichia vulneris. | Escherichia vulneris | ||
| EWINGELLA AMERICANA | C86391 | CDC ENTERIC GROUP 40 | Any bacterial organism that can be assigned to the species Ewingella americana. | Ewingella americana | ||
| EXIGUOBACTERIUM ACETYLICUM | C86886 | BREVIBACTERIUM ACETYLICUM | Any bacterial organism that can be assigned to the species Exiguobacterium acetylicum. | Exiguobacterium acetylicum | ||
| GORDONIA BRONCHIALIS | C86416 | GORDONA BRONCHIALIS;RHODOCOCCUS BRONCHIALIS | Any bacterial organism that can be assigned to the species Gordonia bronchialis. | Gordonia bronchialis | ||
| GORDONIA SPUTI | C86418 | GORDONA SPUTI | Any bacterial organism that can be assigned to the species Gordonia sputi. | Gordonia sputi | ||
| HAEMOPHILUS AEGYPTIUS | C86428 | Any bacterial organism that can be assigned to the species Haemophilus aegyptius. | Haemophilus aegyptius | |||
| HAEMOPHILUS INFLUENZAE | C86431 | H-FLU | Any bacterial organism that can be assigned to the species Haemophilus influenzae. | Haemophilus influenzae | ||
| HENDRA VIRUS | C112289 | Any viral organism that can be assigned to the species Hendra virus. | Hendra Virus | |||
| HEPATITIS A VIRUS | C14325 | HAV | Any viral organism that can be assigned to the species Hepatitis A virus. | Hepatitis A Virus | ||
| HEPATITIS B VIRUS | C14215 | HBV | Any viral organism that can be assigned to the species Hepatitis B virus. | Hepatitis B Virus | ||
| HEPATITIS C VIRUS | C14312 | HCV | Any viral organism that can be assigned to the species Hepatitis C virus. | Hepatitis C Virus | ||
| HEPATITIS D VIRUS | C93324 | HDV | Any viral organism that can be assigned to the species Hepatitis D virus. | Hepatitis D Virus | ||
| HEPATITIS E VIRUS | C14295 | HEV | Any viral organism that can be assigned to the species Hepatitis E virus. | Hepatitis E Virus | ||
| HUMAN HERPESVIRUS 1 | C14311 | HHV-1;HSV-1;Herpes Simplex Virus type 1 | Any viral organism that can be assigned to the species Human Herpesvirus 1 within the genus Simplexvirus. | Human Herpesvirus 1 | ||
| HUMAN HERPESVIRUS 2 | C112313 | HHV-2;HSV-2;Herpes Simplex Virus type 2 | Any viral organism that can be assigned to the species Human Herpesvirus 2 within the genus Simplexvirus. | Human Herpesvirus 2 | ||
| HUMAN HERPESVIRUS 3 | C71091 | HHV-3;VZV;Varicella Zoster Virus | Any viral organism that can be assigned to the species Human Herpesvirus 3. | Varicella Zoster Virus | ||
| HUMAN HERPESVIRUS 4 | C14204 | EBV;Epstein-Barr Virus;HHV-4 | Any viral organism that can be assigned to the species Human Herpesvirus 4. | Epstein-Barr Virus | ||
| HUMAN HERPESVIRUS 5 | C112314 | HCMV;HHV-5;Human Cytomegalovirus | Any viral organism that can be assigned to the species Human Herpesvirus 5. | Human Herpesvirus 5 | ||
| HUMAN HERPESVIRUS 6 | C14218 | HHV-6 | Any viral organism that can be assigned to the species Human Herpesvirus 6. | Human Herpesvirus 6 | ||
| HUMAN HERPESVIRUS 7 | C112315 | HHV-7 | Any viral organism that can be assigned to the species Human Herpesvirus 7. | Human Herpesvirus 7 | ||
| HUMAN HERPESVIRUS 8 | C14327 | HHV-8;KSHV;Kaposi's sarcoma-associated herpesvirus | Any viral organism that can be assigned to the species Human herpesvirus 8. | Human Herpesvirus 8 | ||
| HUMAN IMMUNODEFICIENCY VIRUS 1 | C14220 | HIV-1;LAV-1 | Any viral organism that can be assigned to the species Human Immunodeficiency virus 1. | Human Immunodeficiency Virus 1 | ||
| HUMAN IMMUNODEFICIENCY VIRUS 2 | C14221 | HIV-2;LAV-2 | Any viral organism that can be assigned to the species Human Immunodeficiency virus 2. | Human Immunodeficiency Virus 2 | ||
| HUMAN PARVOVIRUS B19 | C89772 | B19 Virus;Human Erythrovirus B19;Parvovirus B19 | Any viral organism that can be assigned to the species Human Parvovirus B19. | Parvovirus B19 | ||
| HUMAN RESPIRATORY SYNCYTIAL VIRUS | C14267 | Human RSV;RSV;hRSV | Any viral organism that can be assigned to the species Human Respiratory Syncitial virus. | Human Respiratory Syncytial Virus | ||
| INFLUENZA A VIRUS | C53454 | FLUAV;Influenza Virus Type A | Any viral organism that can be assigned to the species Influenza A virus. | Influenza A Virus | ||
| INFLUENZA B VIRUS | C53468 | FLUBV;Influenza Virus Type B | Any viral organism that can be assigned to the species Influenza B virus. | Influenza B Virus | ||
| INFLUENZA C VIRUS | C97157 | FLUCV;Influenza Virus Type C | Any viral organism that can be assigned to the species Influenza C virus. | Influenza C Virus | ||
| JC VIRUS | C14229 | Human polyomavirus (type JC);Polyomavirus hominis 2;polyomavirus JC | Any viral organism that can be assigned to the species JC polyomavirus. | JC Virus | ||
| KLEBSIELLA OZAENAE | C86456 | KLEBSIELLA PNEUMONIAE SUBSP. OZAENAE | Any bacterial organism that can be assigned to the species Klebsiella ozaenae. | Klebsiella ozaenae | ||
| KLEBSIELLA PNEUMONIAE | C86457 | K. PNEUMONIAE | Any bacterial organism that can be assigned to the species Klebsiella pneumoniae. | Klebsiella pneumoniae | ||
| KLEBSIELLA RHINOSCLEROMATIS | C86458 | KLEBSIELLA PNEUMONIAE SUBSP. RHINOSCLEROMATIS | Any bacterial organism that can be assigned to the species Klebsiella rhinoscleromatis. | Klebsiella rhinoscleromatis | ||
| KLEBSIELLA SINGAPORENSIS | C86459 | Any bacterial organism that can be assigned to the species Klebsiella singaporensis. | Klebsiella singaporensis | |||
| KLEBSIELLA VARIICOLA | C86460 | Any bacterial organism that can be assigned to the species Klebsiella variicola. | Klebsiella variicola | |||
| KLUYVERA ASCORBATA | C86462 | CDC ENTERIC GROUP 8 | Any bacterial organism that can be assigned to the species Kluyvera ascorbata. | Kluyvera ascorbata | ||
| KLUYVERA CRYOCRESCENS | C86463 | Any bacterial organism that can be assigned to the species Kluyvera cryocrescens. | Kluyvera cryocrescens | |||
| KOCURIA KRISTINAE | C86468 | MICROCOCCUS KRISTINAE | Any bacterial organism that can be assigned to the species Kocuria kristinae. | Kocuria kristinae | ||
| KOCURIA RHIZOPHILA | C86513 | MICROCOCCUS LUTEUS;SARCINA LUTEA | Any bacterial organism that can be assigned to the species Kocuria rhizophila. | Micrococcus luteus | ||
| KOCURIA ROSEA | C86469 | Any bacterial organism that can be assigned to the species Kocuria rosea. | Kocuria rosea | |||
| KOCURIA VARIANS | C86470 | Any bacterial organism that can be assigned to the species Kocuria varians. | Kocuria varians | |||
| LEGIONELLA PNEUMOPHILA | C86489 | Any bacterial organism that can be assigned to the species Legionella pneumophila. | Legionella pneumophila | |||
| MANNHEIMIA HAEMOLYTICA | C86508 | PASTEURELLA HAEMOLYTICA | Any bacterial organism that can be assigned to the species Mannheimia haemolytica. | Mannheimia haemolytica | ||
| MEASLES VIRUS | C14237 | Rubeola Virus;SSPEV;rougeole virus;subacute sclerosing panencephalitis virus | Any viral organism that can be assigned to the species Measles virus. | Measles Virus | ||
| MEGASPHAERA ELSDENII | C86896 | PEPTOSTREPTOCOCCUS ELSDENII | Any bacterial organism that can be assigned to the species Megasphaera elsdenii. | Megasphaera elsdenii | ||
| METHYLOBACTERIUM MESOPHILICUM | C86510 | PSEUDOMONAS MESOPHILICA | Any bacterial organism that can be assigned to the species Methylobacterium mesophilicum. | Methylobacterium mesophilicum | ||
| MICROBACTERIUM PARAOXYDANS | C86512 | Any bacterial organism that can be assigned to the species Microbacterium paraoxydans. | Microbacterium paraoxydans | |||
| MICROCOCCUS LYLAE | C86514 | Any bacterial organism that can be assigned to the species Micrococcus lylae. | Micrococcus lylae | |||
| MITSUOKELLA MULTACIDA | C86516 | Any bacterial organism that can be assigned to the species Mitsuokella multacida. | Mitsuokella multacida | |||
| MOLLUSCUM CONTAGIOSUM VIRUS | C112357 | MCV;MOCV | Any viral organism that can be assigned to the species Molluscum contagiosum virus. | Molluscum Contagiosum Virus | ||
| MORAXELLA BOVIS | C86524 | Any bacterial organism that can be assigned to the species Moraxella bovis. | Moraxella bovis | |||
| MORAXELLA CATARRHALIS | C76210 | BRANHAMELLA CATARRHALIS | Any bacterial organism that can be assigned to the species Moraxella catarrhalis. | Moraxella catarrhalis | ||
| MORAXELLA LACUNATA | C86526 | MORAXELLA LIQUEFACIENS | Any bacterial organism that can be assigned to the species Moraxella lacunata. | Moraxella lacunata | ||
| MYCOBACTERIUM FORTUITUM | C86538 | Any bacterial organism that can be assigned to the species Mycobacterium fortuitum. | Mycobacterium fortuitum | |||
| MYCOBACTERIUM PEREGRINUM | C86546 | Any bacterial organism that can be assigned to the species Mycobacterium peregrinum. | Mycobacterium peregrinum | |||
| MYCOBACTERIUM SMEGMATIS | C86590 | Any bacterial organism that can be assigned to the species Mycobacterium smegmatis. | Mycobacterium smegmatis | |||
| MYCOPLASMA PNEUMONIAE | C86599 | Any bacterial organism that can be assigned to the species Mycoplasma pneumoniae. | Mycoplasma pneumoniae | |||
| MYROIDES ODORATUS | C86954 | FLAVOBACTERIUM ODORATUM | Any bacterial organism that can be assigned to the species Myroides odoratus. | Myroides odoratus | ||
| NEISSERIA GONORRHOEAE | C86603 | Any bacterial organism that can be assigned to the species Neisseria gonorrhoeae. | Neisseria gonorrhoeae | |||
| NEWCASTLE DISEASE VIRUS | C93023 | Avian Paramyxovirus Type 1;NDV | Any viral organism that can be assigned to the species Newcastle disease virus. | Newcastle Disease Virus | ||
| NIPAH VIRUS | C112359 | NiV | Any viral organism that can be assigned to the species Nipah virus. | Nipah Virus | ||
| NORWALK VIRUS | C112363 | NV;Norwalk calicivirus | Any viral organism that can be assigned to the species Norwalk virus. | Norwalk Virus | ||
| POLIOVIRUS | C14259 | Enterovirus C;Human enterovirus C | Any viral organism that can be assigned to the species Poliovirus. | Poliovirus | ||
| PROTEUS MIRABILIS | C86019 | Any bacterial organism that can be assigned to the species Proteus mirabilis. | Proteus mirabilis | |||
| PROTEUS PENNERI | C86688 | INDOLE NEGATIVE PROTEUS VULGARIS | Any bacterial organism that can be assigned to the species Proteus penneri. | Proteus penneri | ||
| PSEUDOCOWPOX VIRUS | C112401 | Paravaccinia virus;Pseudocowpoxvirus | Any viral organism that can be assigned to the species Pseudocowpox virus. | Pseudocowpox Virus | ||
| PSEUDOMONAS AERUGINOSA | C86696 | Any bacterial organism that can be assigned to the species Pseudomonas aeruginosa. | Pseudomonas aeruginosa | |||
| RABIES VIRUS | C112405 | Any viral organism that can be assigned to the species Rabies virus. | Rabies Virus | |||
| RHINOVIRUS A | C112407 | Human Rhinovirus A | Any viral organism that can be assigned to the species Rhinovirus A. | Rhinovirus A | ||
| RHINOVIRUS B | C112408 | Human Rhinovirus B | Any viral organism that can be assigned to the species Rhinovirus B. | Rhinovirus B | ||
| RHINOVIRUS C | C112409 | Human Rhinovirus C | Any viral organism that can be assigned to the species Rhinovirus C. | Rhinovirus C | ||
| ROSS RIVER VIRUS | C112411 | RRV | Any viral organism that can be assigned to the species Ross River virus. | Ross River Virus | ||
| RUBELLA VIRUS | C77198 | German Measles Virus | Any viral organism that can be assigned to the species Rubella virus. | Rubella Virus | ||
| SAPPORO VIRUS | C112415 | Human calicivirus SLV;Human calicivirus Sapporo-like Virus | Any viral organism that can be assigned to the species Sapporo virus. | Sapporo Virus | ||
| SARS CORONAVIRUS | C112432 | HCoV-SARS;SARS;Severe Acute Respiratory Syndrome Coronavirus | Any viral organism that can be assigned to the species SARS coronavirus. | SARS Coronavirus | ||
| SERRATIA PLYMUTHICA | C86740 | Any bacterial organism that can be assigned to the species Serratia plymuthica. | Serratia plymuthica | |||
| STAPHYLOCOCCUS AUREUS | C50921 | STAPH. AUREUS | Any bacterial organism that can be assigned to the species Staphylococcus aureus. | Staphylococcus aureus | ||
| STAPHYLOCOCCUS CAPITIS | C86752 | Any bacterial organism that can be assigned to the species Staphylococcus capitis. | Staphylococcus capitis | |||
| STAPHYLOCOCCUS COHNII | C86756 | Any bacterial organism that can be assigned to the species Staphylococcus cohnii. | Staphylococcus cohnii | |||
| STREPTOCOCCUS PNEUMONIAE | C76384 | DIPLOCOCCUS PNEUMONIAE | Any bacterial organism that can be assigned to the species Streptococcus pneumoniae. | Streptococcus pneumoniae | ||
| SUTTONELLA INDOLOGENES | C86816 | KINGELLA INDOLOGENES | Any bacterial organism that can be assigned to the species Suttonella indologenes. | Suttonella indologenes | ||
| TATLOCKIA MICDADEI | C86817 | LEGIONELLA MICDADEI | Any bacterial organism that can be assigned to the species Legionella micdadei. | Tatlockia micdadei | ||
| TICK-BORNE ENCEPHALITIS VIRUS | C112422 | FSME virus;TBEV | Any viral organism that can be assigned to the species Tick-borne encephalitis virus. | Tick-Borne Encephalitis Virus | ||
| VACCINIA VIRUS | C14281 | VV | Any viral organism that can be assigned to the species Vaccinia virus. | Vaccinia Virus | ||
| VARIOLA VIRUS | C96527 | Smallpox Virus;Variola Virus VAR | Any viral organism that can be assigned to the species Variola virus. | Variola Virus | ||
| VIBRIO ALGINOLYTICUS | C86840 | Any bacterial organism that can be assigned to the species Vibrio alginolyticus. | Vibrio alginolyticus | |||
| VIBRIO PARAHAEMOLYTICUS | C86846 | Any bacterial organism that can be assigned to the species Vibrio parahaemolyticus. | Vibrio parahaemolyticus | |||
| VIBRIO VULNIFICUS | C86847 | BENECKEA VULNIFICA | Any bacterial organism that can be assigned to the species Vibrio vulnificus. | Vibrio vulnificus | ||
| WEST NILE VIRUS | C71877 | WNV | Any viral organism that can be assigned to the species West Nile virus. | West Nile Virus | ||
| YELLOW FEVER VIRUS | C97156 | Flavivirus febricis;YFV | Any viral organism that can be assigned to the species Yellow fever virus. | Yellow Fever Virus | ||
| YERSINIA PESTIS | C86860 | PASTEURELLA PESTIS | Any bacterial organism that can be assigned to the species Yersinia pestis. | Yersinia pestis | ||
| Back to top | ||||||
| CL.C66769.AESEV | Severity/Intensity Scale for Adverse Events (AESEV) | text Extensible: No | C66769 | Severity/Intensity Scale for Adverse Events | A scale that defines the degree or state of disease existing in a patient as a result of the occurrence of an adverse event. (NCI) | CDISC SDTM Severity Intensity Scale for Adverse Event Terminology |
| MILD | C41338 | 1;Grade 1 | A type of adverse event that is usually transient and may require only minimal treatment or therapeutic intervention. The event does not generally interfere with usual activities of daily living. | Mild Adverse Event | ||
| MODERATE | C41339 | 2;Grade 2 | A type of adverse event that is usually alleviated with additional specific therapeutic intervention. The event interferes with usual activities of daily living, causing discomfort but poses no significant or permanent risk of harm to the research participant. | Moderate Adverse Event | ||
| SEVERE | C41340 | 3;Grade 3 | A type of adverse event that interrupts usual activities of daily living, or significantly affects clinical status, or may require intensive therapeutic intervention. | Severe Adverse Event | ||
| Back to top | ||||||
| CL.C66731.SEX | Sex (SEX) | text Extensible: No | C66731 | Sex | The assemblage of physical properties or qualities by which male is distinguished from female; the physical difference between male and female; the distinguishing peculiarity of male or female. (NCI) | CDISC SDTM Sex of Individual Terminology |
| F | C16576 | Female | A person who belongs to the sex that normally produces ova. The term is used to indicate biological sex distinctions, or cultural gender role distinctions, or both. (NCI) | Female | ||
| M | C20197 | Male | A person who belongs to the sex that normally produces sperm. The term is used to indicate biological sex distinctions, cultural gender role distinctions, or both. (NCI) | Male | ||
| U | C17998 | U;Unknown | Not known, not observed, not recorded, or refused. (NCI) | Unknown | ||
| UNDIFFERENTIATED | C45908 | A person (one of unisexual specimens) who is born with genitalia and/or secondary sexual characteristics of indeterminate sex, or which combine features of both sexes. (NCI) | Intersex | |||
| Back to top | ||||||
| CL.C66732.SEXPOP | Sex of Participants (SEXPOP) | text Extensible: No | C66732 | Sex of Participants | The specific sex, either male, female, or mixed of the subject group being studied. (NCI) | CDISC SDTM Sex of Study Group Terminology |
| BOTH | C49636 | One and the other; relating to or being two in conjunction. (NCI) | Both | |||
| F | C16576 | Female | A person who belongs to the sex that normally produces ova. The term is used to indicate biological sex distinctions, or cultural gender role distinctions, or both. (NCI) | Female | ||
| M | C20197 | Male | A person who belongs to the sex that normally produces sperm. The term is used to indicate biological sex distinctions, cultural gender role distinctions, or both. (NCI) | Male | ||
| Back to top | ||||||
| CL.C66733.SIZE | Size (SIZE) | text Extensible: Yes | C66733 | Size | The physical magnitude of something. (NCI) | CDISC SDTM Size Terminology |
| LARGE | C49508 | Of considerable or relatively great size, extent, or capacity. (NCI) | Large | |||
| MEDIUM | C49507 | Mid-way between small and large in number, quantity, magnitude or extent. (NCI) | Medium | |||
| SMALL | C25376 | Limited in number, quantity, magnitude or extent. (NCI) | Small | |||
| Back to top | ||||||
| CL.C76351.SKINCLAS | Skin Classification (SKINCLAS) | text Extensible: Yes | C76351 | Skin Classification | A classification system used to categorize the sensitivity of a subject's skin to sunlight. | CDISC Skin Classification Terminology |
| TYPEI | C74569 | TYPE1 | Individuals who never tan and always sunburn if exposed to any appreciable amount of sunlight, primarily red headed individuals and lightly complected blondes. (Reference: Fitzpatrick TB: The validity and practicality of sun-reactive skin types I through VI. Arch. Dermatol. 1998 124: 869-871) | Fitzpatrick Skin Type I | ||
| TYPEII | C74570 | TYPE2 | Individuals who frequently burn but are able to tan to a small degree after extended sun exposure. (Reference: Fitzpatrick TB: The validity and practicality of sun-reactive skin types I through VI. Arch. Dermatol. 1998 124: 869-871) | Fitzpatrick Skin Type II | ||
| TYPEIII | C74571 | TYPE3 | Individuals who burn infrequently and tan readily. (Reference: Fitzpatrick TB: The validity and practicality of sun-reactive skin types I through VI. Arch. Dermatol. 1998 124: 869-871) | Fitzpatrick Skin Type III | ||
| TYPEIV | C74572 | TYPE4 | Individuals who rarely burn and tan heavily with moderate sun exposures, especially individuals of Asian, American Indian, Mediterranean and Latin American descent. (Reference: Fitzpatrick TB: The validity and practicality of sun-reactive skin types I through VI. Arch. Dermatol. 1998 124: 869-871) | Fitzpatrick Skin Type IV | ||
| TYPEV | C74573 | TYPE5 | Individuals who have dark constitutive pigmentation but become noticeably darker with sun exposure, especially light complected black individuals, those of Indian descent. (Reference: Fitzpatrick TB: The validity and practicality of sun-reactive skin types I through VI. Arch. Dermatol. 1998 124: 869-871) | Fitzpatrick Skin Type V | ||
| TYPEVI | C74574 | TYPE6 | Individuals who have the heaviest constitutive pigmentation, especially dark skinned black individuals. (Reference: Fitzpatrick TB: The validity and practicality of sun-reactive skin types I through VI. Arch. Dermatol. 1998 124: 869-871) | Fitzpatrick Skin Type VI | ||
| Back to top | ||||||
| CL.C112024.SRTESTCD | Skin Response Test Code (SRTESTCD) | text Extensible: Yes | C112024 | Skin Response Test Code | A terminology codelist based on the test codes for dermal responses to antigens. | CDISC SDTM Skin Response Test Code Terminology |
| ASRINDEX | C112221 | Allergen Skin Response Index | A relative measurement (ratio or percentage) of the allergen wheal size to the positive control wheal size in an allergen skin test. | Allergen Skin Response Index | ||
| ASRINT | C112222 | Allergen Skin Response Intensity | A semi-quantitative assessment of the intensity of the wheal and flare reaction. | Allergen Skin Response Intensity | ||
| FLARESZ | C112283 | Flare Size | The size of the area of redness that forms around the site of an antigenic challenge to the skin. | Flare Size | ||
| FLRLDIAM | C112281 | Flare Longest Diameter | The longest diameter of the area of redness that forms around the site of an antigenic challenge to the skin. | Flare Longest Diameter | ||
| FLRMDIAM | C112282 | Flare Mean Diameter | The mean diameter of the area of redness that forms around the site of an antigenic challenge to the skin. | Flare Mean Diameter | ||
| WHEALSZ | C112429 | Wheal Size | A semi-quantitative size assessment of the flat, circular, slightly raised area that forms around the site of an antigenic challenge to the skin. | Wheal Size | ||
| WHLLDIAM | C112427 | Wheal Longest Diameter | The longest diameter of the flat, circular, slightly raised area that forms around the site of an antigenic challenge to the skin. | Wheal Longest Diameter | ||
| WHLMDIAM | C112428 | Wheal Mean Diameter | The mean diameter of the flat, circular, slightly raised area that forms around the site of an antigenic challenge to the skin. | Wheal Mean Diameter | ||
| Back to top | ||||||
| CL.C112023.SRTEST | Skin Response Test Name (SRTEST) | text Extensible: Yes | C112023 | Skin Response Test Name | A terminology codelist based on the test names for dermal responses to antigens. | CDISC SDTM Skin Response Test Name Terminology |
| Allergen Skin Response Index | C112221 | Allergen Skin Response Index | A relative measurement (ratio or percentage) of the allergen wheal size to the positive control wheal size in an allergen skin test. | Allergen Skin Response Index | ||
| Allergen Skin Response Intensity | C112222 | Allergen Skin Response Intensity | A semi-quantitative assessment of the intensity of the wheal and flare reaction. | Allergen Skin Response Intensity | ||
| Flare Longest Diameter | C112281 | Flare Longest Diameter | The longest diameter of the area of redness that forms around the site of an antigenic challenge to the skin. | Flare Longest Diameter | ||
| Flare Mean Diameter | C112282 | Flare Mean Diameter | The mean diameter of the area of redness that forms around the site of an antigenic challenge to the skin. | Flare Mean Diameter | ||
| Flare Size | C112283 | Flare Size | The size of the area of redness that forms around the site of an antigenic challenge to the skin. | Flare Size | ||
| Wheal Longest Diameter | C112427 | Wheal Longest Diameter | The longest diameter of the flat, circular, slightly raised area that forms around the site of an antigenic challenge to the skin. | Wheal Longest Diameter | ||
| Wheal Mean Diameter | C112428 | Wheal Mean Diameter | The mean diameter of the flat, circular, slightly raised area that forms around the site of an antigenic challenge to the skin. | Wheal Mean Diameter | ||
| Wheal Size | C112429 | Wheal Size | A semi-quantitative size assessment of the flat, circular, slightly raised area that forms around the site of an antigenic challenge to the skin. | Wheal Size | ||
| Back to top | ||||||
| CL.C74561.SKINTYP | Skin Type (SKINTYP) | text Extensible: Yes | C74561 | Skin Type | A distinctive characteristic of the skin marked by the amount of sebum secreted by sebaceous glands. | CDISC SDTM Skin Type Terminology |
| DRY | C74592 | The pores are generally fine with a papery thin texture that feels dry to the touch. Usually flaky and dull looking. | Dry Skin | |||
| NORMAL | C74593 | The pores are visible but not large. The texture is neither fine or thick and it neither feels dry or oily to the touch. | Normal Skin | |||
| OILY | C74591 | The pores of the skin are generally large and visible with a coarse or thick texture. It has a tendency to look dull and greasy and feels oily to the touch. | Oily Skin | |||
| Back to top | ||||||
| CL.C102587.RISKSOC | Social Risk Factor (RISKSOC) | text Extensible: Yes | C102587 | Social Risk Factor | Terminology relevant to the social factors such as personal behavior, lifestyle, or environment belonging to the subject which are known to increase the likelihood of infection and disease. | CDISC SDTM Social Risk Factor Terminology |
| CONTACT WITH TUBERCULOSIS SOURCE | C102714 | An individual that came into contact with a source of Tuberculosis. | Subject in Contact With Tuberculosis Source | |||
| CURRENT OR RECENT EMPLOYEE OR VOLUNTEER IN HOMELESS SHELTER | C102613 | An individual who is presently or not long ago worked or offered to assist without pay at a temporary housing facility for persons without a stable or permanent residence. | Current or Recent Employee or Volunteer in Homeless Shelter | |||
| CURRENT OR RECENT EMPLOYEE OR VOLUNTEER IN JAIL OR PRISON | C102614 | An individual who is presently or not long ago worked or offered to assist without pay at an institution where persons are confined for punishment and to protect the public. | Current or Recent Employee or Volunteer in Jail or Prison | |||
| CURRENT OR RECENT EMPLOYEE OR VOLUNTEER IN NURSING HOME | C102615 | An individual who is presently or not long ago worked or offered to assist without pay at a residential health care facility for persons with chronic illness or disability. | Current or Recent Employee or Volunteer in Nursing Home | |||
| HOMELESS DURING PAST YEAR | C102645 | An individual without a stable or permanent residence within the last 365 days. | Homeless During Past Year | |||
| IMMIGRANT FROM HIGH TUBERCULOSIS PREVALENT AREA | C102648 | An individual that has migrated from a country with a high occurrence of tuberculosis. | Immigrant From High Tuberculosis Prevalent Area | |||
| INCARCERATION | C85521 | The state of being confined to jail or prison. | Incarceration | |||
| LIVED IN REFUGEE CAMP | C102657 | An individual that resided in a camp for those displaced from their homeland. | Lived in Refugee Camp | |||
| LONG-TERM FACILITY RESIDENT | C102660 | An individual that lives at a healthcare facility that provides rehabilitative, restorative, and/or ongoing skilled nursing care to patients or residents in need of assistance with activities of daily living. | Long-term Facility Resident | |||
| MIGRATORY WORKER | C102670 | An individual who moves from one location to another location within or outside of their homeland for work. | Migratory Worker | |||
| REFUGEE FROM HIGH TUBERCULOSIS PREVALENT AREA | C102705 | An individual that has fled a country for their own safety which has a high occurrence of tuberculosis. | Refugee From High Tuberculosis Prevalent Area | |||
| TRAVEL TO HIGH BURDEN COUNTRY | C102719 | Entry into one or more of the 22 countries that have a relatively high prevalence of tuberculosis cases. | Travel To High Burden Tuberculosis Country | |||
| UNEMPLOYMENT | C75563 | The state of not having a job. | Unemployment | |||
| Back to top | ||||||
| CL.C78733.SPECCOND | Specimen Condition (SPECCOND) | text Extensible: Yes | C78733 | Specimen Condition | The physical state or quality of a biological specimen. | CDISC SDTM Specimen Condition Terminology |
| AUTOLIZED | C78725 | Autolized Specimen | A specimen that has undergone autolysis, or self-digestion by the specimen's own digestive enzymes. (NCI) | Autolized Specimen | ||
| CALCIFIED | C78723 | Calcified Specimen | A specimen that has undergone calcification. (NCI) | Calcified Specimen | ||
| CLOTTED | C78724 | Clotted Specimen | A specimen that has become coagulated. (NCI) | Clotted Specimen | ||
| CONTAMINATED | C68768 | The presence of any substance or organism that makes a preparation impure. (NCI) | Contamination | |||
| DRIED | C84516 | Dried Specimen | A specimen that has become dessicated or dehydrated. | Dried Specimen | ||
| FRESH | C84517 | Fresh Specimen | A specimen that is analyzed in the state that it was collected. | Fresh Specimen | ||
| FROZEN | C70717 | Frozen Specimen | A specimen that has been subjected to and immobilized by severe cold. (NCI) | Frozen Specimen | ||
| HEMOLYZED | C70720 | Hemolysis in Specimen | A specimen that has undergone the destruction of red blood cells followed by the release of the hemoglobin. (NCI) | Hemolysis in Specimen | ||
| ICTERIC | C98744 | Icteric Specimen | A specimen that exhibits a yellowish pigmentation due to jaundice. (NCI) | Icteric Specimen | ||
| LIPEMIC | C70715 | Lipemic Specimen | A specimen that consists of or contains excessive amounts of fat and fatty substances. (NCI) | Lipemic Specimen | ||
| PARAFFIN-EMBEDDED | C19597 | Paraffin Block;Paraffin-Embedded Specimen | A specimen that has been fixed and preserved in paraffin. | Paraffin Embedded Tissue | ||
| REFRIGERATED | C70718 | Refrigerated Specimen | A specimen that has been kept or preserved at a low temperature in a refrigerator. (NCI) | Refrigerated Specimen | ||
| ROOM TEMPERATURE | C70719 | Ambient Temperature;Specimen at Room Temperature | A specimen that has been subjected to and adjusted to the average ambient temperature of a room, usually considered to be around 20 degrees C (68 degrees F). (NCI) | Specimen at Room Temperature | ||
| Back to top | ||||||
| CL.C78734.SPECTYPE | Specimen Type (SPECTYPE) | text Extensible: Yes | C78734 | Specimen Type | The name and description of a biological specimen. | CDISC SDTM Specimen Type Terminology |
| ADIPOSE TISSUE | C12472 | Adipose Tissue;Body Fat;Fat Tissue | A specialized form of connective tissue consisting primarily of adipocytes (fat cells), surrounded by a meshwork of collagen fibers. (NCI) | Adipose Tissue | ||
| AMNIOTIC FLUID | C13188 | Aqua Amnii | The fluid within the amniotic cavity which surrounds and protects the developing embryo. (NCI) | Amniotic Fluid | ||
| AQUEOUS HUMOR | C13190 | Aqueous Humour | The watery fluid which is present in the anterior and posterior chambers of the eye. (NCI) | Aqueous Humor | ||
| ARTERIAL BLOOD | C78729 | Oxygenated blood which is transported with nutrients to body tissues through the arterial system. The exception is blood within the pulmonary artery which carries deoxygenated blood to the lungs. (NCI) | Arterial Blood | |||
| ATHEROSCLEROTIC PLAQUE | C78739 | Fatty tissue which is deposited in the inner lining of the arterial wall. (NCI) | Atherosclerotic Plaque | |||
| BILE | C13192 | Fluid composed of waste products, bile acids, salts, cholesterol, and electrolytes. It is secreted by the liver parenchyma and stored in the gallbladder. (NCI) | Bile | |||
| BLOOD | C12434 | Blood;Peripheral Blood | A liquid tissue with the primary function of transporting oxygen and carbon dioxide. It supplies the tissues with nutrients, removes waste products, and contains various components of the immune system defending the body against infection. | Blood | ||
| BONE | C12366 | Bone | Calcified connective tissue that forms the skeletal components of the body. (NCI) | Bone | ||
| BONE MARROW | C12431 | Bone Marrow | The tissue occupying the spaces of bone. It consists of blood vessel sinuses and a network of hematopoietic cells which give rise to the red cells, white cells, and megakaryocytes. (NCI) | Bone Marrow | ||
| BREAST MILK | C13257 | Milk produced by females for the purpose of feeding their young. (NCI) | Breast Milk | |||
| BUFFY COAT | C84507 | The middle fraction of an anticoagulated blood specimen following separation by centrifugation. It contains most of the white blood cells and platelets. | Buffy Coat | |||
| CALCULUS | C35708 | Accumulated material from the secretions of an organ. It is solid and representative examples include gallbladder stones, kidney stones, and salivary gland stones. (NCI) | Stone | |||
| CAPILLARY BLOOD | C112235 | A mixture of arterial blood, venous blood and interstitial fluid, which is found in the capillaries. | Capillary Blood | |||
| CARDIAC MUSCLE TISSUE | C12371 | Myocardium | The striated muscle tissue of the heart enveloped by the epicardium and the endocardium. (NCI) | Myocardium | ||
| CEREBROSPINAL FLUID | C12692 | CSF | The fluid that is contained within the brain ventricles, the subarachnoid space and the central canal of the spinal cord. (NCI) | Cerebrospinal Fluid | ||
| CERUMEN | C32293 | A wax secreted by glands in the ear canal. | Cerumen | |||
| CIRCULATING TUMOR CELL | C63797 | CTC | A metastatic cancer cell found in the peripheral blood. (NCI) | Circulating Tumor Cell | ||
| COLOSTRUM | C32348 | A thick, protein-rich substance secreted by the breasts during the second half of pregnancy and for a few days after birth before the breast milk comes in. | Human Colostrum | |||
| CORD BLOOD | C13300 | Umbilical Cord Blood | Blood present in the umbilical vessels at the time of delivery. | Umbilical Cord Blood | ||
| CORD SERUM | C119550 | The clear portion of the blood that remains after the removal of the blood cells and the clotting proteins from the cord blood of a newborn baby. | Umbilical Cord Serum | |||
| DIALYSIS FLUID | C106515 | Dialysate | The fluid which runs through a dialysis machine and captures, for discard or analysis, the excess water and waste from the blood stream through diffusion and ultrafiltration. (NCI) | Dialysis Fluid | ||
| EMESIS | C77666 | Emesis;Vomit | Stomach contents that have returned to the mouth or are ejected beyond the mouth. (NCI) | Vomitus | ||
| ERYTHROCYTES | C12521 | RBC;Red Blood Cells | Cell specialized for oxygen transport, having a high concentration of hemoglobin in the cytoplasm and little else; biconcave, anucleate discs, 7nm diameter in mammals. | Erythrocyte | ||
| EXPIRED AIR | C78741 | The air that moves out of the chest during expiration. It contains a higher percentage of carbon dioxide and a lower percentage of oxygen compared to the inhaled air. (NCI) | Expired Air | |||
| EXUDATE | C13233 | Fluid, cells or cellular debris that escapes from the blood vessels and accumulates in nearby tissues. It is the result of inflammation and is rich in proteins. | Exudate | |||
| FLUID | C13236 | Liquid substances produced by the body. | Body Fluid or Substance | |||
| GASTRIC CONTENTS | C77614 | Digestive Contents;Ingesta | The contents of the stomach that may include undigested food mixed with juices secreted by the gastric mucosal glands. (NCI) | Gastric Content | ||
| HAIR | C32705 | Hair | The filamentous outgrowth of the epidermis. (NCI) | Hair | ||
| HAIR FOLLICLE | C13317 | A tube-like invagination of the epidermis from which the hair shaft develops and into which the sebaceous glands open; the follicle is lined by a cellular inner and outer root sheath of epidermal origin and is invested with a fibrous sheath derived from the dermis. (NCI) | Hair Follicle | |||
| INFRANATANT, PLASMA | C106554 | The liquid, solid or semi-solid lying below a liquid residue, which is separated by crystallization, precipitation or centrifugation of a plasma sample. (NCI) | Plasma Infranatant | |||
| INFRANATANT, PLEURAL FLUID | C106558 | The liquid, solid or semi-solid lying below a liquid residue, which is separated by crystallization, precipitation or centrifugation of a pleural fluid sample. (NCI) | Pleural Fluid Infranatant | |||
| INFRANATANT, SERUM | C106565 | The liquid, solid or semi-solid lying below a liquid residue, which is separated by crystallization, precipitation or centrifugation of a serum sample. (NCI) | Serum Infranatant | |||
| ISOLATE | C53471 | Microbial Isolate | A specific individual microbe and its genetically identical progeny separated on a single occasion from a sample taken from a host or culture system. | Isolate | ||
| LAVAGE FLUID | C103411 | Fluid introduced into, and collected from, a body cavity by lavage procedure. (NCI) | Lavage Fluid | |||
| LOCHIA | C78742 | Vaginal discharge occurring during the post-partum period. It consists of a mixture of blood, mucus, and placental remnants. (NCI) | Lochia | |||
| LUNG SURFACTANT | C13273 | Surfactant | Pulmonary surfactant lines the lung epithelium and lowers surface tension to prevent collapse at end-expiration. Deficiency of pulmonary surfactant results in respiratory distress syndrome (RDS) in premature infants. Lung surfactant is synthesized in alveolar type II cells, stored in lamellar bodies and secreted via exocytosis. (NCI) | Lung Surfactant | ||
| LYMPH | C13252 | A clear, transparent, sometimes faintly yellow and slightly opalescent fluid that is collected from the tissues throughout the body, flows in the lymphatic vessels (through the lymph nodes), and is eventually added to the venous blood circulation. Lymph consists of a clear liquid portion, varying numbers of white blood cells (chiefly lymphocytes), and a few red blood cells. (NCI) | Lymph | |||
| LYSATE | C62004 | The cellular debris and fluid produced by lysis of cells. | Lysate | |||
| MECONIUM | C78743 | The newborn's first intestinal discharge. It is a dark-green, thick substance composed of mucus, intestinal secretions, hair, and intestinal mucosa cells. (NCI) | Meconium | |||
| MENSTRUAL BLOOD | C78740 | The discharged blood from the uterus during the reproductive years. The discharge occurs approximately once a month. (NCI) | Menstrual Blood | |||
| MUCUS | C13259 | The thick fluid secreted by the mucus glands in the aerodigestive tract and the vagina. (NCI) | Mucus | |||
| NAIL | C33156 | Nail | The cutaneous plate on the dorsal surface of the distal end of a finger or toe. (NCI) | Nail | ||
| PERIPHERAL BLOOD MONONUCLEAR CELL | C12954 | PBMC | A peripheral blood cell with a single nucleus, for example lymphocytes and monocytes. | Peripheral Blood Mononuclear Cell | ||
| PERSPIRATION | C13280 | Sweat | The liquid secreted by the sweat glands. (NCI) | Sweat | ||
| PLASMA | C13356 | Plasma is the fluid (acellular) portion of the circulating blood, as distinguished from the serum that is the fluid portion of the blood obtained by removal of the fibrin clot and blood cells after coagulation. | Plasma | |||
| PLATELET | C12520 | Thrombocyte | An irregular, disc-shaped structure in the blood that assists in blood clotting. Platelets are not blood cells, they are fragments of large bone marrow cells called megakaryocytes. (NCI) | Platelet | ||
| PLATELET POOR PLASMA | C106556 | PPP | A plasma sample that is prepared from whole blood, which has undergone a number of centrifugation steps to decrease the amount of platelets. (NCI) | Platelet-poor Plasma | ||
| PLATELET RICH PLASMA | C106557 | PRP | A plasma sample that is prepared from whole blood, which has undergone a number of centrifugation steps to concentrate the amount of platelets. (NCI) | Platelet-rich Plasma | ||
| PLEURAL FLUID | C77613 | Pleural Fluid | The fluid that is abnormally collected in the pleural cavity. (NCI) | Pleural Fluid | ||
| PROSTATIC FLUID | C100896 | A slightly alkaline, white fluid secreted from the prostate and is a constituent of semen. | Prostatic Fluid | |||
| PUS | C50718 | A yellowish substance produced during bacterial inflammation. It contains necrotic cells and cells fighting the infection. (NCI) | Pus | |||
| SALIVA | C13275 | A clear liquid secreted into the mouth by the salivary glands and mucous glands of the mouth; moistens the mouth and starts the digestion of starches. (NCI) | Saliva | |||
| SEBUM | C13276 | A thick, oily substance produced by the sebaceous glands located in the dermis. (NCI) | Sebum | |||
| SEMEN | C13277 | Seminal Plasma | The thick, whitish secretion of the male reproductive organs. It is composed of spermatozoa in their nutrient plasma, secretions from the prostate, seminal vesicles, and various other glands, epithelial cells, and minor constituents. (NCI) | Semen | ||
| SEMINAL FLUID | C33529 | Part of the ejaculated fluid. It contains secretions from the seminal vesicles, Cowper gland, and prostate gland. | Seminal Fluid | |||
| SERUM | C13325 | Sera | The clear portion of the blood that remains after the removal of the blood cells and the clotting proteins. (NCI) | Serum | ||
| SKELETAL MUSCLE TISSUE | C13050 | Skeletal Muscle Tissue | Striated muscles that are under voluntary control of the organism. They are connected at either or both ends to a bone and are utilized for locomotion and other movements. (NCI) | Skeletal Muscle Tissue | ||
| SMEGMA | C33574 | A white secretion of the sebaceous glands of the foreskin. (NCI) | Smegma | |||
| SMOOTH MUSCLE TISSUE | C12437 | Involuntary muscle tissue of the internal organs. It is composed of elongated muscle cells or fibers that are not arranged in a striated pattern and form layers of muscle tissue. The smooth muscle cells contain a contractile apparatus composed of thin and thick filaments and a cytoskeleton composed of intermediate filaments. (NCI) | Smooth Muscle Tissue | |||
| SOFT TISSUE | C12471 | Soft Tissue | Refers to muscle, fat, fibrous tissue, blood vessels or other supporting tissue of the body. | Soft Tissue | ||
| SPUTUM | C13278 | Material containing mucus, cellular debris, microorganisms and sometimes blood or pus. It is ejected through the mouth from the lungs, bronchi, and trachea. (NCI) | Sputum | |||
| STOOL | C13234 | Feces | The material discharged from the bowel during defecation. It consists of undigested food, intestinal mucus, epithelial cells, and bacteria. (NCI) | Feces | ||
| STRIATED MUSCLE TISSUE | C12436 | Striated muscles are appendicular and axial muscles typically connected at either or both ends to the bony skeleton of the body. Striated muscle fibers contain a highly organized, contractile cytoskeletal apparatus with a striated microscopic appearance; muscle contraction is typically under voluntary control. (NCI) | Striated Muscle Tissue | |||
| SUPERNATANT, PLASMA | C106555 | The liquid lying above a liquid, solid or semi-solid residue, which is separated by crystallization, precipitation or centrifugation of a plasma sample. (NCI) | Plasma Supernatant | |||
| SUPERNATANT, PLEURAL FLUID | C106559 | The liquid lying above a liquid, solid or semi-solid residue, which is separated by crystallization, precipitation or centrifugation of a pleural fluid sample. (NCI) | Pleural Fluid Supernatant | |||
| SUPERNATANT, SERUM | C106566 | The liquid lying above a liquid, solid or semi-solid residue, which is separated by crystallization, precipitation or centrifugation of a serum sample. (NCI) | Serum Supernatant | |||
| SYNOVIAL FLUID | C33718 | Synovia;Synovial Fluid | A viscid fluid secreted by the synovial membrane, serving as a lubricant. (NCI) | Synovial Fluid | ||
| TISSUE | C12801 | An anatomical structure consisting of similarly specialized cells and intercellular matrix, aggregated according to genetically determined spatial relationships, performing a specific function. (NCI) | Tissue | |||
| TRANSUDATE | C78744 | The fluid that passes through the wall of the veins and capillaries to the surrounding tissues because of increased intravascular pressure. It has low protein content. (NCI) | Transudate | |||
| TUMOR TISSUE | C18009 | A tumor sample, or entire tumor that is removed for examination. | Tumor Tissue | |||
| URINE | C13283 | The fluid that is excreted by the kidneys. It is stored in the bladder and discharged through the urethra. (NCI) | Urine | |||
| VENOUS BLOOD | C78730 | Deoxygenated blood containing urea and other waste products which is transported through the venous system to the heart and lungs. The exception is blood within the pulmonary vein which is oxygenated and travels from the lungs to the left atrium of the heart. (NCI) | Venous Blood | |||
| VITREOUS HUMOR | C13323 | The clear colorless transparent jelly that fills the posterior chamber of the eyeball. (NCI) | Vitreous Humor | |||
| Back to top | ||||||
| CL.C119020.STCARCRS | Stent Thrombosis, Coronary ARC Grade Responses (STCARCRS) | text Extensible: No | C119020 | Stent Thrombosis, Coronary ARC Grade Responses | A terminology codelist relevant to the Academic Research Council grade for the probability that coronary artery stent thrombosis has occurred. | CDISC SDTM ARC Coronary Stent Thrombosis Grade Responses Terminology |
| STENT THROMBOSIS ARC GRADE DEFINITE | C119598 | Includes acute ischemic symptoms at rest, acute post ischemic ECG, positive biomarkers and pathological evidence. Definite stent thrombosis is considered to have occurred when there is either angiographic or pathological confirmation. Angiographic confirmation is the presence of a thrombus at coronary angiography that originates in the stent or in the segment 5 mm proximal or distal to the stent, with the presence of at least 1 of 3 clinical criteria within a 48-hour time window: 1) acute onset of ischemic symptoms at rest; 2) new ischemic ECG changes that suggest acute ischemia; or 3) typical rise and fall in cardiac biomarkers. Pathological confirmation is evidence of recent thrombus within the stent determined at autopsy or via examination of tissue retrieved following thrombectomy. (Cutlip DE, Windecker S, Mehran R, et al. Clinical End Points in Coronary Stent Trials : A Case for Standardized Definitions. Circulation. 2007;115:2344-2351) | ARC Definite Stent Thrombosis | |||
| STENT THROMBOSIS ARC GRADE POSSIBLE | C119600 | Possible stent thrombosis is considered to have occurred with any unexplained death more than 30 days after intracoronary stenting. (Cutlip DE, Windecker S, Mehran R, et al. Clinical End Points in Coronary Stent Trials : A Case for Standardized Definitions. Circulation. 2007;115:2344-2351) | ARC Possible Stent Thrombosis | |||
| STENT THROMBOSIS ARC GRADE PROBABLE | C119599 | Includes death within 30 days and myocardial infarction of stent territory. Probable stent thrombosis is considered to have occurred after intracoronary stenting in the following situations: 1) any unexplained death within the first 30 days; or 2) irrespective of the time after the index procedure, any MI that is related to documented acute ischemia in the territory of the implanted stent without angiographic confirmation of stent thrombosis and in the absence of any other obvious cause. (Cutlip DE, Windecker S, Mehran R, et al. Clinical End Points in Coronary Stent Trials : A Case for Standardized Definitions. Circulation. 2007;115:2344-2351) | ARC Probable Stent Thrombosis | |||
| Back to top | ||||||
| CL.C119019.STCTIMRS | Stent Thrombosis, Coronary, ARC Timing Responses (STCTIMRS) | text Extensible: No | C119019 | Stent Thrombosis, Coronary, ARC Timing Responses | A terminology codelist relevant to the Academic Research Council grade for the timing of the stent thrombosis after stent implantation. | CDISC SDTM ARC Coronary Stent Thrombosis Timing Terminology |
| STENT THROMBOSIS ARC ACUTE | C119594 | 0 to 24 hours after stent implantation. (Cutlip DE, Windecker S, Mehran R, et al. Clinical Endpoints in Coronary Stent Trials : A Case for Standardized Definitions. Circulation. 2007;115:2344-2351) | ARC Stent Thrombosis Timing Acute | |||
| STENT THROMBOSIS ARC LATE | C119596 | Greater than 30 days to 1 year after stent implantation. (Cutlip DE, Windecker S, Mehran R, et al. Clinical Endpoints in Coronary Stent Trials : A Case for Standardized Definitions. Circulation. 2007;115:2344-2351) | ARC Stent Thrombosis Timing Late | |||
| STENT THROMBOSIS ARC SUBACUTE | C119595 | Greater than 24 hours to 30 days after stent implantation. (Cutlip DE, Windecker S, Mehran R, et al. Clinical Endpoints in Coronary Stent Trials : A Case for Standardized Definitions. Circulation. 2007;115:2344-2351) | ARC Stent Thrombosis Timing Subacute | |||
| STENT THROMBOSIS ARC VERY LATE | C119597 | Greater than 1 year after stent implantation. (Cutlip DE, Windecker S, Mehran R, et al. Clinical Endpoints in Coronary Stent Trials : A Case for Standardized Definitions. Circulation. 2007;115:2344-2351) | ARC Stent Thrombosis Timing Very Late | |||
| Back to top | ||||||
| CL.C99077.STYPE | Study Type (STYPE) | text Extensible: No | C99077 | Study Type | Describes the role the study plays in determining the interventions a subject receives. | CDISC SDTM Study Type Terminology |
| EXPANDED ACCESS | C98722 | Studies that provide a means for obtaining an experimental drug or device for patients who are not adequately treated by existing therapy, who do not meet the eligibility criteria for enrollment, or who are otherwise unable to participate in another clinical study. Expanded Access studies include individual-patient IND, treatment IND, compassionate use, emergency use or continued access. | Expanded Access Study | |||
| INTERVENTIONAL | C98388 | Studies in which individuals are assigned by an investigator based on a protocol to receive specific interventions. Subjects may receive diagnostic, therapeutic or other types of interventions. The assignment of the intervention may or may not be random. The individuals are then followed and biomedical and/or health outcomes are assessed. | Interventional Study | |||
| OBSERVATIONAL | C16084 | Studies in which biomedical and/or health outcomes are assessed in pre-defined groups of individuals. Subjects in the study may receive diagnostic, therapeutic, or other interventions, but the investigator does not assign specific interventions to the subjects of the study. | Observational Study | |||
| Back to top | ||||||
| CL.C74559.SCTESTCD | Subject Characteristic Test Code (SCTESTCD) | text Extensible: Yes | C74559 | Subject Characteristic Test Code | The test code representing each subject characteristic. | CDISC SDTM Subject Characteristic Test Code Terminology |
| BRFEDIND | C112233 | Breast Fed Indicator | An indication as to whether the subject was breast fed (received mother's milk) as an infant. | Breast Fed Indicator | ||
| CNTCINV | C102625 | Contact Investigation | A public health activity whereby individuals who have been exposed to a person with a suspected or confirmed contagious illness are identified, usually for the purpose of identifying additional cases of the illness, or to offer some form of prophylactic intervention to either prevent or ameliorate disease in the exposed individual. | Disease Contact Investigation | ||
| CTRYDDTC | C102631 | Entry Date from Ptntl Cntry Disease Exp | The date on which the subject arrived in the reporting country from the country of potential disease exposure. | Entry Date from Country of Potential Disease Exposure | ||
| CTRYDEXP | C102612 | Country of Potential Disease Exposure | System of classification based on the nation in which an individual was exposed to a disease, regardless of the nation in which he/she currently resides. | Country of Potential Disease Exposure | ||
| EDLEVEL | C17953 | Education Level | Years of education that a person has completed. | Education Level | ||
| EMPJOB | C25193 | Employee Job | A code specifying the job performed by the employee for the employer. For example, accountant, programmer analyst, patient care associate, staff nurse, etc. | Occupation | ||
| HANDDOM | C114182 | Dominant Hand | The preferred hand of use for controlled and efficient performance of motor tasks. | Dominant Hand | ||
| JOBCLAS | C74565 | Employee Job Class | A code qualifying the employment in various ways, such as, full-time vs. part time, etc. | Employee Job Class | ||
| MARISTAT | C25188 | Marital Status | A demographic parameter indicating a person's current conjugal status. | Marital Status | ||
| NATORIG | C28407 | National Origin | System of classification based on nation from which a person originates, regardless of the nation in which he/she currently resides. | National Origin | ||
| PREMBRTH | C112400 | Premature Birth Indicator | An indication as to whether the subject was born prior to 38 weeks gestation. | Premature Birth Indicator | ||
| PRICON | C102699 | Priority of Disease Contact | The categorization of individuals with or without the potential for having a particular disease. | Priority of Disease Contact | ||
| RISKPOP | C102666 | Member of High Risk Population | An indication that a subject is part of a population group that has a greater chance of contracting a disease or disorder. | Member Of High Risk Population | ||
| RISKSOC | C102711 | Social Risk Factor | Social factors such as personal behavior, lifestyle, or environment belonging to the subject which are known to increase the likelihood of infection and disease. | Social Risk Factor | ||
| SALTYP | C74566 | Employee Salary Type | A code specifying the method used by the employer to compute the employee's salary or wages. For example, hourly, annual, or commission. | Employee Salary Type | ||
| SETCON | C102708 | Setting of Contact | The environment within which the person may have come into contact with a disease carrier, or played the role of a disease carrier. | Setting of Disease Contact | ||
| SKINCLAS | C74563 | Skin Classification | A classification system used to categorize the sensitivity of a subject's skin to sunlight. | Fitzpatrick Classification Scale | ||
| SKINTYP | C74580 | Skin Type | A distinctive characteristic of the skin marked by the amount of sebum secreted by sebaceous glands. | Skin Type | ||
| SRCCSINV | C102713 | Source Case Investigation | A public health activity for the determination of who transmitted a disease to another subject and whether this person: is still infectious; was reported to the health department as a disease case or suspect; or has infected others. | Source Case Investigation | ||
| SYMPTOM | C4876 | Symptom | Subjective evidence of disease perceived by the patient. | Symptom | ||
| TWINTYP | C112424 | Twin Type | The classification of the two offspring born from the same pregnancy. | Twin Type | ||
| TYPCON | C102723 | Type of Contact | Identification and clinical investigation of disease contacts. | Type of Contagion Contact | ||
| Back to top | ||||||
| CL.C103330.SCTEST | Subject Characteristic Test Name (SCTEST) | text Extensible: Yes | C103330 | Subject Characteristic Test Name | The test name representing each subject characteristic. | CDISC SDTM Subject Characteristic Test Name Terminology |
| Breast Fed Indicator | C112233 | Breast Fed Indicator | An indication as to whether the subject was breast fed (received mother's milk) as an infant. | Breast Fed Indicator | ||
| Contact Investigation | C102625 | Contact Investigation | A public health activity whereby individuals who have been exposed to a person with a suspected or confirmed contagious illness are identified, usually for the purpose of identifying additional cases of the illness, or to offer some form of prophylactic intervention to either prevent or ameliorate disease in the exposed individual. | Disease Contact Investigation | ||
| Country of Potential Disease Exposure | C102612 | Country of Potential Disease Exposure | System of classification based on the nation in which an individual was exposed to a disease, regardless of the nation in which he/she currently resides. | Country of Potential Disease Exposure | ||
| Dominant Hand | C114182 | Dominant Hand | The preferred hand of use for controlled and efficient performance of motor tasks. | Dominant Hand | ||
| Education Level | C17953 | Education Level | Years of education that a person has completed. | Education Level | ||
| Employee Job | C25193 | Employee Job | A code specifying the job performed by the employee for the employer. For example, accountant, programmer analyst, patient care associate, staff nurse, etc. | Occupation | ||
| Employee Job Class | C74565 | Employee Job Class | A code qualifying the employment in various ways, such as, full-time vs. part time, etc. | Employee Job Class | ||
| Employee Salary Type | C74566 | Employee Salary Type | A code specifying the method used by the employer to compute the employee's salary or wages. For example, hourly, annual, or commission. | Employee Salary Type | ||
| Entry Date from Ptntl Cntry Disease Exp | C102631 | Entry Date from Ptntl Cntry Disease Exp | The date on which the subject arrived in the reporting country from the country of potential disease exposure. | Entry Date from Country of Potential Disease Exposure | ||
| Marital Status | C25188 | Marital Status | A demographic parameter indicating a person's current conjugal status. | Marital Status | ||
| Member of High Risk Population | C102666 | Member of High Risk Population | An indication that a subject is part of a population group that has a greater chance of contracting a disease or disorder. | Member Of High Risk Population | ||
| National Origin | C28407 | National Origin | System of classification based on nation from which a person originates, regardless of the nation in which he/she currently resides. | National Origin | ||
| Premature Birth Indicator | C112400 | Premature Birth Indicator | An indication as to whether the subject was born prior to 38 weeks gestation. | Premature Birth Indicator | ||
| Priority of Disease Contact | C102699 | Priority of Disease Contact | The categorization of individuals with or without the potential for having a particular disease. | Priority of Disease Contact | ||
| Setting of Contact | C102708 | Setting of Contact | The environment within which the person may have come into contact with a disease carrier, or played the role of a disease carrier. | Setting of Disease Contact | ||
| Skin Classification | C74563 | Skin Classification | A classification system used to categorize the sensitivity of a subject's skin to sunlight. | Fitzpatrick Classification Scale | ||
| Skin Type | C74580 | Skin Type | A distinctive characteristic of the skin marked by the amount of sebum secreted by sebaceous glands. | Skin Type | ||
| Social Risk Factor | C102711 | Social Risk Factor | Social factors such as personal behavior, lifestyle, or environment belonging to the subject which are known to increase the likelihood of infection and disease. | Social Risk Factor | ||
| Source Case Investigation | C102713 | Source Case Investigation | A public health activity for the determination of who transmitted a disease to another subject and whether this person: is still infectious; was reported to the health department as a disease case or suspect; or has infected others. | Source Case Investigation | ||
| Symptom | C4876 | Symptom | Subjective evidence of disease perceived by the patient. | Symptom | ||
| Twin Type | C112424 | Twin Type | The classification of the two offspring born from the same pregnancy. | Twin Type | ||
| Type of Contact | C102723 | Type of Contact | Identification and clinical investigation of disease contacts. | Type of Contagion Contact | ||
| Back to top | ||||||
| CL.C101852.SDTHSDTP | Sudden Death Syndrome Type (SDTHSDTP) | text Extensible: No | C101852 | Sudden Death Syndrome Type | A terminology codelist that describes syndromes or conditions that put a subject at risk for sudden death. | CDISC SDTM Sudden Death Syndrome Type Terminology |
| BRUGADA SYNDROME | C71059 | Ventricular arrhythmia associated with Brugada syndrome | Polymorphic ventricular tachycardia in the absence of structural heart disease, associated with a baseline ECG pattern during sinus rhythm showing right bundle branch block with ST segment elevation in leads V1 through V3. It can also be characterized by documentation of ECG patterns associated with Brugada Syndrome, some of which may be unmasked when provoked with drugs. The most common genetic mutations identified for Brugada syndrome are in the sodium channel gene SCN5A. | Brugada Syndrome Ventricular Arrhythmia by ECG Finding | ||
| CATECHOLAMINERGIC POLYMORPHIC VENTRICULAR TACHYCARDIA | C99936 | Ventricular Tachycardia associated with syncope and/or cardiac arrest triggered by emotion or exercise in patients whose baseline ECG is normal. | Catecholaminergic Polymorphic Ventricular Tachycardia by ECG Finding | |||
| IDIOPATHIC PRIMARY VENTRICULAR TACHYCARDIA/VENTRICULAR FLUTTER | C100036 | Ventricular tachycardia or ventricular fibrillation whose cause is unknown. | Idiopathic Primary Ventricular Tachycardia/Ventricular Flutter by ECG Finding | |||
| LONG QT SYNDROME | C34786 | Ventricular arrhythmia associated with long QT syndrome | Long QT Syndrome includes prolongation of the corrected QT interval beyond 440 ms for adult males, 460 ms for adult females and 50 ms in the presence of ventricular depolarization abnormalities (i.e., bundle branch blocks or IVCB more than 120 ms. A normal QT interval in a resting ECG with a failure to shorten with an increase in heart rate qualifies as Long QT Syndrome. | Long QT Syndrome | ||
| OTHER | C17649 | Other | Different than the one(s) previously specified or mentioned. (NCI) | Other | ||
| SHORT QT SYNDROME | C71060 | Ventricular arrhythmia associated with short QT syndrome | Short QT Syndrome is characterized by a QT interval of less than or equal to 300 ms. | Short QT Syndrome | ||
| Back to top | ||||||
| CL.C102579.EVDRETRT | Supporting Evidence for Re-Treatment (EVDRETRT) | text Extensible: Yes | C102579 | Supporting Evidence for Re-Treatment | Terminology relevant to the clinical evidence to support reason for re-treatment of disease. | CDISC SDTM Supporting Evidence for Re-Treatment Terminology |
| BACTERIOLOGICAL FINDING | C102602 | Objective evidence of bacterial infection perceptible to the examiner by laboratory procedure. | Bacteriological Finding | |||
| CLINICAL FINDING | C100104 | Clinical Signs | Objective evidence of disease perceptible to the examiner (sign) and subjective evidence of disease perceived by the subject (symptom). | Sign or Symptom | ||
| RADIOLOGIC FINDING | C35869 | Objective evidence of disease perceptible to the examiner by radiological procedure. | Radiologic Finding | |||
| Back to top | ||||||
| CL.C101841.TIMIFLRS | TIMI Flow Responses (TIMIFLRS) | text Extensible: No | C101841 | TIMI Flow Responses | A terminology codelist of acceptable values to describe TIMI Flow. | CDISC SDTM Thrombolysis in Myocardial Infarction Flow Responses Terminology |
| TIMI GRADE 0 | C100040 | Thrombolysis in Myocardial Infarction Flow - 0 | No perfusion. There is no antegrade flow beyond the point of occlusion. (Chesebro JH, Knatterud GL, Roberts R, et al, Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: a comparison between intravenous tissue plasminogen activator and intravenous streptokinase: Clinical findings through hospital discharge, Circulation 76, No. 1, 142-154, 1987) | Thrombolysis in Myocardial Infarction Flow-0 | ||
| TIMI GRADE 1 | C100041 | Thrombolysis in Myocardial Infarction Flow - 1 | Penetration without perfusion. Contrast material passes beyond the area of obstruction but "hangs up" and fails to opacify the entire coronary bed distal to the obstruction for the duration of the cineangiographic filming sequence. (Chesebro JH, Knatterud GL, Roberts R, et al, Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: a comparison between intravenous tissue plasminogen activator and intravenous streptokinase: Clinical findings through hospital discharge, Circulation 76, No. 1, 142-154, 1987) | Thrombolysis in Myocardial Infarction Flow-1 | ||
| TIMI GRADE 2 | C100042 | Thrombolysis in Myocardial Infarction Flow - 2 | Partial perfusion. The contrast material passes across the obstruction and opacifies the coronary bed distal to the obstruction. However, the rate of entry of contrast material into the vessel distal to the obstruction or its rate of clearance from the distal bed (or both) is perceptibly slower than its entry into or clearance from comparable areas not perfused by the previously occluded vessel (e.g., the opposite coronary artery or the coronary bed proximal to the obstruction). (Chesebro JH, Knatterud GL, Roberts R, et al, Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: a comparison between intravenous tissue plasminogen activator and intravenous streptokinase: Clinical findings through hospital discharge, Circulation 76, No. 1, 142-154, 1987) | Thrombolysis in Myocardial Infarction Flow-2 | ||
| TIMI GRADE 3 | C100043 | Thrombolysis in Myocardial Infarction Flow - 3 | Complete perfusion. Antegrade flow into the bed distal to the obstruction occurs as promptly as into the bed from the involved bed and is as rapid as clearance from an uninvolved bed in the same vessel or the opposite artery. (Chesebro JH, Knatterud GL, Roberts R, et al, Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: a comparison between intravenous tissue plasminogen activator and intravenous streptokinase: Clinical findings through hospital discharge, Circulation 76, No. 1, 142-154, 1987) | Thrombolysis in Myocardial Infarction Flow-3 | ||
| Back to top | ||||||
| CL.C102589.TRTEPSD | Treatment Episode (TRTEPSD) | text Extensible: No | C102589 | Treatment Episode | Terminology relevant to whether an individual is being treated for a disease for the first time. | CDISC SDTM Treatment Episode Terminology |
| NEW | C25586 | Having no previous example or precedent or parallel; of a kind not seen before. | New | |||
| RETREATMENT | C54055 | The repeated act of the dispensing, applying, or tendering of something to another after an initial treatment. | Retreatment | |||
| Back to top | ||||||
| CL.C102585.REASTRTF | Treatment Failure Reason (REASTRTF) | text Extensible: Yes | C102585 | Treatment Failure Reason | Terminology relevant to the reason the drug or therapy was unsuccessful in treating the condition. | CDISC SDTM Treatment Failure Reason Terminology |
| ANTIBIOTIC RESISTANCE | C17449 | The mechanisms, functions, activities, or processes exhibited by microorganisms, especially bacteria, to resist or to become tolerant to antibiotics. | Antibiotic Resistance | |||
| DRUG INTERRUPTED | C49501 | An indication that a medication schedule was modified by temporarily terminating a prescribed regimen of medication. (NCI) | Drug Interrupted | |||
| PATIENT NONCOMPLIANCE | C91752 | Failure of a patient to follow medical advice, take medication as directed, or adhere to a prescribed course of treatment. | Patient Noncompliance | |||
| SUB-THERAPEUTIC DRUG LEVEL | C102715 | A drug serum concentration below therapeutic levels. | Sub-therapeutic Drug Level | |||
| Back to top | ||||||
| CL.C66735.TBLIND | Trial Blinding Schema (TBLIND) | text Extensible: Yes | C66735 | Trial Blinding Schema | The name of a code list that contains terms to define the type of blinding for the trial. (NCI) | CDISC SDTM Trial Blinding Schema Terminology |
| DOUBLE BLIND | C15228 | A study in which neither the subject nor the investigator nor the research team interacting with the subject or data during the trial knows what treatment a subject is receiving. (CDISC glossary) | Double Blind Study | |||
| OPEN LABEL | C49659 | A trial in which subjects and investigators know which product each subject is receiving; opposite of a blinded or double-blind study. (CDISC glossary) | Open Label Study | |||
| SINGLE BLIND | C28233 | A study in which one party, either the investigator or the subject, does not know which medication or placebo is administered to the subject; also called singlemasked study. (CDISC glossary) | Single Blind Study | |||
| Back to top | ||||||
| CL.C66736.TINDTP | Trial Indication Type (TINDTP) | text Extensible: Yes | C66736 | Trial Indication Type | The name of a code list that contains terms to define the type of trial, e.g. cure or prevention. (NCI) | CDISC SDTM Trial Indication Type Terminology |
| CURE | C49654 | A type of study protocol designed to evaluate intervention(s) aimed to cure a disease or condition. (NCI) | Cure Study | |||
| DIAGNOSIS | C49653 | A type of study protocol designed to evaluate intervention(s) aimed at identifying a disease or condition. (NCI) | Diagnosis Study | |||
| MITIGATION | C49655 | A type of study designed to identify actions necessary to eliminate or reduce the risk to human life or well-being as a result of a particular medication or treatment regimen. (NCI) | Adverse Effect Mitigation Study | |||
| PREVENTION | C49657 | A type of study designed to identify actions necessary to permanently eliminate or reduce the long-term risk to human life as a result of a particular medication or treatment regimen. | Prevention Study | |||
| TREATMENT | C49656 | A type of study protocol designed to evaluate intervention(s) for treatment of disease, syndrome or condition. | Treatment Study | |||
| Back to top | ||||||
| CL.C66737.TPHASE | Trial Phase (TPHASE) | text Extensible: Yes | C66737 | Trial Phase | Clinical trials are broken into three or four phases: Phase I tests a new drug or treatment for safety in a small group; Phase II expands the study to a larger group of people; Phase III expands the study to an even larger group of people to measure whether the treatment actually benefits patients, and whether its benefits exceed its risks; and Phase IV takes place after the drug or treatment has been licensed and marketed. (NCI) | CDISC SDTM Trial Phase Terminology |
| NOT APPLICABLE | C48660 | NA;Not Applicable | Determination of a value is not relevant in the current context. (NCI) | Not Applicable | ||
| PHASE I TRIAL | C15600 | 1;Trial Phase 1 | The initial introduction of an investigational new drug into humans. Phase 1 studies are typically closely monitored and may be conducted in patients or normal volunteer subjects. NOTE: These studies are designed to determine the metabolism and pharmacologic actions of the drug in humans, the side effects associated with increasing doses, and, if possible, to gain early evidence on effectiveness. During Phase 1, sufficient information about the drug's pharmacokinetics and pharmacological effects should be obtained to permit the design of well-controlled, scientifically valid, Phase 2 studies. The total number of subjects and patients included in Phase I studies varies with the drug, but is generally in the range of 20 to 80. Phase 1 studies also include studies of drug metabolism, structure-activity relationships, and mechanism of action in humans, as well as studies in which investigational drugs are used as research tools to explore biological phenomena or disease processes. [After FDA CDER Handbook, ICH E8] (CDISC glossary) | Phase I Trial | ||
| PHASE I/II TRIAL | C15693 | 1-2;Trial Phase 1-2 | A class of clinical study that combines elements characteristic of traditional Phase I and Phase II trials. See also Phase I, Phase II. | Phase I/II Trial | ||
| PHASE II TRIAL | C15601 | 2;Trial Phase 2 | Phase 2. Controlled clinical studies conducted to evaluate the effectiveness of the drug for a particular indication or indications in patients with the disease or condition under study and to determine the common short-term side effects and risks associated with the drug. NOTE: Phase 2 studies are typically well controlled, closely monitored, and conducted in a relatively small number of patients, usually involving no more than several hundred subjects. [After FDA CDER Handbook, ICH E8] (CDISC glossary) | Phase II Trial | ||
| PHASE II/III TRIAL | C15694 | 2-3;Trial Phase 2-3 | A class of clinical study that combines elements characteristic of traditional Phase II and Phase III trials. | Phase II/III Trial | ||
| PHASE IIA TRIAL | C49686 | 2A;Trial Phase 2A | A clinical research protocol generally referred to as a pilot or feasibility trial that aims to prove the concept of the new intervention in question. (NCI) | Phase IIa Trial | ||
| PHASE IIB TRIAL | C49688 | 2B;Trial Phase 2B | A clinical research protocol generally referred to as a well-controlled and pivotal trial that aims to prove the mechanism of action of the new intervention in question. A pivotal study will generally be well-controlled, randomized, of adequate size, and whenever possible, double-blind. (NCI) | Phase IIb Trial | ||
| PHASE III TRIAL | C15602 | 3;Trial Phase 3 | Phase 3. Studies are expanded controlled and uncontrolled trials. They are performed after preliminary evidence suggesting effectiveness of the drug has been obtained, and are intended to gather the additional information about effectiveness and safety that is needed to confirm efficacy and evaluate the overall benefit-risk relationship of the drug and to provide an adequate basis for physician labeling. NOTE: Phase 3 studies usually include from several hundred to several thousand subjects. [After FDA CDER Handbook, ICH E8] (CDISC glossary) | Phase III Trial | ||
| PHASE IIIA TRIAL | C49687 | 3A;Trial Phase 3A | A classification typically assigned retrospectively to a Phase III trial upon determination by regulatory authorities of a need for a Phase III B trial. (NCI) | Phase IIIa Trial | ||
| PHASE IIIB TRIAL | C49689 | 3B;Trial Phase 3B | A subcategory of Phase III trials done near the time of approval to elicit additional findings. NOTE: Dossier review may continue while associated Phase IIIB trials are conducted. These trials may be required as a condition of regulatory authority approval. | Phase IIIb Trial | ||
| PHASE IV TRIAL | C15603 | 4;Trial Phase 4 | Phase 4. Postmarketing (Phase 4) studies to delineate additional information about the drug's risks, benefits, and optimal use that may be requested by regulatory authorities in conjunction with marketing approval. NOTE: These studies could include, but would not be limited to, studying different doses or schedules of administration than were used in Phase 2 studies, use of the drug in other patient populations or other stages of the disease, or use of the drug over a longer period of time. [After FDA CDER Handbook, ICH E8] (CDISC glossary) | Phase IV Trial | ||
| PHASE V TRIAL | C47865 | 5;Trial Phase 5 | Postmarketing surveillance is sometimes referred to as Phase V. | Phase V Trial | ||
| Back to top | ||||||
| CL.C66738.TSPARMCD | Trial Summary Parameter Test Code (TSPARMCD) | text Extensible: Yes | C66738 | Trial Summary Parameter Test Code | The test code for an individual characteristic of a clinical trial, e.g. description of trial design, trial blinding schema, and primary objective of trial. | CDISC SDTM Trial Summary Parameter Terminology by Code |
| ACTSUB | C98703 | Actual Number of Subjects | Actual number of subjects enrolled; may include subjects who were not randomized. | Actual Subject Number | ||
| ADAPT | C98704 | Adaptive Design | Indicate if the study includes a prospectively planned opportunity for modification of one or more specified aspects of the study design and hypotheses based on analysis of data (usually interim data) from subjects in the study. | Adaptive Design | ||
| ADDON | C49703 | Added on to Existing Treatments | The addition of a therapeutic product to the existing regimen in a clinical trial, where both entities remain as discrete products. | Test Product Added to Existing Treatment | ||
| AGEMAX | C49694 | Planned Maximum Age of Subjects | The anticipated maximum age of the subjects to be entered in a clinical trial. (NCI) | Planned Maximum Age of Subjects | ||
| AGEMIN | C49693 | Planned Minimum Age of Subjects | The anticipated minimum age of the subjects to be entered in a clinical trial. (NCI) | Planned Minimum Age of Subjects | ||
| COMPTRT | C68612 | Comparative Treatment Name | A therapeutically active agent that is intended to provide reference measurements for the experimental protocol of a clinical trial. | Active Comparator Drug | ||
| CRMDUR | C98715 | Confirmed Response Minimum Duration | The protocol specified minimum amount of time needed to meet the definition of a confirmed response to treatment. | Confirmed Response Minimum Duration | ||
| CURTRT | C85582 | Current Therapy or Treatment | The literal identifier of the therapy or medication that is currently being given per protocol. | Current Therapy | ||
| DCUTDESC | C98718 | Data Cutoff Description | Text that describes the cutoff date. | Data Cutoff Date Description | ||
| DCUTDTC | C98717 | Data Cutoff Date | A date which indicates any data collected by this date will be used for analysis. | Data Cutoff Date | ||
| DOSE | C25488 | Dose Level;Dose per Administration | The amount of drug administered to a patient or test subject at one time or the total quantity administered. [AMA Manual of Style] (CDISC Glossary) | Dose | ||
| DOSFRQ | C89081 | Dosing Frequency | The number of doses administered per a specific interval. | Dose Frequency | ||
| DOSU | C73558 | Dose Units | The unit of measure for the dosage form. | Dosage Form Unit | ||
| DXCRIT | C117960 | Diagnostic Criteria | A standard from which a judgment concerning a medical diagnosis can be established. | Diagnostic Criteria | ||
| EGBLIND | C119560 | ECG Reading Blinded | Indicates whether assessors of ECGs for this study were blinded to subject identity, timing and treatment. | ECG Evaluator Blinding Parameters | ||
| EGCTMON | C119561 | ECG Continuous Monitoring | Indicates whether the 10-second ECGs for this study were extracted from a continuous recording. | ECG Continuous Monitoring Indicator | ||
| EGLEADPR | C119562 | ECG Planned Primary Lead | The ECG lead which was planned to be used for ECG interval measurements for this study. | ECG Planned Primary Lead for Study | ||
| EGLEADSM | C119563 | ECG Used Same Lead | Indicates whether all ECG interval measurements for the study were based on the same lead. | ECG Used Same Lead Indicator | ||
| EGRDMETH | C119564 | ECG Read Method | The degree of automation involved in assessing the ECGs for this study. | ECG Read Method Degree of Automation | ||
| EGREPLBL | C119565 | ECG Replicates at Baseline | Indicates whether this study includes replicate ECGs for time points during the baseline portion of the study. | ECG Replicates at Baseline Indicator | ||
| EGREPLTR | C119566 | ECG Replicates On-Treatment | Indicates whether this study includes replicate ECGs for time points during the on-treatment portion of the study. | ECG Replicates On-Treatment Indicator | ||
| EGTWVALG | C119582 | ECG Twave Algorithm | The algorithm used to identify the end of the T wave for ECGs for this study. | ECG T Wave Algorithm | ||
| FCNTRY | C98770 | Planned Country of Investigational Sites | The country name of planned study facility which has received IRB approval. | Planned Country of Investigational Site | ||
| HLTSUBJI | C98737 | Healthy Subject Indicator | Indicate if persons who have not had the condition(s) being studied or otherwise related conditions or symptoms, as specified in the eligibility requirements, may participate in the study. | Healthy Subject Indicator | ||
| INDIC | C112038 | Trial Indication | The condition, disease or disorder that the clinical trial is intended to investigate or address. | Trial Indication | ||
| INTMODEL | C98746 | Intervention Model | The trial design developed to compare treatment groups. | Intervention Model | ||
| INTTYPE | C98747 | Intervention Type | The kind of product or procedure studied in a trial. | Intervention Type | ||
| LENGTH | C49697 | Trial Length | Planned length of observation for a single subject. | Trial Length | ||
| NARMS | C98771 | Planned Number of Arms | The planned number of intervention groups. | Planned Number of Arms | ||
| OBJPRIM | C85826 | Trial Primary Objective | The principal purpose of the trial. | Trial Primary Objective | ||
| OBJSEC | C85827 | Trial Secondary Objective | The auxiliary purpose of the trial. | Trial Secondary Objective | ||
| OUTMSEXP | C98724 | Exploratory Outcome Measure | Exploratory measures that will be used to evaluate the intervention(s) or, for observational studies, that are exploratory of the study. | Exploratory Outcome Measure | ||
| OUTMSPRI | C98772 | Primary Outcome Measure | The primary measurement(s) or observation(s) used to measure the effect of experimental variables in a study, or for observational studies, to describe patterns of diseases or traits or associations with exposures, risk factors or treatment. These are the outcome measures used to assess the primary objective(s). | Primary Outcome Measure | ||
| OUTMSSEC | C98781 | Secondary Outcome Measure | Other key measures that will be used to evaluate the intervention(s) or, for observational studies, that are a focus of the study. These are the outcome measures used to assess the secondary objective(s). | Secondary Outcome Measure | ||
| PCLAS | C98768 | Pharmacological Class of Invest. Therapy | The pharmacological class of the investigational product. | Pharmacological Class of Investigational Therapy | ||
| PLANSUB | C49692 | Anticipated Enrollment;Planned Enrollment;Planned Number of Subjects;Target Enrollment | The planned number of subjects to be entered in a clinical trial. (NCI) | Planned Subject Number | ||
| RANDOM | C25196 | Trial is Randomized | The process of assigning trial subjects to treatment or control groups using an element of chance to determine the assignments in order to reduce bias. NOTE: Unequal randomization is used to allocate subjects into groups at a differential rate; for example, three subjects may be assigned to a treatment group for every one assigned to the control group. [ICH E6 1.48] See also balanced study. (CDISC glossary) | Randomization | ||
| RANDQT | C98775 | Randomization Quotient | The randomization quotient is the number of planned subjects to be exposed to investigational therapy, independent of dose or other factors, divided by the total number of planned subjects. | Randomization Quotient | ||
| REGID | C98714 | Registry Identifier | Identification numbers assigned to the protocol by clinicaltrials.gov, EudraCT, or other registries. | Clinical Trial Registry Identifier | ||
| RLPSCRIT | C117961 | Relapse Criteria | A standard from which a judgment concerning a disease relapse can be established. | Relapse Criteria | ||
| ROUTE | C38114 | Route of Administration | The course by which a substance was administered in order to reach the site of action in the body. | Route of Administration | ||
| SDMDUR | C98783 | Stable Disease Minimum Duration | The protocol specified minimum amount of time needed to meet the definition of stable disease. | Stable Disease Minimum Duration | ||
| SENDTC | C90462 | Study End Date | Final date on which data was collected for any subject (Date/Time of End of Participation, RFPENDTC) based on the protocol. | Study End Date | ||
| SEVCRIT | C117962 | Severity Criteria | A standard from which a judgment concerning the severity of an event, disease or condition can be established. | Severity Criteria | ||
| SEXPOP | C49696 | Sex Of Participants;Sex of Participants | The specific sex, either male, female, or mixed of the subject group being studied. (NCI) | Sex of Study Group | ||
| SPONSOR | C70793 | Clinical Study Sponsor;Sponsor;Study Sponsor | An entity that is responsible for the initiation, management, and/or financing of a clinical study. | Clinical Study Sponsor | ||
| SSTDTC | C69208 | Study Start Date | The earliest date of informed consent among any subject (Date/Time of Informed Consent, RFICDTC) that enrolled in the study. For studies conducted without informed consent (ie. emergency use) use the date of treatment. Dates for subjects who were screen failures are not included. | Study Start Date | ||
| STOPRULE | C49698 | Study Stop Rules | The rule, regulation and/or condition that determines the point in time when a clinical trial will be terminated. (NCI) | Study Stop Rule | ||
| STRATFCT | C16153 | Stratification Factor | Selected pre-treatment factors by which patients are segregated to assure balance of these factors before randomization to the intervention arms of a clinical protocol. | Stratification Factors | ||
| STYPE | C15320 | Study Type | Describes the role the study plays in determining the interventions a subject receives. | Study Design | ||
| TBLIND | C49658 | Trial Blinding Schema | The name of a code list that contains terms to define the type of blinding for the trial. (NCI) | Trial Blinding Schema | ||
| TCNTRL | C49647 | Control Type | Comparator against which the study treatment is evaluated (e.g., concurrent (placebo, no treatment, dose-response, active), external (historical, published literature). | Control Type | ||
| TDIGRP | C49650 | Diagnosis Group | A grouping of individuals on the basis of a shared procedure or disease, or lack thereof (e.g. healthy volunteers, type 2 diabetic subjects, subjects with renal cell cancer). Standardized naming systems are available that define the groups within which a subject should be placed. (NCI) | Diagnosis Group | ||
| TINDTP | C49652 | Trial Indication Type | The name of a code list that contains terms to define the type of trial, e.g. cure or prevention. (NCI) | Clinical Study by Intent | ||
| TITLE | C49802 | Trial Title | The name of a clinical trial. (NCI) | Trial Title | ||
| TPHASE | C48281 | Trial Phase Classification | Clinical trials are broken into three or four phases: Phase I tests a new drug or treatment for safety in a small group; Phase II expands the study to a larger group of people; Phase III expands the study to an even larger group of people to measure whether the treatment actually benefits patients, and whether its benefits exceed its risks; and Phase IV takes place after the drug or treatment has been licensed and marketed. (NCI) | Trial Phase | ||
| TRT | C41161 | Investigational Therapy or Treatment | The investigational product under study. | Protocol Agent | ||
| TTYPE | C49660 | Trial Type | The type of clinical trial performed e.g. efficacy, safety. (NCI) | Trial Type | ||
| Back to top | ||||||
| CL.C67152.TSPARM | Trial Summary Parameter Test Name (TSPARM) | text Extensible: Yes | C67152 | Trial Summary Parameter Test Name | The test name for an individual characteristic of a clinical trial, e.g. description of trial design, trial blinding schema, and primary objective of trial. | CDISC SDTM Trial Summary Parameter Terminology by Name |
| Actual Number of Subjects | C98703 | Actual Number of Subjects | Actual number of subjects enrolled; may include subjects who were not randomized. | Actual Subject Number | ||
| Adaptive Design | C98704 | Adaptive Design | Indicate if the study includes a prospectively planned opportunity for modification of one or more specified aspects of the study design and hypotheses based on analysis of data (usually interim data) from subjects in the study. | Adaptive Design | ||
| Added on to Existing Treatments | C49703 | Added on to Existing Treatments | The addition of a therapeutic product to the existing regimen in a clinical trial, where both entities remain as discrete products. | Test Product Added to Existing Treatment | ||
| Clinical Study Sponsor | C70793 | Clinical Study Sponsor;Sponsor;Study Sponsor | An entity that is responsible for the initiation, management, and/or financing of a clinical study. | Clinical Study Sponsor | ||
| Comparative Treatment Name | C68612 | Comparative Treatment Name | A therapeutically active agent that is intended to provide reference measurements for the experimental protocol of a clinical trial. | Active Comparator Drug | ||
| Confirmed Response Minimum Duration | C98715 | Confirmed Response Minimum Duration | The protocol specified minimum amount of time needed to meet the definition of a confirmed response to treatment. | Confirmed Response Minimum Duration | ||
| Control Type | C49647 | Control Type | Comparator against which the study treatment is evaluated (e.g., concurrent (placebo, no treatment, dose-response, active), external (historical, published literature). | Control Type | ||
| Current Therapy or Treatment | C85582 | Current Therapy or Treatment | The literal identifier of the therapy or medication that is currently being given per protocol. | Current Therapy | ||
| Data Cutoff Date | C98717 | Data Cutoff Date | A date which indicates any data collected by this date will be used for analysis. | Data Cutoff Date | ||
| Data Cutoff Description | C98718 | Data Cutoff Description | Text that describes the cutoff date. | Data Cutoff Date Description | ||
| Diagnosis Group | C49650 | Diagnosis Group | A grouping of individuals on the basis of a shared procedure or disease, or lack thereof (e.g. healthy volunteers, type 2 diabetic subjects, subjects with renal cell cancer). Standardized naming systems are available that define the groups within which a subject should be placed. (NCI) | Diagnosis Group | ||
| Diagnostic Criteria | C117960 | Diagnostic Criteria | A standard from which a judgment concerning a medical diagnosis can be established. | Diagnostic Criteria | ||
| Dose per Administration | C25488 | Dose Level;Dose per Administration | The amount of drug administered to a patient or test subject at one time or the total quantity administered. [AMA Manual of Style] (CDISC Glossary) | Dose | ||
| Dose Units | C73558 | Dose Units | The unit of measure for the dosage form. | Dosage Form Unit | ||
| Dosing Frequency | C89081 | Dosing Frequency | The number of doses administered per a specific interval. | Dose Frequency | ||
| ECG Continuous Monitoring | C119561 | ECG Continuous Monitoring | Indicates whether the 10-second ECGs for this study were extracted from a continuous recording. | ECG Continuous Monitoring Indicator | ||
| ECG Planned Primary Lead | C119562 | ECG Planned Primary Lead | The ECG lead which was planned to be used for ECG interval measurements for this study. | ECG Planned Primary Lead for Study | ||
| ECG Read Method | C119564 | ECG Read Method | The degree of automation involved in assessing the ECGs for this study. | ECG Read Method Degree of Automation | ||
| ECG Reading Blinded | C119560 | ECG Reading Blinded | Indicates whether assessors of ECGs for this study were blinded to subject identity, timing and treatment. | ECG Evaluator Blinding Parameters | ||
| ECG Replicates at Baseline | C119565 | ECG Replicates at Baseline | Indicates whether this study includes replicate ECGs for time points during the baseline portion of the study. | ECG Replicates at Baseline Indicator | ||
| ECG Replicates On-Treatment | C119566 | ECG Replicates On-Treatment | Indicates whether this study includes replicate ECGs for time points during the on-treatment portion of the study. | ECG Replicates On-Treatment Indicator | ||
| ECG Twave Algorithm | C119582 | ECG Twave Algorithm | The algorithm used to identify the end of the T wave for ECGs for this study. | ECG T Wave Algorithm | ||
| ECG Used Same Lead | C119563 | ECG Used Same Lead | Indicates whether all ECG interval measurements for the study were based on the same lead. | ECG Used Same Lead Indicator | ||
| Exploratory Outcome Measure | C98724 | Exploratory Outcome Measure | Exploratory measures that will be used to evaluate the intervention(s) or, for observational studies, that are exploratory of the study. | Exploratory Outcome Measure | ||
| Healthy Subject Indicator | C98737 | Healthy Subject Indicator | Indicate if persons who have not had the condition(s) being studied or otherwise related conditions or symptoms, as specified in the eligibility requirements, may participate in the study. | Healthy Subject Indicator | ||
| Intervention Model | C98746 | Intervention Model | The trial design developed to compare treatment groups. | Intervention Model | ||
| Intervention Type | C98747 | Intervention Type | The kind of product or procedure studied in a trial. | Intervention Type | ||
| Investigational Therapy or Treatment | C41161 | Investigational Therapy or Treatment | The investigational product under study. | Protocol Agent | ||
| Pharmacological Class of Invest. Therapy | C98768 | Pharmacological Class of Invest. Therapy | The pharmacological class of the investigational product. | Pharmacological Class of Investigational Therapy | ||
| Planned Country of Investigational Sites | C98770 | Planned Country of Investigational Sites | The country name of planned study facility which has received IRB approval. | Planned Country of Investigational Site | ||
| Planned Maximum Age of Subjects | C49694 | Planned Maximum Age of Subjects | The anticipated maximum age of the subjects to be entered in a clinical trial. (NCI) | Planned Maximum Age of Subjects | ||
| Planned Minimum Age of Subjects | C49693 | Planned Minimum Age of Subjects | The anticipated minimum age of the subjects to be entered in a clinical trial. (NCI) | Planned Minimum Age of Subjects | ||
| Planned Number of Arms | C98771 | Planned Number of Arms | The planned number of intervention groups. | Planned Number of Arms | ||
| Planned Number of Subjects | C49692 | Anticipated Enrollment;Planned Enrollment;Planned Number of Subjects;Target Enrollment | The planned number of subjects to be entered in a clinical trial. (NCI) | Planned Subject Number | ||
| Primary Outcome Measure | C98772 | Primary Outcome Measure | The primary measurement(s) or observation(s) used to measure the effect of experimental variables in a study, or for observational studies, to describe patterns of diseases or traits or associations with exposures, risk factors or treatment. These are the outcome measures used to assess the primary objective(s). | Primary Outcome Measure | ||
| Randomization Quotient | C98775 | Randomization Quotient | The randomization quotient is the number of planned subjects to be exposed to investigational therapy, independent of dose or other factors, divided by the total number of planned subjects. | Randomization Quotient | ||
| Registry Identifier | C98714 | Registry Identifier | Identification numbers assigned to the protocol by clinicaltrials.gov, EudraCT, or other registries. | Clinical Trial Registry Identifier | ||
| Relapse Criteria | C117961 | Relapse Criteria | A standard from which a judgment concerning a disease relapse can be established. | Relapse Criteria | ||
| Route of Administration | C38114 | Route of Administration | The course by which a substance was administered in order to reach the site of action in the body. | Route of Administration | ||
| Secondary Outcome Measure | C98781 | Secondary Outcome Measure | Other key measures that will be used to evaluate the intervention(s) or, for observational studies, that are a focus of the study. These are the outcome measures used to assess the secondary objective(s). | Secondary Outcome Measure | ||
| Severity Criteria | C117962 | Severity Criteria | A standard from which a judgment concerning the severity of an event, disease or condition can be established. | Severity Criteria | ||
| Sex of Participants | C49696 | Sex Of Participants;Sex of Participants | The specific sex, either male, female, or mixed of the subject group being studied. (NCI) | Sex of Study Group | ||
| Stable Disease Minimum Duration | C98783 | Stable Disease Minimum Duration | The protocol specified minimum amount of time needed to meet the definition of stable disease. | Stable Disease Minimum Duration | ||
| Stratification Factor | C16153 | Stratification Factor | Selected pre-treatment factors by which patients are segregated to assure balance of these factors before randomization to the intervention arms of a clinical protocol. | Stratification Factors | ||
| Study End Date | C90462 | Study End Date | Final date on which data was collected for any subject (Date/Time of End of Participation, RFPENDTC) based on the protocol. | Study End Date | ||
| Study Start Date | C69208 | Study Start Date | The earliest date of informed consent among any subject (Date/Time of Informed Consent, RFICDTC) that enrolled in the study. For studies conducted without informed consent (ie. emergency use) use the date of treatment. Dates for subjects who were screen failures are not included. | Study Start Date | ||
| Study Stop Rules | C49698 | Study Stop Rules | The rule, regulation and/or condition that determines the point in time when a clinical trial will be terminated. (NCI) | Study Stop Rule | ||
| Study Type | C15320 | Study Type | Describes the role the study plays in determining the interventions a subject receives. | Study Design | ||
| Trial Blinding Schema | C49658 | Trial Blinding Schema | The name of a code list that contains terms to define the type of blinding for the trial. (NCI) | Trial Blinding Schema | ||
| Trial Indication | C112038 | Trial Indication | The condition, disease or disorder that the clinical trial is intended to investigate or address. | Trial Indication | ||
| Trial Indication Type | C49652 | Trial Indication Type | The name of a code list that contains terms to define the type of trial, e.g. cure or prevention. (NCI) | Clinical Study by Intent | ||
| Trial is Randomized | C25196 | Trial is Randomized | The process of assigning trial subjects to treatment or control groups using an element of chance to determine the assignments in order to reduce bias. NOTE: Unequal randomization is used to allocate subjects into groups at a differential rate; for example, three subjects may be assigned to a treatment group for every one assigned to the control group. [ICH E6 1.48] See also balanced study. (CDISC glossary) | Randomization | ||
| Trial Length | C49697 | Trial Length | Planned length of observation for a single subject. | Trial Length | ||
| Trial Phase Classification | C48281 | Trial Phase Classification | Clinical trials are broken into three or four phases: Phase I tests a new drug or treatment for safety in a small group; Phase II expands the study to a larger group of people; Phase III expands the study to an even larger group of people to measure whether the treatment actually benefits patients, and whether its benefits exceed its risks; and Phase IV takes place after the drug or treatment has been licensed and marketed. (NCI) | Trial Phase | ||
| Trial Primary Objective | C85826 | Trial Primary Objective | The principal purpose of the trial. | Trial Primary Objective | ||
| Trial Secondary Objective | C85827 | Trial Secondary Objective | The auxiliary purpose of the trial. | Trial Secondary Objective | ||
| Trial Title | C49802 | Trial Title | The name of a clinical trial. (NCI) | Trial Title | ||
| Trial Type | C49660 | Trial Type | The type of clinical trial performed e.g. efficacy, safety. (NCI) | Trial Type | ||
| Back to top | ||||||
| CL.C66739.TTYPE | Trial Type (TTYPE) | text Extensible: Yes | C66739 | Trial Type | The type of clinical trial performed e.g. efficacy, safety. (NCI) | CDISC SDTM Trial Type Terminology |
| BIO-AVAILABILITY | C49664 | A study of the degree to which or rate at which a drug or other substance is absorbed or becomes available at the site of physiological activity after administration. (NCI) | Bioavailability Study | |||
| BIO-EQUIVALENCE | C49665 | A study most often used to compare the efficacy of different formulations to treat a given disease. It is the testing of an old versus a new formulation in healthy volunteers or subjects with the disease under study and usually in one dose. (NCI) | Therapeutic Equivalency Study | |||
| EFFICACY | C49666 | A study of the relative therapeutic efficacy of treatment of a disease. Usually this is a Phase II or III study. (NCI) | Efficacy Study | |||
| FOOD EFFECT | C98729 | Studies that are conducted to assess the effect of food on the rate and extent of absorption of a drug, either compared to a fasted state or to a reference drug. | Food Effect Study | |||
| PHARMACODYNAMIC | C49662 | A study of the biochemical and physiological effect of a drug and the mechanism of drug action and the relationship between drug concentration and effect. (NCI) | Pharmacodynamic Study | |||
| PHARMACOECONOMIC | C39493 | A study that assesses the value associated with a given drug in therapeutic and economic terms. This type of study is multidisciplinary in nature and takes into consideration the social and economic costs (resource utilization costs including direct, indirect, and intangible costs) of drug therapy in addition to its direct therapeutic benefits. Analyses relate the difference in therapeutic benefits to the difference in costs between treatment alternatives. (NCI) | Pharmacoeconomic Study | |||
| PHARMACOGENOMIC | C49661 | A study of identification and analysis of genomic variations that affect the efficacy of a drug. Pharmacogenomic studies can potentially be predictive of an individual's drug-response or adverse reactions or susceptibility to iatrogenic disorders, and may also reveal new targets that can help in the design of new drugs. (NCI) | Pharmacogenomic Study | |||
| PHARMACOKINETIC | C49663 | A study of the process by which a drug is absorbed, distributed, metabolized, and eliminated by the body. (NCI) | Pharmacokinetic Study | |||
| SAFETY | C49667 | A study that assesses the medical risks to a subject. Safety is usually assessed by examining a wide range of clinical parameters, including adverse events, vital signs, physical exam, laboratory tests. | Safety Study | |||
| TOLERABILITY | C98791 | A type of safety study that assesses the degree to which overt adverse effects can be tolerated by the subject. | Tolerability Study | |||
| Back to top | ||||||
| CL.C96780.TUMIDENT | Tumor and Lesion Identification Results (TUMIDENT) | text Extensible: Yes | C96780 | Tumor and Lesion Identification Results | Terminology relevant to tumor and lesion identification results. | CDISC SDTM Tumor and Lesion Identification Result Terminology |
| BENIGN | C14172 | Benign | For neoplasms, a non-infiltrating and non-metastasizing neoplastic process that is characterized by the absence of morphologic features associated with malignancy (e.g., severe atypia, nuclear pleomorphism, tumor cell necrosis, and abnormal mitoses). For other conditions, a process that is mild in nature and not dangerous to health. (NCI) | Benign | ||
| MEASURED | C103416 | The identification of a tumor, lesion, or site of disease that is present at baseline and will be quantifiably measured. | Measured Tumor Identification | |||
| NEW | C94522 | The identification of a tumor, lesion, or site of disease which has not been previously seen or characterized. | New Lesion Identification | |||
| NON-MEASURABLE | C103423 | The identification of a tumor, lesion, or site of disease that is incapable of being measured at baseline. | Non-Measurable Tumor Identification | |||
| NON-TARGET | C94521 | The identification of a tumor, lesion or site of disease that is present at baseline and not considered a target, but may be part of the objective assessment of the response to the therapeutic intervention. | Non-Target Lesion Identification | |||
| NOT MEASURED | C103425 | The identification of a tumor, lesion, or site of disease that is present at baseline and will not be quantifiably measured. | Not Measured Tumor Identification | |||
| TARGET | C94520 | The identification of a tumor, lesion, or site of disease that is present at baseline and is the target of the therapeutic intervention. | Target Lesion Identification | |||
| TARGET EXTRA NODAL | C103442 | The identification of a tumor or lesion that is present at baseline, located outside of or independent of any lymph nodes, and is the target of the therapeutic intervention. | Target Extra Nodal Tumor Identification | |||
| TARGET NODAL | C103443 | The identification of a tumor or lesion located at or near the lymph node that is present at baseline and is the target of the therapeutic intervention. | Target Nodal Tumor Identification | |||
| TARGET NODULE | C103444 | The identification of a nodule that is the target of the therapeutic intervention. | Target Nodule Tumor Identification | |||
| Back to top | ||||||
| CL.C96784.TUTESTCD | Tumor Identification Test Code (TUTESTCD) | text Extensible: Yes | C96784 | Tumor Identification Test Code | Terminology relevant to the test codes that describe tumor assessments for identification purposes. | CDISC SDTM Tumor Identification Test Code Terminology |
| GRLIDENT | C119567 | Graft Lesion Identification | An indication that a graft with a lesion has been located and characterized. | Graft Lesion Identification | ||
| LESIDENT | C94189 | Lesion Identification | An indication that a lesion has been located and characterized. | Lesion Identification | ||
| LMLIDENT | C119568 | Limb Lesion Identification | An indication that a limb containing a lesion has been selected and characterized. | Limb Associated Lesion Identification | ||
| TUMERGE | C94525 | Tumor Merged | An indication that multiple tumors have coalesced into one tumor. | Matted Tumor Mass Present | ||
| TUMIDENT | C94523 | Tumor Identification | An indication that a tumor has been located and characterized. | Tumor Identification | ||
| TUSPLIT | C96642 | Tumor Split | An indication that a single tumor has divided into two or more tumors. | Tumor Split | ||
| VSLIDENT | C119569 | Vessel Lesion Identification | An indication that a vessel with a lesion has been located and characterized. | Vessel Lesion Identification | ||
| Back to top | ||||||
| CL.C96783.TUTEST | Tumor Identification Test Name (TUTEST) | text Extensible: Yes | C96783 | Tumor Identification Test Name | Terminology relevant to the test names that describe tumor assessments for identification purposes. | CDISC SDTM Tumor Identification Test Name Terminology |
| Graft Lesion Identification | C119567 | Graft Lesion Identification | An indication that a graft with a lesion has been located and characterized. | Graft Lesion Identification | ||
| Lesion Identification | C94189 | Lesion Identification | An indication that a lesion has been located and characterized. | Lesion Identification | ||
| Limb Lesion Identification | C119568 | Limb Lesion Identification | An indication that a limb containing a lesion has been selected and characterized. | Limb Associated Lesion Identification | ||
| Tumor Identification | C94523 | Tumor Identification | An indication that a tumor has been located and characterized. | Tumor Identification | ||
| Tumor Merged | C94525 | Tumor Merged | An indication that multiple tumors have coalesced into one tumor. | Matted Tumor Mass Present | ||
| Tumor Split | C96642 | Tumor Split | An indication that a single tumor has divided into two or more tumors. | Tumor Split | ||
| Vessel Lesion Identification | C119569 | Vessel Lesion Identification | An indication that a vessel with a lesion has been located and characterized. | Vessel Lesion Identification | ||
| Back to top | ||||||
| CL.C96779.TRTESTCD | Tumor or Lesion Properties Test Code (TRTESTCD) | text Extensible: Yes | C96779 | Tumor or Lesion Properties Test Code | Terminology relevant to the test codes that describe the assessment or measurement of a tumor, lesion or site of disease. | CDISC SDTM Tumor or Lesion Properties Test Code Terminology |
| ACHNAD | C103347 | Absolute Change From Nadir | The current value minus the lowest value previously recorded. | Absolute Change From Nadir | ||
| ACNSD | C112218 | Absolute Change Nadir in Sum of Diam | The current sum of diameters minus the lowest sum of diameters previously recorded. | Absolute Change From Nadir in Sum of Diameter | ||
| AREA | C25244 | Area | The extent of a 2-dimensional surface enclosed within a boundary. (NCI) | Area | ||
| AVMETSUV | C96566 | Average Metabolic Standard Uptake Value | A semiquantitative analysis of the average uptake of analyte by body tissue in relation to the total administered dose of the analyte. | Average Metabolic Standard Uptake Value | ||
| DIAMETER | C25285 | Diameter | The length of a straight line passing through the center of a circle or sphere and connecting two points on the circumference. (NCI) | Diameter | ||
| LDIAM | C96684 | Longest Diameter | The longest possible length of a straight line passing through the center of a circular or spheroid object that connects two points on the circumference. | Longest Diameter | ||
| LESFLIND | C119551 | Lesion Failure Indicator | An indication as to whether lesion failure occurred. | Lesion Failure Indicator | ||
| LESRVIND | C119552 | Lesion Revascularization Indicator | An indication as to whether repeat revascularization of a lesion occurred. | Lesion Revascularization Indicator | ||
| LESSCIND | C119553 | Lesion Success Indicator | An indication as to whether a performed procedure of a target lesion is considered successful. | Lesion Success Indicator | ||
| LMBFLIND | C119554 | Limb Failure Indicator | An indication as to whether limb failure occurred. | Limb Failure Indicator | ||
| LPERP | C96685 | Longest Perpendicular | The longest possible straight line or plane through a body or figure that is at a right angle to a given line or plane. | Longest Perpendicular | ||
| LRISCIND | C119555 | Lesion Revas Ischemia Indicator | An indication as to whether clinical or functional ischemia is present before lesion revascularization occurred. | Lesion Revascularization Ischemia Indicator | ||
| LRVCLIND | C119556 | Lesion Revas Clinical Indicator | An indication as to whether an appropriate clinical context was present before lesion revascularization occurred. | Lesion Revascularization Clinical Indicator | ||
| NEWCONF | C103421 | New Tumor Confirmed | The verification/confirmation by other methods or modalities that a tumor, which has not been previously seen or characterized, is present in the subject. | New Tumor Confirmation | ||
| PCBSA | C112369 | Percent Change Baseline in Sum of Area | The (current sum of areas minus the baseline sum of areas) divided by the baseline sum of areas, multiplied by 100. | Percent Change From Baseline in Sum of Area | ||
| PCBSD | C112370 | Percent Change Baseline in Sum of Diam | The (current sum of diameters minus the baseline sum of diameters) divided by the baseline sum of diameters, multiplied by 100. | Percent Change From Baseline in Sum of Diameter | ||
| PCBSLD | C112371 | Percent Change Baseline Sum Longest Diam | The (current sum of longest diameters minus the baseline sum of longest diameters) divided by the baseline sum of longest diameters, multiplied by 100. | Percent Change From Baseline in Sum of Longest Diameter | ||
| PCBSV | C112372 | Percent Change Baseline in Sum of Volume | The (current sum of volumes minus the baseline sum of volumes) divided by the baseline sum of volumes, multiplied by 100. | Percent Change From Baseline in Sum of Volume | ||
| PCHGBL | C96621 | Percent Change From Baseline | The (current value minus the baseline value) divided by the baseline value, multiplied by 100. | Percent Change From Baseline | ||
| PCHGNAD | C96622 | Percent Change From Nadir | The (current value minus the lowest value previously recorded) divided by the lowest value previously recorded, multiplied by 100. | Percent Change From Nadir | ||
| PCNSD | C112373 | Percent Change Nadir in Sum of Diam | The (current sum of diameters minus the lowest sum of diameters previously recorded) divided by the lowest sum of diameters previously recorded, multiplied by 100. | Percent Change From Nadir in Sum of Diameter | ||
| PCNSLD | C112374 | Percent Change Nadir in Sum Longest Diam | The (current sum of longest diameters minus the lowest sum of longest diameters previously recorded) divided by the lowest sum of longest diameters previously recorded, multiplied by 100. | Percent Change From Nadir in Sum of Longest Diameter | ||
| RADIODEN | C96627 | Radiodensity | The transparency of a material to the passage of X-rays and other forms of radiation. | Radiodensity | ||
| SAXIS | C94982 | Short Axis | The plane through a body or figure that is at the shortest width of that body or figure. | Short Axis | ||
| SUMAREA | C96630 | Sum of Area;Sum of Products of Perpendicular Diameters | A calculation of the aggregated area values. | Sum of Areas | ||
| SUMDIAM | C96631 | Sum of Diameter | A calculation of the aggregated diameter values. | Sum of Diameters | ||
| SUMLDIAM | C96632 | Sum of Longest Diameter | A calculation of the aggregated longest diameter values. | Sum of Longest Diameters | ||
| SUMLPERP | C96633 | Sum of Longest Perpendicular | A calculation of the aggregated longest perpendicular values. | Sum of Longest Perpendiculars | ||
| SUMNLNLD | C103441 | Sum Diameters of Non Lymph Node Tumors | A calculation of the aggregated diameter values for tumors other than the lymph nodes. | Sum of Diameters of Non Lymph Node Tumors | ||
| SUMVDIAM | C96634 | Sum of Viable Diameter | A calculation of the aggregated diameter values taken from the viable portion of the tumor mass. | Sum of Viable Diameters | ||
| SUMVOL | C96635 | Sum of Volume | A calculation of the aggregated volume values. | Sum of Volumes | ||
| TUMSTATE | C96643 | Tumor State | A condition or state of a tumor at a particular time. | Tumor Status | ||
| VDIAM | C96646 | Viable Diameter | The diameter of the portion of the tumor mass that is capable of growth, proliferation and metastasis. | Viable Tumor Diameter | ||
| VOLUME | C25335 | Volume | The amount of three dimensional space occupied by an object or the capacity of a space or container. (NCI) | Volume | ||
| VSLFLIND | C119557 | Vessel Failure Indicator | An indication as to whether vessel failure occurred. | Vessel Failure Indicator | ||
| VSLPIND | C119558 | Vessel Patency Indicator | An indication as to whether an artery is patent (free of TLR or restenosis) following intervention. | Vessel Patency Indicator | ||
| VSLRVIND | C119559 | Vessel Revascularization Indicator | An indication as to whether repeat revascularization of an artery containing a lesion occurred. | Vessel Revascularization Indicator | ||
| Back to top | ||||||
| CL.C96778.TRTEST | Tumor or Lesion Properties Test Name (TRTEST) | text Extensible: Yes | C96778 | Tumor or Lesion Properties Test Name | Terminology relevant to the test codes that describe the assessment or measurement of a tumor, lesion or site of disease. | CDISC SDTM Tumor or Lesion Properties Test Name Terminology |
| Absolute Change From Nadir | C103347 | Absolute Change From Nadir | The current value minus the lowest value previously recorded. | Absolute Change From Nadir | ||
| Absolute Change Nadir in Sum of Diam | C112218 | Absolute Change Nadir in Sum of Diam | The current sum of diameters minus the lowest sum of diameters previously recorded. | Absolute Change From Nadir in Sum of Diameter | ||
| Area | C25244 | Area | The extent of a 2-dimensional surface enclosed within a boundary. (NCI) | Area | ||
| Average Metabolic Standard Uptake Value | C96566 | Average Metabolic Standard Uptake Value | A semiquantitative analysis of the average uptake of analyte by body tissue in relation to the total administered dose of the analyte. | Average Metabolic Standard Uptake Value | ||
| Diameter | C25285 | Diameter | The length of a straight line passing through the center of a circle or sphere and connecting two points on the circumference. (NCI) | Diameter | ||
| Lesion Failure Indicator | C119551 | Lesion Failure Indicator | An indication as to whether lesion failure occurred. | Lesion Failure Indicator | ||
| Lesion Revas Clinical Indicator | C119556 | Lesion Revas Clinical Indicator | An indication as to whether an appropriate clinical context was present before lesion revascularization occurred. | Lesion Revascularization Clinical Indicator | ||
| Lesion Revas Ischemia Indicator | C119555 | Lesion Revas Ischemia Indicator | An indication as to whether clinical or functional ischemia is present before lesion revascularization occurred. | Lesion Revascularization Ischemia Indicator | ||
| Lesion Revascularization Indicator | C119552 | Lesion Revascularization Indicator | An indication as to whether repeat revascularization of a lesion occurred. | Lesion Revascularization Indicator | ||
| Lesion Success Indicator | C119553 | Lesion Success Indicator | An indication as to whether a performed procedure of a target lesion is considered successful. | Lesion Success Indicator | ||
| Limb Failure Indicator | C119554 | Limb Failure Indicator | An indication as to whether limb failure occurred. | Limb Failure Indicator | ||
| Longest Diameter | C96684 | Longest Diameter | The longest possible length of a straight line passing through the center of a circular or spheroid object that connects two points on the circumference. | Longest Diameter | ||
| Longest Perpendicular | C96685 | Longest Perpendicular | The longest possible straight line or plane through a body or figure that is at a right angle to a given line or plane. | Longest Perpendicular | ||
| New Tumor Confirmed | C103421 | New Tumor Confirmed | The verification/confirmation by other methods or modalities that a tumor, which has not been previously seen or characterized, is present in the subject. | New Tumor Confirmation | ||
| Percent Change Baseline in Sum of Area | C112369 | Percent Change Baseline in Sum of Area | The (current sum of areas minus the baseline sum of areas) divided by the baseline sum of areas, multiplied by 100. | Percent Change From Baseline in Sum of Area | ||
| Percent Change Baseline in Sum of Diam | C112370 | Percent Change Baseline in Sum of Diam | The (current sum of diameters minus the baseline sum of diameters) divided by the baseline sum of diameters, multiplied by 100. | Percent Change From Baseline in Sum of Diameter | ||
| Percent Change Baseline in Sum of Volume | C112372 | Percent Change Baseline in Sum of Volume | The (current sum of volumes minus the baseline sum of volumes) divided by the baseline sum of volumes, multiplied by 100. | Percent Change From Baseline in Sum of Volume | ||
| Percent Change Baseline Sum Longest Diam | C112371 | Percent Change Baseline Sum Longest Diam | The (current sum of longest diameters minus the baseline sum of longest diameters) divided by the baseline sum of longest diameters, multiplied by 100. | Percent Change From Baseline in Sum of Longest Diameter | ||
| Percent Change From Baseline | C96621 | Percent Change From Baseline | The (current value minus the baseline value) divided by the baseline value, multiplied by 100. | Percent Change From Baseline | ||
| Percent Change From Nadir | C96622 | Percent Change From Nadir | The (current value minus the lowest value previously recorded) divided by the lowest value previously recorded, multiplied by 100. | Percent Change From Nadir | ||
| Percent Change Nadir in Sum Longest Diam | C112374 | Percent Change Nadir in Sum Longest Diam | The (current sum of longest diameters minus the lowest sum of longest diameters previously recorded) divided by the lowest sum of longest diameters previously recorded, multiplied by 100. | Percent Change From Nadir in Sum of Longest Diameter | ||
| Percent Change Nadir in Sum of Diam | C112373 | Percent Change Nadir in Sum of Diam | The (current sum of diameters minus the lowest sum of diameters previously recorded) divided by the lowest sum of diameters previously recorded, multiplied by 100. | Percent Change From Nadir in Sum of Diameter | ||
| Radiodensity | C96627 | Radiodensity | The transparency of a material to the passage of X-rays and other forms of radiation. | Radiodensity | ||
| Short Axis | C94982 | Short Axis | The plane through a body or figure that is at the shortest width of that body or figure. | Short Axis | ||
| Sum Diameters of Non Lymph Node Tumors | C103441 | Sum Diameters of Non Lymph Node Tumors | A calculation of the aggregated diameter values for tumors other than the lymph nodes. | Sum of Diameters of Non Lymph Node Tumors | ||
| Sum of Area | C96630 | Sum of Area;Sum of Products of Perpendicular Diameters | A calculation of the aggregated area values. | Sum of Areas | ||
| Sum of Diameter | C96631 | Sum of Diameter | A calculation of the aggregated diameter values. | Sum of Diameters | ||
| Sum of Longest Diameter | C96632 | Sum of Longest Diameter | A calculation of the aggregated longest diameter values. | Sum of Longest Diameters | ||
| Sum of Longest Perpendicular | C96633 | Sum of Longest Perpendicular | A calculation of the aggregated longest perpendicular values. | Sum of Longest Perpendiculars | ||
| Sum of Viable Diameter | C96634 | Sum of Viable Diameter | A calculation of the aggregated diameter values taken from the viable portion of the tumor mass. | Sum of Viable Diameters | ||
| Sum of Volume | C96635 | Sum of Volume | A calculation of the aggregated volume values. | Sum of Volumes | ||
| Tumor State | C96643 | Tumor State | A condition or state of a tumor at a particular time. | Tumor Status | ||
| Vessel Failure Indicator | C119557 | Vessel Failure Indicator | An indication as to whether vessel failure occurred. | Vessel Failure Indicator | ||
| Vessel Patency Indicator | C119558 | Vessel Patency Indicator | An indication as to whether an artery is patent (free of TLR or restenosis) following intervention. | Vessel Patency Indicator | ||
| Vessel Revascularization Indicator | C119559 | Vessel Revascularization Indicator | An indication as to whether repeat revascularization of an artery containing a lesion occurred. | Vessel Revascularization Indicator | ||
| Viable Diameter | C96646 | Viable Diameter | The diameter of the portion of the tumor mass that is capable of growth, proliferation and metastasis. | Viable Tumor Diameter | ||
| Volume | C25335 | Volume | The amount of three dimensional space occupied by an object or the capacity of a space or container. (NCI) | Volume | ||
| Back to top | ||||||
| CL.C96782.RSTESTCD | Tumor Response Assessment Test Code (RSTESTCD) | text Extensible: Yes | C96782 | Tumor Response Assessment Test Code | Terminology relevant to the test codes that describe an assessment of tumor response to treatment or therapy. | CDISC SDTM Tumor Response Assessment Test Code Terminology |
| BESTRESP | C94536 | Best Overall Response;Best Response | An assessment of the most clinically favorable overall response of the disease to the therapy. | Best Overall Response | ||
| NEWLPROG | C103420 | New Lesion Progression | An assessment of the equivocality of disease progression based on a newly identified lesion. | New Lesion Progression | ||
| NRADPROG | C96608 | Non-Radiological Progression | A non-radiological determination of disease progression based on symptoms or other findings. | Non-Radiological Progression | ||
| NTRGRESP | C94535 | Non-target Response | An assessment of the response of a non-target tumor(s) to the therapy. | Response in Non-Target Lesion | ||
| OVRLRESP | C96613 | Overall Response | An assessment of the overall response of the disease to the therapy. (NCI) | Overall Response | ||
| TRGRESP | C94534 | Target Response | An assessment of the response of a target tumor(s) to the therapy. | Response in Target Lesion | ||
| Back to top | ||||||
| CL.C96781.RSTEST | Tumor Response Assessment Test Name (RSTEST) | text Extensible: Yes | C96781 | Tumor Response Assessment Test Name | Terminology relevant to the test names that describe an assessment of tumor response to treatment or therapy. | CDISC SDTM Tumor Response Assessment Test Name Terminology |
| Best Overall Response | C94536 | Best Overall Response;Best Response | An assessment of the most clinically favorable overall response of the disease to the therapy. | Best Overall Response | ||
| New Lesion Progression | C103420 | New Lesion Progression | An assessment of the equivocality of disease progression based on a newly identified lesion. | New Lesion Progression | ||
| Non-Radiological Progression | C96608 | Non-Radiological Progression | A non-radiological determination of disease progression based on symptoms or other findings. | Non-Radiological Progression | ||
| Non-target Response | C94535 | Non-target Response | An assessment of the response of a non-target tumor(s) to the therapy. | Response in Non-Target Lesion | ||
| Overall Response | C96613 | Overall Response | An assessment of the overall response of the disease to the therapy. (NCI) | Overall Response | ||
| Target Response | C94534 | Target Response | An assessment of the response of a target tumor(s) to the therapy. | Response in Target Lesion | ||
| Back to top | ||||||
| CL.C96785.RSSTRESC | Tumor Response Result (RSSTRESC) | text Extensible: Yes | C96785 | Tumor Response Result | The result of an assessment of tumor response to treatment or therapy. | CDISC SDTM Tumor Response Result Terminology |
| CR | C4870 | Complete Remission;Complete Response | The disappearance of all signs of cancer in response to treatment. (NCI) | Complete Remission | ||
| CRi | C103385 | Complete Remission with Incomplete Blood Count Recovery;Complete Response with Incomplete Bone Marrow Recovery | The disappearance of all signs of cancer in response to treatment accompanied by incomplete bone marrow recovery, as evidenced by persistent anemia, thrombocytopenia or neutropenia. | Complete Response with Incomplete Bone Marrow Recovery | ||
| EQUIVOCAL | C86071 | EQUIVOCAL | Open to question. | Equivocal | ||
| NE | C62222 | Not Evaluable | Unable to be evaluated. (NCI) | Unevaluable | ||
| Non-CR/Non-PD | C96700 | Non Complete Response/Non Progressive Disease | Persistence of one or more non-target lesion(s) and/or maintenance of tumor marker levels above the normal limits. (RECIST) | Non Complete Response/Non Progressive Disease | ||
| NOT ALL EVALUATED | C103424 | Not All Evaluated | Not all target tumors were assessed. Or not all non-target tumors were assessed. | Not All Tumors Evaluated | ||
| nPR | C103422 | Nodular Partial Response | Remission with remaining lymphoid nodules reflecting residual disease. | Nodular Partial Response | ||
| PD | C35571 | Progressive Disease | A disease process that is increasing in scope or severity. (NCI) | Progressive Disease | ||
| PR | C18058 | Partial Remission;Partial Response | A finding indicating that there is a decrease in the size and the extent of tissue involvement by a malignant tumor in a patient. (NCI) | Partial Remission | ||
| SD | C18213 | Stable Disease | Cancer that is neither decreasing nor increasing in extent or severity. (NCI) | Stable Disease | ||
| UPD | C96644 | Unequivocal Progression | An overall level of substantial worsening in non-target disease that is of a magnitude that, even in the presence of SD or PR in target disease, the treating physician would feel it important to change therapy. (RECIST) | Unequivocal Progression | ||
| Back to top | ||||||
| CL.C71620.UNIT | Unit (UNIT) | text Extensible: Yes | C71620 | Unit | Terminology codelist used for units within CDISC. | CDISC SDTM Unit of Measure Terminology |
| % | C25613 | Percentage | A fraction or ratio with 100 understood as the denominator. (NCI) | Percentage | ||
| % INHIBITION | C117963 | Percent Inhibition | The rate of measured normal activity minus inhibited activity, divided by the rate of normal activity of a given object. It is expressed as a percentage. | Percent Inhibition | ||
| %(v/v) | C48571 | Percent Volume per Volume;vol% | A percent ratio of volume to volume, defined by the equation: [volume of solute (in ml)/ volume of solution (in ml)](100), typically used for admixtures of solutions.(NCI) | Percent Volume per Volume | ||
| %(w/v) | C48527 | Percent Weight per Volume | A percent ratio of weight to volume, defined by the equation: [weight of solute (in gm)/volume of solution (in dl)](100). Since the numerator and denominator of this ratio have different units, it is not a true percentage. A 1% w/v solution is defined as being 1 gram of solute dissolved in 100 milliliters of solvent.(NCI) | Percent Mass per Volume | ||
| %(w/w) | C48528 | Percent Weight per Weight | A percent ratio of weight to weight, defined by the equation: [weight of solute (in gm)/weight of solution (in gm)](100).(NCI) | Percent Mass per Mass | ||
| %/min | C114240 | Percent per Minute | A unit of frequency expressed as the percentage of entities or events per minute. | Percent per Minute | ||
| /100 HPFs | C102695 | per 100 High Powered Fields | A unit of measurement of the number of entities per unit of area equal to one hundred high powered fields. | Per 100 High Powered Fields | ||
| /100 WBC | C67219 | Per 100 White Blood Cells | Natural number unit of measurement for a portion of a particular type of cell (excluding white blood cell subtypes) per 100 white blood cells. | Per 100 White Blood Cells | ||
| /10^3 cells | C116240 | A unit of measure equal to the instances of an entity per 1000 cells. | Per Thousand Cells | |||
| /day | C25473 | Daily;Per Day | Occurring or done each day. (NCI) | Daily | ||
| /dL | C105514 | Per Deciliter | A volume unit equal to one deciliter used as a denominator to build a derived unit expressed as a ratio. (NCI) | Per Deciliter | ||
| /h | C66966 | Per Hour | A rate of occurrences of something within a period of time equal to sixty minutes. | Per Hour | ||
| /HPF | C96619 | per High Powered Field | A unit of measure equal to the instances of an entity per visual field of a microscope set to its maximum magnification power. | Per High Powered Field | ||
| /L | C105515 | Per Liter | A volume unit equal to one liter used as a denominator to build a derived unit expressed as a ratio. (NCI) | Per Liter | ||
| /LPF | C96620 | per Low Powered Field | A unit of measure equal to the instances of an entity per visual field of a microscope set to its minimum magnification power. | Per Low Powered Field | ||
| /mL | C103452 | Per Milliliter | A volume unit equal to one milliliter used as a denominator to build a derived unit expressed as a ratio. (NCI) | Per Milliliter | ||
| /month | C64498 | Every Month;Per Month | Every month. (NCI) | Monthly | ||
| /nL | C116243 | Per Nanoliter | A volume unit equal to one nanoliter used as a denominator and a unitless measure used as the numerator. | Per Nanoliter | ||
| /pL | C117964 | Per Picoliter | A volume unit equal to one picoliter used as a denominator to build a derived unit expressed as a ratio. | Per Picoliter | ||
| /uL | C67254 | Per Microliter | A volume unit equal to one microliter used as a denominator to build a derived unit expressed as a ratio. (NCI) | Per Microliter | ||
| /VF | C105516 | per Visual Field | A unit of measure equal to the instances of an entity per visual field of a microscope. (NCI) | Per Visual Field | ||
| /wk | C67069 | Every week;Per Week;QS | Every week. (NCI) | Weekly | ||
| 100 IU/mL | C71185 | 100 International units/Milliliter | A unit of arbitrary substance concentration (biologic activity concentration) defined as the concentration of one hundred international units per one milliliter of system volume.(NCI) | 100 International Units per Milliliter | ||
| 10^10/L | C105517 | 10^4/mm3;10^4/uL;10^7/mL | A unit of measurement equal to 10 to the tenth power of entities per unit of volume equal to one liter. (NCI) | Ten Billion Per Liter | ||
| 10^11/L | C105488 | 10^5/mm3;10^5/uL;10^8/mL | A unit of measurement equal to 10 to the eleventh power of entities per unit of volume equal to one liter. | Hundred Billion Per Liter | ||
| 10^12 IU/L | C105518 | TIU/L;Tera International Unit per Liter | Unit of arbitrary substance concentration (biologic activity concentration) defined as the concentration of 10^12 international unit per one liter of system volume.(NCI) | Tera International Unit Per Liter | ||
| 10^12/L | C67308 | 10^6/mm3;10^6/uL;T/L;TI/L;Tera/L | A unit of measurement equal to 10 to the twelfth power of the number of entities per unit of volume equal to one liter. | Million per Microliter | ||
| 10^3 CFU | C68895 | Thousand CFU;Thousand Colony Forming Units | A unit of measurement of viable bacterial numbers equal to 10 to the third power colony forming units. | Thousand Colony Forming Units | ||
| 10^3 CFU/g | C68899 | Thousand CFU/g;Thousand Colony Forming Units per Gram | A unit of measurement of viable bacterial organisms in a unit mass of substance of interest defined as the number of 10 to the third power colony forming units in one gram of substance. | Thousand Colony Forming Units per Gram | ||
| 10^3 CFU/mL | C68903 | Thousand CFU/mL;Thousand Colony Forming Units per Milliliter | A unit of measurement of viable bacterial organisms in a unit volume of substance of interest defined as the number of 10 to the third power colony forming units in one milliliter of substance. | Thousand Colony Forming Units per Milliliter | ||
| 10^3 copies/mL | C100897 | The unit of concentration expressed as the number of 10 to the third power copies in unit volume equal to one milliliter. (NCI) | Thousand Copies per Milliliter | |||
| 10^3 DNA copies/mL | C98788 | A unit of measurement equal to 10 to the third power of the number of deoxyribonucleic acid (DNA) copies per unit of volume equal to one milliliter. | Thousand DNA Copies per Milliliter | |||
| 10^3 organisms | C71187 | Thousand Organisms | A unit of measure of quantity of organisms expressed in 10 to the third power of organisms. | Thousand Organisms | ||
| 10^3 organisms/g | C71190 | Thousand Organisms per Gram;Thousand Organisms/g | A unit of measure of organism content expressed in 10 to the third power of organisms per unit of mass equal to one gram. | Thousand Organisms per Gram | ||
| 10^3 organisms/mL | C71195 | Thousand Organisms per Milliliter;Thousand Organisms/mL | A unit of measure of organism concentration expressed in 10 to the third power of organisms per unit of volume equal to one milliliter. | Thousand Organisms per Milliliter | ||
| 10^3 RNA copies/mL | C98790 | A unit of measurement equal to 10 to the third power of the number of ribonucleic acid (RNA) copies per unit of volume equal to one milliliter. | Thousand RNA Copies per Milliliter | |||
| 10^3/hpf | C98789 | A unit of measurement equal to 10 to the third power of the number of entities per unit of area equal to one high powered field. | Thousand per High Powered Field | |||
| 10^3/L | C105519 | A unit of measurement equal to 10 to the third power of entities per unit of volume equal to one liter. | Thousand Per Liter | |||
| 10^4/hpf | C98787 | A unit of measurement equal to 10 to the fourth power of the number of entities per unit of area equal to one high powered field. | Ten Thousand per High Powered Field | |||
| 10^4/L | C73771 | A unit of measurement equal to 10 to the fourth power of entities per unit of volume equal to one liter. | Thousand per Deciliter | |||
| 10^5/hpf | C98743 | A unit of measurement equal to 10 to the fifth power of the number of entities per unit of area equal to one high powered field. | Hundred Thousand per High Powered Field | |||
| 10^5/L | C105490 | 10^2/mL | A unit of measurement equal to 10 to the fifth power of entities per unit of volume equal to one liter. | Hundred Thousand Per Liter | ||
| 10^6 CFU | C68896 | Million CFU;Million Colony Forming Units | A unit of measurement of viable bacterial numbers equal to 10 to the sixth power colony forming units. | Million Colony Forming Units | ||
| 10^6 CFU/g | C68900 | Million CFU/g;Million Colony Forming Units per Gram | A unit of measurement of viable bacterial organisms in a unit mass of substance of interest defined as the number of 10 to the sixth power colony forming units in one gram of substance. | Million Colony Forming Units per Gram | ||
| 10^6 CFU/mL | C68904 | Million CFU/mL;Million Colony Forming Units per Milliliter | A unit of measurement of viable bacterial organisms in a unit volume of substance of interest defined as the number of 10 to the sixth power colony forming units in one milliliter of substance. | Million Colony Forming Units per Milliliter | ||
| 10^6 copies/mL | C100898 | The unit of concentration expressed as the number of 10 to the sixth power copies in unit volume equal to one milliliter. (NCI) | Million Copies per Milliliter | |||
| 10^6 DNA copies/mL | C98756 | A unit of measurement equal to 10 to the sixth power of the number of deoxyribonucleic acid (DNA) copies per unit of volume equal to one milliliter. | Million DNA Copies per Milliliter | |||
| 10^6 IU | C67335 | Million IU;Million International Units | A unit of biological activity equal to 10 to the sixth power international units. | Million International Units | ||
| 10^6 IU/mL | C98757 | A unit of measurement equal to 10 to the sixth power of the number of international units of an entity per unit of volume equal to one milliliter. | Million International Units per Milliliter | |||
| 10^6 organisms | C71188 | Million Organisms | A unit of measure of quantity of organisms expressed in 10 to the sixth power of organisms. | Million Organisms | ||
| 10^6 organisms/g | C71191 | Million Organisms per Gram;Million Organisms/g | A unit of measure of organism content expressed in 10 to the sixth power of organisms per unit of mass equal to one gram. | Million Organisms per Gram | ||
| 10^6 organisms/mg | C71193 | Million Organisms per Milligram;Million Organisms/mg | A unit of measure of organism content expressed in 10 to the sixth power of organisms per unit of mass equal to one milligram. | Million Organisms per Milligram | ||
| 10^6 organisms/mL | C71196 | Million Organisms per Milliliter;Million Organisms/mL | A unit of measure of organism concentration expressed in 10 to the sixth power of organisms per unit of volume equal to one milliliter. | Million Organisms per Milliliter | ||
| 10^6 RNA copies/mL | C98760 | A unit of measurement equal to 10 to the sixth power of the number of ribonucleic acid (RNA) copies per unit of volume equal to one milliliter. | Million RNA Copies per Milliliter | |||
| 10^6/g | C98758 | A unit of measurement equal to 10 to the sixth power of the number of entities per unit of mass equal to one gram. | Million per Gram | |||
| 10^6/hpf | C98759 | A unit of measurement equal to 10 to the sixth power of the number of entities per unit of area equal to one high powered field. | Million per High Powered Field | |||
| 10^6/L | C67452 | 10^3/mL;M/L;Mega/L | A unit of measurement equal to 10 to the sixth power of the number of entities per unit of volume equal to one liter. | Thousand per Milliliter | ||
| 10^7/L | C98786 | 10^6/dL | A unit of measurement equal to 10 to the seventh power of the number of entities per unit of volume equal to one liter. | Ten Million per Liter | ||
| 10^8/L | C105489 | 10^2/mm3;10^2/uL;10^5/mL | A unit of measurement equal to 10 to the eighth power of entities per unit of volume equal to one liter. | Hundred Million Per Liter | ||
| 10^9 CFU | C68897 | Billion CFU;Billion Colony Forming Units | A unit of measurement of viable bacterial numbers equal to 10 to the ninth power colony forming units. | Billion Colony Forming Units | ||
| 10^9 CFU/g | C68901 | Billion CFU/g;Billion Colony Forming Units per Gram | A unit of measurement of viable bacterial organisms in a unit mass of substance of interest defined as the number of 10 to the ninth power colony forming units in one gram of substance. | Billion Colony Forming Units per Gram | ||
| 10^9 CFU/mL | C68905 | Billion CFU/mL;Billion Colony Forming Units per Milliliter | A unit of measurement of viable bacterial organisms in a unit volume of substance of interest defined as the number of 10 to the ninth power colony forming units in one milliliter of substance. | Billion Colony Forming Units per Milliliter | ||
| 10^9 organisms | C71189 | Billion Organisms | A unit of measure of quantity of organisms expressed in 10 to the ninth power of organisms. | Billion Organisms | ||
| 10^9 organisms/g | C71192 | Billion Organisms per Gram;Billion Organisms/g | A unit of measure of organism content expressed in 10 to the ninth power of organisms per unit of mass equal to one gram. | Billion Organisms per Gram | ||
| 10^9 organisms/mg | C71194 | Billion Organisms per Milligram;Billion Organisms/mg | A unit of measure of organism content expressed in 10 to the ninth power of organisms per unit of mass equal to one milligram. | Billion Organisms per Milligram | ||
| 10^9 organisms/mL | C71197 | Billion Organisms per Milliliter;Billion Organisms/mL | A unit of measure of organism concentration expressed in 10 to the ninth power of organisms per unit of volume equal to one milliliter. | Billion Organisms per Milliliter | ||
| 10^9/L | C67255 | 10^3/mm3;10^3/uL;10^6/mL;G/L;GI/L;Giga per Liter | A unit of measurement equal to 10 to the ninth power of the number of entities per unit of volume equal to one liter. | Billion per Liter | ||
| AFU | C77534 | Arbitrary Fluorescence Unit | Arbitrary unit(s) of fluorescent luminescence. (NCI) | Arbitrary Fluorescence Units | ||
| ag | C64553 | Attogram | A unit of mass equal to one quintillionth of a gram (10E-18 gram).(NCI) | Attogram | ||
| AgU/mL | C70500 | Antigen Unit per Milliliter | A measure of an antigen potency defined as a number of antigen units per one milliliter of product.(NCI) | Antigen Unit per Milliliter | ||
| amol | C68855 | Attomole | A unit of amount of substance equal to one quintillionth of a mole (10E-18 mole).(NCI) | Attomole | ||
| amp | C42536 | Ampere | A unit of electric current, named after the French physicist Andre Ampere. It is that constant current which, if maintained in two straight parallel conductors of infinite length and zero diameter separated by one meter in a vacuum, would produce between these conductors a force equal to 2(10E7) Newton per meter of length. This is dependent upon the definitions of the meter, kilogram, and second. One Ampere represents 6.24 x 10(E18) unit electric charge carriers, such as electrons, passing a specified fixed point in one second.(NCI) | Ampere | ||
| AMPULE | C48473 | Ampule Dosing Unit | A dosing measurement based on the ampule unit.(NCI) | Ampule Dosing Unit | ||
| amu | C64559 | Atomic Mass Unit | A small unit of mass used to express atomic and molecular masses. (NCI) | Atomic Mass Unit | ||
| anti-Xa IU | C70497 | Anti-Xa Activity International Unit | A unit of unfractionated or low molecular weight heparin anticoagulation potency determined as the amount that neutralizes one unit of coagulation factor Xa preparation defined as an international biological standard by WHO (World Health Organization) First International Low Molecular Weight Heparin Reference Standard.(NCI) | Anti-Xa Activity International Unit | ||
| anti-Xa IU/mL | C70498 | Anti-Xa Activity International Unit per Milliliter | A specific anticoagulation activity of unfractionated or low molecular weight heparin on factor Xa, expressed as a number of international anti-Xa heparin units per one milliliter of plasma.(NCI) | Anti-Xa Activity International Unit per Milliliter | ||
| Antibody Unit | C111129 | A unit of antibody concentration measured by comparison against a known concentration of antibodies in a standard reference specimen. | Antibody Unit | |||
| APL U/mL | C117965 | Immunoglobin A Phospholipid Units per Milliliter | A unit for semiquantitative measurement of IgA autoantibodies to proteins associated with negatively charged phospholipids evaluated against an established reference standard, per unit of volume equal to one milliliter. | Immunoglobin A Phospholipid Unit per Milliliter | ||
| APPLICATION | C25397 | Application Dosing Unit | A dosing measurement based on the amount of substance applied. | Application Unit | ||
| atm | C54711 | Atmosphere | A unit of pressure, equal to a barometer reading of 760 mm Hg. 1 atmosphere is 101325 Pascals and 1.01325 bar. This unit of pressure is roughly equal to the average atmospheric pressure at sea level on the earth.(NCI) | Atmosphere | ||
| AU | C73686 | Absorbance Unit | A unit of optical density expressed as the absorbance of light transmitted through the medium on the logarithmic scale. (NCI) | Absorbance Unit | ||
| AU/min | C73687 | Absorbance Unit per Minute | A unit of a speed of optical density change expressed as a logarithm of absorbance of light transmitted through a partially absorbing substance per minute. (NCI) | Absorbance Unit per Minute | ||
| AU/mL | C70504 | Allergy Unit per Milliliter | Unit of measure of potency of allergenic product expressed as a number of allergy units per one milliliter of formulation.(NCI) | Allergy Unit per Milliliter | ||
| BAG | C48474 | Bag Dosing Unit | A dosing measurement based on the bag unit.(NCI) | Bag Dosing Unit | ||
| BAR | C48475 | Bar Dosing Unit | A dosing measurement based on the bar unit.(NCI) | Bar Dosing Unit | ||
| BAU | C70505 | Bioequivalent Allergy Unit | A unit used for standardization of an allergenic product based on evaluation of product potency against reference standard in combined in vivo (skin test) and in vitro (IgE-based ELISA) testing.(NCI) | Bioequivalent Allergy Unit | ||
| BAU/mL | C116235 | Bioequivalent Allergy Unit per Milliliter | Unit of measure of potency of allergenic product expressed as a number of bioequivalent allergy units per one milliliter of formulation. | Bioequivalent Allergy Unit per Milliliter | ||
| BE/mL | C116231 | Biological Unit per Milliliter | Unit of measure of potency of allergenic product expressed as a number of biological units per one milliliter of formulation. | Biological Allergy Unit per Milliliter | ||
| BEATS/MIN | C49673 | Beats per Minute | The number of heartbeats measured per minute time. (NCI) | Beats per Minute | ||
| bel | C71200 | Bel | A logarithmic ratio unit (base-10 logarithms) used to express relative magnitude of a physical quantity (usually power or intensity) in comparison with a specified or implied reference level. Particularly, Bel is used as a unit of relative sound intensity. In the latter context it is equal to ten decibels or to approximately 1.151293 nepers.(NCI) | Bel | ||
| BISCUIT | C111139 | A measurement based on the biscuit unit. | Biscuit Dosing Unit | |||
| BLOCKS | C111140 | A unit of measure to quantify the number of rectangular areas in a city surrounded by streets. | Block Unit of Distance | |||
| BOLUS | C48476 | Bolus Dosing Unit | A dosing measurement based on the bolus unit.(NCI) | Bolus Dosing Unit | ||
| BOTTLE | C48477 | Bottle Dosing Unit | A dosing measurement based on the bottle unit.(NCI) | Bottle Dosing Unit | ||
| BOX | C48478 | Box Dosing Unit | A dosing measurement based on the box unit.(NCI) | Box Dosing Unit | ||
| Bq | C42562 | Becquerel | A unit of activity of a radionuclide, equal to one nuclear disintegration or other nuclear transition from a particular energy state occurring in an amount of a radionuclide during one second-long time interval.(NCI) | Becquerel | ||
| Bq/g | C70522 | Becquerel per Gram | A unit of specific radioactivity (massic activity) equal to activity of one Becquerel of the sample with total mass of one gram.(NCI) | Becquerel per Gram | ||
| Bq/kg | C70521 | Becquerel per Kilogram | A unit of specific radioactivity (massic activity) equal to activity of one Becquerel of the sample with total mass of one kilogram.(NCI) | Becquerel per Kilogram | ||
| Bq/L | C71165 | Becquerel per Liter | A unit of volumetric radioactivity concentration defined as a concentration of a radionuclide with an activity equal to one Becquerel per unit volume equal to one liter.(NCI) | Becquerel per Liter | ||
| Bq/mg | C70524 | Becquerel per Milligram;Kilobecquerel per Gram;kBq/g | A unit of specific radioactivity (massic activity) equal to activity of one Becquerel of the sample with total mass of one milligram.(NCI) | Becquerel per Milligram | ||
| Bq/mL | C71167 | Becquerel per Milliliter;Kilobecquerel per Liter;kBq/L | A unit of volumetric radioactivity concentration defined as a concentration of a radionuclide with an activity equal to one Becquerel per unit volume equal to one milliliter or one kilobecquerel per liter.(NCI) | Becquerel per Milliliter | ||
| Bq/ug | C70523 | Becquerel per Microgram;Bq/mcg;Kilobecquerel per Milligram;MBq/g;Megabecquerel per Gram;kBq/mg | A unit of specific radioactivity (massic activity) equal to activity of one Becquerel of the sample with total mass of one microgram.(NCI) | Becquerel per Microgram | ||
| Bq/uL | C71166 | Becquerel per Microliter;Kilobecquerel per Milliliter;MBq/L;Megabecquerel per Liter;kBq/mL | A unit of volumetric radioactivity concentration defined as a concentration of a radionuclide with an activity equal to one Becquerel per unit volume equal to one millionth of a liter.(NCI) | Becquerel per Microliter | ||
| BREATHS/MIN | C49674 | Breaths per Minute | The number of breaths (inhalation and exhalation) taken per minute time. (NCI) | Breaths per Minute | ||
| BU | C117966 | Bethesda Unit | A unit of measurement for blood coagulation inhibitor activity, expressed in the amount of an inhibitor neutralizing 50% of a coagulant during the incubation period. | Bethesda Unit | ||
| BU/mL | C117967 | Bethesda Unit per Milliliter | A unit of measurement for blood coagulation inhibitor activity, expressed as a Bethesda Unit per unit of volume equal to one milliliter. (NCI) | Bethesda Unit per Milliliter | ||
| C | C42559 | Degree Celsius | A unit of temperature of the temperature scale designed so that the freezing point of water is 0 degrees and the boiling point is 100 degrees at standard atmospheric pressure. The current official definition of the Celsius sets 0.01 C to be at the triple point of water and a degree to be 1/273.16 of the difference in temperature between the triple point of water and absolute zero. One degree Celsius represents the same temperature difference as one Kelvin. (NCI) | Degree Celsius | ||
| cal | C67193 | Calorie | A measurement of nutritional energy. The quantity of thermal energy required to raise one gram of water one degree Centigrade under standard conditions. 1 calorie equals 4.186 joules. (NCI) | calorie | ||
| CAN | C48479 | Can Dosing Unit | A dosing measurement based on the can unit.(NCI) | Can Dosing Unit | ||
| CAPFUL | C102405 | Capful Dosing Unit | A unit of measure equal to the amount that the cap on the bottle can contain. | Capful Dosing Unit | ||
| CAPLET | C64696 | Caplet Dosing Unit | A dosing measurement based on the caplet unit. | Caplet Dosing Unit | ||
| CAPSULE | C48480 | Capsule Dosing Unit;cap | A dosing measurement based on the capsule unit.(NCI) | Capsule Dosing Unit | ||
| CARTRIDGE | C48481 | Cartridge Dosing Unit | A dosing measurement based on the cartridge unit.(NCI) | Cartridge Dosing Unit | ||
| CCID 50 | C70534 | 50 Percent Cell Culture Infective Dose | A potency unit defined as a minimal dose of infectious material at which preparation causes cytopathic effects (changes in the morphology and metabolism of cell culture cells, indicating cell death, due to suspected infection) in the 50% of the cell culture-containing vessels inoculated with that dilution of infectious material.(NCI) | 50 Percent Cell Culture Infective Dose | ||
| CCID 50/dose | C70535 | 50 Percent Cell Culture Infective Dose per Dose | A potency unit equal to the potency at which one dose of preparation contains one 50 percent cell culture infective dose.(NCI) | 50 Percent Cell Culture Infective Dose per Dose | ||
| cd | C42538 | Candela | The candela is the basic unit of luminous intensity. It is the luminous intensity in a given direction of a small monochromatic light source at 540 terahertz emitting 1/683 watt per steradian in that direction. This is dependent upon the definitions of the meter, kilogram, and second.(NCI) | Candela | ||
| cells/kg | C116239 | A unit of cell concentration expressed in cells per unit of mass equal to one kilogram. | Cells per Kilogram | |||
| cells/uL | C67242 | cells/mm3 | A unit of cell concentration expressed in cells per unit of area equal to one cubic millimeter. | Cells per Microliter | ||
| CFU/g | C68898 | Colony Forming Unit per Gram | A unit of measurement of viable bacterial organisms in a unit mass of substance of interest defined as the number of colony forming units in one gram of substance.(NCI) | Colony Forming Unit per Gram | ||
| CFU/mL | C68902 | Colony Forming Unit per Milliliter | A unit of measurement of viable bacterial organisms in a unit volume of substance of interest defined as the number of colony forming units in one milliliter of substance.(NCI) | Colony Forming Unit per Milliliter | ||
| cg | C64554 | Centigram | A unit of mass equal to one hundredth of a gram.(NCI) | Centigram | ||
| cGy | C64693 | Centigray | The metric unit of absorbed radiation dose equal to the absorption of one hundredth of joule of radiation energy per kilogram of matter. | Centigray | ||
| Ci | C48466 | Curie | A unit of radioactivity defined as 3.7 E10 atomic disintegrations or other nuclear transformations per second. One Curie is equal to 37 gigabecquerels.(NCI) | Curie | ||
| Ci/g | C70528 | Curie per Gram;Microcurie per Microgram;Millicurie per Milligram;mCi/mg;uCi/ug | A unit of specific radioactivity (massic activity) equal to activity of one Curie of the sample with total mass of one gram.(NCI) | Curie per Gram | ||
| Ci/kg | C70529 | Curie per Kilogram;Microcurie per Milligram;Millicurie per Gram;mCi/g;uCi/mg | A unit of specific radioactivity (massic activity) equal to activity of one Curie of the sample with total mass of one kilogram.(NCI) | Curie per Kilogram | ||
| Ci/L | C71170 | Curie per Liter;Microcurie per Microliter;uCi/uL | A unit of volumetric radioactivity concentration defined as a concentration of a radionuclide with an activity equal to one Curie per unit volume equal to one liter.(NCI) | Curie per Liter | ||
| Ci/mg | C70531 | Curie per Milligram;Millicurie per Microgram;mCi/ug | A unit of specific radioactivity (massic activity) equal to activity of one Curie of the sample with total mass of one milligram.(NCI) | Curie per Milligram | ||
| Ci/mL | C71172 | Curie per Milliliter | A unit of volumetric radioactivity concentration defined as a concentration of a radionuclide with an activity equal to one Curie per unit volume equal to one milliliter.(NCI) | Curie per Milliliter | ||
| Ci/ug | C70530 | Ci/mcg;Curie per Microgram | A unit of specific radioactivity (massic activity) equal to activity of one Curie of the sample with total mass of one microgram.(NCI) | Curie per Microgram | ||
| Ci/uL | C71171 | Ci/mcL;Curie per Microliter | A unit of volumetric radioactivity concentration defined as a concentration of a radionuclide with an activity equal to one Curie per unit volume equal to one millionth of a liter.(NCI) | Curie per Microliter | ||
| CIGAR | C116244 | Cigar Dosing Unit | A dosing measurement based on the cigar unit. | Cigar Dosing Unit | ||
| CIGARETTE | C116245 | Cigarette Dosing Unit | A dosing measurement based on the cigarette unit. | Cigarette Dosing Unit | ||
| cL | C69087 | Centiliter | The unit of volume equal to one hundredth of a liter or 10 milliliters or 10 cubic centimeters or 0.6102 cubic inch. | Centiliter | ||
| cm | C49668 | Centimeter | A basic unit of length equal to one hundredth of a meter or approximately 0.393700787 inch. | Centimeter | ||
| cm H2O | C91060 | A unit of pressure defined by a column of water with a height of one centimeter, frequently used to measure central venous pressure, intracranial pressure, and for pressures during mechanical ventilation. | Centimeters of Water | |||
| cm/min | C105481 | Centimeters per Minute | A unit of both speed (scalar) and velocity (vector), defined as the distance of one centimeter travelled per unit time equal to one minute. (NCI) | Centimeter Per Minute | ||
| cm/s | C102406 | cm/sec | A unit of both speed (scalar) and velocity (vector), defined as the distance of one centimeter travelled per unit time equal to one second. (NCI) | Centimeter per Second | ||
| cm2 | C48460 | Square Centimeter | A unit of area measurement equal to a square measuring one centimeter on each side. One square centimeter is equal to 10E-4 square meter.(NCI) | Square Centimeter | ||
| cmol | C68687 | Centimole | A unit of amount of substance equal to one hundredth of a mole (10E-2 mole).(NCI) | Centimole | ||
| cmol/L | C68886 | Millimoles per Deciliter;mmol/dL | A unit of concentration (molarity unit) equal to one centimole of solute in one liter of solution. (NCI) | Centimole per Liter | ||
| COAT | C48483 | Coat Dosing Unit | A dosing measurement based on the coat unit.(NCI) | Coat Dosing Unit | ||
| CONTAINER | C48484 | Container Dosing Unit | A dosing measurement based on the container unit.(NCI) | Container Dosing Unit | ||
| copies/mL | C100900 | A unit of concentration expressed as a number of copies per unit volume equal to one milliliter. | Copies per Milliliter | |||
| copies/uL | C116237 | A unit of concentration expressed as a number of copies per unit volume equal to one microliter. | Copies per Microliter | |||
| Coulomb | C42550 | Coulomb | A unit of quantity of electricity, equal to the quantity of charge transferred in one second across a conductor in which there is a constant current of one Ampere.(NCI) | Coulomb | ||
| cpm | C73688 | Counts per Minute | A unit of frequency expressed as the detection rate of ionization events per minute. | Count per Minute | ||
| cs | C105482 | 10^-2 sec;Centisecond;csec | A unit of time equal to one hundredth of a second (10E-2 seconds). (NCI) | Centisecond | ||
| CUP | C54703 | Cup Dosing Unit | A dosing measurement based on the cup unit.(NCI) | Cup Dosing Unit | ||
| cy/cm | C114242 | Grating Cycles per Centimeter;cpcm | A unit of measure for the number of repeating vertical or horizontal bars per unit of length equal to one centimeter on a visual acuity testing card. | Grating Cycles per Centimeter | ||
| cycle/min | C71176 | Cycle per Minute | A unit of frequency equal to the frequency at which one complete execution of a periodically repeated phenomenon, alternation, event, or sequence of events occurs per unit of time equal to one minute.(NCI) | Cycle per Minute | ||
| cycle/sec | C71480 | Cycle per Second | A unit of frequency equal to the frequency at which one complete execution of a periodically repeated phenomenon, alternation, event, or sequence of events occurs per unit of time equal to one second.(NCI) | Cycle per Second | ||
| CYLINDER | C48489 | Cylinder Dosing Unit | A dosing measurement based on the cylinder unit.(NCI) | Cylinder Dosing Unit | ||
| DAgU | C70501 | D Antigen Unit | A unit of potency of poliovirus vaccine used for poliomyelitis prevention. The unit is poliovirus type-specific.(NCI) | D Antigen Unit | ||
| DAgU/mL | C70502 | D Antigen Unit per Milliliter | A unit of potency of poliovirus vaccine expressed as a number of D antigen units per one milliliter of vaccine formulation.(NCI) | D Antigen Unit per Milliliter | ||
| damol/L | C105483 | Decamole per Liter;Moles per Deciliter;mol/dL | A unit of concentration (molarity unit) equal to one decamole of solute in one liter of solution. (NCI) | Decamole Per Liter | ||
| DAYS | C25301 | Day | The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours. This also refers to a specific day. (NCI) | Day | ||
| dB | C102407 | Decibel | A unit of measure representing the intensity of an electrical signal or sound which is equal to ten times the logarithm of the ratio of two signals. | Decibel | ||
| deg | C68667 | Degree Unit of Plane Angle | A unit of plane angle measurement equal to the length of the arc cut out by the angle, divided by the circumference of the circle, and multiplied by 360. The symbol for degrees is a small superscript circle. One radian is about 57 degrees and one degree is pi/180 radians.(NCI) | Degree Unit of Plane Angle | ||
| DIOPTER | C100899 | Diopter | A unit of measurement of the optical power of a curved mirror or lens represented by the inverse of the focal length in meters. | Diopter | ||
| DISK | C48490 | Disk Dosing Unit | A dosing measurement based on the disk unit.(NCI) | Disk Dosing Unit | ||
| dL | C64697 | Deciliter | The unit of volume equal to one tenth of a liter. Accepted for use with the SI. (NCI) | Deciliter | ||
| dmol | C68685 | Decimole | A unit of amount of substance equal to one tenth of a mole (10E-1 mole).(NCI) | Decimole | ||
| DNA copies/mL | C98719 | DNA Copies per Milliliter | The unit of concentration of deoxyribonucleic acid (DNA) copies expressed as a number of copies in unit volume equal to one milliliter. | DNA Copies per Milliliter | ||
| DPM | C73710 | Disintegrations per Minute | A unit of radioactive decay expressed in atoms of radioactive material that decay over a period of time equal to sixty seconds. (NCI) | Disintegration per Minute | ||
| dpm/100mg | C117968 | Disintegrations per Minute per 100 milligrams;dpm/cg | A unit of radioactive decay expressed in atoms of radioactive material that decay over a period of time equal to sixty seconds in a mass unit equal to one hundred milligrams. | Disintegration per Minute per 100 milligrams | ||
| dpm/mg | C117969 | Disintegrations per Minute per Milligram | A unit of radioactive decay expressed in atoms of radioactive material that decay over a period of time equal to sixty seconds in a mass unit equal to one milligram. | Disintegration per Minute per Milligram | ||
| dpm/mL | C117970 | Disintegrations per Minute per Milliliter | A unit of radioactive decay expressed in atoms of radioactive material that decay over a period of time equal to sixty seconds in a volume unit equal to one milliliter. | Disintegration per Minute per Milliliter | ||
| dram | C64564 | Dram | A unit of mass equal to 1/16 Avoirdupois ounce or 1/256 Avoirdupois pound. One dram equals approximately 1.7718451953125 grams.(NCI) | Dram Mass Unit | ||
| DRUM | C48492 | Drum Dosing Unit | A dosing measurement based on the drum unit.(NCI) | Drum Dosing Unit | ||
| dyn | C70470 | Dyne | A unit of force defined as the force that accelerates a mass of one gram at the rate of one centimeter per second squared. One dyne is equal to 10E-5 Newton and 2.248E-6 pounds of force.(NCI) | Dyne | ||
| EID 50 | C70532 | 50 Percent Embryo Infective Dose | Amount of infectious agent or biological product that causes infection in the 50% of embryos such as chicken embryos used in the product potency assay or pathogen activity assay.(NCI) | 50 Percent Embryo Infective Dose | ||
| EID 50/dose | C70533 | 50 Percent Embryo Infective Dose per Dose | A potency unit for measuring infectious activity of a biologic product or an infectious agent preparation equal to the potency at which one dose of infectious material contains one 50 percent embryo infective dose.(NCI) | 50 Percent Embryo Infective Dose per Dose | ||
| ELISA unit | C68875 | Enzyme-Linked Immunosorbent Assay Unit | A unit for measuring concentration or/and reactivity of a test substance (an antigen or antibody of interest) as defined in the literature reference standard for the particular quantitative enzyme-linked immunosorbent assay method. The enzyme-linked immunosorbent assay unit is used to express potency of immunologically active substances and products, e.g. vaccines.(NCI) | Enzyme-Linked Immunosorbent Assay Unit | ||
| ELISA unit/dose | C68876 | Enzyme-Linked Immunosorbent Assay Unit per Dose | A unit for measuring potency of immunologically active substance in a product determined as reactivity in a quantitative immunoassay for particular antigen or antibody and expressed per quantity of preparation used as a single dose.(NCI) | Enzyme-Linked Immunosorbent Assay Unit per Dose | ||
| ELISA unit/mL | C68877 | Enzyme-Linked Immunosorbent Assay Unit per Milliliter | A unit for measuring potency of immunologically active substance in a product determined as reactivity in a quantitative immunoassay for particular antigen or antibody and expressed per unit volume equal to one milliliter.(NCI) | Enzyme-Linked Immunosorbent Assay Unit per Milliliter | ||
| Enzyme U | C64778 | Enzyme Unit | A unit of catalytic activity measurement defined as the quantity of a particular enzyme that catalyzes the transformation of one micromole of the substrate per minute under standard conditions for specified assay system. | Enzyme Unit | ||
| eq | C67273 | Equivalent Weight | A unit of relative amount of a substance that combines with or displaces 8.0 grams of oxygen or 1.008 gram of hydrogen. The unit is usually expressed in grams and is equal to the amount of substance that gains or loses one mole of electrons in a redox reaction, or to the amount of substances that releases or accepts one mole of hydrogen ions in a neutralization reaction; or to the amount of electrolyte that carries one mole of positive or negative charge. This is a large unit and measurements are more often done in its derivatives, e.g. in milliequivalents.(NCI) | Equivalent Weight | ||
| EU | C96599 | EU/dL;Ehrlich Units | A unit of measure equal to one milligram of urobilinogen per deciliter. | Ehrlich Unit | ||
| F | C44277 | Degree Fahrenheit | The Fahrenheit temperature scale is named after the German physicist Gabriel Fahrenheit (1686-1736), who proposed it in 1724. In this scale, the freezing point of water is 32 degrees Fahrenheit and the boiling point is 212 degrees, placing the boiling and melting points of water 180 degrees apart. In this scale a degree Fahrenheit is 5/9ths of a Kelvin (or of a degree Celsius), and minus 40 degrees Fahrenheit is equal to minus 40 degrees Celsius. (NCI) | Degree Fahrenheit | ||
| Farad | C42552 | Farad | A unit of capacitance equal to the capacitance of a capacitor having an equal and opposite charge of one coulomb on each plate and a potential difference of one volt between the plates.(NCI) | Farad | ||
| FEU | C96649 | Fibrinogen Equivalent Units | A unit of measure for the concentration of fibrin degradation products in a sample, calculated based upon the mass of fibrinogen contained within that sample. | Fibrinogen Equivalent Unit | ||
| fg | C64552 | Femtogram | A unit of mass equal to one quadrillionth of a gram (10E-15 gram).(NCI) | Femtogram | ||
| FINGERTIP UNIT | C71321 | Fingertip Unit | An arbitrary dosing unit used predominantly for semisolid topical formulations such as cream, ointment, paste, etc. One fingertip unit is the amount of a product that is squeezed out from a standard tube with 5-millimeter diameter nozzle along an adult's fingertip. A fingertip length is defined from the tip of the index finger to the first finger crease. A fingertip dosing unit varies with age and size of the body. The average fingertip unit is equal to approximately 0.5 gram for an adult male and 0.4 gram for an adult female.(NCI) | Fingertip Dosing Unit | ||
| fL | C64780 | Cubic Micrometer;Cubic Micron;Femtoliter;um3 | The unit of volume equal 10E-15 liter. | Femtoliter | ||
| fmol | C68854 | Femtomole | A unit of amount of substance equal to one quadrillionth of a mole (10E-15 mole).(NCI) | Femtomole | ||
| fmol/g | C73711 | Femtomole per Gram | A molality unit that describes the amount of substance, expressed in femtomole(s) per gram. (NCI) | Femtomole per Gram | ||
| fmol/L | C68887 | Femtomole per Liter | A unit of concentration (molarity unit) equal to one quadrillionth of a mole (10E-15 mole) of solute in one liter of solution. (NCI) | Femtomole per Liter | ||
| foz_br | C48577 | Fluid Ounce Imperial | A traditional unit of liquid volume equal in the British Imperial system to 1/20 pint, or 1.733871 cubic inches or 28.413063 milliliters. | Fluid Ounce British | ||
| foz_us | C48494 | Fluid Ounce US | A traditional unit of liquid volume equal in the US customary system to 1/16 pint, or 1.804687 cubic inches or 29.573531 milliliters. | Fluid Ounce US | ||
| fraction of 1 | C105484 | A unit for expressing a percentage as a decimal whereby the total value is measured as a fraction of the numeric 1. | Fraction of 1 | |||
| Frames/s | C106524 | F/s;FPS;Frames per Second;Frames/sec | A unit of measure equal to the number of visual frames per unit of time equal to one second. (NCI) | Frames Per Second | ||
| ft | C71253 | Foot | A unit of length defined by the U.S. National Bureau of Standards as 30.48 centimeters. It is equal to 0.3048 meter, 12 inches, or to approximately 0.999998 survey foot.(NCI) | International Foot | ||
| ft2 | C48461 | Square Foot | A unit of area equal to 144 square inches, 929.0304 square centimeters, or 9.290304E-2 square meters.(NCI) | Square Foot | ||
| ft3 | C68859 | Standard Cubic Foot | A unit used in physical chemistry to express the amount of substance of an ideal gas in one cubic foot at 60 degrees Fahrenheit and pressure of one atmosphere.(NCI) | Standard Cubic Foot | ||
| g | C48155 | Gram | A metric unit of mass equal to one one thousandth of a kilogram. (NCI) | Gram | ||
| g/animal | C73713 | Gram per Animal | A unit of measure expressed in gram(s) per animal. | Gram per Animal | ||
| g/animal/day | C73714 | Gram per Animal per Day | A unit of measure expressed in gram(s) per animal per period of time equal to twenty-four hours. | Gram per Animal per Day | ||
| g/animal/wk | C73715 | Gram per Animal per Week | A unit of measure expressed in gram(s) per animal per period of time equal to seven days. | Gram per Animal per Week | ||
| g/cage | C73716 | Gram per Cage | A unit of measure expressed in gram(s) per cage. | Gram per Cage | ||
| g/cage/day | C73717 | Gram per Cage per Day | A unit of measure expressed in gram(s) per cage per period of time equal to twenty-four hours. | Gram per Cage per Day | ||
| g/cage/wk | C73718 | Gram per Cage per Week | A unit of measure expressed in gram(s) per cage per period of time equal to seven days. | Gram per Cage per Week | ||
| g/cm2 | C71201 | Gram per Square Centimeter | A unit of area density defined as a spread rate at which one gram of a substance is spread over the area of one square centimeter. The unit is also used as a dose calculation unit.(NCI) | Gram per Square Centimeter | ||
| g/day | C67372 | Gram per Day;g/24h;g/d;gram/24 Hours;gram/day | A dose calculation unit expressed in gram(s) per period of time equal to twenty-four hours. | Gram per 24 Hours | ||
| g/dL | C64783 | Gram per Deciliter;g% | A unit of mass concentration defined as the concentration of one gram of a substance per unit volume of the mixture equal to one deciliter (100 milliliters). The concept also refers to the metric unit of mass density (volumic mass) defined as the density of substance which mass equal to one gram occupies the volume one deciliter.(NCI) | Gram per Deciliter | ||
| g/g | C70453 | Gram per Gram | A unit of a mass fraction expressed as a number of grams of substance per gram of mixture. | Gram per Gram | ||
| g/g/day | C73720 | Gram per Gram per Day | A unit of measure expressed in gram(s) per gram per period of time equal to twenty-four hours. | Gram per Gram per Day | ||
| g/kg | C69104 | Gram per Kilogram;Milligram per Gram;mg/g | A unit of a mass fraction expressed as a number of grams of substance per kilogram of mixture. The unit is also used as a dose calculation unit.(NCI) | Gram per Kilogram | ||
| g/kg/day | C66975 | Gram per Kilogram per Day;Milligram per Gram per Day;mg/g/day | A dose administration rate unit equal to the rate at which one gram of a product per kilogram of body mass is delivered or administered over the period of one day. (NCI) | Gram per Kilogram per Day | ||
| g/L | C42576 | Gram per Liter;Kilogram per Cubic Meter;Microgram per Microliter;Milligram per Milliliter;g/L;kg/m3;mg/mL;ug/uL | A unit of concentration or mass density equal to one milligram of substance per milliliter of solution or one gram of substance per liter of solution. | Kilogram per Cubic Meter | ||
| g/m2 | C67282 | Gram per Square Meter | A unit of area density defined as a spread rate at which one gram of a substance is spread over the area of one square meter. It is equal to approximately 0.029 4935 ounce per square yard. Also used as a dose calculation unit.(NCI) | Gram per Square Meter | ||
| g/m2/day | C73722 | Gram per Square Meter per Day | A dose calculation unit expressed in gram(s) per square meter per period of time equal to twenty-four hours. | Gram per Square Meter per Day | ||
| g/mol | C73721 | Gram per Mole | A unit of mass commonly used to express the molar mass of a substance in gram(s) per mole. (NCI) | Gram per Mole | ||
| Gauss | C68915 | Gauss | The unit of magnetic flux density. A field of one Gauss exerts a force on a conductor, placed in the field of 0.1 dyne per Ampere of current per centimeter of conductor. One Gauss represents a magnetic flux of one Maxwell per square centimeter of cross-section perpendicular to the field. One Gauss equals 10-4 Tesla.(NCI) | Gauss | ||
| GBq | C70513 | Gigabecquerel | A unit of radioactivity equal to one billion nuclear disintegrations or other nuclear transformations per second, or to 10E9 Becquerels.(NCI) | Gigabecquerel | ||
| GBq/g | C70525 | Gigabecquerel per Gram;Kilobecquerel per Microgram;kBq/ug | A unit of specific radioactivity (massic activity) equal to activity of one gigabecquerel of the sample with total mass of one gram.(NCI) | Gigabecquerel per Gram | ||
| GBq/mg | C70527 | Gigabecquerel per Milligram;MBq/mcg;MBq/ug;Megabecquerel per Microgram | A unit of specific radioactivity (massic activity) equal to activity of one gigabecquerel of the sample with total mass of one milligram.(NCI) | Gigabecquerel per Milligram | ||
| GBq/ug | C70526 | GBq/mcg;Gigabecquerel per Microgram;MBq/ng;Megabecquerel per nanogram | A unit of specific radioactivity (massic activity) equal to activity of one gigabecquerel of the sample with total mass of one microgram.(NCI) | Gigabecquerel per Microgram | ||
| GPL U/mL | C117971 | Immunoglobin G Phospholipid Units per Milliliter | A unit for semiquantitative measurement of IgG autoantibodies to proteins associated with negatively charged phospholipids evaluated against an established reference standard, per unit of volume equal to one milliliter. | Immunoglobin G Phospholipid Unit per Milliliter | ||
| grain | C48497 | Grain | A unit of mass derived from the weight of a grain and equal to one seven-thousandth of a pound, or 1/480 troy ounce, or 64.79891 milligrams. The original English grain unit based on the mass of a ripe grain barleycorn was larger the corresponding grain units of France and other European nations which were based on the weight of the smaller wheat grain.(NCI) | Grain | ||
| gtt | C69442 | Drop | A unit of volume equal to 0.05 milliliter (20 drops/ml).(NCI) | Medical Drop | ||
| Gy | C18063 | Gray | A unit of absorbed radiation dose. One gray is equal to an absorbed dose of one joule per kilogram of matter, or to 100 rads.(NCI) | Gray | ||
| Henry | C42558 | Henry | A unit of electric inductance. A coil with an inductance of one Henry requires a flux of one Weber for each Ampere of induced current. If it is the current which changes, then the induced field will generate a potential difference within the coil: if the inductance is one Henry a current change of one Ampere per second generates a potential difference of one volt. The Henry is a large unit; inductances in practical circuits are measured in millihenrys or microhenrys.(NCI) | Henry | ||
| HEP | C116232 | Histamine Equivalent Prick Unit | Unit of measure of potency of allergenic product expressed as a number of histamine equivalent prick units. | Histamine Equivalent Prick Unit | ||
| HOMEOPATHIC DILUTION | C48498 | Homeopathic Dilution Unit | A dosing measurement based on the homeopathic dilution unit.(NCI) | Homeopathic Dilution Unit | ||
| Hounsfield Unit | C94908 | HU | The unit of measure for the radiodensity of a substance. The radiodensity of distilled water at standard temperature and pressure is zero on the Hounsfield scale. | Hounsfield Unit | ||
| HOURS | C25529 | Hour;hr | A unit measure of time equal to 3,600 seconds or 60 minutes. It is approximately 1/24 of a median day. (NCI) | Hour | ||
| hPa | C105487 | Hectopascal | A SI derived unit of pressure equivalent to one hundred pascals, 1 millibar or 0.0145 pounds per square inch. | Hectopascal | ||
| HPF | C67274 | High Power Field | The area visible under the maximum magnification power of the objective being used in microscopy.(NCI) | High Power Field | ||
| Hz | C42545 | Hertz | A unit of frequency equal to one cycle per second.(NCI) | Hertz | ||
| IMPLANT | C48499 | Implant Dosing Unit | A dosing measurement based on the implant unit.(NCI) | Implant Dosing Unit | ||
| in | C48500 | Inch | A traditional unit of length equal to 2.54 centimeters. (NCI) | Inch | ||
| in2 | C68871 | Square Inch | A unit of area equal to the area of a square with sides of one inch. It is equal to 6.4516 square centimeters.(NCI) | Square Inch | ||
| INHALATION | C48501 | Inhalation Dosing Unit | A dosing measurement based on the inhalation unit.(NCI) | Inhalation Dosing Unit | ||
| IU | C48579 | IE;International Unit | The unitage assigned by the WHO (World Health Organization) to International Biological Standards - substances, classed as biological according to the criteria provided by WHO Expert Committee on Biological Standardization, to enable the results of biological and immunological assay procedures to be expressed in the same way throughout the world. The definition of an international unit is generally arbitrary and technical, and has to be officially approved by the International Conference for Unification of Formulae.(NCI) | International Unit | ||
| IU/g | C70493 | International Unit per Gram | A unit of measure of quantity of substance per unit mass, expressed in terms of the International Unit per grams.(NCI) | International Unit per Gram | ||
| IU/kg | C67379 | International Unit per Kilogram | An arbitrary unit of substance content expressed in international units of biological activity per one kilogram of mass of the system. It is also used as a dose calculation unit expressed in international units of biological activity per one kilogram of body mass.(NCI) | International Unit per Kilogram | ||
| IU/kg/h | C71209 | International units per Kilogram per Hour | A dose calculation unit equal to one international unit (an arbitrary unit of biological activity) of a product per one kilogram of body mass administered per unit of time equal to one hour.(NCI) | International Unit per Kilogram per Hour | ||
| IU/L | C67376 | IE/L;IU/L;International Unit per Liter;mIU/mL | A unit of concentration (biologic activity) equal to one milli-international unit of substance per milliliter of solution or one international unit of substance per liter of solution. | International Unit per Liter | ||
| IU/mg | C67380 | International Unit per Milligram | A unit of measure of quantity of substance per unit mass, expressed in terms of international units per milligram. | International Unit per Milligram | ||
| IU/mL | C67377 | IE/mL;International Unit per Milliliter;Kilo International Unit per Liter;kIU/L | A unit of concentration (biologic activity) equal to one international unit of substance per milliliter of solution. | International Unit per Milliliter | ||
| JAR | C48502 | Jar Dosing Unit | A dosing measurement based on the jar unit.(NCI) | Jar Dosing Unit | ||
| Joule | C42548 | Joule | A unit of electrical, mechanical, and thermal energy (as well as work and quantity of heat), equal to the work done when the point of application of a force of one Newton is displaced through a distance of one meter in the direction of the force or the work done when a current of one Ampere passes through a resistance of one ohm for one second. One joule is equal to 0.23889 gram-calorie (mean).(NCI) | Joule | ||
| KALLIKREIN INHIBITOR UNIT | C48503 | Kallikrein Inhibitor Unit | A dosing measurement based on the Kallikrein inhibitor unit.(NCI) | Kallikrein Inhibitor Unit | ||
| kat | C42566 | Katal | A unit for measuring catalytic (e.g. enzymatic) activity, the ability of the compound to accelerate the chemical reaction by providing a lower energy pathway between the reactants and the products. One katal is that catalytic activity which will raise the rate of reaction by one mole per second in a specified assay system. When the katal is used, the measurand should be specified by reference to the measurement procedure; the measurement procedure must identify the indicator reaction. The katal is not used to express a rate of reaction itself, which should be expressed in moles per second.(NCI) | Katal | ||
| kBq | C70511 | Kilobecquerel | A unit of radioactivity equal to one thousand nuclear disintegrations or other nuclear transformations per second, or to 10E3 Becquerels.(NCI) | Kilobecquerel | ||
| kBq/uL | C71168 | GBq/L;Gigabecquerel per Liter;Kilobecquerel per Microliter;MBq/mL;Megabecquerel per Milliliter | A unit of volumetric radioactivity concentration defined as a concentration of a radionuclide with an activity equal to one thousand Becquerels per unit volume equal to one millionth of a liter.(NCI) | Kilobecquerel per Microliter | ||
| kcal | C67194 | Kilogram-Calorie | A unit of energy defined as the amount of heat required to raise the temperature of one kilogram of pure water by one degree Centigrade under standard conditions (the specific heat of the water at 15 degrees Celsius and the constant pressure of 101.325 kilopascals or one atm being defined as unity), equal to approximately 4.1855 kJ. It is also is used by nutritionists in measuring the energy-producing potential of food as a unit of potential energy contained by a substance, which can be liberated when the material is oxidized, usually by combustion in the presence of oxygen.(NCI) | Calorie | ||
| kDa | C105491 | Kilodalton;Kilounified Atomic Mass Unit;ku | A mass unit equal to one thousand daltons. | Kilodalton | ||
| kg | C28252 | Kilogram | The basic SI unit of mass. It is defined as the mass of an international prototype in the form of a platinum-iridium cylinder kept at Sevres in France. It is the only basic unit still defined in terms of a material object, and also the only one with a prefix [kilo] already in place. A kilogram is equal to 1,000 grams and 2.204 622 6 pounds. (NCI) | Kilogram | ||
| kg/cm2 | C69094 | Kilogram per Square Centimeter | A unit of spread rate of a substance by mass expressed in kilograms per area unit equal to one square centimeter, used also as a measure of area density and as a dose calculation unit.(NCI) | Kilogram per Square Centimeter | ||
| kg/L | C64566 | Gram per Milliliter;Kilogram per Liter;g/mL;gram/mL;kg/L;mg/uL | A unit of concentration or mass density equal to one gram of substance per milliliter of solution or one kilogram of substance per liter of solution. | Kilogram per Liter | ||
| kg/m2 | C49671 | Kilogram per Square Meter | A unit expressed as kilogram of mass per square meter of area.(NCI) | Kilogram per Square Meter | ||
| kHz | C67279 | kilohertz | A unit of measure denoting the frequency equal to 1000 cycles per second meaning e.g. that the cylical waveform changes from one state to the other (from one polarity to the other) 1000 times per second. (NCI) | Kilohertz | ||
| KIT | C48504 | Kit Dosing Unit | A dosing measurement based on the kit unit.(NCI) | Kit Dosing Unit | ||
| kIU | C70492 | Kilo International Unit | A unit equal to one thousand international units.(NCI) | Kilointernational Unit | ||
| km | C71177 | Kilometer | A unit of distance equal to 1000 meters, 0.621 miles, 1094 yards, or 3281 feet.(NCI) | Kilometer | ||
| km/h | C71203 | Kilometer Per Hour | A unit of both speed (scalar) and velocity (vector), defined as the distance of one thousand meters travelled per unit time equal to one hour.(NCI) | Kilometer per Hour | ||
| kN/cm2 | C92615 | Kilonewton per Centimeter Squared;kdyn/cm2 | The kilonewton per centimeter squared is an SI derived unit of pressure; one newton is computed as the force necessary to accelerate a mass of one gram at the rate of one centimeter per second squared. One kilonewton per centimeter squared is descriptive of the amount of force exerted in a particular area. This measurement is frequently used when describing conditions of cellular movement. (NCI) | Kilonewton per Centimeter Squared | ||
| kPa | C67284 | Kilopascal | A SI derived unit of pressure equivalent to 1000 newtons per square meter or 10000 bars or to 0.145 pound per square inch. (NCI) | Kilopascal | ||
| kPa/L/sec | C105492 | Pa/mL/sec | A unit of resistance equal to the number of kilopascals per unit of volume equal to one liter per unit of time equal to one second. (NCI) | Kilopascal Per Liter Per Second | ||
| ks | C105493 | 10^3 sec;Kilosecond;ksec | A unit of time equal to one thousand seconds (10E3 seconds). (NCI) | Kilosecond | ||
| kUSP | C71202 | Kilo United States Pharmacopoeia Unit | A unit of potency equal to one thousand US Pharmacopoeia Units.(NCI) | Kilo United States Pharmacopeia Unit | ||
| L | C48505 | Liter | A unit of volume equal to a cubic decimeter, or one thousandth of cubic meter, or 1000 cubic centimeters, or approximately 61.023 744 cubic inches.(NCI) | Liter | ||
| L/h | C69160 | L/h | Liters per hour. | Liter per Hour | ||
| L/h/m2 | C105494 | Liters per Hour per Square Meter | A unit expressed as one liter of volume per unit of time equal to one hour per square meter of area. (NCI) | Liter Per Hour Per Square Meter | ||
| L/kg | C73725 | Liter per Kilogram | A dose calculation unit expressed in liter(s) per kilogram. (NCI) | Liter per Kilogram | ||
| L/L | C105495 | Liter per Liter;dL/dL;mL/mL;uL/uL | A unit of volume concentration equal to the number of liters per unit of volume equal to one liter. | Liter Per Liter | ||
| L/min | C67388 | Liters per Minute | A unit of volumetric flow rate defined as the rate at which one liter of matter travels during the period of time equal to one minute.(NCI) | Liter per Minute | ||
| L/min/m2 | C105496 | Liters per Minute per Square Meter | A unit expressed as one liter of volume per unit of time equal to one minute per square meter of area. (NCI) | Liter Per Minute Per Square Meter | ||
| L/s | C67390 | L/sec | Liters per second. | Liter per Second | ||
| LB | C48531 | Pound | A traditional unit of mass. By international agreement, one avoirdupois pound is equal to exactly 0.453 592 37 kilogram, 16 ounces, or 1.215 28 troy pounds. (NCI) | Pound | ||
| lm | C42560 | Lumen | A unit of luminous flux. It is the amount of light that falls on a unit area at unit distance from a source of one candela.(NCI) | Lumen | ||
| log EID 50/dose | C70480 | Log10 50 Percent Embryo Infective Dose per Dose | A logarithmic-scale (base 10) potency unit for measuring infectious activity of a biologic product or infectious agent preparation equal to the potency at which one dose of infectious material contains one 50 percent embryo infective dose.(NCI) | Log10 50 Percent Embryo Infective Dose per Dose | ||
| log10 CCID 50 | C70484 | Log10 50 Percent Cell Culture Infective Dose | A potency unit for measuring infectious activity of a biologic product or infectious agent preparation equal to a base-10 logarithm of amount of product or agent preparation that causes infection in the 50% of the cell culture-containing vessels inoculated with that dilution of infectious material in the product potency assay or pathogen activity assay.(NCI) | Log10 50 Percent Cell Culture Infective Dose | ||
| log10 CCID 50/dose | C70485 | Log10 50 Percent Cell Culture Infective Dose per Dose | A logarithmic-scale (base 10) potency unit for measuring infectious activity of a biologic product or infectious agent preparation equal to the potency at which one dose of infectious material contains one 50 percent cell culture infective dose.(NCI) | Log10 50 Percent Cell Culture Infective Dose per Dose | ||
| log10 CFU/g | C102658 | A logarithmic-scale (base 10) unit for measuring colony forming units per unit of mass equal to one gram. | Log10 Colony Forming Units per Gram | |||
| log10 CFU/mL | C102659 | A logarithmic-scale (base 10) unit for measuring colony forming units per unit of volume equal to one milliliter. | Log10 Colony Forming Units per Milliliter | |||
| log10 copies/mL | C117972 | A logarithmic-scale (base 10) unit for measuring copies per unit of volume equal to one milliliter. | Log10 Copies per Milliliter | |||
| log10 EID 50 | C70479 | Log10 50 Percent Embryo Infective Dose | A potency unit for measuring infectious activity of a biologic product or infectious agent equal to a base-10 logarithm of amount of product or agent preparation that causes infection in the 50% of embryos (such as chicken embryos) used in the product potency assay or pathogen activity assay.(NCI) | Log10 50 Percent Embryo Infective Dose | ||
| Log10 ELISA unit | C68878 | Log10 Enzyme-Linked Immunosorbent Assay Unit | A logarithmic-scale (base 10) unit for measuring concentration and/or reactivity of a test substance (an antigen or antibody of interest) as defined in the literature reference for the particular quantitative enzyme-linked immunosorbent assay method.(NCI) | Log10 Enzyme-Linked Immunosorbent Assay Unit | ||
| Log10 ELISA unit/dose | C68879 | Log10 Enzyme-Linked Immunosorbent Assay Unit per Dose | A logarithmic-scale (base 10) unit for measuring potency of immunologically active substance in a product determined as reactivity in a quantitative immunoassay for particular antigen or antibody and expressed per quantity of preparation used as a single dose.(NCI) | Log10 Enzyme-Linked Immunosorbent Assay Unit per Dose | ||
| log10 IU/mL | C116238 | A logarithmic-scale (base 10) unit for measuring international units per unit of volume equal to one milliliter. | Log10 International Units per Milliliter | |||
| log10 TCID 50 | C70488 | Log10 50 Percent Tissue Culture Infective Dose | A potency unit for measuring infectious activity of a biologic product or infectious agent preparation equal to a base-10 logarithm of amount of product or agent preparation that causes infection in the 50% of the tissue culture-containing flasks inoculated with that dilution of infectious material in the product potency assay or pathogen activity assay.(NCI) | Log10 50 Percent Tissue Culture Infective Dose | ||
| log10 TCID 50/dose | C70489 | Log10 50 Percent Tissue Culture Infective Dose per Dose | A logarithmic-scale (base 10) potency unit for measuring infectious activity of a biologic product or infectious agent preparation equal to the potency at which one dose of infectious material contains one 50 percent tissue culture infective dose.(NCI) | Log10 50 Percent Tissue Culture Infective Dose per Dose | ||
| LOZENGE | C48506 | Lozenge Dosing Unit | A dosing measurement based on the lozenge unit.(NCI) | Lozenge Dosing Unit | ||
| LPF | C67307 | Low Power Field | The area visible in one view field of the microscope under the low magnification of the objective being used in microscopy.(NCI) | Low Power Field | ||
| lx | C42561 | Lux | A unit of illuminance equal to the direct illumination on a surface that is everywhere one meter from a uniform point source of one candela; a unit of illuminance that is equal to one lumen per square meter.(NCI) | Lux | ||
| m | C41139 | Meter | A meter is defined as the length of the path traveled by light in a vacuum during a time interval of 1/299 792 458 of a second and is equal to 1.093 61 yards.(NCI) | Meter | ||
| m/sec | C42571 | Meter Per Second | A unit of both speed (scalar) and velocity (vector), defined as the distance of one meter travelled per unit time equal to one second.(NCI) | Meter per Second | ||
| m2 | C42569 | Square Meter | The SI unit of area measurement equal to a square whose sides are one meter long. Square meter is equal to 10,000 square centimeters; 0.01 ares; 1.196 square yards; 10.76 square feet; 1550 square inches. (NCI) | Square Meter | ||
| m3 | C42570 | Cubic Meter | A unit of volume or capacity equal to the volume of a cube with edges one meter in length. It is equal to 1,000 liters; 1,000 cubic decimeters; 10(E6) cubic centimeters; 25.3 cubic feet; 6.29 barrels.(NCI) | Cubic Meter | ||
| MBq | C70512 | Megabecquerel | A unit of radioactivity equal to one million nuclear disintegrations or other nuclear transformations per second, or to 10E6 Becquerels.(NCI) | Megabecquerel | ||
| MBq/uL | C71169 | GBq/mL;Gigabecquerel per Milliliter;Megabecquerel per Microliter | A unit of volumetric radioactivity concentration defined as a concentration of a radionuclide with an activity equal to one million Becquerels per unit volume equal to one millionth of a liter.(NCI) | Megabecquerel per Microliter | ||
| mCi | C48511 | Millicurie | A unit of radioactivity equal to one thousandth of a Curie or 37 megabecquerels, and corresponding to a radioactivity of 37 millions of atomic disintegrations per second.(NCI) | Millicurie | ||
| mCi/kg | C70570 | Microcurie per Gram;Millicurie per Kilogram;uCi/g | A unit of specific radioactivity (massic activity) equal to activity of one millicurie of the sample with total mass of one kilogram.(NCI) | Millicurie per Kilogram | ||
| mCi/L | C71174 | Microcurie per Milliliter;Millicurie per Liter;uCi/mL | A unit of volumetric radioactivity concentration defined as a concentration of a radionuclide with an activity equal to one thousandth of a Curie per unit volume equal to one liter.(NCI) | Millicurie per Liter | ||
| mEq | C48512 | Milliequivalent | A unit of relative amount of a substance equal to one thousandth of an equivalent weight.(NCI) | Milliequivalent | ||
| mEq/day | C67471 | Milliequivalents per Day | A unit of relative amount of substance flow rate equivalent to the rate at which one thousandth of an equivalent of substance travels to a given object or space over a period of time equal to twenty four hours.(NCI) | Milliequivalent per 24 Hours | ||
| mEq/dL | C67473 | Milliequivalent per Deciliter | A concentration unit measured as a number of milliequivalents of solute per deciliter of solution. (NCI) | Milliequivalent per Deciliter | ||
| mEq/g | C70580 | Milliequivalent Per Gram | A unit of relative amount of substance content equivalent to the content at which one gram of mixture contains one thousandth of an equivalent of a component. The unit is also used as a dose calculation unit.(NCI) | Milliequivalent per Gram | ||
| mEq/g Creatinine | C105501 | A unit of relative amount of substance concentration defined as the concentration of milliequivalents per gram of creatinine. | Milliequivalent Per Gram of Creatinine | |||
| mEq/kg | C67475 | Milliequivalent Per Kilogram | A unit of relative amount of substance content equivalent to the content at which one kilogram of mixture contains one thousandth of an equivalent of a component. The unit is also used as a dose calculation unit.(NCI) | Milliequivalent per Kilogram | ||
| mEq/L | C67474 | Milliequivalent Per Liter;Millivalent per Liter;mval/L | A concentration unit measured as a number of milliequivalents of solute per liter of solution.(NCI) | Milliequivalent per Liter | ||
| mEq/mL | C73737 | Milliequivalent per Milliliter | A concentration unit expressed in milliequivalent(s) of solute per milliliter of solution. (NCI) | Milliequivalent per Milliliter | ||
| mEq/mmol | C92616 | Milliequivalent per Millimole | A concentration unit measured as a number of one thousandth of an equivalent weight per millimole of substance. (NCI) | Milliequivalent per Milliimole | ||
| mEq/ug | C70581 | Milliequivalent Per Microgram;mEq/mcg | A unit of relative amount of substance content equivalent to the content at which one millionth of a gram of mixture contains one thousandth of an equivalent of a component. The unit is also used as a dose calculation unit.(NCI) | Milliequivalent per Microgram | ||
| mEq/uL | C70578 | Milliequivalent Per Microliter | A concentration unit measured as a number of milliequivalents of solute per microliter of solution.(NCI) | Milliequivalent per Microliter | ||
| MESF | C96691 | Molecules of Equivalent Soluble Fluorochromes | A unit of measure of the fluorescence intensity of a fluorochrome-labeled sample, which is equivalent to the fluorescence intensity of a solution containing an equivalent number of molecules of free fluorochrome in solution, under identical experimental conditions. | Molecule of Equivalent Soluble Fluorochrome | ||
| MFI | C96687 | Median Fluorescence Intensity | A unit of measure equal to the geometric mean fluorescence intensity of a log-normal distribution of fluorescence signals. | Median Fluorescence Intensity | ||
| mg | C28253 | Milligram | The unit of mass equal to one thousandth of a gram or 1000 micrograms. One milligram equals approximately 0.015432 grain or 35.274 x 10E-6 ounce.(NCI) | Milligram | ||
| mg/animal | C73738 | Milligram per Animal | A unit of measure expressed in milligram(s) per animal. | Milligram per Animal | ||
| mg/day | C67399 | Milligram per Day | A unit of measure referring to the ratio between mass expressed in milligrams per day.(NCI) | Milligram per 24 Hours | ||
| mg/dL | C67015 | Milligram per Deciliter;mg% | A unit of mass concentration defined as the concentration of one milligram of a substance in unit volume of the mixture equal to one cubic deciliter or 100 cubic centimeters. It is also a unit of mass density (volumic mass) defined as the density of substance which mass equal to one milligram occupies the volume one cubic deciliter or 100 cubic centimeters.(NCI) | Milligram per Deciliter | ||
| mg/g Creatinine | C105502 | A unit of substance concentration defined as the number of milligrams per gram of creatinine. | Milligram Per Gram of Creatinine | |||
| mg/g/h | C73740 | Milligram per Gram per Hour | A dose calculation unit expressed in milligram(s) per gram per period of time equal to sixty minutes. (NCI) | Milligram per Gram per Hour | ||
| mg/g/min | C73741 | Milligram per Gram per Minute | A dose calculation unit expressed in milligram(s) per gram per period of time equal to sixty seconds. (NCI) | Milligram per Gram per Minute | ||
| mg/h | C66969 | Milligram per Hour | A unit of mass flow rate equivalent to the rate at which one thousandth of a gram of matter travels to a given object or space over a period of time equal to one hour.(NCI) | Milligram per Hour | ||
| mg/kg | C67401 | Milligram per Kilogram;ug/g | A unit of a mass fraction expressed as a number of milligrams of substance per kilogram of mixture. The unit is also used as a dose calculation unit.(NCI) | Milligram per Kilogram | ||
| mg/kg/day | C66976 | Milligram per Kilogram per Day | A dose calculation unit expressed in milligram(s) per kilogram per period of time equal to twenty-four hours. (NCI) | Milligram per Kilogram per Day | ||
| mg/kg/h | C71362 | Milligram per Kilogram per Hour | A dose calculation unit equal to one thousandth of a gram of a preparation per one kilogram of body mass administered per unit of time equal to one hour.(NCI) | Milligram per Kilogram per Hour | ||
| mg/kg/min | C71207 | Milligram per Kilogram per Minute | A dose calculation unit equal to one thousandth of a gram of a preparation per one kilogram of body mass administered per unit of time equal to one minute.(NCI) | Milligram per Kilogram per Minute | ||
| mg/L | C64572 | Gram per Cubic Meter;Microgram per Milliliter;Milligram per Liter;g/m3;mcg/mL;mg/L;ng/uL;ug/mL | A unit of concentration or mass density equal to one microgram of substance per milliliter of solution or one milligram of substance per liter of solution. | Microgram per Milliliter | ||
| mg/m2 | C67402 | Milligram per Square Meter | A unit of area density equal to approximately 2.94935E-5 ounce per square yard. Also used as a dose calculation unit.(NCI) | Milligram per Square Meter | ||
| mg/m2/day | C66974 | Milligram per Square Meter per Day | A dose calculation unit expressed in milligram(s) per square meter per period of time equal to twenty-four hours. (NCI) | Milligram per Square Meter per Day | ||
| mg/m2/h | C73743 | Milligram per Square Meter per Hour | A dose calculation unit expressed in milligram(s) per square meter per period of time equal to sixty minutes. (NCI) | Milligram per Square Meter per Hour | ||
| mg/m2/min | C73744 | Milligram per Square Meter per Minute | A dose calculation unit expressed in milligram(s) per square meter per period of time equal to sixty seconds. (NCI) | Milligram per Square Meter per Minute | ||
| mg/min | C73742 | Milligram per Minute | Milligrams per minute. | Milligram per Minute | ||
| mg/mL/min | C67403 | Milligram per Milliliter per Minute | A unit expressed in milligrams per milliliter per period of time equal to sixty seconds. | Milligram per Milliliter per Minute | ||
| MHz | C67314 | Megahertz | The SI derived unit of frequency; equal to one million oscillations per second or to 10E6 hertz. (NCI) | Megahertz | ||
| Mile | C71183 | International Mile | A unit of distance equal to 5280 international feet, 1760 international yards, or 1609.344 meters.(NCI) | Mile | ||
| min | C48154 | Minute Unit of Time | A unit measure of time equal to 60 seconds.(NCI) | Minute | ||
| mIU/L | C67405 | Micro-International Unit per milliliter;mIE/L;mIU/L;mcIU/mL;uIU/mL | A unit of concentration (biologic activity) equal to one micro-international unit of substance per milliliter of solution or one milli-international unit of substance per liter of solution. | Microinternational Unit per Milliliter | ||
| mJoule/cm2 | C116241 | A unit of radiant exposure defined as a unit of energy equal to one millijoule applied to a unit of area equal to one square centimeter. | Millijoules per Square Centimeter | |||
| mkat | C70507 | Millikatal | A unit of catalytic activity measurement equal to one thousandth of one katal (10E-3 katal).(NCI) | Millikatal | ||
| mL | C28254 | Milliliter;cm3 | The unit of volume equal to one thousandth of a liter, one cubic centimeter, 10E-6 cubic meter, or approximately to 0.061 023 7 cubic inch.(NCI) | Milliliter | ||
| mL/animal | C73746 | Milliliter per Animal | A unit of measure expressed in milliliter(s) per animal. | Milliliter per Animal | ||
| mL/animal/day | C73747 | Milliliter per Animal per Day | A unit of measure expressed in milliliter(s) per animal per period of time equal to twenty-four hours. | Milliliter per Animal per Day | ||
| mL/animal/wk | C73748 | Milliliter per Animal per Week | A unit of measure expressed in milliliter(s) per animal per period of time equal to seven days. | Milliliter per Animal per Week | ||
| mL/breath | C73749 | Milliliter per Breath | A unit of measure expressed in milliliter(s) per inspiration or expiration of breath. | Milliliter per Breath | ||
| mL/cage | C73750 | Milliliter per Cage | A unit of measure expressed in milliliter(s) per cage. | Milliliter per Cage | ||
| mL/cage/day | C73751 | Milliliter per Cage per Day | A unit of measure expressed in milliliter(s) per cage per period of time equal to twenty-four hours. | Milliliter per Cage per Day | ||
| mL/cage/wk | C73752 | Milliliter per Cage per Week | A unit of measure expressed in milliliter(s) per cage expressed per period of time equal to seven days. | Milliliter per Cage per Week | ||
| mL/cm | C105503 | Milliliter per Centimeter;dL/m | A unit of measure equal to the number of milliliters per unit of length equal to one centimeter. (NCI) | Milliliter per Centimeter | ||
| mL/cm H2O | C98755 | A unit of pressure expressed in milliliter(s) per centimeter of water. (NCI) | Milliliter per Centimeter of Water | |||
| mL/day | C67410 | Milliliter per Day | Milliliters per day. | Milliliter per 24 Hours | ||
| mL/dL | C105504 | Milliliters per Deciliter | A unit of volume concentration equal to the number of milliliters per unit of volume equal to one deciliter. | Milliliter per Deciliter | ||
| mL/g | C73754 | Milliliter per Gram | A unit of measure expressed in milliliter(s) per gram. | Milliliter per Gram | ||
| mL/g/day | C73755 | L/day/kg;L/kg/d;Milliliter per Gram per Day;mL/day/g;mL/g/day;uL/day/mg;uL/mg/day | Liters per kilogram per day. | Milliliter per Gram per Day | ||
| mL/g/h | C73756 | Milliliter per Gram per Hour | Milliliters per gram per hour. | Milliliter per Gram per Hour | ||
| mL/g/min | C73757 | Milliliter per Gram per Minute | Milliliters per gram per minute. | Milliliter per Gram per Minute | ||
| mL/h | C66962 | Milliliters per Hour | A unit of volumetric flow rate defined as the rate at which one milliliter of matter travels during the period of time equal to one hour.(NCI) | Milliliter per Hour | ||
| mL/kg | C67411 | Milliliter per Kilogram | A dose calculation unit equal to one milliliter of preparation per one kilogram of body mass. (NCI) | Milliliter per Kilogram | ||
| mL/kg/day | C73758 | Milliliter per Kilogram per Day | Milliliters per kilogram per day. | Milliliter per Kilogram per Day | ||
| mL/kg/h | C73759 | Milliliter per Kilogram per Hour | Milliliters per kilogram per hour. | Milliliter per Kilogram per Hour | ||
| mL/kg/min | C73760 | Milliliter per Kilogram per Minute;mL/kg/min;mL/min/kg;uL/g/min;uL/min/g | Milliliters per kilogram per minute. | Milliliter per Kilogram per Minute | ||
| mL/m2 | C73761 | Milliliter per Square Meter | A unit of measure expressed in milliliter(s) per square meter. | Milliliter per Square Meter | ||
| mL/m2/day | C66977 | Milliliter per Square Meter per Day | A dose calculation unit expressed in milliliter(s) per square meter per period of time equal to twenty-four hours. (NCI) | Milliliter per Square Meter per Day | ||
| mL/m2/h | C73762 | Milliliter per Square Meter per Hour | A dose calculation unit expressed in milliliter(s) per square meter per period of time equal to sixty minutes. (NCI) | Milliliter per Square Meter per Hour | ||
| mL/m2/min | C73763 | Milliliter per Square Meter per Minute | A dose calculation unit expressed in milliliter(s) per square meter per period of time equal to sixty seconds. (NCI) | Milliliter per Square Meter per Minute | ||
| mL/min | C64777 | Milliliters per Minute | A metric unit of volumetric flow rate defined as the rate at which one milliliter of matter travels during the period of time equal to one minute.(NCI) | Milliliter per Minute | ||
| mL/min/1.73m2 | C67412 | A metric unit of volumetric flow rate defined as the rate at which one milliliter of matter travels during the period of time equal to one minute per 1.73 meters squared of body surface area. | Milliliter per Minute per 1.73 m2 of Body Surface Area | |||
| mL/min/mmHg | C67417 | Milliliter per Minute per Torr | A unit of measure equal to the number of milliliters per unit of time equal to one minute per unit of pressure equal to one milliter of mercury (mmHg). | Milliliter per Minute per Millimeters of Mercury | ||
| mL/mmHg | C106542 | Milliliters per Millimeter of Mercury | A unit equal to the volume in milliliters per one millimeter rise of mercury in a barometer at the Earth's surface. (NCI) | Milliliters Per Millimeter of Mercury | ||
| mL/mmHg/min/L | C67418 | A unit of gas diffusion capacity equal to one milliliter per millimeter of mercury per minute per liter of volume. | Milliliter per Minute per Millimeters of Mercury per Liter | |||
| mL/s | C69073 | mL/sec | Milliliters per second. | Milliliter per Second | ||
| mL/sec/1.73m2 | C105505 | A metric unit of volumetric flow rate defined as the rate at which one milliliter of matter travels during the period of time equal to one second per 1.73 meters squared of body surface area. | Milliliter Per Second Per 1.73 Meter Squared | |||
| mm | C28251 | Millimeter | A unit of measure equal to one thousandth of a meter. (NCI) | Millimeter | ||
| mm/2h | C105509 | Millimeters per Two Hours | A unit of both speed (scalar) and velocity (vector), defined as the distance of one centimeter travelled per unit time equal to two hours. (NCI) | Millimeter per Two Hours | ||
| mm/h | C67419 | Millimeter per Hour | A unit of both speed (scalar) and velocity (vector), defined as the distance of one millimeter travels per unit time equal to one hour.(NCI) | Millimeter per Hour | ||
| mm/min | C105507 | Millimeters per Minute | A unit of both speed (scalar) and velocity (vector), defined as the distance of one millimeter travelled per unit time equal to one minute. (NCI) | Millimeter Per Minute | ||
| mm/sec | C105508 | Millimeters per Second | A unit of both speed (scalar) and velocity (vector), defined as the distance of one millimeter travelled per unit time equal to one second. (NCI) | Millimeter Per Second | ||
| mm2 | C65104 | Square Millimeter | A unit of area measurement equal to a square measuring one millimeter on each side. One square millimeter is equal to 10(E-2) square centimeter and 10(E-6) square meter.(NCI) | Square Millimeter | ||
| mmHg | C49670 | Millimeter of Mercury | A unit of pressure equal to 0.001316 atmosphere and equal to the pressure indicated by one millimeter rise of mercury in a barometer at the Earth's surface. (NCI) | Millimeter of Mercury | ||
| mmHg/L/min | C105506 | A unit of resistance equal to the number of millimeters of mercury per unit of volume equal to one liter per unit of time equal to one minute. | Millimeter Mercury Per Liter Per Minute | |||
| mmHg/sec | C73764 | Millimeter of Mercury per Second | A rate of inflation or deflation of a manometric device based on the unit of pressure equal to 133,332 Pa or 1.316E10-3 standard atmosphere during period of time equal to one sixtieth of a minute. (NCI) | Millimeter of Mercury per Second | ||
| mmol | C48513 | Millimole | A unit of amount of substance equal to 0.001 mole.(NCI) | Millimole | ||
| mmol/day | C67420 | Millimole per 24 Hours | A unit of amount of substance flow rate equivalent to the rate at which one thousandth of a mole of substance travels or is delivered to a given object or space over a period of time equal to 24 hours.(NCI) | Millimole per 24 Hours | ||
| mmol/g | C68740 | Millimole per Gram | A unit amount of substance content (molality unit) defined as one mole of solute per one kilogram of solvent.(NCI) | Mole per Kilogram | ||
| mmol/g Creatinine | C105510 | A unit of substance concentration defined as the concentration of millimoles of solute per gram of creatinine. | Millimole Per Gram of Creatinine | |||
| mmol/kg | C68892 | Millimole per Kilogram | A unit of amount of substance content (molality unit) defined as one thousandth of mole (10E-3 mole) of solute per one kilogram of solvent.(NCI) | Millimole per Kilogram | ||
| mmol/L | C64387 | Micromole per Milliliter;Millimole per Liter;Mole per Cubic Meter;mcmol/mL;mmol/L;mol/m3;nmol/uL;umol/mL | A unit of concentration (molarity unit) equal to one millimole of solute per liter of solution. | Millimole per Liter | ||
| mmol/min/kPa | C116242 | A unit of gas diffusion capacity equal to one millimole per minute per kilopascal. | Millimoles per Minute per Kilopascal | |||
| mmol/min/kPa/L | C67423 | A unit of gas diffusion capacity equal to one millimole per minute per kilopascal per liter of volume. | Millimole per Minute per Thousand Pascal per Liter | |||
| mmol/mol | C111253 | A unit of fraction expressed as the ratio of the amount of a substance in solution, in millimoles, to the amount of a different substance in the mixture, in moles. | Millimole per Mole | |||
| mmol/mol Creatinine | C105511 | A unit of substance concentration defined as the concentration of millimoles of solute per mole of creatinine. | Millimole Per Mole of Creatinine | |||
| mol | C42539 | Mole | A unit defined as the amount of substance that contains as many elementary units as there are atoms in 0.012 kg of carbon-12. When the mole is used, the elementary entities must be specified and may be atoms, molecules, ions, electrons, other particles, or specified groups of such particles.(NCI) | Mole | ||
| mol/g | C68893 | Mole per Gram | A unit of amount of substance content (molality unit) defined as one mole of solute per one gram of solvent.(NCI) | Mole per Gram | ||
| mol/L | C48555 | Mole per Liter;mmol/mL;mol/L | A unit of concentration (molarity unit) equal to one mole of solute in one liter of solution.(NCI) | Mole per Liter | ||
| mol/mg | C68894 | Mole per Milligram | A unit of amount of substance content (molality unit) defined as one mole of solute per one milligram of solvent.(NCI) | Mole per Milligram | ||
| mol/mL | C68891 | Mole per Milliliter | A unit of concentration (molarity unit) equal to one mole of solute in one milliliter of solution.(NCI) | Mole per Milliliter | ||
| mol/mol | C70455 | Mole per Mole;mmol/mmol | A unit of fraction expressed as the ratio of the amount of substance of solute in moles to the amount of substance of the mixture in moles.(NCI) | Mole per Mole | ||
| MONTHS | C29846 | Month | One of the 12 divisions of a year as determined by a calendar. It corresponds to the unit of time of approximately to one cycle of the moon's phases, about 30 days or 4 weeks. (NCI) | Month | ||
| mOsm | C67318 | Milliosmole | A unit of osmotic pressure equal to one thousandth of an osmole or osmotic pressure of 0.001 molar solution of a substance that does not dissociate. (NCI) | Milliosmole | ||
| mOsm/kg | C67427 | Milliosmole per Kilogram | A unit of osmotic pressure equal to one thousandth of an osmole per kilogram substance. | Milliosmole per Kilogram | ||
| mPa | C73765 | Millipascal | A SI derived unit of pressure equivalent to one thousandth of one pascal. (NCI) | Millipascal | ||
| mph | C105500 | Miles per Hour | A unit of both speed (scalar) and velocity (vector), defined as the distance of one mile travelled per unit time equal to one hour. (NCI) | Mile Per Hour | ||
| MPL U/mL | C117973 | Immunoglobin M Phospholipid Units per Milliliter | A unit for semiquantitative measurement of IgM autoantibodies to proteins associated with negatively charged phospholipids evaluated against an established reference standard, per unit of volume equal to one milliliter. | Immunoglobin M Phospholipid Unit per Milliliter | ||
| msec | C41140 | Millisecond | A unit of time, which is equal to one thousandth of a second.(NCI) | Millisecond | ||
| mU/L | C67408 | An arbitrary unit of substance concentration equal to the concentration at which one liter of mixture contains one thousandth of a unit of a substance. | Microunit per Milliliter | |||
| mV | C67324 | Millivolt | A unit of electric potential and electromotive force equal to one thousandth of a volt.(NCI) | Millivolt | ||
| mV*min | C105512 | Millivolt * Minutes | A SI derived unit of magnetic flux, equal to the flux that produces in a circuit of one turn an electromotive force of one millivolt, when the flux is uniformly reduced to zero within one minute. (NCI) | Millivolt Minute | ||
| mV2/Hz | C114241 | Millivolt Squared per Hertz;Millivolt^2/Hertz | A unit equal to one thousandth of a volt squared per unit of frequency equal to one Hertz. | Millivolt Squared per Hertz | ||
| nCi | C67352 | Nanocurie | A unit of radioactivity equal to one billionth of Curie or 37 Becquerels, and corresponding to a radioactivity of 37 atomic disintegrations per second.(NCI) | Nanocurie | ||
| NEBULE | C71204 | Nebule | A unit of measurement based on the nebule dosing unit.(NCI) | Nebule Dosing Unit | ||
| NEEDLE GAUGE | C101687 | A number representing the outer diameter of a needle. (NCI) | Needle Gauge | |||
| Newton | C42546 | Newton | A unit of force which, when applied in a vacuum to a body having a mass of one kilogram, causes an acceleration of one meter per second squared. It is equal to 10E5 dynes.(NCI) | Newton | ||
| ng | C48516 | Nanogram | A unit of mass equal to one billionth (10E-9) of a gram, or one millionth (10E-6) of a milligram.(NCI) | Nanogram | ||
| ng/dL | C67326 | Nanogram per Deciliter | A unit of mass concentration defined as the concentration of one nanogram of a substance in unit volume of the mixture equal to one deciliter. The concept also refers to the unit of mass density (volumic mass) defined as the density of substance which mass equal to one nanogram occupies the volume one deciliter.(NCI) | Nanogram per Deciliter | ||
| ng/L | C67327 | Microgram per Cubic Meter;ng/L;pg/mL;ug/m3 | A unit of concentration or mass density equal to one picogram of substance per milliliter of solution or one nanogram of substance per liter of solution. | Nanogram per Liter | ||
| NIU | C77535 | Normalized Fluorescence Intensity Unit;Normalized Intensity Unit;Relative Fluorescence Intensity Unit;Relative Intensity Unit | A unit of measurement that estimates the size or amount of material in a sample by normalizing its luminescence to that of a reference standard. (NCI) | Relative Fluorescence Unit | ||
| nkat | C70508 | Nanokatal | A unit of catalytic activity measurement equal to one billionth of one katal (10E-9 katal).(NCI) | Nanokatal | ||
| nkat/L | C70510 | Nanokatal per Liter | A unit of catalytic activity concentration defined as the catalytic activity of the component equal to one billionth of one katal (10E-9 katal) in the unit volume of the system equal to one liter.(NCI) | Nanokatal per Liter | ||
| nL | C69188 | Nanoliter | A unit of volume equal to one billionth of a liter (10E-9 liter).(NCI) | Nanoliter | ||
| nm | C67328 | Nanometer | A unit of length equal to one billionth of a meter (10E-9 meter). Nanometer is used as a unit for light wavelength measurement.(NCI) | Nanometer | ||
| nmol | C48517 | Nanomole | A unit of amount of substance equal to one billionth (10E-9) of a mole.(NCI) | Nanomole | ||
| nmol BCE/L | C117974 | Nanomoles Bone Collagen Equivalents per Liter | A unit of relative amount of substance concentration equal to nanomoles of bone collagen equivalent weight per unit of volume equal to one liter. | Nanomole Bone Collagen Equivalent per Liter | ||
| nmol BCE/mmol | C118137 | Nanomoles Bone Collagen Equivalents per Millimole | A unit of relative amount of substance concentration equal to nanomoles of bone collagen equivalent weight per unit of substance concentration equal to one millimole. | Nanomole Bone Collagen Equivalent per Millimole | ||
| nmol/L | C67432 | Nanomole per Liter | A unit of concentration (molarity unit) equal to one nanomole of solute per liter of solution. | Nanomole per Liter | ||
| nmol/mL/min | C92613 | Nanomole per Milliliter per Minute | A unit of concentration (molarity unit) equal to one billionth of a mole (10E-9 mole) of solute in one milliliter of solution to be administered per minute of time. | Nanomole per Minute per Milliliter | ||
| nsec | C73767 | Nanosecond | A unit of time equal to one billionth of a second. (NCI) | Nanosecond | ||
| nU/cL | C105513 | Nanounit per Centiliter | An arbitrary unit of substance content expressed in nanounit(s) per centiliter. (NCI) | Nanounit Per Centiliter | ||
| ohm | C42554 | Ohm | A unit of electrical resistance equal to the resistance between two points on a conductor when a potential difference of one volt between them produces a current of one Ampere. Ohm is also used to measure impedance and reactance for complex resistance. A measurement in ohms is the reciprocal of a measurement in Siemens. (NCI) | Ohm | ||
| osm | C67330 | Osmole | A unit of osmotic pressure equal to that of an ideal solution of a nondissociating substance that has a concentration of one mole of solute per liter of solution.(NCI) | Osmole | ||
| oz | C48519 | Ounce | A unit of mass, the avoirdupois ounce is equal to 1/16 pound, or 28.3495 grams, or 0.911 457 troy ounce.(NCI) | Ounce | ||
| PA | C74924 | /Year;Every Year;Per Annum;Per Year | A frequency rate of occurrences of something within a period of time equal to three hundred sixty-five days. | Per Year | ||
| Pa | C42547 | Pascal | A unit of pressure equivalent to one Newton per square meter or 10 bars or to 1.45x10(E-4) pounds per square inch.(NCI) | Pascal | ||
| PACK | C62653 | A number of individual items packaged as a unit. | Pack | |||
| Pack Year | C73993 | A quantification of lifetime tobacco exposure defined as (number of cigarettes smoked per day x number of years smoked)/20. One pack-year is smoking 20 cigarettes a day for one year. | Pack Year | |||
| PACKAGE | C48520 | Pack Dosing Unit;Package Dosing Unit | A dosing measurement based on the package unit.(NCI) | Package Dosing Unit | ||
| PACKET | C48521 | Packet Dosing Unit | A dosing measurement based on the packet unit.(NCI) | Packet Dosing Unit | ||
| PATCH | C48524 | Patch Dosing Unit | A dosing measurement based on the patch unit.(NCI) | Patch Dosing Unit | ||
| PELLET | C48525 | Pellet Dosing Unit | A dosing measurement based on the pellet unit.(NCI) | Pellet Dosing Unit | ||
| per min | C66967 | Per Minute | The number of occurrences of something within a minute of time.(NCI) | Per Minute | ||
| per sec | C66965 | Per Second | The number of occurrences of something within a second of time.(NCI) | Per Second | ||
| PFU | C67264 | Plaque Forming Unit | A measure of viable infectious entities (e.g. viral particle or group of particles) in the specimen or product defined as the smallest quantity that can produce a cytopathic effect in the host cell culture challenged with the defined inoculum, visible under the microscope or/and to the naked eye as a plaque. A number of plaque forming units (PFU) per unit volume is a conventional way to refer the titer of an infective entity in a specimen or preparation.(NCI) | Plaque Forming Unit | ||
| PFU/dose | C71198 | Plaque Forming Unit per Dose | A unit of potency of a biological product expressed as a quantity of viable infectious entities capable to produce a cytopathic effect in the appropriate cell culture per a single dose of the preparation.(NCI) | Plaque Forming Unit per Dose | ||
| PFU/mL | C71199 | Plaque Forming Unit per Milliliter | A unit of potency of a biological product expressed as a quantity of viable infectious entities capable to produce a cytopathic effect in the appropriate cell culture per one milliliter of the preparation.(NCI) | Plaque Forming Unit per Milliliter | ||
| pg | C64551 | Picogram | A unit of mass equal to one trillionth of a gram (10E-12 gram).(NCI) | Picogram | ||
| pg/dL | C67331 | Picogram per Deciliter | Picograms per deciliter. | Picogram per Deciliter | ||
| pg/L | C85597 | fg/mL;pg/L | A unit of concentration or mass density equal to one femtogram of substance per milliliter of solution or one picogram of substance per liter of solution. | Femtogram per Milliliter | ||
| PIPE | C116246 | Pipe Dosing Unit | A dosing measurement based on the pipe unit. | Pipe Dosing Unit | ||
| PIXEL | C48367 | The smallest resolvable rectangular area of an image, either on a screen or stored in memory. (NCI) | Pixel | |||
| PIXELS/cm | C114238 | PPCM;Pixels per Centimeter | A unit of image resolution expressed in the numbers of pixels per centimeter in the horizontal or vertical direction. | Pixels per Centimeter | ||
| PIXELS/in | C114239 | PPI;Pixels per Inch | A unit of image resolution expressed in the numbers of pixels per inch in the horizontal or vertical direction. | Pixels per Inch | ||
| pkat | C70509 | Picokatal | A unit of catalytic activity measurement equal to trillionth of one katal (10E-12 katal).(NCI) | Picokatal | ||
| pL | C69189 | Picoliter | A unit of volume equal to one trillionth of a liter (10E-12 liter). (NCI) | Picoliter | ||
| pm | C69148 | Picometer | A unit of length equal to one trillionth of a meter (10E-12 meter).(NCI) | Picometer | ||
| pmol | C65045 | Picomole | A unit of amount of substance equal to a trillionth (10E-12) of a mole.(NCI) | Picomole | ||
| pmol/L | C67434 | Femtomole per Milliliter;Picomole per Liter;fmol/mL | A unit of concentration (molarity unit) equal to one picomole of solute per liter of solution. | Picomole per Liter | ||
| PNU/mL | C116236 | Protein Nitrogen Unit per Milliliter | Unit of measure of potency of an allergenic product expressed as a number of protein nitrogen units per one milliliter of formulation. | Allergenic Protein Nitrogen Unit per Milliliter | ||
| POUCH | C48530 | Pouch Dosing Unit | A dosing measurement based on the pouch unit.(NCI) | Pouch Dosing Unit | ||
| ppb | C70565 | Part per Billion | A unit of measure referring to one entity counted per one billion entities.(NCI) | Part Per Billion | ||
| ppm | C48523 | Part per Million | A unit of measurement referring to one entity counted per one million entities.(NCI) | Part Per Million | ||
| ppth | C69112 | Part per Thousand | A unit of proportion equal to 10E-3.(NCI) | Part per Thousand | ||
| pptr | C70566 | Parts per Trillion | A unit of measure referring to one entity counted per one trillion entities.(NCI) | Part Per Trillion | ||
| PRESSOR UNITS | C48532 | Pressor Unit | A dosing measurement based on the pressor unit.(NCI) | Pressor Unit | ||
| psec | C73768 | Picosecond | A unit of time equal to one trillionth of a second. (NCI) | Picosecond | ||
| psi | C67334 | Pounds per Square Inch | A unit of pressure equivalent to 6.894757 kilopascals, or 703.0696 kilograms per square meter, or 51.71507 millimeters of mercury.(NCI) | Pound per Square Inch | ||
| pt_br | C69114 | British Pint;Imperial Pint | A traditional unit of volume equal to 20 British fluid ounces, 34.678 cubic inches or approximately 568.261 milliliters. | Pint British | ||
| pt_us | C48529 | US Pint | A United States liquid unit equal to 16 US fluid ounces or 28.875 cubic inches or approximately 473.177 milliliters. | Pint | ||
| PUFF | C65060 | Puff | A means of delivering a defined dose of a therapeutic aerolized solution into either the upper or lower respiratory tract. Metered-dose inhalers or spray pumps are devices that provide a puff dose for delivery into either the oral or the nasal cavity.(NCI) | Puff Dosing Unit | ||
| QUANTITY SUFFICIENT | C48590 | Quantity Sufficient | A quantity of an ingredient or product needed to bring up a volume or weight of the preparation to a final amount as it is indicated in the prescription; also refers to a determination of an adequate supply of medicine to fulfill either a prescribed amount or a sufficient quantity to provide treatment over a specified time frame.(NCI) | Quantity Sufficient | ||
| Rad | C18064 | Rad | The special unit for absorbed radiation dose, which is the amount of energy from any type of ionizing radiation (e.g., alpha, beta, gamma, neutrons, etc.) deposited in any medium (e.g., water, tissue, air). A dose of one rad means the absorption of 100 ergs per gram of absorbing tissue. One rad is equal to 0.01 gray.(NCI) | Rad | ||
| RATIO | C44256 | A unit of measurement for the quotient of the amount of one entity to another. | Ratio | |||
| RING | C62609 | Ring Dosing Unit | A dosing measurement based on the ring unit.(NCI) | Ring Dosing Unit | ||
| RNA copies/mL | C67441 | RNA Copies per Milliliter | The unit of concentration of Ribonucleic Acid (RNA) copies expressed as a number of copies in unit volume equal to one milliliter.(NCI) | RNA Copy per Milliliter | ||
| Roentgen | C70575 | Roentgen | A unit of exposure to ionizing radiation. One Roentgen is the amount of gamma or x-rays required to produce ions resulting in a charge of 2.58E-4 Coulombs/kilogram of air under standard conditions.(NCI) | Roentgen | ||
| rpm | C70469 | Revolution per Minute | A unit of frequency equal to one revolution per unit of time equal to one minute.(NCI) | Revolution per Minute | ||
| SACHET | C71324 | Sachet dosing unit | A dosing unit that contains a solid pharmaceutical preparation in the form of a small packet or bag made from a flexible, often porous material.(NCI) | Sachet Dosing Unit | ||
| SBE/mL | C116233 | Standardized Biological Unit per Milliliter | Unit of measure of potency of allergenic product expressed as a number of standardized biological units per one milliliter of formulation. | Standardized Allergy Biological Unit per Milliliter | ||
| scm | C68858 | Standard Cubic Meter | A unit used in physical chemistry to express the amount of substance of an ideal gas in one cubic meter at standard conditions: temperature 273.15 K and pressure of one atmosphere (101.325 kilopascals).(NCI) | Standard Cubic Meter | ||
| SCOOPFUL | C48536 | Scoopful Dosing Unit | A dosing measurement based on the scoopful unit.(NCI) | Scoopful Dosing Unit | ||
| sec | C42535 | Second | The second is a unit of time with a duration of 919 263 177 0 periods of the specified light radiation corresponding to the transition between the two hyperfine levels of the cesium 133 atom in its ground state at 0 K. According to the convention, 60 seconds constitute one minute; 3,600 seconds constitute one hour. Abbreviation Sec. is acceptable in non-scientific usage only.(NCI) | Second | ||
| Shock Wave | C112433 | Shock Wave | A dosing measurement based on the shock wave unit. | Shockwave Dosing Unit | ||
| Siemens | C42555 | Siemens | A unit of electrical conductance, admittance, and susceptance. A conductor has a conductance of one Siemens if an electrical potential difference of one volt produces a one Ampere current in it. The conductance in Siemens is the reciprocal of its resistance in ohms.(NCI) | Siemens | ||
| SPRAY | C48537 | Spray Dosing Unit | A dosing measurement based on the spray unit.(NCI) | Spray Dosing Unit | ||
| SQU/mL | C116234 | Standardized Quality Unit per Milliliter | Unit of measure of potency of allergenic product expressed as a number of standardized quality units per one milliliter of formulation. | Standardized Allergy Quality Unit per Milliliter | ||
| STEPS | C111318 | A unit of measure to quantify the number of strides taken during a normal walking gait. | Step Unit of Distance | |||
| STRIP | C48538 | Strip Dosing Unit | A dosing measurement based on the strip unit.(NCI) | Strip Dosing Unit | ||
| SUPPOSITORY | C48539 | Suppository Dosing Unit | A dosing measurement based on the suppository unit.(NCI) | Suppository Dosing Unit | ||
| Sv | C42553 | Sievert | A unit of equivalent radiation dose. One Sv is received when the actual absorbed dose of ionizing radiation, after being multiplied by the dimensionless factors Q (the relative biological efficiency or quality factor) and N (the product of any other multiplying factors that takes into account the distribution of energy throughout the dose), is one joule per kilogram. In this scheme, the relationship between the absorbed dose of radiation D and the dose equivalent H is, therefore, given by H = QND. Both Q and N are stipulated by the International Commission on Radiological Protection. One Sv is equal to 100 rem.(NCI) | Sievert | ||
| SYRINGE | C48540 | Syringe Dosing Unit | A dosing measurement based on the syringe unit.(NCI) | Syringe Dosing Unit | ||
| TABLET | C48542 | Tablet Dosing Unit;tab | A dosing measurement based on the tablet unit.(NCI) | Tablet Dosing Unit | ||
| TAMPON | C48543 | Tampon Dosing Unit | A dosing measurement based on the tampon unit.(NCI) | Tampon Dosing Unit | ||
| Tbsp | C48541 | Tablespoon Dosing Unit | A unit of volume informally used in pharmacy. The tablespoon has been standardized at 15 milliliters in US, Britain, Canada, and New Zealand, and at 20 milliliters in Australia and some European countries.(NCI) | Tablespoon Dosing Unit | ||
| TCID 50/dose | C70537 | 50 Percent Tissue Culture Infective Dose per Dose | A potency unit equal to the potency at which one dose of preparation contains one 50 percent tissue culture infective dose.(NCI) | 50 Percent Tissue Culture Infective Dose per Dose | ||
| Tesla | C42557 | Tesla | A unit of magnetic flux density equal to the magnitude of the magnetic field vector necessary to produce a force of one Newton on a charge of one coulomb moving perpendicular to the direction of the magnetic field vector with a velocity of one meter per second. It is equivalent to one Weber per square meter.(NCI) | Tesla | ||
| titer | C67454 | Concentration of a substance in a solution as determined by the quantitative reaction with added measured volume(s) of a solution of the precisely known concentration(s) of a standard reagent. | Titer | |||
| Torr | C112423 | Torr | A non-SI manometric unit of pressure equal to 1/760 of a standard atmosphere (a standard atmosphere being defined as equal to 101325 pascals). One Torr is equal to 133.3223684 pascals. | Torr | ||
| TRACE | C48547 | Trace Dosing Unit | An extremely small amount.(NCI) | Trace Dosing Unit | ||
| TROCHE | C48548 | Troche Dosing Unit | A dosing measurement based on the troche unit.(NCI) | Troche Dosing Unit | ||
| tsp | C48544 | Teaspoon Dosing Unit | A unit of volume used in pharmacy equal to 5 milliliters.(NCI) | Teaspoon Dosing Unit | ||
| TUBE | C48549 | Tube Dosing Unit | A dosing measurement based on the tube unit.(NCI) | Tube Dosing Unit | ||
| tuberculin unit | C65132 | Tuberculin Unit | An arbitrary unit of tuberculin dosage defined by comparison of clinical response with a preparation of the purified protein derivative standardized for use in humans for tuberculin skin test reaction.(NCI) | Tuberculin Unit | ||
| tuberculin unit/mL | C70506 | Tuberculin Unit per Milliliter | A unit of biologic activity of tuberculin expressed as a number of arbitrary units of tuberculin in one milliliter of preparation.(NCI) | Tuberculin Unit per Milliliter | ||
| U | C44278 | Unit | A single undivided thing occurring in the composition of something else. | Unit | ||
| U/animal | C73773 | Unit per Animal | An arbitrary dosing unit expressed in unit(s) per animal. (NCI) | Unit per Animal | ||
| U/cL | C105520 | Unit per Centiliter | An arbitrary unit of substance content expressed in unit(s) per centiliter. | Unit Per Centiliter | ||
| U/dL | C105521 | Unit per Deciliter | An arbitrary unit of substance content expressed in unit(s) per deciliter. | Unit Per Deciliter | ||
| U/g | C77606 | Unit per Gram | An arbitrary unit of substance content expressed in unit(s) per gram. (NCI) | Unit per Gram | ||
| U/g Creatinine | C105523 | A unit of arbitrary substance concentration (biologic activity concentration) defined as the concentration of one unit per gram of creatinine. | Unit Per Gram of Creatinine | |||
| U/g HGB | C105522 | Units per Gram Hemoglobin | Unit of arbitrary substance concentration (biologic activity concentration) defined as the concentration of one unit per gram of hemoglobin. (NCI) | Unit Per Gram Hemoglobin | ||
| U/g/day | C73774 | Unit per Gram per Day | An arbitrary unit of substance rate expressed in unit(s) per gram per period of time equal to twenty-four hours. (NCI) | Unit per Gram per Day | ||
| U/g/h | C73775 | Unit per Gram per Hour | An arbitrary unit of substance rate expressed in unit(s) per gram per period of time equal to sixty minutes. (NCI) | Unit per Gram per Hour | ||
| U/g/min | C73776 | Unit per Gram per Minute | An arbitrary unit of substance rate expressed in unit(s) per gram per period of time equal to sixty seconds. (NCI) | Unit per Gram per Minute | ||
| U/kg | C67465 | Unit per Kilogram | An arbitrary unit of substance content expressed in units of biological activity per unit of mass equal to one kilogram. Unit per kilogram is also used as a dose calculation unit expressed in arbitrary units per one kilogram of body mass. (NCI) | Unit per Kilogram | ||
| U/kg/day | C73777 | Unit per kilogram per Day | An arbitrary unit of substance rate expressed in unit(s) per kilogram per period of time equal to twenty-four hours. (NCI) | Unit per Kilogram per Day | ||
| U/kg/h | C73778 | Unit per Kilogram per Hour | An arbitrary unit of substance rate expressed in unit(s) per kilogram per period of time equal to sixty minutes. (NCI) | Unit per Kilogram per Hour | ||
| U/kg/min | C73779 | Unit per Kilogram per Minute | An arbitrary unit of substance rate expressed in unit(s) per kilogram per period of time equal to sixty seconds. (NCI) | Unit per Kilogram per Minute | ||
| U/L | C67456 | Unit per Liter;mU/mL | An arbitrary unit of substance concentration equal to the concentration at which one liter of mixture contains one unit of a substance. (NCI) | Unit per Liter | ||
| U/m2 | C67467 | Unit per Square Meter | A unit expressed as a number of arbitrary units of substance per one square meter of a body surface area. | Unit per Square Meter | ||
| U/m2/day | C73783 | Unit per Square Meter per Day | An arbitrary unit of substance rate expressed in unit(s) per square meter per period of time equal to twenty-four hours. (NCI) | Unit per Square Meter per Day | ||
| U/m2/h | C73784 | Unit per Square Meter per Hour | An arbitrary unit of substance rate expressed in unit(s) per square meter per period of time equal to sixty minutes. (NCI) | Unit per Square Meter per Hour | ||
| U/m2/min | C73785 | Unit per Square Meter per Minute | An arbitrary unit of substance rate expressed in unit(s) per square meter per period of time equal to sixty seconds. (NCI) | Unit per Square Meter per Minute | ||
| U/mg | C73780 | Unit per Milligram | An arbitrary unit of substance content expressed in unit(s) per milligram. (NCI) | Unit per Milligram | ||
| U/mL | C77607 | Unit per Milliliter | An arbitrary unit of substance content expressed in unit(s) per milliliter. (NCI) | Unit per Milliliter | ||
| U/mmol | C92618 | Unit per Millimole | An arbitrary unit of substance concentration equal to the concentration at which one millimole of a mixture contains one unit of a substance. (NCI) | Unit per Millimole | ||
| uCi | C48507 | Microcurie;mcCi | A unit of radioactivity equal to one millionth of a Curie or 37 kilobecquerels, and corresponding to a radioactivity of 37 000 atomic disintegrations per second.(NCI) | Microcurie | ||
| uCi/kg | C70571 | Microcurie per Kilogram;mcCi/kg | A unit of specific radioactivity (massic activity) equal to activity of one microcurie of the sample with total mass of one kilogram.(NCI) | Microcurie per Kilogram | ||
| uCi/L | C71173 | Microcurie per Liter;mcCi/L | A unit of volumetric radioactivity concentration defined as a concentration of a radionuclide with an activity equal to one millionth of a Curie per unit volume equal to one liter.(NCI) | Microcurie per Liter | ||
| uEq | C73726 | Microequivalent | A unit of relative amount of a substance equal to one millionth of an equivalent weight.(NCI) | Microequivalent | ||
| uEq/L | C117975 | Microequivalent per Liter;Nanoequivalent per Milliliter;nEq/mL | A concentration unit measured as a number of microequivalents of solute per liter of solution. | Microequivalent per Liter | ||
| ug | C48152 | Microgram;mcg | The unit of mass equal to one millionth of a gram or one thousandth of a milligram.(NCI) | Microgram | ||
| ug/animal | C73728 | Microgram per Animal | A unit of measure expressed in microgram(s) per animal. | Microgram per Animal | ||
| ug/day | C71205 | Microgram per Day;mcg/day | A unit of mass flow rate equivalent to the rate at which one millionth of a gram of matter travels to a given object or space over a period of time equal to twenty four hours. Microgram per day is also a dose administration rate unit equal to the rate at which one millionth of a gram of a product is administered per unit of time equal to twenty four hours.(NCI) | Microgram per Day | ||
| ug/dL | C67305 | Microgram per Deciliter | A unit of mass concentration defined as the concentration of one microgram of a substance per unit volume of the mixture equal to one deciliter. The concept also refers to the unit of mass density (volumic mass) defined as the density of substance which mass equal to one microgram occupies the volume one deciliter. (NCI) | Microgram per Deciliter | ||
| ug/g/day | C74921 | Microgram per Gram per Day | A dose calculation unit expressed in microgram(s) per gram per period of time equal to twenty-four hours. (NCI) | Microgram per Gram per Day | ||
| ug/g/h | C74922 | Microgram per Gram per Hour | A dose calculation unit expressed in microgram(s) per gram per period of time equal to sixty minutes. (NCI) | Microgram per Gram per Hour | ||
| ug/g/min | C74923 | Microgram per Gram per Minute | A dose calculation unit expressed in microgram(s) per gram per period of time equal to sixty seconds. (NCI) | Microgram per Gram per Minute | ||
| ug/h | C67394 | Micrograms per Hour;mcg/h | A unit of mass flow rate equivalent to the rate at which one millionth of a gram of matter travels to a given object or space over a period of time equal to one hour.(NCI) | Microgram per Hour | ||
| ug/kg | C67396 | Microgram per Kilogram;mcg/kg;ng/g;ug/kg | A unit of a mass fraction expressed as a number of micrograms of substance per kilogram of mixture. The unit is also used as a dose calculation unit.(NCI) | Microgram per Kilogram | ||
| ug/kg/day | C73729 | Microgram per Kilogram per Day | A dose calculation unit expressed in microgram(s) per kilogram per period of time equal to twenty-four hours. (NCI) | Microgram per Kilogram per Day | ||
| ug/kg/h | C73730 | Microgram per Kilogram per Hour | A dose calculation unit expressed in microgram(s) per kilogram per period of time equal to sixty minutes. (NCI) | Microgram per Kilogram per Hour | ||
| ug/kg/min | C71210 | Gamma per Kilogram per Minute;Microgram per Kilogram per Minute;gamma/kg/min;mcg/kg/min | A dose calculation unit equal to one millionth of a gram of a preparation per one kilogram of body mass administered per unit of time equal to one minute.(NCI) | Microgram per Kilogram per Minute | ||
| ug/L | C67306 | Microgram per Liter;Milligram per Cubic Meter;Nanogram per Milliliter;mcg/L;mg/m3;ng/mL;ug/L | A unit of concentration or mass density equal to one nanogram of substance per milliliter of solution or one microgram of substance per liter of solution. | Microgram per Liter | ||
| ug/m2 | C67312 | Microgram per Square Meter | A dose calculation unit expressed in microgram(s) per square meter. | Microgram per Square Meter | ||
| ug/m2/day | C73787 | Microgram per Square Meter per Day | A dose calculation unit expressed in microgram(s) per square meter per period of time equal to twenty-four hours. (NCI) | Microgram per Square Meter per Day | ||
| ug/m2/h | C73727 | Microgram per Square Meter per Hour | A dose calculation unit expressed in microgram(s) per square meter per period of time equal to sixty minutes. (NCI) | Microgram per Square Meter per Hour | ||
| ug/m2/min | C73733 | Microgram per Square Meter per Minute | A dose calculation unit expressed in microgram(s) per square meter per period of time equal to sixty seconds. (NCI) | Microgram per Square Meter per Minute | ||
| ug/min | C71211 | Micrograms per Minute;mcg/min | A unit of mass flow rate equivalent to the rate at which one millionth of a gram of matter travels to a given object or space over a period of time equal to one minute. Microgram per minute is also a dose administration rate unit equal to the rate at which one millionth of a gram of a product is administered per unit of time equal to one minute.(NCI) | Microgram per Minute | ||
| ug/mL/h | C75905 | Microgram per Milliliter per Hour | A dose calculation unit expressed in microgram(s) per milliliter of solution per period of time equal to sixty minutes. (NCI) | Microgram per Milliliter per Hour | ||
| ugEq | C105497 | Microgram Equivalent | A unit of relative amount of substance concentration equal to one millionth of a gram of an equivalent weight. (NCI) | Microgram Equivalent | ||
| ukat | C70562 | Microkatal;mckat | A unit of catalytic activity measurement equal to one millionth of katal (10E-6 katal).(NCI) | Microkatal | ||
| ukat/L | C67397 | Microkatal per Liter;mckat/L | Unit of catalytic activity concentration defined as activity equal to one millionth of katal per one liter of the system volume.(NCI) | Microkatal per Liter | ||
| uL | C48153 | Microliter;mcL;mm3 | A unit of volume accepted for use with the SI and equal to one millionth of a liter (10E-6 liter).(NCI) | Microliter | ||
| uL/mL | C69175 | Microliter per Milliliter;mcL/mL | A unit of volume fraction expressed as a number of microliters of the constituent per the volume of the system represented in milliliters.(NCI) | Microliter per Milliliter | ||
| um | C48510 | Micron;mcm | A unit of length in metric system equal to 10E-6 meter, or micrometer.(NCI) | Micron | ||
| um2 | C73770 | MicroSquare Meter | A SI unit of area measurement equal to a square whose sides are one micrometer long. (NCI) | Square Micrometer | ||
| umol | C48509 | Micromole;mcmol | A unit of amount of substance equal to one millionth (10E-6) of a mole.(NCI) | Micromole | ||
| umol/day | C67406 | Micromoles per Day;mcmol/day | A unit of amount of substance flow rate equivalent to the rate at which one millionth of a mole of substance travels to a given object or space over a period of time equal to 24 hours.(NCI) | Micromole per 24 Hours | ||
| umol/L | C48508 | Micromole per Liter | A unit of concentration (molarity unit) equal to one micromole of solute per liter of solution. | Micromole per Liter | ||
| umol/L/sec | C105498 | Micromoles per Liter per Second | A concentration unit equal to one micromole of solute in one liter of solution per unit of time equal to one second. (NCI) | Micromole Per Liter Per Second | ||
| umol/mg/min | C73735 | Micromole per Milligram per Minute | A unit of concentration (molarity unit) equal to one millionth of a mole (10E-6 mole) per milligram of a substance per period of time equal to sixty seconds. (NCI) | Micromole per Milligram per Minute | ||
| umol/min | C85708 | mcmol/min;umol/min | Micromoles per minute. | Micromole per Minute | ||
| uOsM | C73736 | Microosmole | A unit of osmotic pressure equal to one millionth of an osmole or the osmotic pressure of a 10E-6 molar solution of a substance that does not dissociate. (NCI) | Microosmole | ||
| usec | C69149 | Microsecond | A unit of time equal to one millionth of a second. (NCI) | Microsecond | ||
| uV | C71175 | Microvolt;mcV | A unit of an electric potential and electromotive force equal to one millionth of a volt.(NCI) | Microvolt | ||
| uV*sec | C105499 | Microvolt * Seconds | A SI derived unit of magnetic flux, equal to the flux that produces in a circuit of one turn an electromotive force of one microvolt, when the flux is uniformly reduced to zero within one second. (NCI) | Microvolt Second | ||
| V | C42551 | Volt | A unit of electric potential and electromotive force, equal to the difference of electric potential between two points on a conducting wire carrying a constant current of one Ampere when the power dissipated between the points is one watt. This is equivalent to the potential difference across a resistance of one ohm when one Ampere of current flows through it.(NCI) | Volt | ||
| V/sec | C105524 | V/s;Volt per Second | A SI derived rate unit equal to one volt per unit of time equal to one second. | Volt Per Second | ||
| v/v | C67469 | volume fraction | Quotient of the volume of a substance and the total volume of the sample containing the substance. | Volume Fraction | ||
| VIAL | C48551 | Vial Dosing Unit | A dosing measurement based on the vial unit.(NCI) | Vial Dosing Unit | ||
| VIRTUAL PIXEL | C114237 | A type of pixel created from overlying two adjacent real pixels to create an additional virtual image of a pixel that is visible to the human eye. | Virtual Pixel | |||
| WAFER | C48552 | Wafer Dosing Unit | A dosing measurement based on the wafer unit.(NCI) | Wafer Dosing Unit | ||
| Watt | C42549 | Watt | A unit of power equal to the power which in one second produces or transfers the energy of one joule. The unit is used in measurements of power emitted, transferred or received as radiation, sound waves, heat flow rate, and rate of energy transfer. Equal to 1/746 of horsepower.(NCI) | Watt | ||
| Weber | C42556 | V*sec;Volt Second;Volt-second;Weber | A unit of magnetic flux, equal to the flux that produces in a circuit of one turn an electromotive force of one volt, when the flux is uniformly reduced to zero within one second.(NCI) | Weber | ||
| WEEKS | C29844 | Week | Any period of seven consecutive days. (NCI) | Week | ||
| yd | C48553 | Yard | A unit of length equal to 3 feet, or 36 inches, or 0.9144 meter.(NCI) | Yard | ||
| YEARS | C29848 | Year | The period of time that it takes for Earth to make a complete revolution around the sun, approximately 365 days; a specific one year period. (NCI) | Year | ||
| Back to top | ||||||
| CL.C66770.VSRESU | Units for Vital Signs Results (VSRESU) | text Extensible: Yes | C66770 | Units for Vital Signs Results | The unit used to record and describe the result of a test investigating a vital sign. (NCI) | CDISC SDTM Unit for Vital Sign Result Terminology |
| % | C25613 | Percentage | A fraction or ratio with 100 understood as the denominator. (NCI) | Percentage | ||
| BEATS/MIN | C49673 | Beats per Minute | The number of heartbeats measured per minute time. (NCI) | Beats per Minute | ||
| BREATHS/MIN | C49674 | Breaths per Minute | The number of breaths (inhalation and exhalation) taken per minute time. (NCI) | Breaths per Minute | ||
| C | C42559 | Degree Celsius | A unit of temperature of the temperature scale designed so that the freezing point of water is 0 degrees and the boiling point is 100 degrees at standard atmospheric pressure. The current official definition of the Celsius sets 0.01 C to be at the triple point of water and a degree to be 1/273.16 of the difference in temperature between the triple point of water and absolute zero. One degree Celsius represents the same temperature difference as one Kelvin. (NCI) | Degree Celsius | ||
| cm | C49668 | Centimeter | A basic unit of length equal to one hundredth of a meter or approximately 0.393700787 inch. | Centimeter | ||
| F | C44277 | Degree Fahrenheit | The Fahrenheit temperature scale is named after the German physicist Gabriel Fahrenheit (1686-1736), who proposed it in 1724. In this scale, the freezing point of water is 32 degrees Fahrenheit and the boiling point is 212 degrees, placing the boiling and melting points of water 180 degrees apart. In this scale a degree Fahrenheit is 5/9ths of a Kelvin (or of a degree Celsius), and minus 40 degrees Fahrenheit is equal to minus 40 degrees Celsius. (NCI) | Degree Fahrenheit | ||
| g | C48155 | Gram | A metric unit of mass equal to one one thousandth of a kilogram. (NCI) | Gram | ||
| in | C48500 | Inch | A traditional unit of length equal to 2.54 centimeters. (NCI) | Inch | ||
| kg | C28252 | Kilogram | The basic SI unit of mass. It is defined as the mass of an international prototype in the form of a platinum-iridium cylinder kept at Sevres in France. It is the only basic unit still defined in terms of a material object, and also the only one with a prefix [kilo] already in place. A kilogram is equal to 1,000 grams and 2.204 622 6 pounds. (NCI) | Kilogram | ||
| kg/m2 | C49671 | Kilogram per Square Meter | A unit expressed as kilogram of mass per square meter of area.(NCI) | Kilogram per Square Meter | ||
| LB | C48531 | Pound | A traditional unit of mass. By international agreement, one avoirdupois pound is equal to exactly 0.453 592 37 kilogram, 16 ounces, or 1.215 28 troy pounds. (NCI) | Pound | ||
| m2 | C42569 | Square Meter | The SI unit of area measurement equal to a square whose sides are one meter long. Square meter is equal to 10,000 square centimeters; 0.01 ares; 1.196 square yards; 10.76 square feet; 1550 square inches. (NCI) | Square Meter | ||
| mm | C28251 | Millimeter | A unit of measure equal to one thousandth of a meter. (NCI) | Millimeter | ||
| mmHg | C49670 | Millimeter of Mercury | A unit of pressure equal to 0.001316 atmosphere and equal to the pressure indicated by one millimeter rise of mercury in a barometer at the Earth's surface. (NCI) | Millimeter of Mercury | ||
| Back to top | ||||||
| CL.C102590.VCNEVD | Vaccination Evidence Source (VCNEVD) | text Extensible: Yes | C102590 | Vaccination Evidence Source | Terminology relevant to the source of information regarding the subject's vaccination status. | CDISC SDTM Vaccination Evidence Source Terminology |
| SCAR | C34483 | A mark left (usually on the skin) by the healing of injured tissue. | Scar | |||
| SELF-REPORT | C74528 | An individual's perspective or subjective interpretation of an event or information. | Self-Report | |||
| WRITTEN DOCUMENTATION | C86042 | The collecting, abstracting, and coding of printed or written information for future reference. | Written Documentation | |||
| Back to top | ||||||
| CL.C116110.VRTESTCD | Viral Resistance Findings Test Code (VRTESTCD) | text Extensible: Yes | C116110 | Viral Resistance Findings Test Code | Terminology used for virology test codes of the CDISC Standard Data Tabulation Model. | CDISC SDTM Viral Resistance Findings Test Code Terminology |
| IC50FCB | C116250 | IC50 Fold Change from Baseline | A fold change based on a concentration of a specific drug expected to produce 50% inhibition of the standard growth of a viral organism, or of a biological/biochemical reaction. It is a ratio calculated by the current IC50 Treatment Result divided by the IC50 Treatment Result from the baseline visit. | Half Maximal Inhibitory Concentration Fold Change from Baseline Measurement | ||
| IC50FCR | C116249 | IC50 Fold Change from Reference | A fold change based on a concentration of a specific drug expected to produce 50% inhibition of the standard growth of a viral organism, or of a biological/biochemical reaction. It is a ratio calculated by the IC50 Treatment Result divided by the IC50 Reference Control Result. | Half Maximal Inhibitory Concentration Fold Change from Reference Measurement | ||
| IC50R | C116248 | IC50 Reference Control Result | A reference control sample response based on a concentration of a specific drug expected to produce 50% inhibition of the standard growth of a viral organism, or of a biological/biochemical reaction. | Half Maximal Inhibitory Concentration Reference Control Result Measurement | ||
| IC50T | C116247 | IC50 Treatment Result | A measurement of titer of a viral organism or biological/biochemical reaction that has been exposed to a concentration of a specific drug expected to produce 50% inhibition of the standard growth of the viral organism, or of a reaction. | Half Maximal Inhibitory Concentration Treatment Result Measurement | ||
| IC95FCB | C116254 | IC95 Fold Change from Baseline | A fold change based on a concentration of a specific drug expected to produce 95% inhibition of the standard growth of a viral organism, or of a biological/biochemical reaction. It is a ratio calculated by the current IC95 Treatment Result divided by the IC95 Treatment Result from the baseline visit. | 95 Percent Maximal Inhibitory Concentration Fold Change from Baseline Measurement | ||
| IC95FCR | C116253 | IC95 Fold Change from Reference | A fold change based on a concentration of a specific drug expected to produce 95% inhibition of the standard growth of a viral organism, or of a biological/biochemical reaction. It is a ratio calculated by the IC95 Treatment Result divided by the IC95 Reference Control Result. | 95 Percent Maximal Inhibitory Concentration Fold Change from Reference Measurement | ||
| IC95R | C116252 | IC95 Reference Control Result | A reference control sample response based on a concentration of a specific drug expected to produce 95% inhibition of the standard growth of a viral organism, or of a biological/biochemical reaction. | 95 Percent Maximal Inhibitory Concentration Reference Control Result Measurement | ||
| IC95T | C116251 | IC95 Treatment Result | A measurement of titer of a viral organism or biological/biochemical reaction that has been exposed to a concentration of a specific drug expected to produce 95% inhibition of the standard growth of the viral organism, or of a reaction. | 95 Percent Maximal Inhibitory Concentration Treatment Result Measurement | ||
| ICNETAS | C116255 | Inhibitory Concentration Net Assessment | An indication of reduced or increased susceptibility of a viral organism, or activity of a biological/biochemical reaction in response to the inhibitory concentration (IC50 and/or IC95) of a specific drug. | Inhibitory Concentration Net Assessment Measurement | ||
| Back to top | ||||||
| CL.C116109.VRTEST | Viral Resistance Findings Test Name (VRTEST) | text Extensible: Yes | C116109 | Viral Resistance Findings Test Name | Terminology used for virology test names of the CDISC Standard Data Tabulation Model. | CDISC SDTM Viral Resistance Findings Test Name Terminology |
| IC50 Fold Change from Baseline | C116250 | IC50 Fold Change from Baseline | A fold change based on a concentration of a specific drug expected to produce 50% inhibition of the standard growth of a viral organism, or of a biological/biochemical reaction. It is a ratio calculated by the current IC50 Treatment Result divided by the IC50 Treatment Result from the baseline visit. | Half Maximal Inhibitory Concentration Fold Change from Baseline Measurement | ||
| IC50 Fold Change from Reference | C116249 | IC50 Fold Change from Reference | A fold change based on a concentration of a specific drug expected to produce 50% inhibition of the standard growth of a viral organism, or of a biological/biochemical reaction. It is a ratio calculated by the IC50 Treatment Result divided by the IC50 Reference Control Result. | Half Maximal Inhibitory Concentration Fold Change from Reference Measurement | ||
| IC50 Reference Control Result | C116248 | IC50 Reference Control Result | A reference control sample response based on a concentration of a specific drug expected to produce 50% inhibition of the standard growth of a viral organism, or of a biological/biochemical reaction. | Half Maximal Inhibitory Concentration Reference Control Result Measurement | ||
| IC50 Treatment Result | C116247 | IC50 Treatment Result | A measurement of titer of a viral organism or biological/biochemical reaction that has been exposed to a concentration of a specific drug expected to produce 50% inhibition of the standard growth of the viral organism, or of a reaction. | Half Maximal Inhibitory Concentration Treatment Result Measurement | ||
| IC95 Fold Change from Baseline | C116254 | IC95 Fold Change from Baseline | A fold change based on a concentration of a specific drug expected to produce 95% inhibition of the standard growth of a viral organism, or of a biological/biochemical reaction. It is a ratio calculated by the current IC95 Treatment Result divided by the IC95 Treatment Result from the baseline visit. | 95 Percent Maximal Inhibitory Concentration Fold Change from Baseline Measurement | ||
| IC95 Fold Change from Reference | C116253 | IC95 Fold Change from Reference | A fold change based on a concentration of a specific drug expected to produce 95% inhibition of the standard growth of a viral organism, or of a biological/biochemical reaction. It is a ratio calculated by the IC95 Treatment Result divided by the IC95 Reference Control Result. | 95 Percent Maximal Inhibitory Concentration Fold Change from Reference Measurement | ||
| IC95 Reference Control Result | C116252 | IC95 Reference Control Result | A reference control sample response based on a concentration of a specific drug expected to produce 95% inhibition of the standard growth of a viral organism, or of a biological/biochemical reaction. | 95 Percent Maximal Inhibitory Concentration Reference Control Result Measurement | ||
| IC95 Treatment Result | C116251 | IC95 Treatment Result | A measurement of titer of a viral organism or biological/biochemical reaction that has been exposed to a concentration of a specific drug expected to produce 95% inhibition of the standard growth of the viral organism, or of a reaction. | 95 Percent Maximal Inhibitory Concentration Treatment Result Measurement | ||
| Inhibitory Concentration Net Assessment | C116255 | Inhibitory Concentration Net Assessment | An indication of reduced or increased susceptibility of a viral organism, or activity of a biological/biochemical reaction in response to the inhibitory concentration (IC50 and/or IC95) of a specific drug. | Inhibitory Concentration Net Assessment Measurement | ||
| Back to top | ||||||
| CL.C66741.VSTESTCD | Vital Signs Test Code (VSTESTCD) | text Extensible: Yes | C66741 | Vital Signs Test Code | The test code given to the test that analyzes a particular set of vital signs including temperature, respiratory rate, heart rate, and blood pressure. | CDISC SDTM Vital Sign Terminology by Code |
| ABSKNF | C103346 | Abdominal Skinfold Thickness | A measurement for determining the subcutaneous fat layer thickness whereby a pinch of skin approximately five centimeters to the right of the umbilicus is measured using calipers. (NCI) | Abdominal Skinfold Thickness | ||
| BMI | C16358 | Body Mass Index | A general indicator of the body fat an individual is carrying based upon the ratio of weight to height. (NCI) | Body Mass Index | ||
| BODLNGTH | C81298 | Body Length | The linear extent in space from one end of the body to the other end, or the extent of the body from beginning to end. | Total Body Length | ||
| BODYFAT | C12472 | Adipose Tissue;Body Fat;Fat Tissue | A specialized form of connective tissue consisting primarily of adipocytes (fat cells), surrounded by a meshwork of collagen fibers. (NCI) | Adipose Tissue | ||
| BSA | C25157 | Body Surface Area | A measure of the 2-dimensional extent of the body surface (i.e., the skin). Body surface area (BSA) can be calculated by mathematical formula or from a chart that relates height to weight. BSA is often an important factor in dosing. (NCI) | Body Surface Area | ||
| DIABP | C25299 | Diastolic Blood Pressure | The blood pressure after the contraction of the heart while the chambers of the heart refill with blood. (NCI) | Diastolic Blood Pressure | ||
| FARMCIR | C100946 | Forearm Circumference | The distance around an individual's forearm. | Forearm Circumference | ||
| FRMSIZE | C49680 | Body Frame Size | The categorization of a person's body frame into small, medium and large based on the measurement of wrist circumference or the breadth of the elbow. (NCI) | Body Frame Size | ||
| HDCIRC | C81255 | Head Circumference | A circumferential measurement of the head at the widest point. | Head Circumference | ||
| HEIGHT | C25347 | Height | The vertical measurement or distance from the base to the top of an object; the vertical dimension of extension. (NCI) | Height | ||
| HIPCIR | C100947 | Hip Circumference | The distance around an individual's pelvic area or hips. | Hip Circumference | ||
| HR | C49677 | Heart Rate | The number of heartbeats per unit of time, usually expressed as beats per minute. (NCI) | Heart Rate | ||
| IDEALWT | C117976 | Ideal Body Weight | A person's optimum weight as calculated by a standard methodology. | Ideal Body Weight | ||
| KNEEHEEL | C84372 | Knee to Heel Length;Lower Leg Length | A measurement of the length of the lower leg from the top of the knee to the bottom of the heel. This measurement may be taken with a knemometer or calipers. (NCI) | Knee to Heel Length Measurement | ||
| LBM | C71258 | Lean Body Mass | The weight of all organs and tissue in an individual less the weight of the individual's body fat. | Lean Body Mass | ||
| MAP | C49679 | Mean Arterial Pressure | The mean pressure of the blood within the arterial circulation. The arterial pressure may be directly measured by insertion of an intra-arterial catheter connected to a transducer. The mean arterial pressure (MAP) can be calculated by subsequent analysis of the waveform. MAP can be approximated without an invasive procedure using the following formula: diastolic pressure plus 1/3 of the pulse pressure, where pulse pressure is systolic pressure - diastolic pressure. (NCI) | Mean Arterial Pressure | ||
| OXYSAT | C60832 | Oxygen Saturation | A measurement of the oxygen-hemoglobin saturation of a volume of blood. | Oxygen Saturation Measurement | ||
| PULSE | C49676 | Pulse Rate | The rate of the pulse as observed in an artery, expressed as beats per minute. It can be measured at several anatomical sites, including the wrist, neck, temple, groin, behind the knees, or on top of the foot. (NCI) | Pulse Rate | ||
| PULSEPR | C100945 | Pulse Pressure | The change in systolic to diastolic pressure which produces a pulse. | Pulse Pressure | ||
| RESP | C49678 | Respiratory Rate | The rate of breathing (inhalation and exhalation) measured within in a unit time, usually expressed as breaths per minute. (NCI) | Respiratory Rate | ||
| SAD | C87054 | Sagittal Abdominal Diameter | A standard measure of visceral obesity, or abdominal fat, which is measured from the patient's back to upper abdomen between the bottom of the rib cage and the top of the pelvic area. This measurement may be taken with the patient standing or in the supine position. (NCI) | Sagittal Abdominal Diameter | ||
| SSSKNF | C98785 | Subscapular Skinfold Thickness | A measurement of the thickness of a pinch of skin situated below or on the underside of the scapula. (NCI) | Subscapular Skinfold Thickness | ||
| SYSBP | C25298 | Systolic Blood Pressure | The blood pressure during the contraction of the left ventricle of the heart. (NCI) | Systolic Blood Pressure | ||
| TBW | C104622 | Total Body Water | A measurement of the quantity of water within the body, including both the intracellular and extracellular compartments. | Total Body Water Measurement | ||
| TEMP | C25206 | Temperature | The property of a body or region of space that determines whether or not there will be a net flow of heat into it or out of it from a neighboring body or region and in which direction (if any) the heat will flow, perceptible by living organism as a somatic sensation of cold or heat. It is a measure of the average translational kinetic energy associated with the disordered microscopic motion of atoms and molecules. Temperature is measured in one of the three standard temperature scales: Celsius, Kelvin, and Fahrenheit. (NCI) | Temperature | ||
| TRSKNF | C98793 | Triceps Skinfold Thickness | A measurement of the thickness of a pinch of skin on the triceps. (NCI) | Triceps Skinfold Thickness | ||
| WEIGHT | C25208 | Weight | The vertical force exerted by a mass as a result of gravity. (NCI) | Weight | ||
| WSTCIR | C100948 | Waist Circumference | The distance around an individual's midsection or waist. | Waist Circumference | ||
| Back to top | ||||||
| CL.C67153.VSTEST | Vital Signs Test Name (VSTEST) | text Extensible: Yes | C67153 | Vital Signs Test Name | The test name given to the test that analyzes a particular set of vital signs including temperature, respiratory rate, heart rate, and blood pressure. | CDISC SDTM Vital Sign Terminology by Name |
| Abdominal Skinfold Thickness | C103346 | Abdominal Skinfold Thickness | A measurement for determining the subcutaneous fat layer thickness whereby a pinch of skin approximately five centimeters to the right of the umbilicus is measured using calipers. (NCI) | Abdominal Skinfold Thickness | ||
| Adipose Tissue | C12472 | Adipose Tissue;Body Fat;Fat Tissue | A specialized form of connective tissue consisting primarily of adipocytes (fat cells), surrounded by a meshwork of collagen fibers. (NCI) | Adipose Tissue | ||
| Body Frame Size | C49680 | Body Frame Size | The categorization of a person's body frame into small, medium and large based on the measurement of wrist circumference or the breadth of the elbow. (NCI) | Body Frame Size | ||
| Body Length | C81298 | Body Length | The linear extent in space from one end of the body to the other end, or the extent of the body from beginning to end. | Total Body Length | ||
| Body Mass Index | C16358 | Body Mass Index | A general indicator of the body fat an individual is carrying based upon the ratio of weight to height. (NCI) | Body Mass Index | ||
| Body Surface Area | C25157 | Body Surface Area | A measure of the 2-dimensional extent of the body surface (i.e., the skin). Body surface area (BSA) can be calculated by mathematical formula or from a chart that relates height to weight. BSA is often an important factor in dosing. (NCI) | Body Surface Area | ||
| Diastolic Blood Pressure | C25299 | Diastolic Blood Pressure | The blood pressure after the contraction of the heart while the chambers of the heart refill with blood. (NCI) | Diastolic Blood Pressure | ||
| Forearm Circumference | C100946 | Forearm Circumference | The distance around an individual's forearm. | Forearm Circumference | ||
| Head Circumference | C81255 | Head Circumference | A circumferential measurement of the head at the widest point. | Head Circumference | ||
| Heart Rate | C49677 | Heart Rate | The number of heartbeats per unit of time, usually expressed as beats per minute. (NCI) | Heart Rate | ||
| Height | C25347 | Height | The vertical measurement or distance from the base to the top of an object; the vertical dimension of extension. (NCI) | Height | ||
| Hip Circumference | C100947 | Hip Circumference | The distance around an individual's pelvic area or hips. | Hip Circumference | ||
| Ideal Body Weight | C117976 | Ideal Body Weight | A person's optimum weight as calculated by a standard methodology. | Ideal Body Weight | ||
| Knee to Heel Length | C84372 | Knee to Heel Length;Lower Leg Length | A measurement of the length of the lower leg from the top of the knee to the bottom of the heel. This measurement may be taken with a knemometer or calipers. (NCI) | Knee to Heel Length Measurement | ||
| Lean Body Mass | C71258 | Lean Body Mass | The weight of all organs and tissue in an individual less the weight of the individual's body fat. | Lean Body Mass | ||
| Mean Arterial Pressure | C49679 | Mean Arterial Pressure | The mean pressure of the blood within the arterial circulation. The arterial pressure may be directly measured by insertion of an intra-arterial catheter connected to a transducer. The mean arterial pressure (MAP) can be calculated by subsequent analysis of the waveform. MAP can be approximated without an invasive procedure using the following formula: diastolic pressure plus 1/3 of the pulse pressure, where pulse pressure is systolic pressure - diastolic pressure. (NCI) | Mean Arterial Pressure | ||
| Oxygen Saturation | C60832 | Oxygen Saturation | A measurement of the oxygen-hemoglobin saturation of a volume of blood. | Oxygen Saturation Measurement | ||
| Pulse Pressure | C100945 | Pulse Pressure | The change in systolic to diastolic pressure which produces a pulse. | Pulse Pressure | ||
| Pulse Rate | C49676 | Pulse Rate | The rate of the pulse as observed in an artery, expressed as beats per minute. It can be measured at several anatomical sites, including the wrist, neck, temple, groin, behind the knees, or on top of the foot. (NCI) | Pulse Rate | ||
| Respiratory Rate | C49678 | Respiratory Rate | The rate of breathing (inhalation and exhalation) measured within in a unit time, usually expressed as breaths per minute. (NCI) | Respiratory Rate | ||
| Sagittal Abdominal Diameter | C87054 | Sagittal Abdominal Diameter | A standard measure of visceral obesity, or abdominal fat, which is measured from the patient's back to upper abdomen between the bottom of the rib cage and the top of the pelvic area. This measurement may be taken with the patient standing or in the supine position. (NCI) | Sagittal Abdominal Diameter | ||
| Subscapular Skinfold Thickness | C98785 | Subscapular Skinfold Thickness | A measurement of the thickness of a pinch of skin situated below or on the underside of the scapula. (NCI) | Subscapular Skinfold Thickness | ||
| Systolic Blood Pressure | C25298 | Systolic Blood Pressure | The blood pressure during the contraction of the left ventricle of the heart. (NCI) | Systolic Blood Pressure | ||
| Temperature | C25206 | Temperature | The property of a body or region of space that determines whether or not there will be a net flow of heat into it or out of it from a neighboring body or region and in which direction (if any) the heat will flow, perceptible by living organism as a somatic sensation of cold or heat. It is a measure of the average translational kinetic energy associated with the disordered microscopic motion of atoms and molecules. Temperature is measured in one of the three standard temperature scales: Celsius, Kelvin, and Fahrenheit. (NCI) | Temperature | ||
| Total Body Water | C104622 | Total Body Water | A measurement of the quantity of water within the body, including both the intracellular and extracellular compartments. | Total Body Water Measurement | ||
| Triceps Skinfold Thickness | C98793 | Triceps Skinfold Thickness | A measurement of the thickness of a pinch of skin on the triceps. (NCI) | Triceps Skinfold Thickness | ||
| Waist Circumference | C100948 | Waist Circumference | The distance around an individual's midsection or waist. | Waist Circumference | ||
| Weight | C25208 | Weight | The vertical force exerted by a mass as a result of gravity. (NCI) | Weight | ||
| Back to top | ||||||
| CL.C117746.HEPENCGR | West Haven Hepatic Encephalopathy Grade (HEPENCGR) | text Extensible: No | C117746 | West Haven Hepatic Encephalopathy Grade | A grading system to describe the severity of hepatic encephalopathy based on the level of mental status by the West Haven Hepatic Encephalopathy Grade. | CDISC SDTM West Haven Hepatic Encephalopathy Grade Terminology |
| GRADE 0 | C117824 | Minimal - symptoms or pathological characteristics include minimal hepatic encephalopathy, lack of detectable changes in personality or behavior, minimal changes in memory, concentration and intellectual function, and absence of coordination asterixis. (Adapted from: Hepatic Encephalopathy. David C Wolf. http://emedicine.medscape.com/article/186101-overview) | West Haven Hepatic Encephalopathy Grade 0 | |||
| GRADE 1 | C117825 | Mild - symptoms or pathological characteristics include trivial lack of awareness, shortened attention span, impaired ability to perform addition or subtraction, hypersomnia, insomnia, or inversion of sleep pattern, euphoria, depression or irritability, mild confusion, slowing of ability to perform mental tasks. (Adapted from: Hepatic Encephalopathy. David C Wolf. http://emedicine.medscape.com/article/186101-overview.) | West Haven Hepatic Encephalopathy Grade 1 | |||
| GRADE 2 | C117826 | Moderate - symptoms or pathological characteristics include lethargy or apathy, disorientation, inappropriate behavior, slurred speech, obvious asterixis, drowsiness, lethargy, gross deficits in ability to perform mental tasks, obvious personality changes, inappropriate behavior, and intermittent disorientation, unsurely regarding time. (Adapted from: Hepatic Encephalopathy. David C Wolf. http://emedicine.medscape.com/article/186101-overview.) | West Haven Hepatic Encephalopathy Grade 2 | |||
| GRADE 3 | C117827 | Severe - symptoms or pathological characteristics include somnolence with some arousability, inability to perform mental tasks, disorientation about time and place, marked confusion, amnesia, occasional fits of rage, present but incomprehensible speech. (Adapted from: Hepatic Encephalopathy. David C Wolf. http://emedicine.medscape.com/article/186101-overview.) | West Haven Hepatic Encephalopathy Grade 3 | |||
| GRADE 4 | C117828 | Coma - symptoms or pathological characteristics include coma with or without response to painful stimuli. (Adapted from: Hepatic Encephalopathy. David C Wolf. http://emedicine.medscape.com/article/186101-overview.) | West Haven Hepatic Encephalopathy Grade 4 | |||
| Back to top | ||||||